PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Sharma, P; Dedeurwaerdere, S; Vandenberg, MAD; Fang, K; Johnston, LA; Shultz, SR; O'Brien, TJ; Gilby, KL				Sharma, Pragati; Dedeurwaerdere, Stefanie; Vandenberg, Michael A. D.; Fang, Ke; Johnston, Leigh A.; Shultz, Sandy R.; O'Brien, Terence J.; Gilby, Krista L.			Neuroanatomical differences in FAST and SLOW rat strains with differential vulnerability to kindling and behavioral comorbidities	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Neurodevelopmental disorders; White matter; Brain morphology; Kindling susceptibility	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ONSET PEDIATRIC EPILEPSY; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; SEIZURE-PRONE; RESISTANT RATS; AUTISM; MRI; ADULTS; VOLUME	Objective: The neurobiological factors underlying a predisposition towards developing epilepsy and its common behavioral comorbidities are poorly understood. FAST rats are a strain that has been selectively bred for enhanced vulnerability to kindling, while the SLOW strain has been bred to be resistant to kindling. FAST rats also exhibit behavioral traits reminiscent of those observed in neurodevelopmental disorders (autism spectrum disorder (ASD)/attention-deficit/hyperactivity disorder (ADHD)) commonly comorbid with epilepsy. In this study, we aimed to investigate neuroanatomical differences between these strains that may be associated with a differential vulnerability towards these interrelated disorders. Methods: Ex vivo high-resolution magnetic resonance imaging on adult male FAST and SLOW rat brains was performed to identify morphological differences in regions of interest between the two strains. Behavioral examination using open-field, water consumption, and restraint tests was also conducted on a subgroup of these rats to document their differential ASD/ADHD-like behavior phenotype. Using optical stereological methods, the volume of cerebellar granule, white matter, and molecular layer and number of Purkinje cells were compared in a separate cohort of adult FAST and SLOW rats. Results: Behavioral testing demonstrated hyperactivity, impulsivity, and polydipsia in FAST versus SLOW rats, consistent with an ASD/ADHD-like phenotype. Magnetic resonance imaging analysis identified brain structural differences in FAST compared with SLOW rats, including increased volume of the cerebrum, corpus callosum, third ventricle, and posterior inferior cerebellum, while decreased volume of the anterior cerebellar vermis. Stereological measurements on histological slices indicated significantly larger white matter layer volume, reduced number of Purkinje cells, and smaller molecular layer volume in the cerebellum in FAST versus SLOW rats. Significance: These findings provide evidence of structural differences between the brains of FAST and SLOW rats that may be mechanistically related to their differential vulnerability to kindling and associated comorbid ASD/ADHD-like behaviors. (C) 2016 Elsevier Inc All rights reserved.	[Sharma, Pragati; Dedeurwaerdere, Stefanie; Shultz, Sandy R.; O'Brien, Terence J.; Gilby, Krista L.] Univ Melbourne, Melbourne Brain Ctr, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Dedeurwaerdere, Stefanie] Univ Antwerp, Dept Translat Neurosci, Antwerp, Belgium; [Johnston, Leigh A.] Univ Melbourne, Dept Elect & Elect Engn, Melbourne, Vic, Australia; [Fang, Ke; Johnston, Leigh A.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Vandenberg, Michael A. D.] Carleton Univ, Dept Neurosci, Ottawa, ON, Canada; [Fang, Ke] Bruker Beijing Sci Technol Co Ltd, Beijing, Peoples R China		Sharma, P (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3010, Australia.	pragatis@student.unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Johnston, Leigh A/D-7102-2014	Johnston, Leigh A/0000-0002-5032-4674; O'Brien, Terence/0000-0002-7198-8621	University of MelbourneUniversity of Melbourne; FWO grantFWO [G058612N]	This work was supported by the University of Melbourne Early Career Research Grant and FWO grant (G058612N) to Prof. Dr. Stefanie Dedeurwaerdere and the University of Melbourne Early Career Research Grant to Dr. Krista Gilby.	Anisman H, 2002, J NEUROSCI, V22, P7809; Araujo D, 2006, EPILEPSIA, V47, P1354, DOI 10.1111/j.1528-1167.2006.00605.x; Bigler ED, 2010, DEV NEUROPSYCHOL, V35, P278, DOI 10.1080/87565641003696817; Chou IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057926; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Ciesielski KT, 1997, NEUROPSYCHOLOGIA, V35, P643, DOI 10.1016/S0028-3932(96)00119-4; Nguyen DK, 2013, CAN J NEUROL SCI, V40, P198, DOI 10.1017/S0317167100013731; Dowell NG, 2016, NMR BIOMED, V29, P614, DOI 10.1002/nbm.3502; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gilby KL, 2005, EPILEPSIA, V46, P3, DOI 10.1111/j.1528-1167.2005.01001.x; Gilby KL, 2007, EPILEPSIA, V48, P114, DOI 10.1111/j.1528-1167.2007.01298.x; Gilby KL, 2007, BEHAV NEUROSCI, V121, P370, DOI 10.1037/0735-7044.121.2.370; Gilmore JH, 2001, SCHIZOPHR RES, V48, P219, DOI 10.1016/S0920-9964(00)00140-7; Hakami T, 2013, NEUROLOGY, V81, P920, DOI 10.1212/WNL.0b013e3182a35193; Hardan AY, 2009, PSYCHIAT RES-NEUROIM, V174, P57, DOI 10.1016/j.pscychresns.2009.03.005; Hardan AY, 2001, J CHILD NEUROL, V16, P421, DOI 10.1177/088307380101600607; HASHIMOTO T, 1995, J AUTISM DEV DISORD, V25, P1, DOI 10.1007/BF02178163; Hermann B, 2007, BRAIN, V130, P3135, DOI 10.1093/brain/awm227; Jackson DC, 2011, EPILEPSIA, V52, P2225, DOI 10.1111/j.1528-1167.2011.03323.x; Kibby MY, 2008, J CHILD NEUROL, V23, P368, DOI 10.1177/0883073807309235; Lewis JD, 2013, HUM BRAIN MAPP, V34, P1685, DOI 10.1002/hbm.22018; Liu RSN, 2002, ANN NEUROL, V52, P573, DOI 10.1002/ana.10338; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Ma C, 2016, EUR J NEUROL; Makris N, 2015, J ATTEN DISORD, V19, P944, DOI 10.1177/1087054713506041; Mostofsky SH, 2007, BRAIN, V130, P2117, DOI 10.1093/brain/awm129; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; O'Dwyer R, 2010, EPILEPSY BEHAV, V19, P376, DOI 10.1016/j.yebeh.2010.06.049; Okano S, 2005, J PHARMACOL SCI, V98, P411, DOI 10.1254/jphs.FP0050353; Okazaki M, 2007, PSYCHIAT CLIN NEUROS, V61, P330, DOI 10.1111/j.1440-1819.2007.01663.x; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Racine RJ, 1999, EPILEPSY RES, V35, P183, DOI 10.1016/S0920-1211(99)00013-3; Reinhart CJ, 2004, DEV PSYCHOBIOL, V45, P83, DOI 10.1002/dev.20016; Sandok EK, 2000, EPILEPSIA, V41, P1315, DOI 10.1111/j.1528-1157.2000.tb04611.x; Sato W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00957; Saute R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095269; Schmitz C, 2005, NEUROSCIENCE, V130, P935, DOI 10.1016/j.neuroscience.2004.08.034; Terai K, 1999, BRAIN DEV-JPN, V21, P103, DOI 10.1016/S0387-7604(98)00079-5; Tosun D, 2011, BRAIN, V134, P1003, DOI 10.1093/brain/awr027; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Wolff JJ, 2015, BRAIN, V138, P2046, DOI 10.1093/brain/awv118; Woolfenden S, 2012, DEV MED CHILD NEUROL, V54, P306, DOI 10.1111/j.1469-8749.2012.04223.x	43	8	8	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	DEC	2016	65						42	48		10.1016/j.yebeh.2016.08.022			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	EG3XB	WOS:000390976900007	27866083				2022-02-06	
J	Yu, YH; Cao, F; Ran, QS; Sun, XC				Yu, Yunhu; Cao, Fang; Ran, Qishan; Sun, Xiaochuan			Regulatory T cells exhibit neuroprotective effect in a mouse model of traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						cytokines; FoxP3; inflammatory response; microglia activation; neuro-protective effect; regulatory T cells; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; MICROGLIAL ACTIVATION; BARRIER PERMEABILITY; SELF-TOLERANCE; NKT CELLS; MODULATION; MECHANISM; CYTOKINES	Traumatic brain injury (TBI) is a major health and socioeconomic problem as it is associated with high rates of mortality and morbidity worldwide. Regulatory T cells (Tregs) have been reported to reduce inflammatory response in several diseases, including myasthenia gravis, viral myocarditis and cerebral infarction. The present study investigated the role of Tregs in mediating neuro-protective effects in a mouse model of TBI. Initially, Treg levels were determined, and compared between the controlled cortical impact (CCI) model for moderate TBI and the sham group, by using flow cytometry and ELISA. Afterwards, the number of Tregs was upregulated (by injection) and downregulated (by depletion), respectively, to elucidate the effect of Tregs in the presence of an inflammatory reaction and a deficient neurological function and consequently, in the prognosis of TBI in the mouse. The expression of pro-inflammatory cytokines [tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6)] and anti-inflammatory cytokines [IL-10, transforming growth factor (TGF)-beta] in blood and brain tissues was also measured in the five groups: Mice receiving a saline injection, mice experiencing Treg depletion, small-dose (SD Tregs, 1.25x10(5)), and mice receiving different doses of Tregs: Moderate-dose (MD Tregs, 2.5x10(5)) and large-dose (LD Tregs, 5x10(5)), using ELISA and PCR. Co-cultures of Tregs and microglia were performed to evaluate the expression of pro-inflammatory cytokines and observe the interaction between the two types of cells. The regulation patterns in JNK-NF-kappa B pathway by Tregs were also evaluated by western blot analysis. Treg levels were significantly reduced in TBI mouse group on the 3rd day after TBI (P<0.05). In the mouse model of TBI, the expression of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6) was enhanced, while the expression of anti-inflammatory cytokines (IL-10, TGF-beta) was reduced (P<0.05). Tregs exhibited a suppressive effect on inflammatory reactions. In the MD group, the activation of microglia cells was markedly inhibited, compared to the activation in SD and LD groups. The expression of ERK1/2, JNK1/2/3 and NK-kappa B was significantly downregulated in the MD group. The results indicated that Tregs exhibited significant neuro-protective effects, suppressing pro-inflammatory responses and promoting tissue repair after TBI injury in the mouse, specifically by deactivating the JNK-NF-kappa B pathway. The results of the study show that Tregs potentially participates in neuro-therapeutic approaches for TBI.	[Yu, Yunhu; Sun, Xiaochuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Cao, Fang] Zunyi Med Coll, Affiliated Hosp 1, Dept Cerebrovasc Dis, Zunyi 563000, Guizhou, Peoples R China; [Ran, Qishan] Zunyi Med Coll, Affiliated Hosp 3, Dept Neurosurg, Zunyi 563000, Guizhou, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China.	sunxiaochuan0709@163.com		sun, xiao chuan/0000-0001-6992-332X	GuiZhou Province Scientific Award for Society Development [SY (2012) 3118]	The present study was supported by GuiZhou Province Scientific Award for Society Development SY (2012) 3118.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Balandina A, 2005, BLOOD, V105, P735, DOI 10.1182/blood-2003-11-3900; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Bassil R, 2011, J IMMUNOL, V187, P2322, DOI 10.4049/jimmunol.1100725; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Denes A, 2010, J NEUROSCI, V30, P10086, DOI 10.1523/JNEUROSCI.1227-10.2010; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Fattorossi A, 2005, IMMUNOLOGY, V116, P134, DOI 10.1111/j.1365-2567.2005.02220.x; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ishibashi S, 2009, J CEREBR BLOOD F MET, V29, P606, DOI 10.1038/jcbfm.2008.153; Ji JX, 2009, INT IMMUNOL, V21, P283, DOI 10.1093/intimm/dxn146; La Cava A, 2006, TRENDS IMMUNOL, V27, P322, DOI 10.1016/j.it.2006.05.003; Li M, 2015, CHINESE MED J-PEKING, V128, P1072, DOI 10.4103/0366-6999.155094; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Liu RL, 2010, EUR J IMMUNOL, V40, P1577, DOI 10.1002/eji.200939792; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Meng X, 2012, MOL MED, V18, P598, DOI 10.2119/molmed.2011.00471; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Scheffold A, 2007, NAT IMMUNOL, V8, P1285, DOI 10.1038/ni1207-1285; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Strisciuglio C, 2010, IMMUNOTHERAPY-UK, V2, P749, DOI [10.2217/imt.10.63, 10.2217/IMT.10.63]; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Whalen MJ, 2000, CRIT CARE MED, V28, P3710, DOI 10.1097/00003246-200011000-00029; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Zhang Q, 2013, J MOL CELL BIOL, V5, P85, DOI 10.1093/jmcb/mjs063; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	37	8	9	1	12	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	DEC	2016	14	6	B				5556	5566		10.3892/mmr.2016.5954			11	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	EG5HZ	WOS:000391076200018	27878274	hybrid, Green Published, Green Submitted			2022-02-06	
J	Cikriklar, HI; Uysal, O; Ekici, MA; Ozbek, Z; Cosan, DT; Yucel, M; Yurumez, Y; Baydemir, C				Cikriklar, Halil Ibrahim; Uysal, Onur; Ekici, Mehmet Ali; Ozbek, Zuhtu; Turgut Cosan, Didem; Yucel, Murat; Yurumez, Yusuf; Baydemir, Canan			Effectiveness of GFAP in Determining Neuronal Damage in Rats with Induced Head Trauma	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Experimental; GFAP; Astrocyte; Rat	FIBRILLARY ACIDIC PROTEIN; COMA SCALE SCORE; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; CHILDREN; MODEL; CT; EXPRESSION; ASTROGLIOSIS	AIM: To determine whether the serum level of glial fibrillary acidic protein (GFAP), an important indicator of neuron damage, correlates with the extent of tissue damage in the rat with induced head trauma and to obtain data in order to avoid unnecessary cranial computed tomography analyses. MATERIAL and METHODS: Three-month-old male Sprague-Dawley rats were used. Rats were divided into 5 groups. The experimental head trauma model was examined in five groups (n=8) as follows: The control group had no intervention; Group 1: Head trauma was induced by dropping a 25 mg ball from a height of 20 cm; Group 2: Head trauma was induced by dropping a 50 mg ball from a height of 20 cm; Group 3: Head trauma was induced by dropping a 50 mg ball from a height of 80 cm; Group 4: Head trauma was induced by dropping a 100 mg ball from a height of 80 cm. Thus, according to the Newton's Law, respectively 0.05, 0.1, 0.2 and 0.4 N trauma was created. Serum GFAP levels were analyzed and the damage to cerebral tissues was evaluated in all groups. RESULTS: We determined that number of apoptotic cells and particularly the number of GFAP (+) protoplasmic astrocytes at the perilesional region of the cortex increased in association with the increased serum GFAP level as long as the severity of the trauma increased. CONCLUSION: Serum GFAP concentration can be used as a marker of the severity of head trauma and traumatic brain injury. However, more animal studies are required to reflect this result in clinical practice.	[Cikriklar, Halil Ibrahim; Yucel, Murat; Yurumez, Yusuf] Sakarya Univ, Sch Med, Dept Emergency Med, Sakarya, Turkey; [Uysal, Onur] Eskisehir Osmangazi Univ, Vocat Sch Hlth Serv, Eskisehir, Turkey; [Ekici, Mehmet Ali] Sevket Yilmaz Res & Training Hosp, Neurosurg Clin, Bursa, Turkey; [Ozbek, Zuhtu] Eskisehir Osmangazi Univ, Sch Med, Dept Neurosurg, Eskisehir, Turkey; [Turgut Cosan, Didem] Eskisehir Osmangazi Univ, Sch Med, Dept Med Biol, Eskisehir, Turkey; [Baydemir, Canan] Eskisehir Osmangazi Univ, Sch Med, Dept Biostat, Eskisehir, Turkey		Ekici, MA (corresponding author), Sevket Yilmaz Res & Training Hosp, Neurosurg Clin, Bursa, Turkey.	mehmetali.ekici@gmail.com	Ekici, Mehmet Ali/ABE-1571-2020; YURUMEZ, YUSUF/AAC-3612-2021; Yurumez, Yusuf/AAF-8670-2021; cikriklar, halil ibrahim/AAH-8714-2021; Cosan, Didem Turgut/ABC-1466-2020; UYSAL, ONUR/W-4144-2017	Cosan, Didem Turgut/0000-0002-8488-6405; UYSAL, ONUR/0000-0001-6800-5607			Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Ananiadou Olga G, 2005, Interact Cardiovasc Thorac Surg, V4, P597; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Conroy BP, 2001, ANN THORAC SURG, V71, P1325, DOI 10.1016/S0003-4975(01)02401-8; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; GALEA E, 1995, J NEUROSCI RES, V41, P452, DOI 10.1002/jnr.490410404; Goodwin V, 2001, CURR PEDIAT, V11, P420; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Gurses Dolunay, 2002, Ulus Travma Derg, V8, P156; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Holmes JF, 1997, ACAD EMERG MED, V4, P788, DOI 10.1111/j.1553-2712.1997.tb03786.x; Huang W, 1999, EUR J PHARMACOL, V366, P127, DOI 10.1016/S0014-2999(98)00929-7; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P166, DOI 10.5505/tjtes.2011.22800; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P46, DOI 10.5505/tjtes.2011.57431; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kalayci M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-75; Karasu A, 2009, ULUS TRAVMA ACIL CER, V15, P159; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lafuente JV, 2007, NEUROSCI RES, V57, P354, DOI 10.1016/j.neures.2006.11.005; Li FH, 2002, AM J NEURORADIOL, V23, P180; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Mirzai Hasan, 2005, Ulus Travma Acil Cerrahi Derg, V11, P146; Missler U, 1999, CLIN CHEM, V45, P138; Olshaker Jonathan S., 1993, Emergency Medicine Clinics of North America, V11, P165; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Quayle KS, 1999, PEDIATR CLIN N AM, V46, P1189, DOI 10.1016/S0031-3955(05)70182-6; Reed MJ, 2005, ARCH DIS CHILD, V90, P859, DOI 10.1136/adc.2004.053603; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Silva DD, 2012, ACTA CIR BRAS, V27, P290; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Turedi S, 2008, J EMERG MED, V34, P253, DOI 10.1016/j.jemermed.2007.05.055; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Woodcock RJ, 2001, SEMIN ULTRASOUND CT, V22, P162, DOI 10.1016/S0887-2171(01)90043-5; Woolard DJ, 1994, J EMERGENCY MED, V12, P435; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c	58	8	9	0	7	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	NOV	2016	26	6					878	889		10.5137/1019-5149.JTN.13946-15.2			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EB3XI	WOS:000387302000012	27509453	Bronze			2022-02-06	
J	Kuo, CL; Chen, TL; Liao, CC; Yeh, CC; Chou, CL; Lee, WR; Lin, JG; Shih, CC				Kuo, C. L.; Chen, T. L.; Liao, C. C.; Yeh, C. C.; Chou, C. L.; Lee, W. R.; Lin, J. G.; Shih, C. C.			Birth month and risk of atopic dermatitis: a nationwide population-based study	ALLERGY			English	Article						atopic dermatitis; birth month	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; ADVERSE OUTCOMES; BULIMIA-NERVOSA; DISEASE; PREVALENCE; CHILDREN; COHORT; AGE; SCHOOLCHILDREN	BackgroundAn individual's birth month has been associated with allergic diseases, but little is known about the association between birth month and atopic dermatitis (AD). ObjectiveThe aim of this study was to investigate the risk of AD in children born in various months. MethodsUsing Taiwan's National Health Insurance Research Database, we conducted a case-control study that included 31 237 AD cases and 124 948 age- and gender-matched controls without AD. Data regarding sociodemographic factors and coexisting medical conditions were collected and controlled in the multivariate logistic regression to determine the adjusted odds ratios and 95% confidence intervals for AD associated with the participant's birth month. ResultsCompared with people born in May, people born in December had the highest risk of AD (OR 1.17, 95% CI 1.10-1.25), followed by people born in October (OR 1.15, 95% CI 1.08-1.22) and November (OR 1.13, 95% CI 1.06-1.20). Low income (OR 1.28), asthma (OR 1.88), allergic rhinitis (OR 1.70), psoriasis (OR 2.36), vitiligo (OR 1.99), urticaria (OR 2.14), and systemic lupus erythematosus (OR 1.91) were significant coexisting medical conditions associated with AD. ConclusionBeing born in December, October, or November may be associated with an increased risk of AD. Future investigations are needed to evaluate the possible mechanism behind the association between birth month and AD.	[Kuo, C. L.; Liao, C. C.; Lin, J. G.] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Chen, T. L.; Liao, C. C.] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, T. L.; Liao, C. C.] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, T. L.; Liao, C. C.] Taipei Med Univ, Dept Anesthesiol, Sch Med, Coll Med, Taipei, Taiwan; [Yeh, C. C.] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, C. C.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Chou, C. L.; Lee, W. R.] Taipei Med Univ, Dept Dermatol, Shuang Ho Hosp, New Taipei, Taiwan; [Lin, J. G.] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Shih, C. C.] I Shou Univ, Sch Chinese Med Postbaccalaureate, 8 Yida Rd, Kaohsiung 824, Taiwan; [Shih, C. C.] Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan		Shih, CC (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, 8 Yida Rd, Kaohsiung 824, Taiwan.	hwathai@seed.net.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP99-RD-035]; Taiwan Ministry of Science and Technology [MOST104-2314-B-038-027-MY2, MOST103-2320-B-214-010-MY2, NSC102-2314-B-038-021-MY3]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	This study was supported in part by the Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (CCMP99-RD-035); Taiwan Ministry of Science and Technology (MOST104-2314-B-038-027-MY2; MOST103-2320-B-214-010-MY2; NSC102-2314-B-038-021-MY3); the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).	Andersson NW, 2016, ALLERGY, V71, P15, DOI 10.1111/all.12762; Bohme M, 2002, ACTA DERM-VENEREOL, V82, P98, DOI 10.1080/00015550252948112; Boland MR, 2015, J AM MED INFORM ASSN, V22, P1042, DOI 10.1093/jamia/ocv046; Brewerton TD, 2012, INT J EAT DISORDER, V45, P131, DOI 10.1002/eat.20898; DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569; Disanto G, 2011, BRIT J PSYCHIAT, V198, P404, DOI 10.1192/bjp.bp.110.085944; Fuertes E, 2015, ALLERGY, V70, P873, DOI 10.1111/all.12609; Gardener H, 2010, MOVEMENT DISORD, V25, P1560, DOI 10.1002/mds.23339; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Javaras KN, 2011, INT J EAT DISORDER, V44, P630, DOI 10.1002/eat.20864; Kahn HS, 2009, DIABETES CARE, V32, P2010, DOI 10.2337/dc09-0891; Kusunoki T, 1999, J ALLERGY CLIN IMMUN, V103, P1148, DOI 10.1016/S0091-6749(99)70191-0; Lee JH, 2012, ASIA PAC ALLERGY, V2, P59, DOI 10.5415/apallergy.2012.2.1.59; Levitan RD, 2010, NEUROPSYCHOPHARMACOL, V35, P1729, DOI 10.1038/npp.2010.38; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; McDowell TY, 2010, NEUROEPIDEMIOLOGY, V34, P238, DOI 10.1159/000297749; Messias E, 2006, J NERV MENT DIS, V194, P870, DOI 10.1097/01.nmd.0000243762.63694.e6; Nagamine Satomi, 2011, Open Orthop J, V5, P134, DOI 10.2174/1874325001105010134; Naldi L, 2009, ACTA DERM-VENEREOL, V89, P122, DOI 10.2340/00015555-0591; Ohmachi N, 1994, Arerugi, V43, P796; Pomeroy E, 2014, AM J PHYS ANTHROPOL, V154, P115, DOI 10.1002/ajpa.22484; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Seiffert K, 2005, DERMATOLOGY, V210, P286, DOI 10.1159/000084752; Smit LAM, 2015, ALLERGY, V70, P653, DOI 10.1111/all.12605; Staples J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1640; Tobin MC, 2008, ANN ALLERG ASTHMA IM, V100, P49, DOI 10.1016/S1081-1206(10)60404-8; Vassallo MF, 2010, ANN ALLERG ASTHMA IM, V104, P307, DOI 10.1016/j.anai.2010.01.019; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	33	8	9	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	NOV	2016	71	11					1626	1631		10.1111/all.12954			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	DZ7YD	WOS:000386083700013	27286483				2022-02-06	
J	Leung, LY; Deng-Bryant, Y; Cardiff, K; Winter, M; Tortella, F; Shear, D				Leung, Lai Yee; Deng-Bryant, Ying; Cardiff, Katherine; Winter, Megan; Tortella, Frank; Shear, Deborah			Neurochemical changes following combined hypoxemia and hemorrhagic shock in a rat model of penetrating ballistic-like brain injury: A microdialysis study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Cerebral glucose metabolism; hemorrhagic shock; hypoxemia; intracerebral microdialysis; traumatic brain injury	POSITRON-EMISSION-TOMOGRAPHY; TISSUE OXYGEN-TENSION; EXTRACELLULAR GLUCOSE; CEREBRAL METABOLISM; HYPOXIA-HYPOTENSION; HEAD-INJURY; ISCHEMIA; LACTATE; TRAUMA; HYPERGLYCOLYSIS	BACKGROUND Energy metabolic dysfunction is a key determinant of cellular damage following traumatic brain injury and may be worsened by additional insults. This study evaluated the acute/subacute effects of combined hypoxemia (HX) and hemorrhagic shock (HS) on cerebral interstitial levels of glucose, lactate, and pyruvate in a rat model of penetrating ballistic-like brain injury (PBBI). METHODS Rats were randomly assigned into the sham control, PBBI, and combined injury (P + HH) groups. The P + HH group received PBBI followed by 30-minute HX and 30 minute HS. Samples were collected from striatum (perilesional region) using intracerebral microdialysis at 1 to 3 hours after injury and then at 1 to 3, 7, and 14 days after injury. Glucose, lactate, and pyruvate were measured in the dialysate samples. RESULTS Glucose levels dropped significantly up to 24 hours following injury in both PBBI and P + HH groups (p < 0.05). A reduction in pyruvate was observed in the PBBI group from 24 to 72 hours after injury (vs. sham). In the P + HH group, the pyruvate was significantly reduced from 2 to 24 hours after injury (p < 0.05 vs. PBBI). This prominent reduction persisted for 14 days after injury. In contrast, lactate levels were significantly increased in the PBBI group during the first 24 hours after injury and remained elevated out to 7 days. The P + HH group exhibited a similar trend of lactate increase as did the PBBI group. Critically, P + HH further increased the lactate-to-pyruvate ratio by more than twofold (vs. PBBI) during the first 24 hours. The ratio reached a peak at 2 hours and then gradually decreased, but the level remained significantly higher than that in the sham control from 2 to 14 days after injury (p < 0.05). CONCLUSION This study identified the temporal profile of energy-related neurochemical dysregulation induced by PBBI and combined injury in the perilesional region. Furthermore, combined HX and HS further reduced the pyruvate level and increased the lactate-to-pyruvate ratio following PBBI, indicating the exacerbation of posttraumatic metabolic perturbation.	[Leung, Lai Yee; Deng-Bryant, Ying; Cardiff, Katherine; Winter, Megan; Tortella, Frank; Shear, Deborah] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		Leung, LY (corresponding author), 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	laiyee.leung.ctr@mail.mil			Combat Casualty Care Research ProgramUnited States Department of Defense	This research is funded by the Combat Casualty Care Research Program.	ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Berg J.M, 2002, BIOCHEMISTRY-US; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blanie A, 2012, J NEUROTRAUM, V29, P2782, DOI 10.1089/neu.2012.2381; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; D'Alessandro A, 2015, AM J PHYSIOL-REG I, V308, pR1034, DOI 10.1152/ajpregu.00030.2015; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gajavelli S, 2015, J CEREBR BLOOD F MET, V35, P773, DOI 10.1038/jcbfm.2014.243; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Geeraerts T, 2006, J NEUROTRAUM, V23, P1059, DOI 10.1089/neu.2006.23.1059; GIBSON GE, 1981, AM J MED, V70, P1247, DOI 10.1016/0002-9343(81)90834-2; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Leung LY, 2006, NEUROSCI LETT, V397, P135, DOI 10.1016/j.neulet.2005.12.006; Levin BE, 2011, ENDOCRINOLOGY, V152, P2552, DOI 10.1210/en.2011-0194; MACMILLAN V, 1972, SCAND J CLIN LAB INV, V30, P127, DOI 10.3109/00365517209081101; MACNEILL C, 1988, J CEREBR BLOOD F MET, V8, P495, DOI 10.1038/jcbfm.1988.90; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Robertson CS, 1998, NEUROL RES, V20, pS91; Salci K, 2010, UPSALA J MED SCI, V115, P221, DOI 10.3109/03009734.2010.503906; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tortella FC, 2015, SHOCK, V44, P17, DOI 10.1097/SHK.0000000000000380; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	41	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2016	81	5					860	867		10.1097/TA.0000000000001206			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EC0IG	WOS:000387782800009	27769083				2022-02-06	
J	Livingstone, LT; Coventry, WL; Corley, RP; Willcutt, EG; Samuelsson, S; Olson, RK; Byrne, B				Livingstone, Luisa T.; Coventry, William L.; Corley, Robin P.; Willcutt, Erik G.; Samuelsson, Stefan; Olson, Richard K.; Byrne, Brian			Does the Environment Have an Enduring Effect on ADHD? A Longitudinal Study of Monozygotic Twin Differences in Children	JOURNAL OF ABNORMAL CHILD PSYCHOLOGY			English	Article						ADHD; Environment; Genetics; Longitudinal; Twins	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; STATE-OCCASION MODEL; LOW-BIRTH-WEIGHT; ATTENTION PROBLEMS; SYMPTOM DIMENSIONS; ASSOCIATION; PRESCHOOL; AGE; ADOLESCENCE	Environmental factors play a key role in the development of Attention-Deficit/Hyperactivity Disorder (ADHD), but the long-term effects of these factors are still unclear. This study analyses data from 1024 monozygotic (identical) twins in Australia, the United States, and Scandinavia who were assessed for ADHD in Preschool, Kindergarten, Grade 1, and Grade 2. Differences within each twin pair were used as a direct measure of non-shared environmental effects. The Trait-State-Occasion (TSO) model developed by Cole et al. (Psychological Methods, 10, 3-20, 2005) was used to separate the non-shared environmental effects into stable factors, and transient factors that excluded measurement error. Stable factors explained, on average, 44 % and 39 % of the environmental variance in hyperactive-impulsive and inattentive symptoms, respectively. Transient effects explained the remaining 56 % and 60 % of variance. The proportion of stable variance was higher than expected based on previous research, suggesting promise for targeted interventions if future research identifies these stable risk factors.	[Livingstone, Luisa T.; Coventry, William L.; Byrne, Brian] Univ New England, Sch Behav Cognit & Social Sci, Armidale, NSW, Australia; [Corley, Robin P.; Willcutt, Erik G.; Olson, Richard K.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Samuelsson, Stefan] Linkoping Univ, Dept Behav Sci, Linkoping, Sweden; [Samuelsson, Stefan] Stavanger Univ, Natl Ctr Reading Educ & Res, Stavanger, Norway		Livingstone, LT (corresponding author), Univ New England, Sch Behav Cognit & Social Sci, Armidale, NSW, Australia.	luisa.livingstone@gmail.com		Coventry, William/0000-0003-0864-5463	Australian Research CouncilAustralian Research Council [A79906201, DP0770805, DP0663498]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2 P50 HD27802, 1 R01 HD38526]; Research Council of NorwayResearch Council of Norway [154715/330]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [345-2002-3701]; University of Stavanger; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD038526] Funding Source: NIH RePORTER	This research is being conducted with the support of the Australian Research Council (A79906201, DP0770805, and DP0663498), the National Institutes of Health (2 P50 HD27802 and 1 R01 HD38526), the Research Council of Norway (154715/330), the Swedish Research Council (345-2002-3701), and the University of Stavanger. We are grateful to the many twins, their families, and the twins' teachers for their participation, and to the Colorado and Australian Twin Registries.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arbuckle JL., 2011, IBM SPSS AMOS 20 USE; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2015, ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS AND CHILDREN, P53; Barkley Russell Alan, 2006, ATTENTION DEFICIT HY, V3rd; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Breslau N, 1996, J ABNORM CHILD PSYCH, V24, P385, DOI 10.1007/BF01441637; Byrne B, 2002, ANN DYSLEXIA, V52, P49; Byrne B., 2012, MULTIVARIATE APPL SE; Chen J, 2010, TWIN RES HUM GENET, V13, P194, DOI 10.1375/twin.13.2.194; Cole DA, 2005, PSYCHOL METHODS, V10, P3, DOI 10.1037/1082-989X.10.1.3; Cole DA, 2008, J ABNORM PSYCHOL, V117, P16, DOI 10.1037/0021-843X.117.1.16; Cole DA, 2006, INT J BEHAV DEV, V30, P20, DOI 10.1177/0165025406059969; DANFORTH JS, 1991, CLIN PSYCHOL REV, V11, P703, DOI 10.1016/0272-7358(91)90127-G; Donnellan MB, 2012, J RES PERS, V46, P634, DOI 10.1016/j.jrp.2012.07.005; Friedman-Weieneth JL, 2009, J ATTEN DISORD, V13, P42, DOI 10.1177/1087054708322991; Graetz BW, 2001, J AM ACAD CHILD PSY, V40, P1410, DOI 10.1097/00004583-200112000-00011; Greven CU, 2011, J ABNORM CHILD PSYCH, V39, P623, DOI 10.1007/s10802-011-9513-7; Groen-Blokhuis MM, 2011, J AM ACAD CHILD PSY, V50, P1247, DOI 10.1016/j.jaac.2011.09.007; Gupta R, 2009, PROG BRAIN RES, V176, P259, DOI 10.1016/S0079-6123(09)17614-8; Hatton H, 2008, J FAM PSYCHOL, V22, P448, DOI 10.1037/0893-3200.22.3.448; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IBM, 2010, DIFF FIML FULL INF M; IBM Corp, 2011, IBM SPSS AM VERS 20; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; Jepsen JRM, 2006, NORD PSYCHOL, V58, P108, DOI 10.1027/1901-2276.58.2.108; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Lahey BB, 2005, ARCH GEN PSYCHIAT, V62, P896, DOI 10.1001/archpsyc.62.8.896; Leslie DL, 2008, J AM ACAD CHILD PSY, V47, P1166, DOI 10.1097/CHI.0b013e3181825a3d; Luhmann M, 2011, J RES PERS, V45, P186, DOI 10.1016/j.jrp.2011.01.004; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2003, J INT NEUROPSYCH SOC, V9, P815, DOI 10.1017/S1355617703960012; Mullane JC, 2011, J ATTEN DISORD, V15, P310, DOI 10.1177/1087054710366384; National Health and Medical Research Council, 2009, AUSTR GUID IN PRESS; NICHOLS RC, 1966, ACTA GENET STAT MED, V16, P265; Nigg JT, 2010, J CHILD PSYCHOL PSYC, V51, P58, DOI 10.1111/j.1469-7610.2009.02135.x; Nikolas MA, 2010, J ABNORM PSYCHOL, V119, P1, DOI 10.1037/a0018010; Olatunji BO, 2009, PSYCHOL ASSESSMENT, V21, P412, DOI 10.1037/a0016206; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; PLOMIN R, 2008, BEHAV GENETICS; Posner M. I., 2014, ADV NEUROSCIENCE; Prenoveau JM, 2011, J ABNORM PSYCHOL, V120, P832, DOI 10.1037/a0023939; Price TS, 2005, BEHAV GENET, V35, P121, DOI 10.1007/s10519-004-1013-x; Rietveld MJH, 2004, J CHILD PSYCHOL PSYC, V45, P577, DOI 10.1111/j.1469-7610.2004.00247.x; Sagiv SK, 2013, J ATTEN DISORD, V17, P47, DOI 10.1177/1087054711427563; Schaufeli WB, 2011, J OCCUP ORGAN PSYCH, V84, P248, DOI 10.1111/j.2044-8325.2010.02013.x; Schmitt N, 2008, HUM RESOUR MANAGE R, V18, P210, DOI 10.1016/j.hrmr.2008.03.003; University of Texas, 2012, STRUCT EQ MOD US AMO; Wymbs BT, 2015, J ABNORM CHILD PSYCH, V43, P107, DOI 10.1007/s10802-014-9887-4; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	54	8	8	1	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0091-0627	1573-2835		J ABNORM CHILD PSYCH	J. Abnorm. Child Psychol.	NOV	2016	44	8					1487	1501		10.1007/s10802-016-0145-9			15	Psychology, Clinical; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	DZ8JM	WOS:000386116700004	26993487	Green Accepted			2022-02-06	
J	Lopez, OS; Springer, SB; Nelson, JB				Lopez, Omar S.; Springer, Stephen B.; Nelson, Jeffrey B.			Veterans in the College Classroom Guidelines for Instructional Practices	ADULT LEARNING			English	Article						veterans; traumatic brain injury; post-traumatic stress disorder; instructional practices		Post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) remain central topics in institutions' efforts to address student veteran needs. From the authors' experiences with student veterans, they present the five principles of effective instructional practice identified by the National Research Council (NRC) within the context of college teaching. The purpose of this article is to inform faculty of the benefits of implementing these principles, thereby increasing the likelihood of academic success for all students, especially student veterans.	[Lopez, Omar S.] Texas State Univ Round Rock, Round Rock, TX 78665 USA; [Springer, Stephen B.; Nelson, Jeffrey B.] Texas State Univ San Marcos, San Marcos, TX USA		Lopez, OS (corresponding author), Texas State Univ Round Rock, Dept Occupat Workforce & Leadership Studies, 1555 Univ Blvd, Round Rock, TX 78665 USA.	oil4@txstate.edu		Lopez, Omar/0000-0001-8952-4035			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson L. W., 2001, TAXONOMY LEARNING TE; [Anonymous], 2012, BLOG POST; ARKIN W, 1978, J SOC ISSUES, V34, P151, DOI 10.1111/j.1540-4560.1978.tb02546.x; Arnold K., 2005, DESIGNING EFFECTIVE; Boice R., 1998, TEACHING LEARNING CO, P347; Congressional Budget Office, 2012, VET HLTH ADM TREATM, DOI [11-2012/reports/02-09-PTSD_0.pdf, DOI 11-2012/REPORTS/02-09-PTSD_0.PDF]; Coppola B. P., 2002, J COLL SCI TEACH, V31, P448; Defense and Veterans Brain Injury Center, 2012, TRAUM BRAIN INJ GUID; Dunbar C, 2004, BEST PRACTICES CLASS; Fink L. D., 2003, CREATING SIGNIFICANT; Hall JC, 2009, SMITH COLL STUD SOC, V79, P335, DOI 10.1080/00377310903115465; Hay J., 2009, COMMUNICATION   0429; James W. B., 1985, LIFELONG LEARNING, V3, P214; Kim Y., 2009, SOLDIER STUDENT EASI; Krathwohl DR., 1956, TAXONOMY ED OBJECTIV; McBain L., 2012, SOLDIER STUDENT 2 AS; Merriam S.B., 2007, LEARNING ADULTHOOD C; National Center for PTSD, 2012, RET WAR ZON GUID FAM; National Institute for Staff and Organizational Development, 2013, INNOVATION ABSTRACTS, VXXXV; National Research Council, 2000, PEOPLE LEARN BRAIN M; Needleman M., 2007, BLOG POST; Odom S, 2009, INT J TEACHING LEARN, V21, P108; Orlich D., 2004, TEACHING STRATEGIES; Ormiston M., 2011, CREATING DIGITAL RIC; Palmer P.J., 1998, COURAGE TEACH EXPLOR; Pashler Harold, 2008, Psychol Sci Public Interest, V9, P105, DOI 10.1111/j.1539-6053.2009.01038.x; Pham H. L., 2011, J COLL TEACH LEARN, V9, P13, DOI [10.19030/tlc.v9i1.6710, DOI 10.19030/TLC.V9I1.6710]; Popp PA, 2011, J EDUC STUDENTS PLAC, V16, P275, DOI 10.1080/10824669.2011.610236; Pressley M., 2008, J ED, V189, P77; Quinn E., 2013, VISUALIZATION TECHNI; Reeves TC, 2006, INT J LEARN TECHNOL, V2, P294, DOI 10.1504/IJLT.2006.011336; SHANNON SV, 2008, I LEARNING STYLES J, V1, P14; Snyder T. D., 2012, 2012001 NCES I ED; Sorcinelli M. D., 2002, ENGAGING LARGE CLASS, P44; Stronge J. H., 2007, QUALITIES EFFECTIVE; Sweitzer H Frederick, 2003, J Contin Educ Nurs, V34, P263; SWEITZER HF, 1990, HUMAN SERVICE ED, V10, P39; Thompson M., 2003, LEARNING FOCUSED STR; U. S. Department of Veterans Affairs, 2012, DEP VET AFF ED PROGR; Wiggins G.P., 2005, UNDERSTANDING DESIGN; Wlodkowski RJ, 1995, DIVERSITY MOTIVATION; Zinger Lana, 2010, CONT ISSUES ED RES, V3, P39, DOI DOI 10.19030/CIER.V3I1.160	44	8	8	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1045-1595	2162-4070		ADULT LEARN	Adult Learn.	NOV	2016	27	4					143	151		10.1177/1045159515601825			9	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VH3MQ	WOS:000452807800001					2022-02-06	
J	Sutherland, MA; Watson, TJ; Johnson, CB; Millman, ST				Sutherland, M. A.; Watson, T. J.; Johnson, C. B.; Millman, S. T.			Evaluation of the efficacy of a non-penetrating captive bolt to euthanase neonatal goats up to 48 hours of age	ANIMAL WELFARE			English	Article						animal welfare; electroencephalogram; euthanasia; goats; insensibility; non-penetrating captive bolt	ELECTROENCEPHALOGRAPHY EEG; CERVICAL DISLOCATION; BLUNT TRAUMA; SLAUGHTER; BRAIN; INSENSIBILITY; CALVES; RESPONSES; BEHAVIOR; TURKEYS	Manual blunt force trauma is a common method of euthanasia or culling of goat kids, however it is difficult to apply consistently and may vary in effectiveness. Therefore, a controlled mechanical method is needed. The overall objective of this research was to evaluate the effectiveness of a non-penetrating captive bolt (NPCB) to euthanase goats (Capra hircus) up to 48 h of age. In a pilot study (n = 27), the optimum anatomical site for placement of the NPCB was evaluated using signs of insensibility and death, and post mortem assessment of traumatic brain injury. Three different anatomical sites (frontal bone, poll or behind the poll) were evaluated. In Experiment 1 (n = 100), goats were euthanased using the optimum anatomical placement determined in the pilot study and the presence of brainstem reflexes, rhythmic respiration, convulsions and cardiac activity were recorded. In Experiment 2 (n = 7), electroencephalogram (EEG) was recorded to assess awareness following application of the NPCB. Results from the pilot study showed that immediate insensibility followed by death was achieved when the muzzle of the NPCB was positioned behind the poll and the goat's head was bent so that the chin touched the chest. In Experiment 1, all goats were rendered immediately insensible without return to sensibility prior to cessation of cardiac activity. In Experiment 2, application of the NPCB resulted in the immediate onset of EEG activity which was incompatible with awareness. In conclusion, the NPCB reliably caused immediate insensibility and death in goats up to 48 h of age.	[Sutherland, M. A.; Watson, T. J.] AgResearch, Ruakura Res Ctr, Hamilton 3240, New Zealand; [Johnson, C. B.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North 4442, New Zealand; [Millman, S. T.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA		Sutherland, MA (corresponding author), AgResearch, Ruakura Res Ctr, Hamilton 3240, New Zealand.	mhairi.sutherland@agresearch.co.nz			New Zealand Ministry of Business, Innovation and EmploymentNew Zealand Ministry of Business, Innovation and Employment (MBIE) [C10X1307]	Funding was provided by the New Zealand Ministry of Business, Innovation and Employment (C10X1307). We would also like to thank the Dairy Goat Co-operative (NZ) Ltd and suppliers for their input into this project. In addition, the authors gratefully acknowledge the assistance from AgResearch staff especially Gemma Lowe and Stephanie Delaney, and Alan Julian from New Zealand Veterinary Pathology Ltd (Hamilton, New Zealand).	American Veterinary Medical Association, 2013, AVMA GUIDELINES EUTH; BAGER F, 1992, RES VET SCI, V52, P162, DOI 10.1016/0034-5288(92)90005-M; Blackmore D.W., 1988, SLAUGHTER STOCK PRAC; BLACKMORE DK, 1982, MEAT SCI, V7, P19, DOI 10.1016/0309-1740(82)90094-8; BLACKMORE DK, 1984, RES VET SCI, V37, P223, DOI 10.1016/S0034-5288(18)31909-X; Casey-Trott TM, 2014, J ANIM SCI, V92, P5166, DOI 10.2527/jas.2014-7980; Casey-Trott TM, 2013, J ANIM SCI, V91, P5477, DOI 10.2527/jas.2013-6320; COOPER DKC, 1989, ANN ROY COLL SURG, V71, P261; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Finnie JW, 2000, AUST VET J, V78, P775, DOI 10.1111/j.1751-0813.2000.tb10451.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Ganong W.F., 1993, REV MED PHYSL; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2009, NEW ZEAL VET J, V57, P77, DOI 10.1080/00480169.2009.36882; Gilliam JN, 2012, ANIM WELFARE, V21, P99, DOI 10.7120/096272812X13353700593806; Grandin T, 2010, MEAT SCI, V86, P56, DOI 10.1016/j.meatsci.2010.04.022; Gregory NG, 2005, MEAT SCI, V70, P481, DOI 10.1016/j.meatsci.2004.06.026; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Humane Slaughter Association, 2008, CAPTIVE BOLT STUNNIN; Murrell JC, 2006, J VET PHARMACOL THER, V29, P325, DOI 10.1111/j.1365-2885.2006.00758.x; Rault JL, 2014, ANIM WELFARE, V23, P391, DOI 10.7120/09627286.23.4.391; Rault JL, 2015, PHYSIOL BEHAV, V151, P29, DOI 10.1016/j.physbeh.2015.06.026; Sadler LJ, 2014, J ANIM SCI, V92, P793, DOI 10.2527/jas.2013-6598; Sandercock DA, 2014, PHYSIOL BEHAV, V133, P252, DOI 10.1016/j.physbeh.2014.05.030; World Organisation for Animal Health (OIE), 2015, KILL AN DIS CONTR PU	27	8	9	0	16	UNIV FEDERATION ANIMAL WELFARE	WHEATHAMPSTEAD	OLD SCHOOL, BREWHOUSE HILL, WHEATHAMPSTEAD AL4 8AN, HERTS, ENGLAND	0962-7286			ANIM WELFARE	Anim. Welf.	NOV	2016	25	4					471	479		10.7120/09627286.25.4.471			9	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	ED7TS	WOS:000389074900008					2022-02-06	
J	Traub, SJ; Wijdicks, EF				Traub, Stephen J.; Wijdicks, Eelco F.			Initial Diagnosis and Management of Coma	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Coma; Coma mimics; Pathophysiology	ALTERED MENTAL STATUS; CEREBRAL BLOOD-FLOW; SUBDURAL-HEMATOMA; TRAUMA PATIENTS; CERVICAL-SPINE; PLAIN FILMS; 4 SCORE; DISEASE; HYPOGLYCEMIA; INTUBATION	Coma represents a true medical emergency. Drug intoxications are a leading cause of coma; however, other metabolic disturbances and traumatic brain injury are also common causes. The general emergency department approach begins with stabilization of airway, breathing, and circulation, followed by a thorough physical examination to generate a limited differential diagnosis that is then refined by focused testing. Definitive treatment is ultimately disease-specific. This article presents an overview of the pathophysiology, causes, examination, and treatment of coma.	[Traub, Stephen J.] Mayo Clin Arizona, Dept Emergency Med, 1-738,5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Wijdicks, Eelco F.] Mayo Clin, Dept Neurol, Rochester, MN USA		Traub, SJ (corresponding author), Mayo Clin Arizona, Dept Emergency Med, 1-738,5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	traub.stephen@mayo.edu					ACKERMANN H, 1995, FORTSCHR NEUROL PSYC, V63, P59, DOI 10.1055/s-2007-996603; Adam N, 2013, EXPERT REV ANTI-INFE, V11, P211, DOI [10.1586/eri.12.159, 10.1586/ERI.12.159]; Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; [Anonymous], 2014, J INTENSIVE CARE MED, V29, P59, DOI 10.1177/0885066612445978; Bast RP, 2000, SOUTH MED J, V93, P397; Bautista RED, 2007, J CLIN NEUROPHYSIOL, V24, P16, DOI 10.1097/WNP.0b013e318030e8cb; Bawaskar HS, 2004, WILD ENVIRON MED, V15, P257; Baxter CL, 2003, INT J PSYCHIAT MED, V33, P317, DOI 10.2190/YVP4-3GTC-0EWK-42E8; BENASULY S, 1975, AM J MED SCI, V269, P267, DOI 10.1097/00000441-197503000-00015; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bertol E, 2013, J ANAL TOXICOL, V37, P659, DOI 10.1093/jat/bkt063; Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Bosco L, 2013, J CHILD NEUROL, V28, P1677, DOI 10.1177/0883073812464684; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Boyer EW, 2007, NEW ENGL J MED, V356, P2437; Boyer EW, 2009, NEW ENGL J MED, V361, P1714; BRETT AS, 1988, ARCH INTERN MED, V148, P437, DOI 10.1001/archinte.148.2.437; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brown DJ, 2013, NEW ENGL J MED, V368, P394; Brown DJA, 2012, NEW ENGL J MED, V367, P1930, DOI 10.1056/NEJMra1114208; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Cardwell Michael S, 2013, Tex Med, V109, pe1; CAROFF SN, 1993, MED CLIN N AM, V77, P185, DOI 10.1016/S0025-7125(16)30278-4; Cavazzoni E, 2008, CLIN TOXICOL, V46, P760, DOI 10.1080/15563650701601790; CLEMMESEN C, 1961, CLIN PHARMACOL THER, V2, P220; Constant EL, 2001, J CLIN ENDOCR METAB, V86, P3864, DOI 10.1210/jc.86.8.3864; Cuturic M, 2005, ANN PHARMACOTHER, V39, P2119, DOI 10.1345/aph.1G167; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; De Bonis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068732; Devereaux D, 2014, EMERG MED CLIN N AM, V32, P277, DOI 10.1016/j.emc.2013.12.001; Diaz JJ, 2003, J TRAUMA, V55, P658, DOI 10.1097/01.TA.0000088120.99247.4A; Dietze P, 2014, ACAD EMERG MED, V21, P1226, DOI 10.1111/acem.12516; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Dunham CM, 2003, J TRAUMA, V55, P162, DOI 10.1097/01.ta.0000083335.93868.2c; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Emson PC, 2007, PROG BRAIN RES, V160, P43, DOI 10.1016/S0079-6123(06)60004-6; Enderson BL, 2001, J TRAUMA, V51, P668; Eva KW, 2010, ACAD MED, V85, P1112, DOI 10.1097/ACM.0b013e3181e16103; Forsberg S, 2012, AM J EMERG MED, V30, P1986, DOI 10.1016/j.ajem.2012.04.032; Gaucher DJ, 2002, ARCH INTERN MED, V162, P1904, DOI 10.1001/archinte.162.16.1904; Ghobrial MW, 2002, SOUTHERN MED J, V95, P552; GIBB WRG, 1985, POSTGRAD MED J, V61, P607, DOI 10.1136/pgmj.61.717.607; GORELICK PB, 1986, NEUROLOGY, V36, P1445, DOI 10.1212/WNL.36.11.1445; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Han CY, 2005, OTOLARYNG CLIN N AM, V38, P569, DOI 10.1016/j.otc.2005.01.005; He Q, 2013, J NEUROPHYSIOL, V109, P1333, DOI 10.1152/jn.00350.2012; Heninger M, 2013, AM J FOREN MED PATH, V34, P237, DOI 10.1097/PAF.0b013e3182834b32; Ku CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118995; Kurien M, 2015, ACTA DIABETOL, V52, P1167, DOI 10.1007/s00592-015-0808-y; Kwaku Maxwell P, 2007, J Intensive Care Med, V22, P224, DOI 10.1177/0885066607301361; LaBuzetta JN, 2010, AM J MED, V123, P885, DOI 10.1016/j.amjmed.2010.02.029; LeGrand SB, 2011, AM J HOSP PALLIAT ME, V28, P515, DOI 10.1177/1049909111414164; Letarte PB, 2003, J TRAUMA, V55, P663; Li SF, 2008, AM J EMERG MED, V26, P792, DOI 10.1016/j.ajem.2007.10.003; LIUSHINDO M, 1989, INT J PEDIATR OTORHI, V17, P109, DOI 10.1016/0165-5876(89)90086-4; LORBER D, 1995, MED CLIN N AM, V79, P39, DOI 10.1016/S0025-7125(16)30083-9; Lucas MJ, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000009; Maxelner H, 2007, NEUROSURGERY, V61, P267, DOI 10.1227/01.neu.0000279222.76375.d4; Mayr R, 2012, ARCH ORTHOP TRAUM SU, V132, P1445, DOI 10.1007/s00402-012-1559-7; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; MIYASAKA M, 1968, INT J NEUROPHARMACOL, V7, P557; OLSEN RW, 1986, LIFE SCI, V39, P1969, DOI 10.1016/0024-3205(86)90320-6; Pasquel FJ, 2014, DIABETES CARE, V37, P3124, DOI 10.2337/dc14-0984; Rafat C, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0066-8; Rengarajan A, 2013, CLIN TOXICOL, V51, P493, DOI 10.3109/15563650.2013.801982; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Schenarts PJ, 2001, J TRAUMA, V51, P663, DOI 10.1097/00005373-200110000-00007; Schloot NC, 2016, DIABETES-METAB RES, V32, P316, DOI 10.1002/dmrr.2722; Seifter JL, 2011, SEMIN NEUROL, V31, P139, DOI 10.1055/s-0031-1277984; Singh TD, 2015, NEUROLOGY, V84, P359, DOI 10.1212/WNL.0000000000001190; Stahl SM, 2013, CNS SPECTRUMS, V18, P171, DOI 10.1017/S109285291300045X; Sterns RH, 2015, NEW ENGL J MED, V372, P55, DOI 10.1056/NEJMra1404489; STRANDGAARD S, 1989, AM J HYPERTENS, V2, P486, DOI 10.1093/ajh/2.6.486; TEASDALE G, 1974, LANCET, V2, P81; Traub SJ, 2002, J URBAN HEALTH, V79, P549, DOI 10.1093/jurban/79.4.549; Valenzuela CF, 2015, CEREBELLUM, V14, P438, DOI 10.1007/s12311-014-0639-3; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; WALLIS WE, 1978, LANCET, V2, P400; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Widjicks EFM, 2014, THE COMATOSE PATIENT; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; WILLIAMS HE, 1984, MED CLIN N AM, V68, P33, DOI 10.1016/S0025-7125(16)31239-1; Zehtabchi S, 2011, EPILEPSY BEHAV, V22, P139, DOI 10.1016/j.yebeh.2011.06.012	87	8	9	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	NOV	2016	34	4					777	+		10.1016/j.emc.2016.06.017			18	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EB1EL	WOS:000387092300007	27741988				2022-02-06	
J	Venza, EE; Chapman, SB; Aslan, S; Zientz, JE; Tyler, DL; Spence, JS				Venza, Erin E.; Chapman, Sandra B.; Aslan, Sina; Zientz, Jennifer E.; Tyler, David L.; Spence, Jeffrey S.			Enchancing Executive Function and Neural Health in Bipolar Disorder through Reasoning Training	FRONTIERS IN PSYCHOLOGY			English	Article						bipolar disorder; cerebral blood flow; cognition; cognitive training; executive function; frontal networks; memory	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; PREFRONTAL CORTEX; DEPRESSIVE SYMPTOMS; MEMORY; SCHIZOPHRENIA; DYSFUNCTION; TRIAL	Cognitive deficits in executive function and memory among individuals with bipolar disorder (BD) are well-documented; however, only recently have efforts begun to address whether such cognitive deficits can be ameliorated through cognitive training. This pilot study examined the effects of a top down, cognitive reasoning training program in adults with BD on both brain and cognitive measures. Twenty-seven participants (11 males, 16 females), aged 21-70 years old, completed the study. Participants completed neurocognitive testing and functional magnetic resonance imaging (fMRI) before and after training, consisting of 8 h (2 h/week) of training in small groups. The training delivered information processing strategies that were implemented and applicable to a variety of daily living contexts. Results indicated that participants showed significant gains in the primary outcome measure of complex abstraction, also referred to as gist reasoning, as well as in untrained domains of executive function and memory. We found a significant increase in resting cerebral blood flow (CBF) in left inferior frontal gyrus after cognitive training. We also found that resting CBF in the right frontal middle gyrus correlated positively with performance on the measure of complex abstraction. This feasibility study provides promising evidence that short-term reasoning training can enhance cognitive performance and brain health in adults with BD. These data motivate further efforts to explore adjuvant therapeutics to improve cognitive performance and underlying brain systems in bipolar, as well as other psychiatric disorders. Clinicaltrials.gov Identifier: NCT02843282, http://www.clinicaltrials.gov/ct2/show/NCT02843282	[Venza, Erin E.; Chapman, Sandra B.; Aslan, Sina; Zientz, Jennifer E.; Spence, Jeffrey S.] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX USA; [Aslan, Sina] Adv MRI LLC, Frisco, TX USA		Chapman, SB (corresponding author), Univ Texas Dallas, Ctr BrainHlth, Dallas, TX USA.	schapman@utdallas.edu			Dunlap family Grant [20249169]	This study was funded by private donation from the Dunlap family (Grant # 20249169).	Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Benabarre A, 2005, AUST NZ J PSYCHIAT, V39, P227, DOI 10.1080/j.1440-1614.2004.01558.x; Benton AL, 1994, MULTILINGUAL APHASIA; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P601, DOI 10.1001/archpsyc.60.6.601; Burdick KE, 2012, J CLIN PSYCHIAT, V73, P103, DOI 10.4088/JCP.11m07299; Chapman S.B., 2014, MAKE YOUR BRAIN SMAR; Chapman SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00338; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Chapman Sandra B., 2012, ADOLESCENT BRAIN LEA, P123, DOI DOI 10.1037/13493-005; Chapman SB, 2002, ALZ DIS ASSOC DIS, V16, P177, DOI 10.1097/00002093-200207000-00008; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056733; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Danker JF, 2008, CEREB CORTEX, V18, P2674, DOI 10.1093/cercor/bhn027; Deckersbach T, 2010, CNS NEUROSCI THER, V16, P298, DOI 10.1111/j.1755-5949.2009.00110.x; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demant KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127955; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Gamino JF, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00188; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Green MJ, 2007, J AFFECT DISORDERS, V103, P29, DOI 10.1016/j.jad.2007.01.024; Kronhaus DM, 2006, BIPOLAR DISORD, V8, P28, DOI 10.1111/j.1399-5618.2006.00282.x; Martinez-Aran A, 2004, BIPOLAR DISORD, V6, P224, DOI 10.1111/j.1399-5618.2004.00111.x; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; Michalak EE, 2010, BIPOLAR DISORD, V12, P727, DOI 10.1111/j.1399-5618.2010.00865.x; Motes MA, 2014, BRAIN COGNITION, V84, P44, DOI 10.1016/j.bandc.2013.10.007; Mozolic JL, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.016.2010; Mudar R., 2013, COGN NEUR SOC ANN M; Mudar RA, 2017, INT J GERIATR PSYCH, V32, P548, DOI 10.1002/gps.4492; OCONNELL RA, 1995, J NEUROIMAGING, V5, P101, DOI 10.1111/jon199552101; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Preiss M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00108; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; Race EA, 2009, J COGNITIVE NEUROSCI, V21, P1766, DOI 10.1162/jocn.2009.21132; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Rey A., 1964, EXAMEN CLIN PSYCHOL; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; Schmidt M., 1996, REY AUDITORY VERBAL; Sojkova J, 2008, J NUCL MED, V49, P1465, DOI 10.2967/jnumed.108.051946; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971; van Gorp WG, 1998, ARCH GEN PSYCHIAT, V55, P41, DOI 10.1001/archpsyc.55.1.41; Vas A., 2016, J APPL BIOBEHAV RES; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas Asha K, 2015, Handb Clin Neurol, V128, P497, DOI 10.1016/B978-0-444-63521-1.00031-5; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Vreeker A, 2015, EUR NEUROPSYCHOPHARM, V25, P969, DOI 10.1016/j.euroneuro.2015.04.014; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6	58	8	9	0	20	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	NOV 1	2016	7								1676	10.3389/fpsyg.2016.01676			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EA4ZE	WOS:000386624900001	27847486	Green Published, gold			2022-02-06	
J	Tomaciello, F; Leclercq, K; Kaminski, RM				Tomaciello, Francesca; Leclercq, Karine; Kaminski, Rafal M.			Resveratrol lacks protective activity against acute seizures in mouse models	NEUROSCIENCE LETTERS			English	Article						Resveratrol; Antiepileptic drugs; Pentylenetetrazole; Maximal electroshock; 6-Hz seizure; Mice	PENTYLENETETRAZOL-INDUCED SEIZURE; TRAUMATIC BRAIN-INJURY; TRANS-RESVERATROL; NITRIC-OXIDE; KAINIC ACID; IN-VIVO; ANTIEPILEPTIC DRUGS; STATUS EPILEPTICUS; OXIDATIVE STRESS; RATS	Resveratrol (3,4',5-stilbenetriol) is a natural product having diverse anti-inflammatory and antioxidant properties. The compound has a wide spectrum of pharmacological and metabolic activity, including cardioprotective, neuroprotective, anticarcinogenic and anti-aging effects reported in numerous studies. Some reports also suggest potential anticonvulsant properties of resveratrol. In the present study, we used in mice three different seizure models which are routinely applied in preclinical drug discovery. The protective effects of resveratrol were evaluated in the pentylenetetrazole (PTZ), maximal electroshock (MES) and 6-Hz electrical seizure models. Resveratrol (up to 300 mg/kg) administered ip (5-60 min pretreatment time) remained without any protective activity against seizures induced in these models. There was only a trend towards a delay in seizure latency, which reached statistical significance after treatment with resveratrol (100 mg/kg; 15 min) in case of tonic convulsions induced by PTZ. Phenobarbital (PHB, ip, 45 min), used as a reference compound, displayed a clear-cut and dose-dependent protection against seizures in all the models. The ED50 values obtained with PHB were as follows: 7.3 mg/kg (PTZ model), 13.3 mg/kg (MES model) and 29.7 mg/kg (6-Hz model). The present data demonstrate that an acute treatment with resveratrol does not provide any significant protection in three seizure models which collectively are able to detect anticonvulsants with diverse mechanisms of action. However, it cannot be excluded that chronic treatment with resveratrol may offer some protection in these or other seizure models. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Tomaciello, Francesca; Leclercq, Karine; Kaminski, Rafal M.] UCB Pharma, Neurosci TA, B-1420 Braine Lalleud, Belgium; [Tomaciello, Francesca] Univ Sannio, Fac Sci, Benevento, Italy		Leclercq, K (corresponding author), UCB Pharma, Ave Ind, B-1420 Braine Lalleud, Belgium.	Karine.Leclercq@ucb.com			Lifelong Learning Program of the European Parliament [1720/2006/EC]	Francesca Tomaciello's program was conducted under financial compensation by the Lifelong Learning Program of the European Parliament (No.1720/2006/EC).	Akula KK, 2008, EUR J PHARMACOL, V587, P129, DOI 10.1016/j.ejphar.2008.03.038; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chung S., 2012, ARCH BIOCHEM BIOPHYS, V501, P79; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Das S, 2005, VASC PHARMACOL, V42, P281, DOI 10.1016/j.vph.2005.02.013; Dhir A, 2006, PROG NEURO-PSYCHOPH, V30, P1478, DOI 10.1016/j.pnpbp.2006.06.003; Dong WP, 2008, J VASC SURG, V48, P709, DOI 10.1016/j.jvs.2008.04.007; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gupta YK, 2002, PHARMACOLOGY, V65, P170, DOI 10.1159/000058044; Gupta YK, 2002, PHARMACOL BIOCHEM BE, V71, P245, DOI 10.1016/S0091-3057(01)00663-3; Gupta YK, 2001, METHOD FIND EXP CLIN, V23, P241, DOI 10.1358/mf.2001.23.5.662120; Ilhan A, 2005, NEUROPHARMACOLOGY, V49, P456, DOI 10.1016/j.neuropharm.2005.04.004; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaminski R, 1998, PHARMACOL RES, V37, P375, DOI 10.1006/phrs.1998.0309; Kaminski RM, 2004, EPILEPSIA, V45, P864, DOI 10.1111/j.0013-9580.2004.04504.x; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; Marini H, 2004, EXP NEUROL, V188, P178, DOI 10.1016/j.expneurol.2004.03.023; Mishra V, 2015, SCI REP-UK, V5, DOI 10.1038/srep17807; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Rauca C, 1999, BRAIN RES, V847, P347, DOI 10.1016/S0006-8993(99)02084-3; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; Sengottuvelan M, 2006, CARCINOGENESIS, V27, P1038, DOI 10.1093/carcin/bgi286; Sharma S, 2007, FUND CLIN PHARMACOL, V21, P89, DOI 10.1111/j.1472-8206.2006.00455.x; Shetty AK, 2011, PHARMACOL THERAPEUT, V131, P269, DOI 10.1016/j.pharmthera.2011.04.008; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Tutka P, 2002, EUR J PHARMACOL, V437, P47, DOI 10.1016/S0014-2999(01)01600-4; Tutka P, 2007, PHARMACOL REP, V59, P259; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Virgili M, 2000, NEUROSCI LETT, V281, P123, DOI 10.1016/S0304-3940(00)00820-X; Wang Q, 2004, NEUROCHEM RES, V29, P2105, DOI 10.1007/s11064-004-6883-z; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; White HS, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s7.10.x	38	8	8	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	OCT 6	2016	632						199	203		10.1016/j.neulet.2016.09.002			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY7PF	WOS:000385320900033	27600732				2022-02-06	
J	Binder, H; Majdan, M; Tiefenboeck, TM; Fochtmann, A; Michel, M; Hajdu, S; Mauritz, W; Leitgeb, J				Binder, H.; Majdan, M.; Tiefenboeck, T. M.; Fochtmann, A.; Michel, M.; Hajdu, S.; Mauritz, W.; Leitgeb, J.			Management and outcome of traumatic epidural hematoma in 41 infants and children from a single center	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Traumatic brain injury; Epidural hematoma; Infants; Children and adolescent; Prognostic factors; Outcome	EXTRADURAL HEMATOMAS; CONSERVATIVE MANAGEMENT; PRACTICAL SCALE; BRAIN-INJURY; HEAD-INJURY; EXPERIENCE; EMERGENCY; PROGNOSIS; CARE; AGE	Background: Traumatic brain injury (TBI) is a frequent cause of mortality and acquired neurological impairment in children. Hypothesis: We hypothese that due to adequate treatment of EDH in children and adolescence excellent clinical and functional outcome can be reached. Purpose: To evaluate retrospectively our treatment process of EDH and to elucidate the relationship between trauma mechanism, injury pattern, radiological presentation, subsequent therapy and functional outcome. Patients and methods: Hundred and twenty infants and children with traumatic brain injuries (TBI) were treated between 1992 and 2009 at a single level-one trauma center. Data regarding accident, treatment and outcomes were collected retrospectively. To classify the outcomes the Glasgow Outcome Scale (GOS) scores at hospital discharge and at follow-up visits were used. EDH was classified according to the Rotterdam score. Results: Finally, 41 cases were diagnosed with an EDH and therefore included in our study. Twenty-one cases were treated surgically; however of these in 11 patients delayed surgery was necessary. Twenty patients were treated conservatively. Two patients (5%) died within 24 hours, 39 patients (95%) survived. One of the operatively treated patients (2%) presented in a vegetative state, another one had severe disability, and however, 32 patients (78%) showed good recovery at latest follow-up. Discussion: Age, severity of TBI, and neurological status were the main factors influencing outcome after TBI due to acute EDH. We found that immediate as well as delayed surgical evacuation of EDH resulted in excellent outcomes in most cases. Conservative treatment was started in 76% of our cases - however needing in 35% delayed surgical intervention. Overall in all groups excellent final clinical and neurological outcomes could be reached. (C) 2016 Elsevier Masson SAS. All rights reserved.	[Binder, H.; Tiefenboeck, T. M.; Michel, M.; Hajdu, S.; Leitgeb, J.] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Fochtmann, A.] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria; [Mauritz, W.] Lorenz Bohler Hosp, Dept Anesthesiol & Intens Care Med, Vienna, Austria; [Majdan, M.] Int Neurotrauma Res Org, Vienna, Austria		Binder, H (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Trauma Surg, Waehringerguertel 18-20, A-1090 Vienna, Austria.	harald.binder@meduniwien.ac.at	Majdan, Marek/K-5017-2012	Majdan, Marek/0000-0001-8037-742X; Tiefenboeck, Thomas/0000-0002-8698-8341; Fochtmann-Frana, Alexandra/0000-0003-1652-4856; Binder, Harald/0000-0002-9212-7214			Adelson PD, 2003, CRIT CARE MED, V4, pS2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Ben Abraham R, 2000, PEDIATR NEUROSURG, V33, P70, DOI 10.1159/000028990; Beni-Adani L, 1999, J TRAUMA, V46, P306, DOI 10.1097/00005373-199902000-00018; Browne GJ, 2002, PEDIATR EMERG CARE, V18, P86, DOI 10.1097/00006565-200204000-00006; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; CHOUX M, 1975, CHILD BRAIN, V1, P337; Chowdhury SMNK, 2012, TURK NEUROSURG, V22, P39, DOI 10.5137/1019-5149.JTN.4550-11.1; DUHAIME AC, 1992, PEDIATRICS, V90, P179; GALLAGHE.JP, 1968, J NEUROSURG, V29, P1, DOI 10.3171/jns.1968.29.1.0001; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; HELFER RE, 1977, PEDIATRICS, V60, P533; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; JENNETT B, 1975, LANCET, V1, P480; Khan MB, 2014, CHILD NERV SYST, V30, P1249, DOI 10.1007/s00381-014-2391-x; Lee ACW, 1997, J PAEDIATR CHILD H, V33, P446; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maggi G, 1998, J Neurosurg Sci, V42, P95; Marion DW, 2006, NEUROSURGERY, V58, P655; MAZZA C, 1982, ACTA NEUROCHIR, V65, P67, DOI 10.1007/BF01405443; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; PASZTOR A, 1985, Zentralblatt fuer Neurochirurgie, V46, P243; PILLAY R, 1995, S AFR MED J, V85, P672; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8	34	8	9	0	2	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	OCT	2016	102	6					769	774		10.1016/j.otsr.2016.06.003			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	DY6WI	WOS:000385269400015	27622712	Bronze			2022-02-06	
J	Brewer-Smyth, K; Cornelius, M; Pohlig, RT				Brewer-Smyth, Kathleen; Cornelius, Monica; Pohlig, Ryan T.			Childhood Adversity and Mental Health Correlates of Obesity in a Population at Risk	JOURNAL OF CORRECTIONAL HEALTH CARE			English	Article						obesity; BMI; child abuse; childhood sexual abuse; TBI; suicide attempts	PERRY AGGRESSION QUESTIONNAIRE; TBI IDENTIFICATION METHOD; TRAUMATIC BRAIN-INJURY; FEMALE PRISON-INMATES; CARE YOUTH SURVEY; BODY-MASS INDEX; SEXUAL-ABUSE; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; SALIVARY CORTISOL	The staggering prevalence of obesity and obesity-related health conditions takes exorbitant tolls on health care resources. This cross-sectional study with private evaluations of 636 adult inmates in a southern state prison was conducted with regressions comparing obese (body mass index [BMI] >= 30) to nonobese individuals to define obesity risk factors. Obese individuals more likely were female, were victims of childhood sexual abuse, suffered greater severity of childhood sexual abuse, attempted suicide, reported drug dependency, were non-Caucasian, and were older than nonobese. Psychopathy predicted lower BMI. Though obesity might be expected in victims of childhood physical abuse, traumatic brain injury, or other mental health conditions due to mobility or decision-making deficits, neither were significant. Adjusting for related variables, childhood sexual abuse remained significant. Females attempted suicide more frequently and suffered greater childhood sexual abuse.	[Brewer-Smyth, Kathleen] Univ Delaware, Sch Nursing, Coll Hlth Sci, McDowell Hall, Newark, DE 19716 USA; [Cornelius, Monica] Med Univ South Carolina, Charleston, SC 29425 USA; [Pohlig, Ryan T.] Univ Delaware, Coll Hlth Sci, Newark, DE USA		Brewer-Smyth, K (corresponding author), Univ Delaware, Sch Nursing, Coll Hlth Sci, McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu		Brewer-Smyth, PhD, RN, CRRN, FAAN, Kathleen/0000-0001-8468-6991	Medical University of South Carolina from the Division of Injury Response [U49CE001318]; National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U49CE001318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Cooperative Agreement No. U49CE001318 to E. Elisabeth Pickelsimer, DA, Medical University of South Carolina from the Division of Injury Response, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.	Aaron DJ, 2007, OBESITY, V15, P1023, DOI 10.1038/oby.2007.634; Arthur MW, 2007, EVAL PROGRAM PLANN, V30, P197, DOI 10.1016/j.evalprogplan.2007.01.009; Arthur MW, 2002, EVALUATION REV, V26, P575, DOI 10.1177/019384102237850; Bai JR, 2015, J CORRECT HEALTH CAR, V21, P255, DOI 10.1177/1078345815587510; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K, 2008, ADV NURS SCI, V31, P119, DOI 10.1097/01.ANS.0000319562.84007.22; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Brewer-Smyth K, 2014, REHABIL NURS, V39, P183, DOI 10.1002/rnj.150; Bryant FB, 2001, J RES PERS, V35, P138, DOI 10.1006/jrpe.2000.2302; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Centers for Disease Control and Prevention, 2016, DEF AD OV OB; Centers for Disease Control and Prevention, 2017, AD OB FACTS; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; CROSSONTOWER C, 2015, CONFRONTING CHILD AD; Diamond PM, 2005, CRIM JUSTICE BEHAV, V32, P546, DOI 10.1177/0093854805278416; FELITTI VJ, 1993, SOUTHERN MED J, V86, P732, DOI 10.1097/00007611-199307000-00002; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hemmingsson E, 2014, OBES REV, V15, P882, DOI 10.1111/obr.12216; Hemmingsson E, 2014, OBES REV, V15, P769, DOI 10.1111/obr.12197; Henriksen CA, 2014, J NERV MENT DIS, V202, P379, DOI 10.1097/NMD.0000000000000135; Herbert K, 2012, LANCET, V379, P1975, DOI 10.1016/S0140-6736(12)60319-5; Hesse M, 2012, BRIT J CLIN PSYCHOL, V51, P172, DOI 10.1111/j.2044-8260.2011.02019.x; Houle B, 2011, SOC SCI MED, V72, P1667, DOI 10.1016/j.socscimed.2011.03.039; Johnson SB, 2013, PEDIATRICS, V131, P319, DOI 10.1542/peds.2012-0469; Joung KE, 2014, J CLIN ENDOCR METAB, V99, pE1055, DOI 10.1210/jc.2013-3669; Kim HK, 2015, PSYCHONEUROENDOCRINO, V51, P35, DOI 10.1016/j.psyneuen.2014.09.013; Knight K., 2002, RES REPORT; Leigey ME, 2015, J CORRECT HEALTH CAR, V21, P276, DOI 10.1177/1078345815588171; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Maniam J, 2012, NEUROPHARMACOLOGY, V63, P97, DOI 10.1016/j.neuropharm.2012.04.017; Mason SM, 2013, OBESITY, V21, pE775, DOI 10.1002/oby.20500; Mezzich AC, 1997, DRUG ALCOHOL DEPEN, V44, P157, DOI 10.1016/S0376-8716(96)01333-6; Millon T., 2006, MILLON CLIN MULTIAXI, VThird; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pardini DA, 2003, J AM ACAD CHILD PSY, V42, P364, DOI 10.1097/00004583-200303000-00018; Pew Charitable Trusts and MacArthur Foundation, 2014, STAT PRIS HLTH CAR S; Roberti JW, 2003, J PERS ASSESS, V81, P291, DOI 10.1207/S15327752JPA8103_12; Sellbom M, 2011, LAW HUMAN BEHAV, V35, P440, DOI 10.1007/s10979-010-9249-x; Shah S, 2011, Public Health, V125, P349, DOI 10.1016/j.puhe.2011.01.014; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Slopen N, 2014, J PEDIATR-US, V164, P631, DOI 10.1016/j.jpeds.2013.11.003; Smith TJ, 2014, AM J HEALTH BEHAV, V38, P529, DOI 10.5993/AJHB.38.4.6; Snelbaker AJ, 2001, PERSP INDIV, P259; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Talbot NL, 2004, AM J GERIAT PSYCHIAT, V12, P536, DOI 10.1176/appi.ajgp.12.5.536; Tomiyama AJ, 2011, PSYCHONEUROENDOCRINO, V36, P1513, DOI 10.1016/j.psyneuen.2011.04.005; Tryon MS, 2013, PHYSIOL BEHAV, V120, P233, DOI 10.1016/j.physbeh.2013.08.010; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; Veldwijk J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-840; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Warner DF, 2011, SOC SCI MED, V72, P1236, DOI 10.1016/j.socscimed.2011.02.034; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC; Williamson DF, 2002, INT J OBESITY, V26, P1075, DOI 10.1038/sj.ijo.0802038; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757	62	8	10	1	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3458	1940-5200		J CORRECT HEALTH CAR	J. Correct. Health Care	OCT	2016	22	4					367	382		10.1177/1078345816670161			16	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DZ3LI	WOS:000385748200011	27742859	Green Accepted			2022-02-06	
J	Cairncross, M; Peterson, A; Lazosky, A; Gofton, T; Weijer, C				Cairncross, Molly; Peterson, Andrew; Lazosky, Andrea; Gofton, Teneille; Weijer, Charles			Assessing Decision-Making Capacity in Patients with Communication Impairments A Case Study	CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS			English	Article						autonomy; ethics; brain trauma; decision-making capacity; communication impairments; neuropsychology	TRAUMATIC BRAIN-INJURY; INFORMED CONSENT; COGNITIVE PREDICTORS; COMPETENCE; MODELS	The ethical principle of autonomy requires physicians to respect patient autonomy when present, and to protect the patient who lacks autonomy. Fulfilling this ethical obligation when a patient has a communication impairment presents considerable challenges. Standard methods for evaluating decision-making capacity require a semistructured interview. Some patients with communication impairments are unable to engage in a semistructured interview and are at risk of the wrongful loss of autonomy. In this article, we present a general strategy for assessing decision-making capacity in patients with communication impairments. We derive this strategy by reflecting on a particular case. The strategy involves three steps: (1) determining the reliability of communication, (2) widening the bandwidth of communication, and (3) using compensatory measures of decision-making capacity. We argue that this strategy may be useful for assessing decision-making capacity and preserving autonomy in some patients with communication impairments.	[Cairncross, Molly] Univ Windsor, Clin Neuropsychol Program, Windsor, ON, Canada; [Cairncross, Molly] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Peterson, Andrew] Western Univ, Rotman Inst Philosophy, London, ON, Canada; [Peterson, Andrew] Western Univ, Brain & Mind Inst, London, ON, Canada; [Lazosky, Andrea] Victoria Hosp, London Hlth Sci Ctr, London, ON, Canada; [Lazosky, Andrea] Western Univ, Dept Clin Neurol Sci, London, ON, Canada; [Lazosky, Andrea] Western Univ, Dept Psychiat & Psychol, London, ON, Canada; [Gofton, Teneille] Western Univ, Dept Clin Neurol Sci, Schulich Sch Med & Dent, London, ON, Canada; [Weijer, Charles] Western Univ, Dept Philosophy, Rotman Inst Philosophy, London, ON, Canada; [Weijer, Charles] Western Univ, Dept Med, Rotman Inst Philosophy, London, ON, Canada; [Weijer, Charles] Western Univ, Dept Epidemiol & Biostat, Rotman Inst Philosophy, London, ON, Canada; [Weijer, Charles] Western Univ, Canada Res Chair Bioeth, Rotman Inst Philosophy, London, ON, Canada		Cairncross, M (corresponding author), Univ Windsor, Clin Neuropsychol Program, Windsor, ON, Canada.; Cairncross, M (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.		Weijer, Charles/ABC-5433-2020	Weijer, Charles/0000-0002-5510-1074	Vanier Canada Graduate Scholarship; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	AP is supported by a Vanier Canada Graduate Scholarship. CW holds a Canada Research Chair in Bioethics. This research was supported by an operating grant from the Canadian Institutes of Health Research.	Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; APPELBAUM PS, 1995, LAW HUMAN BEHAV, V19, P105, DOI 10.1007/BF01499321; Beauchamp T., 2001, PRINCIPLES BIOMEDICA, V5th; Buchanan A, 1989, DECIDING OTHERS ETHI; Carling-Rowland E A, 2011, THESIS; Coughlan AK, 2005, MED SCI LAW, V45, P249, DOI 10.1258/rsmmsl.45.3.249; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diener Bethany L, 2004, Top Stroke Rehabil, V11, P84; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dunn, 2007, PPVT 4 PEABODY PICTU; Dunn LB, 2001, NEUROPSYCHOPHARMACOL, V24, P595, DOI 10.1016/S0893-133X(00)00218-9; Faden RR, 1986, HIST THEORY INFORM C; Gerstenecker A, 2015, CANCER-AM CANCER SOC, V121, P2013, DOI 10.1002/cncr.29326; Grisso T., 1998, ASSESSING COMPETENCE; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Maiser S, 2016, J PAIN SYMPTOM MANAG, V51, P789, DOI 10.1016/j.jpainsymman.2015.10.021; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; Peterson A, 2013, AJOB NEUROSCI, V4, P3, DOI DOI 10.1080/21507740.2013.821189; Peterson A, 2013, AJOB NEUROSCIENCE, V4, P52; Rowland A, 2009, SOC WORK EDUC, V28, P128, DOI 10.1080/02615470802029965; Silvers A, 2009, METAPHILOSOPHY, V40, P475, DOI 10.1111/j.1467-9973.2009.01602.x; Stern RA, 2003, NEUROPSYCHOLOGICAL A; TAUB HA, 1981, EXP AGING RES, V7, P137, DOI 10.1080/03610738108259796; TAUB HA, 1983, EXP AGING RES, V9, P135, DOI 10.1080/03610738308258441; Triebel KL, 2016, J HEAD TRAUMA REHAB, V31, pE49, DOI 10.1097/HTR.0000000000000163	25	8	8	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0963-1801	1469-2147		CAMB Q HEALTHC ETHIC	Camb. Q. Healthc. Ethics	OCT	2016	25	4					691	699		10.1017/S0963180116000414			9	Health Care Sciences & Services; Health Policy & Services; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Biomedical Social Sciences	DX5PL	WOS:000384433300012	27634720				2022-02-06	
J	Guo, XM; Chen, B; Lv, JM; Lei, Q; Pan, YJ; Yang, Q				Guo, Xiao-Min; Chen, Bo; Lv, Jian-Meng; Lei, Qi; Pan, Ya-Juan; Yang, Qian			Knockdown of IRF6 Attenuates Hydrogen Dioxide-Induced Oxidative Stress via Inhibiting Mitochondrial Dysfunction in HT22 Cells	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						IRF6; Mitochondrial dysfunction; Oxidative stress; Apoptosis	TRAUMATIC BRAIN-INJURY; CORTICAL-NEURONS; ANTIOXIDANT THERAPIES; PROTECTS; METABOLISM; APOPTOSIS; SURVIVAL; DISEASE; TARGETS; DAMAGE	Oxidative stress-induced cell damage is involved in many neurological diseases. Interferon regulatory factor 6 (IRF6), a member of the IRF family of transcription factors, is required for the differentiation of skin, breast epithelium, and oral epithelium. However, the regulation and function of IRF6 in central nervous system remain unknown. This study aimed to investigate the role of IRF6 in hydrogen peroxide (H2O2)-induced oxidative neuronal injury in HT22 mouse hippocampal cells. Treatment with H2O2 significantly increased the expression of IRF6 at both mRNA and protein levels, and knockdown of IRF6 using specific small interfering RNA reduced H2O2-induced cytotoxicity, as evidenced by increased cell viability and decreased apoptosis. Knockdown of IRF6 attenuated intracellular reactive oxygen species (ROS) generation and lipid peroxidation, and also preserved endogenous antioxidant enzyme activities. The inhibitory effect of IRF6 knockdown on mitochondrial dysfunction was demonstrated by reduced mitochondrial oxidative level, preserved mitochondrial membrane potential (MMP) and ATP generation, as well as attenuated mitochondrial swelling. In addition, down-regulation of IRF6 inhibited the activation of mitochondrial apoptotic factors, whereas IRF6 knockdown together with caspase inhibitors had no extra effect on cell viability and LDH release. These results suggest that knockdown of IRF6 has protective effects against H2O2-induced oxidative stress by reducing ROS accumulation and apoptosis, and these protective effects are dependent on preservation of mitochondrial function.	[Guo, Xiao-Min; Lv, Jian-Meng; Lei, Qi; Pan, Ya-Juan; Yang, Qian] Shaanxi Prov Peoples Hosp, Dept Neurol, 256 Youyi West Rd, Xian 710068, Shaanxi, Peoples R China; [Chen, Bo] Shaanxi Prov Peoples Hosp, Dept Neurosurg, Xian 710068, Shaanxi, Peoples R China		Yang, Q (corresponding author), Shaanxi Prov Peoples Hosp, Dept Neurol, 256 Youyi West Rd, Xian 710068, Shaanxi, Peoples R China.	yangqian_syy@126.com			Shaanxi Province Scientific and Technological Research and Development Program [2004K14-G, K01-154]; Shaanxi Province Natural Science Foundation Research Program [2014JM4131]	This study has been funded by the Shaanxi Province Scientific and Technological Research and Development Program (No. 2004K14-G; No. 2010, K01-154) and Shaanxi Province Natural Science Foundation Research Program (No. 2014JM4131). The authors would like to thank Dr. Terry Chen for his technical support for the experiments and the preparation of the manuscript.	Alexander M, 2003, ACTA NEUROPATHOL, V105, P420, DOI 10.1007/s00401-002-0658-x; Armogida M, 2012, BRIT J PHARMACOL, V166, P1211, DOI 10.1111/j.1476-5381.2012.01912.x; Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055601; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen WJ, 2010, CELL SIGNAL, V22, P883, DOI 10.1016/j.cellsig.2009.12.005; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dai SH, 2014, INT J MOL SCI, V15, P14591, DOI 10.3390/ijms150814591; Dai SH, 2014, INT J MOL MED, V34, P1159, DOI 10.3892/ijmm.2014.1876; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Hacker G, 2007, EXPERT OPIN THER TAR, V11, P515, DOI 10.1517/14728222.11.4.515; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jones JLP, 2010, J CRANIOFAC SURG, V21, P1350, DOI 10.1097/SCS.0b013e3181ec6aad; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Lei BP, 1998, BRAIN RES PROTOC, V3, P33, DOI 10.1016/S1385-299X(98)00018-X; Lin YC, 2016, CELL MOL NEUROBIOL, V36, P27, DOI 10.1007/s10571-015-0217-3; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Salahshourifar I, 2012, EUR J MED GENET, V55, P389, DOI 10.1016/j.ejmg.2012.02.006; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Schutte BC, 1993, GENEREVIEWS; Senderowicz AM, 2000, JNCI-J NATL CANCER I, V92, P376, DOI 10.1093/jnci/92.5.376; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Xiang M, 2014, J NEUROCHEM, V129, P988, DOI 10.1111/jnc.12682; Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030	39	8	8	0	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2016	36	7					1077	1086		10.1007/s10571-015-0301-8			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DS3KA	WOS:000380680500006	26620051				2022-02-06	
J	Morbitzer, KA; Jordan, JD; Sullivan, KA; Durr, EA; Olm-Shipman, CM; Rhoney, DH				Morbitzer, Kathryn A.; Jordan, J. Dedrick; Sullivan, Kelly A.; Durr, Emily A.; Olm-Shipman, Casey M.; Rhoney, Denise H.			Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke	NEUROCRITICAL CARE			English	Article						Vancomycin; Pharmacokinetics; Subarachnoid hemorrhage; Intracerebral hemorrhage; Hemorrhagic stroke	AUGMENTED RENAL CLEARANCE; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; MEDICAL COMPLICATIONS; CREATININE CLEARANCE; 30-DAY READMISSION; PREDICTION; MANAGEMENT	Infections are a common medical complication in hemorrhagic stroke patients, with vancomycin commonly used as empiric therapy. The purpose of this study was to evaluate the pharmacokinetic parameters of vancomycin in hemorrhagic stroke patients. This was a retrospective study of adult patients with aneurysmal subarachnoid hemorrhage (aSAH) or intracerebral hemorrhage (ICH) admitted between May 2010 and February 2015 who received vancomycin. Predicted pharmacokinetic parameters based on population data were compared with calculated pharmacokinetic parameters based on serum trough concentrations. Eighty aSAH patients and 66 ICH patients met inclusion criteria. In the aSAH group, the mean dosing regimen was 17.6 +/- 4 mg/kg every 12 (8-12) h. The mean measured trough concentration was lower than the predicted trough concentration (9.9 +/- 4.1 vs. 19 +/- 8.7 mu g/mL; p < 0.001). The mean calculated elimination rate constant was higher than the predicted value (0.135 +/- 0.04 vs. 0.092 +/- 0.03 h(-1); p < 0.001), and the mean calculated half-life was lower than predicted (5.7 +/- 1.8 vs. 8.3 +/- 2.9 h; p < 0.001). In the ICH group, the mean dosing regimen was 15.9 +/- 4.3 mg/kg every 12 (8-12) h. Similarly, the mean measured trough concentration was lower than the predicted trough concentration (10.7 +/- 4.6 vs. 17.5 +/- 8.5 mu g/mL; p < 0.001). The mean calculated elimination rate constant was higher than the predicted value (0.106 +/- 0.03 vs. 0.079 +/- 0.02 h(-1); p < 0.001), and the mean calculated half-life was lower than predicted (7.2 +/- 2.3 vs. 9.6 +/- 3.2 h; p < 0.001). Patients with hemorrhagic stroke exhibited pharmacokinetic alterations favoring increased elimination of vancomycin when compared to predicted pharmacokinetic parameters based on population data. This may result in underexposure to vancomycin, leading to treatment failure and other medical complications.	[Morbitzer, Kathryn A.; Sullivan, Kelly A.; Durr, Emily A.] UNC Hlth Care, Dept Pharm, Chapel Hill, NC USA; [Morbitzer, Kathryn A.; Durr, Emily A.; Rhoney, Denise H.] Univ North Carolina Chapel Hill, UNC Eshelman Sch Pharm, Div Practice Adv & Clin Educ, 115 Beard Hall,Campus Box 7574, Chapel Hill, NC 27599 USA; [Jordan, J. Dedrick; Olm-Shipman, Casey M.] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC USA; [Jordan, J. Dedrick; Olm-Shipman, Casey M.] Univ N Carolina, Sch Med, Dept Neurosurg, Chapel Hill, NC USA		Rhoney, DH (corresponding author), Univ North Carolina Chapel Hill, UNC Eshelman Sch Pharm, Div Practice Adv & Clin Educ, 115 Beard Hall,Campus Box 7574, Chapel Hill, NC 27599 USA.	drhoney@unc.edu		Jordan, Dedrick/0000-0002-0706-9583			Ambrose P.J., 2004, BASIC CLIN PHARMACOK, P451; Andaluz N, 2009, J NEUROSURG, V110, P403, DOI 10.3171/2008.5.17559; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Campassi María Luz, 2014, Rev. bras. ter. intensiva, V26, P13, DOI 10.5935/0103-507X.20140003; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Liotta EM, 2013, CRIT CARE MED, V41, P2762, DOI 10.1097/CCM.0b013e318298a10f; MATZKE GR, 1984, ANTIMICROB AGENTS CH, V25, P433, DOI 10.1128/AAC.25.4.433; May CC, 2015, NEUROCRIT CARE, V23, P374, DOI 10.1007/s12028-015-0127-8; MCQUEEN EG, 1961, BRIT HEART J, V23, P1; Morbitzer KA, 2015, NEUROCRIT CARE, V22, P258, DOI 10.1007/s12028-014-0079-4; Naidech AM, 2009, NEUROCRIT CARE, V10, P11, DOI 10.1007/s12028-008-9148-x; Ohwaki K, 2008, NEUROCRIT CARE, V8, P271, DOI 10.1007/s12028-007-9007-1; SAWYER WT, 1983, AM J HOSP PHARM, V40, P2175, DOI 10.1093/ajhp/40.12.2175; Singh M, 2013, NEUROCRIT CARE, V19, P306, DOI 10.1007/s12028-013-9908-0; Siu K H, 1994, J Clin Neurosci, V1, P243, DOI 10.1016/0967-5868(94)90064-7; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2011, NAT REV NEPHROL, V7, P539, DOI 10.1038/nrneph.2011.92; Udy AA, 2010, CLIN PHARMACOKINET, V49, P1, DOI 10.2165/11318140-000000000-00000; Wartenberg KE, 2006, CURR OPIN CRIT CARE, V12, P78, DOI 10.1097/01.ccx.0000216571.80944.65; Wartenberg KE, 2010, NEUROSURG CLIN N AM, V21, P325, DOI 10.1016/j.nec.2009.10.012; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wu FLL, 2015, THER DRUG MONIT, V37, P609, DOI 10.1097/FTD.0000000000000187; Wurtz R, 1997, CLIN INFECT DIS, V25, P112, DOI 10.1086/514505	30	8	11	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2016	25	2					250	257		10.1007/s12028-016-0264-8			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DY5YN	WOS:000385181000013	26942732				2022-02-06	
J	Pretz, CR; Kozlowski, AJ; Chen, YY; Charlifue, S; Heinemann, AW				Pretz, Christopher R.; Kozlowski, Allan J.; Chen, Yuying; Charlifue, Susan; Heinemann, Allen W.			Trajectories of Life Satisfaction After Spinal Cord Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Longitudinal studies; Quality of life; Rehabilitation; Spinal cord injuries	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SYSTEMS NATIONAL DATABASE; GROWTH CURVE MODELS; LONGITUDINAL DESCRIPTION; DISABILITY; REHABILITATION; INSTITUTE; INDIVIDUALS; PREDICTORS	Objective: To describe individual-level temporal change in life satisfaction after spinal cord injury. Design: Individual growth curve (IGC) analysis of prospectively collected data from the National Institute on Disability, Independent Living, and Rehabilitation Research National Spinal Cord Injury Database (NSCID). Setting: Multicenter, longitudinal database study. Participants: Participants (N=4846) in the NSCID. Interventions: Not applicable. Main Outcome Measure: Rasch-transformed Satisfaction With Life Scale scores. Results: Individual-level trajectories reflecting life satisfaction vary extensively and are associated with deniographic and injury-related characteristics. Demographic characteristics include race, sex, pre-employment and discharge marital status, and level of education; injury-related factors include days in rehabilitation, neurologic level, age at injury, and injury etiology. Results are displayed graphically by way of a computer generated interactive tool and represent different trajectories of individual-level changes in life satisfaction. Conclusions: IGC methodology allows researchers and clinicians to anticipate patient-specific trajectories through use of an automated interactive tool. Projected trajectories hold promise in facilitating planning for inpatient and outpatient services, which could enhance long-term outcomes. (C) 2016 by the American Congress of Rehabilitation Medicine	[Pretz, Christopher R.; Charlifue, Susan] Craig Hosp, 3425 S Clarkson St, Englewood, CO 80132 USA; [Pretz, Christopher R.] Traumat Brain Injury Natl Data & Stat Ctr, 3425 S Clarkson St, Englewood, CO 80132 USA; [Kozlowski, Allan J.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Chen, Yuying] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Pretz, CR (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80132 USA.; Pretz, CR (corresponding author), Traumat Brain Injury Natl Data & Stat Ctr, 3425 S Clarkson St, Englewood, CO 80132 USA.	Christopher_pretz@hotmail.com	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0011]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant no. 90DP0011). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Chen YY, 2008, ARCH PHYS MED REHAB, V89, P2285, DOI 10.1016/j.apmr.2008.06.008; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; Dijkers MPJM, 2005, J REHABIL RES DEV, V42, P87, DOI 10.1682/JRRD.2004.08.0100; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; Hernandez CL, 2014, REHABIL PSYCHOL, V59, P183, DOI 10.1037/a0035887; Hill MR, 2010, SPINAL CORD, V48, P438, DOI 10.1038/sc.2009.164; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, pS154, DOI 10.1016/j.apmr.2012.11.050; Krause JS, 2014, REHABIL PSYCHOL, V59, P176, DOI 10.1037/a0035778; LARSEN RJ, 1985, SOC INDIC RES, V17, P1, DOI 10.1007/BF00354108; Melnyk B, 2014, EVIDENCE BASED PRACT; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Post MWM, 1998, ARCH PHYS MED REHAB, V79, P395, DOI 10.1016/S0003-9993(98)90139-3; Pretz CR, 2014, SPINAL CORD, V52, P671, DOI 10.1038/sc.2014.94; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Pretz CR, 2015, J NEUROTRAUMA; Putzke JD, 2004, J SPINAL CORD MED, V27, P106, DOI 10.1080/10790268.2004.11753739; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; van Koppenhagen CF, 2008, ARCH PHYS MED REHAB, V89, P1733, DOI 10.1016/j.apmr.2007.12.042; van Leeuwen CM, 2011, ARCH PHYS MED REHAB, V92, P207, DOI 10.1016/j.apmr.2010.10.011	30	8	9	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2016	97	10					1706	1713		10.1016/j.apmr.2016.04.022			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DY7TX	WOS:000385333300014	27240429				2022-02-06	
J	Wali, B; Sayeed, I; Guthrie, DB; Natchus, MG; Turan, N; Liotta, DC; Stein, DG				Wali, Bushra; Sayeed, Iqbal; Guthrie, David B.; Natchus, Michael G.; Turan, Nefize; Liotta, Dennis C.; Stein, Donald G.			Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats	NEUROPHARMACOLOGY			English	Article						Traumatic brain injury; Neurosteroid; Progesterone; Progesterone analogs; Edema	RANDOMIZED CONTROLLED-TRIAL; BINDING PROTEIN 25-DX; MIDDLE-AGED RATS; HP-BETA-CD; INFLAMMATORY RESPONSE; FUNCTIONAL RECOVERY; COGNITIVE RECOVERY; CLINICAL-TRIALS; ISCHEMIC-STROKE; DOSE-RESPONSE	The poor aqueous solubility of progesterone (PROG) limits its potential use as a therapeutic agent. We designed and tested EIDD-1723, a novel water-soluble analog of PROG with >100-fold higher solubility than that of native PROG, as candidate for development as a field-ready treatment for traumatic brain injury (TBI). The pharmacokinetic effects of EIDD-1723 on morphological and functional outcomes in rats with bilateral cortical impact injury were evaluated. Following TBI, 10-mg/kg doses of EIDD-1723 or PROG were given intramuscularly (i.m.) at 1, 6 and 24 h post-injury, then daily for the next 6 days, with tapering of the last 2 treatments. Rats were tested pre-injury to establish baseline performance on grip strength and sensory neglect, and then retested at 4, 9 and 21 days post-TBI. Spatial learning was evaluated from days 11-17 post-TBI. At 22 days post-injury, rats were perfused and brains extracted and processed for lesion size. For the edema assay the animals were killed and brains removed at 24 h post injury. EIDD-1723 significantly reduced cerebral edema and improved recovery from motor, sensory and spatial learning deficits as well as, or better than, native PROG. Pharmacokinetic investigation after a single i.m. injection in rats revealed that EIDD-1723 was rapidly converted to the active metabolite EIDD-036, demonstrating first-order elimination kinetics and ability to cross the blood-brain barrier. Our results suggest that EIDD-1723 represents a substantial advantage over current PROG formulations because it overcomes storage, formulation and delivery limitations of PROG and can thereby reduce the time between injury and treatment. (C) 2016 Elsevier Ltd. All rights reserved.	[Wali, Bushra; Sayeed, Iqbal; Stein, Donald G.] Emory Univ, Brain Res Lab, Dept Emergency Med, 1365B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA; [Guthrie, David B.; Natchus, Michael G.; Liotta, Dennis C.] Emory Univ, Emory Inst Drug Dev, Dept Chem, Atlanta, GA 30322 USA; [Turan, Nefize] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA		Wali, B (corresponding author), Emory Univ, Brain Res Lab, Dept Emergency Med, 1365B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	bwali@emory.edu	Stein, Donald/AAJ-5139-2020; turan, nefize/N-7771-2017	Wali, Bushra/0000-0001-9278-8744; Turan, Nefize/0000-0002-4751-1292	Georgia Research Alliance funding [VL14.C13]	This work was supported by Georgia Research Alliance funding (Grant # VL14.C13).	Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Bergeron R, 1999, BRIT J PHARMACOL, V127, P1769, DOI 10.1038/sj.bjp.0702724; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Guthrie DB, 2012, ACS MED CHEM LETT, V3, P362, DOI 10.1021/ml200303r; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Harvey KA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0005-6; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; Howard R.B., 2015, J NEUROTRAUMA; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Lou PH, 2015, ANESTH ANALG, V120, P329, DOI 10.1213/ANE.0000000000000558; MacNevin CJ, 2009, J MED CHEM, V52, P6012, DOI 10.1021/jm900712n; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Mani SK, 2006, NEUROSCIENCE, V138, P773, DOI 10.1016/j.neuroscience.2005.07.034; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Mermelstein F, 2013, PHARMACOTHERAPY, V33, P1012, DOI 10.1002/phar.1304; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Muller SH, 2015, J ANESTH, V29, P920, DOI 10.1007/s00540-015-2036-6; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Preskorn SH, 2005, CLIN PHARMACOKINET, V44, P1117, DOI 10.2165/00003088-200544110-00002; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sun ZL, 2014, J NEURAL TRANSM, V121, P79, DOI 10.1007/s00702-013-1078-x; Taftachi F, 2012, EUR REV MED PHARMACO, V16, P38; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; VALERA S, 1992, P NATL ACAD SCI USA, V89, P9949, DOI 10.1073/pnas.89.20.9949; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; WASAN KM, 1994, LAB ANIM, V28, P138, DOI 10.1258/002367794780745290; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198	63	8	8	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	OCT	2016	109						148	158		10.1016/j.neuropharm.2016.05.017			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DU1EJ	WOS:000381950700016	27267687				2022-02-06	
J	Whyte, T; Gibson, T; Anderson, R; Eager, D; Milthorpe, B				Whyte, Thomas; Gibson, Tom; Anderson, Robert; Eager, David; Milthorpe, Bruce			Mechanisms of Head and Neck Injuries Sustained by Helmeted Motorcyclists in Fatal Real-World Crashes: Analysis of 47 In-Depth Cases	JOURNAL OF NEUROTRAUMA			English	Article						helmet; mechanisms; motorcyclist; traumatic injury	DIFFUSE AXONAL INJURY; BRAIN; BIOMECHANICS; ELEMENT	Despite an improved understanding of traumatic head and neck injury mechanisms, the impact tests required by major motorcycle helmet standards have remained unchanged for decades. Development of new test methods must reflect the specific impact loads causing injury in real crashes as well as test criteria appropriate for the observed injury profiles. This study analysed a collection of in-depth crash investigations of fatally injured helmeted riders in the Adelaide metropolitan region between 1983 and 1994 inclusive to review the head and neck injury patterns that resulted from specific types of impact. Inertial brain injury was sustained in 49% of examined cases, most often resulting from facial impacts but also in a large proportion of tangential, run over, and occipital impact cases. Focal brain and brainstem injury was also common (53%) and regularly associated with skull vault (11/12) and skull base fractures (22/31). Prevention of these fractures in impacts outside the area of required protection and in impacts with a straight edge would provide a significant increase in helmeted rider protection. Cervical spinal cord injury was sustained in facial, straight edge, and tangential impacts on the head. Motorcycle helmets are effective for preventing local skull fractures in impacts for which they are designed, whereas other serious injuries such as basilar skull fracture (BSF) and inertial brain injury persist despite helmet protection. Further impact test procedures should be developed for injurious impact types not currently assessed by major helmet standards, in particular facial impacts, and using test criteria based on commonly observed injuries. This study provides the necessary link, from impact load to injury, for guiding impact test development.	[Whyte, Thomas; Gibson, Tom] Univ Technol Sydney, Human Impact Engn, Sydney, NSW, Australia; [Eager, David] Univ Technol Sydney, Fac Engn & Informat Technol, Sch Elect Mech & Mechatron Syst, Sydney, NSW, Australia; [Milthorpe, Bruce] Univ Technol Sydney, Fac Sci, Sydney, NSW, Australia; [Anderson, Robert] Univ Adelaide, Ctr Automot Safety Res, Adelaide, SA, Australia		Whyte, T (corresponding author), Univ Technol Sydney, Human Impact Engn, CB11B4-107,POB 123, Broadway, NSW 2007, Australia.	Thomas.C.Whyte@student.uts.edu.au	Milthorpe, Bruce K/A-7014-2008; Milthorpe, Bruce/Z-1153-2019	Milthorpe, Bruce/0000-0002-0867-9586; Whyte, Tom/0000-0002-3562-3844			Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Alem N.M., 1982, SUPERIOR INFERIOR HE; Becker EB, 1998, BIOM HLTH R, V21, P113; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Centre for Road Safety Transport for NSW, 2013, ROAD TRAFF CRASH NEW, P93; Dowdell B, 1988, STUDY HELMET DAMAGE; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli TA, 1981, HEAD NECK INJURY CRI, P20; Gentry L., 2009, MAGNETIC RESONANCE I, P894; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Hopper R., 1994, STAPP CAR CRASH C FT, P125; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Liu BC, 2009, COCHRANE COLLAB, V1, P1; Mackay M, 2005, SOLID MECH APPL, V124, P3; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; Otte D., 1991, P 35 STAPP CAR CRASH, P335; Pang TY, 2011, INT J CRASHWORTHINES, V16, P297, DOI 10.1080/13588265.2011.559799; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Shaw Lindsay Alexander, 2014, THESIS; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; SIMPSON DA, 1989, J TRAUMA, V29, P1519, DOI 10.1097/00005373-198911000-00011; Singh A, 2011, APPL MECH MATER, V66-68, P1472, DOI 10.4028/www.scientific.net/AMM.66-68.1472; Thom D., 2001, P INT MOT SAF C KISS; Thom D.R., 1993, 37 ANN P ASS ADV AUT, V1; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; YAMAKI T, 1992, ACTA NEUROCHIR, V119, P153, DOI 10.1007/BF01541800	31	8	8	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2016	33	19					1802	1807		10.1089/neu.2015.4208			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DY8KP	WOS:000385379100010	26910490				2022-02-06	
J	Duclos, C; Dumont, M; Potvin, MJ; Desautels, A; Gilbert, D; Menon, DK; Bernard, F; Gosselin, N				Duclos, Catherine; Dumont, Marie; Potvin, Marie-Julie; Desautels, Alex; Gilbert, Danielle; Menon, David K.; Bernard, Francis; Gosselin, Nadia			Evolution of severe sleep-wake cycle disturbances following traumatic brain injury: a case study in both acute and subacute phases post-injury	BMC NEUROLOGY			English	Article						Traumatic brain injury; Sleep disorders; Actigraphy; Circadian rhythms; Neurocritical care; Neuropsychiatry	WRIST ACTIGRAPHY; DISORDERS; IMPACT; PAIN; DEPRIVATION; SCALE; POLYSOMNOGRAPHY; REHABILITATION; CLASSIFICATION; COMMUNICATION	Background: Sleep-wake disturbances are frequently reported following traumatic brain injury (TBI), but they remain poorly documented in the acute stage of injury. Little is known about their origin and evolution. Case presentation: This study presents the case of a patient in the acute phase of a severe TBI. The patient was injured at work when falling 12 m into a mine and was hospitalized in the regular wards of a level I trauma centre. From days 31 to 45 post-injury, once he had reached a level of medical stability and continuous analgosedation had been ceased, his sleep-wake cycle was monitored using actigraphy. Results showed significant sleep-wake disturbances and severe sleep deprivation. Indeed, the patient had an average nighttime sleep efficiency of 32.7 +/- 15.4 %, and only an average of 4.8 +/- 1.3 h of sleep per 24-h period. After hospital discharge to the rehabilitation centre, where he remained for 5 days, the patient was readmitted to the same neurological unit for paranoid delusions. During his second hospital stay, actigraphy recordings resumed from days 69 to 75 post-injury. A major improvement in his sleep-wake cycle was observed during this second stay, with an average nighttime sleep efficiency of 96.3 +/- 0.9 % and an average of 14.1 +/- 0.9 h of sleep per 24-h period. Conclusion: This study is the first to extensively document sleep-wake disturbances in both the acute and subacute phases of severe TBI. Results show that prolonged sleep deprivation can be observed after TBI, and suggest that the hospital environment only partially contributes to sleep-wake disturbances. Continuous actigraphic monitoring may prove to be a useful clinical tool in the monitoring of patients hospitalized after severe TBI in order to detect severe sleep deprivation requiring intervention. The direct impact of sleep-wake disturbances on physiological and cognitive recovery is not well understood within this population, but is worth investigating and improving.	[Duclos, Catherine; Dumont, Marie; Desautels, Alex; Gosselin, Nadia] Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local E-0300, Montreal, PQ H4J 1C5, Canada; [Duclos, Catherine; Dumont, Marie] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada; [Potvin, Marie-Julie; Gilbert, Danielle; Bernard, Francis] Hop Sacre Coeur Montreal, Traumatol Program, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada; [Desautels, Alex] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93, Cambridge CB2 2QQ, England; [Bernard, Francis] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gilbert, Danielle] Hop Sacre Coeur Montreal, Dept Radiol, 5400 Boul Gouin Ouest,Local E-0330, Montreal, PQ H4J 1C5, Canada		Gosselin, N (corresponding author), Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local E-0300, Montreal, PQ H4J 1C5, Canada.; Gosselin, N (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	nadia.gosselin@umontreal.ca		Potvin, Marie-Julie/0000-0001-5503-8063	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Fonds de la recherche du Quebec, Sante (FRQS); National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	The research was supported by the Canadian Institutes of Health Research (CIHR), by the Fonds de la recherche du Quebec, Sante (FRQS), which both provided funding for materials, data collection and research assistants. Studentship to CD was also provided by the CIHR, University of Montreal, by the Fondation Neurotrauma Marie-Robert, and by the J. A. De Seve foundation.	Acebo Christine, 2006, Respir Care Clin N Am, V12, P23; Barczi S, 2011, PRINCIPLES PRACTICE, P1524; Beecroft JM, 2008, INTENS CARE MED, V34, P2076, DOI 10.1007/s00134-008-1180-y; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Blood ML, 1997, SLEEP, V20, P388; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Dispersyn G, 2008, CHRONOBIOL INT, V25, P835, DOI 10.1080/07420520802551386; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Espana RA, 2011, SLEEP, V34, P845, DOI 10.5665/SLEEP.1112; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; GULEVICH G, 1966, ARCH GEN PSYCHIAT, V15, P29, DOI 10.1001/archpsyc.1966.01730130031005; Hagen C, 1972, RANCHO AMIGOS LEVELS; Holcomb EM, 2015, J HEAD TRAUMA REHABI; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Manian FA, 2015, AM J MED SCI, V349, P56, DOI 10.1097/MAJ.0000000000000355; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Peplow M, 2013, NATURE, V497, pS2, DOI 10.1038/497S2a; Ponsford JL, 2013, NEUROREHABIL NEURAL; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raymond I, 2004, SLEEP MED, V5, P551, DOI 10.1016/j.sleep.2004.07.007; Raymond I, 2001, PAIN, V92, P381, DOI 10.1016/S0304-3959(01)00282-2; Shamsuzzaman ASM, 2002, CIRCULATION, V105, P2462, DOI 10.1161/01.CIR.0000018948.95175.03; Sitnick SL, 2008, SLEEP, V31, P395, DOI 10.1093/sleep/31.3.395; Soehner AM, 2013, SLEEP MED CLIN, V8, P361, DOI 10.1016/j.jsmc.2013.04.007; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Sutton EL, 2014, MED CLIN N AM, V98, P1123, DOI 10.1016/j.mcna.2014.06.009; TEASDALE G, 1974, LANCET, V2, P81; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Wiseman-Hakes C, 2011, BRAIN INJURY, V25, P1256, DOI 10.3109/02699052.2011.608215	46	8	8	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	SEP 27	2016	16								186	10.1186/s12883-016-0709-x			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX6LS	WOS:000384495800001	27677675	Green Published, gold, Green Submitted			2022-02-06	
J	Gillis, MM; Garcia, S; Hampstead, BM				Gillis, M. Meredith; Garcia, Sarah; Hampstead, Benjamin M.			Working memory contributes to the encoding of object location associations: Support for a 3-part model of object location memory	BEHAVIOURAL BRAIN RESEARCH			English	Article						Hippocampus; Learning; Memory; fMRI; Working memory	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; SHORT-TERM-MEMORY; N-BACK TASK; FUNCTIONAL NEUROANATOMY; EFFECTIVE CONNECTIVITY; CONSTRUCT-VALIDITY; PREFRONTAL CORTEX; RHESUS-MONKEY; FMRI	A recent model by Postma and colleagues posits that the encoding of object location associations (OLAs) requires the coordination of several cognitive processes mediated by ventral (object perception) and dorsal (spatial perception) visual pathways as well as the hippocampus (feature binding) [1]. Within this model, frontoparietal network recruitment is believed to contribute to both the spatial processing and working memory task demands. The current study used functional magnetic resonance imaging (fMRI) to test each step of this model in 15 participants who encoded OLAs and performed standard n-back tasks. As expected, object processing resulted in activation of the ventral visual stream. Object in location processing resulted in activation of both the ventral and dorsal visual streams as well as a lateral frontoparietal network. This condition was also the only one to result in medial temporal lobe activation, supporting its role in associative learning. A conjunction analysis revealed areas of shared activation between the working memory and object in location phase within the lateral frontoparietal network, anterior insula, and basal ganglia; consistent with prior working memory literature. Overall, findings support Postma and colleague's model and provide clear evidence for the role of working memory during OLA encoding. Published by Elsevier B.V.	[Hampstead, Benjamin M.] Atlanta VAMC, Rehabil R&D Ctr Excellence, 1670 Clairmont Rd 151R, Decatur, GA 30033 USA; [Hampstead, Benjamin M.] VA Ann Arbor Hlth Care Syst, Mental Hlth Serv, 2215 Fuller Rd, Ann Arbor, MI 48105 USA; [Gillis, M. Meredith; Hampstead, Benjamin M.] Emory Univ, Sch Med, Ctr Rehabil Med, Dept Rehabil Med, 1441 Clifton Rd NE, Atlanta, GA 30322 USA; [Garcia, Sarah; Hampstead, Benjamin M.] Univ Michigan Hlth Syst, Dept Psychiat, Neuropsychol Sect, 2101 Commonwealth Blvd Suite C, Ann Arbor, MI 48105 USA		Hampstead, BM (corresponding author), Univ Michigan Hlth Syst, Dept Psychiat, Neuropsychol Sect, 2101 Commonwealth Blvd Suite C, Ann Arbor, MI 48105 USA.	bhampste@med.umich.edu			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and Rehabilitation Research and Development Service [B6366W]	None of the authors have any conflict of interest. This work was supported through grant funding from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and Rehabilitation Research and Development Service (grant B6366W to BMH). The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the United States Government.	Babor TF, 2001, AUDIT ALCOHOL USE DI; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1990, BECK ANXIETY INVENTO; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Carlson T, 2011, CORTEX, V47, P14, DOI 10.1016/j.cortex.2009.08.015; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cerasa A, 2008, BRAIN RES, V1201, P114, DOI 10.1016/j.brainres.2008.01.048; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Gillis M. M., 2014, BRAIN IMAGING BEHAV; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Hampstead BM, 2016, NEUROIMAGE, V124, P997, DOI 10.1016/j.neuroimage.2015.10.002; Hampstead BM, 2012, HIPPOCAMPUS, V22, P1652, DOI 10.1002/hipo.22006; Hampstead BM, 2012, NEUROPSYCHOLOGY, V26, P385, DOI 10.1037/a0027545; Hampstead BM, 2011, NEUROPSYCHOLOGIA, V49, P2349, DOI 10.1016/j.neuropsychologia.2011.04.008; Hampstead BM, 2011, NEUROREHAB NEURAL RE, V25, P210, DOI 10.1177/1545968310382424; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kearney-Ramos TE, 2014, J INT NEUROPSYCH SOC, V20, P736, DOI 10.1017/S135561771400054X; Kellenbach ML, 2005, CORTEX, V41, P121, DOI 10.1016/S0010-9452(08)70887-6; Kiyosawa M, 1996, GRAEF ARCH CLIN EXP, V234, P110, DOI 10.1007/BF00695250; Kwon H, 2001, AM J PSYCHIAT, V158, P1040, DOI 10.1176/appi.ajp.158.7.1040; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Manelis A, 2012, CEREB CORTEX, V22, P828, DOI 10.1093/cercor/bhr151; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Olson IR, 2006, J COGNITIVE NEUROSCI, V18, P1087, DOI 10.1162/jocn.2006.18.7.1087; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Passaro AD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00105; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Piekema C, 2006, NEUROIMAGE, V33, P374, DOI 10.1016/j.neuroimage.2006.06.035; Postle BR, 2000, NEUROIMAGE, V11, P409, DOI 10.1006/nimg.2000.0570; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; Sala JB, 2007, CORTEX, V43, P5, DOI 10.1016/S0010-9452(08)70442-8; SELTZER B, 1984, EXP BRAIN RES, V55, P301; Simons JS, 2003, NEUROIMAGE, V19, P613, DOI 10.1016/S1053-8119(03)00096-X; Sneve MH, 2013, J COGNITIVE NEUROSCI, V25, P1944, DOI 10.1162/jocn_a_00426; Spiers HJ, 2001, HIPPOCAMPUS, V11, P715, DOI 10.1002/hipo.1087; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Talairach J., 1988, COPLANAR STEREOTACTI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; WechslerD, 2001, WECHSLER TEST ADULT; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016	53	8	9	0	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 15	2016	311						192	200		10.1016/j.bbr.2016.05.037			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DS1XJ	WOS:000380418200021	27233825				2022-02-06	
J	Tao, X; Xu, ZW; Men, XM				Tao, Xin; Xu, Ziwei; Men, Xiaoming			Analysis of Serum microRNA Expression Profiles and Comparison with Small Intestinal microRNA Expression Profiles in Weaned Piglets	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CIRCULATING MICRORNAS; OXIDATIVE STRESS; BIOMARKERS; DISEASE; PLASMA; DIAGNOSIS; CANCER; CHALLENGE; DISORDERS	Weaning stress induces tissue injuries and impairs health and growth in piglets, especially during the first week post-weaning. MicroRNAs (miRNAs) play vital roles in regulating stresses and diseases. Our previous study found multiple differentially expressed miRNAs in small intestine of piglets at four days post-weaning. To better understand the roles of miRNAs during weaning stress, we analyzed the serum miRNA expressional profile in weaned piglets (at four days post-weaning) and in suckling piglets (control) of the same age using miRNA microarray technology. We detected a total of 300 expressed miRNAs, 179 miRNAs of which were differentially expressed between the two groups. The miRNA microarray results were validated by RT-qPCR. The biological functions of these differentially expressed miRNAs were predicted by GO terms and KEGG pathway annotations. We identified 10 highly expressed miRNAs in weaned piglets including miR-31, miR-205, and miR21 (upregulated) and miR-144, miR-30c-5p, miR-363, miR-194a, miR-186, miR-150, and miR-194b-5p (downregulated). Additionally, miR-194b-5p expression was significantly downregulated in serum and small intestine of weaned piglets. Our results suggest that weaning stress affects serum miRNA profiles in piglets. And serum miR-194b-5p levels can reflect its expressional changes in small intestine of piglets by weaning stress.	[Tao, Xin; Xu, Ziwei; Men, Xiaoming] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China		Xu, ZW (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China.	xzwfyz@sina.com			Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15C170004]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31101725]; Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research System of China [CARS-36]; National Key Technology R D ProgramNational Key Technology R&D Program [2012BAD39B03-04]; Agro-scientific Research in the Public Interest [201403047]	This work was supported by grants from the Zhejiang Provincial Natural Science Foundation (LY15C170004), the National Natural Science Foundation of China (31101725), the Science Technology Department of Zhejiang Province, the Modern Agro-industry Technology Research System of China (CARS-36), National Key Technology R & D Program (2012BAD39B03-04), and Agro-scientific Research in the Public Interest (201403047). The funders had no role in study collection, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Bao LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116067; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Ignacio C, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0195-x; Khan IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135440; Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592; Liao YL, 2013, GENES NUTR, V8, P69, DOI 10.1007/s12263-012-0297-3; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Liu YL, 2013, J NUTR, V143, P1799, DOI 10.3945/jn.113.179960; Madhavan Dharanija, 2013, Frontiers in Genetics, V4, P116, DOI 10.3389/fgene.2013.00116; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Murugaiyan G, 2015, ONCOTARGET, V6, P9644, DOI 10.18632/oncotarget.3928; Niculescu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140958; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sugiharto S, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-17; Tang WB, 2014, J CELL MOL MED, V18, P1580, DOI 10.1111/jcmm.12348; Tao X, 2016, CZECH J ANIM SCI, V61, P82, DOI 10.17221/8731-CJAS; Tao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079343; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang JQ, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0285-6; Wang X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0099-8; Wang XC, 2014, WORLD J GASTROENTERO, V20, P17914, DOI 10.3748/wjg.v20.i47.17914; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wozniak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125026; Yang CH, 2015, PHARMACEUTICALS, V8, P836, DOI 10.3390/ph8040836; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; Yao LQ, 2015, INT J CLIN EXP PATHO, V8, P7675; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Zhang H, 2012, WORLD J GASTROENTERO, V18, P5188, DOI 10.3748/wjg.v18.i37.5188; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	54	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162776	10.1371/journal.pone.0162776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	WOS:000383706900078	27632531	Green Published, gold			2022-02-06	
J	Hu, SK; Wu, G; Ding, X; Zhang, Y				Hu, Shukun; Wu, Gang; Ding, Xin; Zhang, Yi			Thrombin preferentially induces autophagy in glia cells in the rat central nervous system	NEUROSCIENCE LETTERS			English	Article						Intracerebral hemorrhage; Autophagy; Thrombin; Astrocyte; Neuron	EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; ASTROCYTES; APOPTOSIS; ISCHEMIA; DEATH	Autophagy widely occurs after intracerebral hemorrhage (ICH). In our previous study, we demonstrated that thrombin, a serine protease produced after hematoma, contributes to ICH-induced autophagy. However, whether thrombin plays a neuronal and/or astrocytic role in autophagy induction is largely unknown. Here, we examined the autophagic role of thrombin on neurons and glia cells, respectively. In vivo, we found that intracaudate injection of thrombin specifically elevated the astrocytic expression of beclin-1 and LC3, two autophagic markers, and promoted the formation of autophagic vacuoles within astrocytes rather than neurons in the ipsilateral basal ganglia. Consistent with this, thrombin enhanced the LC3-II level and increased the number of MDC-Iabeled autophagic vacuoles in cultured astrocytes. These results indicated that thrombin preferentially activated astrocytic autophagy after ICH, and therefore provided novel insights into the pathophysiological mechanisms and therapeutic targets for hemorrhage stroke and brain trauma. (C) 2016 Published by Elsevier Ireland Ltd.	[Hu, Shukun; Wu, Gang; Zhang, Yi] Fudan Univ, Affiliated Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai 200042, Peoples R China; [Ding, Xin] Soochow Univ, Affiliated Childrens Hosp, Div Neonatol, Suzhou 215003, Peoples R China		Zhang, Y (corresponding author), Fudan Univ, Affiliated Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai 200042, Peoples R China.	zhangyi@huashan.org.cn			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272374, 81501007]	This work was supported by Grants from the National Science Foundation of China (Nos. 81272374, and 81501007).	Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; CHOI BH, 1990, AM J PATHOL, V137, P741; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Fisher MJ, 2013, STROKE, V44, P3275, DOI 10.1161/STROKEAHA.113.000736; Gong Y, 2008, ACTA NEUROCHIR SUPPL, V105, P47; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Hu SK, 2011, BRAIN RES, V1424, P60, DOI 10.1016/j.brainres.2011.09.062; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lee JY, 2009, BRAIN RES, V1287, P126, DOI 10.1016/j.brainres.2009.06.028; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Yang SX, 2008, STROKE, V39, P2079, DOI 10.1161/STROKEAHA.107.508911; Zhong W., 2012, J MOL NEUROSCI, V46, P192	26	8	8	2	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 6	2016	630						53	58		10.1016/j.neulet.2016.07.023			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DV5ZG	WOS:000383008600008	27431453	Bronze			2022-02-06	
J	Amagasa, S; Matsui, H; Tsuji, S; Moriya, T; Kinoshita, K				Amagasa, Shunsuke; Matsui, Hikoro; Tsuji, Satoshi; Moriya, Takashi; Kinoshita, Kosaku			Accuracy of the history of injury obtained from the caregiver in infantile head trauma	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							YOUNG-CHILDREN; SUBDURAL-HEMATOMA; BRAIN-INJURY; FALL; BED; JAPAN; CARE	Objective: We investigated the accuracy of parental reports of infant trauma history. Methods: We retrospectively reviewed 166 infants from 3 tertiary institutions in Japan that had suffered a traumatic intracranial hemorrhage between 2002 and 2013. The infants were classified into 3 groups based on the parents' report of the mechanism of injury: the low-risk group consisted of injuries sustained from falling off a height below 3 ft. (n = 84); the middle-to-high-risk group comprised other mechanisms of injury (n = 54); and the unknown-risk group consisted of unknown mechanisms of injury (n = 28). The severity, neurological outcomes, clinical features, and evaluation for abuse were compared among these 3 groups. Results: Infants in the low-risk group had a higher severity, a worse neurological outcome, and a higher percentage of household injuries, retinal hemorrhage, subdural hematoma, and subdural hematoma suggestive of abusive head trauma (AHT) than those in the middle-to-high-risk group (P < .05). Infants in the unknown-risk group had the highest severity and the worst neurological outcomes, and a higher rate of features suggestive of AHT (P < .05). Conclusions: The accuracy of the history obtained from the caregivers of infants may be low in severe infantile head trauma. Therefore, medical professionals should treat themechanism of injury obtained from caregivers as secondary information and investigate for possible AHT in cases with inconsistencies between the history that was taken and the severity of the injury observed. (C) 2016 Elsevier Inc. All rights reserved.	[Amagasa, Shunsuke; Matsui, Hikoro] Nagano Childrens Hosp, Dept Pediat Intens Care, 3100 Toyoshina, Azumino City, Nagano 3998288, Japan; [Tsuji, Satoshi] Natl Ctr Child Hlth & Dev, Div Emergency Serv & Transport Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan; [Moriya, Takashi; Kinoshita, Kosaku] Nihon Univ, Sch Med, Dept Acute Med, Div Emergency & Crit Care Med,Itabashi Ku, 30-1 Otaniguti, Tokyo 1738610, Japan		Amagasa, S (corresponding author), Nagano Childrens Hosp, Dept Pediat Intens Care, 3100 Toyoshina, Azumino City, Nagano 3998288, Japan.	amagasa0828@gmail.com		Amagasa, Shunsuke/0000-0002-8371-1507			AOKI N, 1986, NEUROSURGERY, V18, P475, DOI 10.1227/00006123-198604000-00017; AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; DUHAIME AC, 1992, PEDIATRICS, V90, P179; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Fujiwara T, 2010, CLIN MED INSIGHTS-PE, V4, P11; Fung ELW, 2002, PEDIATR INT, V44, P37, DOI 10.1046/j.1442-200X.2002.01500.x; HELFER RE, 1977, PEDIATRICS, V60, P533; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelvin JD, 2001, SHAKEN BABY SYNDROME, P137; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; King WJ, 2003, CAN MED ASSOC J, V168, P155; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LEVENE S, 1991, ARCH DIS CHILD, V66, P1047, DOI 10.1136/adc.66.9.1047; LYONS TJ, 1993, PEDIATRICS, V92, P125; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	22	8	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2016	34	9					1863	1867		10.1016/j.ajem.2016.06.085			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DT7KA	WOS:000381664300024	27422215				2022-02-06	
J	Brettle, M; Patel, S; Fath, T				Brettle, Merryn; Patel, Shrujna; Fath, Thomas			Tropomyosins in the healthy and diseased nervous system	BRAIN RESEARCH BULLETIN			English	Article						Actin cytoskeleton; Tropomyosin; Neurite outgrowth; Central nervous system; Regeneration	PHOSPHATE-ACTIVATED GLUTAMINASE; AMYOTROPHIC-LATERAL-SCLEROSIS; BUNDLING PROTEIN FASCIN; ACTIN-FILAMENT FUNCTION; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; DENDRITIC SPINES; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; ARP2/3 COMPLEX	Regulation of the actin cytoskeleton is dependent on a plethora of actin-associated proteins in all eukaryotic cells. The family of tropomyosins plays a key role in controlling the function of several of these actin-associated proteins and their access to actin filaments. In order to understand the regulation of the actin cytoskeleton in highly dynamic subcellular compartments of neurons such as growth cones of developing neurons and the synaptic compartment of mature neurons, it is pivotal to decipher the functional role of tropomyosins in the nervous system. In this review, we will discuss the current understanding and recent findings on the regulation of the actin cytoskeleton by tropomyosins and potential implication that this has for the dysregulation of the actin cytoskeleton in neurological diseases. (C) 2016 Elsevier Inc. All rights reserved.	[Brettle, Merryn; Patel, Shrujna; Fath, Thomas] Univ New South Wales, Sch Med Sci, Neurodegenerat & Repair Unit, Sydney, NSW 2052, Australia		Fath, T (corresponding author), Univ New South Wales, Sch Med Sci, Neurodegenerat & Repair Unit, Sydney, NSW 2052, Australia.	t.fath@unsw.edu.au		Brettle, Merryn/0000-0001-8128-1251; Fath, Thomas/0000-0002-6877-7567; Patel, Shrujna/0000-0003-4928-692X	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1083209]	This work was supported by Project Grant APP1083209 from the Australian National Health and Medical Research Council (NHMRC) (T.F.). The authors would like to thank Dr Jeff Hook for his critical reading of the manuscript.	Aoki C, 2009, J COMP NEUROL, V517, P105, DOI 10.1002/cne.22137; Bach CTT, 2010, CELL ADHES MIGR, V4, P226, DOI 10.4161/cam.4.2.10888; Bae N, 2013, J PROTEOMICS, V80, P236, DOI 10.1016/j.jprot.2013.01.013; BAILEY K, 1946, NATURE, V157, P368, DOI 10.1038/157368b0; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Bhambhvani HP, 2016, NEUROREPORT, V27, P145, DOI 10.1097/WNR.0000000000000514; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Boopathy S, 2015, P NATL ACAD SCI USA, V112, P7984, DOI 10.1073/pnas.1424108112; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brayford S., 2016, CURR BIOL IN PRESS; Brettle M, 2015, NEUROSCI LETT, V609, P223, DOI 10.1016/j.neulet.2015.09.034; Brown JA, 2009, DEV NEUROBIOL, V69, P633, DOI 10.1002/dneu.20732; Bruneau EG, 2005, SCHIZOPHR RES, V75, P27, DOI 10.1016/j.schres.2004.12.012; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Bu YF, 2015, J BIOL CHEM, V290, P25395, DOI 10.1074/jbc.M115.644229; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Castano EM, 2013, NEUROCHEM INT, V62, P145, DOI 10.1016/j.neuint.2012.12.001; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chandrasekar I, 2013, J NEUROSCI, V33, P16131, DOI 10.1523/JNEUROSCI.2229-13.2013; Chevy Q, 2015, J NEUROSCI, V35, P15772, DOI 10.1523/JNEUROSCI.1735-15.2015; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Clinton SM, 2003, AM J PSYCHIAT, V160, P1100, DOI 10.1176/appi.ajp.160.6.1100; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Conrad CC, 2000, BIOCHEM BIOPH RES CO, V275, P678, DOI 10.1006/bbrc.2000.3356; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; Cox PR, 2003, MOL CELL NEUROSCI, V23, P1, DOI 10.1016/S1044-7431(03)00025-3; Creed SJ, 2011, EXP CELL RES, V317, P249, DOI 10.1016/j.yexcr.2010.10.019; Curthoys NM, 2014, MOL CELL NEUROSCI, V58, P11, DOI 10.1016/j.mcn.2013.10.011; Dachsel JC, 2010, PARKINSONISM RELAT D, V16, P650, DOI 10.1016/j.parkreldis.2010.08.018; Datta D, 2015, BIOL PSYCHIAT, V78, P775, DOI 10.1016/j.biopsych.2015.03.030; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Del Poggetto E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12332; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Dufour C, 1998, IMMUNOL CELL BIOL, V76, P424, DOI 10.1046/j.1440-1711.1998.00765.x; Dzamko N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00057; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fath Thomas, 2013, Biomol Concepts, V4, P89, DOI 10.1515/bmc-2012-0037; Fath T, 2011, EUR J CELL BIOL, V90, P291, DOI 10.1016/j.ejcb.2010.10.014; Fath T, 2010, EUR J CELL BIOL, V89, P489, DOI 10.1016/j.ejcb.2009.11.028; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Flynn KC, 2009, DEV NEUROBIOL, V69, P761, DOI 10.1002/dneu.20734; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Gaisler-Salomon I, 2009, NEUROPSYCHOPHARMACOL, V34, P2305, DOI 10.1038/npp.2009.58; GALLOWAY PG, 1987, J NEUROPATH EXP NEUR, V46, P185, DOI 10.1097/00005072-198703000-00006; GALLOWAY PG, 1991, BRAIN RES, V541, P347, DOI 10.1016/0006-8993(91)91036-Z; GALLOWAY PG, 1990, AM J PATHOL, V137, P291; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; GOLDMAN JE, 1983, J NEUROPATH EXP NEUR, V42, P146, DOI 10.1097/00005072-198303000-00004; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; Guven Kim, 2011, Bioarchitecture, V1, P284; HAD L, 1994, J CELL SCI, V107, P2961; Habig K, 2013, BBA-MOL BASIS DIS, V1832, P2352, DOI 10.1016/j.bbadis.2013.09.009; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; HIRANO A, 1968, J NEUROPATH EXP NEUR, V27, P167, DOI 10.1097/00005072-196804000-00001; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hook J, 2004, MOL CELL BIOL, V24, P2318, DOI 10.1128/MCB.24.6.2318-2323.2004; Hook Jeff, 2011, Bioarchitecture, V1, P49; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hsiao JY, 2015, CURR BIOL, V25, P1573, DOI 10.1016/j.cub.2015.04.038; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Ivanov A, 2009, J CELL SCI, V122, P524, DOI 10.1242/jcs.033464; Jayo A, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-72; Johnson M, 2014, CURR BIOL, V24, P1525, DOI 10.1016/j.cub.2014.05.034; Kalinderi K., 2016, ACTA NEUROL SCAND; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; Keeney JTR, 2015, J ALZHEIMERS DIS, V48, P411, DOI 10.3233/JAD-150348; Kett LR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009407; Kim IH, 2013, J NEUROSCI, V33, P6081, DOI 10.1523/JNEUROSCI.0035-13.2013; Kim Y H, 2006, SYNTHESIS LECT SOLID, V1, P1; Kis-Bicskei N, 2013, CYTOSKELETON, V70, P755, DOI 10.1002/cm.21143; Kojima N, 2016, NEUROSCIENCE, V324, P218, DOI 10.1016/j.neuroscience.2016.03.015; Kolomeets NS, 2005, SYNAPSE, V57, P47, DOI 10.1002/syn.20153; Kong KY, 2006, J BIOL CHEM, V281, P9589, DOI 10.1074/jbc.M512064200; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; Kvamme E, 2000, NEUROCHEM RES, V25, P1407, DOI 10.1023/A:1007668801570; LEESMILLER JP, 1990, MOL CELL BIOL, V10, P1729, DOI 10.1128/MCB.10.4.1729; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Li LJ, 2008, FREE RADICAL RES, V42, P354, DOI 10.1080/10715760802008114; Lim CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6951; Liu A, 2016, J CELL BIOL, V212, P449, DOI 10.1083/jcb.201509023; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Luo J, 2005, NEUROCHEM RES, V30, P291, DOI 10.1007/s11064-005-2602-7; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mantha AK, 2012, J NEUROSCI RES, V90, P1230, DOI 10.1002/jnr.23018; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Martins-De-Souza D, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-17; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Mello CF, 2007, NEUROSCIENCE, V147, P674, DOI 10.1016/j.neuroscience.2007.04.003; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; Moroz N, 2013, PEERJ, V1, DOI 10.7717/peerj.7; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; Ng JMJ, 2012, J CELL MOL MED, V16, P789, DOI 10.1111/j.1582-4934.2011.01361.x; Noor NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027465; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oliveira LT, 2015, BRAIN RES, V1615, P42, DOI 10.1016/j.brainres.2015.04.026; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Owen JB, 2009, J PROTEOME RES, V8, P471, DOI 10.1021/pr800667a; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; Sakurai M, 2003, J VASC SURG, V37, P446, DOI 10.1067/mva.2003.100; Schevzov G, 1997, MOL CELL NEUROSCI, V8, P439, DOI 10.1006/mcne.1997.0599; Schevzov G, 2005, MOL BIOL CELL, V16, P3425, DOI 10.1091/mbc.E04-10-0951; Schevzov Galina, 2011, Bioarchitecture, V1, P135; SHIRAO T, 1987, BRAIN RES, V413, P374, DOI 10.1016/0006-8993(87)91032-8; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Sonego M, 2013, J NEUROSCI, V33, P12171, DOI 10.1523/JNEUROSCI.0653-13.2013; STAMM S, 1993, P NATL ACAD SCI USA, V90, P9857, DOI 10.1073/pnas.90.21.9857; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Suarez C, 2015, DEV CELL, V32, P43, DOI 10.1016/j.devcel.2014.10.027; TemmGrove CJ, 1996, CELL MOTIL CYTOSKEL, V33, P223, DOI 10.1002/(SICI)1097-0169(1996)33:3<223::AID-CM6>3.0.CO;2-B; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Tristan-Clavijo E, 2015, NEUROBIOL AGING, V36, P3171, DOI 10.1016/j.neurobiolaging.2015.09.004; Ujfalusi Z, 2012, J BIOL CHEM, V287, P31894, DOI 10.1074/jbc.M112.341230; Ujfalusi Z, 2009, BIOPHYS J, V96, P162, DOI 10.1529/biophysj.108.138420; Vrhovski B, 2003, J NEUROSCI RES, V72, P373, DOI 10.1002/jnr.10586; Walton M, 1997, MOL BRAIN RES, V44, P167, DOI 10.1016/S0169-328X(96)00291-4; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watakabe A, 1996, J CELL SCI, V109, P2299; Wawro B, 2007, BIOCHEMISTRY-US, V46, P8146, DOI 10.1021/bi700686p; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wei Z, 2014, J NEUROCHEM, V130, P678, DOI 10.1111/jnc.12740; Weinberger R, 1996, J NEUROSCI, V16, P238; WEINBERGER RP, 1993, J CELL BIOL, V120, P205, DOI 10.1083/jcb.120.1.205; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Wolf M, 2015, CEREB CORTEX, V25, P2863, DOI 10.1093/cercor/bhu081; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu XM, 2013, J MOL HISTOL, V44, P37, DOI 10.1007/s10735-012-9461-8; Xia XW, 2012, WORLD NEUROSURG, V78, P689, DOI 10.1016/j.wneu.2011.07.042; Yamashiro S, 2008, J CELL SCI, V121, P3867, DOI 10.1242/jcs.040477; Yamashiro S, 2014, J BIOL CHEM, V289, P11616, DOI 10.1074/jbc.M114.555128; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; YAMAWAKIKATAOKA Y, 1987, J BIOL CHEM, V262, P10791; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zhou L, 2012, J BIOL CHEM, V287, P9346, DOI 10.1074/jbc.M111.302802	163	8	9	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2016	126		3		SI		311	323		10.1016/j.brainresbull.2016.06.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB8GJ	WOS:000387629200007	27298153				2022-02-06	
J	Chu, SF; Chiu, WT; Lin, HW; Chiang, YH; Liou, TH				Chu, Shu-Fen; Chiu, Wen-Ta; Lin, Hui-Wen; Chiang, Yung-Hsiao; Liou, Tsan-Hon			Hazard Ratio and Repeat Injury for Dementia in Patients With and Without a History of Traumatic Brain Injury: A Population-Based Secondary Data Analysis in Taiwan	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						traumatic brain injury; dementia; hazard ratio; population-based study; repeated injury	HEAD-INJURY; HYPOXIA; DISEASE; RISK	The impact of traumatic brain injury (TBI) on the pathogenic hazard ratio (HR) for dementia patients is still controversial. Some studies have supported the association between TBI and dementia, especially for Alzheimer's disease, and our study determined that the HR of dementia patients with and without a history of TBI or repeated TBI (RTBI). We determined the HR for dementia patients with a diagnosis of TBI (n = 12931) and a comparative cohort with age- and gender-matched controls (n = 51724) during 2004-2005, using Taiwan's National Health Insurance Research Database. The adjusted HR (HR = 3.21) for dementia patients with TBI showed that they were more likely to develop dementia than the comparison cohort. The HR for dementia patients with RTBI was increased to 3.62. The results of this large-scale study suggested that TBI increases dementia risk. Future studies using animal models and epidemiological databases could elucidate medical and biological mechanisms linking TBI and the development of dementia.	[Chu, Shu-Fen] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Neutrit, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth & Neutrit, Shuang Ho Hosp, Taipei, Taiwan; [Lin, Hui-Wen] Soochow Univ, Dept Math, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Dept Neurosurg, Shuang Ho Hosp, Taipei, Taiwan; [Liou, Tsan-Hon] Taipei Med Univ, Sch Med, Dept Rehabil, Coll Med, Taipei, Taiwan; [Liou, Tsan-Hon] Taipei Med Univ, Shuang Ho Hosp, Dept Rehabil, Taipei, Taiwan		Liou, TH (corresponding author), Taipei Med Univ, 250 Wu Hsing St, Taipei 110, Taiwan.	peter_liou@s.tmu.edu.tw	Liou, Tsan-Hon/I-8808-2019	Liou, Tsan-Hon/0000-0002-0959-4023	Injury Prevention and Disaster Medicine Research Foundation	The raw data for TBI patients and the comparison cohort are from the Taiwan National Health Insurance Research Database. The authors declare that no conflict of interest is associated with this research. The study was supported by the Injury Prevention and Disaster Medicine Research Foundation.	Beltowski J, 2010, J PHARMACOL EXP THER, V334, P358, DOI 10.1124/jpet.110.166637; Bharucha AJ, 2009, AM J GERIAT PSYCHIAT, V17, P88, DOI 10.1097/JGP.0b013e318187dde5; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; CHEN CH, 1985, STAT MED, V4, P39, DOI 10.1002/sim.4780040107; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fuh J.L., 2008, TAIWAN GERIATR GERON, V3, P169, DOI [10.29461/TGG.200808.0002, DOI 10.29461/TGG.200808.0002]; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hung C C, 1991, J Formos Med Assoc, V90, P1227; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Lewy-Trenda Iwona, 2002, Polish Journal of Pathology, V53, P129; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Oka H., 2011, EVID-BASED COMPL ALT, V2011; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rota-Bartelink Alice, 2010, Care Manag J, V11, P112; Scarpino S, 2004, J PATHOL, V202, P352, DOI 10.1002/path.1522; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Winkler L, 1989, Przegl Lek, V46, P595	31	8	8	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	SEP	2016	28	6					519	527		10.1177/1010539516662956			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DV4AF	WOS:000382866500006	27614252				2022-02-06	
J	Doucette, ML; Bulzacchelli, MT; Gillum, TL; Whitehill, JM				Doucette, Mitchell L.; Bulzacchelli, Maria T.; Gillum, Tameka L.; Whitehill, Jennifer M.			The Massachusetts School Sports Concussions Law: A Qualitative Study of Local Implementation Experiences	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							LEGISLATION; KNOWLEDGE; SERVICES; INJURY	Background: Reducing the incidence and negative consequences of concussion among youth athletes is a public health priority. In 2010, Massachusetts passed legislation aimed at addressing the issue of concussions in school athletics. We sought to understand local-level implementation decisions of the Massachusetts concussion law. Methods: A qualitative multiple-case study approach was utilized. Semi-structured interviews with school-employed actors associated with the law's implementation were used for analysis. Interview data were subjected to a conventional content analysis. Results: A total of 19 participants from 5 schools were interviewed. Schools were purposefully selected from communities varying in socioeconomic status and population. Participants included 5 athletic directors, 5 coaches, 4 athletic trainers, 4 school nurses, and 1 health and wellness coordinator. Eight themes emerged regarding specific ways schools have implemented the law. Six themes emerged regarding factors influencing implementation. Conclusions: All cases employ neurocognitive testing as a means to assess concussions, place decision-making authority in athletic trainers' hands, and use a 30-minute online video to disseminate concussion education. Employing athletic trainers could pose challenges to school districts with limited financial capacity, as financial assistance from the state is not provided under the law. The validity of neurocognitive testing and the effectiveness of online concussion training need further study. Cooperation from student athletes, their parents, and physicians is necessary for full implementation of the law.	[Doucette, Mitchell L.] Univ Massachusetts, Amherst, MA 01003 USA; [Bulzacchelli, Maria T.; Gillum, Tameka L.; Whitehill, Jennifer M.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Promot & Policy, Amherst, MA 01003 USA		Doucette, ML (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.			Doucette, Mitchell/0000-0002-5558-2218			Alsalaheen B, 2015, J HEAD TRAUMA REHABI; Baugh CM, 2015, J LAW BIOSCI, V2, P449, DOI 10.1093/jlb/lsv023; Burris S, 2010, MILBANK Q, V88, P169, DOI 10.1111/j.1468-0009.2010.00595.x; Centers for Disease Control and Prevention, IMPL RET PLAY LEARN; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T., 2012, AM J SPORTS MED, V20, P1; Coyne T. I., 1996, J ADV NURS, V26, P623; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; GOLDING D, 1992, RISK ANAL, V12, P27, DOI 10.1111/j.1539-6924.1992.tb01304.x; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Institute of Medicine, 2013, SPORTS RELATED CONCU; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McDermott KA, 2006, J PUBL ADM RES THEOR, V16, P45, DOI 10.1093/jopart/mui024; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016	24	8	8	1	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	FAL	2016	44	3					503	513		10.1177/1073110516667946			11	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	DV6IA	WOS:000383035900013	27587454				2022-02-06	
J	Lapchak, PA; Boitano, PD				Lapchak, Paul A.; Boitano, Paul D.			A novel method to promote behavioral improvement and enhance mitochondrial function following an embolic stroke	BRAIN RESEARCH			English	Article						Disease of aging; Neurodegeneration; Ischemic stroke; Cerebral blood flow; Neuroprotection; Thrombolysis; Combination therapy; transcranial laser therapy; photobiostimulation	ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; INFRARED-LASER THERAPY; CLINICAL RATING SCORES; TRAUMATIC BRAIN-INJURY; THROMBOLYTIC THERAPY; TRANSCRANIAL LASER; LIGHT THERAPY; NEUROTHERA EFFECTIVENESS; RABBITS	Tissue plasminogen activator (tPA) is the only FDA-approved treatment for stroke; tPA increases cerebral reperfusion, blood flow and improved behavior. Novel transcranial laser therapy (TLT) also enhances cerebral blood flow and activates mitochondrial function. Using the rabbit small clot embolic stroke model (RSCEM), we studied the effects of continuous wave TLT (7.5 mW/cm(2)) alone or in combination with standardized intravenous (IV) tPA (3.3 mg/kg) applied 1 h post-embolization on 3 endpoints: 1) behavioral function measured 2 days [effective stroke dose (P-50 in mg) producing neurological deficits in 50% of embolized rabbits], 2) intracerebral hemorrhage (ICH) rate, and 3) cortical adenosine-5'-triphosphate (ATP) content was measured 6 h following embolization. TLT and tPA significantly (p < 0.05) increased P-50 values by 95% and 56% (p < 0.05), respectively over control. TLT-tPA increased P-50 by 136% over control (p < 0.05). Embolization reduced cortical ATP content by 39%; decreases that were attenuated by either TLT or tPA treatment (p < 0.05). TLT-tPA further enhanced cortical ATP levels 22% above that measured in naive control. TLT and tPA both effectively and safely, without affecting ICH rate, improved behavioral outcome in embolized rabbits; and there was a trend (p > 0.05) for the TLT-tPA combination to further increase P-50. TLT and tPA both attenuated stroke-induced ATP deficits, and the combination of tPA and TLT produced an additive effect on ATP levels. This study demonstrates that the combination of TLT-tPA enhances ATP production, and suggests that tPA-induced reperfusion in combination with TLT neuroprotection therapy may optimally protect viable cells in the cortex measured using ATP levels as a marker. (C) 2016 Elsevier B.V. All rights reserved.	[Lapchak, Paul A.; Boitano, Paul D.] Cedars Sinai Med Ctr, Dept Neurol & Neurosurg, Adv Hlth Sci Pavil Suite 8305, Los Angeles, CA 90048 USA		Lapchak, PA (corresponding author), Cedars Sinai Med Ctr, Dept Neurol & Neurosurg, Adv Hlth Sci Pavil Suite 8305, Los Angeles, CA 90048 USA.	Paul.Lapchak@cshs.org; paul.boitano@cshs.org	Lapchak, Paul/P-1845-2019	Lapchak, Paul/0000-0003-4413-7554	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS060685]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS060685] Funding Source: NIH RePORTER	This study was supported by donations to fund stroke research. This research was not directly supported by NIH or any other institutional funding source. PAL was partially supported by NINDS (NS060685).	Alper BS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1075; Beadell NC, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0657-x; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; del Zoppo G, 1988, CURR CONCEPTS CEREBR, V23, P7; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Ginsberg MD, 2015, INT J STROKE, V10, P494, DOI 10.1111/ijs.12476; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Jayaraman MV, 2015, J NEUROINTERV SURG, V7, P316, DOI 10.1136/neurintsurg-2015-011717; Kasner SE, 2013, STROKE, V44, P2025, DOI 10.1161/STROKEAHA.113.000870; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lampl Yair, 2007, Expert Rev Neurother, V7, P961, DOI 10.1586/14737175.7.8.961; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lansberg MG, 2009, STROKE, V40, P2438, DOI 10.1161/STROKEAHA.109.552547; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2004, EXP NEUROL, V188, P286, DOI 10.1016/j.expneurol.2004.03.003; Lapchak PA, 2004, EXP NEUROL, V185, P154, DOI 10.1016/j.expneurol.2003.09.009; Lapchak PA, 2002, EXPERT OPIN INV DRUG, V11, P1623, DOI 10.1517/13543784.11.11.1623; Lapchak PA, 2000, STROKE, V31, P3034, DOI 10.1161/01.STR.31.12.3034; Lapchak PA, 2008, BRAIN RES, V1238, P208, DOI 10.1016/j.brainres.2008.08.017; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Lapchak PA, 2015, TRANSL STROKE RES, V6, P345, DOI 10.1007/s12975-015-0419-5; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Lapchak PA, 2015, EXP NEUROL, V266, P143, DOI 10.1016/j.expneurol.2015.02.016; Lapchak PA, 2015, TRANSL STROKE RES, V6, P99, DOI 10.1007/s12975-015-0386-x; Lapchak PA, 2013, STROKE, V44, P841, DOI 10.1161/STROKEAHA.112.680439; Lapchak PA, 2012, SPR SER TRANSL STROK, P541, DOI 10.1007/978-1-4419-9530-8_27; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, TRANSL STROKE RES, V1, P96, DOI 10.1007/s12975-010-0018-4; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Lapchak PA, 2010, BRAIN RES, V1309, P136, DOI 10.1016/j.brainres.2009.10.067; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Lapchak PA, 2009, BRAIN RES, V1294, P211, DOI 10.1016/j.brainres.2009.07.058; Li M, 2016, STROKE, V47, P187, DOI 10.1161/STROKEAHA.115.009687; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Lyden PD, 2006, LANCET NEUROL, V5, P722, DOI 10.1016/S1474-4422(06)70530-0; Lyden PD, 2006, NAT CLIN PRACT CARD, V3, P184, DOI 10.1038/ncpcardio0511; LYDEN PD, 1989, NEUROLOGY, V39, P703, DOI 10.1212/WNL.39.5.703; Medeiros DM, 2002, J BIOENERG BIOMEMBR, V34, P389, DOI 10.1023/A:1021206220851; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Pitzschke A, 2015, PHYS MED BIOL, V60, P2921, DOI 10.1088/0031-9155/60/7/2921; Pitzschke A, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.2.025006; Smith WS, 2015, STROKE, V46, P3012, DOI 10.1161/STROKEAHA.115.010817; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; THOMAS GR, 1993, J PHARMACOL EXP THER, V264, P67; Urban I., 1972, STEREOTAXIC ATLAS NZ; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577; Weiner GM, 2015, NEUROSURGERY, V76, pN15, DOI 10.1227/01.neu.0000465854.55834.37; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988; ZIVIN JA, 1992, STROKE, V23, P767, DOI 10.1161/01.STR.23.5.767; ZIVIN JA, 1987, BRAIN RES, V435, P305, DOI 10.1016/0006-8993(87)91613-1; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754; ZIVIN JA, 1988, ARCH NEUROL-CHICAGO, V45, P387, DOI 10.1001/archneur.1988.00520280033012; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	69	8	8	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2016	1646						125	131		10.1016/j.brainres.2016.04.039			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT9TH	WOS:000381844700014	27180104				2022-02-06	
J	Liraz-Zaltsman, S; Yaka, R; Shabashov, D; Shohami, E; Biegon, A				Liraz-Zaltsman, Sigal; Yaka, Rami; Shabashov, Dalia; Shohami, Esther; Biegon, Anat			Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Cognitive deficits; NMDA receptors; Endotoxin; LPS; DCS; Neuroinflammation	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; CLOSED-HEAD INJURY; PERIPHERAL BENZODIAZEPINE-RECEPTORS; AGONIST D-CYCLOSERINE; NMDA RECEPTORS; MOUSE MODEL; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; DYNAMIC CHANGES	Cognitive deficits, especially memory loss, are common following many types of brain insults which are associated with neuroinflammation, although the underlying mechanisms are not entirely clear. The present study aimed to characterize the long-term cognitive and behavioral impairments in a mouse model of neuroinflammation in the absence of other insults and to evaluate the therapeutic potential of d-cycloserine (DCS). DCS is a co-agonist of the NMDA receptor that ameliorates cognitive deficits in models of TBI and stroke. Using a mouse model of global neuroinflammation induced by intracisternal (i.c.) administration of endotoxin (LPS), we found long-lasting microgliosis, memory deficits, impaired LTP, and reduced levels of the obligatory NR1 subunit of the NMDA receptor. A single administration of DCS, 1 day after i.c. LPS reduced microgliosis, reversed the cognitive deficits and restored LTP and NR1 levels. These results demonstrate that neuroinflammation alone, in the absence of trauma or ischemia, can cause persistent (> 6 months) memory deficits linked to deranged NNMDA receptor function and suggest a possible role for NMDA co-agonists in reducing the cognitive sequelae of neuroinflammation.	[Liraz-Zaltsman, Sigal; Biegon, Anat] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel; [Liraz-Zaltsman, Sigal; Yaka, Rami; Shabashov, Dalia; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, Jerusalem, Israel; [Biegon, Anat] SUNY Stony Brook, Sch Med, Dept Neurol, Stony Brook, NY 11794 USA		Liraz-Zaltsman, S (corresponding author), Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel.	s.lirazaltsman@gmail.com; Yaka-ramiy@ekmd.huji.ac.il; dalia.shabashov@mail.huji.ac.il; esty@cc.huji.ac.il; anatbiegon@gmail.com			BSFUS-Israel Binational Science Foundation [2005-021-01]	This work was supported by a BSF grant # 2005-021-01 to ES and AB.	Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Andersen JM, 2002, BEHAV BRAIN RES, V129, P211, DOI 10.1016/S0166-4328(01)00318-7; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Biegon A, 2002, J NEUROCHEM, V82, P924, DOI 10.1046/j.1471-4159.2002.01050.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOJE KMK, 1995, J PHARMACOL EXP THER, V274, P1199; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; de Araujo Furtado M, 2012, NEUROTOXICOLOGY; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dhawan J, 2011, FUTUR NEUROL, V6, P823, DOI 10.2217/FNL.11.55; Dhawan J, 2010, NEUROIMAGE, V51, P599, DOI 10.1016/j.neuroimage.2010.02.073; Donzis EJ, 2014, NEUROSCI LETT, V571, P50, DOI 10.1016/j.neulet.2014.04.035; Duncan EJ, 2004, SCHIZOPHR RES, V71, P239, DOI 10.1016/j.schres.2004.03.013; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Grossman R, 2012, FUTUR NEUROL, V7, P329, DOI 10.2217/FNL.12.25; GUILARTE TR, 1995, NEUROTOXICOLOGY, V16, P441; Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y; Hauss-Wegrzyniak B, 2000, BRAIN RES, V859, P157, DOI 10.1016/S0006-8993(00)01999-5; Heifets L B, 1994, Semin Respir Infect, V9, P84; Henry G K, 2000, Appl Neuropsychol, V7, P65, DOI 10.1207/S15324826AN0702_1; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Ho YJ, 2011, BEHAV BRAIN RES, V219, P280, DOI 10.1016/j.bbr.2011.01.028; Hofmann SG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0532-2; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Hovens IB, 2012, BRAIN BEHAV IMMUN, V26, P1169, DOI 10.1016/j.bbi.2012.06.004; Kelly DL, 2015, J CLIN PSYCHOPHARM, V35, P374, DOI 10.1097/JCP.0000000000000345; Kravitz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081244; Laake K, 2002, Cochrane Database Syst Rev, V2; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Levite M, 2014, J NEURAL TRANSM, V121, P1029, DOI 10.1007/s00702-014-1193-3; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Muller N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00372; Noble F, 2007, NEUROSCI LETT, V424, P106, DOI 10.1016/j.neulet.2007.07.005; Onur OA, 2010, BIOL PSYCHIAT, V67, P1205, DOI 10.1016/j.biopsych.2010.01.022; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Pawlak CR, 2012, KAOHSIUNG J MED SCI, V28, P407, DOI 10.1016/j.kjms.2012.02.010; Pozniak PD, 2014, J NEUROIMMUNE PHARM, V9, P133, DOI 10.1007/s11481-013-9517-x; Qiu W, 2015, MICROBIOL MOL ORAL; Rao AAN, 2011, J NEURO-ONCOL, V105, P191, DOI 10.1007/s11060-011-0582-9; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rodriguez Juan I, 2011, Neuron Glia Biol, V7, P205, DOI 10.1017/S1740925X12000142; Rouaud E, 2003, BRIT J PHARMACOL, V140, P1051, DOI 10.1038/sj.bjp.0705541; Sauvage MM, 2013, BEHAV BRAIN RES, V254, P22, DOI 10.1016/j.bbr.2013.04.048; Schneider JS, 2000, BRAIN RES, V860, P190, DOI 10.1016/S0006-8993(00)02036-9; Scoccianti S, 2012, J NEURO-ONCOL, V108, P291, DOI 10.1007/s11060-012-0821-8; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Sheppard E, 2012, EPILEPSY RES TREAT, V2012, DOI DOI 10.1155/2012/984124.EPUB; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; SIMIAND J, 1984, PSYCHOPHARMACOLOGY, V84, P48, DOI 10.1007/BF00432023; Sparkman NL, 2005, PHYSIOL BEHAV, V86, P244, DOI 10.1016/j.physbeh.2005.07.016; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Stein TD, 2015, NEUROPATHOL ACTA; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; Sun LX, 1998, FEBS LETT, V441, P392, DOI 10.1016/S0014-5793(98)01590-7; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Thiel A, 2014, STROKE, V45, P2825, DOI 10.1161/STROKEAHA.114.004285; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tyler AL, 2012, J NEUROSCI, V32, P11365, DOI 10.1523/JNEUROSCI.1516-12.2012; Vogt MA, 2016, BEHAV BRAIN RES, V301, P96, DOI 10.1016/j.bbr.2015.12.015; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Zerche M, 2015, STROKE, V46, P1180, DOI 10.1161/STROKEAHA.114.008323	82	8	8	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2016	60	1					46	62		10.1007/s12031-016-0786-8			17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DU3US	WOS:000382138300006	27421842				2022-02-06	
J	Polito, F; Cicciu', M; Aguennouz, M; Cucinotta, M; Cristani, M; Lauritano, F; Sindoni, A; Gioffre'-Florio, M; Fama, F				Polito, Francesca; Cicciu', Marco; Aguennouz, Mohammed; Cucinotta, Maria; Cristani, Mariateresa; Lauritano, Floriana; Sindoni, Alessandro; Gioffre'-Florio, Maria; Fama, Fausto			Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study	INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY			English	Article						high-mobility group box-1 (HMGB1); Injury Severity Score; multiple trauma; nuclear factor erythroid 2-related (Nrf2); outcome; oxidative stress markers	MOBILITY GROUP BOX-1; BRAIN-INJURY	Serious multiple traumatic injuries may rapidly become fatal or be complicated by a life-threatening sequelae leading to a significant increase of the mortality rate. Trauma scoring systems are used to evaluate the critical status of the patient and recently many different biomarkers have been taken into account to better estimate the potential clinical outcome. The aim of the present study is to analyse the expression pattern of high-mobility group box-1 (HMGB1), oxidative stress markers and nuclear factor erythroid 2-related (Nrf2) in critically ill traumatic patients (at hospital admittance and after 6 and 24 h), in order to find out their potential role as early post-traumatic predictors markers. Forty-seven patients admitted for multiple trauma and 15 healthy participants were prospectively recruited. Eight patients (17%) died within 92 h of admission; this subgroup of patients presented the highest severity scores and their HMGB1 expression levels were significantly correlated with ISS, whereas patients with higher ISS exhibited higher levels of HMGB1 (P <0.001). Our study suggests the role of HMGB1 as a predictive biomarker of outcome in injured patients and hypothesizes the protective role of Nrf2 in bringing down the oxidative stress and HMGB1 release; measuring HMGB1 in combination with Nrf2 might represent a potentially useful tool in the early detection of post-trauma complications.	[Polito, Francesca; Lauritano, Floriana; Sindoni, Alessandro] Univ Hosp Messina, Dept Biomed & Dent Sci & Morphol & Funct Images, Messina, Italy; [Cicciu', Marco; Gioffre'-Florio, Maria; Fama, Fausto] Univ Hosp Messina, Dept Human Pathol, Messina, Italy; [Aguennouz, Mohammed; Cucinotta, Maria] Univ Hosp Messina, Dept Clin & Expt Med, Messina, Italy; [Cristani, Mariateresa] Univ Messina, Dept Drug Sci & Hlth Prod, Messina, Italy		Cicciu', M (corresponding author), Univ Messina, Sch Dent, Dept Human Pathol, Via Consolare Valeria, I-98100 Messina, Italy.	acromarco@yahoo.it	Fama', Fausto/L-3071-2015; Sindoni, Alessandro/AAF-6877-2020; Ciccio, Marco/Q-2671-2015	Fama', Fausto/0000-0002-9017-1991; Ciccio, Marco/0000-0001-7058-4126; Gioffre'-Florio, Maria/0000-0001-8781-9008; Lauritano, Floriana/0000-0001-5948-3658; SINDONI, ALESSANDRO/0000-0002-7564-0518			Bitto A, 2010, PHARMACOL RES, V61, P116, DOI 10.1016/j.phrs.2009.07.014; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Gunn ML, 2015, RADIOL CLIN N AM, V53, P639, DOI 10.1016/j.rcl.2015.02.006; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Roth E, 2004, CURR OPIN CLIN NUTR, V7, P161, DOI 10.1097/00075197-200403000-00010; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247	12	8	8	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0394-6320			INT J IMMUNOPATH PH	Int. J. Immunopathol. Pharmacol.	SEP	2016	29	3					504	509		10.1177/0394632016656187			6	Immunology; Pathology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pathology; Pharmacology & Pharmacy	DU4VF	WOS:000382210000021	27343243	Green Published, Bronze			2022-02-06	
J	Popescu, M; Hughes, JD; Popescu, EA; Riedy, G; DeGraba, TJ				Popescu, Mihai; Hughes, John D.; Popescu, Elena-Anda; Riedy, Gerard; DeGraba, Thomas J.			Reduced prefrontal MEG alpha-band power in mild traumatic brain injury with associated posttraumatic stress disorder symptoms	CLINICAL NEUROPHYSIOLOGY			English	Article						Post-traumatic stress disorder; Traumatic brain injury; Resting-state; Alpha-band oscillations; Magnetoencephalography	NUCLEUS-ACCUMBENS; NETWORK CONNECTIVITY; OSCILLATORY ACTIVITY; EEG; VETERANS; CORTEX; RISK; MECHANISMS; RHYTHMS; ANXIETY	Objective: To determine if changes in cortical alpha-band power in patients with mild traumatic brain injury (mTBI) are associated with the severity of their post-traumatic stress disorder (PTSD) symptoms, and if injury severity and level of exposure to psychologically traumatic events are predictors of these electrophysiological changes. Methods: Resting-state magnetoencephalographic recordings were analyzed in 32 patients with mTBI. Alpha-band power was estimated for each patient in 68 cortical regions and was compared between groups of patients with low versus high PTSD symptoms severity. Results: Participants with high PTSD symptom severity showed reduced alpha-band power bilaterally in the superior and middle frontal gyri and frontal poles, and in the left inferior frontal gyrus. Alpha-band power in bilateral middle frontal gyri and frontal poles was negatively correlated with scores reflecting symptoms of emotional numbing. Loss of consciousness (LOC) associated with mTBI and level of exposure to psychologically traumatic events were predictors of decreased prefrontal alpha-band power in some of these regions. Conclusion: Altered prefrontal alpha-band activity, shown to be partly explained by mTBI-related LOC, is associated with PTSD symptoms severity. Significance: Our findings will guide future studies addressing the electrophysiological mechanisms underlying a higher incidence of PTSD in patients with mTBI. Published by Elsevier Ireland Ltd on behalf of International Federation of Clinical Neurophysiology.	[Popescu, Mihai; Hughes, John D.; Popescu, Elena-Anda; Riedy, Gerard; DeGraba, Thomas J.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Hughes, John D.] Naval Med Res Ctr, Dept NeuroTrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Hughes, JD (corresponding author), Naval Med Res Ctr, Dept NeuroTrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	john.d.hughes4.mil@mail.mil					American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P760; Babiloni C, 2013, CLIN NEUROPHYSIOL, V124, P837, DOI 10.1016/j.clinph.2012.09.017; Babiloni C, 2009, HUM BRAIN MAPP, V30, P1431, DOI 10.1002/hbm.20612; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bordbar MRF, 2013, J CLIN PSYCHOPHARM, V33, P706, DOI 10.1097/JCP.0b013e31829a88ed; Bosboom JLW, 2009, CLIN NEUROPHYSIOL, V120, P910, DOI 10.1016/j.clinph.2009.03.004; Brassen S, 2003, PHARMACOPSYCHIATRY, V36, P304; Brooks JA, 2007, NEUROPHARMACOLOGY, V53, P455, DOI 10.1016/j.neuropharm.2007.06.006; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davidson RJ, 2000, NEUROPSYCHOLOGY EMOT, P269, DOI DOI 10.1016/S0959-4388(99)80032-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DiGangi JA, 2016, NEUROSCI LETT, V615, P37, DOI 10.1016/j.neulet.2016.01.010; Ebert U, 2001, J CLIN PHARMACOL, V41, P51, DOI 10.1177/00912700122009836; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Heller W, 1998, CURRENT DIRECTIONS P, V7, P2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horschig JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138685; Howlett JR, 2015, TRANSLATIONAL RES TR; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2006, J COGNITIVE NEUROSCI, V18, P1266, DOI 10.1162/jocn.2006.18.8.1266; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; Kikuchi M, 1999, NEUROPSYCHOBIOLOGY, V39, P219, DOI 10.1159/000026588; Kluetsch RC, 2014, ACTA PSYCHIAT SCAND, V130, P123, DOI 10.1111/acps.12229; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lega BC, 2011, NEUROREPORT, V22, P795, DOI 10.1097/WNR.0b013e32834b2975; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Philip NS, 2013, EUR NEUROPSYCHOPHARM, V23, P24, DOI 10.1016/j.euroneuro.2012.10.008; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; SANTAMARIA J, 1987, J CLIN NEUROPHYSIOL, V4, P327, DOI 10.1097/00004691-198710000-00002; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Sebban C, 1999, BRIT J PHARMACOL, V128, P1045, DOI 10.1038/sj.bjp.0702894; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Taghva A, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.27360; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Tenovuo OS, 2006, CURR DRUG THER, V1, P187, DOI 10.2174/157488506776930932; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Tschiffely AE, 2015, J NEUROSCI RES, V93, P1769, DOI 10.1002/jnr.23641; Veltmeyer Melinda D., 2006, Journal of Integrative Neuroscience, V5, P123, DOI 10.1142/S0219635206001057; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zmarowski A, 2007, SYNAPSE, V61, P115, DOI 10.1002/syn.20354	74	8	8	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	SEP	2016	127	9					3075	3085		10.1016/j.clinph.2016.06.004			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS9CQ	WOS:000381080400016	27472543				2022-02-06	
J	Stary, JM; Hutchins, L; Vega, RA				Stary, Joel M.; Hutchins, Leslie; Vega, Rafael A.			Tranexamic Acid for Recurring Subdural Hematomas Following Surgical Evacuation: A Clinical Case Series	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						craniotomy; subdural hematoma; tranexamic acid; traumatic brain injury	RECURRENCE; FIBRINOLYSIS; METAANALYSIS; COAGULATION; HEMORRHAGE	Background Chronic subdural hematomas (SDHs) are commonly encountered in neurosurgery. Optimal management of SDHs remains a significant challenge. Current treatment options generally include supportive care or surgical intervention. A significant proportion of patients have surgery; however, the reoperation rate is considered high. There are also cases in which additional surgical procedures would carry significant morbidity, and as a result, there is a need for nonsurgical medical therapies. We describe the use of tranexamic acid (TXA) as a nonsurgical option for the treatment of recurrent SDHs following surgery. Methods Patients were identified as candidates for potential TXA therapy and followed prospectively. The decision to administer TXA was made on the basis of history, presentation, and prognosis after further surgical intervention. Data collected included patient imaging, treatment administered, and both radiologic and clinical outcomes. Results Three patients underwent surgical evacuation of a chronic SDH (two via burr hole washout and one via craniotomy). All patients had recurrence identified on subsequent imaging. Two patients had poorer predicted outcomes if additional surgical intervention was necessary, and one refused additional surgical intervention. TXA was administered, in the same dosing and scheduled course, to all patients. Complete resolution was observed on imaging, and in the case of the patient who was symptomatic, clinical improvement was also noted. Conclusion TXA may be considered for the treatment of recurrent SDHs following surgical evacuation in patients for whom additional surgery would add significant morbidity.	[Stary, Joel M.; Hutchins, Leslie; Vega, Rafael A.] Virginia Commonwealth Univ Hlth Syst, Dept Neurosurg, Med Coll Virginia, 417 N 11th St,6th Floor, Richmond, VA 23298 USA		Vega, RA (corresponding author), Virginia Commonwealth Univ Hlth Syst, Dept Neurosurg, Med Coll Virginia, 417 N 11th St,6th Floor, Richmond, VA 23298 USA.	rafael.vega@vcuhealth.org					Borger V, 2012, ACTA NEUROCHIR, V154, P1549, DOI 10.1007/s00701-012-1434-x; Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9; Ducloy-Bouthors AS, 2011, CRIT CARE, V15, DOI 10.1186/cc10143; FUJISAWA H, 1995, J NEUROL NEUROSUR PS, V59, P388, DOI 10.1136/jnnp.59.4.388; Garber S, 2016, J NEUROL SURG PART A, V77, P233, DOI 10.1055/s-0035-1570128; Goksu E, 2009, ULUS TRAVMA ACIL CER, V15, P95; Javadi A, 2011, WORLD NEUROSURG, V75, P731, DOI 10.1016/j.wneu.2010.11.042; Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162; KASSELL NF, 1984, J NEUROSURG, V61, P225, DOI 10.3171/jns.1984.61.2.0225; KAWAKAMI Y, 1989, NEUROSURGERY, V25, P25, DOI 10.1227/00006123-198907000-00005; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Kitazono M, 2012, NEUROL MED-CHIR, V52, P810, DOI 10.2176/nmc.52.810; Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; Tugcu B, 2014, J NEUROL SURG PART A, V75, P37, DOI 10.1055/s-0032-1330961; Vujkovac B, 2000, NEPHROL DIAL TRANSPL, V15, P107, DOI 10.1093/ndt/15.1.107; Wang D, 2014, J NEUROL SCI, V336, P237, DOI 10.1016/j.jns.2013.11.005; Weigel R, 2015, BRIT J NEUROSURG, V29, P538, DOI 10.3109/02688697.2015.1015101	18	8	9	1	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	SEP	2016	77	5					422	426		10.1055/s-0036-1584212			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ED6UW	WOS:000388993200008	27300772				2022-02-06	
J	Treble-Barna, A; Zang, HY; Zhang, NH; Martin, LJ; Yeates, KO; Taylor, HG; Wade, SL; Kurowski, BG				Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Martin, Lisa J.; Yeates, Keith Owen; Taylor, H. Gerry; Wade, Shari L.; Kurowski, Brad G.			Does Apolipoprotein e4 Status Moderate the Association of Family Environment with Long-Term Child Functioning following Early Moderate to Severe Traumatic Brain Injury? A Preliminary Study	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Adaptive function; Brain injuries; Genetics; Gene-environment interaction; Parenting style; Neurobehavioral outcomes	COGNITIVE FUNCTION; APOE EPSILON-4; E GENOTYPE; RECOVERY; OUTCOMES; ALLELE; LIFE	Objectives: To examine whether apolipoprotein e4 (APOE) status moderates the association of family environment with child functioning following early traumatic brain injury (TBI). Methods: Sixty-five children with moderate to severe TBI and 70 children with orthopedic injury (OI) completed assessments 6, 12, 18 months, and 3.5 and 6.8 years post injury. DNA was extracted from saliva samples and genotyped for APOE e4 status. Linear mixed models examined moderating effects of APOE e4 status on associations between two family environment factors (parenting style, home environment) and three child outcomes (executive functioning, behavioral adjustment, adaptive functioning). Results: Children with TBI who were carriers of the e4 allele showed poorer adaptive functioning relative to non-carriers with TBI and children with OI in the context of low authoritarianism. At high levels of authoritarianism, non-carriers with TBI showed the poorest adaptive functioning among groups. There were no main effects or interactions involving APOE and executive functioning or behavioral adjustment. Conclusions:The APOE e4 allele was detrimental for long-term adaptive functioning in the context of positive parenting, whereas in less optimal parenting contexts, being a non-carrier was detrimental. We provide preliminary evidence for an interaction of APOE e4 status and parenting style in predicting long-term outcomes following early TBI.	[Treble-Barna, Amery; Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Martin, Lisa J.; Wade, Shari L.; Kurowski, Brad G.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA		Treble-Barna, A (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	amery.treble-barna@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Martin, Lisa/E-2425-2016; Yeates, Keith/AAJ-4223-2020	Martin, Lisa/0000-0001-8702-9946; Zhang, Nanhua/0000-0001-5796-3404; Yeates, Keith/0000-0001-7680-2892	Institutional Clinical and Translational Science Award, NIH/NCRR [1UL1RR026314]; Rehabilitation Medicine Scientist Training Program (RMSTP) [K-12 HD001097-16]; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; Trauma Research grants from State of Ohio Emergency Medical Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, R01HD042729, K23HD074683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This publication was supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314 and in part, by the Rehabilitation Medicine Scientist Training Program (RMSTP) K-12 HD001097-16 and National Institute for Child Health and Human Development K23HD074683-01A1. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Additional support provided to Dr. Wade included grant R01 HD42729 from NICHD and Trauma Research grants from the State of Ohio Emergency Medical Services.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; BERG K, 1989, CLIN GENET, V35, P437; BRADLEY RH, 1984, DEV PSYCHOL, V20, P315, DOI 10.1037/0012-1649.20.2.315; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hodges K, 1998, J BEHAV HEALTH SER R, V25, P325, DOI 10.1007/BF02287471; HOLM S, 1979, SCAND J STAT, V6, P65; Ihle A, 2012, NEUROPSYCHOLOGY, V26, P267, DOI 10.1037/a0026769; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Lee BK, 2011, ARCH GEN PSYCHIAT, V68, P314, DOI 10.1001/archgenpsychiatry.2011.6; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lo TYM, 2009, CHILD NERV SYST, V25, P47, DOI 10.1007/s00381-008-0723-4; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Ritchie K, 2011, INT J GERIATR PSYCH, V26, P503, DOI 10.1002/gps.2553; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	27	8	8	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2016	22	8					859	864		10.1017/S1355617716000631			6	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	DX4BU	WOS:000384324800007	27480909	Green Accepted			2022-02-06	
J	Zander, NE; Piehler, T; Banton, R; Benjamin, R				Zander, Nicole E.; Piehler, Thuvan; Banton, Rohan; Benjamin, Richard			Effects of Repetitive Low-Pressure Explosive Blast on Primary Neurons and Mixed Cultures	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						primary blast; mild traumatic brain injury; in vitro model; primary cultures; repetitive blast	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; MECHANICAL STRETCH; NEUROTRAUMA; DAMAGE; TBI; EXPRESSION; DEATH	Repetitive mild traumatic brain injury represents a considerable health concern, particularly for athletes and military personnel. For blast-induced brain injury, threshold shock-impulse levels required to induce such injuries and cumulative effects with single and/or multiple exposures are not well characterized. Currently, there is no established in vitro experimental model with blast pressure waves generated by live explosives. This study presents results of primary neurons and mixed cultures subjected to our unique in vitro indoor experimental platform that uses real military explosive charges to probe the effects of primary explosive blast at the cellular level. The effects of the blast on membrane permeability, generation of reactive oxygen species (ROS), uptake of sodium ions, intracellular calcium, and release of glutamate were probed 2 and 24 hr postblast. Significant changes in membrane permeability and sodium uptake among the sham, singleblast-injured, and triple-blast-injured samples were observed. A significant increase in ROS and glutamate release was observed for the triple-blast-injured samples compared with the sham. Changes in intracellular calcium were not significant. These results suggest that blast exposure disrupts the integrity of the plasma membrane, leading to the upset of ion homeostasis, formation of ROS, and glutamate release. Published 2016. dagger This article is a U.S. Government work and is in the public domain in the USA	[Zander, Nicole E.; Piehler, Thuvan; Banton, Rohan; Benjamin, Richard] US Army Res Lab, Weap & Mat Res Directorate, Bldg 4600, Aberdeen, MD 21005 USA		Zander, NE (corresponding author), US Army Res Lab, Dept Army, RDRL WMM G, Bldg 4600, Aberdeen, MD 21005 USA.	nicole.e.zander.civ@mail.mil			U.S. Army Research Laboratory's Director's Strategic Initiative [DSI-13-WMR-2D-005]	Contract grant sponsor: U.S. Army Research Laboratory's Director's Strategic Initiative; Contract grant number: DSI-13-WMR-2D-005.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bailey ZS, 2015, NEUROSCI LETT, V604, P119, DOI 10.1016/j.neulet.2015.07.035; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bradshaw K, 2008, BJA EDUC, V8, P129, DOI 10.1093/bjaceaccp/mkn019; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; CHEN Y, 2013, ADV MAT SCI ENG, V2013, P1, DOI DOI 10.1111/GCBB.12304; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kane MJ, 2011, BRAIN RES, V1425, P123, DOI 10.1016/j.brainres.2011.09.047; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; von Leden RE, 2013, LASER SURG MED, V45, P253, DOI 10.1002/lsm.22133; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zander NE, 2016, ANAL BIOCHEM, V504, P4, DOI 10.1016/j.ab.2016.03.009; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594	40	8	8	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	SEP	2016	94	9					827	836		10.1002/jnr.23786			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DV9SU	WOS:000383282900007	27317559				2022-02-06	
J	Zhao, M; Yu, ZB; Zhang, Y; Huang, XL; Hou, JM; Zhao, YG; Luo, W; Chen, L; Ou, L; Li, HT; Zhang, JQ				Zhao, Ming; Yu, Zhibo; Zhang, Yang; Huang, Xueling; Hou, Jingming; Zhao, Yangang; Luo, Wei; Chen, Lin; Ou, Lan; Li, Haitao; Zhang, Jiqiang			IRON-INDUCED NEURONAL DAMAGE IN A RAT MODEL OF POST-TRAUMATIC STRESS DISORDER	NEUROSCIENCE			English	Article						post-traumatic stress disorder; cognition; iron; ferritin; transferrin receptor	CONTEXTUAL FEAR EXTINCTION; SINGLE PROLONGED STRESS; TRANSFERRIN-RECEPTOR; PSYCHOLOGICAL STRESS; OXIDATIVE STRESS; BRAIN IRON; FERRITIN; EXPRESSION; HIPPOCAMPUS; MECHANISMS	Previous studies have shown that iron redistribution and deposition in the brain occurs in some neurodegenerative diseases, and oxidative damage due to abnormal iron level is a primary cause of neuronal death. In the present study, we used the single prolonged stress (SPS) model to mimic post-traumatic stress disorder (PTSD), and examined whether iron was involved in the progression of PTSD. The anxiety-like behaviors of the SPS group were assessed by the elevated plus maze (EPM) and open field tests, and iron levels were measured by inductively coupled plasma optical emission spectrometer (ICP-OES). Expression of glucocorticoid receptors and transferrin receptor 1 (TfR1) and ferritin (Fn) was detected by Western blot and immunohistochemistry in selected brain areas; TfR1 and Fn mRNA expression were detected by quantitative-polymerase chain reaction (Q-PCR). Ultrastructures of the hippocampus were observed under a transmission electron microscope. Our results showed that SPS exposure induced anxiety-like symptoms and increased the level of serum cortisol and the concentration of iron in key brain areas such as the hippocampus, prefrontal cortex, and striatum. The stress induced region-specific changes in both protein and mRNA levels of TfR1 and Fn. Moreover, swelling mitochondria and cell apoptosis were observed in neurons in brain regions with iron accumulation. We concluded that SPS stress increased iron in some cognition-related brain regions and subsequently cause neuronal injury, indicating that the iron may function in the pathology of PTSD. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Zhao, Ming; Yu, Zhibo; Zhang, Yang; Luo, Wei; Chen, Lin; Ou, Lan; Li, Haitao] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing 400038, Peoples R China; [Yu, Zhibo] PLA 324 Hosp, Dept Med Imaging, Chongqing 400020, Peoples R China; [Huang, Xueling] Chongqing Three Gorges Med Coll, Chongqing 404100, Peoples R China; [Hou, Jingming] Third Mil Med Univ, Southwest Hosp, Dept Rehabil, Chongqing 400038, Peoples R China; [Zhao, Yangang; Zhang, Jiqiang] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing 400038, Peoples R China		Li, HT (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing 400038, Peoples R China.; Zhang, JQ (corresponding author), Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing 400038, Peoples R China.	liihait@163.com; zhangjqtmmu@yahoo.com	Zhang, Jiqiang/B-4488-2008	Zhang, Jiqiang/0000-0002-1905-8750	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171283, 81301679]; Funds for Young Scientists of Southwest Hospital [291289554]	This work was supported predominantly by the National Nature Science Foundation of China No. 81171283 and No. 81301679, and in part by Funds for Young Scientists of Southwest Hospital No. 291289554.	Alexandrov PN, 2005, J ALZHEIMERS DIS, V8, P117; An LN, 2013, BIOL TRACE ELEM RES, V151, P277, DOI 10.1007/s12011-012-9564-9; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cairo G, 1998, HEPATOLOGY, V28, P173, DOI 10.1002/hep.510280123; Chen JB, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-83; CONNOR JR, 1995, J NEUROCHEM, V65, P717; Crespo AC, 2014, NEUROBIOL AGING, V35, P777, DOI 10.1016/j.neurobiolaging.2013.10.078; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Dickinson TK, 1998, BRAIN RES, V801, P171, DOI 10.1016/S0006-8993(98)00575-7; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Faucheux BA, 2002, J NEUROCHEM, V83, P320, DOI 10.1046/j.1471-4159.2002.01118.x; Ganon-Elazar E, 2013, PSYCHONEUROENDOCRINO, V38, P1675, DOI 10.1016/j.psyneuen.2013.01.014; Gao GF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00019; Gao J, 2014, MED SCI MONITOR, V20, P499, DOI 10.12659/MSM.890589; Grunblatt E, 2011, J NEURAL TRANSM, V118, P371, DOI 10.1007/s00702-010-0426-3; Han F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069340; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Ke ZJ, 2004, NEUROCHEM INT, V45, P361, DOI 10.1016/j.neuint.2003.09.008; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kim EJ, 2015, LEARN MEMORY, V22, P411, DOI 10.1101/lm.037291.114; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Konig D, 1998, EXERC IMMUNOL REV, V4, P2; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Lee B, 2016, J NAT MED-TOKYO, V70, P133, DOI 10.1007/s11418-015-0943-3; Leskovjan AC, 2011, NEUROIMAGE, V55, P32, DOI 10.1016/j.neuroimage.2010.11.073; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Liochev SI, 1999, MET IONS BIOL SYST, V36, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUKASKI HC, 1990, AM J CLIN NUTR, V51, P1093, DOI 10.1093/ajcn/51.6.1093; LYLE RM, 1992, AM J CLIN NUTR, V56, P1049, DOI 10.1093/ajcn/56.6.1049; Ma L, 2008, BIOL TRACE ELEM RES, V126, P204, DOI 10.1007/s12011-008-8197-5; Maaroufi K, 2009, PHYSIOL BEHAV, V96, P343, DOI 10.1016/j.physbeh.2008.10.019; MORRIS CM, 1994, NEUROPATH APPL NEURO, V20, P468, DOI 10.1111/j.1365-2990.1994.tb00997.x; MORRIS CM, 1994, NEUROPATH APPL NEURO, V20, P473, DOI 10.1111/j.1365-2990.1994.tb00998.x; Nikolova-Todorova Zorka, 2003, Med Arh, V57, P29; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Spoont MR, 2015, JAMA-J AM MED ASSOC, V314, P501, DOI 10.1001/jama.2015.7877; Sumbria RK, 2013, MOL PHARMACEUT, V10, P3507, DOI 10.1021/mp400348n; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Wang L, 2008, NEUROSCIENCE, V155, P24, DOI 10.1016/j.neuroscience.2008.03.091; Wieler M, 2015, PARKINSONISM RELAT D, V21, P179, DOI 10.1016/j.parkreldis.2014.11.017; Wu ZM, 2016, J NEUROL SCI, V360, P133, DOI 10.1016/j.jns.2015.11.056; Wu ZY, 2016, BEHAV PROCESS, V124, P123, DOI 10.1016/j.beproc.2016.01.001; Yamamoto S, 2008, NEUROPSYCHOPHARMACOL, V33, P2108, DOI 10.1038/sj.npp.1301605; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629; Yu SY, 2011, NUTRITION, V27, P1048, DOI 10.1016/j.nut.2010.11.007; Zhang ZH, 2003, EUR J PHARMACOL, V467, P41, DOI 10.1016/S0014-2999(03)01597-8; Zhu WZ, 2009, RADIOLOGY, V253, P497, DOI 10.1148/radiol.2532082324	55	8	8	1	29	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 25	2016	330						90	99		10.1016/j.neuroscience.2016.05.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP5GD	WOS:000378523400010	27208615				2022-02-06	
J	Ghezta, NK; Bhardwaj, Y; Rani, P; Ram, R				Ghezta, Narotam Kumar; Bhardwaj, Yogesh; Rani, Pooja; Ram, Rangila			Efficacy of Retromandibular Transparotid Approach for the Management of Extracapsular Subcondylar Mandibular Fractures Using 2-mm Titanium Miniplates: A Prospective Clinical Study	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							CONDYLAR PROCESS FRACTURES; SURGICAL-TREATMENT; CLOSED TREATMENT; OPEN REDUCTION; OUTCOMES	Purpose: The aim of this study was to evaluate the long-term clinical and radiologic results of the retromandibular transparotid approach to displaced extracapsular subcondylar mandibular fractures. Patients and Methods: A prospective cohort study was conducted over a period of 5 years on patients surgically treated for displaced extracapsular subcondylar mandibular fractures by the retromandibular transparotid approach. Variables including the type of fracture, degree of mouth opening, fracture displacement, deviation, excursive movements of the mandible, and facial nerve function were monitored before and after treatment. Appropriate statistics were computed. Results: Thirty-nine patients with 47 fractures were evaluated. There were 34 subcondylar fractures (located below the sigmoid notch) (87%), and 5 fractures were located in the head region in bilateral cases. Of the fractures, 31 (79%) were unilateral and 8 (21%) were bilateral. In a multivariate study, condylar coronal displacement, coronal sagittal displacement, difference in the ramal height, maximal interincisal distance, protrusive movements, and deviation of the mandible on opening showed statistically significant differences in pretreatment and post-treatment patients (P = .001). The interincisal distance was 46.8 mm (SD, 5.2 mm) postoperatively versus 24.1 mm (SD, 6.7 mm) before treatment. The average range of protrusion was significantly lower (P = .001) in patients before treatment, at 1.9 mm (SD, 1.2 mm), when compared with 6.1 mm (SD, 2.0 mm) postoperatively. During mouth opening, deviation of the mandible is often a sign of compensatory movement of the contralateral joint due to shortening of the ascending ramal height on the affected joint. The mean deviation of the mandible from the midline was 4.2 mm (SD, 1.0 mm) in patients before treatment, with a significant difference (P = .001) in patients after treatment, with a mean of 1.9 mm (SD, 0.995 mm). Temporary injuries to the facial nerve branches were observed in 3 cases (8%) 1 week after treatment, which later resolved within 3 weeks to 3 months. Conclusions: The retromandibular transparotid approach provides good exposure and facilitates accurate reduction and fixation of the subcondylar fragment with positive outcomes, good cosmetic results, and rare major complications. Most facial nerve injuries are transient in nature after this approach. A Synthes 2-mm titanium single mini-plate (West Chester, PA) provides stable results after fixation. (C) 2016 American Association of Oral and Maxillofacial Surgeons	[Ghezta, Narotam Kumar; Bhardwaj, Yogesh; Ram, Rangila] HP Govt Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Shimla, India; [Rani, Pooja] PDM Dent Coll & Res Inst, Dept Oral & Maxillofacial Surg, Sect 3A, Bahadurgarh, Haryana, India		Rani, P (corresponding author), PDM Dent Coll & Res Inst, Dept Oral & Maxillofacial Surg, Sect 3A, Bahadurgarh, Haryana, India.	dasspr009@gmail.com					Alkan A, 2007, BRIT J ORAL MAX SURG, V45, P145, DOI 10.1016/j.bjoms.2006.04.011; Chossegros C, 1996, ORAL SURG ORAL MED O, V82, P248, DOI 10.1016/S1079-2104(96)80347-7; De Riu G, 2001, INT J ORAL MAX SURG, V30, P384, DOI 10.1054/ijom.2001.0103; Ellis E, 2000, J ORAL MAXIL SURG, V58, P950, DOI 10.1053/joms.2000.8734; Ellis E, 2000, J ORAL MAXIL SURG, V58, P719, DOI 10.1053/joms.2000.7253; Ellis E, 2005, J ORAL MAXIL SURG, V63, P115, DOI 10.1016/j.joms.2004.02.019; ELLIS E, 1993, ORAL SURG ORAL MED O, V76, P6, DOI 10.1016/0030-4220(93)90285-C; Ellis E 3rd, 2000, Facial Plast Surg, V16, P193, DOI 10.1055/s-2000-12579; Gerbino G, 2009, J ORAL MAXIL SURG, V67, P1009, DOI 10.1016/j.joms.2008.06.009; Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868; HINDS EC, 1967, ORAL SURG ORAL MED O, V24, P164, DOI 10.1016/0030-4220(67)90256-3; Hyde N, 2002, BRIT J ORAL MAX SURG, V40, P19, DOI 10.1054/bjom.2001.0734; MALKIN M, 1964, Oral Surg Oral Med Oral Pathol, V17, P152, DOI 10.1016/0030-4220(64)90133-1; Manisali M, 2003, INT J ORAL MAX SURG, V32, P253, DOI 10.1054/ijom.2002.0270; Palmieri C, 1999, J ORAL MAXIL SURG, V57, P764, DOI 10.1016/S0278-2391(99)90810-8; Talwar RM, 1998, J ORAL MAXIL SURG, V56, P430, DOI 10.1016/S0278-2391(98)90707-8; Tang W, 2009, J ORAL MAXIL SURG, V67, P552, DOI 10.1016/j.joms.2008.06.066; Widmark G, 1996, INT J ORAL MAX SURG, V25, P107, DOI 10.1016/S0901-5027(96)80052-X; Zide MF, 1983, ORAL MAXILLOFAC SURG, V41, P89	19	8	10	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	AUG	2016	74	8					1613	1621		10.1016/j.joms.2016.03.045			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	DS1AF	WOS:000380327400017	27134156				2022-02-06	
J	Hu, B; Han, QP; Mengke, N; He, KR; Zhang, YQ; Nie, ZQ; Zeng, HK				Hu, Bei; Han, Qianpeng; Mengke, Nashun; He, Kairan; Zhang, Yiqin; Nie, Zhiqiang; Zeng, Hongke			Prognostic value of ICU-acquired hypernatremia in patients with neurological dysfunction	MEDICINE			English	Article						critically neurological patients; ICU-acquired hypernatremia; prognosis	INTENSIVE-CARE-UNIT; TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; MORTALITY; SODIUM; DISTURBANCES; DYSNATREMIAS; QUALITY; WATER; RISK	Many studies have indicated that hypernatremia is associated with increased mortality. In this study, we aimed to explore the relationship between intensive care unit (ICU)-acquired hypernatremia and the prognosis of critically neurological patients.Based on serum sodium level in the ICU, 450 patients were divided into 3 groups: 222 had normal serum sodium, 142 had mild hypernatremia, and 86 had severe hypernatremia. Kaplan-Meier and multivariable binary logistic regression analyses were performed to evaluate the prognostic value of hypernatremia in critically neurological patients. Receiver operating characteristic (ROC) curve was constructed for serum sodium levels to determine their roles in predicting ICU mortality.Hypernatremia was significantly related with age, Glasgow Coma Scale (GCS) score, serum sodium, APACHE II score, and serum creatinine. Moreover, the different treatment outcome including mechanical ventilation, the days of stayed in ICU, and Glasgow Outcome Scale score had correlation with serum sodium levels. Old ages, GCS score, therapeutic intervention scoring system (TISS) score, APACHE II score, serum sodium peak, and so on were all associated with the mortality. In addition, hypernatremia was an independent prognostic factor for critically neurological patients by logistic regression analysis (odds ratio=1.192, 95% confidence interval=1.135-1.252, P=0.000). Moreover, we got the sensitivity of 79.4% and specificity of 74.5% in the ROC analysis between peak serum sodium and the mortality. The area under the ROC curve was 0.844, and the optimal cutoff value was 147.55.Our results showed that ICU-acquired hypernatremia may be a potential prognosis marker for critically neurological patients.	[Hu, Bei; Han, Qianpeng; Mengke, Nashun; Zhang, Yiqin; Zeng, Hongke] Southern Med Univ, 1063 Shatai Nan Rd, Guangzhou 510515, Guangdong, Peoples R China; [Hu, Bei; Han, Qianpeng; Mengke, Nashun; He, Kairan; Zhang, Yiqin; Zeng, Hongke] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Emergency & Crit Care Med, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China; [Nie, Zhiqiang] Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangdong Gen Hosp, Dept Cardiovasc Epidemiol,Cardiac Surg, Guangzhou, Guangdong, Peoples R China		Zeng, HK (corresponding author), Southern Med Univ, 1063 Shatai Nan Rd, Guangzhou 510515, Guangdong, Peoples R China.; Zeng, HK (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Emergency & Crit Care Med, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China.	zenghongke@vip.163.com		Zhiqiang, Nie/0000-0001-7642-3286	Guangdong Medical Scientific Research Foundation [A2014022]; Science and Technology Planning Project of Guangdong Province [2014A020212236]; Construction Project of National Key Clinical Specialty [2012-649]; Pilot Construction Project of Guangzhou Clinical Medical Research and Transformation Center [201508020005]	This work was supported by the Guangdong Medical Scientific Research Foundation (A2014022), Science and Technology Planning Project of Guangdong Province (2014A020212236), Construction Project of National Key Clinical Specialty (2012-649), and Pilot Construction Project of Guangzhou Clinical Medical Research and Transformation Center (201508020005).	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Alam M N, 2012, Mymensingh Med J, V21, P594; Bataille S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-37; BRATUSCHMARRAIN PR, 1983, DIABETES, V32, P1028, DOI 10.2337/diabetes.32.11.1028; Darmon M, 2013, CRIT CARE, V17, DOI 10.1186/cc11937; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Hoorn EJ, 2008, NEPHROL DIAL TRANSPL, V23, P1562, DOI 10.1093/ndt/gfm831; KNOCHEL JP, 1982, AM J MED, V72, P521, DOI 10.1016/0002-9343(82)90522-8; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Kumar S, 1998, LANCET, V352, P220, DOI 10.1016/S0140-6736(97)12169-9; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lindner G, 2013, J CRIT CARE, V28; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Lindner G, 2012, NEPHROL DIAL TRANSPL, V27, P962, DOI 10.1093/ndt/gfr428; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Palevsky PM, 1996, ANN INTERN MED, V124, P197, DOI 10.7326/0003-4819-124-2-199601150-00002; Polderman KH, 1999, CRIT CARE MED, V27, P1105, DOI 10.1097/00003246-199906000-00029; SNYDER NA, 1987, ANN INTERN MED, V107, P309, DOI 10.7326/0003-4819-107-2-309; Spatenkova V, 2013, ACTA NEUROL BELG, V113, P139, DOI 10.1007/s13760-012-0137-7; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Sterns RH, 1999, CRIT CARE MED, V27, P1041, DOI 10.1097/00003246-199906000-00005; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Waite MD, 2013, J CRIT CARE, V28, P405, DOI 10.1016/j.jcrc.2012.11.013; Zhang YZ, 2015, EUR NEUROL, V73, P29, DOI 10.1159/000368353	25	8	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	AUG	2016	95	35							e3840	10.1097/MD.0000000000003840			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX0HC	WOS:000384041400002	27583842	Green Published, gold			2022-02-06	
J	Martindale, SL; Morissette, SB; Kimbrel, NA; Meyer, EC; Kruse, MI; Gulliver, SB; Dolan, SL				Martindale, Sarah L.; Morissette, Sandra B.; Kimbrel, Nathan A.; Meyer, Eric C.; Kruse, Marc I.; Gulliver, Suzy B.; Dolan, Sara L.			Neuropsychological Functioning, Coping, and Quality of Life Among Returning War Veterans	REHABILITATION PSYCHOLOGY			English	Article						military; veterans; coping; quality of life; neuropsychology	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; INTELLECTUAL RESOURCES; COMBAT VETERANS; PTSD; DEPLOYMENT; IRAQ; TBI; AFGHANISTAN; STYLE	The present research tested the hypothesis that action- and emotion-focused coping strategies would mediate the relationship between neuropsychological functioning and quality of life among a sample of returning Iraq/Afghanistan veterans. Method: Veterans (N = 130) who served as part of the wars in Iraq and Afghanistan completed a diagnostic assessment of PTSD, a battery of questionnaires assessing coping style, traumatic brain injury (TBI), and quality of life, and neuropsychological tests measuring attention, learning and memory, working memory, inhibition, executive control, and visual motor coordination. Results: Executive control, immediate and delayed verbal recall, and visual motor coordination were associated with quality of life. However, after controlling for the effects of combat exposure, PTSD, and probable TBI, no measure of neuropsychological functioning was directly associated with quality of life. Mediation analyses indicated that delayed verbal recall influenced quality of life through its effect on action- focused coping. Conclusions: Although replication is needed, these findings indicate that delayed verbal recall may indirectly influence quality of life among Iraq/Afghanistan veterans through its association with action- focused coping strategies. Psychologists who are working with veterans that are experiencing memory difficulties and poor quality of life may consider focusing on improving coping skills prior to rehabilitation of memory deficits. Impact and Implications Identification of malleable treatment factors is imperative to improve quality of life among veterans who have high rates of traumatic brain injury, psychological disorders and neuropsychological difficulties. Veterans with delayed verbal recall problems may benefit from focusing on learning coping skills to improve quality of life.	[Martindale, Sarah L.; Dolan, Sara L.] Baylor Univ, Dept Psychol & Neurosci, One Bear Pl 97334, Waco, TX 76798 USA; [Martindale, Sarah L.; Morissette, Sandra B.; Meyer, Eric C.; Dolan, Sara L.] Cent Texas Vet Hlth Care Syst, VA VISN Ctr Excellence Res Returning War Vet 17, Waco, TX 76711 USA; [Morissette, Sandra B.; Meyer, Eric C.; Kruse, Marc I.; Gulliver, Suzy B.] Texas A&M Hlth Sci Ctr, Coll Med, Bryan, TX 77807 USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Kruse, Marc I.] Austin Travis Cty Emergency Med Serv Austin, Austin Fire Dept, Austin, TX 78704 USA; [Gulliver, Suzy B.] Baylor Scott & White Healthcare Syst, Warriors Res Inst, Dallas, TX 75246 USA; [Martindale, Sarah L.] WG Bill Hefner Vet Affairs Med Ctr, Salisbury, NC USA; [Martindale, Sarah L.] VA Mid Atlantic Mental Illness Res Educ & Clin Ct, Baltimore, MD 21201 USA; [Morissette, Sandra B.] Univ Texas San Antonio, San Antonio, TX USA		Dolan, SL (corresponding author), Baylor Univ, Dept Psychol & Neurosci, One Bear Pl 97334, Waco, TX 76798 USA.	sara_dolan@baylor.edu	Gulliver, Suzy/X-9776-2019; Martindale, Sarah L/O-8553-2018; Kimbrel, Nathan/P-3109-2016	Martindale, Sarah L/0000-0002-0059-3454; Kimbrel, Nathan/0000-0001-7218-1005; Gulliver, Suzy Bird/0000-0002-6476-9447	Merit Award from the Rehabilitation Research and Development Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD) [I01RX000304]; VISN 17 New Investigator Award; Clinical Science Research and Development Service of VA ORD [IK2 CX000525]; VA VISN 17 Center of Excellence for Research on Returning War Veterans; Central Texas Veterans Health Care System; Baylor University Graduate School; Veterans AffairsUS Department of Veterans Affairs [I01RX000304, IK2CX000525] Funding Source: NIH RePORTER	This research was supported by a Merit Award (I01RX000304) to Sandra B. Morissette from the Rehabilitation Research and Development Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD); a VISN 17 New Investigator Award to Eric C. Meyer; a Career Development Award (IK2 CX000525) to Nathan A. Kimbrel from the Clinical Science Research and Development Service of VA ORD; the VA VISN 17 Center of Excellence for Research on Returning War Veterans; Central Texas Veterans Health Care System; and Baylor University Graduate School. We appreciate the contributions of veterans who participated in this study as well as numerous study staff who helped conduct the study. A complete list of publications from the project is available upon request from Sandra B. Morissette at Sandra. Morissette@utsa.edu. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Amir M, 1997, PERS INDIV DIFFER, V23, P399, DOI 10.1016/S0191-8869(97)80005-0; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Billings A G, 1981, J Behav Med, V4, P139, DOI 10.1007/BF00844267; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Creech SK, 2013, J TRAUMA STRESS, V26, P507, DOI 10.1002/jts.21823; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Golden CJ, 1978, STROOP COLOR WORD TE; Gregorio GW, 2015, BRIT J CLIN PSYCHOL, V54, P291, DOI 10.1111/bjc.12074; Halligan P.W., 2005, EFFECTIVENESS REHABI; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huijts I, 2012, J TRAUMA STRESS, V25, P71, DOI 10.1002/jts.21665; Jastak J. F., 2006, WIDE RANGE ACHIEVEME; Johnsen BH, 2002, SCAND J PSYCHOL, V43, P181, DOI 10.1111/1467-9450.00285; Jones DE, 2008, MIL MED, V173, P241, DOI 10.7205/MILMED.173.3.241; King D. W., 2003, MANUAL DEPLOYMENT RI; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Najavits L. M., 2012, PTSD MILD TRAUMATIC, P124; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reid-Arndt SA, 2010, PSYCHO-ONCOLOGY, V19, P535, DOI 10.1002/pon.1581; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosen CS, 2004, J TRAUMA STRESS, V17, P213, DOI 10.1023/B:JOTS.0000029264.23878.53; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sohlberg M., 2001, COGNITIVE REHABILITA; Stock EM, 2014, INT J METH PSYCH RES, V23, P345, DOI 10.1002/mpr.1442; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 1997, ASSESSMENT, V4, P51, DOI 10.1177/107319119700400107; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wallin MT, 2009, COGN BEHAV NEUROL, V22, P155, DOI 10.1097/WNN.0b013e3181b278e8; Wechsler D., 2008, WECHSLER ADULT INTEL; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836	53	8	8	1	20	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2016	61	3					231	239		10.1037/rep0000076			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	DV9HR	WOS:000383251900002	26891248	Green Accepted			2022-02-06	
J	Ramos, TN; Arynchyna, AA; Blackburn, TE; Barnum, SR; Johnston, JM				Ramos, Theresa N.; Arynchyna, Anastasia A.; Blackburn, Tessa E.; Barnum, Scott R.; Johnston, James M.			Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children	JCI INSIGHT			English	Article							CENTRAL-NERVOUS-SYSTEM; C-REACTIVE PROTEIN; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; PROPIONIBACTERIUM-ACNES; VENTRICULOPERITONEAL SHUNTS; PEDIATRIC HYDROCEPHALUS; BACTERIAL-MENINGITIS; UNITED-STATES; FACTOR B	BACKGROUND. Children treated with cerebrospinal fluid (CSF) shunts to manage hydrocephalus frequently develop shunt failure and/or infections, conditions that present with overlapping symptoms. The potential life-threatening nature of shunt infections requires rapid diagnosis; however, traditional microbiology is time consuming, expensive, and potentially unreliable. We set out to identify a biomarker that would identify shunt infection. METHODS. CSF was assayed for the soluble membrane attack complex (sMAC) by ELISA in patients with suspected shunt failure or infection. CSF was obtained at the time of initial surgical intervention. Statistical analysis was performed to assess the diagnostic potential of sMAC in pyogenic-infected versus noninfected patients. RESULTS. Children with pyogenic shunt infection had significantly increased sMAC levels compared with noninfected patients (3,211 +/- 1,111 ng/ml vs. 26 +/- 3.8 ng/ml, P = 0.0001). In infected patients undergoing serial CSF draws, sMAC levels were prognostic for both positive and negative clinical outcomes. Children with delayed, broth-only growth of commensal organisms (P. acnes, S. epidermidis, etc.) had the lowest sMAC levels (7.96 +/- 1.7 ng/ml), suggesting contamination rather than shunt infection. CONCLUSION. Elevated CSF sMAC levels are both sensitive and specific for diagnosing pyogenic shunt infection and may serve as a useful prognostic biomarker during recovery from infection.	[Ramos, Theresa N.; Blackburn, Tessa E.; Barnum, Scott R.] Univ Alabama Birmingham, Childrens Alabama, Dept Microbiol, Birmingham, AL USA; [Arynchyna, Anastasia A.; Johnston, James M.] Univ Alabama Birmingham, Childrens Alabama, Dept Neurosurg, Div Pediat Neurosurg, 1600 7th Ave S,Lowder 400, Birmingham, AL 35233 USA; [Barnum, Scott R.] Univ Alabama Birmingham, Childrens Alabama, Dept Neurol, Birmingham, AL USA		Johnston, JM (corresponding author), Univ Alabama Birmingham, Childrens Alabama, Dept Neurosurg, Div Pediat Neurosurg, 1600 7th Ave S,Lowder 400, Birmingham, AL 35233 USA.	James.Johnston@childrensal.org		Johnston, James/0000-0001-8564-1808	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI007051] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32 AI007051] Funding Source: Medline		Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Al-Tamimi YZ, 2014, NEUROSURGERY, V74, P29, DOI 10.1227/NEU.0000000000000196; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Arumugam TV, 2009, NEUROSCIENCE, V158, P1074, DOI 10.1016/j.neuroscience.2008.07.015; AsiBautista MC, 1997, CRIT CARE MED, V25, P1713, DOI 10.1097/00003246-199710000-00022; Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; BAYSTON R, 1994, EUR J CLIN MICROBIOL, V13, P417, DOI 10.1007/BF01972001; BAYSTON R, 1979, ARCH DIS CHILD, V54, P545, DOI 10.1136/adc.54.7.545; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Boyle TP, 2015, PEDIATR EMERG CARE, V31, P435, DOI 10.1097/PEC.0000000000000462; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; Derer S, 2014, CRIT REV IMMUNOL, V34, P199, DOI 10.1615/CritRevImmunol.2014009761; Francis Karen, 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403006252; Garton HJL, 2001, J NEUROSURG, V94, P202, DOI 10.3171/jns.2001.94.2.0202; Gasque P, 1998, J IMMUNOL, V160, P3543; GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P; Gutierrez-Murgas Y, 2014, J NEUROIMMUNOL, V276, P1, DOI 10.1016/j.jneuroim.2014.08.006; Harboe M, 2011, ADV DRUG DELIVER REV, V63, P976, DOI 10.1016/j.addr.2011.05.010; Heep A, 2004, PEDIATR RES, V56, P768, DOI 10.1203/01.PDR.0000141524.32142.53; Heidemann SM, 2010, PEDIATR NEUROSURG, V46, P255, DOI 10.1159/000320130; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kestle JR, 2016, J NEUROSURG PEDIAT, P361; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lindsberg PJ, 1996, ANN NEUROL, V40, P587, DOI 10.1002/ana.410400408; Lolak S, 2013, SURG INFECT, V14, P192, DOI 10.1089/sur.2011.070; Lundberg F, 1999, J NEUROSURG, V90, P101, DOI 10.3171/jns.1999.90.1.0101; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; MOLLNES TE, 1987, J NEUROL SCI, V78, P17, DOI 10.1016/0022-510X(87)90074-8; Morales DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115045; Morgan BP, 2016, IMMUNOBIOLOGY, V221, P747, DOI 10.1016/j.imbio.2015.04.006; Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3; Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/eri.11.137, 10.1586/ERI.11.137]; Rekate HL, 2008, CEREBROSPINAL FLUID, V2008, P5; Rutkowski MJ, 2010, IMMUNOL CELL BIOL, V88, P781, DOI 10.1038/icb.2010.48; Sanders M E, 1988, Ann N Y Acad Sci, V540, P387, DOI 10.1111/j.1749-6632.1988.tb27109.x; Schuhmann MU, 2005, J NEUROSURG, V103, P223, DOI 10.3171/ped.2005.103.3.0223; Serna M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10587; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Sivaganesan A, 2012, PEDIATR RADIOL, V42, P1029, DOI 10.1007/s00247-012-2410-6; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090; Sonnen Andreas F-P, 2014, Subcell Biochem, V80, P83, DOI 10.1007/978-94-017-8881-6_6; Stahel PF, 1997, J IMMUNOL, V159, P861; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 1997, IMMUNOPHARMACOLOGY, V38, P65, DOI 10.1016/S0162-3109(97)80150-6; Stahel PF, 1997, LANCET, V349, P1886, DOI 10.1016/S0140-6736(05)63877-9; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Stevens NT, 2012, BRIT J NEUROSURG, V26, P792, DOI 10.3109/02688697.2011.651514; Tamber MS, 2014, J NEUROSURG-PEDIATR, V14, P60, DOI 10.3171/2014.7.PEDS14328; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Tully HM, 2014, EUR J MED GENET, V57, P359, DOI 10.1016/j.ejmg.2014.06.002; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; VandeVord PJ, 2004, BIOMATERIALS, V25, P3853, DOI 10.1016/j.biomaterials.2003.10.024; Vinchon M, 2012, CHILD NERV SYST, V28, P847, DOI 10.1007/s00381-012-1723-y; Viraraghavan R, 2004, CLIN PEDIATR, V43, P393, DOI 10.1177/000992280404300413; Winston KR, 2013, J NEUROSURG-PEDIATR, V11, P635, DOI 10.3171/2013.3.PEDS12478; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12179	62	8	8	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	2379-3708			JCI INSIGHT	JCI Insight	JUL 7	2016	1	10							e87919	10.1172/jci.insight.87919			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EB1LL	WOS:000387113300017	27699221	Green Published, gold			2022-02-06	
J	Tsuda, S; Hou, J; Nelson, RL; Wilkie, ZJ; Mustafa, G; Sinharoy, A; Watts, JV; Thompson, FJ; Bose, PK				Tsuda, Shigeharu; Hou, Jiamei; Nelson, Rachel L.; Wilkie, Zachary J.; Mustafa, Golam; Sinharoy, Ankita; Watts, Joseph V.; Thompson, Floyd J.; Bose, Prodip K.			Prolonged hippocampal cell death following closed-head traumatic brain injury in rats	NEUROREPORT			English	Article						cell death; cell injury; hippocampus; traumatic brain injury	NEURONS; MODEL; CONCUSSION; CONTUSION; ISCHEMIA	Traumatic brain injury (TBI) leads to enduring cognitive disorders. Although recent evidence has shown that controlled cortical impact in a rodent may induce memory deficits with prolonged cell death in the dentate gyrus (DG) of the hippocampus, few studies have reported long-term chronic hippocampal cell death following 'closed-head' TBI (cTBI), the predominant form of human TBI. Therefore, the aim of this study was to quantify terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)(+) apoptotic hippocampal cells as well as hippocampal cells with hallmark morphological features of degenerating cells in a chronic setting of cTBI in rats. TUNEL assays and Cresyl violet staining were performed using 6-month post-TBI fixed hippocampal sections. Evidence of prolonged hippocampal cell death was shown by the presence of a significantly increased number of TUNEL(+) cells in the cornu ammonis 1-3 (CA1-CA3) and DG of the hippocampus compared with intact controls. In addition, Cresyl violet staining indicated a significantly elevated number of cells with the degenerative morphological features in all hippocampal subregions (CA1-CA3, hilus, and DG). These results suggest that prolonged cell death may occur in multiple regions of the hippocampus following cTBI. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Tsuda, Shigeharu; Hou, Jiamei; Nelson, Rachel L.; Wilkie, Zachary J.; Mustafa, Golam; Sinharoy, Ankita; Watts, Joseph V.; Thompson, Floyd J.; Bose, Prodip K.] North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr Excellence, Malcom Randall VA Med Ctr, Gainesville, FL 32608 USA; [Tsuda, Shigeharu; Hou, Jiamei; Mustafa, Golam; Thompson, Floyd J.; Bose, Prodip K.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Thompson, Floyd J.] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Bose, Prodip K.] Univ Florida, Coll Med, Dept Neurol, McKnight Brain Inst, Gainesville, FL 32611 USA		Bose, PK (corresponding author), North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr Excellence, Malcom Randall VA Med Ctr, Gainesville, FL 32608 USA.	pkbose@ufl.edu		Sinharoy, Ankita/0000-0002-6911-196X	Merit Review Award from the United States Department of Veterans Affairs Rehabilitation Research and Development Service [B6570R, B78071, B1005-R]; Veterans AffairsUS Department of Veterans Affairs [I01RX001005] Funding Source: NIH RePORTER	This work was supported by Merit Review Award # B6570R, B78071, B1005-R, from the United States Department of Veterans Affairs Rehabilitation Research and Development Service. This work contains a part of the PhD dissertation of Shigeharu Tsuda.	Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hashem HE, 2010, EGYPT J HISTOL, V33, P659; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Kaler Saroj, 2013, Toxicol Int, V20, P160, DOI 10.4103/0971-6580.117259; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lopez-Meraz ML, 2010, NEUROBIOL DIS, V37, P394, DOI 10.1016/j.nbd.2009.10.019; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; Manickam B., 2009, International Journal of Tropical Medicine, V4, P9; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Pei DS, 2006, BRAIN, V129, P465, DOI 10.1093/brain/awh700; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5; Segal D, 2009, ACTA NEUROPATHOL, V117, P385, DOI 10.1007/s00401-008-0379-x; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Wen TC, 1998, J EXP MED, V188, P635, DOI 10.1084/jem.188.4.635; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055	30	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUL 6	2016	27	10					724	729		10.1097/WNR.0000000000000598			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ8FZ	WOS:000379445800002	27213933				2022-02-06	
J	Newsome, MR; Mayer, AR; Lin, XD; Troyanskaya, M; Jackson, GR; Scheibel, RS; Walder, A; Sathiyaraj, A; Wilde, EA; Mukhi, S; Taylor, BA; Levin, HS				Newsome, Mary R.; Mayer, Andrew R.; Lin, Xiaodi; Troyanskaya, Maya; Jackson, George R.; Scheibel, Randall S.; Walder, Annette; Sathiyaraj, Ajithraj; Wilde, Elisabeth A.; Mukhi, Shalini; Taylor, Brian A.; Levin, Harvey S.			Chronic Effects of Blast-Related TBI on Subcortical Functional Connectivity in Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Globus pallidus; fMRI; Functional magnetic resonance imaging; PTSD; Military personnel	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DEFAULT MODE NETWORK; RESTING HUMAN BRAIN; MILITARY PERSONNEL; PARKINSONS-DISEASE; OXIDATIVE STRESS; WORKING-MEMORY; BASAL GANGLIA; SAMPLE-SIZE	Objectives: Blast explosions are the most frequent mechanism of traumatic brain injury (TBI) in recent wars, but little is known about their long-term effects. Methods: Functional connectivity (FC) was measured in 17 veterans an average of 5.46 years after their most serious blast related TBI, and in 15 demographically similar veterans without TBI or blast exposure. Subcortical FC was measured in bilateral caudate, putamen, and globus pallidus. The default mode and fronto-parietal networks were also investigated. Results: In subcortical regions, between-groups t tests revealed altered FC from the right putamen and right globus pallidus. However, following analysis of covariance (ANCOVA) with age, depression (Center for Epidemiologic Studies Depression Scale), and posttraumatic stress disorder symptom (PTSD Checklist - Civilian version) measures, significant findings remained only for the right globus pallidus with anticorrelation in bilateral temporal occipital fusiform cortex, occipital fusiform gyrus, lingual gyrus, and cerebellum, as well as the right occipital pole. No group differences were found for the default mode network. Although reduced FC was found in the fronto-parietal network in the TBI group, between-group differences were nonsignificant after the ANCOVA. Conclusions: FC of the globus pallidus is altered years after exposure to blast related TBI. Future studies are necessary to explore the trajectory of changes in FC in subcortical regions after blast TBI, the effects of isolated versus repetitive blast-related TBI, and the relation to long-term outcomes in veterans.	[Newsome, Mary R.; Lin, Xiaodi; Troyanskaya, Maya; Scheibel, Randall S.; Wilde, Elisabeth A.; Taylor, Brian A.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Res Serv Line, Houston, TX USA; [Newsome, Mary R.; Lin, Xiaodi; Troyanskaya, Maya; Scheibel, Randall S.; Wilde, Elisabeth A.; Taylor, Brian A.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Jackson, George R.] Michael E DeBakey VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, Houston, TX USA; [Jackson, George R.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Walder, Annette] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Sathiyaraj, Ajithraj] Dartmouth Inst Hlth Policy Clin Practice, Lebanon, NH USA; [Wilde, Elisabeth A.; Mukhi, Shalini; Taylor, Brian A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Mukhi, Shalini; Taylor, Brian A.] Michael E DeBakey VA Med Ctr, Diagnost & Therapeut Care Line, Houston, TX USA		Newsome, MR (corresponding author), Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Phys Med & Rehabil, BCM 637, Houston, TX 77030 USA.	mnewsome@bcm.edu		Taylor, Brian/0000-0001-9745-1075	Department of Veterans Affairs, Veterans Health Administration, Office of Rehabilitation Research and Development [B6812C, B45961, I21RX001608, B1320-I, O1062-I]; Veterans AffairsUS Department of Veterans Affairs [I01RX001320, I21RX001608] Funding Source: NIH RePORTER	This study was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Rehabilitation Research and Development, #B6812C Traumatic Brain Injury Center of Excellence (HSL), #B45961 (HSL), #I21RX001608 (MRN), B1320-I (HSL and RSS), and O1062-I (RSS & EAW). The South Central Mental Illness Research, Education, and Clinical Center (SCMIRECC) at the Michael E. DeBakey VA Medical Center provided facilities that allowed analyses of the fMRI data. We also gratefully acknowledge the assistance and computing resources provided by the CIBR Center for Computational and Integrative Biomedical Research of Baylor College of Medicine in the completion of this work. We are grateful to Qisheng Liu for technical assistance. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs. There are no potential conflicts of interest, including financial, between any of the authors and the work presented in this manuscript. We are grateful to the veterans taking part in this research.	Ahmed RM, 2016, JAMA NEUROL, V73, P282, DOI 10.1001/jamaneurol.2015.4478; Akbar N, 2016, MULT SCLER J, V22, P792, DOI 10.1177/1352458515602336; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anteraper SA, 2014, BRAIN CONNECT, V4, P81, DOI 10.1089/brain.2013.0180; Ashby F. G., 2011, PROCESSING STAT ANAL; Babor T.F., 2001, AUDIT THE ALCOHOL US; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown L., 2010, TEST NONVERBAL INTEL; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Crozier JC, 2014, DEV PSYCHOPATHOL, V26, P491, DOI 10.1017/S095457941400008X; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Rover M, 2008, HUM BRAIN MAPP, V29, P1068, DOI 10.1002/hbm.20445; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; Eid L, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00111; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 2013, NEUROIMAGE, V81, P503, DOI 10.1016/j.neuroimage.2013.02.057; Gauthier J, 1999, BRAIN RES, V834, P228, DOI 10.1016/S0006-8993(99)01573-5; Green P, 2001, ARCH CLIN NEUROPSYCH, V16, P849; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hosseini SMH, 2013, NEUROIMAGE, V78, P402, DOI 10.1016/j.neuroimage.2013.04.032; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kang XJ, 2015, LATERALITY, V20, P658, DOI 10.1080/1357650X.2015.1032975; Kwon HG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00041; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lindquist MA, 2013, NEUROIMAGE, V81, P499, DOI 10.1016/j.neuroimage.2013.02.056; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Miller G. A., 2001, MISUNDERSTANDING ANA; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelletier-Baldelli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134936; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao JA, 2016, J INT NEUROPSYCH SOC, V22, P225, DOI 10.1017/S1355617716000011; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sakamoto H, 2005, NEUROIMAGE, V26, P813, DOI 10.1016/j.neuroimage.2005.02.032; Scheibel RS, 2015, BRAIN IMAGING BEHAV, V9, P513, DOI 10.1007/s11682-015-9376-6; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8	74	8	8	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2016	22	6					631	642		10.1017/S1355617716000448			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	DU8SM	WOS:000382484700006	27264731				2022-02-06	
J	Takahashi, DK; Gu, F; Parada, I; Vyas, S; Prince, DA				Takahashi, D. Koji; Gu, Feng; Parada, Isabel; Vyas, Shri; Prince, David A.			Aberrant excitatory rewiring of layer V pyramidal neurons early after neocortical trauma	NEUROBIOLOGY OF DISEASE			English	Article						Neocortex; Traumatic brain injury; Excitatory synapses; Excitatory circuits; EPSCs; Laser scanning photostimulation; Epileptogenesis; Pyramidal cells; VGLUT1; PSD95	INJURED EPILEPTOGENIC NEOCORTEX; RAT BARREL CORTEX; POSTTRAUMATIC EPILEPSY; VISUAL-CORTEX; IN-VITRO; FUNCTIONAL ALTERATIONS; EPILEPTIFORM ACTIVITY; ELECTRON-MICROSCOPY; GOLGI PREPARATIONS; SYNAPTIC CURRENTS	Lesioned neuronal circuits form new functional connections after a traumatic brain injury (TBI). In humans and animal models, aberrant excitatory connections that form after TBI may contribute to the pathogenesis of post traumatic epilepsy. Partial neocortical isolation ("undercut" or "UC") leads to altered neuronal circuitry and network hyperexcitability recorded in vivo and in brain slices from chronically lesioned neocortex. Recent data suggest a critical period for maladaptive excitatory circuit formation within the first 3 days post UC injury (Graber and Prince 1999, 2004; Li et al. 2011, 2012b). The present study focuses on alterations in excitatory connectivity within this critical period. Immunoreactivity (IR) for growth-associated protein (GAP)-43 was increased in the UC cortex 3 days after injury. Some GAP-43-expressing excitatory terminals targeted the somata of layer V pyramidal (Pyr) neurons, a domain usually innervated predominantly by inhibitory terminals. Immunocytochemical analysis of pre- and postsynaptic markers showed that putative excitatory synapses were present on somata of these neurons in UC neocortex. Excitatory postsynaptic currents from UC layer V Pyr cells displayed properties consistent with perisomatic inputs and also reflected an increase in the number of synaptic contacts. Laser scanning photostimulation (LSPS) experiments demonstrated reorganized excitatory connectivity after injury within the UC. Concurrent with these changes, spontaneous epileptiform bursts developed in UC slices. Results suggest that aberrant reorganization of excitatory connectivity contributes to early neocortical hyperexcitability in this model. The findings are relevant for understanding the pathophysiology of neocortical post-traumatic epileptogenesis and are important in terms of the timing of potential prophylactic treatments. (C) 2016 Elsevier Inc. All rights reserved.	[Takahashi, D. Koji; Gu, Feng; Parada, Isabel; Vyas, Shri; Prince, David A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Epilepsy Res Labs, Stanford, CA 94305 USA		Prince, DA (corresponding author), 300 Pasteur Dr SUMC RM M016, Stanford, CA 94305 USA.	daprince@stanford.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12151, NS39579, NS82644];  [(F32) NS077623]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012151, R01NS039579, R01NS006477, R01NS082644, R56NS039579, R01NS090076, F32NS077623, P01NS012151] Funding Source: NIH RePORTER	This work was supported by NINDS Grants NS12151, NS39579 and NS82644 to DAP and postdoctoral fellowship (F32) NS077623 to DKT. Daniel Richter provided preliminary anatomical results. We thank John Huguenard for advice in laser scanning and confocal experiments and Paul Buckmaster for helpful suggestions regarding analysis of putative synapses.	Abegg MH, 2004, J PHYSIOL-LONDON, V554, P439, DOI 10.1113/jphysiol.2003.052662; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bergles DE, 1998, J NEUROSCI, V18, P7709; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; CARNEVALE NT, 1982, J NEUROPHYSIOL, V47, P606, DOI 10.1152/jn.1982.47.4.606; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Chuckowree JA, 2004, NEUROSCIENTIST, V10, P280, DOI 10.1177/1073858404263511; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; DeFelipe J., 1991, CAJALS DEGENERATION; Deleuze C, 2006, J NEUROSCI, V26, P8633, DOI 10.1523/JNEUROSCI.2333-06.2006; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Faria LC, 2012, NEUROBIOL DIS, V45, P821, DOI 10.1016/j.nbd.2011.11.006; Faria LC, 2010, J NEUROPHYSIOL, V104, P280, DOI 10.1152/jn.00351.2010; FISHMAN PS, 1993, J NEUROTRAUM, V10, P457, DOI 10.1089/neu.1993.10.457; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Graber KD, 2006, MODELS OF SEIZURES AND EPILEPSY, P477, DOI 10.1016/B978-012088554-1/50040-2; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kapur A, 1998, J NEUROPHYSIOL, V80, P1623, DOI 10.1152/jn.1998.80.4.1623; Kharazia VN, 2001, NEUROSCIENCE, V102, P23, DOI 10.1016/S0306-4522(00)00467-X; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Laudes T, 2012, NEUROSCIENCE, V222, P215, DOI 10.1016/j.neuroscience.2012.07.005; LEUNG LWS, 1994, EPILEPSIA, V35, P785, DOI 10.1111/j.1528-1157.1994.tb02512.x; LEVAY S, 1973, J COMP NEUROL, V150, P53, DOI 10.1002/cne.901500104; Li C, 2012, J MOL NEUROSCI, V46, P595, DOI 10.1007/s12031-011-9647-7; Li HF, 2005, J NEUROPHYSIOL, V93, P146, DOI 10.1152/jn.00665.2004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Li HF, 2011, NEUROSCI LETT, V497, P172, DOI 10.1016/j.neulet.2011.02.042; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; PARNAVELAS JG, 1977, CELL TISSUE RES, V183, P499; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Prince DA, 1998, EPILEPSY RES, V32, P83, DOI 10.1016/S0920-1211(98)00042-4; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Salin P, 1995, J NEUROSCI, V15, P8234; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Smeal RM, 2008, EUR J NEUROSCI, V28, P2041, DOI 10.1111/j.1460-9568.2008.06505.x; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Taniguchi N, 2000, J PHYSIOL-LONDON, V527, P579, DOI 10.1111/j.1469-7793.2000.t01-1-00579.x; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Tseng GF, 1996, J NEUROPHYSIOL, V75, P248, DOI 10.1152/jn.1996.75.1.248; ULRICH D, 1993, J NEUROPHYSIOL, V69, P1769, DOI 10.1152/jn.1993.69.5.1769; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Yamamoto T, 2000, NEUROREPORT, V11, P1603, DOI 10.1097/00001756-200006050-00002; Yang L, 1997, J NEUROPHYSIOL, V78, P2804, DOI 10.1152/jn.1997.78.5.2804; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244	89	8	8	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2016	91						166	181		10.1016/j.nbd.2016.03.003			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DL8IL	WOS:000375885600015	26956396	Green Accepted			2022-02-06	
J	Ware, JB; Biester, RC; Whipple, E; Robinson, KM; Ross, RJ; Nucifora, PG				Ware, Jeffrey B.; Biester, Rosette C.; Whipple, Elizabeth; Robinson, Keith M.; Ross, Richard J.; Nucifora, Paolo G.			Combat-related Mild Traumatic Brain Injury: Association between Baseline Diffusion-Tensor Imaging Findings and Long-term Outcomes	RADIOLOGY			English	Article							AXONAL INJURY; SYMPTOMS; VETERANS; RETURN; WORK; PTSD	Purpose: To determine whether functional outcomes of veterans who sustained combat-related mild traumatic brain injury (TBI) are associated with scalar metrics derived from diffusion- tensor (DT) imaging at their initial postdeployment evaluation. Materials and Methods: This HIPAA-compliant retrospective study was approved by the institutional review board, and the requirement to obtain informed consent was waived. From 2010 to 2013, initial postdeployment evaluation, including clinical assessment and brain magnetic resonance (MR) examination with DT imaging, was performed in combat veterans who sustained mild TBI while deployed. Outcomes from chart review encompassed initial postdeployment clinical assessment as well as later functional status, including evaluation of occupational status and health care utilization. Scalar diffusion metrics from the initial postdeployment evaluation were compared with outcomes by using multivariate analysis. Veterans who did and did not return to work were also compared for differences in clinical variables by using t and x(2) tests. Results: Postdeployment evaluation was performed a mean of 3.8 years after injury (range, 0.5-9 years; standard deviation, 2.5 years). After a mean follow-up of 1.4 years (range, 0.5-2.5 years; standard deviation, 0.8 year), 34 of 57 veterans (60%) had returned to work. Return to work was associated with diffusion metrics in multiple regions of white matter, particularly in the left internal capsule and the left frontal lobe (P = .02-.05). Overall, veterans had a mean of 46 health care visits per year during the follow-up period (range, 3-196 visits per year; standard deviation, 41 visits per year). Cumulative health care visits over time were inversely correlated with diffusion anisotropy of the splenium of the corpus callosum and adjacent parietal white matter (P < .05). Clinical measures obtained during initial postdeployment evaluation were not predictive of later functional status (P = .12-.8). Conclusion: Differences in white matter microstructure may partially account for the variance in functional outcomes among veterans who sustained combat-related mild TBI. (C) RSNA, 2016	[Ware, Jeffrey B.; Nucifora, Paolo G.] Philadelphia VA Med Ctr, Dept Radiol, Philadelphia, PA USA; [Biester, Rosette C.; Whipple, Elizabeth; Robinson, Keith M.] Philadelphia VA Med Ctr, Dept Rehabil Med, Philadelphia, PA USA; [Ross, Richard J.] Philadelphia VA Med Ctr, Behav Hlth Serv, Philadelphia, PA USA; [Ware, Jeffrey B.; Nucifora, Paolo G.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Ross, Richard J.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA		Nucifora, PG (corresponding author), Loyola Univ, Med Ctr, Dept Radiol, Maywood, IL 60153 USA.; Nucifora, PG (corresponding author), Loyola Univ, Med Ctr, Dept Neurol, 2160 S 1st Ave, Maywood, IL 60153 USA.	paolo.nucifora@lumc.edu		Ware, Jeffrey/0000-0002-3495-9733			Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Soriano-Raya JJ, 2014, J CEREBR BLOOD F MET, V34, P861, DOI 10.1038/jcbfm.2014.26; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Oishi K., 2010, JHU MNI SS ATLAS; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Ware J, 2014, RAD SOC N AM SCI ASS, P362; Weathers F., 1993, P ANN C INT SOC TRAU; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358	30	8	9	0	9	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUL	2016	280	1					212	219		10.1148/radiol.2016151013			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DP8BC	WOS:000378721900023	27022770	Bronze			2022-02-06	
J	Wu, GQ; Chou, XM; Ji, WJ; Yang, XG; Lan, LX; Sheng, YJ; Shen, YF; Li, JR; Huang, GZ; Yu, WH; Dong, XQ; Du, Q; Yang, DB; Zhang, ZY; Wang, H; Shen, YF; Jiang, L				Wu, Gang-Qun; Chou, Xiao-Min; Ji, Wen-Jian; Yang, Xiao-Gang; Lan, Luo-Xin; Sheng, Yan-Jun; Shen, Yang-Fang; Li, Jian-Rong; Huang, Guo-Zhong; Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Yang, Ding-Bo; Zhang, Zu-Yong; Wang, Hao; Shen, Yong-Feng; Jiang, Li			The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Nesfatin-1; Posttraumatic cerebral infarction; Progressive hemorrhagic injury; Acute traumatic coagulopathy; Mortality	POSTTRAUMATIC CEREBRAL INFARCTION; ACUTE INTRACEREBRAL HEMORRHAGE; BASAL GANGLIA HEMORRHAGE; RISK-FACTORS; HEAD TRAUMA; RAT-BRAIN; COAGULOPATHY; MODERATE; PATHOPHYSIOLOGY; PROGRESSION	Background: Nesfatin-1 is related to inflammation. Its increased circulating concentrations are associated with the severity and prognosis of subarachnoid hemorrhage. In-hospital major adverse events (IMAEs), including acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction, are correlated with mortality after traumatic brain injury (TBI). The present study was designed to investigate the changes of plasma nesfatin-1 concentrations and further assess its association with inflammation, trauma severity, in-hospital mortality and IMAEs following TBI. Methods: We measured plasma nesfatin-1 concentrations of 100 severe TBI patients and 100 controls. Progressive hemorrhagic injury and posttraumatic cerebral infarction were diagnosed based on a follow-up computerized tomography scan. Acute traumatic coagulopathy was identified according to a coagulation test. Results: Plasma nesfatin-1 concentrations were significantly higher in patients than in controls and associated highly with Glasgow coma scale (GCS) scores and plasma C-reactive protein concentrations. Nesfatin-1 was indicated as an independent predictor for in-hospital mortality and IMAEs. In accordance with area under receiver operating characteristic curve, its predictive value was similar to GCS scores. Conclusion: Increased plasma nesfatin-1 concentrations are associated closely with inflammation, trauma severity and clinical outcomes, indicating that nesfatin-1 might be involved in inflammation and become a good prognostic biomarlcer following TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Wu, Gang-Qun; Chou, Xiao-Min; Ji, Wen-Jian; Yang, Xiao-Gang; Lan, Luo-Xin; Sheng, Yan-Jun; Shen, Yang-Fang; Li, Jian-Rong; Huang, Guo-Zhong] Tonglu TCM Hosp, Dept Neurosurg, 25 Guangchang Rd, Tonglu 311500, Peoples R China; [Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Yang, Ding-Bo; Wang, Hao; Shen, Yong-Feng; Jiang, Li] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Zhang, Zu-Yong] Hangzhou Hosp Tradit Chinese Med, Dept Neurosurg, 453 Tiyuchang Rd, Hangzhou 310007, Zhejiang, Peoples R China		Wu, GQ (corresponding author), Tonglu TCM Hosp, Dept Neurosurg, 25 Guangchang Rd, Tonglu 311500, Peoples R China.	huauna@126.com			Zhejiang Province Medical and Health Project [2014KYA177, 2016RCB016]; Hangzhou Medical Research Fund Project [2014Z06]	The authors thank all staffs in Department of Neurosurgery, The Hangzhou First People's Hospital (Hangzhou, China) for their technical support. This study was supported financially by Zhejiang Province Medical and Health Project (Nos. 2014KYA177, 2016RCB016) and Hangzhou Medical Research Fund Project (No. 2014Z06).	Ademoglu EN, 2014, J ENDOCRINOL INVEST, V37, P715, DOI 10.1007/s40618-014-0089-2; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Bonnet MS, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-27; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Cakir M., 2016, INT J NEUROSCI, V12, P1; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Colmers WF, 2007, TRENDS ENDOCRIN MET, V18, P131, DOI 10.1016/j.tem.2007.02.009; Dai HY, 2013, PEPTIDES, V46, P167, DOI 10.1016/j.peptides.2013.06.006; Dong XQ, 2010, WORLD NEUROSURG, V74, P286, DOI 10.1016/j.wneu.2010.02.019; Dong XQ, 2010, CRIT CARE, V14, DOI 10.1186/cc9307; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Huang Q, 2013, PEPTIDES, V39, P55, DOI 10.1016/j.peptides.2012.11.006; Jiang LF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/631251; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Latronico N, 2009, J TRAUMA, V66, P1745, DOI 10.1097/TA.0b013e3181a56c8b; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Ozsavci D, 2011, NEUROSURGERY, V68, P1699, DOI 10.1227/NEU.0b013e318210f258; Scotece M, 2014, J ORTHOP RES, V32, P653, DOI 10.1002/jor.22585; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Tang CH, 2012, PEPTIDES, V36, P39, DOI 10.1016/j.peptides.2012.04.014; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Wang C, 2015, MED SCI MONITOR, V21, P1072, DOI [10.12659/MSM.894058, 10.12659/MSM.892875]; Wang WH, 2011, CLIN CHIM ACTA, V412, P1626, DOI 10.1016/j.cca.2011.05.016; Weng JF, 2013, PEPTIDES, V40, P8, DOI 10.1016/j.peptides.2012.12.017; Zammit Christopher, 2013, Emerg Med Pract, V15, P1	35	8	9	0	222	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JUL 1	2016	458						124	128		10.1016/j.cca.2016.05.001			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	DP4GL	WOS:000378454300023	27155585				2022-02-06	
J	Zander, NE; Piehler, T; Banton, R; Boggs, M				Zander, Nicole E.; Piehler, Thuvan; Banton, Rohan; Boggs, Mary			The effect of explosive blast loading on human neuroblastoma cells	ANALYTICAL BIOCHEMISTRY			English	Article						Traumatic brain injury; Explosive blast; In vitro model; Neurons; Membrane damage; Oxidative stress	TRAUMATIC BRAIN-INJURY; IN-VITRO; CULTURES; DAMAGE; MODEL	Diagnosis of mild to moderate traumatic brain injury is challenging because brain tissue damage progresses slowly and is not readily detectable by conventional imaging techniques. We have developed a novel in vitro model to study primary blast loading on dissociated neurons using nitroamine explosives such as those used on the battlefield. Human neuroblastoma cells were exposed to single and triple 50 psi explosive blasts and single 100-psi blasts. Changes in membrane permeability and oxidative stress showed a significant increase for the single and triple 100-psi blast conditions compared with single 50 psi blast and controls. Published by Elsevier Inc.	[Zander, Nicole E.; Piehler, Thuvan; Banton, Rohan] US Army Res Lab, Weap & Mat Res Directorate, Aberdeen Proving Ground, MD 21005 USA; [Boggs, Mary] Univ Delaware, Dept Biol, Newark, DE 19716 USA		Zander, NE (corresponding author), US Army Res Lab, Weap & Mat Res Directorate, Aberdeen Proving Ground, MD 21005 USA.	nicole.e.zander.civ@mail.mil			U.S. Army Research Laboratory's Director's Science Initiative [DSI-13-WMR-2D-005]	This research was supported by the U.S. Army Research Laboratory's Director's Science Initiative (DSI-13-WMR-2D-005).	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594	11	8	8	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	JUL 1	2016	504						4	6		10.1016/j.ab.2016.03.009			3	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	DN4RN	WOS:000377055000002	27033003	Bronze			2022-02-06	
J	Foster, SN; Brock, MS; Hansen, S; Collen, JF; Walter, R; O'Connor, P; Wall, P; Mysliwiec, V				Foster, Shannon N.; Brock, Matthew S.; Hansen, Shana; Collen, Jacob F.; Walter, Robert; O'Connor, Peter; Wall, Patricia; Mysliwiec, Vincent			Sleep disorders related to deployment in active duty service members and veterans	CURRENT PULMONOLOGY REPORTS			English	Article						Sleep; Deployment; Military; Veterans; Service members	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MILITARY PERSONNEL; COMBAT VETERANS; COMORBID INSOMNIA; UNITED-STATES; WAR VETERANS; PREVALENCE; APNEA; PTSD	Active duty service members (ADSM) are a unique population at risk for complex health issues; among the most frequent are sleep disorders. Sleep disturbances are prevalent, debilitating, and persistent in ADSM following combat deployments. Multiple factors associated with deployment and combat operations place ADSM at risk for acute sleep disturbances. If untreated, acute sleep disturbances can become chronic sleep disorders that result in physical and mental impairments and decreased military readiness. Sleep disorders are frequently comorbid with posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI). However, they are independent clinical disorders which require specific therapy. The consequences of sleep disorders are increasingly recognized in both ADSM and veterans and pose an unprecedented challenge to medical providers who care for these populations.	[Foster, Shannon N.; Brock, Matthew S.; Hansen, Shana; Walter, Robert; O'Connor, Peter; Mysliwiec, Vincent] San Antonio Mil Med Ctr, Dept Sleep Med, JBSA Lackland, 2200 Bergquist Dr,Suite 1, San Antonio, TX 78236 USA; [Hansen, Shana; Collen, Jacob F.; Walter, Robert; O'Connor, Peter] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Collen, Jacob F.] Walter Reed Natl Mil Med Ctr, Pulm Crit Care & Sleep Med, 8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Wall, Patricia] Triserv Nursing Res Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Foster, SN (corresponding author), San Antonio Mil Med Ctr, Dept Sleep Med, JBSA Lackland, 2200 Bergquist Dr,Suite 1, San Antonio, TX 78236 USA.	shannon.n.foster3.mil@mail.mil					AMERICAN ACADEMY OF SLEEP MEDICINE, 2014, INT CLASSIFICATION S; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P8; Babson KA, 2013, J CLIN SLEEP MED, V9, P1253, DOI 10.5664/jcsm.3262; Barlas FM, 2013, 2011 HLTH RELATED BE; Bray RM., 2009, 2008 DEP DEFENSE SUR; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Colvonen PJ, 2015, J CLIN SLEEP MED, V11, P513, DOI 10.5664/jcsm.4692; Czeisler CA, 2011, J CLIN SLEEP MED, V7, pS6, DOI 10.5664/JCSM.1340; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Defense Health Agency, 2014, STAT PCMH MIL HLTH S; Dorheim SK, 2009, SLEEP, V32, P847, DOI 10.1093/sleep/32.7.847; Dorrian J, 2003, SLEEP, V26, P871, DOI 10.1093/sleep/26.7.871; Engdahl BE, 2000, BIOL PSYCHIAT, V47, P520, DOI 10.1016/S0006-3223(99)00201-2; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; Facco FL, 2010, OBSTET GYNECOL, V115, P77, DOI 10.1097/AOG.0b013e3181c4f8ec; Fleetham JA, 2014, CAN MED ASSOC J, V186, pE273, DOI 10.1503/cmaj.120808; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; Goodwin RD, 2002, ADDICTION, V97, P555, DOI 10.1046/j.1360-0443.2002.00098.x; Hermes E, 2014, SLEEP MED, V15, P508, DOI 10.1016/j.sleep.2013.12.010; Jaoude P, 2015, ANN AM THORAC SOC, V12, P259, DOI 10.1513/AnnalsATS.201407-299FR; Jenkins MM, 2015, SLEEP, V38, P1547, DOI 10.5665/sleep.5044; Johnson EO, 1998, SLEEP, V21, P178, DOI 10.1093/sleep/21.2.178; Knutson KL, 2010, SLEEP, V33, P37, DOI 10.1093/sleep/33.1.37; Krakow BJ, 2015, SLEEP MED REV, V24, P37, DOI 10.1016/j.smrv.2014.11.001; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Kryger MH, 2003, MIL MED, V168, P7; Kudlow PA, 2013, SLEEP MED, V14, P943, DOI 10.1016/j.sleep.2013.04.017; Lee YC, 2013, J KOREAN MED SCI, V28, P1373, DOI 10.3346/jkms.2013.28.9.1373; Lentino Cynthia V, 2013, US Army Med Dep J, P98; Lettieri CJ, 2016, CHEST, V149, P483, DOI 10.1378/chest.15-0693; Lewis Paul E, 2014, MSMR, V21, P6; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Mindell J A, 2000, J Obstet Gynecol Neonatal Nurs, V29, P590; Monti JM, 2005, INT REV PSYCHIATR, V17, P247, DOI 10.1080/09540260500104516; Morris KL, 1999, NUTR REV, V57, P273; Mysliwiec V, 2015, J CLIN SLEEP MED, V11, P1393, DOI 10.5664/jcsm.5272; Mysliwiec V, 2014, J CLIN SLEEP MED, V10, P1143, DOI 10.5664/jcsm.4120; Mysliwiec V, 2014, MIL MED, V179, P294, DOI 10.7205/MILMED-D-13-00396; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Okpala N, 2011, MIL MED, V176, P561, DOI 10.7205/MILMED-D-10-00319; Pedersen ER, 2015, MIL MED, V180, P4, DOI 10.7205/MILMED-D-14-00264; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Picchioni D, 2010, MIL PSYCHOL, V22, P340, DOI 10.1080/08995605.2010.491844; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Ram S, 2010, SLEEP BREATH, V14, P63, DOI 10.1007/s11325-009-0281-3; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Stocker RPJ, 2016, J CLIN SLEEP MED, V12, P49, DOI 10.5664/jcsm.5392; Swinkels CM, 2013, SLEEP, V36, P1019, DOI 10.5665/sleep.2800; Terri T, 2014, DEPLOYMENT LIFE STUD; Troxel WM, 2015, SLEEP MILITARY PROMO; Ulmer CS, 2015, J CLIN SLEEP MED, V11, P995, DOI 10.5664/jcsm.5012; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845; Wright KM, 2011, STRESS HEALTH, V27, P325, DOI 10.1002/smi.1373; Yesavage JA, 2012, AM J GERIAT PSYCHIAT, V20, P199, DOI 10.1097/JGP.0b013e3181e446ea	80	8	8	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA		2199-2428		CURR PULMONOL REP	Curr. Pulmonol. Rep.	JUN	2016	5	2					101	110		10.1007/s13665-016-0147-7			10	Respiratory System	Emerging Sources Citation Index (ESCI)	Respiratory System	DU9AG	WOS:000382508000006					2022-02-06	
J	Neumann, D; McDonald, BC; West, J; Keiski, MA; Wang, Y				Neumann, Dawn; McDonald, Brenna C.; West, John; Keiski, Michelle A.; Wang, Yang			Neurobiological mechanisms associated with facial affect recognition deficits after traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Neuroimaging; Emotion; Facial affect recognition; Traumatic brain injury; Functional MRI; fMRI	FUSIFORM FACE AREA; EMOTION RECOGNITION; NONVERBAL-COMMUNICATION; HOLISTIC PERCEPTION; SPECTRUM DISORDER; SOCIAL COMPETENCE; EXPRESSION; AUTISM; DEPRESSION; FMRI	The neurobiological mechanisms that underlie facial affect recognition deficits after traumatic brain injury (TBI) have not yet been identified. Using functional magnetic resonance imaging (fMRI), study aims were to 1) determine if there are differences in brain activation during facial affect processing in people with TBI who have facial affect recognition impairments (TBI-I) relative to people with TBI and healthy controls who do not have facial affect recognition impairments (TBI-N and HC, respectively); and 2) identify relationships between neural activity and facial affect recognition performance. A facial affect recognition screening task performed outside the scanner was used to determine group classification; TBI patients who performed greater than one standard deviation below normal performance scores were classified as TBI-I, while TBI patients with normal scores were classified as TBI-N. An fMRI facial recognition paradigm was then performed within the 3T environment. Results from 35 participants are reported (TBI-I=11, TBI-N=12, and HC=12). For the fMRI task, TBI-I and TBI-N groups scored significantly lower than the HC group. Blood oxygenation level-dependent (BOLD) signals for facial affect recognition compared to a baseline condition of viewing a scrambled face, revealed lower neural activation in the right fusiform gyrus (FG) in the TBI-I group than the HC group. Right fusiform gyrus activity correlated with accuracy on the facial affect recognition tasks (both within and outside the scanner). Decreased FG activity suggests facial affect recognition deficits after TBI may be the result of impaired holistic face processing. Future directions and clinical implications are discussed.	[Neumann, Dawn] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [McDonald, Brenna C.; West, John] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, Indiana Univ, 355 W 16th St,GH Suite 4100, Indianapolis, IN 46202 USA; [Keiski, Michelle A.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Ctr Neuroimaging, Indiana Univ, 355 W 16th St,GH Suite 4100, Indianapolis, IN 46202 USA; [Wang, Yang] Med Coll Wisconsin, Dept Biophys, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu; mcdonalb@iupui.edu; jdwest@iupui.edu; michellekeiski@gmail.com; yangwang@mcw.edu					Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Avidan G, 2011, NEUROPSYCHOLOGIA, V49, P2541, DOI 10.1016/j.neuropsychologia.2011.05.002; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359; Busigny T, 2014, NEUROPSYCHOLOGIA, V56, P312, DOI 10.1016/j.neuropsychologia.2014.01.018; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Ganel T, 2005, NEUROPSYCHOLOGIA, V43, P1645, DOI 10.1016/j.neuropsychologia.2005.01.012; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li HJ, 2010, SCHIZOPHRENIA BULL, V36, P1029, DOI 10.1093/schbul/sbn190; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McIntire K. A., 1997, M SE PSYCH ASS ATL G; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Neumann D, 2014, BRAIN IMAGING BEHAV, V8, P460, DOI 10.1007/s11682-013-9285-5; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nowicki S, 1998, GENET SOC GEN PSYCH, V124, P39; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Ogai Masahiro, 2003, Neuroreport, V14, P559, DOI 10.1097/00001756-200303240-00006; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Piggot J, 2004, J AM ACAD CHILD PSY, V43, P473, DOI 10.1097/00004583-200404000-00014; Rossion B, 2013, VIS COGN, V21, P139, DOI 10.1080/13506285.2013.772929; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Schiltz C, 2010, J VISION, V10, DOI 10.1167/10.2.25; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; SPIELBERGER CD, 1995, ASSESSMENT EMOTIONAL; Spielberger CD., 1970, STATE TRAIT ANXIETY; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203	49	8	8	2	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2016	10	2					569	580		10.1007/s11682-015-9415-3			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7JK	WOS:000382390000023	26040980	Green Submitted			2022-02-06	
J	Shabtai, L; Arkader, A				Shabtai, Lior; Arkader, Alexandre			Percutaneous Reduction of Displaced Radial Neck Fractures Achieves Better Results Compared With Fractures Treated by Open Reduction	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						radial neck fractures; closed reduction; percutaneous reduction; stiffness	CLOSED REDUCTION; CHILDREN; EXPERIENCE; MANAGEMENT; HEAD	There is uniform agreement in the literature that radial neck fracture with < 30 degrees of angulation and minimal translation in younger children can be managed by casting alone, without the need for closed reduction. For more severe fractures, closed manipulation techniques followed by percutaneous reduction technique (in case closed reduction fails) should be performed before switching to an open reduction technique. Debate still exists regarding the best treatment protocol for severely displaced fractures. Although some surgeons favor open reduction with the argument that repeat manipulations may cause iatrogenic injuries, and stiffness, others believe that open reduction is one of the most contributing factors for poor outcome. On the basis of this paradigm, we present our treatment algorithm based on the data demonstrating that percutaneous reduction of displaced radial neck fractures achieve better results than open reduction.	[Shabtai, Lior] Childrens Hosp Los Angeles, Childrens Orthoped Ctr, Los Angeles, CA 90027 USA; [Arkader, Alexandre] Childrens Hosp Philadelphia, 3401 Civ Ctr Blvd,2nd Floor Wood Bldg, Philadelphia, PA 19104 USA		Arkader, A (corresponding author), Childrens Hosp Philadelphia, 3401 Civ Ctr Blvd,2nd Floor Wood Bldg, Philadelphia, PA 19104 USA.	arkadera1@email.chop.edu					Basmajian HG, 2014, J PEDIATR ORTHOP B, V23, P369, DOI 10.1097/BPB.0000000000000057; De Mattos CB, 2016, J PEDIATR ORTHOPED, V36, P6, DOI 10.1097/BPO.0000000000000387; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P257; GonzalezHerranz P, 1997, J PEDIATR ORTHOPED, V17, P325, DOI 10.1097/00004694-199705000-00011; Herring JA, 2002, TACHDJIANS PEDIAT OR, V5th; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; Malmvik J, 2003, J PEDIATR ORTHOP B, V12, P63, DOI 10.1097/00009957-200301000-00012; MERCHAN ECR, 1994, J TRAUMA, V37, P812; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; Monson R, 2009, J PEDIATR ORTHOPED, V29, P243, DOI 10.1097/BPO.0b013e3181990745; Neher CG, 2003, J PEDIATR ORTHOPED, V23, P626, DOI 10.1097/01241398-200309000-00009; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; Pring Maya E, 2012, J Pediatr Orthop, V32 Suppl 1, pS14, DOI 10.1097/BPO.0b013e31824b251d; Radomisli TE, 1998, CLIN ORTHOP RELAT R, P30; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; Song KS, 2015, J PEDIATR ORTHOPED, V35, pE26, DOI 10.1097/BPO.0000000000000305; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760, DOI 10.1302/0301-620X.74B5.1527130; Stiefel D, 2001, J BONE JOINT SURG BR, V83B, P536, DOI 10.1302/0301-620X.83B4.11060; Tan Bryan Hsi Ming, 2011, J Orthop Surg (Hong Kong), V19, P209; Tarallo L, 2013, J ORTHOP TRAUMATOL, V14, P291, DOI 10.1007/s10195-013-0252-0; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; Wang J, 2013, J PEDIATR ORTHOP B, V22, P127, DOI 10.1097/BPB.0b013e32835b5700; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	23	8	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JUN	2016	36	4		1			S63	S66					4	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	DO3LL	WOS:000377683000015	27100035				2022-02-06	
J	Verriden, AL; Roscoe, EM				Verriden, Amanda L.; Roscoe, Eileen M.			COMPARISON OF PREFERENCE-ASSESSMENT METHODS	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						autism; preference assessment; preference stability; problem behavior; reinforcement	DISABILITIES; BEHAVIOR	In Study 1, we evaluated preference stability across 4 preference-assessment methods for 6 individuals, 5 of whom had autism spectrum disorder and 1 of whom had traumatic brain injury. We also measured participants' problem behavior as a corollary measure during all assessment methods. The highest mean correlation coefficients and Kendall rank coefficients of concordance across administrations were observed for the paired-stimulus and multiple-stimulus-without-replacement methods. Lower correspondence across administrations was observed for the free-operant and response-restriction methods. Although differentially higher levels of problem behavior did not occur with a single method, lower levels were consistently observed with the free-operant method. During Study 2, we evaluated the implications of lower coefficients on reinforcer efficacy by comparing an initially identified and an immediately identified high-preference stimulus in a reinforcer assessment. Initially identified and immediately identified high-preference stimuli were equally effective reinforcers, suggesting that fluctuations in preference do not necessarily affect reinforcer efficacy in practice.	Western New England Univ, Springfield, MA USA; [Roscoe, Eileen M.] New England Ctr Children, 33 Turnpike Rd, Southborough, MA 01772 USA		Roscoe, EM (corresponding author), New England Ctr Children, 33 Turnpike Rd, Southborough, MA 01772 USA.	eroscoe@necc.org					Carr JE, 2000, J APPL BEHAV ANAL, V33, P353, DOI 10.1901/jaba.2000.33-353; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Ciccone FJ, 2007, BEHAV INTERVENT, V22, P223, DOI 10.1002/bin.238; DeLeon IG, 2001, J APPL BEHAV ANAL, V34, P463, DOI 10.1901/jaba.2001.34-463; DeLeon IG, 1996, J APPL BEHAV ANAL, V29, P519, DOI 10.1901/jaba.1996.29-519; FISHER W, 1992, J APPL BEHAV ANAL, V25, P491, DOI 10.1901/jaba.1992.25-491; Fisher WW, 1996, AM J MENT RETARD, V101, P15; Hanley GP, 2006, J APPL BEHAV ANAL, V39, P189, DOI 10.1901/jaba.2006.163-04; Hanley GP, 2003, J APPL BEHAV ANAL, V36, P47, DOI 10.1901/jaba.2003.36-47; Kang S, 2010, J APPL BEHAV ANAL, V43, P137, DOI 10.1901/jaba.2010.43-137; Roane HS, 1998, J APPL BEHAV ANAL, V31, P605, DOI 10.1901/jaba.1998.31-605; Roscoe EM, 1999, J APPL BEHAV ANAL, V32, P479, DOI 10.1901/jaba.1999.32-479; Salkind N. J., 2013, STAT PEOPLE WHO THIN; Zhou LM, 2001, J APPL BEHAV ANAL, V34, P179, DOI 10.1901/jaba.2001.34-179	14	8	8	1	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8855	1938-3703		J APPL BEHAV ANAL	J. Appl. Behav. Anal.	JUN	2016	49	2					265	285		10.1002/jaba.302			21	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DW5HQ	WOS:000383675100004	27037669				2022-02-06	
J	Chernomordikl, V; Amyot, F; Kenney, K; Wassermann, E; Diaz-Arrastia, R; Gandjbakhche, A				Chernomordikl, Victor; Amyot, Franck; Kenney, Kimbra; Wassermann, Eric; Diaz-Arrastia, Ramon; Gandjbakhche, Amir			Abnormality of low frequency cerebral hemodynamics oscillations in TBI population	BRAIN RESEARCH			English	Article						Cerebral autoregulation; Functional Near InfraRed; Spectroscopy; Low frequency oscillations; Parametric effect of the judgment of; complexity; Traumatic brain injury	NEAR-INFRARED SPECTROSCOPY; COMPLEXITY	Functional Near Infrared Spectroscopy (fNIRS) can non-invasively capture dynamic cognitive activation and underlying physiological processes by measuring changes in oxy- and deoxyhemoglobin levels, correlated to brain activation. It is a portable, inexpensive and user-friendly device which is easily adapted to the outpatient setting for the assessment of cognitive functions after Traumatic Brain Injury (TBI). Low frequency oscillations in hemodynamic signal, attributed in the literature to cerebral autoregulation, were assessed using recently introduced metrics, Oxygenation Variability (OV Index), obtained from oxy/deoxy-hemoglobin variations in response to mental tasks for a group of healthy control (HC, n=14) and TBI (n=29). Participants responded to an action complexity judgment task (evaluating the complexity of daily life activities by classifying the number of steps as "few" or "many") with a varying degree of cognitive load to produce brain activation. During the task, we measured blood variations with fNIRS and analyzed OV Index changes. Mean OV indices, corresponding to high complexity tasks, are higher than that of low complexity tasks in the HC group, revealing strong parametric effect (0.039 +/- 0.017 for low, 0.057 +/- 0.036 for high, p-value=0.069). However, no significant difference has been recorded for the OV indexes for two different loads in the TBI group (0.055 +/- 0.033 for low, 0.054 +/- 0.035 for high, p=0.9). OV index metrics proves to be sensitive to chronic TBI and can potentially be used to separate subpopulations TBI vs. HC. Noticeable differences in OV index spatial distributions between subpopulations have been observed. Published by Elsevier B.V.	[Chernomordikl, Victor; Amyot, Franck; Kenney, Kimbra; Wassermann, Eric; Diaz-Arrastia, Ramon; Gandjbakhche, Amir] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA		Gandjbakhche, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	amir@helix.nih.gov	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Diaz-Arrastia, Ramon/0000-0001-6051-3594	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD000261, ZIAHD008882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977, ZIANS003138] Funding Source: NIH RePORTER	We acknowledge the funding of the intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Neurological Disorders and Stroke and Center for Neuroscience and Regenerative Medicine. We also thank Ross Passo, Leah Harburg, Carol Moore, Afrouz Anderson, Nader Shahni Karamzadeh and Fatima Chowdhry for their valuable help.	Amyot F, 2012, NEUROIMAGE, V60, P879, DOI 10.1016/j.neuroimage.2012.01.104; Anderson AA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00393; BOASHASH B, 1992, P IEEE, V80, P520, DOI 10.1109/5.135376; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cope M., 1991, APPL NEAR INFRARED S; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Krueger F, 2009, NEUROREPORT, V20, P1093, DOI 10.1097/WNR.0b013e32832e7ea5; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Pierro M., 2011, SPIE BIOS; Rosen VM, 2003, BEHAV RES METH INS C, V35, P32, DOI 10.3758/BF03195495; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; Sassaroli A, 2012, IEEE J SEL TOP QUANT, V18, P1478, DOI 10.1109/JSTQE.2012.2183581; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Schytz Henrik W., 2010, J CEREB BLOOD FLOW M, V19, P465	18	8	8	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2016	1639						194	199		10.1016/j.brainres.2016.02.018			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP4DW	WOS:000378447400017	26996413	hybrid			2022-02-06	
J	Davenport, ND				Davenport, Nicholas D.			The Chaos of Combat: An Overview of Challenges in Military Mild Traumatic Brain Injury Research	FRONTIERS IN PSYCHIATRY			English	Article						mTBI; concussion; military; neuroimaging	POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER ABNORMALITIES; DIFFUSION-TENSOR; NEUROPSYCHOLOGICAL OUTCOMES; OEF/OIF VETERANS; BLAST EXPOSURE; IRAQI FREEDOM; SELF-REPORT; SYMPTOMS; PTSD	Mild traumatic brain injury (mTBI), or concussion, is among the most common injuries affecting Veterans of recent combat deployments. Military mTBI differs from civilian mTBI in fundamental ways that make assessment and diagnosis difficult, including a reliance on retrospective self-report and the potential influence of comorbid psychopathology. These unique features and their implications for research and clinical practice are summarized, and neuroimaging studies are discussed in the context of these complicating factors.	[Davenport, Nicholas D.] Minneapolis VA Hlth Care Syst, Res Serv, Minneapolis, MN USA; [Davenport, Nicholas D.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Davenport, ND (corresponding author), Minneapolis VA Hlth Care Syst, Res Serv, Minneapolis, MN USA.; Davenport, ND (corresponding author), Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.	nicholas.davenport@va.gov	Davenport, Nicholas/AAY-8057-2020	Davenport, Nicholas/0000-0002-3441-7256	VA Rehabilitation Research and Development Career Development Award [IK2RX000709]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000709] Funding Source: NIH RePORTER	Preparation of this manuscript was supported by a VA Rehabilitation Research and Development Career Development Award (IK2RX000709) to the author. The views expressed are solely those oldie author and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Davenport ND, 2015, BRAIN IMAGING BEHAV, V9, P472, DOI 10.1007/s11682-015-9371-y; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358	50	8	8	0	13	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	MAY 13	2016	7								85	10.3389/fpsyt.2016.00085			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DL6VV	WOS:000375778700001	27242555	gold, Green Published			2022-02-06	
J	Franchini, D; Cavaliere, L; Valastro, C; Carnevali, F; van der Esch, A; Lai, O; Di Bello, A				Franchini, D.; Cavaliere, L.; Valastro, C.; Carnevali, F.; van der Esch, A.; Lai, O.; Di Bello, A.			Management of severe head injury with brain exposure in three loggerhead sea turtles Caretta caretta	DISEASES OF AQUATIC ORGANISMS			English	Article						Wound healing; Dressing; Skull fracture; Brain injury; Trauma; Chelonid	ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; WOUNDS; CYTOTOXICITY; MECHANISMS; BONE	The loggerhead Caretta caretta is the most common sea turtle in the Mediterranean. Currently, sea turtles are considered endangered, mainly due to the impact of human activities. Among traumatic lesions, those involving the skull, if complicated by brain exposure, are often life-threatening. In these cases, death could be the outcome of direct trauma of the cerebral tissue or of secondary meningoencephalitis. This uncontrolled study aims to evaluate the use of a plant-derived dressing (1 Primary Wound Dressing (R)) in 3 sea turtles with severe lesions of the skull exposing the brain. Following surgical curettage, the treatment protocol involved exclusive use of the plant-derived dressing applied on the wound surface as the primary dressing, daily for the first month and then every other day until the end of treatment. The wound and peri-wound skin were covered with a simple secondary dressing without any active compound (non-woven gauze with petroleum jelly). Data presented herein show an excellent healing process in all 3 cases and no side effects due to contact of the medication with the cerebral tissue.	[Franchini, D.; Cavaliere, L.; Valastro, C.; Lai, O.; Di Bello, A.] Univ Bari, Dept Vet Med, Str Prov Casamassima Km 3, I-70010 Valenzano, Ba, Italy; [Carnevali, F.; van der Esch, A.] Casaccia Res Ctr, Energy & Sustainable Econ Dev ENEA, Via Anguillarese 301, I-00123 Rome, Italy		Franchini, D (corresponding author), Univ Bari, Dept Vet Med, Str Prov Casamassima Km 3, I-70010 Valenzano, Ba, Italy.	delia.franchini@uniba.it		van der Esch, Stephen Andrew/0000-0002-0221-303X			Banwell H, 2006, DERMATOLOGY, V212, P66, DOI 10.1159/000089202; Camacho M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132217; CARNEVALI F, 2014, J ANIM VET SCI, V1, P6; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Di Bello A, 2011, P 31 ANN S SEA TURTL, P187; Di Bello A, 2010, J ZOO WILDLIFE MED, V41, P516, DOI 10.1638/2008-0195.1; Drosou A, 2003, WOUNDS, V15, P149; Goldberg DW, 2010, CIENC RURAL, V40, P2402, DOI 10.1590/S0103-84782010001100026; Hidalgo E, 2001, TOXICOL IN VITRO, V15, P271, DOI 10.1016/S0887-2333(01)00020-0; Keller KA, 2014, J ZOO WILDLIFE MED, V45, P866, DOI 10.1638/2014-0037.1; Lauchli S, 2012, J WOUND CARE, V21, P228; Lauchli S, 2012, HOSP HLTH EUR, V2012; Lee SY, 2006, INFECT CONT HOSP EP, V27, P1226, DOI 10.1086/507962; Lloyd DH, 1999, VET DERMATOL, V10, P249, DOI 10.1046/j.1365-3164.1999.00187.x; Lutcavage ME, 1997, BIOL SEA TURTLES, V1, P387; Mader DR, 2013, CURRENT THERAPY REPT; Mainetti S, 2013, J WOUND CARE, V22, P681, DOI 10.12968/jowc.2013.22.12.681; McArthur Stuart, 2004, P35, DOI 10.1002/9780470698877.ch3; Mitchell Mark A., 2004, Veterinary Clinics of North America Exotic Animal Practice, V7, P123, DOI 10.1016/j.cvex.2003.08.006; Naganobu K, 2000, J VET MED SCI, V62, P103, DOI 10.1292/jvms.62.103; Niedner R, 1997, DERMATOLOGY, V195, P89, DOI 10.1159/000246038; Noble W. C., 1992, Veterinary Dermatology, V3, P71, DOI 10.1111/j.1365-3164.1992.tb00147.x; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Paterson DL, 2005, J ANTIMICROB CHEMOTH, V55, P965, DOI 10.1093/jac/dki117; Rantala M, 2004, ACTA VET SCAND, V45, P37, DOI 10.1186/1751-0147-45-37; Rinaldi S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-39; Sharman D., 2003, DIABET FOOT J, V6, P112; SMITH DA, 1988, CAN J VET RES, V52, P111; SNOW SN, 1994, J AM ACAD DERMATOL, V31, P450, DOI 10.1016/S0190-9622(94)70209-8; Soderstrom V, 1997, J EXP BIOL, V200, P815; van der Esch SA, 2007, P 17 EWMA C 2 4 MAY; Wilson Judy R, 2005, Adv Skin Wound Care, V18, P373, DOI 10.1097/00129334-200509000-00011	34	8	8	0	9	INTER-RESEARCH	OLDENDORF LUHE	NORDBUNTE 23, D-21385 OLDENDORF LUHE, GERMANY	0177-5103	1616-1580		DIS AQUAT ORGAN	Dis. Aquat. Org.	MAY 3	2016	119	2					145	152		10.3354/dao02983			8	Fisheries; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Fisheries; Veterinary Sciences	DM5FO	WOS:000376373300006	27137072	Green Submitted			2022-02-06	
J	Waqas, M; Shamim, MS; Enam, SF; Qadeer, M; Bakhshi, SK; Patoli, I; Ahmad, K				Waqas, Muhammad; Shamim, Muhammad Shahzad; Enam, Syed Faaiz; Qadeer, Mohsin; Bakhshi, Saqib Kamran; Patoli, Iqra; Ahmad, Khabir			Predicting outcomes of decompressive craniectomy: use of Rotterdam Computed Tomography Classification and Marshall Classification	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Decompressive craniectomy; Glasgow outcome scale; Rotterdam Classification; traumatic brain injury; unfavourable outcomes	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL PERFUSION-PRESSURE; IMPACT; TRIAL	Background Data on the evaluation of the Rotterdam Computed Tomography Classification (RCTS) as a predictor of outcomes in patients undergoing decompressive craniectomy (DC) for trauma is limited and lacks clarity. Objective To explore the role of RCTS in predicting unfavourable outcomes, including mortality in patients undergoing DC for head trauma. Methods This was an observational cohort study conducted from 1 January 2009 to 31 March 2013. CT scans of adults with head trauma prior to emergency DC were scored according to RCTS. A receiver operating characteristic curve analysis was performed to identify the optimal cut-off RCTS for predicting unfavourable outcomes [Glasgow outcome scale (GOS)=1-3]. Binary logistic regression analysis was performed to evaluate the relationship between RCTS and unfavourable outcomes including mortality. Results One hundred ninety-seven patients (mean age: 31.4 +/- 18.7 years) were included in the study. Mean Glasgow coma score at presentation was 8.1 +/- 3.6. RCTS was negatively correlated with GOS (r=-0.370; p<0.001). The area under the curve was 0.687 (95% CI: 0.595-0.779; p<0.001) and 0.666 (95% CI: 0.589-0.742; p<0.001) for mortality and unfavourable outcomes, respectively. RCTS independently predicted both mortality (adjusted odds ratio for RCTS>3 compared with RCTS3: 2.792, 95% CI: 1.235-6.311) and other unfavourable outcomes (adjusted odds ratio for RCTS>3 compared with RCTS3: 2.063, 95% CI: 1.056-4.031). Conclusion RCTS is an independent predictor of unfavourable outcomes and mortality among patients undergoing emergency DC.	[Waqas, Muhammad; Shamim, Muhammad Shahzad; Enam, Syed Faaiz; Qadeer, Mohsin; Bakhshi, Saqib Kamran; Patoli, Iqra; Ahmad, Khabir] Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Stadium Rd,POB 74800, Karachi, Pakistan		Shamim, MS (corresponding author), Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Stadium Rd,POB 74800, Karachi, Pakistan.	shahzad.shamim@aku.edu		Enam, Syed Faaiz/0000-0002-5320-6809			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bloomfield GL, 1996, J TRAUMA, V40, P936, DOI 10.1097/00005373-199606000-00012; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Razzak JA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-357; Sabin C, 2000, MED STAT GLANCE; SAUL TG, 1982, AM SURGEON, V48, P477; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; Shamim Muhammad S, 2011, J Emerg Trauma Shock, V4, P147, DOI 10.4103/0974-2700.76817; Shamim Muhammad Shahzad, 2011, Surg Neurol Int, V2, P166, DOI 10.4103/2152-7806.90027; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	24	8	8	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					258	263		10.3109/02688697.2016.1139047			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900018	26828246				2022-02-06	
J	Al-Amad, SH; Awad, MA; Al-Farsi, LH; Elkhaled, RH				Al-Amad, Suhail H.; Awad, Manal A.; Al-Farsi, Laila H.; Elkhaled, Rawan H.			Reporting child abuse cases by dentists working in the United Arab Emirates (UAE)	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Child abuse; Education; Dentistry; Reporting; United Arab Emirates	PHYSICAL ABUSE; KNOWLEDGE; ATTITUDES; NEGLECT; EXPERIENCE; INJURIES; HEAD	Reporting of suspicious cases of child abuse is a sensitive issue that is often hindered by uncertainty of diagnosis. This cross sectional study aimed to assess the UAE dentists' experiences in child abuse recognition, the factors that prevent them from reporting suspicious cases to authorities and their perceived training needs. A closed-ended, self-administered questionnaire was distributed to 350 dentists working in the UAE. Chi Square test was used to determine association between training needs on child abuse and its reporting rate. Logistic regression was used to determine the association between perceived training needs and other covariates. One hundred and ninety three respondents satisfied the inclusion criteria. Forty seven (25%) dentists reported encountering a suspicious child abuse case at least once in their career, but only 15 (32%) of those reported their suspicion. Fear of making the wrong diagnosis was the most frequent challenge hindering reporting and dentists who demonstrated a need for specialized training were more likely to express this fear (OR = 5.88, 95% CI: 0.07, 0.45; P = 0.00). The majority of UAE dentists do not report their suspicion to authorities and specialized training should be offered to build dentists' capacity in diagnosing and appropriately reporting suspicious child abuse cases. (C) 2016 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Al-Amad, Suhail H.; Awad, Manal A.] Univ Sharjah, Coll Dent Med, Room M28-132,POB 27272, Sharjah, U Arab Emirates; [Al-Farsi, Laila H.; Elkhaled, Rawan H.] Univ Dent Hosp Sharjah, Sharjah, U Arab Emirates		Al-Amad, SH (corresponding author), Univ Sharjah, Coll Dent Med, Room M28-132,POB 27272, Sharjah, U Arab Emirates.	salamad@sharjah.ac.ae		Al-Amad, Suhail/0000-0001-8872-4887			Al-Dabaan R, 2014, SAUDI DENT J, V26, P79, DOI 10.1016/j.sdentj.2014.03.008; Al-Habsi SA, 2009, BR DENT J, V28, P206; Bankole O O, 2008, Afr J Med Med Sci, V37, P125; Benomran F, 2010, J FORENSIC LEG MED, V17, P188, DOI 10.1016/j.jflm.2009.12.009; Bsoul Samer A, 2003, Pediatr Dent, V25, P541; Cairns A M, 2005, Int J Paediatr Dent, V15, P310, DOI 10.1111/j.1365-263X.2005.00661.x; Cavalcanti AL, 2010, DENT TRAUMATOL, V26, P149, DOI 10.1111/j.1600-9657.2009.00859.x; Christian CW, 2010, PEDIATRICS, V126, P592, DOI 10.1542/peds.2010-2006; Cukovic-Bagic I, 2014, INT J PAEDIAT DENT, V15; da Fonseca M A, 1992, Pediatr Dent, V14, P152; Dubai Foundation For Women And Children, 2009, DWAFC 2 ANN REP, P25; Ivanoff CS, 2013, J DENT EDUC, V77, P695; JESSEE SA, 1995, J DENT CHILD, V62, P245; John V, 1999, AUST DENT J, V44, P259, DOI 10.1111/j.1834-7819.1999.tb00230.x; Laud A, 2013, INT J PAEDIATR DENT, V23, P64, DOI 10.1111/j.1365-263X.2012.01225.x; Naidoo S, 2000, CHILD ABUSE NEGLECT, V24, P521, DOI 10.1016/S0145-2134(00)00114-9; National Editorial, 2012, NATL NEWSPAPER  1225; Nereim V, 2012, NATL NEWSPAPER  0928; Owais AIN, 2009, INT J PAEDIATR DENT, V19, P291, DOI 10.1111/j.1365-263X.2009.00971.x; Ramos-Gomez F, 1998, J AM DENT ASSOC, V129, P340, DOI 10.14219/jada.archive.1998.0208; Sonbol HN, 2012, EUR J DENT EDUC, V16, pE158, DOI 10.1111/j.1600-0579.2011.00691.x; Uldum B, 2010, INT J PAEDIATR DENT, V20, P361, DOI 10.1111/j.1365-263X.2010.01070.x	22	8	10	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	MAY	2016	40						12	15		10.1016/j.jflm.2016.01.033			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	DK8TJ	WOS:000375200900003	26950173				2022-02-06	
J	Caccese, JB; Kaminski, TW				Caccese, Jaclyn B.; Kaminski, Thomas W.			Comparing Computer-Derived and Human-Observed Scores for the Balance Error Scoring System	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; postural stability; reliability	POSTURAL STABILITY; CONCUSSION; SPORT; RELIABILITY	Context: The Balance Error Scoring System (BESS) is the current standard for assessing postural stability in concussed athletes on the sideline. However, research has questioned the objectivity and validity of the BESS, suggesting that while certain subcategories of the BESS have sufficient reliability to be used in evaluation of postural stability, the total score is not reliable, demonstrating limited interrater and intrarater reliability. Recently, a computerized BESS test was developed to automate scoring. Objective: To compare computer derived BESS scores with those taken from 3 trained human scorers. Design: Interrater reliability study. Setting: Athletic training room. Patients: NCAA Division I student athletes (53 male, 58 female; 19 +/- 2 y, 168 +/- 41 cm, 69 +/- 4 kg). Interventions: Subjects were asked to perform the BESS while standing on the Tekscan (Boston, MA) MobileMat (R) BESS. The MobileMat BESS software displayed an error score at the end of each trial. Simultaneously, errors were recorded by 3 separate examiners. Errors were counted using the standard BESS scoring criteria. Main Outcome Measures: The number of BESS errors was computed for the 6 stances from the software and each of the 3 human scorers. Interclass correlation coefficients (ICCs) were used to compare errors for each stance scored by the MobileMat BESS software with each of 3 raters individually. The ICC values were converted to Fisher Z scores, averaged, and converted back into ICC values. Results: The double-leg, single-leg, and tandem-firm stances resulted in good agreement with human scorers (ICC = .999, .731, and .648). All foam stances resulted in fair agreement. Conclusions: Our results suggest that the MobileMat BESS is suitable for identifying BESS errors involving each of the 6 stances of the BESS protocol. Because the MobileMat BESS scores consistently and reliably, this system can be used with confidence by clinicians as an effective alternative to scoring the BESS.	[Caccese, Jaclyn B.; Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA		Caccese, JB (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA.	jcaccese@udel.edu	Caccese, Jaclyn B./AAH-4571-2020; Caccese, Jaclyn/O-2315-2016; Buckley, Thomas A/B-7525-2016	Caccese, Jaclyn B./0000-0003-2329-3603; Buckley, Thomas A/0000-0002-0515-0150			Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brenton-Rule A, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-21; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71	11	8	8	2	12	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAY	2016	25	2					133	136		10.1123/jsr.2014-0281			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DO8EN	WOS:000378015500005	25365511				2022-02-06	
J	Denny, VC; Cassese, JS; Jacobsen, KH				Denny, Vanessa C.; Cassese, James S.; Jacobsen, Kathryn H.			Nonfatal injury incidence and risk factors among middle school students from four Polynesian countries: The Cook Islands, Niue, Samoa, and Tonga	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Adolescents; Injuries; Accidental falls; GSHS; Cook Islands; Niue; Samoa; Tonga; Oceania; Pacific Islands	GLOBAL BURDEN; YOUNG-PEOPLE; UNINTENTIONAL INJURIES; SOCIAL DETERMINANTS; DEPRESSIVE SYMPTOMS; ADOLESCENT HEALTH; PACIFIC; BEHAVIOR; YOUTH; EPIDEMIOLOGY	Introduction: The burden of injuries in Pacific Island countries is understudied despite the known challenges associated with many residents having limited access to advanced medical and surgical care when they sustain a serious injury. This paper examines nonfatal injuries among early adolescent schoolchildren (those primarily ages 13-15 years) from four Polynesian countries. Methods: Self-reported data from the 5507 middle school students who were randomly sampled for participation in the nationwide Global School-based Student Health Surveys (GSHS) in the Cook Islands (in the year 2009), Niue (2010), Samoa (2011), and Tonga (2010) were analysed with various statistical methods including regression models. Injuries were defined by the GSHS questionnaire as serious if they resulted in a full day of missed school or other usual activities or required medical treatment. Results: The proportion of students reporting a serious injury in the past year was 43.1% in the Cook Islands, 40.8% in Niue, 73.8% in Samoa, and 49.1% in Tonga. In the Cook Islands and Samoa, boys reported more injuries than girls (p < 0.01). The most common types of serious injuries reported were cuts and other skin trauma; broken bones and dislocated joints; and concussions, other head injuries, or difficulty breathing. The most common causes of serious injuries reported were falls; motor vehicle accidents; and attacks, fights, or abuse. For both boys and girls, being bullied in the past month, being physically attacked or in a physical fight in the past year, using alcohol and tobacco, skipping school, and having anxiety or loneliness were associated with a higher likelihood of injuries. Conclusions: School-based health education programs targeting prevention of intentional and unintentional injuries may benefit from emphasising Polynesian values and promoting personal mental and physical health, healthy behaviours, and healthy family and community relationships. (C) 2015 Elsevier Ltd. All rights reserved.	[Denny, Vanessa C.; Cassese, James S.; Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr 5B7, Fairfax, VA 22030 USA		Jacobsen, KH (corresponding author), George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr 5B7, Fairfax, VA 22030 USA.	kjacobse@gmu.edu	Jacobsen, Kathryn H./B-5857-2008	Jacobsen, Kathryn H./0000-0002-4198-6246			BARKER JC, 1993, AM J HUM BIOL, V5, P61, DOI 10.1002/ajhb.1310050110; Barry MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-835; Baxendale S, 2012, AGGRESS VIOLENT BEH, V17, P297, DOI 10.1016/j.avb.2012.03.002; Becker AE, 2010, ETHNIC HEALTH, V15, P181, DOI 10.1080/13557851003615552; Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Capstick S, 2009, SOC SCI MED, V68, P1341, DOI 10.1016/j.socscimed.2009.01.002; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Cook Islands Ministry of Health, 2014, COOK ISL GLOB HLTH S; Craig W, 2009, INT J PUBLIC HEALTH, V54, P216, DOI 10.1007/s00038-009-5413-9; Deva MP, 2010, ASIAN J PSYCHIATR, V3, P47, DOI 10.1016/j.ajp.2010.01.007; Due P, 2005, EUR J PUBLIC HEALTH, V15, P128, DOI 10.1093/eurpub/cki105; Due Pernille, 2008, Int J Adolesc Med Health, V20, P209; Enoka MIS, 2013, ASIA-PAC PSYCHIAT, V5, P108, DOI 10.1111/j.1758-5872.2012.00201.x; Fiaui PA, 2009, AGGRESS VIOLENT BEH, V14, P478, DOI 10.1016/j.avb.2009.07.003; Fleming LC, 2010, HEALTH PROMOT INT, V25, P73, DOI 10.1093/heapro/dap046; Fragar L, 2013, J RURAL HEALTH, V29, P12, DOI 10.1111/j.1748-0361.2012.00423.x; Gielen AC, 2003, EPIDEMIOL REV, V25, P65, DOI 10.1093/epirev/mxg004; Gini G, 2013, PEDIATRICS, V132, P720, DOI 10.1542/peds.2013-0614; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Grossman DC, 2000, FUTURE CHILD, V10, P23, DOI 10.2307/1602824; Hale M, 2012, HEALTH PROMOT PRACT, V13, P404, DOI 10.1177/1524839912443239; Herbert HK, 2011, INFECT DIS CLIN N AM, V25, P653, DOI 10.1016/j.idc.2011.06.004; Herman J, 2014, INJURY, V45, P586, DOI 10.1016/j.injury.2013.06.007; Herman J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-479; HINGSON R, 1993, ADDICTION, V88, P877, DOI 10.1111/j.1360-0443.1993.tb02105.x; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lippe Jaclynn, 2008, Morbidity and Mortality Weekly Report, V57, P28; McCool J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1100; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pacific Islands Forum Secretariat, 2012, 2012 PAC ISL MDG TRA; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Peden M, 2008, WORLD REPORT CHILD I; Peltzer K, 2008, INJURY PREV, V14, P381, DOI 10.1136/ip.2008.018598; Peltzer K, 2012, INT J ENV RES PUB HE, V9, P2851, DOI 10.3390/ijerph9082851; Petersen S, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24896; Phongsavan P, 2011, ASIA-PAC J PUBLIC HE, V23, P57, DOI 10.1177/1010539510390927; Pickett W, 2005, INJURY PREV, V11, P213, DOI 10.1136/ip.2004.007021; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Rapaport M, 1989, Asia Pac J Public Health, V3, P129, DOI 10.1177/101053958900300207; Rumsey M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-9; Shochat T, 2014, SLEEP MED REV, V18, P75, DOI 10.1016/j.smrv.2013.03.005; Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616; Smith BJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-145; Smith-Khuri E, 2004, ARCH PEDIAT ADOL MED, V158, P539, DOI 10.1001/archpedi.158.6.539; Stevens DL, 2013, YOUTH SOC, V45, P428, DOI 10.1177/0044118X11424756; Stoddard FJ, 2001, J AM ACAD CHILD PSY, V40, P1128, DOI 10.1097/00004583-200110000-00007; Teevale T, 2012, NEW ZEAL MED J, V125, P60; Tiesman HM, 2006, INJURY PREV, V12, P172, DOI 10.1136/ip.2006.011544; Tonga Ministry of Health, 2012, TONG 2010 GLOB SCH B; U.S. Centers for Disease Control and Prevention (CDC), 2013, GLOB SCH BAS STUD HL; United Nations Department of Economics and Social Affairs, 2014, WORLD STAT POCK; World Health Organisation (WHO), 2014, WORLD HLTH STAT 2014; World Health Organization, 2013, GLOB STAT REP ROAD S; Yamamoto TS, 2012, ASIA-PAC J PUBLIC HE, V24, P697, DOI 10.1177/1010539512453259	56	8	9	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2016	47	5					1135	1142		10.1016/j.injury.2015.12.018			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DK6TA	WOS:000375057000027	26775210				2022-02-06	
J	O'Connell, E; Molloy, MG				O'Connell, E.; Molloy, M. G.			Concussion in rugby: knowledge and attitudes of players	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Knowledge; Attitude; Concussion; Brain; Sports	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; SPORT HELD; SCHOOL; COACHES; HOCKEY; ZURICH	Concussion is a traumatic brain injury, resulting in the alteration of mental status with or without loss of consciousness. There is increasing awareness that recurrent concussion may contribute to long-term neurological complication. To determine player knowledge and attitudes regarding concussion. To identify sources of information and medical care, and to estimate the incidence of concussion in this group. To determine if player gender and grade of competition are associated with differences in knowledge, attitudes, medical care, and incidence. Five rugby teams were recruited and players invited to complete a paper-based questionnaire. The questionnaire sought information on player demographics, knowledge level, attitudes and concussion experience. 90.8 % of players knew they should not continue playing when concussed. 75 % of players would continue an important game even if concussed. Of those concussed, 39.1 % have tried to influence medical assessment with 78.2 % stating it is possible or quite easy to do so. Males are less likely to worry about long-term effects of concussion (chi (2) = 9.23, p = 0.026). Club players are less likely to have medical care at training (chi (2) = 28.2, p < 0.001) or matches (chi (2) = 19.47 p < 0.001). Despite good knowledge of concussion complications, management players engage in unsafe behaviour with little difference between gender and competition grades. Information regarding symptoms and management should be available to all players, coaches, and parents. Provision of medical care should be mandatory at every level of competition.	[O'Connell, E.; Molloy, M. G.] Cork Univ Hosp, Dept Rheumatol, Cork, Ireland		O'Connell, E (corresponding author), Cork Univ Hosp, Dept Rheumatol, Cork, Ireland.	emer.oconnell@umail.ucc.ie; mgmmolloy@eircom.net					Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herring SA, 2011, MED SCI SPORTS EXERC, V43, P2412; International Rugby Board (IRB), 2013, IRB CONC GUID; Irish Rugby Football Union, 2013, STOP INFORM REST RET; Jamie Kissick MD, 2005, THINKFIRST SPORTSMAR; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	19	8	10	0	14	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	MAY	2016	185	2					521	528		10.1007/s11845-015-1313-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK0AZ	WOS:000374576100031	26026952				2022-02-06	
J	Spiegel, DP; Reynaud, A; Ruiz, T; Lague-Beauvais, M; Hess, R; Farivar, R				Spiegel, Daniel P.; Reynaud, Alexandre; Ruiz, Tatiana; Lague-Beauvais, Maude; Hess, Robert; Farivar, Reza			First- and second-order contrast sensitivity functions reveal disrupted visual processing following mild traumatic brain injury	VISION RESEARCH			English	Article						Traumatic brain injury; First order vision; Second order vision; Motion perception; Contrast sensitivity	CRITICAL FLICKER FREQUENCY; DIRECT-CURRENT STIMULATION; SPATIAL-FREQUENCY; MOTION PERCEPTION; RESPONSES; DEFICITS; SELECTIVITY; THRESHOLDS; MODULATION; BLINDSIGHT	Vision is disrupted by traumatic brain injury (TBI), with vision-related complaints being amongst the most common in this population. Based on the neural responses of early visual cortical areas, injury to the visual cortex would be predicted to affect both 1st order and 2nd order contrast sensitivity functions (CSFs) the height and/or the cut-off of the CSF are expected to be affected by TBI. Previous studies have reported disruptions only in 2nd order contrast sensitivity, but using a narrow range of parameters and divergent methodologies no study has characterized the effect of TBI on the full CSF for both 1st and 2nd order stimuli. Such information is needed to properly understand the effect of TBI on contrast perception, which underlies all visual processing. Using a unified framework based on the quick contrast sensitivity function, we measured full CSFs for static and dynamic 1st and 2nd order stimuli. Our results provide a unique dataset showing alterations in sensitivity for both 1st and 2nd order visual stimuli. In particular, we show that TBI patients have increased sensitivity for 1st order motion stimuli and decreased sensitivity to orientation-defined and contrast-defined 2nd order stimuli. In addition, our data suggest that TBI patients' sensitivity for both 1st order stimuli and 2nd order contrast-defined stimuli is shifted towards higher spatial frequencies. (C) 2016 The Authors. Published by Elsevier Ltd.	[Spiegel, Daniel P.; Lague-Beauvais, Maude; Farivar, Reza] McGill Univ, Ctr Hlth, Res Inst, Traumat Brain Injury Program, Montreal, PQ, Canada; [Spiegel, Daniel P.; Reynaud, Alexandre; Ruiz, Tatiana; Hess, Robert; Farivar, Reza] McGill Univ, Dept Ophthalmol, McGill Vis Res Unit, Montreal, PQ H3A 2T5, Canada; [Lague-Beauvais, Maude] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Spiegel, DP; Farivar, R (corresponding author), Montreal Gen Hosp, McGill Vis Res Unit, Dept Ophthalmol, L7-213, Montreal, PQ H3G 1A4, Canada.	daniel.spiegel@mcgill.ca; reza.farivar@mcgill.ca	Farivar, Reza/AAA-5762-2020	Reynaud, Alexandre/0000-0002-6537-3575	Research Institute of the McGill University Health Center; Psychological Health and Traumatic Brain Injury Research Program of the U.S. Department of Defense [W81XWH-14-1-0320]	This research was funded by the Research Institute of the McGill University Health Center grant and by the Psychological Health and Traumatic Brain Injury Research Program of the U.S. Department of Defense under award W81XWH-14-1-0320. Views and opinions of, and endorsements by the author(s) do not reflect those of the US Army or the Department of Defense. There are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.	Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2005, CEPHALALGIA, V25, P788, DOI 10.1111/j.1468-2982.2005.00949.x; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; BODISWOLLNER I, 1976, BRAIN, V99, P695, DOI 10.1093/brain/99.4.695; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Cantu D., 2014, CEREB CORTEX; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Ciuffreda K. J., 2008, MED MANAGEMENT ADULT, P407; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cowey A, 2010, CURR BIOL, V20, pR702, DOI 10.1016/j.cub.2010.07.014; Dakin SC, 2000, VISION RES, V40, P311, DOI 10.1016/S0042-6989(99)00179-0; Defense Centers of Excellence for Psychological Health & Traumatic Brain Injury, 2013, ASS MAN VIS DYSF ASS; El-Shamayleh Y, 2011, J NEUROSCI, V31, P8543, DOI 10.1523/JNEUROSCI.5974-10.2011; Gao Y., 2014, VISION RES; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hayes R. D., 2006, CEREBRAL CORTEX; HESS RF, 1990, CLIN VISION SCI, V5, P203; Holmes CC, 2015, BAYESIAN ANAL, V10, P297, DOI 10.1214/14-BA914; ISHIAI S, 1993, NEUROLOGY, V43, P106, DOI 10.1212/WNL.43.1_Part_1.106; Joanette Y., 1989, INT J CLIN NEUROPSYC; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Larsson J, 2010, J NEUROPHYSIOL, V104, P2940, DOI 10.1152/jn.00400.2010; Lesmes LA, 2010, J VISION, V10, DOI 10.1167/10.3.17; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McKendrick AM, 2004, CEPHALALGIA, V24, P363, DOI 10.1111/j.1468-2982.2004.00679.x; MERIGAN WH, 1993, J NEUROSCI, V13, P3180; Merigan WH, 2000, VISUAL NEUROSCI, V17, P949, DOI 10.1017/S095252380017614X; Meso AI, 2010, VISION RES, V50, P1475, DOI 10.1016/j.visres.2010.04.021; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piponnier J.-C., 2015, J NEUROTRAUMA; Reynaud A, 2014, J VISION, V14, DOI 10.1167/14.9.3; Reynaud A, 2012, EXP BRAIN RES, V220, P135, DOI 10.1007/s00221-012-3124-6; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Spiegel DP, 2015, VISION RES, V109, P38, DOI 10.1016/j.visres.2015.02.020; Spiegel DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036220; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; SUTTER A, 1995, VISION RES, V35, P915, DOI 10.1016/0042-6989(94)00196-S	48	8	8	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	MAY	2016	122						43	50		10.1016/j.visres.2016.03.004			8	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	DL9MO	WOS:000375967600005	27036098	hybrid			2022-02-06	
J	Olson, E; Badder, C; Sullivan, S; Smith, C; Propert, K; Margulies, SS				Olson, Emily; Badder, Carlie; Sullivan, Sarah; Smith, Colin; Propert, Kathleen; Margulies, Susan S.			Alterations in Daytime and Nighttime Activity in Piglets after Focal and Diffuse Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavior; TBI; sleep; symptoms; pediatric	PIGS SUS-SCROFA; NEUROPSYCHOLOGICAL ASSESSMENT; SLEEP; ACTIGRAPHY; POLYSOMNOGRAPHY; DISTURBANCES; ADOLESCENTS; ACCELEROMETER; TRAJECTORIES; CHILDREN	We have developed and implemented a noninvasive, objective neurofunctional assessment for evaluating the sustained effects of traumatic brain injury (TBI) in piglets with both diffuse and focal injury types. Derived from commercial actigraphy methods in humans, this assessment continuously monitors the day/night activity of piglets using close-fitting jackets equipped with tri-axial accelerometers to monitor movements of the thorax. Acceleration metrics were correlated (N = 7 naive piglets) with video images to define values associated with a range of activities, from recumbancy (rest) to running. Both focal (N = 8) and diffuse brain injury (N = 9) produced alterations in activity that were significant 4 days post-TBI. Compared to shams (N = 6) who acclimated to the animal facility 4 days after an anesthesia experience by blurring the distinction between day and night activity, post-TBI time-matched animals had larger fractions of inactive periods during the daytime than nighttime, and larger fractions of active time in the night were spent in high activity (e.g., constant walking, intermittent running) than during the day. These persistent disturbances in rest and activity are similar to those observed in human adults and children post-TBI, establishing actigraphy as a translational metric, used in both humans and large animals, for assessment of injury severity, progressions, and intervention.	[Olson, Emily; Badder, Carlie; Sullivan, Sarah; Margulies, Susan S.] Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA; [Propert, Kathleen] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Dept Neuropathol, Edinburgh, Midlothian, Scotland		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	Margulies@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545, R01NS39679, U01 NS069545] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545, R01NS039679] Funding Source: NIH RePORTER		Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Chen PY, 2015, J HEAD TRAUMA REHAB, V30, pE50, DOI 10.1097/HTR.0000000000000086; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Goncalves BSB, 2014, SLEEP SCI, V7, P158, DOI 10.1016/j.slsci.2014.09.013; Hekler EB, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3505; Hillmann E, 2003, APPL ANIM BEHAV SCI, V81, P99, DOI 10.1016/S0168-1591(02)00254-X; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS REL CONC YOUT; JeanLouis G, 1996, SLEEP, V19, P739; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; KUIPERS M, 1979, APPL ANIM ETHOL, V5, P145, DOI 10.1016/0304-3762(79)90085-3; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Meltzer LJ, 2015, SLEEP, V38, P1323, DOI 10.5665/sleep.4918; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; ROBERT S, 1986, PHYSIOL BEHAV, V37, P289, DOI 10.1016/0031-9384(86)90235-0; Rosen CL, 2012, SLEEP, V35, P757, DOI 10.5665/sleep.1870; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; Van de Weerd HA, 2003, APPL ANIM BEHAV SCI, V84, P101, DOI 10.1016/S0168-1591(03)00150-3; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	27	8	8	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2016	33	8					734	740		10.1089/neu.2015.4085			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DJ0ZM	WOS:000373932900003	26414329	Green Published			2022-02-06	
J	Khajavikhan, J; Vasigh, A; Kokhazade, T; Khani, A				Khajavikhan, Javaher; Vasigh, Aminolah; Kokhazade, Taleb; Khani, Ali			Association between Hyperglycaemia with Neurological Outcomes Following Severe Head Trauma	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Critical Care; Head injury; Icu; Serum glucose; Traumatic brain injury	QUALITY-OF-LIFE; BRAIN-INJURY; PSYCHIATRIC-DISORDERS; PREDICTOR; CHILDREN; IMPACT	Introduction: Head Trauma (HT) is a major cause of death, disability and important public health problem. HT is also the main cause of hyperglycaemia that can increase mortality. Aim: The aim of this study was to assess the correlation between hyperglycaemia with neurological outcomes following severe Traumatic Brain Injury (TBI). Materials and Methods: This is a descriptive and correlation study that was carried out at the Imam Khomeini Hospital affiliated with Ilam University of Medical Sciences, Ilam, IR, during March 2014-March 2015 on patients with severe TBI. Data were collected from the patient records on mortality, Intensive Care Unit (ICU) length of stay, hospital length of stay, admission GCS score, Injury Severity Score (ISS), mechanical ventilation, Ventilation Associated Pneumonia (VAP) and Acute Respiratory Distress Syndrome (ARDS). Random Blood Sugar (RBS) level on admission was recorded. Patients with diabetes mellitus (to minimize the overlap between acute stress hyperglycaemia and diabetic hyperglycaemia) were excluded. Results: About 34(40%) of patients were admitted with hyperglycaemia (RBS >= 200 mg/dl) over the study period. The mortality rate, length of ICU stay, hospital stay, ISS and VAP & ARDS in patients with RBS levels >= 200 mg was significantly higher than patients with RBS levels below = 200mg (p < 0.05, p < 0.001). A significant correlation was found between RBS with GCS arrival, length of ICU stay, length of hospital stay, ISS, mechanical ventilation and VAP & ARDS (p < 0.05, p < 0.001). RBS is a predicate factor for ISS (p < 0.05, OR : 1.36), GCS (p < 0.001, OR : 1.69), mechanical ventilation (p < 0.05, OR : 1.27), VAP & ARDS (p < 0.001, OR : 1.68), length of ICU stay (p < 0.001, OR : 1.87) and length of hospital stay (p < 0.05, OR : 1.24). Conclusion: Hyperglycaemia after severe TBI (RBS >= 200) is associated with poor outcome. It can be a predictive factor for mortality rate, ICU stay, GCS arrival, VAP & RDS, hospital stay and ISS. Management of hyperglycaemia with insulin protocol in cases with value >200mg/dl, is critical in improving the outcome of patients with TBI.	[Khajavikhan, Javaher; Vasigh, Aminolah] Ilam Univ Med Sci, Fac Med, Dept Anaesthesiol, Ilam, Iran; [Kokhazade, Taleb; Khani, Ali] Ilam Univ Med Sci, Nursing & Midwifery Fac, Dept Nursing, Ilam, Iran		Vasigh, A (corresponding author), Ilam Univ Med Sci, Fac Med, Dept Anaesthesiol, Ilam, Iran.	draminvasigh@gmail.com		Vasigh, Aminolah/0000-0002-1543-0367			Adeolu AA, 2015, J NEUROSCI RURAL PRA, V6, P216, DOI 10.4103/0976-3147.153230; Alvis-Miranda Hernando Raphael, 2014, Bull Emerg Trauma, V2, P65; Asilioglu N, 2011, J PEDIAT-BRAZIL, V87, P325, DOI [10.1590/S0021-75572011000400009, 10.2223/JPED.2097]; Battista AD, 2014, PLOS ONE, V9, P1; Bonizzoli M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-69; Danisman B, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0010-0; De Souza Campos BBN, 2012, REV BRAS TER INTENSI, V24, P97; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Eakins James, 2009, J Diabetes Sci Technol, V3, P1373; Hatefi M, 2015, JCDR, V9; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kim MS, 2012, KOREAN J NEUROTRAUMA, V8, P44; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Miller RD, 2004, MILLERS ANESTHESIA, P1776; Nichol AD, 2010, INJURY, DOI [10.1016/j.injury.2010.11.047, DOI 10.1016/J.INJURY.2010.11.047]; Paolino Alison S, 2005, J Neurosci Nurs, V37, P130; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; Salim A, 2009, AM SURGEON, V75, P25; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Torbati M, 2015, J ANAL RES CLIN MED, V3, P107; Melo JRT, 2009, ARQ NEURO-PSIQUIAT, V67, P804, DOI 10.1590/S0004-282X2009000500004; van der Horst ICC, 2004, JAMA-J AM MED ASSOC, V291, P558, DOI 10.1001/jama.291.5.558-b; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wylie GR, 2015, PLOS ONE, P1, DOI [10.1371/journal.pone.0126110, DOI 10.1371/JOURNAL.PONE.0126110:1-18]; Yousefzadeh Chabok SH, 2009, ACTA MED IRANICA, V47, P57	34	8	10	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	APR	2016	10	4					PC11	PC13		10.7860/JCDR/2016/17208.7686			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ1RZ	WOS:000397848600098	27190880	Green Published, gold			2022-02-06	
J	Tripathi, M; Shukla, DP; Bhat, DI; Bhagavatula, ID; Mishra, T				Tripathi, Manjul; Shukla, Dhaval P.; Bhat, Dhananjaya Ishwar; Bhagavatula, Indira Devi; Mishra, Tejesh			Craniofacial injuries in professional cricket: no more a red herring	NEUROSURGICAL FOCUS			English	Article						cricket; helmet; protective gears; ball; batsman; head injury; concussion	NECK INJURIES; ICE HOCKEY; HELMET; HEAD; PERFORMANCE; EQUIPMENT; BASEBALL	The issue of head injury in a noncontact sport like cricket is a matter of great debate and it carries more questions than answers. Recent incidents of fatal head injuries in individuals wearing a helmet have caused some to question the protective value of the helmet. The authors discuss the pattern, type of injury, incidents, and location of cranio-facio-ocular injuries in professional cricket to date. They evaluate the history of usage of the helmet in cricket, changes in design, and the protective value, and they compare the efficacy of various sports' helmets with injury profiles similar to those in cricket. The drop test and air cannon test are compared for impact energy attenuation performance of cricket helmets. A total of 36 cases of head injuries were identified, of which 5 (14%) were fatal and 9 (22%) were career-terminating events. Batsmen are the most vulnerable to injury, bearing 86% of the burden, followed by wicketkeepers (8%) and fielders (5.5%). In 53% of cases, the ball directly hit the head, while in 19.5% of cases the ball entered the gap between the peak and the faceguard. Ocular injuries to 3 wicketkeepers proved to be career-terminating injuries. The air cannon test is a better test for evaluating cricket helmets than the drop test. Craniofacial injuries are more common than popularly believed. There is an urgent need to improve the efficacy and compliance of protective restraints in cricket. A strict injury surveillance system with universal acceptance is needed to identify the burden of injuries and modes for their prevention.	[Tripathi, Manjul; Shukla, Dhaval P.; Bhat, Dhananjaya Ishwar; Bhagavatula, Indira Devi; Mishra, Tejesh] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India		Bhagavatula, ID (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	bidevidr@gmail.com	Tripathi, Manjul/AAE-7128-2019; Tripathi, Manjul/AAN-8701-2021	Tripathi, Manjul/0000-0002-5679-3439; 			[Anonymous], PROT HELM WORN S MOH; Bey T, 2009, WEST J EMERG MED, V10, P6; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Bolton P, 2014, TELEGRAPH; Brewster R, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.3.FOCUS1552; Cross KM, 2003, CLIN SPORT MED, V22, P639, DOI 10.1016/S0278-5919(02)00099-6; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Dean J, 2014, FAST CO DESIGN; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Mann DL, 2013, BRIT J SPORT MED, V47, P607, DOI 10.1136/bjsports-2012-091688; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; Miller H, 1967, Curr Med Drugs, V7, P3; Mukherjee A., 2014, CRICKET COUNTRY; Mukherjee A, 2015, CRICKET COUNTRY 0611; Newman J, CRITERIA HEAD INJURY; NOCSAE, STAND PERF SPEC NEWL; Orchard J, 2003, J SCI MED SPORT, V6, P520, DOI 10.1016/S1440-2440(03)80278-5; Orchard JW, 2013, BRIT J SPORT MED, V47, P605, DOI 10.1136/bjsports-2012-092138; Pang TY, 2013, PROCEDIA ENGINEER, V60, P143, DOI 10.1016/j.proeng.2013.07.013; Pardini J, 2011, YOUMANS NEUROLOGICAL, P3380; Piesse K, 2003, CRICKETS COLOSSEUM 1; Ranson C, 2011, BRIT J SPORT MED, V47, P637; Ranson C, 2013, CRICKET HELMET SAFET; Ranson C, 2013, BRIT J SPORT MED, V47, P644, DOI 10.1136/bjsports-2012-091898; Ranson C, 2013, BRIT J SPORT MED, V47, P609, DOI 10.1136/bjsports-2012-091889; Shaw L, 2008, BRIT J SPORT MED, V42, P437, DOI 10.1136/bjsm.2007.041947; Standards Australia/Standards New Zealand, 1997, 44991 ASNZS; Stone P, NEW STUDY CONFIRMS R; Stretch R, 2011, S AFR J SPORTS MED, V23, P45; Velani N, 2013, IRCOBI C 2013 ZUR IN, P424; White GL, 2013, BRIT J SPORT MED, V47, P599, DOI 10.1136/bjsports-2013-092526	32	8	8	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4								10.3171/2016.2.FOCUS15341			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500014	27032914	gold			2022-02-06	
J	Wu, XH; Zhou, XL; Gao, L; Wu, X; Fei, L; Mao, Y; Hu, J; Zhou, LF				Wu, Xuehai; Zhou, Xiaolan; Gao, Liang; Wu, Xing; Fei, Li; Mao, Ying; Hu, Jin; Zhou, Liangfu			Diagnosis and Management of Combined Central Diabetes Insipidus and Cerebral Salt Wasting Syndrome After Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Central diabetes insipidus; Cerebral salt wasting syndrome; Cortisone acetate; Polyuria; Traumatic brain injury; Vasopressin	ANTIDIURETIC-HORMONE; HYPONATREMIA; CHILDREN; SECRETION	BACKGROUND: Combined central diabetes insipidus and cerebral salt wasting syndrome after traumatic brain injury (TBI) is rare, is characterized by massive polyuria leading to severe water and electrolyte disturbances, and usually is associated with very high mortality mainly as a result of delayed diagnosis and improper management. METHODS: We retrospectively reviewed the clinical presentation, management, and outcomes of 11 patients who developed combined central diabetes insipidus and cerebral salt wasting syndrome after traumatic brain injury to define distinctive features for timely diagnosis and proper management. RESULTS: The most typical clinical presentation was massive polyuria (10,000 mL/24 hours or > 1000 mL/hour) refractory to vasopressin alone but responsive to vasopressin plus cortisone acetate. Other characteristic presentations included low central venous pressure, high brain natriuretic peptide precursor level without cardiac dysfunction, high 24-hour urine sodium excretion and hypovolemia, and much higher urine than serum osmolarity; normal serum sodium level and urine specific gravity can also be present. Timely and adequate infusion of sodium chloride was key in treatment. Of 11 patients, 5 had a good prognosis 3 months later (Extended Glasgow Outcome Scale score >= 6), 1 had an Extended Glasgow Outcome Scale score of 4, 2 died in the hospital of brain hernia, and 3 developed a vegetative state. CONCLUSIONS: For combined diabetes insipidus and cerebral salt wasting syndrome after traumatic brain injury, massive polyuria is a major typical presentation, and intensive monitoring of fluid and sodium status is key for timely diagnosis. To achieve a favorable outcome, proper sodium chloride supplementation and cortisone acetate and vasopressin coadministration are key.	[Wu, Xuehai; Gao, Liang; Wu, Xing; Mao, Ying; Hu, Jin; Zhou, Liangfu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Zhou, Xiaolan] Fudan Univ, Huashan Hosp, Worldwide Med Ctr, Shanghai 200433, Peoples R China; [Fei, Li] Fudan Univ, Jinshan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	hujin_dana@126.com		Mao, Ying/0000-0001-8055-115X	Shanghai Nature Science Foundation [08411952000, 10ZR1405400]; Shanghai Health Bureau [2008114]; 863 National Science and Technology ProgramNational High Technology Research and Development Program of China [2015AA020501]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571025]	This study was supported by the Shanghai Nature Science Foundation (Grant Numbers 08411952000 and 10ZR1405400), Shanghai Health Bureau (Grant Number 2008114), 863 National Science and Technology Program (Grant Number 2015AA020501), and National Natural Science Foundation of China (Grant Number 81571025).	Adam P, 1997, AM FAM PHYSICIAN, V55, P2146; Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; Berger TM, 2002, CRIT CARE MED, V30, P792, DOI 10.1097/00003246-200204000-00012; Berkenbosch JW, 2002, PEDIATR NEUROSURG, V36, P75, DOI 10.1159/000048356; Brimioulle S, 2008, INTENS CARE MED, V34, P125, DOI 10.1007/s00134-007-0905-7; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Chang CH, 2008, AM J MED SCI, V335, P390, DOI 10.1097/MAJ.0b013e318149e6f1; Fukui S, 2003, ACT NEUR S, V86, P489; Ghirardello S, 2007, J PEDIATR ENDOCR MET, V20, P359; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Ibarra de la Rosa I, 1999, AN ESP PEDIAT, V51, P27; Jimenez R, 2006, PEDIATR NEUROL, V35, P261, DOI 10.1016/j.pediatrneurol.2006.05.004; John CA, 2012, CRIT CARE NURSE, V32, pE1, DOI 10.4037/ccn2012904; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Laredo S, 1996, J AM SOC NEPHROL, V7, P2527; Lee YJ, 1996, EUR J PEDIATR, V155, P245, DOI 10.1007/BF01953946; Lin JJ, 2009, PEDIATR NEUROL, V40, P84, DOI 10.1016/j.pediatrneurol.2008.09.010; Lugo N, 1997, J PEDIATR ENDOCR MET, V10, P633; Oliveira M A, 1993, Arq Neuropsiquiatr, V51, P554; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57	20	8	10	2	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						483	487		10.1016/j.wneu.2015.10.011			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700063	26485413				2022-02-06	
J	Xu, HM; Pi, HY; Ma, LL; Su, XY; Wang, JR				Xu, Hongmei; Pi, Hongying; Ma, Lili; Su, Xinyang; Wang, Jianrong			Incidence of Headache After Traumatic Brain Injury in China: A Large Prospective Study	WORLD NEUROSURGERY			English	Article						Brain injuries; Head trauma; Headache; Posttraumatic headache; Traumatic brain injury	POSTTRAUMATIC HEADACHE; PREVALENCE; CLASSIFICATION; PATHOGENESIS; EPIDEMIOLOGY; MODERATE	BACKGROUND: There have yet to be any large-scale studies in China on headaches after traumatic brain injury (TBI). We evaluate the incidence of headache after TBI and investigate risk factors and functional outcome in a large tertiary center with a high caseload. METHODS: A total of 543 patients (82% men, 18% women) with a mean age of 48.4 +/- 18.6 years presenting with TBI were prospectively enrolled in this study between March 2011 and July 2013. Patient demographics, severity of TBI, incidence and classification of headache, and treatment information were collected during initial hospitalization and at 3, 6, and 12 months follow-up. RESULTS: Of our 543 patients (82% men, 18% women), 62% were injured in motor vehicle collisions and 27% in falls. Most patients (97%) were considered to have mild TBI. Follow-up rates at 3, 6, and 12 months were 91%, 75%, and 61%, respectively. Only 12% of patients reported pre-TBI headaches, whereas 58% of respondents reported headache at 3 months follow-up, 54% at 6 months follow-up, and 49% at 1 year follow-up. No statistically significant correlations between age, sex, or TBI severity and posttraumatic headaches were observed. CONCLUSIONS: We present the findings of the first study on headaches after TBI in China. Headaches were found to occur in most patients with TBI and persisted through the first year after injury. The incidence of posttraumatic headache observed here is comparable with previously published studies outside China.	[Xu, Hongmei; Pi, Hongying; Wang, Jianrong] Gen Hosp Chinese Peoples Liberat Army, Dept Nursing, Beijing, Peoples R China; [Xu, Hongmei; Ma, Lili; Su, Xinyang] Binzhou Med Coll, Affiliated Hosp, Dept Nursing, Binzhou, Shandong, Peoples R China		Wang, JR (corresponding author), Gen Hosp Chinese Peoples Liberat Army, Dept Nursing, Beijing, Peoples R China.	wangjr_301@163.com					Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dikmen S, 2010, J INT NEUROPSYCH SOC, V28, P1719; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S., 2011, PM&R, V3, P406; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Riechers Ronald G 2nd, 2015, Handb Clin Neurol, V128, P567, DOI 10.1016/B978-0-444-63521-1.00036-4; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scher AI, 2014, CEPHALALGIA, V34, P83, DOI 10.1177/0333102413499644; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vargas BB, 2009, CURR PAIN HEADACHE R, V13, P64, DOI 10.1007/s11916-009-0013-1; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	32	8	8	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						289	296		10.1016/j.wneu.2015.12.028			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700041	26746335				2022-02-06	
J	Harun, R; Hare, KM; Brough, EM; Munoz, MJ; Grassi, CM; Torres, GE; Grace, AA; Wagner, AK				Harun, Rashed; Hare, Kristin M.; Brough, Elizabeth M.; Munoz, Miranda J.; Grassi, Christine M.; Torres, Gonzalo E.; Grace, Anthony A.; Wagner, Amy K.			Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent, regionally selective bimodal effects on striatal dopamine kinetics invivo	JOURNAL OF NEUROCHEMISTRY			English	Article						dopamine; dyskinesia; levodopa; Parkinson's disease; striatum; voltammetry	TRAUMATIC BRAIN-INJURY; LEVODOPA-INDUCED DYSKINESIAS; RAT DORSAL STRIATUM; PARKINSONS-DISEASE; TRANSPORTER FUNCTION; NUCLEUS-ACCUMBENS; NEUROTRANSMITTER RELEASE; SURFACE LOCALIZATION; GENE POLYMORPHISM; VEGETATIVE STATE	Parkinson's disease (PD) is a debilitating condition that is caused by a relatively specific degeneration of dopaminergic (DAergic) neurons of the substantia nigra pars compacta. L-DOPA was introduced as a viable treatment option for PD over 40years ago and still remains the most common and effective therapy for PD. Though the effects of L-DOPA to augment striatal DA production are well known, little is actually known about how L-DOPA alters the kinetics of DA neurotransmission that contribute to its beneficial and adverse effects. In this study, we examined the effects of L-DOPA administration (50mg/kg carbidopa+0, 100, and 250mg/kg L-DOPA) on regional electrically stimulated DA response kinetics using fast-scan cyclic voltammetry in anesthetized rats. We demonstrate that L-DOPA enhances DA release in both the dorsal striatum (D-STR) and nucleus accumbens (NAc), but surprisingly causes a delayed inhibition of release in the D-STR. In both regions, L-DOPA progressively attenuated reuptake kinetics, predominantly through a decrease in V-max. These findings have important implications on understanding the pharmacodynamics of L-DOPA, which may be informative for understanding its therapeutic effects and also common side effects like L-DOPA-induced dyskinesias (LID).	[Harun, Rashed; Torres, Gonzalo E.; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Harun, Rashed; Hare, Kristin M.; Brough, Elizabeth M.; Munoz, Miranda J.; Grassi, Christine M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Harun, Rashed; Brough, Elizabeth M.; Wagner, Amy K.] Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Munoz, Miranda J.] Carnegie Mellon Univ, Dept Biol Sci, Mellon Coll Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Torres, Gonzalo E.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Grace, Anthony A.; Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Grace, Anthony A.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Grace, Anthony A.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA		Wagner, AK (corresponding author), Dept Phys Med & Rehabil, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.; Wagner, AK (corresponding author), Safar Ctr Resuscitat Res, Rehabil Res, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Munoz, Miranda/0000-0002-3782-6530; Harun, Rashed/0000-0003-1843-6710	University of Pittsburgh Rehabilitation Institute; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R37MH057440, R01MH101180] Funding Source: NIH RePORTER	This study was supported by the University of Pittsburgh Rehabilitation Institute. We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.	Ahlskog JE, 1999, MOVEMENT DISORD, V14, P940, DOI 10.1002/1531-8257(199911)14:6<940::AID-MDS1005>3.0.CO;2-Y; Amatore C, 2005, BIOPHYS J, V88, P4411, DOI 10.1529/biophysj.104.053736; Atluri PP, 1998, J NEUROSCI, V18, P8214; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bedard C, 2011, PARKINSONISM RELAT D, V17, P593, DOI 10.1016/j.parkreldis.2011.05.012; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Berman SB, 1996, J NEUROCHEM, V67, P593; Block ER, 2015, J NEUROSCI, V35, P12845, DOI 10.1523/JNEUROSCI.1391-15.2015; Brimblecombe KR, 2015, J PHYSIOL-LONDON, V593, P929, DOI 10.1113/jphysiol.2014.285890; Budygin EA, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0002.2002; Camicioli R, 2001, CLIN NEUROPHARMACOL, V24, P208, DOI 10.1097/00002826-200107000-00003; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Crownover J, 2012, CURR GERIATR REP, V1, P149, DOI 10.1007/s13670-012-0021-6; Di Monte DA, 2000, MOVEMENT DISORD, V15, P459, DOI 10.1002/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dresel SHJ, 1998, EUR J NUCL MED, V25, P31; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Fleckenstein AE, 1997, EUR J PHARMACOL, V334, P111, DOI 10.1016/S0014-2999(97)01175-8; Foltynie T, 2009, J NEUROL NEUROSUR PS, V80, P141, DOI 10.1136/jnnp.2008.154294; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Gagnon D, 2016, BRAIN STRUCT FUNCT, V221, P3675, DOI 10.1007/s00429-015-1125-5; Garcia-Olivares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059788; GASPAR P, 1993, EXP BRAIN RES, V96, P100, DOI 10.1007/BF00230443; German CL, 2012, J NEUROCHEM, V123, P288, DOI 10.1111/j.1471-4159.2012.07875.x; Gnegy ME, 2003, EUR J PHARMACOL, V479, P83, DOI 10.1016/j.ejphar.2003.08.059; Gorentla BK, 2005, NEUROPHARMACOLOGY, V49, P759, DOI 10.1016/j.neuropharm.2005.08.011; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Gulley JM, 2002, J NEUROCHEM, V83, P400, DOI 10.1046/j.1471-4159.2002.01133.x; Guttman M, 2001, NEUROLOGY, V56, P1559, DOI 10.1212/WNL.56.11.1559; Guttman M, 1997, NEUROLOGY, V49, P1060, DOI 10.1212/WNL.49.4.1060; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HARDEN DG, 1995, J NEUROSCI, V15, P6157; Harun R, 2015, BRAIN RES, V1599, P67, DOI 10.1016/j.brainres.2014.12.020; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; JONES SR, 1995, J NEUROCHEM, V64, P2581; JONES SR, 1995, J PHARMACOL EXP THER, V274, P396; Jonkers N, 2001, J NEURAL TRANSM, V108, P559, DOI 10.1007/s007020170056; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; Kaiser R, 2003, NEUROLOGY, V60, P1750, DOI 10.1212/01.WNL.0000068009.32067.A1; Kita JM, 2007, J NEUROCHEM, V102, P1115, DOI 10.1111/j.1471-4159.2007.04621.x; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Maina FK, 2010, ACS CHEM NEUROSCI, V1, P450, DOI 10.1021/cn100003u; Marek K, 2002, EUR J NEUROL, V9, P15, DOI 10.1046/j.1468-1331.9.s3.2.x; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; Metzger RR, 2002, EUR J PHARMACOL, V456, P39, DOI 10.1016/S0014-2999(02)02647-X; Moquin KF, 2009, J NEUROCHEM, V110, P1491, DOI 10.1111/j.1471-4159.2009.06254.x; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Oliveri RL, 1999, NEUROLOGY, V53, P1425, DOI 10.1212/WNL.53.7.1425; Paxinos G., 2007, RAT BRAIN STEREOTAXI, P21; Peters JL, 2000, J NEUROCHEM, V74, P1563, DOI 10.1046/j.1471-4159.2000.0741563.x; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Povlock S. L., 1996, CNS NEUROTRANSMITTER, P21; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Richards TL, 2009, J NEUROCHEM, V108, P1575, DOI 10.1111/j.1471-4159.2009.05910.x; Rodriguez M, 2007, SYNAPSE, V61, P61, DOI 10.1002/syn.20342; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Scheffel U, 1996, SYNAPSE, V23, P61; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Sombers LA, 2004, J NEUROSCI, V24, P303, DOI 10.1523/JNEUROSCI.1119-03.2004; STAMFORD JA, 1991, BRIT J PHARMACOL, V102, P45, DOI 10.1111/j.1476-5381.1991.tb12130.x; STAMFORD JA, 1988, BRAIN RES, V448, P381, DOI 10.1016/0006-8993(88)91282-6; Strong JA, 2006, MOVEMENT DISORD, V21, P654, DOI 10.1002/mds.20785; Thanvi BR, 2004, POSTGRAD MED J, V80, P452, DOI 10.1136/pgmj.2003.013912; Troiano AR, 2009, NEUROLOGY, V72, P1211, DOI 10.1212/01.wnl.0000338631.73211.56; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Venton BJ, 2006, J NEUROSCI, V26, P3206, DOI 10.1523/JNEUROSCI.4901-04.2006; Volz TJ, 2008, J PHARMACOL EXP THER, V327, P161, DOI 10.1124/jpet.108.139386; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang J, 2001, NEUROLOGY, V56, P1757, DOI 10.1212/WNL.56.12.1757; Wang SR, 2011, J NEUROCHEM, V119, P342, DOI 10.1111/j.1471-4159.2011.07440.x; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; WIGHTMAN RM, 1990, BRAIN RES REV, V15, P135, DOI 10.1016/0165-0173(90)90015-G; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; Wu Q, 2001, J NEUROSCI METH, V112, P119, DOI 10.1016/S0165-0270(01)00459-9; Wu Q, 2002, J NEUROSCI, V22, P6272; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zappia M, 2005, ARCH NEUROL-CHICAGO, V62, P601, DOI 10.1001/archneur.62.4.601; Zhang TJ, 2009, J HUAZHONG U SCI-MED, V29, P29, DOI 10.1007/s11596-009-0106-4; Zhou FM, 2005, NEURON, V46, P65, DOI 10.1016/j.neuron.2005.02.010	91	8	8	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2016	136	6					1270	1283		10.1111/jnc.13444			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DG7WZ	WOS:000372295700015	26611352	Green Accepted, Bronze			2022-02-06	
J	McKechnie, D; Fisher, MJ; Pryor, J				McKechnie, Duncan; Fisher, Murray J.; Pryor, Julie			A Case-control Study Examining the Characteristics of Patients who Fall in an Inpatient Traumatic Brain Injury Rehabilitation Setting	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						fall; TBI; post-traumatic amnesia; head injury; PTA; brain injury	RISK-FACTORS; FUNCTIONAL INDEPENDENCE; STROKE PATIENTS; PREDICTION; ADULTS; SCALE; TOOLS	Objective: The purpose of the study was to describe the characteristics of patients who fall in the inpatient traumatic brain injury (TBI) rehabilitation setting. Setting: Specialized inpatient TBI rehabilitation unit. Participants: Fifty-four patients with history of falls and 55 nonequivalent patients without history of falls. Design: Retrospective nonequivalent case-control study. Main Measures: The Functional Independence Measure, Glasgow Coma Scale, Westmead Post-traumatic Amnesia Scale, demographic and functional characteristics, and behavior and medication variables. Results: No significant difference between patients with and without history of falls for age, sex, medication class or total number of medications administered on admission, and median admission Westmead Post-traumatic Amnesia Scale score was observed. Patients with history of falls had a significantly longer duration of post-traumatic amnesia, rehabilitation length of stay, and lower mean total admission Functional Independence Measure score and median Glasgow Coma Scale score at the time of injury. Patients with history of falls were more than 10 times more likely than patients without history of falls to require assistance on admission for activities of daily living, transfers, and continence/toileting. Neurobehaviors including noncompliance and anosognosia were significantly associated with patients with history of falls. Conclusions: A patient in the rehabilitation setting with a more severe TBI characterized by multisystem impairments is at an increased risk of falling, whereas some traditional fall risk factors were not associated with patients who fall. Rehabilitation settings should consider cohort-specific fall risk profiling. The Ontario STRATIFY Falls Risk Screening Tool is perhaps not the best tool to screen for falls in this inpatient population.	[McKechnie, Duncan; Fisher, Murray J.; Pryor, Julie] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [McKechnie, Duncan] Royal Rehab, Brain Injury Unit, 235 Morrison Rd, Sydney, NSW 2112, Australia; [Fisher, Murray J.; Pryor, Julie] Royal Rehab, Nursing Res & Dev, Sydney, NSW 2112, Australia		McKechnie, D (corresponding author), Royal Rehab, Brain Injury Unit, 235 Morrison Rd, Sydney, NSW 2112, Australia.	duncan.mckechnie@royalrehab.com.au		Pryor, Julie/0000-0003-4907-8530			Aisen M L, 1994, J Am Paraplegia Soc, V17, P179; Aranda-Gallardo M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-122; Australian National Ageing and Research Institute, 2004, AN RES PREV FALLS FA; Brain Injury Association of Queensland Inc, 2002, SURV ACQ BRAIN INJ A; Carmine H, 2005, BRAIN INJ PROFESS, V2, P26; Carr DB, 2010, PM&R, V2, ps154; Cohen J., 2013, STAT POWER ANAL BEHA; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Faul M, 2010, TRAUMATIC BRAIN INJU; Forrest G, 2012, REHABIL NURS, V37, P56, DOI 10.1002/RNJ.00010; Forrest GP, 2013, REHABIL NURS, V38, P186, DOI 10.1002/rnj.86; Frisina PG, 2010, REHABIL NURS, V35, P141, DOI 10.1002/j.2048-7940.2010.tb00039.x; GAEBLER S, 1993, J ADV NURS, V18, P1895, DOI 10.1046/j.1365-2648.1993.18121895.x; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Giles LC, 2006, CIN-COMPUT INFORM NU, V24, P167, DOI 10.1097/00024665-200605000-00014; Gilewski MJ, 2007, REHABIL NURS, V32, P234, DOI 10.1002/j.2048-7940.2007.tb00180.x; Grant J S, 1987, Rehabil Nurs, V12, P74; GRIFFITHS K, 1997, GUIDE UNDERSTANDING; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; Healey F, 2008, QUAL SAF HEALTH CARE, V17, P424, DOI 10.1136/qshc.2007.024695; Hendrich AL, 2003, APPL NURS RES, V16, P9, DOI 10.1053/apnr.2003.YAPNR2; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Koh GC-H, 2013, BR MED J OPEN, V3, P1; Kwan F, 2012, REHABIL NURS, V37, P30, DOI 10.1002/RNJ.00004; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; McKechnie D, 2015, DISABIL REHABIL, V37, P2291, DOI 10.3109/09638288.2014.1002578; McNamee A, 2010, ANAESTH INTENS CARE, V38, P1125; Murphy MP, 2014, REHABIL NURS, V39, P113, DOI 10.1002/rnj.89; NSW Department of Health and the Clinical Excellence Commission, 2008, CLIN INC MAN NSW PUB; Papaioannou A, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-1; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Rosario ER, 2014, REHABIL NURS, V39, P86, DOI 10.1002/rnj.114; Salamon LA, 2012, REHABIL NURS, V37, P292, DOI 10.1002/rnj.036; Saverino A, 2006, Eura Medicophys, V42, P179; Saverino A, 2014, DISABIL REHABIL, V36, P963, DOI 10.3109/09638288.2013.829525; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P329, DOI 10.1053/apmr.2002.29623; Vassallo M, 2009, GERIATR GERONTOL INT, V9, P41, DOI 10.1111/j.1447-0594.2008.00506.x; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	45	8	8	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E59	E70		10.1097/HTR.0000000000000146			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300006	26098255				2022-02-06	
J	Nazem, S; Forster, JE; Brenner, LA; Matthews, EE				Nazem, Sarra; Forster, Jeri E.; Brenner, Lisa A.; Matthews, Ellyn E.			Actigraphic and Sleep Diary Measures in Veterans With Traumatic Brain Injury: Discrepancy in Selected Sleep Parameters	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Bland-Altman plots; insomnia; actigraphy; Veterans; dyssomnia; sleep disorders; traumatic brain injury; mental health	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; INTELLECTUAL DISABILITIES; DAYTIME SLEEPINESS; SELF-AWARENESS; OLDER-ADULTS; DISTURBANCES; INSOMNIA; ANXIETY; SCALE	Objective: To examine the discrepancy between sleep diary and actigraphic measures of sleep in Veterans with moderate-severe post-acute traumatic brain injury (TBI) and to explore whether these discrepancies vary according to participant characteristics. Setting: VA Medical Center in the Rocky Mountain United States. Participants: Nineteen males with moderate-severe post-acute TBI and insomnia symptoms as measured by the Insomnia Severity Index. Design: Descriptive, cross-sectional. Main Measures: Sleep diary, wrist actigraphy, Ohio State University TBI-Identification Method, Insomnia Severity Index, and Hospital Anxiety and Depression Scale. Results: There was poor agreement between actigraphic and sleep diary measurements of (1) total sleep time, (2) wake after sleep onset, and (3) sleep onset latency. On average, actigraphy measured greater duration of all 3 sleep parameters. Discrepancies were not found to be associated with specific TBI characteristics or mood-related symptoms. Conclusion: When measuring sleep-related outcomes among Veterans with moderate-severe post-acute TBI, notable mismatches were found between actigraphic and self-reported sleep diary data. Knowledge regarding measure-related limitations is important for both clinical and research practices among those with moderate-severe post-acute TBI.	[Nazem, Sarra; Forster, Jeri E.; Brenner, Lisa A.; Matthews, Ellyn E.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, 1055 Clermont St, Denver, CO 80220 USA; [Nazem, Sarra; Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Nazem, Sarra; Forster, Jeri E.; Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Matthews, Ellyn E.] Univ Arkansas Med Sci, Coll Nursing, Little Rock, AR 72205 USA		Nazem, S (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, 1055 Clermont St, Denver, CO 80220 USA.	Sarra.Nazem@va.gov	Matthews, Ellyn/ABF-8012-2020; Brenner, Lisa A./AAG-2442-2019		Veterans Health Administration Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Denver, Colorado	The authors received financial support for the research and/or authorship of this article from the Veterans Health Administration Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC), Denver, Colorado.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROWN A, 1990, PROG CLIN BIOL RES, V341, P77; BROWN AC, 1990, CHRONOBIOL INT, V7, P125, DOI 10.3109/07420529009056964; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calhoun PS, 2007, J TRAUMA STRESS, V20, P1009, DOI 10.1002/jts.20255; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Chapman DP, 2013, PSYCHIAT SERV, V64, P385, DOI 10.1176/appi.ps.201200226; Colten HR, 2006, SLEEP DISORDERS SLEE; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Dean GE, 2013, ONCOL NURS FORUM, V40, P441, DOI 10.1188/13.ONF.441-451; Dockree PM, 2006, BRAIN, V129, P128, DOI 10.1093/brain/awh664; Edinger JD, 2000, J CONSULT CLIN PSYCH, V68, P586, DOI 10.1037/0022-006X.68.4.586; EDINGER JD, 1995, SLEEP, V18, P232, DOI 10.1093/sleep/18.4.232; Hare DJ, 2006, J INTELL DISABIL RES, V50, P701, DOI 10.1111/j.1365-2788.2006.00830.x; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kay K, 1993, J HEAD TRAUMA REHAB, V8, P86; Kobayashi I, 2012, SLEEP, V35, P957, DOI 10.5665/sleep.1960; Liu Y, 2013, SLEEP, V36, P1421, DOI 10.5665/sleep.3028; Maaskant M, 2013, RES DEV DISABIL, V34, P1144, DOI 10.1016/j.ridd.2012.12.009; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; McKnight-Eily L. R., 2011, Morbidity and Mortality Weekly Report, V60, P233; Moore CM, 2014, BEHAV SLEEP MED, V13, P1; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Okifuji A, 2011, CLIN J PAIN, V27, P289, DOI 10.1097/AJP.0b013e31820485db; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; VA/DoD, 2009, J REHABIL RES DEV, V46, pCP1; van de Wouw E, 2013, RES DEV DISABIL, V34, P2291, DOI 10.1016/j.ridd.2013.04.012; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Wang MY, 2011, J NURS RES, V19, P173, DOI 10.1097/JNR.0b013e318229c42f; Westermeyer J, 2007, J ANXIETY DISORD, V21, P966, DOI 10.1016/j.janxdis.2006.11.009; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	55	8	8	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		136	146		10.1097/HTR.0000000000000225			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100007	26959667				2022-02-06	
J	Ruocco, AC				Ruocco, Anthony C.			Compliance on Neuropsychological Performance Validity Testing in Patients With Borderline Personality Disorder	PSYCHOLOGICAL ASSESSMENT			English	Article						borderline personality disorder; neuropsychology; symptom validity; performance validity; malingering	TRAUMATIC BRAIN-INJURY; 1ST-DEGREE RELATIVES; SCHIZOPHRENIA; DEPRESSION; DYSFUNCTION; CRITERIA	Complaints of cognitive dysfunction are common in patients with borderline personality disorder (BPD), and they are often accompanied by deficits on neuropsychological testing. Prior studies of BPD, however, did not evaluate compliance on neuropsychological performance validity testing, which could partially account for cognitive deficits observed in patients. The aims of the current study were to evaluate the frequency at which patients with BPD show less than adequate compliance on performance validity testing, and whether patients showing less compliance perform lower on standardized neuropsychological measures. Fifty outpatients with BPD completed the Victoria Symptom Validity Test, a 2-alternative, forced-choice recognition test as part of a larger neuropsychological test battery for research on cognitive functioning in BPD. As a group, patients with BPD made more errors and had longer response latencies on seemingly difficult items as compared to healthy individuals. Based on established guidelines for interpretation of performances on the Victoria Symptom Validity Test, 2% of the sample was classified as probably not compliant, 10% questionably compliant, and 88% compliant. Patients with questionably or probably not compliant performances had lower estimated premorbid intellectual functioning and displayed poorer response control on neuropsychological testing than compliant patients. These findings highlight the value of incorporating performance validity testing in neuropsychological studies of patients with BPD and suggest that prior research on the disorder should be interpreted with caution because the results may not be based on valid performances.	[Ruocco, Anthony C.] Univ Toronto, Scarborough, ON M1C 1A4, Canada		Ruocco, AC (corresponding author), Univ Toronto, Dept Psychol, Clin Neurosci Lab, Scarborough, ON M1C 1A4, Canada.	anthony.ruocco@gmail.com	Ruocco, Anthony Charles/AAM-4794-2021		Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [123413, MSH-130177]; University of Toronto ScarboroughUniversity of Toronto	This study was supported by an Operating Grant (Funding Reference Number 123413) and a New Investigator Salary Award (MSH-130177) from the Canadian Institutes of Health Research and a University of Toronto Scarborough (Vice Principal-Research) Research Competitiveness Grant awarded to Anthony C. Ruocco.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barr WB, 2008, ARCH CLIN NEUROPSYCH, V23, P671; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict, 2001, HOPKINS VERBAL LEARN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone K, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P551, DOI 10.1007/978-0-387-76978-3_18; Conners C. K., 2000, CONNERS CONTINUOUS P; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Delis DC., 2001, DELIS KAPLAN EXECUTI; Egeland J, 2003, J CLIN EXP NEUROPSYC, V25, P79, DOI 10.1076/jcen.25.1.79.13630; FELDMAN MD, 1994, SOUTHERN MED J, V87, P736, DOI 10.1097/00007611-199407000-00012; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Goldberg H.E., 2007, ASSESSMENT FEIGNED C, P281; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Nehls N, 1999, RES NURS HEALTH, V22, P285, DOI 10.1002/(SICI)1098-240X(199908)22:4<285::AID-NUR3>3.0.CO;2-R; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pfohl B., 1995, STRUCTURED INTERVIEW; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Rund BR, 2006, ACTA PSYCHIAT SCAND, V113, P350, DOI 10.1111/j.1600-0447.2005.00626.x; Ruocco AC, 2005, PSYCHIAT RES, V137, P191, DOI 10.1016/j.psychres.2005.07.004; Ruocco AC, 2014, CAN J PSYCHIAT, V59, P335, DOI 10.1177/070674371405900607; Ruocco AC, 2012, NEUROPSYCHOLOGY, V26, P473, DOI 10.1037/a0028715; Ruocco AC, 2009, PERSONAL MENT HEALTH, V3, P313, DOI 10.1002/pmh.99; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SNYDER S, 1986, AM J PSYCHIAT, V143, P1287; SPITZER RL, 1979, ARCH GEN PSYCHIAT, V36, P17; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; SUTHERLAND AJ, 1990, PSYCHOSOMATICS, V31, P392, DOI 10.1016/S0033-3182(90)72133-0; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2002, WTAR WECHSLER TEST A	33	8	9	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	MAR	2016	28	3					345	350		10.1037/a0039481			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DF1DM	WOS:000371078800011	26121384				2022-02-06	
J	Wang, ZR; Li, YX; Lei, HY; Yang, DQ; Wang, LQ; Luo, MY				Wang, Zi-Ran; Li, Yu-Xin; Lei, Hong-Yan; Yang, Dai-Qun; Wang, Li-Quan; Luo, Ming-Yu			Regulating effect of activated NF-kappa B on edema induced by traumatic brain injury of rats	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Nuclear transcription factor-kappa B; Traumatic brain injury; Astrocytes; Rat	OXIDATIVE STRESS; PATHWAY; MICE; KB	Objective: To observe the effect of nuclear transcription factor-kappa B (NF-kappa B) on cerebral edema in rats with traumatic brain injury (TBI). Methods: Male SD rats with fluid percussion injury (FPI) were selected. After separation and culture, rats' astrocytes all suffered FPI. The expression of NF-kappa B and the water content were detected at the animal and cellular levels, while the activity of NOX was evaluated at the cellular level. Results: According to the results, the positive expression of NF-kappa B and expression of mRNA were significantly increased and the water content was increased for rats after TBI, while NF-kappa B inhibitor BAY11-7082 could significantly reduce the effect of TBI. 1 and 3h after FPI of astrocytes, the activation of NF-kappa B was increased and BAY 11-7082 could significantly improve the injury-induced swelling of astrocytes. After the injury of astrocytes, the activity of NOX was also increased, while BAY 11-7082 could reduce the activity of NOX. Conclusions: The results show that the activation of NF-kappa B in astrocytes is a key factor in the process of cerebral edema after TBI of rats.	[Wang, Zi-Ran; Li, Yu-Xin; Lei, Hong-Yan; Yang, Dai-Qun; Wang, Li-Quan; Luo, Ming-Yu] Linyi Peoples Hosp, Dept Cerebral Surg, Lanshan 276000, Shandong, Peoples R China		Luo, MY (corresponding author), Linyi Peoples Hosp, Dept Cerebral Surg, Lanshan 276000, Shandong, Peoples R China.				Technology Program for Development of Pharmacy of Shandong [2013WS0351]	It was supported by Technology Program for Development of Pharmacy of Shandong 2013 (No. 2013WS0351).	Bai LX, 2013, CHIN J BRAIN DIS REH, V3, P35; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Hong SH, 2014, MOL MED REP, V10, P3241, DOI 10.3892/mmr.2014.2613; Jayakumar AR, 2011, NEUROBIOL DIS, V41, P498, DOI 10.1016/j.nbd.2010.10.021; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jiang P, 2014, MOL MED REP, V10, P689, DOI 10.3892/mmr.2014.2254; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lu XY, 2014, J SURG RES, V188, P206, DOI 10.1016/j.jss.2013.11.1106; Luengo-Blanco M, 2008, BLOOD, V112, P1453, DOI 10.1182/blood-2007-07-099267; Manea A., 2007, Archives of Physiology and Biochemistry, V113, P163, DOI 10.1080/13813450701531235; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Siomek A, 2012, ACTA BIOCHIM POL, V59, P323; Sticozzi C, 2013, NEUROSCIENCE, V252, P367, DOI 10.1016/j.neuroscience.2013.07.061; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; Wang CG, 2012, CHIN J BRAIN DIS REH, V2, P30; Yu HL, 2015, INT J MOL MED, V36, P1127, DOI 10.3892/ijmm.2015.2315; Yu XJ, 2015, TOXICOL APPL PHARM, V284, P315, DOI 10.1016/j.taap.2015.02.023; Zhang Y, 1999, Hua Xi Yi Ke Da Xue Xue Bao, V30, P363	20	8	9	0	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1995-7645	2352-4146		ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	MAR	2016	9	3					269	272		10.1016/j.apjtm.2016.01.027			4	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	DC2HU	WOS:000369038600013	26972401	gold			2022-02-06	
J	Young, B; Kalanuria, A; Kumar, M; Burke, K; Balu, R; Amendolia, O; McNultya, K; Marion, B; Beckmann, B; Ciocco, L; Miller, K; Schuele, D; Maloney-Wilensky, E; Frangos, S; Wright, D				Young, Bethany; Kalanuria, Atul; Kumar, Monisha; Burke, Kathryn; Balu, Ramani; Amendolia, Olivia; McNultya, Kyle; Marion, BethAnn; Beckmann, Brittany; Ciocco, Lauren; Miller, Kimberly; Schuele, Donnamarie; Maloney-Wilensky, Eileen; Frangos, Suzanne; Wright, Danielle			Cerebral Microdialysis	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Cerebral microdialysis; Brain metabolism; Lactate/pyruvate ratio; Brain energy crisis; Multimodality monitoring	TRAUMATIC BRAIN-INJURY; PERFUSION-PRESSURE AUGMENTATION; EXCITATORY AMINO-ACIDS; TIGHT GLYCEMIC CONTROL; WAKE-UP TEST; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; METABOLIC CRISIS; BEDSIDE MICRODIALYSIS	A variety of neuromonitoring techniques are available to aid in the care of neurocritically ill patients. However, traditional monitors lack the ability to measure brain biochemistry and may provide inadequate warning of potentially reversible deleterious conditions. Cerebral microdialysis (CMD) is a safe, novel method of monitoring regional brain biochemistry. Analysis of CMD analytes as part of a multimodal approach may help inform clinical decision- making, guide medical treatments, and aid in prognostication of patient outcome. Its use is most frequently documented in traumatic brain injury and subarachnoid hemorrhage. Incorporating CMD into clinical practice is a multidisciplinary effort.	[Young, Bethany; Amendolia, Olivia; McNultya, Kyle; Marion, BethAnn; Beckmann, Brittany; Ciocco, Lauren; Miller, Kimberly; Schuele, Donnamarie; Wright, Danielle] Hosp Univ Penn, Dept Nursing, 3400 Spruce St,2nd Floor Rhoads Bldg, Philadelphia, PA 19104 USA; [Kalanuria, Atul; Balu, Ramani] Univ Penn, Dept Neurol, 3400 Spruce St,3 West Gates Bldg, Philadelphia, PA 19104 USA; [Kumar, Monisha] Univ Penn, Perelman Sch Med, Dept Neurol, 3400 Spruce St,3 West Gates Bldg, Philadelphia, PA 19104 USA; [Burke, Kathryn] Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA; [Maloney-Wilensky, Eileen; Frangos, Suzanne] Univ Penn, Dept Neurosurg, 3400 Spruce St,3 West Gates Bldg, Philadelphia, PA 19104 USA		Young, B (corresponding author), Hosp Univ Penn, Dept Nursing, 3400 Spruce St,2nd Floor Rhoads Bldg, Philadelphia, PA 19104 USA.	Bethany.young@uphs.upenn.edu					Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Agren-Wilsson A, 2003, J NEUROL NEUROSUR PS, V74, P217, DOI 10.1136/jnnp.74.2.217; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Berger C, 2002, STROKE, V33, P519, DOI 10.1161/hs0102.100878; Borg A, 2013, NEUROMETHODS, V75, P1; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Chen J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-279; Castro VHC, 2014, CURR NEUROPHARMACOL, V12, P490, DOI 10.2174/1570159X13666141223223657; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; DURING MJ, 1993, LANCET, V341, P1607; Eide PK, 2010, J NEUROSURG, V112, P414, DOI 10.3171/2009.5.09122; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; FOSTER AC, 1987, NATURE, V329, P395, DOI 10.1038/329395a0; Frontera J, 2015, NEUROCRIT CARE, V22, P348, DOI 10.1007/s12028-015-0133-x; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kinoshita K, 2010, J SURG RES, V162, P221, DOI 10.1016/j.jss.2009.06.009; Kitagawa R, 2013, NEUROSURG CLIN N AM, V24, P417, DOI 10.1016/j.nec.2013.02.002; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Miller CM, 2015, NEUROCRITICAL CARE MONITORING, P70; Nagel A, 2009, NEUROCRIT CARE, V11, P384, DOI 10.1007/s12028-009-9269-x; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nikaina I, 2012, J CRIT CARE, V27, P83, DOI 10.1016/j.jcrc.2011.04.004; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Paraforou Theoniki, 2011, BMC Res Notes, V4, P540, DOI 10.1186/1756-0500-4-540; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Presciutti M, 2009, J NEUROSCI NURS, V41, P131, DOI 10.1097/JNN.0b013e3181a23e7d; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Samuelsson C, 2009, ACTA NEUROCHIR, V151, P437, DOI 10.1007/s00701-009-0265-x; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Schmidt JM, 2012, CRITICAL CARE, V16, pR15; Schneweis S, 2001, STROKE, V32, P1863, DOI 10.1161/01.STR.32.8.1863; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Skoglund K, 2014, NEUROCRIT CARE, V20, P413, DOI 10.1007/s12028-013-9876-4; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tofteng F, 2002, HEPATOLOGY, V36, P1333, DOI 10.1053/jhep.2002.36944; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zetterling M, 2011, J NEUROSURG, V115, P66, DOI 10.3171/2011.3.JNS10899	80	8	11	1	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	MAR	2016	28	1					109	+		10.1016/j.cnc.2015.09.005			17	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DD1TR	WOS:000369705200011	26873764				2022-02-06	
J	MacDonald, S				MacDonald, Sheila			Assessment of higher level cognitive-communication functions in adolescents with ABI: Standardization of the student version of the functional assessment of verbal reasoning and executive strategies (S-FAVRES)	BRAIN INJURY			English	Article						mTBI; adolescent; reasoning; concussion; Cognitive-communication; paediatric; assessment; communication; executive functions; acquired brain injury; mild brain injury	TRAUMATIC BRAIN-INJURY; CHILDHOOD HEAD-INJURY; ECOLOGICAL ASSESSMENT; SOCIAL COGNITION; YOUNG-CHILDREN; OUTCOMES; TBI; REHABILITATION; DISORDERS; DISCOURSE	Background: Childhood acquired brain injuries can disrupt communication functions needed for success in school, work and social interaction. Cognitive-communication difficulties may not be apparent until adolescence, when academic, environmental and social-emotional demands increase. Objective: The Functional Assessment of Verbal Reasoning and Executive Strategies for Students (S-FAVRES) is a new activity-level measure of cognitive-communication skills in complex, contextual and integrative tasks that simulate real world communication challenges. It is hypothesized that S-FAVRES performance would differentiate adolescents with and without acquired brain injury (ABI) on scores for Accuracy, Rationale, Reasoning Subskills and Time. Methods: S-FAVRES was administered to 182 typically-developing (TD) and 57 adolescents with mild-to-severe ABI aged 12-19. Group differences, internal consistency, sensitivity, specificity, reliability and contributing factors to performance (age, gender, brain injury) were examined statistically. Results: Those with ABI attained statistically lower Accuracy, Rationale and Reasoning sub-skills scores than their TD peers. Time scores were not significantly different. Performance trends were consistent across tasks, administrations, gender and age groups. Inter-rater reliability for scoring was acceptable. Conclusion: The S-FAVRES provides a reliable, functional and quantifiable measure of subtle cognitive-communication difficulties in adolescents that can assist speech-language pathologists in planning treatment and integration to school and real world communication.	[MacDonald, Sheila] Sheila MacDonald & Associates, Guelph, ON, Canada		MacDonald, S (corresponding author), Orchard Pk Off Ctr, Suite 108,5420 Highway 6 North, Guelph, ON N1H 6J2, Canada.	sheilamacdonald@rogers.com					Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; Aiken L.R., 2000, PSYCHOL TESTING ASSE; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barker LA, 2010, NEUROPSYCHOLOGIA, V48, P2550, DOI 10.1016/j.neuropsychologia.2010.05.001; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; BARONCOHEN S, 1988, J AUTISM DEV DISORD, V18, P379, DOI 10.1007/BF02212194; Barwood CHS, 2013, BRAIN INJURY, V27, P671, DOI 10.3109/02699052.2013.775500; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Byom, 2010, ASHA LEADER, V15, P8, DOI [10.1044/leader.FTR1.15152010.8, DOI 10.1044/LEADER.FTR1.15152010.8]; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Ciccia AH, 2009, TOP LANG DISORD, V29, P249, DOI 10.1097/TLD.0b013e3181b53211; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Code, 2014, SOCIAL COMMUNICATION, P1; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Cook DA, 2006, AM J MED, V119, pe7, DOI DOI 10.1016/J.AMJMED.2005.10.036; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; GALOTTI KM, 1989, PSYCHOL BULL, V105, P331, DOI 10.1037/0033-2909.105.3.331; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goldblum Glenn, 2010, Seminars in Speech and Language, V31, P177, DOI 10.1055/s-0030-1257534; Green CR, 2009, J CHILD PSYCHOL PSYC, V50, P688, DOI 10.1111/j.1469-7610.2008.01990.x; HAGEN C, 1979, AM SPEECH LANG HEAR; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2006, NEUROCASE, V12, P247, DOI 10.1080/13554790600910490; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hotz G, 2001, J HEAD TRAUMA REHAB, V16, P426, DOI 10.1097/00001199-200110000-00003; Hotz G., 2010, PEDIAT TEST BRAIN IN; Hughes J, 2007, CAN J SPEECH-LANG PA, V31, P134; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Isaki E, 2000, BRAIN INJURY, V14, P441; Ivanova MV, 2013, APHASIOLOGY, V27, P891, DOI 10.1080/02687038.2013.805728; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kline P., 1993, HDB PSYCHOL TESTING; Krawczyk DC, 2010, FRONT HUM NEUROSCI, V4, P13; Krumnack A, 2011, COGN SYST RES, V12, P377, DOI 10.1016/j.cogsys.2010.11.001; Larkins B, 2008, BRAIN IMPAIR, V9, P247, DOI 10.1375/brim.9.3.247; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacDonald S, 1996, BRAIN INJURY, V10, P531, DOI 10.1080/026990596124241; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Marlowe WB, 2000, DEV NEUROPSYCHOL, V18, P445, DOI 10.1207/S1532694209Marlowe; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; McDonald S., 2012, DEV SOCIAL NEUROSCIE, P325; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mueller JA, 2013, SYSTEMATIC REV ASSES, V56, P1044; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Nippold MA, 2005, LANG SPEECH HEAR SER, V36, P125, DOI 10.1044/0161-1461(2005/012); Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Saltzman-Benaiah J, 2007, CLIN NEUROPSYCHOL, V21, P294, DOI 10.1080/13854040500473760; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schneider SL, 2009, PERSPECTIVES NEUROPH, V19, P31; Shordone R., 1999, FORENSIC NEUROPSYCHO, P227; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Sturman DA, 2011, NEUROSCI BIOBEHAV R, V35, P1704, DOI 10.1016/j.neubiorev.2011.04.003; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Stuss DT, 1987, BNI Q, V7, P28; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2003, ARCH PHYS MED REHAB, V84, P604, DOI 10.1053/apmr.2003.50146; Turkstra LS, 2002, J COMMUN DISORD, V35, P467, DOI 10.1016/S0021-9924(02)00118-1; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Turkstra Lyn S., 2010, Seminars in Speech and Language, V31, P162, DOI 10.1055/s-0030-1257532; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; World Health Organization, 2001, INT CLASS FUNCT DIS, P237; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Ylvisaker M, 2003, 6131 ASHA, P61; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	121	8	8	3	39	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					295	310		10.3109/02699052.2015.1091947			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900007	26679634				2022-02-06	
J	Rosner, MS; Feinberg, DL; Doble, JE; Rosner, AJ				Rosner, Mark S.; Feinberg, Debby L.; Doble, Jennifer E.; Rosner, Arthur J.			Treatment of vertical heterophoria ameliorates persistent post-concussive symptoms: A retrospective analysis utilizing a multi-faceted assessment battery	BRAIN INJURY			English	Article						headache; prism lenses; vertical heterophoria; TBI; binocular vision dysfunction; post-concussive symptoms; dizziness; Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD); reading or learning disability; convergence insufficiency; anxiety	TRAUMATIC BRAIN-INJURY; TBI	Primary objective: To examine the effectiveness of neutralizing prismatic lenses for reduction of headache, dizziness and anxiety in patients with persistent post-concussive symptoms and vertical heterophoria (VH). Background: Approximately 5-10% of patients with traumatic brain injury (TBI) develop persistent post-concussive symptoms. Many rehabilitation/treatment modalities are tried, but are largely unsuccessful, indicating a need for more effective treatment. Design and method: This retrospective study included 38 patients with persistent post-concussive symptoms, who were diagnosed by an optometric binocular vision sub-specialist with VH (a sub-set of binocular vision dysfunction [BVD] that manifests as vertical eye and image misalignment). Data was collected both before and after prism application and included validated survey instruments for headache, dizziness, anxiety and BVD symptom burden; subjective rating (0-10 scale) of headache, dizziness and anxiety severity; and a sub-analysis of the BVD survey instrument questions that pertain specifically to headache, dizziness and anxiety. Upon conclusion of treatment, subjective assessment of overall improvement of heterophoria symptoms was obtained utilizing a 10 cm visual analogue scale. Outcomes: Results demonstrated marked reduction in all measures of headache, dizziness and anxiety (19.1-60.8%) and an overall subjective improvement of VH symptoms of 80.2%. Conclusions: Neutralizing prismatic lenses are an effective treatment of headache, dizziness and anxiety in patients with persistent post-concussive symptoms and VH.	[Rosner, Mark S.; Doble, Jennifer E.] St Joseph Mercy Hosp, Ypsilanti, MI USA; [Rosner, Mark S.; Feinberg, Debby L.] Vis Specialists Inst, Bloomfield Hills, MI USA; [Rosner, Mark S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Rosner, Arthur J.] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA		Rosner, MS (corresponding author), 2550 S Telegraph Rd,Suite 100, Bloomfield Hills, MI 48302 USA.	msr50@vsinst.com					Borish IM, 1975, CLIN REFRACTION, P871; Borish IM, 1975, CLIN REFRACTION, P866; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Duke-Elder S, 1973, SYSTEM OPTHAMOLOGY, P530; Duke-Elder S, 1973, SYSTEM OPTHAMOLOGY, p[529, 551]; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Gall Ronald, 2003, Optometry, V74, P309; Gray LS, 2008, GRAEF ARCH CLIN EXP, V246, P627, DOI 10.1007/s00417-008-0799-2; Jackson DN, 2012, STRABISMUS, V20, P17, DOI 10.3109/09273972.2011.650813; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Karania R, 2006, OPHTHAL PHYSL OPT, V26, P507, DOI 10.1111/j.1475-1313.2006.00385.x; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Schroeder TL, 1996, OPTOMETRY VISION SCI, V73, P389, DOI 10.1097/00006324-199606000-00006; Singman E., 2013, MED INSTRUM, DOI [10.7243/2052-6962-1-3, DOI 10.7243/2052-6962-1-3]; SURDACKI M, 1991, OPTOMETRY VISION SCI, V68, P261, DOI 10.1097/00006324-199104000-00002; Wick BB., 1997, J OPTOM VIS DEV, V28, P77	19	8	8	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					311	317		10.3109/02699052.2015.1113564			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900008	26829465				2022-02-06	
J	Levy, NK; Milgram, N				Levy, Naomi Kahana; Milgram, Noach			Cognitive contributions to theory of mind ability in children with a traumatic head injury	CHILD NEUROPSYCHOLOGY			English	Article						Theory of mind; Cognitive; Traumatic head injury; Executive functions; Israel	BRAIN-INJURY; EXECUTIVE FUNCTION; EMOTION RECOGNITION; INHIBITORY CONTROL; WORKING-MEMORY; FALSE-BELIEF; ADOLESCENTS; INFANTS; DEFICITS; METAANALYSIS	The objective of the current study is to examine the contribution of intellectual abilities, executive functions (EF), and facial emotion recognition to difficulties in Theory of Mind (ToM) abilities in children with a traumatic head injury. Israeli children with a traumatic head injury were compared with their non-injured counterparts. Each group included 18 children (12 males) ages 7-13. Measurements included reading the mind in the eyes, facial emotion recognition, reasoning the other's characteristics based on motive and outcome, Raven's Coloured Progressive Matrices, similarities and digit span (Wechsler Intelligence Scale for Children - Revised 95 subscales), verbal fluency, and the Behaviour Rating Inventory of Executive Functions. Non-injured children performed significantly better on ToM, abstract reasoning, and EF measures compared with children with a traumatic head injury. However, differences in ToM abilities between the groups were no longer significant after controlling for abstract reasoning, working memory, verbal fluency, or facial emotion recognition. Impaired ToM recognition and reasoning abilities after a head injury may result from other cognitive impairments. In children with mild and moderate head injury, poorer performance on ToM tasks may reflect poorer abstract reasoning, a general tendency to concretize stimuli, working memory and verbal fluency deficits, and difficulties in facial emotion recognition, rather than deficits in the ability to understand the other's thoughts and emotions. ToM impairments may be secondary to a range of cognitive deficits in determining social outcomes in this population.	[Levy, Naomi Kahana; Milgram, Noach] Ariel Univ, Dept Behav Sci, Ariel, Israel		Levy, NK (corresponding author), MB 87, IL-99833 Nehusha, Israel.	Naomile11@gmail.com					Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Baron-Cohen S., 2001, J DEV LEARN DISORD, V5, P47, DOI [10.1177/1362361303007002005, DOI 10.1177/1362361303007002005]; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brent E, 2004, AUTISM, V8, P283, DOI 10.1177/1362361304045217; Burg-Malki M., 2009, THESIS; CAHAN S, 1998, MANUAL WISC R 95; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Carlson SM, 2015, J COGN DEV, V16, P186, DOI 10.1080/15248372.2013.824883; Catroppa C., 2006, DEV NEUROREHABIL, V9, P89, DOI 10.1080/13638490500155458; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; FRITH U, 1994, SOCIAL DEV, V3, P108, DOI DOI 10.1111/J.1467-9507.1994.TB00031.X; Geller R., 2006, THESIS; Gioia G.A., 2000, BRIEF BEHAV RATING I; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Heyman GD, 1998, DEV PSYCHOL, V34, P310, DOI 10.1037/0012-1649.34.2.310; Hughes C, 2004, SOC DEV, V13, P590, DOI 10.1111/j.1467-9507.2004.00285.x; Hughes C, 2007, DEV PSYCHOL, V43, P1447, DOI 10.1037/0012-1649.43.6.1447; KAUFMAN AS, 1999, ESSENTIALS WAIS 3 AS; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Liberman Z, 2014, J EXP PSYCHOL GEN, V143, P966, DOI 10.1037/a0034481; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Montague DPF, 2001, DEV PSYCHOL, V37, P826, DOI 10.1037//0012-1649.37.6.826; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Mutter B, 2006, PERCEPT MOTOR SKILL, V102, P819, DOI 10.2466/PMS.102.3.819-835; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; PREMACK D, 1978, BEHAV BRAIN SCI, V0001, DOI DOI 10.1017/S0140525X00076512; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Raven J. C., 1978, MANUAL RAVENS PROGR; Raven JC, 1956, COLOURED PROGR MATRI; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSENTHAL M, 1990, REHABILITATION ADULT; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; SERRANO JM, 1992, DEV PSYCHOBIOL, V25, P411, DOI 10.1002/dev.420250603; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Tager-Flusberg H., 2001, DEV AUTISM PERSPECTI, P150; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Tonks J, 2010, NEUROPSYCHOL REHABIL, V20, P922, DOI 10.1080/09602011.2010.519209; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Warschausky S, 2003, REHABIL PSYCHOL, V48, P250, DOI 10.1037/0090-5550.48.4.250; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	59	8	8	0	50	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	FEB 17	2016	22	2					177	196		10.1080/09297049.2014.985642			20	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CW2GV	WOS:000364810400004	25495376				2022-02-06	
J	Caccese, V; Ferguson, J; Lloyd, J; Edgecomb, M; Seidi, M; Hajiaghamemar, M				Caccese, V.; Ferguson, J.; Lloyd, J.; Edgecomb, M.; Seidi, M.; Hajiaghamemar, M.			Response of an Impact Test Apparatus for Fall Protective Headgear Testing Using a Hybrid-III Head/Neck Assembly	EXPERIMENTAL TECHNIQUES			English	Article						Head Impact; Helmet Impact Testing; Protective Wear; Traumatic Brain Injury; Linear/Angular Acceleration; Falls; Biomechanics	ANGULAR ACCELERATION; BRAIN-INJURY; CONCUSSION; ACCIDENTS	A test method based upon a Hybrid-III head and neck assembly that includes measurement of both linear and angular acceleration is investigated for potential use in impact testing of protective headgear. The test apparatus is based upon a twin wire drop test system modified with the head/neck assembly and associated flyarm components. This study represents a preliminary assessment of the test apparatus for use in the development of protective headgear designed to prevent injury due to falls. By including angular acceleration in the test protocol it becomes possible to assess and intentionally reduce this component of acceleration. Comparisons of standard and reduced durometer necks, various anvils, front, rear, and side drop orientations, and response data on performance of the apparatus are provided. Injury measures summarized for an unprotected drop include maximum linear and angular acceleration, head injury criteria (HIC), rotational injury criteria (RIC), and power rotational head injury criteria (PRHIC). Coefficient of variation for multiple drops ranged from 0.4 to 6.7% for linear acceleration. Angular acceleration recorded in a side drop orientation resulted in highest coefficient of variation of 16.3%. The drop test apparatus results in a reasonably repeatable test method that has potential to be used in studies of headgear designed to reduce head impact injury.	[Caccese, V.; Edgecomb, M.; Seidi, M.; Hajiaghamemar, M.] Univ Maine, Dept Mech Engn, 5711 Boardman Hall,Room 206, Orono, ME 04469 USA; [Ferguson, J.] Alba Tech LLC, Dept Corp Operat, Winthrop, ME USA; [Lloyd, J.] James A Haley VA Hosp, Dept Res, Tampa, FL USA		Caccese, V (corresponding author), Univ Maine, Dept Mech Engn, 5711 Boardman Hall,Room 206, Orono, ME 04469 USA.	vince.caccese@umit.maine.edu			National Institutes of Health/National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [NIH 5R44AGO33936-03]; Maine Technology Institute [MTAF-3001]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R44AG033936] Funding Source: NIH RePORTER	The authors gratefully acknowledge support for these efforts from the National Institutes of Health/National Institute on Aging under grant number NIH 5R44AGO33936-03. Dr. Lyndon Joseph is the cognizant program officer. Also acknowledged is support from the Maine Technology Institute under grant number MTAF-3001 for funding of the laboratory facility.	[Anonymous], 2011, 00111M11 NOCSAE DOC; [Anonymous], 2007, J2111 SAE; [Anonymous], 2007, F42910 ASTM; [Anonymous], 2011, F243906 ASTM, DOI [10.1520/F2439-06R11, DOI 10.1520/F2439-06R11]; [Anonymous], 1995, SNELL B 95 STAND STA; [Anonymous], 1994, J1733 SAE; [Anonymous], 2011, F144611A ASTM, DOI [10.1520/F1446-11A, DOI 10.1520/F1446-11A]; [Anonymous], 2012, 02111M12 NOCSAE DOC; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Beusenberg MC., 2000, P INT RES C BIOM IMP; Caccese V, 2013, COMPOS STRUCT, V100, P404, DOI 10.1016/j.compstruct.2012.12.034; Digges K., 1998, AGARD C BIOM DAYT OH; DiMassi F.P, 1985, 39 STAPP CAR CRASH C, P425; Doorly MC, 2005, SOLID MECH APPL, V124, P81; Eppinger R., 2000, I ITSA; Fenner H., 2005, WORKSH CRIT HEAD INJ; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; GENNARELLI TA, 1987, HEAD INJ MECH S REP, P9; GURDJIAN ES, 1953, RADIOLOGY, V60, P226, DOI 10.1148/60.2.226; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Herbst B., 1998, 16 INT TECHN C ENH S; Holbourn AHS, 1943, LANCET, V2, P438; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kimpara H., 2011, INT J AUTOMOTIVE ENG, V2, P3; King A. I., 2003, INT RES C BIOM IMP I; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Lloyd J., 2012, TAIL MED HELM UNPUB; Mertz H. J, 1985, 851245 SAE; MERTZ HJ, 1971, 15 STAPP CAR CRASH C; Mills NJ, 1996, INT J CRASHWORTHINES, V2, P7; Moss W.C., 2011, LLNLSR471496 LAWR LI; Nahum A.M., 1993, BIOMECHANICS IMPACT; Newman J, 2000, 44 STAPP CAR CRASH C; NEWMAN JA, 1986, INT C BIOM IMP IRCOB; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Thibault L. E., 1985, 10 INT TECHN C EXP S; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Yi SI, 2011, P I MECH ENG D-J AUT, V225, P54, DOI 10.1243/09544070JAUTO1568; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	51	8	8	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0732-8818	1747-1567		EXP TECHNIQUES	Exp. Tech.	FEB	2016	40	1					413	427		10.1007/s40799-016-0046-4			15	Engineering, Mechanical; Mechanics; Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics; Materials Science	DX9YE	WOS:000384752200042	28216804	Green Accepted			2022-02-06	
J	Fuller, G; McClelland, G; Lawrence, T; Russell, W; Lecky, F				Fuller, Gordon; McClelland, Graham; Lawrence, Thomas; Russell, Wanda; Lecky, Fiona			The diagnostic accuracy of the HITSNS prehospital triage rule for identifying patients with significant traumatic brain injury: a cohort study	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						triage; emergency medical services; craniocerebral trauma; trauma systems; trauma centres	MAJOR TRAUMA; SYSTEM	Diversion of suspected traumatic brain injury (TBI) patients to trauma centres may improve outcomes by expediting access to specialist neurosurgical care. This study aimed to determine the accuracy of the Head Injury Straight to Neurosurgery (HITSNS) triage rule for identifying patients with significant TBI. A diagnostic cohort study was performed using data from the HITSNS trial, the Trauma Audit and Research Network registry and the North East Ambulance service database. Sensitivity and specificity of the HITSNS triage rule were calculated against a reference standard of significant TBI, defined by a cranial Abbreviated Injury Scale score of at least 3 or by the performance of a neurosurgical procedure. A total of 3628 patients were included in the complete case analyses. The HITSNS triage tool demonstrated a sensitivity of 28.3% (95% confidence interval 21.8-35.4) and a specificity of 94.4% (95% confidence interval 93.6-95.2). The low sensitivity of the HITSNS triage rule suggests that a considerable proportion of patients with significant TBI may not be triaged directly to trauma centres, and further research is needed to improve the accuracy of bypass protocols.	[Fuller, Gordon; Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Emergency Med Res Sheffield Grp, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [McClelland, Graham] North East Ambulance Serv NHS Fdn Trust, Dept Res & Dev, Newcastle Upon Tyne, Tyne & Wear, England; [Lawrence, Thomas; Lecky, Fiona] Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Hlth Sci Res Grp, Trauma Audit & Res Network, Eccles Old Rd, Salford, Lancs, England; [Russell, Wanda] Univ Manchester, Sch Nursing Midwifery & Social Work, Univ Pl, Manchester, Lancs, England		Fuller, G (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Emergency Med Res Sheffield Grp, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	g.fuller@sheffield.ac.uk	; Russell, Wanda/O-9051-2014	Fuller, Gordon Ward/0000-0001-8532-3500; Russell, Wanda/0000-0003-2671-1938; McClelland, Graham/0000-0002-4502-5821	National Institute for Health ResearchNational Institute for Health Research (NIHR) [08/116/85, DRF-2011-04-050] Funding Source: researchfish; Department of HealthEuropean Commission [08/116/85, DRF-2011-04-050] Funding Source: Medline		Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; HITSNS Research Team, HEAD INJ STRAIGHT NE; Lecky FRW, 2015, HLTH TECHNO IN PRESS; Lendrum RA, 2013, ANAESTHESIA, V68, P30, DOI 10.1111/anae.12049; Newgard CD, 2011, J AM COLL SURGEONS, V213, P709, DOI 10.1016/j.jamcollsurg.2011.09.012; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; Xiang HY, 2014, AM J EMERG MED, V32, P997, DOI 10.1016/j.ajem.2014.05.038	9	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	FEB	2016	23	1					61	64		10.1097/MEJ.0000000000000327			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DI5AA	WOS:000373509300013	26375361				2022-02-06	
J	Khajavikhan, J; Vasigh, A; Khani, A; Jaafarpour, M; Kokhazade, T				Khajavikhan, Javaher; Vasigh, Aminolah; Khani, Ali; Jaafarpour, Molouk; Kokhazade, Taleb			Outcome and Predicting Factor Following Severe Traumatic Brain Injury: A Retrospective Cross-Sectional Study	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Glasgow Coma Scale; Glasgow Outcome Scale; Head trauma; Quality of Life; SF-36	QUALITY-OF-LIFE; HEAD-INJURY; PSYCHIATRIC-DISORDERS; INTENSIVE-CARE; PROGESTERONE; EPIDEMIOLOGY; EMERGENCY; MORTALITY	Introduction: Severe traumatic brain injury (TBI) is a major and challenging problem in critical care medicine. Aim: To assess the outcome and predicting factor following severe TBI. Materials and Methods: This is a retrospective and cross-sectional study. Data were collected from two sections; one section consisting of a questionnaire answered by the patients and other section from the patient records. The instruments used included the Glasgow Outcome Scale (GOS), SF-36 and the Hospital Anxiety and Depression Scale (HAD). Results: The mortality rate of the patients was 46.2%. The quality of life (QOL) of the patients in most dimension were impaired and (58%) of patients had unfavourable QOL. About (37.5%) of patients with anxiety and (27.5%) had a depression. A significant correlation was found between age, GCS arrival, length of ICU stay, mechanical ventilation, VAP & ARDS and pupil reactivity with QOL, GOS, HAD-A and HAD-D (p< 0.05, p< 0.001). GCS arrival a predicate factor for QOL and GOS (p < 0.001, OR: 1.75, 1.94 respectively); length of ICU stay a predicate factor for QOL and GOS (p < 0.05, OR : 1.11, 1.28 respectively); mechanical ventilation a predicate factor for GOS (p < 0.001, OR : 1.78); ventilation associated pneumonia (VAP) & acute respiratory distress syndrome (ARDS) and pupil reactivity a predicate factor for GOS (p < 0.05, OR : 1.36; p< 0.001, OR: 1.94 respectively). The GCS arrival and ICU stay a predicate factor for HAD-A (p< 0.05, OR: 1.73, 1.38 respectively). Conclusion: With respect to results advanced in pre hospital, medical and surgical care for the decrease in mortality rates of Head trauma (HT), the use of trauma triage tools and strict enforcement of traffic rules are necessary.	[Khajavikhan, Javaher; Vasigh, Aminolah] Ilam Univ Med Sci, Fac Med, Dept Anesthesiol, Ilam, Iran; [Khani, Ali; Kokhazade, Taleb] Ilam Univ Med Sci, Nursing & Midwifery Fac, Dept Nursing, Ilam, Iran; [Jaafarpour, Molouk] Ilam Univ Med Sci, Nursing & Midwifery Fac, Dept Midwifery, Ilam, Iran		Jaafarpour, M (corresponding author), Ilam Univ Med Sci, Nursing & Midwifery Fac, Dept Midwifery, Ilam, Iran.	jaafarpourm@gmail.com		Scopus - Author details - Jaafarpour, Molouk/0000-0001-7314-9955; Vasigh, Aminolah/0000-0002-1543-0367			Alvis-Miranda Hernando Raphael, 2014, Bull Emerg Trauma, V2, P65; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Battista AD, 2014, PLOS ONE, V9, P1; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Settervall CHC, 2012, ACTA PAUL ENFERM, V25, P364, DOI 10.1590/S0103-21002012000300008; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Hefny AF, 2013, AFR HEALTH SCI, V13, P731, DOI 10.4314/ahs.v13i3.30; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Kavusipur Somaye, 2013, Bull Emerg Trauma, V1, P86; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Mondello S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/473419; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol AD, 2010, INJURY, DOI [10.1016/j.injury.2010.11.047, DOI 10.1016/J.INJURY.2010.11.047]; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yousefzade-Chabok SH, 2014, HEALTH, V6, P496; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	8	9	0	4	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	FEB	2016	10	2					PC16	PC19		10.7860/JCDR/2016/16390.7294			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ1RN	WOS:000397847400084	27042518	Green Published, gold			2022-02-06	
J	Nalder, E; Fleming, J; Cornwell, P; Foster, M; Skidmore, E; Bottari, C; Dawson, DR				Nalder, Emily; Fleming, Jennifer; Cornwell, Petrea; Foster, Michele; Skidmore, Elizabeth; Bottari, Carolina; Dawson, Deirdre R.			Sentinel Events During the Transition From Hospital to Home: A Longitudinal Study of Women With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Community integration; Rehabilitation; Traumatic brain injuries; Women	ANXIETY STRESS SCALES; GENDER-DIFFERENCES; DEPRESSION; INDIVIDUALS; OUTCOMES; HEALTH; PARTICIPATION; CAREGIVERS; AWARENESS; VALIDITY	Objective: To describe the occurrence of sentinel events and their influence on community integration of women with traumatic brain injury (TBI) transitioning from hospital to home. Design: A longitudinal study was completed with data collected before and at 1, 3, and 6 months after hospital discharge. Setting: Brain injury rehabilitation unit and acute neuroscience ward. Participants: Women (N=25) with severe TBI (aged between 17 and 50 years; duration of posttraumatic amnesia ranged from 1 to 123d). Sixteen family caregivers also participated. Interventions: Not applicable. Main Outcome Measures: Community integration was measured using the Mayo-Portland Adaptability Inventory. Depression, anxiety, and stress were measured using the Depression Anxiety Stress Scale. The Sentinel Events Questionnaire was used to record life events that potentially influence the transition process. Results: Most women (>16 at each time point) experienced mild to moderate impairments in psychosocial integration. A third of the sample reported symptoms of depression (n=8), anxiety (n=9), and stress (n=7) that exceeded clinical cutoff levels on at least 1 occasion. At 6 months, 3 women reported clinically significant depression and anxiety (12%) and 2 reported significant stress levels (8%). Positive sentinel events such as return to meaningful occupation were common (n=14). Negative sentinel events were also quite common. For example, reduced access to therapy, reported by 10 women, was associated with poorer participation levels. Conclusions: These findings suggest that the presence of sentinel events influences the transition experiences of women with TBI in this sample. Rehabilitation should consider the occurrence and impact of sentinel events because this may facilitate successful transitions. (C) 2016 by the American Congress of Rehabilitation Medicine	[Nalder, Emily; Dawson, Deirdre R.] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Nalder, Emily; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Metro South Hosp & Hlth Serv, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Cornwell, Petrea] Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Behav Basis Hlth Program, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Foster, Michele] Univ Queensland, Sch Social Work & Human Serv, Brisbane, Qld, Australia; [Skidmore, Elizabeth] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Pittsburgh, PA USA; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre R.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada		Nalder, E (corresponding author), Univ Toronto, Rehabil Sci Bldg,160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	Emily.nalder@utoronto.ca	Cornwell, Petrea/AAE-5547-2019; Dawson, Deirdre/I-8882-2014	Dawson, Deirdre/0000-0001-7517-6121; Fleming, Jennifer/0000-0002-5603-2410	Australian Research Council Linkage Project GrantAustralian Research Council [LP0776294]; Department of Communities (Disability Services); Acquired Brain Injury Outreach Service	Supported by an Australian Research Council Linkage Project Grant (grant no. LP0776294) and partner organizations, Department of Communities (Disability Services) and Acquired Brain Injury Outreach Service.	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dawson DR, 2005, J HEAD TRAUMA REHAB, V20, P426, DOI 10.1097/00001199-200509000-00004; Elder G.H., 2009, CRAFT LIFE COURSE RE; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming J., 2006, BRAIN IMPAIR, V7, P83, DOI [https://doi.org/10.1375/brim.7.2.83, DOI 10.1375/BRIM.7.2.83, 10.1375/brim.7.2.83]; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Goodman J., 2006, COUNSELING ADULTS TR; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hosmer DW, 2005, APPL LOGISTIC REGRES; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Kvam L, 2015, DISABIL REHABIL, V37, P78, DOI 10.3109/09638288.2014.907827; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Lovibond PF, 1998, J ABNORM PSYCHOL, V107, P520, DOI 10.1037/0021-843X.107.3.520; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Shores E A, 1995, Appl Neuropsychol, V2, P167; StataCorp, 2013, STATA STAT SOFTWARE; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Twisk JWR, 2013, APPL LONGITUDINAL DA; VERBRUGGE LM, 1989, J HEALTH SOC BEHAV, V30, P282, DOI 10.2307/2136961; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; World Health Organization, 2007, INT CLASS FUNCT DIS	44	8	8	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2		1			S46	S53		10.1016/j.apmr.2014.07.428			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DC4RI	WOS:000369207600007	25662399	Green Published, Green Accepted			2022-02-06	
J	Asadollahi, S; Heidari, K; Taghizadeh, M; Seidabadi, AM; Jamshidian, M; Vafaee, A; Manoochehri, M; Shojaee, AH; Hatamabadi, HR				Asadollahi, Shadi; Heidari, Kamran; Taghizadeh, Mehrdad; Seidabadi, Arash Mohammad; Jamshidian, Morteza; Vafaee, Ali; Manoochehri, Mohammad; Shojaee, Ali Habibzade; Hatamabadi, Hamid Reza			Reducing head computed tomography after mild traumatic brain injury: Screening value of clinical findings and S100B protein levels	BRAIN INJURY			English	Article						Computed tomography; diagnosis; demographics; traumatic brain injury; S100 protein; risk	SERUM-LEVELS; BLOOD; GUIDELINES; S-100B; EDEMA; RULE; MULTICENTER; MANAGEMENT; ADULTS; DAMAGE	Primary objective: The present prospective study was performed to investigate whether primary clinical findings and serum S100B concentrations at 3 and 6 hours post-trauma can contribute to the selection of patients for an initial computed tomography (CT) scanning. Research design and methods: S100B was measured in serum samples obtained at 3 and 6 hours after the injury. Adjusted odds ratios (OR) and 95% confidence interval (CI) associated with demographics and clinical predictors of positive CT scan were calculated. Sensitivity, specificity, negative and positive predictive values were also calculated for S100B levels. Main outcomes and results: It was found that the presence of loss of consciousness (OR = 2.3; 95% CI = 1.00-4.01; p = 0.008) and post-traumatic vomiting >= 2 episodes (OR = 1.8; 95% CI = 1.08-3.29; p = 0.019) are factors associated with positive CT scan. In this study the best cut-off point of 0.115 mu g L-1 for 3-hour S100B has sensitivity of 94.9% (95% CI = 86.8-98.3) with specificity of 35.4% (95% CI = 25.2-47.0) to predict intracranial injury on CT scanning. The corresponding results for 6-hour S100B > 0.210 mu g L-1 were 98.7% (95% CI = 92.1-99.9) for sensitivity and 39.2% (95% CI = 28.6-50.8) for specificity. Conclusions: Serum S100B measurement along with clinical evaluation of patients with mild traumatic brain injury has promising screening value to support selection of patients for CT scanning.	[Asadollahi, Shadi; Shojaee, Ali Habibzade] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran; [Heidari, Kamran; Taghizadeh, Mehrdad; Seidabadi, Arash Mohammad; Vafaee, Ali; Manoochehri, Mohammad] Shahid Beheshti Univ Med Sci, Dept Emergency Med, Loghmane Hakim Hosp, Tehran, Iran; [Jamshidian, Morteza] Shahid Beheshti Univ Med Sci, Dept Emergency Med, Imam Hossein Hosp, Tehran, Iran; [Hatamabadi, Hamid Reza] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran		Hatamabadi, HR (corresponding author), Imam Hossein Hosp, Dept Emergency Med, Nezam Abad St, Tehran, Iran.	hhatamabadi@sbmu.ac.ir	Hatamabadi, Hamid Reza/B-9715-2016; VAFAEI, ALI/AAU-9473-2021	VAFAEI, ALI/0000-0002-7129-6457; Hatamabadi, Hamid Reza/0000-0002-9085-8806	Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran (Iran)Tehran University of Medical Sciences	The authors report no conflicts of interest. The study was financially supported by a grant from Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran (Iran).	Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Raabe A, 2005, ANESTHESIOLOGY, V102, P713, DOI 10.1097/00000542-200504000-00003; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI 10.1089/neu.2009-0928; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Singh J, 2015, J PHARMACOL PHARMACO, V6, P185, DOI 10.4103/0976-500X.162004; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stiell IG, 2000, NEW ENGL J MED, V343, P1570; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; World Medical Association, 2013, WMA DECL HELS ETH PR; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	45	8	8	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2016	30	2					172	178		10.3109/02699052.2015.1091504			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DF3MM	WOS:000371248400007	26671496				2022-02-06	
J	Bohman, LE; Riley, J; Milovanova, TN; Sanborn, MR; Thom, SR; Armstead, WM				Bohman, Leif-Erik; Riley, John; Milovanova, Tatyana N.; Sanborn, Matthew R.; Thom, Stephen R.; Armstead, William M.			Microparticles Impair Hypotensive Cerebrovasodilation and Cause Hippocampal Neuronal Cell Injury after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						endothelin; fluid percussion injury; hypotensive cerebrovasodilation; microparticles; tissue plasminogen activator; traumatic brain injury	CIRCULATING ENDOTHELIAL MICROPARTICLES; AGE-DEPENDENT IMPAIRMENT; CEREBROVASCULAR RESPONSE; SUBARACHNOID HEMORRHAGE; CEREBRAL-CIRCULATION; PREVENTS IMPAIRMENT; ENDOGENOUS TPA; NEWBORN PIGS; K-ATP; AUTOREGULATION	Endothelin-1 (ET-1), tissue plasminogen activator (tPA), and extracellular signal-regulated kinases-mitogen activated protein kinase (ERK-MAPK) are mediators of impaired cerebral hemodynamics after fluid percussion brain injury (FPI) in piglets. Microparticles (MPs) are released into the circulation from a variety of cells during stress, are pro-thrombotic and pro-inflammatory, and may be lysed with polyethylene glycol telomere B (PEG-TB). We hypothesized that MPs released after traumatic brain injury impair hypotensive cerebrovasodilation and that PEG-TB protects the vascular response via MP lysis, and we investigated the relationship between MPs, tPA, ET-1, and ERK-MAPK in that process. FPI was induced in piglets equipped with a closed cranial window. Animals received PEG-TB or saline (vehicle) 30-minutes post-injury. Serum and cerebrospinal fluid (CSF) were sampled and pial arteries were measured pre- and post-injury. MPs were quantified by flow cytometry. CSF samples were analyzed with enzyme-linked immunosorbent assay. MP levels, vasodilatory responses, and CSF signaling assays were similar in all animals prior to injury and treatment. After injury, MP levels were elevated in the serum of vehicle but not in PEG-TB-treated animals. Pial artery dilation in response to hypotension was impaired after injury but protected in PEG-TB-treated animals. After injury, CSF levels of tPA, ET-1, and ERK-MAPK were all elevated, but not in PEG-TB-treated animals. PEG-TB-treated animals also showed reduction in neuronal injury in CA1 and CA3 hippocampus, compared with control animals. These results show that serum MP levels are elevated after FPI and lead to impaired hypotensive cerebrovasodilation via over-expression of tPA, ET-1, and ERK-MAPK. Treatment with PEG-TB after injury reduces MP levels and protects hypotensive cerebrovasodilation and limits hippocampal neuronal cell injury.	[Bohman, Leif-Erik; Sanborn, Matthew R.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Riley, John; Armstead, William M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Milovanova, Tatyana N.; Thom, Stephen R.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Milovanova, Tatyana N.; Thom, Stephen R.] Univ Penn, Inst Environm Med, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD57355] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5T32NS043126-10] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126] Funding Source: NIH RePORTER		Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Armstead WM, 2011, NEUROL RES, V33, P127, DOI 10.1179/016164111X12881719352138; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Armstead WM, 2011, BRAIN RES, V1376, P88, DOI 10.1016/j.brainres.2010.12.052; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2001, J NEUROTRAUM, V18, P1039, DOI 10.1089/08977150152693737; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1999, J NEUROTRAUM, V16, P391, DOI 10.1089/neu.1999.16.391; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Beppu S, 1997, J AM SOC ECHOCARDIOG, V10, P11, DOI 10.1016/S0894-7317(97)80028-4; Bidot L, 2008, J THROMB HAEMOST, V6, P913, DOI 10.1111/j.1538-7836.2008.02963.x; Blann A, 2009, SEMIN THROMB HEMOST, V35, P488, DOI 10.1055/s-0029-1234144; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Grayburn PA, 1998, J AM COLL CARDIOL, V32, P230, DOI 10.1016/S0735-1097(98)00219-8; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LEFFLER CW, 1987, AM J PHYSIOL, V252, pH687, DOI 10.1152/ajpheart.1987.252.4.H687; LEFFLER CW, 1986, CIRC RES, V59, P562, DOI 10.1161/01.RES.59.5.562; Mackman N, 2009, CIRC RES, V104, P925, DOI 10.1161/CIRCRESAHA.109.196840; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Nantakomol Duangdao, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P146; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Sanborn MR, 2012, J NEUROSURG, V117, P579, DOI 10.3171/2012.6.JNS111163; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Zubkov AY, 2000, STROKE, V31, P526, DOI 10.1161/01.STR.31.2.526	42	8	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					168	174		10.1089/neu.2015.3885			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800002	26230045	Green Published			2022-02-06	
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. W.			The Effects of Repeat Testing, Malingering, and Traumatic Brain Injury on Computerized Measures of Visuospatial Memory Span	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						digit span; reaction time; concussion; feigning; head injury; reliability; computer	SHORT-TERM-MEMORY; DIGIT SPAN; EXECUTIVE FUNCTIONS; PERFORMANCE; VETERANS; DISORDER; DEFICITS; AGE	Spatial span tests (SSTs) such as the Corsi Block Test (CBT) and the SST of the Wechsler Memory Scale are widely used to assess deficits in spatial working memory. We conducted three experiments to evaluate the test-retest reliability and clinical sensitivity of a new computerized spatial span test (C-SST) that incorporates psychophysical methods to improve the precision of spatial span measurement. In Experiment 1, we analyzed C-SST test-retest reliability in 49 participants who underwent three test sessions at weekly intervals. Intraclass correlation coefficients (ICC) were higher for a psychophysically derived mean span (MnS) metric (0.83) than for the maximal span and total correct metrics used in traditional spatial-span tests. Response times (ReTs) also showed high ICCs (0.93) that correlated negatively with MnS scores and correlated positively with response time latencies from other tests of processing speed. Learning effects were insignificant. Experiment 2 examined the performance of Experiment 1 participants when instructed to feign symptoms of traumatic brain injury (TBI): 57% showed abnormal MnS z-scores. A MnS z-score cutoff of 3.0 correctly classified 36% of simulated malingerers and 91% of the subgroup of 11 control participants with abnormal spans. Malingerers also made more substitution errors than control participants with abnormal spans (sensitivity = 43%, specificity = 91 %), In addition, malingerers showed no evidence of ReT slowing, in contrast to significant abnormalities seen on other malingered tests of processing speed. As a result, differences between ReT z-scores and z-scores on other processing speed tests showed very high sensitivity and specificity in distinguishing malingering and control participants with either normal or abnormal spans. Experiment 3 examined C-SST performance in a group of patients with predominantly mild TBI: neither MnS nor ReT z-scores showed significant group-level abnormalities. The C-SST improves the reliability and sensitivity of spatial span testing, can accurately detect malingering, and shows that visuospatial working memory is largely preserved in patients with predominantly mild TBI.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. W.] Vet Affairs Northern Calif Hlth Care Syst, Martinez, CA 94553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA		Woods, DL (corresponding author), Vet Affairs Northern Calif Hlth Care Syst, Martinez, CA 94553 USA.	dlwoods@ucdavis.edu		Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	VA Rehabilitation Research and Development [CX000583, CX001000]; Veterans AffairsUS Department of Veterans Affairs [I01CX001000, I01CX000583] Funding Source: NIH RePORTER	This research was supported by VA Rehabilitation Research and Development Grants CX000583 and CX001000 to DW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the U.S. Government. We would like to thank Ben Edwards, Oren Poliva, Masood Younus, Nabeel Rahman, and Kerry Hubei who gathered data used in this report, and Robert Hink who developed the MySQL database.	Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baldo JV, 2012, APHASIOLOGY, V26, P338, DOI 10.1080/02687038.2011.602391; Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Chechlacz M, 2014, NEUROPSYCHOLOGIA, V64, P240, DOI 10.1016/j.neuropsychologia.2014.09.038; Chey J, 2002, PSYCHIAT RES, V110, P259, DOI 10.1016/S0165-1781(02)00105-1; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Flaks MK, 2014, J PSYCHIATR RES, V48, P32, DOI 10.1016/j.jpsychires.2013.10.009; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Kertzman S, 2006, ISRAEL J PSYCHIAT, V43, P112; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Livengood M, 2010, BRAIN INJURY, V24, P598, DOI 10.3109/02699051003652815; Lo AHY, 2012, J NEUROPSYCHOL, V6, P212, DOI 10.1111/j.1748-6653.2011.02023.x; Luukkainen-Markkula R, 2011, RESTOR NEUROL NEUROS, V29, P321, DOI 10.3233/RNN-2011-0602; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; ORSINI A, 1986, PERCEPT MOTOR SKILL, V63, P727, DOI 10.2466/pms.1986.63.2.727; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Sozda CN, 2014, NEUROPSYCHOLOGY, V28, P347, DOI 10.1037/neu0000043; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wiechmann A, 2010, AGING NEUROPSYCHOL C, V18, P56, DOI 10.1080/13825585.2010.510556; Wilde NJ, 2004, J CLIN EXP NEUROPSYC, V26, P539, DOI 10.1080/13803390490496605; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Yaguez L, 2006, J NEUROL, V253, P186, DOI 10.1007/s00415-005-0951-4; Yang BR, 2011, PSYCHOL MED, V41, P2593, DOI 10.1017/S0033291711000869; Ylioja SG, 2009, ARCH CLIN NEUROPSYCH, V24, P729, DOI 10.1093/arclin/acp078	40	8	8	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JAN 5	2016	9								690	10.3389/fnhum.2015.00690			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DA2SE	WOS:000367645700001	26779001	gold, Green Published			2022-02-06	
J	Donaworth, MA; Grandhi, RK; Logan, K; Gubanich, PJ; Myer, GD				Donaworth, Michael A.; Grandhi, Ravi K.; Logan, Kelsey; Gubanich, Paul J.; Myer, Gregory D.			Is current medical education adequately preparing future physicians to manage concussion: an initial evaluation	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; medical students; medical education; sports medicine	SPORT-RELATED CONCUSSION; KNOWLEDGE; SYMPTOMS; CHILDREN	Objectives: In 2010, there were 2.5 million hospitalizations, emergency room visits, or deaths associated with concussions in the United States.[1] Knowledge deficits exist among physicians regarding concussion management, which can lead to severe repercussions, including poor patient outcomes, poor patient satisfaction, and potential medical-legal issues. While concussion is a prevalent condition evaluated in the medical field, medical students continue to have a knowledge deficit regarding concussion diagnosis, prognosis, medical management, and return to play guidelines. Methods: Medical students from a mid-western medical school completed a survey on concussion diagnosis, prognosis, medical management, and return to play guidelines. Results: The response rate was 40%. The data suggests that the vast majority of medical students are able to define concussion; however, most reported never having a lecture dedicated to concussion during medical school and also lacked clinical experience with acute concussion and post-concussive syndrome. There are clear areas of deficiency as noted by the inability of students to correctly identify symptoms and appropriate management of concussion. Conclusion: The current study indicates that at an individual, mid-western, top 50 medical school, current medical trainees may not be adequately educated to identify and manage concussion. Future research is warranted to determine the optimal guidelines to educate future physicians as it pertains to concussion diagnosis, management, prognosis, and return to play guidelines.	[Donaworth, Michael A.; Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, POB 670212, Cincinnati, OH 45267 USA; [Donaworth, Michael A.; Grandhi, Ravi K.; Logan, Kelsey; Gubanich, Paul J.; Myer, Gregory D.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Logan, Kelsey; Gubanich, Paul J.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Logan, Kelsey; Gubanich, Paul J.; Myer, Gregory D.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.] Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA		Donaworth, MA (corresponding author), Univ Cincinnati, Dept Orthopaed Surg, POB 670212, Cincinnati, OH 45267 USA.	michael.donaworth@uc.edu	Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422			[Anonymous], TRAUM BRAIN INJ US F; [Anonymous], 2014, US NEWS WORLD REPORT; Bey T, 2009, WEST J EMERG MED, V10, P6; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Demorest RA, 2005, PEDIATRICS, V115, P28, DOI 10.1542/peds.2004-0266; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pomerantz WJ, 2014, P AM ASS PED NAT C E; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190	16	8	8	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2016	44	1					1	7		10.1080/00913847.2016.1135039			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	DE5GS	WOS:000370660000001	26758683				2022-02-06	
J	Alsalaheen, B; McClafferty, A; Haines, J; Smith, L; Yorke, A				Alsalaheen, Bara; McClafferty, Adam; Haines, Jamie; Smith, Laura; Yorke, Amy			Reference values for the balance error scoring system in adolescents	BRAIN INJURY			English	Article						Concussion; mTBI; postural stability; normative	SPORT CONCUSSION; POSTURAL CONTROL; BASE-LINE; SCAT2; BASKETBALL; STATEMENT; DEFICITS; PLAYERS	Objectives: Adolescents with mild traumatic brain injury (i.e. concussion) may experience postural stability impairments. The Balance Error Scoring System (BESS) is widely used in assessment of postural stability after concussion. Despite its common use in adolescents, the BESS lacks reference values in adolescents, limiting its clinical utility. The objective of this study is to report the reference values for the BESS in adolescents and to examine the effect of gender on the BESS scores. Methods: One hundred and ninety-one high school adolescents between the ages of 14-18 (M= 16.1, SD = 1.1) years of age completed the BESS. The effects of gender, age, body mass and height on the performance of BESS were examined. Additionally, the reported reference values for the BESS were stratified by gender. Results: Female participants demonstrated better performance on five of the six BESS conditions as well as the total error score (p < 0.001). No relationships were observed between age and body mass to the BESS scores. Conclusions: The effects of gender on the BESS performance support the gender-specific reference values reported in this study. These reference values provide benchmarks for clinicians when interpreting the BESS in the absence of individual baseline scores.	[Alsalaheen, Bara; McClafferty, Adam; Haines, Jamie; Smith, Laura; Yorke, Amy] Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA		Alsalaheen, B (corresponding author), Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	alsalahe@umich.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313	Dr. Ben F. Bryer Foundation Medical Research Fund; University of Michigan-Flint's Research and Creative Activity (RCA) Award	This project was funded by Dr. Ben F. Bryer Foundation Medical Research Fund and by the University of Michigan-Flint's Research and Creative Activity (RCA) Award. The authors report no other conflicts of interest.	Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valente M, 2007, J AM ACAD AUDIOL, V18, P461, DOI 10.3766/jaaa.18.6.2; Valovich TC, 2003, J ATHL TRAINING, V38, P51	28	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					914	918		10.3109/02699052.2016.1146965			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400011	27057617				2022-02-06	
J	Bardes, JM; Turner, J; Bonasso, P; Hobbs, G; Wilson, A				Bardes, James M.; Turner, Jason; Bonasso, Patrick; Hobbs, Gerald; Wilson, Alison			Delineation of Criteria for Admission to Step Down in the Mild Traumatic Brain Injury Patient	AMERICAN SURGEON			English	Article							MINIMAL HEAD-INJURY; CRANIAL COMPUTED-TOMOGRAPHY; INFLUENCE MANAGEMENT; REMAINS IMPORTANT; CT; PROGRESSION	Patients that suffer a mild traumatic brain injury (TBI) with intracranial hemorrhage are commonly admitted to an intensive care unit with repeat imaging in 12 to 24 hours. This is costly to the health-care system. This study aimed to evaluate this practice and to identify criteria to triage patients to lower levels of monitored care. A retrospective review was performed at a university-based Level I trauma center. Patients with mild TBI were included. Data were collected on demographics, neurological status at 6, 12, and 24 hours, CT scan results, and medical or surgical interventions were required. A total of 389 patients were evaluated, 53 had a documented neurological decline while being admitted. Factors found to be associated with a neurological decline included Glasgow Coma Scale (GCS) < 15 (P = 0.002), age greater than 55 (P < 0.001), and warfarin use (P = 0.039). Aspirin and Plavix were not associated with neurological decline. No patient age < 55 with a GCS of 15 had a documented decline. Several risk factors were found to be associated with neurological decline after mild TBI. These include age, GCS < 15, and warfarin use. Patients aged <55 with GCS 15, posed minimal risk for deterioration. Patients aged <55 and with a GCS of 15 can be admitted to a monitored step-down bed with less frequent neurological checks.	[Bardes, James M.; Turner, Jason; Bonasso, Patrick; Hobbs, Gerald; Wilson, Alison] W Virginia Univ, Dept Surg, Div Trauma Acute Care Surg & Crit Care, Morgantown, WV 26506 USA		Bardes, JM (corresponding author), W Virginia Univ, Dept Surg, Hlth Sci Ctr, Suite 7700, Morgantown, WV 26506 USA.	jbardes2@hsc.wvu.edu		Bardes, James/0000-0002-9361-6263	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM104942, U54GM104942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER		Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Croce MA, 2010, J AM COLL SURGEONS, V210, P831; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Schuster R, 2005, AM SURGEON, V71, P701; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sing RF, 2006, J TRAUMA, V60, P499; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	12	8	8	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JAN	2016	82	1					36	40					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DI1OU	WOS:000373266200021	26802855				2022-02-06	
J	Boxley, L; Flaherty, JM; Spencer, RJ; Drag, LL; Pangilinan, PH; Bieliauskas, LA				Boxley, Laura; Flaherty, Jennifer M.; Spencer, Robert J.; Drag, Lauren L.; Pangilinan, Percival H.; Bieliauskas, Linas A.			Reliability and factor structure of the Hospital Anxiety and Depression Scale in a polytrauma clinic	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						anxiety; concussion; confirmatory factor analysis; depression; factor structure; internal consistency; mild traumatic brain injury; polytrauma; reliability; self-report	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-SYMPTOMS; INVALID PERFORMANCE; VALIDITY; VETERANS; HADS; INVENTORY; DISORDER	The Hospital Anxiety and Depression Scale (HADS) is a brief self-report measure of anxiety and depression symptoms. This study examined the internal consistency and factor structure of the HADS among Veterans in a polytrauma/traumatic brain injury clinic. The sample consisted of 312 Veterans. A confirmatory factor analysis of the depression and anxiety subscales showed, not surprisingly, that the two factors were highly correlated (r = 0.70). Goodness of fit statistics for the two-factor model were acceptable (root mean square error of approximation = 0.06, comparative fit index = 0.94). The HADS demonstrated very good reliability overall (alpha = 0.89) and for the individual subscales (alpha = 0.84). This study supports the use of the HADS as a screen for depression and anxiety in the assessment of mild traumatic brain injury in a Veteran population.	[Boxley, Laura] Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, Columbus, OH 43210 USA; [Flaherty, Jennifer M.] Eastern Virginia Med Sch, Dept Psychiat & Behav Sci, Norfolk, VA 23501 USA; [Spencer, Robert J.; Pangilinan, Percival H.; Bieliauskas, Linas A.] Dept Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Drag, Lauren L.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Pangilinan, Percival H.; Bieliauskas, Linas A.] Univ Michigan, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA		Flaherty, JM (corresponding author), EVMS Neuropsychol Program, Andrews Hall,Ste 461,721 Fairfax Ave, Norfolk, VA 23507 USA.	flaherjm@evms.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1993, BECK ANXIETY INVENTO; Beck AT, 1987, MANUAL REVISED BECK; BENSON J, 1994, QUAL QUANT, V28, P117, DOI 10.1007/BF01102757; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bieliauskas LA, 2015, REV NEUROPSYCHOLOGY, VII, P26; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brown M.W., 1993, SOCIOL METHOD RES, P136; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Dennis RE, 2007, AGING MENT HEALTH, V11, P668, DOI 10.1080/13607860701529916; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dunbar M, 2000, BRIT J CLIN PSYCHOL, V39, P79, DOI 10.1348/014466500163121; Flaherty JM, 2015, BRAIN INJURY, V29, P1630, DOI 10.3109/02699052.2015.1075249; Flint AJ, 2002, INT J GERIATR PSYCH, V17, P117, DOI 10.1002/gps.535; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Golden J, 2007, J AFFECT DISORDERS, V100, P265, DOI 10.1016/j.jad.2006.10.020; Gough K, 2009, J PAIN SYMPTOM MANAG, V37, P797, DOI 10.1016/j.jpainsymman.2008.04.012; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Kraal AZ, 2015, REHABIL PSYCHOL, V60, P36, DOI 10.1037/rep0000017; Leung C M, 1993, Int J Psychosom, V40, P29; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Loehlin JC, 1998, LATENT VARIABLE MODE; Martin C R, 2000, Psychol Health Med, V5, P193, DOI 10.1080/713690189; Martin CR, 2004, BRIT J CLIN PSYCHOL, V43, P51, DOI 10.1348/014466504772812968; McCrae M., 2008, MILD TRAUMATIC BRAIN; McCue P, 2003, Psychol Health Med, V8, P425, DOI 10.1080/1354850310001604568; Mccue P, 2006, BRIT J CLIN PSYCHOL, V45, P483, DOI 10.1348/014466505X82379; McHale M, 2008, PSYCHOSOM MED, V70, P869, DOI 10.1097/PSY.0b013e318186dea9; Mondolo F, 2007, NEUROL SCI, V28, P270, DOI 10.1007/s10072-007-0834-9; Mondolo F, 2006, BEHAV NEUROL, V17, P109, DOI 10.1155/2006/136945; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Poole NA, 2006, GEN HOSP PSYCHIAT, V28, P55, DOI 10.1016/j.genhosppsych.2005.08.004; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stafford L, 2007, GEN HOSP PSYCHIAT, V29, P417, DOI 10.1016/j.genhosppsych.2007.06.005; Sukantarat KT, 2007, ANAESTHESIA, V62, P239, DOI 10.1111/j.1365-2044.2006.04948.x; Thompson DR., 1999, PSYCHOL HEALTH MED, V4, P369, DOI 10.1080/135485099106117; Trajkovic G, 2011, PSYCHIAT RES, V189, P1, DOI 10.1016/j.psychres.2010.12.007; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Walker J, 2007, J PSYCHOSOM RES, V63, P83, DOI 10.1016/j.jpsychores.2007.01.009; Wang YP, 2013, CLINICS, V68, P1274, DOI 10.6061/clinics/2013(09)15; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Woolrich Rachel A, 2006, Psychol Health Med, V11, P80, DOI 10.1080/13548500500294211; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	8	8	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	6					873	880		10.1682/JRRD.2015.05.0088			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EK5SC	WOS:000393985100019	28273327	gold			2022-02-06	
J	Bush, EJ; Hux, K; Guetterman, TC; McKelvey, M				Bush, Erin J.; Hux, Karen; Guetterman, Timothy C.; McKelvey, Miechelle			The diverse vocational experiences of five individuals returning to work after severe brain injury: A qualitative inquiry	BRAIN INJURY			English	Article						Traumatic brain injury (TBI); multiple case study	PRODUCTIVE WORK; FOLLOW-UP; EMPLOYMENT; ADJUSTMENT; WORKPLACE	Objective: The researchers explored the return-to-work experiences of five adults with severe traumatic brain injuries (TBIs) and those associated with them by performing a qualitative, multiple case study investigation involving in-depth, semi-structured interviews. Selection of this qualitative methodology allowed for personal, individualized accounts of adults with TBI returning to work. Specifically, this methodology promoted accurate representation of the idiosyncratic nature of each participant's experiences. Methods: The researchers asked individuals to participate based on the diversity of their vocational experiences following TBI. Results: Four of the five participants had returned to their pre-injury jobs. Two were subsequently fired and, at the time of research participation, were unemployed. One participant never returned to paid employment; however, he had held two volunteer positions for several years post-injury. Salient content from interview transcripts allowed for the identification of five to eight themes pertinent to each case. Conclusions: Interpretation of the themes led to three main conjectures about return-to-work experiences following TBI: (a) job satisfaction may relate more to involvement in productive activities than monetary compensation; (b) adults with TBI can be successful in holding and maintaining positions with high cognitive demands; and (c) individualized job modifications and strategies are likely necessary for adults with TBI to succeed vocationally.	[Bush, Erin J.] Univ Wyoming, Div Commun Disorders, Laramie, WY 82071 USA; [Hux, Karen] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Guetterman, Timothy C.] Univ Michigan, Dept Family Med, Ann Arbor, MI USA; [McKelvey, Miechelle] Univ Nebraska Kearney, Dept Commun Disorders, Kearney, NE USA		Bush, EJ (corresponding author), 1000 E Univ Ave,Dept 3311,247E, Laramie, WY 82071 USA.	bushjanis6@gmail.com	Bush, Erin/I-9606-2016; Guetterman, Timothy/H-5423-2015; Hux, Karen/AAQ-2078-2020	Bush, Erin/0000-0003-1710-8619; Guetterman, Timothy/0000-0002-0093-858X; 			Applebaum PD., 1992, CONCEPT WORK ANCIENT; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; CSIKSZENTMIHALYI M, 1989, J PERS SOC PSYCHOL, V56, P815, DOI 10.1037/0022-3514.56.5.815; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kielhofner Gary, 1999, Work, V12, P37; Kohn M., 1983, WORK PERSONALITY ENQ; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V5, P9; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lundqvist A, 2012, BRAIN INJURY, V26, P1574, DOI 10.3109/02699052.2012.698363; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Power PW, 2003, BRAIN INJURY, V17, P1021, DOI 10.1080/0269905031000110526; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Stake E. R., 2006, MULTIPLE CASE STUDY; Swanson K M, 1993, Image J Nurs Sch, V25, P352; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	35	8	9	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					422	436		10.3109/02699052.2015.1131849			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200007	26910611				2022-02-06	
J	Calabro, RS; Nibali, VC; Naro, A; Floridia, D; Pizzimenti, M; Salmeri, L; Salviera, C; Bramanti, P				Calabro, Rocco Salvatore; Nibali, Valeria Conti; Naro, Antonino; Floridia, Daniela; Pizzimenti, Maria; Salmeri, Lucia; Salviera, Carlo; Bramanti, Placido			Is non-invasive neuromuscular electrical stimulation effective in severe chronic neurogenic dysphagia? Report on a post-traumatic brain injury patient	NEUROREHABILITATION			English	Article						Metaplasticity; neurogenic dysphagia; NMES; PAS; vitalstim	PAIRED ASSOCIATIVE STIMULATION; PHARYNGEAL MOTOR CORTEX; STROKE; NMES	BACKGROUND: Neurogenic dysphagia is a difficulty in swallowing induced by nervous system disease. It often causes serious complications, which are preventable if dysphagia is properly managed. There is growing debate concerning the usefulness of non-invasive neuromuscular electrical stimulation (NMES) in treating swallowing dysfunction. OBJECTIVE: Aim of this study was to assess the effectiveness of Vitalstim (c) device, and to investigate the neurophysiological mechanisms underlying functional recovery. METHODS: A 34-year-old man, affected by severe chronic dysphagia following traumatic brain injury, underwent two different intensive rehabilitation trainings, including either conventional rehabilitation alone or coupled to Vitalstim training. We evaluated patient swallowing function in two separate sessions (i.e. before and after the two trainings) by means of ad hoc swallowing function scales and electrophysiological parameters (rapid paired associative stimulation). The overall Vitalstim program was articulated in 6 weekly sessions for 6 weeks. RESULTS: The patient did not report any side-effect either during or following both the intensive rehabilitation trainings. We observed an important improvement in swallowing function only after Vitalstim training. In fact, the patient was eventually able to safely eat even solid food. CONCLUSIONS: This is the first report objectively suggesting (by means of rPAS) a correlation between the brain neuroplastic changes induced by Vitalstim and the swallowing function improvement. It is hypothesizable that Vitalstim may have targeted cortical (and maybe subcortical) brain areas that are recruited during the highly coordinated function of swallowing, and it may have thus potentiated the well-known neuroplastic changes induced by repetitive and intensive swallowing exercises, probably thanks to metaplasticity phenomena.	[Calabro, Rocco Salvatore; Nibali, Valeria Conti; Naro, Antonino; Floridia, Daniela; Pizzimenti, Maria; Salmeri, Lucia; Bramanti, Placido] IRCCS Ctr Neurolesi Bonino Pulejo Messina, SS 113, I-98124 Messina, Italy; [Salviera, Carlo] Univ Messina, Dept Otorinolaringoiatry, Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo Messina, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	Calabro, Rocco S/K-7520-2016; calabro, rocco salvatore/L-9570-2019; Bramanti, Placido/K-5117-2016	calabro, rocco salvatore/0000-0002-8566-3166; 			Alhashemi HH, 2010, NEUROSCIENCES, V15, P231; Bakheit AMO, 2001, POSTGRAD MED J, V77, P694, DOI 10.1136/pmj.77.913.694; Beom J, 2015, DYSPHAGIA, V30, P423, DOI 10.1007/s00455-015-9617-2; Bulow M, 2008, DYSPHAGIA, V23, P302, DOI 10.1007/s00455-007-9145-9; Carnaby-Mann GD, 2007, ARCH OTOLARYNGOL, V133, P564, DOI 10.1001/archotol.133.6.564; Cassidy JM, 2014, PHYS THER, V94, P139, DOI 10.2522/ptj.20130027; Coates C, 1997, EUR NEUROL, V38, P49, DOI 10.1159/000112902; Goroszeniuk T, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0412-9; Gow D, 2004, CLIN NEUROPHYSIOL, V115, P2382, DOI 10.1016/j.clinph.2004.05.017; Johnson Mark, 2014, Nurs Stand, V28, P44, DOI 10.7748/ns.28.40.44.e8565; KIDD D, 1993, Q J MED, V86, P825; Kim L, 2011, ANN REHABIL MED-ARM, V35, P765, DOI 10.5535/arm.2011.35.6.765; LAKE DA, 1992, SPORTS MED, V13, P320, DOI 10.2165/00007256-199213050-00003; Li L., 2014, EUR J PHYS REHAB MED, V51, P71; Lim KB, 2014, ANN REHABIL MED-ARM, V38, P592, DOI 10.5535/arm.2014.38.5.592; Ludlow CL, 2010, CURR OPIN OTOLARYNGO, V18, P159, DOI 10.1097/MOO.0b013e3283395dec; Martin RE, 2009, DYSPHAGIA, V24, P218, DOI 10.1007/s00455-008-9193-9; Michou E, 2013, NEUROREHAB NEURAL RE, V27, P355, DOI 10.1177/1545968312469837; Michou E, 2012, GASTROENTEROLOGY, V142, P29, DOI 10.1053/j.gastro.2011.09.040; Poorjavad M, 2014, STROKE RES TREAT, V2014, DOI 10.1155/2014/918057; Quartarone A, 2006, J PHYSIOL-LONDON, V575, P657, DOI 10.1113/jphysiol.2006.114025; Shaw GY, 2007, ANN OTO RHINOL LARYN, V116, P36, DOI 10.1177/000348940711600107; Singh I., 2009, ESSENTIALS ANATOMY; Takahashi S., 2002, J ORTHODONTICS, V29, P313; Terre R, 2015, EUR J NEUROL, V22, P687, DOI 10.1111/ene.12631; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954	26	8	9	0	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	1					53	57		10.3233/NRE-151295			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DE6CC	WOS:000370719800007	26889798				2022-02-06	
J	Canner, JK; Giuliano, K; Gani, F; Schneider, EB				Canner, Joseph K.; Giuliano, Katherine; Gani, Faiz; Schneider, Eric B.			Thirty-day re-admission after traumatic brain injury: Results from MarketScan (R)	BRAIN INJURY			English	Article						Traumatic brain injury; re-hospitalization; rehabilitation	MULTICENTER ANALYSIS; UNITED-STATES; SEVERITY; REHOSPITALIZATION; REHABILITATION; EPIDEMIOLOGY; VALIDATION	Objective: To estimate the national 30-day re-admission rate after traumatic brain injury (TBI) in insured patients under age 65 and to examine factors that predict re-admission. Methods: This study reviewed data on patients hospitalized with a primary diagnosis of TBI in the MarketScan (R) database from 2010-2012. Patients with substantial concurrent injury to non-head regions were excluded. This study identified all hospitalizations within 30 days after index discharge and compared characteristics of patients who were re-admitted vs those who were not. Results: This study identified 26 831 patients with a primary diagnosis of TBI who survived the index hospitalization. Overall, 6.6% of patients were re-admitted within 30 days. TBI was the most common primary diagnosis for re-admission (28.5%), followed by psychiatric disorders (12.5%). Patients who were older, had a head Abbreviated Injury Score of 3 or more, one or more comorbidities, longer length of stay or who were discharged to an inpatient rehabilitation facility demonstrated greater odds of being re-admitted within 30 days. Conclusions: Factors associated with re-admission after TBI should be considered in discharge planning. Further research is warranted to examine re-admission beyond 30 days and further elucidate causes of re-admission in order to develop strategies to reduce re-admission among patients with TBI.	[Canner, Joseph K.; Giuliano, Katherine; Gani, Faiz; Schneider, Eric B.] Johns Hopkins Univ, Sch Med, Dept Surg, Johns Hopkins Surg Ctr Outcomes Res, 600 N Wolfe St,Blalock 618, Baltimore, MD 21287 USA; [Schneider, Eric B.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Baltimore, MD USA		Canner, JK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Johns Hopkins Surg Ctr Outcomes Res, 600 N Wolfe St,Blalock 618, Baltimore, MD 21287 USA.	jcanner1@jhmi.edu					Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Boutin A, 2013, CRITICAL CARE S2, V17, P331; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Clark DE., ICDPIC STATA MODULE; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A., 2014, CLIN CLASSIFICATIONS; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Guillamondegui OD, 2011, COMP EFFECTIVENESS R, V25; Hansen L., 2012, WHITE PAPER HLTH RES; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39	20	8	8	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1570	1575		10.1080/02699052.2016.1199898			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800008	27589200				2022-02-06	
J	Colantonio, A; Salehi, S; Kristman, V; Cassidy, JD; Carter, A; Vartanian, O; Bayley, M; Kirsh, B; Hebert, D; Lewko, J; Kubrak, O; Mantis, S; Vernich, L				Colantonio, Angela; Salehi, Sara; Kristman, Vicki; Cassidy, J. David; Carter, Angela; Vartanian, Oshin; Bayley, Mark; Kirsh, Bonnie; Hebert, Debbie; Lewko, John; Kubrak, Olena; Mantis, Steve; Vernich, Lee			Return to work after work-related traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; return to work; facilitators; barriers	SLEEP DISTURBANCE; HEAD-INJURIES; PERSPECTIVE; POPULATION; PREDICTION; COMPLAINTS; MODERATE; PAIN; EPIDEMIOLOGY; PERFORMANCE	BACKGROUND: Work-related traumatic brain injury (wrTBI) comprises up to 24% of TBIs, yet relatively little is known about it even though wrTBI incurs high costs to employers, insurers, and injured. OBJECTIVES: To compare demographic, clinical, and occupation-related factors following mild-to-moderate TBI of those who successfully returned to work (RTW) versus those who did not, and to determine perceived facilitators of and barriers to RTW. METHODS: Retrospective cohort study from a consecutive sample of persons with TBI seen in an outpatient assessment clinic. Surveys were mailed to eligible potential participants. Consenting participants were interviewed by telephone or returned a completed survey via mail. RESULTS: Fifty of 116 eligible individuals participated in the study. Half of the participants returned to work. Participants in this group were significantly younger and had more years of education than the no-RTW group. The most common factors perceived to assist the RTW group were support of family and friends (92%) and of treatment providers (80%), and employers who provided accommodations (76%). Difficulty thinking and concentrating (94%) and fatigue (94%) were the most common barriers to RTW. CONCLUSIONS: This study highlights the importance of support from family, friends and employers as RTW facilitators. These factors merit further investigation in TBI rehabilitation studies.	[Colantonio, Angela; Kirsh, Bonnie; Hebert, Debbie] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela; Carter, Angela; Bayley, Mark; Hebert, Debbie] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Salehi, Sara] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Kristman, Vicki] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON, Canada; [Kristman, Vicki] Inst Work & Hlth, Toronto, ON, Canada; [Cassidy, J. David] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Vartanian, Oshin] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada; [Lewko, John] Laurentian Univ, Ctr Res Human Dev, Sudbury, ON, Canada; [Kubrak, Olena] Publ Serv Hlth & Safety Assoc, Toronto, ON, Canada; [Mantis, Steve] Res Act Alliance Consequences Work Injury, Thunder Bay, ON, Canada; [Vernich, Lee] Univ Toronto, Dalla Lana Sch Publ Hlth, Res Serv Unit, Toronto, ON, Canada		Colantonio, A (corresponding author), 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765; Bayley, Mark/0000-0001-7860-9463	Research Advisory Committee of the Ontario Workers Safety and Insurance Board [10034]; Saunderson Family Chair in Acquired Brain Injury Research from the Toronto Rehabilitation Institute; CIHR-IGH grant in Gender, Work and Health [CGW-126580]; Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This study was funded by the Research Advisory Committee of the Ontario Workers Safety and Insurance Board (#10034). Dr. Colantonio acknowledges salary support from the Saunderson Family Chair in Acquired Brain Injury Research from the Toronto Rehabilitation Institute and a CIHR-IGH grant in Gender, Work and Health (CGW-126580). We thank study participants and the neurology services staff at the Toronto Rehabilitation Institute for their support. The Toronto Rehabilitation Institute receives support from the Ministry of Health and Long Term Care. Dr. Kristman is supported by a Canadian Institutes of Health Research New Investigator Award in Community-based Primary Health Care.	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brouwer S, 2009, J OCCUP REHABIL, V19, P166, DOI 10.1007/s10926-009-9172-5; Cancelliere C, 2013, HDB WORK DISABILITY, P303; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dionne CE, 2013, J OCCUP REHABIL, V23, P280, DOI 10.1007/s10926-012-9399-4; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Franche R., 2012, J OCCUPATIONAL REHAB, V12, P233; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Friesen Margaret N., 2001, Work, V17, P11; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kissinger DB, 2008, WORK, V31, P309; Kling RN, 2010, SLEEP, V33, P611, DOI 10.1093/sleep/33.5.611; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Lombardi DA, 2012, CHRONOBIOL INT, V29, P556, DOI 10.3109/07420528.2012.675253; Lysaght RM, 2008, WORK, V30, P255; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Mollayeva T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0432-z; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Picot G, 2009, IMMIGRANT LOW INCOME; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Salehi S., 2011, ARCH PHYS MED REHAB, V92, P1725; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Smith MT, 2010, SLEEP MED, V11, P745, DOI 10.1016/j.sleep.2010.05.004; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; The Lancet Neurology, 2013, LANCET NEUROLOGY, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; UPADHYAY D, 2008, MIDDLE E J SCI RES, V3, P120; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wei Chia, 2012, Minn Med, V95, P55; Wendling T., 2010, PREVENTION WORK WORK; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	53	8	8	1	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	3					389	399		10.3233/NRE-161370			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DW7XA	WOS:000383865200006	27497471				2022-02-06	
J	Del Razo, MJ; Morofuji, Y; Meabon, JS; Huber, BR; Peskind, ER; Banks, WA; Mourad, PD; Leveque, RJ; Cook, DG				Del Razo, M. J.; Morofuji, Y.; Meabon, J. S.; Huber, B. R.; Peskind, E. R.; Banks, W. A.; Mourad, P. D.; Leveque, R. J.; Cook, D. G.			COMPUTATIONAL AND IN VITRO STUDIES OF BLAST-INDUCED BLOOD-BRAIN BARRIER DISRUPTION	SIAM JOURNAL ON SCIENTIFIC COMPUTING			English	Article						traumatic brain injury; shock tube; blood-brain barrier disruption; Euler equations with interfaces; Tammann equation of state	MILITARY TRAUMATIC BRAIN; HLLC RIEMANN SOLVER; ALZHEIMERS-DISEASE; FOCUSED ULTRASOUND; HEAD-INJURY; CAVITATION THRESHOLD; WAVE-PROPAGATION; MODEL; EULER; PERMEABILITY	There is growing concern that blast-exposed individuals are at risk of developing neurological disorders later in life. Therefore, it is important to understand the dynamic properties of blast forces on brain cells, including the endothelial cells that maintain the blood-brain barrier (BBB), which regulates the passage of nutrients into the brain and protects it from toxins in the blood. To better understand the effect of shock waves on the BBB we have investigated an in vitro model in which BBB endothelial cells are grown in transwell vessels and exposed in a shock tube, confirming that BBB integrity is directly related to shock wave intensity. It is difficult to directly measure the forces acting on these cells in the transwell container during the experiments, and so a computational tool has been developed and presented in this paper. Two-dimensional axisymmetric Euler equations with the Tammann equation of state were used to model the transwell materials, and a high-resolution finite volume method based on Riemann solvers and the Clawpack software was used to solve these equations in a mixed Eulerian/Lagrangian frame. Results indicated that the geometry of the transwell plays a significant role in the observed pressure time series in these experiments. We also found that pressures can fall below vapor pressure due to the interaction of reflecting and diffracting shock waves, suggesting that cavitation bubbles could be a damage mechanism. Computations that include a simulated hydrophone inserted in the transwell suggest that the instrument itself could significantly alter blast wave properties. These findings illustrate the need for further computational modeling studies aimed at understanding possible blast-induced BBB damage.	[Del Razo, M. J.; Leveque, R. J.] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Morofuji, Y.] Nagasaki Univ, Dept Neurosurg, Nagasaki, Japan; [Meabon, J. S.; Huber, B. R.; Peskind, E. R.] VA Puget Sound Hlth Care Syst VA Puget Sound, Northwest Network Mental Illness Res Educ & Clin, Seattle, WA USA; [Meabon, J. S.; Huber, B. R.; Peskind, E. R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98108 USA; [Banks, W. A.; Cook, D. G.] VA Puget Sound Hlth Care Syst VA Puget Sound, GRECC, Seattle, WA 98108 USA; [Banks, W. A.; Cook, D. G.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Mourad, P. D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98105 USA; [Mourad, P. D.] Univ Washington, Div Engn & Math, Seattle, WA 98011 USA		Del Razo, MJ (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	maojrs@uw.edu; yoichi51@hotmail.com; james64@u.washington.edu; bhuber@u.washington.edu; peskind@uw.edu; wabanks1@u.washington.edu; doumitt@uw.edu; rjl@uw.edu; dgcook@uw.edu	del Razo, Mauricio J/J-9430-2018; Banks, William A/K-1330-2017; Morofuji, Yoichi/AAB-1840-2021	del Razo, Mauricio J/0000-0002-9747-790X; Banks, William A/0000-0002-0496-3619; Morofuji, Yoichi/0000-0001-7135-2220	NSF grantNational Science Foundation (NSF) [DMS-1216732]; National Science and Technology Council of Mexico [CONACyT]Consejo Nacional de Ciencia y Tecnologia (CONACyT); NIH institutional fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AG000258]; Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005136]; VA RRD [I01RX001195]; University of Washington Friends of Alzheimer's Research; Department of Veterans Affairs Office of Research and Development Medical Research ServiceUS Department of Veterans Affairs	Department of Applied Mathematics, University of Washington, Seattle, WA 98195-3925 (maojrs@uw.edu, rjl@uw.edu). The work of the authors was supported by NSF grant DMS-1216732. The first author was also supported by National Science and Technology Council of Mexico [CONACyT].; Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC), VA Puget Sound Health Care System (VA Puget Sound), Seattle, WA, and Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98108 (james64@u.washington.edu, bhuber@u.washington.edu, peskind@uw.edu). The first author's work was supported by NIH institutional fellowship [T32 AG000258]. The second author's work was supported by Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs. The third author's work was supported by NIH/NIA P50 AG005136 [ADRC]; VA RR&D [I01RX001195] and University of Washington Friends of Alzheimer's Research.; Geriatric Research Education and Clinical Center (GRECC) VA Puget Sound Health Care System (VA Puget Sound), Seattle, WA 98108 and Department of Medicine, University of Washington, Seattle, WA 98195 (wabanks1@u.washington.edu, dgcook@uw.edu). The second author's work was supported in part by the Department of Veterans Affairs Office of Research and Development Medical Research Service and by University of Washington Friends of Alzheimer's Research.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Al-Anbaki D, 2008, ZBL CHIR, V133, P306, DOI 10.1055/s-2008-1076827; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Anderson J., 2003, MODERN COMPRESSIBLE; Andras IE, 2003, J NEUROSCI RES, V74, P255, DOI 10.1002/jnr.10762; Balsara DS, 2014, J COMPUT PHYS, V261, P172, DOI 10.1016/j.jcp.2013.12.029; Balsara DS, 2012, J COMPUT PHYS, V231, P7476, DOI 10.1016/j.jcp.2011.12.025; Banks WA, 2005, PEPTIDES, V26, P287, DOI 10.1016/j.peptides.2004.09.016; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bigelow TA, 2009, ULTRASOUND MED BIOL, V35, P1026, DOI 10.1016/j.ultrasmedbio.2008.12.001; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Calhoun DA, 2008, SIAM REV, V50, P723, DOI 10.1137/060664094; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1997, Vojnosanit Pregl, V54, P91; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen H, 2011, ULTRASOUND MED BIOL, V37, P2139, DOI 10.1016/j.ultrasmedbio.2011.09.013; Chertock A, 2008, ESAIM-MATH MODEL NUM, V42, P991, DOI 10.1051/m2an:2008036; Clawpack Development Team, 2014, CLAWP SOFTW VERS 5 2; Coisne C, 2005, LAB INVEST, V85, P734, DOI 10.1038/labinvest.3700281; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; Del Razo M. J., SIAM J SCI COM UNPUB; Del Razo M. J., B BRAZ MATH IN PRESS; Del Razo M. J., 2015, COMPUTATIONAL EXPT B; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fagnan K. M., 2010, THESIS; Fagnan K, 2013, COMM APP MATH COM SC, V8, P159, DOI 10.2140/camcos.2013.8.159; Fey M, 1998, J COMPUT PHYS, V143, P159, DOI 10.1006/jcph.1998.5958; Fey M, 1998, J COMPUT PHYS, V143, P181, DOI 10.1006/jcph.1998.5959; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Ivings MJ, 1998, INT J NUMER METH FL, V28, P395, DOI 10.1002/(SICI)1097-0363(19980915)28:3<395::AID-FLD718>3.0.CO;2-S; Jacob A, 2010, FASEB J, V24, P1682, DOI 10.1096/fj.09-138834; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lemoine G. I., 2013, THESIS; Lemoine GI, 2014, SIAM J SCI COMPUT, V36, pB396, DOI 10.1137/130920824; LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839; LeVeque RJ, 1997, J COMPUT PHYS, V131, P327, DOI 10.1006/jcph.1996.5603; LeVeque RJ, 2002, FINITE VOLUME METHOD, V31; Li YS, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-52; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McDannold N, 2008, ULTRASOUND MED BIOL, V34, P834, DOI 10.1016/j.ultrasmedbio.2007.10.016; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Nakaoke R, 2005, EXP NEUROL, V193, P101, DOI 10.1016/j.expneurol.2004.11.020; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI 10.1529/biophysj.106.075366; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pelanti M, 2014, J COMPUT PHYS, V259, P331, DOI 10.1016/j.jcp.2013.12.003; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Przekwas A., 2009, INT STAT OF THE SCI; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; ROE PL, 1986, J COMPUT PHYS, V63, P458, DOI 10.1016/0021-9991(86)90204-4; ROE PL, 1981, J COMPUT PHYS, V43, P357, DOI 10.1016/0021-9991(81)90128-5; Rossa J, 2014, BIOCHEM J, V464, P49, DOI 10.1042/BJ20140431; RUAN JS, 1993, 933114 SAE; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saurel R, 1999, SIAM J SCI COMPUT, V21, P1115, DOI 10.1137/S1064827597323749; Saurel R, 2001, J FLUID MECH, V431, P239, DOI 10.1017/S0022112000003098; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shreiber DI, 1997, SAE TECHNICAL PAPER; Shyue KM, 1998, J COMPUT PHYS, V142, P208, DOI 10.1006/jcph.1998.5930; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Toro E. F., 1994, Shock Waves, V4, P25, DOI 10.1007/BF01414629; Toro E.F, 2008, RIEMANN SOLVERS NUME; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Tung YS, 2010, ULTRASOUND MED BIOL, V36, P840, DOI 10.1016/j.ultrasmedbio.2010.02.009; Wakeland W, 2005, ACT NEUR S, V95, P321; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu Z, 2006, IEEE T ULTRASON FERR, V53, P1412, DOI 10.1109/TUFFC.2006.1665098; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhou C., 1997, P INT RES COUNC BIOM, V24, P35; Ziejewski M., 2007, BRAIN INJ PROF, V4, P10; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	109	8	8	0	16	SIAM PUBLICATIONS	PHILADELPHIA	3600 UNIV CITY SCIENCE CENTER, PHILADELPHIA, PA 19104-2688 USA	1064-8275	1095-7197		SIAM J SCI COMPUT	SIAM J. Sci. Comput.		2016	38	3					B347	B374		10.1137/15M1010750			28	Mathematics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	DY7AY	WOS:000385282800029		Green Submitted			2022-02-06	
S	Deng-Bryant, Y; Readnower, R; Leung, LY; Tortella, F; Shear, D		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Deng-Bryant, Ying; Readnower, Ryan; Leung, Lai Yee; Tortella, Frank; Shear, Deborah			Methods of Drug Delivery in Neurotrauma	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Neurotrauma; Traumatic brain injury; Drug delivery; Intravenous; Intranasal	BLOOD-BRAIN-BARRIER; INTRANASAL DELIVERY; JUGULAR-VEIN; TRANSGENIC MICE; RAT; INJURY; CATHETERIZATION; CANNULATION; SEVERITY; MEMORY	The central nervous system (CNS) is protected by blood-brain barrier (BBB) and blood-cerebrospinal-fluid (CSF) barrier that limit toxic agents and most molecules from penetrating the brain and spinal cord. However, these barriers also prevent most pharmaceuticals from entering into the CNS. Drug delivery to the CNS following neurotrauma is complicated. Although studies have shown BBB permeability increases in various TBI models, it remains as the key mitigating factor for delivering drugs into the CNS. The commonly used methods for drug delivery in preclinical neurotrauma studies include intraperitoneal, subcutaneous, intravenous, and intracerebroventricular delivery. It should be noted that for a drug to be successfully translated into the clinic, it needs to be administered preclinically as it would be anticipated to be administered to patients. And this likely leads to better dose selection of the drug, as well as recognition of any possible side effects, prior to transition into a clinical trial. Additionally, novel approach that is noninvasive and yet circumvents BBB, such as drug delivery through nerve pathways innervating the nasal passages, needs to be investigated in animal models, as it may provide a viable drug delivery method for patients who sustain mild CNS injury or require chronic treatments. Therefore, the focus of this chapter is to present rationales and methods for delivering drugs by IV infusion via the jugular vein, and intranasally in preclinical studies.	[Deng-Bryant, Ying; Readnower, Ryan; Leung, Lai Yee; Tortella, Frank; Shear, Deborah] Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Deng-Bryant, Y (corresponding author), Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.						BAKAR SK, 1983, J PHARM SCI-US, V72, P1027, DOI 10.1002/jps.2600720915; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bardelmeijer HA, 2003, LAB ANIM-UK, V37, P181, DOI 10.1258/002367703766453010; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; Cook AM, 2009, EXPERT OPIN DRUG SAF, V8, P411, DOI 10.1517/14740330903066742; Cook AM, 2009, PHARMACOTHERAPY, V29, P832, DOI 10.1592/phco.29.7.832; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; de Lange ECM, 2002, CLIN PHARMACOKINET, V41, P691, DOI 10.2165/00003088-200241100-00001; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Dhillon HS, 1999, J NEUROTRAUM, V16, P455, DOI 10.1089/neu.1999.16.455; Fine JM, 2012, EXP BRAIN RES, V219, P381, DOI 10.1007/s00221-012-3101-0; Fliedner S, 2006, ENDOCRINOLOGY, V147, P2088, DOI 10.1210/en.2005-1016; FLORCZYK AP, 1981, PHARMACOL BIOCHEM BE, V14, P255, DOI 10.1016/0091-3057(81)90253-7; Gomez Diana, 2012, Front Biosci (Schol Ed), V4, P74; Gozes I, 2007, CURR ALZHEIMER RES, V4, P507, DOI 10.2174/156720507783018208; Hanson LR, 2007, J NEUROIMMUNE PHARM, V2, P81, DOI 10.1007/s11481-006-9039-x; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Hashizume R, 2008, NEURO-ONCOLOGY, V10, P112, DOI 10.1215/15228517-2007-052; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Parker KJ, 2005, PSYCHONEUROENDOCRINO, V30, P924, DOI 10.1016/j.psyneuen.2005.04.002; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shen DD, 2004, ADV DRUG DELIVER REV, V56, P1825, DOI 10.1016/j.addr.2004.07.011; Thrivikraman KV, 2002, BRAIN RES PROTOC, V10, P84, DOI 10.1016/S1385-299X(02)00185-X; Wolf DA, 2012, MOL GENET METAB, V106, P131, DOI 10.1016/j.ymgme.2012.02.006	27	8	8	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						89	100		10.1007/978-1-4939-3816-2_6	10.1007/978-1-4939-3816-2		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500008	27604714				2022-02-06	
J	Dmytriyeva, O; Pankratova, S; Korshunova, I; Walmod, PS				Dmytriyeva, Oksana; Pankratova, Stanislava; Korshunova, Irina; Walmod, Peter S.			Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects	MEDIATORS OF INFLAMMATION			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; CYTOKINE PRODUCTION; MULTIPLE-SCLEROSIS; STATUS EPILEPTICUS; NERVOUS-SYSTEM; MOUSE MODEL; PEPTIDE	The cytokine erythropoietin (EPO) stimulates proliferation and differentiation of erythroid progenitor cells. Moreover, EPO has neuroprotective, anti-inflammatory, and antioxidative effects, but the use of EPO as a neuroprotective agent is hampered by its erythropoietic activity. We have recently designed the synthetic, dendrimeric peptide, Epobis, derived from the sequence of human EPO. This peptide binds the EPO receptor and promotes neuritogenesis and neuronal cell survival. Here we demonstrate that Epobis in vitro promotes neuritogenesis in primary motoneurons and has anti-inflammatory effects as demonstrated by its ability to decrease TNF release from activated AMJ2-C8 macrophages and rat primary microglia. When administered systemically Epobis is detectable in both plasma and cerebrospinal fluid, demonstrating that the peptide crosses the blood-brain barrier. Importantly, Epobis is not erythropoietic, but systemic administration of Epobis in rats delays the clinical signs of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, and the peptide has long-term, but not short-term, effects on working memory, detected as an improved social memory 3 days after administration. These data reveal Epobis to be a nonerythropoietic and neuroprotective EPO receptor agonist with anti-inflammatory and memory enhancing properties.	[Dmytriyeva, Oksana; Pankratova, Stanislava; Korshunova, Irina; Walmod, Peter S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Lab Neural Plast, Copenhagen, Denmark; [Dmytriyeva, Oksana] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Res Lab Stereol & Neurosci, Copenhagen, Denmark; [Pankratova, Stanislava] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Copenhagen, Denmark		Pankratova, S; Walmod, PS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Lab Neural Plast, Copenhagen, Denmark.; Pankratova, S (corresponding author), Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Copenhagen, Denmark.	stasya@sund.ku.dk; psw@sund.ku.dk	Walmod, Peter Schledermann/B-2130-2008	Walmod, Peter Schledermann/0000-0001-6350-2727; Korshunova, Irina/0000-0003-1921-6170; Pankratova, Stanislava/0000-0002-5406-5163; Dmytriyeva, Oksana/0000-0002-2075-338X	Danish Multiple Sclerosis Society [R192-Rp27173]; Danish Strategic Research Council (NEOMUNE research platform); Lundbeck FoundationLundbeckfonden [R44-A4226, R118-A11752]; Augustinus Foundation	The authors gratefully acknowledge the financial support of the Danish Multiple Sclerosis Society (R192-Rp27173), the Danish Strategic Research Council (NEOMUNE research platform), the Lundbeck Foundation (R44-A4226, R118-A11752), and the Augustinus Foundation.	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Al-Qahtani JM, 2014, NEUROCHEM RES, V39, P161, DOI 10.1007/s11064-013-1201-2; Barichello T, 2014, TRANSL RES, V163, P503, DOI 10.1016/j.trsl.2013.12.008; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Bunn HF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011619; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Campana WM, 2006, EUR J NEUROSCI, V23, P617, DOI 10.1111/j.1460-9568.2006.04606.x; Cervellini Ilaria, 2013, Methods Mol Biol, V982, P163, DOI 10.1007/978-1-62703-308-4_10; Chen H, 2014, J NEUROIMMUNOL, V268, P64, DOI 10.1016/j.jneuroim.2014.01.006; Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x; Creange A, 2013, NEUROPHYSIOL CLIN, V43, P303, DOI 10.1016/j.neucli.2013.09.004; Dhanushkodi A, 2013, GENES BRAIN BEHAV, V12, P224, DOI 10.1111/gbb.12001; Enevoldsen MN, 2012, NEUROBIOL DIS, V48, P533, DOI 10.1016/j.nbd.2012.07.016; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; Rodriguez JCG, 2009, THESCIENTIFICWORLDJO, V9, P970, DOI 10.1100/tsw.2009.103; Gotfryd K, 2007, NEUROPHARMACOLOGY, V52, P764, DOI 10.1016/j.neuropharm.2006.09.017; Hamidi Gholamali, 2013, Pathophysiology, V20, P153, DOI 10.1016/j.pathophys.2013.01.001; Hines-Beard J, 2013, CURR GENE THER, V13, P275; Jang W, 2014, J NEUROL SCI, V337, P47, DOI 10.1016/j.jns.2013.11.015; Kang SY, 2009, J CLIN NEUROL, V5, P39, DOI 10.3988/jcn.2009.5.1.39; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Klementiev B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-27; Lee ST, 2012, J NEUROCHEM, V120, P115, DOI 10.1111/j.1471-4159.2011.07534.x; Maiese K, 2012, INT J MOL SCI, V13, P11102, DOI 10.3390/ijms130911102; Mariotti C, 2013, J NEUROCHEM, V126, P80, DOI 10.1111/jnc.12301; Mathiasen JR, 2010, CURR PROTOC PHARM, V49, P1; Maurice T, 2013, J PSYCHOPHARMACOL, V27, P1044, DOI 10.1177/0269881113494939; Miskowiak KW, 2012, PSYCHOPHARMACOLOGY, V219, P687, DOI 10.1007/s00213-011-2511-1; Moldovan M, 2013, MOL MED, V19, P43, DOI 10.2119/molmed.2012.00248; Nguyen AQ, 2014, EXP BIOL MED, V239, P1461, DOI 10.1177/1535370214523703; Ning B, 2011, NEUROSCI LETT, V490, P57, DOI 10.1016/j.neulet.2010.12.025; Noh MY, 2014, NEUROSCI LETT, V574, P53, DOI 10.1016/j.neulet.2014.05.001; Pang L, 2013, J BIOCHEM MOL TOXIC, V27, P266, DOI 10.1002/jbt.21484; Pankratova S, 2012, J NEUROCHEM, V121, P915, DOI 10.1111/j.1471-4159.2012.07751.x; Pankratova S, 2010, BRAIN, V133, P2281, DOI 10.1093/brain/awq101; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Ryan LK, 1997, IN VITRO CELL DEV-AN, V33, P647, DOI 10.1007/s11626-997-0116-0; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Secher T, 2006, NEUROSCIENCE, V141, P1289, DOI 10.1016/j.neuroscience.2006.04.059; Shin T, 2012, ANAT CELL BIOL, V45, P215, DOI 10.5115/acb.2012.45.4.215; Sozmen SC, 2012, BRAIN DEV-JPN, V34, P189, DOI 10.1016/j.braindev.2011.05.002; Subiros N, 2012, THER ADV NEUROL DISO, V5, P161, DOI 10.1177/1756285611434926; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Turner JD, 2010, WORLD NEUROSURG, V73, P500, DOI 10.1016/j.wneu.2010.02.026; Varzaneh FN, 2014, ACTA NEUROL BELG, V114, P273, DOI 10.1007/s13760-014-0286-y; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wei X, 2014, INFECT IMMUN, V82, P165, DOI 10.1128/IAI.00929-13; Yazihan N, 2008, ADV THER, V25, P502, DOI 10.1007/s12325-008-0055-5; Zellinger C, 2011, EPILEPSY RES, V96, P241, DOI 10.1016/j.eplepsyres.2011.06.009; Zhou QH, 2010, MOL PHARMACEUT, V7, P2148, DOI 10.1021/mp1001763	52	8	8	1	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2016	2016								1346390	10.1155/2016/1346390			11	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	EE4NF	WOS:000389578700001	27990061	Green Submitted, Green Published, gold			2022-02-06	
J	Gamdzyk, M; Ziembowicz, A; Bratek, E; Salinska, E				Gamdzyk, Marcin; Ziembowicz, Apolonia; Bratek, Ewelina; Salinska, Elzbieta			Combining hypobaric hypoxia or hyperbaric oxygen postconditioning with memantine reduces neuroprotection in 7-day-old rat hypoxia-ischemia	PHARMACOLOGICAL REPORTS			English	Article						Hypoxia-ischemia; Neuroprotection; Memantine; Hyperbaric oxygen; Combination therapy	NMDA RECEPTOR ANTAGONISTS; TRAUMATIC BRAIN-INJURY; CEREBRAL-PALSY; CELL-DEATH; THERAPY; DAMAGE; ENCEPHALOPATHY; TOLERANCE; GLUTAMATE; MODEL	Background: Perinatal hypoxia-ischemia causes brain injury in neonates, but a fully successful treatment to prevent changes in the brain has yet to be developed. The aim of this study was to evaluate the effect of combining memantine treatment with HBO (2.5 ATA) or HH (0.47 ATA) on neonatal hypoxia-ischemia brain injury. Methods: 7-day old rats were subjected to hypoxia-ischemia (H-I) and treated with combination of memantine and HBO or HH. The brain damage was evaluated by examination of infarct area and the number of apoptotic cells in CM region of hippocampus. Additionally, the level of reactive oxygen species (ROS) was measured. Results: Memantine, HBO or HH postconditioning applied at short time (1-6 h) after H-I, and repeated for two subsequent days, resulted in significant neuroprotection. The reduction in ipsilateral hemisphere weight deficit and in the size of infarct area was observed 14 days after H-I. A reduction in apoptosis and ROS level was also observed. Combining memantine with HBO or HH resulted in a loss of neuroprotection. Conclusions: Our results show that, combining HBO or HH postconditioning with memantine produce no additive increase in the neuroprotective effect. On the contrary, combining the treatments resulted in lower neuroprotection in comparison to the effects of memantine, HBO or HH alone. (C) 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.	[Gamdzyk, Marcin; Ziembowicz, Apolonia; Bratek, Ewelina; Salinska, Elzbieta] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Warsaw, Poland		Salinska, E (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Warsaw, Poland.	esalinska@imdik.pan.pl		Salinska, Elzbieta/0000-0003-4212-221X			Aarsland D, 2009, LANCET NEUROL, V8, P613, DOI 10.1016/S1474-4422(09)70146-2; Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Chen SY, 2009, NEUROSCI LETT, V465, P171, DOI 10.1016/j.neulet.2009.09.011; Sanchez EC, 2013, CRIT CARE NURS Q, V36, P280, DOI 10.1097/CNQ.0b013e318294e95b; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; ERDO SL, 1991, EUR J PHARMACOL, V198, P215, DOI 10.1016/0014-2999(91)90625-Z; Gamdzyk M, 2014, NEUROCHEM RES, V39, P68, DOI 10.1007/s11064-013-1191-0; Gong SJ, 2012, NEUROCHEM RES, V37, P527, DOI 10.1007/s11064-011-0639-3; Gu N, 2012, EUR J PAIN, V16, P1094, DOI 10.1002/j.1532-2149.2012.00113.x; Haddad John J, 2013, Curr Mol Pharmacol, V6, P104; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jantas D, 2009, PHARMACOL REP, V61, P827, DOI 10.1016/S1734-1140(09)70138-0; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; JOHNSTON MV, 1995, BRAIN DEV-JPN, V17, P301, DOI 10.1016/0387-7604(95)00079-Q; Kislin M. S., 2013, Biomeditsinskaya Khimiya, V59, P673; Kuszczyk M, 2010, PHARMACOL REP, V62, P1041, DOI 10.1016/S1734-1140(10)70366-2; Lacey DJ, 2012, ANN NEUROL, V72, P695, DOI 10.1002/ana.23681; Lafemina MJ, 2006, PEDIATR RES, V59, P680, DOI 10.1203/01.pdr.0000214891.35363.6a; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu CH, 2009, BRAIN RES, V1282, P173, DOI 10.1016/j.brainres.2009.05.071; Liu XH, 2013, NEUROCHEM INT, V62, P922, DOI 10.1016/j.neuint.2013.03.004; Liu ZL, 2006, BRIT MED J, V333, P374, DOI 10.1136/bmj.38776.731655.2F; Lorrio S, 2009, BRAIN RES, V1254, P128, DOI 10.1016/j.brainres.2008.11.095; Makarewicz D, 2014, FOLIA NEUROPATHOL, V52, P270, DOI 10.5114/fn.2014.45568; Malek M, 2013, EXP BRAIN RES, V224, P1, DOI 10.1007/s00221-012-3283-5; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Mukherjee A, 2014, UNDERSEA HYPERBAR M, V41, P77; Nie H, 2006, J CEREBR BLOOD F MET, V26, P666, DOI 10.1038/sj.jcbfm.9600221; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Puisieux F, 2004, BRAIN RES, V1027, P30, DOI 10.1016/j.brainres.2004.08.067; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rybnikova E, 2012, NEUROSCI LETT, V513, P100, DOI 10.1016/j.neulet.2012.02.019; Shankaran S, 2012, CLIN PERINATOL, V39, P919, DOI 10.1016/j.clp.2012.09.008; Teo JD, 2015, PEDIATR RES, V77, P757, DOI 10.1038/pr.2015.47; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Wang F, 2015, MOL NEUROBIOL, V52, P1458, DOI 10.1007/s12035-014-8949-5; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; WELLER M, 1993, BRAIN RES, V613, P143, DOI 10.1016/0006-8993(93)90464-X; Yigit U, 2011, MOL VIS, V17, P1024; Yin XJ, 2013, INT J CLIN EXP PATHO, V6, P66; Zhang X, 2015, HIPPOCAMPUS, V25, P286, DOI 10.1002/hipo.22372; Zhao H, 2007, J NEUROIMMUNE PHARM, V2, P313, DOI 10.1007/s11481-007-9089-8; Zhou Bei-Yan, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P133	47	8	9	0	5	POLISH ACAD SCIENCES INST PHARMACOLOGY	KRAKOW	SMETNA 12, 31-343 KRAKOW, POLAND	1734-1140			PHARMACOL REP	Pharmacol. Rep.		2016	68	5					1076	1083		10.1016/j.pharep.2016.06.009			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DX6UC	WOS:000384517600033	27552063				2022-02-06	
J	Glushakov, AV; Arias, RA; Tolosano, E; Dore, S				Glushakov, Alexander, V; Arias, Rodrigo A.; Tolosano, Emanuela; Dore, Sylvain			Age-Dependent Effects of Haptoglobin Deletion in Neurobehavioral and Anatomical Outcomes Following Traumatic Brain Injury	FRONTIERS IN MOLECULAR BIOSCIENCES			English	Article						controlled cortical impact; Iba1; GFAP; gliosis; hemoglobin; hemorrhage; trauma	CONTROLLED CORTICAL IMPACT; SCAVENGER RECEPTOR CD163; TRANSCRANIAL DOPPLER; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; HEAD-INJURY; HEMOGLOBIN; BARRIER; EXPRESSION	Cerebral hemorrhages are common features of traumatic brain injury (TBI) and their presence is associated with chronic disabilities. Recent clinical and experimental evidence suggests that haptoglobin (Hp), an endogenous hemoglobin-binding protein most abundant in blood plasma, is involved in the intrinsic molecular defensive mechanism, though its role in TBI is poorly understood. The aim of this study was to investigate the effects of Hp deletion on the anatomical and behavioral outcomes in the controlled cortical impact model using wildtype (WT) C57BL/6 mice and genetically modified mice lacking the Hp gene (Hp(-/-)) in two age cohorts [2-4 mo-old (young adult) and 7-8 mo-old (older adult)]. The data obtained suggest age-dependent significant effects on behavioral and anatomical TBI outcomes and recovery from injury. Moreover, in the adult cohort, neurological deficits in Hp(-/-) mice at 24 h were significantly improved compared to WT, whereas there were no significant differences in brain pathology between these genotypes. In contrast, in the older adult cohort, Hp(-/-) mice had significantly larger lesion volumes compared to WT, but neurological deficits were not significantly different. Immunohistochemistry for ionized calcium-binding adapter molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP) revealed significant differences in microglial and astrocytic reactivity between Hp(-/-) and WT in selected brain regions of the adult but not the older adult-aged cohort. In conclusion, the data obtained in the study provide clarification on the age-dependent aspects of the intrinsic defensive mechanisms involving Hp that might be involved in complex pathways differentially affecting acute brain trauma outcomes.	[Glushakov, Alexander, V; Arias, Rodrigo A.; Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Tolosano, Emanuela] Univ Torino, Dept Mol Biotechnol, Turin, Italy; [Tolosano, Emanuela] Univ Torino, Dept Hlth Sci, Turin, Italy; [Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Psychol, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Pharmaceut, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA		Glushakov, AV; Dore, S (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Coll Med, Dept Psychol, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Coll Med, Dept Pharmaceut, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.	glushakov@bellsouth.net; sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020; Glushakov, Alexander V/B-5452-2008; Tolosano, Emanuela/A-4684-2015	Glushakov, Alexander V/0000-0003-2872-8960; Dore, Sylvain/0000-0003-3771-5109; Tolosano, Emanuela/0000-0002-1622-2340	McKnight Brain Research Foundation; Brain and Spinal Cord Injury Research Trust Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS046400, R01AT007429]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046400] Funding Source: NIH RePORTER	This work was supported by a grant from the McKnight Brain Research Foundation, Brain and Spinal Cord Injury Research Trust Lund (SD) and grants from the National Institutes of Health NS046400 and R01AT007429 (SD). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Aminmansour B, 2009, J RES MED SCI, V14, P343; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; AUER L, 1978, ACTA NEUROCHIR, V42, P229, DOI 10.1007/BF01405338; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bhasin RR, 2002, ACTA NEUROCHIR SUPPL, V81, P249; Borsody M, 2006, NEUROLOGY, V66, P634, DOI 10.1212/01.wnl.0000200781.62172.1d; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Chamoun V, 2001, J NEUROL SCI, V182, P117, DOI 10.1016/S0022-510X(00)00461-5; Chen RL, 2011, BIOMARK MED, V5, P837, DOI [10.2217/BMM.11.89, 10.2217/bmm.11.89]; Chen WH, 1998, EXP EYE RES, V67, P83, DOI 10.1006/exer.1998.0494; DArmiento J, 1997, GENE, V195, P19, DOI 10.1016/S0378-1119(97)00123-6; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Galea J, 2012, J NEUROCHEM, V121, P785, DOI 10.1111/j.1471-4159.2012.07716.x; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Glushakov AV, 2015, J TRAUMA CARE, V1, P1007; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; HOJ L, 1984, ACTA PATH MICRO IM C, V92, P129; Kalanuria A, 2013, NEUROSURG CLIN N AM, V24, P441, DOI 10.1016/j.nec.2013.02.005; Kantor E, 2014, J NEUROSURG, V120, P386, DOI 10.3171/2013.10.JNS13219; Keep RF, 2008, ACT NEUR S, V105, P73; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Kordestani RK, 1997, NEUROSURGERY, V41, P351, DOI 10.1097/00006123-199708000-00003; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Leclerc JL, 2015, P NATL ACAD SCI USA, V112, P1155, DOI 10.1073/pnas.1412833112; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Lee P, 2012, EXP NEUROL, V234, P50, DOI 10.1016/j.expneurol.2011.12.016; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; McIntosh TK, 1996, LAB INVEST, V74, P315; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P194; Nakamura T, 2005, BRAIN RES, V1039, P30, DOI 10.1016/j.brainres.2005.01.036; NONAKA T, 1979, Neurologia Medico-Chirurgica, V19, P53, DOI 10.2176/nmc.19.53; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Schaer DJ, 2005, EUR J HAEMATOL, V74, P6, DOI 10.1111/j.1600-0609.2004.00318.x; Schaer DJ, 2007, ANTIOXID REDOX SIGN, V9, P991, DOI 10.1089/ars.2007.1576; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vejda S, 2002, MOL CELL PROTEOMICS, V1, P387, DOI 10.1074/mcp.M200004-MCP200; WADA T, 1970, J RETICULOENDOTH SOC, V8, P185; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Yang SG, 2013, J NEUROSCI RES, V91, P230, DOI 10.1002/jnr.23159; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038; Zhao XR, 2011, ACTA NEUROCHIR SUPPL, V111, P107, DOI 10.1007/978-3-7091-0693-8_17; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009	74	8	8	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-889X		FRONT MOL BIOSCI	Front. Mol. Biosci.		2016	3								34	10.3389/fmolb.2016.00034			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VH8CX	WOS:000455328600034	27486583	gold, Green Published			2022-02-06	
J	Greiss, C; Yonclas, PP; Jasey, N; Lequerica, A; Ward, I; Chiaravalloti, N; Felix, G; Dabaghian, L; Livingston, DH				Greiss, Christine; Yonclas, Peter P.; Jasey, Neil; Lequerica, Anthony; Ward, Irene; Chiaravalloti, Nancy; Felix, Gabriel; Dabaghian, Laurie; Livingston, David H.			Presence of a dedicated trauma center physiatrist improves functional outcomes following traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						TBI; rehabilitation; physiatrist; functional outcomes; neurostimulant	HEAD-INJURY; REHABILITATION; METHYLPHENIDATE; ORIENTATION	BACKGROUND Maximizing long-term recovery following traumatic brain injury (TBI) is an important end point. We hypothesized that the addition of a dedicated physiatrist specializing in brain injury medicine to the trauma team would lead to improved functional outcomes. METHODS Data from the Northern NJ TBI Model Systems were queried for all patients admitted to rehabilitation from four regional trauma centers, one with a full-time TBI physiatrist (PHYS) and three without (NO-PHYS). Patient demographics, mechanism of injury, Glasgow Coma Scale (GCS) score, length of posttraumatic amnesia, length of stay, and Functional Independence Measure (FIM) were abstracted. TBI severity was determined by GCS score and length of posttraumatic amnesia. FIM motor and cognitive scores at rehabilitation admission and discharge were the primary outcome measure. TBI medications (stimulants, sleep, and neurodepressants) administered in acute care were reviewed to evaluate prescription patterns. RESULTS A total of 148 patients treated at four trauma centers and discharged to a single acute inpatient rehabilitation center between 2005 to 2013 were divided into two groups, PHYS with 44 patients and NO-PHYS with 104 patients. Compared with those in the NO-PHYS group, patients from the PHYS group had significant improvement in FIM motor and cognitive scores (p < 0.05). Prescription patterns differed. Patients from the PHYS group received significantly more neurostimulants (p < 0.001) and sleep medications (p = 0.02) compared with the NO-PHYS group. Analysis of covariance was conducted to examine FIM (motor and cognitive) changes from rehabilitation admission to discharge based on medications initiated in acute care. Those who received neither a neurostimulant nor a sleep medication had significantly lower FIM motor scores compared with those who received at least one of these medications (p = 0.047) and compared with those who received both types of medication (p = 0.17). No significant differences were found in FIM cognitive scores. CONCLUSION The addition of a dedicated physiatrist providing early specialized care to patients who sustained a moderate or severe TBI was associated with improved functional outcomes upon discharge from rehabilitation. The presence of a dedicated trauma center physiatrist, trained in TBI rehabilitation, was also associated with a change in neuroprotective medication management in the acute care setting.	[Greiss, Christine; Dabaghian, Laurie] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, DE USA; [Yonclas, Peter P.; Livingston, David H.] Rutgers New Jersey Med Sch, Dept Surg, Newark, DE USA; [Greiss, Christine] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, W Orange, NJ 07052 USA; [Jasey, Neil; Lequerica, Anthony; Ward, Irene; Chiaravalloti, Nancy; Felix, Gabriel] Kessler Inst Rehabil, W Orange, NJ USA		Greiss, C (corresponding author), JFK Johnson Rehabil Inst, 65 James St, Edison, NJ 08820 USA.	cgreiss@gmail.com		Chiaravalloti, Nancy/0000-0003-2943-7567			Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Perna R, 2004, J HEAD TRAUMA REHAB, V19, P516, DOI 10.1097/00001199-200411000-00009; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rotondo Micharel F., 2014, RESOURCES OPTIMAL CA, P1; Stahl S, 2010, STAHLS ESSENTIAL PHA; US Department of Health and Human Service, 1999, TRAUM BRAIN INJ US R; US Department of Health and Human Services Centers for Disease Control and Prevention, 1997, MORBIDITY MORTALITY; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Zasler N. D., 2012, BRAIN INJURY MED PRI	21	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2016	80	1					70	75		10.1097/TA.0000000000000890			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	DA1GN	WOS:000367544400010	26491804				2022-02-06	
J	Hanks, RA; Jackson, AM; Crisanti, LK				Hanks, Robin A.; Jackson, Andrea M.; Crisanti, Lauren K.			Predictive validity of a brief outpatient neuropsychological battery in individuals 1-25 years post traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychological assessment; traumatic brain injury; functional outcomes; rehabilitation; predictive validity	DISABILITY RATING-SCALE; VERBAL-LEARNING TEST; UNITED-STATES; COMMUNITY INTEGRATION; FUNCTIONAL OUTCOMES; HEAD-INJURY; FOLLOW-UP; PRODUCTIVITY; 1-YEAR; SUPERVISION	Objective: The purpose of this research was to examine the predictive validity of a brief, outpatient neuropsychological battery relative to concurrent functional outcomes 1-25years post traumatic brain injury. Method: A cross-sectional analysis from an archival database. Participants were 377 persons aged 16-85, 1-25years post mild-complicated to severe traumatic brain injury. Neuropsychological testing and outcome assessment were completed as part of a routine follow-up associated with enrollment in the Southeastern Michigan Traumatic Brain Injury System project, which is a longitudinal research project. Neuropsychological measures included trail making test, California verbal learning test-II (CVLT-II), word generation, Wisconsin card sort testing - 64 card version, digit vigilance test, and Wechsler test of adult reading (WTAR). Outcome measures included the disability rating scale, Glasgow outcome scale-extended, supervisor rating scale, and employment. Results: Multiple regression analyses revealed that although demographic and injury characteristics were predictive of level of disability, level of supervision, and employment, neuropsychological test scores including CVLT-II total score for learning trials 1-5; Trails B, and the WTAR represented independent predictors across all outcome measures. Conclusions: These findings demonstrate the utility of a brief, outpatient battery in prediction of concurrent outcomes up to 25years post injury. Given the difficulty in receiving full reimbursement for neuropsychological assessment services, the data provide needed empirical support for use of more economical and efficient testing.	[Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; [Hanks, Robin A.; Crisanti, Lauren K.] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI 48201 USA; [Jackson, Andrea M.] Univ Windsor, Dept Psychol, Windsor, CT USA		Hanks, RA (corresponding author), Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA.; Hanks, RA (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI 48201 USA.	rhanks@med.wayne.edu					Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benge JF, 2007, BRAIN INJURY, V21, P395, DOI 10.1080/02699050701311091; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Delis D.C., 2000, CALIFORNIA VERBAL LE; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Heaton R., 2000, WISCONSIN CARD SORTI; Kanauss K, 2005, ARCH CLIN NEUROPSYCH, V20, P341, DOI 10.1016/j.acn.2004.09.002; Lewis R, 1979, MANUAL REPEATABLE CO; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Millis S R, 1994, Int J Neurosci, V79, P165; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Neese LE, 2000, BRAIN INJURY, V14, P719; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Teasdale G. M., 1998, J NEUROTRAUM, V29, P1126; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WechslerD, 2001, WECHSLER TEST ADULT; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	44	8	8	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	7					1074	1086		10.1080/13854046.2016.1194479			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DY9FU	WOS:000385440100010	27270111				2022-02-06	
J	Hsieh, JT; Lei, BL; Sheng, HX; Venkatraman, T; Lascola, CD; Warner, DS; James, ML				Hsieh, Justin T.; Lei, Beilei; Sheng, Huaxin; Venkatraman, Talagnair; Lascola, Christopher D.; Warner, David S.; James, Michael L.			Sex-Specific Effects of Progesterone on Early Outcome of Intracerebral Hemorrhage	NEUROENDOCRINOLOGY			English	Article						Intracerebral hemorrhage; Stroke; Progesterone; Sex difference; Cerebral edema; Neuroinflammation; Cytokines; Rat; Neurobehavioral recovery; Magnetic resonance imaging	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; NECROSIS-FACTOR-ALPHA; FEMALE RATS; INFLAMMATORY RESPONSE; FUNCTIONAL DEFICITS; SERUM PROGESTERONE; CONTUSION INJURY; STROKE SUBTYPES; ISCHEMIC-STROKE	Background: Preclinical evidence suggests that progesterone improves recovery after intracerebral hemorrhage (ICH); however, gonadal hormones have sex-specific effects. Therefore, an experimental model of ICH was used to assess recovery after progesterone administration in male and female rats. Methods: ICH was induced in male and female Wistar rats via stereotactic intrastriatal injection of clostridial collagenase (0.5 U). Animals were randomized to receive vehicle or 8 mg/kg progesterone intraperitoneally at 2 h, then subcutaneously at 5, 24, 48, and 72 h after injury. Outcomes included relevant physiology during the first 3 h, hemorrhage and edema evolution over the first 24 h, proinflammatory transcription factor and cytokine regulation at 24 h, rotarod latency and neuroseverity score over the first 7 days, and microglial activation/macrophage recruitment at 7 days after injury. Results: Rotarod latency (p = 0.001) and neuroseverity score (p = 0.01) were improved in progesterone-treated males, but worsened in progesterone-treated females (p = 0.028 and p = 0.008, respectively). Progesterone decreased cerebral edema (p = 0.04), microglial activation/macrophage recruitment (p < 0.001), and proinflammatory transcription factor phosphorylated nuclear factor-kappa B p65 expression (p = 0.0038) in males but not females, independent of tumor necrosis factor-alpha, interleukin-6, and toll-like receptor-4 expression. Cerebral perfusion was increased in progesterone-treated males at 4 h (p = 0.043) but not 24 h after injury. Hemorrhage volume, arterial blood gases, glucose, and systolic blood pressure were not affected. Conclusions: Progesterone administration improved early neurobehavioral recovery and decreased secondary neuroinflammation after ICH in male rats. Paradoxically, progesterone worsened neurobehavioral recovery and did not modify neuroinflammation in female rats. Future work should isolate mechanisms of sex-specific progesterone effects after ICH. (C) 2015 S. Karger AG, Basel	[Hsieh, Justin T.] Duke Natl Univ Singapore, Grad Sch Med, 8 Coll Rd, Singapore 169857, Singapore; [Hsieh, Justin T.; Lei, Beilei; Sheng, Huaxin; Venkatraman, Talagnair; Lascola, Christopher D.; Warner, David S.; James, Michael L.] Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC USA; [Lei, Beilei; Sheng, Huaxin; Warner, David S.; James, Michael L.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC USA; [Venkatraman, Talagnair; Lascola, Christopher D.] Duke Univ, Med Ctr, Dept Radiol Neuroradiol, Durham, NC USA; [Warner, David S.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC USA; [Warner, David S.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [James, Michael L.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA		Hsieh, JT (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, 8 Coll Rd, Singapore 169857, Singapore.	Justin.hsieh@u.duke.nus.edu	Lascola, Christopher D/B-9126-2017; James, Michael L./AAJ-5592-2020	Lascola, Christopher D/0000-0002-8031-782X; James, Michael L./0000-0002-8715-5210; Hsieh, Justin/0000-0002-9701-0998			Aguirre C, 2010, J NEUROCHEM, V115, P1277, DOI 10.1111/j.1471-4159.2010.07038.x; Aguirre CC, 2009, EUR J NEUROSCI, V29, P447, DOI 10.1111/j.1460-9568.2008.06591.x; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Askew D, 1996, GLIA, V18, P118, DOI 10.1002/(SICI)1098-1136(199610)18:2<118::AID-GLIA4>3.0.CO;2-X; Balla DZ, 2014, J PHARMACOL TOX MET, V70, P35, DOI 10.1016/j.vascn.2014.03.003; Baudry M, 2013, NEUROSCIENCE, V239, P280, DOI 10.1016/j.neuroscience.2012.10.051; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; BROWNGRA.K, 1970, J ENDOCRINOL, V48, P295, DOI 10.1677/joe.0.0480295; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Chang CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/207616; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Chen Z, 2011, ACTA NEUROCHIR SUPPL, V111, P289, DOI 10.1007/978-3-7091-0693-8_48; Chisholm N. C., 2015, NEUROBIOL DIS; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Ishikawa S, 2008, J EPIDEMIOL, V18, P144, DOI 10.2188/jea.JE2007438; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Lei B, 2014, JOVE-J VIS EXP, V89; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Li Y, 2013, BEHAV BRAIN RES, V256, P520, DOI 10.1016/j.bbr.2013.09.002; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu GP, 1996, MICROVASC RES, V51, P393, DOI 10.1006/mvre.1996.0035; Luheshi NM, 2009, TRAFFIC, V10, P16, DOI 10.1111/j.1600-0854.2008.00840.x; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P9, DOI 10.1007/978-3-7091-0693-8_2; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; MILLER AE, 1980, ENDOCRINOLOGY, V106, P1579, DOI 10.1210/endo-106-5-1579; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ratilal BO, 2014, J NEUROSURG, V121, P55, DOI 10.3171/2014.2.JNS132197; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; SUBRAMANIAN M, 1993, NEUROSCI LETT, V155, P151, DOI 10.1016/0304-3940(93)90695-H; Thrift AG, 2009, NEUROEPIDEMIOLOGY, V32, P11, DOI 10.1159/000170086; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Tveiten A, 2012, EUR NEUROL, V67, P240, DOI 10.1159/000336299; Umeano O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081664; Vaartjes I, 2009, CEREBROVASC DIS, V28, P564, DOI 10.1159/000247600; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner I, 2012, EUR J NEUROL, V19, P1477, DOI 10.1111/j.1468-1331.2011.03628.x; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Woo D, 2004, STROKE, V35, P1703, DOI 10.1161/01.STR.0000130855.70683.c8; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Young AMH, 2012, CURR DRUG SAF, V7, P202, DOI 10.2174/157488612803251261; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046	93	8	8	1	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2016	103	5					518	530		10.1159/000440883			13	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	DV6OL	WOS:000383056200010	26356626				2022-02-06	
J	Krings, M; Hollig, A; Liu, JJ; Grusser, L; Rossaint, R; Coburn, M				Krings, Matthias; Hoellig, Anke; Liu, Jingjin; Gruesser, Linda; Rossaint, Rolf; Coburn, Mark			Desflurane impairs outcome of organotypic hippocampal slices in an in vitro model of traumatic brain injury	MEDICAL GAS RESEARCH			English	Article						desflurane; neuroprotection; traumatic brain injury; organotypic hippocampal slices	CEREBRAL-ISCHEMIA; VOLATILE ANESTHETICS; NEONATAL EXPOSURE; SEVOFLURANE; ISOFLURANE; RAT; NEUROPROTECTION; CULTURES; NEUROTOXICITY; DEFICITS	Decreased mortality and disability after traumatic brain injury is a significant medical challenge. Desflurane, a widely used volatile anesthetic has proven to be neuroprotective in a variety of in vitro and in vivo models of ischemic brain injury. The aim of this study was to investigate whether desflurane exhibits neuroprotective properties in an in vitro model of traumatic brain injury. Organotypic hippocampal slice cultures were prepared from brains of 5-7-day-old C57/BL6 mouse pups. After 14 days of culture, the slices were subjected to a focal mechanical trauma and thereafter incubated with three different concentrations of desflurane (2, 4 and 6%) for 2, 24 and 72 hours. Cell injury was assessed with propodium iodide uptake. Our results showed that after 2 hours of desflurane exposure, no significant change in trauma intensity was observed. However, 2% and 4% desflurane could reduce the trauma intensity significantly in the no trauma group than in the no desflurane and trauma group. Incubation with 4% desflurane for 24 hours doubled the trauma intensity in comparison to the trauma control group and the trauma intensity further increased after 72 hours of incubation. Furthermore, a dose-dependent increase of trauma intensity after 24 hours exposure was observed. Our results suggest that a general neuroprotective attribute of desflurane in an in vitro model of traumatic brain injury was not observed.	[Krings, Matthias; Liu, Jingjin; Gruesser, Linda; Rossaint, Rolf; Coburn, Mark] RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany; [Hoellig, Anke] RWTH Aachen Univ Hosp, Dept Neurosurg, Aachen, Germany		Coburn, M (corresponding author), RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany.	mcoburn@ukaachen.de			Baxter Healthcare Corporation	The project was partly supported by a grant from Baxter Healthcare Corporation.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; Brosnan H, 2013, ANESTHESIOLOGY, V119, P335, DOI 10.1097/ALN.0b013e31829417f0; Cao L, 2014, NEURAL REGEN RES, V9, P1897, DOI 10.4103/1673-5374.145357; Culley DJ, 2011, ANESTHESIOLOGY, V115, P754, DOI 10.1097/ALN.0b013e318223b78b; Erdem AF, 2005, SAUDI MED J, V26, P1424; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Haelewyn B, 2003, BRIT J ANAESTH, V91, P390, DOI 10.1093/bja/aeg186; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kodama M, 2011, ANESTHESIOLOGY, V115, P979, DOI 10.1097/ALN.0b013e318234228b; Liu JJ, 2014, EUR J ANAESTH, V31, P669, DOI 10.1097/EJA.0000000000000073; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Matchett GA, 2009, NEUROL RES, V31, P128, DOI 10.1179/174313209X393546; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Sanders RD, 2013, BRIT J ANAESTH, V110, P53, DOI 10.1093/bja/aet054; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stratmann G, 2011, ANESTH ANALG, V113, P1170, DOI 10.1213/ANE.0b013e318232066c; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Wang CB, 2007, BRAIN RES, V1152, P201, DOI 10.1016/j.brainres.2007.03.030; Wenker O, 1999, INTERNET J ANESTHESI, V3, P3; Wise-Faberowski L, 2005, ANESTH ANALG, V101, P651, DOI 10.1213/01.ane.0000167382.79889.7c; Wise-Faberowski L, 2013, BRAIN INJURY, V27, P444, DOI 10.3109/02699052.2012.750755; Yu Qiong, 2010, Front Biosci (Elite Ed), V2, P1275; Zhang B, 2012, ANESTH ANALG, V114, P410, DOI 10.1213/ANE.0b013e31823b2602	38	8	9	1	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	JAN-MAR	2016	6	1					3	9		10.4103/2045-9912.179338			7	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	DJ4ML	WOS:000374179600002	27826417	Green Published			2022-02-06	
J	Lepka, K; Berndt, C; Hartung, HP; Aktas, O				Lepka, Klaudia; Berndt, Carsten; Hartung, Hans-Peter; Aktas, Orhan			Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						antioxidants; clinical trials; multiple sclerosis; redox signaling; oxidative stress	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS; AXONAL DEGENERATION; NITRIC-OXIDE; GLUTATHIONE; BRAIN; INFLAMMATION; MECHANISMS; TARGET	Neuroinflammation in the central nervous system (CNS) is characterized by increased production of chemokines and cytokines, altered integrity of the blood-brain-barrier, influx of leukocytes as well as the activation of microglia and astroglia. Although not all characteristics are present under the following conditions, stimuli eliciting a neuroinflammatory response can be toxins, infections, autoimmune reactions, traumatic injury, psychological stress, and epileptic seizures (Vezzani et al., 2011; Barnum et al., 2012; Xanthos and Sandkuhler, 2014). Further, neuroinflammation has been linked to mechanisms of disease and clinical outcomes in neurodegenerative disorders like Alzheimer's and Parkinson's disease (Amor et al., 2010). In the following, we will mainly concentrate on Multiple Sclerosis (MS) as the prototype for an autoimmune inflammatory and degenerative disorder of the CNS. According to our current understanding, the immunopathogenesis of MS is as heterogeneous as its dinical manifestations and course and may be mediated by myelin-reactive T lymphocytes, leading to oligodendroglial cell death and demyelination, as well as to bystander axonal degeneration, neuronal loss and, finally, gliosis (Hartung et al., 2014). B cells may have a fundamental role in presenting antigens to T cells and as a consequence trigger an aberrant T cell response. Moreover, upon differentiation into plasmablasts and plasma cells that manufacture antibodies (Yuseff et al., 2013; Nutt et al., 2015), they may induce demyelination through antibody-mediated complement activation (Holers, 2014). Of note, while remyelination may occur in early stages of disease, regeneration is severely compromised as the disease progresses (Kremer et al., 2016). However, the etiology and cause for disease progression and failure of recovery remain largely elusive. Regarding possible factors, reactive oxygen (ROS), and nitrogen species (RNS) have attracted increasing interest in the last two decades. Focusing on MS we will discuss the role of ROS and RNS in disease onset and progression of this disabling disease and further emphasize the role of specific redox signaling modulating protein activity and its underestimated role in the development of new therapeutic agents.	[Lepka, Klaudia; Berndt, Carsten; Hartung, Hans-Peter; Aktas, Orhan] Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany		Berndt, C; Aktas, O (corresponding author), Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany.	carsten.berndt@hhu.de; orhan.aktas@hhu.de	Aktas, Orhan/B-7623-2009; Berndt, Carsten/X-6260-2018	Aktas, Orhan/0000-0002-2020-9210; Berndt, Carsten/0000-0001-8583-7966	Walter und Ilse Rose-Stiftung; James and Elisabeth Cloppenburg Stiftung; German Research foundation (priority program 1710); Heinrich-Heine-University graduate school iBrain; Ilselore Luckow Stiftung	Our research is funded by the Walter und Ilse Rose-Stiftung, the lames and Elisabeth Cloppenburg Stiftung, the Ilselore Luckow Stiftung, the German Research foundation (priority program 1710), and the Heinrich-Heine-University graduate school iBrain.	Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Barnum CJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-9; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Berndt C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00168; Brautigam L, 2011, P NATL ACAD SCI USA, V108, P20532, DOI 10.1073/pnas.1110085108; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Buendia I, 2016, PHARMACOL THERAPEUT, V157, P84, DOI 10.1016/j.pharmthera.2015.11.003; CALABRESE V, 1994, INT J CLIN PHARM RES, V14, P119; Campbell GR, 2014, MULT SCLER J, V20, P1806, DOI 10.1177/1352458514544537; Carvalho AN, 2014, MULT SCLER J, V20, P1425, DOI 10.1177/1352458514533400; Carvalho AN, 2017, CURR DRUG TARGETS, V18, P705, DOI 10.2174/1389450117666160401120514; Chiurchiu V, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7909380; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dubey D, 2015, EXPERT REV NEUROTHER, V15, P339, DOI 10.1586/14737175.2015.1025755; Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fox EJ, 2006, CLIN THER, V28, P461, DOI 10.1016/j.clinthera.2006.04.013; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Haider L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/725370; HALL ED, 1992, ANN NEUROL, V32, pS137, DOI 10.1002/ana.410320724; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; HANSEN LA, 1995, J NEUROIMMUNOL, V62, P69, DOI 10.1016/0165-5728(95)00104-A; Hartung HP, 2014, HAND CLINIC, V122, P3, DOI 10.1016/B978-0-444-52001-2.00001-7; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Holley JE, 2007, MULT SCLER, V13, P955, DOI 10.1177/1352458507078064; Ingwersen J, 2016, NEUROTHERAPEUTICS, V13, P47, DOI 10.1007/s13311-015-0412-4; Ingwersen J, 2012, CLIN IMMUNOL, V142, P15, DOI [10.1016/j.clim.2011.05.005, 10.1016/j.clim.2011.10.008]; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Kremer D, 2016, TRENDS NEUROSCI, V39, P246, DOI 10.1016/j.tins.2016.02.004; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Aon-Bertolino ML, 2011, BBA-GEN SUBJECTS, V1810, P93, DOI 10.1016/j.bbagen.2010.06.011; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Licht-Mayer S, 2015, ACTA NEUROPATHOL, V130, P263, DOI 10.1007/s00401-015-1452-x; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Nijland PG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0170-2; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Ohl K, 2016, EXP NEUROL, V277, P58, DOI 10.1016/j.expneurol.2015.11.010; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Petratos S, 2010, J NEUROPATH EXP NEUR, V69, P323, DOI 10.1097/NEN.0b013e3181d60ddb; Prozorovski T, 2015, BBA-GEN SUBJECTS, V1850, P1543, DOI 10.1016/j.bbagen.2015.01.022; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Sies H., 2007, ENCY STRESS, P47; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Socha K, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-62; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617; Yun HM, 2015, ONCOTARGET, V6, P20875, DOI 10.18632/oncotarget.5205; Yuseff MI, 2013, NAT REV IMMUNOL, V13, P475, DOI 10.1038/nri3469; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	57	8	8	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.		2016	4								63	10.3389/fcell.2016.00063			5	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	VH8AH	WOS:000455229700063	27446915	Green Published, gold			2022-02-06	
J	Lexell, J; Wihlney, AK; Jacobsson, LJ				Lexell, J.; Wihlney, A. -K.; Jacobsson, L. J.			Vocational outcome 6-15 years after a traumatic brain injury	BRAIN INJURY			English	Article						Brain injuries; employment; long-term outcome; occupations; rehabilitation; vocational	PORTLAND ADAPTABILITY INVENTORY; REACTION-LEVEL-SCALE; QUALITY-OF-LIFE; TERM-FOLLOW-UP; NORTHERN SWEDEN; SUPPORTED EMPLOYMENT; HEAD-INJURY; REHABILITATION; WORK; DISABILITY	Primary objective: To describe vocational outcome 6-15 years after a traumatic brain injury (TBI) among individuals who were productive by working or studying at the time of their TBI and determine the associations with variables related to the time of injury and at follow-up.Methods and procedures: Thirty-four individuals with a mild TBI and 45 with a moderate-to-severe TBI were assessed on average 10 years post-injury. Logistic regression was used to determine the association between their current vocational situation and variables related to the time of injury (gender, age, injury severity and educational level) and at follow-up (time since injury, marital status and overall disability).Results: A total of 67% were productive at follow-up. Age at injury, injury severity and the degree of disability at follow-up were strongly associated with being productive. Younger individuals with milder TBI and less severe disability were significantly more likely to be fully productive. No significant associations were found between productivity and gender, education, time since injury or marital status.Conclusions: This study indicates that return to productivity in a long-term perspective after a TBI is possible, in particular when the individual is young, has sustained a mild TBI and has a milder form of overall disability.	[Lexell, J.; Wihlney, A. -K.; Jacobsson, L. J.] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lexell, J.] Skane Univ Hosp, Dept Neurol & Rehabil Med, Lund, Sweden; [Lexell, J.; Jacobsson, L. J.] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden; [Jacobsson, L. J.] Sunderby Hosp, Dept Rehabil Med, Lulea, Sweden		Lexell, J (corresponding author), Lund Univ, Dept Hlth Sci, Rehabil Med Res Grp, S-22100 Lund, Sweden.	jan.lexell@med.lu.se			Norrbotten County Council	The authors report no conflicts of interest. This work was supported by a research grant from Norrbotten County Council.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Eker C, 2000, BRAIN INJURY, V14, P605; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jacobsson L, 2013, J REHABIL MED, V45, P1010, DOI 10.2340/16501977-1204; Johansson U, 2001, DISABIL REHABIL, V23, P474; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; KIM JA, 1997, OCCUPATIONAL THERAPY, V4, P178; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Lexell J, 2012, J REHABIL MED, V44, P65, DOI 10.2340/16501977-0897; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; SCHALEN W, 1994, BRAIN INJURY, V8, P37, DOI 10.3109/02699059409150957; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	39	8	8	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	8					969	974		10.3109/02699052.2016.1148196			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DS6OP	WOS:000380901800004	27185082				2022-02-06	
J	Lippa, SM; Axelrod, BN; Lange, RT				Lippa, Sara M.; Axelrod, Bradley N.; Lange, Rael T.			The Mild Brain Injury Atypical Symptoms (mBIAS) scale in a mixed clinical sample	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Symptom validity; Diagnosis; Exaggeration; Military	REPORTED SYMPTOMS; VALIDITY SCALES; SERVICE MEMBERS; EXAGGERATION; UTILITY; MMPI-2; PERFORMANCE; COMPLAINTS; DISORDERS; INVENTORY	Introduction: The Mild Brain Injury Atypical Symptoms (mBIAS) scale was developed as a symptom validity test (SVT) for use with patients following mild traumatic brain injury. This study was the first to examine the clinical utility of the mBIAS in a mixed clinical sample presenting to a Department of Veterans Affairs (VA) neuropsychology clinic. Method: Participants were 117 patients with mixed etiologies (85.5% male; age: M = 39.2 years, SD = 11.6) from a VA neuropsychology clinic. Participants were divided into pass/fail groups using two different SVT criteria, based on select validity scales from the Minnesota Multiphasic Personality Inventory-2 (MMPI-2): first, Infrequency Scale (F) scores: (a) MMPI-F-Fail (n = 21) and (b) MMPI-F-Pass (n = 96); and, second, Symptom Validity Scale (FBS) scores: (a) MMPI-FBS-Fail (n = 36) and (b) MMPI-FBS-Pass (n = 81). Results: The mBIAS demonstrated good internal consistency, and each item contributed meaningfully to the total score. At a symptom exaggeration base rate of 35%, an mBIAS cutoff of 11 was optimal for screening symptom exaggeration when groups were classified using both F and FBS scales. This cutoff score resulted in very high specificity (.89 to .94); moderate-high positive predictive power (.71 to .75) and negative predictive power (.72 to .79); and low-moderate sensitivity (.31 to .57). At all base rates of probable somatic exaggeration, a cutoff of 16 resulted in perfect specificity and positive predictive power, but very low sensitivity. Conclusions: The mBIAS has potential for use in samples outside of mild traumatic brain injury. In settings where the symptom exaggeration base rate is 35%, a cutoff of 11 may be used as a red flag for further evaluation, but should not be relied on for clinical decision making. At all base rates of probable somatic exaggeration, psychologists with patients who score 16 can be confident that those patients were exaggerating. Importantly, however, this cutoff may fail to identify a large proportion of patients who are exaggerating.	[Lippa, Sara M.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Lippa, Sara M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lippa, Sara M.; Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Axelrod, Bradley N.] Vet Affairs Med Ctr, John D Dingell Dept, Detroit, MI USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19,Room 6009,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	sara.lippa.ctr@mail.mil					Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J, 1989, MANUAL ADM SCORING M; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Henry GK, 2009, CLIN NEUROPSYCHOL, V23, P153, DOI 10.1080/13854040801969524; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Morey LC., 1990, PERSONALITY ASSESSME; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; ROGERS R, 1992, J CLIN PSYCHOL, V48, P643; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Tellegen, 2008, MINNESOTA MULTIPHASI; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Widows M. R., 2005, STRUCTURED INVENTORY	22	8	8	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2016	38	7					721	729		10.1080/13803395.2016.1161732			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO5IT	WOS:000377817500001	27159359				2022-02-06	
J	Matuseviciene, G; Eriksson, G; DeBoussard, CN				Matuseviciene, Giedre; Eriksson, Gunilla; DeBoussard, Catharina Nygren			NO EFFECT OF AN EARLY INTERVENTION AFTER MILD TRAUMATIC BRAIN INJURY ON ACTIVITY AND PARTICIPATION: A RANDOMIZED CONTROLLED TRIAL	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; concussion; intervention; outcome; activity; participation; quality of life; sick leave	POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; HEAD-INJURY; POSTTRAUMATIC-STRESS; OCCUPATIONAL GAPS; SEX-DIFFERENCES; HEALTH SURVEY; FOLLOW-UP; QUESTIONNAIRE; DISABILITY	Objective: To evaluate measures of activity, participation and quality of life 3 months after mild traumatic brain injury and the effect of an early intervention for patients with an estimated high risk for problems after mild traumatic brain injury. Patients: Consecutive patients attending the emergency room with mild traumatic brain injury. Design: Randomized controlled trial. Methods: Patients reporting <3 symptoms after 10 days were considered to have a low risk for prolonged problems. Patients with >= 3 symptoms (high-risk patients) were randomized to a visit to a physician or treatment-as-usual. Data on self-reported limitations in activity, restrictions in participation, and quality of life were collected for all patients at 3 months. Results: At 3 months post-injury, low-risk patients reported good quality of life and significantly fewer problems in everyday life compared with high-risk patients. The intervention had no effect on activity, participation or quality of life. Conclusion: Patients who report few symptoms early after mild traumatic brain injury are likely to have a good outcome regarding activity and participation. The intervention offered in this study, focusing on reassurance of a good outcome and treatment of comorbidities, had no effect.	[Matuseviciene, Giedre; DeBoussard, Catharina Nygren] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Matuseviciene, Giedre; DeBoussard, Catharina Nygren] Danderyd Hosp, Dept Rehabil Med, SE-18288 Stockholm, Sweden; [Eriksson, Gunilla] Karolinska Inst, Div Occupat Therapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Eriksson, Gunilla] Uppsala Univ, Dept Neurosci Rehabil Med, Uppsala, Sweden		Matuseviciene, G (corresponding author), Danderyd Hosp, Dept Rehabil Med, SE-18288 Stockholm, Sweden.	giedre.matuseviciene@ds.se			AFA Insurance; ALF-grants from Danderyd Hospital	The authors would like to thank the patients, SIC study collaborators in Uppsala, Gothenburg, Umea and Jonkoping, and colleagues in the emergency room for enabling recruitment of their patients. This study was supported by a grant from AFA Insurance. The funders had no access to the data and provided no input to the study design or data analysis. GM and CNB received support from ALF-grants from Danderyd Hospital. The authors thank Seija Lund and Sandra Hallstrom, nurses and coordinators, and Lisbet Broman for all help with tables, figures and advice on statistical aspects. We also thank Professor Jorgen Borg for valuable support.	Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Cancelliere C, 2015, ARCH PHYS MED REHABI; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Eriksson G, 2013, SCAND J OCCUP THER, V20, P152, DOI 10.3109/11038128.2012.749944; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Health Organization, 1992, THE ICD 10 CLASSIFIC	36	8	8	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JAN	2016	48	1					19	26		10.2340/16501977-2025			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DE0IF	WOS:000370307600004	26536843	Green Submitted, gold			2022-02-06	
J	Naylor, JC; Kilts, JD; Szabo, ST; Dunn, CE; Keefe, FJ; Tupler, LA; Shampine, LJ; Morey, RA; Strauss, JL; Hamer, RM; Wagner, HR; Marx, CE				Naylor, Jennifer C.; Kilts, Jason D.; Szabo, Steven T.; Dunn, Charlotte E.; Keefe, Francis J.; Tupler, Larry A.; Shampine, Lawrence J.; Morey, Rajendra A.; Strauss, Jennifer L.; Hamer, Robert M.; Wagner, H. Ryan; Marx, Christine E.		MIRECC Workgrp	Allopregnanolone Levels Are Inversely Associated with Self-Reported Pain Symptoms in US Iraq and Afghanistan-Era Veterans: Implications for Biomarkers and Therapeutics	PAIN MEDICINE			English	Article						Allopregnanolone; Pain; GABA; Veteran; Neurosteroid	TRAUMATIC BRAIN-INJURY; EMOTION REGULATION NEUROCIRCUITS; STEROID-HORMONE METABOLITES; NEUROSTEROID ALLOPREGNANOLONE; PREFRONTAL CORTEX; NEUROPATHIC PAIN; GABA RECEPTOR; CELL-DEATH; C DISEASE; IN-VIVO	Background and Objectives. Pain symptoms are common among Iraq/Afghanistan-era veterans, many of whom continue to experience persistent pain symptoms despite multiple pharmacological interventions. Preclinical data suggest that neurosteroids such as allopregnanolone demonstrate pronounced analgesic properties, and thus represent logical biomarker candidates and therapeutic targets for pain. Allopregnanolone is also a positive GABAA receptor modulator with anxiolytic, anticonvulsant, and neuroprotective actions in rodent models. We previously reported inverse associations between serum allopregnanolone levels and self-reported pain symptom severity in a pilot study of 82 male veterans. Methods. The current study investigates allopregnanolone levels in a larger cohort of 485 male Iraq/Afghanistan-era veterans to attempt to replicate these initial findings. Pain symptoms were assessed by items from the Symptom Checklist-90-R (SCL-90-R) querying headache, chest pain, muscle soreness, and low back pain over the past 7 days. Allopregnanolone levels were quantified by gas chromatography/mass spectrometry. Results. Associations between pain ratings and allopregnanolone levels were examined with Poisson regression analyses, controlling for age and smoking. Bivariate nonparametric Mann-Whitney analyses examining allopregnanolone levels across high and low levels of pain were also conducted. Allopregnanolone levels were inversely associated with muscle soreness [P = 0.0028], chest pain [P = 0.032], and aggregate total pain (sum of all four pain items) [P = 0.0001]. In the bivariate analyses, allopregnanolone levels were lower in the group reporting high levels of muscle soreness [P = 0.001]. Conclusions. These findings are generally consistent with our prior pilot study and suggest that allopregnanolone may function as an endogenous analgesic. Thus, exogenous supplementation with allopregnanolone could have therapeutic potential. The characterization of neurosteroid profiles may also have biomarker utility.	[Naylor, Jennifer C.; Kilts, Jason D.; Szabo, Steven T.; Dunn, Charlotte E.; Tupler, Larry A.; Shampine, Lawrence J.; Morey, Rajendra A.; Strauss, Jennifer L.; Wagner, H. Ryan; Marx, Christine E.] Durham Vet Affairs Med Ctr, Res & Dev Mental Hlth Serv, Durham, NC USA; [Naylor, Jennifer C.; Kilts, Jason D.; Szabo, Steven T.; Keefe, Francis J.; Tupler, Larry A.; Shampine, Lawrence J.; Morey, Rajendra A.; Strauss, Jennifer L.; Wagner, H. Ryan; Marx, Christine E.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Naylor, Jennifer C.; Kilts, Jason D.; Szabo, Steven T.; Dunn, Charlotte E.; Tupler, Larry A.; Shampine, Lawrence J.; Morey, Rajendra A.; Strauss, Jennifer L.; Wagner, H. Ryan; Marx, Christine E.; MIRECC Workgrp] Res Educ & Clin Ctr MIRECC, VISN Mid Atlantic Mental Illness 6, Durham, NC USA; [Hamer, Robert M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Hamer, Robert M.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA		Marx, CE (corresponding author), Durham VA Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	christine.marx@duke.edu	Morey, Rajendra A/P-3079-2018	Morey, Rajendra A/0000-0002-6517-6969	VA Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC); Office of Mental Health Services, Department of Veterans AffairsUS Department of Veterans Affairs; VA Career Development Transition Award; VA Merit Review AwardsUS Department of Veterans Affairs; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [1lK2RX000908]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000908] Funding Source: NIH RePORTER	This work was supported by the VA Mid-Atlantic Mental Illness Research Education and Clinical Center (MIRECC), PI John Fairbank, which is supported by the Office of Mental Health Services, Department of Veterans Affairs. Additional support is from VA Career Development Transition Award (Marx) and VA Merit Review Awards (Marx). Dr. Naylor is supported by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1lK2RX000908).	Afrazi S, 2014, J STEROID BIOCHEM, V139, P98, DOI 10.1016/j.jsbmb.2013.10.010; Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; Aouad M, 2014, EUR J PAIN, V18, P258, DOI 10.1002/j.1532-2149.2013.00367.x; Backstrom T, 2005, EUR J PHARMACOL, V512, P15, DOI 10.1016/j.ejphar.2005.01.049; Bilmes L., 2007, ALL SOC SCI ASS M CH; Charalampopoulos L, 2004, P NATL ACAD SCI USA, V101, P8209, DOI 10.1073/pnas.0306631101; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Emerson DJ, 2013, J AM CHEM SOC, V135, P5389, DOI 10.1021/ja311171u; FRYE CA, 1994, BRAIN RES, V643, P194, DOI 10.1016/0006-8993(94)90025-6; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Ghezzi P, 2000, EUR CYTOKINE NETW, V11, P464; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Institute of Medicine, 2013, RET HOM IQ AFGH ASS; Kavaliers M, 2000, NEUROSCIENCE, V95, P807; Kawano T, 2011, NEUROREPORT, V22, P984, DOI 10.1097/WNR.0b013e32834da80d; Kilts JD, 2010, PAIN MED, V11, P1469, DOI 10.1111/j.1526-4637.2010.00927.x; Korneyev A, 1996, HORM BEHAV, V30, P37, DOI 10.1006/hbeh.1996.0006; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P598, DOI 10.1016/j.pbb.2006.07.026; Marx CE, 2006, PSYCHOPHARMACOLOGY, V186, P462, DOI 10.1007/s00213-005-0226-x; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Mechlin B, 2007, PAIN, V131, P142, DOI 10.1016/j.pain.2006.12.027; Mellon S, 2004, ENDOCR RES, V30, P727, DOI 10.1081/ERC-200044016; Meyer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080915; Meyer L, 2011, PAIN, V152, P170, DOI 10.1016/j.pain.2010.10.015; MOK WM, 1990, BRAIN RES, V533, P42, DOI 10.1016/0006-8993(90)91792-F; MORROW AL, 1987, EUR J PHARMACOL, V142, P483, DOI 10.1016/0014-2999(87)90094-X; Nadeson R, 2001, BRIT J ANAESTH, V86, P704, DOI 10.1093/bja/86.5.704; Noorbakhsh F, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00134; Office of the Army Surgeon General, 2010, PAIN MAN TASK FORC R, P1; Patte-Mensah C, 2010, PAIN, V150, P522, DOI 10.1016/j.pain.2010.06.004; Pinna G, 2003, P NATL ACAD SCI USA, V100, P2035, DOI 10.1073/pnas.0337642100; Scioli-Salter ER, 2015, CLIN J PAIN, V31, P363, DOI 10.1097/AJP.0000000000000115; Sripada RK, 2014, HUM BRAIN MAPP, V35, P3249, DOI 10.1002/hbm.22399; Sripada RK, 2013, NEUROPSYCHOPHARMACOL, V38, P1798, DOI 10.1038/npp.2013.79; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Svensson E, 2013, NEUROSCI LETT, V548, P27, DOI 10.1016/j.neulet.2013.05.027; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; WINFREE CJ, 1992, LIFE SCI, V50, P1007, DOI 10.1016/0024-3205(92)90095-7	48	8	8	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	JAN	2016	17	1					25	32		10.1111/pme.12860			8	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	DI8DD	WOS:000373730500006	26176345	Green Submitted, Bronze			2022-02-06	
J	Noghani, MA; Brooks, DE				Noghani, M. Alizadeh; Brooks, D. E.			Progesterone binding nano-carriers based on hydrophobically modified hyperbranched polyglycerols	NANOSCALE			English	Article							UNIMOLECULAR MICELLES; HEAD-INJURY; BIOLOGICAL EVALUATION; BLOOD COMPATIBILITY; BIOCOMPATIBILITY	Progesterone (Pro) is a potent neurosteroid and promotes recovery from moderate Traumatic Brain Injury but its clinical application is severely impeded by its poor water solubility. Here we demonstrate that reversibly binding Pro within hydrophobically modified hyperbranched polyglycerol (HPG-C-n-MPEG) enhances its solubility, stability and bioavailability. Synthesis, characterization and Pro loading into HPG-C-n-MPEG is described. The release kinetics are correlated with structural properties and the results of Differential Scanning Calorimetry studies of a family of HPG-C-n-MPEGs of varying molecular weight and alkylation. While the maximum amount of Pro bound correlates well with the amount of alkyl carbon per molecule contributing to its hydrophobicity, the dominant first order rate constant for Pro release correlates strongly with the amount of structured or bound water in the dendritic domain of the polymer. The results provide evidence to justify more detailed studies of interactions with biological systems, both single cells and in animal models.	[Noghani, M. Alizadeh; Brooks, D. E.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Noghani, M. Alizadeh; Brooks, D. E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Brooks, D. E.] Univ British Columbia, Dept Chem & Pathol, Vancouver, BC V6T 1Z3, Canada; [Brooks, D. E.] Univ British Columbia, Dept Lab Med, Vancouver, BC V6T 1Z3, Canada		Brooks, DE (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada.; Brooks, DE (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada.; Brooks, DE (corresponding author), Univ British Columbia, Dept Chem & Pathol, Vancouver, BC V6T 1Z3, Canada.; Brooks, DE (corresponding author), Univ British Columbia, Dept Lab Med, Vancouver, BC V6T 1Z3, Canada.	don.brooks@ubc.ca		Brooks, Donald/0000-0002-7946-4320	Discovery Grant from Natural Sciences and Engineering Research Council Canada; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; BC Knowledge Development FundGeneral Electric	We would like to thank Dr Johan Janzen and Irina Chafeeva for their excellent technical assistance, Dr Jay Kizhakkedathu for ongoing discussion and Dr Rajesh Shenoi for helpful advice. We also would like to thank Dr Lawrence Amankwa and Dr Clement Mugabe at Centre for Drug Research and Development at UBC for the outstanding UPLC method they have developed, which we employed for the binding and releasing study. This research was supported by a Discovery Grant to D.E.B. from the Natural Sciences and Engineering Research Council Canada and benefited from infrastructure in the UBC Centre for Blood Research funded by the Canada Foundation for Innovation and the BC Knowledge Development Fund.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Chapanian R, 2012, BIOMATERIALS, V33, P7871, DOI 10.1016/j.biomaterials.2012.07.015; CORKIN S, 1989, J NEUROSCI, V9, P3876; Du CG, 2014, BIOMATERIALS, V35, P1378, DOI 10.1016/j.biomaterials.2013.10.076; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Guthrie DB, 2012, ACS MED CHEM LETT, V3, P362, DOI 10.1021/ml200303r; HAWKER CJ, 1993, J CHEM SOC PERK T 1, P1287, DOI 10.1039/p19930001287; Heise A, 1999, J AM CHEM SOC, V121, P8647, DOI 10.1021/ja984456g; Hong HY, 2007, MACROMOL RAPID COMM, V28, P591, DOI 10.1002/marc.200600752; Jain NK, 2008, EXPERT OPIN DRUG MET, V4, P1035, DOI 10.1517/17425255.4.8.1035 ; Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9; Kainthan RK, 2008, BIOMATERIALS, V29, P1693, DOI 10.1016/j.biomaterials.2007.11.030; Kainthan RK, 2007, BIOMATERIALS, V28, P4779, DOI 10.1016/j.biomaterials.2007.07.046; Kainthan RK, 2008, BIOCONJUGATE CHEM, V19, P2231, DOI 10.1021/bc800090v; Kainthan RK, 2008, BIOMACROMOLECULES, V9, P886, DOI 10.1021/bm701208p; Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011; Kainthan RK, 2006, MACROMOLECULES, V39, P7708, DOI 10.1021/ma0613483; Kainthan RK, 2006, BIOMATERIALS, V27, P5377, DOI 10.1016/j.biomaterials.2006.06.021; Kainthan RK, 2006, BIOMACROMOLECULES, V7, P703, DOI 10.1021/bm0504882; KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2; Liu HB, 2000, J CONTROL RELEASE, V68, P167, DOI 10.1016/S0168-3659(00)00247-9; Liu MJ, 2000, J CONTROL RELEASE, V65, P121, DOI 10.1016/S0168-3659(99)00245-X; Liu ZH, 2010, BIOMATERIALS, V31, P3364, DOI 10.1016/j.biomaterials.2010.01.021; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mugabe C, 2011, INT J PHARMACEUT, V404, P238, DOI 10.1016/j.ijpharm.2010.11.010; Mugabe C, 2012, BIOMATERIALS, V33, P692, DOI 10.1016/j.biomaterials.2011.09.081; Mugabe C, 2009, BJU INT, V103, P978, DOI 10.1111/j.1464-410X.2008.08132.x; NEWKOME GR, 1991, ANGEW CHEM INT EDIT, V30, P1178, DOI 10.1002/anie.199111781; Radowski MR, 2007, ANGEW CHEM INT EDIT, V46, P1265, DOI 10.1002/anie.200603801; Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Rossi NAA, 2010, BIOMATERIALS, V31, P4167, DOI 10.1016/j.biomaterials.2010.01.137; Rossi NAA, 2010, J AM CHEM SOC, V132, P3423, DOI 10.1021/ja909174x; Rossi NAA, 2009, BIOMATERIALS, V30, P638, DOI 10.1016/j.biomaterials.2008.09.057; Satoh T, 2009, SOFT MATTER, V5, P1972, DOI 10.1039/b819748b; Shenoi RA, 2013, BIOMATERIALS, V34, P6068, DOI 10.1016/j.biomaterials.2013.04.043; Song L., 2011, THESIS U KENTUCKYSON; Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w; Tanaka M, 2013, POLYM J, V45, P701, DOI 10.1038/pj.2012.229; Tanford C., 1979, HYDROPHOBIC EFFECT F; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tirosh O, 1998, BIOPHYS J, V74, P1371, DOI 10.1016/S0006-3495(98)77849-X; Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Zhang JG, 2008, BIOCONJUGATE CHEM, V19, P1241, DOI 10.1021/bc8000408	46	8	8	1	32	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2016	8	9					5189	5199		10.1039/c5nr08175k			11	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	DF6PW	WOS:000371479000045	26878269				2022-02-06	
J	Park, KD; Lim, OK; Yoo, CJ; Kim, YW; Lee, S; Park, Y; Lee, JK				Park, Ki Deok; Lim, Oh Kyung; Yoo, Chan Jong; Kim, Yong Wook; Lee, Sihoon; Park, Yongbum; Lee, Ju Kang			Voxel-based statistical analysis of brain metabolism in patients with growth hormone deficiency after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; growth hormone; PET; cognition	ANTERIOR-PITUITARY DYSFUNCTION; I IGF-I; COGNITIVE FUNCTION; RAT-BRAIN; INCREASES; REPLACEMENT; SYSTEM; AGE; NEUROTRANSMITTERS; EXPRESSION	Objective: The aim of this study was to investigate the regional cerebral metabolism related to growth hormone deficiency (GHD) after traumatic brain injury (TBI) using F-18 fluorodeoxyglucose positron emission tomography (F-18 FDG PET) images. Methods: Twenty-three patients with diffuse axonal injury following TBI were enrolled. They underwent brain F-18 FDG PET study and an insulin tolerance test (ITT). According to the results of ITT, they were divided into two groups: patients with GHD and subjects with TBI but normal Growth Hormone (GH). Voxel-based statistical analysis was performed and the regional cerebral glucose metabolism shown on F-18 FDG PET from 10 patients with GHD was compared with those from 13 patients without GHD. Analysis was performed using SPM2 to identify regions where decreased changes in regional cerebral glucose metabolism were significantly related to GHD. Results: Compared with subjects with TBI but normal GH, patients with GHD after TBI showed decreased cerebral glucose metabolism in the Left superior frontal gyrus, Right angular gyrus, Right superior temporal gyrus, Left inferior temporal gyrus, Left anterior and middle cingulate gyrus and Right anterior and middle cingulate gyrus. (p(uncorrected) <0.005). Conclusions: The findings are suggestive of the brain region influenced by GHD. These cortical areas are involved in regulation of intellectual function, executive function and working memory.	[Park, Ki Deok; Lim, Oh Kyung; Lee, Ju Kang] Gachon Univ, Dept Rehabil Med, Gil Med Ctr, Inchon, South Korea; [Yoo, Chan Jong] Gachon Univ, Dept Neurosurg, Gil Med Ctr, Inchon, South Korea; [Kim, Yong Wook] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul, South Korea; [Lee, Sihoon] Gachon Univ, Gil Med Ctr, Dept Internal Med, Inchon, South Korea; [Lee, Sihoon] Gachon Univ, Gil Med Ctr, Mol Endocrinol Lab, Inchon, South Korea; [Park, Yongbum] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Rehabil Med, Seoul, South Korea		Lee, JK (corresponding author), 774-21 Namdong Daero, Inchon 405760, South Korea.	pmrdoc@gilhospital.com		park, yongbum/0000-0002-8288-9450; KIM, YONGWOOK/0000-0002-5234-2454	National Research Foundation of Korea (NRF) - Korea government (MEST)Ministry of Education, Science and Technology, Republic of KoreaNational Research Foundation of KoreaKorean Government [2011-0014043]	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2011-0014043). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; ADEM A, 1989, BRAIN RES, V503, P299, DOI 10.1016/0006-8993(89)91678-8; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; ARAUJO DM, 1989, BRAIN RES, V484, P130, DOI 10.1016/0006-8993(89)90355-7; Burman P, 1998, PSYCHOTHER PSYCHOSOM, V67, P154, DOI 10.1159/000012276; Burman P, 1996, CLIN ENDOCRINOL, V44, P319, DOI 10.1046/j.1365-2265.1996.617439.x; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Dentremont KD, 1999, DEV BRAIN RES, V114, P135, DOI 10.1016/S0165-3806(99)00024-3; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P184, DOI 10.1097/00001199-200403000-00010; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P541, DOI 10.1097/00001199-200311000-00008; Gillespie CM, 1997, J ENDOCRINOL, V155, P351, DOI 10.1677/joe.0.1550351; GUNN IR, 1991, ANN CLIN BIOCHEM, V28, P327, DOI 10.1177/000456329102800402; JOHANSSON JO, 1995, NEUROENDOCRINOLOGY, V61, P57, DOI 10.1159/000126813; Kalmijn S, 2000, J CLIN ENDOCR METAB, V85, P4551, DOI 10.1210/jc.85.12.4551; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; LAI ZN, 1993, BRAIN RES, V621, P260, DOI 10.1016/0006-8993(93)90114-3; Le Greves M, 2006, EXP BRAIN RES, V173, P267, DOI 10.1007/s00221-006-0438-2; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LOBIE PE, 1993, DEV BRAIN RES, V74, P225, DOI 10.1016/0165-3806(93)90008-X; Lynch CD, 2001, ENDOCRINOLOGY, V142, P506, DOI 10.1210/en.142.1.506; Mahmoud GS, 2006, J NEUROPHYSIOL, V95, P2962, DOI 10.1152/jn.00947.2005; Maruff P, 2005, HORM RES, V64, P100, DOI 10.1159/000089325; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; NILSSONHAKANSSON L, 1993, NEUROREPORT, V4, P1111; Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Pathipati P, 2011, NEUROSCIENCE, V190, P409, DOI 10.1016/j.neuroscience.2011.05.029; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; Schneider HJ, 2003, EUR J ENDOCRINOL, V149, P377, DOI 10.1530/eje.0.1490377; Siemensma EPC, 2012, J CLIN ENDOCR METAB, V97, P2307, DOI 10.1210/jc.2012-1182; Sonntag WE, 2000, BRAIN RES BULL, V51, P331, DOI 10.1016/S0361-9230(99)00259-2; Sonntag WE, 1997, ENDOCRINOLOGY, V138, P3515, DOI 10.1210/en.138.8.3515; STERN WC, 1975, PHARMACOL BIOCHEM BE, V3, P1115, DOI 10.1016/0091-3057(75)90025-8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Dam PS, 2004, EUR J PHARMACOL, V490, P87, DOI 10.1016/j.ejphar.2004.02.047; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0	38	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					407	413		10.3109/02699052.2015.1127997			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200005	26910852				2022-02-06	
J	Rejmstad, P; Akesson, G; Aneman, O; Wardell, K				Rejmstad, Peter; Akesson, Gustav; Aneman, Oscar; Wardell, Karin			A laser Doppler system for monitoring cerebral microcirculation: implementation and evaluation during neurosurgery	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Microcirculation; Brain tumour; Laser Doppler perfusion monitoring (LDPM); Pulsatility index (PI); Neurosurgery	BLOOD-FLOW; PERFUSION; RESECTION; PULSATILITY; GLIOMA; TUMORS; CT	The aim of this study was to adapt and evaluate laser Doppler perfusion monitoring (LDPM) together with custom-designed brain probes and software for continuous recording of cerebral microcirculation in patients undergoing neurosurgery. The LDPM system was used to record perfusion and backscattered light (TLI). These parameters were displayed together with the extracted heart rate (HR), pulsatility index (PI) and signal trends from adjustable time intervals. Technical evaluation was done on skin during thermal provocation. Clinical measurements were performed on ten patients undergoing brain tumour surgery. Data from 76 tissue sites were captured with a length varying between 10 s to 15 min. Statistical comparisons were done using Mann-Whitney tests. Grey and tumour tissue could be separated from white matter using the TLI signal (p < 0.05). The perfusion was significantly higher in grey and tumour tissue compared to white matter (p < 0.005). LDPM was successfully used as an intraoperative tool for monitoring local blood flow and additional parameters linked to cerebral microcirculation (perfusion, TLI, HR and PI) during tumour resection. The systems stability opens up for studies in the postoperative care of patients with, for example, traumatic brain injury or subarachnoid haemorrhage.	[Rejmstad, Peter; Wardell, Karin] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden; [Akesson, Gustav; Aneman, Oscar] Linkoping Univ, Dept Neurosurg, Dept Clin & Expt Med, Linkoping, Sweden		Rejmstad, P (corresponding author), Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden.	peter.rejmstad@liu.se		Wardell, Karin/0000-0002-0012-7867	Swedish Research CouncilSwedish Research CouncilEuropean Commission [6212-010-4216]	The authors would like to thank the clinical staff at the Neurosurgical Department of Linkoping University Hospital for their help during the surgical measurements. The authors also acknowledge research engineer Mats Andersson and Per Sveider at the Department of Biomedical Engineering for skilful fabrication of the custom optical probes. This study was supported by the Swedish Research Council (Grant No. 6212-010-4216).	Arshi B, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/987934; Barazangi N, 2008, NEUROL INDIA, V56, P405; Barone DG, 2014, SCI WORLD J, DOI 10.1155/2014/795762; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Ellika SK, 2007, AM J NEURORADIOL, V28, P1981, DOI 10.3174/ajnr.A0688; Giller CA, 2003, J NEUROSURG, V98, P1299, DOI 10.3171/jns.2003.98.6.1299; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; HABERL RL, 1993, ACTA NEUROCHIR, P64; Haj-Hosseini N, 2010, LASER SURG MED, V42, P9, DOI 10.1002/lsm.20868; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Hillman J, 2005, BRIT J NEUROSURG, V19, P395, DOI 10.1080/02688690500389898; Jacobs P, 1993, Endosc Surg Allied Technol, V1, P57; JAKOBSSON A, 1993, MED BIOL ENG COMPUT, V31, P301, DOI 10.1007/BF02458050; Johansson JD, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3210781; Johansson JD, 2009, STEREOT FUNCT NEUROS, V87, P105, DOI 10.1159/000202977; Karlsson MGD, 2003, MED BIOL ENG COMPUT, V41, P255, DOI 10.1007/BF02348429; KELLER E, 2011, ACTA NEUROCHIR SUPPL, V2, P217, DOI DOI 10.1007/978-3-7091-0356-2_39; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nasrallah I, 2013, SEMIN NUCL MED, V43, P449, DOI 10.1053/j.semnuclmed.2013.06.003; Nilsson G., 2003, BIOMEDICAL PHOTONICS; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P597, DOI 10.1109/TBME.1980.326582; Parthasarathy AB, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526368; Raabe A, 2009, NEUROIMAGE, V44, P1284, DOI 10.1016/j.neuroimage.2008.10.049; Rejmstad P, 2012, IEEE ENG MED BIO, P1988, DOI 10.1109/EMBC.2012.6346346; Richter JCO, 2011, LASER SURG MED, V43, P8, DOI 10.1002/lsm.21022; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Su XWW, 2011, PEDIATR RES, V70, P181, DOI 10.1203/PDR.0b013e3182226b75; Tarumi T, 2014, J CEREBR BLOOD F MET, V34, P971, DOI 10.1038/jcbfm.2014.44; WARDELL K, 1994, MICROVASC RES, V48, P26, DOI 10.1006/mvre.1994.1036; WARDELL K, 1993, IEEE T BIO-MED ENG, V40, P309, DOI 10.1109/10.222322; Wardell K, 2007, STEREOT FUNCT NEUROS, V85, P279, DOI 10.1159/000107360; Wardell K, 2013, NEUROSURGERY, V72, P127, DOI 10.1227/NEU.0b013e31827e5821; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Winkler MKL, 2012, EPILEPSIA, V53, P22, DOI 10.1111/j.1528-1167.2012.03699.x; You J, 2014, BIOMED OPT EXPRESS, V5, P3217, DOI 10.1364/BOE.5.003217; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002	40	8	8	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	JAN	2016	54	1					123	131		10.1007/s11517-015-1332-5			9	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	DF6AU	WOS:000371437900010	26105147	Green Submitted			2022-02-06	
J	Saban, KL; Mathews, HL; Collins, EG; Hogan, NS; Tell, D; Bryant, FB; Pape, TLB; Griffin, JM; Janusek, LW				Saban, Karen L.; Mathews, Herbert L.; Collins, Eileen G.; Hogan, Nancy S.; Tell, Dina; Bryant, Fred B.; Pape, Theresa Louise Bender; Griffin, Joan M.; Janusek, Linda Witek			The Man I Once Knew: Grief and Inflammation in Female Partners of Veterans With Traumatic Brain Injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						grief; blame; caregivers; cytokines; brain injury; TNF-alpha; anger	NECROSIS-FACTOR-ALPHA; QUALITY-OF-LIFE; PSYCHOLOGICAL STRESS; DEPRESSIVE SYMPTOMS; SYSTEMIC INFLAMMATION; FAMILY CAREGIVERS; STROKE SURVIVORS; PHYSICAL HEALTH; BLOOD-PRESSURE; SHORT-FORM	Grief, although traditionally conceptualized as a bereavement-related reaction, is also experienced by significant others in response to the profound cognitive and personality changes associated with a traumatic brain injury (TBI) in a loved one. Grief associated with the death of a loved one is related to increases in proinflammatory cytokines, yet it is not clear whether this is the case for grief experienced by individuals caring for a significant other with TBI. The purpose of this cross-sectional, exploratory study was to examine grief and its association with a proinflammatory cytokine, tumor necrosis factor (TNF-), in wives/partners caring for veterans with TBI. Participants completed written measures of grief, perceived stress, and depressive symptoms and provided morning saliva samples for TNF- analysis. Participants reported levels of grief comparable to those reported in studies evaluating individuals grieving the death of a loved one. Path analysis revealed that grief was not associated with TNF-; however, participants reporting high levels of blame/anger, a subscale of the grief scale, had higher levels of TNF-. In addition, both grief and blame/anger were related to increased perceived stress and depressive symptoms; however, path analysis demonstrated that perceived stress and depressive symptoms did not mediate the influence of blame/anger on TNF-. These findings suggest that blame/anger associated with grief may be related to the elevations in TNF- exhibited by individuals caring for a loved one with TBI.	[Saban, Karen L.; Collins, Eileen G.; Pape, Theresa Louise Bender] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Hines, IL USA; [Saban, Karen L.; Hogan, Nancy S.; Tell, Dina; Janusek, Linda Witek] Loyola Univ, Marcella Niehoff Sch Nursing, Chicago, IL 60611 USA; [Mathews, Herbert L.] Loyola Univ, Stritch Sch Med, Maywood, IL 60153 USA; [Collins, Eileen G.] Univ Illinois, Coll Nursing, Chicago, IL USA; [Bryant, Fred B.] Loyola Univ, Dept Psychol, Chicago, IL 60626 USA; [Pape, Theresa Louise Bender] Northwestern Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA; [Griffin, Joan M.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA		Saban, KL (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, 2160S First Ave, Maywood, IL 60153 USA.	ksaban@luc.edu		Saban, Karen/0000-0001-5767-5453; Bender Pape, Theresa/0000-0001-7738-5963	Department of Veterans Affairs Nursing Research Initiative [HSRD NRI 12-413]; Veterans AffairsUS Department of Veterans Affairs [I01HX000456] Funding Source: NIH RePORTER	The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Supported by Department of Veterans Affairs Nursing Research Initiative (#HSR&D NRI 12-413).	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Berg Jenny, 2004, Eur J Health Econ, V5 Suppl 1, pS84, DOI 10.1007/s10198-005-0293-2; Boss P., 1999, AMBIGUOUS LOSS LEARN; Boss P, 2010, PASTOR PSYCHOL, V59, P137, DOI 10.1007/s11089-009-0264-0; Calvete E, 2012, BRAIN INJURY, V26, P834, DOI 10.3109/02699052.2012.655363; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Defense and Veterans Brain Injury Center (DBVIC), 2012, DOD WORLDW NUMB TBI; Domingue P., 2010, THESIS; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Gumus P, 2014, J PERIODONTOL, V85, P270, DOI 10.1902/jop.2013.130117; Hampton NZ, 2000, REHABIL COUNS BULL, V43, P66; HARRELL EJ, 2001, REGRESSION MODELING; Hintz J., 2011, POWER ANAL SAMPLE SI; Hogan NS, 2001, DEATH STUD, V25, P1, DOI 10.1080/074811801750058609; Holt-Lunstad J, 2008, PSYCHOSOM MED, V70, P976, DOI 10.1097/PSY.0b013e318187aef7; Howell D. C., 2009, STAT METHODS PSYCHOL; Jacobsen JC, 2010, DEATH STUD, V34, P257, DOI 10.1080/07481180903559303; JORESKOG GK, 1996, LISREL 8 USERS REFER; Kabagambe EK, 2011, AM J EPIDEMIOL, V174, P284, DOI 10.1093/aje/kwr085; Kaunonen M., 2000, THESIS; Kiecolt-Glaser JK, 2011, PSYCHOSOM MED, V73, P16, DOI 10.1097/PSY.0b013e31820573b6; Kim SH, 2009, AGING MENT HEALTH, V13, P38, DOI 10.1080/13607860802154457; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Leishman SJ, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/948569; Loucks EB, 2010, SOC SCI MED, V71, P187, DOI 10.1016/j.socscimed.2010.03.012; Lu XT, 2013, J CARDIOVASC PHARM, V62, P6, DOI 10.1097/FJC.0b013e3182858fac; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mak A, 2013, LUPUS, V22, P254, DOI 10.1177/0961203312471872; Mallinckrodt B, 2006, J COUNS PSYCHOL, V53, P372, DOI 10.1037/0022-0167.53.3.372; Marques-Vidal P, 2012, OBESITY FACTS, V5, P734, DOI 10.1159/000345045; Marwit SJ, 2005, DEATH STUD, V29, P191, DOI 10.1080/07481180590916335; Mastrolonardo M, 2007, ARCH MED RES, V38, P206, DOI 10.1016/j.arcmed.2006.09.009; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Miller GE, 2003, J BEHAV MED, V26, P501, DOI 10.1023/A:1026273817984; Mostofsky E, 2012, CIRCULATION, V125, P491, DOI 10.1161/CIRCULATIONAHA.111.061770; Navarro VP, 2006, PFLUG ARCH EUR J PHY, V453, P73, DOI 10.1007/s00424-006-0113-2; O'Connor MF, 2012, PSYCHONEUROENDOCRINO, V37, P725, DOI 10.1016/j.psyneuen.2011.08.009; O'Donovan A, 2012, BRAIN BEHAV IMMUN, V26, P642, DOI 10.1016/j.bbi.2012.02.003; Ostwald SK, 2009, TOP STROKE REHABIL, V16, P93, DOI 10.1310/tsr1602-93; Out D, 2012, BRAIN BEHAV IMMUN, V26, P543, DOI 10.1016/j.bbi.2012.01.019; Pandya R, 2005, PSYCHOSOMATICS, V46, P131, DOI 10.1176/appi.psy.46.2.131; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riggs L, 2004, J EARLY ADOLESCENCE, V24, P200, DOI 10.1177/0272431604265683; Saban KL, 2012, BIOL RES NURS, V14, P396, DOI 10.1177/1099800412439458; Saban KL, 2010, J NEUROSCI NURS, V42, P128, DOI 10.1097/JNN.0b013e3181d4a3ee; Santic Z, 2006, CROAT MED J, V47, P416; Schultze-Florey CR, 2012, BRAIN BEHAV IMMUN, V26, P1066, DOI 10.1016/j.bbi.2012.06.009; Sjogren E, 2006, BRAIN BEHAV IMMUN, V20, P270, DOI 10.1016/j.bbi.2005.08.001; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Stevenson RJ, 2012, BRAIN BEHAV IMMUN, V26, P1160, DOI 10.1016/j.bbi.2012.07.010; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; Tryon WW, 2001, PSYCHOL METHODS, V6, P371, DOI 10.1037//1082-989X.6.4.371; Usui T, 2011, JPN J PHYS FIT SPORT, V60, P295, DOI 10.7600/jspfsm.60.295; Wang RP, 2011, STRESS, V14, P567, DOI 10.3109/10253890.2011.571729; Ware J. E., 2002, SCORE VERSION 2 SF 1; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; [No title captured]	64	8	8	1	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JAN	2016	18	1					50	59		10.1177/1099800414568661			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CZ7AD	WOS:000367251400006	25636402				2022-02-06	
J	Schoell, SL; Weaver, AA; Talton, JW; Baker, G; Doud, AN; Barnard, RT; Stitzel, JD; Zonfrillo, MR				Schoell, Samantha L.; Weaver, Ashley A.; Talton, Jennifer W.; Baker, Gretchen; Doud, Andrea N.; Barnard, Ryan T.; Stitzel, Joel D.; Zonfrillo, Mark R.			Functional outcomes of motor vehicle crash head injuries in pediatric and adult occupants	TRAFFIC INJURY PREVENTION			English	Article						Disability; motor vehicle crash; head injuries; Abbreviated Injury Scale; pediatric	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INPATIENT REHABILITATION; ARTERY INJURIES; DATA-BANK; MORTALITY; CHILDREN; BLUNT; DISABILITY; INDEPENDENCE	Objective: The objective of the study was to develop a disability-based metric for motor vehicle crash (MVC) injuries, with a focus on head injuries, and compare the functional outcomes between the pediatric and adult populations.Methods: Disability risk (DR) was quantified using Functional Independence Measure (FIM) scores within the National Trauma Data BankResearch Data System (NTDB-RDS) for the top 95% most frequently occurring Abbreviated Injury Scale (AIS) 3, 4, and 5 head injuries in NASS-CDS 2000-2011. Pediatric (ages 7-18), adult (19-45), middle-aged (46-65), and older adult (66+) patients with an FIM score available who were alive at discharge and had an AIS 3, 4, or 5 injury were included in the study. The NTDB-RDS contains a truncated form of the FIM instrument, including 3 items (self-feed, locomotion, and verbal expression), each graded on a scale of 1 (full functional dependence) to 4 (full functional independence). Patients within each age group were classified as disabled or not disabled based on the FIM scale. The DR was calculated for each age group by dividing the number of patients who sustained a specific injury and were disabled by the number of patients who sustained the specific injury. To account for the impact of more severe associated coinjuries, a maximum AIS (MAIS) adjusted DR (DRMAIS) was also calculated for each injury. DR and DRMAIS ranged from 0 (0% disability risk) to 1 (100% disability risk).Results: An analysis of the most frequent FIM components associated with disabling MVC head injuries revealed that disability across all 3 items (self-feed, locomotion, and expression) was the most frequent for pediatric and adult patients. Only locomotion was the most frequent for middle-aged and older adults. The mean DRMAIS for MVC head injuries was 35% for pediatric patients, 36% for adults, 38% for middle-aged adults, and 44% for older adults. Further analysis was conducted by grouping the head injuries into 8 groups based on the structure of injury and injury type. The pediatric population possessed higher DRMAIS values for brain stem injuries as well as loss of consciousness injuries. Older adults possessed higher DRMAIS values for contusion/hemorrhage injuries, epidural hemorrhage, intracerebral hemorrhage, skull fracture, and subdural/subarachnoid hemorrhage.Conclusion: At-risk populations such as pediatric and older adult patients possessed higher DRMAIS values for different head injuries. Disability in pediatric patients is critical due to loss of quality life years. Disability risk can supplement severity metrics to improve the ability of such metrics to discriminate the severity of different injuries that do not lead to death. Understanding of age-related differences in injury outcomes when compared to adults could inform future age-specific modifications to the AIS.	[Schoell, Samantha L.; Weaver, Ashley A.; Baker, Gretchen; Stitzel, Joel D.] Virginia Tech Wake Forest Univ, Ctr Injury Biomech, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA; [Schoell, Samantha L.; Weaver, Ashley A.; Doud, Andrea N.; Stitzel, Joel D.] Wake Forest Sch Med, Winston Salem, NC USA; [Talton, Jennifer W.; Barnard, Ryan T.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA		Schoell, SL (corresponding author), Virginia Tech Wake Forest Univ, Ctr Injury Biomech, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	sschoell@wakehealth.edu	Stitzel, Joel/B-4045-2012; Zonfrillo, Mark R./H-9403-2017; Weaver, Ashley/ABB-5845-2021	Stitzel, Joel/0000-0001-9762-3033; Zonfrillo, Mark R./0000-0002-0610-9563; Weaver, Ashley/0000-0002-4383-0106; Baker, Gretchen/0000-0002-7302-6995	National Science Foundation (NSF) Center for Child Injury Prevention Studies at the Children's Hospital of Philadelphia (CHOP)National Science Foundation (NSF); Industry Advisory Board (IAB); National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241] Funding Source: NIH RePORTER	The authors acknowledge the National Science Foundation (NSF) Center for Child Injury Prevention Studies at the Children's Hospital of Philadelphia (CHOP) for sponsoring this study and its Industry Advisory Board (IAB) members for their support, valuable input, and advice. This publication was also supported by the National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development, grant K08HD073241. The views presented are those of the authors and not necessarily the views of CHOP, the NSF, the IAB members, or the NIH.	Aitken ME, 1999, ARCH PHYS MED REHAB, V80, P889, DOI 10.1016/S0003-9993(99)90079-5; American College of Surgeons, 2007, NAT TRAUM DAT BANK R; Andersen Daniel, 2010, Ann Adv Automot Med, V54, P359; [Anonymous], 2007, UN DAT SYST MED REH; Arthurs ZM, 2009, J VASC SURG, V49, P988, DOI 10.1016/j.jvs.2008.11.052; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; Barnard RT, 2013, ACCIDENT ANAL PREV, V52, P133, DOI 10.1016/j.aap.2012.11.030; Bergen G, 2014, MMWR-MORBID MORTAL W, V63, P894; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Burd RS, 2009, ACAD EMERG MED, V16, P639, DOI 10.1111/j.1553-2712.2009.00446.x; Centers for Disease Control and Prevention, 2013, 10 LEAD CAUS DEATH I; Crandall JR, 2012, PEDIAT INJURY BIOMEC; Doud AN, 2015, TRAFFIC INJ PREV, V16, pS201, DOI 10.1080/15389588.2015.1048337; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JURKOVICH G, 1995, J TRAUMA, V39, P625, DOI 10.1097/00005373-199510000-00001; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Martin MJ, 2005, J TRAUMA, V59, P860, DOI 10.1097/01.ta.0000187964.47703.e9; Martin MJ, 2005, AM J SURG, V190, P836, DOI 10.1016/j.amjsurg.2005.05.051; McCarthy ML, 2007, J TRAUMA, V63, pS122, DOI 10.1097/TA.0b013e31815accdf; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; NHTSA, 2011, NAT AUT SAMPL SYST; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Peden M, 2008, WORLD REPORT CHILD I; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; Spaniolas K, 2008, WORLD J SURG, V32, P2190, DOI 10.1007/s00268-008-9687-5; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Weaver Ashley A, 2013, Ann Adv Automot Med, V57, P235; Willis CD, 2006, INJURY, V37, P1185, DOI 10.1016/j.injury.2006.07.011; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7; Zonfrillo MR, 2014, J PEDIATR-US, V164, P130, DOI 10.1016/j.jpeds.2013.09.022; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	35	8	8	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2016	17			1	SI		27	33		10.1080/15389588.2016.1201203			7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	DW8ID	WOS:000383897600007	27586099	Green Accepted			2022-02-06	
J	Semenova, ZB; Marshintsev, AV; Melnikov, AV; Meshcheryakov, SV; Adayev, AR; Lukyanov, VI				Semenova, Zh. B.; Marshintsev, A. V.; Melnikov, A. V.; Meshcheryakov, S. V.; Adayev, A. R.; Lukyanov, V. I.			Infrascanner (TM) in the diagnosis of intracranial lesions in children with traumatic brain injuries	BRAIN INJURY			English	Article						Infrascanner; intracranial haemorrhage; mild head injury; near-infrared spectroscopy; paediatric TBI; traumatic brain injury	HEAD-INJURY; COMPUTED-TOMOGRAPHY; DEVICE; RULE	Background: The number of traumatic injuries among children is increasing. However, so-called mild TBI might result in unfavourable outcomes. Early diagnosis of intracranial haematomas prior to development of serious complications may be a decisive factor for a favourable outcome. InfraScan company developed and brought to the market the Infrascanner (R) model 1000, which is a portable detector of blood collections that operates in the near infrared (NIR) band. Objective: To estimate the efficiency of the Infrascanner (R) model 1000 for detection of intracranial haematomas among children with mild TBI. Materials and methods: Ninety-five patients with mild TBI were examined. An indication for cerebral CT after mild TBI was the presence of risk factors of intracranial lesions. The Infrascanner was used by a neurosurgeon during primary examination. CT was performed in 43 patients (45%), while 52 patients (55%) with a low risk of intracranial lesions were under observation. Results: The results of examination of patients using CT and infrared scanning coincided in 39 cases and intracranial haematomas were detected in eight patients. False-positive results were obtained in three cases. The sensitivity of the procedure used in this group of patients with a medium and high risk of development of intracranial haemorrhages was 1.00 (0.66; 1.00). The specificity was 0.91 (0.81; 1.00)-the proportions and a 95% CI. The false-positive risk is 0.27 (0.00; 0.58). During infrared scanning in patients with low risk of intracranial lesions, false-positive results were obtained in four cases and false-negative results were absent. Conclusion: Infra-scanning might be viewed as a screening technique for intracranial haemorrhages in ambulances and outpatient trauma centres in order to decide on hospitalization, CT scanning and referral to a neurosurgeon. Infra-scanning combined with evaluation of risk factors of intracranial damage might reduce the number of unnecessary radiological examinations.	[Semenova, Zh. B.; Marshintsev, A. V.; Melnikov, A. V.; Meshcheryakov, S. V.; Adayev, A. R.; Lukyanov, V. I.] Res Inst Emergency Pediat Surg & Trauma, Dept Hlth, 20 Bolshaya Polyanka, Moscow, Russia		Semenova, ZB (corresponding author), Res Inst Emergency Pediat Surg & Trauma, Dept Hlth, 20 Bolshaya Polyanka, Moscow, Russia.	jseman@mail.ru	Semenova, Zhanna/ABB-9352-2020				Artaryan AA, 1998, TRAUMATIC BRAIN IN A, P69; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Iova AS, 2008, IMPROVEMENT MED CARE, P25; Lavelle JM, 1998, ARCH PEDIAT ADOL MED, V152, P1220; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; Potapov AA, 2003, EVIDENCE BASED NEURO, P517; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	13	8	8	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	1					18	22		10.3109/02699052.2014.989401			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DJ8YT	WOS:000374501200003	26653997				2022-02-06	
J	Simpson, G; Pfeiffer, D; Keogh, S; Lane, B				Simpson, Grahame; Pfeiffer, Daniella; Keogh, Shay; Lane, Brigitte			Describing an Early Social Work Intervention Program for Families after Severe Traumatic Brain Injury	JOURNAL OF SOCIAL WORK IN DISABILITY & REHABILITATION			English	Article						Caregiver; case management; counselors; evidence-based practice; family; intervention; psychosocial; social work; traumatic brain injury	SEVERE HEAD-INJURY; PSYCHOLOGICAL DISTRESS; BEHAVIOR MANAGEMENT; CAREGIVER BURDEN; FOLLOW-UP; REHABILITATION; COMMUNITY; IMPACT; INDIVIDUALS; RELATIVES	A necessary step to evaluating practice is the accurate specification of social work interventions. Interventions delivered to 27 families with a relative with traumatic brain injury (TBI) admitted to a specialist inpatient brain injury rehabilitation service were coded (655 hr of social work services). The most frequent interventions were counseling, education, and case management. Services addressed person-oriented (65%; e.g., adjustment to hospital, adjustment to disability, family conflict) and environment-oriented (35%; e.g., transport, accommodation, finance, legal, and immigration) issues. This is the first description of a family intervention program after TBI delivered in an inpatient setting and lays the groundwork for future evaluation.	[Simpson, Grahame] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Pfeiffer, Daniella] Hlth Educ Training Inst, Gladesville, Australia; [Keogh, Shay] Eight Mile Plains Community Hlth Ctr, Aged Care Assessment Team, Caboolture, Australia		Simpson, G (corresponding author), Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Locked Bag 7279, Liverpool Bc, NSW 1871, Australia.	grahame.simpson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			Access Economics, 2008, EC COST SPIN CORD IN; ACORN S, 1995, J ADV NURS, V21, P872, DOI 10.1046/j.1365-2648.1995.21050872.x; Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Arean P. A., 2013, HIGH QUALITY PSYCHOT; Australasian Faculty of Rehabilitation Medicine, 2011, STAND PROV INP AD RE; Barclay DA, 2013, J SOC WORK DISABIL R, V12, P159, DOI 10.1080/1536710X.2013.810093; Barrow FH, 2006, J SOC WORK DISABIL R, V5, P65, DOI 10.1300/J198v05n01_04; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bronstein L, 2007, SOC WORK HEALTH CARE, V45, P59, DOI 10.1300/J010v45n02_04; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; BUTRYM Z, 1968, MED SOCIAL WORK ACTI; CARLTON TO, 1990, SOC SCI MED, V31, P5, DOI 10.1016/0277-9536(90)90003-B; Carnevale GJ, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199602000-00005; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Chambless DL, 1998, J CONSULT CLIN PSYCH, V66, P7, DOI 10.1037/0022-006X.66.1.7; Charles N, 2007, NEUROREHABILITATION, V22, P61; Cleak H., 2002, AUST SOC WORK, V55, P38, DOI [https://doi.org/10.1080/03124070208411670, DOI 10.1080/03124070208411670]; Daisley A., 2009, HEAD INJURY; Davis C, 2004, INT SOC WORK, V47, P346, DOI 10.1177/0020872804043958; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; EPSTEIN NB, 1978, J MARRIAGE FAM COUNS, V4, P19, DOI 10.1111/j.1752-0606.1978.tb00537.x; Feltham C., 2000, TAKING SUPERVISION F, P5; Forster A., 2004, COCHRANE LIB, V1, P1; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Goldberg D., 1988, USERS GUIDE GEN HLTH; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Johnson YM, 1999, SOC WORK, V44, P323, DOI 10.1093/sw/44.4.323; Judd RG, 2010, SOC WORK HEALTH CARE, V49, P856, DOI 10.1080/00981389.2010.499825; KAYSER K, 1995, RES SOCIAL WORK PRAC, V5, P485, DOI 10.1177/104973159500500407; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kreutzer J. S., 2000, SERVICE OBSTACLES SC; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lechman C., 2003, INTERVENTION TRAVAIL, V18, P15; LEVESQUE JD, 1988, SOC WORK HEALTH CARE, V13, P49, DOI 10.1300/J010v13n04_05; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McNair D.M., 1981, PROFILE MOOD STATES; Munro E, 2004, BRIT J SOC WORK, V34, P1075, DOI 10.1093/bjsw/bch130; National Allied Health Casemix Committee, 1997, AUSTR ALL HLTH CLASS; Nilsson D, 2013, SOC WORK HEALTH CARE, V52, P280, DOI 10.1080/00981389.2012.737901; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Reed M, 2015, AUST SOC WORK, V68, P244, DOI 10.1080/0312407X.2014.913070; Rosen A, 1999, SOC WORK RES, V23, P4, DOI 10.1093/swr/23.1.4; Royse D., 2008, RES METHODS SOCIAL W; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Sanguinetti M, 1987, J Neurosci Nurs, V19, P271; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Simpson G., 2002, AUST SOC WORK, V55, P24, DOI [10.1080/03124070208411669, DOI 10.1080/03124070208411669]; SIMPSON G, 2004, BRAIN IMPAIR, V5, DOI DOI 10.1375/BRIM.5.1.67.35401; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Sinnakaruppan I, 2005, BRAIN INJURY, V19, P283, DOI 10.1080/02699050400003924; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tverdov AH, 2016, BRAIN INJURY, V30, P324, DOI 10.3109/02699052.2015.1113566; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, P1793, DOI 10.1016/j.apmr.2004.04.024; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; WILLIAMS JH, 1991, GERONTOLOGIST, V31, P84, DOI 10.1093/geront/31.1.84; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Woodruff I., 2000, REPORT DEV ALLIED HL; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]	78	8	8	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1536-710X	1536-7118		J SOC WORK DISABIL R	J. Soc. Work Disabil. Rehabil.		2016	15	3-4					213	233		10.1080/1536710X.2016.1220888			21	Social Work	Emerging Sources Citation Index (ESCI)	Social Work	EB4NM	WOS:000387348600004	27645886				2022-02-06	
J	Sobin, L; Kopp, R; Walsh, R; Kellman, RM; Harris, T				Sobin, Lindsay; Kopp, Robert; Walsh, Ronald; Kellman, Robert M.; Harris, Tucker			Incidence of Concussion in Patients With Isolated Mandible Fractures	JAMA FACIAL PLASTIC SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; FACIAL FRACTURES; CHRONIC PAIN	IMPORTANCE This study examines the association between isolated mandible fractures and mild traumatic brain injury (mTBI). OBJECTIVE To determine the rates of mTBI in patients who have sustained isolated mandible fractures. DESIGN, SETTING, AND PARTICIPANTS A prospective study was conducted among patients who sustained isolated mandible fractures within 24 hours of presentation. Patients were administered the Military Acute Concussion Evaluation (MACE). Recorded data included demographics, time since injury, use of alcohol or illicit drugs, nonfacial pain, and mechanism of injury. All patients were evaluated in the emergency department of a level I trauma center between June 20, 2013, and June 20, 2014. In addition, discharge data from the Nationwide Inpatient Sample database was analyzed to identify current rates of patients with a diagnosis of both mandible fractures and concussions. MAIN OUTCOMES AND MEASURES Rates of concussion. Patients with a MACE score of less than 25 were considered to have mTBI. RESULTS Sixteen patients met the study criteria over a 1-year period. Fourteen patients (88%) were male, and mean age was 27.5 years. The mean time since injury was 11.25 hours (range, 3-21 hours). The mechanism of injury was assault in 12 patients (75%), sports in 2 patients (13%), all-terrain vehicle crash in 1 patient (6%), and biking in 1 patient (6%). Eight patients (50%) admitted to the use of alcohol, and none reported the use of illicit drugs. Eleven patients (69%) reported loss of consciousness. Twelve patients (75%) met criteria for concussion according to the MACE. Among these 12 patients, 7 (58%) admitted to the use of alcohol at the time of injury. There was no relationship between the rates of concussion and the use of alcohol. CONCLUSIONS AND RELEVANCE Mandible fractures are often sustained after high-force impacts during altercations between men. In our study, a 75%(12 of 16) rate of concussions associated with isolated mandible fractures was identified. Patients with isolated mandible fractures may benefit from being screened for concussion and referred to a concussion clinic.	[Sobin, Lindsay; Kopp, Robert; Walsh, Ronald; Kellman, Robert M.] State Univ New York Upstate Med Ctr, Dept Otolaryngol, Syracuse, NY USA; [Sobin, Lindsay] Boston Childrens Hosp, Dept Otolaryngol, 300 Longwood Ave, Boston, MA 02115 USA		Sobin, L (corresponding author), Boston Childrens Hosp, Dept Otolaryngol, 300 Longwood Ave, Boston, MA 02115 USA.	lindsay.sobin@childrens.harvard.edu					Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; BROOK IM, 1983, INT J ORAL MAXILLOF, V12, P293, DOI 10.1016/S0300-9785(83)80016-7; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fischer K, 2001, PLAST RECONSTR SURG, V108, P328, DOI 10.1097/00006534-200108000-00006; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Kellman RM, 2009, LARYNGOSCOPE, V119, P1682, DOI 10.1002/lary.20583; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LUCE EA, 1979, PLAST RECONSTR SURG, V63, P26, DOI 10.1097/00006534-197901000-00005; McCrea M., 2000, STANDARDIZED ASSESSM; Messerer O., 1880, ELASTICITAT FESTIGKE; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; Ogundare BO, 2003, J ORAL MAXIL SURG, V61, P713, DOI 10.1053/joms.2003.50118; Sojot A J, 2001, J Can Dent Assoc, V67, P640; Swearingen JJ, 1965, TOLERANCE HUMAN FACE; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	22	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6076	2168-6092		JAMA FACIAL PLAST SU	JAMA Facial Plast. Surg.	JAN-FEB	2016	18	1					15	18		10.1001/jamafacial.2015.1339			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DG5WY	WOS:000372152000003	26448310				2022-02-06	
J	Steppacher, I; Kaps, M; Kissler, J				Steppacher, Inga; Kaps, Michael; Kissler, Johanna			Against the odds: a case study of recovery from coma after devastating prognosis	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; MINIMALLY CONSCIOUS STATE; SEVERE HEAD-INJURY; PUPIL REACTIVITY; MEDICAL ASPECTS; ADMISSION; PREDICTION; VARIABLES; CHILDREN	To demonstrate the possibility for hidden rehabilitation potential even following most severe brain injury and the uncertainty of current prognosis factors for coma and unresponsive wakefulness syndrome, we detail the rehabilitation of J. W., after coma from traumatic brain injury. Originally, with many negative prognosis factors and several medical complications, prognosis was devastating. But, with continuing treatment, J. W. improved to a high level of independence in everyday life. This shows the need for rehabilitation research to further specify the prognostic power of various combinations of prognosis factors, so that practitioners can come to accurate single-case recommendations when both positive and negative predictors are present.	[Steppacher, Inga; Kissler, Johanna] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [Kaps, Michael] Kliniken Schmieder, Lurija Inst, Allensbach, Germany		Steppacher, I (corresponding author), Univ Bielefeld, Univ Str 25, D-33615 Bielefeld, Germany.	inga.steppacher@uni-bielefeld.de	Kissler, Johanna/B-7361-2019	Kissler, Johanna/0000-0002-4567-1997			Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Cook RJ, 1996, J CLIN NEUROSCI, V3, P143, DOI 10.1016/S0967-5868(96)90008-9; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Pryor JP, 2003, J TRAUMA, V55, P442; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	21	8	8	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JAN	2016	3	1					61	65		10.1002/acn3.269			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DA8VE	WOS:000368083700007	26783551	Green Published, gold			2022-02-06	
J	Suarez, R; Barquet, A; Fresco, R				Suarez, Roberto; Barquet, Antonio; Fresco, Rodrigo			EPIDEMIOLOGY AND TREATMENT OF MONTEGGIA LESION IN ADULTS: SERIES OF 44 CASES	ACTA ORTOPEDICA BRASILEIRA			English	Article						Monteggia's fracture; Wounds and Injuries; Surgical Procedures; Operative	FRACTURES; ULNA	Objective: To analyze the epidemiology, treatment and outcome of a series of adult patients with Monteggia lesion treated in Uruguayan institutions. Methods: This is a retrospective article, we retrospectively identified from two Uruguayan institutions 44 adult patients with Monteggia lesion and analyzed their characteristics including Bado classification, associated injuries, treatment modality and outcome (Morrey score). Results: Using Bado classification, 23 cases (52%) were type II, 12 (27%) type I, seven (16%) type IV and two cases (5%) type III. Associated lesions were radial head fractures, found in 15 patients, coronoid ipsilateral fractures in seven patients, and neurological injuries in four. Radial head dis-location was reduced in 93% of the cases with closed maneuvers. Ulna fractures underwent open reduction and internal fixation in all 30 cases using 3.5 mm DCP plates. Complications after surgery occurred in 21 cases. Revision surgery was done in 15 cases. Outcomes after primary and revision surgery were good or excellent in 37 cases. Conclusions: In our series we observed that Monteggia lesion in adults is a serious injury with a high number of complications that often require revision surgeries.	[Suarez, Roberto] Asociac Espanola, Banco Seguros Estado, Montevideo, Uruguay; [Barquet, Antonio] Univ Republica, Asociac Espanola, Banco Seguros Estado, Montevideo, Uruguay; [Fresco, Rodrigo] Univ Republica, Montevideo, Uruguay		Suarez, R (corresponding author), Ave Brasil 2679,Ap 101, Montevideo, Uruguay.	rsuarez2004@hotmail.com		Fresco, Rodrigo/0000-0001-5342-3486			Bado J L, 1967, Clin Orthop Relat Res, V50, P71; BARQUET A, 1984, INJURY, V15, P390, DOI 10.1016/0020-1383(84)90203-1; BRUCE HE, 1974, J BONE JOINT SURG AM, VA 56, P1563, DOI 10.2106/00004623-197456080-00003; Eathiraju S, 2007, HAND CLIN, V23, P165, DOI 10.1016/j.hcl.2007.01.008; Fayaz HC, 2010, ACTA CHIR ORTHOP TR, V77, P457; Givon U, 1997, CLIN ORTHOP RELAT R, P208; HERTEL P, 1988, ORTHOPADE, V17, P328; Jupiter J B, 1991, J Orthop Trauma, V5, P395, DOI 10.1097/00005131-199112000-00003; Konrad GG, 2007, J BONE JOINT SURG BR, V89B, P354, DOI 10.1302/0301-620X.89B3.18199; Korner J, 2004, UNFALLCHIRURG, V107, P1026, DOI 10.1007/s00113-004-0825-8; Llusa Perez M, 2002, Chir Main, V21, P293; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; Morrey B., 1993, ELBOW ITS DISORDERS, V2, P86; POIGENFURST J, 1990, UNFALLCHIRURG, V93, P303; REGAN W, 1989, J BONE JOINT SURG AM, V71A, P1348, DOI 10.2106/00004623-198971090-00011; Ring D, 1998, J BONE JOINT SURG AM, V80A, P1733, DOI 10.2106/00004623-199812000-00003; Ring D, 2013, ORTHOP CLIN N AM, V44, P59, DOI 10.1016/j.ocl.2012.08.007; Siebenlist S, 2011, Z ORTHOP UNFALLCHIR, V149, pE1, DOI 10.1055/s-0030-1271144; Sotereanos Dean G, 2007, Instr Course Lect, V56, P369; Trillat A, 1969, Rev Chir Orthop Reparatrice Appar Mot, V55, P639	20	8	10	0	3	ATHA COMUNICACAO & EDITORA	SAO PAULO SP	RUA MACHADO BITTENCOURT, 190-40 ANDAR, CONJ 410, SAO PAULO SP, 00000, BRAZIL	1413-7852	1809-4406		ACTA ORTOP BRAS	Acta Ortop. Bras.	JAN-FEB	2016	24	1					48	51		10.1590/1413-785220162401152249			4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	DG8ID	WOS:000372326100009	26997915	gold, Green Submitted, Green Published			2022-02-06	
J	Sweis, BM; Bachour, SP; Brekke, JA; Gewirtz, JC; Sadeghi-Bazargani, H; Hevesi, M; Divani, AA				Sweis, Brian M.; Bachour, Salam P.; Brekke, Julia A.; Gewirtz, Jonathan C.; Sadeghi-Bazargani, Homayoun; Hevesi, Mario; Divani, Afshin A.			A modified beam-walking apparatus for assessment of anxiety in a rodent model of blast traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Anxiety; Motor; Elevated plus maze; Modified beam-walking; Blast traumatic brain injury; Rats	ELEVATED PLUS-MAZE; ANIMAL-MODEL; OPEN-FIELD; MICE; RATS; RECOVERY; BEHAVIOR; STRESS; TESTS	The elevated plus maze (EPM) is used to assess anxiety in rodents. Beam-walking tasks are used to assess vestibulomotor function. Brain injury in rodents can disrupt performance on both of these tasks. Developing novel paradigms that integrate tasks like these can reduce the need for multiple tests when attempting to assess multiple behaviors in the same animal. Using adult male rats, we evaluated the use of a modified beam-walking (MBW) apparatus as a surrogate indicator for anxiety. We used a model of blast-induced traumatic brain injury (bTBI). A total of 39 rats were assessed before and at 3, 6, 24, 72, and 168 h either post- bTBI (n=33) or no-injury (n=6) using both EPM and MBW. A novel anxiety index was calculated that encompassed peeks and re-emergences on MBW. The proposed MBW anxiety index was compared with the standard anxiety index calculated from exploration into different sections of EPM. Post- bTBI, rats had an increased anxiety index when measured using EPM. Similarly, they peeked or fully emerged less out of the safe box on MBW. It was found that this novel MBW anxiety index captured similar aspects of behavior when compared to the standard anxiety index obtained from EPM. Further, these effects were dissociated from the effects of bTBI on motor function simultaneously measured on MBW. Over the course of 168 h post-bTBI, rats gradually recovered on both EPM and MBW. The MBW apparatus succeeded at capturing and dissociating two separate facets of rat behavior, motor function and anxiety, simultaneously. (C) 2015 Elsevier B.V. All rights reserved.	[Sweis, Brian M.; Bachour, Salam P.; Brekke, Julia A.; Hevesi, Mario; Divani, Afshin A.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Sweis, Brian M.; Hevesi, Mario] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Sweis, Brian M.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Brekke, Julia A.; Divani, Afshin A.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Gewirtz, Jonathan C.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Sadeghi-Bazargani, Homayoun] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Divani, Afshin A.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA		Divani, AA (corresponding author), Univ Minnesota, Dept Neurol, MMC 295,420 Delaware St SE, Minneapolis, MN 55455 USA.	divani@umn.edu	Sadeghi-Bazargani, Homayoun/M-5522-2017	Riedl, Julia/0000-0003-2207-2614; Sweis, Brian/0000-0002-2123-5824; Hevesi, Mario/0000-0001-6208-878X; Sadeghi-Bazargani, Homayoun/0000-0002-0396-8709	Summer Student Fellowship program at the Stroke Research Center, University of Minnesota from Lake Region Medical; Summer Student Fellowship program at the Stroke Research Center, University of Minnesota from Covidien; Nelson Heart Scholarship from the American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008471] Funding Source: NIH RePORTER	The study was supported in part by the Summer Student Fellowship program at the Stroke Research Center, University of Minnesota that has been established by a generous support from Lake Region Medical and Covidien. Mario Hevesi, BS, was also supported by Nelson Heart Scholarship from the American Heart Association.	BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; Divani AA, 2015, J NEUROTRAUMA; FILE SE, 1993, BEHAV BRAIN RES, V58, P199, DOI 10.1016/0166-4328(93)90103-W; FILE SE, 1993, PSYCHOPHARMACOLOGY, V111, P491, DOI 10.1007/BF02253541; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HANDLEY SL, 1993, J PHARMACOL TOX MET, V29, P129, DOI 10.1016/1056-8719(93)90063-K; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Kalueff AV, 2005, BRAIN RES PROTOC, V14, P87, DOI 10.1016/j.brainresprot.2004.11.002; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lalonde R, 2008, J NEUROSCI METH, V171, P48, DOI 10.1016/j.jneumeth.2008.02.003; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rebolledo-Solleiro D, 2013, PHYSIOL BEHAV, V120, P130, DOI 10.1016/j.physbeh.2013.08.002; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Soo C, 2007, COCHRANE DB SYST REV, V3; Sweis BM, 2013, NEUROSCIENCE, V246, P142, DOI 10.1016/j.neuroscience.2013.04.052; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	35	8	10	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 1	2016	296						149	156		10.1016/j.bbr.2015.09.015			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CY0EL	WOS:000366079100021	26367471				2022-02-06	
J	Tobi, KU; Azeez, AL; Agbedia, SO				Tobi, K. U.; Azeez, A. L.; Agbedia, S. O.			Outcome of traumatic brain injury in the intensive care unit: a five-year review	SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA			English	Article						traumatic brain injury; ICU; outcome		Introduction: Traumatic brain injury (TBI) is a major challenge in the intensive care unit (ICU) with a high mortality. In a recent study, severe TBI accounted for 14.3% of all ICU admissions with a mortality of 54.0%.Methodology: This was a retrospective, case-control study of all cases of TBI admitted into the ICU during the study period. Data retrieved included socio-demographic parameters, causes of TBI, blood transfusion, length of stay and ICU outcome in terms of mortality.Result: One hundred and eighty-two (182) TBI patients were admitted into the ICU, with a mean age of 3418.92years. The male:female ratio was 3:1, but females had a better outcome with a p-value of 0.026. Patients who stayed between 1 and 7 days were>4 times more likely to die in the ICU compared with those who stayed for more than 7 days. In addition, TBI patients who had blood transfusion had a better outcome (p = 0.004). Also, TBI patients who received ventilatory support had higher mortality compared with those who did no, (p = 0.006).Conclusion: Patients with traumatic brain injury admitted to the intensive care unit have a high mortality. A review of the present line of management and strict compliance with guidelines of management may perhaps improve outcome.	[Tobi, K. U.; Agbedia, S. O.] Univ Benin Teaching Hosp, Dept Anaesthesiol, Benin, Nigeria; [Azeez, A. L.] Univ Benin Teaching Hosp, Dept Surg, Benin, Nigeria		Tobi, KU (corresponding author), Univ Benin Teaching Hosp, Dept Anaesthesiol, Benin, Nigeria.	tobikingsley@yahoo.com	Tobi, Kingsley Ufuoma/AAW-4832-2020				Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Idowu OE, 2014, INJURY, V45, P1717, DOI 10.1016/j.injury.2014.05.028; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Opondo EA, 2004, ANN AFR SURG, V1, P1; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; TEASDALE G, 1974, LANCET, V2, P81; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046	13	8	8	0	0	MEDPHARM PUBLICATIONS PTY LTD	CENTURION	PO BOX 14804 LYTTELTON MANOR, CENTURION, 0140, SOUTH AFRICA	2220-1181	2220-1173		SOUTH AFR J ANAESTH	South. Afr. J. Anaesth. Analg.		2016	22	5					135	139		10.1080/22201181.2016.1206293			5	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	EB2AT	WOS:000387159700002		gold			2022-02-06	
J	Usui, A; Kawasumi, Y; Hosokai, Y; Kozakai, M; Saito, H; Funayama, M				Usui, Akihito; Kawasumi, Yusuke; Hosokai, Yoshiyuki; Kozakai, Masataka; Saito, Haruo; Funayama, Masato			Usefulness and limitations of postmortem computed tomography in forensic analysis of gunshot injuries: Three case reports	LEGAL MEDICINE			English	Article						Multidetector-row computed tomography; Wounds; Penetrating; Autopsy	AUTOPSY; CT; RADIOLOGY; WOUNDS	Gunshot injury has always been an important field of investigation in postmortem forensic radiology. The localization and retrieval of the bullet and of potentially important fragments are vital to these cases. Using postmortem multidetector-row computed tomography (MDCT) prior to forensic autopsy, we sought to illustrate the importance of this modality in the noninvasive characterization of gunshot wounds. We obtained and analyzed MDCT images in three cases of gunshot wounds (accidental close range shotgun shooting, suicidal contact gunshot to the head and accidental long-range buckshot shooting). We discuss the value of postmortem MDCT findings in gunshot wound cases by comparing with forensic autopsy findings in Japan, a developing country with miserably low autopsy rate. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Usui, Akihito; Hosokai, Yoshiyuki; Kozakai, Masataka; Saito, Haruo] Tohoku Univ, Grad Sch Med, Dept Diagnost Image Anal, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Kawasumi, Yusuke] Tohoku Univ, Grad Sch Med, Dept Clin Imaging, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Funayama, Masato] Tohoku Univ, Grad Sch Med, Dept Forens Med, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan		Usui, A (corresponding author), Tohoku Univ, Grad Sch Med, Dept Diagnost Image Anal, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	t7402r0506@med.tohoku.ac.jp		Hosokai, Yoshiyuki/0000-0001-5320-1074; Usui, Akihito/0000-0003-1889-7496			[Anonymous], 2001, J TRAUMA S, V51, pS7; Calhoun PS, 1999, RADIOGRAPHICS, V19, P745, DOI 10.1148/radiographics.19.3.g99ma14745; Colard T, 2013, LEGAL MED-TOKYO, V15, P318, DOI 10.1016/j.legalmed.2013.07.002; Dalrymple NC, 2005, RADIOGRAPHICS, V25, P1409, DOI 10.1148/rg.255055044; Di Maio VJM, 1999, GUNSHOT WOUNDS PRACT; Fishman EK, 2006, RADIOGRAPHICS, V26, P905, DOI 10.1148/rg.263055186; Folio LR, 2010, COMBAT RADIOLOGY: DIAGNOSTIC IMAGING OF BLAST AND BALLISTIC INJURIES, P41, DOI 10.1007/978-1-4419-5854-9_5; Levy A. D., 2011, ESSENTIALS FORENSIC; Maiese A, 2014, LEGAL MED-TOKYO, V16, P357, DOI 10.1016/j.legalmed.2014.06.005; Makhlouf F, 2013, LEGAL MED-TOKYO, V15, P145, DOI 10.1016/j.legalmed.2012.11.002; Okuda T, 2013, FORENSIC SCI INT, V225, P3, DOI 10.1016/j.forsciint.2012.03.010; Pomara C, 2009, RADIOL MED, V114, P1367, DOI 10.1007/s11547-009-0435-1; Puentes K, 2009, J FORENSIC LEG MED, V16, P407, DOI 10.1016/j.jflm.2009.04.003; SAUKKO P, 2004, KNIGHTS FORENSIC PAT, P245; Tartaglione T, 2012, RADIOL MED, V117, P461, DOI 10.1007/s11547-011-0784-4; Thali MJ, 2003, AM J FOREN MED PATH, V24, P22	16	8	9	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JAN	2016	18						98	103		10.1016/j.legalmed.2016.01.004			6	Medicine, Legal; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Biomedical Social Sciences	DE8OA	WOS:000370894400019	26832386				2022-02-06	
J	van Markus-Doornbosch, F; de Kloet, AJ; Berger, MAM; Lambregts, SAM; Wolterbeek, R; Vlieland, TPMV				van Markus-Doornbosch, F.; de Kloet, A. J.; Berger, M. A. M.; Lambregts, S. A. M.; Wolterbeek, R.; Vlieland, T. P. M. Vliet			Factors related to fatigue after paediatric acquired brain injury (ABI)	BRAIN INJURY			English	Article						Health-related quality-of-life; fatigue; acquired brain injury; paediatrics; participation	QUALITY-OF-LIFE; ACUTE LYMPHOBLASTIC-LEUKEMIA; OUTCOME 30 MONTHS; 1ST 2 YEARS; YOUNG-ADULTS; HEAD-INJURY; FOLLOW-UP; CHILDREN; CHILDHOOD; SCALE	Objective: To assess the degree of fatigue in children and youth after traumatic and non-traumatic brain injury (TBI and NTBI) and related factors. Method: Follow-up study including patients with a hospital-based diagnosis of acquired brain injury (ABI), aged 4-20 years at onset and their parents. Parents and children (dependent on age) completed the Paediatric Quality of Life Inventory (TM) Multidimensional Fatigue Scale (PedsQL (TM) MFS), which measures general fatigue (GF), sleep/rest fatigue (SRF) and cognitive fatigue (CF). Additional assessments included the Child & Family Follow-up Survey (CFFS) and PedsQL (TM) 4.0 General Core Scales and sociodemographic and disease characteristics. Results: Eighty-eight parents completed the PedsQL (TM) MFS 24-30 months after diagnosis, with 49/88 patients (56%) completing the child version. The median age of the patients was 11 years (interquartile range [IQR] = 7). There were 69 patients with TBI (16% moderate/severe TBI) and 19 patients with NTBI (16% moderate/severe NTBI). The median parent-reported and child reported PedsQL (TM) MFS Total Scale Scores were 76.5 (SD = 16.4) and 78.5 (12.9), respectively (Spearman r= 0.450, p = 0.001). Apart from NTBI, increasing age and a single-parent household were significantly associated with more fatigue according to the parent-reported PedsQL (TM) MFS Total Score (and/or one or more sub-scale scores). Conclusion: Two years after onset, in particular, the parent-reported fatigue after NTBI was considerable. Moreover, older children and children from a single-parent household were found to have higher fatigue levels.	[van Markus-Doornbosch, F.; de Kloet, A. J.; Vlieland, T. P. M. Vliet] Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands; [de Kloet, A. J.; Berger, M. A. M.] The Hague Univ Appl Sci, The Hague, Netherlands; [Lambregts, S. A. M.] Revant Rehabil Ctr, Breda, Netherlands; [Lambregts, S. A. M.] Erasmus Univ, Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands; [Wolterbeek, R.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Vlieland, T. P. M. Vliet] Leiden Univ, Med Ctr, Rehabil & Phys Therapy, Dept Orthopaed, Leiden, Netherlands; [Vlieland, T. P. M. Vliet] Rijnlands Rehabil Ctr, Leiden, Netherlands		van Markus-Doornbosch, F (corresponding author), Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	f.vanmarkus@SophiaRevalidatie.nl	Vlieland, Thea Vliet/AAJ-8119-2020	Vlieland, Thea Vliet/0000-0001-6322-3859			Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Aarsen FK, 2006, CANCER-AM CANCER SOC, V106, P396, DOI 10.1002/cncr.21612; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Barlow KM, 2010, PEDIATRICS, V257, P1692; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Berger MA, 2015, DEV NEUROREHABIL, P1; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, J DEV BEHAV PEDIATR, V36, P342, DOI 10.1097/DBP.0000000000000169; Delsing BJP, 2001, PEDIATR NEUROL, V24, P283, DOI 10.1016/S0887-8994(01)00245-4; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Elovic EP, 2005, ISS CLIN COGN NEUROP, P89; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Falk AC, 2013, SCAND J CARING SCI, V27, P51, DOI 10.1111/j.1471-6712.2012.00999.x; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Giza CC, 2008, DEV NEUROSCIENCE, V28, P364; Gordijn MS, 2011, QUAL LIFE RES, V20, P1103, DOI 10.1007/s11136-010-9836-9; Gordijn MS, 2013, PEDIATR BLOOD CANCER, V60, P479, DOI 10.1002/pbc.24261; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Haverman L, 2014, QUAL LIFE RES, V23, P2841, DOI 10.1007/s11136-014-0734-4; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; IBM Corp, 2015, IBM SPSS STAT WIND V; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Meeske K, 2004, CANCER, V101, P2116, DOI 10.1002/cncr.20609; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; Norman, 2003, HLTH MEASUREMENT SCA; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Overweg-Plandsoen WCG, 1999, EUR J PEDIATR, V158, P249, DOI 10.1007/s004310051061; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Simonetti BG, 2015, NEUROLOGY, V84, P1941, DOI 10.1212/WNL.0000000000001555; TEASDALE G, 1974, LANCET, V2, P81; ter Wolbeek M, 2008, PEDIATRICS, V121, pE449, DOI 10.1542/peds.2007-1093; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Visser-Keizer AC, 2015, ARCH PHYS MED REHAB, V96, P1056, DOI 10.1016/j.apmr.2014.12.010; Winward C, 2009, STROKE, V40, P757, DOI 10.1161/STROKEAHA.108.527101; Wu SM, 2015, STROKE, V46, P893, DOI 10.1161/STROKEAHA.114.006647; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	62	8	8	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1533	1541		10.1080/02699052.2016.1197968			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800004	27564406				2022-02-06	
J	Waqas, M; Bakhshi, SK; Shamim, MS; Anwar, S				Waqas, Muhammad; Bakhshi, Saqib Kamran; Shamim, Muhammad Shahzad; Anwar, Saleha			Radiological prognostication in patients with head trauma requiring decompressive craniectomy: Analysis of optic nerve sheath diameter and Rotterdam CT Scoring System	JOURNAL OF NEURORADIOLOGY			English	Article						Decompressive craniectomy; Optic nerve sheath diameter; Rotterdam Computed Tomography Score; Outcomes; Traumatic brain injury	BRAIN-INJURY; INTRACRANIAL HYPERTENSION; TOMOGRAPHY SCAN; PREDICTORS; IMPACT	Introduction: Optic nerve sheath diameter (ONSD) measured on CT scan has been shown to predict outcomes of patients with severe traumatic brain injury. No such relation has been studied in patients undergoing decompressive craniectomy (DC). We evaluated ONSD on admission CT scan to predict outcomes of patients undergoing DC along with Rotterdam CT Score (RCTS). Materials and methods: This retrospective cohort study was approved by the institutional ethics committee. All the consecutive patients undergoing DC with available images and records were included. We measured ONSD 3 mm behind the eyeball and calculated RCTS. Glasgow Outcome Scale (GOS) was measured at last follow-up. We analyzed the data on SPSS v 19. Receiver operator curve analysis (ROC) was done to measure the predictive values of ONSD and RCTS for mortality and unfavorable outcomes. Results: One hundred and seventeen patients were included. Twenty patients had bilateral DC. Mean GCS at presentation was 8.5 +/- 3.5. Mean follow-up was 7.5 +/- 1.2 months. Thirty-day mortality was 19%. Mean ONSD of both eyes was 6.73 +/- 0.89 mm. Area under the curve (AUC) for bilateral mean ONSD as predictor of mortality was 0.49 [95%CI: 0.36-0.62]. AUC for RCTS was as a predictor of 30-day mortality was significant, i.e. 0.67 [95%Cl: 0.572-0.820]. The difference of mean ONSD was also not significantly different between survivor and non-survivors. Conclusion: Admission ONSD in DC patients is high but does not predict mortality and unfavorable outcomes. RCTS has a better prognostic value for predicting mortality and unfavorable outcomes in DC patients. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Waqas, Muhammad; Bakhshi, Saqib Kamran; Shamim, Muhammad Shahzad] Aga Khan Univ Hosp, Neurosurg Sect, Stadium Rd, Karachi 74800, Pakistan; [Anwar, Saleha] Liaquat Natl Hosp Karachi, Dept Radiol, Karachi, Pakistan		Shamim, MS (corresponding author), Aga Khan Univ Hosp, Neurosurg Sect, Stadium Rd, Karachi 74800, Pakistan.	shaiq_waqas@hotmail.com; saqib_dmc@hotmail.com; shahzad.shamim@aku.edu; salehaanwar@hotmail.com	Waqas, Muhammad/A-5673-2013	Waqas, Muhammad/0000-0003-4500-7954			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Carenini BB, 2002, ACTA OPHTHALMOL SCAN, V80, P40; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; GIBBY WA, 1993, AM J ROENTGENOL, V160, P143, DOI 10.2214/ajr.160.1.8416612; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Lovblad KO, 2015, J NEURORADIOLOGY, V42, P191, DOI 10.1016/j.neurad.2015.06.001; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marshall LF, 1991, NEW CLASSIFICATION S, V75, pS14; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Sobani ZA, 2011, SURG NEUROL INT, V2; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	23	8	10	0	3	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	JAN	2016	43	1					25	30		10.1016/j.neurad.2015.07.003			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DE4GL	WOS:000370587100005	26492980				2022-02-06	
J	Worsham, JR; Elliott, MR; Harris, AM				Worsham, Jacob R.; Elliott, Mark R.; Harris, Anthony M.			Open Calcaneus Fractures and Associated Injuries	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						calcaneus chest trauma; open fracture; polytrauma; vascular injury	OS CALCIS; MANAGEMENT	Open calcaneus fractures are usually the result of high-energy mechanisms and are associated with other orthopedic and whole body system injures. Understanding the difference between open versus closed fractures is essential for the provider, and they must be vigilant for the associated injuries that present with this condition. We performed a retrospective medical record review of 62 patients (64 calcaneus fractures) with open calcaneus fractures from January 2003 to January 2013 presenting at a level 1 trauma center. Sex, age, laterality, mechanism of injury, wound appearance, initial management, and associated injures were recorded. The most common mechanisms were motor vehicle accidents (35 [56.4%]) and falls from >6 ft (15 [24.1%]). Four (6.4%) patients had a posterior tibial artery transection. Eight (12.9%) patients had a femoral shaft fracture, 14 (22.5%) an ipsilateral ankle fracture, 16 (25.8%) a metatarsal fracture, and 11 (17.7%) had associated midfoot fractures. Of the midfoot fractures, 12 (19.3%) patients had a talus fracture and 5 (8.0%) a cuboid fracture. Spinal fractures were present in 9 (14.5%) of the patients, with lumbar fractures occurring in 6 (9.6%) patients. Fifteen (24.1%) patients had associated upper extremity fractures. Thirteen (20.9%) patients had an associated pulmonary injury, including 8 pneumothoraces. Ten (16.1%) patients had a closed head injury and 6 (9.6%) had an abdominal injury. Fifteen (23.4%) patients were treated with percutaneous wire fixation and 7 (10.9%) with open reduction internal fixation. A total of 44 (68.7%) fractures were treated without internal fixation. Overall, 5 (8.0%) patients with an open calcaneus fracture eventually underwent a below-the-knee amputation. Open calcaneus fractures are severe, high-energy injuries with the potential for considerable morbidity to the patient, given the high rate of concomitant orthopedic and whole body system injuries. Type III open injuries have an increased risk of requiring subsequent amputation. The management of these injuries should include intravenous antibiotics, tetanus prophylaxis, and urgent debridement and irrigation. (C) 2016 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Worsham, Jacob R.; Elliott, Mark R.; Harris, Anthony M.] Univ Florida, Coll Med Jacksonville, Dept Orthopaed Surg & Rehabil, Jacksonville, FL 32209 USA		Worsham, JR (corresponding author), Univ Florida, Coll Med Jacksonville, Dept Orthopaed Surg & Rehabil, 655 West 8th St,ACC Bldg,2nd Floor, Jacksonville, FL 32209 USA.	Jacob.Worsham@jax.ufl.edu					Aldridge JM, 2004, J ORTHOP TRAUMA, V18, P7, DOI 10.1097/00005131-200401000-00002; Berry GK, 2004, J ORTHOP TRAUMA, V18, P202, DOI 10.1097/00005131-200404000-00002; Brauer CA, 2005, J BONE JOINT SURG AM, V87A, P2741, DOI 10.2106/JBJS.E.00166; Browner B., 2009, FOOT INJURIES, P2626; ESSEXLOPRESTI P, 1952, BRIT J SURG, V39, P395, DOI 10.1002/bjs.18003915704; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; Hermann OJ, 1937, J BONE JOINT SURG, V19, P709; LANCE E M, 1964, J Trauma, V4, P15, DOI 10.1097/00005373-196401000-00003; Lance E M, 1963, Clin Orthop Relat Res, V30, P76; LINDSAY WRN, 1958, AM J SURG, V95, P555, DOI 10.1016/0002-9610(58)90438-0; Mehta S, 2010, J ORTHOP TRAUMA, V24, P142, DOI 10.1097/BOT.0b013e3181b5c0a4; Mitchell M J, 2009, Foot (Edinb), V19, P197, DOI 10.1016/j.foot.2009.05.001; MYERSON M, 1993, J BONE JOINT SURG AM, V75A, P331, DOI 10.2106/00004623-199303000-00004; Ricci WM, 2002, J BONE JOINT SURG AM, V84A, P557, DOI 10.2106/00004623-200204000-00008; ROWE CR, 1963, JAMA-J AM MED ASSOC, V184, P920, DOI 10.1001/jama.1963.03700250056007; Schofield RO, 1936, J BONE JOINT SURG, V18, P566; Sillesen Nanna Hylleholt, 2010, Ugeskr Laeger, V172, P3489; Walters JL, 2014, J FOOT ANKLE SURG, V53, P279, DOI 10.1053/j.jfas.2014.01.012	18	8	10	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	JAN-FEB	2016	55	1					68	71		10.1053/j.jfas.2015.06.015			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	CZ4KF	WOS:000367071200016	26243720				2022-02-06	
J	Zhao, L; Wang, W; Zhong, JW; Li, YY; Cheng, YZ; Su, ZJ; Zheng, W; Guan, XD				Zhao, Ling; Wang, Wei; Zhong, Jiwen; Li, Yayun; Cheng, Yanzi; Su, Zhenjiao; Zheng, Wei; Guan, Xiang-Dong			The effects of magnesium sulfate therapy after severe diffuse axonal injury	THERAPEUTICS AND CLINICAL RISK MANAGEMENT			English	Article						diffuse axonal injury; magnesium sulfate; outcome	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; RATS; ISCHEMIA; DEFICITS; AGE	Purpose: To evaluate the clinical effects of magnesium sulfate in the treatment of diffuse axonal injury (DAI). Patients and methods: This study was a randomized, double-blind, placebo-controlled trial conducted in the First Affiliated Hospital of Sun Yat-sen University, Guangzhou and Zhuhai People's Hospital, Zhuhai, two trauma center hospitals. A total of 128 patients suffered from DAI, with initial Glasgow coma scale (GCS) scores of 3-8. They were randomly divided into two groups: magnesium sulfate treatment (MST) group (n=64) and control group (n=64). The MST group received 250 mu mol/kg magnesium sulfate intravenously 20 minutes after admission, followed by 750 mu mol/kg magnesium sulfate intravenously daily for 5 days. The control group received standard management without MST. GCS scores and serum neuron-specific enolase values were measured and recorded at admission, and on days 3 and 7 after injury. Outcomes were determined by Glasgow outcome scale scores at discharge and at 3 months' follow-up, respectively. Results: After the 7-day treatment, patients in the MST group, compared with those in the control group, had a lower serum neuron-specific enolase level (25.40 +/- 6.66 vs 29.58 +/- 7.32, respectively, P=0.001) and higher GCS score (8.23 +/- 2.72 vs 7.05 +/- 2.64, respectively, P=0.016). Although the length of stay and mortality did not differ between the groups in the intensive care unit, Glasgow outcome scale score was significantly lower in the MST group at discharge (3.30 +/- 1.35 vs 3.90 +/- 1.10, P=0.004) and 3 months after discharge (2.95 +/- 1.48 vs 3.66 +/- 1.44, P=0.009). Conclusion: Early treatment with magnesium sulfate resulted in a significant improvement in DAI outcome. Further studies are needed to confirm the clinical significance of treatment of DAI patients with magnesium sulfate.	[Zhao, Ling; Wang, Wei; Zhong, Jiwen; Li, Yayun; Cheng, Yanzi; Su, Zhenjiao; Zheng, Wei] Zhuhai Peoples Hosp, Dept Crit Care Med, Zhuhai, Guangdong, Peoples R China; [Guan, Xiang-Dong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Crit Care Med, 58,Second Rd ZhongShan Rd, Guangzhou 239000, Guangdong, Peoples R China		Guan, XD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Crit Care Med, 58,Second Rd ZhongShan Rd, Guangzhou 239000, Guangdong, Peoples R China.	13727021051@sina.cn		Wang, Wei/0000-0002-0313-187X			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALTURA BM, 1993, BIOCHIM BIOPHYS ACTA, V1182, P329, DOI 10.1016/0925-4439(93)90077-E; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Clerc P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079982; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Gee JB, 1999, PEDIATR RES, V46, P281, DOI 10.1203/00006450-199909000-00006; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; Kara H, 2014, CLIN INTERV AGING, V9, P17, DOI 10.2147/CIA.S56542; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; MCDONALD JW, 1990, NEUROSCI LETT, V109, P234, DOI 10.1016/0304-3940(90)90569-U; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Muir KW, 1998, STROKE, V29, P918, DOI 10.1161/01.STR.29.5.918; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rowe WJ, 2012, CLIN INTERV AGING, V7, P51, DOI 10.2147/CIA.S28768; STYS PK, 1990, NEUROSCI LETT, V115, P293, DOI 10.1016/0304-3940(90)90471-K; Vennemeyer JJ, 2014, NEUROSCI RES, V84, P72, DOI 10.1016/j.neures.2014.05.001; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; [王维平 Wang Weiping], 2002, [中华创伤杂志, Chinese Journal of Traumatology], V18, P415; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113	26	8	10	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-203X			THER CLIN RISK MANAG	Therap. Clin. Risk Manag.		2016	12									10.2147/TCRM.S109482			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	DX8CA	WOS:000384614500001	27729796	gold, Green Published			2022-02-06	
J	Zhou, YJ; Lu, G; Yang, JL				Zhou, Y. J.; Lu, G.; Yang, J. L.			Finite element study of energy absorption foams for headgear in football (soccer) games	MATERIALS & DESIGN			English	Article						Head injury; Football; Headgear; Energy absorption	IMPACT; CONCUSSION; INJURIES; PLAYERS; MODELS; STRAIN	A validated anatomical finite element head model is used to simulate a scenario of front-rear head impact in football games. The impact responses of the two heads are obtained to assess head injury risks. It has been shown that when the impact velocity nu = 2.5/s the possibility of inducing moderate injury is high and that for server injury is low. However, when the impact velocity nu >= 4/s, the risks of both kinds of injuries are nearly 100%. Consequently, headgear made from energy absorption foams is used in football games to protect the players' heads. The results show that for expanded polypropylene (EPP) foam headgear the optimum thickness is between 8 and 12 mm. In addition, the use of carbon nanotube (CNT) containing foam is proposed for headgear. The effectiveness of CNT foam as headgear is evaluated and compared with that of traditional foams, i.e., EPP and expanded polystyrene (EPS). When impact velocity nu <= 4/s, all these foams with the density of 63 kg/m(3) and the thickness of 8 mm can provide effective protection. CNT foam shows the most effective protection in two-head impact, due to its high energy absorption capacity and excellent property of being recoverable. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhou, Y. J.; Yang, J. L.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Lu, G.] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia		Lu, G (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.	glu@swin.edu.au	Yang, Jinglei/B-1933-2008; Yang, Jinglei/L-2321-2019; Lu, Guoxing/A-3852-2011; Lu, Guoxing/A-6002-2008	Yang, Jinglei/0000-0002-9413-9016; Yang, Jinglei/0000-0002-9413-9016; Lu, Guoxing/0000-0002-4187-616X			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Association FIdF, 2007, 2006 FBC; Avalle M, 2007, INT J IMPACT ENG, V34, P3, DOI 10.1016/j.ijimpeng.2006.06.012; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bradford PD, 2011, CARBON, V49, P2834, DOI 10.1016/j.carbon.2011.03.012; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen WS, 2014, MATER DESIGN, V60, P409, DOI 10.1016/j.matdes.2014.04.038; Coelho RM, 2013, MATER DESIGN, V43, P384, DOI 10.1016/j.matdes.2012.07.020; Cui L, 2009, MAT SCI ENG A-STRUCT, V507, P215, DOI 10.1016/j.msea.2008.12.011; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Franceschini G, 2006, MECH HUMAN BRAIN TIS; Gimbel GM, 2008, EUR J SPORT SCI, V8, P341, DOI 10.1080/17461390802438763; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S., 2007, 20 ESV C P; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Maheo L, 2013, INT J IMPACT ENG, V53, P84, DOI 10.1016/j.ijimpeng.2012.03.011; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mertz H.J., 2002, ACCIDENTAL INJURY BI, P89; Posey R., 2006, SOCCER HEADGEAR EFFE; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Raney JR, 2013, CARBON, V52, P193, DOI 10.1016/j.carbon.2012.09.020; Raps D, 2015, POLYMER, V56, P5, DOI 10.1016/j.polymer.2014.10.078; Ruan J. S., 1994, IMPACT BIOMECHANICS; Schraad MW, 2006, INT J SOLIDS STRUCT, V43, P3542, DOI 10.1016/j.ijsolstr.2005.05.018; Shuaeib FM, 2007, MATER DESIGN, V28, P182, DOI 10.1016/j.matdes.2005.04.015; Srivastava V, 2014, J MATER SCI, V49, P2681, DOI 10.1007/s10853-013-7974-5; Swaren M., 2012, SPORTS TECHNOL, V6, P43; Theuamaran R, 2015, CARBON, V84, P390, DOI 10.1016/j.carbon.2014.12.006; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; Versace J, REV SEVERITY INDEX; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174	41	8	8	2	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	DEC 25	2015	88						162	169		10.1016/j.matdes.2015.08.120			8	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	CV4SR	WOS:000364257300021					2022-02-06	
J	Dahm, J; Ponsford, J				Dahm, Jane; Ponsford, Jennie			Predictors of global functioning and employment 10 years following traumatic brain injury compared with orthopaedic injury	BRAIN INJURY			English	Article							LONG-TERM OUTCOMES; FINNISH PATIENTS 5; QUALITY-OF-LIFE; COMMUNITY INTEGRATION; HEAD-INJURY; MULTIPLE INJURIES; REHABILITATION; DISABILITY; SEVERITY; HEALTH		[Dahm, Jane; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Dahm, Jane; Ponsford, Jennie] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Dahm, J (corresponding author), Monash Univ, Sch Psychol Sci, Bldg 17, Clayton, Vic 3800, Australia.	janedahm@bigpond.com			Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR)	Information for individuals with traumatic brain injury was accessed from data collected for the Longitudinal Head Injury Study funded by the Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR). The authors acknowledge the contribution of Bridget Hill, who calculated ISS and Bethesda scores for all participants.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fleming J, 1999, BRAIN INJURY, V13, P417; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Leung K L, 2005, Work, V25, P333; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Mkandawire NC, 2002, INJURY, V33, P111, DOI 10.1016/S0020-1383(01)00047-X; Morris S, 2000, J TRAUMA, V49, P461, DOI 10.1097/00005373-200009000-00013; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Redmill DA, 2006, INJURY, V37, P243, DOI 10.1016/j.injury.2005.11.014; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zeckey C, 2011, BRAIN INJURY, V25, P551, DOI 10.3109/02699052.2011.568036	56	8	8	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1539	1546		10.3109/02699052.2015.1075141			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800003	26379124				2022-02-06	
J	Ronning, P; Gunstad, PO; Skaga, NO; Langmoen, IA; Stavem, K; Helseth, E				Ronning, Pal; Gunstad, Per Ole; Skaga, Nils-Oddvar; Langmoen, Iver Arne; Stavem, Knut; Helseth, Eirik			The impact of blood ethanol concentration on the classification of head injury severity in traumatic brain injury	BRAIN INJURY			English	Article						TBI; ethanol; head injury; prognosis; coma	GLASGOW COMA SCALE; ALCOHOL-INTOXICATION; SCORE; GUIDELINES; MANAGEMENT; MODERATE; OUTCOMES; LEVEL	Background: Traumatic brain injury (TBI) is classified into mild, moderate and severe, based on the Glasgow Coma Score (GCS). However, TBI patients are often influenced by ethanol, which in itself can attenuate the level of consciousness. This study investigated the effect of ethanol on the GCS group classification in TBI patients.Methods: The Oslo University Hospital trauma database was searched for all patients admitted with a head injury where the blood ethanol concentration (BEC) had been measured (n=1004). The effect of BEC on GCS groups was analysed using multivariate ordinal logistic regression.Results: This study identified 546, 142 and 316 patients in the mild, moderate and severe groups, respectively. Increasing BEC by 1gkg(-1) and pre-hospital intubation had OR=1.34 and 16.34 for being in a more severe GCS group, respectively. Increasing head abbreviated injury scale (head-AIS) was significantly associated with being in a more severe GCS group. The modelled probability of detecting a head-AIS of 4 or 5 in a patient with BEC of 2.0gkg(-1) was 20%, 38% and 65% in the mild, moderate and severe groups, respectively.Conclusions: Increasing BEC was associated with increasing odds of being in a more severe GCS group. However, because the modelled probability of significant brain injury was high in patients with high levels of BEC, a reduced level of consciousness in intoxicated patients mandates further radiological investigations.	[Ronning, Pal; Langmoen, Iver Arne; Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, N-0407 Oslo, Norway; [Gunstad, Per Ole; Langmoen, Iver Arne; Stavem, Knut; Helseth, Eirik] Univ Oslo, Fac Med, N-0316 Oslo, Norway; [Skaga, Nils-Oddvar] Oslo Univ Hosp, Dept Anesthesiol, N-0407 Oslo, Norway; [Stavem, Knut] Akershus Univ Hosp, Res Ctr, Dept Pulm Med, Lorenskog, Norway; [Stavem, Knut] Akershus Univ Hosp, Res Ctr, HOKH, Lorenskog, Norway		Ronning, P (corresponding author), Oslo Univ Hosp, Dept Neurosurg, N-0407 Oslo, Norway.	palronning@gmail.no	Helseth, Eirik/AAH-2466-2020				Agresti A, 2012, ANALYSIS OF ORDINAL; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; American College of Surgeons, 2008, ATLS ADV TRAUM LIF S; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation, 2007, J NEUROTRAUMA S, V24, pS1; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; Goodman LS, 2011, GOODMAN GILMANS THE, pXVI; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hodgkinson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g104; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; R Development Core Team, 2010, R LANG ENV STAT COMP; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Skaga NO, 2007, INJURY, V38, P84, DOI 10.1016/j.injury.2006.04.123; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TEASDALE G, 1974, LANCET, V2, P81; [The American Association of Neurological Surgeons The Brain Trauma Foundation], 2000, J NEUROTRAUM, V17, P463; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; [No title captured]	31	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1648	1653		10.3109/02699052.2015.1075154			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800016	26480239				2022-02-06	
J	Cacioppo, S; Cacioppo, JT				Cacioppo, S.; Cacioppo, J. T.			Why may allopregnanolone help alleviate loneliness?	MEDICAL HYPOTHESES			English	Article							PERCEIVED SOCIAL-ISOLATION; PROGESTERONE METABOLITE; NEUROACTIVE STEROIDS; PHYSIOLOGICAL-ROLE; EXTENDED AMYGDALA; GENE-EXPRESSION; MODEL RELEVANT; BED NUCLEUS; STRESS; HEALTH	Impaired biosynthesis of Allopregnanolone (ALLO), a brain endogenous neurosteroid, has been associated with numerous behavioral dysfunctions, which range from anxiety- and depressive-like behaviors to aggressive behavior and changes in responses to contextual fear conditioning in rodent models of emotional dysfunction. Recent animal research also demonstrates a critical role of ALLO in social isolation. Although there are likely aspects of perceived social isolation that are uniquely human, there is also continuity across species. Both human and animal research show that perceived social isolation (which can be defined behaviorally in animals and humans) has detrimental effects on physical health, such as increased hypothalamic pituitary adrenal (HPA) activity, decreased brain-derived neurotrophic factor (BDNF) expression, and increased depressive behavior. The similarities between animal and human research suggest that perceived social isolation (loneliness) may also be associated with a reduction in the synthesis of ALLO, potentially by reducing BDNF regulation and increasing HPA activity through the hippocampus, amygdala, and bed nucleus of the stria terminalis (BNST), especially during social threat processing. Accordingly, exogenous administration of ALLO (or ALLO precursor, such as pregnenolone), in humans may help alleviate loneliness. Congruent with our hypothesis, exogenous administration of ALLO (or ALLO precursors) in humans has been shown to improve various stress-related disorders that show similarities between animals and humans i.e., post-traumatic stress disorders, traumatic brain injuries. Because a growing body of evidence demonstrates the benefits of ALLO in socially isolated animals, we believe our ALLO hypothesis can be applied to loneliness in humans, as well. (C) 2015 Elsevier Ltd. All rights reserved.	[Cacioppo, S.] Univ Chicago, Pritzker Sch Med, Dept Psychiat & Behav Neurosci, Div Biol Sci, Chicago, IL 60637 USA; [Cacioppo, J. T.] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA		Cacioppo, S (corresponding author), Univ Chicago, Pritzker Sch Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	scacioppo@bsd.uchicago.edu			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG033590]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG033590] Funding Source: NIH RePORTER	Preparation of this article was supported by the National Institute on Aging Grant No. R37AG033590. The authors thank James Estaver from the HPEN laboratory.	Agis-Balboa RC, 2007, P NATL ACAD SCI USA, V104, P18736, DOI 10.1073/pnas.0709419104; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Biggio G, 2014, PSYCHOPHARMACOLOGY, V231, P3437, DOI 10.1007/s00213-014-3521-6; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Brunton PJ, 2014, PROG NEUROBIOL, V113, P106, DOI 10.1016/j.pneurobio.2013.08.005; Cacioppo J.T., 2013, LETHALITY LONELINESS; Cacioppo JT, 2015, PERSPECT PSYCHOL SCI, V10, P202, DOI 10.1177/1745691614564876; Cacioppo JT, 2015, ANNU REV PSYCHOL, V66, P733, DOI 10.1146/annurev-psych-010814-015240; Cacioppo JT, 2014, SOC PERSONAL PSYCHOL, V8, P58, DOI 10.1111/spc3.12087; Cacioppo JT, 2014, COGNITION EMOTION, V28, P3, DOI 10.1080/02699931.2013.837379; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Cacioppo JT, 2000, INT J PSYCHOPHYSIOL, V35, P143, DOI 10.1016/S0167-8760(99)00049-5; Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cacioppo JT, 2002, PSYCHOL SCI, V13, P384, DOI 10.1111/j.0956-7976.2002.00469.x; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Cacioppo JT, 2011, INVISIBLE FORCES POW, P17; Cacioppo S., 2015, COGNITIVE NEUROSCI, P1; Cacioppo S, 2015, CORTEX; Cacioppo S, 2015, PERSPECT PSYCHOL SCI, V10, P238, DOI 10.1177/1745691615570616; Cacioppo S, 2014, PSYCHOL BULL, V140, P1464, DOI 10.1037/a0037618; Cacioppo S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00051; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Cole SW, 2008, BRAIN BEHAV IMMUN, V22, P1049, DOI 10.1016/j.bbi.2008.02.006; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Cole SW, 2011, P NATL ACAD SCI USA, V108, P3080, DOI 10.1073/pnas.1014218108; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Ernst JM, 1999, APPL PREV PSYCHOL, V8, P1, DOI 10.1016/S0962-1849(99)80008-0; Evans J, 2012, NEUROPHARMACOLOGY, V63, P1315, DOI 10.1016/j.neuropharm.2012.08.012; Goossens L, 2015, PERSPECT PSYCHOL SCI, V10, P213, DOI 10.1177/1745691614564878; Griffin LD, 1999, P NATL ACAD SCI USA, V96, P13512, DOI 10.1073/pnas.96.23.13512; Holvast F, 2015, J AFFECT DISORDERS, V185, P1, DOI 10.1016/j.jad.2015.06.036; Kapheim KM, 2015, SCIENCE, V348, P1139, DOI 10.1126/science.aaa4788; Kearns A, 2015, PSYCHOL HEALTH MED, V20, P332, DOI 10.1080/13548506.2014.940354; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Lauder William, 2006, Psychol Health Med, V11, P233, DOI 10.1080/13548500500266607; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Melcangi RC, 2014, PROG NEUROBIOL, V113, P1, DOI 10.1016/j.pneurobio.2013.09.005; Nappi RE, 2001, OBSTET GYNECOL, V97, P77, DOI 10.1016/S0029-7844(00)01112-1; Nelson M, 2011, NEUROPHARMACOLOGY, V60, P1154, DOI 10.1016/j.neuropharm.2010.10.011; Nin Mauricio Schuler, 2011, Front Endocrinol (Lausanne), V2, P73, DOI 10.3389/fendo.2011.00073; Pibiri F, 2008, P NATL ACAD SCI USA, V105, P5567, DOI 10.1073/pnas.0801853105; Pinna G, 2010, BEHAV PHARMACOL, V21, P438, DOI 10.1097/FBP.0b013e32833d8ba0; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Puia G, 2003, NEUROPHARMACOLOGY, V44, P49, DOI 10.1016/S0028-3908(02)00341-6; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; Rapkin AJ, 1997, OBSTET GYNECOL, V90, P709, DOI 10.1016/S0029-7844(97)00417-1; Reddy DS, 2006, NEUROSCIENCE, V138, P911, DOI 10.1016/j.neuroscience.2005.10.016; ROBINSON JA, 1973, ENDOCRINOLOGY, V93, P430, DOI 10.1210/endo-93-2-430; Romeo E, 1998, AM J PSYCHIAT, V155, P910, DOI 10.1176/ajp.155.7.910; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; SIEGEL A, 1990, PROGR PSYCHOBIOLOGY, V14, P135; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Steptoe A, 2004, PSYCHONEUROENDOCRINO, V29, P593, DOI 10.1016/S0306-4530(03)00086-6; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Uzunova V, 1998, P NATL ACAD SCI USA, V95, P3239, DOI 10.1073/pnas.95.6.3239; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2	63	8	8	0	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	DEC	2015	85	6					947	952		10.1016/j.mehy.2015.09.004			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	CY2IG	WOS:000366231400045	26365247	Green Accepted			2022-02-06	
J	Duan, CW; Liu, YH; Lu, L; Cai, RX; Xue, HQ; Mao, XX; Chen, C; Qian, R; Zhang, DM; Shen, AG				Duan, Chengwei; Liu, Yonghua; Lu, Lu; Cai, Rixin; Xue, Huaqing; Mao, Xingxing; Chen, Chen; Qian, Rong; Zhang, Dongmei; Shen, Aiguo			CDK14 Contributes to Reactive Gliosis via Interaction with Cyclin Y in Rat Model of Spinal Cord Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						CDK14; Cyclin Y; Spinal cord injury	TRAUMATIC BRAIN-INJURY; CELL-CYCLE; CONSERVED CYCLIN; NERVOUS-SYSTEM; SCAR FORMATION; REGENERATION; ASTROCYTES; PROTEINS; SUPPRESSION; ACTIVATION	Cyclin-dependent kinases (CDKs) are perceived as the engine that drives cell cycle progression whereas cyclins are considered to be the gears that are changed to aid the transition between cycle phases. CDK14 is a cdc2-related serine/threonine protein kinase and plays an important role in normal cell cycle progression. However, its distribution and function in the central nervous system (CNS) lesion remain unclear. In this study, we mainly investigated the protein expression and cellular localization of CDK14 during spinal cord injury (SCI). Western blot analysis revealed that the expression of CDK14 was gradually increased and reached a peak at 3 days after SCI. The expression of CDK14 was further analyzed by immunohistochemistry. Double immunofluorescence staining showed that CDK14 was co-expressed prominent in astrocytes. Co-localization CDK14/proliferating cell nuclear antigen (PCNA) were detected in glial cells. cyclin Y, which can interact with CDK14, was detected that had same expression trend was consistent with CDK14 Western blot results in SCI. Double-immunofluorescence staining indicated that CDK14 co-expressed with cyclin Y in some cells. Co-immunoprecipitation had been showed that CDK14 could interact with cyclin Y after acute SCI. Taken together, these data suggested that both CDK14 and cyclin Y may play important roles in spinal cord pathophysiology.	[Duan, Chengwei; Xue, Huaqing; Shen, Aiguo] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Liu, Yonghua; Zhang, Dongmei] Nantong Univ, Dept Pathogen Biol, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China; [Lu, Lu; Cai, Rixin] Nantong Univ, Dept Histol & Embryol, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Mao, Xingxing; Chen, Chen; Qian, Rong] Nantong Univ, Dept Orthopaed, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China		Zhang, DM (corresponding author), Nantong Univ, Dept Pathogen Biol, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	zdm@ntu.edu.cn; shen_aiguo@yahoo.com			National Basic Research Program of China (973 Program)National Basic Research Program of China [2012CB822104]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170766, 31270802, 31300902, 31500647]; Natural Science Foundation of the Jiangsu Higher Education Institutions of ChinaNational Natural Science Foundation of China (NSFC) [15KJA310003]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Basic Research Program of China (973 Program, No. 2012CB822104), National Natural Science Foundation of China (31170766, 31270802, 31300902, 31500647); the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 15KJA310003), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen MH, 2014, CELL TISSUE RES, V358, P277, DOI 10.1007/s00441-014-1946-1; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Khalatbary AR, 2012, IRAN RED CRESCENT ME, V14, P229; Lazzaro MA, 1997, J NEUROCHEM, V69, P348, DOI 10.1046/j.1471-4159.1997.69010348.x; Liu DM, 2010, FLY, V4, P278, DOI 10.4161/fly.4.4.12881; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; Mikolcevic P, 2012, CELL CYCLE, V11, P3758, DOI 10.4161/cc.21592; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Shu F, 2007, P NATL ACAD SCI USA, V104, P9248, DOI 10.1073/pnas.0703327104; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tator C H, 1996, J Spinal Cord Med, V19, P206; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011; Witzke O, 2001, TRANSPLANTATION, V72, P369, DOI 10.1097/00007890-200108150-00004; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2; Yang T, 2001, GENE, V267, P165, DOI 10.1016/S0378-1119(01)00391-2; Ying-Tao Z, 2005, EUR J GASTROEN HEPAT, V17, P725, DOI 10.1097/00042737-200507000-00006; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	31	8	8	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	DEC	2015	57	4					571	579		10.1007/s12031-015-0639-x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CW5HJ	WOS:000365026000015	26315607				2022-02-06	
J	Majdan, M; Brazinova, A; Wilbacher, I; Rusnak, M; Mauritz, W				Majdan, M.; Brazinova, A.; Wilbacher, I.; Rusnak, M.; Mauritz, W.			The impact of body mass index on severity, patterns and outcomes after traumatic brain injuries caused by low level falls	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Body mass index; Obesity; Traumatic brain injuries; Outcome; Severity	OBESITY; EPIDEMIOLOGY; RISK	Low level falls are a common cause of traumatic brain injuries (TBI) and are associated with significant mortality and disability. The aim of this study was to analyse whether BMI, height and weight of patients were related to severity, patterns and outcomes of TBI caused by low level falls. Data on patients with TBI where cause of injury was a low level fall (fall < 3 m) with known body mass index (BMI) (N = 683) were analysed. Patients were categorized into underweight, normal, pre-obese and obese based on BMI and demographic characteristics, injury severity, patterns and outcomes were compared. In addition, physiological status, comorbidities and length of hospitalization were analysed in a subset of patients where this information was available. The median BMI was 25.6. About 1/10 of patients were obese. The mean age and proportion of male sex of patients was increasing with increasing BMI. The patients in all BMI groups were of similar injury severity and neurological status. There was also no difference in mortality and functional outcome based on patient's BMI. Obese and pre-obese patients required longer stay at ICU and in hospital. We found no associations between BMI and severity or outcome of TBI caused by low level falls. More detailed data and further studies are needed to fully elucidate these complex relationships.	[Majdan, M.; Brazinova, A.; Rusnak, M.] Trnava Univ, Dept Publ Hlth, Fac Hlth Sci & Social Work, Trnava 91843, Slovakia; [Majdan, M.; Brazinova, A.; Wilbacher, I.; Rusnak, M.; Mauritz, W.] Int Neurotrauma Res Org, A-1080 Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Dept Publ Hlth, Fac Hlth Sci & Social Work, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org; abrazinova@igeh.org; ingrid@wilbacher.at; rusnakm@igeh.org; walter.mauritz@igeh.org	Rusnak, Martin/K-9349-2016; Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Rusnak, Martin/0000-0003-3321-1042; Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X	Ministry of Health; Austrian Worker's Compensation Board (AUVA) [FK 11/2008, FK 11/2010]; Open Society Institute; European Community, Program INCO-DEV: International Cooperation with Developing Countries [ICA2-CT-2002-10005]; Trnava University [12/TU/2014]	We are very grateful to the investigators of the studies within which the data for this analyses were collected who enrolled patients and collected data: Hospital Amstetten (A. Frisch MD, A. Liedler MD, Harald Schmied MD); hospital Feldkirch (R. Folie MD, R. Germann MD PhD, J. Graber RN ICU), Graz University hospital (K. Michaeli MD, R.F. Oswald MD, A. Waltensdorfer MD), trauma hospital Graz (T. Haidacher MD, J. Menner MD), hospital Horn (A. Hublauer MD, E. Nodl MD), Innsbruck University hospital (Ch. Freund MD, KH. Stadlbauer MD), general hospital Klagenfurt (M. Oher MD, E. Trampitsch MD, A. Zechner MD), generalhospital Linz (F. Gruber MD, W. Mitterndorfer MD, S. Rathmaier MS), traumahospital Linz (N. Bauer MD), generalhospital Salzburg (P. Hohenauer MD), traumahospital Salzburg (J. Lanner MD, W. Voelckel Prof. MD), generalhospital Sankt Poelten (C. Mirth MD), hospital Schwarzach (H. Artmann MD, B. Cudrigh MD), general hospital Wiener Neustadt (D. Csomor MD, G. Herzer MD, A. Hofinger MD, H. Trimmel MD), traumahospital Wien Meidling (V. Lorenz MD, H. Steltzer Prof. MD), trauma hospital Wien, Lorenz Boehler"(W. Mauritz Prof. MD) and others. The data used for this study was collected for multiple projects: a project funded by the Ministry of Health (Contract Oct. 15, 2008) and the Austrian Worker's Compensation Board (AUVA; FK 11/2008 and FK 11/2010); the project: An International Health Care Initiative: Improving Patient Outcome from Head Injury in Central and Eastern Europe (1999-2001) was funded by the Open Society Institute; and the project: Reducing mortality and long-term disability of TBI victims through research into treatment procedures used in Bosnia-Herzegovina, Macedonia and Croatia ("RESEARCH TREAT TBI") was financed by the European Community, Program INCO-DEV: International Cooperation with Developing Countries (1998-2002) Project no. ICA2-CT-2002-10005. INRO is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham, and by small donations from various sources. The work of Marek Majdan on this paper was partly funded by an institutional grant of the Trnava University (grant #12/TU/2014).	[Anonymous], 2000, WHO TECHN REP SER; Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; Hoffmann M, 2012, INJURY, V43, P184, DOI 10.1016/j.injury.2011.05.029; Jehle D, 2012, AM J EMERG MED, V30, P191, DOI 10.1016/j.ajem.2010.10.017; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Mock CN, 2002, ACCIDENT ANAL PREV, V34, P221, DOI 10.1016/S0001-4575(01)00017-3; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Newell MA, 2007, J AM COLL SURGEONS, V204, P62, DOI [DOI 10.1016/J.JAMC0LL-62-4), 10.1016/ j. jamcoll-]; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; Osborne Z, 2014, AM J SURG, V207, P387, DOI 10.1016/j.amjsurg.2013.10.013; Pohlert T., 2014, PAIRWISE MULTIPLE CO; R Development Core Team, 2012, R LANG ENV STAT COMP; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryb GE, 2008, J TRAUMA, V64, P406, DOI 10.1097/TA.0b013e31802beff9; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Toevs CC, 2010, CRIT CARE CLIN, V26, P689, DOI 10.1016/j.ccc.2010.06.010	22	8	8	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2015	41	6					651	656		10.1007/s00068-014-0490-8			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CX5TQ	WOS:000365765800009	26038011				2022-02-06	
J	Morrow, SA; Rosehart, H				Morrow, Sarah A.; Rosehart, Heather			Effects of single dose mixed amphetamine salts - extended release on processing speed in multiple sclerosis: a double blind placebo controlled study	PSYCHOPHARMACOLOGY			English	Article						Multiple sclerosis; Randomized clinical trial; Cognitive impairment; Processing speed; Amphetamine; Treatment	DIGIT MODALITIES TEST; NEUROPSYCHOLOGICAL SCREENING QUESTIONNAIRE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; MS PATIENTS; COGNITIVE IMPAIRMENT; SLI381 ADDERALL; METHYLPHENIDATE; VALIDITY; BEHAVIOR	Multiple sclerosis (MS) commonly affects cognitive function, most frequently presenting as impaired processing speed (PS). There are currently no approved treatments for PS in this population, but previous studies suggest amphetamines may be beneficial. The objective of this study is to determine if mixed amphetamine salts, extended release (MAS-XR) has the potential to improve impaired PS in MS patients in a randomized controlled pre- and post-dose testing study. Fifty-two MS patients demonstrating PS impairment on either the Symbol Digit Modalities Test (SDMT) or Paced Auditory Serial Addition Test (PASAT) were randomized to a single dose of 5 mg MAS-XR (n = 18), 10 mg MAS-XR (n = 20), or placebo (n = 14). Subjects were evaluated a second time, after taking the blinded medication. ANOVA was used to compare the change on the SDMT and PASAT in each of the treatment groups compared to the placebo. Cohen's d was used to calculate effect size. At baseline, the mean SDMT score was 43.3 +/- 7.2 and the mean PASAT was 34.8 +/- 13.4, with 47 (90.4 %) and 25 (48.1 %) categorized as impaired on the SDMT and PASAT, respectively. The change in SDMT scores from baseline to post-treatment demonstrated significant improvement for the MAS-XR 10-mg dose compared to placebo, increasing by 5.2 +/- 4.5 vs. 0.6 +/- 4.4 points (p = 0.043), with a medium effect size of 0.47. Change on the PASAT was not significantly different in either treatment group. This study supports MAS-XR 10 mg as a potential treatment for MS patients with demonstrated PS impairment, warranting a larger longitudinal study.	[Morrow, Sarah A.; Rosehart, Heather] Univ Western Ontario, London Hlth Sci Ctr, Dept Clin Neurol Sci, LHSC UH, London, ON N5A 5A5, Canada		Morrow, SA (corresponding author), Univ Western Ontario, London Hlth Sci Ctr, Dept Clin Neurol Sci, LHSC UH, 339 Windermere Rd, London, ON N5A 5A5, Canada.	sarah.morrow@lhsc.on.ca			Internal Research Fund (IRF), Department of Clinical Neurological Sciences, Western University	Funding was provided by the Internal Research Fund (IRF), Department of Clinical Neurological Sciences, Western University.	Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Barch DM, 2005, SCHIZOPHR RES, V77, P43, DOI 10.1016/j.schres.2004.12.019; Beatty WW, 1995, J NEUROL REHABIL, V9, P167; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Benedict RHB, 2001, J NEUROPSYCH CLIN N, V13, P70, DOI 10.1176/appi.neuropsych.13.1.70; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; Biederman J, 2002, PEDIATRICS, V110, P258, DOI 10.1542/peds.110.2.258; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gehring K, 2012, J NEURO-ONCOL, V107, P165, DOI 10.1007/s11060-011-0723-1; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Harel Y, 2009, J NEUROL SCI, V276, P38, DOI 10.1016/j.jns.2008.08.025; Heal DJ, 2009, NEUROPHARMACOLOGY, V57, P608, DOI 10.1016/j.neuropharm.2009.08.020; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kujala P, 1997, BRAIN, V120, P289, DOI 10.1093/brain/120.2.289; Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076; McGough JJ, 2003, J AM ACAD CHILD PSY, V42, P684, DOI 10.1097/01.CHI.0000046850.56865.CB; McKeage K, 2003, CNS DRUGS, V17, P669, DOI 10.2165/00023210-200317090-00006; Morrow SA, 2010, MULT SCLER J, V16, P1385, DOI 10.1177/1352458510378021; Morrow SA, 2013, J NEUROL, V260, P489, DOI 10.1007/s00415-012-6663-7; Morrow SA, 2010, CLIN NEUROPSYCHOL, V24, P1131, DOI 10.1080/13854046.2010.511272; Morrow SA, 2009, J NEUROL, V256, P1095, DOI 10.1007/s00415-009-5074-x; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; Pharmaceuticals S, 2011, MED GUID HIGHL PRESC; Pietrzak RH, 2010, HUM PSYCHOPHARM CLIN, V25, P353, DOI 10.1002/hup.1118; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; Rao SM., 1991, MANUAL BRIEF REPEATA; Rhodes SM, 2004, PSYCHOPHARMACOLOGY, V175, P319, DOI 10.1007/s00213-004-1833-7; Schweitzer JB, 2004, BIOL PSYCHIAT, V56, P597, DOI 10.1016/j.biopsych.2004.07.011; Schwid SR, 2007, J NEUROL SCI, V255, P57, DOI 10.1016/j.jns.2007.01.070; Smith A., 1982, SYMBOL DIGIT MODALIT; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7	41	8	8	0	21	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	DEC	2015	232	23					4253	4259		10.1007/s00213-015-4051-6			7	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CU1GP	WOS:000363268800002	26289355				2022-02-06	
J	Pan, JW; Gao, XW; Jiang, H; Li, YF; Xiao, F; Zhan, RY				Pan, Jian-Wei; Gao, Xiong-Wei; Jiang, Hao; Li, Ya-Feng; Xiao, Feng; Zhan, Ren-Ya			Low serum ficolin-3 levels are associated with severity and poor outcome in traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Ficolin-3; Traumatic brain injury; Clinical outcome; Mortality	MANNAN-BINDING-LECTIN; COMPLEMENT-SYSTEM; INFLAMMATION; ACTIVATION; PATHWAY; NEUROPROTECTION; BIOMARKERS; PROGNOSIS; MORTALITY; PROPERDIN	Background: Ficolin-mediated activation of the lectin pathway of complement contributes to the complement-independent inflammatory processes of traumatic brain injury. Lower serum ficolin-3 levels have been demonstrated to be highly associated with unfavorable outcome after ischemic stroke. This prospective observatory study was designed to investigate the relationships between serum ficolin-3 levels and injury severity and clinical outcomes after severe traumatic brain injury. Methods: Serum ficolin-3 levels of 128 patients and 128 healthy controls were measured by sandwich immunoassays. An unfavorable outcome was defined as Glasgow Outcome Scale score of 1-3. Study endpoints included mortality at 1 week and 6 months and unfavorable outcome at 6 months after head trauma. Injury severity was assessed by Glasgow Coma Scale score. Multivariate logistic models were structured to evaluate the relationships between serum ficolin-3 levels and study endpoints and injury severity. Results: Compared with the healthy controls, serum ficolin-3 levels on admission were statistically decreased in patients with severe traumatic brain injury. Serum ficolin-3 levels were independently correlated with Glasgow Coma Scale scores. Ficolin-3 was also identified as an independent prognostic predictor for 1-week mortality, 6-month mortality, and 6-month unfavorable outcome. Under receiver operating characteristics curves, ficolin-3 has similar prognostic predictive values for all study endpoints compared with Glasgow Coma Scale scores. Conclusions: It was proposed that lower serum ficolin-3 levels, correlated with injury severity, had the potential to be the useful, complementary tool to predict short-or long-term clinical outcomes after severe traumatic brain injury.	[Pan, Jian-Wei; Jiang, Hao; Xiao, Feng; Zhan, Ren-Ya] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Xiong-Wei; Li, Ya-Feng] Sanmen Peoples Hosp, Dept Neurosurg, Sanmen 317100, Peoples R China		Zhan, RY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jwpfxjsryz@163.com		Pan, Jianwei/0000-0001-6353-1843	National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81200954]	The authors thank all staffs in the Department of Neurosurgery of the Sanmen People's Hospital (Sanmen, China) for their technical support. This project is supported by the National Natural Science Foundation (grant no. 81200954).	Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Boldt ABW, 2012, ADV CLIN CHEM, V56, P105, DOI 10.1016/B978-0-12-394317-0.00012-1; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Chen H, 2012, J MOL CELL BIOL, V4, P256, DOI 10.1093/jmcb/mjs032; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Doni A, 2012, IMMUNOBIOLOGY, V217, P1122, DOI 10.1016/j.imbio.2012.07.004; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Fust G, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-185; Fujita T, 2013, DIABETES-METAB RES, V29, P220, DOI 10.1002/dmrr.2380; Fulkerson DH, 2015, J NEUROSURG PEDIAT, V3, P1; Gadjeva M, 2001, CURR OPIN IMMUNOL, V13, P74, DOI 10.1016/S0952-7915(00)00185-0; Gadjeva M, 2014, METHODS MOL BIOL, V1100, P1, DOI 10.1007/978-1-62703-724-2_1; Gorji Mohammad Ali Heidari, 2015, Int J Appl Basic Med Res, V5, P92, DOI 10.4103/2229-516X.157152; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Halmos A, 2012, CLIN EXP IMMUNOL, V169, P49, DOI 10.1111/j.1365-2249.2012.04590.x; Harvey H, 2014, EXP BRAIN RES, V232, P3363, DOI 10.1007/s00221-014-4078-7; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Hertle E, 2014, MOL IMMUNOL, V61, P135, DOI 10.1016/j.molimm.2014.06.031; Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Matsushita M, 1996, RES IMMUNOL, V147, P115, DOI 10.1016/0923-2494(96)87185-9; Monaco EA, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000430738.63491.f3; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Nonaka Masaru, 2014, Subcell Biochem, V80, P31, DOI 10.1007/978-94-017-8881-6_3; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Prohaszka Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060976; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Xu JF, 2012, J TRAUMA ACUTE CARE, V72, P491, DOI 10.1097/TA.0b013e318226ec39; Yanamadala V, 2010, TRENDS MOL MED, V16, P69, DOI 10.1016/j.molmed.2009.12.001; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zanier ER, 2014, NEUROLOGY, V82, P126, DOI 10.1212/WNL.0000000000000020; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003; Zhang XY, 2016, ACTA DIABETOL, V53, P295, DOI 10.1007/s00592-015-0780-6; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	49	8	8	2	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	DEC 1	2015	12								226	10.1186/s12974-015-0444-z			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CX5ZY	WOS:000365782200003	26627059	gold, Green Published			2022-02-06	
J	Sucksdorff, D; Brown, AS; Chudal, R; Jokiranta-Olkoniemi, E; Leivonen, S; Suominen, A; Heinimaa, M; Sourander, A				Sucksdorff, Dan; Brown, Alan S.; Chudal, Roshan; Jokiranta-Olkoniemi, Elina; Leivonen, Susanna; Suominen, Auli; Heinimaa, Markus; Sourander, Andre			Parental and comorbid epilepsy in persons with bipolar disorder	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Bipolar disorder; Epilepsy; Parental psychopathology; Population-based study; Register; Epidemiology	POPULATION-BASED COHORT; TRAUMATIC BRAIN-INJURY; I DISORDER; PSYCHIATRIC-DISORDERS; PSYCHOTIC DISORDERS; NATURAL-HISTORY; RISK-FACTORS; PREVALENCE; REGISTER; LIFETIME	Background: Population based studies have demonstrated an overrepresentation of bipolar disorder (BPD) in individuals with epilepsy. However, few studies have examined the reverse association, i.e. comorbid epilepsy in individuals selected based on BPD diagnosis. No previous population based study having examined the co occurrence of BPD and epilepsy has adjusted for parental psychopathology. Such an adjustment is motivated by population based studies reporting an overrepresentation of various types of parental psychiatric disorders in both BPD and epilepsy. Furthermore, art association between epilepsy in first degree relatives and BPD has previously only been examined and demonstrated in a small clinical sample. The objective of this study is to examine the associations between parental and comorbicl epilepsy and BPD, adjusting for parental psychopathology. Methods: This nested case control study identified 1861 cases with BPD, age up to 25 years, 3643 matched controls, and their parents from Finnish national registers. Conditional logistic regression was used to calculate odds ratios (ORs) with 95% confidence intervals (Cls) and two-sided significance limits of p < 0.05. Results: BPD was associated with comorbid epilepsy (adjusted OR 2.53, 95% Cl. 1.73-3.70) but not with parental epilepsy. Epilepsy was found in 3.33% of cases versus 1.29% of controls, 2.69% of cases' parents versus 2.53% of controls' parents. Limitations: The diagnoses were register-based, not based on standardized procedures with direct ascertainment. Conclusions: An association between BPD and comorbid epilepsy persists even after adjusting for parental psychopathology. Lack of familial clustering of BPD and epilepsy would suggest that the elevated co-occurrence of these disorders is influenced by non-genetic factors. (c) 2015 Elsevier B.V. All rights reserved	[Sucksdorff, Dan; Chudal, Roshan; Jokiranta-Olkoniemi, Elina; Leivonen, Susanna; Suominen, Auli; Sourander, Andre] Univ Turku, Res Ctr Child Psychiat, Turku 20014, Finland; [Brown, Alan S.] Columbia Univ, Med Ctr, Dept Psychiat, New York State Psychiat Inst, New York, NY USA; [Brown, Alan S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Heinimaa, Markus] Univ Turku, Dept Psychiat, Turku, Finland; [Sourander, Andre] Univ Turku, Dept Child Psychiat, Turku, Finland		Sucksdorff, D (corresponding author), Univ Turku, Res Ctr Child Psychiat, Lemminkaisenkatu 3 Teutori 3rd Floor, Turku 20014, Finland.	dansuc@utu.fi		Sourander, Andre/0000-0003-0361-7244	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH082052] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH082052] Funding Source: Medline		Adelow C, 2012, NEUROLOGY, V78, P396, DOI 10.1212/WNL.0b013e318245f461; Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; Bakken IJ, 2014, EPILEPSY RES, V108, P1435, DOI 10.1016/j.eplepsyres.2014.06.021; Castagnini AC, 2013, PSYCHOL MED, V43, P2369, DOI 10.1017/S0033291713000044; Chang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059999; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Chudal R, 2014, NORD J PSYCHIAT, V68, P169, DOI 10.3109/08039488.2013.789073; Clarke MC, 2012, BIOL PSYCHIAT, V71, P836, DOI 10.1016/j.biopsych.2012.01.011; Corey LA, 2011, EPILEPSY RES, V97, P103, DOI 10.1016/j.eplepsyres.2011.07.018; Dean K, 2010, ARCH GEN PSYCHIAT, V67, P822, DOI 10.1001/archgenpsychiatry.2010.86; DUBOVSKY SL, 1994, EUR ARCH PSY CLIN N, V243, P229, DOI 10.1007/BF02191579; Ettinger AB, 2005, NEUROLOGY, V65, P535, DOI 10.1212/01.wnl.0000172917.70752.05; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Hsieh MH, 2012, BIPOLAR DISORD, V14, P677, DOI 10.1111/j.1399-5618.2012.01039.x; Italiano D, 2015, BRIT J CLIN PHARMACO, V79, P1010, DOI 10.1111/bcp.12577; Jerrell JM, 2010, J CLIN PSYCHIAT, V71, P1518, DOI 10.4088/JCP.09m05585ora; Jidda MS, 2014, J AFFECT DISORDERS, V161, P84, DOI 10.1016/j.jad.2014.02.040; Kanner AM, 2009, NEUROLOGY, V72, P793, DOI 10.1212/01.wnl.0000343850.85763.9c; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P699; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khalsa HMK, 2008, J AFFECT DISORDERS, V106, P179, DOI 10.1016/j.jad.2007.05.027; Kieseppa T, 2000, ACTA NEUROPSYCHIATR, V12, P106, DOI 10.1017/S0924270800035535; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Kjeldsen MJ, 2001, EPILEPSY RES, V44, P167, DOI 10.1016/S0920-1211(01)00196-6; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Laursen TM, 2005, ARCH GEN PSYCHIAT, V62, P841, DOI 10.1001/archpsyc.62.8.841; Martin RC, 2014, EPILEPSIA, V55, P1120, DOI 10.1111/epi.12649; Mazza M, 2007, NEUROSCIENTIST, V13, P392, DOI 10.1177/10738584070130041101; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Morgan VA, 2012, BRIT J PSYCHIAT, V200, P282, DOI 10.1192/bjp.bp.111.093070; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; Mula M, 2010, EXPERT REV NEUROTHER, V10, P13, DOI 10.1586/ERN.09.139; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; SPECKMANN EJ, 1993, NEUROPSYCHOBIOLOGY, V27, P122, DOI 10.1159/000118966; Sucksdorff D, 2014, SOC PSYCH PSYCH EPID, V49, P1973, DOI 10.1007/s00127-014-0885-1; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Wotton CJ, 2014, SOC PSYCH PSYCH EPID, V49, P1483, DOI 10.1007/s00127-014-0853-9; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	40	8	8	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	DEC 1	2015	188						107	111		10.1016/j.jad.2015.08.051			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CV3OI	WOS:000364168100015	26356289	Green Accepted			2022-02-06	
J	Terzioglu, B; Ekinci, O; Berkman, Z				Terzioglu, Berna; Ekinci, Osman; Berkman, Zafer			Hyperglycemia is a predictor of prognosis in traumatic brain injury: Tertiary intensive care unit study	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Acute physiology and chronic health examination (APACHE) II; Glasgow coma scale (GCS); glucose; hyperglycemia; intensive care unit (ICU); mortality; traumatic brain injury	ADMISSION HYPERGLYCEMIA; EMERGENCY-DEPARTMENT; MORTALITY; ASSOCIATION; IMPACT	Background: Hyperglycemia is frequently encountered in critically ill patients and has been shown to contribute to both morbidity and mortality. We aimed to study the predictive role of blood glucose level in clinical outcomes of mechanically ventilated patients with traumatic brain injury during intensive care unit (ICU) stay and to explore its relationship with Glasgow coma scale (GCS) and acute physiology and chronic health examination (APACHE) II scores that are used in the evaluation of ICU patients as predictor. Materials and Methods: A total of 185 patients with craniocerebral trauma who were hospitalized in the ICU were included in the study. Comparisons of mean glucose values (MGVs) and APACHE II scores between survivors and nonsurvivors were made with Student's t-test and chi-square test. Survival analysis was performed with log rank (Mantel-Cox) test and Cox regression was used for mortality risk factors analysis. Results: MGVs at the initial, last, and all measurements were significantly higher for nonsurvivors than for survivors. Hazard rate at any given time point for patients with mean glucose value (MGV) between 150 and 179 was found to be 3.691 times that of patients with MGV values between 110 and 149. The hazard rate at any given time point for patients with MGV values >= 180 was found to be 6.571 times that of patients with MGV values between 110 and 149. Conclusion: High glucose level is an independent risk factor for mortality in mechanically ventilated ICU patients with traumatic brain injury.	[Terzioglu, Berna] Haydarpasa Numune Res & Training Hosp, Pharmacol & Toxicol Unit, Dept Biochem, TR-34668 Istanbul, Turkey; [Ekinci, Osman] Haydarpasa Numune Res & Training Hosp, Dept Anesthesiol & Reanimat, TR-34668 Istanbul, Turkey; [Berkman, Zafer] Haydarpasa Numune Res & Training Hosp, Dept Neurosurg, TR-34668 Istanbul, Turkey		Terzioglu, B (corresponding author), Haydarpasa Numune Res & Training Hosp, Pharmacol & Toxicol Unit, Dept Biochem, TR-34668 Istanbul, Turkey.	bernaterzioglu@yahoo.com	Terzioglu, Berna/AAW-9716-2020; BEBITOGLU, BERNA TERZIOGLU/E-1533-2019	Terzioglu, Berna/0000-0003-4601-7871; BEBITOGLU, BERNA TERZIOGLU/0000-0003-4601-7871			Bian LH, 2013, CLIN NEUROL NEUROSUR, V115, P959, DOI 10.1016/j.clineuro.2012.09.026; Bochicchio GV, 2007, J TRAUMA, V63, P1353, DOI 10.1097/TA.0b013e31815b83c4; Bochicchio Grant V, 2008, Adv Surg, V42, P261, DOI 10.1016/j.yasu.2008.03.006; Gardner LS, 2015, EMERG MED J, V32, P608, DOI 10.1136/emermed-2014-204046; Gore DC, 2001, J TRAUMA, V51, P540, DOI 10.1097/00005373-200109000-00021; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Krinsley JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0908-7; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Martin WG, 2015, INTERN MED J, V45, P916, DOI 10.1111/imj.12841; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Weir CJ, 1997, BMJ-BRIT MED J, V314, P1303, DOI 10.1136/bmj.314.7090.1303; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zali Ali Reza, 2012, Glob J Health Sci, V4, P179, DOI 10.5539/gjhs.v4n3p179	18	8	9	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	DEC	2015	20	12					1166	1171		10.4103/1735-1995.172984			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB6MV	WOS:000368630000007	26958051	Green Published, gold, Green Submitted			2022-02-06	
J	Wortzel, HS; Granacher, RP				Wortzel, Hal S.; Granacher, Robert P., Jr.			Mild Traumatic Brain Injury Update: Forensic Neuropsychiatric Implications	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							HEAD-INJURY; CONCUSSION; RECOVERY	Traumatic brain injury (TBI) involves a wide range of potential neuropsychiatric outcomes, from death or profound impairment to full and fast recovery. This circumstance has contributed to an atmosphere with considerable potential for both clinical confusion and unjustified medicolegal outcomes. Given that mild (m)TBI accounts for most (similar to 80%) TBI events and is generally associated with an excellent prognosis, the risk for erroneous clinical formulations and unmerited legal outcomes seems particularly high in cases involving mTBI. In this article, we summarize the recent results published by the International Collaboration on Mild Traumatic Brain Injury Prognosis (ICMTBIP) and the new approach of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, to TBI, and we explore the clinical and medicolegal implications. Symptoms that emerge after mTBI remain nonspecific, and potential etiologies are diverse. Clinicians and medicolegal experts should be familiar with the natural history of mTBI, able to recognize atypical outcomes, and willing to search for alternative explanations when confronted with persistent or severe impairment.	[Wortzel, Hal S.] Denver Vet Med Ctr, Neuropsychiat Consultat Serv, Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Denver, CO USA; [Wortzel, Hal S.] Univ Colorado, Sch Med, Neurocognit Dis, Denver, CO USA; [Wortzel, Hal S.] Univ Colorado, Sch Med, Psychiat Neurol & Phys Med & Rehabil, Denver, CO USA; [Granacher, Robert P., Jr.] Univ Kentucky, Coll Med, Psychiat, Lexington, KY USA		Wortzel, HS (corresponding author), Denver Vet Hosp, Rocky Mt MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	hal.wortzel@ucdenver.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS101, DOI 10.1016/j.apmr.2013.12.001; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Felthous AR, 2014, J AM ACAD PSYCHIATRY, V42, P305; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086	26	8	10	0	8	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law	DEC 1	2015	43	4					499	505					7	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	CZ9MR	WOS:000367422200013	26668228				2022-02-06	
J	Chiou, KS; Sandry, J; Chiaravalloti, ND				Chiou, Kathy S.; Sandry, Joshua; Chiaravalloti, Nancy D.			Cognitive contributions to differences in learning after moderate to severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Cognition; Memory disorders; Rehabilitation; Brain injuries	WORKING-MEMORY CAPACITY; LONG-TERM-MEMORY; ADULT INTELLIGENCE SCALE; INDIVIDUAL-DIFFERENCES; HEAD-INJURY; FLUID INTELLIGENCE; DIGIT SPAN; CONSOLIDATION DEFICITS; EXECUTIVE ATTENTION; DIVIDED ATTENTION	Introduction: Deficits in learning and memory are commonly observed after traumatic brain injury (TBI); however, the mechanisms underlying such deficits are poorly understood. This study examines the contribution of other cognitive processes in verbal learning after moderate to severe TBI. Adults with TBI who have verbal learning deficits were predicted to perform worse on executive measures than adults who are able to learn. Method: Participants were 51 community-dwelling adult volunteers (age 18-59) with moderate to severe TBI. Injury severity was determined by Glasgow Coma Scale score <= 12 and corroborating information from medical records. Group membership (TBI-learners or TBI-nonlearners) was determined by a learning criterion of perfect recall on 2 consecutive trials within 15 trials on the open-trial Selective Reminding Test. All participants completed a comprehensive neuropsychological test battery. Group differences were examined using independent-samples t tests, and logistic regression was used to determine significant predictors of learning ability. Results: The TBI-learner group performed better than the TBI-nonlearner group most consistently on tasks of executive control and working memory. Results of a logistic regression showed that working memory capacity was the most significant predictor of learning ability after TBI. Conclusions: Working memory significantly influences the ability to learn verbal information after TBI. The documented relationship between working memory and learning will guide the development of more efficacious treatments to rehabilitate learning and memory deficits after TBI.	[Chiou, Kathy S.; Chiaravalloti, Nancy D.] Kessler Fdn, Traumat Brain Injury Res, W Orange, NJ 07052 USA; [Chiou, Kathy S.; Sandry, Joshua; Chiaravalloti, Nancy D.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Sandry, Joshua; Chiaravalloti, Nancy D.] Kessler Fdn, Neuropsychol & Neurosci Res, W Orange, NJ 07052 USA		Chiou, KS (corresponding author), Kessler Fdn, Traumat Brain Injury Res, 300 Execut Dr,Suite 70, W Orange, NJ 07052 USA.	kchiou@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	Northern NJ TBI Model Systems [H133A070037]; US Department of Education-National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133P090009]	This work was supported by the Northern NJ TBI Model Systems [grant number H133A070037]; and the US Department of Education-National Institute on Disability and Rehabilitation Research [grant number H133P090009]. However, the contents do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Government should not be assumed.	Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Andersen R, 2013, EUR PSYCHIAT, V28, P332, DOI 10.1016/j.eurpsy.2012.06.003; Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Burgess N, 2005, TRENDS COGN SCI, V9, P535, DOI 10.1016/j.tics.2005.09.011; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Camos V, 2015, PSYCHON B REV, V22, P1029, DOI 10.3758/s13423-014-0772-5; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Chiaravalloti N. D., NEUROREHABI IN PRESS; Chiaravalloti ND, 2013, J CLIN EXP NEUROPSYC, V35, P180, DOI 10.1080/13803395.2012.760537; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Chiaravalloti ND, 2003, J CLIN EXP NEUROPSYC, V25, P489, DOI 10.1076/jcen.25.4.489.13878; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Constantinidou F, 2014, J INT NEUROPSYCH SOC, V20, P822, DOI 10.1017/S1355617714000678; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cowan N., 2005, WORKING MEMORY CAPAC; Delis D, 2000, DELIS KAPLAN EXECUTI; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donders J, 2008, J CLIN EXP NEUROPSYC, V30, P741, DOI 10.1080/13803390701689595; Dougherty MR, 2016, PSYCHON B REV, V23, P306, DOI 10.3758/s13423-015-0865-9; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Germano C, 2005, NEUROPSYCHOL REV, V15, P1, DOI 10.1007/s11065-005-3583-7; Glosser G, 2002, NEUROPSYCHOLOGY, V16, P190, DOI 10.1037//0894-4105.16.2.190; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Harrison TL, 2013, PSYCHOL SCI, V24, P2409, DOI 10.1177/0956797613492984; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Karbach J, 2014, PSYCHOL SCI, V25, P2027, DOI 10.1177/0956797614548725; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lange G, 2000, ARCH PHYS MED REHAB, V81, P89, DOI 10.1016/S0003-9993(00)90227-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loaiza VM, 2013, AGING NEUROPSYCHOL C, V20, P471, DOI 10.1080/13825585.2012.738289; Loaiza VM, 2012, MEM COGNITION, V40, P191, DOI 10.3758/s13421-011-0148-2; Loaiza VM, 2011, J EXP PSYCHOL LEARN, V37, P1258, DOI 10.1037/a0023923; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Martin DM, 2013, INT J NEUROPSYCHOPH, V16, P1927, DOI 10.1017/S1461145713000539; MASSON MEJ, 1983, J EDUC PSYCHOL, V75, P314, DOI 10.1037/0022-0663.75.2.314; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCabe DP, 2008, J MEM LANG, V58, P480, DOI 10.1016/j.jml.2007.04.004; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McKinlay W. M., 1999, REHABILITATION ADULT; Melby-Lervag M, 2016, PSYCHON B REV, V23, P324, DOI 10.3758/s13423-015-0862-z; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ranganath C, 2005, J COGNITIVE NEUROSCI, V17, P994, DOI 10.1162/0898929054475118; Richmond LL, 2014, J COGNITIVE NEUROSCI, V26, P2443, DOI 10.1162/jocn_a_00657; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rose NS, 2012, J EXP PSYCHOL LEARN, V38, P1019, DOI 10.1037/a0026976; Rose NS, 2010, J EXP PSYCHOL LEARN, V36, P471, DOI 10.1037/a0018405; SALTHOUSE TA, 1994, J EXP PSYCHOL LEARN, V20, P1486, DOI 10.1037/0278-7393.20.6.1486; Sandry J, 2015, NEURODEGENER DIS MAN, V5, P1, DOI [10.2217/nmt.14.51, 10.2217/NMT.14.51]; Sandry J, 2015, J NEUROL, V262, P59, DOI 10.1007/s00415-014-7523-4; Sandry J, 2014, J INT NEUROPSYCH SOC, V20, P868, DOI 10.1017/S1355617714000630; Sarkis R.A., 2014, CURR BEHAV NEUROSCI, V1, P74, DOI 10.1007/s40473-014-0009-y; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shipstead Z, 2014, J MEM LANG, V72, P116, DOI 10.1016/j.jml.2014.01.004; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Smith A., 1982, SYMBOL DIGIT MODALIT; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Unsworth N, 2016, J EXP PSYCHOL LEARN, V42, P50, DOI 10.1037/xlm0000148; Unsworth N, 2014, COGNITIVE PSYCHOL, V71, P1, DOI 10.1016/j.cogpsych.2014.01.003; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Whiting MD, 2008, BRAIN RES, V1213, P69, DOI 10.1016/j.brainres.2008.01.107; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9	106	8	8	0	44	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 26	2015	37	10					1074	1085		10.1080/13803395.2015.1078293			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CR5OR	WOS:000361393100006	26325609				2022-02-06	
J	Falchook, AD; Porges, EC; Nadeau, SE; Leon, SA; Williamson, JB; Heilman, KM				Falchook, Adam D.; Porges, Eric C.; Nadeau, Stephen E.; Leon, Susan A.; Williamson, John B.; Heilman, Kenneth M.			Cognitive-motor dysfunction after severe traumatic brain injury: A cerebral interhemispheric disconnection syndrome	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Ideomotor apraxia; Action-intention; Traumatic brain injury; Limb kinetic apraxia; Corpus callosum	LIMB-KINETIC APRAXIA; CLOSED-HEAD-INJURY; CALLOSAL DISCONNECTION; PARKINSON-DISEASE; REACTION-TIMES; NEGLECT; STROKE; REPRESENTATIONS; DEGENERATION; PERFORMANCE	Background/Objectives: In most right-handed people, the left hemisphere is dominant for programming the temporal and spatial "how" (praxis) aspects of purposeful skilled movements, and the right hemisphere is dominant for control of the intentional "when" aspects of actions that mediate initiation, persistence, termination, and inhibition. Since the interhemispheric axons of the corpus callosum are especially susceptible to shearing from torsional forces during traumatic brain injury (TBI), the goal of this study was to learn whether participants with a history of severe traumatic brain injury demonstrate three types of cognitive-motor impairments that may result from callosal injury: ideomotor apraxia of the left hand, limb kinetic apraxia of the left hand, and hypokinesia of the right hand in response to left hemispatial stimuli. Method: Nine participants with severe TBI and nine healthy control participants were studied for the presence of ideomotor apraxia, limb kinetic apraxia, and hypokinesia. Results: When compared to the control participants, the participants with TBI revealed ideomotor apraxia and limb kinetic apraxia of the left hand and hypokinesia in response to left-sided visual stimuli when tested with the right hand. Conclusions: TBI appears to cause unilateral disorders of cognitive-motor functions. Future research is needed to understand how these cognitive-motor disorders are related to interhemispheric disconnection most likely induced by injury to the corpus callosum.	[Falchook, Adam D.; Porges, Eric C.; Nadeau, Stephen E.; Leon, Susan A.; Williamson, John B.; Heilman, Kenneth M.] Malcom Randall VAMC, Brain Rehabil Res Ctr, Gainesville, FL USA; [Falchook, Adam D.; Nadeau, Stephen E.; Leon, Susan A.; Williamson, John B.; Heilman, Kenneth M.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Falchook, Adam D.; Nadeau, Stephen E.; Leon, Susan A.; Williamson, John B.; Heilman, Kenneth M.] McKnight Brain Inst, Ctr Neuropsychol Studies, Gainesville, FL USA; [Falchook, Adam D.; Porges, Eric C.; Nadeau, Stephen E.; Williamson, John B.; Heilman, Kenneth M.] Univ Florida, Inst Aging, Gainesville, FL USA; [Heilman, Kenneth M.] Malcom Randall VAMC, Geriatr Res Educ & Clin Ctr, Gainesville, FL USA		Falchook, AD (corresponding author), Boca Raton Neurol Associates, 1050 NW 15th St,Suite 216A, Boca Raton, FL 33486 USA.	adam.falchook@gmail.com			Department of Veterans Affairs Office of Rehabilitation Research and Development as a Career Development Award 1 [1 IK1 RX000961-01A1]	This work is supported by the Department of Veterans Affairs Office of Rehabilitation Research and Development as a Career Development Award 1 to Adam D. Falchook, MD for the study Motor Impairments in Traumatic Brain Injury: Effects of Callosal Disconnection [grant number 1 IK1 RX000961-01A1].	Acosta LM, 2014, NEUROCASE, V20, P599, DOI 10.1080/13554794.2013.826683; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BOLDRINI P, 1992, CORTEX, V28, P135, DOI 10.1016/S0010-9452(13)80172-4; Buxbaum LJ, 2007, CORTEX, V43, P411, DOI 10.1016/S0010-9452(08)70466-0; Buxbaum LJ, 1995, NEUROCASE, V1, P3, DOI 10.1093/neucas/1.1.3; CLARKE JM, 1989, BRAIN, V112, P849, DOI 10.1093/brain/112.4.849; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; GESCHWIND N, 1962, NEUROLOGY, V12, P675, DOI 10.1212/WNL.12.10.675; GESCHWIND NORMAN, 1963, TRANS AMER NEUROL ASSOC, V88, P219; Hanna-Pladdy B, 2002, J NEUROL NEUROSUR PS, V73, P574, DOI 10.1136/jnnp.73.5.574; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Heilman K. M., 2012, CLIN NEUROPSYCHOLOGY, P214; Heilman KM, 2008, CORTEX, V44, P975, DOI 10.1016/j.cortex.2007.10.010; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; HEILMAN KM, 1986, CORTEX, V22, P141, DOI 10.1016/S0010-9452(86)80038-7; HEILMAN KM, 1979, NEUROPSYCHOLOGIA, V17, P315, DOI 10.1016/0028-3932(79)90077-0; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; HEILMAN KM, 1976, ARCH NEUROL-CHICAGO, V33, P139, DOI 10.1001/archneur.1976.00500020067011; HEILMAN KM, 1983, NEUROLOGY, V33, P661, DOI 10.1212/WNL.33.5.661; HEILMAN KM, 1984, BRAIN, V107, P519, DOI 10.1093/brain/107.2.519; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; Liepmann H., 1920, ERGEBNISSE GESAMTEN, V27, P516; Liepmann H, 1907, Z PSYCHOL NEUROLOGIE, V10, P214; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Mendoza JE, 2009, ARCH CLIN NEUROPSYCH, V24, P287, DOI 10.1093/arclin/acp030; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Poffenberger A.T., 1912, ARCH PSYCHOL, V12, P1; POIZNER H, 1990, BRAIN, V113, P85, DOI 10.1093/brain/113.1.85; Quencer K, 2007, NEUROLOGY, V68, P150, DOI 10.1212/01.wnl.0000250331.35912.a5; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Valenstein, 2012, CLIN NEUROPSYCHOLOGY, P296; Vanbellingen T, 2011, J NEUROL NEUROSUR PS, V82, P389, DOI 10.1136/jnnp.2010.213371; VARNEY NR, 1975, NEUROPSYCHOLOGIA, V13, P449, DOI 10.1016/0028-3932(75)90068-8; VUILLEUMIER P, 1995, CLIN NEUROL NEUROSUR, V97, P39, DOI 10.1016/0303-8467(94)00056-C; WATSON RT, 1983, BRAIN, V106, P391, DOI 10.1093/brain/106.2.391; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Zaidel E., 2012, CLIN NEUROPSYCHOLOGY, P349	45	8	9	0	23	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 26	2015	37	10					1062	1073		10.1080/13803395.2015.1077930			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CR5OR	WOS:000361393100005	26340588				2022-02-06	
J	Song, S; Race, NS; Kim, A; Zhang, T; Shi, R; Ziaie, B				Song, S.; Race, N. S.; Kim, A.; Zhang, T.; Shi, R.; Ziaie, B.			A Wireless Intracranial Brain Deformation Sensing System for Blast-Induced Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							MODEL; MECHANISMS; TISSUE; STRAIN; LEVEL	Blast-induced traumatic brain injury (bTBI) has been linked to a multitude of delayed-onset neurodegenerative and neuropsychiatric disorders, but complete understanding of their pathogenesis remains elusive. To develop mechanistic relationships between bTBI and post-blast neurological sequelae, it is imperative to characterize the initiating traumatic mechanical events leading to eventual alterations of cell, tissue, and organ structure and function. This paper presents a wireless sensing system capable of monitoring the intracranial brain deformation in real-time during the event of a bTBI. The system consists of an implantable soft magnet and an external head-mounted magnetic sensor that is able to measure the field in three dimensions. The change in the relative position of the soft magnet WITH respect to the external sensor as the result of the blast wave induces changes in the magnetic field. The magnetic field data in turn is used to extract the temporal and spatial motion of the brain under the blast wave in real-time. The system has temporal and spatial resolutions of 5 mu s and 10 mu m. Following the characterization and validation of the sensor system, we measured brain deformations in a live rodent during a bTBI.	[Song, S.; Kim, A.; Zhang, T.; Ziaie, B.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Song, S.; Kim, A.; Zhang, T.; Ziaie, B.] Birck Nanotechnol Ctr, W Lafayette, IN USA; [Race, N. S.; Shi, R.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Shi, R.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Race, N. S.] Indiana Univ, Sch Med, Indianapolis, IN USA		Ziaie, B (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	riyi@purdue.edu; bziaie@purdue.edu	; Kim, Albert/Q-9686-2017	Race, Nicholas/0000-0002-2683-1692; Kim, Albert/0000-0003-1539-1246	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R21 NS090244-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090244] Funding Source: NIH RePORTER	We would like to thank Professor Youngblood and Jen-chieh Liu of Materials Engineering, Purdue University for their assistance in mechanical characterization of the soft magnets. This project was funded by NIH (1 R21 NS090244-01).	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baker W.E., 1973, EXPLOSIONS AIR; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fischer H., 2009, INF RES, V6; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garo A, 2007, BIORHEOLOGY, V44, P51; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Kamkin A., 2008, MECHANOSENSITIVITY N; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; Newman AJ, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4002183; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, SUMMARY RECOMMENDATI; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Walls M., 2015, J NEUROSURG IN PRESS; Warden DL, 2005, NEW ENGL J MED, V353, P633; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024	27	8	8	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 20	2015	5								16959	10.1038/srep16959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5EC	WOS:000365017200001	26586273	Green Published, gold, Green Submitted			2022-02-06	
J	Costa, TL; Zaninotto, ALC; Benute, GG; De Lucia, MCS; Paiva, WS; Wagemans, J; Boggio, PS				Costa, Thiago L.; Zaninotto, Ana Luiza C.; Benute, Glaucia G.; De Lucia, Mara C. S.; Paiva, Wellingson S.; Wagemans, Johan; Boggio, Paulo S.			Perceptual organization deficits in traumatic brain injury patients	NEUROPSYCHOLOGIA			English	Article						Traumatic brain injury; Diffuse axonal injury; Perceptual organization; L-POST; Embedded figures; Coherent motion	VISUAL FUNCTION; VETERANS; VALIDITY; MODERATE; PLAYERS; ACUITY; SPEED	Traumatic brain injury (TBI) is a prevalent condition and there is limited visual perception research with this population. Here, we investigated perceptual organization changes in a rather homogeneous sample of closed head TBI outpatients with diffuse axonal injury only and no other known comorbidities. Patients had normal or corrected visual acuity. Perceptual organization was measured with the Leuven Perceptual Organization Screening Test (L-POST), a coherent motion task (CM) and the Leuven Embedded Figures Test (L-EFT). These tests were chosen to screen for deficits in different aspects of perceptual organization (L-POST), to evaluate local and global processing (L-EFT) and grouping in a dynamic set of stimuli (CM). TBI patients were significantly impaired compared to controls in all measures for both response time and accuracy, except for CM thresholds and object recognition subtests. The TBI group was similarly affected in all aspects of the L-EFT. TBI was also similarly affected in all perceptual factors of the L-POST. No significant correlations were found between scores and time post-injury, except for CM thresholds (r(s)=-0.74), which might explain the lack of group-level differences. The only score significantly correlated to IQ was L-EFT response time (r(s)=-0.67). These findings demonstrate that perceptual organization is diffusely affected in TBI and this effect has no substantial correlations with IQ. As many of the neuropsychological tests used to measure different cognitive functions involve some level of visual discrimination and perceptual organization demands, these results must be taken into account in the general neuropsychological evaluation of TBI patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Costa, Thiago L.; Boggio, Paulo S.] Univ Prebiteriana Mackenzie, Social & Cognit Neurosci Lab, Sao Paulo, Brazil; [Costa, Thiago L.; Boggio, Paulo S.] Univ Prebiteriana Mackenzie, Dev Disorders Prog, Sao Paulo, Brazil; [Costa, Thiago L.; Zaninotto, Ana Luiza C.; Benute, Glaucia G.; De Lucia, Mara C. S.] Univ Sao Paulo, Sch Med, Hosp Clin, Div Psychol, Sao Paulo, Brazil; [Paiva, Wellingson S.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil; [Wagemans, Johan] Univ Leuven, Lab Expt Psychol, Dept Brain & Cognit, Leuven, Belgium		Costa, TL (corresponding author), Lab Neurociencia Cognit & Social, Rua Piaui 181, BR-01241001 Sao Paulo, Brazil.	e.thiagocosta@gmail.com	Wagemans, Johan/M-3878-2019; Boggio, Paulo S/K-6272-2012; Zaninotto, Ana Luiza C./I-4095-2016; Paiva, Wellingson S/G-5517-2013; Benute, Glaucia R/P-8050-2016	Boggio, Paulo S/0000-0002-6109-0447; Zaninotto, Ana Luiza C./0000-0003-0639-0612; Paiva, Wellingson S/0000-0002-5165-7040; Benute, Glaucia R/0000-0003-4545-1887; Wagemans, Johan/0000-0002-7970-1541; Guerra Benute, Glaucia Rosana/0000-0003-0781-1976	FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/11668-5]; Flemish GovernmentEuropean Commission [METH/08/02]	We would like to thank Dr. Lee de-Wit for help in the development of the rationale behind this research, and Dr. Micah Murray and two anonymous reviewers for their suggestions in improving this manuscript. This work was presented at the Vision Sciences Society 15th Annual Meeting and thoughtful suggestions of VSS participants were also taken into account in the present manuscript. TLC is supported by a FAPESP Postdoctoral Grant (2014/11668-5). PSB is a CNPq research fellow. JW is supported by long-term structural funding from the Flemish Government (METH/08/02).	Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Behrmann M, 2003, J EXP PSYCHOL HUMAN, V29, P19, DOI 10.1037/0096-1523.29.1.19; Binetti G, 1998, NEUROPSYCHOLOGY, V12, P29, DOI 10.1037/0894-4105.12.1.29; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brown J, 2015, AUGMENT ALTERN COMM, V31, P15, DOI 10.3109/07434618.2014.995224; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Costa TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042961; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Deary IJ, 1996, AM PSYCHOL, V51, P599; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gennarelli TA, 1992, J EMERGENCY MED, V11, P5; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kardon R, 2013, INVEST OPHTH VIS SCI, V54; Keane BP, 2015, PSYCHON B REV, V22, P121, DOI 10.3758/s13423-014-0647-9; Keane BP, 2014, NEUROPSYCHOLOGIA, V65, P221, DOI 10.1016/j.neuropsychologia.2014.10.031; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Quental NBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068398; Pavawalla SP, 2006, J INT NEUROPSYCH SOC, V12, P802, DOI 10.1017/S135561770606098X; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Ritchie SJ, 2014, CURR BIOL, V24, pR681, DOI 10.1016/j.cub.2014.06.012; Robertson CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048173; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; RYAN JJ, 1988, J CLIN PSYCHOL, V44, P950, DOI 10.1002/1097-4679(198811)44:6<950::AID-JCLP2270440616>3.0.CO;2-6; Schmitter-Edgecombe M, 2015, J CLIN EXP NEUROPSYC, V37, P162, DOI 10.1080/13803395.2014.998170; Silverstein SM., 2009, LEARN PERCEPT, V1, P229, DOI [DOI 10.1556/LP.1.2009.2.111, 10.1556/LP.1.2009.2.111]; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Torfs K, 2014, BEHAV RES METHODS, V46, P472, DOI 10.3758/s13428-013-0382-6; van der Helm PA, 2012, COGN PROCESS, V13, P13, DOI 10.1007/s10339-011-0425-9; Vancleef K, 2015, J NEUROPSYCHOL, V9, P271, DOI 10.1111/jnp.12050; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wagemans J., 2005, HDB COGNITION, P3; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Walsh DV, 2015, MIL MED, V180, P178, DOI 10.7205/MILMED-D-14-00230; Witkin H.A., 1962, PSYCHOL DIFFERENTIAT; Witkin HA, 1971, MANUAL GROUP EMBEDDE; Zaninotto AL, 2014, NEUROPSYCH DIS TREAT, V10, P1155, DOI 10.2147/NDT.S62728; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	8	9	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	NOV	2015	78						142	152		10.1016/j.neuropsychologia.2015.10.008			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CW5RH	WOS:000365053800016	26455804				2022-02-06	
J	Peethambaran, AK; Gopal, VV; Valsalamony, J				Peethambaran, Anil Kumar; Gopal, Vinu V.; Valsalamony, Jiji			Four-quadrant osteoplastic decompressive craniotomy: A novel technique for refractory intracranial hypertension - A pilot study	NEUROLOGY INDIA			English	Article						Decompressive craniectomy; four-quadrant osteoplastic decompressive craniotomy; intracranial hypertension	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY INFARCTION; SEVERE HEAD-INJURY; EARLY CRANIOPLASTY; HINGE CRANIOTOMY; CRANIECTOMY; HEMICRANIECTOMY; HYDROCEPHALUS; COMPLICATIONS	Background: Decompressive craniectomy (DC) with duroplasty is the gold standard for refractory intracranial hypertension despite paucity of randomized controlled trials. There are several morbidities associated with DC of which the persistence of bony defect is of paramount importance. Studies have shown that many of the morbidities associated with DC get reversed following replacement of the bone flap. Aim: To design a novel technique for control of refractory intracranial pressure (ICP), as well as to study its safety and efficacy compared to the conventional DC technique. Material and Methods: We conducted a prospective, comparative, observational pilot study comparing four-quadrant osteoplastic decompressive craniotomy (FoQOsD) with conventional DC. The demographic features, postoperative variables such as operating time, number of days of intensive care unit (ICU) stay and survival, as well as radiographic variables such as change in the midline shift (MLS) and expansion of the compressed brain were analyzed using relevant statistical tests. Results: Twenty patients were selected and grouped into two groups of 10 patients each. The male: female ratio in the two groups were 8: 2 and 7: 3, respectively, and the mean age at presentation was 42.7 +/- 1.45 years in the FoQOsD group and 43.6 +/- 1.32 years in the DC group. Both the groups were comparable in relation to the duration of surgery, duration of ICU stay, and survival (P > 0.05). There was significant brain expansion and reversal of MLS (P < 0.001) in the FoQOsD group, factors which were comparable to that in the DC group. Conclusions: FoQOsD may be as effective as conventional DC in managing intracranial hypertension. This procedure mainly avoids a revision cranioplasty. A prospective randomized controlled trial with a large sample size may be initiated for obtaining more accurate data.	[Peethambaran, Anil Kumar; Gopal, Vinu V.] Govt Med Coll, Dept Neurosurg, Trivandrum, Kerala, India; [Valsalamony, Jiji] Reg Canc Ctr, Dept Imageol, Trivandrum 695011, Kerala, India		Peethambaran, AK (corresponding author), House 12,Avittom Rd,Med Coll PO, Trivandrum 695011, Kerala, India.	anilpeethambaran@yahoo.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Ann DH, 2009, J KOREAN NEUROSURG S, V46, P417, DOI 10.3340/jkns.2009.46.4.417; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Chen W, 2013, JOVE-J VIS EXP, DOI 10.3791/3871; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Erdogan E, 2003, NEUROL INDIA, V51, P479; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Inamasu J, 2010, J TRAUMA, V68, P183, DOI 10.1097/TA.0b013e3181c45384; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Kumar GSS, 2004, NEUROL INDIA, V52, P504; Pillai A, 2007, J NEUROSURG, V106, P59, DOI 10.3171/jns.2007.106.1.59; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rai VK, 2014, NEUROL INDIA, V62, P26, DOI 10.4103/0028-3886.128273; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Sinha S, 2015, NEUROL INDIA, V63, P175, DOI 10.4103/0028-3886.156277; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348	31	8	8	1	6	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2015	63	6					895	902		10.4103/0028-3886.170081			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX4UL	WOS:000365695700017	26588623				2022-02-06	
J	Breuer, T; Emontzpohl, C; Coburn, M; Benstoem, C; Rossaint, R; Marx, G; Schalte, G; Bernhagen, J; Bruells, CS; Goetzenich, A; Stoppe, C				Breuer, Thomas; Emontzpohl, Christoph; Coburn, Mark; Benstoem, Carina; Rossaint, Rolf; Marx, Gernot; Schaelte, Gereon; Bernhagen, Juergen; Bruells, Christian S.; Goetzenich, Andreas; Stoppe, Christian			Xenon triggers pro-inflammatory effects and suppresses the anti-inflammatory response compared to sevoflurane in patients undergoing cardiac surgery	CRITICAL CARE			English	Article							MIGRATION INHIBITORY FACTOR; ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY BYPASS; SURGICAL-PATIENTS; PROPOFOL ANESTHESIA; ELECTIVE SURGERY; HEART-FAILURE; IN-VITRO; ISOFLURANE	Introduction: Cardiac surgery encompasses various stimuli that trigger pro-inflammatory mediators, reactive oxygen species and mobilization of leucocytes. The aim of this study was to evaluate the effect of xenon on the inflammatory response during cardiac surgery. Methods: This randomized trial enrolled 30 patients who underwent elective on-pump coronary-artery bypass grafting in balanced anaesthesia of either xenon or sevoflurane. For this secondary analysis, blood samples were drawn prior to the operation, intra-operatively and on the first post-operative day to measure the pro- and anti-inflammatory cytokines interleukin-6 (IL-6), interleukin-8/C-X-C motif ligand 8 (IL-8/CXCL8), and interleukin-10 (IL-10). Chemokines such as C-X-C motif ligand 12/ stromal cell-derived factor-1 alpha (CXCL12/SDF-1 alpha) and macrophage migration inhibitory factor (MIF) were measured to characterize xenon's perioperative inflammatory profile and its impact on migration of peripheral blood mononuclear cells (PBMC). Results: Xenon enhanced the postoperative increase of IL-6 compared to sevoflurane (Xenon: 90.7 versus sevoflurane: 33.7 pg/ml; p = 0.035) and attenuated the increase of IL-10 (Xenon: 127.9 versus sevoflurane: 548.3 pg/ml; p = 0.028). Both groups demonstrated a comparable intraoperative increase of oxidative stress (intra-OP: p = 0.29; post-OP: p = 0.65). While both groups showed an intraoperative increase of the cardioprotective mediators MIF and CXCL12/SDF-1 alpha, only MIF levels decreased in the xenon group on the first postoperative day (50.0 ng/ml compared to 23.3 ng/ml; p = 0.012), whereas it remained elevated after sevoflurane anaesthesia (58.3 ng/ml to 53.6 ng/ml). Effects of patients' serum on chemotactic migration of peripheral mononuclear blood cells taken from healthy volunteers indicated a tendency towards enhanced migration after sevoflurane anaesthesia (p = 0.07). Conclusions: Compared to sevoflurane, balanced xenon anaesthesia triggers pro-inflammatory effects and suppresses the anti-inflammatory response in cardiac surgery patients even though the clinical significance remains unknown.	[Breuer, Thomas; Coburn, Mark; Rossaint, Rolf; Schaelte, Gereon; Stoppe, Christian] Rhein Westfal TH Aachen, Dept Anaesthesiol, Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany; [Emontzpohl, Christoph; Benstoem, Carina; Goetzenich, Andreas; Stoppe, Christian] Rhein Westfal TH Aachen, Dept Thorac & Cardiovasc Surg, Univ Hosp, D-52074 Aachen, Germany; [Breuer, Thomas; Marx, Gernot; Bruells, Christian S.] Rhein Westfal TH Aachen, Dept Intens & Intermediate Care, Univ Hosp, D-52074 Aachen, Germany; [Emontzpohl, Christoph; Bernhagen, Juergen; Stoppe, Christian] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Univ Hosp, D-52074 Aachen, Germany		Breuer, T (corresponding author), Rhein Westfal TH Aachen, Dept Anaesthesiol, Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany.	tbreuer@ukaachen.de; christian.stoppe@gmail.com		Coburn, Mark/0000-0002-7930-0270; Stoppe, Christian/0000-0002-2028-2039	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [CO 799/3-1]	This study was supported by the Deutsche Forschungsgemeinschaft (DFG; CO 799/3-1).	BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Baumert JH, 2008, BRIT J ANAESTH, V100, P605, DOI 10.1093/bja/aen050; Boeken U, 1998, EUR J CARDIO-THORAC, V13, P541, DOI 10.1016/S1010-7940(98)00062-1; Clark JA, 2005, J CARDIOTHOR VASC AN, V19, P488, DOI 10.1053/j.jvca.2005.05.007; Coburn M, 2005, BRIT J ANAESTH, V94, P198, DOI 10.1093/bja/aei023; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; CRUMRINE RC, 1991, J CEREBR BLOOD F MET, V11, P272, DOI 10.1038/jcbfm.1991.59; de Rossi LW, 2004, EUR J ANAESTH, V21, P139, DOI 10.1017/S0265021504002108; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Fahlenkamp AV, 2014, BRIT J ANAESTH, V112, P272, DOI 10.1093/bja/aet330; Franke A, 2005, EUR J CARDIO-THORAC, V28, P569, DOI 10.1016/j.ejcts.2005.07.007; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Hartlage MAG, 2004, ANESTH ANALG, V99, P655, DOI 10.1213/01.ANE.0000129999.74324.4E; HEARSE DJ, 1978, J MOL CELL CARDIOL, V10, P641, DOI 10.1016/S0022-2828(78)80004-2; Heindl B, 1999, BASIC RES CARDIOL, V94, P102, DOI 10.1007/s003950050132; Hirai Shinji, 2003, Ann Thorac Cardiovasc Surg, V9, P365; Kawamura T, 2006, J CARDIOTHOR VASC AN, V20, P503, DOI 10.1053/j.jvca.2006.01.011; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Lin TJ, 2000, J IMMUNOL, V165, P211, DOI 10.4049/jimmunol.165.1.211; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Nader ND, 2006, J CARDIOTHOR VASC AN, V20, P57, DOI 10.1053/j.jvca.2005.07.030; Palmieri B, 2007, EUR REV MED PHARMACO, V11, P309; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Preckel B, 2000, ANESTH ANALG, V91, P1327, DOI 10.1097/00000539-200012000-00003; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Roth E, 2004, CURR OPIN CLIN NUTR, V7, P161, DOI 10.1097/00075197-200403000-00010; Saravanan P, 2009, BRIT J ANAESTH, V103, P805, DOI 10.1093/bja/aep297; Schilling T, 2011, ANESTHESIOLOGY, V115, P65, DOI 10.1097/ALN.0b013e318214b9de; Schmidt M, 2005, ANESTHESIOLOGY, V102, P929, DOI 10.1097/00000542-200505000-00011; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Stoppe C, 2013, BRIT J ANAESTH, V111, P406, DOI 10.1093/bja/aet072; Stoppe C, 2011, BRIT J ANAESTH, V107, P645, DOI 10.1093/bja/aer285; Stoppe C, 2013, ANTIOXID REDOX SIGN, V19, P231, DOI 10.1089/ars.2012.5015; Stoppe C, 2012, MOL MED, V18, P843, DOI 10.2119/molmed.2012.00071; Suzuki H, 2005, INT J CARDIOL, V100, P415, DOI 10.1016/j.ijcard.2004.08.041; Tandon M, 2012, EUR J ANAESTH, V29, P296, DOI 10.1097/EJA.0b013e328351660a; Wappler F, 2007, ANESTHESIOLOGY, V106, P463, DOI 10.1097/00000542-200703000-00010; Zakkar M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/189863	47	8	9	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	OCT 15	2015	19								365	10.1186/s13054-015-1082-7			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT3JN	WOS:000362703100001	26467531	Green Published, gold			2022-02-06	
J	Riley, GA; Hagger, BF				Riley, Gerard A.; Hagger, Barbara F.			Disclosure of a stigmatized identity: A qualitative study of the reasons why people choose to tell or not tell others about their traumatic brain injury	BRAIN INJURY			English	Article						Neuropsychological rehabilitation; self-disclosure; stigma	SOCIAL SUPPORT; SELF-CONCEALMENT; HEALTH; MISCONCEPTIONS; CONSEQUENCES; MANAGEMENT; AVOIDANCE; MODEL; ESTEEM; FAMILY	Objective: To investigate what goals influence the decisions of people with a traumatic brain injury to disclose (or not to disclose) information about their brain injury.Method: Ten people with a traumatic brain injury were interviewed about disclosing information about their injury to others. Thematic analysis was used to analyse the data.Results: The report focuses on disclosure to people other than immediate family and close friends. Reasons for not disclosing included concern about negative reactions from others, feelings of shame about the injury, wanting to avoid getting distressed, wanting to fit in, lack of interest from others and the perception that the stress associated with the act of disclosing outweighed the benefits. Reasons for disclosing included obtaining emotional and practical support from others, the emotional release obtained from disclosure, the need to explain their behaviour to others and giving others the benefit of their experience. Experience of negative and stigmatizing reactions from others was common. Participants varied in their willingness to disclose.Conclusion: Disclosure can have important advantages and disadvantages. Some people with a TBI may need support in making optimal decisions about disclosure.	[Riley, Gerard A.; Hagger, Barbara F.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England		Riley, GA (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	g.a.riley@bham.ac.uk	riley, gerard/AAP-1439-2020; Riley, Gerard Anthony/J-1646-2012	Riley, Gerard Anthony/0000-0002-1167-8023			Afifi WA, 2006, COMMUN RES, V33, P467, DOI 10.1177/0093650206293250; Baldwin VN, 2011, NEUROPSYCHOL REHABIL, V21, P484, DOI 10.1080/09602011.2011.582378; Beals KP, 2009, PERS SOC PSYCHOL B, V35, P867, DOI 10.1177/0146167209334783; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; CAIN R, 1991, SOC WORK, V36, P67; Chaudoir SR, 2010, PSYCHOL BULL, V136, P236, DOI 10.1037/a0018193; Clair JA, 2005, ACAD MANAGE REV, V30, P78, DOI 10.5465/AMR.2005.15281431; COLLINS NL, 1994, PSYCHOL BULL, V116, P457, DOI 10.1037/0033-2909.116.3.457; Creed WED, 2000, J MANAGE INQUIRY, V9, P391, DOI 10.1177/105649260000900410; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Derlega V, 2008, HDB RELATIONSHIP INI; Derlega VJ, 2004, J SOC CLIN PSYCHOL, V23, P747, DOI 10.1521/jscp.23.6.747.54804; Derlega VJ, 2000, LEA TELECOMMUN, P53; Derlega VJ, 1979, SELF DISCLOSURE ORIG, P151; Elliot AJ, 1999, EDUC PSYCHOL-US, V34, P169, DOI 10.1207/s15326985ep3403_3; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gable SL, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P203; Goldberg AE, 2007, J FAM ISSUES, V28, P100, DOI 10.1177/0192513X06293606; Gray J. A, 1987, PSYCHOL FEAR STRESS; Gray JA, 1991, NEUROBIOLOGY LEARNIN; GREENBERG MA, 1992, J PERS SOC PSYCHOL, V63, P75, DOI 10.1037/0022-3514.63.1.75; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468; Heimpel SA, 2006, J PERS, V74, P1293, DOI 10.1111/j.1467-6494.2006.00410.x; Herek GM, 2009, J INTERPERS VIOLENCE, V24, P54, DOI 10.1177/0886260508316477; Jetten J, 2014, SOC ISS POLICY REV, V8, P103, DOI 10.1111/sipr.12003; Jones Janelle M., 2012, SOCIAL CURE IDENTITY, P255; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kawamura KY, 2004, COGNITIVE THER RES, V28, P183, DOI 10.1023/B:COTR.0000021539.48926.c1; Kelly AE, 1996, PSYCHOL BULL, V120, P450, DOI 10.1037/0033-2909.120.3.450; LARSON DG, 1990, J SOC CLIN PSYCHOL, V9, P439, DOI 10.1521/jscp.1990.9.4.439; LEARY MR, 1990, PSYCHOL BULL, V107, P34, DOI 10.1037/0033-2909.107.1.34; Matthews A., 2003, J MENTAL HLTH, V12, P235, DOI [DOI 10.1080/0963823031000118221, 10.1080/0963823031000118221]; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; Moorhead C, 1999, INT J SEXUALITY GEND, V4, P327, DOI DOI 10.1023/A:1023253513903; Morry MM, 2005, CAN J BEHAV SCI, V37, P211, DOI 10.1037/h0087258; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Omarzu J, 2000, PERS SOC PSYCHOL REV, V4, P174, DOI 10.1207/S15327957PSPR0402_05; Oswald DL, 2006, PERS RELATIONSHIP, V13, P333, DOI 10.1111/j.1475-6811.2006.00121.x; Pachankis JE, 2007, PSYCHOL BULL, V133, P328, DOI 10.1037/0033-2909.133.2.328; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Ragins BR, 2008, ACAD MANAGE REV, V33, P194, DOI 10.5465/amr.2008.27752724; Remennick L, 2000, SEX ROLES, V43, P821, DOI 10.1023/A:1011084821700; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Sprecher S, 2004, J SOC CLIN PSYCHOL, V23, P857, DOI 10.1521/jscp.23.6.857.54803; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; WOOD JV, 1994, J PERS SOC PSYCHOL, V67, P713, DOI 10.1037/0022-3514.67.4.713	51	8	8	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1480	1489		10.3109/02699052.2015.1071427			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200013	26305180	Green Submitted			2022-02-06	
J	Ativie, F; Albayram, O; Bach, K; Pradier, B; Zimmer, A; Bilkei-Gorzo, A				Ativie, F.; Albayram, O.; Bach, K.; Pradier, B.; Zimmer, A.; Bilkei-Gorzo, A.			Enhanced microglial activity in FAAH(-/-) animals	LIFE SCIENCES			English	Article						Neuroinflammation; Anandamide; FAAH; Microglia; Astrocyte; Ageing	FATTY-ACID AMIDE; TRAUMATIC BRAIN-INJURY; CANNABINOID RECEPTORS; HYDROLASE FAAH; CB2 RECEPTORS; TNF-ALPHA; ANANDAMIDE; INFLAMMATION; CELLS; MICE	Aims: Several lines of evidence suggest that the endocannabinoid system is involved in the regulation of glial activity. Enhanced levels of the endocannabinoid N-arachidonoyl ethanolamine (AEA, also referred to as anandamide) as well as non-cannabinoid lipids like palmitoylethanolamine (PEA) due to genetic deletion or pharmacologic blockade of its degrading enzyme fatty acid amide hydrolase (FAAH) reduced neuroinflammatoiy changes in models of neurodegeneration. Now we addressed the question if genetic deletion of FAAH also influences agerelated neuroinflammation. Main methods: To answer this question we compared the number and size of microglia in young and old wild-type and FAAH(-/-) mice and analysed the distribution of microglia sizes in the four groups. Additionally, we analysed IL-6 and IL-1 beta levels with ELISA and astrocyte activities as ratio of GFAP-positive areas in the hippocampus. Key findings: Ageing was associated with an increased number and activity of microglia, elevated IL-6 and IL-1 beta levels and enhanced area covered by astrocytes in wild-type animals. Unexpectedly, in FAAH(-/-) animals the number of microglia and the ratio of activated microglia and IL-1 beta level were already higher in young animals than in age-matched wild-type controls. There was no further age-related increase in these inflammation markers in the knockout line. Significance: Our results suggest that AEA is involved in the regulation of microglia activity. Life-long elevation of AEA levels disturbs microglial regulation and leads to pro-inflammatory changes. (C) 2015 Elsevier Inc. All rights reserved.	[Ativie, F.; Albayram, O.; Bach, K.; Pradier, B.; Zimmer, A.; Bilkei-Gorzo, A.] Univ Bonn, Inst Mol Psychiat, Bonn, Germany		Bilkei-Gorzo, A (corresponding author), Sigmund Freud Str 25, D-53127 Bonn, Germany.	abilkei@uni-bonn.de	Bilkei-Gorzo, Andras/F-8114-2010; Zimmer, Andreas/B-8357-2009	Albayram, Onder/0000-0002-2028-1458; Pradier, Bruno/0000-0001-9792-6042	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [FOR926, SFB 645]; BONFOR grant of the Medical Faculty of the University of Bonn [O-178.0014]	This work was financed by the Deutsche Forschungsgemeinschaft, grants FOR926 (SP2 and CP2) and SFB 645 (TP B7), as well as a BONFOR grant O-178.0014 of the Medical Faculty of the University of Bonn. A.Z. is a member of the DFG Cluster of Excellence ImmunoSensation.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Albayram O, 2011, P NATL ACAD SCI USA, V108, P11256, DOI 10.1073/pnas.1016442108; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; Benito C, 2012, BRIT J PHARMACOL, V166, P1474, DOI 10.1111/j.1476-5381.2012.01889.x; Bilkei-Gorzo A, 2005, P NATL ACAD SCI USA, V102, P15670, DOI 10.1073/pnas.0504640102; Bilkei-Gorzo A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.009; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Calignano A, 2001, EUR J PHARMACOL, V419, P191, DOI 10.1016/S0014-2999(01)00988-8; Conti S, 2002, BRIT J PHARMACOL, V135, P181, DOI 10.1038/sj.bjp.0704466; Correa F, 2011, BRAIN BEHAV IMMUN, V25, P736, DOI 10.1016/j.bbi.2011.01.020; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Czikora A, 2012, LIFE SCI, V90, P407, DOI 10.1016/j.lfs.2011.12.016; D'Agostino G, 2009, EUR J PHARMACOL, V613, P54, DOI 10.1016/j.ejphar.2009.04.022; Di Marzo M, 2006, J PEPT SCI, V12, P575, DOI 10.1002/psc.754; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Gamaleddin I, 2011, BRIT J PHARMACOL, V164, P1652, DOI 10.1111/j.1476-5381.2011.01440.x; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hernangomez M, 2012, GLIA, V60, P1437, DOI 10.1002/glia.22366; Ho KW, 2014, GLIA, V62, P1435, DOI 10.1002/glia.22691; Hovens I. B., 2004, NEUROIMMUNOL NEUROIN, V1, P82; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kuc C, 2012, MOL CARCINOGEN, V51, P139, DOI 10.1002/mc.20770; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Lynch MA, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.006.2009; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Murphy Niamh, 2012, J Neuroinflammation, V9, P79, DOI 10.1186/1742-2094-9-79; Nader J., 2014, NEUROPHARMACOLOGY; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Schilling T, 2010, J NEUROIMMUNOL, V225, P190, DOI 10.1016/j.jneuroim.2010.05.024; Schlosburg JE, 2009, AAPS J, V11, P39, DOI 10.1208/s12248-008-9075-y; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Skaper SD, 2013, MOL NEUROBIOL, V48, P340, DOI 10.1007/s12035-013-8487-6; Skaper SD, 2012, PHILOS T R SOC B, V367, P3312, DOI 10.1098/rstb.2011.0391; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Tham CS, 2007, FEBS LETT, V581, P2899, DOI 10.1016/j.febslet.2007.05.037; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022	53	8	8	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	OCT 1	2015	138				SI		52	56		10.1016/j.lfs.2014.12.016			5	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	CS1UG	WOS:000361852900008	25534441				2022-02-06	
J	Schilte, C; Bouzat, P; Millet, A; Boucheix, P; Pernet-Gallay, K; Lemasson, B; Barbier, EL; Payen, JF				Schilte, Clotilde; Bouzat, Pierre; Millet, Anne; Boucheix, Perrine; Pernet-Gallay, Karin; Lemasson, Benjamin; Barbier, Emmanuel L.; Payen, Jean-Francois			Mannitol Improves Brain Tissue Oxygenation in a Model of Diffuse Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						blood oxygenation level dependent; brain edema; brain oxygenation; diffusion-weighted magnetic resonance imaging; magnetic resonance imaging; mannitol; traumatic brain injury	CEREBRAL-BLOOD-FLOW; HYPERTONIC SALINE; INTRACRANIAL-PRESSURE; EQUIOSMOLAR SOLUTIONS; HEAD-INJURY; METABOLISM; DELIVERY; MICROVESSELS	Objectives: Based on evidence supporting a potential relation between posttraumatic brain hypoxia and microcirculatory derangements with cell edema, we investigated the effects of the antiedematous agent mannitol on brain tissue oxygenation in a model of diffuse traumatic brain injury. Design: Experimental study. Setting: Neurosciences and physiology laboratories. Subjects: Adult male Wistar rats. Interventions: Thirty minutes after diffuse traumatic brain injury (impact-acceleration model), rats were IV administered with either a saline solution (traumatic brain injury-saline group) or 20% mannitol (1 g/kg) (traumatic brain injury-mannitol group). Sham-saline and sham-mannitol groups received no insult. Measurements and Main Results: Two series of experiments were conducted 2 hours after traumatic brain injury (or equivalent) to investigate 1) the effect of mannitol on brain edema and oxygenation, using a multiparametric magnetic resonance-based approach (n = 10 rats per group) to measure the apparent diffusion coefficient, tissue oxygen saturation, mean transit time, and blood volume fraction in the cortex and caudoputamen; 2) the effect of mannitol on brain tissue Po-2 and on venous oxygen saturation of the superior sagittal sinus (n = 5 rats per group); and 3) the cortical ultrastructural changes after treatment (n = 1 per group, taken from the first experiment). Compared with the sham-saline group, the traumatic brain injury-saline group had significantly lower tissue oxygen saturation, brain tissue Po-2, and venous oxygen saturation of the superior sagittal sinus values concomitant with diffuse brain edema. These effects were associated with microcirculatory collapse due to astrocyte swelling. Treatment with mannitol after traumatic brain injury reversed all these effects. In the absence of traumatic brain injury, mannitol had no effect on brain oxygenation. Mean transit time and blood volume fraction were comparable between the four groups of rats. Conclusion: The development of posttraumatic brain edema can limit the oxygen utilization by brain tissue without evidence of brain ischemia. Our findings indicate that an antiedematous agent such as mannitol can improve brain tissue oxygenation, possibly by limiting astrocyte swelling and restoring capillary perfusion.	[Schilte, Clotilde; Bouzat, Pierre; Boucheix, Perrine; Payen, Jean-Francois] CHU Grenoble, Hop Michallon, Pole Anesthesie Reanimat, F-38043 Grenoble, France; [Schilte, Clotilde; Bouzat, Pierre; Millet, Anne; Boucheix, Perrine; Pernet-Gallay, Karin; Lemasson, Benjamin; Barbier, Emmanuel L.; Payen, Jean-Francois] INSERM, U836, Grenoble, France; [Schilte, Clotilde; Bouzat, Pierre; Millet, Anne; Boucheix, Perrine; Pernet-Gallay, Karin; Lemasson, Benjamin; Barbier, Emmanuel L.; Payen, Jean-Francois] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Millet, Anne] Hop Couple Enfant, Dept Reanimat Pediat & Neonatale, Grenoble, France; INSERM U836, Grenoble, France; Univ Grenoble 1, Grenoble, France		Payen, JF (corresponding author), CHU Grenoble, Hop Michallon, Pole Anesthesie Reanimat, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/AAC-4105-2019; Bouzat, Pierre/L-6881-2014; Lemasson, Benjamin/AAC-4092-2019; Barbier, Emmanuel/E-6302-2011; Lemasson, Benjamin/L-1608-2014	Bouzat, Pierre/0000-0003-4667-6738; Lemasson, Benjamin/0000-0003-0446-3531; Barbier, Emmanuel/0000-0002-4952-1240; Lemasson, Benjamin/0000-0003-0446-3531; PERNET GALLAY, Karin/0000-0003-3468-3316	"Fondation Gueules Cassees"; French program "Investissement d'Avenir"French National Research Agency (ANR) [ANR-11-INBS-0006]	Supported, in part, by the "Fondation Gueules Cassees." The MRI facility IRMaGe is partly funded by the French program "Investissement d'Avenir" run by the French National Research Agency, grant "Infrastructure d'avenir en Biologie Sante" (ANR-11-INBS-0006).	Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chen KB, 2013, NEUROREPORT, V24, P303, DOI 10.1097/WNR.0b013e32835f8acb; Christen T, 2014, J CEREBR BLOOD F MET, V34, P1550, DOI 10.1038/jcbfm.2014.116; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Helbok R, 2011, J NEUROL NEUROSUR PS, V82, P378, DOI 10.1136/jnnp.2009.198754; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.3.CO;2-V; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Wang LC, 2013, ANESTHESIOLOGY, V118, P903, DOI 10.1097/ALN.0b013e31828156ff	33	8	9	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2015	43	10					2212	2218		10.1097/CCM.0000000000001137			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5DC	WOS:000361358900020	26121074				2022-02-06	
J	Lazarus, RC; Buonora, JE; Flora, MN; Freedy, JG; Holstein, GR; Martinelli, GP; Jacobowitz, DM; Mueller, GP				Lazarus, Rachel C.; Buonora, John E.; Flora, Michael N.; Freedy, James G.; Holstein, Gay R.; Martinelli, Giorgio P.; Jacobowitz, David M.; Mueller, Gregory P.			Protein citrullination: a proposed mechanism for pathology in traumatic brain injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; citrullination; astrocytes; calcium; glial fibrillary acidic protein	CENTRAL-NERVOUS-SYSTEM; PEPTIDYLARGININE DEIMINASE; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; MOLECULAR-MECHANISMS; HIPPOCAMPAL-NEURONS; DISEASE; CALCIUM; PATHOGENESIS; ASTROCYTES	Protein citrullination is a calcium-driven post-translational modification proposed to play a causative role in the neurodegenerative disorders of Alzheimer's disease, multiple sclerosis (MS), and prion disease. Citrullination can result in the formation of antigenic epitopes that underlie pathogenic autoimmune responses. This phenomenon, which is best understood in rheumatoid arthritis, may play a role in the chronic dysfunction following traumatic brain injury (TBI). Despite substantial evidence of aberrations in calcium signaling following TBI, there is little understanding of how TBI alters citrullination in the brain. The present investigation addressed this gap by examining the effects of TBI on the distribution of protein citrullination and on the specific cell types involved. Immunofluorescence revealed that controlled cortical impact in rats profoundly upregulated protein citrullination in the cerebral cortex, external capsule, and hippocampus. This response was exclusively seen in astrocytes; no such effects were observed on the status of protein citrullination in neurons, oligodendrocytes or microglia. Further, proteomic analyses demonstrated that the effects of TBI on citrullination were confined to a relatively small subset of neural proteins. Proteins most notably affected were those also reported to be citrullinated in other disorders, including prion disease and MS. In vivo findings were extended in an in vitro model of simulated TBI employing normal human astrocytes. Pharmacologically induced calcium excitotoxicity was shown to activate the citrullination and breakdown of glial fibrillary acidic protein, producing a novel candidate TBI biomarker and potential target for autoimmune recognition. In summary, these findings demonstrate that the effects of TBI on protein citrullination are selective with respect to brain region, cell type, and proteins modified, and may contribute to a role for autoimmune dysfunction in chronic pathology following TBI.	[Lazarus, Rachel C.; Jacobowitz, David M.; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Buonora, John E.] US Army, Grad Program Anesthesia Nursing, Ft Sam Houston, TX USA; [Flora, Michael N.; Freedy, James G.; Jacobowitz, David M.; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Holstein, Gay R.; Martinelli, Giorgio P.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Mueller, GP (corresponding author), Uniformed Serv Univ Hlth Sci, C2117,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gregory.mueller@usuhs.edu			Defense Medical Research and Development Program, Department of Defense in the Center for Neuroscience and Regenerative Medicine [G1703D, D61_I_10_J6_152]; Uniformed Services University of the Health Sciences [T0702554, R07028414]	The authors would like to acknowledge the expert technical assistance of Ms. Tinghua Chen. Support for this work included a grant from the Defense Medical Research and Development Program (D61_I_10_J6_152), Department of Defense in the Center for Neuroscience and Regenerative Medicine (G1703D) as well as funding from the Uniformed Services University of the Health Sciences (T0702554 and R07028414).	Acharya NK, 2012, J AUTOIMMUN, V38, P369, DOI 10.1016/j.jaut.2012.03.004; Adamus G, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-48; Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Asaga H, 2001, NEUROSCI LETT, V299, P5, DOI 10.1016/S0304-3940(00)01735-3; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bhattacharya SK, 2006, INVEST OPHTH VIS SCI, V47, P2508, DOI 10.1167/iovs.05-1499; Bradford C, 2002, PROTEIN DEIMINATION, P165; Bradford CM, 2014, J NEUROIMMUNOL, V273, P85, DOI 10.1016/j.jneuroim.2014.05.007; Chirivi RGS., 2013, J CLIN CELL IMMUNOL, DOI [10.4172/2155-9899.1000146, DOI 10.4172/2155-9899.1000146]; Chung YH, 2001, NEUROSCI LETT, V302, P93, DOI 10.1016/S0304-3940(01)01683-4; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Duffy S, 1996, J NEUROSCI, V16, P71; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; HAUN SE, 1992, BRAIN RES, V593, P45, DOI 10.1016/0006-8993(92)91261-C; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ishigami A, 2005, J NEUROSCI RES, V80, P120, DOI 10.1002/jnr.20431; Ishigami A, 2010, GERIATR GERONTOL INT, V10, pS53, DOI 10.1111/j.1447-0594.2010.00593.x; Jang B, 2008, AM J PATHOL, V173, P1129, DOI 10.2353/ajpath.2008.080388; Jang B, 2010, ACTA NEUROPATHOL, V119, P199, DOI 10.1007/s00401-009-0625-x; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Luban S, 2010, INT J RHEUM DIS, V13, P284, DOI 10.1111/j.1756-185X.2010.01553.x; Martinelli GPT, 2002, NEUROSCIENCE, V114, P111, DOI 10.1016/S0306-4522(02)00238-5; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; Murinson BB, 2008, NEUROLOGY, V71, P1955, DOI 10.1212/01.wnl.0000327342.58936.e0; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Nicholas AP, 2004, J COMP NEUROL, V473, P128, DOI 10.1002/cne.20102; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Raijmakers R, 2005, J COMP NEUROL, V486, P243, DOI 10.1002/cne.20529; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rondas Dieter, 2015, Diabetes, V64, P573, DOI 10.2337/db14-0621; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tranquill LR, 2000, MULT SCLER J, V6, P220, DOI 10.1177/135245850000600402; VIBULSRETH S, 1987, BRAIN RES, V422, P303, DOI 10.1016/0006-8993(87)90937-1; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao Yi, 2010, Zhonghua Yi Xue Za Zhi, V90, P628; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	49	8	9	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 22	2015	6								204	10.3389/fneur.2015.00204			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CV0HP	WOS:000363931500001	26441823	Green Published, gold			2022-02-06	
J	Garcia-Laredo, E; Maestu, F; Castellanos, MA; Molina, JD; Perez-Moreno, E				Garcia-Laredo, Eduardo; Maestu, Fernando; Angel Castellanos, Miguel; Molina, Juan D.; Perez-Moreno, Elisa			The Relationship Between Educational Years and Phonemic Verbal Fluency (PVF) and Semantic Verbal Fluency (SVF) Tasks in Spanish Patients Diagnosed With Schizophrenia, Bipolar Disorder, and Psychotic Bipolar Disorder	MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CATEGORY FLUENCY; COGNITIVE RESERVE; NORMATIVE DATA; META-ANALYSIS; WORD FLUENCY; POPULATION; PERFORMANCE; DEFICITS; DISEASE	Semantic and verbal fluency tasks are widely used as a measure of frontal capacities. It has been well described in literature that patients affected by schizophrenic and bipolar disorders present a worse execution in these tasks. Some authors have also noted the importance of educational years. Our objective is to analyze whether the effect of cognitive malfunction caused by apathology is superior to the expected effect of years of education in phonemic verbal fluency (PVF) and semantic verbal fluency (SVF) task execution.A total of 62 individuals took part in this study, out of which 23 were patients with schizophrenic paranoid disorder, 11 suffered from bipolar disorder with psychotic symptomatology, 13 suffered from bipolar disorder without psychotic symptomatology, and 15 participants were nonpathological individuals. All participants were evaluated with the PVF and SVF tests (animals and tools). The performance/execution results were analyzed with a mixed-model ANCOVA, with educational years as a covariable.The effect of education seems to be more determined by PVF FAS tests than by SVF. With PVF FAS tasks, the expected effect of pathology disappears when the covariable EDUCATION is introduced. With SVF tasks, the effect continues to be significant, even though the EDUACTION covariable dims such effect.These results suggest that SVF tests (animals category) are better evaluation tools as they are less dependent on the patients' education than PVF FAS tests.	[Garcia-Laredo, Eduardo] Univ Complutense, Fac Psychol, Basic Psychol Dept 2, Campus Somosaguas, Madrid 28223, Spain; [Maestu, Fernando] Univ Complutense Madrid, Lab Cognit & Computat Neurosci, Ctr Biomed Technol CTB, Madrid, Spain; [Angel Castellanos, Miguel; Perez-Moreno, Elisa] Technol Univ Madrid UPM, Madrid, Spain; [Molina, Juan D.] Univ Complutense, Dept Methodol Behav Sci, Fac Psychol, Madrid 28223, Spain; [Molina, Juan D.] Dr R Lafora Psychiat Hosp, Acute Inpatients Unit, Madrid, Spain		Garcia-Laredo, E (corresponding author), Univ Complutense, Fac Psychol, Basic Psychol Dept 2, Campus Somosaguas, Madrid 28223, Spain.	eduardoglaredo@gmail.com	Molina, Juan D./S-9616-2018; maestu, fernando/M-7480-2019; Garcia-Laredo, Eduardo/AAI-3650-2021; Maestu, Fernando/E-3213-2012	Molina, Juan D./0000-0001-8561-8130; maestu, fernando/0000-0002-3195-0071; Garcia-Laredo, Eduardo/0000-0002-7250-0456; Maestu, Fernando/0000-0002-3195-0071			American Psychiatric Association, 2014, GUIA CONS CRIT DIAGN; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Artiola L., 1999, MANUAL NORMAS PROCED; AYLWARD E, 1984, SCHIZOPHRENIA BULL, V10, P430, DOI 10.1093/schbul/10.3.430; Balanza-Martinez V, 2009, MANUAL PSIQUIATRIA, P195; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; Barnett JH, 2006, PSYCHOL MED, V36, P1053, DOI 10.1017/S0033291706007501; Benito-Cuadrado MM, 2002, J CLIN EXP NEUROPSYC, V24, P1117, DOI 10.1076/jcen.24.8.1117.8376; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Buriel Y, 2004, NEUROLOGIA, V19, P153; Carnero-Pardo C, 1999, REV NEUROLOGIA, V29, P709, DOI 10.33588/rn.2908.99233; Casals-Coll M, 2013, NEUROLOGIA, V28, P33, DOI 10.1016/j.nrl.2012.02.010; DAVID A, 1995, BRIT J PSYCHIAT, V167, P621, DOI 10.1192/bjp.167.5.621; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Gourovitch ML, 2000, NEUROPSYCHOLOGY, V14, P353, DOI 10.1037//0894-4105.14.3.353; Green MF, 2005, SCHIZOPHR RES, V74, P253, DOI 10.1016/j.schres.2004.05.023; Grossman M, 1998, NEUROLOGY, V50, P324, DOI 10.1212/WNL.50.2.324; Gutierrez A. L., 2006, REV MEX PSICOL, V23, P37; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; Hurks PPM, 2006, J CLIN EXP NEUROPSYC, V28, P684, DOI 10.1080/13803390590954191; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Lawrence MA, 2012, EZ EASY ANAL VISUALI; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Martinez-Aran A, 2002, NEUROPSYCHOBIOLOGY, V46, P16, DOI 10.1159/000068016; Martinez-Aran A, 2007, PRACTICAL COGNITION, P37; Martinez-Aran A., 2001, TRASTORNOS BIPOLARES TRASTORNOS BIPOLARES, P49; Meier MH, 2014, AM J PSYCHIAT, V171, P91, DOI 10.1176/appi.ajp.2013.12111438; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; Munro JC, 2002, ACTA PSYCHIAT SCAND, V106, P139, DOI 10.1034/j.1600-0447.2002.02030.x; Ostrosky-Solis F, 2007, ARCH CLIN NEUROPSYCH, V22, P367, DOI 10.1016/j.acn.2007.01.011; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; Rami L, 2011, REV NEUROLOGIA, V52, P195, DOI 10.33588/rn.5204.2010478; Reichenberg A, 2002, AM J PSYCHIAT, V159, P2027, DOI 10.1176/appi.ajp.159.12.2027; Rende B, 2002, NEUROPSYCHOLOGY, V16, P309, DOI 10.1037//0894-4105.16.3.309; Reverberi C, 2006, NEUROPSYCHOLOGIA, V44, P469, DOI 10.1016/j.neuropsychologia.2005.05.011; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Saez-Zea C, 2008, NEUROLOGIA, V23, P356; Schwartz S, 2003, BRAIN LANG, V87, P400, DOI 10.1016/S0093-934X(03)00141-X; Schwartz S, 2001, NEUROPSYCHOLOGIA, V39, P1209, DOI 10.1016/S0028-3932(01)00053-7; SHORES EA, 2006, BRAIN IMPAIRMENT, V0007, P00026; Thurstone L.L., 1938, PRIMARY MENTAL ABILI	45	8	9	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP	2015	94	39							e1596	10.1097/MD.0000000000001596			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC9IK	WOS:000369534600038	26426640	Green Published, gold			2022-02-06	
J	Kerr, ZY; Marshall, SW; Simon, JE; Hayden, R; Snook, EM; Dodge, T; Gallo, JA; McLeod, TCV; Mensch, J; Murphy, JM; Nittoli, VC; Dompier, TP				Kerr, Zachary Y.; Marshall, Stephen W.; Simon, Janet E.; Hayden, Ross; Snook, Erin M.; Dodge, Thomas; Gallo, Joseph A.; McLeod, Tamara C. Valovich; Mensch, James; Murphy, Joseph M.; Nittoli, Vincent C.; Dompier, Thomas P.			Injury Rates in Age-Only Versus Age-and-Weight Playing Standard Conditions in American Youth Football	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; youth football; injury risk	TIME-LOSS INJURIES; MATURITY; PLAYERS	Background: American youth football leagues are typically structured using either age-only (AO) or age-and-weight (AW) playing standard conditions. These playing standard conditions group players by age in the former condition and by a combination of age and weight in the latter condition. However, no study has systematically compared injury risk between these 2 playing standards. Purpose: To compare injury rates between youth tackle football players in the AO and AW playing standard conditions. Study Design: Cohort study; Level of evidence, 2. Methods: Athletic trainers evaluated and recorded injuries at each practice and game during the 2012 and 2013 football seasons. Players (age, 5-14 years) were drawn from 13 recreational leagues across 6 states. The sample included 4092 athlete-seasons (AW, 2065; AO, 2027) from 210 teams (AW, 106; 0, 104). Injury rate ratios (RRs) with 95% Cls were used to compare the playing standard conditions. Multivariate Poisson regression was used to estimate RRs adjusted for residual effects of age and clustering by team and league. There were 4 endpoints of interest: (1) any injury, (2) non time loss (NTL) injuries only, (3) time loss (TL) injuries only, and (4) concussions only. Results: Over 2 seasons, the cohort accumulated 1475 injuries and 142,536 athlete-exposures (AEs). The most common injuries were contusions (34.4%), ligament sprains (16.3%), concussions (9.6%), and muscle strains (7.8%). The overall injury rate for both playing standard conditions combined was 10.3 per 1000 AEs (95% CI, 9.8-10.9). The TL injury, NTL injury, and concussion rates in both playing standard conditions combined were 3.1, 7.2, and 1.0 per 1000 AEs, respectively. In multivariate Poisson regression models controlling for age, team, and league, no differences were found between playing standard conditions in the overall injury rate (RRoverall, 1.1; 95% CI, 0.4-2.6). Rates for the other 3 endpoints were also similar (RRNTL, 1.1 [95% CI, 0.4-3.0]; RR-FL, 0.9 [95% CI, 0.4-1.9]; RRconcussion, 0.6 [95% CI, 0.3-1.4]). Conclusion: For the injury endpoints examined in this study, the injury rates were similar in the AO and AW playing standards. Future research should examine other policies, rules, and behavioral factors that may affect injury risk within youth football.	[Kerr, Zachary Y.; Marshall, Stephen W.; Simon, Janet E.; Hayden, Ross; Snook, Erin M.; Dodge, Thomas; Gallo, Joseph A.; McLeod, Tamara C. Valovich; Mensch, James; Murphy, Joseph M.; Nittoli, Vincent C.; Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA		Dompier, TP (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	tdompier@datalyscenter.org	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Kerr, Zachary/0000-0003-1423-1259			Dompier TP, 2007, J ATHL TRAINING, V42, P395; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Institute of Medicine, 2013, SPORTS REL CONC YOUT; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; LINDER MM, 1995, CLIN J SPORT MED, V5, P167, DOI 10.1097/00042752-199507000-00006; Malina RM, 2007, CLIN J SPORT MED, V17, P362, DOI 10.1097/JSM.0b013e31815400f4; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; National Council of Youth Sports, 2008, REP TRENDS PART ORG; Poole C, 2001, EPIDEMIOLOGY, V12, P291, DOI 10.1097/00001648-200105000-00005; Pop Warner Little Scholars, 2014, AG WEIGHT STRUCT CHA; Powell JW, 2004, J ATHL TRAINING, V39, P56; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645	13	8	8	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	SEP	2015	3	9								10.1177/2325967115603979			6	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	DE1ZP	WOS:000370425900007	26672778	Green Submitted, Green Published, gold			2022-02-06	
J	Sullivan, S; Coats, B; Margulies, SS				Sullivan, Sarah; Coats, Brittany; Margulies, Susan S.			Biofidelic neck influences head kinematics of parietal and occipital impacts following short falls in infants	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Pediatric traumatic brain injury; Biomechanics; Anthropomorphic test device	ANTHROPOMORPHIC TEST DEVICE; DIFFUSE AXONAL INJURY; LOW-HEIGHT FALLS; SKULL FRACTURE; CHILDREN; BIOMECHANICS; DIRECTION; FOOTBALL; RISK; AGE	Falls are a major cause of traumatic head injury in children. Understanding head kinematics during low height falls is essential for evaluating injury risk and designing mitigating strategies. Typically, these measurements are made with commercial anthropomorphic infant surrogates, but these surrogates are designed based on adult biomechanical data. In this study, we improve upon the state-of-the-art anthropomorphic testing devices by incorporating new infant cadaver neck bending and tensile data. We then measure head kinematics following head-first falls onto 4 impact surfaces from 3 fall heights with occipital and parietal head impact locations. The biofidelic skull compliance and neck properties of the improved infant surrogate significantly influenced the measured kinematic loads, decreasing the measured impact force and peak angular accelerations, lowering the expected injury risk. Occipital and parietal impacts exhibited distinct kinematic responses in primary head rotation direction and the magnitude of the rotational velocities and accelerations, with larger angular velocities as the head rebounded after occipital impacts. Further evaluations of injury risk due to short falls should take into account the impact surface and head impact location, in addition to the fall height. (C) 2015 Elsevier Ltd. All rights reserved.	[Sullivan, Sarah; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Coats, Brittany] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA		Margulies, SS (corresponding author), 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu	Coats, Brittany/A-4523-2009		Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [NCIPC R49CE000411]; National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1NS039679]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000411, R01CE001445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER	We gratefully acknowledge Megan Well for her assistance in conducting the drop tests. This study was made possible by the Centers for Disease Control and Prevention grant NCIPC R49CE000411 and the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) grant RO1NS039679.	Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Centers for Disease Control and Prevention, 2000, CDC GROWTH CHARTS; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Delye H, 2007, J NEUROTRAUM, V24, P1576, DOI 10.1089/neu.2007.0283; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Haney SB, 2010, PEDIATR EMERG CARE, V26, P914, DOI 10.1097/PEC.0b013e3181fe9139; HELFER RE, 1977, PEDIATRICS, V60, P533; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; Irwin A., 1997, 973317 SAE; Luck J. F., 2012, THESIS DUKE U; Luck JF, 2008, STAPP CAR C, V52, P107; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mayr JM, 1999, ACTA PAEDIATR, V88, P319, DOI 10.1080/08035259950170105; Melvin J., 1995, SAE T, V950872, P1; Monea AG, 2014, J MECH BEHAV BIOMED, V33, P3, DOI 10.1016/j.jmbbm.2013.06.011; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; STRAIT RT, 1995, PEDIATRICS, V96, P667; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Thompson A, 2013, ACCIDENT ANAL PREV, V50, P16, DOI 10.1016/j.aap.2012.09.011; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Thompson AK, 2009, J TRAUMA, V66, P1019, DOI 10.1097/TA.0b013e31817dac8b; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; WEBER W, 1984, Z RECHTSMED, V92, P87, DOI 10.1007/BF02116216; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014	40	8	8	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2015	82						143	153		10.1016/j.aap.2015.05.020			11	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CO4ZD	WOS:000359168500017	26072183	Green Accepted			2022-02-06	
J	Vipin, A; Kortelainen, J; Al-Nashash, H; Chua, SM; Thow, XY; Manivannan, J; Astrid,; Thakor, NV; Kerr, CL; All, AH				Vipin, Ashwati; Kortelainen, Jukka; Al-Nashash, Hasan; Chua, Soo Min; Thow, Xinyuan; Manivannan, Janani; Astrid; Thakor, Nitish V.; Kerr, Candace L.; All, Angelo H.			Prolonged Local Hypothermia Has No Long-Term Adverse Effect on the Spinal Cord	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article							SOMATOSENSORY-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; SYSTEMIC HYPOTHERMIA; MILD HYPOTHERMIA; CARDIAC-ARREST; ANIMAL-MODELS; CONTUSION; ISCHEMIA; OUTCOMES	Hypothermia is known to be neuroprotective and is one of the most effective and promising first-line treatments for central nervous system (CNS) trauma. At present, induction of local hypothermia, as opposed to general hypothermia, is more desired because of its ease of application and safety; fewer side effects and an absence of severe complications have been noted. Local hypothermia involves temperature reduction of a small and specific segment of the spinal cord. Our group has previously shown the neuroprotective effect of short-term, acute moderate general hypothermia through improvements in electrophysiological and motor behavioral assessments, as well as histological examination following contusive spinal cord injury (SCI) in rats. We have also shown the benefit of using short-term local hypothermia versus short-term general hypothermia post-acute SCI. The overall neuroprotective benefit of hypothermia can be categorized into three main components: (1) induction modality, general versus local, (2) invasive, semi-invasive or noninvasive, and (3) duration of hypothermia induction. In this study, a series of experiments were designed to investigate the feasibility, long-term safety, as well as eventual complications and side effects of prolonged, semi-invasive, moderate local hypothermia (30 degrees C +/- 0.5 degrees C for 5 and 8 hours) in rats with uninjured spinal cord while maintaining their core temperature at 37 degrees C +/- 0.5 degrees C. The weekly somatosensory evoked potential and motor behavioral (Basso, Beattie and Bresnahan) assessments of rats that underwent 5 and 8 hours of semi-invasive local hypothermia, which revealed no statistically significant changes in electrical conductivity and behavioral outcomes. In addition, 4 weeks after local hypothermia induction, histological examination showed no anatomical damages or morphological changes in their spinal cord structure and parenchyma. We concluded that this method of prolonged local hypothermia is feasible, safe, and has the potential for clinical translation.	[Vipin, Ashwati; Chua, Soo Min; Thow, Xinyuan; Astrid; Thakor, Nitish V.; All, Angelo H.] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 119228, Singapore; [Kortelainen, Jukka] Univ Oulu, Dept Comp Sci & Engn, Biomed Engn Res Grp, Oulu, Finland; [Al-Nashash, Hasan] Amer Univ Sharjah, Dept Elect Engn, Sharjah, U Arab Emirates; [Manivannan, Janani; All, Angelo H.] Natl Univ Singapore, Dept Orthoped Surg, Singapore 119228, Singapore; [Thakor, Nitish V.; All, Angelo H.] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD USA; [Kerr, Candace L.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [All, Angelo H.] Natl Univ Singapore, Dept Biomed Engn, Singapore 119228, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Med, Div Neurol, Singapore 119228, Singapore; [All, Angelo H.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA		All, AH (corresponding author), Natl Univ Singapore, Dept Orthoped Surg, 1E Kent Ridge Rd,NUHS Tower Block,Level 2, Singapore 119228, Singapore.	angelo.all@nuhs.edu.sg	Kortelainen, Jukka/P-5512-2014; Thakor, Nitish V/A-5878-2008	Kortelainen, Jukka/0000-0003-2585-2376; Al-Nashash, Hasan/0000-0002-9685-4937; Manivannan, Janani/0000-0003-0062-1416	National University of Singapore (NUS)National University of Singapore [R-175-000-122-112, R-175-000-121-133, R-175-000-121-733]; Singapore Institute for Neurotechnology (SINAPSE), Institute Seed Fund; Maryland Stem Cell Research Fund [2013-MSCRFII-0109-00]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HL071568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071568] Funding Source: NIH RePORTER	This research was supported by the National University of Singapore (NUS) grant: R-175-000-122-112 (Tier 1, PI: A. All) and R-175-000-121-133 and R-175-000-121-733 (Start-Up, PI: A. All), and the Singapore Institute for Neurotechnology (SINAPSE, PI: A. All) Institute Seed Fund. It was also supported by the Maryland Stem Cell Research Fund grant proposal (2013-MSCRFII-0109-00, PI: A. All) and the National Institutes of Health under grant 5R01HL071568 (PI: N. Thakor).	Agrawal G, 2010, J CLIN NEUROSCI, V17, P1159, DOI 10.1016/j.jocn.2010.02.005; Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Agrawal G, 2009, J CLIN NEUROSCI, V16, P1052, DOI 10.1016/j.jocn.2008.08.009; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Auriat AM, 2012, THER HYPOTHERMIA TEM, V2, P37, DOI 10.1089/ther.2012.0005; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; Batista LM, 2010, RESUSCITATION, V81, P398, DOI 10.1016/j.resuscitation.2009.12.016; Bazley FA, 2014, IEEE T NEUR SYS REH, V22, P953, DOI 10.1109/TNSRE.2014.2319313; Bazley FA, 2014, THER HYPOTHERMIA TEM, V4, P115, DOI 10.1089/ther.2014.0002; Bazley FA, 2013, IEEE ENG MED BIO, P6321, DOI 10.1109/EMBC.2013.6610999; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bazley FA, 2011, IEEE ENG MED BIO, P2005, DOI 10.1109/IEMBS.2011.6090564; Beddingfield E, 2012, CLIN NURSE SPEC, V26, P12, DOI 10.1097/NUR.0b013e31823f8a02; Belliard G, 2007, RESUSCITATION, V75, P252, DOI 10.1016/j.resuscitation.2007.04.014; Bro-Jeppesen J, 2009, RESUSCITATION, V80, P171, DOI 10.1016/j.resuscitation.2008.09.009; Castillo-Abrego G.A., 2012, CRIT CARE, V16, pA12, DOI [10.1186/cc11270, DOI 10.1186/CC11270]; Chang M, 2012, WEST J EMERG MED, V13, P111, DOI 10.5811/westjem.2011.4.6659; Dietrich WD, 2012, CRIT CARE MED, V40, P691, DOI 10.1097/CCM.0b013e318236eacb; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrich WD, 2009, CRIT CARE MED, V37, pS238, DOI 10.1097/CCM.0b013e3181aa5d85; Dietrich WD, 2011, CURR SPORT MED REP, V10, P50, DOI 10.1249/JSR.0b013e318205e0b3; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073; Gupta R, 2010, J AM ACAD ORTHOP SUR, V18, P210, DOI 10.5435/00124635-201004000-00004; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kang JW, 2010, J VASC SURG, V52, P435, DOI 10.1016/j.jvs.2010.03.021; Kawamura N, 2006, EXP NEUROL, V202, P487, DOI 10.1016/j.expneurol.2006.07.012; Khan S, 2007, J SPINAL CORD MED, V30, P27, DOI 10.1080/10790268.2007.11753910; Kortelainen J, 2008, NEUROSCI LETT, V446, P70, DOI 10.1016/j.neulet.2008.09.056; Kortelainen J, 2014, IEEE ENG MED BIO, P4286, DOI 10.1109/EMBC.2014.6944572; Kwon BK, 2008, SPINE J, V8, P859, DOI 10.1016/j.spinee.2007.12.006; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Lakhan SE, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/295906; Lenhardt Rainer, 2010, Front Biosci (Schol Ed), V2, P1145; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Li N, 2013, J NEUROTRAUM, V30, P1325, DOI 10.1089/neu.2012.2516; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Lotocki G, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2010.0011; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P619, DOI 10.1016/S0003-9993(99)90162-4; Melhuish Tracey, 2009, Nurs Manage, V40, P42, DOI 10.1097/01.NUMA.0000365472.26379.be; Morizane K, 2012, NEUROSCI RES, V72, P279, DOI 10.1016/j.neures.2011.12.003; Piironen K, 2014, STROKE, V45, P486, DOI 10.1161/STROKEAHA.113.003180; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Saito T, 2013, J VASC SURG, V57, P173, DOI 10.1016/j.jvs.2012.05.101; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yoshitake A, 2007, J THORAC CARDIOV SUR, V134, P1220, DOI 10.1016/j.jtcvs.2007.06.015; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Zhang LH, 2007, SURG NEUROL, V67, P117, DOI 10.1016/j.surneu.2006.05.064	55	8	8	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	SEP 1	2015	5	3					152	162		10.1089/ther.2015.0005			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR1UC	WOS:000361109600008	26057714	Green Published			2022-02-06	
J	Williams, G; Banky, M; Olver, J				Williams, Gavin; Banky, Megan; Olver, John			Severity and distribution of spasticity does not limit mobility or influence compensatory strategies following traumatic brain injury	BRAIN INJURY			English	Article						Brain injuries; gait; mobility limitation; muscle spasticity; muscle strength; running; walking	HIGH-LEVEL MOBILITY; ASSESSMENT-TOOL HIMAT; JOINT POWER-GENERATION; MODIFIED TARDIEU SCALE; ASHWORTH SCALE; WALKING SPEED; GAIT; STROKE; HIP; CLASSIFICATION	Primary objectives: To determine whether the severity of lower limb spasticity had a differential effect on mobility following traumatic brain injury (TB!) and to investigate whether the distribution of lower limb spasticity influenced compensation strategies when walking. Research design: Ninety-three people attending physiotherapy for mobility limitations following TBI participated in this study. Participants were grouped according to the presence and distribution of lower limb spasticity for comparison. Main outcomes and results: Mobility was measured using a 10-metre walk test and the high level mobility assessment tool. Three dimensional gait analysis was used to measure power generation and spasticity was assessed using the Tardieu scale. No significant relationship was found between the severity of lower limb spasticity and mobility limitations. There was a strong relationship between ankle power generation and mobility performance. Proximal compensation strategies did not vary significantly between groups with different distributions of lower limb spasticity. Conclusion: The ability to generate ankle power has a large impact on mobility outcome following TBI. Although spasticity was prevalent, the severity and distribution did not appear to impact mobility outcomes. Proximal compensation strategies were not influenced by the distribution of lower limb spasticity following TBI.	[Williams, Gavin; Banky, Megan; Olver, John] Epworth Med Fdn, Richmond, Vic 3121, Australia; [Williams, Gavin] Univ Melbourne, Melbourne, Vic, Australia; [Williams, Gavin] La Trobe Univ, Melbourne, Vic, Australia; [Olver, John] Epworth Monash Rehabil Med Unit, Melbourne, Vic, Australia		Banky, M (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	megan.banky@epworth.org.au		Olver, John/0000-0001-7069-1191; Williams, Gavin/0000-0003-2758-7473	Victorian Neurotrauma Initiative; Royal Automobile Club Victoria	The authors report no conflicts of interest and no commercial interest related to this project. This project was supported by grants from the Victorian Neurotrauma Initiative and Royal Automobile Club Victoria.	Baguley I, 2000, BRAIN INJURY, V14, P505; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; Cohen J., 2013, STAT POWER ANAL BEHA; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Haugh AB, 2006, DISABIL REHABIL, V28, P899, DOI 10.1080/09638280500404305; JENNETT B, 1975, LANCET, V1, P480; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kahn M, 2015, AM J PHYS MED REHAB, V94, P114, DOI 10.1097/PHM.0000000000000196; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim CM, 2003, PHYS THER, V83, P49, DOI 10.1093/ptj/83.1.49; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Morris, 2002, PHYS THER REV, V7, P53, DOI [10.1179/108331902125001770, DOI 10.1179/108331902125001770]; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; Nadeau S, 1999, AM J PHYS MED REHAB, V78, P123, DOI 10.1097/00002060-199903000-00007; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Olver J, 2010, EUR J NEUROL, V17, P57, DOI 10.1111/j.1468-1331.2010.03128.x; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Platz T, 2005, DISABIL REHABIL, V27, P7, DOI 10.1080/09638280400014634; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Requiao LF, 2005, J ELECTROMYOGR KINES, V15, P393, DOI 10.1016/j.jelekin.2004.12.004; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Singh P, 2011, ANN INDIAN ACAD NEUR, V14, P23, DOI 10.4103/0972-2327.78045; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams G, 2015, J HEAD TRAUMA REHAB, V30, pE49, DOI 10.1097/HTR.0000000000000094; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	43	8	8	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1232	1238		10.3109/02699052.2015.1035328			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400013	26083045				2022-02-06	
J	Tyler, CW; Likova, LT; Mineff, KN; Nicholas, SC				Tyler, Christopher W.; Likova, Lora T.; Mineff, Kristyo N.; Nicholas, Spero C.			Deficits in the activation of human oculomotor nuclei in chronic traumatic brain injury	FRONTIERS IN NEUROLOGY			English	Article						oculomotor; dynamics; vergence; binocular; eye movements; fMRI; traumatic brain injury	VERGENCE DEFICITS; NEURONS	Binocular eye movements form a finely tuned system that requires accurate coordination of the oculomotor dynamics of the brainstem control nuclei when tracking the fine binocular disparities required for 3D vision. They are particularly susceptible to disruption by brain injury and other neural dysfunctions. Here, we report functional magnetic resonance imaging activation of the brainstem oculomotor control nuclei by binocular saccadic and vergence eye movements, and significant reductions in their response amplitudes in mild or diffuse traumatic brain injury (dTBI). Bilateral signals were recorded from a non-TBI control group (n = 11) in the oculomotor control system of the superior colliculi, the oculomotor nuclei, the abducens nuclei, and in the supra-oculomotor area (SOA), which mediate vergence eye movements. Signals from these nuclei were significantly reduced overall in a dTBI group (n = 12) and in particular for the SOA for vergence movements, which also showed significant decreases in velocity for both the convergence and divergence directions.	[Tyler, Christopher W.; Likova, Lora T.; Mineff, Kristyo N.; Nicholas, Spero C.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; [Tyler, Christopher W.] City Univ London, Div Optometry, London EC1V 0HB, England		Tyler, CW (corresponding author), Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA.	cwtyler2020@gmail.com			CDMRPUnited States Department of Defense [DM 102524]	Supported by CDMRP DM 102524.	Alkan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025866; Alvarez TL, 2010, VISION RES, V50, P2163, DOI 10.1016/j.visres.2010.08.018; Augustine G., 2001, NEUROSCIENCE; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; BUSETTINI C, 2007, NEW ENCY NEUROSCIENC; Cui DM, 2003, J NEUROPHYSIOL, V89, P2678, DOI 10.1152/jn.00501.2002; GAMLIN PDR, 1994, J NEUROPHYSIOL, V72, P2368, DOI 10.1152/jn.1994.72.5.2368; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; Gamlin PDR, 2002, ANN NY ACAD SCI, V956, P264, DOI 10.1111/j.1749-6632.2002.tb02825.x; GAMLIN PDR, 1992, J NEUROPHYSIOL, V67, P64, DOI 10.1152/jn.1992.67.1.64; GAMLIN PDR, 1989, J NEUROPHYSIOL, V62, P70, DOI 10.1152/jn.1989.62.1.70; Gandhi NJ, 2004, VISUAL NEUROSCIENCES, P1449; Horn Anja K E, 2011, Handb Clin Neurol, V102, P21, DOI 10.1016/B978-0-444-52903-9.00008-X; Likova LT, 2007, NEUROIMAGE, V38, P293, DOI 10.1016/j.neuroimage.2007.06.039; Linzenbold W, 2011, NEUROIMAGE, V57, P1116, DOI 10.1016/j.neuroimage.2011.05.052; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Rambold H, 2004, NEUROLOGY, V62, P1850, DOI 10.1212/01.WNL.0000125331.95849.62; Sander T, 2009, BRAIN, V132, P103, DOI 10.1093/brain/awn306; Shires J, 2010, CURR OPIN NEUROBIOL, V20, P717, DOI 10.1016/j.conb.2010.08.008; Straube A, 2007, NEUROOPHTHALMOLOGY N; Tyler C W, 2011, VISUAL FUNCTION ITS; Tyler CW, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00282; Tyler CW, 2012, J VISION, V12, DOI 10.1167/12.11.21	24	8	8	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 25	2015	6								173	10.3389/fneur.2015.00173			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU9KA	WOS:000363862200001	26379615	gold, Green Accepted, Green Published			2022-02-06	
J	Albicini, M; McKinlay, A				Albicini, Michelle; McKinlay, Audrey			Internalizing disorders in adults with a history of childhood traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Students; Traumatic brain injury; Behavioral problems; anxiety; Internalizing disorders	TERM BEHAVIOR PROBLEMS; CLOSED-HEAD INJURY; 1ST 6 MONTHS; ANXIETY DISORDERS; GENDER-DIFFERENCES; PSYCHIATRIC-DISORDERS; CHILDREN; ADOLESCENTS; PREVALENCE; SYMPTOMS	Introduction: While the presence of externalizing behavioral problems following traumatic brain injury (TBI) has been well established in the literature, less is known regarding internalizing disorders, and more specifically anxiety disorders, in such a population. This study explored the presence, rate, and incidence of internalizing behavior problems, including anxiety, depression, somatic complaints, avoidant personality symptomatology, and overall internalizing behavior problems in university students aged 18-25 years. Method: A convenience sample of 247 university students (197 non-TBI, 47 mild TBI, 2 moderate TBI, 1 severe TBI) aged 18-25 years was utilized. Participants completed a self-report measure on behavioral functioning, the Adult Self Report (ASR), to identify internalizing behaviors, and a questionnaire to identify TBI history. Results: Raw scores of behavior indicated that participants with a history of childhood TBI reported significantly higher levels of withdrawal, somatic complaints, and internalizing behavioral problems than the non-TBI participants. When analyzing standardized T-scores for borderline and clinically elevated ASR syndromes and Diagnostic and Statistical Manual of Mental Disorders (DSM)-oriented scales, individuals in the TBI group were significantly more likely to have higher rates of borderline anxiety, somatic complaints, avoidant personality problems, and overall internalizing disorders, and clinically elevated somatic complaints. Adults with a history of childhood TBI were also significantly more likely to report at least 1 or more DSM disorders. Conclusion: These results clearly suggest that individuals with a childhood history of TBI are at a heightened risk for a range of internalizing disorders in early adulthood, which is particularly troubling in a university sample pursuing tertiary education.	[Albicini, Michelle] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [McKinlay, Audrey] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia		Albicini, M (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol & Psychiat, Wellington Rd, Clayton, Vic 3800, Australia.	michelle.albicini@monash.edu		McKinlay, Audrey/0000-0001-9846-8514			Achenbach TM, 2005, J PERS ASSESS, V84, P49, DOI 10.1207/s15327752jpa8401_10; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Chaves C, 2012, BRAIN INJURY, V26, P882, DOI 10.3109/02699052.2012.666373; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Lewinsohn PM, 1998, J ABNORM PSYCHOL, V107, P109, DOI 10.1037/0021-843X.107.1.109; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A., FRESH LOOK IN PRESS; McKinlay A., 2014, TRAUMATIC BRAIN INJU; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Ohio Valley Center for Brain Injury Prevention and Rehabilitation, 2015, SCREEN TBI SYNAPSHOT; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008	43	8	8	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 9	2015	37	7					776	784		10.1080/13803395.2015.1053843			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CQ1ZS	WOS:000360399700009	26299189				2022-02-06	
J	Birkeland, P; Lauritsen, J; Poulsen, FR				Birkeland, Peter; Lauritsen, Jens; Poulsen, Frantz Rom			Aspirin is associated with an increased risk of subdural hematoma in normal-pressure hydrocephalus patients following shunt implantation	JOURNAL OF NEUROSURGERY			English	Article						subdural hematoma; normal-pressure hydrocephalus; aspirin; cerebrospinal fluid shunt; traumatic brain injury	ANTICOAGULATION THERAPY; OVERDRAINAGE; VALVE	OBJECT In this paper the authors investigate whether shunt-treated patients with normal-pressure hydrocephalus receiving aspirin therapy are at increased risk of developing subdural hematoma (SDH). METHODS Records from 80 consecutive patients who had undergone implantation of a cerebrospinal fluid shunt for the treatment of normal-pressure hydrocephalus were retrospectively reviewed. RESULTS Eleven cases of symptomatic SDH occurred, all among patients receiving aspirin or clopidogrel. The 5-year survival estimate was 0.3 (p < 0.0001) for users of aspirin and the hazard ratio was 12.8 (95% CI 3.1-53). CONCLUSIONS Patients on an aspirin therapy regimen have a markedly increased risk of SDH after a shunt has been implanted for the treatment of normal-pressure hydrocephalus. Users of clopidogrel may have an even greater risk.	[Birkeland, Peter; Poulsen, Frantz Rom] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense C, Denmark; [Lauritsen, Jens] Odense Univ Hosp, Dept Orthoped Surg, DK-5000 Odense C, Denmark; [Lauritsen, Jens; Poulsen, Frantz Rom] Univ Southern Denmark, Inst Clin Res, Odense, Denmark		Birkeland, P (corresponding author), Odense Univ Hosp, Dept Neurosurg, Sdr Blvd 29, DK-5000 Odense C, Denmark.	peter@birkeland.dk		Poulsen, Frantz Rom/0000-0001-5715-6901; Lauritsen, Jens/0000-0001-9281-8990			Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; BALDINI M, 1980, SCHWEIZ ARCH NEUROL, V127, P5; Brean A, 2008, ACTA NEUROL SCAND, V118, P48, DOI 10.1111/j.1600-0404.2007.00982.x; Chrissicopoulos C, 2012, ACTA NEUROCHIR SUPPL, V113, P119, DOI 10.1007/978-3-7091-0923-6_24; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; De Bonis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068732; Goodwin CR, 2007, NEUROSURGERY, V60, P497, DOI 10.1227/01.NEU.0000255349.71700.E1; Gurer B, 2012, CLIN NEUROL NEUROSUR, V114, P196, DOI 10.1016/j.clineuro.2011.10.006; Hayes Jackson, 2012, J Med Case Rep, V6, P393, DOI 10.1186/1752-1947-6-393; KAMANO S, 1991, SURG NEUROL, V35, P381, DOI 10.1016/0090-3019(91)90050-J; KATZMAN R, 1970, NEUROLOGY, V20, P534, DOI 10.1212/WNL.20.6.534; Khan QU, 2013, J NEUROSURG, V119, P1498, DOI 10.3171/2013.7.JNS13484; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; O'Brien D F, 2000, Ir Med J, V93, P244; Zeilinger FS, 2000, ACT NEUR S, V76, P559	15	8	9	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2015	123	2					423	426		10.3171/2014.11.JNS14804			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CS6OV	WOS:000362200800020	25555087	Bronze			2022-02-06	
J	Hayashi, H; Takagi, N				Hayashi, Hideki; Takagi, Norio			Endogenous Neuroprotective Molecules and Their Mechanisms in the Central Nervous System	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						neuroprotectant; central nervous system; neuronal damage	HEPATOCYTE GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; TRAUMATIC BRAIN-INJURY; VASOACTIVE-INTESTINAL-PEPTIDE; RECEPTOR-RELATED PROTEIN-1; E-CONTAINING LIPOPROTEINS; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; ADENYLATE-CYCLASE; TISSUE INHIBITOR	Functions of the central nervous system (CNS) are based on a complex neural network. It is believed that the CNS has several neuroprotective mechanisms operated by neurons, glia and other types of cells against various types of neuronal damage. Since mature, differentiated neurons are not able to divide, it is important to protect neurons from damage prior to death. The neuroprotective effects of a number of pharmaceutical agents and natural products against necrosis and apoptosis of the CNS neurons have been reported, thus this review will mainly discuss several endogenous neuroprotectants and their mechanisms.	[Hayashi, Hideki; Takagi, Norio] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Appl Biochem, Hachioji, Tokyo 1920392, Japan		Hayashi, H (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Appl Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	hhayashi@toyaku.ac.jp			Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K06781]; Takeda Science FoundationTakeda Science Foundation (TSF); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15K06781] Funding Source: KAKEN	This work was supported by Grantin-Aid for Scientific Research C (No. 15K06781) from Japan Society for the Promotion of Science (JSPS) and the Takeda Science Foundation.	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54; Bartesaghi S, 2005, NEUROTOXICOLOGY, V26, P923, DOI 10.1016/j.neuro.2005.01.016; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Baydyuk M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00254; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Dicicco-Bloom E, 1998, ANN NY ACAD SCI, V865, P274, DOI 10.1111/j.1749-6632.1998.tb11188.x; Du SW, 2015, NEUROSCI LETT, V584, P56, DOI 10.1016/j.neulet.2014.09.045; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; Fujita R, 2007, CELL DEATH DIFFER, V14, P1839, DOI 10.1038/sj.cdd.4402189; Genc S, 2004, BRAIN RES, V1000, P19, DOI 10.1016/j.brainres.2003.12.037; Grupke S, 2015, CLIN NEUROL NEUROSUR, V129, P1, DOI 10.1016/j.clineuro.2014.11.013; Halder SK, 2013, J NEUROCHEM, V125, P713, DOI 10.1111/jnc.12132; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hayashi H, 2012, J BIOL CHEM, V287, P25395, DOI 10.1074/jbc.M112.370130; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Ishihara N, 2005, J NEUROCHEM, V95, P1277, DOI 10.1111/j.1471-4159.2005.03446.x; Jang SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011528; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Ji JZ, 2004, EUR J NEUROSCI, V19, P265, DOI 10.1111/j.0953-816X.2003.03107.x; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaur H, 2013, PHARMACOLOGY, V92, P324, DOI 10.1159/000356320; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Miyazawa T, 1998, J CEREBR BLOOD F MET, V18, P345, DOI 10.1097/00004647-199804000-00001; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Niimura M, 2006, J CEREBR BLOOD F MET, V26, P1354, DOI 10.1038/sj.jcbfm.9600287; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Rege SD, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00218; Ren ZH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02786; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segade F, 1999, INT J BIOCHEM CELL B, V31, P1243, DOI 10.1016/S1357-2725(99)00094-1; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Souvenir R, 2011, NEUROBIOL DIS, V44, P28, DOI 10.1016/j.nbd.2011.05.020; Stroth N, 2011, ANN NY ACAD SCI, V1220, P49, DOI 10.1111/j.1749-6632.2011.05904.x; Sytkowski AJ, 2011, CELL MOL NEUROBIOL, V31, P931, DOI 10.1007/s10571-011-9695-0; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI [10.1089/neu.2009-0959, 10.1089/neu.2009.0959]; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Uren RT, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00039, 10.3389/fnmo1.2014.00039]; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang XK, 1998, J CEREBR BLOOD F MET, V18, P1173, DOI 10.1097/00004647-199811000-00002; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Yamauchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075497	69	8	8	0	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1104	1108		10.1248/bpb.b15-00361			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000004	26235573	gold			2022-02-06	
J	Hunt, AW; Le Dorze, G; Polatajko, H; Bottari, C; Dawson, DR				Hunt, Anne W.; Le Dorze, Guylaine; Polatajko, Helene; Bottari, Carolina; Dawson, Deirdre R.			Communication during goal-setting in brain injury rehabilitation: What helps and what hinders?	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Brain injury; goal-setting; communication	EXECUTIVE DYSFUNCTION; SELF-AWARENESS; STROKE; PERFORMANCE; PERSPECTIVES; ENGAGEMENT; PEOPLE; ADULTS	Introduction Setting goals with individuals with acquired brain injury may be challenging due to impairments in cognition and communication. The purpose of this study was to explore how occupational therapists' communication behaviours during goal-setting with individuals with traumatic brain injury facilitated and hindered this process. Method This exploratory study used a conversation analysis inspired approach and frequency calculations to analyse and interpret videotaped goal-setting sessions. Sequences of dialogue leading to, and distracting from, problem identification, a key step in goal-setting, were identified and analysed. Specific therapist behaviours that facilitated or hindered problem identification were subsequently distinguished. Results Acknowledgements and affirmations, open-ended questions about specific tasks and reflective listening, were found to lead to problem identification by the client (facilitators). Instances of disconnections were characterized by a single theme, lack of uptake.' Examples of these hindrances to goal-setting included, abrupt topic shifts, lack of acknowlegement and failure to explore what the client said. Conclusion Clinicians should consider their language use during goal-setting interviews and aim to utilize conversational behaviours that are facilitative whilst minimizing those that distract to optimize their client's engagement during the problem identification phase of goal-setting.	[Hunt, Anne W.] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Le Dorze, Guylaine] Univ Montreal, Sch Speech Language Pathol & Audiol, Ctr Interdisciplinary Res Rehabil Greater Montrea, Quebec City, PQ, Canada; [Polatajko, Helene] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Ctr Interdisciplinary Res Rehabil Greater Montrea, Quebec City, PQ, Canada; [Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Baycrest, ON, Canada; [Dawson, Deirdre R.] Rotman Res Inst, Baycrest, ON, Canada		Dawson, DR (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave Ontario, Toronto, ON M5G 1V7, Canada.	d.dawson@utoronto.ca	Le Dorze, Guylaine/A-1790-2014; Dawson, Deirdre/I-8882-2014	Dawson, Deirdre/0000-0001-7517-6121			Barnard RA, 2010, QUAL HEALTH RES, V20, P239, DOI 10.1177/1049732309358327; Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Drew P, 2001, Health Expect, V4, P58, DOI 10.1046/j.1369-6513.2001.00125.x; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Gauggel S, 2002, J CLIN EXP NEUROPSYC, V24, P1070, DOI 10.1076/jcen.24.8.1070.8377; Heritage J, 2006, STUD INTERACT SOCIO, P1, DOI 10.1017/CBO9780511607172; Holliday RC, 2007, J NEUROL NEUROSUR PS, V78, P576, DOI 10.1136/jnnp.2006.102509; Kuipers P., 2004, BRAIN IMPAIR, V5, P30, DOI DOI 10.1375/BRIM.5.1.30.35404; Kus S, 2011, J REHABIL MED, V43, P156, DOI 10.2340/16501977-0636; Lawler J, 1999, J ADV NURS, V30, P401, DOI 10.1046/j.1365-2648.1999.01086.x; Levack WMM, 2006, BRAIN INJURY, V20, P1439, DOI 10.1080/02699050601118422; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Lund MARIA LARSSON, 2001, Occup Ther Int, V8, P151; McColl M. A., 2006, RES CANADIAN OCCUPAT; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Melville LL, 2002, AM J OCCUP THER, V56, P650, DOI 10.5014/ajot.56.6.650; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Parry RH, 2004, CLIN REHABIL, V18, P668, DOI 10.1191/0269215504cr745oa; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Pollock N, 1998, CANADIAN OCCUPATIONA; Ponte-Allan M, 1998, AM J OCCUPATIONAL TH, V53, P646; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; Schoeb V, 2009, MANUAL THER, V14, P665, DOI 10.1016/j.math.2009.02.004; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Sumison T, 2004, BRIT J OCCUPATIONAL, V67, P2; ten Have P., 2007, DOING CONVERSATION A; TOWNSEND E, 1997, ENABLING OCCUPATION; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	36	8	8	0	22	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	AUG	2015	78	8					488	498		10.1177/0308022614562784			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CP3WN	WOS:000359813600005					2022-02-06	
J	Ran, QS; Yu, YH; Fu, XH; Wen, YC				Ran, Qi-shan; Yu, Yun-hu; Fu, Xiao-hong; Wen, Yuan-chao			Activation of the Notch signaling pathway promotes neurovascular repair after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; endothelial progenitor cells; traumatic brain injury; Notch signaling pathway; cell migration; invasion; angiogenesis; jetPEI (TM) system; neural regeneration	ENDOTHELIAL PROGENITOR CELLS; STEM-CELLS; DIFFERENTIATION; PROLIFERATION; RECOVERY; JAGGED1; GROWTH; VEGF	The Notch signaling pathway plays a key role in angiogenesis and endothelial cell formation, but it remains unclear whether it is involved in vascular repair by endothelial progenitor cells after traumatic brain injury. Therefore, in the present study, we controlled the Notch signaling pathway using overexpression and knockdown constructs. Activation of the Notch signaling pathway by Notch1 or Jagged1 overexpression enhanced the migration, invasiveness and angiogenic ability of endothelial progenitor cells. Suppression of the Notch signaling pathway with Notch1 or Jagged1 siRNAs reduced the migratory capacity, invasiveness and angiogenic ability of endothelial progenitor cells. Activation of the Notch signaling pathway in vivo in a rat model of mild traumatic brain injury promoted neurovascular repair. These findings suggest that the activation of the Notch signaling pathway promotes blood vessel formation and tissue repair after brain trauma.	[Ran, Qi-shan; Yu, Yun-hu; Fu, Xiao-hong; Wen, Yuan-chao] ZunYi Med Coll, Affiliated Hosp 3, Peoples Hosp ZunYi 1, Dept Neurosurg, Zunyi, Guizhou Provinc, Peoples R China		Ran, QS (corresponding author), ZunYi Med Coll, Affiliated Hosp 3, Peoples Hosp ZunYi 1, Dept Neurosurg, Zunyi, Guizhou Provinc, Peoples R China.	ranqishan1203@126.com			Natural Science Foundation of Guizhou Province in China [Qiankehe J (2013)2311]	This study was supported by the Natural Science Foundation of Guizhou Province in China, No. Qiankehe J (2013)2311.	Ahrens I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023210; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Brew N, 2014, AM J PHYSIOL-REG I, V306, pR773, DOI 10.1152/ajpregu.00487.2013; Burger D, 2012, J AM SOC HYPERTENS, V6, P85, DOI 10.1016/j.jash.2011.11.003; Dai Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.137; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Giordano A, 2014, VASC PHARMACOL, V61, P63, DOI 10.1016/j.vph.2014.04.002; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Kamei N, 2012, J NEUROTRAUM, V29, P1758, DOI 10.1089/neu.2011.2139; Koob AO, 2012, ANAL BIOCHEM, V425, P120, DOI 10.1016/j.ab.2012.02.034; Kunishio K, 1989, No To Shinkei, V41, P1195; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Lee SH, 2014, CIRC RES, V115, P215, DOI 10.1161/CIRCRESAHA.115.303142; Li QY, 2013, BIOMATERIALS, V34, P4982, DOI 10.1016/j.biomaterials.2013.03.030; Liu J, 2014, GENESIS, V52, P809, DOI 10.1002/dvg.22790; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Shim Y, 2015, ANAL CHIM ACTA, V853, P501, DOI 10.1016/j.aca.2014.10.036; Stefini R, 2008, EUR J ANAESTH, V25, P192, DOI 10.1017/S0265021508003517; Suchting S, 2009, CELL, V137, P988, DOI 10.1016/j.cell.2009.05.024; Sun NX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100340; von Grabowiecki Y, 2015, J PHARMACOL EXP THER, V352, P23, DOI 10.1124/jpet.114.216879; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wei HJ, 2010, CHIN J TRAUMATOL, V13, P316, DOI 10.3760/cma.j.issn.1008-1275.2010.05.013; Xie CC, 2015, BRAIN RES, V1602, P1, DOI 10.1016/j.brainres.2014.03.021; Xu J, 2009, AM J PHYSIOL-CELL PH, V296, pC535, DOI 10.1152/ajpcell.00310.2008; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	31	8	10	0	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG	2015	10	8					1258	1264		10.4103/1673-5374.162758			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CQ5HX	WOS:000360635300024	26487853	Green Published, gold			2022-02-06	
J	Streibelt, M; Menzel-Begemann, A				Streibelt, M.; Menzel-Begemann, A.			Does the Success of Work-related Interventions in the Rehabilitation of Neurological Diseases Depend on the Return-to-Work Prognosis? A Re-analysis of 2 Randomised Controlled Trials	REHABILITATION			German	Article						work-related medical rehabilitation (WMR); neurological rehabilitation; randomised controlled trials (RCT)	TRAUMATIC BRAIN-INJURY; VOCATIONAL-REHABILITATION; MEDICAL REHABILITATION; STROKE; PARTICIPATION; PROGRAMS	Objective: The paper examines whether patients with neurological diseases and a poor return to work (RTW) prognosis gain more from work-related medical rehabilitation (WMR). Methods: Re-analysis of matched samples of 2 randomised controlled trials (N=442; questionnaire at admission of rehabilitation and 15-month follow-up). Linear regression models were used calculating the effect of the WMR dependent on the RTW prognosis. Primary outcome was time of sick leave in the follow-up and physical and mental health measured by the SF-36. As secondary outcomes, strategies of coping skills and work-related attitudes were defined. Results: Only for patients with a high non-RTW risk could positive effects of WMR be demonstrated on mental health, coping skills and the scale work as a resource. In the 15-month follow-up, there were no differences in effects on duration of sick leave and physical health. Conclusions: The results based on this analysis indicate that patients with neurological diseases derive benefit from WMR only if their empirical RTW prognosis is poor. However, this only applies for the mental health in the medium term. Our study confirms the previous findings that suggest different effectiveness of the WMR for patients with different RTW risk.	[Streibelt, M.] Deutsch Rentenversicherung Bund, Abt Rehabil, D-10704 Berlin, Germany; [Menzel-Begemann, A.] Fachhsch Munster, Lehr & Forsch Gebiet Rehabil Wissensch, Fachbereich Pflege & Gesundheit, Munster, Germany		Streibelt, M (corresponding author), Deutsch Rentenversicherung Bund, Abt Rehabil, Hohenzollerndamm 47, D-10704 Berlin, Germany.	dr.marco.streibelt@drv-bund.de					Baldwin C, 2011, TOP STROKE REHABIL, V18, P562, DOI 10.1310/tsr1805-562; Bell SH, 2002, LABOUR ECON, V9, P279, DOI 10.1016/S0927-5371(02)00006-4; Bethge M, 2014, REHABILITATION, V53, P184, DOI 10.1055/s-0033-1353192; Bethge M, 2011, J BACK MUSCULOSKELET, V24, P161, DOI 10.3233/BMR-2011-0290; Bethge M, 2011, REHABILITATION, V50, P145, DOI 10.1055/s-0031-1275687; Bonneterre V., 2013, Annals of Physical and Rehabilitation Medicine, V56, P652, DOI 10.1016/j.rehab.2013.10.001; BULLINGER M, 1998, SF 36 FRAGEBOGEN GES; Burger W, 2002, Rehabilitation (Stuttg), V41, P92; Chan Mei Leng, 2008, Occup Ther Int, V15, P87, DOI 10.1002/oti.248; Claros-Salinas D, 2004, THESIS U KONSTANZ KO; Cohen J., 2013, STAT POWER ANAL BEHA; Deck R, 1998, Z GESUNDHEITSPSYCHOL, V6, P101; Deutsche Rentenversicherung Bund, 2012, ANF DURCHF MED BER O, V3; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Hartke RJ, 2011, TOP STROKE REHABIL, V18, P341, DOI 10.1310/tsr1804-341; Kittell J, 2008, REHABILITATION, V47, P14, DOI 10.1055/s-2007-1004606; Koch S, 2012, DRV SCHRIFTEN, V98, P244; Lacher S, 2004, DRV SCHRIFTEN, V52, P215; Lipsey M.W., 2001, PRACTICAL META ANAL; Lukasczik M, 2012, DRV SCHRIFTEN, V98, P215; Menzel-Begemann A, 2012, BERUFLICHE ORIENTIER; Menzel-Begemann A, 2014, DRV SCHRIFTEN, V103, P45; Menzel-Begemann A, 2011, DRV SCHRIFTEN, V93, P365; Neuderth S, 2014, DRV SCHRIFTEN, V103, P57; Pearn John, 2013, Practitioner, V257, P23; Pohl M, 2009, DRV SCHRIFTEN, V83, P340; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Schupp W, 2011, REHABILITATION, V50, P354, DOI 10.1055/s-0031-1285916; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Streibelt M, 2011, REHABILITATION, V50, P160, DOI 10.1055/s-0031-1275721; Streibelt M, 2014, INT J REHABIL RES, V37, P61, DOI 10.1097/MRR.0000000000000031; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Wang YC, 2014, WORK, V47, P553, DOI 10.3233/WOR-131627; Waterschoot FPC, 2014, PAIN, V155, P179, DOI 10.1016/j.pain.2013.10.006; Wendel C, 2002, THESIS U BREMEN BREM; Wolfenden B, 2009, INT J REHABIL RES, V32, P93, DOI 10.1097/MRR.0b013e328325a358	37	8	8	0	17	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0034-3536	1439-1309		REHABILITATION	Rehabilitation	AUG	2015	54	4					252	258		10.1055/s-0035-1555905			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	CQ5HO	WOS:000360634400007	26317841				2022-02-06	
J	Chen, Y; Bang, S; Park, S; Shi, H; Kim, SF				Chen, Yong; Bang, Sookhee; Park, Soohyun; Shi, Hanyuan; Kim, Sangwon F.			Acyl-CoA-binding domain containing 3 modulates NAD(+) metabolism through activating poly(ADP-ribose) polymerase 1	BIOCHEMICAL JOURNAL			English	Article						acyl-CoA-binding domain containing 3 (ACBD3); lipid metabolism; nicotinamide adenine dinucleotide (NAD(+)) metabolism; poly(ADP-ribose) polymerase 1 (PARP1); poly(ADP-ribosyl) ation (PARylation)	PARP-1 ACTIVATION; ADP-RIBOSYLATION; HISTONE H1; CELL-DEATH; PROTEIN; STRESS; GCP60; IDENTIFICATION; ACBD3; LOCALIZATION	NAD(+) plays essential roles in cellular energy homoeostasis and redox state, functioning as a cofactor along the glycolysis and citric acid cycle pathways. Recent discoveries indicated that, through the NAD(+) -consuming enzymes, this molecule may also be involved in many other cellular and biological outcomes such as chromatin remodelling, gene transcription, genomic integrity, cell division, calcium signalling, circadian clock and pluripotency. Poly(ADP-ribose) polymerase 1 (PARP1) is such an enzyme and dysfunctional PARP1 has been linked with the onset and development of various human diseases, including cancer, aging, traumatic brain injury, atherosclerosis, diabetes and inflammation. In the present study, we showed that overexpressed acyl-CoA-binding domain containing 3 (ACBD3), a Golgi-bound protein, significantly reduced cellular NAD(+) content via enhancing PARP1's polymerase activity and enhancing auto-modification of the enzyme in a DNA damage-independent manner. We identified that extracellular signal-regulated kinase (ERK) 1/2 as well as de novo fatty acid biosynthesis pathways are involved in ACBD3-mediated activation of PARP1. Importantly, oxidative stressinduced PARP1 activation is greatly attenuated by knocking down the ACBD3 gene. Taken together, these findings suggest that ACBD3 has prominent impacts on cellular NAD(+) metabolism via regulating PARP1 activation-dependent auto-modification and thus cell metabolism and function.	[Chen, Yong; Bang, Sookhee; Park, Soohyun; Shi, Hanyuan; Kim, Sangwon F.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Perlman Sch Med, Philadelphia, PA 19104 USA; [Kim, Sangwon F.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Ctr Neurobiol & Behav, Perlman Sch Med, Philadelphia, PA 19104 USA		Kim, SF (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Perlman Sch Med, Philadelphia, PA 19104 USA.	sangwonk@mail.med.upenn.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD026979, MH079614, DK084336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK084336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K99MH079614, R00MH079614] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health [grant numbers HD026979, MH079614 and DK084336 (to S.F.K.)].	Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Burkle A, 2005, INT J BIOCHEM CELL B, V37, P1043, DOI 10.1016/j.biocel.2004.10.006; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Canuelo A, 2012, MOL CELL BIOCHEM, V363, P101, DOI 10.1007/s11010-011-1162-1; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Chen Y, 2013, J NEUROSCI, V33, P3582, DOI 10.1523/JNEUROSCI.1497-12.2013; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049906; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohen-Armon M, 2004, SCIENCE, V304, P1820, DOI 10.1126/science.1096775; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; DEMATTEIS MA, 1994, P NATL ACAD SCI USA, V91, P1114, DOI 10.1073/pnas.91.3.1114; Erener S, 2012, MOL ENDOCRINOL, V26, P79, DOI 10.1210/me.2011-1163; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Fontan-Lozano A, 2010, J NEUROSCI, V30, P13305, DOI 10.1523/JNEUROSCI.3010-10.2010; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Greninger AL, 2012, J VIROL, V86, P3605, DOI 10.1128/JVI.06778-11; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hsiao JR, 2009, CANCER RES, V69, P4461, DOI 10.1158/0008-5472.CAN-09-0277; Huang Q, 2009, CELL DEATH DIFFER, V16, P264, DOI 10.1038/cdd.2008.151; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lai YS, 2012, P NATL ACAD SCI USA, V109, P3772, DOI 10.1073/pnas.1108595109; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meinnel T, 2008, FRONT BIOSCI, V13, P6326, DOI 10.2741/3157; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Mironov A, 1997, J CELL BIOL, V139, P1109, DOI 10.1083/jcb.139.5.1109; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sala A, 2008, PLOS BIOL, V6, P2329, DOI 10.1371/journal.pbio.0060252; Sasaki J, 2012, EMBO J, V31, P754, DOI 10.1038/emboj.2011.429; Sbodio JI, 2007, J BIOL CHEM, V282, P29874, DOI 10.1074/jbc.M705794200; Sbodio JI, 2006, J BIOL CHEM, V281, P27924, DOI 10.1074/jbc.M603276200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Zhang FX, 2013, J BIOL CHEM, V288, P11348, DOI 10.1074/jbc.M112.429134; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	62	8	8	0	6	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0264-6021	1470-8728		BIOCHEM J	Biochem. J.	JUL 15	2015	469		2				189	198		10.1042/BJ20141487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR0ZG	WOS:000361051800004	25940138				2022-02-06	
J	Birk, DM; Tobin, MK; Moss, HE; Feinstein, E; Charbel, FT; Alaraj, A				Birk, Daniel M.; Tobin, Matthew K.; Moss, Heather E.; Feinstein, Eric; Charbel, Fady T.; Alaraj, Ali			Improvement in venous outflow following superior sagittal sinus decompression after a gunshot wound to the head: case report	JOURNAL OF NEUROSURGERY			English	Article						superior sagittal sinus; intracranial hypertension; gunshot wound; skull fracture; craniectomy; traumatic brain injury	DEPRESSED SKULL FRACTURE; IDIOPATHIC INTRACRANIAL HYPERTENSION; MAGNETIC-RESONANCE ANGIOGRAPHY; OF-THE-LITERATURE; MANAGEMENT; STENOSIS	The most commonly described indications for surgical management of closed depressed skull fractures are hematoma evacuation and repair of extensive cosmetic deformity. Venous sinus injury, which occurs in a subset of depressed skull fractures, is not typically listed as an indication for surgical treatment due to the potential for major venous hemorrhage associated with surgery near these structures. However, if patients exhibit signs and symptoms of intracranial hypertension and radiographic findings demonstrate sinus compromise, surgical elevation of the depressed skull fragments is indicated. The authors present the case of a 25-year-old woman with a depressed skull fracture secondary to a gunshot wound with symptomatic compromise in venous outflow of the posterior one-third of the superior sagittal sinus. The patient was treated with surgical decompression via bilateral craniectomy along with intracranial pressure lowering medical therapy and had almost full resolution of her presenting symptoms with documented improvement in flow through the superior sagittal sinus. While the use of surgical treatment for these types of injuries is highly debated, the authors demonstrate here that safe, effective surgical management of these patients is possible and that surgical decompression should always be considered in the case of symptomatic venous sinus flow obstruction.	[Birk, Daniel M.; Tobin, Matthew K.; Charbel, Fady T.; Alaraj, Ali] Univ Illinois, Dept Neurosurg, Chicago, IL 60612 USA; [Moss, Heather E.; Feinstein, Eric] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [Moss, Heather E.] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60612 USA		Alaraj, A (corresponding author), Univ Illinois, Dept Neurosurg, 912 S Wood St,MC-799, Chicago, IL 60612 USA.	alaraj@uic.edu		Moss, Heather/0000-0003-4373-447X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 EY 024345]; Departmental Grant from Research to Prevent Blindness; NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23EY024345] Funding Source: NIH RePORTER	Dr. Alaraj is a consultant to Cordis-Codman and Immersive Touch and receives support from an unrelated NIH grant. Dr. Charbel has financial interest in VasSol, Inc. Dr. Moss receives funding from NIH K23 EY 024345 and an unrestricted Departmental Grant from Research to Prevent Blindness. Dr. Feinstein receives funding from an unrestricted Departmental Grant from Research to Prevent Blindness.	Alex BV, 1996, NEUROTRAUMA, P119; Alperin N, 2013, AM J NEURORADIOL, V34, P29, DOI 10.3174/ajnr.A3171; Amin-Hanjani S, 2005, STROKE, V36, P1140, DOI 10.1161/01.STR.0000166195.63276.7c; Amin-Hanjani S, 2010, STROKE, V41, P2534, DOI 10.1161/STROKEAHA.110.594739; Bauer AM, 2009, J NEUROIMAGING, V19, P250, DOI 10.1111/j.1552-6569.2008.00297.x; Binder DK, 2004, NEUROSURGERY, V54, P538, DOI 10.1227/01.NEU.0000109042.87246.3C; Calderon-Arnulphi M, 2011, AM J NEURORADIOL, V32, P1552, DOI 10.3174/ajnr.A2546; CAUDILL CM, 1953, NEUROLOGY, V3, P231, DOI 10.1212/WNL.3.3.231; Cooper PR, 1993, BRAIN SURG COMPLICAT, P1273; Donovan DJ, 2005, SURG NEUROL, V63, P380, DOI 10.1016/j.surneu.2004.06.020; du Plessis JJ, 1993, J TRAUMA, V34, P290; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; Fuentes S, 2005, BRIT J NEUROSURG, V19, P438, DOI 10.1080/02688690500390193; Ghogawala Z, 2013, J STROKE CEREBROVASC, V22, P1029, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.016; KAPP JP, 1972, SURGERY, V71, P913; KAPP JP, 1977, SURG NEUROL, V7, P339; LeFeuvre D, 2004, SURG NEUROL, V62, P121, DOI 10.1016/j.surneu.2003.10.048; MacIntosh PW, 2014, SURV OPHTHALMOL, V59, P664, DOI 10.1016/j.survophthal.2014.01.010; MEIER U, 1992, ACTA NEUROCHIR, V119, P91, DOI 10.1007/BF01541788; MILLER JD, 1968, LANCET, V2, P991; Ozer FD, 2005, J EMERG MED, V29, P137, DOI 10.1016/j.jemermed.2005.03.006; RAY BS, 1951, ANN SURG, V134, P376, DOI 10.1097/00000658-195113430-00009; STEINBOK P, 1987, J NEUROSURG, V66, P506, DOI 10.3171/jns.1987.66.4.0506; Uzan M, 1998, J NEUROSURG, V88, P598, DOI 10.3171/jns.1998.88.3.0598; vandenBrink WA, 1996, NEUROSURGERY, V38, P1044, DOI 10.1097/00006123-199605000-00039; Ward JD, 1996, NEUROTRAUMA, P859; Zaco JC, 2011, YOUMANS NEUROLOGICAL, V6, P3424	27	8	8	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2015	123	1					81	85		10.3171/2014.10.JNS141349			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CL5DY	WOS:000356981200011	25839927	Green Accepted			2022-02-06	
J	Chong, SL; Barbier, S; Liu, N; Ong, GYK; Ng, KC; Ong, MEH				Chong, Shu-Ling; Barbier, Sylvaine; Liu, Nan; Ong, Gene Yong-Kwang; Ng, Kee Chong; Ong, Marcus Eng Hock			Predictors for moderate to severe paediatric head injury derived from a surveillance registry in the emergency department	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain injuries; Traumatic brain injury; Children; Paediatrics	TRAUMATIC BRAIN-INJURIES; CLINICAL DECISION RULES; COMPUTED-TOMOGRAPHY; CHILDREN; CHILDHOOD; SCANS; RISK	Introduction and aim: Head injuries are a common complaint among children presenting to the emergency department (ED). This study is part of an ongoing prospective surveillance of head injured children presenting to a paediatric ED. We aim to derive predictors for moderate to severe head injury in our population. Materials and methods: We performed an unmatched case-control study. Cases were defined as those who presented to the ED with moderate to severe head injury, during the period from 2006 to 2014. Controls were obtained from the prospective surveillance head injury database and were children who presented to the ED with head injury but who remained well on follow up. We compared variables from demographics, mechanism of injury, history, and physical examination. Results: There were 39 cases and 1173 controls. In the prospective database, our event rate was 0.5% and our computed tomography (CT) rate was 1%. Among those with moderate to severe head injury, they were more likely to be involved in road traffic accidents, have a history of difficult arousal, confusion or disorientation and a history of seizure. On physical examination, cases were more likely to have the presence of altered mental status, base of skull fracture, scalp hematoma and anisocoria. On multivariable analysis, the following 4 predictors remained statistically significant: Involvement in road traffic accident (p < 0.001), difficult arousal (p < 0.001), vomiting (p = 0.003) and signs of base of skull fracture (p < 0.001). Using these 4 variables, the Area under Curve was 0.97 {Sensitivity 92.3% (79.1-98.4%), Specificity 93.0% (91.4-94.4%), positive predictive value 30.5% (22-40%), negative predictive value 99.7% (99.2-99.9%)}. Conclusion: Involvement in road traffic accident, difficult arousal, base of skull fracture and vomiting are independent predictors for moderate to severe head injury in our paediatric population. (C) 2015 Elsevier Ltd. All rights reserved.	[Chong, Shu-Ling; Ong, Gene Yong-Kwang; Ng, Kee Chong] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Chong, Shu-Ling; Ong, Gene Yong-Kwang; Ng, Kee Chong] Duke NUS Grad Med Sch, SingHlth Duke NUS Paediat Acad Clin Programme, Singapore, Singapore; [Barbier, Sylvaine; Liu, Nan] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Liu, Nan; Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore; [Ong, Marcus Eng Hock] Duke NUS Grad Med Sch, Hlth Serv & Syst Res, Singapore, Singapore		Chong, SL (corresponding author), KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore.	Chong.Shu-Ling@kkh.com.sg	Ong, Gene/W-3154-2019; Liu, Nan/L-9529-2013	Ong, Gene/0000-0002-9879-0594; Liu, Nan/0000-0003-3610-4883	Paediatrics Academic Clinical Program (ACP), Singapore	The prospective head injury surveillance receives funding support from the Paediatrics Academic Clinical Program (ACP), Singapore. We would like to thank the following: Dr John Allen for his advice in the statistical analysis and revision of this paper, Ms Dianna Sri, Ms Lau Yew Ping and Ms Jasmine Feng for their assistance in data collection, and the staff of the Emergency Department of KK Women's and Children's Hospital for their contribution to the surveillance registry.	Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lyttle MD, 2013, EMERG MED J, V30, P790, DOI 10.1136/emermed-2012-201887; Lyttle MD, 2014, ARCH DIS CHILD, V99, pA6, DOI [http://dx.doi.org/10.1136/archdischild-2014-306237.13, DOI 10.1136/ARCHDISCHILD-2014-306237.13]; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mckenna C, 2014, ARCH DIS CHILD, V99, pA341, DOI [http://dx.doi.org/10.1136/archdischild-2014-307384.947, DOI 10.1136/ARCHDISCHILD-2014-307384.947]; Nath PC, 2015, INDIAN J NEUROTRAUMA, DOI [http://dx.doi.org/10.1016/j.ijnt.2014.12.010, DOI 10.1016/J.IJNT.2014.12.010]; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pala A, 2014, J CHILD NEUROL; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Vestergaard V, 2014, ACTA NEUROL SCAND, V129, P168, DOI 10.1111/ane.12158	21	8	8	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2015	46	7					1270	1274		10.1016/j.injury.2015.04.002			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CP8EK	WOS:000360124800014	25907402				2022-02-06	
J	Fraas, MR				Fraas, Michael R.			Narrative Medicine Suggestions for Clinicians to Help Their Clients Construct a New Identity Following Acquired Brain Injury	TOPICS IN LANGUAGE DISORDERS			English	Article						identity; narrative medicine; phenomenology; rehabilitation; stroke; traumatic brain injury	COGNITIVE REHABILITATION; STROKE; SELF; PHENOMENOLOGY; EXPERIENCE; COMMUNITY; SURVIVORS; LIFE	Survivors of brain injury from trauma and stroke often lose their sense of identity and face a series of lifelong obstacles that challenge their ability to integrate back into their communities and live meaningful and productive lives. Their stories provide powerful accounts of these challenges, which can inform clinical decision-making. Arguably, the act of telling their stories is, in and of itself, a means for creating a new identity and fostering recovery. This article examines how clinicians can utilize the subjective techniques of narrative medicine to facilitate the rehabilitation process and provide their clients with a holistic approach to meet their needs. Narrative accounts from survivors of acquired brain injury support the relevance of this process as a therapeutic modality.	[Fraas, Michael R.] Western Washington Univ, Dept Commun Sci & Disorders, 516 High St, Bellingham, WA 98225 USA		Fraas, MR (corresponding author), Western Washington Univ, Dept Commun Sci & Disorders, 516 High St, Bellingham, WA 98225 USA.	Michael.fraas@wwu.edu					[Anonymous], 2015, TOP STROKE REHABIL, V18, P35; Bleakley A, 2005, MED EDUC, V39, P534, DOI 10.1111/j.1365-2929.2005.02126.x; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fraas MR, 2007, DISABIL REHABIL, V29, P1449, DOI 10.1080/09638280601102311; Fraas MR, 2011, TOP STROKE REHABIL, V18, P40, DOI 10.1310/tsr1801-40; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Goldberg G, 2011, TOP STROKE REHABIL, V18, P1, DOI 10.1310/tsr1801-1; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Greenfield B, 2011, TOP STROKE REHABIL, V18, P35, DOI 10.1310/tsr1801-35; GREENHALGH T, 2003, NARRATIVE BASED HLTH; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hinckley JJ, 2006, TOP STROKE REHABIL, V13, P25, DOI 10.1310/FLJ3-04DQ-MG8W-89EU; HINCKLEY JJ, 2008, NARRATIVE BASED PRAC; KAUFMAN S, 1988, J AGING STUD, V2, P217, DOI 10.1016/0890-4065(88)90002-3; KAUFMAN SR, 1988, QUALITATIVE GERONTOL, P82; Lakoff G.., 1999, PHILOS FLESH EMBODIE; Lorenz LS, 2010, SOCIOL HEALTH ILL, V32, P862, DOI 10.1111/j.1467-9566.2010.01244.x; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; Medved MI, 2011, TOP STROKE REHABIL, V18, P47, DOI 10.1310/tsr1801-47; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2011, TOP STROKE REHABIL, V18, P30, DOI 10.1310/tsr1801-30; Riessman CatherineK., 2007, NARRATIVE METHODS HU; Seidman I., 1998, INTERVIEWING QUALITA, V2nd; Shapiro AB, 2011, TOP STROKE REHABIL, V18, P18, DOI 10.1310/tsr1801-18; Thorne A, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P169; World Health Organization (WHO), 2006, NEUR DIS; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	37	8	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2015	35	3					210	218		10.1097/TLD.0000000000000063			9	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	DD0DX	WOS:000369591600003					2022-02-06	
J	Genet, F; Minooee, K; Jourdan, C; Ruet, A; Denormandie, P; Schnitzler, A				Genet, Francois; Minooee, Kambiz; Jourdan, Claire; Ruet, Alexis; Denormandie, Philippe; Schnitzler, Alexis			Troublesome heterotopic ossification and stroke: Features and risk factors. A case control study	BRAIN INJURY			English	Article						Epidemiology; hemiplegic; heterotopic; ossification; stroke	TRAUMATIC BRAIN; SPINAL-CORD; HEMORRHAGIC STROKE; HEMIPLEGIA; RESECTION; PATTERNS; INJURY; BONE; CARE	Primary objective: To determine the features of stroke-related HO in a large sample of patients and to assess if HO risk is increased by haemorrhagic stroke. Research design: A case control study (risk factor of a rare event using retrospective analysis). Methods and procedures: Sixty-one patients with stroke-81 troublesome HOs-were included, each was matched with four controls, i.e. 244 patients with no HO after stroke. Matching criteria were age (+/- 3.5 years) and sex. Data recorded were time from stroke to surgery, ischaemic or haemorrhagic stroke and presence of HO risk factors. Main outcomes and results: Mean age at time of stroke=46.02 +/- 11.4 years (15.9-76.3) for the case sub-group. Time from stroke to surgery = 23.4 +/- 27.8 months (3.6-150.0). There was a significant relationship between haennorrhagic stroke and HO development (OR = 3.01; 95% CI = 1.14-7.98; p<0.05), but not for ischaemic stroke. This became non-significant when all matching and risk factors were included in the model (adjusted OR = 1.98; 95% CI = 0.60-6.54; p=0.26). Conclusion: Haemorrhagic stroke appears to increase the risk of HO development. Further studies are required to determine if this risk factor is independent from other comorbid factors.	[Genet, Francois; Jourdan, Claire; Ruet, Alexis; Schnitzler, Alexis] Hop Raymond Poincare, Dept Phys Med & Rehabil, F-92380 Garches, France; [Genet, Francois; Denormandie, Philippe] Univ Versailles St Quentin Yvelines, End Icap, UFR Sci Sante Simone Veil, Versailles, France; [Minooee, Kambiz; Schnitzler, Alexis] Free Univ Brussels, Erasme Hosp, Dept Rheumatol & Rehabil Med, B-1050 Brussels, Belgium; [Jourdan, Claire] Univ Versailles St Quentin Yvelines, Handiresp, UFR Sci Sante Simone Veil, Versailles, France; [Denormandie, Philippe] Hop Raymond Poincare, Dept Orthoped Surg, F-92380 Garches, France		Genet, F (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.ir	RUET, Alexis/L-8726-2015	RUET, Alexis/0000-0002-5080-5734			Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; BRESLOW N, 1982, ANNU REV PUBL HEALTH, V3, P29, DOI 10.1146/annurev.pu.03.050182.000333; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Chari V, 2010, PAIN RES MANAG, V15, P24, DOI 10.1155/2010/923481; Chiu D, J STROKE CEREBROVASC, V19, P225; Chua KSG, 2003, BRAIN INJURY, V17, P535, DOI 10.1080/0269905021000010104; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Gurcay E, 2013, BRAIN INJURY, V27, P1727, DOI 10.3109/02699052.2013.831123; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Haran M, 2004, COCHRANE DB SYST REV, V5; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Kluger G, 2000, J CHILD NEUROL, V15, P406, DOI 10.1177/088307380001500610; Leung AWS, 2010, NEUROREHABILITATION, V27, P351, DOI 10.3233/NRE-2010-0619; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; RADT P, 1970, GERIATRICS, V25, P142; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; ROSIN AJ, 1975, ANN RHEUM DIS, V34, P499, DOI 10.1136/ard.34.6.499; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Salga M, 2015, SKELETAL RADIOL, V44, P233, DOI 10.1007/s00256-014-2003-6; Shehab D, 2002, J NUCL MED, V43, P346; Smith EE, 2009, NEUROLOGY, V73, P709, DOI 10.1212/WNL.0b013e3181b59a6e; Spieler JF, 2004, REV NEUROL-FRANCE, V160, P1023, DOI 10.1016/S0035-3787(04)71139-X; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Taly AB, 2001, NEUROL INDIA, V49, P37; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wei JW, 2010, STROKE, V41, P1877, DOI 10.1161/STROKEAHA.110.586909; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	36	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					866	871		10.3109/02699052.2015.1005133			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800011	25915823				2022-02-06	
J	Honaker, JA; Criter, RE; Patterson, JN; Jones, SM				Honaker, Julie A.; Criter, Robin E.; Patterson, Jessie N.; Jones, Sherri M.			Gaze Stabilization Test Asymmetry Score as an Indicator of Previous Concussion in a Cohort of Collegiate Football Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						gaze stabilization test; vestibulo-ocular reflex; head injury; concussion; postural control; visual acuity	SPORT-RELATED CONCUSSION; POSTURAL STABILITY; VESTIBULAR DYSFUNCTION; HEAD-INJURY; SYMPTOMS; DEFICITS; BRAIN; AGE	Objective:Vestibular dysfunction may lead to decreased visual acuity with head movements, which may impede athletic performance and result in injury. The purpose of this study was to test the hypothesis that athletes with history of concussion would have differences in gaze stabilization test (GST) as compared with those without a history of concussion.Design:Cross-sectional, descriptive.Setting:University Athletic Medicine Facility.Participants:Fifteen collegiate football players with a history of concussion, 25 collegiate football players without a history of concussion.Intervention:Participants completed the dizziness handicap inventory (DHI), static visual acuity, perception time test, active yaw plane GST, stability evaluation test (SET), and a bedside oculomotor examination.Main Outcome Measures:Independent samples t test was used to compare GST, SET, and DHI scores per group, with Bonferroni-adjusted alpha at P < 0.01. Receiver operating characteristic curve analysis and area under the curve (AUC) were used to assess the clinical performance of the GST and SET.Results:Athletes with previous concussion had a larger GST asymmetry score [mean (M) = 12.40, SD = 9.09] than those without concussion (M = 4.92, SD = 4.67; t (18.70) = -2.955, P = 0.008, 95% CI, -12.79 to -2.18, d = -1.37). Clinical performance of the GST (AUC = 0.77) was better than the SET (AUC = 0.61).Conclusions:Results suggest peripheral vestibular or vestibular-visual interaction deficits in collegiate athletes with a history of concussion. The results support further research on the use of GST for sport-related concussion evaluation and monitoring.Clinical Relevance:Inclusion of objective vestibular tests in the concussion protocol may reveal the presence of peripheral vestibular or visual-vestibular deficits. Therefore, the GST may add an important perspective on the effects of concussion.	[Honaker, Julie A.; Criter, Robin E.; Patterson, Jessie N.; Jones, Sherri M.] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA		Honaker, JA (corresponding author), Univ Nebraska, Dept Special Educ & Commun Disorders, 271 Barkley Ctr, Lincoln, NE 68583 USA.	julie.honaker@unl.edu			Department of DefenseUnited States Department of Defense; American Academy of Audiology; Celerion, Inc.	Supported by grant from the Department of Defense (to J.A.H. and S.M.J.) and from the American Academy of Audiology (to R.E.C.).; J. A. Honaker has received consulting payment from Celerion, Inc. S. M. Jones has received travel reimbursement and honorarium for lectures from the National Institutes of Health, National Institute on Deafness and other Communication Disorders, Legacy Health Systems, Stanford University, and Case Western Reserve University and travel expense reimbursement for the Auditory and Vestibular Dysfunction Research Enhancement Award Program. In addition, she is currently receiving royalties from Plural Publishing for a textbook she co-authored. This work was not supported by a grant; the authors disclosed current funding related to the topic, but the funding did not support the project. The remaining authors report no conflicts of interest.	Almasi Stephen J, 2012, WMJ, V111, P21; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Badaracco C, 2007, OTOL NEUROTOL, V28, P809, DOI 10.1097/MAO.0b013e3180cab73f; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cohen J., 2013, STAT POWER ANAL BEHA; Curthoys I., 2007, VESTIBULAR REHABILIT, V3rd Edn, P76; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demer J L, 1990, J Vestib Res, V1, P263; DEMER JL, 1996, DISORDERS VESTIBULAR, P73; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Furman J. M., 2010, VESTIBULAR DISORDERS; GANNON RP, 1978, ARCH OTOLARYNGOL, V104, P404; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Highstein S., 1996, DISORRDERS VESTIBULA, P3; Honaker JA, 2010, J VESTIBUL RES-EQUIL, V20, P357, DOI 10.3233/VES-2010-0365; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KAY DWK, 1971, LANCET, V2, P1052; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Linthicum FH, 1931, J OTOLARYNGOL, V13, P785; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pritcher MR, 2008, OTOL NEUROTOL, V29, P982, DOI 10.1097/MAO.0b013e31818457fb; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Whitney SL, 2009, GAIT POSTURE, V29, P194, DOI 10.1016/j.gaitpost.2008.08.002	36	8	8	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2015	25	4					361	366		10.1097/JSM.0000000000000138			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CM2EK	WOS:000357492400009	25061806				2022-02-06	
J	Stone, ME; Safadjou, S; Farber, B; Velazco, N; Man, JL; Reddy, SH; Todor, R; Teperman, S				Stone, Melvin E., Jr.; Safadjou, Saman; Farber, Benjamin; Velazco, Nerissa; Man, Jianliang; Reddy, Srinivas H.; Todor, Roxanne; Teperman, Sheldon			Utility of the Military Acute Concussion Evaluation as a screening tool for mild traumatic brain injury in a civilian trauma population	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Military Acute Concussion Evaluation; concussion screening; mild traumatic brain injury		BACKGROUND Mild traumatic brain injury (mTBI) constitutes 75% of more than 1.5 million traumatic brain injuries annually. There exists no consensus on point-of-care screening for mTBI. The Military Acute Concussion Evaluation (MACE) is a quick and easy test used by the US Army to screen for mTBI; however, its utility in civilian trauma is unclear. It has two parts: a history section and the Standardized Assessment of Concussion (SAC) score (0-30) previously validated in sports injury. As a performance improvement project, our institution sought to evaluate the MACE as a concussion screening tool that could be used by housestaff in a general civilian trauma population. METHODS From June 2013 to May 2014, patients 18 years to 65 years old with suspected concussion were given the MACE within 72 hours of admission to our urban Level I trauma center. Patients with a positive head computed tomography were excluded. Demographic data and MACE scores were recorded in prospect. Concussion was defined as loss of consciousness and/or posttraumatic amnesia; concussed patients were compared with those nonconcussed. Sensitivity and specificity for each respective MACE score were used to plot a receiver operating characteristic (ROC) curve. An ROC curve area of 0.8 was set as the benchmark for a good screening test to distinguish concussion from nonconcussion. RESULTS There were 84 concussions and 30 nonconcussed patients. Both groups were similar; however, the concussion group had a lower mean MACE score than the nonconcussed patients. Data analysis demonstrated the sensitivity and specificity of a range of MACE scores used to generate an ROC curve area of only 0.65. CONCLUSION The MACE showed a lower mean score for individuals with concussion, defined by loss of consciousness and/or posttraumatic amnesia. However, the ROC curve area of 0.65 highly suggests that MACE alone would be a poor screening test for mTBI in a general civilian trauma population. LEVEL OF EVIDENCE Diagnostic study, level II.	[Stone, Melvin E., Jr.; Safadjou, Saman; Farber, Benjamin; Velazco, Nerissa; Man, Jianliang; Reddy, Srinivas H.; Todor, Roxanne; Teperman, Sheldon] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10461 USA		Stone, ME (corresponding author), Albert Einstein Coll Med, Jacobi Med Ctr, 1400 Pelham Pkwy S,Bldg 1,Suite 1213, Bronx, NY 10461 USA.	melvinomd@gmail.com					[Anonymous], 2009, J REHABIL RES DEV; Barbosa RR, 2012, J TRAUMA ACUTE CA S4, V73, P307; Barth J., 2010, MILITARY NEUROPSYCHO, P127; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; MacLeod JBA, 2011, INJURY, V42, P922, DOI 10.1016/j.injury.2010.01.098; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70	12	8	8	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2015	79	1					147	151		10.1097/TA.0000000000000679			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CL7LN	WOS:000357153700022	26091328				2022-02-06	
J	Vermaelen, J; Greiffenstein, P; deBoisblanc, BP				Vermaelen, James; Greiffenstein, Patrick; deBoisblanc, Bennett P.			Sleep in Traumatic Brain Injury	CRITICAL CARE CLINICS			English	Article						Traumatic brain injury; Critical care; Sleep disorders; Delirium; Melatonin	CRITICALLY-ILL PATIENTS; IN-VITRO MODEL; CONTROLLED-TRIAL; WAKE DISTURBANCES; BETA-BLOCKERS; FDG-PET; DEXMEDETOMIDINE; QUALITY; METAANALYSIS; METABOLISM	More than one-half million patients are hospitalized annually for traumatic brain injury (TBI). One-quarter demonstrate sleep-disordered breathing, up to 50% experience insomnia, and half have hypersomnia. Sleep disturbances after TBI may result from injury to sleep-regulating brain tissue, nonspecific neurohormonal responses to systemic injury, ICU environmental interference, and medication side effects. A diagnosis of sleep disturbances requires a high index of suspicion and appropriate testing. Treatment starts with a focus on making the ICU environment conducive to normal sleep. Treating sleep-disordered breathing likely has outcome benefits in TBI. The use of sleep promoting sedative-hypnotics and anxiolytics should be judicious.	[Vermaelen, James; deBoisblanc, Bennett P.] Louisiana State Univ, Hlth Sci Ctr, Sect Pulm & Crit Care Med, New Orleans, LA 70112 USA; [Greiffenstein, Patrick] Louisiana State Univ, Hlth Sci Ctr, Sect Trauma & Crit Care Surg, New Orleans, LA 70112 USA		Vermaelen, J (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sect Pulm & Crit Care Med, 1901 Perdido St,Suite 3205, New Orleans, LA 70112 USA.	jverma@lsuhsc.edu					Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Alexopoulou C, 2014, ANESTHESIOLOGY, V121, P801, DOI 10.1097/ALN.0000000000000361; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; BETTS TA, 1985, EUR J CLIN PHARMACOL, V28, P65, DOI 10.1007/BF00543712; Birkbak J, 2014, J CLIN SLEEP MED, V10, P103, DOI 10.5664/jcsm.3376; Bonnet MH, 2006, J CLIN NEUROPHYSIOL, V23, P50, DOI 10.1097/01.wnp.0000190415.83841.17; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Centers for Disease Control and Prevention, 2014, RAT TBI REL EM DEP V; Chlan LL, 2013, JAMA-J AM MED ASSOC, V309, P2335, DOI 10.1001/jama.2013.5670; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Faraklas I, 2013, J BURN CARE RES, V34, P249, DOI 10.1097/BCR.0b013e318283d175; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fraser GL, 2013, CRIT CARE MED, V41, pS30, DOI 10.1097/CCM.0b013e3182a16898; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gu JW, 2014, J CRIT CARE, V29, P287, DOI 10.1016/j.jcrc.2013.10.021; [郝江 Hao Jiang], 2013, [中华危重病急救医学, Chinese Critical Care Medicine], V25, P373; Hatta K, 2014, JAMA PSYCHIAT, V71, P397, DOI 10.1001/jamapsychiatry.2013.3320; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Kamdar BB, 2013, CRIT CARE MED, V41, P800, DOI 10.1097/CCM.0b013e3182746442; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Patel J, 2014, ANAESTHESIA, V69, P540, DOI 10.1111/anae.12638; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Roth T, 2006, SLEEP, V29, P417; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Weinhouse GL, 2009, CRIT CARE, V13, DOI 10.1186/cc8131; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yaeger K, 2014, AM J ROENTGENOL, V202, P614, DOI 10.2214/AJR.13.11091; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	53	8	8	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	JUL	2015	31	3					551	+		10.1016/j.ccc.2015.03.012			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5FM	WOS:000358455200012	26118920				2022-02-06	
J	Zheng, P; He, B; Guo, YJ; Zeng, JS; Tong, WS				Zheng, Ping; He, Bin; Guo, Yijun; Zeng, Jingsong; Tong, Wusong			Decreased apparent diffusion coefficient in the pituitary and correlation with hypopituitarism in patients with traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						apparent diffusion coefficient; diffusion-weighted imaging; traumatic brain injury; hypopituitarism	AXONAL INJURY; COGNITIVE DYSFUNCTION; STROKE; GLAND	OBJECT The relationship between microstructural abnormality in patients with traumatic brain injury (TBI) and hormone-secreting status remains unknown. In this study, the authors aimed to identify the role of the apparent diffusion coefficient (ADC) using a diffusion-weighted imaging (DWI) technique and to evaluate the association of such changes with hypopituitarism in patients with TBI. METHODS Diffusion-weighted images were obtained in 164 consecutive patients with TBI within 2 weeks after injury to generate the pituitary ADC as a measure of microstructural change. Patients with TBI were further grouped into those with and those without hypopituitarism based on the secretion status of pituitary hormones at 6 months postinjury. Thirty healthy individuals were enrolled in the study and underwent MRI examinations for comparison. Mean ADC values were compared between this control group, the patients with TBI and hypopituitarism, and the patients with TBI without hypopituitarism; correlational studies were also performed. Neurological outcome was assessed with the Glasgow Outcome Scale (GOS) for all TBI patients 6 months postinjury. RESULTS In the TBI group, 84 patients had hypopituitarism and 80 had normal pituitary function. The pituitary ADC in TBI patients was significantly less than that in controls (1.83 +/- 0.16 vs 4.13 +/- 0.33, p < 0.01). Furthermore, the mean ADC was much lower in TBI patients with hypopituitarism than in those without pituitary dysfunction (1.32 +/- 0.09 vs 2.28 +/- 0.17, p < 0.05). There was also a significant difference in ADC values between patients with hyperprolactinemia and those with normal prolactin levels (p < 0.05). Additionally, the receiver operating characteristic curve analysis showed that the pituitary ADC could predict hypopituitarism with a sensitivity of 90.0% and a specificity of 90.1% at the level of 1.720 (ADC value). Finally, the ADC value was positively correlated with neurological outcome at 6 months following TBI (r = 0.602, p < 0.05). CONCLUSIONS Use of DWI demonstrated that the pituitary ADC is correlated with hormone-secreting status in TBI patients. The authors suggest that pituitary ADC may be a useful biomarker to predict pituitary function in patients with TBI.	[Zheng, Ping; He, Bin; Guo, Yijun; Zeng, Jingsong; Tong, Wusong] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China		Zheng, P (corresponding author), 490 South Chuanhuan Rd, Shanghai 201200, Peoples R China.	jojo_ras@126.com			Ministry of Health, Pudong New Area, Shanghai, China [PW2011A-13]	This study was supported by a grant for the promotion of science from the Ministry of Health, Pudong New Area, Shanghai, China (grant PW2011A-13). The authors declare no conflict of interest concerning the materials and methods used in this study or the findings specified in this paper.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Fiehler J, 2001, J CEREBR BLOOD F MET, V21, P577, DOI 10.1097/00004647-200105000-00012; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; Kibayashi K, 2012, AM J FOREN MED PATH, V33, P206, DOI 10.1097/PAF.0b013e3181fe33e8; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Nicoli F, 2003, STROKE, V34, pE82, DOI 10.1161/01.STR.0000078659.43423.0A; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Song JK, 1999, J NEUROSURG, V90, P1141, DOI 10.3171/jns.1999.90.6.1141; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y	21	8	9	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2015	123	1					75	80		10.3171/2014.12.JNS132308			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CL5DY	WOS:000356981200010	25679273				2022-02-06	
J	Fournier, AJ; Hogan, JD; Rajbhandari, L; Shrestha, S; Venkatesan, A; Ramesh, KT				Fournier, Adam J.; Hogan, James D.; Rajbhandari, Labchan; Shrestha, Shiva; Venkatesan, Arun; Ramesh, K. T.			Changes in Neurofilament and Microtubule Distribution following Focal Axon Compression	PLOS ONE			English	Article							IN-VITRO; STRETCH-INJURY; BRAIN-INJURY; OPTIC-NERVE; VISUALIZATION; ACCUMULATION; MECHANISMS; CULTURES; TRAUMA; STRAIN	Although a number of cytoskeletal derangements have been described in the setting of traumatic axonal injury (TAI), little is known of early structural changes that may serve to initiate a cascade of further axonal degeneration. Recent work by the authors has examined conformational changes in cytoskeletal constituents of neuronal axons undergoing traumatic axonal injury (TAI) following focal compression through confocal imaging data taken in vitro and in situ. The present study uses electron microscopy to understand and quantify in vitro alterations in the ultrastructural composition of microtubules and neurofilaments within neuronal axons of rats following focal compression. Standard transmission electron microscopy processing methods are used to identify microtubules, while neurofilament identification is performed using antibody labeling through gold nanoparticles. The number, density, and spacing of microtubules and neurofilaments are quantified for specimens in sham Control and Crushed groups with fixation at <1min following load. Our results indicate that the axon caliber dependency known to exist for microtubule and neurofilament metrics extends to axons undergoing TAI, with the exception of neurofilament spacing, which appears to remain constant across all Crushed axon diameters. Confidence interval comparisons between Control and Crushed cytoskeletal measures suggests early changes in the neurofilament spatial distributions within axons undergoing TAI may precede microtubule changes in response to applied loads. This may serve as a trigger for further secondary damage to the axon, representing a key insight into the temporal aspects of cytoskeletal degeneration at the component level, and suggests the rapid removal of neurofilament sidearms as one possible mechanism.	[Fournier, Adam J.; Ramesh, K. T.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Hogan, James D.] Johns Hopkins Univ, Hopkins Extreme Mat Inst, Baltimore, MD USA; [Rajbhandari, Labchan; Shrestha, Shiva; Venkatesan, Arun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Fournier, AJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	afourni3@jhu.edu	Ramesh, KT/D-5451-2009	Ramesh, KT/0000-0003-2659-4698; Rajbhandari, Labchan/0000-0002-9252-2580; Hogan, James/0000-0002-9212-9252	Hopkins Extreme Materials Institute; US ArmyUnited States Department of Defense	Funding for this work came from the Hopkins Extreme Materials Institute and the US Army. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aberts B, 2008, MOL BIOL CELL; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chang R, 2009, J MOL BIOL, V391, P648, DOI 10.1016/j.jmb.2009.06.045; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; de Mey J., 1986, P229; DEMEY J, 1982, P NATL ACAD SCI-BIOL, V79, P1898; DEMEY J, 1981, CELL BIOL INT REP, V5, P889, DOI 10.1016/0309-1651(81)90204-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fournier AJ, 2014, FASEB J, V28, P5277, DOI 10.1096/fj.14-251942; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Gennarelli T. A., 1993, HEAD INJURY, V2, P108; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Koike T, 2008, NEUROCHEM INT, V52, P751, DOI 10.1016/j.neuint.2007.09.007; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Mukhopadhyay R, 2004, BIOESSAYS, V26, P1017, DOI 10.1002/bies.20088; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Ouyang H, 2010, MICR UGIM 2010 18 BI, P1; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844	45	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131617	10.1371/journal.pone.0131617			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	WOS:000356933800163	26111004	Green Submitted, Green Published, gold			2022-02-06	
J	Childs, C; Shen, L				Childs, Charmaine; Shen, Liang			Regional pressure and temperature variations across the injured human brain: comparisons between paired intraparenchymal and ventricular measurements	CRITICAL CARE			English	Article							INTRACRANIAL-PRESSURE; RELIABILITY; SENSORS; CARE	Introduction: Intraparenchymal, multimodality sensors are commonly used in the management of patients with severe traumatic brain injury (TBI). The 'gold standard', based on accuracy, reliability and cost for intracranial pressure (ICP) monitoring is within the cerebral ventricle (external strain gauge). There are no standards yet for intracerebral temperature monitoring and little is known of temperature differences between brain tissue and ventricle. The aim of the study therefore was to determine pressure and temperature differences at intraparenchymal and ventricular sites during five days of continuous neuromonitoring. Methods: Patients with severe TBI requiring emergency surgery. Inclusion criteria: patients who required ICP monitoring were eligible for recruitment. Two intracerebral probe types were used: a) intraventricular, dual parameter sensor (measuring pressure, temperature) with inbuilt catheter for CSF drainage: b) multiparameter intraparenchymal sensor measuring pressure, temperature and oxygen partial pressure. All sensors were inserted during surgery and under aseptic conditions. Results: Seventeen patients, 12 undergoing neurosurgery (decompressive craniectomy n = 8, craniotomy n = 4) aged 21-78 years were studied. Agreement of measures for 9540 brain tissue-ventricular temperature 'pairs' and 10,291 brain tissue-ventricular pressure 'pairs' were determined using mixed model to compare mean temperature and pressure for longitudinal data. There was no significant overall difference for mean temperature (p = 0.92) or mean pressure readings (p = 0.379) between tissue and ventricular sites. With 95.8 % of paired temperature readings within 2SD (-0.4 to 0.4 degrees C) differences in temperature between brain tissue and ventricle were clinically insignificant. For pressure, 93.5 % of readings pairs fell within the 2SD range (-9.4756 to 7.8112 mmHg). However, for individual patients, agreement for mean tissue-ventricular pressure differences was poor on occasions. Conclusions: There is good overall agreement between paired temperature measurements obtained from deep white matter and brain ventricle in patients with and without early neurosurgery. For paired ICP measurements, 93.5 % of readings were within 2SD of mean difference. Whilst the majority of paired readings were comparable (within 10 mmHg) clinically relevant tissue-ventricular dissociations were noted. Further work is required to unravel the events responsible for short intervals of pressure dissociation before tissue pressure readings can be definitively accepted as a reliable surrogate for ventricular pressure.	[Childs, Charmaine] Sheffield Hallam Univ, Ctr Hlth & Social Care Res, Sheffield S10 2BP, S Yorkshire, England; [Shen, Liang] Natl Univ Singapore, Deans Off, Dept Biostat, Natl Univ Hosp, Singapore 119074, Singapore		Childs, C (corresponding author), Sheffield Hallam Univ, Ctr Hlth & Social Care Res, Montgomery House,32 Collegiate Crescent, Sheffield S10 2BP, S Yorkshire, England.	c.childs@shu.ac.uk					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P37, DOI DOI 10.1089/NEU.2007.9990; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2012, BRAIN INJURY, V26, P1163; Childs Charmaine, 2014, Journal of Medical Engineering & Technology, V38, P339, DOI 10.3109/03091902.2014.937834; Childs C, 2013, CRIT CARE, V17, DOI 10.1186/cc11892; Childs C, 2009, CRIT CARE, V13, DOI 10.1186/cc7943; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; GAMBARDELLA G, 1992, NEUROSURGERY, V31, P918, DOI 10.1227/00006123-199211000-00014; Ghajar J, 1995, New Horiz, V3, P395; GRAF W, 1959, ACTA PHYSIOL SCAND, V46, P1; Huschak G, 2009, J NEUROSURG ANESTH, V21, P155, DOI 10.1097/ANA.0b013e31818f2eac; Kirk D, 2009, CRIT CARE, V13, DOI 10.1186/cc7898; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Machin G., 2010, Journal of Medical Engineering & Technology, V34, P192, DOI 10.3109/03091900903509156; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; Nakagawa K, 2011, NEUROCRIT CARE, V15, P101, DOI 10.1007/s12028-010-9446-y; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Sukstanskii AL, 2004, J THERM BIOL, V29, P583, DOI 10.1016/j.jtherbio.2004.08.028; Zhu MM, 2006, J APPL PHYSIOL, V101, P1481, DOI 10.1152/japplphysiol.00319.2006	25	8	8	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JUN 23	2015	19								267	10.1186/s13054-015-0982-x			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM6CY	WOS:000357776600001	26100266	gold, Green Accepted, Green Published			2022-02-06	
J	Antona-Makoshi, J; Eliasson, E; Davidsson, J; Ejima, S; Ono, K				Antona-Makoshi, Jacobo; Eliasson, Erik; Davidsson, Johan; Ejima, Susumu; Ono, Koshiro			Effect of Aging on Brain Injury Prediction in Rotational Head Trauma-A Parameter Study with a Rat Finite Element Model	TRAFFIC INJURY PREVENTION			English	Article; Proceedings Paper	24th International Technical Conference on Enhanced Safety of Vehicles (ESV)	JUN, 2015	Gothenburg, SWEDEN			traumatic brain injury (TBI); acute subdural hematoma (ASDH); age; finite element method; diffuse axonal injuries (DAI)	AGE-RELATED-CHANGES; SUBDURAL-HEMATOMA; LIPID-COMPOSITION; CRITERIA; GENDER; IMPACT	Objective: The aim of this study was to investigate the possible effects of age-related intracranial changes on the potential outcome of diffuse axonal injuries and acute subdural hematoma under rotational head loading. Methods: A simulation-based parametric study was conducted using an updated and validated finite element model of a rat head. The validation included a comparison of predicted brain cortex sliding with respect to the skull. Further, model material properties were modified to account for aging; predicted tissue strains were compared with experimental data in which groups of rats in 2 different lifecycle stages, young adult and mature adult, were subjected to rotational trauma. For the parameter study, 2 age-dependent factors-brain volume and region-specific brain material properties-were implemented into the model. The models young adult and old age were subjected to several injurious and subinjurious sagittal plane rotational acceleration levels. Results: Sequential analysis of the simulated trauma progression indicates that an increase in acute subdural hematoma injury risk indicator occurs at an early stage of the trauma, whereas an increase in diffuse axonal injury risk indicators occurs at a later stage. Tissue stiffening from young adult to mature adult rats produced an increase in strain-based thresholds accompanied by a wider spread of strain distribution toward the rear part of the brain, consistent with rotational trauma experiments with young adult and mature adult rats. Young adult to old age brain tissue softening and brain atrophy resulted in an increase in diffuse axonal injuries and acute subdural hematoma injury risk indicators, respectively. Conclusions: The findings presented in this study suggest that age-specific injury thresholds should be developed to enable the development of superior restraint systems for the elderly. The findings also motivate other further studies on age-dependency of head trauma.	[Antona-Makoshi, Jacobo; Eliasson, Erik; Davidsson, Johan] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Antona-Makoshi, Jacobo; Ejima, Susumu; Ono, Koshiro] Japan Automot Res Inst, Tsukuba, Ibaraki, Japan		Antona-Makoshi, J (corresponding author), 2530 Karima, Tsukuba, Ibaraki 3050822, Japan.	ajacobo@jari.or.jp	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514; Brynskog, Erik/0000-0002-2812-3382	Japan Society for the Promotion of Science (JSPS) Summer ProgramMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Japan Automobile Research Institute (JARI); Chalmers University Areas of Advance within Transport, Sweden	Funding for this research was provided by the Japan Society for the Promotion of Science (JSPS) Summer Program, the Japan Automobile Research Institute (JARI), and Chalmers University Areas of Advance within Transport, Sweden.	Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Antona-Makoshi J, 2013, INT RES COUNC BIOM I; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CAMERON TP, 1982, LAB ANIM SCI, V32, P495; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; Davidsson J, 2011, FRONTIERS NEUROTRAUM, V2, P1; Davidsson J, 2009, INT RES COUNC BIOM I; Davidsson J, 2015, FRONTIERS NEUR UNPUB; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Jacobo A-M, 2014, INT J AUTOMOTIVE ENG, V5, P31; Kameyama M, 2008, NEUROTRAUMATOLOGY, V31, P46; Kimpara H, 2006, STAPP CAR CRASH J, V50, P27; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lamy M, 2009, INT RES COUNC BIOM I; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; McElhaney JH, 1976, HDB HUMAN TOLERANCE; Meaney DF, 1991, THESIS U PENNSYLVANI; Meaney DF, 1993, ASME CRASHWORTHINESS, V25, P169; ROUSER G, 1968, LIPIDS, V3, P284, DOI 10.1007/BF02531202; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sawauchi S, 2007, NEUROL SURG TOKYO, V35, P665; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD POP PROSP 2012; World Health Organization, 2012, GLOB PLAN DEC ACT RO; Xu J, 2000, AM J NEURORADIOL, V21, P112; Yanaoka T., 2013, INT RES COUNC BIOM I; Zhang L, 2001, Stapp Car Crash J, V45, P369	40	8	8	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	JUN 1	2015	16			1	SI		S91	S99		10.1080/15389588.2015.1021416			9	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Transportation	CJ3SQ	WOS:000355404600013	26027980	Green Submitted			2022-02-06	
J	Bambakidis, T; Dekker, SE; Liu, BL; Maxwell, J; Chtraklin, K; Linzel, D; Li, YQ; Alam, HB				Bambakidis, Ted; Dekker, Simone E.; Liu, Baoling; Maxwell, Jake; Chtraklin, Kiril; Linzel, Durk; Li, Yongqing; Alam, Hasan B.			Hypothermia and valproic acid activate prosurvival pathways after hemorrhage	JOURNAL OF SURGICAL RESEARCH			English	Article						Hemorrhagic shock; Resuscitation; Hypothermia; Apoptosis	TRAUMATIC BRAIN-INJURY; LARGE ANIMAL-MODEL; PHARMACOLOGICAL RESUSCITATION; ISCHEMIA-REPERFUSION; GENE-EXPRESSION; NORMAL SALINE; SWINE MODEL; SHOCK; SURVIVAL; INHIBITION	Background: Therapeutic hypothermia (hypo) and valproic acid (VPA, a histone deacetylase inhibitor) have independently been shown to be protective in models of trauma and hemorrhagic shock but require logistically challenging doses to be effective. Theoretically, combined treatment may further enhance effectiveness, allowing us to use lower doses of each modality. The aim of this study was to determine whether a combination of mild hypo and VPA treatments would offer better cytoprotection compared with that of individual treatments in a hemorrhage model. Materials and methods: Male Sprague-Dawley rats were subjected to 40% volume-controlled hemorrhage, kept in shock for 30 min, and assigned to one of the following treatment groups: normothermia (36 degrees C-37 degrees C), hypo (30 +/- 2 degrees C), normothermia + VPA (300 mg/kg), and hypo + VPA (n = 5 per group). After 3 h of observation, the animals were sacrificed, liver tissue was harvested and subjected to whole cell lysis, and levels of key proteins in the prosurvival Akt pathway were measured using Western blot. Results: Activation of the proapoptotic protein cleaved caspase-3 was significantly lower in the combined treatment group relative to normothermia (P < 0.05). Levels of the prosurvival Bcl-2 was significantly higher in the combined treatment group relative to sham, normothermia, and normothermia + VPA groups (P < 0.005). The downstream prosurvival protein phospho-GSK-3 beta was significantly higher in the sham, hypo, and combined treatment groups compared with that in normothermia groups with or without VPA (P < 0.05). Levels of the prosurvival beta-catenin were significantly higher in the combined treatment group relative to normothermia (P < 0.01). Conclusions: This is the first in vivo study to demonstrate that combined treatment with VPA and hypo offers better cytoprotection than these treatments given independently. (C) 2015 Elsevier Inc. All rights reserved.	[Bambakidis, Ted; Dekker, Simone E.; Liu, Baoling; Maxwell, Jake; Chtraklin, Kiril; Linzel, Durk; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hosp, Trauma Translat & Clin Res Lab, Dept Surg, Ann Arbor, MI 48109 USA; [Dekker, Simone E.] Vrije Univ Amsterdam, Inst Cardiovasc Res, Dept Anesthesiol, Med Ctr, Amsterdam, Netherlands; [Linzel, Durk] Vrije Univ Amsterdam, Dept Emergency Med, Med Ctr, Amsterdam, Netherlands		Alam, HB (corresponding author), Univ Michigan Hosp, Trauma Translat & Clin Res Lab, Dept Surg, 2920 Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM84127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM084127] Funding Source: NIH RePORTER	This study was funded by a grant from the National Institutes of Health R01GM84127 (H.B.A.).	Alam HB, 2012, BRIT J SURG, V99, P29, DOI 10.1002/bjs.7756; Alam HB, 2012, J TRAUMA ACUTE CARE, V73, P809, DOI 10.1097/TA.0b013e318265d1b8; Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Alam HB, 2004, RESUSCITATION, V60, P91, DOI 10.1016/j.resuscitation.2003.08.006; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Chaudhry Neera, 2013, J Pediatr Neurosci, V8, P135, DOI 10.4103/1817-1745.117847; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; Dekker SE, 2014, J SURG RES, V190, P312, DOI 10.1016/j.jss.2014.02.049; GIAJA J, 1956, NATURE, V178, P1286, DOI 10.1038/1781286a0; Gushchin V, 2003, J AM COLL SURGEONS, V197, P426, DOI 10.1016/S1072-7515(03)00418-6; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Kim K, 2012, RESUSCITATION, V83, P243, DOI 10.1016/j.resuscitation.2011.07.029; LEE HB, 1985, J NUCL MED, V26, P72; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; Zhao T, 2014, J TRAUMA ACUTE CARE, V77, P913, DOI 10.1097/TA.0000000000000347; Zhao T, 2014, SURGERY, V156, P235, DOI 10.1016/j.surg.2014.03.033; Zhao T, 2013, SURGERY, V154, P206, DOI 10.1016/j.surg.2013.04.003	28	8	8	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 1	2015	196	1					159	165		10.1016/j.jss.2015.02.036			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CH9EE	WOS:000354338000023	25777823	Green Accepted			2022-02-06	
J	Bell, CC; Jackson, WM; Bell, BH				Bell, Carl C.; Jackson, Willie Mae; Bell, Briatta H.			Misdiagnosis of African-Americans with Psychiatric Issues - Part II	JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION			English	Article							PROTECTIVE FACTORS; RISKY BEHAVIORS; VICTIMIZATION; CHILDREN; DYSFUNCTION; POPULATION; VIOLENCE; NEED	Purpose: The second Misdiagnosis of African-Americans with Psychiatric Issues article focuses on traumatic life experiences that meet a proposed criteria for Developmental Trauma Disorder (DTD).1 Method: Psychiatric evaluations of 330 patients were reviewed and clinically identifiable variables of: a) childhood mental retardation (MR), special education, Attention Deficit Hyperactive Disorder (ADHD), or Autism/Pervasive Developmental Disorder (PDD); b) head injury causing Organic Brain Syndrome (OBS) or Temporal Lobe Epilepsy (TLE); c) a history of chronic substance abuse prior to the development of psychiatric symptoms; or d) childhood trauma causing Anxiety, Depression, and Panic Disorders were tabulated. Results: In Part I,2-Reference Part I we learn that the above four variables did not influence two-thirds of the African-American patients psychiatric diagnoses; however, excluding patients with multiple diagnoses, 26.7% of the patients diagnoses were shaped by these variables. Of these, 20% (18 of 88 patients), or 5.5% of the total 330 patients, had diagnoses that were strongly influenced by childhood traumatic experiences. Accordingly, we present two case histories that explicate the psychopathology seen in African-Americans traumatized as children. Conclusions: This study helps to stress and confirm the importance of how understanding childhood traumatic experiences shape adult African-American psychopathology and the potential for misdiagnosis - an important factor for prevention and appropriate treatment of African-American patients with psychiatric issues.	[Bell, Carl C.] Commnunity Mental Hlth Council Inc CMHC, 8704 S Constance, Chicago, IL 60617 USA; [Bell, Carl C.] Univ Illinois, Psychiat & Publ Hlth, Chicago, IL USA; [Jackson, Willie Mae] Northwestern Univ, Evanston, IL 60208 USA		Bell, CC (corresponding author), Commnunity Mental Hlth Council Inc CMHC, 8704 S Constance, Chicago, IL 60617 USA.	bell-carl@att.net					Amaya-Jackson L, 1993, CHILD ADOL PSYCH CL, V2, P639; Angelou M, 1969, I KNOW WHY CAGED BIR; [Anonymous], 2010, MORBIDITY MORTALIT, V59, P1609; Bean R, 1992, 4 CONDITIONS; Beardslee BR, 2011, FUTURE PSYCHIAT, V62, P247; Bell C.C., 2011, RESILIENCE MENTAL HL, P176; Bell CC, 2008, J NATL MED ASSOC, V100, P936, DOI 10.1016/S0027-9684(15)31408-5; Bell CC, 2010, JAMA-J AM MED ASSOC, V304, P565, DOI 10.1001/jama.2010.1058; BELL CC, 1988, J NATL MED ASSOC, V80, P853; Bell CC, 1997, J NATL MED ASSOC, V89, P335; BELL CC, 1987, COMMUNITY MENT HLT J, V23, P217, DOI 10.1007/BF00754433; BELL CC, 1988, J NATL MED ASSOC, V80, P41; Bell CC, 2001, J ADOLESCENT HEALTH, V29, P375, DOI 10.1016/S1054-139X(01)00306-8; Blackstock C, 2011, CHILD YOUTH SERV REV, V33, P187, DOI 10.1016/j.childyouth.2010.09.002; BURTON D, 1994, J TRAUMA STRESS, V7, P83, DOI 10.1007/BF02111914; Costner Sizemore Chris, 1978, IM EVE; Davidson J, 1993, REV PSYCHIAT, V12; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; FULLILOVE MT, 1994, ANXIETY DISORDERS IN AFRICAN AMERICANS, P89; Griffin G, 2011, PSYCHIAT CLIN N AM, V34, P185, DOI 10.1016/j.psc.2010.11.014; Herman J.L., 1992, TRAUMA RECOVERY; Hobfoll S. E., 2009, FOCUS, V7, P221; JENKINS EJ, 1994, ANXIETY DISORDERS IN AFRICAN AMERICANS, P76; JENKINS EJ, 1989, J NATL MED ASSOC, V81, P246; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; SHAKOOR BH, 1991, J NATL MED ASSOC, V83, P233; Shore JH, 1986, AM J PSYCHIAT, V143, P590; U.S. Public Health Service, 2000, REP SURG GEN C; *US PHS, 2001, MENT HLTH CULT RAC E; van der Kolk BA, 2005, PSYCHIAT ANN, V35, P401, DOI 10.3928/00485713-20050501-06	30	8	8	0	4	NATL MED ASSOC	WASHINGON	1012 10TH ST, N W, WASHINGON, DC 20001 USA	0027-9684	1943-4693		J NATL MED ASSOC	J. Natl. Med. Assoc.	SUM	2015	107	3					35	41		10.1016/S0027-9684(15)30049-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC4FG	WOS:000369175300007	27282721				2022-02-06	
J	Castellani, RJ				Castellani, Rudy J.			Chronic traumatic encephalopathy: A paradigm in search of evidence?	LABORATORY INVESTIGATION			English	Article							NATIONAL-FOOTBALL-LEAGUE; AMYOTROPHIC-LATERAL-SCLEROSIS; POSITION STATEMENT CONCUSSION; ALZHEIMER-DISEASE PATHOLOGY; AMERICAN MEDICAL SOCIETY; DIFFUSE AXONAL INJURY; BRAIN-INJURY; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; HEAD-INJURY	Chronic traumatic encephalopathy (CTE) has been in the medical literature since the 1920s. It is characterized clinically by diverse neuropsychiatric symptoms, and pathologically by variable degrees of phosphorylated tau accumulation in the brain. The evolving paradigm for the pathogenesis of CTE suggests that concussion or subconcussion from athletic participation initiates a cascade of pathologic events, encompassing neuroinflammation and protein templating with trans-synaptic neurotoxicity. The end result is neurologic and neurobehavioral deterioration, often with self-harm. Although these concepts warrant further investigation, the available evidence permits no conclusions as regards the pathogenesis of the reported findings. Investigations into the role of premorbid or co-morbid neurodegenerative diseases has been limited to date, and in-depth genetic analyses have not been performed. The role of concussion or subconcussion if any, whether and how the condition progresses over time, the extent of phosphorylated tau in clinically normal athletes, the role of phosphorylated tau as a toxic species versus an inert disease response, and whether protein templating has any in vivo relevance remain to be elucidated.	Univ Maryland, Sch Med, Div Neuropathol, Baltimore, MD 21201 USA		Castellani, RJ (corresponding author), Univ Maryland, Sch Med, Div Neuropathol, 22 S Greene St, Baltimore, MD 21201 USA.	rcastellani@som.umaryland.edu					Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Augustine C, 2014, NEUROSCIENCE, V274, P1, DOI 10.1016/j.neuroscience.2014.05.009; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Beghi E, 2013, AMYOTROPH LAT SCL FR, V14, P501, DOI 10.3109/21678421.2013.809764; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Brayne C, 2009, J ALZHEIMERS DIS, V18, P645, DOI 10.3233/JAD-2009-1182; Callister JB, 2014, EXP NEUROL, V262, P84, DOI 10.1016/j.expneurol.2014.06.001; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Castellani RJ, 2008, J ALZHEIMERS DIS, V14, P377; Castellani RJ, 2008, J NEUROPATH EXP NEUR, V67, P523, DOI 10.1097/NEN.0b013e318177eaf4; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Constantinides J, 1967, ARCH SUISS NEUROL, V100, P117; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DAWSON SL, 1980, HUM PATHOL, V11, P155, DOI 10.1016/S0046-8177(80)80136-5; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Drachman DA, 1999, NEW ENGL J MED, V340, P1269, DOI 10.1056/NEJM199904223401609; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Goldman JG, 2014, MOVEMENT DISORD, V29, P608, DOI 10.1002/mds.25866; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hamidou B, 2014, EUR J EPIDEMIOL, V29, P459, DOI 10.1007/s10654-014-9923-2; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Huisman MHB, 2013, J NEUROL NEUROSUR PS, V84, P976, DOI 10.1136/jnnp-2012-304724; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; JONES BE, 1991, PROG BRAIN RES, V88, P15; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Keage HAD, 2014, J ALZHEIMERS DIS, V42, P641, DOI 10.3233/JAD-132351; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Liu Y, 2013, J NEUROL SCI, V335, P26, DOI 10.1016/j.jns.2013.09.013; Llado A, 2008, J NEUROL, V255, P488, DOI 10.1007/s00415-008-0565-8; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mohamed NV, 2013, EUR J NEUROSCI, V37, P1939, DOI 10.1111/ejn.12229; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	98	8	8	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JUN	2015	95	6					576	584		10.1038/labinvest.2015.54			9	Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pathology	CJ0DZ	WOS:000355145600001	25867769	Bronze			2022-02-06	
J	Dolenec, P; Pilipovic, K; Rajic, J; Zupan, G				Dolenec, Petra; Pilipovic, Kristina; Rajic, Jelena; Zupan, Gordana			Temporal Pattern of Neurodegeneration, Programmed Cell Death, and Neuroplastic Responses in the Thalamus After Lateral Fluid Percussion Brain Injury in the Rat	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Apoptosis; Neurodegeneration; Neuroplasticity; Rat; Thalamus; Traumatic brain injury	APOPTOSIS-INDUCING FACTOR; FOCAL CEREBRAL-ISCHEMIA; NUCLEAR TRANSLOCATION; HEAD-INJURY; INCREASED EXPRESSION; BEHAVIORAL RECOVERY; NEURONAL APOPTOSIS; DNA FRAGMENTATION; SPINAL-CORD; GAP-43	The effects of traumatic brain injury (TBI) on the thalamus are not well characterized. We analyzed neuronal degeneration and loss, apoptosis, programmed cell death-executing pathways, and neuroplastic responses in the rat thalamus during the first week after lateral fluid percussion injury (LFPI). The most prominent neurodegenerative and neuroplastic changes were observed in the region containing the posterior thalamic nuclear group and ventral posteromedial and posterolateral thalamic nuclei ipsilateral to the LFPI. There was progressive neurodegeneration in these regions, with maximal neuronal loss on Day 7. Increases in numbers of apoptotic cells were detected on Day 1 and were enhanced on Days 3 and 7 after TBI. There was unchanged expression of active caspase-3 at all postinjury time points, but there was increased expression of apoptosis-inducing factor (AIF) on Day 7. The AIF nuclear translocation was detected on Day 1 and was maximal on Day 7. Total thalamic synaptophysin expression was unchanged, but immunostaining intensities were increased at all time points after TBI. Decreased growth-associated protein-43 expression and signal intensity were observed on Day 1. Our results suggest that progressive neuronal damage and loss, AIF signaling pathway-dependent programmed cell death, and limited neuroplastic changes occur in the rat thalamus during the first week after LFPI induction.	[Dolenec, Petra; Pilipovic, Kristina; Rajic, Jelena; Zupan, Gordana] Univ Rijeka, Fac Med, Dept Pharmacol, Rijeka 51000, Croatia		Zupan, G (corresponding author), Univ Rijeka, Fac Med, Dept Pharmacol, Brace Branchetta 20, Rijeka 51000, Croatia.	gordana.zupan@medri.uniri.hr	Pilipovic, Kristina/Q-5974-2018; Zupan, Gordana/R-4927-2018; Zupan, Gordana/AAO-7020-2021; Rajic Bumber, Jelena/S-2849-2018; Dolenec, Petra/AAV-1118-2021; Dolenec, Petra/S-3997-2018; Zupan, Gordana/AAO-7057-2021	Pilipovic, Kristina/0000-0002-7129-1621; Zupan, Gordana/0000-0002-4422-9021; Rajic Bumber, Jelena/0000-0002-5751-0752; Dolenec, Petra/0000-0002-9960-0385; Dolenec, Petra/0000-0002-9960-0385; Zupan, Gordana/0000-0002-4422-9021			Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carrera E, 2006, NEUROLOGY, V66, P1817, DOI 10.1212/01.wnl.0000219679.95223.4c; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheng Q, 2013, INT J NEUROSCI, V123, P832, DOI 10.3109/00207454.2013.794421; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Emery DL, 2000, J COMP NEUROL, V424, P521; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Fujikawa DG, 2000, EPILEPSIA, V41, pS9, DOI 10.1111/j.1528-1157.2000.tb01549.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lee BI, 2005, STROKE, V36, P2712, DOI 10.1161/01.STR.0000190001.97140.cf; Li GL, 1996, ACTA NEUROPATHOL, V92, P19, DOI 10.1007/s004010050484; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; MEBERG PJ, 1993, MOL BRAIN RES, V17, P295, DOI 10.1016/0169-328X(93)90014-G; Miyake K, 2002, BRAIN RES, V935, P24, DOI 10.1016/S0006-8993(02)02420-4; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Naffah-Mazzacoratti MG, 1999, NEUROSCIENCE, V91, P485, DOI 10.1016/S0306-4522(98)00631-9; Neese SL, 2010, BRAIN RES, V1362, P93, DOI 10.1016/j.brainres.2010.09.055; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; STROEMER RP, 1993, NEUROSCI LETT, V162, P51, DOI 10.1016/0304-3940(93)90557-2; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053	72	8	9	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6					512	526		10.1097/NEN.0000000000000194			15	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800004	25933386				2022-02-06	
J	Kaldoja, ML; Kolk, A				Kaldoja, Mari-Liis; Kolk, Anneli			Does Gender Matter? Differences in Social-Emotional Behavior Among Infants and Toddlers Before and After Mild Traumatic Brain Injury: A Preliminary Study	JOURNAL OF CHILD NEUROLOGY			English	Article						childhood mild traumatic brain injury; social-emotional behavior; gender differences; risk factors; interaction skills	EXTERNALIZING BEHAVIORS; YOUNG-CHILDREN; PRESCHOOL-CHILDREN; COMPETENCE; FAMILY; RISK; ADOLESCENTS; PREDICTORS	Traumatic brain injury is a common cause of acquired disability in childhood. While much is known about cognitive sequelae of brain trauma, gender-specific social-emotional problems in children with mild traumatic brain injury is far less understood. The aims of the study were to investigate gender differences in social-emotional behavior before and after mild traumatic brain injury. Thirty-five 3- to 65-month-old children with mild traumatic brain injury and 70 controls were assessed with Ages and Stages Questionnaires: Social-Emotional. Nine months later, 27 of 35 patients and 54 of 70 controls were reassessed. We found that before injury, boys had more self-regulation and autonomy difficulties and girls had problems with adaptive functioning. Nine months after injury, boys continued to struggle with self-regulation and autonomy and new difficulties with interaction had emerged, whereas in girls, problems in interaction had evolved. Even mild traumatic brain injury in early childhood disrupts normal social-emotional development having especially devastating influence on interaction skills.	[Kaldoja, Mari-Liis] Univ Tartu, Inst Psychol, EE-50090 Tartu, Estonia; [Kaldoja, Mari-Liis] Tallinn Univ, Inst Psychol, EE-10120 Tallinn, Estonia; [Kaldoja, Mari-Liis] Tallinn Childrens Hosp, Psychiat Clin, Tallinn, Estonia; [Kolk, Anneli] Tartu Univ Hosp, Childrens Clin, Dept Neurol & Neurorehabil, Tartu, Estonia; [Kolk, Anneli] Univ Tartu, Dept Pediat, EE-50090 Tartu, Estonia		Kaldoja, ML (corresponding author), Tallinn Univ, Inst Psychol, Narva Mnt 29, EE-10120 Tallinn, Estonia.	mari-liis.kaldoja@ut.ee		Kaldoja, Mari-Liis/0000-0002-7471-5813	Estonian Science Foundation [GARLA 9016]; Estonian Ministry of Education and ResearchMinistry of Education and Research, Estonia [IUT 3-3]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Estonian Science Foundation (GARLA 9016). MLK was also supported by institutional research funding (IUT 3-3) of the Estonian Ministry of Education and Research.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Baker SP, 1992, THE INJURY FACT BOOK, VSecond; Bijur BE, 1995, TRAUMATIC HEAD INJUR; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; *CAN I CHILD HLTH, 1994, HLTH CAN CHILDR CICH; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gartstein MA, 2003, J APPL DEV PSYCHOL, V24, P143, DOI 10.1016/S0193-3973(03)00043-1; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Granie MA, 2010, ACCIDENT ANAL PREV, V42, P726, DOI 10.1016/j.aap.2009.10.022; Guthrie E, 1999, CHILD ADOL PSYCH CL, V8, P807; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Kaldoja ML, 2008, THESIS U TARTU TARTU; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ministry of Social Affairs, 1995, INT STAT CLASS DIS R; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P433, DOI 10.1093/jpepsy/jsh047; Morrongiello BA, 1999, J APPL DEV PSYCHOL, V20, P227, DOI 10.1016/S0193-3973(99)00015-5; Rothbart MK, 2011, EMOT REV, V3, P207, DOI 10.1177/1754073910387943; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schwebel DC, 1999, CHILD DEV, V70, P700, DOI 10.1111/1467-8624.00050; Squires J, 2001, EARLY CHILD RES Q, V16, P405, DOI 10.1016/S0885-2006(01)00115-6; Squires J, 2003, ASQ SE USERS GUIDE A; van Aken C, 2007, J PEDIATR PSYCHOL, V32, P230, DOI 10.1093/jpepsy/jsj118; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081	34	8	8	1	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2015	30	7					860	867		10.1177/0883073814544705			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CI2AM	WOS:000354546700005	25143483				2022-02-06	
J	Koren, G				Koren, Gideon			Pharmacological Treatment of Disruptive Behavior in Children with Fetal Alcohol Spectrum Disorder	PEDIATRIC DRUGS			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; ANTIPSYCHOTIC PRESCRIPTION; CLINICAL-RESPONSE; ADOLESCENTS; METHYLPHENIDATE; EXPOSURE; SUPPLEMENTATION; STIMULANTS	Fetal alcohol spectrum disorder (FASD) is considered to be the most common cause of developmental disability, affecting more than 1 % of the general population in North America. Inattention, hyperactivity, and impulsivity afflict 50-90 % of children with FASD and are 3-9 times more common than in the general population. Of importance, a large proportion of children with FASD are affected by oppositional defiant/conduct disorder (ODD/CD), including lack of social judgment and failure to learn from experience. These devastating numbers are contrasted by almost no pharmacological research into treatment of these pervasive conditions in FASD. This review focuses on analyzing the published evidence on the effectiveness and safety of therapy for disruptive behaviors in FASD. Often, the child afflicted by FASD will not be allowed to participate in class activities without such therapies, which makes such analysis critical.	Univ Toronto, Hosp Sick Children, Motherisk Program, Div Clin Pharmacol Toxicol,Dept Paediat, Toronto, ON M5G 1X8, Canada		Koren, G (corresponding author), Univ Toronto, Hosp Sick Children, Motherisk Program, Div Clin Pharmacol Toxicol,Dept Paediat, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	gkoren@sickkids.ca	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875			Bachmann CJ, 2014, DTSCH ARZTEBL INT, V111, P25, DOI 10.3238/arztebl.2014.0025; Baeza I, 2014, J CLIN PSYCHOPHARM, V34, P613, DOI 10.1097/JCP.0000000000000190; Doig J, 2008, J CHILD ADOL PSYCHOP, V18, P365, DOI 10.1089/cap.2007.0121; Drew PD, 2014, INT REV NEUROBIOL, V118, P41, DOI 10.1016/B978-0-12-801284-0.00003-8; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; Frankel F, 2006, J CHILD ADOL PSYCHOP, V16, P777, DOI 10.1089/cap.2006.16.777; Ipser J, 2007, PSYCHOPHARMACOLOGY, V191, P127, DOI 10.1007/s00213-006-0537-6; Jacobson SW, 2004, ALCOHOL CLIN EXP RES, V28, P1732, DOI 10.1097/01.ALC.0000145691.81233.FA; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Lee RD, 2004, J TOXICOL ENV HEAL A, V67, P2073, DOI 10.1080/15287390490515001; Mattson SN, 2000, ALCOHOL CLIN EXP RES, V24, P226, DOI 10.1097/00000374-200002000-00014; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; Niccols A, 2007, BRAIN COGNITION, V65, P135, DOI 10.1016/j.bandc.2007.02.009; Nugent Kevin, 2014, Neuropsychiatr Dis Treat, V10, P1781, DOI 10.2147/NDT.S64136; O'Connor MJ, 2002, AM J DRUG ALCOHOL AB, V28, P745, DOI 10.1081/ADA-120015880; O'Malley KD, 2002, CAN J PSYCHIAT, V47, P349, DOI 10.1177/070674370204700405; O'Malley KD, 2000, CAN J PSYCHIAT, V45, P90; Oades RD, 2005, DEVELOPMENTAL SCI, V8, P122, DOI 10.1111/j.1467-7687.2005.00399.x; Oesterheld JR, 1998, J CHILD ADOL PSYCHOP, V8, P39, DOI 10.1089/cap.1998.8.39; Ozarfati J, J POP THER IN PRESS; Panevska Lidija Sushevska, 2014, Mater Sociomed, V26, P253, DOI 10.5455/msm.2014.253-255; Patten AR, 2013, J NUTR BIOCHEM, V24, P760, DOI 10.1016/j.jnutbio.2012.04.003; Patten SB, 2012, CAN J PSYCHIAT, V57, P717, DOI 10.1177/070674371205701202; Pringsheim T, 2012, CAN J PSYCHIAT, V57, P722, DOI 10.1177/070674371205701203; Rasmussen C, 2005, ALCOHOL CLIN EXP RES, V29, P1359, DOI 10.1097/01.alc.0000175040.91007.d0; Ronsley R, 2013, CAN J PSYCHIAT, V58, P361, DOI 10.1177/070674371305800608; Rubia K, 2014, BIOL PSYCHIAT, V76, P616, DOI 10.1016/j.biopsych.2013.10.016; Silva D, 2014, COMMUNITY MENT HLTH; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Smith SM, 2014, BIRTH DEFECTS RES C, V102, P210, DOI 10.1002/bdrc.21078; Snyder J, 1997, CHALLENGE OF FETAL ALCOHOL SYNDROME, P64; Snyder J, 1997, OVERCOMING PREVENTIN; STEINHAUSEN HC, 1993, J AM ACAD CHILD PSY, V32, P990, DOI 10.1097/00004583-199309000-00016; Streissguth AP, 2004, J DEV BEHAV PEDIATR, V25, P228, DOI 10.1097/00004703-200408000-00002; Ter-Stepanian M, 2010, CAN J PSYCHIAT, V55, P305, DOI 10.1177/070674371005500506; Wozniak JR, 2013, NUTR RES, V33, P897, DOI 10.1016/j.nutres.2013.08.005	36	8	9	0	14	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1174-5878	1179-2019		PEDIATR DRUGS	Pediatr. Drugs	JUN	2015	17	3					179	184		10.1007/s40272-015-0118-4			6	Pediatrics; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Pharmacology & Pharmacy	CJ7TG	WOS:000355702000002	25634057				2022-02-06	
J	Nambiar, M; Maclsaac, C; Grabinski, R; Liew, D; Kavar, B				Nambiar, Mithun; Maclsaac, Christopher; Grabinski, Rafal; Liew, Danny; Kavar, Bhadrakant			Outcomes of decompressive craniectomy in patients after traumatic brain injury	CRITICAL CARE AND RESUSCITATION			English	Article							SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; APACHE-II; EXTERNAL VALIDATION; MANAGEMENT; IMPACT; SCALE; COMA; PREDICTION; SEVERITY	Objective: Traumatic brain injury (TBI) can result in cerebral oedema and vascular changes resulting in an increase in intracranial pressure (ICP), which can lead to further secondary damage. Decompressive craniectomy (DC) is a surgical option in the management of ICP. We aimed to investigate outcomes of DC after TBI. Design: We performed a retrospective audit of 57 adult patients (aged > 15 years) who underwent DC after TBI, at the Royal Melbourne Hospital from 1 January 2005 to 30 June 2011. Our functional outcome measure was the Extended Glasgow Outcome Scale (GOSE). Results: Patients had a median age of 30 years (range, 17 73 years). The hospital mortality rate was 47% (27 patients). A higher postoperative median ICP was the most significant predictor of hospital mortality (OR, 1.1; 95% CI, 1-1.3). There was a mean decrease of 7.7 mmHg in ICP between the mean preoperative and postoperative ICP values (95% Cl, 10.5 to 5.0 mmHg). There was a mean decrease of 3.5 mmHg in the mean cerebral perfusion pressure (CPP) from preoperative to postoperative CPP values (95% Cl, 6.2 to 0.8 mmHg). At the 6-month follow-up, a poor outcome (GOSE score, 1-4) was seen in 39 patients (68%), while a good outcome (GOSE score, 5 8) was noted in 15 patients (26%). A high APACHE II score on admission was the most significant predictor of a worse GOSE score at 6 months (OR, 1.3; 95% CI, 1.1-1.5). Analysis of the APACHE ll and IMPACT scores as models for predicting mortality at 6 months showed an area under the curve (AUC) of 0.792 and 0.805, respectively, and for predicting poor outcome at 6 months, showed an AUC of 0.862 and 0.883, respectively. Conclusion: DC decreased ICP postoperatively. The IMPACT and APACHE II scores are good models for prediction of death and poor outcome at 6 months.	[Nambiar, Mithun; Kavar, Bhadrakant] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3050, Australia; [Maclsaac, Christopher] Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Grabinski, Rafal] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Liew, Danny] Univ Melbourne, Ctr Clin Epidemiol Biostat & Hlth Serv Res, Melbourne, Vic, Australia; [Kavar, Bhadrakant] Royal Melbourne Hosp, Dept Neurosurg, Melbourne, Vic, Australia		Nambiar, M (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3050, Australia.	mithunnambiar@hotmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gennarelli TA., 2008, ABBREVIATED INJURY S; HARTLEY C, 1995, BRIT J NEUROSURG, V9, P179, DOI 10.1080/02688699550041520; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nejmi H, 2014, INDIAN J CRIT CARE M, V18, P369, DOI 10.4103/0972-5229.133895; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schneider GH, 2002, ACT NEUR S, V81, P77; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	28	8	8	0	3	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2015	17	2					67	72					6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0ID	WOS:000355158100003	26017122				2022-02-06	
J	Reddy, D; Morrow, BM; Argent, AC				Reddy, Deveshni; Morrow, Brenda M.; Argent, Andrew C.			Acinetobacter baumannii infections in a South African paediatric intensive care unit	JOURNAL OF TROPICAL PEDIATRICS			English	Article						nosocomial infection; Acinetobacter baumannii; ventilator-associated pneumonia; infection control; paediatric; intensive care; infectious disease	VENTILATOR-ASSOCIATED PNEUMONIA; RISK-FACTORS; NOSOCOMIAL INFECTIONS; DEVELOPING-COUNTRY; ACQUISITION	Objectives: To describe and compare characteristics and outcomes of patients colonized or infected with Acinetobacter baumannii (cases) to a control group. Methods: A retrospective case-controlled study of patients admitted to a South African paediatric intensive care unit (PICU) between January and December 2010. Results: Acinetobacter baumannii was isolated in 194 patients. Mortality was similar between cases (9.3%) and controls (9.8%). Median duration of PICU stay and mechanical ventilation in cases vs. controls was 10 vs. 2 (p< 0.0001) and 9 vs. 1 days (p< 0.0001), respectively. Admission diagnosis of traumatic brain injury [adjusted odds ratio (OR): 5.6, 95% CI: 1.2-27.0; p = 0.03] and duration of mechanical ventilation (adjusted OR: 1.4, 95% CI: 1.3-1.5; p< 0.0001) were independently associated with A. baumannii aquisition. Conclusion: Acinetobacter baumannii acquisition was common and associated with increased morbidity, but not increased mortality.	[Reddy, Deveshni; Argent, Andrew C.] Red Cross War Mem Childrens Hosp, Paediat Intens Care Unit, ZA-7700 Cape Town, South Africa; [Reddy, Deveshni; Morrow, Brenda M.; Argent, Andrew C.] Univ Cape Town, Dept Paediat & Child Hlth, ZA-7700 Cape Town, South Africa		Morrow, BM (corresponding author), Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, 5th Floor,ICH Bldg,Klipfontein Rd, ZA-7700 Cape Town, South Africa.	brenda.morrow@uct.ac.za	Morrow, Brenda/AAI-3819-2020; Argent, Andrew/J-1605-2019	Morrow, Brenda/0000-0001-5193-918X; Argent, Andrew/0000-0001-9333-2036			Balkhy HH, 2012, EUR J CLIN MICROBIOL, V31, P2645, DOI 10.1007/s10096-012-1608-8; Baran G, 2008, INT J INFECT DIS, V12, P16, DOI 10.1016/j.ijid.2007.03.005; Chang Po-Yang, 2007, Journal of Microbiology Immunology and Infection, V40, P406; Ebenezer K, 2011, INDIAN PEDIATR, V48, P964, DOI 10.1007/s13312-011-0152-4; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Ho J, 2010, CAN J INFECT DIS MED, V21, P83, DOI 10.1155/2010/690715; Hong KB, 2012, PEDIATR INFECT DIS J, V31, P685, DOI 10.1097/INF.0b013e318256f3e6; Jeena P, 2001, ANN TROP PAEDIATR, V21, P245, DOI 10.1080/02724930120077835; Jung JY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-228; Katragkou A, 2006, INTENS CARE MED, V32, P1384, DOI 10.1007/s00134-006-0239-x; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; McGrath EJ, 2011, INDIAN J PEDIATR, V78, P176, DOI 10.1007/s12098-010-0253-4; Morrow BM, 2012, PEDIATR CRIT CARE ME, V13, pE25, DOI 10.1097/PCC.0b013e31820ac0a2; Morrow BM, 2009, J PAEDIATR CHILD H, V45, P104, DOI 10.1111/j.1440-1754.2008.01437.x; Ozdemir H, 2011, TURKISH J PEDIATR, V53, P255; Sachdev A, 2011, INDIAN PEDIATR, V48, P949, DOI 10.1007/s13312-011-0154-2	16	8	10	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	JUN	2015	61	3					182	187		10.1093/tropej/fmv017			6	Pediatrics; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Tropical Medicine	CK2KR	WOS:000356039800005	25833097	Bronze			2022-02-06	
J	Zhou, HH; Liu, Q; Yang, RT; Li, Z; Li, ZB				Zhou, Hai-Hua; Liu, Qi; Yang, Rong-Tao; Li, Zhi; Li, Zu-Bing			Traumatic head injuries in patients with maxillofacial fractures: a retrospective case-control study	DENTAL TRAUMATOLOGY			English	Article						Head injury; Maxillofacial fractures; Prevalence; Retrospective study	MIDDLE CRANIAL FOSSA; FACIAL FRACTURES; MANDIBULAR CONDYLE; BRAIN; DISLOCATION; IMPACT	ObjectivesTo analyse and evaluate the correlation between traumatic head injuries (THIs) and maxillofacial fractures (MF). Age, gender and trauma mechanism correlated with THI were also investigated. Patients and MethodsWe conducted a hospital-based retrospective case-control study at Stomatology College and Hospital, Wuhan University. From January 2000 to December 2009, a total of 1131 patients with MF were enrolled in the statistical study to evaluate the association of THI and other risk factors with MF. Among these patients, 86 presented with THI. We utilized binary logistic regression and risk analysis to investigate the associations among MF and other risk factors with HI. ResultsHead injuries (103 injuries) were sustained by 86 patients (7.6%), with male-to-female ratio of 4.1:1.0. Most of the patients (52 patients, 50.5%) also exhibited cranial bone fractures. The age group with most patients was the 30-39years age group (26 patients, 30.2%), followed by the 19-29years age group (22 patients, 25.6%). Motor vehicle accident (MVA) was the most common mechanism of injury (49 patients, 74.1%). Patients older than 50years showed the highest risk for head injury (OR, 2.0; 95% confidence interval, 1.1-3.7; P=0.025). MVA had a sixfold risk of head injury (OR, 6.2; 95% confidence interval, 1.5-26.1; P=0.013). Head injuries were more prone to occur in patients who had combined fracture of the mid-face and mandible (OR=4.6, P<0.001), and only a 0.3-fold risk of multimandible fractures (P<0.001), 0.5-fold risk of single mandibular fracture (P=0.017) and 0.3-fold risk of patients who sustained only single mandibular condylar fracture (P=0.019). ConclusionsThe occurrence of head injuries is significantly related to age, aetiology and the pattern and position of maxillofacial fractures.	[Zhou, Hai-Hua; Liu, Qi; Yang, Rong-Tao; Li, Zhi; Li, Zu-Bing] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Liu, Qi; Yang, Rong-Tao; Li, Zhi; Li, Zu-Bing] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Liu, Qi; Yang, Rong-Tao; Li, Zhi; Li, Zu-Bing] Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430079, Hubei, Peoples R China		Li, ZB (corresponding author), Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	lizubing0827@163.com			Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2042014kf0137, 2042014kf0163]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300854]	This work was supported by "the Fundamental Research Funds for the Central Universities (Grant No. 2042014kf0137)"; "the Fundamental Research Funds for the Central Universities (Grant No. 2042014kf0163)"; "National Natural Science Foundation of China (Grant No. 81300854)".	Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Chan J, 2004, INT J PEDIATR OTORHI, V68, P877, DOI 10.1016/j.ijporl.2004.01.021; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; HAMPSON D, 1995, J BIOMECH, V28, P1; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; HAYTER JP, 1991, BRIT J ORAL MAX SURG, V29, P370, DOI 10.1016/0266-4356(91)90003-N; Hohlrieder M, 2003, INTENS CARE MED, V29, P1095, DOI 10.1007/s00134-003-1804-1; Hung YC, 2004, J ORAL MAXIL SURG, V62, P938, DOI 10.1016/j.joms.2004.01.018; Isik D, 2012, ULUS TRAVMA ACIL CER, V18, P200, DOI 10.5505/tjtes.2012.01047; Kanno T, 2008, J JPN ASS ACUTE MED, V19, P1023; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kloss F, 2008, J CRANIO MAXILL SURG, V36, P372, DOI 10.1016/j.jcms.2007.12.002; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; Man C, 2011, INT J ORAL MAX SURG, V40, P118, DOI 10.1016/j.ijom.2010.02.028; Martin RCG, 2002, AM SURGEON, V68, P477; Mithani SK, 2009, PLAST RECONSTR SURG, V123, P1293, DOI 10.1097/PRS.0b013e31819e26f2; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Rosa Vera L M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe4, DOI 10.1016/j.tripleo.2006.02.004; Struewer J, 2012, J CRANIO MAXILL SURG, V40, P396, DOI 10.1016/j.jcms.2011.07.006; Thoren H, 2010, J ORAL MAXIL SURG, V68, P805, DOI 10.1016/j.joms.2009.09.057; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	30	8	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2015	31	3					209	214		10.1111/edt.12165			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CH7AM	WOS:000354188000007	25721373				2022-02-06	
J	Caldwell, M; Hapuarachchi, T; Highton, D; Elwell, C; Smith, M; Tachtsidis, I				Caldwell, Matthew; Hapuarachchi, Tharindi; Highton, David; Elwell, Clare; Smith, Martin; Tachtsidis, Ilias			BrainSignals Revisited: Simplifying a Computational Model of Cerebral Physiology	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE; OXYGEN-SATURATION; METABOLIC-RATE; BLOOD-FLOW; INTRACRANIAL-PRESSURE; SENSITIVITY-ANALYSIS; CYTOCHROME-OXIDASE; SYSTEMS BIOLOGY	Multimodal monitoring of brain state is important both for the investigation of healthy cerebral physiology and to inform clinical decision making in conditions of injury and disease. Near-infrared spectroscopy is an instrument modality that allows non-invasive measurement of several physiological variables of clinical interest, notably haemoglobin oxygenation and the redox state of the metabolic enzyme cytochrome c oxidase. Interpreting such measurements requires the integration of multiple signals from different sources to try to understand the physiological states giving rise to them. We have previously published several computational models to assist with such interpretation. Like many models in the realm of Systems Biology, these are complex and dependent on many parameters that can be difficult or impossible to measure precisely. Taking one such model, BrainSignals, as a starting point, we have developed several variant models in which specific regions of complexity are substituted with much simpler linear approximations. We demonstrate that model behaviour can be maintained whilst achieving a significant reduction in complexity, provided that the linearity assumptions hold. The simplified models have been tested for applicability with simulated data and experimental data from healthy adults undergoing a hypercapnia challenge, but relevance to different physiological and pathophysiological conditions will require specific testing. In conditions where the simplified models are applicable, their greater efficiency has potential to allow their use at the bedside to help interpret clinical data in near real-time.	[Caldwell, Matthew; Hapuarachchi, Tharindi; Elwell, Clare; Tachtsidis, Ilias] UCL, Dept Med Phys & Biomed Engn, London, England; [Hapuarachchi, Tharindi] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Highton, David; Smith, Martin] Univ Coll London Hosp, Neurocrit Care Unit, London, England		Tachtsidis, I (corresponding author), UCL, Dept Med Phys & Biomed Engn, London, England.	i.tachtsidis@ucl.ac.uk	Tachtsidis, Ilias/N-2747-2018; Highton, David/K-9544-2017	Tachtsidis, Ilias/0000-0002-8125-0313; Highton, David/0000-0002-4608-4081; Caldwell, Matthew/0000-0002-9578-1676; Elwell, Clare/0000-0002-7281-7234	Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/K020315/1]; Wellcome TrustWellcome TrustEuropean Commission [089914]; Central and East London Comprehensive Local Research Network [45-09-FSF]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [17803]; UCLH/UCL National institute for Health Research Biomedical Research Centre; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/K020315/1] Funding Source: UKRI	This work was funded by the following grants: Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk), EP/K020315/1 (CE MS IT MC DH); Wellcome Trust (http://www.wellcome.ac.uk), 089914 (CE MS); Central and East London Comprehensive Local Research Network, 45-09-FSF (MS CE); and Medical Research Council (http://www.mrc.ac.uk), 17803 (CE MS). MS is partially funded by the UCLH/UCL National institute for Health Research Biomedical Research Centre (http://www.uclhospitals.brc.nihr.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderliesten T, 2014, NEUROIMAGE, V85, P255, DOI 10.1016/j.neuroimage.2013.07.015; An Hongyu, 2014, Curr Radiol Rep, V2, P39; An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Bainbridge A, 2014, NEUROIMAGE, V102, P173, DOI 10.1016/j.neuroimage.2013.08.016; Bale G, 2014, BIOMED OPT EXPRESS, V5, P3450, DOI 10.1364/BOE.5.003450; Banaji M, 2005, MATH BIOSCI, V194, P125, DOI 10.1016/j.mbs.2004.10.005; Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; Baxter SM, 2006, PLOS COMPUT BIOL, V2, P975, DOI 10.1371/journal.pcbi.0020087; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Christen T, 2014, J CEREBR BLOOD F MET, V34, P1550, DOI 10.1038/jcbfm.2014.116; Cooper CE, 1997, PHILOS T R SOC B, V352, P669, DOI 10.1098/rstb.1997.0048; Cooper CE, 2009, ADV EXP MED BIOL, V645, P123, DOI 10.1007/978-0-387-85998-9_19; Cooper RJ, 2012, NEUROIMAGE, V59, P3128, DOI 10.1016/j.neuroimage.2011.11.028; CUKIER RI, 1973, J CHEM PHYS, V59, P3873, DOI 10.1063/1.1680571; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Dehaes M, 2014, J CEREBR BLOOD F MET, V34, P87, DOI 10.1038/jcbfm.2013.165; Delpy DT, 1997, PHILOS T R SOC B, V352, P649, DOI 10.1098/rstb.1997.0046; Diop M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3123347; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Edvinsson L, 1992, CEREBRAL BLOOD FLOW; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gehricke JG, 2013, PHARMACOL BIOCHEM BE, V112, P78, DOI 10.1016/j.pbb.2013.10.001; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hapuarachchi T, 2013, ADV EXP MED BIOL, V789, P331, DOI 10.1007/978-1-4614-7411-1_44; Hastie T., 2009, ELEMENTS STAT LEARNI; Highton D, 2014, ADV EXP MED BIOL, V812, P195, DOI 10.1007/978-1-4939-0620-8_26; Highton D, 2013, ADV EXP MED BIOL, V765, P87, DOI 10.1007/978-1-4614-4989-8_13; Iwata S, 2014, INT J DEV NEUROSCI, V37, P1, DOI 10.1016/j.ijdevneu.2014.05.010; Jelfs B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038297; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kakihana Y, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940583; Kirkpatrick PJ, 1996, J NEUROL NEUROSUR PS, V60, P131, DOI 10.1136/jnnp.60.2.131; Kirkpatrick PJ, 1997, PHILOS T ROY SOC B, V352, P701, DOI 10.1098/rstb.1997.0052; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kolyva C, 2014, NEUROIMAGE, V85, P234, DOI 10.1016/j.neuroimage.2013.05.070; Kolyva C, 2012, BIOMED OPT EXPRESS, V3, P2550, DOI 10.1364/BOE.3.002550; Lee JM, 2003, ANN NEUROL, V53, P227, DOI 10.1002/ana.10433; Lynch JM, 2014, ACAD RADIOL, V21, P162, DOI 10.1016/j.acra.2013.10.013; Moroz T, 2012, J R SOC INTERFACE, V9, P1499, DOI 10.1098/rsif.2011.0766; Moroz T, 2012, ADV EXP MED BIOL, V737, P293, DOI 10.1007/978-1-4614-1566-4_43; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Muehlschlegel S, 2009, NEUROCRIT CARE, V11, P288, DOI 10.1007/s12028-009-9254-4; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Naulaers G, 2007, NEONATOLOGY, V92, P120, DOI 10.1159/000101063; Neal ML, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003849; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Papademetriou MD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.067008; Petersen BK, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0095-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Roche-Labarbe N, 2014, NEUROIMAGE, V85, P279, DOI 10.1016/j.neuroimage.2013.01.035; Roche-Labarbe N, 2012, J CEREBR BLOOD F MET, V32, P481, DOI 10.1038/jcbfm.2011.145; Roche-Labarbe N, 2010, HUM BRAIN MAPP, V31, P341, DOI 10.1002/hbm.20868; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Smith M, 2011, PHILOS T R SOC A, V369, P4452, DOI 10.1098/rsta.2011.0242; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Tichauer KM, 2010, J APPL PHYSIOL, V109, P878, DOI 10.1152/japplphysiol.01432.2009; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Tisdall MM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718541; Transtrum MK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036701; Transtrum MK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.060201; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; Verdecchia K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.027007; Vermeij A, 2014, NEUROIMAGE, V85, P608, DOI 10.1016/j.neuroimage.2013.04.107; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wanner G., 1996, SOLVING ORDINARY DIF; Wilcox T, 2012, NEUROIMAGE, V62, P1833, DOI 10.1016/j.neuroimage.2012.05.039; Wintermark P, 2014, NEUROIMAGE, V85, P287, DOI 10.1016/j.neuroimage.2013.04.072; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Wolff CB, 2013, ADV EXP MED BIOL, V789, P37, DOI 10.1007/978-1-4614-7411-1_6	77	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126695	10.1371/journal.pone.0126695			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	WOS:000354542500136	25961297	Green Published, gold, Green Submitted			2022-02-06	
J	Phelps, SF				Phelps, Sue F.			The Veteran Student Experience and the Academic Librarian	JOURNAL OF ACADEMIC LIBRARIANSHIP			English	Article						Veterans; Veteran students; Higher education; Post-traumatic stress syndrome; Traumatic brain injury; Military sexual trauma	POSTTRAUMATIC-STRESS-DISORDER	With the increase of student veteran enrollment under the Post 9/11 Veterans Education Assistance Act of 2008, colleges and university campuses are beginning to accommodate the needs of this population. Student veterans present unique challenges to institutions of higher education as they are adjusting to a new culture and coping with both visible and invisible injuries. Some of these war-related injuries affect behavior in both classroom and extracurricular settings and some result in learning disabilities. Librarians who understand the experiences of student veterans can better assist these students with their academic goals. (C) 2015 Elsevier Inc. All rights reserved.	Washington State Univ, Lib, Vancouver, WA 98686 USA		Phelps, SF (corresponding author), Washington State Univ, Lib, 14204 NE Salmon Creek Ave, Vancouver, WA 98686 USA.	asphelps@vancouver.wsu.edu		Phelps, Sue F./0000-0002-2337-9012			Anderson Julia, 2012, THESIS G MASON U ARC; Barry AE, 2014, J STUD AFF RES PRACT, V51, P30, DOI 10.1515/jsarp-2014-0003; Burns B, 2014, AM J PUBLIC HEALTH, V104, P345, DOI 10.2105/AJPH.2013.301576; Callahan Ron, 2014, CHANGE MAGAZINE HIGH, V46, P36, DOI DOI 10.1080/00091383.2014.897189; Church TE, 2009, J POSTSECOND EDUC DI, V22, P43; Evans Karen, 2012, COLL RES LIB NEWS, P470, DOI DOI 10.5860/CRLN.73.8.8812; Helton Rae, 2010, KENTUCKY LIB, V74, P14; LAFFERTY CL, 2008, SAM ADV MANAGE J, V73, P4; Lighthall A., 2012, NEA HIGHER ED J THOU, V28, P81; Manderscheid RW, 2007, ARCH PSYCHIAT NURS, V21, P122, DOI 10.1016/j.apnu.2006.12.006; McBain Leslie, 2012, SOLDIER STUDENT, p[7, 47]; Medina J., 2008, BRAIN RULES 12 PRINC; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Roost A., 2014, ACAD AM ASS U PROFES, V100, P31; Schmeling James, 2011, CHRONICLE HIGHER ED, V58; Shea K. P., 2012, NEW DIRECTIONS ADULT, V2012, P53; Sinski JB, 2012, J POSTSECOND EDUC DI, V25, P87; Sojdehei Virginia, 2013, COLL RES LIB NEWS, P537, DOI DOI 10.5860/CRLN.74.10.9029; Street Mark, 2014, CHRON HIGHER EDUC, V60, P30; Temple University Disabilities Resources and Services (d), TRAUMATIC BRAIN INJU; U.S. Department of Veteran's Affairs, 2014, ED PROGR BEN FY2000	21	8	8	2	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1333	1879-1999		J ACAD LIBR	J. Acad. Librariansh.	MAY	2015	41	3					236	240		10.1016/j.acalib.2015.04.001			5	Information Science & Library Science	Social Science Citation Index (SSCI)	Information Science & Library Science	CI3QT	WOS:000354663200003					2022-02-06	
J	Thomsen, GM; Vit, JP; Lamb, A; Gowing, G; Shelest, O; Alkaslasi, M; Ley, EJ; Svendsen, CN				Thomsen, Gretchen M.; Vit, Jean-Philippe; Lamb, Alexander; Gowing, Genevieve; Shelest, Oksana; Alkaslasi, Mor; Ley, Eric J.; Svendsen, Clive N.			Acute Traumatic Brain Injury Does Not Exacerbate Amyotrophic Lateral Sclerosis in the SOD1(G93A) Rat Model(1,2,3)	ENEURO			English	Article						ALS; amyotrophic lateral sclerosis; neurodegeneration; SOD1; TBI; traumatic brain injury	SPINAL-CORD CONTUSION; MOTOR-NEURON DEGENERATION; HEXANUCLEOTIDE REPEAT; CELL TRANSPLANTATION; PHYSICAL-ACTIVITY; ANIMAL-MODELS; HEAD TRAUMA; MUTANT SOD1; NEURODEGENERATION; POPULATION	Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease in which upper and lower motor neurons degenerate, leading to muscle atrophy, paralysis, and death within 3 to 5 years of onset. While a small percentage of ALS cases are genetically linked, the majority are sporadic with unknown origin. Currently, etiological links are associated with disease onset without mechanistic understanding. Of all the putative risk factors, however, head trauma has emerged as a consistent candidate for initiating the molecular cascades of ALS. Here, we test the hypothesis that traumatic brain injury (TBI) in the SOD1G93A transgenic rat model of ALS leads to early disease onset and shortened lifespan. We demonstrate, however, that a one-time acute focal injury caused by controlled cortical impact does not affect disease onset or survival. Establishing the negligible involvement of a single acute focal brain injury in an ALS rat model increases the current understanding of the disease. Critically, untangling a single focal TBI from multiple mild injuries provides a rationale for scientists and physicians to increase focus on repeat injuries to hopefully pinpoint a contributing cause of ALS.	[Thomsen, Gretchen M.; Gowing, Genevieve; Shelest, Oksana; Alkaslasi, Mor; Svendsen, Clive N.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Vit, Jean-Philippe; Svendsen, Clive N.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Vit, Jean-Philippe] Cedars Sinai Med Ctr, Biobehav Res Core, Los Angeles, CA 90048 USA; [Lamb, Alexander; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org; Clive.Svendsen@cshs.org	vit, jean-philippe/Q-7286-2019	Vit, Jean-Philippe/0000-0001-5057-8554	Board of Governors Regenerative Medicine Institute; ALS Association	This work was supported by the Board of Governors Regenerative Medicine Institute and the ALS Association.	Abel EL, 2007, PERCEPT MOTOR SKILL, V104, P1251, DOI 10.2466/PMS.104.4.1251-1254; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beghi E, 2010, AMYOTROPH LATERAL SC, V11, P289, DOI 10.3109/17482960903384283; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P205, DOI 10.1080/17482960902721634; Choo AMT, 2009, J NEUROSCI METH, V181, P6, DOI 10.1016/j.jneumeth.2009.04.007; Das MM, 2015, NEUROBIOL AGING, V36, P1130, DOI 10.1016/j.neurobiolaging.2014.09.020; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Gotkine M, 2014, AMYOTROPH LAT SCL FR, V15, P534, DOI 10.3109/21678421.2014.932383; Grad LI, 2014, PRION, V8, P33, DOI 10.4161/pri.27602; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jin Y, 2014, EXP NEUROL, V257, P57, DOI 10.1016/j.expneurol.2014.04.016; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Li K, 2014, J NEUROSCI, V34, P7622, DOI 10.1523/JNEUROSCI.4690-13.2014; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mazzini L, 2012, CYTOTHERAPY, V14, P56, DOI 10.3109/14653249.2011.613929; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Savica R, 2014, NEUROLOGY, V83, P298, DOI 10.1212/WNL.0000000000000630; Seelen M, 2014, J NEUROL, V261, P1949, DOI 10.1007/s00415-014-7445-1; Suzuki M, 2010, EXP NEUROL, V221, P346, DOI 10.1016/j.expneurol.2009.12.004; Thomsen GM, 2014, J NEUROSCI, V34, P15587, DOI 10.1523/JNEUROSCI.2037-14.2014; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Young W, 2002, PROG BRAIN RES, V137, P231	39	8	8	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	MAY-JUN	2015	2	3							e0059	10.1523/ENEURO.0059-14.2015			8	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3T8L	WOS:000218581400009	26464984	Green Published, gold			2022-02-06	
J	Chen, HW; Liu, GD; Ou, S; Fei, J; Zhao, GS; Wu, LJ; Pan, J				Chen, Hong-wei; Liu, Guo-dong; Ou, Shan; Fei, Jun; Zhao, Gang-sheng; Wu, Li-jun; Pan, Jun			Operative Treatment of Terrible Triad of the Elbow via Posterolateral and Anteromedial Approaches	PLOS ONE			English	Article							MEDIAL COLLATERAL LIGAMENT; CORONOID PROCESS; RADIAL HEAD; FRACTURE-DISLOCATIONS; FIXATION; INJURY; REPAIR; INSTABILITY	The aim of the study was to explore the clinical outcome of posterolateral and anteromedial approaches in treatment of terrible triad of the elbow. The study involved 12 patients with closed terrible triad of the elbow treated by posterolateral and anteromedial approaches between January 2010 and June 2012. The mechanism of injury included fall from height in 9 patients and traffic accident in 3. According to O'Driscoll classification for fractures of the ulnar coronoid, there were 11 patients with type. and 1 with type. fractures. According to Mason classification for fractures of the radial head, there were 3 patients with type., 7 with type. and 2 with type. fractures. All patients were followed up for 12-27 months (average 15.5 months), which showed no pain or severe pain in all patients except for 2 patients with mild pain. At the last follow-up, the mean flexion was for 125 degrees(range, 90 degrees-140 degrees), the mean extension loss for 20 degrees(range, 0 degrees-70 degrees), the mean pronation for 66 degrees(range, 20 degrees-85 degrees) and the mean supination for 60 degrees(range, 30 degrees-85 degrees). The bony union time was 8-14 weeks (average 11 weeks) and the elbows were stable in flexion-extension and varus-valgus in all patients. The elbows maintained a concentric reduction of both the ulnotrochlear and the radiocapitellar articulation. Mild heterotopic ossification of the elbow occurred in 3 patients at 6 months after operation and mild degenerative change in 1 patient at 18 months after operation. The Broberg and Morrey elbow performance score was 82 points (range, 58-98 points). The results were excellent in 6 patients, good in 4, fair in 1 and poor in 1, with excellence rate of 83.3%. The results showed that the combined posterolateral and anteromedial approaches can facilitate the reduction and fixation of terrible triad of the elbow. Repair of radial head, coronoid, medial and lateral collateral ligaments can sufficiently restore the elbow stability, allow early postoperative motion and enhance the functional recovery.	[Chen, Hong-wei; Zhao, Gang-sheng] Cent Hosp Yiwu City, Dept Orthoped, Yiwu 322000, Peoples R China; [Liu, Guo-dong] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing 400042, Peoples R China; [Ou, Shan] Chengdu Mil Command, Dept Anesthesiol, Gen Hosp, Chengdu 610083, Peoples R China; [Fei, Jun] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Traumat Ctr, Chongqing 400042, Peoples R China; [Wu, Li-jun] Wenzhou Med Coll, Digital Med Res Inst, Wenzhou 325027, Peoples R China; [Pan, Jun] Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthoped, Wenzhou 325027, Peoples R China		Liu, GD (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing 400042, Peoples R China.	frankliugd@163.com					Beingessner DM, 2007, J SHOULDER ELB SURG, V16, P213, DOI 10.1016/j.jse.2006.06.015; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Doornberg JN, 2007, J SHOULDER ELB SURG, V16, P667, DOI 10.1016/j.jse.2007.03.013; Egol KA, 2007, BULL HOSP JT DIS, V65, P263; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Garrigues GE, 2011, J BONE JOINT SURG AM, V93A, P1873, DOI 10.2106/JBJS.I.01673; Kalicke T, 2007, ARCH ORTHOP TRAUM SU, V127, P925, DOI 10.1007/s00402-007-0424-6; Kraig YB, 2006, J HAND THER, V19, P114; Mathew PK, 2009, J AM ACAD ORTHOP SUR, V17, P137, DOI 10.5435/00124635-200903000-00003; McKee MD, 2003, J SHOULDER ELB SURG, V12, P391, DOI 10.1016/S1058-2746(03)00027-2; McKee MD, 2001, SKELETAL TRAUMA, P1455; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Pai V, 2009, J Orthop Surg (Hong Kong), V17, P31; Papandrea RF, 2007, J SHOULDER ELB SURG, V16, P68, DOI 10.1016/j.jse.2006.03.011; Reichel Lee M, 2012, Tech Hand Up Extrem Surg, V16, P98, DOI 10.1097/BTH.0b013e31824e6a74; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; Rodriguez-Martin J, 2011, INT ORTHOP, V35, P851, DOI 10.1007/s00264-010-1024-6; Seth D, 2013, ORTHOP CLIN N AM, V44, P47, DOI [10.1016/j.ocl.2012.08.006, DOI 10.1016/J.OCL.2012.08.006]; Steinmann SP, 2008, J AM ACAD ORTHOP SUR, V16, P519; Thomas K, 2007, ARCH ORTHOP TRAUMA S, V127, P925; Toros T, 2012, ACTA ORTHOP TRAUMATO, V46, P96, DOI 10.3944/AOTT.2012.2632; Zeiders GJ, 2008, J BONE JOINT SURG AM, V90A, P75, DOI 10.2106/JBJS.H.00893	23	8	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124821	10.1371/journal.pone.0124821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	WOS:000353376800108	25910196	gold, Green Submitted, Green Published			2022-02-06	
J	Chen, LJ; Wang, YJ; Chen, JR; Tseng, GF				Chen, Li-Jin; Wang, Yueh-Jan; Chen, Jeng-Rung; Tseng, Guo-Fang			NMDA receptor triggered molecular cascade underlies compression-induced rapid dendritic spine plasticity in cortical neurons	EXPERIMENTAL NEUROLOGY			English	Article						Cerebral compression; Dendritic spine; NMDA receptor; Trauma	TRAUMATIC BRAIN-INJURY; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; SYNAPSE LOSS; GLUTAMATE; TRAFFICKING; CALCINEURIN; KINASE; MODEL; ACTIVATION	Compression causes the reduction of dendritic spines of underlying adult cortical pyramidal neurons but the mechanisms remain at large. Using a rat epidural cerebral compression model, dendritic spines on the more superficial-lying layer III pyramidal neurons were found quickly reduced in 12 h, while those on the deep-located layer V pyramidal neurons were reduced slightly later, starting 1 day following compression. No change in the synaptic vesicle markers synaptophysin and vesicular glutamate transporter 1 suggest no change in afferents. Postsynaptically, N-methyl-D-aspartate (NMDA) receptor trafficking to synaptic membrane was detected in 10 min and lasting to 1 day after compression. Translocation of calcineurin to synapses and enhancement of its enzymatic activity were detected within 10 min as well. These suggest that compression rapidly activated NMDA receptors to increase postsynaptic calcium, which then activated the phosphatase calcineurin. In line with this, dephosphorylation and activation of the actin severing protein cofilin, and the consequent depolymerization of actin were all identified in the compressed cortex within matching time frames. Antagonizing NMDA receptors with MK801 before compression prevented this cascade of events, including NR1 mobilization, calcineurin activation and actin depolymerization, in the affected cortex. Morphologically, MK801 pretreatment prevented the loss of dendritic spines on the compressed cortical pyramidal neurons as well. In short, we demonstrated, for the first time, mechanisms underlying the rapid compression-induced cortical neuronal dendritic spine plasticity. In addition, the mechanical force of compression appears to activate NMDA receptors to initiate a rapid postsynaptic molecular cascade to trim dendritic spines on the compressed cortical pyramidal neurons within half a day. (C) 2015 Elsevier Inc. All rights reserved.	[Chen, Li-Jin; Wang, Yueh-Jan; Tseng, Guo-Fang] Tzu Chi Univ, Coll Med, Dept Anat, Hualien 97004, Taiwan; [Chen, Jeng-Rung] Natl Chung Hsing Univ, Dept Vet Med, Coll Vet Med, Taichung 40227, Taiwan		Tseng, GF (corresponding author), Tzu Chi Univ, Coll Med, Dept Anat, 701,Sect 3,Jhongyang Rd, Hualien 97004, Taiwan.	guofang@mail.tcu.edu.tw		Chen, Jeng-Rung/0000-0002-4429-283X	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC101-2320-B-320-001-MY3]; Tzu Chi University [TCIRP 101004]	This work was supported by grants from the National Science Council of Taiwan to GFT (NSC101-2320-B-320-001-MY3), and from Tzu Chi University to LJC, YJW and GFT (TCIRP 101004).	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bock J, 1999, P NATL ACAD SCI USA, V96, P2485, DOI 10.1073/pnas.96.5.2485; Bullock M.R., 2006, NEUROSURGERY, V58; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chen JR, 2010, NEUROSCIENCE, V167, P414, DOI 10.1016/j.neuroscience.2010.02.028; Chen JR, 2009, CEREB CORTEX, V19, P2719, DOI 10.1093/cercor/bhp048; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Ding MC, 2008, NEUROSCIENCE, V154, P551, DOI 10.1016/j.neuroscience.2008.03.088; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Gardoni F, 2009, NEUROSCIENCE, V158, P324, DOI 10.1016/j.neuroscience.2008.07.068; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; GARRAGHTY PE, 1991, P NATL ACAD SCI USA, V88, P6976, DOI 10.1073/pnas.88.16.6976; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; GLOBUS A, 1966, NATURE, V212, P463, DOI 10.1038/212463a0; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Halpain S, 1998, J NEUROSCI, V18, P9835; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Huang L, 2001, J NEUROPHYSIOL, V86, P1179, DOI 10.1152/jn.2001.86.3.1179; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; IKONOMIDOU C, 1989, J NEUROSCI, V9, P1693; Kloda A, 2007, P NATL ACAD SCI USA, V104, P1540, DOI 10.1073/pnas.0609649104; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lin Y, 2006, P NATL ACAD SCI USA, V103, P19902, DOI 10.1073/pnas.0609924104; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; OLNEY JW, 1971, J NEUROPATH EXP NEUR, V30, P75, DOI 10.1097/00005072-197101000-00008; PALLEN CJ, 1985, ARCH BIOCHEM BIOPHYS, V237, P281, DOI 10.1016/0003-9861(85)90279-6; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; PARNAVELAS JG, 1974, NATURE, V248, P71, DOI 10.1038/248071a0; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rumi-Masante J, 2012, J MOL BIOL, V415, P307, DOI 10.1016/j.jmb.2011.11.008; RUTLEDGE LT, 1972, BRAIN RES, V41, P249, DOI 10.1016/0006-8993(72)90501-X; Sanchez-Mendoza E, 2010, J NEUROCHEM, V113, P1343, DOI 10.1111/j.1471-4159.2010.06707.x; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SPACEK J, 1987, ACTA NEUROPATHOL, V73, P77; Toyota S, 2001, J NEUROTRAUM, V18, P1349, DOI 10.1089/08977150152725641; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Yan JZ, 2011, J BIOL CHEM, V286, P25187, DOI 10.1074/jbc.M110.192708; Yang HY, 2006, EXP NEUROL, V200, P262, DOI 10.1016/j.expneurol.2006.02.007; Zhang H, 2001, CLIN CHEM, V47, P1458	64	8	8	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2015	266						86	98		10.1016/j.expneurol.2015.02.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG1AF	WOS:000353004700009	25708984				2022-02-06	
J	Urbach, A; Brueckner, J; Witte, OW				Urbach, Anja; Brueckner, Judith; Witte, Otto W.			Cortical spreading depolarization stimulates gliogenesis in the rat entorhinal cortex	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						BrdU; glia cells; proliferation; spreading depolarization	TRAUMATIC BRAIN-INJURY; PROGENITOR CELLS; CEREBRAL-CORTEX; NEUROLOGICAL DISORDERS; CELLULAR PROLIFERATION; FOCAL ISCHEMIA; DEPRESSION; NEUROGENESIS; ASTROCYTES; WIDESPREAD	Recently, we showed that cortical spreading depolarizations (CSDs) are a potent trigger of hippocampal neurogenesis. Here, we evaluated CSD-induced cytogenesis in the entorhinal cortex (EC), which provides the major afferent input to the dentate gyrus. Cortical spreading depolarizations were induced by epidural application of 3 mol/L KCl, controls received equimolar NaCl. Cytogenesis was analyzed at different time points thereafter by means of intraperitoneal 5-bromodeoxyuridine injections (day 2, 4, or days 1 to 7) and immunohistochemistry. Recurrent CSD significantly increased numbers of newborn cells in the ipsilateral EC. The majority of these cells expressed glial markers. Microglia proliferation was maximal at day 2, whereas NG2 glia and astrocytes responded for a prolonged period of time (days 2 to 4). Newborn glia remained detectable for 6 weeks after CSD. Whereas we furthermore detected newborn cells immunopositive for doublecortin, a marker for immature neuronal cells, we found no evidence for the generation of new neurons in the EC. Our results indicate that CSD is a potent gliogenic stimulus, leading to rapid and enduring changes in the glial cellular composition of the affected brain tissue. Thus, CSD facilitates ongoing structural remodeling of the directly affected cortex that might contribute to the pathophysiology of CSD-related brain pathologies.	[Urbach, Anja; Brueckner, Judith; Witte, Otto W.] Jena Univ Hosp, Hans Berger Dept Neurol, D-07747 Jena, Germany; [Witte, Otto W.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Witte, Otto W.] Univ Jena, Jena, Germany		Urbach, A (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Erlanger Allee 101-FZL, D-07747 Jena, Germany.	anja.urbach@med.uni-jena.de	Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01GI9905, 01GZ0306]; German Federal Ministry of Education and Research (DFG) [WI830/10-1]	This work was supported by the German Federal Ministry of Education and Research (BMBF, grant no. 01GI9905 and no. 01GZ0306; DFG, grant no. WI830/10-1).	Abraham H, 2001, BRAIN RES, V906, P115, DOI 10.1016/S0006-8993(01)02569-0; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; DELBIGIO MR, 1994, NEUROREPORT, V5, P639, DOI 10.1097/00001756-199401000-00027; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; Gomes C, J NEUROINFLAMMATION, V10, P16; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hinojosa AE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-77; Holmin S, 2001, NEUROSCI LETT, V314, P151, DOI 10.1016/S0304-3940(01)02292-3; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Komitova M, 2006, EXP NEUROL, V199, P113, DOI 10.1016/j.expneurol.2005.12.007; KRAIG RP, 1991, J NEUROSCI, V11, P2187; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Matsushima K, 1998, BRAIN RES, V807, P47, DOI 10.1016/S0006-8993(98)00716-1; Muramatsu H, 2004, J CEREBR BLOOD F MET, V24, P1167, DOI 10.1097/01.WCB.0000134714.38679.2C; Schroeter M, 1999, NEUROSCIENCE, V89, P1367, DOI 10.1016/S0306-4522(98)00398-4; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; SELMAJ KW, 1990, J IMMUNOL, V144, P129; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Tamura Y, 2004, NEUROSCI RES, V50, P129, DOI 10.1016/j.neures.2004.06.011; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Tamura Y, 2012, J CEREBR BLOOD F MET, V32, P1879, DOI 10.1038/jcbfm.2012.98; Thompson CS, 2005, MOL NEUROBIOL, V32, P51, DOI 10.1385/MN:32:1:051; Unekawa M, 2013, J NEUROSCI RES, V91, P578, DOI 10.1002/jnr.23184; Urbach A, 2008, STROKE, V39, P3064, DOI 10.1161/STROKEAHA.108.518076; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2; Vondran MW, GLIA, V58, P848; Xue JH, 2009, STROKE, V40, pE606, DOI 10.1161/STROKEAHA.109.560334; Yanamoto H, 2005, STROKE, V36, P1544, DOI 10.1161/01.STR.0000169903.09253.c7; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	40	8	8	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2015	35	4					576	582		10.1038/jcbfm.2014.232			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CE7NF	WOS:000352027900007	25515215	Bronze, Green Published			2022-02-06	
J	Wang, Y; Fan, R; Luo, JK; Tang, T; Xing, ZH; Xia, Z; Peng, WJ; Wang, WZ; Lv, HY; Huang, W; Liang, YZ; Yi, LZ; Lu, HM; Huang, X				Wang, Yang; Fan, Rong; Luo, Jiekun; Tang, Tao; Xing, Zhihua; Xia, Zian; Peng, Weijun; Wang, Wenzhu; Lv, Huiying; Huang, Wei; Liang, Yizeng; Yi, Lunzhao; Lu, Hongmei; Huang, Xi			An ultra high performance liquid chromatography with tandem mass spectrometry method for plasma and cerebrospinal fluid pharmacokinetics of rhein in patients with traumatic brain injury after administration of rhubarb decoction	JOURNAL OF SEPARATION SCIENCE			English	Article						Blood-brain barrier; Pharmacokinetics; Rhubarb; Traumatic brain injury; Ultra high performance liquid chromatography with tandem mass spectrometry	BARRIER PERMEABILITY; ARRAY DETECTOR; UPLC-MS/MS; ANTHRAQUINONES; EXTRACT; BLOOD; RATS; PERCUSSION; MODELS; MICE	Damage of blood-brain barrier is a common result of traumatic brain injury. This damage can open the blood-brain barrier and allow drug passage. An ultraperformance liquid chromatography with tandem mass spectrometry method was established to determine the concentration of rhein in the biofluids (plasma and cerebrospinal fluid) of patients with a compromised blood-brain barrier following traumatic brain injury after rhubarb administration. Furthermore, the pharmacokinetic profiles were analyzed. A triple-quadruple tandem mass spectrometer with electrospray ionization was used for rhein detection. The mass transition followed was m/z 283.06239.0. The calibration curve was linear in the concentration range of 10-8000 ng/mL for the biofluids. The intra- and interday precisions were less than 10%. The relative standard deviation of recovery was less than 15% in biological matrices. The pharmacokinetic data showed that rhein was rapidly transported into biofluids, and exhibited a peak concentration 1 h after rhubarb administration. The elimination rate of rhein was slow. The AUC(cerebrospinal fluid)/AUC(plasma) (AUC is area under curve) of rhein was approximately 17%, indicating that portions of rhein could pass the impaired blood-brain barrier. The method was successfully applied to quantify rhein in the biofluids of all patients. The data presented can help to guide clinical applications of rhubarb for treating traumatic brain injury.	[Wang, Yang; Fan, Rong; Luo, Jiekun; Tang, Tao; Xing, Zhihua; Xia, Zian; Peng, Weijun; Wang, Wenzhu; Huang, Wei; Huang, Xi] Cent S Univ, Xiangya Hosp, Lab Ethnopharmacol, Inst Integrated Tradit Chinese & Western Med, Changsha 410008, Hunan, Peoples R China; [Wang, Wenzhu] Johns Hopkins Univ, Sch Med, Dept Anesthesiol, Baltimore, MD USA; [Wang, Wenzhu] Johns Hopkins Univ, Sch Med, Dept Crit Care Med, Baltimore, MD USA; [Lv, Huiying] Hunan Acad Agr Sci, Hunan Agr Prod Proc Inst, Changsha, Hunan, Peoples R China; [Liang, Yizeng; Lu, Hongmei] Cent S Univ, Coll Chem & Chem Engn, Changsha 410008, Hunan, Peoples R China; [Yi, Lunzhao] Kunming Univ Sci & Technol, Yunnan Food Safety Res Inst, Kunming, Peoples R China		Huang, X (corresponding author), Cent S Univ, Xiangya Hosp, Lab Ethnopharmacol, Inst Integrated Tradit Chinese & Western Med, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	tcmhuangx59@163.com	yi, lunzhao/AAS-3256-2021; Peng, Weijun/M-5131-2014	Peng, Weijun/0000-0002-4506-0942	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303074, 81403259, 81373855, 21465016]; Natural Science Foundation of Hunan Province of ChinaNatural Science Foundation of Hunan Province [12JJ5060]	This research was supported by supported by the National Natural Science Foundation of China (n os. 81303074, 81403259, 81373855, and 21465016), and the Natural Science Foundation of Hunan Province of China (n o. 12JJ5060).	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; de Lange ECM, 2013, J PHARMACOKINET PHAR, V40, P315, DOI 10.1007/s10928-013-9301-9; Ding MY, 2003, ANAL SCI, V19, P1163, DOI 10.2116/analsci.19.1163; Fan R., 2011, MODE TRADIT CHIN MED, V13, P676; Gao FY, 2014, J PHARMACEUT BIOMED, V87, P241, DOI 10.1016/j.jpba.2013.04.006; Gau BS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-211; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; Gu JW, 2005, CHINESE MED J-PEKING, V118, P817; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hirshson CI, 2013, NEUROREHABILITATION, V32, P225, DOI 10.3233/NRE-130840; HOMMA M, 1993, LANCET, V341, P1595, DOI 10.1016/0140-6736(93)90732-V; Hou ML, 2014, MOLECULES, V19, P4058, DOI 10.3390/molecules19044058; Jiang JY, 2012, J PHARMACEUT BIOMED, V57, P19, DOI 10.1016/j.jpba.2011.09.001; [蒋心惠 Jiang Xinhui], 2003, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V23, P279; Lee JH, 2003, J ETHNOPHARMACOL, V84, P5, DOI 10.1016/S0378-8741(02)00222-2; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Miller G, 2010, SCIENCE, V328, P297, DOI 10.1126/science.328.5976.297; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Pharmacopoeia Commission of PRC, 2010, PHARMACOPOEIA PEOPLE; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Shia CS, 2011, J ETHNOPHARMACOL, V137, P1388, DOI 10.1016/j.jep.2011.08.003; Sun H, 2012, J SEP SCI, V35, P2063, DOI 10.1002/jssc.201200378; U. S. Department of Health and Human Services, 1999, GUID IND POP PHARM; Wagner KR, 2002, DEV NEUROSCI-BASEL, V24, P154, DOI 10.1159/000065703; Wang Y. S., 1990, CHIN TRADIT PATENT M, V12, P5; Wang Y, 2012, CHIN J INTEGR MED, V18, P690, DOI 10.1007/s11655-012-1053-7; Wang Y, 2011, J MED PLANTS RES, V5, P2879; Wang Zhi-peng, 2003, Zhongguo Zhongyao Zazhi, V28, P974; Wei SY, 2013, FOOD CHEM, V141, P1710, DOI 10.1016/j.foodchem.2013.04.074; Wu WJ, 2014, BIOMED CHROMATOGR, V28, P564, DOI 10.1002/bmc.3070; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhu W, 2005, AM J CHINESE MED, V33, P839, DOI 10.1142/S0192415X05003508; Zhu Wei, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1458	38	8	8	2	37	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	APR	2015	38	7					1100	1108		10.1002/jssc.201401197			9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	CG1SG	WOS:000353053700006	25598181				2022-02-06	
J	Willems, M; Sattin, D; Vingerhoets, AJJM; Leonardi, M				Willems, Michelle; Sattin, Davide; Vingerhoets, Ad J. J. M.; Leonardi, Matilde			Longitudinal Changes in Functioning and Disability in Patients with Disorders of Consciousness: The Importance of Environmental Factors	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; INTENSIVE REHABILITATION IMPROVE; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM OUTCOMES; MULTIDISCIPLINARY REHABILITATION; STROKE MORTALITY; NATURAL-HISTORY; MEDICAL ASPECTS; LATE RECOVERY	Disorders of consciousness are neurological conditions associated with low levels of functioning which pose a serious challenge to public health systems. The current study aimed to examine longitudinal changes in functioning in patients with disorders of consciousness and to identify associated biopsychosocial factors using the International Classification of Functioning, Disability, and Health. An Italian sample of 248 patients was assessed longitudinally. Differences in relative variability (an index of change that controls for baseline levels) between acute and chronic patients and predictors of relative variability in "Activities & Participation" were examined. Results showed that there were subgroups of patients whose functioning improved over time. The number of problems in "Activities & Participation" decreased in acute patients over time, whereas in chronic patients, an increase was found. The significant difference in relative variability for the environmental factor "support and relationships" reflects the increase in facilitators in acute patients, whereas the number of facilitators in chronic patients remained unchanged over time. Age at event, time from event, and relative variability in "Environmental Factors" were significant predictors of relative variability in "Activities & Participation". It is of clinical relevance that patients with disorders of consciousness are kept in a supportive and facilitative environment, in order to prevent a decline in their functioning. Moreover, caregivers should receive tailored support in order to enhance and facilitate appropriate care of patients with disorders of consciousness.	[Willems, Michelle; Sattin, Davide; Leonardi, Matilde] Ist Ricovero & Cura Carattere Sci IRCCS Fdn, Neurol Inst Carlo Besta, Sci Directorate, Neurol,Publ Hlth,Disabil Unit, I-20133 Milan, Italy; [Willems, Michelle; Vingerhoets, Ad J. J. M.] Tilburg Univ, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands		Willems, M (corresponding author), Ist Ricovero & Cura Carattere Sci IRCCS Fdn, Neurol Inst Carlo Besta, Sci Directorate, Neurol,Publ Hlth,Disabil Unit, Via Celoria 11, I-20133 Milan, Italy.	michelle.willems@istituto-besta.it; davide.sattin@istituto-besta.it; vingerhoets@uvt.nl; leonardi@istituto-besta.it	Sattin, Davide/K-5963-2016; leonardi, matilde/J-9997-2018	Sattin, Davide/0000-0001-7736-4337; leonardi, matilde/0000-0003-0552-8923	Italian Ministry of Health-Centre for Disease Control and Prevention (CCM) of the Italian national project "Functioning and disability in patients in vegetative state and minimally conscious state" [DGPREV/P/145021/F.3.a.d/282 - 2008]; PRECIOUS-Taking care of people with acquired severe brain injury [DGPREV/I/F.3.a.d/2010/411 - 2010]; People Programme (Marie Curie Actions) of the European Union under REA [316795]	The research leading to these results has received funding from (1) the Italian Ministry of Health-Centre for Disease Control and Prevention (CCM) in the framework of the Italian national project "Functioning and disability in patients in vegetative state and minimally conscious state" (grant number DGPREV/P/145021/F.3.a.d/282 - 2008), coordinated by Neurological Institute "Carlo Besta" Foundation, (2) "PRECIOUS-Taking care of people with acquired severe brain injury" (grant number DGPREV/I/F.3.a.d/2010/411 - 2010), coordinated by Region of Emilia Romagna [prof. Nino Basaglia and prof. Salvatore Ferro], and (3) the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA grant agreement no 316795 (MARATONE), which also covered the costs to publish in open access.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Bell T N, 1986, J Neurosci Nurs, V18, P279; Bennett J. O., 2010, USING UNDERSTANDING; Bernat JL, 2010, NEUROLOGY, V75, P206, DOI 10.1212/WNL.0b013e3181e8e960; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bickenbach JE, 1999, SOC SCI MED, V48, P1173, DOI 10.1016/S0277-9536(98)00441-9; Chiambretto P, 2010, BRAIN INJURY, V24, P581, DOI 10.3109/02699051003610490; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; DeFina PA, 2010, RESTOR NEUROL NEUROS, V28, P769, DOI 10.3233/RNN-2010-0548; Di Carlo A, 2003, CEREBROVASC DIS, V16, P141, DOI 10.1159/000070594; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Eilander HJ, 2013, J PEDIATR REHAB MED, V6, P73, DOI 10.3233/PRM-130241; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giovannetti AM, 2013, ACTA NEUROL SCAND, V127, P10, DOI 10.1111/j.1600-0404.2012.01666.x; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kuehlmeyer K, 2013, BIOETHICA FORUM, V2013, P137; Kunst AE, 2011, STROKE, V42, P2126, DOI 10.1161/STROKEAHA.110.599712; Latronico N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018706; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Leonardi M, 2014, INT J REHABIL RES, V37, P197, DOI 10.1097/MRR.0000000000000051; Leonardi M, 2013, BRAIN INJURY, V27, P473, DOI 10.3109/02699052.2012.750758; Leonardi M, 2012, INT J REHABIL RES, V35, P352, DOI 10.1097/MRR.0b013e328356425d; Leonardi M, 2009, DISABIL REHABIL, V31, pS128, DOI 10.3109/09638280903317765; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Montagnino BA, 2007, PEDIATR CRIT CARE ME, V8, P440, DOI 10.1097/01.PCC.0000282172.11035.A6; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Owen AM, 2009, PROG BRAIN RES, V177, P399, DOI 10.1016/S0079-6123(09)17728-2; Pagani M, 2014, CLIN PSYCHOL PSYCHOT, V21, P420, DOI 10.1002/cpp.1848; Racine E, 2008, AM J BIOETHICS, V8, P13, DOI 10.1080/15265160802318238; Racine E, 2010, CAN J NEUROL SCI, V37, P758, DOI 10.1017/S0317167100051416; Redon J, 2011, EUR HEART J, V32, P1424, DOI 10.1093/eurheartj/ehr045; Sattin D, 2014, EUR J PHYS REHAB MED, V50, P309; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Sheon S. L., 2013, J NEUROL NEUROPHYSIO, V4, DOI [10.4172/2155-9562.1000163, DOI 10.4172/2155-9562.1000163]; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Wijdicks EFM, 2006, MAYO CLIN PROC, V81, P1332, DOI 10.4065/81.10.1332; World Health Organization, 2007, INT CLASS FUNCT DIS; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; Zhu XL, 2001, BRIT J NEUROSURG, V15, P464, DOI 10.1080/02688690120097688	62	8	8	1	14	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2015	12	4					3707	3730		10.3390/ijerph120403707			24	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CG7MT	WOS:000353488500020	25837348	gold, Green Published, Green Submitted			2022-02-06	
J	Guo, Y; Yuan, H; Jiang, LL; Yang, JL; Zeng, T; Xie, KQ; Zhang, CL; Zhao, XL				Guo, Ying; Yuan, Hua; Jiang, Lulu; Yang, Junlin; Zeng, Tao; Xie, Keqin; Zhang, Cuili; Zhao, Xiulan			Involvement of decreased neuroglobin protein level in cognitive dysfunction induced by 1-bromopropane in rats	BRAIN RESEARCH			English	Article						1-Bromopropane; Neurotoxicity; Oxidative stress; Neuroglobin	MORRIS WATER MAZE; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; PC12 CELLS; GLUTATHIONE; MEMORY; APOPTOSIS; HIPPOCAMPUS; ACTIVATION; EXPOSURE	1-Bromopropane (1-BP) is used as a substitute for ozone-depleting solvents (ODS) in industrial applications. 1-BP could display central nervous system (CNS) neurotoxicity manifested by cognitive dysfunction. Neuroglobin (Ngb) is an endogenous neuroprotectant and is predominantly expressed in the nervous system. The present study aimed to investigate Ngb involvement in CNS neurotoxicity induced by 1-BP in rats. Male Wistar rats were randomly divided into 5 groups (n=14) and treated with 0, 100, 200, 400 and 800 mg/kg bw 1-BP, respectively, by gavage for consecutive 12 days. Rats displayed cognitive dysfunction dose-dependently through Morris water maze (MWM) test. Significant neuron loss in layer 5 of the prelimbic cortex (PL) was observed. Moreover, 1-BP decreased Ngb protein level in cerebral cortex and Ngb decrease was significantly positively correlated with cognitive dysfunction. Glutathione (GSH) content, GSH/oxidized glutathione (GSSG) ratio and glutamate cysteine ligase (GCL) activity decreased in cerebral cortex, coupled with the increase in GSSG content. GSH and GSH/GSSG ratio decrease were significantly positively correlated with cortical Ngb decrease. Additionally, levels of N-epsilon-hexanoyl-lysine (HEL) and 4-hydroxy-2-nonenal (4-HNE) modified proteins in cerebral cortex of 1-BP-treated rats increased significantly. In conclusion, it was suggested that 1-BP resulted in decreased endogenous neuroprotectant Ngb in cerebral cortex, which might play an important role in CNS neurotoxicity induced by 1-BP and that 1-BP-induced oxidative stress in cerebral cortex might partly be responsible for Ngb decrease. (C) 2014 Elsevier B.V. All rights reserved.	[Guo, Ying; Yuan, Hua; Jiang, Lulu; Yang, Junlin; Zeng, Tao; Xie, Keqin; Zhang, Cuili; Zhao, Xiulan] Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China		Zhao, XL (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Toxicol, 44 West Wenhua Rd, Jinan 250100, Shandong, Peoples R China.	zhao.xl@sdu.edu.cn	Jiang, Lulu/ABA-8619-2020; Jiang, Lulu/AAH-7079-2021	Jiang, Lulu/0000-0002-6918-6777	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172708]; Shandong Science and Technology Research Project [2011GSF11814]	This research was supported by National Natural Science Foundation of China (81172708) and Shandong Science and Technology Research Project (2011GSF11814). We thank Ruirui Cou and Shasha Wang (Institute of Toxicology, School of Public Health, Shandong University, Jinan, China) for their assistance with western blot assays.	An L, 2012, PHARMACOL BIOCHEM BE, V102, P196, DOI 10.1016/j.pbb.2012.04.009; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; BOUBLIK T, 1984, VAPOUR PRESSURE PURE; Brittain Thomas, 2012, Cells, V1, P1133, DOI 10.3390/cells1041133; Brittain T, 2010, IUBMB LIFE, V62, P878, DOI 10.1002/iub.405; Brown RW, 2000, PHARMACOL BIOCHEM BE, V67, P473, DOI 10.1016/S0091-3057(00)00398-1; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, NEWS PHYSIOL SCI, V19, P110, DOI 10.1152/nips.01513.2003; Chang JW, 2011, OXID STRESS APPL BAS, P211, DOI 10.1007/978-1-60761-956-7_9; Chen LM, 2012, J NEUROCHEM, V120, P157, DOI 10.1111/j.1471-4159.2011.07275.x; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; Dean O, 2009, BEHAV BRAIN RES, V198, P258, DOI 10.1016/j.bbr.2008.11.017; Fago A, 2008, IUBMB LIFE, V60, P398, DOI 10.1002/iub.35; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Garner CE, 2006, TOXICOL APPL PHARM, V215, P23, DOI 10.1016/j.taap.2006.01.010; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Honma T, 2003, NEUROTOXICOLOGY, V24, P563, DOI 10.1016/S0161-813X(03)00049-4; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Huang ZL, 2012, TOXICOL APPL PHARM, V263, P44, DOI 10.1016/j.taap.2012.05.021; Huang ZL, 2011, TOXICOL APPL PHARM, V257, P93, DOI 10.1016/j.taap.2011.08.023; Ichihara G, 2004, ENVIRON HEALTH PERSP, V112, P1319, DOI 10.1289/ehp.6995; Ichihara G, 2002, J OCCUP HEALTH, V44, P1, DOI 10.1539/joh.44.1; Ichihara G, 2000, TOXICOL SCI, V55, P116, DOI 10.1093/toxsci/55.1.116; Kato Y, 2004, FREE RADICAL BIO MED, V37, P1864, DOI 10.1016/j.freeradbiomed.2004.09.007; Kato Y, 2010, ARCH BIOCHEM BIOPHYS, V501, P182, DOI 10.1016/j.abb.2010.06.010; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Liu HL, 2004, ANN NY ACAD SCI, V1019, P346, DOI 10.1196/annals.1297.059; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Majersik JJ, 2007, CLIN TOXICOL, V45, P270, DOI 10.1080/15563650701226218; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; National Toxicology Program (NTP), 2014, NIH PUBLICATION; Nelson DD, 1997, J PHYS CHEM A, V101, P4987, DOI 10.1021/jp970874g; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; OSHA/NIOSH, 2014, DHHS NIOSH PUBL, V2013-150; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Paxinos G., 2004, RAT NERVOUS SYSTEM; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Rinwa P, 2012, BRAIN RES, V1488, P38, DOI 10.1016/j.brainres.2012.10.002; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schirmer R.H., 1989, COENZYMES COFACTORS, P553; Schmidt M. M., 2012, NEURAL METABOLISM VI, V4, P1029; Sclar G, 1999, CLIN NEUROL NEUROSUR, V101, P199, DOI 10.1016/S0303-8467(99)00034-7; Shukitt-Hale B, 1998, FREE RADICAL BIO MED, V24, P1149, DOI 10.1016/S0891-5849(97)00399-7; Subramanian K, 2012, TOXICOLOGY, V302, P18, DOI 10.1016/j.tox.2012.07.006; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; Yabuki Y, 2013, NEUROSCIENCE, V250, P394, DOI 10.1016/j.neuroscience.2013.07.017; Yamashita T, 2014, CHEM PHARM BULL, V62, P613, DOI 10.1248/cpb.c13-00183; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yu ZY, 2009, NEUROL RES, V31, P122, DOI 10.1179/174313209X389866; Zeng T, 2012, TOXICOLOGY, V296, P56, DOI 10.1016/j.tox.2012.03.005; Zhang JF, 2014, NEURON, V82, P195, DOI 10.1016/j.neuron.2014.01.043; Zhong ZX, 2013, TOXICOLOGY, V306, P16, DOI 10.1016/j.tox.2013.01.022	74	8	11	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 10	2015	1600						1	16		10.1016/j.brainres.2014.12.046			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CF7OR	WOS:000352746700001	25557405				2022-02-06	
J	Arain, M; Khan, M; Craig, L; Nakanishi, ST				Arain, Marium; Khan, Maida; Craig, Laura; Nakanishi, Stan T.			Cannabinoid agonist rescues learning and memory after a traumatic brain injury	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							BEHAVIOR; MODEL; RAT; MITOCHONDRIAL; EXPRESSION; 2-AG; MAZE	Traumatic brain injury can cause persistent challenges including problems with learning and memory. Previous studies suggest that the activation of the cannabinoid 1 receptor after a traumatic brain injury could be beneficial. We tested the hypothesis that posttraumatic brain injury administration of a cannabinoid 1 receptor agonist can rescue deficits in learning and memory. Young adult male rats were subjected to a moderately severe controlled cortical impact brain injury, with a subset given postinjury i.p. injections of a cannabinoid receptor agonist. Utilizing novel object recognition and the morris water task, we found that the brain-injured animals treated with the agonist showed a marked recovery.	[Arain, Marium; Khan, Maida; Nakanishi, Stan T.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Craig, Laura] Univ Calgary, Regenerat Unit, Neurobiol Core Facil, Calgary, AB, Canada; [Nakanishi, Stan T.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA		Nakanishi, ST (corresponding author), Univ Hawaii, Dept Biol, Hilo, HI 96720 USA.	stn@hawaii.edu					Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Blair RE, 2009, NEUROPHARMACOLOGY, V57, P208, DOI 10.1016/j.neuropharm.2009.06.007; Blokland A, 2012, BEHAV BRAIN RES, V228, P16, DOI 10.1016/j.bbr.2011.11.042; Breivogel CS, 2009, INT REV PSYCHIATR, V21, P113, DOI 10.1080/09540260902782760; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Mathison R, 2004, BRIT J PHARMACOL, V142, P1247, DOI 10.1038/sj.bjp.0705889; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Prevention CfDCa, 2010, TRAUMATIC BRAIN INJU; Rudenko V, 2012, PHARMACOL BIOCHEM BE, V100, P474, DOI 10.1016/j.pbb.2011.10.005; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Vera G, 2013, PHARMACOL BIOCHEM BE, V105, P205, DOI 10.1016/j.pbb.2013.02.008; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; WHIMBEY AE, 1967, J COMP PHYSIOL PSYCH, V63, P500, DOI 10.1037/h0024620; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Zoppi S, 2011, NEUROPSYCHOPHARMACOL, V36, P805, DOI 10.1038/npp.2010.214	25	8	8	1	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	MAR	2015	2	3					289	294		10.1002/acn3.163			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ3BY	WOS:000366980300007	25815355	Green Published, gold			2022-02-06	
J	Lenell, S; Nyholm, L; Lewen, A; Enblad, P				Lenell, Samuel; Nyholm, Lena; Lewen, Anders; Enblad, Per			Updated periodic evaluation of standardized neurointensive care shows that it is possible to maintain a high level of favorable outcome even with increasing mean age	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Standardized neurosurgical intensive care; Periodic evaluation; Outcome; Quality register	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; AGGRESSIVE TREATMENT; MANAGEMENT; COUNTY; SCALE	Periodic evaluation of neurointensive care (NIC) is important. There is a risk that quality of daily care declines and there may also be unrecognized changes in patient characteristics and management. The aim of this work was to investigate the characteristics and outcome for traumatic brain injury (TBI) patients in the period 2008-2009 in comparison with 1996-1997 and to some extent also with earlier periods. TBI patients 16-79 years old admitted from 2008 to 2009 were selected for the study. Glasgow Coma Scale Motor score at admission (GCS M), radiology, surgery, and outcome (Glasgow Outcome Extended Scale) were collected from Uppsala Traumatic Brain Injury Register. The study included 148 patients (mean age, 45 years). Patients > 60 years old increased from 16 % 1996-1997 to 30 % 2008-2009 (p < 0.01). The proportion of GCS M 4-6 were similar, 92 vs. 93 % (NS). In 1996-1997 patients, 73 % had diffuse injury (Marshall classification) compared to 77 % for the 2008-2009 period (NS). More patients underwent surgery during 2008-2009 (43 %) compared to 1996-1997 (32 %, p < 0.05). Good recovery increased and mortality decreased substantially from 1980-1981 to 1987-1988 and to 1996-1997, but then the results were unchanged in the 2008-2009 period, with 73 % favorable outcome and 11 % mortality. Mortality increased in GCS M 6-4, from 2.8 % in 1996-1997 to 10 % in 2008-2009 (p < 0.05); most of the patients that died had aggravating factors, e.g., high age, malignancy. A large-proportion favorable outcome was maintained despite that patients > 60 years with poorer prognosis doubled, indicating that the quality of NIC has increased or at least is unchanged. More surgery may have contributed to maintaining the large proportion of favorable outcome. For future improvements, more knowledge about TBI management in the elderly is required.	[Lenell, Samuel; Nyholm, Lena; Lewen, Anders; Enblad, Per] Uppsala Univ, Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden		Lenell, S (corresponding author), Uppsala Univ, Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden.	samuel.lenell@akademiska.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Lenell, Samuel/0000-0001-8914-5086	Swedish Research CouncilSwedish Research CouncilEuropean Commission	The study was supported by grants from the Swedish Research Council.	ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Nordstrom C H, 1989, Brain Inj, V3, P267, DOI 10.3109/02699058909029640; Nyholm L, 2012, ISRN NEUROL, V2012; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Skoglund K, 2014, NEUROCRIT CARE, V20, P413, DOI 10.1007/s12028-013-9876-4; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	18	8	8	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2015	157	3					417	425		10.1007/s00701-014-2329-9			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CC0LR	WOS:000350027700009	25591801				2022-02-06	
J	Pineau, H; Marchand, A; Guay, S				Pineau, Helene; Marchand, Andre; Guay, Stephane			Specificity of Cognitive and Behavioral Complaints in Post- Traumatic Stress Disorder and Mild Traumatic Brain Injury	BEHAVIORAL SCIENCES			English	Article						cognitive and behavioral complaints; PTSD; MTBI; comorbidity; depression; anxiety		Characterization of cognitive and behavioral complaints is explored in Post-traumatic stress disorder (PTSD) and mild traumatic brain injury (MTBI) samples according to the severity of PTSD, depression and general anxiety conditions. Self-reported questionnaires on cognitive and behavioral changes are administered to PTSD, MTBI, MTBI/PTSD and control groups. Confounding variables are controlled. All groups report more complaints since the traumatic event. PTSD and MTBI/PTSD groups report more anxiety symptoms, depression and complaints compared to the MTBI group. Relatives of the PTSD group confirm most of the behavioral changes reported. Results suggest the utility of self-reported questionnaires to personalize cognitive and behavioral interventions in PTSD and MTBI to cope with the impacts of the traumatic event.	[Pineau, Helene; Marchand, Andre] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Pineau, Helene] Lucie Bruneau Rehabil Ctr, Montreal, PQ H2H 1C5, Canada; [Marchand, Andre; Guay, Stephane] Inst Univ Sante Mental Montreal, Montreal, PQ H4H 1R3, Canada; [Guay, Stephane] Univ Montreal, Dept Criminol, Montreal, PQ H3C 3P8, Canada		Marchand, A (corresponding author), Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada.	hpino@hotmail.com; marchand.andre@uqam.ca; stephane.guay@umontreal.ca	Guay, Stephane/AAD-6927-2022	Guay, Stephane/0000-0001-9638-3242	Research Program in Traumatology FRSQ-AERDP-AQESS-SAAQ [9953]	This research was funded by a grant to the second author from the Research Program in Traumatology FRSQ-AERDP-AQESS-SAAQ (No. 9953).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Biddle D, 2002, BEHAV RES THER, V40, P853, DOI 10.1016/S0005-7967(01)00084-5; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blake D. D., 1998, NATL CTR POSTTRAUMAT; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gurvits TV, 2000, ARCH GEN PSYCHIAT, V57, P181, DOI 10.1001/archpsyc.57.2.181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; King NS, 2002, BRAIN INJURY, V16, P65, DOI 10.1080/02699050110088263; Knight J. A., 2004, ASSESSING PSYCHOL TR; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023	29	8	8	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-328X			BEHAV SCI-BASEL	Behav. Sci.	MAR	2015	5	1					43	58		10.3390/bs5010043			16	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	V28RL	WOS:000215444400004	25646994	Green Published, gold			2022-02-06	
J	Presson, N; Krishnaswamy, D; Wagener, L; Bird, W; Jarbo, K; Pathak, S; Puccio, AM; Borasso, A; Benso, S; Okonkwo, DO; Schneider, W				Presson, Nora; Krishnaswamy, Deepa; Wagener, Lauren; Bird, William; Jarbo, Kevin; Pathak, Sudhir; Puccio, Ava M.; Borasso, Allison; Benso, Steven; Okonkwo, David O.; Schneider, Walter			Quantifying White Matter Structural Integrity With High-Definition Fiber Tracking in Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Systems Research Symposium (MHSRS)	AUG 13-16, 2012	Fort Lauderdale, FL				DECONVOLUTION; ARCHITECTURE; LANGUAGE; MRI	There is an urgent, unmet demand for definitive biological diagnosis of traumatic brain injury (TBI) to pinpoint the location and extent of damage. We have developed High-Definition Fiber Tracking, a 3 T magnetic resonance imaging-based diffusion spectrum imaging and tractography analysis protocol, to quantify axonal injury in military and civilian TBI patients. A novel analytical methodology quantified white matter integrity in patients with TBI and healthy controls. Forty-one subjects (23 TBI, 18 controls) were scanned with the High-Definition Fiber Tracking diffusion spectrum imaging protocol. After reconstruction, segmentation was used to isolate bilateral hemisphere homologues of eight major tracts. Integrity of segmented tracts was estimated by calculating homologue correlation and tract coverage. Both groups showed high correlations for all tracts. TBI patients showed reduced homologue correlation and tract spread and increased outlier count (correlations > 2.32 SD below control mean). On average, 6.5% of tracts in the TBI group were outliers with substantial variability among patients. Number and summed deviation of outlying tracts correlated with initial Glasgow Coma Scale score and 6-month Glasgow Outcome Scale-Extended score. The correlation metric used here can detect heterogeneous damage affecting a low proportion of tracts, presenting a potential mechanism for advancing TBI diagnosis.	[Presson, Nora; Krishnaswamy, Deepa; Wagener, Lauren; Bird, William; Pathak, Sudhir; Schneider, Walter] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA; [Puccio, Ava M.; Borasso, Allison; Benso, Steven; Okonkwo, David O.; Schneider, Walter] Univ Pittsburgh, UPMC Presbyterian, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Jarbo, Kevin] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Jarbo, Kevin] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Pathak, Sudhir] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Radiol, Presbyterian Hosp 3950, Pittsburgh, PA 15213 USA		Presson, N (corresponding author), Univ Pittsburgh, Learning Res & Dev Ctr, 3939 OHara St, Pittsburgh, PA 15260 USA.			Krishnaswamy, Deepa/0000-0002-3235-1222	CDMRPUnited States Department of Defense [PT110773 (W81XH-12-2-0140)]; U.S. ArmyUnited States Department of Defense [12342013 (W81XWH-12-2-0319)]	This article was funded by CDMRP PT110773 (W81XH-12-2-0140) and U.S. Army 12342013 (W81XWH-12-2-0319).	Amunts K, 2012, TRENDS COGN SCI, V16, P418, DOI 10.1016/j.tics.2012.06.005; Catani M, 2012, THIEBAUT SCHOTTEN M; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Chmura J, 2015, MIL MED, V180, P122, DOI 10.7205/MILMED-D-14-00441; EMMETT JE, 1958, J BONE JOINT SURG AM, V40, P1169, DOI 10.2106/00004623-195840050-00025; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jian B, 2007, IEEE T MED IMAGING, V26, P1464, DOI 10.1109/TMI.2007.907552; Kaden E, 2007, NEUROIMAGE, V37, P474, DOI 10.1016/j.neuroimage.2007.05.012; Khotanlou H, 2009, FUZZY SET SYST, V160, P1457, DOI 10.1016/j.fss.2008.11.016; Koehler R, 2013, SHOULSON I COGNITIVE; Kraus MF, 2007, BRAIN, V130, P2508; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Pathak S, 2011, SOC NEUR NOV 14 2011; Risling Marten, 2010, Front Neurol, V1, P1, DOI 10.3389/fneur.2010.00001; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Tuzikov AV, 2003, PATTERN RECOGN LETT, V24, P2219, DOI 10.1016/S0167-8655(03)00049-7; Wang YB, 2013, CEREB CORTEX, V23, P2347, DOI 10.1093/cercor/bhs225; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zilles K, 1997, HUM BRAIN MAPP, V5, P218, DOI 10.1002/(SICI)1097-0193(1997)5:4<218::AID-HBM2>3.0.CO;2-6	26	8	8	0	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2015	180	3		S			109	121		10.7205/MILMED-D-14-00413			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CD3OQ	WOS:000350988500023	25747642	Bronze			2022-02-06	
J	Wszalek, JA; Turkstra, LS				Wszalek, Joseph A.; Turkstra, Lyn S.			Language Impairments in Youths With Traumatic Brain Injury: Implications for Participation in Criminal Proceedings	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; brain injury; child; criminal proceedings; juvenile crime; language	MIRANDA RIGHTS; HEAD-INJURY; ADOLESCENTS; CHILDHOOD; COMPETENCE; PREVALENCE; DISCOURSE; OUTCOMES; COMPREHENSION; OFFENDERS	As many as 30% of incarcerated juveniles have a history of traumatic brain injury (TBI). Moderate or severe TBI is associated with a high risk of impairment in language comprehension and expression, which may have profound effects on juveniles' ability to understand and express themselves in criminal proceedings. In this article, we review common language impairments in youths with TBI and discuss potential effects of these impairments on 3 stages of US criminal proceedings: (1) initial encounter with law enforcement; (2) interrogation and Miranda rights; and (3) competence to undergo trial proceedings. We then describe language assessment tools and procedures that may be helpful in legal contexts. Our aim was to inform clinicians and legal staff working with juvenile defendants with TBI, with the long-term goal of developing empirically based guidelines to ensure that juvenile defendants with TBI can fully and effectively participate in criminal proceedings.	[Wszalek, Joseph A.; Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lyn.turkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	Center for European Studies [P015B100189]	This work was supported in part by Fellowship Award P015B100189 to the first author through the Center for European Studies. The authors thank UW-Madison Law Professor David Schultz, for information related to pretrial procedures, and Drs Elena Plante and Laida Restrepo, for assistance with assessment recommendations.	[Anonymous], 2013, VIRG COLL POL SUMM B; Beckworth BP, 2013, TBI JUVENILE JUSTICE; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; GLAZE LAUREN E., 2013, CORRECTIONAL POPULAT, P1; GRISSO T, 1980, CALIF LAW REV, V68, P1134, DOI 10.2307/3480263; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Hotz G, 2002, PEDIAT TEST BRAIN IN; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Kyckelhahn Tracey, 2014, JUSTICE EXPENDITURE; La Vigne M, 2011, BREAKDOWN LANGUAGE Z; LaVigne M, HE GOT MY FACE SO I; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Mendel RA, 2011, NO PLACE KIDS CASE R, P1; Moncrieff Deborah W., 2014, Seminars in Hearing, V35, P39, DOI 10.1055/s-0033-1363523; Morse S, 1999, Pediatr Rehabil, V3, P139; National Center for Juvenile Justice, 2014, JUV ARR RAT OFF SEX; Neal H., 2008, CROSS NATL COMP YOUT; Nelson N. W., 2015, TEST INTEGRATED LANG; O'Connell MJ, 2005, LAW HUMAN BEHAV, V29, P359, DOI 10.1007/s10979-005-2965-y; Rogers R, 2008, PSYCHOL PUBLIC POL L, V14, P63, DOI 10.1037/a0013102; Rogers R, 2007, LAW HUMAN BEHAV, V31, P401, DOI 10.1007/s10979-006-9070-8; Rogers R, 2010, PSYCHOL PUBLIC POL L, V16, P300, DOI 10.1037/a0019316; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Ryba NL, 2003, PROF PSYCHOL-RES PR, V34, P499, DOI 10.1037/0735-7028.34.5.499; Semel W, 2014, CLIN EVALUATION LANG; Semel W, 2013, CLIN EVALUATION LANG; Snow PC, 2015, INT J LANG COMM DIS, V50, P1, DOI 10.1111/1460-6984.12117; Snow PC, 2012, LANG SPEECH HEAR SER, V43, P496, DOI 10.1044/0161-1461(2012/11-0065); Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Stuntz WJ, 2006, HARVARD LAW REV, V119, P780; Togher L, 2006, TOP LANG DISORD, V26, P199, DOI 10.1097/00011363-200607000-00004; Towne R.L., 1993, LANG SPEECH HEAR SER, V24, P100; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Turkstra LS, 1998, APHASIOLOGY, V12, P421, DOI 10.1080/02687039808249541; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wiig EH., 2006, CLIN EVALUATION LANG; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Wisconsin Legislative Fiscal Bureau, 2013, 57 WISC LEG FISC BUR, P1; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zetterqvist B, 2010, J PEDIATR REHAB MED, V3, P251, DOI 10.3233/PRM-2010-0137	55	8	8	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					86	93		10.1097/HTR.0000000000000130			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300011	25734839				2022-02-06	
J	Xiang, P; Zhu, L; Jiang, H; He, BP				Xiang, Ping; Zhu, Lie; Jiang, Hua; He, Bei Ping			The activation of NG2 expressing cells is downstream to microglial reaction and mediated by the transforming growth factor beta 1	JOURNAL OF NEUROIMMUNOLOGY			English	Article						NG2; NG2 expressing cells; Microglia; Lipopolysaccharide; TGF-beta 1	OLIGODENDROCYTE PRECURSOR CELLS; TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; SPINAL-CORD-INJURY; AXON GROWTH; GLIAL-CELLS; RAT-BRAIN; MINOCYCLINE; PROTEOGLYCAN; MACROPHAGES	In the present study, we investigated the mechanism of activation of NG2 expressing cells. Application of microglial inhibitors not only attenuated morphological changes but also significantly retarded increase in the number of NG2 expressing cells. Intracerebral injection of TGF-beta 1 led to a profound activation of NG2 glia as well as an earlier accumulation of NG2(+)-microglia, whilst inhibition of TGF-beta 1 Smad2/3 signalling pathway eventually attenuated their active responses. We conclude that the activation of NG2 expressing cells is an event downstream to microglial reaction and TGF-beta 1 secreted from microglia might play an important role in modulation of the function of NG2 expressing cells. (C) 2015 Elsevier B.V. All rights reserved.	[Xiang, Ping; He, Bei Ping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Zhu, Lie; Jiang, Hua] Chang Zheng Hosp, Dept Plast Surg, Shanghai, Peoples R China		He, BP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, 4 Med Dr, Singapore 117597, Singapore.	anthebp@nus.edu.sg			National Research Foundation of SingaporeNational Research Foundation, Singapore [NRF-CRP 002-082]	These studies were funded by the research grants from the National Research Foundation of Singapore (NRF-CRP 002-082).	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Asher RA, 2005, MOL CELL NEUROSCI, V29, P82, DOI 10.1016/j.mcn.2005.02.001; Asher RA, 2000, J NEUROSCI, V20, P2427; Balasingam V, 1996, J NEUROSCI, V16, P2945; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCK W, 1990, ACTA NEUROPATHOL, V80, P415; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Fan LW, 2005, J NEUROSCI RES, V82, P71, DOI 10.1002/jnr.20623; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Garcia JH, 1996, AM J PATHOL, V148, P241; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; KIEFER R, 1995, INT J DEV NEUROSCI, V13, P331; KIEFER R, 1993, EUR J NEUROSCI, V5, P775, DOI 10.1111/j.1460-9568.1993.tb00929.x; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Lehrmann E, 1998, GLIA, V24, P437, DOI 10.1002/(SICI)1098-1136(199812)24:4<437::AID-GLIA9>3.0.CO;2-X; Lemons ML, 1999, EXP NEUROL, V160, P51, DOI 10.1006/exnr.1999.7184; Li JJ, 2008, NEUROSCIENCE, V156, P662, DOI 10.1016/j.neuroscience.2008.07.061; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Peters A, 2004, J NEUROCYTOL, V33, P345, DOI 10.1023/B:NEUR.0000044195.64009.27; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; Shin WH, 2004, GLIA, V46, P142, DOI 10.1002/glia.10357; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Sugimoto K, 2014, GLIA, V62, P185, DOI 10.1002/glia.22598; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tomas-Camardiel M, 2004, NEUROBIOL DIS, V16, P190, DOI 10.1016/j.nbd.2004.01.010; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wu Z, 2007, J NEUROSCI RES, V85, P184, DOI 10.1002/jnr.21100; Wu Z, 2008, NEUROBIOL DIS, V32, P543, DOI 10.1016/j.nbd.2008.09.002; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhu L, 2010, NEUROSCIENCE, V166, P842, DOI 10.1016/j.neuroscience.2009.12.057; Zhu L, 2012, GLIA, V60, P1417, DOI 10.1002/glia.22362; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	56	8	8	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	FEB 15	2015	279						50	63		10.1016/j.jneuroim.2015.01.006			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CC1GD	WOS:000350088300010	25670001				2022-02-06	
J	Murphy, A; Huang, H; Montgomery, EB; Turkstra, LS				Murphy, A.; Huang, H.; Montgomery, E. B., Jr.; Turkstra, L. S.			Conversational turn-taking in adults with acquired brain injury	APHASIOLOGY			English	Article						language; brain injury; social; communication	SMOOTH TRANSITIONS; SOCIAL COMPETENCE; INFORMATION; IMPAIRMENT; ATTENTION	Background: Social communication problems are a major contributor to negative life outcomes for adults with brain injury, yet the basic skill deficits underlying these problems are poorly understood. Aim: To examine one aspect of social communication that may have a negative impact on social interactions: the ability to successfully take turns in a conversation. Methods & Procedures: Seventeen adults with traumatic brain injury and two with bilateral strokes, and their typical peers matched for age and sex, viewed video-recorded conversations and indicated when they could join in the conversation. Turn timing was compared between groups using a novel statistical method designed for this study. Outcomes & Results: There was a significant between-groups difference in timing of turn-taking but no significant difference in number of turns. The novel analysis method revealed between-groups differences in responding to specific conversational cues. Conclusions: Adults with brain injury may miss or misinterpret verbal and non-verbal cues to turn-taking, which could contribute to conversation partners' perceptions of impaired conversation skills in adults in this population.	[Murphy, A.; Turkstra, L. S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Huang, H.; Montgomery, E. B., Jr.] Greenville Neuromodulat Ctr, Greenville, PA USA; [Montgomery, E. B., Jr.] Thiel Coll, Dept Philosophy, Greenville, PA USA; [Montgomery, E. B., Jr.] Thiel Coll, Dept Neurosci, Greenville, PA USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	Walker Fund at the University of Wisconsin-Madison; Dr Sigmund Rosen Scholarship in Neurology at the University of Alabama at Birmingham	This work was supported by the Walker Fund at the University of Wisconsin-Madison, and the Dr Sigmund Rosen Scholarship in Neurology at the University of Alabama at Birmingham.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Bernicot J, 2001, INT J LANG COMM DIS, V36, P245; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Boersma P., 2012, PRAAT DOING PHONETIC; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BUDER EH, 1991, COMMUN RES, V18, P174, DOI 10.1177/009365091018002003; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; De Ruiter JP, 2006, LANGUAGE, V82, P515, DOI 10.1353/lan.2006.0130; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; DODGE KA, 1986, MONOGR SOC RES CHILD, V51, P1; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Faul M, 2010, TRAUMATIC BRAIN INJU; Heldner M, 2010, J PHONETICS, V38, P555, DOI 10.1016/j.wocn.2010.08.002; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Magyari L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00376; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCDONALD S, 1999, COMMUNICATION DISORD; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; STEPHENS J, 1986, J LANG SOC PSYCHOL, V5, P119, DOI DOI 10.1177/0261927X8652003; STRUCHEN M, 2003, SOCIAL COMMUNICATION; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; WALKER MB, 1982, J SOC PSYCHOL, V117, P305, DOI 10.1080/00224545.1982.9713444; WALKER MB, 1982, J PSYCHOL, V110, P31, DOI 10.1080/00223980.1982.9915322	35	8	8	1	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	FEB 1	2015	29	2					151	168		10.1080/02687038.2014.959411			18	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	AS9HA	WOS:000344552600002					2022-02-06	
J	Orakcioglu, B; Kentar, MM; Schiebel, P; Uozumi, Y; Unterberg, A; Sakowitz, OW				Orakcioglu, Berk; Kentar, Modar M.; Schiebel, Patrick; Uozumi, Yoichi; Unterberg, Andreas; Sakowitz, Oliver W.			Perihemorrhagic Ischemia Occurs in a Volume-Dependent Manner as Assessed by Multimodal Cerebral Monitoring in a Porcine Model of Intracerebral Hemorrhage	NEUROCRITICAL CARE			English	Article						Experimental ICH; Ischemia; Multimodal neuromonitoring	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; TISSUE OXYGEN; INTRACRANIAL HYPERTENSION; SUBARACHNOID HEMORRHAGE; PERFUSION-PRESSURE; HEAD-INJURY; MICRODIALYSIS; PENUMBRA; EDEMA	Changes in the perihemorrhagic zone (PHZ) of intracerebral hemorrhage (ICH) are variable. Different mechanisms contribute to secondary neuronal injury after ICH. This multimodal monitoring study investigated early changes in the PHZ of ICH. Twenty-four swine were anesthetized, ventilated, and underwent monitoring of vital parameters. Next to an intracranial pressure-probe (ICP), microdialysis (MD), thermodiffusion cerebral blood flow (td-CBF), and oxygen probes (PbrO2) were placed into the gray white matter junction for 12 h of monitoring. ICH was induced using the autologous blood injection model. Pre-defined volumes were 0 ml (sham), 1.5 ml ipsilateral (1.5 ml), 3.0 ml ipsilateral (3.0 ml), and 3.0 ml contralateral (3.0 ml contra). ICP equally increased in all groups after ICH. In the 3.0 ml group tissue oxygenation decreased to ischemic values of 9 +/- A 7 mmHg early after 6 h of monitoring. This decrease was associated with a significant perfusion reduction from 36 +/- A 8 ml/100 g/min to 20 +/- A 10 ml/100 g/min. MD correlated with a threefold lactate/pyruvate ratio increase. Measurements in all other groups were unchanged. Multimodal monitoring demonstrates volume-dependent changes of tissue oxygenation, blood flow, and ischemic MD markers in the PHZ independent of increased ICP suggesting early moderate ischemia. No evidence was found for the existence of a perihemorrhagic ischemia in the small hematoma groups.	[Orakcioglu, Berk; Kentar, Modar M.; Schiebel, Patrick; Uozumi, Yoichi; Unterberg, Andreas; Sakowitz, Oliver W.] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Orakcioglu, Berk] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Uozumi, Yoichi] Kamiiida Dai Ichi Gen Hosp, Dept Neurosurg, Nagoya, Aichi, Japan		Orakcioglu, B (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Neuenheimer Feld 400, Heidelberg, Germany.	berk.orakcioglu@med.uni-heidelberg.de		Uozumi, Yoichi/0000-0002-5985-2764; Sakowitz, Oliver/0000-0003-3248-6335			Belayev L, 2003, STROKE, V34, P2221, DOI 10.1161/01.STR.0000088061.06656.1E; Beseoglu K, 2014, NEURORADIOLOGY; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; He D, 2009, INT J NEUROSCI, V119, P806, DOI 10.1080/00207450802325496; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Herweh C, 2007, STROKE, V38, P2941, DOI 10.1161/STROKEAHA.107.486977; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kirkman MA, 2013, J NEUROSURG ANESTH, V25, P228, DOI 10.1097/ANA.0b013e3182836059; Kirkman MA, 2011, J CEREBR BLOOD F MET, V31, P2135, DOI 10.1038/jcbfm.2011.124; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; MENDELOW AD, 1993, STROKE, V24, pI115; Mendelow AD, 1993, STROKE, V24, pI118; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Orakcioglu B, 2005, EXP NEUROL, V193, P369, DOI 10.1016/j.expneurol.2005.01.017; Orakcioglu B, 2011, ACTA NEUROCHIR SUPPL, V111, P19, DOI 10.1007/978-3-7091-0693-8_4; Pascual AM, 2007, CEREBROVASC DIS, V23, P6, DOI 10.1159/000095752; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Powers WJ, 2001, NEUROLOGY, V57, P18, DOI 10.1212/WNL.57.1.18; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	34	8	9	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					133	139		10.1007/s12028-014-0027-3			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300017	25052158				2022-02-06	
J	Rogers, S; Richards, KC; Davidson, M; Weinstein, AA; Trickey, AW				Rogers, Sandra; Richards, Kathy C.; Davidson, Michele; Weinstein, Ali A.; Trickey, Amber W.			Description of the Moderate Brain Injured Patient and Predictors of Discharge to Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation	ACUTE-CARE; DISPOSITION; DESTINATION; OUTCOMES	Objective: To describe patients with moderate traumatic brain injury (TBI) treated and discharged at levels I and II trauma centers in the United States; and to describe the predictors of discharge to rehabilitation after acute care. Design: Retrospective, cross-sectional, descriptive study. Setting: Trauma centers. Participants: Patients with moderate TBI (N=2087; age range, 18-64y) as reported in the 2010 National Sample Project. Interventions: None. Main Outcome Measure: Discharge destination (rehabilitation vs home with no services). Results: Multivariate logistic regression models revealed that demographic, clinical, and financial characteristics influenced the likelihood of being discharged to rehabilitation. Increased age, increased severity, Medicare use, longer length of stay, and trauma center locations in the Midwest and Northeast all increased the likelihood of discharge to rehabilitation. Conclusions: The decision to discharge a person with moderate TBI from acute care to rehabilitation appears to be based on factors other than just clinical need. These findings should be considered in creating more equitable access to postacute rehabilitation services for patients with moderate TBI because they risk long-term physical and cognitive problems and have the potential for productive lives with treatment. (C) 2015 by the American Congress of Rehabilitation Medicine	[Rogers, Sandra; Richards, Kathy C.; Davidson, Michele; Weinstein, Ali A.] George Mason Univ, Sch Nursing, Fairfax, VA 22030 USA		Rogers, S (corresponding author), George Mason Univ, 4400 Univ Dr, Fairfax, VA 22030 USA.	sgrogers11@cox.net		Richards, Kathy/0000-0002-3468-9024; Weinstein, Ali/0000-0002-3371-6086	Sigma Theta Tau International; George Mason University	Supported by a dissertation award from Sigma Theta Tau International and a dissertation completion award from George Mason University.	American College of Surgeons, 2007, RES OPT CAR INJ PAT; Bergman Karen, 2010, J Trauma Nurs, V17, P102, DOI 10.1097/JTN.0b013e3181ecc452; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; Faul M, 2010, CDC TBI US REP TRAUM; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Janus TJ, 2013, J TRAUMA NURS, V20, P102, DOI 10.1097/JTN.0b013e318296003a; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1	20	8	8	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2015	96	2					276	282		10.1016/j.apmr.2014.09.018			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CA2QF	WOS:000348751800014	25305630				2022-02-06	
J	Pickenbrock, H; Ludwig, VU; Zapf, A; Dressler, D				Pickenbrock, Heidrun; Ludwig, Vera U.; Zapf, Antonia; Dressler, Dirk			Conventional Versus Neutral Positioning in Central Neurological Disease A Multicenter Randomized Controlled Trial	DEUTSCHES ARZTEBLATT INTERNATIONAL			English	Article							TEST-RETEST RELIABILITY; PRESSURE ULCERS; STROKE PATIENTS; CONCURRENT VALIDITY; SHOULDER RANGE; HEMIPLEGIC ARM; HIP RANGE; MOTION; CONTRACTURE; PREVENTION	Background: Severe immobility due to lesions of the brain necessitates therapeutic positioning over the long term. There is little scientific evidence concerning the efficacy of different positioning methods. This clinical trial compares the effects of conventional positioning (CON) with those of positioning in neutral (LiN). Methods: A prospective, multicenter, investigator-blinded, randomized, controlled trial was performed on a total of 218 non-ambulatory patients (underlying disease: stroke, 141 patients; hypoxic brain damage, 28; traumatic brain injury, 20; other, 29). The subjects were randomly assigned to either LiN (105 patients) or CON (113 patients) and stratified within each of these two positioning concepts to five different positions. They remained in the assigned positions for two hours. The primary endpoint was change in the passive range of motion (PROM) of the hip joints. Secondary endpoints were change in the PROM of the shoulder joints and patient comfort. Results: Patients in the LiN group had a significantly better PROM of the hips after positioning than those in the CON group (difference, 12.84 degrees; p<0.001; 95% confidence interval [CI], 5.72 degrees-19.96 degrees). The same was true for PROM of shoulder flexion (11.85 degrees; p<0.001; 95% CI, 4.50 degrees-19.19 degrees) and external rotation (7.08 degrees; p<0.001; 95% CI: 2.70 degrees-11.47 degrees). 81% of patients in the LiN group reported their comfort level as good, compared to only 38% in the CON group (p<0.001). Conclusion: Positioning severely immobilized patients in LiN for two hours improved passive hip and shoulder mobility and patient comfort compared to conventional positioning. Further studies are needed to determine whether prolonged LiN positioning might improve rehabilitation and quality of life, prevent pressure sores, or ease nursing care.	[Pickenbrock, Heidrun; Dressler, Dirk] Hannover Med Sch, Movement Disorders Sect, Dept Neurol, Hannover, Germany; [Ludwig, Vera U.] Charite, Div Mind & Brain Res, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Zapf, Antonia] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany		Pickenbrock, H (corresponding author), Hannover Med Sch, Neurol Klin, Carl Neuberg Str 1, D-30625 Hannover, Germany.	pickenbrock.heidrun@mh-hannover.de	Ludwig, Vera/AAU-9389-2020				Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; Aries MJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002960; Asplund K, 1997, STROKE, V28, P2139, DOI 10.1161/01.STR.28.11.2139; Barr J, 2003, COCHRANE DB SYST REV, V4; Bobath B, 1990, ADULT HEMIPLEGIA EVA, P76; BOHANNON RW, 1986, ARCH PHYS MED REHAB, V67, P514; Borisova Y, 2009, CLIN REHABIL, V23, P681, DOI 10.1177/0269215509334841; Burk RS, 2012, HEART LUNG, V41, P536, DOI 10.1016/j.hrtlng.2012.05.008; CARR EK, 1992, INT J NURS STUD, V29, P355, DOI 10.1016/0020-7489(92)90014-8; Davies PM, 2000, STEPS FOLLOW COMPREH, P101; de Jong LD, 2006, CLIN REHABIL, V20, P656, DOI 10.1191/0269215506cre1007oa; De Jong LD, 2007, DISABIL REHABIL, V29, P1442, DOI 10.1080/09638280601056145; Dowswell G, 2000, J ADV NURS, V32, P286, DOI 10.1046/j.1365-2648.2000.01475.x; Eberlein-Gonska M, 2013, DTSCH ARZTEBL INT, V110, P550, DOI 10.3238/arztebl.2013.0550; Friedhoff M, 2007, PRAXIS BOBATH KONZEP, P93; Friedman LM, 1998, FUNDAMENTALS CLIN TR, P64; Gustafsson L, 2006, CLIN REHABIL, V20, P277, DOI 10.1191/0269215506cr944oa; Haarmann U, 2005, PFLEGE B, V1, P1; Hartnick A, 2006, SCHWESTER PFLEGER, V45, P39; Heuschmann PU, 2010, AKTUEL NEUROL, V37, P333, DOI 10.1055/s-0030-1248611; Holm I, 2000, Physiother Res Int, V5, P241, DOI 10.1002/pri.204; Jones A, 1998, STROKE, V29, P1612, DOI 10.1161/01.STR.29.8.1612; Klein-Tarolli E, 2008, BEWEGTES LAGERN POSI, P29; Kolber MJ, 2012, INT J SPORTS PHYS TH, V7, P306; Moore Z, 2011, J CLIN NURS, V20, P2633, DOI 10.1111/j.1365-2702.2011.03736.x; Muir Susan W, 2010, N Am J Sports Phys Ther, V5, P98; Nussbaumer S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-194; Pohl M, 2002, J NEUROL, V249, P1254, DOI 10.1007/s00415-002-0825-y; Pope PM, 1996, NEUROLOGICAL PHYSIOT, P159; Pua YH, 2008, ARCH PHYS MED REHAB, V89, P1146, DOI 10.1016/j.apmr.2007.10.028; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Schulz KF, 2011, INT J SURG, V9, P672, DOI [10.7326/0003-4819-152-11-201006010-00232, 10.1016/j.ijsu.2011.09.004]; Sullivan N, 2013, ANN INTERN MED, V158, P410, DOI 10.7326/0003-4819-158-5-201303051-00008; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	34	8	8	0	4	DEUTSCHER AERZTE-VERLAG GMBH	COLOGNE	DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY	1866-0452			DTSCH ARZTEBL INT	Dtsch. Arztebl. Int.	JAN 16	2015	112	3					35	+		10.3238/arztebl.2015.0035			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1ZF	WOS:000348707500003	25657075	Green Published			2022-02-06	
J	Johnstone, B; Bayan, S; Gutierrez, L; Lardizabal, D; Lanigar, S; Yoon, DP; Judd, K				Johnstone, Brick; Bayan, Stacey; Gutierrez, Laura; Lardizabal, David; Lanigar, Sean; Yoon, Dong Pil; Judd, Katherine			Neuropsychological correlates of forgiveness	RELIGION BRAIN & BEHAVIOR			English	Article						epilepsy; parietal lobes; neuropsychology; self-orientation; frontal lobes; forgiveness	SOCIAL DESIRABILITY; PARKINSONS-DISEASE; SELF; BRAIN; HEALTH; ANGER; TRANSCENDENCE; SPIRITUALITY; NEUROSCIENCE; PERSONALITY	A recent study of individuals with traumatic brain injury suggests that forgiveness is a neurologically based function related to decreased self-orientation associated with decreased right parietal lobe (RPL) functioning. The current study attempted to replicate these results using 23 individuals with diagnosed seizure disorders. Neuropsychological tests of bilateral frontal, temporal, and parietal lobe functioning were used as indices of cerebral integrity and correlated with a self-report measure of forgiveness. Results indicated that frontal lobe and RPL functions were significantly and negatively correlated with forgiveness. A forward linear regression indicated that only RPL functions predict unique variance in forgiveness. The results support a neuropsychological model of forgiveness that suggests it is related to: (1) decreased self-orientation associated with decreased RPL function, which is experienced as a decreased focus on the perceived wrong to the self; and (2) decreased attention associated with decreased frontal lobe functioning, which is experienced as decreased rumination associated with feeling wronged. Research and practical implications are discussed.	[Johnstone, Brick; Bayan, Stacey; Gutierrez, Laura] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA; [Lardizabal, David; Lanigar, Sean] Univ Missouri, Dept Neurol, Columbia, MO USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO USA; [Judd, Katherine] Truman State Univ, Kirksville, MO USA		Johnstone, B (corresponding author), Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA.	johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			Aftanas LI, 2001, NEUROSCI LETT, V310, P57, DOI 10.1016/S0304-3940(01)02094-8; Azari NP, 2001, EUR J NEUROSCI, V13, P1649, DOI 10.1046/j.0953-816x.2001.01527.x; Bear D. M., 1979, ARCH NEUROL-CHICAGO, V34, P454; Benedict R., 1997, BENTON VISUOSPATIAL; Benton A., 1983, JUDGEMENT LINE ORIEN; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Butler PM, 2011, BEHAV NEUROL, V24, P133, DOI [10.3233/BEN-2011-0282, 10.1155/2011/493013]; Butler PM, 2010, J INT NEUROPSYCH SOC, V16, P252, DOI 10.1017/S1355617709991202; Carson JW, 2005, J PAIN, V6, P84, DOI 10.1016/j.jpain.2004.10.012; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Delis DC., 2001, DELIS KAPLAN EXECUTI; Enright R.D., 2007, J RES ED, V17, P63; Feinberg T., 2005, LOST SELF PATHOLOGIE; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; Gassin EA, 2001, J PSYCHOL THEOL, V29, P187, DOI 10.1177/009164710102900301; Gisi TM, 2000, INT J NEUROSCI, V105, P121, DOI 10.3109/00207450009003271; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Harris AHS, 2006, J CLIN PSYCHOL, V62, P715, DOI 10.1002/jclp.20264; Heaton R. K., 2004, REVISED COMPREHENSIV; HERZOG H, 1991, NEUROPSYCHOBIOLOGY, V23, P182, DOI 10.1159/000119450; Johnstone B., 1995, APPL NEUROPSYCHOL, V2, DOI [10.1207/s15324826an0201_4, DOI 10.1207/S15324826AN0201_4]; Johnstone B, 2012, J RELIG HEALTH, V51, P1017, DOI 10.1007/s10943-012-9615-8; Johnstone B, 2012, INT J PSYCHOL RELIG, V22, P267, DOI 10.1080/10508619.2012.657524; Johnstone B, 2008, ZYGON, V43, P861, DOI 10.1111/j.1467-9744.2008.00964.x; Johnstone B, 2009, J RELIG HEALTH, V48, P146, DOI 10.1007/s10943-008-9179-9; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lundahl BW, 2008, RES SOCIAL WORK PRAC, V18, P465, DOI 10.1177/1049731507313979; Maltby J, 2001, PERS INDIV DIFFER, V30, P881, DOI 10.1016/S0191-8869(00)00080-5; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Mesulam M. M., 2000, PRINCIPLES BEHAV COG, P174; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.5.625-630; Newberg A, 1997, J NUCL MED, V38, P77; Newberg AB, 2000, FORGIVENESS, P91; Newberg Andrew I., 2005, HDB PSYCHOL RELIG SP, P199; Pronk TM, 2010, J PERS SOC PSYCHOL, V98, P119, DOI 10.1037/a0017875; Reitan RM, 1992, TRAIL MAKING TEST MA; Sandage SJ, 2001, J PSYCHOL THEOL, V29, P201, DOI 10.1177/009164710102900302; Schjoedt U, 2009, METH THEORY STUD REL, V21, P310, DOI 10.1163/157006809X460347; Thompson LY, 2005, J PERS, V73, P313, DOI 10.1111/j.1467-6494.2005.00311.x; Tranel D., 2002, HDB MEMORY DISORDERS; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; van der Walt C, 2003, INT J INTERCULT REL, V27, P251, DOI 10.1016/S0147-1767(02)00089-5; Wade NG, 2005, HDB FORGIVENESS, P423; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Witvliet CV, 2001, J PSYCHOL THEOL, V29, P212; Worthington E., 2003, FORGIVING RECONCILIN; Worthington EL, 2006, ALCOHOL TREAT Q, V24, P125, DOI 10.1300/J020v24n01_08	52	8	8	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2153-599X	2153-5981		RELIG BRAIN BEHAV	Relig. Brain Behav.	JAN 2	2015	5	1					24	35		10.1080/2153599X.2014.880069			12	Religion	Emerging Sources Citation Index (ESCI)	Religion	CI0LE	WOS:000354427800004					2022-02-06	
J	Agirbasli, M; Song, JX; Lei, FY; Wang, SG; Kunselman, AR; Clark, JB; Myers, JL; Undar, A				Agirbasli, Mehmet; Song, Jianxun; Lei, Fengyang; Wang, Shigang; Kunselman, Allen R.; Clark, Joseph B.; Myers, John L.; Uendar, Akif			Apolipoprotein E Levels in Pediatric Patients Undergoing Cardiopulmonary Bypass	ARTIFICIAL ORGANS			English	Article; Proceedings Paper	10th International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Bypass	MAY 28-31, 2014	Philadelphia, PA	Penn State Hershey Pediat Cardiovascular Res Ctr, Penn State Hershey Children's Hosp, Penn State Hershey Coll Med, Dept Pediat, Int Soc Pediat Mech Cardiopulmonary		Cardiopulmonary bypass; Apolipoprotein E levels; Pulsatile flow; Nonpulsatile flow; Pediatrics	INFANT CARDIAC-SURGERY; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; E GENOTYPE; PROTEOLYTIC CLEAVAGE; APOE; BIOMARKERS; PROTEIN; RISK	Apolipoprotein E (apoE) may play a critical role in modulating the response to neurological injury after cardiopulmonary bypass (CPB) in children. Plasma samples were collected from 38 pediatric patients. Half of the patients received nonpulsatile flow and the other half underwent pulsatile flow during CPB. Plasma samples were collected at three time points: at baseline prior to incision (T1), 1h after CPB (T2), and 24h after CPB (T3). The study included 38 pediatric patients undergoing heart surgery (mean age 2.5 +/- 2.1 years). Baseline apoE levels were low (<30g/mL) in 21 patients (55%). ApoE levels were significantly decreased at 1h after CPB compared with baseline (22 +/- 14vs. 34 +/- 18g/mL, P=0.001). At 24h after CPB, apoE levels were significantly increased compared with baseline (47 +/- 25 vs. 34 +/- 18g/mL, P=0.002). Pulsatile mode was associated with lower apoE levels at 24h after CPB compared with nonpulsatile mode (38 +/- 14 vs. 57 +/- 29g/mL, P=0.018). ApoE levels correlated negatively with pump time (r=-0.525, P=0.021) and cross-clamp time (r=-0.464, P=0.045) at 24h following CPB for the nonpulsatile group but not for the pulsatile group. In this cohort of young children with congenital heart disease, baseline apoE levels were low in the majority of patients prior to surgery. ApoE levels decreased further at 1h after CPB, and then significantly increased by 24h. The mode of perfusion and the duration of pump time and clamp time influence the apoE levels after CPB. An improved understanding of these mechanisms may translate into the development of new techniques to improve the clinical outcomes after pediatric CPB.	[Agirbasli, Mehmet] Marmara Univ, Dept Cardiol, Coll Med, Istanbul, Turkey; [Song, Jianxun; Lei, Fengyang] Penn State Hershey Childrens Hosp, Dept Microbiol & Immunol, Penn State Hershey Coll Med, Penn State Milton S Hershey Med Ctr, Hershey, PA USA; [Wang, Shigang; Kunselman, Allen R.; Clark, Joseph B.; Myers, John L.; Uendar, Akif] Penn State Hershey Childrens Hosp, Dept Pediat Publ Hlth & Sci Surg & Bioengn, Penn State Hershey Coll Med, Penn State Hershey Pediat Cardiovasc Res Ctr, Hershey, PA USA		Undar, A (corresponding author), Penn State Hershey Coll Med, Dept Pediat, H085,500 Univ Dr,POB 850, Hershey, PA 17033 USA.	aundar@psu.edu					Agirbasli M, 2005, INT J CLIN PRACT, V59, P102, DOI 10.1111/j.1742-1241.2005.00379.x; Agirbasli M, 2010, ARTIF ORGANS, V34, P987, DOI 10.1111/j.1525-1594.2010.01133.x; Agirbasli MA, 2014, ARTIF ORGANS, V38, P28, DOI 10.1111/aor.12182; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Burnham N, 2010, J THORAC CARDIOV SUR, V140, P144, DOI 10.1016/j.jtcvs.2010.01.003; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Gaynor JW, 2007, J THORAC CARDIOV SUR, V133, P1344, DOI 10.1016/j.jtcvs.2006.10.087; Gaynor JW, 2009, PEDIATRICS, V124, P241, DOI 10.1542/peds.2008-2281; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Gunn JK, 2012, INTENS CARE MED, V38, P1539, DOI 10.1007/s00134-012-2608-y; Hauser PS, 2013, CURR ALZHEIMER RES, V10, P809; Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025; Hultman K, 2013, J CEREBR BLOOD F MET, V33, P1251, DOI 10.1038/jcbfm.2013.76; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jarero-Basulto JJ, 2013, J NEUROPATH EXP NEUR, V72, P1145, DOI 10.1097/NEN.0000000000000013; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kirsch RE, 2014, J THORAC CARDIOV SUR, V147, P713, DOI 10.1016/j.jtcvs.2013.03.033; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Rohn TT, 2013, INT J MOL SCI, V14, P14908, DOI 10.3390/ijms140714908; Undar A, 2013, ARTIF ORGANS, V37, P1080, DOI [10.1111/aor.12242, 10.1111/j.1525-1594.2012.01573.x]; Vincent-Viry M, 1998, CLIN CHEM, V44, P957; Williams GD, 2007, SEMIN CARDIOTHORAC V, V11, P23, DOI 10.1177/1089253206297412	26	8	8	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	JAN	2015	39	1					28	33		10.1111/aor.12444			6	Engineering, Biomedical; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering; Transplantation	CB1FX	WOS:000349373600007	25626577				2022-02-06	
J	Barhoum, M; Tobias, S; Elron, M; Sharon, A; Heija, T; Soustiel, JF				Barhoum, Masad; Tobias, Samuel; Elron, Moshe; Sharon, Aviram; Heija, Tariq; Soustiel, Jean F.			Syria civil war: Outcomes of humanitarian neurosurgical care provided to Syrian wounded refugees in Israel	BRAIN INJURY			English	Article						Brain injury; gunshot wound; neurotrauma; penetrating brain injury; war	PENETRATING CRANIOCEREBRAL INJURIES; GUNSHOT WOUNDS; HEAD; AFGHANISTAN; EXPERIENCE; VIETNAM; BRAIN; IRAQ	Background: As an expected consequence of the civil war in Syria, emergent neurosurgical care for battlefield trauma has been provided for severely head-injured Syrians transferred to Northern Israel. Methods: Sixty-six patients suffering from brain injury were brought to the border and then referred to the institution after initial resuscitation. Both the time and type of injury were recorded based on paramedic testimony, forensic material or on details provided by patients. A retrospective analysis of all medical charts and imaging material was performed. Results: Most injuries were combat-related, either caused by blast (13.6%), shrapnel (24.2%), assault (28.8%) or gunshot wound (15.2%). Only a minority of patients (18.2%) suffered from injuries that were not directly caused by weapon. A total of 55 surgical procedures were performed in 46 out of 66 patients, including craniotomies in 40 patients, burr hole alone for placement of intraparenchymal intracranial pressure (ICP) sensor in nine instances and ventricle peritoneal shunt in two patients. Decompressive craniectomy was used only for the treatment of gunshot wound and was performed in eight out of 10 patients. The most common complication consisted in cerebrospinal fluid fistulas (16.7%). Post-operative infections occurred in seven patients (10.6%). Short-term outcomes were favourable in 60.7%, with a mortality rate of 4.5%. Discussion: The present findings suggest that aggressive surgery and neuro-intensive care measures may lead to good functional results, even in the presence of seemingly devastating injuries in some selected patients.	[Barhoum, Masad; Soustiel, Jean F.] Bar Ilan Univ, Fac Med, Safed, Israel; [Barhoum, Masad] Gen Direct, Nahariyya, Israel; [Tobias, Samuel; Elron, Moshe; Sharon, Aviram; Heija, Tariq; Soustiel, Jean F.] Dept Neurosurg, Nahariyya, Israel; [Tobias, Samuel; Elron, Moshe; Sharon, Aviram; Heija, Tariq; Soustiel, Jean F.] Galilee Med Ctr, IL-22100001 Nahariyya, Israel		Soustiel, JF (corresponding author), Galilee Med Ctr, Dept Neurosurg, POB 21, IL-22100001 Nahariyya, Israel.	jean.soustiel@naharia.health.gov.il					AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; Liebenberg WA, 2005, NEUROSURGERY, V57, P293, DOI 10.1227/01.NEU.0000166662.77797.EC; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS09324; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D	11	8	8	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	11					1370	1375		10.3109/02699052.2015.1043346			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR4MF	WOS:000361306100012	26204320				2022-02-06	
J	Carrick, FR; McLellan, K; Brock, JB; Randall, C; Oggero, E				Carrick, Frederick R.; McLellan, Kate; Brock, J. Brandon; Randall, Cagan; Oggero, Elena			Evaluation of the effectiveness of a novel brain and vestibular rehabilitation treatment modality in PTSD patients who have suffered combat-related traumatic brain injuries	FRONTIERS IN PUBLIC HEALTH			English	Article						PTSD; vestibular rehabilitation; off vertical axis rotation; DSM-IV CAPS; brain		Introduction: Blast-related head injuries are among the most prevalent injuries suffered by military personnel deployed in combat and mild traumatic brain injury (mTBI) or concussion on the battlefield in Iraq/Afghanistan has resulted in its designation as a "signature injury." Vestibular complaints are the most frequent sequelae of mTBI, and vestibular rehabilitation (VR) has been established as the most important treatment modality for this group of patients. Materials and Methods: We studied the effectiveness of a novel brain and VR treatment post-traumatic stress disorder (PTSD) in subjects who had suffered combat-related traumatic brain injuries in terms of PTSD symptom reduction. The trial was registered as ClinicalTrials.gov Identifier: NCT02003352. (http://clinicaltrials.gov/ct2/show/NCT02003352? term=carrick&rank=6). We analyzed the difference in the Clinician Administered DSM-IV PTSD Scale (CAPS) scores pre- and post-treatment using our subjects as their own matched controls. The study population consisted of 98 combat veterans maintaining an alpha of <0.05 and power of 80%. Results: Prior to treatment, 75 subjects representing 76.53 % of the sample were classified in the 2 most severe categories of PTSD. Forty-one subjects, representing 41.80 % of the total sample, were classified in the extreme category of PTSD and 34 subjects, representing 34.70 % of the total sample, were classified in the severe category of PTSD. After treatment, we observed a large reduction in CAPS severity scores with both statistical and substantive significance. Discussion: Treatment of PTSD as a physical injury rather than a psychiatric disorder is associated with strong statistical and substantive significant outcomes associated with a decrease of PTSD classification. The stigma associated with neuropsychiatric disorders may be lessened when PTSD is treated with brain and VR with a potential decrease in suffering of patients, family, and society.	[Carrick, Frederick R.; McLellan, Kate; Brock, J. Brandon; Randall, Cagan] Carrick Brain Ctr, Neurol, Dallas, TX 32920 USA; [Carrick, Frederick R.; McLellan, Kate; Brock, J. Brandon; Oggero, Elena] Carrick Inst, Neurol, Cape Canaveral, FL USA; [Carrick, Frederick R.] Harvard Med Sch, GCSRT, Boston, MA 02115 USA; [Oggero, Elena] Univ Wyoming, Elect & Comp Engn Dept, Laramie, WY 82071 USA		Carrick, FR (corresponding author), Carrick Inst, 203-8941 Lake Dr, Cape Canaveral, FL 32920 USA.	drfrcarrick@post.harvard.edu	Brock, Joel/AAZ-3439-2020	Carrick, Frederick/0000-0002-2818-6551; Oggero, Elena/0000-0002-7223-5613			Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Association A.P, 2013, DIAGN STAT MAN MENT; Auxemery Y, 2012, ENCEPHALE, V38, P329, DOI 10.1016/j.encep.2011.07.003; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 2003, BEHAV RES THER, V41, P79, DOI 10.1016/S0005-7967(01)00131-0; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Cohen J., 2013, STAT POWER ANAL BEHA; Gene-Cos N., 2005, POSTTRAUMATIC STRESS; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Hedges L.V., 1985, STAT METHODS META AN; Herdman SJ, 2013, CURR OPIN NEUROL, V26, P96, DOI 10.1097/WCO.0b013e32835c5ec4; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Honaker Julie A, 2012, Int Tinnitus J, V17, P124, DOI 10.5935/0946-5448.20120023; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; King PR, 2012, J CLIN PSYCHOL MED S, V19, P376, DOI 10.1007/s10880-012-9345-9; Leon AC, 2009, J TRAUMA STRESS, V22, P603, DOI 10.1002/jts.20466; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Marshall RD, 2001, AM J PSYCHIAT, V158, P1982, DOI 10.1176/appi.ajp.158.12.1982; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Seidler GH, 2006, PSYCHOL MED, V36, P1515, DOI 10.1017/S0033291706007963; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Williams D, 2003, PERFORM RES, V8, P1	32	8	8	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health		2015	3								15	10.3389/fpubh.2015.00015			8	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	VI6BA	WOS:000498912900015	25699246	gold, Green Published			2022-02-06	
S	Chesnut, RM		Fink, ME; Barchas, JD; Sheikh, JI		Chesnut, Randall M.			What is wrong with the tenets underpinning current management of severe traumatic brain injury?	AFFECTIVE DISORDERS AND TRAUMATIC BRAIN INJURY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	Qatar Clinical Neuroscience Conference	MAR 15-17, 2014	Doha, QATAR	Qatar Fdn Educ Sci & Community Dev			SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; COMA DATA-BANK; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; HYPERTENSION; THRESHOLD	The results of a recent randomized controlled trial comparing intracranial pressure (ICP) monitor-based treatment of severe traumatic brain injury (sTBI) to management without ICP monitoring prompt this skeptical reconsideration of the scientific foundation underlying current sTBI management. Much of current practice arises from research performed under conditions that are no longer relevant today. The definition of an episode of intracranial hypertension is incomplete, and the application of a fixed, universal ICP treatment threshold is poorly founded. Although intracranial hypertension is a valid indicator of disease severity, it remains to be demonstrated that lowering ICP improves outcome. Furthermore, sTBI has not been categorized on the basis of underlying pathophysiology despite the current capability to do so. Similar concerns also apply to manipulation of cerebral perfusion with respect to maintaining universal thresholds for contrived variables rather than tailoring treatment to monitored processes. As such, there is a failure to either optimize management approaches or minimize associated treatment risks for individual sTBI patients. The clinical and research TBI communities need to reassess many of the sTBI management concepts that are currently considered well established.	[Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Sch Global Hlth, Seattle, WA 98104 USA		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Mailstop 359766,325 Ninth Ave, Seattle, WA 98104 USA.	chesnutr@uw.edu		Chesnut, Randall/0000-0001-6377-3666			BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R., 2000, J NEUROTRAUM, V17, P591; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; De Bonis P, 2013, NEW ENGL J MED, V368, P1749, DOI 10.1056/NEJMc1301076; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Luerssen T.G., 1993, INTRACRANIAL PRESSUR, VVIII, P42; MARMAROU A, 1991, J NEUROSURG, V75, pS21, DOI 10.3171/sup.1991.75.1s.0s21; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Peterson E, 2009, J TRAUMA, V67, P944, DOI 10.1097/TA.0b013e3181ae6e6d; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SAUL TG, 1982, AM SURGEON, V48, P477; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	40	8	9	0	1	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.		2015	1345						74	82		10.1111/nyas.12482			9	Clinical Neurology; Psychiatry	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	BC7XP	WOS:000355312300009	25048398				2022-02-06	
J	Dean, D; Martinez, MS; Newgard, CD				Dean, Dylan; Martinez, Michael S.; Newgard, Craig D.			Variability in Early Do Not Attempt Resuscitation Orders Among Patients With Serious Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							DNR ORDERS; OF-LIFE; MORTALITY; CARE; MODELS; TRENDS	ObjectivesThe objective was describe the use of early do not attempt resuscitation (DNAR) orders in patients with serious traumatic brain injury (TBI) and its association with outcomes. MethodsThis was a retrospective cohort study of all serious TBI patients admitted through the emergency department (ED) to acute care hospitals in California between 2002 and 2010 using ED International Classification of Diseases, 9th revision (ICD-9), admitting diagnosis codes specifying intracranial hemorrhage. DNAR placement within 24hours of admission was the primary variable of interest. Outcomes included neurosurgical procedures and in-hospital mortality. Hospital and patient characteristics were analyzed using descriptive statistics and multivariable generalized estimation equation regression models to account for hospital-level clustering. ResultsOf all 76,962 patients with serious TBI, 71,275 were admitted at 141 hospitals that each cared for at least 10 serious TBI patients annually and formed the primary sample. Early DNAR orders were placed in 7.5% of patients (range= 0 to 36.1% by hospital). Early DNAR use varied by trauma designation: Level I, 4.0% (95% confidence interval [CI]=3.8% to 4.4%); Level II, 6.7% (95% CI=6.5% to 7.1%); Level III, 9.7% (95% CI=8.4% to 11.3%); and nontrauma hospitals, 10.8% (95% CI=10.6% to 11.3%). Early DNAR was also less likely in teaching hospitals (9.3% vs. 4.3%). These results persisted after accounting for age, year, and hospital-level clustering. In-hospital mortality (39.4% vs. 8.7%) and neurosurgical interventions (14.5% vs. 19.7%) also differed for patients with versus without early DNAR orders. Patients 65years of age and older constituted 87.7% of those with early DNAR orders; our findings remained qualitatively unchanged when restricted to older adults. ConclusionsUse of early DNAR orders among patients with serious TBI is highly variable by individual hospital and hospital type, suggesting substantial practice variation. Associations with fewer surgical intervention and higher mortality suggest that such practice variation may be contributing to differences in TBI outcomes, particularly among older adults.	[Dean, Dylan; Martinez, Michael S.; Newgard, Craig D.] Oregon Hlth & Sci Univ, Div Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA		Dean, D (corresponding author), Oregon Hlth & Sci Univ, Div Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA.	deand@ohsu.edu			NHLBI, Resuscitation Outcomes Consortium Training Grant NHLBI [K12 5K12HL108974]; OHSU; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024146, UL1RR024131, UL1RR024140, UL1RR025764, UL1RR025744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER	Supported in part through NHLBI, Resuscitation Outcomes Consortium Training Grant NHLBI K12 5K12HL108974, PI Newgard. Dr. Dean received a travel award from OHSU for presentation of data at above indicated meeting. Grants as listed awarded to Dr. Newgard for research endeavors. Dr. Newgard, an associate editor for this journal, had no role in the peer-review process or publication decision for this paper.	Brizzi M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-36; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Hemphill JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5687; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; LEMESHOW S, 1994, CRIT CARE MED, V22, P1351, DOI 10.1097/00003246-199409000-00003; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Richardson DK, 2013, ACAD EMERG MED, V20, P381, DOI 10.1111/acem.12112; Richardson DK, 2013, RESUSCITATION, V84, P483, DOI 10.1016/j.resuscitation.2012.08.327; Silvennoinen K, 2014, INT J STROKE, V9, P53, DOI 10.1111/ijs.12161; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Wade CE, 2013, J TRAUMA ACUTE CARE, V75, pS89, DOI 10.1097/TA.0b013e31828fa422; Zahuranec DB, 2010, NEUROLOGY, V75, P626, DOI 10.1212/WNL.0b013e3181ed9cc9	20	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JAN	2015	22	1					54	60		10.1111/acem.12555			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AY2WW	WOS:000347447900006	25545694	Green Accepted, Bronze			2022-02-06	
J	Doig, RLO; Fitzgerald, M				Doig, Ryan L. O'Hare; Fitzgerald, Melinda			Novel Combinations of Ion Channel Inhibitors for Treatment of Neurotrauma	DISCOVERY MEDICINE			English	Article							SPINAL-CORD-INJURY; CHRONIC SECONDARY DEGENERATION; ISCHEMIC CELL-DEATH; WHITE-MATTER INJURY; METHYL-D-ASPARTATE; LIPID-PEROXIDATION; RECEPTOR ANTAGONIST; IMPROVES RECOVERY; CALCIUM-CHANNELS; MYELINATED AXONS	Neurotrauma results in the progressive degeneration of neurons and glia surrounding the initial injury. Disruptions to myelin structure are a feature of these injuries and are thought to be triggered by excess calcium (Ca2+) influx into myelinating oligodendrocytes and/or their precursor cells. Calcium ions enter oligodendrocytes through a range of receptors including voltage gated calcium channels, N-methyl-D-aspartate (NMDA) receptors, Ca2+ permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and purinergic P2X(7) receptors. Inhibitors have been used to limit excess Ca2+ entry following neurotrauma, but clinical success has been limited. We propose that combinations of calcium channel inhibitors may provide an alternative treatment strategy, whereby entry of excess Ca2+ flux through multiple routes is inhibited simultaneously.	[Doig, Ryan L. O'Hare; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Doig, Ryan O'Hare/AAG-7585-2019; Fitzgerald, Melinda/C-4235-2011	Fitzgerald, Melinda/0000-0002-4823-8179			Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Back SA, 2001, J NEUROSCI, V21, P1302; Bakiri Y, 2008, GLIA, V56, P233, DOI 10.1002/glia.20608; Bizzozero OA, 2001, J NEUROCHEM, V76, P1129, DOI 10.1046/j.1471-4159.2001.00116.x; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; Block F, 1996, NEUROSCI LETT, V208, P41, DOI 10.1016/0304-3940(96)12545-3; Bolanos JP, 1997, J NEUROCHEM, V68, P2227; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Ehrlich M, 1999, J THORAC CARDIOV SUR, V117, P285, DOI 10.1016/S0022-5223(99)70424-1; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Fitzgerald M, 2014, NEURAL REGEN RES, V9, P1096, DOI 10.4103/1673-5374.135307; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Follett PL, 2000, J NEUROSCI, V20, P9235; FRANDSEN A, 1992, P NATL ACAD SCI USA, V89, P2590, DOI 10.1073/pnas.89.7.2590; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Graham SH, 1996, J PHARMACOL EXP THER, V276, P1; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Huang C.C., 2014, MOL NEUROBIOL; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; Jiang QB, 2000, J NEUROCHEM, V74, P2101, DOI 10.1046/j.1471-4159.2000.0742101.x; Kaptanoglu E, 2004, J CLIN NEUROSCI, V11, P879, DOI 10.1016/j.jocn.2004.04.005; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KARSCHIN A, 1988, J NEUROSCI, V8, P2895; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kennedy C., 2007, XPHARM COMPREHENSIVE, P1; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Klein KU, 2010, BEST PRACT RES-CLIN, V24, P535, DOI 10.1016/j.bpa.2010.10.008; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Minematsu T, 2008, DRUG METAB DISPOS, V36, P1496, DOI 10.1124/dmd.107.019828; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ouardouz M, 2005, NEUROPHARMACOLOGY, V48, P566, DOI 10.1016/j.neuropharm.2004.12.007; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Payne SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065710; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Petitjean ME, 1998, ANN FR ANESTH, V17, P114, DOI 10.1016/S0750-7658(98)80058-0; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Ren Y, 2000, J NEUROSCI METH, V102, P165, DOI 10.1016/S0165-0270(00)00304-6; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanli AM, 2012, TURK NEUROSURG, V22, P189, DOI 10.5137/1019-5149.JTN.5193-11.1; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Schnell L, 2011, EUR J NEUROSCI, V34, P1256, DOI 10.1111/j.1460-9568.2011.07862.x; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Shields DC, 1999, P NATL ACAD SCI USA, V96, P11486, DOI 10.1073/pnas.96.20.11486; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Sloane JA, 2003, J NEUROCHEM, V84, P157, DOI 10.1046/j.1471-4159.2003.01541.x; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Tanaka T, 2004, J AM SOC NEPHROL, V15, P2320, DOI 10.1097/01.ASN.0000138287.46849.82; Tomes Daniel J, 2002, Spine J, V2, P35, DOI 10.1016/S1529-9430(01)00151-6; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tuszynski MH, 2005, E SCHERING RES FDN W, V53, P1; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; WONG EHF, 1991, ANNU REV PHARMACOL, V31, P401; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; XUE D, 1994, J CEREBR BLOOD F MET, V14, P251, DOI 10.1038/jcbfm.1994.32; Yamada H, 2006, BRAIN RES, V1071, P75, DOI 10.1016/j.brainres.2005.11.072	80	8	8	0	0	DISCOVERY MEDICINE	TIMONIUM	10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA	1539-6509	1944-7930		DISCOV MED	Discov. Med.	JAN	2015	19	102					41	47					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CL4BA	WOS:000356896200005	25636960				2022-02-06	
J	Kim, JH; Yoo, BH; Won, SJ; Choi, BY; Lee, BE; Kim, IY; Kho, A; Lee, SH; Sohn, M; Suh, SW				Kim, Jin Hee; Yoo, Byung Hoon; Won, Seok Joon; Choi, Bo Young; Lee, Bo Eun; Kim, In Yeol; Kho, Ara; Lee, Song Hee; Sohn, Min; Suh, Sang Won			Melatonin Reduces Hypoglycemia-Induced Neuronal Death in Rats	NEUROENDOCRINOLOGY			English	Article						Hypoglycemia; Insulin; Melatonin; Rats; Zinc; Superoxide; Microglia	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; FOCAL CEREBRAL-ISCHEMIA; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; DIABETES-MELLITUS; OXIDATIVE STRESS; NADPH OXIDASE; IN-VITRO; SUPEROXIDE	Melatonin, N-aceyl-5-methoxytryptamine, is the main secretory product of the pineal gland and has neuroprotective effects on several brain injuries, including ischemic stroke. In the present study, we hypothesized that exogenous melatonin may decrease hypoglycemia-induced neuronal death through the prevention of superoxide generation. To test our hypothesis, hypoglycemia was induced by injecting human insulin (10 U/kg, i.p.) in rats. Melatonin injection was started immediately after hypoglycemia (10 mg/kg, i.p.). The first melatonin injection was performed at the end of a 30-min isoelectric EEG period. The second and third injections were administered at 1 and 3 h after the first injection. Reactive oxygen species generation, as detected by dihydroethidium staining, was significantly reduced by melatonin treatment. Neuronal injury was reduced by the treatment of melatonin in the hippocampal CA1 and dentate granule cells. Microglia activation was robust in the hippocampus after hypoglycemia, which was almost completely prevented by melatonin treatment. Hypoglycemia-induced cognitive impairment was also significantly prevented by melatonin treatment. The present study suggests that melatonin has therapeutic potential to prevent hypoglycemia-induced brain injury. (C) 2015 S. Karger AG, Basel	[Yoo, Byung Hoon; Won, Seok Joon; Suh, Sang Won] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Kim, Jin Hee; Choi, Bo Young; Lee, Bo Eun; Kim, In Yeol; Kho, Ara; Lee, Song Hee; Suh, Sang Won] Hallym Univ, Dept Physiol, Coll Med, Chunchon, South Korea; [Yoo, Byung Hoon] InJe Univ, Sang Gye Baik Hosp, Dept Anesthesiol, Sch Med, Seoul, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea		Suh, SW (corresponding author), Univ Calif San Francisco, VAMC, Dept Neurol, 4150 Clement St, San Francisco, CA 94121 USA.	swsuh@hallym.ac.kr		Choi, Bo Young/0000-0002-9579-3503; SOHN, MIN/0000-0003-4021-2051	National Research Foundation of Korea (NRF) - Korean government (MEST)Ministry of Education, Science and Technology, Republic of KoreaNational Research Foundation of KoreaKorean Government [2012R1A2A2A01040132]; Hallym University Fund [HRF-201412-014]	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (MEST; 2012R1A2A2A01040132) and by Hallym University Fund (HRF-201412-014).	AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Cazevieille C, 1997, BRAIN RES, V768, P120, DOI 10.1016/S0006-8993(97)00611-2; Cervantes M, 2008, J PINEAL RES, V45, P1, DOI 10.1111/j.1600-079X.2007.00551.x; Chahbouni M, 2010, J PINEAL RES, V48, P282, DOI 10.1111/j.1600-079X.2010.00752.x; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Cho S, 1997, BRAIN RES, V755, P335, DOI 10.1016/S0006-8993(97)00188-1; Choi BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081523; Davis EA, 1998, ARCH DIS CHILD, V78, P111, DOI 10.1136/adc.78.2.111; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Giusti P, 1996, FASEB J, V10, P891, DOI 10.1096/fasebj.10.8.8666166; Hershey T, 1997, J Int Neuropsychol Soc, V3, P509; Inamasu J, 2000, J NEUROIMMUNOL, V109, P66, DOI 10.1016/S0165-5728(00)00211-3; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Korkmaz A, 2012, MOL CELL ENDOCRINOL, V349, P128, DOI 10.1016/j.mce.2011.10.013; Lagneux C, 2000, LIFE SCI, V66, P503, DOI 10.1016/S0024-3205(99)00620-7; LANGAN SJ, 1991, DIABETOLOGIA, V34, P337, DOI 10.1007/BF00405006; Lee MY, 2007, J PINEAL RES, V42, P297, DOI 10.1111/j.1600-079X.2007.00420.x; Manev H, 1996, FASEB J, V10, P1546, DOI 10.1096/fasebj.10.13.8940301; Marshall KA, 1996, FREE RADICAL BIO MED, V21, P307, DOI 10.1016/0891-5849(96)00046-9; Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Murakami K, 1998, J NEUROSCI, V18, P205; REITER RJ, 1994, ANN NY ACAD SCI, V719, P1, DOI 10.1111/j.1749-6632.1994.tb56817.x; Reiter RJ, 2014, BRAIN STRUCT FUNCT, V219, P1873, DOI 10.1007/s00429-014-0719-7; RUDEEN PK, 1980, EPILEPSIA, V21, P149, DOI 10.1111/j.1528-1157.1980.tb04056.x; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Skinner DC, 1999, ENDOCRINOLOGY, V140, P4399, DOI 10.1210/endo.140.10.7074; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Vlkolinsky R, 1999, BRAIN RES, V850, P118, DOI 10.1016/S0006-8993(99)02110-1; Won SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-225; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhou JF, 2008, J PINEAL RES, V45, P157, DOI 10.1111/j.1600-079X.2008.00570.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	42	8	9	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2015	102	4					300	310		10.1159/000434722			11	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	CY9SM	WOS:000366746600006	26065386				2022-02-06	
J	Lu, W; Cantor, JB; Aurora, RN; Gordon, WA; Krellman, JW; Nguyen, M; Ashman, TA; Spielman, L; Ambrose, AF				Lu, William; Cantor, Joshua B.; Aurora, R. Nisha; Gordon, Wayne A.; Krellman, Jason W.; Nguyen, Michael; Ashman, Teresa A.; Spielman, Lisa; Ambrose, Anne F.			The relationship between self-reported sleep disturbance and polysomnography in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; fatigue; polysomnography; sleep; sleep initiation maintenance disorders	EXCESSIVE DAYTIME SLEEPINESS; QUALITY INDEX; MULTIDIMENSIONAL ASSESSMENT; RHEUMATOID-ARTHRITIS; FATIGUE SCALE; DISORDERS; INSOMNIA; EEG; COMPLAINTS; PATTERNS	Primary objective: To characterize sleep architecture and self-reported sleep quality, fatigue and daytime sleepiness in individuals with TBI. Possible relationships between sleep architecture and self-reported sleep quality, fatigue and daytime sleepiness were examined. Methods: Forty-four community-dwelling adults with TBI completed the Pittsburgh Sleep Quality Index (PSQI), Multidimensional Assessment of Fatigue (MAF) and Epworth Sleepiness Scale (ESS). They underwent two nights of in-laboratory nocturnal polysomnography (NPSG). Pearson product-moment correlation coefficients and hierarchical linear regression was used to analyse the data. Results: Based on the PSQI cut-off score of >= 10, 22 participants were characterized as poor sleepers. Twenty-seven participants met criteria for clinically significant fatigue as measured by the GFI of the MAF. Fourteen participants met criteria for excessive daytime sleepiness as measured by the ESS. Poor sleep quality was associated with poor sleep efficiency, short duration of stage 2 sleep and long duration of rapid eye movement sleep. There was little-to-no association between high levels of fatigue or daytime sleepiness with NPSG sleep parameters. Conclusions: A high proportion of the sample endorsed poor sleep quality, fatigue and daytime sleepiness. Those who reported poorer sleep quality evidenced a shorter proportion of time spent in stage 2 sleep. These findings suggest that disruptions in stage 2 sleep might underlie the symptoms of sleep disturbance experienced following TBI.	[Lu, William; Cantor, Joshua B.; Gordon, Wayne A.; Krellman, Jason W.; Nguyen, Michael; Spielman, Lisa; Ambrose, Anne F.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Aurora, R. Nisha] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA; [Ashman, Teresa A.] Shepherd Ctr, Atlanta, GA USA		Lu, W (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA.	william.lu@nyumc.org	Ambrose, Anne Felicia/ABE-4161-2020; Ambrose, Anne Felicia/AAQ-9668-2021		National Institute on Disability and Rehabilitation Research [H133A070033, H133A120084-14]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5U49CE002092-02]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133A070033) (grant no. H133A120084-14) and Centers for Disease Control and Prevention (grant no. 5U49CE002092-02). No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; BELZA BL, 1995, J RHEUMATOL, V22, P639; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Braley TJ, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/673936; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Crispim CA, 2011, J CLIN SLEEP MED, V7, P659, DOI 10.5664/jcsm.1476; Fairbrother N, 2008, PSYCHOL ASSESSMENT, V20, P150, DOI 10.1037/1040-3590.20.2.150; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Fuller KH, 1997, SLEEP, V20, P370, DOI 10.1093/sleep/20.5.370; GEORGE B, 1981, NEUROCHIRURGIE, V27, P35; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guilleminault C, 2006, SLEEP MED, V7, P513, DOI 10.1016/j.sleep.2006.03.016; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Lee SJ, 2012, EUR ARCH OTO-RHINO-L, V269, P1143, DOI 10.1007/s00405-011-1808-3; Lequerica A, 2012, J HEAD TRAUMA REHAB, V27, pE28, DOI 10.1097/HTR.0b013e31826fe574; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Mondal P, 2013, NAT SCI SLEEP, V5, P15, DOI 10.2147/NSS.S40608; Neu D, 2010, ACTA NEUROL BELG, V110, P15; Nicassio PM, 2014, BEHAV SLEEP MED, V12, P1, DOI 10.1080/15402002.2012.720315; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Weaver EM, 2004, ARCH OTOLARYNGOL, V130, P453, DOI 10.1001/archotol.130.4.453; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Yue HJ, 2009, SLEEP BREATH, V13, P331, DOI 10.1007/s11325-009-0252-8	52	8	8	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	11					1342	1350		10.3109/02699052.2015.1043947			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR4MF	WOS:000361306100009	26204319				2022-02-06	
J	MacDonald, J; Wilson, J; Young, J; Duerson, D; Swisher, G; Collins, CL; Meehan, WP				MacDonald, James; Wilson, Julie; Young, Julie; Duerson, Drew; Swisher, Gail; Collins, Christy L.; Meehan, William P., III			Evaluation of a Simple Test of Reaction Time for Baseline Concussion Testing in a Population of High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						computerized neurocognitive testing; traumatic brain injury; reaction time; reliability; validity; youth athletes	FOOTBALL PLAYERS; SPORTS; EXERCISE; RELIABILITY; PERFORMANCE; STATEMENT; SYMPTOMS	Objective: A common sequela of concussions is impaired reaction time. Computerized neurocognitive tests commonly measure reaction time. A simple clinical test for reaction time has been studied previously in college athletes; whether this test is valid and reliable when assessing younger athletes remains unknown. Our study examines the reliability and validity of this test in a population of high school athletes. Design: Cross-sectional study. Setting: Two American High Schools. Participants: High school athletes (N = 448) participating in American football or soccer during the academic years 2011 to 2012 and 2012 to 2013. Interventions: All study participants completed a computerized baseline neurocognitive assessment that included a measure of reaction time (RTcomp), in addition to a clinical measure of reaction time that assessed how far a standard measuring device would fall prior to the athlete catching it (RTclin). Main Outcome Measures: Validity was assessed by determining the correlation between RTclin and RTcomp. Reliability was assessed by measuring the intraclass correlation coefficients (ICCs) between the repeated measures of RTclin and RTcomp taken 1 year apart. Results: In the first year of study, RTclin and RTcomp were positively but weakly correlated (r(s) = 0.229, P < 0.001). In the second year, there was no significant correlation between RTclin and RTcomp (r(s) = 0.084, P = 0.084). Both RTclin [ICC = 0.608; 95% confidence interval (CI), 0.434-0.728] and RTcomp (ICC = 0.691; 95% CI, 0.554-0.786) had marginal reliability. Conclusions: In a population of high school athletes, RTclin had poor validity when compared with RTcomp as a standard. Both R-Tclin and RTcomp had marginal test-retest reliability. Before considering the clinical use of RTclin in the assessment of sport-related concussions sustained by high school athletes, the factors affecting reliability and validity should be investigated further. Clinical Relevance: Reaction time impairment commonly results from concussion and is among the most clinically important measures of the condition. The device evaluated in this study has previously been investigated as a reaction time measure in college athletes. This study investigates the clinical generalizability of the device in a younger population. Video Abstract: A video abstract showing how the RTclin device is used in practice is available as Supplemetal Digital Content 1, http://links.lww.com/JSM/A43.	[MacDonald, James; Young, Julie; Duerson, Drew; Swisher, Gail] Nationwide Childrens Hosp, Div Sports Med, Dept Pediat, Columbus, OH USA; [Wilson, Julie] Childrens Hosp Colorado, Dept Orthopaed, Aurora, CO USA; [Collins, Christy L.] Nationwide Childrens Hosp, Ctr Injury Res Policy, Columbus, OH USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA		MacDonald, J (corresponding author), Nationwide Childrens Hosp, Div Sports Med, Dept Pediat, 5680 Venture Dr, Dublin, OH 43017 USA.	james.macdonald@nationwidechildrens.org	Macdonald, James/C-4701-2012	MacDonald, James/0000-0002-0432-0808	Research Institute of Nationwide Children's Hospital; American Medical Society of Sports Medicine (AMSSM) Young Investigator's Grant	J. MacDonald is supported in this research by an internal grant from the Research Institute of Nationwide Children's Hospital and an American Medical Society of Sports Medicine (AMSSM) Young Investigator's Grant.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Becker LA, EFFECT SIZE CALCULAT; Cassas KJ, 2006, AM FAM PHYSICIAN, V73, P1014; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Davranche K, 2006, J SPORT SCI, V24, P323, DOI 10.1080/02640410500132165; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Lau B, 2003, CLIN J SPORT MED, V13, P28; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; MCMORRIS T, 1994, PERCEPT MOTOR SKILL, V78, P123, DOI 10.2466/pms.1994.78.1.123; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Reddy S, 2014, MED SCI SPORT EXER, V46, P429, DOI 10.1249/MSS.0000000000000140; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	30	8	8	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2015	25	1					43	48		10.1097/JSM.0000000000000096			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	AX7BX	WOS:000347072800012	24727576				2022-02-06	
J	McCulloch, K; Pastorek, NJ; Miller, BI; Romesser, J; Linck, J; Sim, AH; Troyanskaya, M; Maestas, KL				McCulloch, Katie; Pastorek, Nicholas J.; Miller, Brian I.; Romesser, Jennifer; Linck, John; Sim, Anita H.; Troyanskaya, Maya; Maestas, Kacey Little			Clinician Versus Veteran Ratings on the Mayo-Portland Participation Index in Veterans With a History of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities of daily living/psychology; brain injuries/rehabilitation; health/classification; psychometrics; questionnaires; Veterans	FAKE-BAD-SCALE; ADAPTABILITY INVENTORY; INTERNATIONAL CLASSIFICATION; MMPI-2; DISABILITY; METAANALYSIS; UTILITY; LIFE	Background: The Department of Veterans Affairs is encouraging administration of the Mayo-Portland Adaptability Inventory-4 Participation Index (M2PI) to identify long-term psychosocial outcomes of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) Veterans with a history of traumatic brain injury (TBI). Objective: To evaluate clinician and Veteran interrater reliability and how response validity influences M2PI item ratings. Participants: A total of 122 OEF/OIF/OND Veterans who reported a history consistent with mild TBI during deployment and were referred for neuropsychological evaluation following Comprehensive TBI Evaluation. Design: Interrater reliability study. Main Measures: M2PI; Minnesota Multiphasic Personality Inventory-2 Symptom Validity Scale (FBS). Results: Veterans reported greater perceived restrictions than clinicians across all M2PI items and total score. Interrater correlations ranged from r(s) = 0.27 (residence) to r(s) = 0.58 (money management) across items, with a total score correlation of r(s) = 0.60. When response bias was indicated, both Veterans and clinicians reported greater participation restrictions than those reported by Veterans without evidenced response bias. Conclusion: Low interrater correlation is consistent with previous findings. As ratings of clinicians and Veterans should not be interpreted as equivalent, documenting the rater's identity is important for interpretation. Using objective indicators of functional outcome may assist clinician raters, particularly when self-report may be biased.	[McCulloch, Katie; Pastorek, Nicholas J.; Miller, Brian I.; Troyanskaya, Maya] Michael E DeBakey VA Med Ctr, Traumat Brain Injury Ctr Excellence, Houston, TX 77030 USA; [Pastorek, Nicholas J.] Michael E DeBakey VA Med Ctr, Rehabil & Extended Care Line, Houston, TX 77030 USA; [McCulloch, Katie] Univ Houston, Dept Psychol, Houston, TX USA; [Pastorek, Nicholas J.; Troyanskaya, Maya; Maestas, Kacey Little] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Miller, Brian I.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Romesser, Jennifer] George E Wahlen VA Med Ctr, Dept Mental Hlth, Salt Lake City, UT USA; [Linck, John] Oklahoma City VA Med Ctr, Dept Mental & Behav Hlth, Oklahoma City, OK USA; [Sim, Anita H.] Minneapolis VA Med Ctr, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Maestas, Kacey Little] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Pastorek, NJ (corresponding author), Michael E DeBakey VA Med Ctr, Rehabil & Extended Care Line, 2002 Holcombe Blvd RECL 117, Houston, TX 77030 USA.	Nicholas.Pastorek@va.gov		Pastorek, Nicholas/0000-0002-9290-380X; McCulloch, Katie/0000-0003-0385-6536	Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs [B6812C]; VA RR&D Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks; Minnesota Veterans Medical Research and Education Foundation	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; B6812C (PI: H. S. Levin) VA RR&D Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks.; Anita H. Sim received funding support through the Minnesota Veterans Medical Research and Education Foundation.	[Anonymous], 2013, VETERANS HEALTH ADMI; Barrett P., 2001, ASSESSING THE RELIAB; Ben-Porath YS, 2008, THE MINNESOTA MULTIP; Bianchini KJ, 2003, J OCCUP ENVIRON MED, V45, P1087, DOI 10.1097/01.jom.0000085886.18136.7d; Boone KB, 2007, ASSESSMENT OF FEIGNE; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Department of Defense, 2012, TRAUMATIC BRAIN INJU; Department of Veterans Affairs Office of the Inspector General, 2005, REVIEW OF STATE VARI; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Frueh BC, 2003, PSYCHIATR SERV, V54, P84, DOI 10.1176/appi.ps.54.1.84; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Iverson GL, 2002, PSYCHOL REP, V90, P131, DOI 10.2466/PR0.90.1.131-136; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lexell J, 2012, J REHABIL MED, V44, P65, DOI 10.2340/16501977-0897; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Malec JFL, 2003, MANUAL FOR THE MAYO; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; National Center for Injury Prevention and Control, 2003, REPORT TO CONGRESS O; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; World Health Organization, 2002, TOWARDS A COMMON LAN	37	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					38	46		10.1097/HTR.0000000000000041			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400013	24695266				2022-02-06	
J	Poellabauer, C; Yadav, N; Daudet, L; Schneider, SL; Busso, C; Flynn, PJ				Poellabauer, Christian; Yadav, Nikhil; Daudet, Louis; Schneider, Sandra L.; Busso, Carlos; Flynn, Patrick J.			Challenges in Concussion Detection Using Vocal Acoustic Biomarkers	IEEE ACCESS			English	Article						Speech analysis; vocal features; mild traumatic brain injuries; concussions; speech recognition	TRAUMATIC BRAIN-INJURY; UNITED-STATES; SPEECH; AUTISM; RECOGNITION; INFANTS; VOICE; DYSARTHRIA; REGRESSION; PATTERNS	Acoustic metrics extracted from speech have the potential to serve as novel biomarkers for a variety of neurological and neurodevelopmental conditions, as is evidenced by the rapidly growing corpus of research articles studying the links between brain impairments and speech. In this paper, we discuss the advantages and the disadvantages of speech biomarkers and the various challenges in the design and the implementation of portable speech-based diagnostic and assessment tools. Furthermore, we provide a case study, presenting our experiences in developing an assessment tool for the detection of mild traumatic brain injuries (concussions) and discuss the challenges in obtaining and analyzing large sets of speech recordings that can be used to study the impact of brain injuries on vocal features.	[Poellabauer, Christian; Yadav, Nikhil; Daudet, Louis; Flynn, Patrick J.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Schneider, Sandra L.] St Marys Coll, Dept Communicat Sci & Disorders, Notre Dame, IN 46556 USA; [Busso, Carlos] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75080 USA		Poellabauer, C (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	cpoellab@nd.edu		Poellabauer, Christian/0000-0002-0599-7941; Busso, Carlos/0000-0002-4075-4072	National Science FoundationNational Science Foundation (NSF) [IIS-1450349]; National Football League and General Electric Health through NFL/GE Head Health Challenge	This work was supported in part by the National Science Foundation under Grant IIS-1450349 and in part by the National Football League and General Electric Health through the NFL/GE Head Health Challenge.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bocklet T., 2011, 2011 IEEE Workshop on Automatic Speech Recognition & Understanding (ASRU), P478, DOI 10.1109/ASRU.2011.6163978; Bone D., 2011, P INTERSPEECH FLOR I, P3217; BRENNER M, 1991, AVIAT SPACE ENVIR MD, V62, P893; Brisson J, 2014, INFANT MENT HEALTH J, V35, P285, DOI 10.1002/imhj.21442; Brown J.R., 1975, MOTOR SPEECH DISORDE; Chenausky K, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/435232; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Deliyski Dimitar D, 2005, Logoped Phoniatr Vocol, V30, P55, DOI 10.1080/1401543051006721; DENG L, 2003, SPEECH PROCESSING DY; Duffy, 2005, MOTOR SPEECH DISORDE; Falcone M, 2013, INT CONF ACOUST SPEE, P7577, DOI 10.1109/ICASSP.2013.6639136; Fort A, 1998, MED ENG PHYS, V20, P432, DOI 10.1016/S1350-4533(98)00045-9; Gauvain JL, 1994, IEEE T SPEECH AUDI P, V2, P291, DOI 10.1109/89.279278; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Geman O, 2011, E HLTH BIOENG C EHB, P1; Goberman AM, 2010, J NEUROLINGUIST, V23, P470, DOI 10.1016/j.jneuroling.2008.11.001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graff D., 1996, 1996 ENGLISH BROADCA; Halpern H., 2012, LANGUAGE MOTOR SPEEC; Hermansky H., 1993, ICASSP-93. 1993 IEEE International Conference on Acoustics, Speech, and Signal Processing (Cat. No.92CH3252-4), P83, DOI 10.1109/ICASSP.1993.319236; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; HOOKE R, 1961, J ACM, V8, P212, DOI 10.1145/321062.321069; Huang Xuedong, 2001, SPOKEN LANGUAGE PROC; Huggins-Daines D, 2006, INT CONF ACOUST SPEE, P185; Kasai K, 2002, AM J PSYCHIAT, V159, P546, DOI 10.1176/appi.ajp.159.4.546; KASTE M, 1982, LANCET, V2, P1186; Kiss G., 2012, P 13 ANN C INT SPEEC, P1343; Krause M. O., 2011, THESIS U MINNESOTA M; Landry Brian M., 2010, P ACM INT C HLTH INF, P780, DOI [10.1145/1882992.1883110, DOI 10.1145/1882992.1883110]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; LEE KF, 1990, IEEE T ACOUST SPEECH, V38, P35, DOI 10.1109/29.45616; LEGGETTER CJ, 1995, COMPUT SPEECH LANG, V9, P171, DOI 10.1006/csla.1995.0010; Levit M., 2001, P PROS SPEECH REC UN, P22; Lind K, 2002, INT J PEDIATR OTORHI, V64, P97, DOI 10.1016/S0165-5876(02)00024-1; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; Mackenzie C, 2011, INT J SPEECH-LANG PA, V13, P125, DOI 10.3109/17549507.2011.524940; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Maier A, 2009, SPEECH COMMUN, V51, P425, DOI 10.1016/j.specom.2009.01.004; Mampe B, 2009, CURR BIOL, V19, P1994, DOI 10.1016/j.cub.2009.09.064; Manfredi C, 2009, MED ENG PHYS, V31, P528, DOI 10.1016/j.medengphy.2008.10.003; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; OKADA M, 1983, MED BIOL ENG COMPUT, V21, P145, DOI 10.1007/BF02441529; PAUL DB, 1992, SPEECH AND NATURAL LANGUAGE, P357; Peppe S, 2011, J NEUROLINGUIST, V24, P41, DOI 10.1016/j.jneuroling.2010.07.005; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; RAMIG LA, 1988, ANN OTO RHINOL LARYN, V97, P164, DOI 10.1177/000348948809700214; Rapcan V, 2010, MED ENG PHYS, V32, P1074, DOI 10.1016/j.medengphy.2010.07.013; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Ryan AJ, 1998, CLIN SPORT MED, V17, P155, DOI 10.1016/S0278-5919(05)70070-3; Sapir S, 2011, COMMUNICATION SWALLO, P89; Schiel F., 2009, P INTERSPEECH 2009 B, P983; Sharda M, 2010, NEUROSCI LETT, V478, P42, DOI 10.1016/j.neulet.2010.04.066; Sheinkopf SJ, 2012, AUTISM RES, V5, P331, DOI 10.1002/aur.1244; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sullivan T. M., 1993, ICASSP-93. 1993 IEEE International Conference on Acoustics, Speech, and Signal Processing (Cat. No.92CH3252-4), P91, DOI 10.1109/ICASSP.1993.319238; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Uma Rani K, 2012, P 2012 3 INT C COMP, P1, DOI DOI 10.1109/ICCCNT.2012.6395886; Ungurean I, 2012, EUR SIGNAL PR CONF, P1733; Valicenti-McDermott M, 2012, J PEDIATR-US, V161, P554, DOI 10.1016/j.jpeds.2012.05.012; Varela A, 2003, LECT NOTES COMPUT SC, V2905, P251; Vasilakis M, 2009, FOLIA PHONIATR LOGO, V61, P153, DOI 10.1159/000219951; Wermke K, 2002, MED ENG PHYS, V24, P501, DOI 10.1016/S1350-4533(02)00061-9; World Health Organization, 2004, GLOB BURD DIS 2004 U; Yadav N, 2014, 2014 IEEE Healthcare Innovation Conference (HIC), P335, DOI 10.1109/HIC.2014.7038943; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; ZWIRNER P, 1991, J COMMUN DISORD, V24, P287, DOI 10.1016/0021-9924(91)90004-3	78	8	8	3	9	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2015	3						1143	1160		10.1109/ACCESS.2015.2457392			18	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	DF5JP	WOS:000371388200087		gold			2022-02-06	
J	Qian, R; Yang, WZ; Wang, XM; Xu, Z; Liu, XD; Sun, B				Qian, Rong; Yang, Weizhong; Wang, Xiumei; Xu, Zhen; Liu, Xiaodong; Sun, Bing			Evaluation of cerebral-cardiac syndrome using echocardiography in a canine model of acute traumatic brain injury	AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE			English	Article						Traumatic brain injury; real-time myocardial contrast echocardiography; strain rate imaging; myocardial ischemia; cerebral-cardiac syndrome	ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEUROGENIC STUNNED MYOCARDIUM; STRESS; HEART; CARDIOMYOPATHY; DYSFUNCTION	Previous studies have confirmed that traumatic brain injury (TBI) can induce general adaptation syndrome (GAS), which subsequently results in myocardial dysfunction and damage in some patients with acute TBI; this condition is also termed as cerebral-cardiac syndrome. However, most clinicians ignore the detection and treatment of myocardial dysfunction, and instead concentrate only on the serious neural damage that is observed in acute TBI, which is one of the most important fatal factors. Therefore, clarification is urgently needed regarding the relationship between TBI and myocardial dysfunction. In the present study, we evaluated 18 canine models of acute TBI, by using real-time myocardial contrast echocardiography and strain rate imaging to accurately evaluate myocardial function and regional microcirculation, including the strain rate of the different myocardial segments, time-amplitude curves, mean ascending slope of the curve, and local myocardial blood flow. Our results suggest that acute TBI often results in cerebral-cardiac syndrome, which rapidly progresses to the serious stage within 3 days. This study is the first to provide comprehensive ultrasonic characteristics of cerebral-cardiac syndrome in an animal model of TBI.	[Qian, Rong; Yang, Weizhong; Wang, Xiumei; Xu, Zhen] 85th Mil Hosp, Dept Special Diag, Shanghai, Peoples R China; [Liu, Xiaodong; Sun, Bing] Fudan Univ, Huashan Hosp, Shanghai Neurosurg Ctr, Dept Neurosurg, Shanghai 200433, Peoples R China		Sun, B (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Neurosurg Ctr, Dept Neurosurg, Shanghai 200433, Peoples R China.	msun-bing@yahoo.com			Nanjing Military Region Medical Research Fund [07M002]	We acknowledge all staff of the Department of Neurosurgery of Huashan Hospital for establishing the animal TBI models. Supported by Nanjing Military Region Medical Research Fund (07M002).	Ako J, 2006, AM J MED, V119, P10, DOI 10.1016/j.amjmed.2005.08.022; Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15; Brander L, 2003, ANAESTH INTENS CARE, V31, P202, DOI 10.1177/0310057X0303100212; Deleu D, 2007, SAUDI MED J, V28, P283; Divekar A, 2006, PEDIATR CARDIOL, V27, P376, DOI 10.1007/s00246-005-1263-2; Goel Radha, 2005, Congest Heart Fail, V11, P99; Huang CC, 2012, AM J EMERG MED, V30, P732, DOI 10.1016/j.ajem.2011.05.003; Lee VH, 2006, NEUROCRIT CARE, V5, P243, DOI 10.1385/NCC:5:3:243; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Milewska A, 2009, J ELECTROCARDIOL, V42, P420, DOI 10.1016/j.jelectrocard.2009.04.001; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Qaqa AY, 2012, ACTA CARDIOL, V67, P635, DOI 10.1080/AC.67.6.2184665; Rosen SD, 2000, ANN MED, V32, P350, DOI 10.3109/07853890008995938; Schiff Nicholas D, 2010, Cleve Clin J Med, V77 Suppl 3, pS27, DOI 10.3949/ccjm.77.s3.05; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Toussaint LG, 2005, NEUROSURGERY, V57, P25, DOI 10.1227/01.NEU.0000163086.23124.70; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zaroff JG, 2000, STROKE, V31, P1136, DOI 10.1161/01.STR.31.5.1136	20	8	11	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-200X			AM J CARDIOVASC DIS	Am. J. Cardiovasc. Dis.		2015	5	1					72	76					5	Cardiac & Cardiovascular Systems	Emerging Sources Citation Index (ESCI)	Cardiovascular System & Cardiology	CR2BY	WOS:000361130900006	26064794				2022-02-06	
J	Surani, S; Lockwood, G; Macias, MY; Guntupalli, B; Varon, J				Surani, Salim; Lockwood, Geoff; Macias, Melissa Y.; Guntupalli, Bharat; Varon, Joseph			Hypertonic Saline in Elevated Intracranial Pressure: Past, Present, and Future	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						hypertonic saline; intracranial hypertension; intracranial pressure; cerebral edema; mannitol; stroke	EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; CRITICAL-CARE; HYPERTENSION; MANAGEMENT; GUIDELINES; MANNITOL; THERAPY; STROKE	Hypertonic Saline (HS) has been a proven and effective therapy and a safe alternative to mannitol in patients with increase intracranial pressure (ICP). We hereby present a case of 25-year-old women with intracranial bleed secondary to right parietal arteriovenous malformation. Patient underwent surgery for evacuation of hematoma and resection of arteriovenous malformation. Post- operative course was complicated by recurrent episodes of elevated ICP. She received total of 17 doses of 23.4% HS and 30 doses of mannitol with good outcome. Despite reluctance from some clinicians to use HS, hypertonic saline seems to be a safe and effective therapy.	[Surani, Salim] Texas A&M Univ, Div Pulm & Crit Care Med, College Stn, TX 77843 USA; [Lockwood, Geoff; Macias, Melissa Y.] Christus Spohn Hosp, Corpus Christi, TX USA; [Varon, Joseph] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Varon, Joseph] Univ Texas Med Branch, Galveston, TX 77555 USA; [Varon, Joseph] Univ Gen Hosp, Houston, TX USA		Surani, S (corresponding author), 1711 West Wheeler Ave, Aransas Pass, TX 78366 USA.	srsurani@hotmail.com	Surani, Salim/AAG-8965-2019; Varon, Joseph/T-9481-2019; Varon, Joseph/R-5198-2019	Surani, Salim/0000-0001-7105-4266; 			Al-Rawi PG, 2010, STROKE, V41, P122, DOI 10.1161/STROKEAHA.109.560698; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Hinson HE, 2013, J INTENSIVE CARE MED, V28, P3, DOI 10.1177/0885066611400688; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 2002, CRIT CARE MED, V30, P435, DOI 10.1097/00003246-200202000-00028; QURESHI AI, 1999, NEUROSURGERY, V44, P63, DOI DOI 10.1097/00006123-199905000-00064; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Valentino Alden K, 2008, J Vasc Interv Neurol, V1, P113; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478	21	8	8	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	JAN	2015	30	1					8	12		10.1177/0885066613487151			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3LD	WOS:000346187300002	23753247				2022-02-06	
J	Tremblay, S; Vernet, M; Bashir, S; Pascual-Leone, A; Theoret, H				Tremblay, Sara; Vernet, Marine; Bashir, Shahid; Pascual-Leone, Alvaro; Theoret, Hugo			Theta burst stimulation to characterize changes in brain plasticity following mild traumatic brain injury: A proof-of-principle study	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; concussion; transcranial magnetic stimulation; plasticity; motor cortex	TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTICAL PLASTICITY; LONG-TERM POTENTIATION; SPORTS CONCUSSION; HEAD-INJURY; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; FOOTBALL PLAYERS; EARLY ADULTHOOD; CORTEX	Purpose: Recent studies investigating the effects of mild traumatic brain injury (mTBI) suggest the presence of unbalanced excitatory and inhibitory mechanisms within primary motor cortex (M1). Whether these abnormalities are associated with impaired synaptic plasticity remains unknown. Methods: The effects of continuous theta burst stimulation (cTBS) on transcranial magnetic stimulation-induced motor evoked potentials (MEPs) were assessed on average two weeks and six weeks following mTBI in five individuals. Results: The procedure was well-tolerated by all participants. Continuous TBS failed to induce a significant reduction of MEP amplitudes two weeks after the injury, but response to cTBS normalized six weeks following injury, as a majority of patients became asymptomatic. Conclusions: These preliminary results suggest that cTBS can be used to assess M1 synaptic plasticity in subacute phase following mTBI and may provide insights into neurobiological substrates of symptoms and consequences of mTBI.	[Tremblay, Sara; Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Tremblay, Sara; Theoret, Hugo] Hop St Justine, Ctr Hosp Univ, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Vernet, Marine; Bashir, Shahid; Pascual-Leone, Alvaro] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA		Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca	Pascual-Leone, Alvaro/AAC-5101-2019; Bashir, Shahid/E-7212-2014; Bashir, Shahid/N-3031-2019; Tremblay, Sara/X-5471-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Bashir, Shahid/0000-0001-6286-6895; Theoret, Hugo/0000-0002-7458-8797; Vernet, Marine/0000-0001-7331-3567	Center for Integration of Medicine and Innovative Technology (CIMIT); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec [8 UL1 TR000170]; Harvard Clinical and Translational Science Center; National Center for Advancing Translational Science; Football Players Health Study at Harvard University; Fyssen Foundation; Sidney R. Baer Jr. Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD069776, R01NS073601, R21 MH099196, R21 NS082870, R21 NS085491, R21 HD07616]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCRR); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCATS NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 RR025758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069776] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH099196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS082870, R01NS073601, R21NS085491] Funding Source: NIH RePORTER	We thank Frederick Ifert-Miller, Anna-Katherine Brem, and Woo-Kyoung Wu for their contribution. This study was supported in part by grants from the Center for Integration of Medicine and Innovative Technology (CIMIT), the Canadian Institutes of Health Research and the Fonds de Recherche du Quebec-Sante, Grant Number 8 UL1 TR000170, Harvard Clinical and Translational Science Center, from the National Center for Advancing Translational Science, and the Football Players Health Study at Harvard University. ST was supported by a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research. MV was supported by the Fyssen Foundation. APL was supported in part by grants from the Sidney R. Baer Jr. Foundation, the National Institutes of Health (R01HD069776, R01NS073601, R21 MH099196, R21 NS082870, R21 NS085491, R21 HD07616), and Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH, UL1 RR025758). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the Canadian Institutes of Health, the National Institutes of Health or the Sidney R. Baer Jr. Foundation.	Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Cardenas-Morales L, 2010, BRAIN TOPOGR, V22, P294, DOI 10.1007/s10548-009-0084-7; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Eggers C, 2010, J NEUROL, V257, P1669, DOI 10.1007/s00415-010-5597-1; Freitas C, 2011, FRONT AGING NEUROSCI, V3, DOI [10.3389/fnagi.2011.00005, 10.3389/fnagi.2011.00006]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P397; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kelly JP, 1997, NEUROLOGY, V48, P581; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Piazza O, 2004, CURR MED RES OPIN, V20, P505, DOI 10.1185/030079904125003296; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Suppa A, 2011, EXP NEUROL, V227, P296, DOI 10.1016/j.expneurol.2010.11.020; Thickbroom GW, 2007, EXP BRAIN RES, V180, P583, DOI 10.1007/s00221-007-0991-3; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Vernet M, 2014, CLIN NEUROPHYSIOL, V125, P320, DOI 10.1016/j.clinph.2013.07.004; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	43	8	8	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	5					611	620		10.3233/RNN-140459			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT6YP	WOS:000362959900003	25735241	Green Accepted			2022-02-06	
J	Verma, R; Giri, P; Rizvi, I				Verma, Rajesh; Giri, Prithvi; Rizvi, Imran			Paroxysmal sympathetic hyperactivity in neurological critical care	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Autonomic seizures; encephalitis; paroxysmal sympathetic hyperactivity; traumatic brain injury		Introduction: Paroxysmal sympathetic hyperactivity ( PSH) is a clinical disorder mainly caused by traumatic brain injury, stroke, encephalitis and other types of brain injury. The clinical features are episodes of hypertension, tachycardia, tachypnea, fever and dystonic postures. In this study, we described clinical profile and outcome of six patients of PSH admitted in neurocritical care unit. Materials and Methods: This was a prospective observational study conducted at neurology critical care unit of a tertiary care center. All patients admitted at neurology critical unit during 6-month period from August 2013 to January 2014 were screened for the occurrence of PSH. The clinical details and outcome was documented. Results: PSH was observed in 6 patients. Male to female ratio was 5:1. Mean age +/- SD was 36.67 +/- 15.19 years. The leading causes were traumatic brain injury (two patients), stroke (two patients) and Japanese encephalitis (JE) (one patient) and tuberculous meningitis (one patient). Conclusion: PSH is an unusual complication in neurocritical care. It prolonged the hospitalization and hampers recovery. The other life-threatening conditions that mimic PSH should be excluded. The association with JE and tuberculous meningitis was not previously described in literature.	[Verma, Rajesh; Giri, Prithvi; Rizvi, Imran] King George Med Univ, Dept Neurol, Lucknow, Uttar Pradesh, India		Verma, R (corresponding author), King George Med Univ, Dept Neurol, Lucknow, Uttar Pradesh, India.	drrajeshverma32@yahoo.com					Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Diamond AL, 2005, NEUROCRIT CARE, V2, P288, DOI 10.1385/NCC:2:3:288; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; DOLCE G, 2008, J NEUROTRAUMA; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Gil Anton J, 2004, An Pediatr (Barc), V61, P449; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071	14	8	10	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	JAN	2015	19	1					34	37		10.4103/0972-5229.148638			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3F5Y	WOS:000218210900007	25624648	Green Published			2022-02-06	
J	Wang, ZL; Xu, DS; Wang, YX; Qin, H; Geng, D				Wang, Z. L.; Xu, D. S.; Wang, Y. X.; Qin, H.; Geng, D.			Effect of single nucleotide polymorphisms in the ATP-binding cassette B1 gene on the clinical outcome of traumatic brain injury	GENETICS AND MOLECULAR RESEARCH			English	Article						ATP-binding cassette B1 gene; Traumatic brain injury; Clinical outcome	MULTIDRUG-RESISTANCE; C3435T POLYMORPHISM; P-GLYCOPROTEIN; EPILEPSY; ABCB1; ASSOCIATION; TRANSPORTERS; EXPRESSION; IMPACT	The critical role of ATP-binding cassette B1 (ABCB1) in the function of the blood-brain barrier led us to conducted this prospective study in order to investigate the clinical outcome of patients suffering from severe traumatic brain injury. A total of 182 patients with traumatic brain injury were included in our study. Genotyping of ABCB1 C3435T and G2677T/A was conducted using polymerase chain reaction-restriction fragment length polymorphism. Using multivariate-logistic regression analysis, we found that patients carrying the CT+CC genotype of ABCB1 C3435T were more likely to have a better neurological outcome when compared with the TT genotype (odds ratio = 2.71, 95% confidence interval = 1.12-6.86). However, no significant association was found between the G2677T/A polymorphism and outcome of traumatic brain injury patients. Our study provides important information regarding the prognostic value of ABCB1 C3435T, and the ABCB1 C3435T polymorphism may be used as a predictive marker for the outcome of traumatic brain injury patients.	[Wang, Z. L.; Xu, D. S.; Wang, Y. X.; Qin, H.; Geng, D.] Xinjiang Med Univ, Affiliated Hosp 1, Dept Neurosurg, Urumqi, Peoples R China		Wang, YX (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Neurosurg, Urumqi, Peoples R China.	wangyx_king@163.com					Basic S, 2008, SEIZURE-EUR J EPILEP, V17, P524, DOI 10.1016/j.seizure.2008.01.003; Cotte S, 2009, BRAIN, V132, P2517, DOI 10.1093/brain/awp164; Cousar JL, 2013, NEUROCRIT CARE, V19, P192, DOI 10.1007/s12028-013-9881-7; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Emich-Widera E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/526837; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hung CC, 2007, PHARMACOGENOMICS, V8, P1151, DOI 10.2217/14622416.8.9.1151; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kwan P, 2007, EPILEPSY BEHAV, V11, P112, DOI 10.1016/j.yebeh.2007.04.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Liang ZY, 2013, EUROINTERVENTION, V9, P316, DOI 10.4244/EIJV9I3A53; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Ebid AHI, 2007, THER DRUG MONIT, V29, P305; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Samanian S, 2011, ASIAN PAC J CANCER P, V12, P3141; Seven M, 2014, MOL BIOL REP, V41, P331, DOI 10.1007/s11033-013-2866-y; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986	22	8	8	0	4	FUNPEC-EDITORA	RIBEIRAO PRETO	RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL	1676-5680			GENET MOL RES	Genet. Mol. Res.		2015	14	3					10948	10953		10.4238/2015.September.21.6			6	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	CS9OX	WOS:000362421700053	26400323	Bronze			2022-02-06	
J	Webbe, FM; Zimmer, A				Webbe, Frank M.; Zimmer, Adam			History of neuropsychological study of sport-related concussion	BRAIN INJURY			English	Article						Concussion; mild brain injury; neuropsychological	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; NORMATIVE DATA; MANAGEMENT; PERFORMANCE; COLLEGIATE; RECOVERY; PLAYERS; ZURICH; RETURN	Although the medical literature has a long history of description and comment on concussion, the occurrence of concussion within the context of sports other than boxing was not judged to be problematic until the 1980s. Neuropsychological assessment played a critical and integral role in identifying the cognitive sequelae of concussion and mapping out the short- and long-term vagaries in recovery. This paper captures that history and expands upon current applications of neuropsychological assessment in the diagnosis and management of sport-related concussion.	[Webbe, Frank M.; Zimmer, Adam] Florida Inst Technol, Melbourne, FL 32901 USA		Webbe, FM (corresponding author), Florida Inst Technol, Sch Psychol, 150 W Univ Blvd, Melbourne, FL 32901 USA.	webbe@fit.edu		Webbe, Frank/0000-0002-4370-5698			[Anonymous], 1960, TACTICS SCI RES EVAL; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; Barth JT, 2011, HDB SPORT NEUROPSYCH, P75; Bell B, 1788, A SYSTEM OF SURG, VIII; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Garber G, 2005, A TORMENTED SOUL; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P111, DOI 10.1007/0-387-32565-4_6; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2001, J ATHL TRAINING, V36, P288; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Report of the Sports Medicine Committee, 1990, GUID MAN CONC SPORTS; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; SYMONDS C, 1962, LANCET, V1, P1; Trotter W, 1924, LANCET, V1, P935; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	55	8	8	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	2					129	138		10.3109/02699052.2014.937746			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AZ4OI	WOS:000348201500002	25093375				2022-02-06	
J	Betthauser, LM; Brenner, LA; Forster, JE; Hostetter, TA; Schneider, AL; Hernandez, TD				Betthauser, Lisa M.; Brenner, Lisa A.; Forster, Jeri E.; Hostetter, Trisha A.; Schneider, Alexandra L.; Hernandez, Theresa D.			A Factor Analysis and Exploration of Attitudes and Beliefs Toward Complementary and Conventional Medicine in Veterans	MEDICAL CARE			English	Article						Veterans; CAM; attitudes	ALTERNATIVE MEDICINE; MILITARY VETERANS; UNITED-STATES; RELIABILITY; VALIDITY; SAMPLE; USERS; PTSD	Background: Although Veterans utilize complementary and alternative medicine (CAM) at rates comparable with civilians, little is known about Veterans' attitudes and beliefs toward CAM. Measures to increase such knowledge may help to identify treatment preferences, particularly among those with signature conditions from the recent conflicts [ie, traumatic brain injury (TBI), posttraumatic stress disorder (PTSD)]. Objective: This exploratory study aimed to: (1) determine the factors of the Complementary, Alternative, and Conventional Medicine Attitudes Scale (CACMAS); and to utilize the resulting factors to describe (2) attitudes and beliefs toward CAM; (3) their association with TBI, PTSD, and history of self-directed violence. Patterns of CAM use were also obtained. Research Design: Factor analysis. Observational study. Subjects: Participants were 97 Veterans seeking care at a Mountain State Veterans Affairs Medical Center. Methods: Participants completed the CACMAS, clinical interviews, and self-report measures during a single visit. Results: CACMAS factors identified were: acceptability of (1) CAM and (2) conventional medicine; (3) mind-body integration; and (4) belief in CAM. Acceptability of CAM was significantly associated with history of mild TBI (mTBI) or PTSD symptom severity. Veterans endorsed a wide range of CAM use. Conclusions: Veterans in this sample were open to CAM and conventional medicine, believed in CAM, and believed that treatments should incorporate the mind and body. Veterans with a history of mTBI or PTSD symptoms may be more accepting of CAM. Understanding Veterans' beliefs and attitudes regarding CAM may help providers deliver patient-centered treatments, particularly among those with conditions for which evidence-based interventions are limited (eg, mTBI).	[Betthauser, Lisa M.; Brenner, Lisa A.; Forster, Jeri E.; Hostetter, Trisha A.; Schneider, Alexandra L.; Hernandez, Theresa D.] MIRECC, Vet Integrated Serv Network VISN 19, 1055 Clermont St, Denver, CO 80220 USA; [Betthauser, Lisa M.] Univ Colorado, Dept Psychol, Denver, CO 80202 USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Sch Med, Dept Psychiat, Denver, CO 80202 USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Sch Med, Dept Neurol, Denver, CO 80202 USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Sch Med, Dept Phys Med & Rehabil, Denver, CO 80202 USA; [Forster, Jeri E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Hernandez, Theresa D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA		Betthauser, LM (corresponding author), MIRECC, Vet Integrated Serv Network VISN 19, 1055 Clermont St, Denver, CO 80220 USA.	lisa.betthauser@va.gov	Brenner, Lisa A./AAG-2442-2019		VISN 19 Mental Illness Research Education and Clinical Center (MIRECC) located at the Denver VA Medical Center	Supported by the VISN 19 Mental Illness Research Education and Clinical Center (MIRECC) located at the Denver VA Medical Center. The views, opinions and/or findings contained in this article are those of the authors and do not necessarily represent the official policy or position of the Department of Veterans Affairs or the United States Government.	Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Astin JA, 2000, J GERONTOL A-BIOL, V55, pM4; Baldwin CM, 2002, ARCH INTERN MED, V162, P1697, DOI 10.1001/archinte.162.15.1697; Barnes Patricia M, 2004, Adv Data, P1; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barrett B, 2000, J FAM PRACTICE, V49, P234; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Campbell DG, 2006, J REHABIL RES DEV, V43, P99, DOI 10.1682/JRRD.2004.08.0110; Chaterji R, 2007, ALTERN THER HEALTH M, V13, P30; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Desylvia D, 2011, EVID-BASED COMPL ALT, P728; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FURNHAM A, 1988, SOC SCI MED, V26, P685, DOI 10.1016/0277-9536(88)90060-3; George S, 2011, MIL MED, V176, P685, DOI 10.7205/MILMED-D-10-00242; Hyland ME, 2003, COMPLEMENT THER MED, V11, P33, DOI 10.1016/S0965-2299(02)00113-9; Jacobson IG, 2009, ANN EPIDEMIOL, V19, P613, DOI 10.1016/j.annepidem.2009.05.001; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Karch DL, SURVEILLANCE VIOLENT; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kersten P, 2011, EVID BASED COMPLEMEN; Kroesen K, 2002, FAM PRACT, V19, P57, DOI 10.1093/fampra/19.1.57; Lie Desiree, 2004, BMC Med Educ, V4, P2, DOI 10.1186/1472-6920-4-2; Lie Desiree A, 2006, BMC Med Educ, V6, P58, DOI 10.1186/1472-6920-6-58; Linehan MM, 2006, PSYCHOL ASSESSMENT, V18, P303, DOI 10.1037/1040-3590.18.3.303; LINEHAN MM, 1996, LIFETIME PARASUICIDE; McEachrane-Gross F Patricia, 2006, BMC Complement Altern Med, V6, P34, DOI 10.1186/1472-6882-6-34; McFadden KL, 2010, EXPLORE-NY, V6, P380, DOI 10.1016/j.explore.2010.08.004; Micek MA, 2007, J ALTERN COMPLEM MED, V13, P190, DOI 10.1089/acm.2006.6147; National Center for Complementary and Alternative Medicine (NCCAM), COMPL ALT INT HLTH W; Pettersen S, 2007, ADV HEALTH SCI EDUC, V12, P35, DOI 10.1007/s10459-005-3054-1; Robinson A, 2007, J ALTERN COMPLEM MED, V13, P207, DOI 10.1089/acm.2006.6182; *SAS I INC, 2002, SAS COMP PROGR; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Sirois FM, 2002, SOC SCI MED, V55, P1025, DOI 10.1016/S0277-9536(01)00229-5; Smith Tyler C, 2007, BMC Complement Altern Med, V7, P16, DOI 10.1186/1472-6882-7-16; Tan M., 2 MILLION TROOPS HAV; Weathers F.W., 1993, ANN CONV INT SOC TRA; White MR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-27	39	8	8	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7079	1537-1948		MED CARE	Med. Care	DEC	2014	52	12		5			S50	S56		10.1097/MLR.0000000000000219			7	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	V45TM	WOS:000209838900010	25397824				2022-02-06	
J	Elnitsky, CA; Lind, JD; Rugs, D; Powell-Cope, G				Elnitsky, Christine A.; Lind, Jason D.; Rugs, Deborah; Powell-Cope, Gail			Implications for patient safety in the use of safe patient handling equipment: A national survey	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						Moving and lifting; Nursing; Quantitative analysis; Qualitative analysis; Safety; Supplies and equipment; Technology; Wounds and injuries	CARE; IMPLEMENTATION; DEVICES; NURSES; LIFTS	Background: The prevalence of musculoskeletal injuries among nursing staff has been high due to patient handling and movement. Internationally, healthcare organizations are integrating technological equipment into patient handling and movement to improve safety. Although evidence shows that safe patient handling programs reduce work-related musculoskeletal injuries in nursing staff, it is not clear how safe these new programs are for patients. Objectives: The objective of this study was to explore adverse patient events associated with safe patient handling programs and preventive approaches in US Veterans Affairs medical centers. Methods: The study surveyed a convenience sample of safe patient handling program managers from 51 US Department of Veterans Affairs medical centers to collect data on skin-related and fall-related adverse patient events. Results: Both skin- and fall-related adverse patient events associated with safe patient handling occurred at VA Medical centers. Skin-related events included abrasions, contusions, pressure ulcers and lacerations. Fall-related events included sprains and strains, fractures, concussions and bleeding. Program managers described contextual factors in these adverse events and ways of preventing the events. Conclusions: The use of safe patient handling equipment can pose risks for patients. This study found that organizational factors, human factors and technology factors were associated with patient adverse events. The findings have implications for how nursing professionals can implement safe patient handling programs in ways that are safe for both staff and patients. Published by Elsevier Ltd.	[Elnitsky, Christine A.] Univ N Carolina, Coll Hlth & Human Serv, Sch Nursing, Charlotte, NC 28223 USA; [Elnitsky, Christine A.; Lind, Jason D.; Rugs, Deborah; Powell-Cope, Gail] James A Haley Vet Hosp, VISN Patient Safety Ctr Inquiry 8, Hlth Serv Res & Dev Ctr Innovat Disabil & Rahabil, Tampa, FL 33612 USA		Elnitsky, CA (corresponding author), James A Haley Vet Hosp, VISN Patient Safety Ctr Inquiry 8, Hlth Serv Res & Dev Ctr Innovat Disabil & Rahabil, 8900 Grand Oak Circle, Tampa, FL 33612 USA.	celnitsk@uncc.edu		Powell-Cope, Gail/0000-0002-4608-0128; Lind, Jason/0000-0002-1610-0431	Veterans Integrated Service Network Region 8 Patient Safety Center of Inquiry	This material is the result of work supported by the Veterans Integrated Service Network Region 8 Patient Safety Center of Inquiry and use of facilities at the James A. Haley Veteran's Affairs Hospital, Tampa, FL. Contents do not represent the views of the sponsor, the Department of Veterans Affairs nor the US Government. Sponsors had no involvement in study design; in the collection, analysis and interpretation of data; in writing the report; or in the decision to submit the paper for publication.	Alamgir H, 2008, INJURY, V39, P570, DOI 10.1016/j.injury.2007.11.420; Ali G, 2001, Prof Nurse, V16, P1153; Attarian D. E., 2012, AM ACAD ORTHOP SURG, V6; Baptiste A, 2008, REHABIL NURS, V33, P22, DOI 10.1002/j.2048-7940.2008.tb00189.x; Battles James B., 2002, Biomedical Instrumentation and Technology, V36, P84; Bernard H, 2009, ANAL QUALITATIVE DAT; Corbin J. M., 2007, BASICS QUALITATIVE R; Cornish Jocelyn, 2012, Br J Nurs, V21, P166; Cornish Jocelyn, 2010, Nurse Educ Pract, V10, P96, DOI 10.1016/j.nepr.2009.03.020; de Ruiter H, 2008, THESIS U MINNESOTA; de Ruiter HP, 2006, AM J NURS, V106, P13, DOI 10.1097/00000446-200609000-00002; de Ruiter HP, 2011, AAOHN J, V59, P337, DOI 10.3928/08910162-20110718-02; FDA US Food and Drug Administration a, 2011, MAN US FAC DEV EXP M; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hignett S, 2009, WORK, V33, P175, DOI 10.3233/WOR-2009-0864; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Koppelaar E, 2009, OCCUP ENVIRON MED, V66, P353, DOI 10.1136/oem.2008.042481; Lang TA, 2004, J NURS ADMIN, V34, P326, DOI 10.1097/00005110-200407000-00005; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Morgan M.G., 2001, RISK COMMUNICATION M; Nelson A, 2009, ILLUSTRATED GUIDE SA; Nelson Audrey, 2004, Online J Issues Nurs, V9, P4; Nelson Audrey, 2003, AAOHN J, V51, P126; Patton M. Q., 1990, QUALITATIVE RES EVAL; Powell-Cope G., 2008, PATIENT SAFETY QUALI; Rugs D., 2012, AM J SAFE PATIENT HA, V2, P112; Schoenfisch AL, 2011, AM J IND MED, V54, P946, DOI 10.1002/ajim.21001; Swain J, 2003, J CLIN NURS, V12, P297, DOI 10.1046/j.1365-2702.2003.00695.x; US Department of Labor, 2013, OCC SAF HLTH ADM WE; Weinger MB, 1998, JAMA-J AM MED ASSOC, V280, P1484, DOI 10.1001/jama.280.17.1484-a; Wright L, 2005, ASS OCCUPATIONAL HLT, P28	31	8	9	2	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	DEC	2014	51	12					1624	1633		10.1016/j.ijnurstu.2014.04.015			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	AX6HL	WOS:000347023500010	24856578				2022-02-06	
J	Garcia-Marin, A; Turegano-Fuentes, F; Sanchez-Arteaga, A; Franco-Herrera, R; Simon-Adiego, C; Sanz-Sanchez, M				Garcia-Marin, A.; Turegano-Fuentes, F.; Sanchez-Arteaga, A.; Franco-Herrera, R.; Simon-Adiego, C.; Sanz-Sanchez, M.			Bullhorn and bullfighting injuries	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Bullfighting; Bullhorn; Penetrating trauma; Blunt trauma; Soft tissue injuries	TAURINA; SPAIN	Our purpose was to present our hospital experience with bullhorn injuries. A retrospective analysis of patients in our Trauma Registry (1993-2012). Fifteen patients were included. All were hemodynamically stable on presentation, with a mean Glasgow Coma Scale (GCS) score and a Revised Trauma Score (RTS) of 15 and 11.9, respectively. The Injury Severity Score (ISS) and New Injury Severity Score were 13.6 +/- A 6 and 15.9 +/- A 9, respectively. Seven had an ISS > 15. Injuries resulted from an isolated blunt trauma (BT) in four, penetrating trauma (PT) in seven, with extensive soft tissue injuries (STI) in three, and a combined BT + PT mechanism in four patients, with extensive STI in all. Three patients had injuries to vessels in the groin, two with prehospital vein ligation. Five patients had abdominal visceral injuries, and another had a sheathed goring, with a traumatic abdominal wall hernia and retroperitoneal hematoma. Four patients had thoracic injuries, and one of them had a traumatic thoracoplasty with a large open thoracic wound, a flail chest, and extensive STI. Two patients had traumatic brain injury, and six had bone fractures. Two-thirds of patients required a surgical procedure under general anesthesia. Morbidity included three surgical site infections, one leg compartment syndrome, and one persistent lymph drainage. There was no mortality, and the mean length of hospital stay was 16 days. Bullhorn and bullfighting injuries frequently have a multimechanistic origin which goes beyond a pure penetrating trauma. Associated blunt and STI were common in our series, and the overall prognosis of patients admitted to hospital was good.	[Garcia-Marin, A.] Univ San Juan Hosp, Gen Surg Serv, Alicante, Spain; [Garcia-Marin, A.] Univ San Juan Hosp, Alicante, Spain; [Garcia-Marin, A.] Miguel Hernandez Univ, Pathol & Surg Dept, Alicante 03550, Spain; [Turegano-Fuentes, F.; Sanchez-Arteaga, A.; Franco-Herrera, R.; Sanz-Sanchez, M.] Univ Gen Hosp Gregorio Maranon, Gen Surg Serv 2, Madrid, Spain; [Turegano-Fuentes, F.; Sanchez-Arteaga, A.; Franco-Herrera, R.; Sanz-Sanchez, M.] Univ Gen Hosp Gregorio Maranon, Emergency Surg Sect, Madrid, Spain; [Simon-Adiego, C.] Univ Gen Hosp Gregorio Maranon, Thorac Surg Serv, Madrid, Spain		Garcia-Marin, A (corresponding author), Miguel Hernandez Univ, Pathol & Surg Dept, Carretera Alicante Valencia S-N, Alicante 03550, Spain.	agmarin1980@gmail.com	SIMON, CARLOS M/H-3969-2017; Simon, Carlos/K-6731-2019	SIMON, CARLOS M/0000-0002-9337-6167; Simon, Carlos/0000-0002-9337-6167; Garcia Marin, Andres/0000-0001-8291-9165			Chambres O, 2003, Rev Laryngol Otol Rhinol (Bord), V124, P221; Crespo Escudero J.L., 2008, Rev Esp Cirug Oral y Maxilofac, V30, P353; Dogan Kamil H, 2008, J Agromedicine, V13, P191, DOI 10.1080/10599240802405975; Lehmann V, 2003, ZBL CHIR, V128, P685; Lloyd MS, 2004, ANN ROY COLL SURG, V86, P3, DOI 10.1308/003588404772614597; Maldonado-Fernandez N, 2013, CIR ESPAN, V91, P340, DOI 10.1016/j.ciresp.2011.11.011; Martinez-Ramos D, 2007, EMERGE, V19, P347; Martinez-Ramos David, 2006, Cir Esp, V80, P16; Minano Perez A, 2007, REV ESP INVEST QUIR, V10, P199; Murphy CG, 2010, INJURY, V41, P548, DOI 10.1016/j.injury.2009.08.006; Pestana-Tirado RA., 1997, TRIB MED, V96, P67; Rios-Pacheco Monica, 2003, Cir Cir, V71, P55; Rudloff U, 2006, J TRAUMA, V61, P970, DOI 10.1097/01.ta.0000196871.19566.92; Spiotta AM, 2011, NEUROSURGERY, V69, P455, DOI 10.1227/NEU.0b013e3182191fb1; Utrilla Lopez A, 1999, ARCH CIR VASCULAR, V8, P1; Vaquero Carlos, 2008, Rev Port Cir Cardiotorac Vasc, V15, P217; Vazquez- ~Bayod R, 2001, REV MEX ORTOP TRAUM, V14, P302; Zamora-Lomeli JA, 2004, CIR GEN, V26, P97; Zumarraga-Navas P., 1999, CIR ESP, V65, P447	19	8	8	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2014	40	6					687	691		10.1007/s00068-014-0381-z			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AU6GL	WOS:000345701700006	26814783				2022-02-06	
J	Morse, JD; Franck, JA; Wilcox, BJ; Crisco, JJ; Franck, C				Morse, Justin D.; Franck, Jennifer A.; Wilcox, Bethany J.; Crisco, Joseph J.; Franck, Christian			An Experimental and Numerical Investigation of Head Dynamics Due to Stick Impacts in Girls' Lacrosse	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Finite element model; Sports-related concussion; Intracranial dynamics; Head acceleration; Maximum principal strain; von Mises stress	INJURIES; CONCUSSION; FOOTBALL; CRITERIA; TRAUMA; HOCKEY	A method of investigating head acceleration and intracranial dynamics from stick impacts in girls' and women's lacrosse was developed using headform impact experiments and a finite element head model. Assessing the likelihood of head injury due to stick-head impacts is of interest in girls' and women's lacrosse due to the current lack of head protection during play. Experimental and simulation data were compared to characterize the head acceleration caused by stick-head impacts. Validation against cadaver head impact experiments ensures that the finite element model, with its relatively simple material properties, can provide means to develop a better understanding of the intracranial dynamics during lacrosse stick impacts. Our numerical results showed the peak acceleration at the center of gravity increased linearly with impact force, and was generally in agreement with the experimental data. von Mises stresses and peak principal strains, two common literature injury indicators, were examined within the finite element model, and peak values were below the previously reported thresholds for mild traumatic brain injury. By reconstructing typical in-game, unprotected stick-head impacts, this investigation lays the foundation for a quantitative methodology of injury prediction in girls' and womens' lacrosse.	[Morse, Justin D.; Wilcox, Bethany J.; Crisco, Joseph J.; Franck, Christian] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Franck, Jennifer A.; Franck, Christian] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Crisco, Joseph J.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; [Crisco, Joseph J.] Rhode Isl Hosp, Providence, RI USA		Franck, C (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	franck@brown.edu	Franck, Jennifer/AAF-1330-2019	Franck, Jennifer/0000-0001-8456-5153; Crisco, Joseph/0000-0002-8786-0905	US Lacrosse; National Operating Committee on Standards for Athletic Equipment (NOCSAE); Rhode Island Science and Technology Advisory Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104937] Funding Source: NIH RePORTER	This study was funded in part by US Lacrosse, the National Operating Committee on Standards for Athletic Equipment (NOCSAE), and the Rhode Island Science and Technology Advisory Council. We would also like to thank Laura Costa for her efforts in performing the impact experiments.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bower A. F., 2010, APPL MECH SOLIDS, P820; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Claessens M., 1997, 973338 SAE; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Dillon P., 2013, 2014 2015 NCAA WOMEN; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Irick E, 2013, 1981 82 2012 13 NCAA; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Littlefield David L, 2011, Stapp Car Crash J, V55, P75; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Miller R. T., 1998, 983154 SAE; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Nahum AM, 1977, P 21 STAPP CAR CRASH; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021; Young PG, 2008, PHILOS T R SOC A, V366, P3155, DOI 10.1098/rsta.2008.0090	43	8	8	0	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2014	42	12					2501	2511		10.1007/s10439-014-1091-8			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AU1QB	WOS:000345394000011	25124650				2022-02-06	
J	Reinbold, ED; Scholl, JL; Oliver, KM; Watt, MJ; Forster, GL				Reinbold, Emily D.; Scholl, Jamie L.; Oliver, Kathryn M.; Watt, Michael J.; Forster, Gina L.			Central CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal	NEUROSCIENCE RESEARCH			English	Article						Anxiety; Stress; Corticotropin-releasing factor; Amygdala; Lateral septum; Antisauvagine-30	CORTICOTROPIN-RELEASING-FACTOR; DORSAL RAPHE NUCLEUS; WEANING SOCIAL-ISOLATION; TRAUMATIC BRAIN-INJURY; STRIA TERMINALIS; BED NUCLEUS; HORMONE RECEPTOR-2; LATERAL SEPTUM; STRESS; BEHAVIOR	Increased depressive and anxiety-like behaviors are exhibited by rats and humans during withdrawal from psychostimulants. Anxiety-like behaviors observed during amphetamine withdrawal are mediated by increased expression and activity of corticotropin releasing factor type 2 (CRF2) receptors in the dorsal raphe nucleus (dRN). Anxiety-like behavior of rats during withdrawal can be reversed by CRF2 receptor antagonism in the dRN, but the efficacy of global central CRF2 receptor antagonism is unknown. Rats were treated with amphetamine (2.5 mg/kg, ip.) or saline daily for 2 weeks, and were tested for anxiety-like behaviors during withdrawal. Rats undergoing withdrawal showed increased anxiety-like behavior, which was reduced by ventricular infusion of the CRF2 antagonist antisauvagine-30 (ASV 2 mu g/2 mu I). Surprisingly, ventricular ASV increased anxiety-like behavior in rats pre-treated with saline, but had an anxiolytic effect in un-treated rats. Western blots were performed to determine whether differences in CRF receptor densities could explain ASV-induced behavioral results. Saline pre-treated rats showed reduced CRF1 receptor expression in the lateral septum compared to amphetamine pre-treated and untreated rats. Overall, these results suggest that central CRF2 antagonism reduces anxiety states during amphetamine withdrawal, and that behavioral effects may be dependent upon the balance of CRF1 and CRF2 receptor activity in anxiety-related regions. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Reinbold, Emily D.; Scholl, Jamie L.; Oliver, Kathryn M.; Watt, Michael J.; Forster, Gina L.] Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, Ctr Brain & Behav Res, Vermillion, SD 57069 USA		Forster, GL (corresponding author), Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, 414 East Clark St, Vermillion, SD 57069 USA.	gforster@usd.edu		Watt, Michael/0000-0003-1164-1367	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DA019921, P20 RR016479]; University of South Dakota Undergraduate Research Award; University of South Dakota INBRE Summer Fellowship; Sanford School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA019921] Funding Source: NIH RePORTER	We would like to thank Dr. Jeffrey Barr for his assistance with these experiments. This work was funded by grants NIH R01 DA019921 (GF). ER was supported by a University of South Dakota Undergraduate Research Award, a University of South Dakota INBRE Summer Fellowship (NIH P20 RR016479) and a Medical Student Summer Fellowship from the Sanford School of Medicine.	Bakshi VP, 2002, J NEUROSCI, V22, P2926, DOI 10.1523/JNEUROSCI.22-07-02926.2002; Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Barr JL, 2010, NEUROPHARMACOLOGY, V59, P395, DOI 10.1016/j.neuropharm.2010.05.011; Bledsoe AC, 2011, BRAIN RES BULL, V85, P117, DOI 10.1016/j.brainresbull.2011.03.003; Cantwell B, 1998, DRUG ALCOHOL DEPEN, V49, P157, DOI 10.1016/S0376-8716(97)00160-9; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; Elharrar E, 2013, BIOL PSYCHIAT, V74, P827, DOI 10.1016/j.biopsych.2013.05.039; Forster GL, 2006, NEUROSCIENCE, V141, P1047, DOI 10.1016/j.neuroscience.2006.04.006; Forster GL, 2008, EUR J NEUROSCI, V28, P299, DOI 10.1111/j.1460-9568.2008.06333.x; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Kishimoto T, 2000, NAT GENET, V24, P415, DOI 10.1038/74271; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Lebow M, 2012, J NEUROSCI, V32, P6906, DOI 10.1523/JNEUROSCI.4012-11.2012; Liu J, 2004, J NEUROSCI, V24, P4020, DOI 10.1523/JNEUROSCI.5531-03.2004; Lukkes JL, 2009, NEUROSCIENCE, V158, P845, DOI 10.1016/j.neuroscience.2008.10.036; Lukkes JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.018.2009; Mantsch JR, 2007, BRAIN RES, V1167, P101, DOI 10.1016/j.brainres.2007.05.080; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pernar L, 2004, J NEUROSCI, V24, P1305, DOI 10.1523/JNEUROSCI.2885-03.2004; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Pringle RB, 2008, NEUROSCI RES, V62, P62, DOI 10.1016/j.neures.2008.05.009; Radulovic J, 1999, J NEUROSCI, V19, P5016; Romanelli F, 2006, PHARMACOTHERAPY, V26, P1148, DOI 10.1592/phco.26.8.1148; SARNYAI Z, 1995, BRAIN RES, V675, P89, DOI 10.1016/0006-8993(95)00043-P; Scholl JL, 2010, EUR J PHARMACOL, V644, P80, DOI 10.1016/j.ejphar.2010.07.008; Schuckit MA, 1999, AM J PSYCHIAT, V156, P41, DOI 10.1176/ajp.156.1.41; Shoptaw SJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003021.pub2; Skorzewska A, 2011, BEHAV BRAIN RES, V221, P155, DOI 10.1016/j.bbr.2011.02.036; Srisurapanont M, 1999, AUST NZ J PSYCHIAT, V33, P89, DOI 10.1046/j.1440-1614.1999.00517.x; Srisurapanont M, 1999, AUST NZ J PSYCHIAT, V33, P94, DOI 10.1046/j.1440-1614.1999.00518.x; Takahashi C, 2011, PEPTIDES, V32, P2384, DOI 10.1016/j.peptides.2011.09.016; Takahashi LK, 2001, NEUROSCI BIOBEHAV R, V25, P627, DOI 10.1016/S0149-7634(01)00046-X; Takahashi LK, 2001, BRAIN RES, V902, P135, DOI 10.1016/S0006-8993(01)02405-2; Ventura-Silva AP, 2012, EUR J NEUROSCI, V36, P3396, DOI 10.1111/j.1460-9568.2012.08262.x; Vuong SM, 2010, BEHAV BRAIN RES, V208, P278, DOI 10.1016/j.bbr.2009.11.036	39	8	8	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	DEC	2014	89						37	43		10.1016/j.neures.2014.08.010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AY9IW	WOS:000347864700004	25205625	Green Accepted			2022-02-06	
J	Wu, WC; Tian, RF; Hao, SY; Xu, FF; Mao, X; Liu, BY				Wu, Weichuan; Tian, Runfa; Hao, Shuyu; Xu, Feifan; Mao, Xiang; Liu, Baiyun			A pre-injury high ethanol intake in rats promotes brain edema following traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						brain edema; ethanol intake; fluid percussion injury; traumatic brain injury	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; INDUCED OXIDATIVE STRESS; INDUCED HYPERPERMEABILITY; BARRIER DYSFUNCTION; EXPRESSION; CELLS; AQUAPORIN-4; NEURODEGENERATION; ACTIVATION	Drinking is a risk factor for traumatic brain injury (TBI), and ethanol can aggravate the outcome by promoting brain edema. The mechanism involved is not fully understood. It has been confirmed that aquaporin-4 (AQP4) and vascular endothelial growth factor (VEGF) play pivotal roles in cytotoxic/vasogenic brain edema individually, and both of these proteins are downstream regulatory factors of hypoxiainducible factor-1 alpha (HIF-1 alpha). In this study, we used a fluid percussion injury (FPI) model in rats to determine the effects of acute ethanol intake on the expression levels of HIF-1 alpha, AQP4, and VEGF prior to FPI. The animals were sacrificed 1, 2, 3, and 4 days post-injury. We found that the expression levels of HIF-1 alpha and AQP4 were significantly upregulated in the ethanol-pretreated groups, whereas the VEGF expression level was not. In addition, there was a positive correlation between HIF-1 alpha and AQP4. The results of this study indicate that cytotoxic brain edema may play an important role in the early stage of FPI in ethanol-pre-treated animals and that HIF-1 alpha and AQP4 might be involved.	[Wu, Weichuan; Tian, Runfa; Hao, Shuyu; Xu, Feifan; Liu, Baiyun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Mao, Xiang] Anhui Med Univ, Dept Clin Med, Hefei, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China.	Liubaiyun1212@163.com					Allansson L, 2001, J NEUROCHEM, V76, P472, DOI 10.1046/j.1471-4159.2001.00097.x; Chavez JC, 2000, J APPL PHYSIOL, V89, P1937, DOI 10.1152/jappl.2000.89.5.1937; Chen XF, 2011, HORM METAB RES, V43, P614, DOI 10.1055/s-0031-1283149; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Crews FT, 2004, ALCOHOL CLIN EXP RES, V28, P350, DOI 10.1097/01.ALC.0000113416.65546.01; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Fischer S, 2004, J CELL PHYSIOL, V198, P359, DOI 10.1002/jcp.10417; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Greiffenstein P, 2007, ALCOHOL CLIN EXP RES, V31, P704, DOI 10.1111/j.1530-0277.2007.00355.x; Han SR, 2011, J KOREAN NEUROSURG S, V50, P472, DOI 10.3340/jkns.2011.50.5.472; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Higashida T, 2011, CURR NEUROVASC RES, V8, P44, DOI 10.2174/156720211794520251; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Jeong HJ, 2005, LIFE SCI, V77, P2179, DOI 10.1016/j.lfs.2005.04.014; Jones A, 2001, CLIN CANCER RES, V7, P1263; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kimura R, 2005, STROKE, V36, P1259, DOI 10.1161/01.STR.0000165925.20413.14; LaManna JC, 2004, J EXP BIOL, V207, P3163, DOI 10.1242/jeb.00976; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nielsen S, 1997, J NEUROSCI, V17, P171; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Shin YJ, 2010, J NEUROIMMUNOL, V229, P81, DOI 10.1016/j.jneuroim.2010.07.008; Stroop R, 1998, ACT NEUR S, V71, P303; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Yu R, 2001, Chin J Traumatol, V4, P218; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	39	8	8	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2014	28	6					739	745		10.3109/02688697.2014.915007			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AU0XG	WOS:000345344900009	24814385				2022-02-06	
J	Sliozberg, Y; Chantawansri, T				Sliozberg, Yelena; Chantawansri, Tanya			Damage in spherical cellular membrane generated by the shock waves: Coarse-grained molecular dynamics simulation of lipid vesicle	JOURNAL OF CHEMICAL PHYSICS			English	Article							TRAUMATIC BRAIN-INJURY; NEURONAL INJURY; IN-VITRO; PRESSURE; MORPHOLOGY; BILAYERS; RUPTURE; MODEL	Traumatic Brain Injury is a major health issue that is hard to diagnose since it often occurs without signs of external injuries. While it is well known that exposure of biological cells to shock waves causes damage to the cell membrane, it is currently unknown by which mechanisms damage is caused, and how it depends on physical parameters such as shock wave velocity, shock pulse duration, or shock pulse shape. In this computational study, we use a coarse-grained model of the lipid vesicle as a generic model of a cell membrane to elucidate the general principles of the cellular damage induced by the shock wave direct passage through the cranium. Results indicate that the extent of the liposome compression does not strongly depend on the pressure pulse and that liposome extension is very sensitive to the change in the negative pressure phase. The structural integrity of the vesicle is altered as pores form in the lipid membrane at overall pressure impulses generated by supersonic shock waves, which are greater than 5 Pa . s at single or repetitive exposure. Consequently, these permeability changes may lead to changes in the influx of sodium, potassium, and calcium ions. (C) 2014 AIP Publishing LLC.	[Sliozberg, Yelena] US Army Res Lab, TKC Global, Aberdeen Proving Ground, MD 21005 USA; [Chantawansri, Tanya] US Army Res Lab, Aberdeen Proving Ground, MD 21005 USA		Sliozberg, Y (corresponding author), US Army Res Lab, TKC Global, 4600 Deer Creek Loop, Aberdeen Proving Ground, MD 21005 USA.				U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911QX-14-C-0016]	The research reported in this document was performed in connection with contract/instrument W911QX-14-C-0016 with the U.S. Army Research Laboratory.	Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; Brennan JK, 2009, MOL SIMULAT, V35, P766, DOI 10.1080/08927020902902783; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fritz D, 2011, PHYS CHEM CHEM PHYS, V13, P10412, DOI 10.1039/c1cp20247b; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Ghoufi A, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13010-7; Glasstone S., 1977, EFFECTS NUCL WEAPONS, V3; Grafmuller A, 2009, BIOPHYS J, V96, P2658, DOI 10.1016/j.bpj.2008.11.073; Groot RD, 2001, BIOPHYS J, V81, P725, DOI 10.1016/S0006-3495(01)75737-2; Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784; Gupta RR, 2013, EARTHQ STRUCT, V4, P1, DOI 10.12989/eas.2013.4.1.1; HESSELINK L, 1988, J FLUID MECH, V196, P513, DOI 10.1017/S0022112088002800; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; KOELMAN JMVA, 1993, EUROPHYS LETT, V21, P363, DOI 10.1209/0295-5075/21/3/018; Koshiyama K, 2008, BBA-BIOMEMBRANES, V1778, P1423, DOI 10.1016/j.bbamem.2008.03.010; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Koshiyama K, 2011, J BIOMECH, V44, P2053, DOI 10.1016/j.jbiomech.2011.05.014; Koshiyama K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018105; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Lin KW, 2014, IEEE T ULTRASON FERR, V61, P251, DOI 10.1109/TUFFC.2014.6722611; Marrink SJ, 2009, BBA-BIOMEMBRANES, V1788, P149, DOI 10.1016/j.bbamem.2008.10.006; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ortiz V, 2005, J PHYS CHEM B, V109, P17708, DOI 10.1021/jp0512762; Peters EAJF, 2004, EUROPHYS LETT, V66, P311, DOI 10.1209/epl/i2004-10010-4; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sliozberg YR, 2011, SOFT MATTER, V7, P7539, DOI 10.1039/c1sm05820g; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Soares JS, 2013, ANN BIOMED ENG, V41, P2318, DOI 10.1007/s10439-013-0829-z; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Trofimov SY, 2003, THERMODYNAMIC CONSIS; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weiner MF, 2009, AM PSYCHIAT PUBLISHI; Wess O., 2006, ISMST, V1, P5; Wilbert DM, 2002, BJU INT, V90, P507, DOI 10.1046/j.1464-410X.2002.02961.x; Xi XF, 2001, J ACOUST SOC AM, V109, P1226, DOI 10.1121/1.1349183	53	8	8	2	26	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0021-9606	1089-7690		J CHEM PHYS	J. Chem. Phys.	NOV 14	2014	141	18							184904	10.1063/1.4901130			10	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Physics	AT3PZ	WOS:000344847600038	25399159				2022-02-06	
J	Garling, RJ; Watts, LT; Sprague, S; Fletcher, L; Jimenez, DF; Digicaylioglu, M				Garling, Richard Justin; Watts, Lora Talley; Sprague, Shane; Fletcher, Lauren; Jimenez, David F.; Digicaylioglu, Murat			Does progesterone show neuroprotective effects on traumatic brain injury through increasing phosphorylation of Akt in the hippocampus?	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; Akt; traumatic brain injury; progesterone; apoptosis; neuroprotection; brain injury; western blotting; controlled cortical impact; neural regeneration	PROTEIN-KINASE B/AKT; CELL-DEATH; ALLOPREGNANOLONE; SURVIVAL; RAT; ACTIVATION; DEFICITS; GLIOSIS; BINDING; EDEMA	There are currently no federally approved neuroprotective agents to treat traumatic brain injury. Progesterone, a hydrophobic steroid hormone, has been shown in recent studies to exhibit neuroprotective effects in controlled cortical impact rat models. Akt is a protein kinase known to play a role in cell signaling pathways that reduce edema, inflammation, apoptosis, and promote cell growth in the brain. This study aims to determine if progesterone modulates the phosphorylation of Akt via its threonine 308 phosphorylation site. Phosphorylation at the threonine 308 site is one of several sites responsible for activating Akt and enabling the protein kinase to carry out its neuroprotective effects. To assess the effects of progesterone on Akt phosphorylation, C57BL/6 mice were treated with progesterone (8 mg/kg) at 1 (intraperitonally), 6, 24, and 48 hours (subcutaneously) post closed-skull traumatic brain injury The hippocampus was harvested at 72 hours post injury and prepared for western blot analysis. Traumatic brain injury caused a significant decrease in Akt phosphorylation compared to sham operation. However, mice treated with progesterone following traumatic brain injury had an increase in phosphorylation of Akt compared to traumatic brain injury vehicle. Our findings suggest that progesterone is a viable treatment option for activating neuroprotective pathways after traumatic brain injury.	[Garling, Richard Justin; Sprague, Shane; Fletcher, Lauren; Jimenez, David F.; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA		Watts, LT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	wattsl@uthscsa.edu	Watts, Lora Talley/A-2724-2012	Watts, Lora Talley/0000-0002-2337-1504	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001118, UL1TR001120] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001120, KL2 TR001118] Funding Source: Medline		Abazov VM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.161602; Adelson PD, 1998, ACT NEUR S, V71, P104; Chan TO, 2001, SCI STKE, V2001; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DENICOLA AF, 1993, ADV NEUROL, V59, P199; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Faul M, 2010, TRAUMATIC BRAIN INJU; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; *NAT CTR INJ PREV, 2003, TBI REP C MILD TRAUM; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	25	8	10	0	9	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	NOV	2014	9	21					1891	1896		10.4103/1673-5374.145355			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AW5OT	WOS:000346324900009	25558238	Green Published, gold			2022-02-06	
J	Idowu, OE; Akinbo, O				Idowu, O. E.; Akinbo, O.			Neurotrauma burden in a tropical urban conurbation level I trauma centre	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Assault; Neurotrauma; Road traffic injury; Traumatic brain injury; Traumatic spine injury	BRAIN-INJURY; UNITED-STATES; BIRTH COHORT; YOUNG-ADULTS; EPIDEMIOLOGY; CHILDREN	BackgroundA Neurotrauma is a preventable public health problem whose quantum is said to be increasing in Third-World countries. This evaluation was performed to collate data which is needed to guide in designing, implementing, and evaluating public health prevention programmes with respect to neurotrauma . Methods: A single institution prospective study was carried out. Data was collected at the surgical emergency (SE) room over a year period (1st October 2012-30th September 2013). These included patients' demographics, cause of injury, region of the body involved, Glasgow coma scale score, and outcome. The patients were further divided into patients with traumatic brain (TBI) and spine injury (TSI). Analysis of the variables was by simple proportion, percentages, Chi-square and analysis of variance was used to determine the differences between group means. A probability (p) of less than 0.05 was considered statistically significant. Results: A total of 2149 neurotrauma cases (38.8%) out of a total of 5541 surgical trauma cases were seen within the study period at our SE unit. Of the neurotrauma cases, 1621 were males, giving a male: female ratio of 3.1: 1. The mean age was 31 years (median 30 years). The most common age group was 20-29 (29.6%) and 30-39 years (29.6%). Assault was the cause of neurotrauma in 903 patients (42%), closely followed by road traffic injury in 744 patients (34.6%). Brain and spine injury separately occurred in 93.2% and 5.3% of cases, respectively. Five hundred patients (23.3%) were resuscitated and referred to other centres due to lack of bed space. Forty (1.9%) patients were dead on arrival, while twenty-six (1.2%) died while on treatment at the emergency room. Conclusion: Neurotrauma is one of the most common form of trauma at our surgical emergency. Assault and road traffic injury (RTI) were the most common cause of TBI and TSI respectively, with RTI being the most common cause of moderate and severe TBI. The incidence and aetiology of TBI varies according to age and gender. (C) 2014 Elsevier Ltd. All rights reserved.	[Idowu, O. E.] Lagos State Univ, Coll Med, Dept Surg, Div Neurosurg, Lagos, Nigeria; [Idowu, O. E.; Akinbo, O.] Lagos State Univ, Teaching Hosp, Dept Surg, Div Neurosurg, Lagos, Nigeria		Idowu, OE (corresponding author), Lagos State Univ, Coll Med, Dept Surg, Div Neurosurg, Lagos, Nigeria.	oeidowu412@yahoo.com		Idowu, Olufemi/0000-0001-9064-1562			Adeolu AA, 2013, WORLD NEUROSURG, V80, P251, DOI 10.1016/j.wneu.2012.11.063; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; CHACKO V, 1986, PARAPLEGIA, V24, P330, DOI 10.1038/sc.1986.48; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Faul M, 2010, TRAUMATIC BRAIN INJU; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kalaiselvan G, 2003, J INJ VIOLENCE RES, V3, P62; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; McGee Kara, 2004, Inj Control Saf Promot, V11, P303, DOI 10.1080/156609704/233/327505; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; National Population Commission of Nigeria, 2006, POP HOUS CENS; Odebode TO, 2008, NIGER J CLIN PRACT, V11, P265; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Peden M., 2004, WORLD REPORT ROAD TR; Peden M., 2002, INJURY CHART BOOK GR; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Raja IA, 2001, WORLD J SURG, V25, P1230; Rathore M Farooq Azam, 2008, J Pak Med Assoc, V58, P53; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; TBI Community, 2013, RES PUBL; Thanni LO, 2008, AFR HEALTH SCI, V6, P104; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741	26	8	8	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2014	45	11					1717	1721		10.1016/j.injury.2014.05.028			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AR9ME	WOS:000343898000009	25034962				2022-02-06	
J	Ingriselli, JM; Register-Mihalik, JK; Schmidt, JD; Mihalik, JP; Goerger, BM; Guskiewicz, KM				Ingriselli, Joseph M.; Register-Mihalik, Johna K.; Schmidt, Julianne D.; Mihalik, Jason P.; Goerger, Benjamin M.; Guskiewicz, Kevin M.			Outcomes, utility, and feasibility of single task and dual task intervention programs: Preliminary implications for post-concussion rehabilitation	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Postconcussion syndrome; Recovery; Paradigm; Brain injury	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; BALANCE CONTROL; NCAA CONCUSSION; COGNITIVE TASK; YOUNG-ADULTS; INDIVIDUALS; MANAGEMENT	Objectives: To examine neurocognitive and balance performance in recreational athletes, prior to and following a dual-task training intervention compared to single-task controls in order to assess the utility and feasibility of these interventions in the clinical setting. Design: Controlled laboratory study. Methods: Thirty healthy, physically active recreational athletes (dual-task group = 15; single-task group = 15; age: 20.3 +/- 1.9 years) completed neurocognitive and balance assessments before and after a four-week intervention. Sensory Organization Test composite score and ratio scores, Balance Error Scoring System total score, and nine CNS Vital Signs composite scores served as outcome measures. Mixed model analyses of variance were used to examine each measure. Results: The single-task group showed greater improvement for complex attention (F-1,F-26 = 5.48, p = .027) following the training period. Both groups improved their performance on the complex attention domain (F-1,F-26 = 6.73, p = .015), the Balance Error Scoring System score (F-1,F-25 = 42.34, p < .001), and the Sensory Organization Test vestibular ratio score (F-1,F-28 = 6.55, p = .016) following the intervention. Conclusions: Our findings suggest combining cognitive and balance tasks as performed does not provide additional benefit to performing these tasks independently among healthy individuals, but appear to be feasible in this setting. Future research should examine integration of single-task and dual-task exercises for concussed patients. (C) 2013 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Ingriselli, Joseph M.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27514 USA; [Register-Mihalik, Johna K.] WakeMed Hlth & Hosp, Emergency Serv Inst, Clin Res Unit, Raleigh, NC USA; [Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Goerger, Benjamin M.] Georgia State Univ, Dept Kinesiol & Hlth, Sports Med Res Lab, Atlanta, GA 30303 USA		Register-Mihalik, JK (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27514 USA.	jmihalik@wakemed.org	Meijer, Anna/K-5118-2016	Mihalik, Jason/0000-0001-6085-8322; Register-Mihalik, Johna/0000-0002-4229-4743; Guskiewicz, Kevin/0000-0002-8682-2130	NC TraCS institute; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000083, KL2TR000084, TL1TR000085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000084, TL1TR000085, UL1TR000083] Funding Source: NIH RePORTER	Drs. Register-Mihalik, Mihalik, and Guskiewicz received funding from the NC TraCS institute that supported this project. The NC TraCS Institute is supported by grants UL1TR000083, KL2TR000084, TL1TR000085 from the National Center for Advancing Translational Sciences, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The remaining authors have no disclosures or conflicts of interest.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Clark M.A., 2012, NASM ESSENTIALS PERS; Damos D. L., 1991, MULTIPLE TASK PERFOR; Gaerlan MG, 2012, J AM ACAD NURSE PRAC, V24, P375, DOI 10.1111/j.1745-7599.2012.00699.x; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hale SA, 2007, J ORTHOP SPORT PHYS, V37, P303, DOI 10.2519/jospt.2007.2322; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Tsang WW, 2004, ARCH PHYS MED REHAB, V85, P129, DOI 10.1016/j.apmr.2003.02.002; Tsang WWN, 2004, MED SCI SPORT EXER, V36, P648, DOI 10.1249/01.MSS.0000121941.57669.BF; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	29	8	8	0	31	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	NOV	2014	17	6					580	585		10.1016/j.jsams.2013.11.006			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AT3PA	WOS:000344845200004	24373772				2022-02-06	
J	Luxton, J; Brinkman, TM; Kimberg, C; Robison, LL; Hudson, MM; Krull, KR				Luxton, Joshua; Brinkman, Tara M.; Kimberg, Cara; Robison, Leslie L.; Hudson, Melissa M.; Krull, Kevin R.			Utility of the N-back task in survivors of childhood acute lymphoblastic leukemia	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						N-back; Working memory; Childhood acute lymphoblastic leukemia	WORKING-MEMORY CAPACITY; TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVORS; NEUROCOGNITIVE DEVELOPMENT; CRANIAL IRRADIATION; SEX-DIFFERENCES; HIGH-RISK; CHILDREN; OUTCOMES; SCHIZOPHRENIA	The N-back task is often used in functional brain imaging studies to activate working memory networks; however, limited information is available on its association to clinical outcomes in children or cancer survivors. A total of 137 survivors of acute lymphoblastic leukemia (ALL; mean current age = 14.3 years, SD = 4.8; time since diagnosis = 7.6 years, SD = 1.6) completed the N-back task and comprehensive neurocognitive testing, including standardized measures of attention, processing speed, and working memory. Results indicated that females demonstrated significantly slower reaction times (0-back p = .02; 1-back p = .03) than males. Survivors <15 years old at the time of testing demonstrated a significant decrease in accuracy as working memory load increased compared to survivors >= 15 years old (p < .001). Performance on the N-back task was associated with nonverbal working memory (r(s) = .56, p < .001) in survivors >= 15 years of age. For younger survivors, N-back performance was more strongly associated with attention skills. Results suggest the N-back assesses different cognitive constructs at younger compared to older childhood ages. These age differences should be considered in interpreting functional brain imaging results.	[Luxton, Joshua; Brinkman, Tara M.; Kimberg, Cara; Robison, Leslie L.; Hudson, Melissa M.; Krull, Kevin R.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38015 USA; [Brinkman, Tara M.; Krull, Kevin R.] St Jude Childrens Res Hosp, Dept Psychol, Memphis, TN 38015 USA; [Hudson, Melissa M.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38015 USA		Krull, KR (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,MS 735, Memphis, TN 38015 USA.	Kevin.Krull@StJude.org	Hudson, Melissa M/N-4441-2018; Krull, Kevin R/N-3882-2018; Brinkman, Tara M/N-8171-2018; Robison, Leslie/N-8122-2018	Hudson, Melissa M/0000-0001-6984-2407; Krull, Kevin R/0000-0002-0476-7001; Brinkman, Tara M/0000-0002-4250-6160; 	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH085849]; Cancer Center Support (CORE) grant [CA21765]; American Lebanese Syrian Associated CharitiesAmerican Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085849] Funding Source: NIH RePORTER	This work was supported by the National Institute of Mental Health (grant number MH085849, to KRK); Cancer Center Support (CORE) grant [grant number CA21765]; and American Lebanese Syrian Associated Charities.	Anderson V, 1997, Pediatr Rehabil, V1, P63; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bhatia S, 2003, BLOOD CELL MOL DIS, V31, P84, DOI 10.1016/S1079-9796(03)00072-X; Borkowska A, 2009, WORLD J BIOL PSYCHIA, V10, P870, DOI 10.1080/15622970701557985; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Buizer AI, 2009, PEDIATR BLOOD CANCER, V52, P447, DOI 10.1002/pbc.21869; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Ciesielski KT, 2006, NEUROIMAGE, V33, P980, DOI 10.1016/j.neuroimage.2006.07.028; Conklin HM, 2012, JNCI-J NATL CANCER I, V104, P1386, DOI 10.1093/jnci/djs344; Conners CK., 1995, CONNERS CONTINUOUS P; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Delis DC., 2001, DELIS KAPLAN EXECUTI; Elsabagh S, 2009, BEHAV BRAIN RES, V201, P41, DOI 10.1016/j.bbr.2009.01.026; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Harvey PO, 2004, J PSYCHIATR RES, V38, P567, DOI 10.1016/j.jpsychires.2004.03.003; Huizinga M, 2007, DEV NEUROPSYCHOL, V31, P193, DOI 10.1080/87565640701190817; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Jain N, 2009, CANCER-AM CANCER SOC, V115, P4238, DOI 10.1002/cncr.24464; Janzen LA, 2008, DEV DISABIL RES REV, V14, P185, DOI 10.1002/ddrr.24; Kalkut EL, 2009, ARCH CLIN NEUROPSYCH, V24, P565, DOI 10.1093/arclin/acp048; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kaplan E, 2004, WISC 4 INTEGRATED; Karatekin C, 2009, INT J PSYCHOPHYSIOL, V73, P294, DOI 10.1016/j.ijpsycho.2009.05.001; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Korkman M, 2013, CHILD NEUROPSYCHOL, V19, P516, DOI 10.1080/09297049.2012.705822; Krull KR, 2008, J CLIN ONCOL, V26, P4138, DOI 10.1200/JCO.2008.16.8864; Krull KR, 2013, J CLIN ONCOL, V31, P2182, DOI 10.1200/JCO.2012.46.7944; Lejbak L, 2011, BRAIN COGNITION, V76, P191, DOI 10.1016/j.bandc.2010.12.002; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Massat I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049392; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meiron O, 2013, PSYCHIAT RES, V209, P1, DOI 10.1016/j.psychres.2012.09.057; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Moleski M, 2000, ARCH CLIN NEUROPSYCH, V15, P603, DOI 10.1016/S0887-6177(99)00050-5; Montour-Proulx I, 2005, J CHILD NEUROL, V20, P129, DOI 10.1177/08830738050200020901; Moore BD, 2005, J PEDIATR PSYCHOL, V30, P51, DOI 10.1093/jpepsy/jsi016; Mulhern Raymond K, 2004, Pediatr Rehabil, V7, P1, DOI 10.1080/13638490310001655528; Mulhern RK, 2004, PEDIAT REHABIL, V7, P15; National Cancer Institute, 2014, AD YOUNG AD CANC; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Phillips LK, 2011, J ABNORM PSYCHOL, V120, P993, DOI 10.1037/a0023542; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robinson KE, 2010, PEDIATR BLOOD CANCER, V54, P585, DOI 10.1002/pbc.22362; Rodriguez-Jimenez R, 2009, BEHAV BRAIN RES, V205, P299, DOI 10.1016/j.bbr.2009.08.022; Schmidt H, 2009, HUM BRAIN MAPP, V30, P3609, DOI 10.1002/hbm.20783; Shelton JT, 2009, INTELLIGENCE, V37, P283, DOI 10.1016/j.intell.2008.11.005; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; Thomason ME, 2009, J COGNITIVE NEUROSCI, V21, P316, DOI 10.1162/jocn.2008.21028; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Waber DP, 2012, PEDIATR BLOOD CANCER, V58, P758, DOI 10.1002/pbc.23234; Wechsler, 2008, WAIS 4 ADM SCORING M; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD	59	8	8	2	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 21	2014	36	9					944	955		10.1080/13803395.2014.957168			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AT7UR	WOS:000345143200004	25252969	Green Accepted			2022-02-06	
J	Bhattacharjee, S; Layek, A; Maitra, S; Sen, S; Pal, S; Gozi, NK				Bhattacharjee, Sulagna; Layek, Amitava; Maitra, Souvik; Sen, Suvadeep; Pal, Sugata; Gozi, Nitis K.			Perioperative Glycemic Status of Adult Traumatic Brain Injury Patients Undergoing Craniotomy: A Prospective Observational Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						stress hyperglycemia; craniotomy; nondiabetic; brain injury; brain trauma; intraoperative hyperglycemia	CARDIAC-SURGERY; HYPERGLYCEMIA; GLUCOSE	Background: Patients of traumatic brain injury (TBI) may have hyperglycemia. and when they undergo craniotomy, hyperglycemia may be exacerbated and worsen outcome. However, epidemiology of perioperative hyperglycemia in these patients is unknown. The epidemiological study has been undertaken to address the correlation between intraoperative blood glucose variability in nondiabetic adult TBI patients undergoing craniotomy with the severity and type of brain trauma and patients' demographic variables. Methods: A total of 200 adult nondiabetic patients undergoing emergency craniotomy for TBI were recruited in this prospective single-group observational study. Baseline capillary blood glucose (CBG) measurement was performed immediately before induction of anesthesia and then at half hourly interval until the end of surgery and 1 hour after the end of surgery. Results: Incidence of at least 1 episode of intraoperative hyperglycemia (CBG >= 180 mg/dL) is 20% in patients with TBI during emergency craniotomy. Independent predictors of intraoperative hyperglycemia are severe head injury (Glasgow-Coma score [GCS] <9) and acute subdural hemorrhage. Baseline CBG also correlates with subsequent intraoperative and postoperative CBG. Conclusions: Hyperglycemia is common during emergency craniotomy in TBI patients. We recommend routine monitoring of blood glucose in the intraoperative and postoperative period at least in severe head injury patients.	[Bhattacharjee, Sulagna; Maitra, Souvik] All India Inst Med Sci, Dept Anaesthesiol & Intens Care, JPNATC, New Delhi 110029, India; [Pal, Sugata] All India Inst Med Sci, Dept Anaesthesiol, JPNATC, New Delhi 110029, India; [Layek, Amitava] Chacha Nehru Bal Chikitsalaya, Dept Anaesthesiol, New Delhi, India; [Sen, Suvadeep] Lilavati Hosp & Res Ctr, Dept Crit Care Med, Mumbai, Maharashtra, India; [Gozi, Nitis K.] Inst Post Grad Med Educ & Res, Dept Anaesthesiol, Kolkata, India		Maitra, S (corresponding author), F 35-2 Third Floor, New Delhi 110049, India.	souvikmaitra@live.com	sen, suvadeep/AAG-3753-2019	sen, suvadeep/0000-0001-8560-1208; Maitra, Souvik/0000-0002-2328-9201			BARTON RN, 1987, BAILLIERE CLIN ENDOC, V1, P355, DOI 10.1016/S0950-351X(87)80067-8; Bower WF, 2010, AM J SURG, V199, P240, DOI 10.1016/j.amjsurg.2009.04.010; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Doenst T, 2005, J THORAC CARDIOV SUR, V130, P1144, DOI 10.1016/j.jtcvs.2005.05.049; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Pecha T, 2011, ANESTH ANALG, V113, P336, DOI 10.1213/ANE.0b013e31821d3dde; Pitkin AD, 2011, ANESTH ANALG, V112, P247, DOI 10.1213/ANE.0b013e3181f98bc9; Salim A, 2009, AM SURGEON, V75, P25; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Shine Timothy S J, 2007, Asian Cardiovasc Thorac Ann, V15, P534; SIEBER F, 1986, ANESTHESIOLOGY, V64, P453, DOI 10.1097/00000542-198604000-00007; THORELL A, 1993, EUR J SURG, V159, P593; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	18	8	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2014	26	4					313	319					7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	AP7QB	WOS:000342270700006	24633214				2022-02-06	
J	Ding, SD; Yang, JJ; Liu, LP; Ye, YR; Wang, XB; Hu, JN; Chen, BC; Zhuge, QC				Ding, Saidan; Yang, Jianjing; Liu, Leping; Ye, Yiru; Wang, Xuebao; Hu, Jiangnan; Chen, Bicheng; Zhuge, Qichuan			Elevated dopamine induces minimal hepatic encephalopathy by activation of astrocytic NADPH oxidase and astrocytic protein tyrosine nitration	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Minimal hepatic encephalopathy; Dopamine; Protein tyrosine nitration; NADPH oxidase	CULTURED RAT ASTROCYTES; TRAUMATIC BRAIN-INJURY; ACUTE LIVER-FAILURE; OXIDATIVE STRESS; CEREBRAL EDEMA; GLUTAMINE-SYNTHETASE; PARKINSONS-DISEASE; MICE; PHOSPHORYLATION; METABOLISM	Background: We previously demonstrated that dopamine (DA) overload may be a key mechanism behind development of minimal hepatic encephalopathy (MHE) in rats. It has been shown that low-grade cerebral oedema and oxidative stress play important roles in the pathogenesis of MHE. In the current study, DA-triggered oxidative injury in cerebral cortex was studied. Methods: An MHE rat model was used. DA was injected intracerebroventricularly (i.c.v.) into rats and added to primary cortical astrocytes (PCAs). Immunoblotting, immunoprecipitation and immunostaining were conducted after DA injection. Results: Cognitive impairment and cerebral edema were observed in MHE rats and rats injected with 10 DA. Astrocyte swelling was increased by DA. Astrocytic protein tyrosine nitration (PTN) was induced by DA. DA-induced PTN was insensitive to L-NMMA but was blunted by apocynin, superoxide dismutase, catalase and uric acid. Exposure to DA substantially increased levels of astrocytic NADPH oxidase subunits and induced p47(Phox) phosphorylation and reactive oxygen species production but decreased the expression and activity of neuronal-type nitric oxide synthase (nNOS). Conclusions: PTN induced by DA, which was attributed to NADPH oxidase and not to nNOS, may alter astrocyte function and thereby contribute to the precipitation of MHE episodes. (C) 2014 Elsevier Ltd. All rights reserved.	[Ding, Saidan; Liu, Leping; Chen, Bicheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Zhejiang Prov Key Lab Aging & Neurol Dis Res, Wenzhou 325000, Peoples R China; [Yang, Jianjing; Hu, Jiangnan; Zhuge, Qichuan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou 325000, Peoples R China; [Ye, Yiru] Wen Zhou Med Univ, Dept Comp, Wenzhou 325000, Peoples R China; [Wang, Xuebao] Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou 325000, Peoples R China		Zhuge, QC (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou City, Zhejiang, Peoples R China.	firstdsdan@hotmail.com	Hu, Jiangnan/ABB-1329-2021; Hu, Jiangnan/ABD-5635-2021; Hu, John/AAL-6376-2021		Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300308, 81171088, 81371396]	This study was funded by the Natural Science Foundation of China (81300308, 81171088, 81371396).	Abdel Rahman TT, 2014, GERIATR GERONTOL INT; BASSETT ML, 1990, GASTROENTEROLOGY, V98, P747, DOI 10.1016/0016-5085(90)90298-F; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bender AS, 1998, J NEUROSCI RES, V52, P307, DOI 10.1002/(SICI)1097-4547(19980501)52:3<307::AID-JNR7>3.0.CO;2-H; BERGERON M, 1989, NEUROCHEM RES, V14, P853, DOI 10.1007/BF00964814; Bernabeu R, 1996, NEUROREPORT, V7, P585, DOI 10.1097/00001756-199601310-00050; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Blei AT, 1999, J HEPATOL, V31, P771, DOI 10.1016/S0168-8278(99)80361-4; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Borkowska HD, 1997, NEUROCHEM RES, V22, P101, DOI 10.1023/A:1027347019707; Borkowska HD, 1999, NEUROSCI LETT, V268, P151, DOI 10.1016/S0304-3940(99)00412-7; Brand A, 1999, J NEUROSCI RES, V58, P576, DOI 10.1002/(SICI)1097-4547(19991115)58:4<576::AID-JNR10>3.3.CO;2-4; Butterworth RF, 2013, NAT REV GASTRO HEPAT, V10, P522, DOI 10.1038/nrgastro.2013.99; Chastre A, 2013, LIVER INT; COLADO MI, 1993, J PHARM PHARMACOL, V45, P220, DOI 10.1111/j.2042-7158.1993.tb05537.x; Coulthard EJ, 2012, BRAIN, V135, P3721, DOI 10.1093/brain/aws273; Dhiman RK, 2009, INDIAN J GASTROENTER, V28, P5, DOI 10.1007/s12664-009-0003-6; Ding SD, 2013, HEPATOL INT, V7, P923, DOI 10.1007/s12072-013-9431-6; Dombro RS, 2000, INT J DEV NEUROSCI, V18, P161, DOI 10.1016/S0736-5748(99)00084-2; Gill T H, 1973, Trans Am Neurol Assoc, V98, P262; Goel A, 2010, LIVER INT, V30, P1143, DOI 10.1111/j.1478-3231.2010.02289.x; Gorg B, 2006, ARCH BIOCHEM BIOPHYS, V449, P104, DOI 10.1016/j.abb.2006.02.012; Gorg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010; Gorg B, 2003, HEPATOLOGY, V37, P334, DOI 10.1053/jhep.2003.50061; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Haussinger D, 2006, HEPATOLOGY, V43, P1187, DOI 10.1002/hep.21235; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; ICHIHARA K, 1989, EUR J PHARMACOL, V164, P189, DOI 10.1016/0014-2999(89)90458-5; ITOH J, 1990, PSYCHOPHARMACOLOGY, V101, P27, DOI 10.1007/BF02253713; Jia L, 2005, WORLD J GASTROENTERO, V11, P908, DOI 10.3748/wjg.v11.i6.908; Johnson JL, 1998, J BIOL CHEM, V273, P35147, DOI 10.1074/jbc.273.52.35147; Kawasumi M, 2004, EUR J NEUROSCI, V19, P2826, DOI 10.1111/j.0953-816X.2004.03397.x; KIEDROWSKI L, 1992, J NEUROCHEM, V58, P335, DOI 10.1111/j.1471-4159.1992.tb09315.x; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; KNELL AJ, 1974, BMJ-BRIT MED J, V1, P549, DOI 10.1136/bmj.1.5907.549; Knorpp T, 2006, J NEURAL TRANSM, V113, P1145, DOI 10.1007/s00702-005-0389-y; Kobza S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050250; Kruczek C, 2009, GLIA, V57, P79, DOI 10.1002/glia.20737; Lachmann V, 2013, ARCH BIOCHEM BIOPHYS, V536, P143, DOI 10.1016/j.abb.2013.05.004; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P337, DOI 10.1038/jcbfm.1991.67; Mamiya T, 1998, BRAIN RES, V783, P236, DOI 10.1016/S0006-8993(97)01406-6; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Martins YC, 2013, MED HYPOTHESES, V81, P777, DOI 10.1016/j.mehy.2013.08.005; Montgomery Jennifer Y, 2011, Curr Gastroenterol Rep, V13, P26, DOI 10.1007/s11894-010-0150-z; Moustafa AA, 2013, NEURODEGENER DIS, V11, P102, DOI 10.1159/000341999; Muijsers RBR, 2000, BRIT J PHARMACOL, V130, P932, DOI 10.1038/sj.bjp.0703401; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; Norenberg MD, 1996, SEMIN LIVER DIS, V16, P245, DOI 10.1055/s-2007-1007237; NORENBERG MD, 1991, NEUROCHEM RES, V16, P833, DOI 10.1007/BF00965694; Pani G, 2001, IUBMB LIFE, V52, P7, DOI 10.1080/15216540252774702; Park JW, 1997, BIOCHEMISTRY-US, V36, P7474, DOI 10.1021/bi9700936; Prakash RK, 2013, CLIN THER, V35, P1458, DOI 10.1016/j.clinthera.2013.07.421; Qi RF, 2013, EUR RADIOL, V23, P3370, DOI 10.1007/s00330-013-2963-2; RECORD CO, 1976, EUR J CLIN INVEST, V6, P387, DOI 10.1111/j.1365-2362.1976.tb00533.x; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504; Schliess F, 2004, GLIA, V47, P21, DOI 10.1002/glia.20019; Schliess F, 2002, FASEB J, V16, P739, DOI 10.1096/fj.01-0862fje; Shiner T, 2012, BRAIN, V135, P1871, DOI 10.1093/brain/aws083; Skowronska M, 2012, NEUROTOX RES, V21, P236, DOI 10.1007/s12640-011-9269-4; Suarez I, 2006, NEUROPATH APPL NEURO, V32, P594, DOI 10.1111/j.1365-2990.2006.00768.x; Torres DS, 2013, METAB BRAIN DIS, V28, P473, DOI 10.1007/s11011-013-9405-3; Vaquero J, 2003, SEMIN LIVER DIS, V23, P259; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Weissenborn K, 2000, METAB BRAIN DIS, V15, P173; WillardMack CL, 1996, NEUROSCIENCE, V71, P589, DOI 10.1016/0306-4522(95)00462-9; Yamada M, 2005, BEHAV BRAIN RES, V164, P139, DOI 10.1016/j.bbr.2005.03.026; YURDAYDIN C, 1990, HEPATOLOGY, V12, P695, DOI 10.1002/hep.1840120413	72	8	10	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	OCT	2014	55						252	263		10.1016/j.biocel.2014.09.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU2YY	WOS:000345481500030	25220477				2022-02-06	
J	Nyholm, L; Steffansson, E; Frojd, C; Enblad, P				Nyholm, Lena; Steffansson, Erika; Frojd, Camilla; Enblad, Per			Secondary Insults Related to Nursing Interventions in Neurointensive Care: A Descriptive Pilot Study	JOURNAL OF NEUROSCIENCE NURSING			English	Article						neurointensive care; nursing interventions; secondary insults	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; INTENSIVE-CARE; HEAD-INJURY	The patients at a neurointensive care unit are frequently cared for in many ways, day and night. The aim of this study was to investigate the amount of secondary insults related to oral care, repositioning, endotracheal suctioning, hygienic measures, and simultaneous interventions at a neurointensive care unit with standardized care and maximum attention on avoiding secondary insults. The definition of a secondary insult was intracranial pressure > 20 mm Hg, cerebral perfusion pressure < 60 mm Hg and systolic blood pressure < 100 mm Hg for 5 minutes or more in a 10-minute period starting from when the nursing intervention began. The insult minutes did not have to be consecutive. The study included 18 patients, seven women and 11 men, aged 36-76 years with different neurosurgical diagnoses. The total number of nursing interventions analyzed was 1,717. The most common kind of secondary insults after a nursing measure was high intracranial pressure (n = 93) followed by low cerebral perfusion pressure (n = 43) and low systolic blood pressure (n = 14). Repositioning (n = 39) and simultaneous interventions (n = 32) were the nursing interventions causing most secondary insults. There were substantial variations between the patients; only one patient had no secondary insult. There were, overall, a limited number of secondary insults related to nursing interventions when a standardized management protocol system was applied to reduce the occurrence of secondary insults. Patients with an increased risk of secondary insults should be recognized, and their care and treatment should be carefully planned and performed to avoid secondary insults.	[Nyholm, Lena; Steffansson, Erika; Enblad, Per] Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden; [Frojd, Camilla] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden		Nyholm, L (corresponding author), Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden.	lena.nyholm@neuro.uu.se					Chamberlain D J, 1998, Aust Crit Care, V11, P123, DOI 10.1016/S1036-7314(98)70499-0; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Prendergast V, 2009, AM J CRIT CARE, V18, P368, DOI 10.4037/ajcc2009621; TEASDALE G, 1974, LANCET, V2, P81; Tume LN, 2011, NURS CRIT CARE, V16, P77, DOI 10.1111/j.1478-5153.2010.00412.x; United States Environmental Protection Agency, 2007, GUID PREP STAND OP P; Walleck C A, 1992, AACN Clin Issues Crit Care Nurs, V3, P19	11	8	10	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2014	46	5					285	291		10.1097/JNN.0000000000000077			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	AP3HC	WOS:000341965200009	25188684				2022-02-06	
J	Srinivasan, V; Pierre, C; Plog, B; Srinivasan, K; Petraglia, AL; Huang, JH				Srinivasan, Vasisht; Pierre, Clifford; Plog, Benjamin; Srinivasan, Kaushik; Petraglia, Anthony L.; Huang, Jason H.			Straight from the horse's mouth: neurological injury in equestrian sports	NEUROLOGICAL RESEARCH			English	Article						Concussion; Closed head injury; Equestrian sports; Neurosurgical trauma; Spine trauma	PATTERNS; PREVENTION; ACCIDENTS; CHILDREN	Objectives: Equestrian sports can result in a variety of injuries to the nervous system due to many factors. We describe our series of 80 patients with injuries sustained during participation in equestrian sports. Methods and Results: All patients seen at the regional trauma center with injuries associated with equestrian sports between 2003 and 2011 were reviewed; 80 patients were identified. Fifty-four per cent were female and the average age was 37 years (2.2-79.3). The mean injury severity score (ISS) was 9.9 +/- 0.7. Only two patients had documented helmet use. Glasgow coma score (GCS) was 15 in 93% of patients. The most common neurosurgical injuries were to the cranial vault (28%), including concussions, intracranial hematomas and hemorrhages, and skull, facial, and spine fractures (10%), with the majority (63%) being transverse process fractures. The mechanisms of injury varied: 55% were kicked or stepped on, 28% were thrown or fell off, and 21% were injured by the horse falling on them. The causes ranged from carelessness and lack of attention to animal factors including inadequate training of horses and animal fear. Fourteen per cent required surgery. There were no mortalities and average length of stay was 3.7 +/- 0.35 days. All patients were discharged home with 95% requiring no services. Discussion: Equestrian sports convey special risks for its participants. With proper protection and precautions, a decrease in the incidence of central nervous system injuries may be achieved. Neurosurgeons can play key roles in advocating for neurologic safety in equestrian sports.	[Srinivasan, Vasisht; Pierre, Clifford; Petraglia, Anthony L.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Plog, Benjamin] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Srinivasan, Kaushik] Case Western Reserve Univ, Sch Law, Cleveland, OH 44106 USA; [Huang, Jason H.] Baylor Scott & White Hlth Syst, Dept Neurosurg, Temple, TX USA		Petraglia, AL (corresponding author), Univ Rochester, Rochester, NY 14627 USA.	anthony_petraglia@urmc.rochester.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168			Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Ball J.E., 2009, J TRAUMA MANAG OUTCO, V3, P2; BARONE GW, 1989, J TRAUMA, V29, P245, DOI 10.1097/00005373-198902000-00019; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; BIXBYHAMMETT DM, 1987, AM FAM PHYSICIAN, V36, P209; BUCKLEY SM, 1993, AUST J PUBLIC HEALTH, V17, P269; Clancy J, 2013, JUMP JOCKS GET NEW C; CONDIE C, 1993, PUBLIC HEALTH REP, V108, P121; Cuenca AG, 2009, J PEDIATR SURG, V44, P148, DOI 10.1016/j.jpedsurg.2008.10.025; Dekker R, 2004, DISABIL REHABIL, V26, P91, DOI 10.1080/09638280310001629688; Eckert V, 2011, CLIN J SPORT MED, V21, P353, DOI 10.1097/JSM.0b013e318221840f; GROSSMAN JAI, 1978, JAMA-J AM MED ASSOC, V240, P1881, DOI 10.1001/jama.240.17.1881; Guyton K, 2013, AM SURGEON, V79, P76; HAMILTON MG, 1993, J TRAUMA, V34, P227, DOI 10.1097/00005373-199302000-00008; Havlik HS, 2010, CURR SPORT MED REP, V9, P299, DOI 10.1249/JSR.0b013e3181f32056; Hobbs Gregory D., 1994, Journal of Emergency Medicine, V12, P143, DOI 10.1016/0736-4679(94)90690-4; Jagodzinski Tanya, 2005, WMJ, V104, P50; Lloyd R G, 1987, Br J Sports Med, V21, P22; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Macnab A J, 1996, Inj Prev, V2, P286, DOI 10.1136/ip.2.4.286; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; McCrory P, 2005, MED SPORT SCI, V48, P8, DOI 10.1159/000084280; Newton AM, 2005, J EMERG NURS, V31, P442, DOI 10.1016/j.jen.2005.08.009; Norwood S, 2000, J TRAUMA, V48, P740, DOI 10.1097/00005373-200004000-00025; Petridou E, 2004, J TRAUMA, V56, P643, DOI 10.1097/01.TA.0000053470.38129.F4; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Smartt P, 2009, J SCI MED SPORT, V12, P376, DOI 10.1016/j.jsams.2008.04.001; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Watt GM, 1996, SPORTS MED, V22, P187, DOI 10.2165/00007256-199622030-00005	29	8	8	0	21	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	OCT	2014	36	10					873	877		10.1179/1743132814Y.0000000373			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO5PP	WOS:000341397500003	24725290	Green Published, hybrid			2022-02-06	
J	Xu, B; Yu, DM; Liu, FS				Xu, Bin; Yu, Dong-Ming; Liu, Fu-Sheng			Effect of siRNA-induced inhibition of IL-6 expression in rat cerebral gliocytes on cerebral edema following traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						interleukin-6; RNA interference; brain trauma; cerebral edema	SPINAL-CORD-INJURY; MOUSE MODEL; INTERLEUKIN-6; ANTAGONIST; CYTOKINES; RESPONSES; TISSUE; PATHOPHYSIOLOGY; INFLAMMATION; BIOMARKERS	The present study aimed to investigate the effect of RNA interference (RNAi) on the inhibition of interleukin (IL)-6 expression in rat cerebral gliocytes. in vitro and rat cerebral traumatic tissues in vivo, as well as the effect of RNAi on cerebral edema. pSUPER vectors containing IL-6 small hairpin RNA (pSUPER-IL-6 1-5) were designed, constructed and transfected into C6 rat glioma cells using cationic liposomes. ELISA was used to select the plasmid with the strongest interference effect. A freefall method was used to generate a rat brain injury model and rats were randomly divided into treatment, empty plasmid and control groups (n=14/group). IL-6 levels, water content and sodium content were determined in the brain tissues at 24 and 72 h post-injury. pSUPER-IL-6 was effectively transfected into C6 cells and was found to inhibit the expression of IL-6 rather than IL-8. The pSUPER-IL-6 1 vector was most effective in inducing RNAi. In vivo, IL-6 levels were observed to be lowest in the interference group and there were statistically significant differences in water and sodium content among the experimental groups (P<0.05). RNAi was found to inhibit IL-6 expression in vivo and in vitro in rat cerebral gliocytes, and the reduction of the IL-6 levels was found to reduce post-traumatic cerebral edema.	[Xu, Bin; Yu, Dong-Ming] Capital Med Univ, Beijing Tiantan Hosp, Dept Emergency, Beijing 100050, Peoples R China; [Liu, Fu-Sheng] Capital Med Univ, Beijing Tiantan Hosp, Brain Tumor Res Ctr, Beijing Neurosurg Inst, Beijing 100050, Peoples R China		Yu, DM (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Emergency, 6 Tiantan Xili, Beijing 100050, Peoples R China.	dongmingyucn@126.com; fsliucn@126.com					Bingham D, 2011, BRAIN RES BULL, V85, P403, DOI 10.1016/j.brainresbull.2011.04.007; Boos TL, 2012, J NAT PROD, V75, P661, DOI 10.1021/np2008957; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campo S, 2005, CYTOKINE, V31, P368, DOI 10.1016/j.cyto.2005.06.006; Caselli C, 2013, CYTOKINE, V63, P113, DOI 10.1016/j.cyto.2013.04.021; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Ekstrom M, 2010, AM J PHYSIOL-ENDOC M, V299, pE234, DOI 10.1152/ajpendo.00115.2010; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Harhay MO, 2013, INT J CARDIOL, V168, P3818, DOI 10.1016/j.ijcard.2013.06.028; Hildebrand F, 2005, UNFALLCHIRURG, V108, P793, DOI 10.1007/s00113-005-1005-1; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Kotzerke K, 2013, EXP DERMATOL, V22, P650, DOI 10.1111/exd.12230; Liu Y, 2010, CELL CYCLE, V9, P3423, DOI 10.4161/cc.9.17.12946; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nakamura M, 2005, CLIN REV ALLERG IMMU, V28, P197, DOI 10.1385/CRIAI:28:3:197; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Purohit A, 2003, BRIT J CANCER, V88, P630, DOI 10.1038/sj.bjc.6600785; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang ZH, 2005, MOL IMMUNOL, V42, P1015, DOI 10.1016/j.molimm.2004.09.033; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	36	8	8	1	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2014	10	4					1863	1868		10.3892/mmr.2014.2462			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AQ4AQ	WOS:000342735000030	25109513	Bronze			2022-02-06	
J	Ambrosini, E; Ferrante, S; Schauer, T; Ferrigno, G; Molteni, F; Pedrocchi, A				Ambrosini, Emilia; Ferrante, Simona; Schauer, Thomas; Ferrigno, Giancarlo; Molteni, Franco; Pedrocchi, Alessandra			An Automatic Identification Procedure to Promote the use of FES-Cycling Training for Hemiparetic Patients	JOURNAL OF HEALTHCARE ENGINEERING			English	Article						Functional electrical stimulation; cycling; hemiparesis; rehabilitation; stimulation parameters	FUNCTIONAL ELECTRICAL-STIMULATION; POST-ACUTE STROKE; MOTOR CONTROL; EXTREMITY; STRENGTH; PEOPLE; FORCE	Cycling induced by Functional Electrical Stimulation (FES) training currently requires a manual setting of different parameters, which is a time-consuming and scarcely repeatable procedure. We proposed an automatic procedure for setting session-specific parameters optimized for hemiparetic patients. This procedure consisted of the identification of the stimulation strategy as the angular ranges during which FES drove the motion, the comparison between the identified strategy and the physiological muscular activation strategy, and the setting of the pulse amplitude and duration of each stimulated muscle. Preliminary trials on 10 healthy volunteers helped define the procedure. Feasibility tests on 8 hemiparetic patients (5 stroke, 3 traumatic brain injury) were performed. The procedure maximized the motor output within the tolerance constraint, identified a biomimetic strategy in 6 patients, and always lasted less than 5 minutes. Its reasonable duration and automatic nature make the procedure usable at the beginning of every training session, potentially enhancing the performance of FES-cycling training.	[Ambrosini, Emilia; Ferrante, Simona; Ferrigno, Giancarlo; Pedrocchi, Alessandra] Politecn Milan, Dept Elect Informat & Bioengn, NearLab, NeuroEngn & Med Robot Lab, I-20133 Milan, Italy; [Ambrosini, Emilia] Salvatore Maugeri Fdn IRCCS, Inst Care & Res, Sci Inst Lissone, Phys Med & Rehabil Unit, Lissone, Italy; [Schauer, Thomas] Tech Univ Berlin, Control Syst Grp, D-10587 Berlin, Germany; [Molteni, Franco] Valduce Hosp, Villa Beretta Rehabil Ctr, I-23845 Costa Masnaga, Lecco, Italy		Ambrosini, E (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, NearLab, NeuroEngn & Med Robot Lab, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.	emilia.ambrosini@polimi.it; simona.ferrante@polimi.it; schauer@control.tu-berlin.de; giancarlo.ferrigno@polimi.it; fmolteni@valduce.it; alessandra.pedrocchi@polimi.it	Pedrocchi, Alessandra/A-6634-2012; Ferrante, Simona/K-4122-2016; Faraldo-Garcia, Ana/H-8133-2019; Schauer, Thomas/J-4137-2012; Pedrocchi, Alessandra/AAF-2655-2019; Ferrigno, Giancarlo/O-5833-2015; Ambrosini, Emilia/R-1371-2016; Schauer, Thomas/AAX-4118-2020; GAYOSO-DIZ, PILAR/M-3533-2013	Pedrocchi, Alessandra/0000-0001-9957-2786; Ferrante, Simona/0000-0002-7835-1965; Faraldo-Garcia, Ana/0000-0001-6741-5188; Schauer, Thomas/0000-0002-0865-4418; Pedrocchi, Alessandra/0000-0001-9957-2786; Ferrigno, Giancarlo/0000-0001-5913-9451; Ambrosini, Emilia/0000-0002-6527-0779; Schauer, Thomas/0000-0002-0865-4418; GAYOSO-DIZ, PILAR/0000-0002-5872-0057	Italian Ministry of Education, Universities and ResearchMinistry of Education, Universities and Research (MIUR) [2010R277FT]; Italian Ministry of Healthy (Fondazione Maugeri) [GR-2010-2312228]; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [FKZ 01EZ0766]	This work was supported by the Italian Ministry of Education, Universities and Research (grant no.: 2010R277FT, project title "Fall risk estimation and prevention in the elderly using a quantitative multifactorial approach"), by the Italian Ministry of Healthy (Fondazione Maugeri, grant no.: GR-2010-2312228, project title "Fall prevention and locomotion recovery in post-stroke patients: a multimodal training towards a more autonomous daily life"), and the German Federal Ministry of Education and Research (project RehaRobES, grant no.: FKZ 01EZ0766).	Alon G, 2011, PHYSIOTHER RES INT, V16, P81, DOI 10.1002/pri.475; Ambrosini E, 2014, J ELECTROMYOGR KINES, V24, P307, DOI 10.1016/j.jelekin.2014.01.006; Ambrosini E, 2012, IEEE T NEUR SYS REH, V20, P320, DOI 10.1109/TNSRE.2012.2191574; Ambrosini E, 2011, STROKE, V42, P1068, DOI 10.1161/STROKEAHA.110.599068; Ambrosini E, 2010, ARTIF ORGANS, V34, P663, DOI 10.1111/j.1525-1594.2009.00941.x; Bergquist AJ, 2011, EUR J APPL PHYSIOL, V111, P2409, DOI 10.1007/s00421-011-2087-9; Braz GP, 2009, NEUROMODULATION, V12, P180, DOI 10.1111/j.1525-1403.2009.00213.x; Chen J J, 1997, IEEE Trans Rehabil Eng, V5, P158, DOI 10.1109/86.593285; Chou LW, 2007, CLIN NEUROPHYSIOL, V118, P1387, DOI 10.1016/j.clinph.2007.02.028; Comolli L, 2010, MED ENG PHYS, V32, P339, DOI 10.1016/j.medengphy.2010.01.005; CRAGO PE, 1980, IEEE T BIO-MED ENG, V27, P679, DOI 10.1109/TBME.1980.326592; de Kroon JR, 2005, J REHABIL MED, V37, P65, DOI 10.1080/16501970410024190; Doucet Barbara M., 2012, Yale Journal of Biology and Medicine, V85, P201; Ferrante S, 2008, EUR J PHYS REHAB MED, V44, P159; Ferrante S, 2008, PROGR BIOL CYBERNETI; Ferrante S, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-47; Gfohler M, 2004, IEEE T NEUR SYS REH, V12, P398, DOI 10.1109/TNSRE.2004.836778; Glinsky J, 2007, PHYSIOTHER RES INT, V12, P175, DOI 10.1002/pri.375; Gorgey AS, 2006, EUR J APPL PHYSIOL, V97, P737, DOI 10.1007/s00421-006-0232-7; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hunt KJ, 2004, IEEE T NEUR SYS REH, V12, P89, DOI 10.1109/TNSRE.2003.819955; Janssen TW, 2008, ARCH PHYS MED REHAB, V89, P463, DOI 10.1016/j.apmr.2007.09.028; Kautz SA, 1998, BRAIN, V121, P515, DOI 10.1093/brain/121.3.515; Mesin L, 2010, J ELECTROMYOGR KINES, V20, P580, DOI 10.1016/j.jelekin.2009.11.008; Perkins TA, 2002, ARTIF ORGANS, V26, P297; PETROFSKY J S, 1985, Journal of Clinical Engineering, V10, P307; Petrofsky JS, 2003, MED BIOL ENG COMPUT, V41, P18, DOI 10.1007/BF02343534; Pomeroy VM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003241.pub2; PONS DJ, 1989, MED BIOL ENG COMPUT, V27, P1, DOI 10.1007/BF02442162; Sharma N, 2011, IEEE T NEUR SYS REH, V19, P601, DOI 10.1109/TNSRE.2011.2166405; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Stapelfeldt B, 2007, INT J SPORTS MED, V28, P326, DOI 10.1055/s-2006-924352; Szecsi J, 2008, CLIN BIOMECH, V23, P1086, DOI 10.1016/j.clinbiomech.2008.05.001	33	8	8	0	12	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2040-2295	2040-2309		J HEALTHC ENG	J. Healthc. Eng.	SEP	2014	5	3					275	291		10.1260/2040-2295.5.3.275			17	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	AR0RO	WOS:000343279200002	25193368	gold, Green Submitted			2022-02-06	
J	Chang, FH; Ni, PS; Jette, AM				Chang, Feng-Hang; Ni, Pengsheng; Jette, Alan M.			Does Activity Limitation Predict Discharge Destination for Postacute Care Patients?	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Discharge Destination; Rehabilitation; Receiver Operating Characteristic Curve; International Classification of Functioning; Disability and Health	TRAUMATIC BRAIN-INJURY; BERG BALANCE SCALE; INPATIENT REHABILITATION; STROKE REHABILITATION; OUTCOMES; HOSPITALIZATION; HOME	Objective: This study aimed to examine the ability of different domains of activity limitation to predict discharge destination (home vs. nonhome settings) 1 mo after hospital discharge for postacute rehabilitation patients. Design: A secondary analysis was conducted using a data set of 518 adults with neurologic, lower extremity orthopedic, and complex medical conditions followed after discharge from a hospital into postacute care. Variables collected at baseline include activity limitations (basic mobility, daily activity, and applied cognitive function, measured by the Activity Measure for Post-Acute Care), demographics, diagnosis, and cognitive status. The discharge destination was recorded at 1 mo after being discharged from the hospital. Results: Correlational analyses revealed that the 1-mo discharge destination was correlated with two domains of activity (basic mobility and daily activity) and cognitive status. However, multiple logistic regression and receiver operating characteristic curve analyses showed that basic mobility functioning performed the best in discriminating home vs. nonhome living. Conclusions: This study supported the evidence that basic mobility functioning is a critical determinant of discharge home for postacute rehabilitation patients. The Activity Measure for Post-Acute Care-basic mobility showed good usability in discriminating home vs. nonhome living. The findings shed light on the importance of basic mobility functioning in the discharge planning process.	[Chang, Feng-Hang; Ni, Pengsheng; Jette, Alan M.] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Boston, MA 02118 USA		Chang, FH (corresponding author), Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, 715 Albany St,T5W, Boston, MA 02118 USA.				Department of Education (National Institute on Disability and Rehabilitation Research) Advanced Rehabilitation Research Training Grant [H133P120001]	Funded in part by the Department of Education (National Institute on Disability and Rehabilitation Research) Advanced Rehabilitation Research & Training Grant H133P120001 (to A.M.J.).	Andres PL, 2003, AM J PHYS MED REHAB, V82, P614, DOI 10.1097/01.PHM.0000073818.34847.F0; Andrich D, 1998, RASH MODELS MEASUREM; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Brauer SG, 2008, ARCH PHYS MED REHAB, V89, P1061, DOI 10.1016/j.apmr.2007.10.042; Campbell SE, 2005, AGE AGEING, V34, P467, DOI 10.1093/ageing/afi141; Cohen-Mansfield J, 2011, ARCH GERONTOL GERIAT, V53, P309, DOI 10.1016/j.archger.2010.12.009; Coster WJ, 2006, J REHABIL MED, V38, P237, DOI 10.1080/16501970600609774; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Frank M, 2010, EUR NEUROL, V63, P227, DOI 10.1159/000279491; Haley SM, 2004, ARCH PHYS MED REHAB, V85, P649, DOI 10.1016/j.apmr.2003.08.098; Haley SM, 2004, MED CARE, V42, P49, DOI 10.1097/01.mlr.0000103520.43902.6c; Jackson JP, 2013, AM J PHYS MED REHAB, V92, P343, DOI 10.1097/PHM.0b013e318278b1df; Jupp BJ, 2011, GERIATR GERONTOL INT, V11, P8, DOI 10.1111/j.1447-0594.2010.00626.x; Lysack CL, 2001, AM J OCCUP THER, V55, P433, DOI 10.5014/ajot.55.4.433; McKenna K, 2002, AM J PHYS MED REHAB, V81, P47, DOI 10.1097/00002060-200201000-00009; Murray PK, 2003, ARCH PHYS MED REHAB, V84, P1129, DOI 10.1016/S0003-9993(03)00149-7; Pohl PS, 2013, DISABIL REHABIL, V35, P990, DOI 10.3109/09638288.2012.717587; Reistetter TA, 2010, ARCH PHYS MED REHAB, V91, P345, DOI 10.1016/j.apmr.2009.11.010; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; van der Zwaluw CS, 2011, J STROKE CEREBROVASC, V20, P549, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.009; Wee JYM, 1999, ARCH PHYS MED REHAB, V80, P448, DOI 10.1016/S0003-9993(99)90284-8; World Health Organization, 2007, INT CLASS FUNCT DIS; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Young YC, 2009, J AM MED DIR ASSOC, V10, P491, DOI 10.1016/j.jamda.2009.03.019	27	8	8	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2014	93	9					782	790		10.1097/PHM.0000000000000097			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AN8CH	WOS:000340828900007	24800717				2022-02-06	
J	Garcia-Rudolph, A; Gibert, K				Garcia-Rudolph, Alejandro; Gibert, Karina			A data mining approach to identify cognitive NeuroRehabilitation Range in Traumatic Brain Injury patients	EXPERT SYSTEMS WITH APPLICATIONS			English	Article						Machine learning; Algorithms; Statistics	REHABILITATION; PLASTICITY; EXPERIENCE; TREE; PREDICTION; FLOW	Cognitive rehabilitation (CR) treatment consists of hierarchically organized tasks that require repetitive use of impaired cognitive functions in a progressively more demanding sequence. Active monitoring of the progress of the subjects is therefore required, and the difficulty of the tasks must be progressively increased, always pushing the subjects to reach a goal just beyond what they can attain. There is an important lack of well-established criteria by which to identify the right tasks to propose to the patient. In this paper, the NeuroRehabilitation Range (NRR) is introduced as a means of identifying formal operational models. These are to provide the therapist with dynamic decision support information for assigning the most appropriate CR plan to each patient. Data mining techniques are used to build data-driven models for NRR. The Sectorized and Annotated Plane (SAP) is proposed as a visual tool by which to identify NRR, and two data-driven methods to build the SAP are introduced and compared. Application to a specific representative cognitive task is presented. The results obtained suggest that the current clinical hypothesis about NRR might be reconsidered. Prior knowledge in the area is taken into account to introduce the number of task executions and task performance into NRR models and a new model is proposed which outperforms the current clinical hypothesis. The NRR is introduced as a key concept to provide an operational model identifying when a patient is experiencing activities in his or her Zone of Proximal Development and, consequently, experiencing maximum improvement. For the first time, data collected through a CR platform has been used to find a model for the NRR. (C) 2014 Elsevier Ltd. All rights reserved.	[Garcia-Rudolph, Alejandro] Hosp Neurorehabil, Inst Guttmann, Barcelona 08916, Spain; [Gibert, Karina] Univ Politecn Cataluna, BarcelonaTech, Dept Estat & Invest Operat, ES-08034 Barcelona, Spain		Gibert, K (corresponding author), Univ Politecn Cataluna, BarcelonaTech, Dept Estat & Invest Operat, Jordi Girona 1-3, ES-08034 Barcelona, Spain.	agarciar@guttmann.com; karina.gibert@upc.edu	Gibert, Karina/L-1003-2017	Gibert, Karina/0000-0002-8542-3509	Ministry of Industry, Tourism and Trade (Spain) AVANZA PLAN-Digital Citizen Subprogram [TSI-020501-2008-0154]; Institute of Health Carlos III (Spain) Strategic Action Health's Call [PI08/900525]; Ministry of Science and Innovation (Spain) INNPACTO Program [300000-201030]; Ministry of Education Social Policy and Social Services (Spain) IMSERSO Program [41/2008]; MARATO TV3 Foundation [091330]; EUEuropean Commission [CIP-ICT-PSP-2007-1, 224985]	This research was supported by: Ministry of Industry, Tourism and Trade (Spain) AVANZA PLAN-Digital Citizen Subprogram (PT: NEUROLEARNING Grant Nr: TSI-020501-2008-0154). Institute of Health Carlos III (Spain) Strategic Action Health's Call (PT: Clinical implantation of PREVIRNEC platform in TBI and stroke patients/ Grant Nr: PI08/900525). Ministry of Science and Innovation (Spain) INNPACTO Program (PT NEUROCONTENT - Grant Nr 300000-201030). Ministry of Education Social Policy and Social Services (Spain) IMSERSO Program (PT COGNIDAC Grant Nr 41/2008). MARATO TV3 Foundation (PT: Improving Social Cognition and meta-cognition in schizophrenia: A tele-rehabilitation project Nr 091330) and EU CIP-ICT-PSP-2007-1 (PT: CLEAR Grant Nr.: 224985). Authors want to express particularly thanks to Dr. Jose Maria Tormos, Scientific Coordinator of Hospital Guttmann, hospital de neurorehabilitacio, for his kind support to this research.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Calero MD, 2007, ARCH CLIN NEUROPSYCH, V22, P63, DOI 10.1016/j.acn.2006.06.020; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Csikszentmihalyi, 1991, FLOW PSYCHOL OPTIMAL; de Norena D, 2010, REV NEUROLOGIA, V51, P687, DOI 10.33588/rn.5111.2009652; DiPiro J. T., 2010, CONCEPTS CLIN PHARMA; Finneran CM, 2005, COMMUN ASSOC INF SYS, V15, P82; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Hall M, 2009, SIGKDD EXPLOR, V11, P10, DOI 10.1145/1656274.1656278; Heuser A, 2006, 2006 INTERNATIONAL WORKSHOP ON VIRTUAL REHABILITATION, P88, DOI 10.1109/IWVR.2006.1707533; Jagaroo V, 2009, NEUROINFORMATICS FOR NEUROPSYCHOLOGY, P1, DOI 10.1007/978-1-4419-0060-9_1; Ji SY, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-2; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marcano-Cedeno A, 2013, EXPERT SYST APPL, V40, P1054, DOI 10.1016/j.eswa.2012.08.034; Mathwick C, 2004, J CONSUM RES, V31, P324, DOI 10.1086/422111; Orvis KA, 2008, COMPUT HUM BEHAV, V24, P2415, DOI 10.1016/j.chb.2008.02.016; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Quinlan R., 1993, C4 5 PROGRAMS MACHIN; Rego P., 2010, INF SYST TECHN CISTI, P1; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Sohlberg M., 2001, COGNITIVE REHABILITA; Vygotsky LS., 1978, MIND SOC DEV HIGHER; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Witten I., 2005, DATA MINING PRACTICA, Vsecond; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	8	9	0	51	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0957-4174	1873-6793		EXPERT SYST APPL	Expert Syst. Appl.	SEP 1	2014	41	11					5238	5251		10.1016/j.eswa.2014.03.001			14	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Operations Research & Management Science	AH5SQ	WOS:000336191800021					2022-02-06	
J	Lawrence, DW; Hutchison, MG; Cusimano, MD; Singh, T; Li, LK				Lawrence, David W.; Hutchison, Michael G.; Cusimano, Michael D.; Singh, Tanveer; Li, Luke			Interrater Agreement of an Observational Tool to Code Knockouts and Technical Knockouts in Mixed Martial Arts	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mixed martial arts; combat sports; knockout; concussion; head injury; technical knockout; video analysis; traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; VIDEO ANALYSIS; INCIDENT ANALYSIS; INJURY; CONCUSSION; FOOTBALL; HEAD; COMPETITION; MECHANISMS	Objective: Interrater agreement evaluation of a tool to document and code the situational factors and mechanisms of knockouts (KOs) and technical knockouts (TKOs) in mixed martial arts (MMA). Design: Retrospective case series. Setting: Professional MMA matches from the Ultimate Fighting Championship-2006-2012. Participants: Two nonmedically trained independent raters. Main Outcome Measures: The MMA Knockout Tool (MMA-KT) consists of 20 factors and captures and codes information on match characteristics, situational context preceding KOs and TKOs, as well as describing competitor states during these outcomes. The MMA-KT also evaluates the mechanism of action and subsequent events surrounding a KO. Results: The 2 raters coded 125 unique events for a total of 250 events. The 8 factors of Part A had an average kappa of 0.87 (SD = 0.10; range = 0.65-0.98); 7 were considered "substantial" agreement and 1 "moderate." Part B consists of 12 factors with an average kappa of 0.84 (SD = 0.16; range = 0.59-1.0); 7 classified as "substantial" agreement, 4 "moderate," and 1 "fair." The majority of the factors in the MMA-KT demonstrated substantial interrater agreement, with an average kappa of 0.86 (SD = 0.13; range = 0.59-1.0). Conclusions: The MMA-KT is a reliable tool to extract and code relevant information to investigate the situational factors and mechanism of KOs and TKOs in MMA competitions.	[Lawrence, David W.] Univ Toronto, Fac Med, Toronto, ON M5S 2W6, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, David L MacIntosh Sport Med Clin, Toronto, ON M5S 2W6, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Div Neurosurg,Injury Prevent Res Off, Toronto, ON M5S 2W6, Canada; [Singh, Tanveer; Li, Luke] Univ Toronto, Toronto, ON M5S 2W6, Canada		Cusimano, MD (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, David L MacIntosh Sport Med Clin, 55 Harbord St, Toronto, ON M5S 2W6, Canada.	michael.hutchison@utoronto.ca	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Strategic Teams in Applied Injury Research	This study received funding by Canadian Institutes of Health Research Strategic Teams in Applied Injury Research. The organizations that contributed funds to the research had no role in the design of the study, the collection, analysis, and interpretation of the data.	Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; Arnason A, 2004, AM J SPORT MED, V32, P1459, DOI 10.1177/0363546504262973; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Buse GJ, 2006, MIL MED, V171, P443, DOI 10.7205/MILMED.171.5.443; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Cantor AB, 1996, PSYCHOL METHODS, V1, P150, DOI 10.1037/1082-989X.1.2.150; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Destombe C, 2006, JOINT BONE SPINE, V73, P182, DOI 10.1016/j.jbspin.2005.02.003; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gross J, 2011, UFC BUYS RIVAL STRIK; Hutchison M. G., 2013, BRIT J SPORT MED, DOI [10.1136/bjsports-2013-092234, DOI 10.1136/BJSP0RTS-2013-092234]; Hutchison MG, BRIT J SPORT MED, DOI [10.1136/bjsports-2013-092235, DOI 10.1136/BJSP0RTS-2013-092235]; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Martin D, UFC 124 ATTENDANCE R; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Pishna K, UFC 129 GATE RECEPIT; Seidenberg PH, 2011, CURR SPORT MED REP, V10, P147, DOI 10.1249/JSR.0b013e31821cc952; Shin W, AM J NEURORADIOL, DOI [10.3174/ajnr.A3676, DOI 10.3174/AJNR.A3676]; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448	30	8	8	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2014	24	5					397	402		10.1097/JSM.0000000000000047			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	AP3OO	WOS:000341986300011	24378405				2022-02-06	
J	Moorin, R; Miller, TR; Hendrie, D				Moorin, Rachael; Miller, Ted R.; Hendrie, Delia			Population-based incidence and 5-year survival for hospital-admitted traumatic brain and spinal cord injury, Western Australia, 2003-2008	JOURNAL OF NEUROLOGY			English	Article						TBI; SCI; Incidence; Standardised mortality rates; Compensation scheme	LONG-TERM SURVIVAL; MODEL SYSTEMS; MORTALITY; REHABILITATION; COHORT; TRENDS; DEATH; CARE	This study aimed at analysing first-time hospitalisations for traumatic brain injury (TBI) and spinal cord injury (SCI) in Western Australia (WA), in terms of socio-demographic profile, cause of injury, relative risks and survival, using tabular and regression analyses of linked hospital discharge and mortality census files and comparing results with published standardised mortality rates (SMRs) for TBI. Participants were all 9,114 first hospital admissions for TBI or SCI from 7/2003 to 6/2008, linked to mortality census data through 12/2008, and the main outcome measures were number of cases by cause, SMRs in hospital and post-discharge by year through year 5. Road crashes accounted for 34 % of hospitalised TBI and 52 % of hospitalised SCI. 8,460 live TBI discharges experienced 580 deaths during 24,494 person-years of follow-up. The life-table expectation of deaths in the cohort was 164. Post-discharge SMRs were 7.66 in year 1, 3.86 in year 2 and averaged 2.31 in years 3 through 5. 317 live SCI discharges experienced 18 deaths during 929 years of follow-up. Post-discharge SMRs were 7.36 in year 1 and a fluctuating average of 2.13 in years 2 through 5. Use of data from model systems does not appear to yield biased SMRs. Similarly no systematic variation was observed between all-age studies and the more numerous studies that focused on those aged 14 to 16 and older. Based on two studies, SMRs for TBI, however, may be higher in year 2 post-discharge in Australia than elsewhere. That possibility and its cause warrant exploration. Expanding public TBI/SCI compensation in WA from road crash to all causes might triple TBI compensation and double SCI compensation.	[Moorin, Rachael; Miller, Ted R.; Hendrie, Delia] Curtin Univ, Fac Hlth Sci, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD 20705 USA		Miller, TR (corresponding author), Curtin Univ, Fac Hlth Sci, Ctr Populat Hlth Res, Bldg 400,GPO Box U1987, Perth, WA 6845, Australia.	miller@pire.org	Moorin, Rachael/AAQ-3650-2020	Moorin, Rachael/0000-0001-8742-7151; Hendrie, Delia/0000-0001-5022-5281; Miller, Ted/0000-0002-0958-2639			[Anonymous], 2009, EC COST SPIN CORD TR; Australian Bureau of Statistics, 2012, 31010 ABS; Australian Bureau of Statistics, 2006, CENS POP HOUS SOC IN; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cripps R, 2008, INJURY CHRONIC HLTH; Cripps RA, 2006, SPINAL CORD INJURY A; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Helps Y, 2008, INJURY RES STAT SERI, V45; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA., 2004, TRAUMATIC BRAIN INJU; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; O'Connor P, 2000, AUSTR INJURY PREVENT, V22; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shavelle R, 2000, J Insur Med, V32, P163; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	28	8	9	0	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	SEP	2014	261	9					1726	1734		10.1007/s00415-014-7411-y			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AP0YA	WOS:000341791300009	24952617				2022-02-06	
J	Thomas, TP; Shih, TM				Thomas, Thaddeus P.; Shih, Tsung-Ming			Stimulation of central A1 adenosine receptors suppresses seizure and neuropathology in a soman nerve agent seizure rat model	TOXICOLOGY MECHANISMS AND METHODS			English	Article						Adenosine agonist; anti-seizure; nerve agent; neuroprotection	INDUCED EPILEPTIFORM ACTIVITY; TRAUMATIC BRAIN-INJURY; ACID-INDUCED SEIZURES; MOVING GUINEA-PIGS; BASAL FOREBRAIN; THERAPEUTIC HYPOTHERMIA; TIME-COURSE; A(1); MECHANISMS; SARIN	The current regimen for treating nerve agent poisoning does not sufficiently suppress the excitotoxic activity that causes severe brain damage, especially in cases where treatment is delayed and nerve agent-induced status epilepticus develops. New therapeutic targets are required to improve survivability and minimize neuropathology after irreversible acetylcholinesterase inactivation. Earlier studies have shown that systemic delivery of adenosine agonists decreases nerve agent lethality; however, the mechanism of protection remains to be understood. The primary aim of this study was to investigate the role of central adenosine receptor (AR) stimulation in neuroprotection by directly injecting (6)-cyclopentyladenosine (CPA), an adenosine agonist specific to the A1 receptor subtype (A1R), into the brain intracerebroventricularly (ICV) in a soman seizure rat model. In addition to general A1R stimulation, we hypothesized that bilateral micro-injection of CPA into the cholinergic basal forebrain (BF) could also suppress excitotoxic activity. The results from these studies demonstrated that centrally administered adenosine agonists are anti-seizure and neuroprotective. CPA-delivered ICV prevented seizure and convulsion in 100% of the animals. Moreover, neuropathological evaluation indicated that adenosine treatments reduced brain damage from severe to minimal. Inhibition of the BF via CPA had varied results. Some animals were protected by treatment; however, others displayed similar pathology to the control. Overall, these data suggest that stimulating central ARs could be an effective target for the next generation countermeasures for nerve agent intoxication.	[Thomas, Thaddeus P.; Shih, Tsung-Ming] US Army, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA; [Thomas, Thaddeus P.] US Army, Res Lab, Aberdeen Proving Ground, MD 21010 USA		Shih, TM (corresponding author), US Army, Med Res Inst Chem Def, ATTN MCMR CDR P, 3100 Ricketts Point Rd, Aberdeen Proving Ground, MD 21010 USA.	tsungming.a.shih.civ@mail.mil			ARLUnited States Department of DefenseUS Army Research Laboratory (ARL)	The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper. The authors also gratefully acknowledge the financial and administrative support that the ARL provided.	ANDERSON R, 1994, BRIT J PHARMACOL, V113, P1386, DOI 10.1111/j.1476-5381.1994.tb17151.x; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; BENINGTON JH, 1995, BRAIN RES, V692, P79, DOI 10.1016/0006-8993(95)00590-M; BIAGGIONI I, 1992, HYPERTENSION, V20, P457, DOI 10.1161/01.HYP.20.4.457; Bjorness TE, 2009, CURR NEUROPHARMACOL, V7, P238, DOI 10.2174/157015909789152182; Bowen SE, 1997, FUND APPL TOXICOL, V35, P189, DOI 10.1006/faat.1996.2278; Bueters TJH, 2003, J PHARMACOL EXP THER, V304, P1307, DOI 10.1124/jpet.102.044644; Bueters TJH, 2002, ARCH TOXICOL, V76, P650, DOI 10.1007/s00204-002-0395-x; Compton JR, 2004, ADENOSINE RECEPTOR A; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; Dixon AK, 1996, BRIT J PHARMACOL, V118, P1461, DOI 10.1111/j.1476-5381.1996.tb15561.x; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; ELETRI MM, 1992, EXP NEUROL, V118, P153, DOI 10.1016/0014-4886(92)90032-L; FOSBRAEY P, 1990, J NEUROCHEM, V54, P72, DOI 10.1111/j.1471-4159.1990.tb13284.x; Geeraerts T, 2009, ANN FR ANESTH, V28, P339, DOI 10.1016/j.annfar.2009.02.016; Gouder N, 2003, EPILEPSIA, V44, P877, DOI 10.1046/j.1528-1157.2003.03603.x; Haas HL, 2000, N-S ARCH PHARMACOL, V362, P375, DOI 10.1007/s002100000314; Harrison PK, 2003, EUR J PHARMACOL, V471, P97, DOI 10.1016/S0014-2999(03)01783-7; Hilaire CS, 2009, J CELL PHYSIOL, V218, P35, DOI 10.1002/jcp.21579; Huber A, 2002, NEUROSCI LETT, V329, P289, DOI 10.1016/S0304-3940(02)00684-5; Joosen MJA, 2007, EUR J PHARMACOL, V555, P122, DOI 10.1016/j.ejphar.2006.10.006; Joosen MJA, 2004, ARCH TOXICOL, V78, P34, DOI 10.1007/s00204-003-0513-4; LALLEMENT G, 1991, BRAIN RES, V563, P234, DOI 10.1016/0006-8993(91)91539-D; Lin JS, 2011, CELL MOL LIFE SCI, V68, P2499, DOI 10.1007/s00018-011-0631-8; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; Lynge J, 2000, ACTA PHYSIOL SCAND, V169, P283; Malva JO, 2003, NEUROCHEM RES, V28, P1501, DOI 10.1023/A:1025618324593; MCDONOUGH JH, 1995, NEUROTOXICOLOGY, V16, P123; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Methippara MM, 2005, AM J PHYSIOL-REG I, V289, pR1715, DOI 10.1152/ajpregu.00247.2005; O'Donnell JC, 2011, ARCH TOXICOL, V85, P1607, DOI 10.1007/s00204-011-0724-z; O'Donnell JC, 2010, TOXICOL MECH METHOD, V20, P600, DOI 10.3109/15376516.2010.521208; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Schindler CW, 2005, BRIT J PHARMACOL, V144, P642, DOI 10.1038/sj.bjp.0706043; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; Schwartz BG, 2012, AM J CARDIOL, V110, P461, DOI 10.1016/j.amjcard.2012.03.048; Semba K, 2000, BEHAV BRAIN RES, V115, P117, DOI 10.1016/S0166-4328(00)00254-0; Shih TM, 2006, TOXICOL APPL PHARM, V215, P119, DOI 10.1016/j.taap.2006.02.003; SHIH TM, 1990, EPILEPSY RES, V7, P105, DOI 10.1016/0920-1211(90)90095-D; SHIH TM, 1991, NEUROSCI BIOBEHAV R, V15, P349; SHIH TM, 1982, PSYCHOPHARMACOLOGY, V78, P170, DOI 10.1007/BF00432257; Shih TM, 2003, TOXICOL APPL PHARM, V188, P69, DOI 10.1016/S0041-008X(03)00019-X; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Strecker RE, 2000, BEHAV BRAIN RES, V115, P183, DOI 10.1016/S0166-4328(00)00258-8; Svenningsson P, 1997, SYNAPSE, V27, P322, DOI 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E; Thakkar MM, 2003, NEUROSCIENCE, V122, P1107, DOI 10.1016/j.neuroscience.2003.08.006; Tuovinen K, 2004, TOXICOLOGY, V196, P31, DOI 10.1016/j.tox.2003.10.013; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; van Helden HPM, 1998, DRUG CHEM TOXICOL, V21, P171, DOI 10.3109/01480549809007409; WADE JV, 1987, J NEUROCHEM, V49, P645, DOI 10.1111/j.1471-4159.1987.tb02912.x; Wardas J, 2002, POL J PHARMACOL, V54, P313; Yildirim M, 2007, BRAIN RES, V1127, P193, DOI 10.1016/j.brainres.2006.10.024; YOUNG D, 1994, NEUROSCIENCE, V58, P245, DOI 10.1016/0306-4522(94)90032-9; Youssef AF, 1997, ENVIRON RES, V73, P52, DOI 10.1006/enrs.1997.3718	59	8	9	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1537-6516	1537-6524		TOXICOL MECH METHOD	Toxicol. Mech. Methods	SEP	2014	24	6					385	395		10.3109/15376516.2014.920450			11	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	AN8BU	WOS:000340827200003	24785252				2022-02-06	
J	Yang, SD; Sun, RC; Zhou, ZY; Zhou, J; Liang, JB; Mu, HJ				Yang, Shudong; Sun, Rongchao; Zhou, Zhiyi; Zhou, Jing; Liang, Jiabei; Mu, Huijun			Expression of Amyloid-beta Protein and Amyloid-beta Precursor Protein After Primary Brain-Stem Injury in Rats	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						diffuse axonal injury; amyloid-beta protein (A beta); amyloid-beta precursor protein (beta-APP); traumatic brain injury	DIFFUSE AXONAL INJURY; CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER; MOUSE MODEL; HEAD-INJURY; PEPTIDE; BINDING; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; ISCHEMIA	Amyloid-beta (A beta) protein and its precursor, amyloid-beta precursor protein (beta-APP), have traditionally been used in the diagnosis of Alzheimer disease. Their use in diagnosis of traumatic brain injury by forensic analysis is becoming more widespread. However, to date, no reliable small animal model exists to evaluate these brain injury indicators. To address this, we have studied primary brain-stem injury in rats to assess the appearance of diffuse axonal injury in brain sections and correlate these findings with appearance of A beta and relative beta-APP mRNA levels. Using an En Vision 2-step immunohistochemical staining method to measure axon diameter, we found that there was significant difference in axon diameters within the medulla oblongata and several time points after brain injury, ranging from 3 to 24 hours. In addition, mRNA expression levels of beta-APP increased following brain injury, peaking 3 hours following injury and decreasing back to baseline levels by 24 hours after injury. These results suggest that using immunohistochemistry and reverse transcription polymerase chain reaction to detect changes in A beta-associated axonal changes and beta-APP mRNA levels, respectively, can be useful for the diagnosis of diffuse axonal injury during autopsy at early time points following fatal brain injury.	[Yang, Shudong; Sun, Rongchao; Zhou, Zhiyi; Zhou, Jing; Liang, Jiabei] Nanjing Med Univ, Dept Pathol, Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China; [Mu, Huijun] Nanjing Med Univ, Cent Lab, Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China		Yang, SD (corresponding author), Nanjing Med Univ, Dept Pathol, Wuxi Peoples Hosp, Qingyang Rd 299, Wuxi 214023, Jiangsu, Peoples R China.	ysd-zh@163.com			Science and Technology Development Fund Key Project of Nanjing Medical University [2011NJMU207]; Wuxi Municipal Health Bureau guiding project [MD201207]	This work was supported by a grant from Science and Technology Development Fund Key Project of Nanjing Medical University (Grant No. 2011NJMU207) and the other was from Wuxi Municipal Health Bureau guiding project (Grant No. MD201207).	Akiyama H, 2004, NAT MED, V10, P117, DOI 10.1038/nm0204-117; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ganjei JK, 2010, DRUG NEWS PERSPECT, V23, P573, DOI 10.1358/dnp.2010.23.9.1507297; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Harrington D, 2000, J Clin Forensic Med, V7, P19, DOI 10.1054/jcfm.2000.0359; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Iino M, 2003, INT J LEGAL MED, V117, P153, DOI 10.1007/s00414-003-0370-y; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kita T, 2000, INT J LEGAL MED, V113, P221, DOI 10.1007/s004149900095; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Moxon-Emre I, 2010, J NEUROPATH EXP NEUR, V69, P1, DOI 10.1097/NEN.0b013e3181c3ce6c; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Pluta R, 2008, ACT NEUR S, V102, P353, DOI 10.1007/978-3-211-85578-2_67; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Shin J, 2010, BMB REP, V43, P704, DOI [10.3858/BMBRep.2010.43.10.704, 10.5483/BMBRep.2010.43.10.704]; Wang HYJ, 2010, RAPID COMMUN MASS SP, V24, P2057, DOI 10.1002/rcm.4620; Wu C, 2011, BIOPHYS J, V100, P1316, DOI 10.1016/j.bpj.2011.01.058; Yang SD, 2010, INT J SURG PATHOL, V18, P85, DOI 10.1177/1066896909331993; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Zhang T, 2010, NEUROSCI LETT, V479, P215, DOI 10.1016/j.neulet.2010.05.064	28	8	8	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2014	35	3					201	205		10.1097/PAF.0000000000000103			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	AO2QE	WOS:000341169500012	24949598				2022-02-06	
J	Diaz, DS				Diaz, Deborah S.			Management of Athletes with Postconcussion Syndrome	SEMINARS IN SPEECH AND LANGUAGE			English	Article						Postconcussion syndrome; treatment; vertigo; dizziness; postural instability; gaze stability; benign paroxysmal positional vertigo; cervicogenic dizziness; graduated exertion	DIZZINESS; SPORT	Rehabilitation for athletes with postconcussion syndrome requires emphasis on both cognitive and physical rest with a gradual return to activity and sports. As the athlete becomes more active, the rehabilitation: and sport professional should pay close attention to symptoms of concussion, like headache, dizziness, nausea, and difficulty concentrating. The Zurich Consensus Statement on Concussion in Sport provides a systematic approach to increasing the intensity of physical activity while attending to postconcussion symptoms. During the incident that led to a concussion, the injured athlete may have incurred injuries to the vestibular and balance system, which are not directly related to concussion. These conditions are best addressed by professionals with specific training in vestibular rehabilitation, most commonly physical therapists. Benign paroxysmal positional vertigo is a condition in which otoconia particles in the inner ear dislodge into the semicircular canals, resulting in severe vertigo and imbalance. This condition frequently resolves with a few sessions with a vestibular therapist and a home exercise program. In conditions like gaze instability, motion sensitivity, impaired postural control, and cervicogenic dizziness, improvement is more gradual and requires longer follow-up with a physical therapist. In all of these conditions, it is important to consider that the patient with postconcussion syndrome will likely recover more slowly than others and should be monitored for symptoms of postconcussion syndrome throughout intervention.	Univ Texas El Paso, Doctor Phys Therapy Program, El Paso, TX 79902 USA		Diaz, DS (corresponding author), Univ Texas El Paso, Doctor Phys Therapy Program, 500 W Univ Ave, El Paso, TX 79902 USA.	dsdiaz@utep.edu					Berliner JIM, VISUAL VERTIGO MOTIO; Berliner JIM, CERVICOGENIC DIZZINE; Bracher ESB, 2000, J MANIP PHYSIOL THER, V23, P96, DOI 10.1016/S0161-4754(00)90074-5; Ciuffreda KJ, 1999, CLIN EYE VIS CARE, V11, P41, DOI DOI 10.1016/S0953-4431(99)00010-7; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Herdman S., 2007, VESTIBULAR REHABILIT, P233; Hornibrook Jeremy, 2011, Int J Otolaryngol, V2011, P835671, DOI 10.1155/2011/835671; Institute of Medicine (IOM) and National Research Council (NRC), SPORTS REL CONC YOUT; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mucha A, 2013, APTA WEBINAR SERIES; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Schubert JC, 2007, VESTIBULAR REHABILIT, P265; Whitney SL, 2007, VESTIBULAR REHABILIT, P309; Wrisley DM, 2000, J ORTHOP SPORT PHYS, V30, P755, DOI 10.2519/jospt.2000.30.12.755	15	8	8	0	27	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	AUG	2014	35	3					204	210		10.1055/s-0034-1384682			7	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AM6PA	WOS:000339985900008	25116214				2022-02-06	
J	Hsieh, PW; Wen, CJ; Yu, HP; Aljuffali, IA; Huang, YH; Fang, JY				Hsieh, Pei-Wen; Wen, Chih-Jen; Yu, Huang-Pin; Aljuffali, Ibrahim A.; Huang, Ya-Huei; Fang, Jia-You			Nanostructured Lipid Carriers Containing a High Percentage of a Pluronic Copolymer Increase the Biodistribution of Novel PDE4 Inhibitors for the Treatment of Traumatic Hemorrhage	JOURNAL OF BIOMEDICAL NANOTECHNOLOGY			English	Article						Nanostructured Lipid Carriers (NLCs); PDE4 Inhibitor; Pharmacokinetics; Biodistribution; Traumatic Hemorrhage	SYSTEMIC INFLAMMATORY RESPONSE; MULTIPLE ORGAN DYSFUNCTION; LUNG INJURY; IN-VITRO; PHOSPHODIESTERASE INHIBITORS; PULMONARY INFLAMMATION; HUMAN NEUTROPHILS; PHARMACOKINETICS; BRAIN; NANOPARTICLES	Although the application of nanotechnology to drug therapy has been widely investigated, very few nanomedicine-based treatments for traumatic hemorrhage have been reported so far. The aim of this work was to develop nanostructured lipid carriers (NLCs) loaded with phosphodiesterase 4 (PDE4) inhibitors to treat acute inflammation in peripheral organs. The pharmacokinetics and biodistribution of DSM-RX78 and EFB-1, two novel PDE4 inhibitors, were examined using rats as an animal model. Entrapment by NLCs resulted in sustained drug release. The plasma concentrations of DSM-RX78 and EFB-1 in NLCs were lower, and their half-lives were much shorter in the NLC condition than in the control condition. PDE4 inhibitors delivered in NLCs accumulated with high abundance in many organs, especially the brain and lungs. Polyethylene glycol (PEG) coating on the particulate surface (P-NLCs) significantly reduced brain delivery of the drugs. P-NLCs enhanced drug distribution to the lungs by 5-fold compared to free control. In vivo real-time imaging confirmed rapid escape of nanoparticles from the blood circulation. Histological examination and aminotransferase measurement revealed that P-NLCs containing EFB-1 improved hemorrhagic shock-induced injuries in the lungs, intestines, and liver. P-NLCs even reversed acute lung inflammation to the level observed in an uninjured condition. Our results indicate that NLC-based delivery of PDE4 inhibitors is a candidate treatment for traumatic hemorrhage.	[Hsieh, Pei-Wen] Chang Gung Univ, Grad Inst Nat Prod, Med Chem Lab, Taoyuan 333, Taiwan; [Wen, Chih-Jen] Chang Gung Mem Hosp, Ctr Vascularized Composite Allotransplantat, Taoyuan 333, Taiwan; [Wen, Chih-Jen; Yu, Huang-Pin] Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan; [Yu, Huang-Pin] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan 333, Taiwan; [Aljuffali, Ibrahim A.] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh 11451, Saudi Arabia; [Huang, Ya-Huei; Fang, Jia-You] Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan 333, Taiwan; [Huang, Ya-Huei] Chang Gung Univ, Healthy Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan 333, Taiwan; [Fang, Jia-You] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan 333, Taiwan; [Fang, Jia-You] China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung 404, Taiwan		Fang, JY (corresponding author), Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan 333, Taiwan.	fajy@mail.cgu.edu.tw			Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPD190353]	The authors are grateful to the financial support from Chang Gung Memorial Hospital (grant number: CMRPD190353).	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Batrakova EV, 2001, J PHARMACOL EXP THER, V296, P551; Boswell-Smith Victoria, 2007, Int J Chron Obstruct Pulmon Dis, V2, P121; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Chen RW, 2007, NEUROSCI LETT, V418, P165, DOI 10.1016/j.neulet.2007.03.033; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Colby T V, 2001, Ann Diagn Pathol, V5, P309, DOI 10.1053/adpa.2001.27923; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; de Montmollin E, 2011, CRIT CARE, V15, DOI 10.1186/cc10359; de Visser YP, 2008, EUR RESPIR J, V31, P633, DOI 10.1183/09031936.00071307; Deree J, 2007, J SURG RES, V143, P99, DOI 10.1016/j.jss.2007.03.083; Fang JY, 2013, J PHARM PHARMACOL, V65, P345, DOI 10.1111/j.2042-7158.2012.01605.x; Fry DE, 2012, AM SURGEON, V78, P1; Gill R, 2011, SHOCK, V35, P164, DOI 10.1097/SHK.0b013e3181eddcab; Hsieh PW, 2007, BIOORG MED CHEM LETT, V17, P1812, DOI 10.1016/j.bmcl.2006.12.038; Hsu SH, 2011, CURR NANOSCI, V7, P191, DOI 10.2174/157341311794653686; Ishihara T, 2010, INT J PHARMACEUT, V385, P170, DOI 10.1016/j.ijpharm.2009.10.025; Jia LJ, 2012, INT J BIOL MACROMOL, V50, P523, DOI 10.1016/j.ijbiomac.2012.01.024; Jia LJ, 2010, COLLOID SURFACE B, V80, P213, DOI 10.1016/j.colsurfb.2010.06.008; Johnston HJ, 2010, TOXICOL APPL PHARM, V242, P66, DOI 10.1016/j.taap.2009.09.015; Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3; Kaur IP, 2008, J CONTROL RELEASE, V127, P97, DOI 10.1016/j.jconrel.2007.12.018; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kochanek AR, 2012, J SURG RES, V176, P185, DOI 10.1016/j.jss.2011.06.007; Lauterbach M, 2006, EUR SURG RES, V38, P399, DOI 10.1159/000094640; Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w; Lin YK, 2010, INT J NANOMED, V5, P117; Liu KS, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095103; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Mirzayan MJ, 2012, EXP TOXICOL PATHOL, V64, P133, DOI 10.1016/j.etp.2010.07.007; Muller RH, 2008, EUR J PHARM BIOPHARM, V68, P535, DOI 10.1016/j.ejpb.2007.07.006; Perry JL, 2012, NANO LETT, V12, P5304, DOI 10.1021/nl302638g; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI 10.1517/17425247.5.4.371 ; Sou K, 2008, INT J PHARM, V352, P287, DOI 10.1016/j.ijpharm.2007.10.033; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Su ZG, 2011, MOL PHARMACEUT, V8, P1641, DOI 10.1021/mp100463n; Szelenyi I, 2012, INFLAMM RES, V61, P1, DOI 10.1007/s00011-011-0393-7; Tsai MJ, 2012, INT J PHARMACEUT, V423, P461, DOI 10.1016/j.ijpharm.2011.12.009; van Griensven M, 2002, EXP TOXICOL PATHOL, V54, P203, DOI 10.1078/0940-2993-00247; Wang JJ, 2009, EUR J PHARM SCI, V38, P138, DOI 10.1016/j.ejps.2009.06.008; Wang YZ, 2008, YAKUGAKU ZASSHI, V128, P941, DOI 10.1248/yakushi.128.941; Wang YQ, 2011, NANOMED-NANOTECHNOL, V7, P385, DOI 10.1016/j.nano.2010.12.006; Xu XF, 2011, DRUG DELIV, V18, P485, DOI 10.3109/10717544.2011.589087; Yu HP, 2006, AM J PHYSIOL-LUNG C, V290, pL1004, DOI 10.1152/ajplung.00504.2005; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026; Yu HP, 2009, BIOCHEM PHARMACOL, V78, P983, DOI 10.1016/j.bcp.2009.06.008; Yuan H, 2007, COLLOID SURFACE B, V60, P174, DOI 10.1016/j.colsurfb.2007.06.011; Zhao X, 2011, J CHROMATOGR B, V879, P3721, DOI 10.1016/j.jchromb.2011.10.015	50	8	8	0	25	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1550-7033	1550-7041		J BIOMED NANOTECHNOL	J. Biomed. Nanotechnol.	AUG	2014	10	8					1520	1535		10.1166/jbn.2014.1858			16	Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	AF0ON	WOS:000334414000012	25016652				2022-02-06	
J	Lippa, SM; Agbayani, KA; Hawes, S; Jokic, E; Caroselli, JS				Lippa, Sara M.; Agbayani, Kristina A.; Hawes, Samuel; Jokic, Emily; Caroselli, Jerome S.			Effort in Acute Traumatic Brain Injury: Considering More Than Pass/Fail	REHABILITATION PSYCHOLOGY			English	Article						effort; head injury; performance validity; traumatic brain injury	NEUROPSYCHOLOGICAL STATUS RBANS; SYMPTOM VALIDITY TESTS; STATUS EFFORT INDEX; REPEATABLE BATTERY; TEST-PERFORMANCE; HEAD-INJURY; GALVESTON ORIENTATION; COGNITIVE IMPAIRMENT; HUNTINGTON DISEASE; GERIATRIC SAMPLES	Purpose/Objective: Performance validity is often conceptualized as a dichotomous process. Effort likely lies on a continuum, however, and psychologists' tendency to rely on pass/fail descriptors of one's effort may not be the only approach. The current study aims to show that when performance validity is considered on a continuum, it may provide clinical information related to cognitive functioning. Research Method/Design: Forty-four patients with moderate or severe traumatic brain injury were evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status upon their emergence from posttraumatic amnesia. From this data, previously developed effort index scores and "other cognitive functions" index scores were calculated. Results: Performance on the effort index significantly accounted for the patients' performance on a cognitive composite score after considering education and severity of injury. Conclusions/Implications: Findings suggest that more in-depth analysis of validity test performance is beneficial to gauge a patient's level of effort and is important to consider when interpreting results and in treatment planning.	[Lippa, Sara M.; Agbayani, Kristina A.; Hawes, Samuel; Jokic, Emily; Caroselli, Jerome S.] TIRR Mem Hermann Hosp, Dept Psychol Neuropsychol, Houston, TX USA; [Lippa, Sara M.] VA Boston Healthcare Syst, Boston, MA USA; [Agbayani, Kristina A.] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Hawes, Samuel] Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15260 USA; [Caroselli, Jerome S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Lippa, SM (corresponding author), Boston VA Med Ctr, Translat Res Ctr TBI & Stress Disorders TRACTS, 150 S Huntington Ave 182-JP, Boston, MA 02130 USA.	saralippa@gmail.com			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH018951] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH018951] Funding Source: Medline		Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Beatty WW, 2003, ARCH CLIN NEUROPSYCH, V18, P509, DOI 10.1016/S0887-6177(02)00148-8; Beglinger LJ, 2010, J CLIN EXP NEUROPSYC, V32, P573, DOI 10.1080/13803390903313564; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone K.B., 2007, ASSESSMENT FEIGNED C; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Duff K, 2011, APPL NEUROPSYCHOL, V18, P11, DOI 10.1080/09084282.2010.523354; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Gontkovsky ST, 2002, PSYCHOL REP, V90, P858, DOI 10.2466/PR0.90.3.858-860; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Gorny I., 2005, J FORENSIC NEUROPSYC, V4, P71, DOI DOI 10.1300/J151V04N04_05; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Hobart MP, 1999, AM J PSYCHIAT, V156, P1951; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Hook JN, 2009, ARCH CLIN NEUROPSYCH, V24, P231, DOI 10.1093/arclin/acp026; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Larson EB, 2005, J CLIN EXP NEUROPSYC, V27, P16, DOI 10.1080/138033990513564; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; MAXWELL SE, 1993, PSYCHOL BULL, V113, P181, DOI 10.1037/0033-2909.113.1.181; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Metternich B, 2009, J PSYCHOSOM RES, V66, P435, DOI 10.1016/j.jpsychores.2008.07.005; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Mooney S, 2007, ARCH CLIN NEUROPSYCH, V22, P175, DOI 10.1016/j.acn.2006.12.005; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Moore RC, 2013, J INT NEUROPSYCH SOC, V19, P198, DOI 10.1017/S1355617712001221; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; O'Mahar KM, 2012, ARCH CLIN NEUROPSYCH, V27, P114, DOI 10.1093/arclin/acr072; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Pollo A, 2009, PROG BRAIN RES, V175, P283, DOI 10.1016/S0079-6123(09)17520-9; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Rogers R., 2008, CLIN ASSESSMENT MALI; Sieck BC, 2013, ARCH CLIN NEUROPSYCH, V28, P135, DOI 10.1093/arclin/acs109; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Sorrell JH, 2006, PSYCHIAT CLIN NEUROS, V60, P174, DOI 10.1111/j.1440-1819.2006.01483.x; Stellton D., 2006, DISSERTATON ABSTRA B, V67; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Walters GD, 2008, PSYCHOL ASSESSMENT, V20, P238, DOI 10.1037/1040-3590.20.3.238; Walters GD, 2009, J CLIN EXP NEUROPSYC, V31, P584, DOI 10.1080/13803390802363728; Wilde MC, 2006, CLIN NEUROPSYCHOL, V20, P702, DOI 10.1080/13854040500246901; Wilde MC, 2010, CLIN NEUROPSYCHOL, V24, P57, DOI 10.1080/13854040902984505; Wilk CM, 2004, SCHIZOPHR RES, V70, P175, DOI 10.1016/j.schres.2003.10.009; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P688, DOI 10.1080/13854046.2012.679624; ZHAO LP, 1992, AM J EPIDEMIOL, V136, P464, DOI 10.1093/oxfordjournals.aje.a116520	63	8	8	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2014	59	3					306	312		10.1037/a0037217			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AN2RH	WOS:000340432500007	25133905	Green Accepted			2022-02-06	
J	Morales, CH; Mejia, C; Roldan, LA; Saldarriaga, MF; Duque, AF				Morales, Carlos H.; Mejia, Camila; Alberto Roldan, Luis; Fernanda Saldarriaga, Maria; Felipe Duque, Andres			Negative pleural suction in thoracic trauma patients: A randomized controlled trial	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Tube thoracostomy; thoracic trauma; negative pleural suction	WATER SEAL; PULMONARY RESECTION; SPONTANEOUS PNEUMOTHORAX; LOBECTOMY; MANAGEMENT; DRAINAGE	BACKGROUND: The study aimed to establish the benefits of using chest tubes with negative pleural suction against trapped water in patients with penetrating or blunt chest trauma who underwent tube thoracostomy, in terms of the incidence of complications, such as persistent air leak, clotted hemothorax, empyema, and duration of stay. METHODS: Patients who underwent tube thoracostomy because of traumatic pneumothorax, hemothorax, or hemopneumothorax were randomly assigned into one of two groups: in Group 1, the three-bottle drainage system was connected to a negative suction; in Group 2, no suction was given. Patients who required mechanical ventilation or emergency surgery (thoracotomy or thoracoscopy) either at the time of admission to the institution or immediately after the tube thoracostomy, patients who had histories of thoracic procedures or chronic pulmonary diseases (chronic obstructive pulmonary disease, diffuse interstitial lung disease), and patients with multiple injuries with severe traumatic brain injury and a Glasgow Coma Scale (GCS) score less than 8 of 15 were excluded from the study. Hospital stay, duration of tube thoracostomy, prolonged fistula, and other clinical variables were compared. RESULTS: One hundred ten patients were included, 56 in the group with suction and 54 in the group without suction. There were no differences in the demographic characteristics of each group. There were no differences between the groups in terms of hospital stay (p = 0.22), duration of tube thoracostomy (p = 0.35) (3 days in each group), or complications. However, the probability of air leak presence in time was greater for the Group 1 patients with negative suction versus the Group 2 patients (p = 0.023). CONCLUSION: The use of negative pleural suction did not demonstrate advantages over the three-bottle chest drainage system without suction in patients with uncomplicated traumatic pneumothorax, hemothorax, or hemopneumothorax. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Morales, Carlos H.; Mejia, Camila; Alberto Roldan, Luis; Fernanda Saldarriaga, Maria; Felipe Duque, Andres] Univ Antioauia, Dept Surg, Medellin, Colombia; [Morales, Carlos H.] St Vincent Paul Univ Hosp HUSVP, Medellin, Colombia		Morales, CH (corresponding author), Univ Antioquia, Fac Med, Carrera 51d 62-29, Medellin, Antioquia, Colombia.	cmorales@medicina.udea.edu.co		SALDARRIAGA ARANGO, MARIA FERNANDA/0000-0002-4214-4358			Alphonso N, 2005, EUR J CARDIO-THORAC, V27, P391, DOI 10.1016/j.ejcts.2004.12.004; Antanavicius G, 2005, AM SURGEON, V71, P416; Ayed AK, 2003, ANN THORAC SURG, V75, P1593, DOI 10.1016/S0003-4975(02)04894-4; Brunelli A, 2005, ANN THORAC SURG, V80, P1052, DOI 10.1016/j.athoracsur.2005.03.073; Brunelli A, 2004, ANN THORAC SURG, V77, P1932, DOI 10.1016/j.athoracsur.2003.12.022; Brunelli Alessandro, 2010, Thorac Surg Clin, V20, P359, DOI 10.1016/j.thorsurg.2010.03.002; Cerfolio RJ, 2001, ANN THORAC SURG, V71, P1613, DOI 10.1016/S0003-4975(01)02474-2; Coughlin SM, 2012, CAN J SURG, V55, P264, DOI 10.1503/cjs.001411; DAVIS JW, 1994, J AM COLL SURGEONS, V179, P553; Di Bartolomeo S, 2001, J TRAUMA, V51, P677, DOI 10.1097/00005373-200110000-00009; Khandhar Sandeep J, 2007, Thorac Surg Clin, V17, P1, DOI 10.1016/j.thorsurg.2007.02.004; Marshall MB, 2002, CHEST, V121, P831, DOI 10.1378/chest.121.3.831; Meyer Dan M, 2007, Thorac Surg Clin, V17, P47; Muslim Muhammad, 2008, J Ayub Med Coll Abbottabad, V20, P108; Okamoto Junichi, 2006, Ann Thorac Cardiovasc Surg, V12, P242; Prokakis C, 2008, WORLD J SURG, V32, P2336, DOI 10.1007/s00268-008-9741-3; SO SY, 1982, THORAX, V37, P46, DOI 10.1136/thx.37.1.46; Uribe CHM, 2008, SURG ENDOSC, V22, P91, DOI 10.1007/s00464-007-9378-6; Villegas MI, 2011, EUR J TRAUMA EMERG S, V37, P583, DOI 10.1007/s00068-010-0064-3	19	8	8	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2014	77	2					251	255		10.1097/TA.0000000000000281			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AN0EJ	WOS:000340255700012	25058250				2022-02-06	
J	Sears, JM; Bowman, SM; Hogg-Johnson, S				Sears, Jeanne M.; Bowman, Stephen M.; Hogg-Johnson, Sheilah			Using Injury Severity to Improve Occupational Injury Trend Estimates	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						injury severity; abbreviated injury scale; injury trends; injury surveillance; occupational injuries; hospital discharge data; workers' compensation; occupational health indicator	TRAUMATIC BRAIN-INJURY; WORK-RELATED INJURIES; MEDICAL COST OUTCOMES; HEALTH SURVEILLANCE; MULTIPLE INJURIES; NEW-JERSEY; CARE; INDICATORS; REIMBURSEMENT; DISABILITY	Background Hospitalization-based estimates of trends in injury incidence are also affected by trends in health care practices and payer coverage that may differentially impact minor injuries. This study assessed whether implementing a severity threshold would improve occupational injury surveillance. Methods Hospital discharge data from four states and a national survey were used to identify traumatic injuries (1998-2009). Negative binomial regression was used to model injury trends with/without severity restriction, and to test trend divergence by severity. Results Trend estimates were generally biased downward in the absence of severity restriction, more so for occupational than non-occupational injuries. Restriction to severe injuries provided a markedly different overall picture of trends. Conclusions Severity restriction may improve occupational injury trend estimates by reducing temporal biases such as increasingly restrictive hospital admission practices, constricting workers' compensation coverage, and decreasing identification/reporting of minor work-related injuries. Injury severity measures should be developed for occupational injury surveillance systems. (C) 2014 Wiley Periodicals, Inc.	[Sears, Jeanne M.] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98195 USA; [Bowman, Stephen M.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Hlth Policy & Management, Little Rock, AR 72205 USA; [Bowman, Stephen M.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD 21218 USA; [Hogg-Johnson, Sheilah] Inst Work & Hlth, Toronto, ON, Canada; [Hogg-Johnson, Sheilah] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Sears, JM (corresponding author), Univ Washington, Dept Hlth Serv, Box 354809, Seattle, WA 98195 USA.	jeannes@uw.edu	Bowman, Stephen/AAF-2154-2019		National Institute for Occupational Safety and Health (NIOSH)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [1R21OH010307]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [R21OH010307] Funding Source: NIH RePORTER	This study was funded by the National Institute for Occupational Safety and Health (NIOSH), grant number 1R21OH010307. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIOSH. We wish to thank David K. Bonauto, M. D., M. P. H., at the Washington State Department of Labor and Industries, for his suggestions and guidance regarding state-based occupational health indicators.	[Anonymous], 2011, NAT TRAUM DAT STAND; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Azaroff LS, 2004, INT J HEALTH SERV, V34, P271, DOI 10.2190/4H2X-XD53-GK0J-91NQ; Azaroff LS, 2002, AM J PUBLIC HEALTH, V92, P1421, DOI 10.2105/AJPH.92.9.1421; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes SL, 2008, SURGERY, V144, P670, DOI 10.1016/j.surg.2008.06.012; Barrett M., 2010, HCUP METHODS SERIES, Vx0023; Bowman SM, 2011, INJURY PREV, V17, P166, DOI 10.1136/ip.2009.023655; Clark DE, 2010, ICDPIC STATA MODULE; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cole BJ, 1998, ORTHOPEDICS, V21, P79; Council of State and Territorial Epidemiologists (CSTE), 2013, OCC HLTH IND GUID TR; Council of State and Territorial Epidemiologists (CSTE), 2014, OCC HLTH IND; Cryer C, 2010, INJURY PREV, V16, P254, DOI 10.1136/ip.2009.023903; Cryer C, 2002, PUBLIC HEALTH, V116, P257, DOI 10.1038/sj.ph.1900878; Cryer C, 2008, DEV INDICATORS INJUR; Cryer PC, 1999, INT J CONS PROD SAFE, V6, P183; Dembe AE, 2003, AM J IND MED, V44, P331, DOI 10.1002/ajim.10273; Dennison C., 2000, DESIGN OPERATION NAT; Derk S. J., 2007, Morbidity and Mortality Weekly Report, V56, P393; Di Bartolomeo S, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-17; Fay MP, 1997, STAT MED, V16, P791; Friedman LS, 2007, OCCUP ENVIRON MED, V64, P454, DOI 10.1136/oem.2006.029322; Friedman LS, 2007, J OCCUP ENVIRON MED, V49, P401, DOI 10.1097/JOM.0b013e31803b9527; Groenewold MR, 2013, HEALTH SERV RES, V48, P1939, DOI 10.1111/1475-6773.12066; Guo XG, 2010, IND LABOR RELAT REV, V63, P340, DOI 10.1177/001979391006300209; Harwood PJ, 2006, J TRAUMA, V60, P334, DOI 10.1097/01.ta.0000197148.86271.13; HELLING TS, 1995, J TRAUMA, V39, P980, DOI 10.1097/00005373-199511000-00027; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Langley John, 2003, Traffic Inj Prev, V4, P291, DOI 10.1080/714040487; Liu W, 2008, 3712008 SAS GLOB FOR; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; McGreevy K, 2010, AM J IND MED, V53, P146, DOI 10.1002/ajim.20746; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Morse T, 2005, AM J IND MED, V48, P40, DOI 10.1002/ajim.20182; Nahm NJ, 2012, J TRAUMA ACUTE CARE, V73, P957, DOI 10.1097/TA.0b013e31825a7723; National Center for Health Statistics (NCHS), 2004, EXP GROUP INJ SEV ME; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Ruestow PS, 2013, AM J IND MED, V56, P1149, DOI 10.1002/ajim.22212; Sears JM, 2014, INJURY, V45, P16, DOI 10.1016/j.injury.2012.12.024; Sears JM, 2013, AM J IND MED, V56, P742, DOI 10.1002/ajim.22179; Sears JM, 2013, J OCCUP REHABIL, V23, P19, DOI 10.1007/s10926-012-9377-x; Sears JM, 2012, J OCCUP ENVIRON MED, V54, P356, DOI 10.1097/JOM.0b013e3182444fe7; Sears JM, 2011, J OCCUP ENVIRON MED, V53, P1243, DOI 10.1097/JOM.0b013e31822cff63; Shishlov KS, 2011, AM J IND MED, V54, P128, DOI 10.1002/ajim.20880; SOROCK GS, 1993, AM J IND MED, V23, P427, DOI 10.1002/ajim.4700230306; Stephenson S, 2005, ACCIDENT ANAL PREV, V37, P825, DOI 10.1016/j.aap.2005.03.024; STIPDA: Injury Surveillance Workgroup 5, 2007, CONS REC INJ SURV ST; Thomas KE, 2012, STATE INJURY INDICAT; Thomsen Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; U.S. Department of Labor Bureau of Labor Statistics, 2008, FAT OCC INJ NONF OCC; U.S. House of Representatives Committee on Education and Labor, 2008, MAJ STAFF REP HIDD T; US Department of Labor Bureau of Labor Statistics, INJ ILLN FAT; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	55	8	8	1	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	AUG	2014	57	8					928	939		10.1002/ajim.22329			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AM9EH	WOS:000340182800008	24811970				2022-02-06	
J	Lincoln, AE; Yeger-McKeever, M; Romani, W; Hepburn, LR; Dunn, RE; Hinton, RY				Lincoln, Andrew E.; Yeger-McKeever, Meira; Romani, William; Hepburn, Lisa R.; Dunn, Reginald E.; Hinton, Richard Y.			Rate of Injury Among Youth Lacrosse Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						lacrosse; youth; injury; concussion; sports; epidemiology	WOMENS LACROSSE; EPIDEMIOLOGY	Objective: This study describes the rate of injury and the types and mechanisms of injuries incurred by girls and boys during youth recreational lacrosse. Design: Prospective cohort study. Setting: Games were played at a large turf community athletic complex. Participants: Participants included male and female lacrosse players aged 9-15 years. A total of 143 games were played, resulting in 4603 athlete-exposures (AEs). Assessment of Risk Factors: Youth players were grouped based on sex and 3 age categories: under 11 (U11; 9-10 years), under 13 (U13; 11-12 years), and under 15 (U15; 13-14 years). Main Outcome Measures: Certified athletic trainers collected data on type of injury and injury mechanism. Results: There were 6.3 injuries per 1000 AEs for boys and girls combined. Girls had 7 injuries (3.4 per 1000 AEs) and boys had 22 injuries (8.7 per 1000 AEs). Contusions and lacerations were the most frequent injury (n = 13), and body-to-body contact (n = 10) was the most common injury mechanism. There were 4 concussions among boys (U13 and U15) and none among girls. Conclusions: Most injuries evaluated in youth lacrosse were contusions/lacerations; however, serious injuries were observed, including concussions in boys in the age group where body contact is allowed.	[Lincoln, Andrew E.; Romani, William; Hepburn, Lisa R.; Dunn, Reginald E.] MedStar Sports Med Res Ctr, Baltimore, MD USA; [Yeger-McKeever, Meira; Hinton, Richard Y.] MedStar Union Mem Hosp, Dept Orthopaed & Sports Med, Baltimore, MD USA		Lincoln, AE (corresponding author), Care of Camire L, MedStar Union Mem Orthopaed, 3333 North Calvert St,Suite 400, Baltimore, MD 21218 USA.	lyn.camire@medstar.net			US Lacrosse; Derek Soloway; ATC; Howard County (MD) Parks; Recreation Lacrosse Program	The authors would like to thank US Lacrosse, Derek Soloway, ATC, and Howard County (MD) Parks and Recreation Lacrosse Program (Michael Milani and Jake Chesnutt) for support of this study. We also thank Lyn Camire, MA, ELS, for editorial assistance.	Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; US Lacrosse, 2011, 2011 US LACR PART SU; US Lacrosse, YOUTH RUL BEST PRACT	6	8	8	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2014	24	4					355	357					3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	AL3VW	WOS:000339060000015	24157466				2022-02-06	
J	Rivara, FP; McCarty, CA; Shandro, J; Wang, J; Zatzick, D				Rivara, Frederick P.; McCarty, Carolyn A.; Shandro, Jamie; Wang, Jin; Zatzick, Douglas			Parental Injury and Psychological Health of Children	PEDIATRICS			English	Article						injury; trauma; quality of life; PTSD	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC LIFE EVENTS; QUALITY-OF-LIFE; REPRESENTATIVE SAMPLE; DEPRESSIVE SYMPTOMS; BRAIN; ADOLESCENTS; RISK; RELIABILITY; OUTCOMES	OBJECTIVE: To determine how parental injury affects the psychological health and functioning of injured as well as uninjured children. METHODS: We recruited 175 parent-child dyads treated at a regional trauma center in 4 groups: parent and child both injured in the same event, child-only injured, parent-only injured, and neither parent nor child met criteria for significant injury. The preinjury health and functioning of parents and children were assessed with follow-up at 5 and 12 months. RESULTS: Parents who were injured themselves showed higher levels of impairment in activities of daily living, quality of life, and depression at both follow-up assessments than parents who were not injured. Children in dyads with both parent and child injured had the highest proportion of posttraumatic stress disorder (PTSD) symptoms at both 5 and 12 months. In addition, children with an injured parent but who were not injured themselves were more likely to report PTSD symptoms at 5 months. CONCLUSIONS: There were bidirectional effects of parental and child injury on the outcomes of each other. Injuries to the parent negatively affected the health-related quality of life of the injured children, over and above the effect of the injury itself on the child. Of great concern is the effect of parental injury on risk of stress and PTSD among uninjured children in the home.	[Rivara, Frederick P.; McCarty, Carolyn A.; Wang, Jin] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Shandro, Jamie] Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA; [Rivara, Frederick P.; Wang, Jin; Zatzick, Douglas] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.; McCarty, Carolyn A.] Seattle Childrens Res Inst, Seattle, WA USA		Rivara, FP (corresponding author), Harborview Injury Prevent & Res Ctr, Box 359960,325 Ninth Ave, Seattle, WA 98104 USA.	fpr@uw.edu			Maternal and Child Health Bureau of the Health Resources Services Administration, Department of Health and Human Services [R40MC17159]	FUNDING: This study was funded by grant R40MC17159 from the Maternal and Child Health Bureau of the Health Resources Services Administration, Department of Health and Human Services.	American Psychiatric Association, 2009, DIAGN STAT MAN MENT; Bryant B, 2004, PSYCHOL MED, V34, P335, DOI 10.1017/S0033291703001053; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Caffo E, 2003, CHILD ADOL PSYCH CL, V12, P493, DOI 10.1016/S1056-4993(03)00004-X; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Gennarelli TA, 2005, ABBREVIATED INJURY S; Ghesquiere A, 2008, J TRAUMA STRESS, V21, P487, DOI 10.1002/jts.20364; Gorman LA, 2010, PSYCHIAT QUART, V81, P1, DOI 10.1007/s11126-009-9116-4; Himmelstein DU, 2005, HLTH AFF MILLWOOD S, pW5, DOI DOI 10.1377/HLTHAFF.W5.6315689369; Hollingworth W, 2007, MED CARE, V45, P702, DOI 10.1097/MLR.0b013e318041f765; Johnston BD, 2000, PEDIATRICS, V105, P562, DOI 10.1542/peds.105.3.562; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Kassam-Adams N, 2011, J TRAUMA STRESS, V24, P252, DOI 10.1002/jts.20640; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee SJ, 2007, AM J PUBLIC HEALTH, V97, P1820, DOI 10.2105/AJPH.2005.084871; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Marsac ML, 2014, CLIN CHILD PSYCHOL P, V19, P233, DOI 10.1177/1359104513487000; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Ramstad SM, 2004, J TRAUMA STRESS, V17, P529, DOI 10.1007/s10960-004-5802-z; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Siegel BS, 2013, PEDIATRICS, V131, pE2002, DOI 10.1542/peds.2013-0940; Stallard P, 2007, J CHILD PSYCHOL PSYC, V48, P194, DOI 10.1111/j.1469-7610.2006.01692.x; Thomas CR, 2009, J BURN CARE RES, V30, P458, DOI 10.1097/BCR.0b013e3181a28c36; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Visser A, 2005, PSYCHO-ONCOLOGY, V14, P746, DOI 10.1002/pon.902; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 1993, SF 35 HLTH SURVEY MA; Winston FK, 2005, ARCH PEDIAT ADOL MED, V159, P1074, DOI 10.1001/archpedi.159.11.1074; Winston FK, 2003, JAMA-J AM MED ASSOC, V290, P643, DOI 10.1001/jama.290.5.643; World Health Organization, 1997, COMP INT DIAGN INT; Zatzick D, 2006, J PEDIATR PSYCHOL, V31, P377, DOI 10.1093/jpepsy/jsj056; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2006, J AM ACAD CHILD PSY, V45, P1188, DOI 10.1097/01.chi.0000231975.21096.45; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	41	8	8	1	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL	2014	134	1					E88	E97		10.1542/peds.2013-3273			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	AK9UZ	WOS:000338774800012	24918226	Green Published			2022-02-06	
J	Singla, N; Singh, SP; Gupta, SK; Karthigeyan, M; Radotra, BD				Singla, Navneet; Singh, Soubam Parkinson; Gupta, Sunil Kumar; Karthigeyan, M.; Radotra, Bishan D.			Histopathology of subcutaneously preserved autologous bone flap after decompressive craniectomy: a prospective study	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Cranioplasty; Autologous bone flap; Subcutaneous preservation; Histopathology	CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CRANIAL BONES; CRANIOPLASTY; HEMICRANIECTOMY; MULTICENTER; EXPERIENCE; TRIAL	Limited reports are available regarding the viability of subcutaneously preserved autologous bone flaps after decompressive craniectomy. The present study was undertaken to evaluate the histopathological changes in these autologous bone flaps. Between January 2011 and July 2012, 50 patients were prospectively studied at the time of cranioplasty. Bone flap retrieved from the abdominal wall was subjected to histopathological examination to look for mononuclear cell infiltration into the Haversian system, presence of osteocytes, osteoblastic activity, angiogenesis and new bone formation. Microbiological culture of bone specimens was also done. Of the 50 patients, there were 40 cases of trauma, 6 of aneurysmal bleed, 2 of tumor, and a single case of intracerebral hemorrhage and middle cerebral artery infarct, respectively. Mean age of the patients was 35.8 years (range, 10-64 years). Histopathological examination revealed the presence of osteocytes in 86 %, which indicates the viability of bone flaps. Osteoblastic activity was noted in 38 % and angiogenesis in 14 % of bone flaps, respectively. New bone formation was found in 6 %, and all had underlying osteoblastic activity. No significant correlation was found between the presence of osteocytes, osteoblasts, angiogenesis and duration of preservation of bone flaps. Acinetobacter species were cultured in a single patient. However, there was no evidence of clinical infection. Subcutaneously preserved bone flap in the anterior abdominal wall remains viable and retains its osteogenic potential, and it is a simple, cost-effective option for storage of bone flaps during decompressive craniotomy. It has a negligible infection rate.	[Singla, Navneet; Singh, Soubam Parkinson; Gupta, Sunil Kumar; Karthigeyan, M.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India; [Radotra, Bishan D.] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India		Singla, N (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India.	drnavi2007@yahoo.co.in		KARTHIGEYAN, MADHIVANAN/0000-0001-7085-7251			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; ACIKGOZ B, 1986, SURG NEUROL, V26, P557, DOI 10.1016/0090-3019(86)90339-3; Baldo S, 2010, WORLD NEUROSURG, V73, P552, DOI 10.1016/j.wneu.2010.02.018; Bhaskar IP, 2011, J CLIN NEUROSCI, V18, P1690, DOI 10.1016/j.jocn.2011.02.046; Bhaskar IP, 2011, ANZ J SURG, V81, P137, DOI 10.1111/j.1445-2197.2010.05584.x; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Dorfer C, 2010, WORLD NEUROSURG, V74, P465, DOI 10.1016/j.wneu.2010.08.001; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Grossman N., 2007, Cell and Tissue Banking, V8, P243, DOI 10.1007/s10561-006-9032-x; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Krishnan P, 2006, NEUROL INDIA, V54, P291; Lu Y, 2012, BRIT J NEUROSURG, V26, P216, DOI 10.3109/02688697.2011.629699; Morina Arsim, 2011, Surg Neurol Int, V2, P72, DOI 10.4103/2152-7806.81735; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; OKLUND SA, 1986, CLIN ORTHOP RELAT R, P269; PROLO DJ, 1991, CLIN ORTHOP RELAT R, P270; Sahoo N, 2010, J CRANIOFAC SURG, V21, P79, DOI 10.1097/SCS.0b013e3181c3ba58; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Wang JC, 2012, J CRANIOFAC SURG, V23, P1404, DOI 10.1097/SCS.0b013e31825e3aeb	31	8	8	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2014	156	7					1369	1373		10.1007/s00701-014-2071-3			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AK1SD	WOS:000338195300018	24752721				2022-02-06	
J	Smith, LB; Radomski, MV; Davidson, LF; Finkelstein, M; Weightman, MM; McCulloch, KL; Scherer, MR				Smith, Laurel B.; Radomski, Mary Vining; Davidson, Leslie Freeman; Finkelstein, Marsha; Weightman, Margaret M.; McCulloch, Karen L.; Scherer, Matthew R.			Development and Preliminary Reliability of a Multitasking Assessment for Executive Functioning After Concussion	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain concussion; executive function; military personnel; reproducibility of results; task performance and analysis	TRAUMATIC BRAIN-INJURY; ECOLOGICAL VALIDITY; EVERYDAY LIFE; PERFORMANCE; VERSION; PEOPLE; SAMPLE; DAMAGE	OBJECTIVES. Executive functioning deficits may result from concussion. The Charge of Quarters (CQ) Duty Task is a multitask assessment designed to assess executive functioning in servicemembers after concussion. In this article, we discuss the rationale and process used in the development of the CQ Duty Task and present pilot data from the preliminary evaluation of interrater reliability (IRR). METHOD. Three evaluators observed as 12 healthy participants performed the CQ Duty Task and measured performance using various metrics. Intraclass correlation coefficient (ICC) quantified IRR. RESULTS. The ICC for task completion was .94. ICCs for other assessment metrics were variable. CONCLUSION. Preliminary IRR data for the CQ Duty Task are encouraging, but further investigation is needed to improve IRR in some domains. Lessons learned in the development of the CQ Duty Task could benefit future test development efforts with populations other than the military.	[Smith, Laurel B.] US Army, Environm Med Res Inst, Natick, MA 01760 USA; [Radomski, Mary Vining; Finkelstein, Marsha; Weightman, Margaret M.] Courage Kenny Res Ctr, Minneapolis, MN USA; [Davidson, Leslie Freeman] Shenandoah Univ, Winchester, VA USA; [McCulloch, Karen L.] Univ N Carolina, Div Phys Therapy, Chapel Hill, NC USA; [Scherer, Matthew R.] Andrew Rader US Army Hlth Clin, Ft Myer, VA USA		Smith, LB (corresponding author), US Army, Environm Med Res Inst, 15 Kansas St, Natick, MA 01760 USA.	laurel.b.smith.mil@mail.mil					Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Baum C. M., 2005, MEASURING OCCUPATION, P49; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cuberos-Urbano G, 2013, J CLIN EXP NEUROPSYC, V35, P329, DOI 10.1080/13803395.2013.776011; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Frisch S, 2012, J NEUROPSYCHOL, V6, P257, DOI 10.1111/j.1748-6653.2012.02026.x; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Radomski MV, 2014, OCCUPATIONAL THERAPY, P121; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Tranel D, 2007, J CLIN EXP NEUROPSYC, V29, P319, DOI 10.1080/13803390600701376; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wolf TJ, 2008, WORK, V31, P221	22	8	8	0	6	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2014	68	4					439	443		10.5014/ajot.2014.012393			5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AL4FR	WOS:000339088800009	25005507	Green Published, Green Submitted			2022-02-06	
J	Fung, CHL; Nguyen, M; Moineddin, R; Colantonio, A; Wiseman-Hakes, C				Fung, Christina Hoi Ling; Nguyen, Michelle; Moineddin, Rahim; Colantonio, Angela; Wiseman-Hakes, Catherine			Reliability and validity of the Daily Cognitive-Communication and Sleep Profile: a new instrument for monitoring sleep, wakefulness and daytime function	INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH			English	Article						cognitive function; communication; mood; sleep quality; validity	TRAUMATIC BRAIN-INJURY; COLLEGE-STUDENTS; QUALITY; HEALTH; DISTURBANCES; SYMPTOMS; ADULTS; PERFORMANCE; COMPLAINTS; VARIABLES	The Daily Cognitive Communicative and Sleep Profile (DCCASP) is a seven-item instrument that captures daily subjective sleep quality, perceived mood, cognitive, and communication functions. The objective of this study was to evaluate the reliability and validity of the DCCASP. The DCCASP was self-administered daily to a convenience sample of young adults (n = 54) for two two-week blocks, interspersed with a two-week rest period. Afterwards, participants completed the Pittsburgh Sleep Quality Index (PSQI). Internal consistency and criterion validity were calculated by Cronbach's coefficient, Concordance Correlation Coefficient (CCC), and Spearman rank (rs) correlation coefficient, respectively. Results indicated high internal consistency (Cronbach-s = 0.864-0.938) among mean ratings of sleep quality on the DCCASP. There were significant correlations between mean ratings of sleep quality and all domains (rs=0.38-0.55, p<0.0001). Criterion validity was established between mean sleep quality ratings on the DCCASP and PSQI (rs=0.40, p<0.001). The DCCASP is a reliable and valid self-report instrument to monitor daily sleep quality and perceived mood, cognitive, and communication functions over time, amongst a normative sample of young adults. Further studies on its psychometric properties are necessary to clarify its utility in a clinical population. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Fung, Christina Hoi Ling; Nguyen, Michelle; Moineddin, Rahim; Colantonio, Angela; Wiseman-Hakes, Catherine] Univ Toronto, Fac Med, Toronto, ON M5G 1V7, Canada		Fung, CHL (corresponding author), Univ Toronto, Fac Med, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	christinahl.fung@mail.utoronto.ca	Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X; Colantonio, Angela/0000-0003-2094-4765	Toronto Rehabilitation Institute (TRI)University of Toronto; Toronto Rehabilitation Institute Foundation; Ontario Ministry of Health and Long-term CareMinistry of Health and Long-Term Care, Ontario; Canadian Institutes of Health Research (CIHR) Clinical Research FellowshipCanadian Institutes of Health Research (CIHR); CIHR Research Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Saunderson Family Chair in Acquired Brain Injury Research at TRI	The authors acknowledge and appreciate the financial support from the Toronto Rehabilitation Institute (TRI), the Toronto Rehabilitation Institute Foundation, and a grant to the TRI from the Ontario Ministry of Health and Long-term Care. Catherine Wiseman-Hakes was supported by a Canadian Institutes of Health Research (CIHR) Clinical Research Fellowship. Angela Colantonio was supported by a CIHR Research Chair in Gender, Work and Health (#CGW-126580) and the Saunderson Family Chair in Acquired Brain Injury Research at TRI. The authors also acknowledge Lee Vernich (MSc) for support with data analysis. Dr Catherine Wiseman-Hakes developed the DCCASP. Finally, the authors thank Sandra Sokoloff for administrative support. This study was conducted in fulfillment of the requirements for the Masters of Science in Occupational Science and Occupational Therapy, Faculty of Medicine, University of Toronto.	AASM, 2005, INT CLASS SLEEP DIS; Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; Aldrich MS, 1999, SLEEP MED; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; BOURGEOIS MS, 1991, J SPEECH HEAR RES, V34, P831, DOI 10.1044/jshr.3404.831; Brown FC, 2002, BEHAV MED, V28, P33, DOI 10.1080/08964280209596396; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carpenter JS, 2007, ONCOLOGIST, V12, P124, DOI 10.1634/theoncologist.12-1-124; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Cooper SA, 2007, BRIT J PSYCHIAT, V190, P27, DOI 10.1192/bjp.bp.106.022483; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Fung C., 2011, SLEEP MED S1, V12, pS127; Goel N, 2005, CHRONOBIOL INT, V22, P905, DOI 10.1080/07420520500263235; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Green A., 2008, BRIT J OCCUPATIONAL, V71, P339, DOI DOI 10.1177/030802260807100808; Hauri PJ, 1997, ACTA NEUROL BELG, V97, P113; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kotagal S, 1996, J CLIN NEUROPHYSIOL, V13, P208, DOI 10.1097/00004691-199605000-00004; Leger D, 2008, CURR MED RES OPIN, V24, P307, DOI 10.1185/030079907X253771; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Manber R, 1997, HEALTH PSYCHOL, V16, P209, DOI 10.1037/0278-6133.16.3.209; McNair D. M, 1971, MANUAL PROFILE MOOD; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Mok VCT, 2004, J NEUROL NEUROSUR PS, V75, P560, DOI 10.1136/jnnp.2003.015107; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Pilcher JJ, 1998, BEHAV MED, V23, P170, DOI 10.1080/08964289809596373; Pilcher JJ, 1997, J AM COLL HEALTH, V46, P121, DOI 10.1080/07448489709595597; Rosenthal MS, 1998, AM J PHARM EDUC, V62, P204; Stein D, 2002, J LEARN DISABIL-US, V35, P268, DOI 10.1177/002221940203500308; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; TOTTERDELL P, 1994, SLEEP, V17, P466, DOI 10.1093/sleep/17.5.466; Touchette E, 2007, SLEEP, V30, P1213, DOI 10.1093/sleep/30.9.1213; Trockel MT, 2000, J AM COLL HEALTH, V49, P125, DOI 10.1080/07448480009596294; Vena C, 2004, ONCOL NURS FORUM, V31, P735, DOI 10.1188/04.ONF.735-746; Vitiello MV, 2001, CNS DRUGS, V15, P777, DOI 10.2165/00023210-200115100-00004; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]; Wiseman-Hakes C, 2011, BRAIN INJURY, V25, P1256, DOI 10.3109/02699052.2011.608215; Zafonte RD, 1996, NEUROREHABILITATION, V7, P189, DOI 10.3233/NRE-1996-7304	51	8	8	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8931	1557-0657		INT J METH PSYCH RES	Int. J. Methods Psychiatr. Res.	JUN	2014	23	2					217	228		10.1002/mpr.1422			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AJ2TB	WOS:000337514600007	24677656	Green Published			2022-02-06	
J	Mason, RA; Prat, CS; Just, MA				Mason, Robert A.; Prat, Chantel S.; Just, Marcel Adam			Neurocognitive Brain Response to Transient Impairment of Wernicke's Area	CEREBRAL CORTEX			English	Article						brain adaptation; brain trauma; functional magnetic resonance imaging; language; repetitive transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; CONCURRENT TMS-FMRI; SENTENCE COMPREHENSION; INDIVIDUAL-DIFFERENCES; PROCESSING DEMANDS; RIGHT-HEMISPHERE; NARRATIVE COMPREHENSION; POSTSTROKE APHASIA; LANGUAGE FUNCTION; IMAGING REVEALS	This study examined how the brain system adapts and reconfigures its information processing capabilities to maintain cognitive performance after a key cortical center [left posterior superior temporal gyrus (LSTGp)] is temporarily impaired during the performance of a language comprehension task. By applying repetitive transcranial magnetic stimulation (rTMS) to LSTGp and concurrently assessing the brain response with functional magnetic resonance imaging, we found that adaptation consisted of 1) increased synchronization between compensating regions coupled with a decrease in synchronization within the primary language network and 2) a decrease in activation at the rTMS site as well as in distal regions, followed by their recovery. The compensatory synchronization included 3 centers: The contralateral homolog (RSTGp) of the area receiving rTMS, areas adjacent to the rTMS site, and a region involved in discourse monitoring (medial frontal gyrus). This approach reveals some principles of network-level adaptation to trauma with potential application to traumatic brain injury, stroke, and seizure.	[Mason, Robert A.; Just, Marcel Adam] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Prat, Chantel S.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Prat, Chantel S.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA		Mason, RA (corresponding author), Carnegie Mellon Univ, Dept Psychol, Ctr Cognit Brain Imaging, Baker Hall, Pittsburgh, PA 15213 USA.	rmason@andrew.cmu.edu		Just, Marcel/0000-0003-1245-3050	Office of Naval ResearchOffice of Naval Research [N00014-10-1-0069]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00DC009634]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH029617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R00DC009634] Funding Source: NIH RePORTER	This research was supported by the Office of Naval Research (Grant N00014-10-1-0069) and by the National Institute of Health Pathway to Independence Award (R00DC009634).	Andoh J, 2006, NEUROIMAGE, V29, P619, DOI 10.1016/j.neuroimage.2005.07.029; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Bohning DE, 1997, NEUROREPORT, V8, P2535, DOI 10.1097/00001756-199707280-00023; Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Brown J. I, 1960, NELSON DENNY READING; CAPPA SF, 1992, APHASIOLOGY, V6, P359, DOI 10.1080/02687039208248607; CHATRIAN GE, 1988, J CLIN NEUROPHYSIOL, V5, P183, DOI 10.1097/00004691-198804000-00005; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Ferstl E. C., 2007, HIGHER LEVEL LANGUAG, P53; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Floel A, 2012, APHASIOLOGY, V26, P1082, DOI 10.1080/02687038.2011.589892; Floel A, 2007, BRAIN RES REV, V53, P250, DOI 10.1016/j.brainresrev.2006.08.006; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Grafman J, 2000, J COMMUN DISORD, V33, P345, DOI 10.1016/S0021-9924(00)00030-7; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Just MA, 2007, COGN AFFECT BEHAV NE, V7, P153, DOI 10.3758/CABN.7.3.153; Karbe H, 1998, BRAIN LANG, V64, P215, DOI 10.1006/brln.1998.1961; Keller TA, 2001, CEREB CORTEX, V11, P223, DOI 10.1093/cercor/11.3.223; Kim YH, 2005, NEUROSCI LETT, V382, P280, DOI 10.1016/j.neulet.2005.03.043; Knecht S, 2002, NAT NEUROSCI, V5, P695, DOI 10.1038/nn868; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Mason R.A., 2006, HDB PSYCHOLINGUISTIC, P765, DOI DOI 10.1016/B978-012369374-7/50020-1; Mason RA, 2003, J EXP PSYCHOL LEARN, V29, P1319, DOI 10.1037/0278-7393.29.6.1319; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Mimura M, 1998, BRAIN, V121, P2083, DOI 10.1093/brain/121.11.2083; Mottaghy FM, 2000, NEUROSCI LETT, V280, P167, DOI 10.1016/S0304-3940(00)00798-9; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Papagno C, 2009, BRAIN RES, V1263, P78, DOI 10.1016/j.brainres.2009.01.037; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Prat CS, 2012, J EXP PSYCHOL LEARN, V38, P282, DOI 10.1037/a0026037; Prat CS, 2011, CEREB CORTEX, V21, P1747, DOI 10.1093/cercor/bhq241; Prat CS, 2011, BRAIN LANG, V116, P1, DOI 10.1016/j.bandl.2010.08.004; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Ruff CC, 2009, J COGNITIVE NEUROSCI, V21, P1146, DOI 10.1162/jocn.2009.21097; Rypma B, 2009, INTELLIGENCE, V37, P207, DOI 10.1016/j.intell.2008.12.004; Sack AT, 2007, CEREB CORTEX, V17, P2841, DOI 10.1093/cercor/bhm013; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schuhmann T, 2009, CORTEX, V45, P1111, DOI 10.1016/j.cortex.2008.10.013; Thiel A, 2006, BRAIN LANG, V98, P57, DOI 10.1016/j.bandl.2006.01.007; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Turkeltaub PE, 2012, CORTEX, V48, P1179, DOI 10.1016/j.cortex.2011.06.010; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; Winhuisen L, 2005, STROKE, V36, P1759, DOI 10.1161/01.STR.0000174487.81126.ef; Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013	57	8	8	2	26	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JUN	2014	24	6					1474	1484		10.1093/cercor/bhs423			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI0IG	WOS:000336529700006	23322403	Green Published, Bronze			2022-02-06	
J	Short, J; McCormack, J; Copley, A				Short, Jessica; McCormack, Jane; Copley, Anna			The current practices of speech-language pathologists in providing information to clients with traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Traumatic brain injury (TBI); speech-language pathologists; service delivery; health literacy	HEALTH LITERACY; STROKE PATIENTS; EDUCATION MATERIALS; VERBAL IMPAIRMENT; SELF-AWARENESS; PUBLIC-HEALTH; REHABILITATION; IMPACT; PEOPLE; PERSPECTIVES	The provision of information about cognitive-communication disorders (CCDs) following traumatic brain injury (TBI) is important given the impact these communication impairments can have on the rehabilitation of people with TBI. This study describes the results of an online survey which investigated the current practices of 74 Australian speech-language pathologists (SLPs) working with adults with TBI. Thirty-seven SLPs outlined their practices in information provision. SLPs reported they provide information to adults with TBI about CCDs, the impact of CCDs on participation in life activities, and rehabilitation from CCDs. In addition, SLPs identified barriers and facilitators to information provision. Barriers identified included time, impairments resulting from TBI, and personal characteristics of the client. Facilitators included family functioning and support and the multidisciplinary team. Findings of this research indicate a need for some changes in the format and content of information that SLPs provide to adults with TBI, to ensure they can achieve fundamental levels of health literacy and better health outcomes.	[Short, Jessica; McCormack, Jane] Charles Sturt Univ, Albury, NSW 2640, Australia; [Copley, Anna] Univ Queensland, Brisbane, Qld, Australia		McCormack, J (corresponding author), Charles Sturt Univ, POB 789, Albury, NSW 2640, Australia.	jmccormack@csu.edu.au	Copley, Anna/D-1067-2011	Copley, Anna/0000-0003-1784-9070; McCormack, Jane/0000-0001-9133-9023	Charles Sturt University Honours Scholarship; Speech Pathology Australia Undergraduate Research Grant	This research was part of the study titled "An investigation of the current practices of speech pathologists working with adults with traumatic brain injury (TBI) in Australia", led by Dr Anna Copley. The authors wish to thank the participants for taking part in this study. This paper is based on an honours dissertation written by the first author and supervised by the subsequent authors. The research was supported by a Charles Sturt University Honours Scholarship and Speech Pathology Australia Undergraduate Research Grant awarded to the first author.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Australian Institute of Health and Welfare, 2007, BULLETIN, V55; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Charmaz K, 1995, SOCIOL QUART, V36, P657, DOI 10.1111/j.1533-8525.1995.tb00459.x; College of Audiologists and Speech-Language Pathologists, 2002, PREF PRACT GUID COGN; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Creswell J.W., 2017, RES DESIGN QUALITATI; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Eames S., 2011, PATIENT EDUC COUNS, V84, P18; Eames S, 2010, TOP STROKE REHABIL, V17, P69, DOI 10.1310/tsr1702-69; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Freund J, 1994, COGNITIVE COMMUNICAT; Gentleman D, 2001, TRAUMA, V3, P193; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Helps Y, 2008, INJURY RES STAT SERI, V45; Hersh D, 2009, INT J SPEECH-LANG PA, V11, P147, DOI 10.1080/17549500802579103; Hill J, 1997, BAILLIERE CLIN RHEUM, V11, P109, DOI 10.1016/S0950-3579(97)80036-2; Hoffmann T., 2004, INT J THERAPY REHABI, V11, P303, DOI DOI 10.12968/IJTR.2004.11.7.13357; Hoffmann T, 2007, TOP STROKE REHABIL, V14, P88, DOI 10.1310/tsr1401-88; Howie L., 2010, RES METHODS HLTH FDN; Imms C., 2010, RES METHODS HLTH FDN; Institute of Medicine, 2004, HLTH LITERACY PRESCR; Kickbusch IS, 2001, HEALTH PROMOT INT, V16, P289, DOI 10.1093/heapro/16.3.289; Kiesler DJ, 2006, PATIENT EDUC COUNS, V61, P319, DOI 10.1016/j.pec.2005.08.002; Knight K, 2006, TOP STROKE REHABIL, V13, P78, DOI 10.1310/FC6M-P7L0-W3XD-4WAE; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2008, CAN J NURS RES, V40, P142; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Mika VS, 2005, FAM COMMUNITY HEALTH, V28, P351, DOI 10.1097/00003727-200510000-00007; Minichiello V, 1999, HDB RES METHODS NURS; Minichiello V., 2008, IN DEPTH INTERVIEWIN; Motor Accidents Authority NSW, 2008, GUID MILD TRAUM BRAI; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Protheroe Jo, 2013, Nurs Manag (Harrow), V20, P20; Ratzan S, 2000, NATL LIB MED CURRENT; Rose TA, 2003, APHASIOLOGY, V17, P947, DOI 10.1080/02687030344000319; Rose T, 2010, TOP STROKE REHABIL, V17, P79, DOI 10.1310/tsr1702-79; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Speros C, 2005, J ADV NURS, V50, P633, DOI 10.1111/j.1365-2648.2005.03448.x; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Volandes AE, 2007, AM J BIOETHICS, V7, P5, DOI 10.1080/15265160701638520; World Health Organization, 2007, INT CLASS FUNCT DIS; YATES AJ, 1963, PSYCHOL BULL, V60, P213, DOI 10.1037/h0044155	59	8	8	1	29	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	JUN	2014	16	3					219	230		10.3109/17549507.2014.882413			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AH9FC	WOS:000336446100005	24588453				2022-02-06	
J	Dias, C; Rocha, J; Pereira, E; Cerejo, A				Dias, Celeste; Rocha, Joao; Pereira, Eduarda; Cerejo, Antonio			Traumatic Brain Injury in Portugal: Trends in Hospital Admissions from 2000 to 2010	ACTA MEDICA PORTUGUESA			English	Article						Intensive Care Units; Brain Injuries; Hospitalization; Portugal	EPIDEMIOLOGY; SEVERITY	Introduction: Traumatic brain injury has a considerable socio-economic impact, being a major cause of morbi-mortality, often with permanent disability. We sought to characterize health resource utilization of adult traumatic brain injury patients in Portugal between 2000 and 2010. Material and Methods: Retrospective study of medical records of adult patients with ICD9 diagnostic code of traumatic brain injury included in the National Diagnosis Related Groups Database from 2000-2010. Descriptive statistical analysis was performed and trends during the decade were evaluated. Results: We analysed 72 865 admissions to 111 hospitals, 64.1% males, mean age 57.9 +/- 21.8 years (18-107). We found a decrease in number of traumatic brain injury in younger patients and an increase in older ones. The number of traffic accidents decreased and the number of falls increased. There was an increase of moderate to severe traumatic brain injury admissions: 47.2% in 2000 / 80% in 2010. Patients admitted in Intensive Care have nearly doubled (15.8% vs 29.5%) as well as the number submitted to neurosurgical procedures (8.2% vs 15.2%). Total mortality increased from 7.1% to 10.6%. Discussion: The decrease of traumatic brain injury may be associated with the trauma prevention campaigns, road network improvement and health politics. The increase in mortality may be related to better pre-hospital care, enabling more severe cases to arrive in-hospital alive, and although treated more frequently in Intensive Care and requiring more neurosurgical procedures, they end up having higher mortality. Also this may be due to an increase in patients' age and worse pre-morbid status. Conclusion: Traumatic brain injury in Portugal is changing. Although hospital admissions due to global traumatic brain injury have decreased, mortality rate has increased.	[Dias, Celeste; Pereira, Eduarda] Univ Porto, Hosp Sao Joao, Neurocrit Care Unit, Dept Intens Care, P-4100 Oporto, Portugal; [Rocha, Joao] Hosp Escala, Dept Neurol, Braga, Portugal; [Cerejo, Antonio] Univ Porto, Hosp Sao Joao, Dept Neurosurg, P-4100 Oporto, Portugal		Dias, C (corresponding author), Univ Porto, Hosp Sao Joao, Neurocrit Care Unit, Dept Intens Care, Rua Campo Alegre 823, P-4100 Oporto, Portugal.		Dias, Celeste/AAV-3820-2020; Cerejo, Antonio/AAT-7863-2020; Dias, Celeste/AAD-8711-2019	Dias, Celeste/0000-0003-0340-9808; Cerejo, Antonio/0000-0001-9136-873X; 			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI DOI 10.1080/02699050801938975; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	13	8	8	0	1	ORDEM MEDICOS	LISBON	AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL	1646-0758			ACTA MEDICA PORT	Acta Medica Port.	MAY-JUN	2014	27	3					349	356		10.20344/amp.4892			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS7DF	WOS:000344416900014	25017347	Green Published, gold, Green Submitted			2022-02-06	
J	Gabbe, BJ; Brooks, C; Demmler, JC; Macey, S; Hyatt, MA; Lyons, RA				Gabbe, Belinda J.; Brooks, Caroline; Demmler, Joanne C.; Macey, Steven; Hyatt, Melanie A.; Lyons, Ronan A.			The association between hospitalisation for childhood head injury and academic performance: evidence from a population e-cohort study	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; LOW-BIRTH-WEIGHT; YOUNG-CHILDREN; OUTCOMES; ADOLESCENTS; SCHOOL; HEALTH; SKILLS; TBI	Background Childhood head injury has the potential for lifelong disability and burden. This study aimed to establish the association between admission to hospital for childhood head injury and early academic performance. Methods The Wales Electronic Cohort for Children (WECC) study is comprised of record-linked routinely collected data, on all children born or residing in Wales. Anonymous linking fields are used to link child and maternal health, environment and education records. Data from WECC were extracted for children born between September 1998 and August 2001. A Generalised Estimating Equation model, adjusted for clustering based on the maternal identifier as well as other key confounders, was used to establish the association between childhood head injury and performance on the Key Stage 1 (KS1) National Curriculum assessment administered to children aged 5-7 years. Head injury was defined as an emergency admission for > 24 h for concussion, skull fracture or intracranial injury prior to KS1 assessment. Results Of the 101 892 eligible children, KS1 results were available for 90 661 (89%), and 290 had sustained a head injury. Children who sustained an intracranial injury demonstrated significantly lower adjusted odds of achieving a satisfactory KS1 result than children who had not been admitted to hospital for head injury (adjusted OR 0.46, 95% CI 0.30 to 0.72). Conclusions The findings of this population e-cohort study quantify the impact of head injury on academic performance, highlighting the need for enhanced head injury prevention strategies. The results have implications for the care and rehabilitation of children admitted to hospital with head injury.	[Gabbe, Belinda J.; Brooks, Caroline; Demmler, Joanne C.; Macey, Steven; Hyatt, Melanie A.; Lyons, Ronan A.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Gabbe, Belinda J.; Lyons, Ronan A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Lyons, Ronan A.] Publ Hlth Wales NHS Trust, Cardiff, S Glam, Wales		Gabbe, BJ (corresponding author), Monash Univ, Alfred Ctr, Dept Epidemiol & Prevent Med, Commercial Rd, Melbourne, Vic 3004, Australia.	belinda.gabbe@monash.edu	Mustard, David/A-2087-2016; Demmler, Joanne/N-1609-2015	Demmler, Joanne/0000-0002-4675-6271; Gabbe, Belinda/0000-0001-7096-7688; Brooks, Caroline/0000-0002-4612-5867; Lyons, Ronan/0000-0001-5225-000X	National Institute for Social Care and Health Research [TPR08-006]; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research: Centre of ExcellenceAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme; British Heart FoundationBritish Heart Foundation; Cancer Research UKCancer Research UK; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [RES-590-28-0005]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Welsh Government; Wellcome Trust under UK Clinical Research CollaborationWellcome Trust [WT087640MA]; Centre for the Improvement of Population Health through E-records Research (CIPHER), one of four UK e-health Informatics Research Centres - Arthritis Research UK; Chief Scientist Office (Scottish Government Health Directorates); National Institute for Health ResearchNational Institute for Health Research (NIHR); National Institute for Social Care and Health Research (Welsh Government); Wellcome TrustWellcome TrustEuropean Commission [MR/K006525/1]; National Health and Medical Research Council of Australia Career Development FellowshipNational Health and Medical Research Council of Australia [APP1048731]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K006525/1, MR/K023233/1] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K006525/1, MR/K023233/1] Funding Source: UKRI	The development of WECC was supported by a Translational Health Research Platform Award from the National Institute for Social Care and Health Research (grant reference: TPR08-006). The work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (RES-590-28-0005), Medical Research Council, the Welsh Government and the Wellcome Trust (WT087640MA), under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. This study was also supported by the Centre for the Improvement of Population Health through E-records Research (CIPHER), one of four UK e-health Informatics Research Centres funded by a joint investment from: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Chief Scientist Office (Scottish Government Health Directorates), the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute for Health Research, the National Institute for Social Care and Health Research (Welsh Government) and the Wellcome Trust (Grant reference: MR/K006525/1). Belinda Gabbe was supported by a National Health and Medical Research Council of Australia Career Development Fellowship (APP1048731) during the preparation of this manuscript.	Allen DM, 1998, CAN J SURG, V41, P53; Anderson ML, 2008, J AM STAT ASSOC, V103, P1481, DOI 10.1198/016214508000000841; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bruns Jnr J, 2003, EPILEPSIA, V44, P2; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cornwell C, 2013, J HUM RESOUR, V48, P236, DOI 10.1353/jhr.2013.0002; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hutchings HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070601; Hyatt M., 2011, ARCH DIS CHILD-FETAL, V96, pFA18, DOI [10.1136/archdischild.2011.300164.6, DOI 10.1136/ARCHDISCHILD.2011.300164.6]; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JOHNSON DA, 1992, BRIT J EDUC PSYCHOL, V62, P404, DOI 10.1111/j.2044-8279.1992.tb01033.x; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Lyons RA, 2012, LANCET, V380, pS6, DOI DOI 10.1016/S0140-6736(13)60362-1; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Renstrom B, 2012, BRAIN INJURY, V26, P1405, DOI 10.3109/02699052.2012.694559; Resnick MB, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e74; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; SCOTTJUPP R, 1992, ARCH DIS CHILD, V67, P222, DOI 10.1136/adc.67.2.222; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150	36	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	MAY	2014	68	5					466	470		10.1136/jech-2013-203427			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CB0CY	WOS:000349294000008	24419234	Green Published, hybrid			2022-02-06	
J	Liubinas, SV; Drummond, KJ; Desmond, PM; Bjorksten, A; Morokoff, AP; Kaye, AH; O'Brien, TJ; Moffat, BA				Liubinas, S. V.; Drummond, K. J.; Desmond, P. M.; Bjorksten, A.; Morokoff, A. P.; Kaye, A. H.; O'Brien, T. J.; Moffat, B. A.			Glutamate quantification in patients with supratentorial gliomas using chemical shift imaging	NMR IN BIOMEDICINE			English	Article						glutamate; glutamine; glioma; magnetic resonance spectroscopy; neurotoxicity; neurodegeneration; epilepsy; LCModel	HUMAN-BRAIN; IN-VIVO; SPECTROSCOPY; METABOLITES; TUMORS	This study aimed to evaluate and validate chemical shift imaging (CSI) for in vivo glutamate (Glu) quantification in patients with supratentorial gliomas. If validated, CSI could become an extremely useful tool to investigate metabolic dysfunction of Glu in excitotoxic neuropathologies. Quantitative CSI estimates of Glu concentrations were compared with known concentrations of Glu in aqueous phantom solutions. Forty-one patients with known or likely supratentorial gliomas underwent preoperative CSI. The spectra obtained were analyzed for Glu concentrations and Glu to creatine (Cr) ratios. These in vivo measurements were correlated against ex vivo Glu content quantified by high performance liquid chromatography (HPLC) measured in 65 resected brain tumor and peritumoral brain specimens. For the phantom solutions the CSI estimates of Glu concentration and the Glu/Cr ratios were highly correlated with known Glu concentration (r(2)=0.95, p=0.002, and r(2)=0.97, p<0.0001, respectively). There was a modest, but statistically significant, correlation between the ex vivo measured Glu and in vivo spectroscopic Glu concentration (r(2)=0.22, p=0.04) and ratios of Glu to Cr (r(2)=0.30, p=0.002). Quantitative measurement of Glu content is feasible in patients with supratentorial gliomas using CSI. The in vitro and in vivo results suggest that this has the potential to be a reliable quantitative imaging assay for brain tumor patients. This may have wide clinical research applications in a number of neurological disorders where Glu excitotoxicity and metabolic dysfunction are known to play a role in pathogenesis, including tumor associated epilepsy, epilepsy, stroke and neurotrauma. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Liubinas, S. V.; Drummond, K. J.; Morokoff, A. P.; Kaye, A. H.] Univ Melbourne, Dept Surg, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Liubinas, S. V.; Drummond, K. J.; Morokoff, A. P.; Kaye, A. H.] Royal Melbourne Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Desmond, P. M.; Moffat, B. A.] Univ Melbourne, Dept Radiol, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Bjorksten, A.] Royal Melbourne Hosp, Dept Anaesthesia, Melbourne, Vic, Australia; [O'Brien, T. J.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia; [O'Brien, T. J.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia		Moffat, BA (corresponding author), Univ Melbourne, Dept Radiol, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia.	bmoffat@unimelb.edu.au	Moffat, Bradford/L-3777-2019; Morokoff, Andrew/ABC-2783-2020; O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Desmond, Patricia/D-1966-2014	Moffat, Bradford/0000-0002-0278-4801; Morokoff, Andrew/0000-0002-5159-3438; Desmond, Patricia/0000-0002-4803-6323; O'Brien, Terence/0000-0002-7198-8621; Kaye, Andrew Henry/0000-0001-5049-8861	National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia [628301, 56992]; University of Melbourne, AustraliaUniversity of Melbourne; Royal Australasian College of Surgeons; Cancer Australia [509322]	This research was generously funded by the National Health and Medical Research Council (NHMRC), Australia (grant number 628301, 56992); The University of Melbourne, Australia; The Royal Australasian College of Surgeons; and Cancer Australia (509322).	Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; BARKER PB, 1994, MAGNET RESON MED, V32, P157, DOI 10.1002/mrm.1910320202; Beaumont A, 2000, ACTA NEUROCHIR, V142, P1, DOI 10.1007/s007010050001; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; Clarke G, 2007, J NEUROSCI METH, V160, P223, DOI 10.1016/j.jneumeth.2006.09.006; Dowling C, 2001, AM J NEURORADIOL, V22, P604; Hattingen E, 2008, NMR BIOMED, V21, P233, DOI 10.1002/nbm.1186; Hattingen E, 2007, J MAGN RESON IMAGING, V26, P427, DOI 10.1002/jmri.20985; Hill DLG, 1998, NEUROSURGERY, V43, P514, DOI 10.1097/00006123-199809000-00066; Kaiser LG, 2005, NEUROBIOL AGING, V26, P665, DOI 10.1016/j.neurobiolaging.2004.07.001; Louis DN, 2007, WHO CLASSIFICATION T, V4th; MICHAELIS T, 1993, RADIOLOGY, V187, P219, DOI 10.1148/radiology.187.1.8451417; Moffat BA, 2009, NEUROIMAG CLIN N AM, V19, P517, DOI 10.1016/j.nic.2009.08.008; NUSSBAUM MA, 1992, ANAL CHEM, V64, P1259, DOI 10.1021/ac00035a012; Opstad KS, 2008, NMR BIOMED, V21, P677, DOI 10.1002/nbm.1239; Provencher S, 2013, LCMODEL; Provencher S. W., 2008, LCMODEL LCMGUI USERS; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; Smith JJ, 2003, RADIOLOGY, V227, P633, DOI 10.1148/radiol.2273020518; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; TAKAGI H, 1981, J NEUROSURG, V54, P797, DOI 10.3171/jns.1981.54.6.0797; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Wellard RM, 2005, AM J NEURORADIOL, V26, P585; Yuen TI, 2012, NEUROLOGY, V79, P883, DOI 10.1212/WNL.0b013e318266fa89; Zhao Q, 2013, 3D INTERACTIVE CHEM	26	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	MAY	2014	27	5					570	577		10.1002/nbm.3095			8	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	AE1TO	WOS:000333753300009	24664947				2022-02-06	
J	Pelletier, EB; Emond, M; Lauzier, F; Savard, M; Turgeon, AF				Pelletier, Elyse Berger; Emond, Marcel; Lauzier, Francois; Savard, Martin; Turgeon, Alexis F.			Hyperosmolar Therapy in Severe Traumatic Brain Injury: A Survey of Emergency Physicians from a Large Canadian Province	PLOS ONE			English	Article							INCREASED INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; HEAD-INJURY; MANAGEMENT; MANNITOL; HYPOTENSION; INFUSION; CARE	Introduction: Worldwide, severe traumatic brain injury is a frequent pathology and is associated with high morbidity and mortality. Mannitol and hypertonic saline are therapeutic options for intracranial hypertension occurring in the acute phase of care. However, current practices of emergency physicians are unknown. Methods: We conducted a self-administered survey of emergency physicians in the province of Quebec, Canada, to understand their attitudes surrounding the use of hyperosmolar solutions in patients with severe traumatic brain injury. Using information from a systematic review of hypertonic saline solutions and experts' opinion, we developed a questionnaire following a systematic approach (items generation and reduction). We tested the questionnaire for face and content validity, and test-retest reliability. Physicians were identified through the department head of each eligible level I and II trauma centers. We administered the survey using a web-based interface and planned email reminders. Results: We received 210 questionnaires out of 429 potentials respondents (response rate 49%). Most respondents worked in level II trauma centers (69%). Fifty-three percent (53%) of emergency physicians stated using hypertonic saline to treat severe traumatic brain injury. Most reported using hyperosmolar therapy in the presence of severe traumatic brain injury and unilateral reactive mydriasis, midline shift or cistern compression on brain computed tomography. Conclusion: Hyperosmolar therapy is believed being broadly used by emergency physicians in Quebec following severe traumatic brain injury. Despite the absence of clinical practice guidelines promoting the use of hypertonic saline, a majority of them said to use these solutions in specific clinical situations.	[Pelletier, Elyse Berger; Emond, Marcel; Lauzier, Francois; Savard, Martin; Turgeon, Alexis F.] Univ Laval, Hop Enfant Jesus, Ctr Hosp Univ Quebec,Res Ctr, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada; [Pelletier, Elyse Berger; Emond, Marcel] Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada; [Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol, Div Crit Care, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Savard, Martin] Univ Laval, Dept Neurol Sci, Quebec City, PQ, Canada		Turgeon, AF (corresponding author), Univ Laval, Hop Enfant Jesus, Ctr Hosp Univ Quebec,Res Ctr, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada.	alexis.turgeon@fmed.ulaval.ca	Savard, Martin/O-2549-2019; Emond, Marcel/G-5804-2014; Lauzier, Francois/B-9237-2015	Emond, Marcel/0000-0001-7158-8110; Lauzier, Francois/0000-0002-6530-5513	Association des medecins d'urgence du Quebec (AMUQ)	The Association des medecins d'urgence du Quebec (AMUQ) partly funded this project. The AMUQ had no influence on the design, conduct, analysis, or decision to submit the manuscript for publication. No additional external funding was received for this study.	American Association for Public Opinion Research, 2011, STAND DEF FIN DISP C; [American College of Surgeons committee on trauma American College of Surgeons], 2008, ADV TRAUM LIF SUPP, P131; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Behnia R, 1996, ANESTH ANALG, V82, P902, DOI 10.1097/00000539-199605000-00002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; BROWN FD, 1979, J NEUROSURG, V50, P423, DOI 10.3171/jns.1979.50.4.0423; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; COTE CJ, 1979, ANESTHESIOLOGY, V50, P30, DOI 10.1097/00000542-197901000-00007; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Dillman DA., 2007, MAIL INTERNET SURVEY; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Papangelou A, 2009, CURR TREAT OPTION NE, V11, P64, DOI 10.1007/s11940-009-0009-5; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Turgeon A, 2009, CRIT CARE MED, V37, pA435; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2014	9	4							e95778	10.1371/journal.pone.0095778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2IS	WOS:000335240300091	24755863	Green Published, gold, Green Submitted			2022-02-06	
J	Bodanapally, UK; Krejza, J; Saksobhavivat, N; Jaffray, PM; Sliker, CW; Miller, LA; Shanmuganathan, K; Dreizin, D				Bodanapally, Uttam K.; Krejza, Jaroslaw; Saksobhavivat, Nitima; Jaffray, Paul M.; Sliker, Clint W.; Miller, Lisa A.; Shanmuganathan, Kathirkamanathan; Dreizin, David			Predicting Arterial Injuries after Penetrating Brain Trauma Based on Scoring Signs from Emergency CT Studies	NEURORADIOLOGY JOURNAL			English	Article						gunshot injuries to head; digital subtraction angiography; intracranial arterial injuries; civilian penetrating traumatic brain injury; traumatic intracranial pseudo-aneurysms		The objective of this study was to determine the accuracy of individual radiologists in detection of vascular injury in patients after penetrating brain injury (PBI) based on head CT findings at admission. We retrospectively evaluated 54 PBI patients who underwent admission head CT and digital subtraction angiography (DSA), used here as a reference standard. Two readers reviewed the CT images to determine the presence or absence of the 29 CT variables of injury profile and quantified selected variables. Four experienced trauma radiologists and one neuroradiologist assigned their own specific scores for each CT variable, a high score indicative of a high probability of artery injury. A sixth set consisted of the average score obtained from the five sets, generated by five experts. Receiver operating characteristic (ROC) curves were constructed for each set to assess the diagnostic performance of an individual radiologist in predicting an underlying vascular injury. The area under ROC curve (AUC) was higher for CT scores obtained from the sixth set (average of five sets of scores) of variable rank score 0.75 (95% CI 0.62-0.88) and for the rest of the data sets, the value ranged from 0.70 (95% CI 0.56-0.84) to 0.74 (95% CI 0.6-0.88). In conclusion, radiologists may be able to recommend DSA with a fair accuracy rate in selected patients, deemed 'high-risk' for developing intracranial vascular injuries after PBI based on admission CT studies. A better approach needs to be developed to reduce the false positive rate to avoid unnecessary emergency DSA.	[Bodanapally, Uttam K.; Krejza, Jaroslaw; Jaffray, Paul M.; Sliker, Clint W.; Miller, Lisa A.; Shanmuganathan, Kathirkamanathan; Dreizin, David] Univ Maryland, Med Ctr, Dept Radiol, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Saksobhavivat, Nitima] Mahidol Univ, Fac Med, Ramathibodi Hosp, Dept Radiol, Bangkok, Thailand		Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu	Krejza, Jaroslaw/A-1355-2009				AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; [Anonymous], 2001, J TRAUMA, V51, pS26; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Nayak S, 2011, NEURORADIOL J, V24, P715, DOI 10.1177/197140091102400508; Salehi MG, 2012, NEURORADIOL J, V25, P563, DOI 10.1177/197140091202500509; Sliker CW, 2008, AM J ROENTGENOL, V190, P790, DOI 10.2214/AJR.07.2378; Takeshita T, 2012, NEURORADIOL J, V25, P469, DOI 10.1177/197140091202500409	14	8	8	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.	APR	2014	27	2					138	145		10.15274/NRJ-2014-10024			8	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3V0X	WOS:000218613800002	24750698	Green Published			2022-02-06	
J	Bonfield, CM; Kumar, AR; Gerszten, PC				Bonfield, Christopher M.; Kumar, Anand R.; Gerszten, Peter C.			The history of military cranioplasty	NEUROSURGICAL FOCUS			English	Article						cranioplasty; cranial defect; decompressive craniectomy; warfare-related trauma	WARTIME DECOMPRESSIVE CRANIECTOMY; PENETRATING WOUNDS; CRANIAL DEFECTS; REPAIR; TANTALUM; WARFARE; BRAIN; PERU; HEAD; WAR	There is evidence that the neurosurgical procedure of cranioplasty is as ancient as its better-known counterpart, trephination. With origins in pre-Incan Peru, cranioplasty remains an important reconstructive procedure for modern craniofacial surgery teams to master. Solutions to the often challenging problem of repairing skull defects continue to evolve to improve patient outcomes. Throughout recorded history, advances in cranioplasty have paralleled major military conflicts due to survivorship after trephination or decompressive craniectomy. Primitive skull coverings used in Peru were later replaced during the Middle Ages by grafts obtained in animals and humans. Improved survivorship secondary to advances in anesthesia and battlefield medicine during the Crimean War and the American Civil War allowed the use of tantalum and acrylic cranioplasty to evolve during World Wars I and II. In the modern era of the Iraq and Afghanistan conflicts, greater survivorship after cranial injury due to improvements in protective armor, medical evacuation, and early "far-forward" neurosurgical treatment have occurred. Consequently, the last decade has seen great advancement in cranial defect reconstruction, including custom-fabricated alloplast implants and the emergence of regenerative cranial treatments such as distraction osteogenesis, protected bone regeneration, and free tissue transfers. Comprehensive rehabilitation after neurotrauma has emerged as the new standard of care.	[Bonfield, Christopher M.; Gerszten, Peter C.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Kumar, Anand R.] Johns Hopkins Univ Hosp, Dept Plast Surg, Baltimore, MD 21287 USA		Bonfield, CM (corresponding author), 200 Lothrop St,Ste B400, Pittsburgh, PA 15213 USA.	bonfieldcm@upmc.edu					Aciduman A, 2007, SURG NEUROL, V68, P349, DOI 10.1016/j.surneu.2006.10.073; Asenjo A, 1963, NEUROSURGICAL TECHNI, P20; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Blackburn TPD, 2000, NEUROSURGERY, V47, P1261, DOI 10.1097/00006123-200012000-00003; CHISOLM JJ, 1983, MANUAL MILITARY SURG; COURVILLE C B, 1959, Bull Los Angel Neuro Soc, V24, P1; Cushing H, 1918, Br Med J, V1, P221; Cushing H., 1908, SURGERY ITS PRINCIPL, P17; Daland Judson, 1935, Ann Med Hist, V7, P550; Fulcher OH, 1943, J AMER MED ASSOC, V121, P931, DOI 10.1001/jama.1943.62840120001009; GURDJIAN ES, 1974, J NEUROSURG, V40, P157, DOI 10.3171/jns.1974.40.2.0157; HAESEKER B, 1988, PLAST RECONSTR SURG, V82, P539, DOI 10.1097/00006534-198809000-00034; Horrax G, 1973, NEUROSURGERY HIST SK, P5; HORSLEY V, 1887, BMJ-BRIT MED J, V1, P582; Kumar AR, 2012, PLAST RECONSTR SURG, V130, P1101, DOI 10.1097/PRS.0b013e318267d5cb; Kumar AR, 2011, PLAST RECONSTR SURG, V127, P1279, DOI 10.1097/PRS.0b013e318205f47c; Lastres J., 1960, TREPANACION CRANEO A; Lemcke Johannes, 2013, Surg Neurol Int, V4, P46, DOI 10.4103/2152-7806.110027; MacCurdy GG, 1923, AM J PHYS ANTHROPOL, V6, P217, DOI 10.1002/ajpa.1330060302; McLeod GHB, 1862, NOTES SURG WAR CRIMA; Meekeren J.J., 1682, OBSERVATIONES MEDICO; Mitchell AB, 1917, BRIT J SURG, V5, P40, DOI 10.1002/bjs.1800051705; Pudenz RH, 1943, J AMER MED ASSOC, V121, P478; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; RIFKINSONMANN S, 1988, NEUROSURGERY, V23, P411, DOI 10.1227/00006123-198810000-00001; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Shoja MM, 2012, CHILD NERV SYST, V28, P1993, DOI 10.1007/s00381-012-1876-8; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; United States Surgeon General's Office, 1883, MED SURG HIST WAR RE, V1; WEBSTER JE, 1946, J NEUROSURG, V3, P7, DOI 10.3171/jns.1946.3.1.0007; WOODHALL B, 1945, ANN SURG, V121, P649, DOI 10.1097/00000658-194505000-00009; Woolf JI, 1945, INT ABSTR SURG, V81, P1; ZELLEM RT, 1985, NEUROSURGERY, V17, P850, DOI 10.1227/00006123-198511000-00024	33	8	10	0	22	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2014	36	4							E18	10.3171/2014.1.FOCUS13504			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AE2XI	WOS:000333836200019	24684330	Bronze			2022-02-06	
J	Gorji, MAH; Hoseini, SH; Gholipur, A; Mohammadpur, RA				Gorji, Mohammad Ali Heidari; Hoseini, Seyed Hosein; Gholipur, Afshin; Mohammadpur, Reza Ali			A comparison of the diagnostic power of the Full Outline of Unresponsiveness scale and the Glasgow coma scale in the discharge outcome prediction of patients with traumatic brain injury admitted to the intensive care unit	SAUDI JOURNAL OF ANAESTHESIA			English	Article						Full outline of unresponsiveness (FOUR) score; glasgow coma scale (GCS); outcome-ICU; traumatic brain injury	4 SCORE; VALIDATION; MORTALITY; MODERATE	Background and Aim: This study aimed to determine whether the Full Outline of Unresponsiveness (FOUR) score is an accurate predictorof discharge outcome in traumatic brain injury (TBI) patients and to compare its performanceto Glasgow coma scale (GCS). Materials and Methods: Thisis diagnostic study conducted prospectively on 53 TBI patients admitted to ICU of education hospitals of Medical Science University of Mazandaran during February 2013 to June 2013. Data collection was done with a checklist including biographic, clinical information and outcome. The FOUR score and GCS were determined by the researcher in the first 24 hours. Outcomes considered as in-hospital mortality and poor neurologic outcome (Glasgow Outcome Scale (GOS) 1-3) in discharge time from the hospital. Results: In terms of predictive power for in-hospital mortality, the area under the receiver operating characteristic (ROC) curve was 0/92 (95% CI. 0/81-0/97) for FOUR score and 0/96 (95% CI. 0/87-0/99) for GCS. In terms of predictive power of poor neurologic outcome, the area under the ROC curve was 0/95 (95% CI. 0/86-0/99) for FOUR score and 0/90 (95% CI. 0/79-0/96) for GCS as evidenced by GOS 1-3. The cut-off of 6 showed sensitivity and specifi city of total four score predicting poor outcome at 0/86 and 0/87 while the cut-off of 4 showed the value of in hospital mortality at 0/90 and 0/90. The total GCS score showed sensitivity and specifi city 0/100 and 0/61 at cut-off 7 in predicting poor outcome while in predicting mortality at cut-off of 4 this range was 0/100 and 0/92. Conclusion: The FOUR score is an accurate predictor of discharge outcome in TBI patients. Thus, researchers recommend for therapeutic Schematizationto use in neurosurgical patients at admission day.	[Gorji, Mohammad Ali Heidari; Hoseini, Seyed Hosein; Mohammadpur, Reza Ali] Mazandaran Univ Med Sci, Dept Nursing Surg, Sari, Iran; [Gholipur, Afshin] Mazandaran Univ Med Sci, Dept Nursing Med, Sari, Iran		Hoseini, SH (corresponding author), Mazandaran Univ Med Sci, Dept Nursing Surg, Sari, Iran.	Gorjim29@yahoo.com	gorji, mohammad ali heidari/F-3989-2017; baradari, Afshin Gholipour/F-4131-2017; Mohammadpour, Reza Ali/F-4279-2017	gorji, mohammad ali heidari/0000-0002-6511-0820; baradari, Afshin Gholipour/0000-0003-2316-1838; Mohammadpour, Reza Ali/0000-0003-2353-5027; hosseini, seyed hossein/0000-0001-6630-1023			Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; Alex BV, 1996, NEUROTRAUMA, P119; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 2000, J Neurotrauma, V17, P563; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Delney KA, 2000, HEAD INJURY, P41; Eftekhar B, 2005, INJURY, V36, P900, DOI 10.1016/j.injury.2004.12.067; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Farid S, 2011, NEUOCRIT CARE, V15, P250; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Izadi F, 2010, J KASHAN U MED, V14, P112; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Joshua K, 2010, NEUOCRIT CARE, V14, P134; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	26	8	12	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1658-354X	0975-3125		SAUDI J ANAESTH	Saudi J. Anaesth.	APR-JUN	2014	8	2					193	197		10.4103/1658-354X.130708			5	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V4P1U	WOS:000219136100009	24843331	Green Published, gold			2022-02-06	
J	Kim, MS; Sim, SY				Kim, Myoung Soo; Sim, Sook Young			Traumatic Aneurysm of the Callosomarginal Artery-Cortical Artery Junction from Penetrating Injury by Scissors	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Pseudoaneurysm; Traumatic aneurysm; Distal anterior cerebral artery; Trapping	INTRACRANIAL WOOD; CEREBRAL-ARTERIES; BRAIN; NAIL	Traumatic intracranial aneurysms (TICAs) are rare and are associated with high rates of morbidity and mortality. TICAs usually result from head injuries caused by traffic accidents, industrial accidents, or gunshots. We report a traumatic aneurysm of the callosomarginal artery-cortical artery junction arising from a penetrating injury by scissors. A 51-year-old woman was admitted to our hospital after suffering a penetrating injury caused by scissors. Computed tomography (CT) and CT-angiography demonstrated a right orbital roof fracture, subarachnoid hemorrhage, frontal lobe hemorrhage, intraventricular hemorrhage, and a traumatic aneurysm of the right callosomarginal artery-cortical artery junction. We trapped the traumatic aneurysm and repositioned a galeal flap. Postoperative CT showed a small infarction in the left frontal lobe. Follow-up angiography two months later showed no residual aneurysm. We suggest that an aggressive surgical intervention be performed whenever TICA is diagnosed.	[Kim, Myoung Soo; Sim, Sook Young] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Neurosurg, Seoul 100032, South Korea		Kim, MS (corresponding author), Inje Univ, Coll Med, Seoul Paik Hosp, Dept Neurosurg, 9 Mareunnae Ro, Seoul 100032, South Korea.	hanibalkms@hanmail.net		Sim, Sook Young/0000-0001-6487-3722	Inje University College of Medicine	This work was supported by research grant from an Inje University College of Medicine.	Agrillo A, 2006, J CRANIOFAC SURG, V17, P442; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Bilotta F, 2007, AM J EMERG MED, V25, P198, DOI 10.1016/j.ajem.2006.05.029; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; Chibbaro S, 2006, ACTA NEUROCHIR, V148, P937, DOI 10.1007/s00701-006-0794-5; Di Roio C, 2000, CHILD NERV SYST, V16, P503, DOI 10.1007/s003810000291; DOOLING JA, 1967, J NEUROSURG, V26, P636, DOI 10.3171/jns.1967.26.6.0636; Endo S, 1974, No Shinkei Geka, V2, P329; Erkutlu I, 2011, ULUS TRAVMA ACIL CER, V17, P79, DOI 10.5505/tjtes.2011.49092; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; Kahler RJ, 1998, NEUROSURGERY, V42, P1370, DOI 10.1097/00006123-199806000-00108; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kumar A, 2011, TURK NEUROSURG, V21, P413, DOI 10.5137/1019-5149.JTN.2838-09.3; Lempert TE, 1998, AM J NEURORADIOL, V19, P907; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; MILLER CF, 1977, SURG NEUROL, V7, P95; MIZUTANI T, 1995, NEUROSURGERY, V36, P905, DOI 10.1227/00006123-199505000-00003; MIZUTANI T, 1995, NEUROSURGERY, V36, P912, DOI DOI 10.1227/00006123-199505000-00003; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; SCHNEIDER RC, 1961, SURG CLIN N AM, V41, P1255; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; YOKOTA H, 1983, Neurological Surgery, V11, P521	25	8	8	0	5	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	APR	2014	55	4					222	225		10.3340/jkns.2014.55.4.222			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AK9PE	WOS:000338758200010	25024829	Green Published, gold, Green Submitted			2022-02-06	
J	Phillipou, A; Douglas, J; Krieser, D; Ayton, L; Abel, L				Phillipou, Andrea; Douglas, Jacinta; Krieser, David; Ayton, Lauren; Abel, Larry			Changes in saccadic eye movement and memory function after mild closed head injury in children	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ANTISACCADE PERFORMANCE; RECOVERY; SCHIZOPHRENIA; CONCUSSION; PREDICTION; PARAMETERS; PROSACCADE; SYMPTOMS; IMPACT	AimThe aim of this study was to determine whether volitional saccadic impairments are present in children with mild closed head injury (mCHI) and whether these deficits are predictive of ongoing cognitive impairment. MethodWe analysed a sample of 26 children with mCHI (20 males, 6 females; mean age 13y 1mo, SD 2y) and 29 age-matched comparison children (20 males, 9 females; mean age 12y 2mo, SD 2y). Participants completed a battery of saccadic eye movement tasks and a set of computer-based cognitive tasks at three time points: within 2weeks of mCHI, and at 3months and 6months. ResultsThe group with mCHI made fewer errors on the antisaccade task at the first time point and showed increased latencies on prosaccades, correct antisaccades, and corrected antisaccade errors at the third time point (6mo). The group with mCHI also showed poorer performance on the cognitive tasks assessing memory. InterpretationEven very mild, uncomplicated mCHI in children may persistently affect aspects of executive control and visual processing.	[Phillipou, Andrea; Abel, Larry] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia; [Douglas, Jacinta] La Trobe Univ, Dept Human Commun Sci, Melbourne, Vic, Australia; [Krieser, David] Sunshine Hosp, Melbourne, Vic, Australia; [Ayton, Lauren] Ctr Eye Res Australia, Melbourne, Vic, Australia		Abel, L (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia.	label@unimelb.edu.au	Krieser, David/AAA-1370-2021; Ayton, Lauren/AAV-2977-2021	Krieser, David/0000-0002-7173-6993; Ayton, Lauren/0000-0001-9907-084X; Abel, Larry/0000-0002-2393-0644; Douglas, Jacinta/0000-0003-0940-6624	Transport Accident Commission, Victoria, Australia	This project was supported by the Transport Accident Commission, Victoria, Australia. We also thank Samantha Law for her assistance in recruiting patients and Elizabeth Bowman for her assistance in data acquisition. The authors have stated that they had no interests which might be perceived as posing a conflict or bias.	Anderson VA, 2000, BRAIN INJURY, V14, P679; Burke JG, 2002, J NEUROL NEUROSUR PS, V72, P449; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dyckman K, 2005, EXP BRAIN RES, V162, P63, DOI 10.1007/s00221-004-2105-9; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Klein C, 2001, EXP BRAIN RES, V139, P1; Klein C, 2001, PSYCHOPHYSIOLOGY, V38, P704, DOI 10.1017/S0048577201000130; Kristjansson A, 2007, SCAND J PSYCHOL, V48, P97, DOI 10.1111/j.1467-9450.2007.00537.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Reilly JL, 2005, BIOL PSYCHIAT, V57, P145, DOI 10.1016/j.biopsych.2004.10.024; Schlichting L., 2005, PEABODY PICTURE VOCA; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; The Royal Children's Hospital Melbourne, 2013, CLIN PRACT GUIDL HEA; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2	33	8	8	0	22	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	APR	2014	56	4					337	345		10.1111/dmcn.12345			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	AC8BJ	WOS:000332757700010	24350895				2022-02-06	
J	Sulaiman, NA; Osman, K; Hamzah, NH; Amir Hamzah, SPA				Sulaiman, Nur Amirah; Osman, Khairul; Hamzah, Noor Hazfalinda; Amir Hamzah, Sri Pawita Albakri			Blunt force trauma to skull with various instruments	MALAYSIAN JOURNAL OF PATHOLOGY			English	Article						blunt trauma; skull; fracture; blunt object; forensic science		Deaths due to blunt force trauma to the head as a result of assault are some of the most common cases encountered by the practicing forensic pathologist. Previous studies have shown inflicting injury to the head region is one of the most effective methods of murder. The important factors that determine severity of trauma include the type of weapon used, type and site of skull fracture, intracranial haemorrhage and severity of brain injury. The aim of this study was to determine the characteristics of blunt force trauma to the skull produced by different instruments. Nine adult monkeys (Macaca fascicularis) skulls were used as models. Commonly found blunt objects comprising of Warrington hammer, hockey stick and open face helmet were used in this study. A machine calibrated force generator was used to hold the blunt object in place and to hit the skulls at forces of 12.5N and 25N. Resultant traumatic effects and fractures (linear, depressed, basilar, comminuted, and distastic) were analyzed according to type of blunt object used; surface area of contact and absolute force (N/cm(2)) delivered. Results showed that all investigated instruments were capable of producing similar injuries. The severity of trauma was not related to the surface area of contact with the blunt objects. However, only high absolute forces produced comminuted fractures. These findings were observational, as the samples were too small for statistical conclusions.	[Sulaiman, Nur Amirah; Osman, Khairul; Hamzah, Noor Hazfalinda; Amir Hamzah, Sri Pawita Albakri] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Diagnost & Appl Hlth Sci, Kuala Lumpur 50300, Malaysia		Amir Hamzah, SPA (corresponding author), Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Diagnost & Appl Hlth Sci, Forens Sci Program, Kuala Lumpur 50300, Malaysia.	drsripaah@gmail.com	Osman, Khairul/Y-2230-2019; Hamzah, Noor Hazfalinda/C-7860-2011	Hamzah, Noor Hazfalinda/0000-0002-5005-8935; Osman, Khairul/0000-0003-3348-0672	Forensic Science Program, UKM	We would like to thank the Forensic Science Program, UKM for providing facilities and financial aid to complete this project. We would like also to express our gratitude to the Diagnostic, Imaging and Radiotherapy Program for the X-ray support.	Bader DMG, 2009, FORENSIC NURSING CON; Batalis NI, 2010, BLUNT FORCE TRAUMA; Chattopadhyay Saurabh, 2010, J Inj Violence Res, V2, P99, DOI 10.5249/jivr.v2i2.46; Christensen JE, 2008, OPEN ANTHR J, V1, P33; Delannoy Y, 2012, LEGAL MED-TOKYO, V14, P258, DOI 10.1016/j.legalmed.2012.04.006; DiMaio VJM, 2007, HDB FORENSIC PATHOLO; Greaves I, 2008, TRAUMA CARE MANUAL; James S. H., 2005, FORENSIC SCI INTRO S; Kimmerle EH, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P1, DOI 10.1201/9781420009118; Mulroy MH, 2012, FORENSIC SCI INT, V214, P167, DOI 10.1016/j.forsciint.2011.07.050; Prahlow J, 2010, FORENSIC PATHOLOGY FOR POLICE, DEATH INVESTIGATORS, ATTORNEYS, AND FORENSIC SCIENTISTS, P1, DOI 10.1007/978-1-59745-404-9; Terzi E, 2010, WORLD C TIMB ENG TRE; Yoshida SJM, 2000, THESIS S FRASER U BU	13	8	8	4	21	MALAYSIAN JOURNAL PATHOLOGY	KUALA LUMPUR	UNIV MALAYSIA, FAC MEDICINE, DEPT PATHOLOGY, KUALA LUMPUR, 59100, MALAYSIA	0126-8635			MALAY J PATHOL	Malay. J. Pathol.	APR	2014	36	1					33	39					7	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	CG0TT	WOS:000352984700005	24763233				2022-02-06	
J	Vallat-Azouvi, C; Pradat-Diehl, P; Azouvi, P				Vallat-Azouvi, Claire; Pradat-Diehl, Pascale; Azouvi, Philippe			Modularity in rehabilitation of working memory: A single-case study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Working memory; Rehabilitation; Stroke; Modularity; Cognition	TRAUMATIC BRAIN-INJURY; CENTRAL EXECUTIVE COMPONENT; SUBJECT DESIGNS; CHILDREN; SCALE; INTELLIGENCE; ATTENTION; DEFICITS; STROKE; ADHD	The objective of the present study was to assess the specificity of rehabilitation on different subdomains of working memory. A 38-year-old female with chronic (4 years) stroke suffered from an impairment of the three subdomains of working memory (modality-specific storage systems for verbal and visuo-spatial information and the central executive). She was given an experimental rehabilitation programme, using a multiple-baseline across behaviour design. After two baseline measures three months apart, the first training stage focused on the phonological loop, the second on the visuo-spatial sketchpad, and the third on central executive functions. Verbal aspects of working memory improved significantly after the first training stage, while visuo-spatial tests improved after the second training stage. Central executive functions improved mainly after the third training stage. Modularity effects were not as pronounced for less specific ecological outcome measures, such as the Working Memory Questionnaire, which improved throughout the trial, irrespective of the training condition. This case study suggests that there are both domain-specific and generalisation effects in rehabilitation of working memory, and that rehabilitation should be adapted and tailored to each individual patient's impairments.	[Vallat-Azouvi, Claire] Hop Raymond Poincare, UGECAM Antenne UEROS SAMSAH 92, Garches, France; [Vallat-Azouvi, Claire; Pradat-Diehl, Pascale; Azouvi, Philippe] UMPC, ER 6, Paris, France; [Pradat-Diehl, Pascale] Salpetriere Hosp, AP HP, Dept Phys Med & Rehabil, Paris, France; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France; [Azouvi, Philippe] Univ Versailles St Quentin, EA 4047, Versailles, France		Vallat-Azouvi, C (corresponding author), Hop Raymond Poincare, Antenne UEROS SAMSAH UGECAM 92, F-92380 Garches, France.	claire.vallat@rpc.aphp.fr					Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD, 2001, BRAIN, V124, P1492, DOI 10.1093/brain/124.8.1492; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DELOCHE G, 1994, J CLIN EXP NEUROPSYC, V16, P195, DOI 10.1080/01688639408402631; Deloche G, 1997, TEST DENOMINATION OR; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ducarne de Ribeaucourt B., 1989, EXAMEN APHASIE; Duval J, 2008, NEUROPSYCHOL REHABIL, V18, P430, DOI 10.1080/09602010701573950; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nespoulous J. L., 1992, MT 86 PROTOCOLE MONT; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Rey A, 1964, EXAMEN CLIN NEUROPSY; Rey A., 1959, TEST COPIE ET REPROD; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Vallat C, 2005, BRAIN INJURY, V19, P1157, DOI 10.1080/02699050500110595; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Vallat-Azouvi C, 2012, NEUROPSYCHOL REHABIL, V22, P634, DOI 10.1080/09602011.2012.681110; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Wechsler D., 1991, WMS R ECHELLE CLIN M; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; Wright HH, 2005, AM J SPEECH-LANG PAT, V14, P107, DOI 10.1044/1058-0360(2005/012); Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110; Zimmermann P., 2009, TAP TESTS DEVALUATIO	43	8	8	1	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR	2014	24	2					220	237		10.1080/09602011.2014.881294			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AI9BG	WOS:000337220800004	24552571				2022-02-06	
J	Meier, C; Rosenkranz, K				Meier, Carola; Rosenkranz, Katja			Cx43 expression and function in the nervous system - implications for stem cell mediated regeneration	FRONTIERS IN PHYSIOLOGY			English	Article						gap junction; stem cell; brain damage; hypoxia; transplantation	CORD BLOOD-CELLS; JUNCTIONAL INTERCELLULAR COMMUNICATION; ASTROCYTIC GAP-JUNCTIONS; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; NEURONAL VULNERABILITY; RAT-BRAIN; TRANSPLANTATION; MODEL; HEMICHANNELS	Pathological conditions of the brain such as ischemia cause major sensorimotor and cognitive impairments. In novel therapeutic approaches to brain injury, stem cells have been applied to ameliorate the pathological outcome. In several experimental models, including hypoxia-ischemia and trauma, transplantation of stem cells correlated with an improved functional and structural outcome. At the cellular level, brain insults also change gap junction physiology and expression, leading to altered intercellular communication. Differences in expression in response to brain injury have been detected in particular in Cx43, the major astrocytic gap junction protein, and its overexpression or deletion was associated with the pathophysiological outcome. We here focus on Cx43 changes in host tissue mediated by stem cells. Stem cell-induced changes in connexin expression, and consecutively in gap junction channel or hemichannel function, might play a part in altered cell interaction, intercellular communication, and neural cell survival, and thereby contribute to the beneficial effects of transplanted stem cells.	[Meier, Carola] Univ Saarland, Dept Anat & Cell Biol, D-66421 Homburg, Germany; [Rosenkranz, Katja] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany		Meier, C (corresponding author), Univ Saarland, Dept Anat & Cell Biol, Bldg 61,Kirrberger Str 1, D-66421 Homburg, Germany.	carola.meier@uks.eu					Ando Y, 2014, BONE, V61, P82, DOI 10.1016/j.bone.2013.12.029; Bennett MVL, 2012, BRAIN RES, V1487, P3, DOI 10.1016/j.brainres.2012.08.042; Blanc EM, 1998, J NEUROCHEM, V70, P958; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Davidson JO, 2013, CURR DRUG TARGETS, V14, P36; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; English D, 2013, J CELL BIOCHEM, V114, P764, DOI 10.1002/jcb.24436; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; HOSSAIN MZ, 1994, BRAIN RES, V652, P311, DOI 10.1016/0006-8993(94)90242-9; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Jaderstad J, 2010, NEUROREPORT, V21, P1126, DOI 10.1097/WNR.0b013e328340a77b; Jaderstad J, 2010, P NATL ACAD SCI USA, V107, P5184, DOI 10.1073/pnas.0915134107; Lavoie JR, 2013, BIOCHIMIE, V95, P2212, DOI 10.1016/j.biochi.2013.06.017; Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023; Li WEI, 2000, EUR J NEUROSCI, V12, P2644, DOI 10.1046/j.1460-9568.2000.00162.x; Li WEI, 1998, EUR J NEUROSCI, V10, P2444, DOI 10.1046/j.1460-9568.1998.00253.x; Maizels L, 2012, HEART RHYTHM, V9, P1512, DOI 10.1016/j.hrthm.2011.12.018; Mankikar Sadanand D, 2010, J Long Term Eff Med Implants, V20, P219; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; Moriyama Y, 2013, NEUROSCI LETT, V543, P152, DOI 10.1016/j.neulet.2013.03.053; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Oyamada M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00085; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Rosenkranz K, 2013, ANN ANAT, V195, P122, DOI 10.1016/j.aanat.2012.09.003; Rosenkranz K, 2012, CELL TISSUE RES, V348, P429, DOI 10.1007/s00441-012-1401-0; Rosenkranz K, 2011, ANN ANAT, V193, P371, DOI 10.1016/j.aanat.2011.03.005; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Talaveron R, 2014, GLIA, V62, P623, DOI 10.1002/glia.22630; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Wasielewski B, 2012, BRAIN RES, V1487, P39, DOI 10.1016/j.brainres.2012.05.066; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Yu B, 2013, ARCH MED SCI, V9, P132, DOI 10.5114/aoms.2012.31438; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106	46	8	10	0	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	MAR 18	2014	5								106	10.3389/fphys.2014.00106			4	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	AX3LI	WOS:000346840400001	24672489	gold, Green Published			2022-02-06	
J	Wright, MJ; Wong, AL; Obermeit, LC; Woo, E; Schmitter-Edgecombe, M; Fuster, JM				Wright, Matthew J.; Wong, Andrew L.; Obermeit, Lisa C.; Woo, Ellen; Schmitter-Edgecombe, Maureen; Fuster, Joaquin M.			Memory for performed and observed activities following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Memory; Temporal order memory; Source memory; Traumatic brain injury; Activity memory	CLOSED-HEAD INJURY; FRONTAL-LOBE LESIONS; DIFFUSE AXONAL INJURY; TEMPORAL-ORDER MEMORY; MODERATE; CONSOLIDATION; IMPAIRMENT; RETRIEVAL; SURVIVORS; RECOVERY	Traumatic brain injury (TBI) is associated with deficits in memory for the content of completed activities. However, TBI groups have shown variable memory for the temporal order of activities. We sought to clarify the conditions under which temporal order memory for activities is intact following TBI. Additionally, we evaluated activity source memory and the relationship between activity memory and functional outcome in TBI participants. Thus, we completed a study of activity memory with 18 severe TBI survivors and 18 healthy age- and education-matched comparison participants. Both groups performed eight activities and observed eight activities that were fashioned after routine daily tasks. Incidental encoding conditions for activities were utilized. The activities were drawn from two counterbalanced lists, and both performance and observation were randomly determined and interspersed. After all of the activities were completed, content memory (recall and recognition), source memory (conditional source identification), and temporal order memory (correlation between order reconstruction and actual order) for the activities were assessed. Functional ability was assessed via the Community Integration Questionnaire (CIQ). In terms of content memory, TBI participants recalled and recognized fewer activities than comparison participants. Recognition of performed and observed activities was strongly associated with social integration on the CIQ. There were no between- or within-group differences in temporal order or source memory, although source memory performances were near ceiling. The findings were interpreted as suggesting that temporal order memory following TBI is intact under conditions of both purposeful activity completion and incidental encoding, and that activity memory is related to functional outcomes following TBI.	[Wright, Matthew J.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Wright, Matthew J.; Fuster, Joaquin M.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA USA; [Wong, Andrew L.] Fuller Theol Seminary, Dept Clin Psychol, Pasadena, CA 91101 USA; [Obermeit, Lisa C.] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Woo, Ellen] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Wright, MJ (corresponding author), LABioMed Harbor UCLA, 1124 W Carson St,B-4 South Box 490, Torrance, CA 90502 USA.	mwright@labiomed.org			Washington State University; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS47690]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA031098] Funding Source: NIH RePORTER	This research was supported by Washington State University (Marchionne Memorial Doctoral Fellowship) and the National Institute of Neurological Disorders and Stroke [grant number NS47690].	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Army Individual Test Battery, 1944, MAN DIR SCOR; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Butters M.A., 1994, NEUROPSYCHOLOGY, V8, P343, DOI DOI 10.1037/0894-4105.8.3.343; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; Delis DC, 1987, CALIFORNIA VERBAL LE; ENGELKAMP J, 1989, PSYCHOL RES-PSYCH FO, V51, P153, DOI 10.1007/BF00309142; FEENAN K, 1990, MEM COGNITION, V18, P515, DOI 10.3758/BF03198484; Fuster JM, 2000, BRAIN RES BULL, V52, P331, DOI 10.1016/S0361-9230(99)00258-0; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; Heaton RK, 1981, MANUAL WISCONSIN CAR; HELSTRUP T, 1989, PSYCHOL RES-PSYCH FO, V50, P237, DOI 10.1007/BF00309258; Hurst W, 1982, Brain Cogn, V1, P294; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Murnane K, 1996, MEM COGNITION, V24, P417, DOI 10.3758/BF03200931; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Schmitter-Edgecombe M, 2003, J CLIN EXP NEUROPSYC, V25, P933, DOI 10.1076/jcen.25.7.933.16493; Schmitter-Edgecombe M, 2012, J CLIN EXP NEUROPSYC, V34, P256, DOI 10.1080/13803395.2011.633497; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Smith A., 1982, SYMBOL DIGITS MODALI; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 1998, NEUROPSY NEUROPSY BE, V11, P212; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Vakil E., 2006, QUANTIFIED PROCESS A, P83; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652	39	8	8	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 16	2014	36	3					268	277		10.1080/13803395.2014.884543			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AE5MG	WOS:000334032600005	24524393	Green Accepted			2022-02-06	
J	Grieve, A; Webne-Behrman, L; Couillou, R; Sieben-Schneider, J				Grieve, Adam; Webne-Behrman, Lisa; Couillou, Ryan; Sieben-Schneider, Jill			Self-Report Assessment of Executive Functioning in College Students with Disabilities	JOURNAL OF POSTSECONDARY EDUCATION AND DISABILITY			English	Article						Executive functioning; self-report; college; disability		This study presents a unique assessment of executive functioning (EF) among postsecondary students with disabilities, with the aim of understanding the extent to which students with different disabilities and in different age groups assess their own difficulties with relevant and educationally-adaptive skills such as planning, initiating, managing time, staying on task, and controlling emotions. Students from a large Midwest public university applying for and/or receiving services at a university-based disability office (n = 50) completed the Behavior Rating Inventory of Executive Function- Adult Version (BRIEF-A) and a demographic questionnaire. Study groups were formed according to participants' self-reported disability or disabilities-including attention deficit hyperactivity disorder (ADHD), psychiatric disabilities, learning disabilities, traumatic brain injury, autism spectrum disorder, deaf and hard of hearing, and/or visual impairment-as well as those reporting single versus multiple disabilities and freshman versus all other class standings. Results revealed elevated EF ratings by students in the ADHD and psychiatric groups, particularly with regand to metacognitive skills. Freshman students reported less frequent EF challenges than older students, and identifying with more than one disability group was not a risk factor for elevated EF scores. Practical implications are discussed in terms of the utility of EF self-assessment in this population, and in supporting metacognitive strategies for postsecondary students with disabilities.	[Grieve, Adam; Webne-Behrman, Lisa; Couillou, Ryan] Univ Wisconsin Madison, Madison, WI 53706 USA; [Sieben-Schneider, Jill] Univ Wisconsin Madison, McBurney Disabil Resource Ctr, Transit Program, Madison, WI USA		Grieve, A (corresponding author), Univ Wisconsin Madison, Madison, WI 53706 USA.	adamjgrieve@gmail.com; rjcouillou@valdosta.edu; jill.schneider@colorado.edu					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Baddeley A, 1998, J INT NEUROPSYCH SOC, V4, P523, DOI 10.1017/S135561779800513X; Bak M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-39; Barkley, 2012, EXECUTIVE FUNCTIONIN; Connors C. K, 2004, CONNORS CONTINUOUS P; Delis DC., 2001, DELIS KAPLAN EXECUTI; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Guy SC, 2004, BRIEF SR BEHAV RATIN; Hall PA, 2006, HEALTH PSYCHOL, V25, P778, DOI 10.1037/0278-6133.25.6.778; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Henry LA, 2010, CHILD ADOL MENT H-UK, V15, P110, DOI 10.1111/j.1475-3588.2010.00557.x; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kubik JA, 2010, J ATTEN DISORD, V13, P442, DOI 10.1177/1087054708329960; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P52, DOI 10.1076/chin.8.1.52.8719; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Metcalfe J, 2005, J MEM LANG, V52, P463, DOI 10.1016/j.jml.2004.12.001; Morris RD, 1998, J EDUC PSYCHOL, V90, P347, DOI 10.1037/0022-0663.90.3.347; Naglieri J. A., 1997, COGNITIVE ASSESSMENT; Parker D.R., 2009, LEARN DISABIL RES PR, V24, P204, DOI DOI 10.1111/J.1540-5826.2009.00294.X; Parker D.R., 2002, ASSES EFF INTERV, V27, P3, DOI [10.1177/073724770202700302, https://doi.org/10.1177/073724770202700302, DOI 10.1177/073724770202700302]; Parker DR, 2013, J ATTEN DISORD, V17, P215, DOI 10.1177/1087054711427561; Parker DR, 2011, J POSTSECOND EDUC DI, V24, P115; Prevatt F, 2015, J ATTEN DISORD, V19, P666, DOI 10.1177/1087054713480036; Reynolds CR, 2008, PSYCHOL SCHOOLS, V45, P875, DOI 10.1002/pits.20332; Roid G., 2003, STANFORD BINET INTEL, V5th ed.; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Schillerstrom JE, 2005, PSYCHOSOMATICS, V46, P508, DOI 10.1176/appi.psy.46.6.508; Span MM, 2004, ACTA PSYCHOL, V117, P155, DOI 10.1016/j.actpsy.2004.05.005; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suchy Y, 2009, ANN BEHAV MED, V37, P106, DOI 10.1007/s12160-009-9097-4; U. S. Department of Education National Center for Education Statistics, 2009, NUMB PERC DISTR STUD; van der Molen MW, 2000, BIOL PSYCHOL, V54, P207, DOI 10.1016/S0301-0511(00)00057-0; Vohs K.D., 2004, HDB SELF REGULATION; Wechsler D, 2008, WECHSLER INDIVIDUAL; Williams PG, 2009, ANN BEHAV MED, V37, P126, DOI 10.1007/s12160-009-9100-0; Wolfson, 1993, HALSTEAD REITAN NEUR; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005	42	8	8	0	0	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD	COLUMBUS	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD, COLUMBUS, OH 00000 USA	2379-7762	2328-3343		J POSTSECOND EDUC DI	J. Postsecond. Educ. Disabil.	SPR	2014	27	1					19	32					14	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VE7GA	WOS:000440153400003					2022-02-06	
J	Hall, EC; Lund, E; Brown, D; Murdock, KR; Gettings, L; Scalea, TM; Stein, DM				Hall, Erin C.; Lund, Eric; Brown, Diane; Murdock, Karen R.; Gettings, Lisa; Scalea, Thomas M.; Stein, Deborah M.			How are you really feeling? A prospective evaluation of cognitive function following trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Cognitive function; physical and occupational therapy; functional trauma outcomes	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; BRAIN-INJURY; SYMPTOMS; HEALTH; DEPRESSION; PREDICTORS; SEVERITY; VETERANS; OUTCOMES	BACKGROUND Mild traumatic brain injury is associated with persistent cognitive difficulties. However, these symptoms may not be specific to the head injury itself. We sought to evaluate the prevalence of these symptoms in patients following trauma. METHODS A prospective analysis of patients who were seen in the outpatient trauma clinic during a 20-month period and completed self-administered Rivermead Post-Concussion Symptoms Questionnaire was conducted. Significant difficulty with cognition was defined by two or more symptoms reported as severe or four or more symptoms reported as moderate. Head injury was defined as head Abbreviated Injury Scale (AIS) score greater than 0, including the diagnosis of concussion. Multivariable logistic regression was used to test associations between head injury, injury severity, sex, and age with significant cognitive difficulties, loss of work/school, and unmet physical, occupational, or psychological therapy needs. RESULTS A total of 587 completed questionnaires were matched to trauma registry admissions (382 early, 111 mid, 86 late). The incidence of significant cognitive difficulties was 37% at less than 1 month, 40% at 1 month to 3 months, and 45% of patients at more than 3 months following injury. Head injury was not associated with increased odds for significant cognitive difficulties (adjusted odds ratio, 1.21; 95% confidence interval, 0.82-1.77; p = 0.3) There was no significant difference in symptoms in patients who carried a head injury diagnosis and those who did not. CONCLUSION Cognitive problems occur frequently following injury even in the absence of a head injury diagnosis. Either mild traumatic brain injury is grossly underdiagnosed or these symptoms are not specific to postconcussive states and simply are the cognitive sequelae of traumatic injury. The reporting of moderate-to-severe symptoms suggests a need to better understand the effects of trauma on cognitive function and strongly suggests that services for these patients are badly needed to maximize cognitive function and return to preinjury quality of life. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level II.	[Hall, Erin C.; Lund, Eric; Brown, Diane; Murdock, Karen R.; Gettings, Lisa; Scalea, Thomas M.; Stein, Deborah M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Hall, Erin C.] Georgetown Univ, Sch Med, Washington, DC USA		Stein, DM (corresponding author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	dtsein@umm.edu		Stein, Deborah/0000-0003-3683-3963			Alarcon LH, 2012, J TRAUMA ACUTE CARE, V72, P629, DOI 10.1097/TA.0b013e31824416aa; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Archer KR, 2010, ARCH PHYS MED REHAB, V91, P774, DOI 10.1016/j.apmr.2010.01.006; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Auxemery Y, 2012, ENCEPHALE, V38, P329, DOI 10.1016/j.encep.2011.07.003; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Brasel KJ, 2010, J TRAUMA, V68, P263, DOI 10.1097/TA.0b013e3181caa58f; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chiu KB, 2011, ACAD EMERG MED, V18, P1156, DOI 10.1111/j.1553-2712.2011.01206.x; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Davis JW, 2012, J TRAUMA ACUTE CARE, V72, P635; Donnell AJ, 2012, CLIN NEUROPSYCHOL; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; MacKenzie EJ, 2004, J BONE JOINT SURG AM, V86A, P1636, DOI 10.2106/00004623-200408000-00006; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8	24	8	8	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2014	76	3					859	864		10.1097/TA.0000000000000148			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	AB8YW	WOS:000332077100057	24553561				2022-02-06	
J	Johnson, CM; Perez, CF; Hoffer, ME				Johnson, Christopher M.; Perez, Colleen F.; Hoffer, Michael E.			The Implications of Physical Injury on Otovestibular and Cognitive Symptomatology following Blast Exposure	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						traumatic brain injury; blast exposure; hearing loss; vestibular disorder; headache; vertigo; amputee		Objective Identify a potential difference in the spectrum of otovestibular and cognitive symptoms in blast-exposed patients comparing individuals with or without significant extremity injuries. Study Design Case series with chart review. Setting A military tertiary care medical center. Subjects and Methods All new patient referrals for otovestibular evaluation after a blast injury or exposure were identified in the electronic medical record. One hundred consecutive patients meeting these criteria were studied. Data including presence of severe extremity injuries, diagnosis of mild traumatic brain injury, symptoms of imbalance, vertigo, headache, tympanic membrane perforation, hearing loss, and tinnitus were collected and analyzed. Results Of 100 patients included, 38 suffered severe extremity injuries. Those patients with severe extremity injuries were more likely to suffer from tympanic membrane perforations (58% vs 23%, P < .001, odds ratio [OR], 4.71, 95% confidence interval [CI], 1.96-11.33) and hearing loss (53% vs 23%, P = .002, OR, 3.81, 95% CI, 1.59-9.11). However, those without severe extremity injuries were more likely to suffer from imbalance (79% vs 32%, P < .001, OR, 8.17, 95% CI, 3.26-20.44) and vertigo (47% vs 2%, P < .001, OR, 32.52, 95% CI, 4.19-252.07) and more likely to have been diagnosed with a mild traumatic brain injury following blast exposure (66% vs 26%, P < .001, OR, 5.47, 95% CI, 2.24-13.36). Conclusion Blast-exposed individuals who sustained severe extremity injuries reported significantly fewer cognitive and vestibular symptoms. In the aftermath of a blast, those who can walk away may have still sustained a significant injury. Specifically, they may suffer more long-term cognitive and vestibular symptoms than those with severe physical injuries.	[Johnson, Christopher M.; Perez, Colleen F.; Hoffer, Michael E.] Naval Med Ctr San Diego, Dept Otolaryngol, San Diego, CA 92134 USA		Hoffer, ME (corresponding author), Naval Med Ctr San Diego, Dept Otolaryngol, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.	michael.hoffer@med.navy.mil					Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; [Anonymous], 2006, DEFENSE VET BRAIN IN; Armstrong JH, 2010, J CRANIOFAC SURG, V21, P954, DOI 10.1097/SCS.0b013e3181e17b79; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; KERR AG, 1975, J LARYNGOL OTOL, V89, P131, DOI 10.1017/S002221510008018X; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353	11	8	8	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	MAR	2014	150	3					437	440		10.1177/0194599813515184			4	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	AB3QR	WOS:000331705800018	24343023				2022-02-06	
J	Mckay, CD; Brooks, BL; Mrazik, M; Jubinville, AL; Emery, CA				Mckay, Carly D.; Brooks, Brian L.; Mrazik, Martin; Jubinville, Andrea L.; Emery, Carolyn A.			Psychometric Properties and Reference Values for the ImPACT Neurocognitive Test Battery in a Sample of Elite Youth Ice Hockey Players	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Pediatric; Neurocognitive assessment; Ice hockey	TEST-RETEST RELIABILITY; HIGH-SCHOOL; BASE-LINE; SPORT CONCUSSION; SEX-DIFFERENCES; ONLINE VERSION; RUGBY PLAYERS; INJURY; HISTORY; MANAGEMENT	This cross-sectional study aimed to determine psychometric properties and reference values for ImPACT in a sample of 704 elite ice hockey players aged 13-17. Baseline ImPACT tests were completed at the beginning of the 2011-2012 season. Players aged 16-17 had better visual motor processing speed, adjusted R-2 = .0522, F(2,45) = 10.79, beta = 2.87, p < .001, and impulse control, adjusted R = .0185, F(2,45) = 7.46, beta = -1.35, p = .001, than younger players, and girls had greater total symptom ratings than boys (z = -3.47, p = .0005). There were no other sex-or age-related differences in neurocognitive performance, and no effect of previous concussion on ImPACT scores. Reference values with cut-off scores are presented.	[Mckay, Carly D.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Brain Injury & Rehabil Programs, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Med, Dept Paediat & Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Alberta Childrens Hosp Res Inst Child & Maternal, Calgary, AB, Canada; [Mrazik, Martin; Jubinville, Andrea L.] Univ Alberta, Dept Educ Psychol, Edmonton, AB T6G 2E1, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Alberta Childrens Hosp Res Inst Child & Maternal, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada		Mckay, CD (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada.	cdmckay@ucalgary.ca	Emery, Carolyn/AAI-2761-2020	McKay, Carly/0000-0001-7664-3211	McCarthy Tetrault Award; Alberta Innovates Health Solutions; Max Bell Foundation; Alberta Children's Hospital Research Institute for Child & Maternal Health (Alberta Children's Hospital Foundation); Alberta Innovates [201201160] Funding Source: researchfish	This work was supported by the McCarthy Tetrault Award (to B.L.B.), Alberta Innovates Health Solutions, Max Bell Foundation, and the Alberta Children's Hospital Research Institute for Child & Maternal Health (Alberta Children's Hospital Foundation).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gioia G, 2004, BRIT J SPORT MED, V38, P657; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; ImPACT Applications, 2011, IM POSTC ASS TEST IM; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi S. N., 2012, MILD TRAUMATIC BRAIN, P119; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maruff P, 2004, BRIT J SPORT MED, V38, P654; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson N. W., 2012, MILD TRAUMATIC BRAIN, P119; Podell K, 2004, STUD NEUROPSYCHOL DE, P375; Randolph C, 2005, J ATHL TRAINING, V40, P139; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	49	8	8	0	19	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2014	29	2					141	151		10.1093/arclin/act116			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AB8FY	WOS:000332026800003	24389705	Bronze, Green Accepted			2022-02-06	
J	Acker, SN; Partrick, DA; Ross, JT; Nadlonek, NA; Bronsert, M; Bensard, DD				Acker, Shannon N.; Partrick, David A.; Ross, James T.; Nadlonek, Nicole A.; Bronsert, Michael; Bensard, Denis D.			Head injury and unclear mechanism of injury: Initial hematocrit less than 30 is predictive of abusive head trauma in young children	JOURNAL OF PEDIATRIC SURGERY			English	Article						Abusive head trauma; Traumatic brain injury; Anemia	NONACCIDENTAL TRAUMA	Purpose: Head injury secondary to abusive head trauma (AHT) is a major cause of morbidity and mortality in susceptible young infants and children. Diagnosing AHT remains challenging and is often complicated by a questionable mechanism of injury. Concern of ionizing radiation risk to children undergoing head CT imaging warrants a selective approach. We aimed to evaluate initial findings that could direct further investigation of AHT. Methods: A retrospective review of the trauma databases at a two level one pediatric trauma centers was performed. We reviewed all patients age five years and under with a diagnosis of traumatic brain injury (TBI) from 2002-2011. Results: A total of 1129 patients (mean age 1.7 +/- 1.7 years; 64% male) with TBI were identified, 429 (38%) of which were the result of AHT. Complete data was available for 921 patients (82%) and were included in statistical evaluation. Forty-eight percent of patients in the AHT group had a hematocrit <= 30% on presentation compared to 19% of patients in the non-AHT group. On univariate analysis, a hematocrit of <= 30% was predictive of AHT as the cause of injury (P < .0001), as was a platelet count of greater than 400,000 (P < .0001). After controlling for age, sex, ISS, GCS on presentation, need for CPR, and survival to hospital discharge, hematocrit of <= 30% and platelets of greater than 400,000 were predictive of AHT as the cause of TBI (P < .05). Conclusions: In the setting of head injury and unclear history of trauma, a hematocrit of <= 30% on presentation increases the likelihood of abusive head trauma in children up to the age of 5 years. (C) 2014 Elsevier Inc. All rights reserved.	[Acker, Shannon N.; Partrick, David A.; Ross, James T.; Nadlonek, Nicole A.; Bensard, Denis D.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat Surg, Aurora, CO USA; [Bronsert, Michael] Univ Colorado, Sch Med, Dept Surg Surg Outcomes & Appl Res, Aurora, CO USA; [Bensard, Denis D.] Denver Hlth & Hosp Author, Dept Surg, Denver, CO USA		Bensard, DD (corresponding author), Denver Hlth Med Ctr, Dept Surg, 777 Bannock St,MC 0206, Denver, CO 80204 USA.	denis.bensard@dhha.org					Barsness KA, 2003, J TRAUMA, V54, P1107, DOI 10.1097/01.TA.0000068992.01030.A8; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Gordy C, 2013, NURS CLIN N AM, V48, P193, DOI 10.1016/j.cnur.2013.01.013; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; Hymel KP, 2013, PEDIATR CRIT CARE ME, V14, P210, DOI 10.1097/PCC.0b013e3182712b09; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P1762, DOI 10.1001/jama.2013.4116; Niederkrotenthaler T, 2013, CHILD ABUSE NEGL, V37, P446, DOI DOI 10.1016/J.CHIABU.2013.02.002; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Roujeau T, 2013, HAND CLINIC, V112, P905, DOI 10.1016/B978-0-444-52910-7.00012-X	13	8	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	FEB	2014	49	2					338	340		10.1016/j.jpedsurg.2013.10.008			3	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	AB0YF	WOS:000331517600026	24528981				2022-02-06	
J	Chen, LK; Fan, XX; Jin, GR; Wan, X; Qiu, R; Yi, GQ; You, Y; Xu, Q				Chen, Lukui; Fan, Xinxin; Jin, Guangrong; Wan, Xing; Qiu, Rong; Yi, Guoqing; You, Yang; Xu, Qiang			Treatment of Rat with Traumatic Brain Injury and MR Tracing In Vivo via Combined Transplantation of Bone Marrow Stromal Cells Labeled with Superparamagnetic Iron Oxide and Schwann Cells	JOURNAL OF BIOMEDICAL NANOTECHNOLOGY			English	Article						Superparamagnetic Iron Oxide; Bone Marrow Stromal Stem Cells; Schwann Cells; Traumatic Brain Injury	MESENCHYMAL STEM-CELLS; DNA HYBRIDIZATION; L-GLUTAMATE; NANOPARTICLES; DIFFERENTIATION; MICROSPHERES; FIBROBLASTS; MIGRATION; REPAIR; ARRAY	Transplantation of bone marrow stromal cells (BMSCs) or Schwann cells (SCs) can facilitate axonal regeneration in nerve injuries. The aim of this study was to assess the effect of BMSCs and SCs transplantation on a rat with traumatic brain injury (TBI) and cellular migration in brain, and investigate whether combined BMSCs and SCs transplantations have more advantages than BMSCs transplantation alone. BMSCs were cultured in vitro and then labeled with SPIO. The labeled and unlabeled cells were assayed by MTT inspection to compare the effect of SPIO on growth activity of rat's BMSCs. Sciatic nerve was taken of the rat and striped off epineurium to obtain SCs by carrying out cell culture using mixed enzyme digestion. The SCs were identified by immunofluorescence labeling for S-100 protein and cellular activities were analyzed by MTT growth curves. Improved Feeney method was adopted to make a rat TBI model. In total, 50 male Sprague Dawley (SD) rats weighing 200-250 g were randomly divided into 5 groups: Groups A-E (n = 10 for each group). Injections of nutrient and stereotactic transplantation of BMSCs labeled with SPIO and stereotactic transplantation of SCs and BMSCs labeled with SPIO were administered in these groups 48 hours after TBI modeling. Neurological severity scores (NSS) were implemented at the 3 day, 1 week, 2 week and 4 week, respectively, after transplantation and 7.0T MRI scanning was done to observe migration situation of transplanted cells. After completion of MRI inspection at 4 weeks post transplantation, all rats were sacrificed and their brain tissue sections taken and assayed by HE staining and prussian blue staining. Numerous BMSCs were successfully labeled with SPIO. The labeling efficiency was more than 90%. There was no obvious difference between cellular proliferation of BMSCs labeled and unlabeled with SPIO at different time points. SCs were cultured in vitro and SCs S-100 detected as positive. MRI results show that T2WI was expressed in low signal area and migrated towards injury side after BMSCs labeled with SPIO were transplanted into brain. The combined transplantation had a quicker migration speed than single transplantation. NSS result shows that the combined transplantation group had a low score than single transplantation group after 2 weeks. In conclusion, BMSCs labeled with SPIO can be transplanted into brain and can be used in 7.0T MRI tracing in vivo. Compared to single transplantation, the combined transplantation of BMSCs and SCs has a quicker cellular migration and a better prognosis.	[Chen, Lukui; Fan, Xinxin; Wan, Xing; Qiu, Rong; Yi, Guoqing; You, Yang] Southeast Univ, Zhongda Hosp, Dept Neurosurg, Nanjing 210009, Jiangsu, Peoples R China; [Jin, Guangrong] Southeast Univ, Coll Med, Nanjing 210009, Jiangsu, Peoples R China; [Xu, Qiang] Guangdong Landau Biotechnol Co Ltd, Guangzhou 510555, Guangdong, Peoples R China		Chen, LK (corresponding author), Southeast Univ, Zhongda Hosp, Dept Neurosurg, Nanjing 210009, Jiangsu, Peoples R China.	neuro_clk@hotmail.com			National Science and Technology Major Project of Key Drug Innovation and Development [2011ZX09307-303-03]	This work is related to the National Science and Technology Major Project of Key Drug Innovation and Development (2011ZX09307-303-03).	Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Deng Y, 2013, J BIOMED NANOTECHNOL, V9, P1378, DOI 10.1166/jbn.2013.1633; Deng Y, 2013, J BIOMED NANOTECHNOL, V9, P1123, DOI 10.1166/jbn.2013.1599; Deng Y, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-190; Deng Y, 2013, J BIOMED NANOTECHNOL, V9, P318, DOI 10.1166/jbn.2013.1487; Deng Y, 2013, NEUROCHEM RES, V38, P504, DOI 10.1007/s11064-012-0942-7; Edamura K, 2012, J VET MED SCI, V74, P923, DOI 10.1292/jvms.11-0388; Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9; Harris LA, 2003, CHEM MATER, V15, P1367, DOI 10.1021/cm020994n; He NY, 2013, J BIOMED NANOTECHNOL, V9, P267, DOI 10.1166/jbn.2013.1478; He NY, 2012, J NANOSCI NANOTECHNO, V12, P2858, DOI 10.1166/jnn.2012.5756; Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909; Hu J, 2007, EXP NEUROL, V204, P658, DOI 10.1016/j.expneurol.2006.11.018; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Ittrich H, 2007, J MAGN RESON IMAGING, V25, P1179, DOI 10.1002/jmri.20925; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Li CY, 2012, J NANOSCI NANOTECHNO, V12, P2964, DOI 10.1166/jnn.2012.6428; Li S, 2013, J BIOMED NANOTECHNOL, V9, P1254, DOI 10.1166/jbn.2013.1610; Li S, 2012, THERANOSTICS, V2, P967, DOI 10.7150/thno.5032; Liu B, 2013, J BIOMED NANOTECHNOL, V9, P247, DOI 10.1166/jbn.2013.1483; Liu B, 2012, J BIOMED NANOTECHNOL, V8, P938, DOI 10.1166/jbn.2012.1453; Liu SY, 2008, ADV MATER RES-SWITZ, V47-50, P1097, DOI 10.4028/www.scientific.net/AMR.47-50.1097; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Lopez-Castro JD, 2011, NANOSCALE, V3, P4597, DOI 10.1039/c1nr10980d; Lynch L, 2007, HUM REPROD, V22, P919, DOI 10.1093/humrep/del456; Ma C, 2012, J BIOMED NANOTECHNOL, V8, P1000, DOI 10.1166/jbn.2012.1454; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Nasu K, 2006, RADIOLOGY, V239, P122, DOI 10.1148/radiol.2383041384; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Reddy AM, 2010, J KOREAN MED SCI, V25, P211, DOI 10.3346/jkms.2010.25.2.211; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang YJ, 2013, THERANOSTICS, V3, P85, DOI 10.7150/thno.5588; Tang YJ, 2013, J BIOMED NANOTECHNOL, V9, P312, DOI 10.1166/jbn.2013.1493; Tomita M, 2002, STEM CELLS, V20, P279, DOI 10.1634/stemcells.20-4-279; Wang F, 2012, J BIOMED NANOTECHNOL, V8, P786, DOI 10.1166/jbn.2012.1446; Wang W, 2013, J BIOMED NANOTECHNOL, V9, P736, DOI 10.1166/jbn.2013.1577; Wang W, 2012, J NANOSCI NANOTECHNO, V12, P7301, DOI 10.1166/jnn.2012.6154; Wang W, 2012, J NANOSCI NANOTECHNO, V12, P7206, DOI 10.1166/jnn.2012.6504; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	8	8	0	57	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1550-7033	1550-7041		J BIOMED NANOTECHNOL	J. Biomed. Nanotechnol.	FEB	2014	10	2					205	215		10.1166/jbn.2014.1765			11	Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	258ZF	WOS:000327496500002	24738329				2022-02-06	
J	Ciclamini, D; Panero, B; Titolo, P; Tos, P; Battiston, B				Ciclamini, Davide; Panero, Bernardino; Titolo, Paolo; Tos, Pierluigi; Battiston, Bruno			Particularities of hand and wrist complex injuries in polytrauma management	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Polytrauma; Hand injuries; Wrist injuries; Complex injuries	DAMAGE CONTROL; STRATEGIES; RESUSCITATION; FAILURE; RELEASE; PATIENT; BLOOD	Hand and wrist lesions are relatively common in polytraumatised patients. These subjects sustain a wide range of potential life-threatening conditions and hand and wrist injuries incurred are often not diagnosed or are insufficiently treated. Closed lesions are the most frequently missed diagnosis, but even severe open lesions may be incorrectly treated. Most of these hand and wrist injuries can have a strong negative impact on long-term quality of life, particularly when treatment of these injuries is poor or delayed. Orthopaedic and hand surgeons should be vigilant in their assessment and treatment of patients with multiple injuries and a global approach, based on the advanced trauma life support (ATLS)-protocol, must be applied. The very common association of head, chest, abdomen, bone and soft-tissue lesions in the polytraumatised patient requires a multidisciplinary team approach from the beginning. The energy of trauma in these patients often causes complex injuries to the wrist and hand; these require correct treatment in terms of both timing and techniques. It is not possible to create a practical, useful guideline with a "one lesion-one solution'' approach, because every case is different; therefore, this paper describes a spectrum of indications and techniques that may be useful in managing hand and wrist injuries, particularly in polytraumatised patients. (C) 2013 Elsevier Ltd. All rights reserved.	[Ciclamini, Davide; Panero, Bernardino; Titolo, Paolo; Tos, Pierluigi; Battiston, Bruno] CTO Hosp, UOD Microsurg, UOC Muscoloskeletal Traumatol, Turin, Italy		Ciclamini, D (corresponding author), Via Zuretti 29, I-10126 Turin, Italy.	davide.ciclamini@gmail.com	Tos, Pierluigi/R-5803-2016; Ciclamini, Davide/ABB-4220-2020; Titolo, Paolo/AAP-9387-2020	Tos, Pierluigi/0000-0002-1349-7082; Ciclamini, Davide/0000-0003-0404-3297; Titolo, Paolo/0000-0002-7186-2164			Aldrian S, 2005, WIEN MED WOCHENSCHR, V155, P227, DOI 10.1007/s10354-005-0173-5; Bakri K, 2007, HAND CLIN, V23, P255, DOI 10.1016/j.hcl.2007.01.003; Bernstein ML, 2007, INJURY, V38, pS3, DOI 10.1016/j.injury.2007.10.038; BIRCH R, 1991, J BONE JOINT SURG BR, V73, P154, DOI 10.1302/0301-620X.73B1.1991753; Blum J, 2005, UNFALLCHIRURG, V108, P843, DOI 10.1007/s00113-005-1003-3; Braakenburg A, 2006, PLAST RECONSTR SURG, V118, P390, DOI 10.1097/01.prs.0000227675.63744.af; Caba-Doussoux P, 2012, INJURY, V43, pS42, DOI 10.1016/S0020-1383(13)70178-5; Committee ACoS, 2004, ADV TRAUM LIF SUPP A; Curry N, 2012, INJURY, V43, P1021, DOI 10.1016/j.injury.2012.03.014; Fox CJ, 2008, J TRAUMA, V65, P1, DOI 10.1097/TA.0b013e318176c533; Freeland AE, 2003, HAND CLIN, V19, P51, DOI 10.1016/S0749-0712(02)00057-4; FREELAND AE, 1987, CLIN ORTHOP RELAT R, P93; Giannoudis PV, 2010, INJURY, V41, P1323, DOI 10.1016/j.injury.2010.09.012; Giannoudis PV, 2003, J BONE JOINT SURG BR, V85B, P478, DOI 10.1302/0301-620X.85B4.14217; Gulgonen A, 2011, GREENS OPERATIVE HAN, P1929; Hernandez JD, 2005, HAND CLIN, V21, P187, DOI 10.1016/j.hcl.2004.12.001; HERZBERG G, 1993, J HAND SURG-AM, V18A, P768, DOI 10.1016/0363-5023(93)90041-Z; Hildebrand F, 2005, UNFALLCHIRURG, V108, P793, DOI 10.1007/s00113-005-1005-1; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kheirabadi BS, 2007, J TRAUMA, V63, P1079, DOI 10.1097/TA.0b013e31815885f1; Lasanianos NG, 2011, INJURY, V42, P617, DOI 10.1016/j.injury.2011.02.011; Lippross S, 2012, INJURY, V43, P137, DOI 10.1016/j.injury.2011.03.044; MARK G, 1989, Handchirurgie Mikrochirurgie Plastische Chirurgie, V21, P51; McGhan LJ, 2012, INJURY, V43, P129, DOI 10.1016/j.injury.2011.05.032; MOORE MN, 1988, SOUTH MED J, V81, P371, DOI 10.1097/00007611-198803000-00019; Netto FS, 2012, INJURY, V43, P1502, DOI 10.1016/j.injury.2010.12.028; Ouellette EA, 1998, HAND CLIN, V14, P431; Pape HC, 2002, AM J SURG, V183, P622, DOI 10.1016/S0002-9610(02)00865-6; Paul S, 2002, LISTERS HAND; Perron DA, 2001, AM J EM MED, V19, P157; Raymondos K, 2012, INJURY, V43, P189, DOI 10.1016/j.injury.2011.05.034; Roberts CS, 2005, J BONE JOINT SURG AM, V87A, P434, DOI 10.2106/00004623-200502000-00030; Rotstein OD, 2003, J TRAUMA, V54, pS203, DOI 10.1097/01.TA.0000064512.62949.92; Sagraves Scott G, 2006, J Intensive Care Med, V21, P5, DOI 10.1177/0885066605282790; Schadel-Hopfner M, 2005, UNFALLCHIRURG, V108, P850, DOI 10.1007/s00113-005-0996-y; Schaller P, 1994, Handchir Mikrochir Plast Chir, V26, P307; Skruodies B, 1989, Unfallchirurgie, V15, P236; Steinwall D, 2012, INJURY, V43, P91, DOI 10.1016/j.injury.2010.11.004; Strickland JW, 2005, HAND CLIN, V21, P219, DOI 10.1016/j.hcl.2004.12.003; Sundine M, 1996, J HAND SURG-BRIT EUR, V21B, P216, DOI 10.1016/S0266-7681(96)80102-1; Tokmadzic VS, 2012, INJURY, V43, P624, DOI 10.1016/j.injury.2010.05.009; Vivino G, 1998, INTENS CARE MED, V24, P808, DOI 10.1007/s001340050670; Walusimbi MS, 2012, INJURY, V43, P180, DOI 10.1016/j.injury.2011.05.028; WEI FC, 1988, PLAST RECONSTR SURG, V82, P346, DOI 10.1097/00006534-198808000-00026; Wolfe S, 2005, GREENS OPERATIVE HAN; Wutzler S, 2012, INJURY, V43, P1507, DOI 10.1016/j.injury.2010.12.029	46	8	9	1	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2014	45	2					448	451		10.1016/j.injury.2013.09.016			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	291JT	WOS:000329825700019	24119831				2022-02-06	
J	Santos, CA; Fonseca, J; Brito, J; Fernandes, T; Goncalves, L; Guerreiro, AS				Santos, Carla Adriana; Fonseca, Jorge; Brito, Jose; Fernandes, Tania; Goncalves, Luisa; Guerreiro, Antonio Sousa			Serum Zn levels in dysphagic patients who underwent endoscopic gastrostomy for long term enteral nutrition	NUTRICION HOSPITALARIA			English	Article						Zinc; Gastrostomy; PEG; Dysphagia; Malnutrition	TRACE-ELEMENTS; ZINC	Background and aims: Dysphagic patients who underwent endoscopic gastrostomy (PEG) usually present protein-energy malnutrition, but little is known about micronutrient malnutrition. The aim of the present study was the evaluation of serum zinc in patients who underwent endoscopic gastrostomy and its relationship with serum proteins, whole blood zinc, and the nature of underlying disorder. Methods: From patients that underwent gastrostomy a blood sample was obtained minutes before the procedure. Serum and whole blood zinc was evaluated using Wavelength Dispersive X-ray Fluorescence Spectroscopy. Serum albumin and transferrin were evaluated. Patients were studied as a whole and divided into two groups: head and neck cancer (HNC) and neurological dysphagia (ND). Results: The study involved 32 patients (22 males), aged 43-88 years: HNC = 15,ND = 17. Most (30/32) had low serum zinc, 17/32 presented normal values of whole blood zinc. Only two, with traumatic brain injury, presented normal serum zinc. Serum zinc levels showed no differences between HNC and ND patients. There was no association between serum zinc and serum albumin or transferrin. There was no association between serum and whole blood zinc. Conclusions: Patients had low serum zinc when gastrostomy was performed, similar in HNC and ND, being related with prolonged fasting and unrelated with the underlying disease. Decrease serum zinc was unrelated with low serum proteins. Serum zinc was more sensitive than whole blood zinc for identifying reduced zinc intake. Teams taking care of PEG-patients should include zinc evaluation as part of the nutritional assessment, or include systematic dietary zinc supply.	[Santos, Carla Adriana; Fonseca, Jorge] Hosp Garcia de Orta, Enteral Feeding Grp, GENE, P-2800 Almada, Portugal; [Brito, Jose; Fernandes, Tania; Goncalves, Luisa] Inst Super Ciencias Saude Egas Moniz, WDXRF Lab, Almada, Portugal; [Guerreiro, Antonio Sousa] Hosp Santa Marta, Ctr Hosp Lisboa Cent, Lisbon, Portugal		Santos, CA (corresponding author), Hosp Garcia de Orta, Av Prof Torrado da Silva, P-2800 Almada, Portugal.	carla.adriana.santos@hotmail.com	Fonseca, Jorge/ABF-6661-2020; Brito, Jose/AAM-5150-2020; Goncalves, Luisa/A-4120-2016	Fonseca, Jorge/0000-0001-6477-7028; Brito, Jose/0000-0002-8558-6754; Goncalves, Luisa/0000-0002-3654-8612; santos, carla/0000-0002-0414-9107; Fernandes, Tania/0000-0002-8384-9602			Basaki M, 2012, BIOL TRACE ELEM RES, V148, P161, DOI 10.1007/s12011-012-9360-6; Cecconi E, 2012, FRONT NEUROL NEUROSC, V30, P86, DOI 10.1159/000333423; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Fonseca J, 2013, CLIN NUTR S1, V32, pS86; Fonseca J, 2013, ACTA MEDICA PORT, V26, P212; Gibson RS, 1990, PRINCIPLES NUTR ASSE, P543; Grilo Ana, 2012, Arq. Gastroenterol., V49, P227, DOI 10.1590/S0004-28032012000300012; Grohnert MO, 2010, TRATADO NUTR, VIII, P973; Ibs KH, 2000, J NUTR, V130, P1452; Johnson KA, 2002, CLIN GERIATR MED, V18, P773, DOI 10.1016/S0749-0690(02)00048-4; Kopanski Z, 2001, FOLIA HISTOCHEM CYTO, V39, P84; Langdon C, 2010, STROKE RES TREAT, V2010, DOI 10.4061/2010/570403; Loser C, 2005, CLIN NUTR, V24, P848, DOI 10.1016/j.clnu.2005.06.013; Lowe NM, 2009, AM J CLIN NUTR, V89, p2040S, DOI 10.3945/ajcn.2009.27230G; Maverakis E, 2007, J AM ACAD DERMATOL, V56, P116, DOI 10.1016/j.jaad.2006.08.015; Obara H, 2008, CLIN NUTR, V27, P587, DOI 10.1016/j.clnu.2008.01.004; Oyama T, 2003, ANTICANCER RES, V23, P605; Pereira M, 2012, J AGING RES CLIN PRA, V1, P252; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Shenkin A., 2008, E SEPN EUROPEAN J CL, V3, pe255, DOI DOI 10.1016/J.ECLNM.2008.06.003; Shrimpton R, 2005, BMJ-BRIT MED J, V330, P347, DOI 10.1136/bmj.330.7487.347; Sriram K, 2009, JPEN-PARENTER ENTER, V33, P548, DOI 10.1177/0148607108328470; Tanzer F, 2004, INT J VITAM NUTR RES, V74, P52, DOI 10.1024/0300-9831.74.1.52; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7; Tinoco-Veras CM, 2011, NUTR HOSP, V26, P293, DOI [10.3305/nh.2011.26.2.4804, 10.1590/S0212-16112011000200008]	25	8	9	0	6	ARAN EDICIONES, S L	MADRID	C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN	0212-1611	1699-5198		NUTR HOSP	Nutr. Hosp.	FEB	2014	29	2					359	364		10.3305/nh.2014.29.2.7035			6	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	AB6SC	WOS:000331918800016	24528353				2022-02-06	
J	Eide, PK; Sorteberg, A; Meling, TR; Sorteberg, W				Eide, Per Kristian; Sorteberg, Angelika; Meling, Torstein R.; Sorteberg, Wilhelm			Baseline pressure errors (BPEs) extensively influence intracranial pressure scores: results of a prospective observational study	BIOMEDICAL ENGINEERING ONLINE			English	Article							TRAUMATIC BRAIN-INJURY; 2 SEPARATE SENSORS; CLINICAL-EVALUATION; SUBARACHNOID HEMORRHAGE; EPIDURAL SPACE; ICP SIGNALS; CODMAN; PARAMETERS; PARENCHYMA; DEVICE	Background: Monitoring of intracranial pressure (ICP) is a cornerstone in the surveillance of neurosurgical patients. The ICP is measured against a baseline pressure (i. e. zero - or reference pressure). We have previously reported that baseline pressure errors (BPEs), manifested as spontaneous shift or drifts in baseline pressure, cause erroneous readings of mean ICP in individual patients. The objective of this study was to monitor the frequency and severity of BPEs. To this end, we performed a prospective, observational study monitoring the ICP from two separate ICP sensors (Sensors 1 and 2) placed in close proximity in the brain. We characterized BPEs as differences in mean ICP despite near to identical ICP waveform in Sensors 1 and 2. Methods: The study enrolled patients with aneurysmal subarachnoid hemorrhage in need of continuous ICP monitoring as part of their intensive care management. The two sensors were placed close to each other in the brain parenchyma via the same burr hole. The monitoring was performed as long as needed from a clinical perspective and the ICP recordings were stored digitally for analysis. For every patient the mean ICP as well as the various ICP wave parameters of the two sensors were compared. Results: Sixteen patients were monitored median 164 hours (ranges 70 - 364 hours). Major BPEs, as defined by marked differences in mean ICP despite similar ICP waveform, were seen in 9 of them (56%). The BPEs were of magnitudes that had the potential to alter patient management. Conclusions: Baseline Pressure Errors (BPEs) occur in a significant number of patients undergoing continuous ICP monitoring and they may alter patient management. The current practice of measuring ICP against a baseline pressure does not comply with the concept of State of the Art. Monitoring of the ICP waves ought to become the new State of the Art as they are not influenced by BPEs.	[Eide, Per Kristian; Sorteberg, Angelika; Meling, Torstein R.; Sorteberg, Wilhelm] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway; [Eide, Per Kristian] Univ Oslo, Fac Med, Oslo, Norway		Eide, PK (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway.	peide@ous-hf.no	Meling, Torstein/Q-2568-2019	Meling, Torstein/0000-0001-6595-0873			Andresen M, 2013, J NEUROSURG, V119, P1119, DOI 10.3171/2013.7.JNS13506; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Citerio G, 2008, NEUROSURGERY, V63, P1152, DOI 10.1227/01.NEU.0000335148.87042.D7; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Di Ieva A, 2013, NEUROSCIENTIST, V19, P592, DOI 10.1177/1073858412474845; Diedler J, 2010, NEUROCRIT CARE, V12, P313, DOI 10.1007/s12028-010-9350-5; Eide PK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-75; Eide PK, 2010, J NEUROSURG, V112, P616, DOI 10.3171/2009.7.JNS081593; Eide PK, 2008, MED ENG PHYS, V30, P34, DOI 10.1016/j.medengphy.2007.01.005; Eide PK, 2006, MED ENG PHYS, V28, P542, DOI 10.1016/j.medengphy.2005.09.003; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Eide PK, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-14; Eide PK, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-66; Eide PK, 2011, NEUROSURGERY, V69, P1105, DOI 10.1227/NEU.0b013e318227e0e1; Eide PK, 2010, J NEUROSURG, V113, P1317, DOI 10.3171/2010.7.JNS10483; Fernandes HM, 1998, ACT NEUR S, V71, P44; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lang JM, 2003, NEUROSURGERY, V52, P1455, DOI 10.1227/01.NEU.0000065136.70455.6F; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Stendel R, 2003, ACTA NEUROCHIR, V145, P185, DOI 10.1007/s00701-002-1052-0	22	8	8	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-925X			BIOMED ENG ONLINE	Biomed. Eng. Online	JAN 28	2014	13								7	10.1186/1475-925X-13-7			15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AE9ZO	WOS:000334371200001	24472296	Green Published, gold			2022-02-06	
J	Emmanouel, A; Kessels, RPC; Mouza, E; Fasotti, L				Emmanouel, Anna; Kessels, Roy P. C.; Mouza, Eirini; Fasotti, Luciano			Sensitivity, specificity and predictive value of the BADS to anterior executive dysfunction	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Neuropsychological assessment; Executive functioning; Ecological validity; Brain injury; Frontal lobes	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DYSFUNCTION; CARD SORTING TEST; DYSEXECUTIVE SYNDROME; BEHAVIORAL-ASSESSMENT; STRATEGY APPLICATION; VERBAL FLUENCY; CLINICAL NEUROPSYCHOLOGY; LESION LOCATION; NORMATIVE DATA	In this study we investigated the validity of the BADS subtests to adequately discriminate anterior lesions (AL) from posterior lesions (PL). Therefore, we compared the performances of 30 AL patients, 22 PL patients and 29 healthy controls (HC) on the BADS subtests. Seven standard executive test variables were also examined. Our multiple comparisons showed that the BADS Zoo Map-Part 1 was not indicative for AL, whereas Rule Shifting, Action Programme, Key Search, Zoo Map-total score, and BADS-total score were found to be sensitive to AL. More importantly, the Modified Six Element Test (MSET), and the Zoo Map-Part 2 were highly specific for AL. In both BADS subtests AL patients performed significantly worse than either the PL or the HC groups, whereas no significant differences on the same variables were found between PL and HC individuals. Further logistic regression analysis revealed that the BADSMSET was the best predictor for distinguishing AL from PL patients, correctly classifying 78.8% of the patients. These results suggest that the BADSMSET is an accurate screening tool for the detection of anterior pathology. Poor performance on this BADS subtest is a significant indicator of executive dysfunctioning after anterior brain damage.	[Emmanouel, Anna; Mouza, Eirini] Rehabil Ctr Anagennisi, Thessaloniki, Greece; [Emmanouel, Anna; Kessels, Roy P. C.; Fasotti, Luciano] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behaviour, NL-6500 HB Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Vincent Gogh Inst Psychiat, Venray, Netherlands; [Fasotti, Luciano] Rehabil Med Ctr Groot Klimmendaal, Arnhem, Netherlands		Emmanouel, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behaviour, POB 9104, NL-6500 HB Nijmegen, Netherlands.	annaemmanouel_psy@yahoo.gr	Kessels, Roy P.C./D-1902-2010	Kessels, Roy P.C./0000-0001-9500-9793			Ahola K, 1996, BRAIN COGNITION, V31, P1, DOI 10.1006/brcg.1996.0021; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Andres P, 2003, CORTEX, V39, P871, DOI 10.1016/S0010-9452(08)70868-2; ANNETT M, 1983, BRIT J PSYCHOL, V74, P269, DOI 10.1111/j.2044-8295.1983.tb01862.x; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Barcelo F, 2001, Span J Psychol, V4, P79; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Cavanagh JTO, 2002, BRIT J PSYCHIAT, V180, P320, DOI 10.1192/bjp.180.4.320; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chan RCK, 2006, SCHIZOPHR RES, V82, P51, DOI 10.1016/j.schres.2005.09.020; Chan RCK, 2006, SCHIZOPHR RES, V81, P173, DOI 10.1016/j.schres.2005.08.011; Chan RCK, 2004, EUR ARCH PSY CLIN N, V254, P256, DOI 10.1007/s00406-00-0492-3; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J INT NEUROPSYCH SOC, V8, P771, DOI 10.1017/S1355617702860052; Channon S, 2004, ACTA PSYCHOL, V115, P235, DOI 10.1016/j.actpsy.2003.12.008; Channon S, 1999, NEUROPSYCHOLOGIA, V37, P757, DOI 10.1016/S0028-3932(98)00138-9; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; CROCKETT D, 1986, INT J NEUROSCI, V30, P241, DOI 10.3109/00207458608985674; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Goel V, 2000, COGN NEUROPSYCHOL, V17, P415, DOI 10.1080/026432900410775; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Heaton R.K., 1981, WISCONSIN CARD SORTI; HECK ET, 1986, J CLIN EXP NEUROPSYC, V8, P313, DOI 10.1080/01688638608401321; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Ihara H, 2000, J NEUROL NEUROSUR PS, V68, P731, DOI 10.1136/jnnp.68.6.731; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Krabbendam L, 1999, CLIN NEUROPSYCHOL, V13, P370, DOI 10.1076/clin.13.3.370.1739; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Messinis L, 2007, ARCH CLIN NEUROPSYCH, V22, P739, DOI 10.1016/j.acn.2007.06.002; Milner B, 1963, ARCH NEUROL-CHICAGO, V9, P100, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Packwood S, 2011, J CLIN EXP NEUROPSYC, V33, P456, DOI 10.1080/13803395.2010.533157; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1993, ATTENTION SELECTION, P00171; Spikman J. M., 2002, CHECKLIST EXECUTIEVE; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Tsapkini K., 2007, 9 EUR C PSYCH ASS 2; Vargas ML, 2009, COGN BEHAV NEUROL, V22, P95, DOI 10.1097/WNN.0b013e318192cd08; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570	67	8	9	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2014	24	1					1	25		10.1080/09602011.2013.863731			25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	295GJ	WOS:000330104300001	24354937				2022-02-06	
J	Bellamkonda, E; Zollman, F				Bellamkonda, Erica; Zollman, Felise			Relationship between employment status and sexual functioning after traumatic brain injury	BRAIN INJURY			English	Article						Employment; head injury; sexuality; traumatic brain injury; work	QUALITY-OF-LIFE; COMMUNITY INTEGRATION; WORK; RETURN; SATISFACTION	Objective: To determine if correlations exist between employment status and sexual functioning in persons with traumatic brain injury (TBI). Design: Descriptive cross-sectional. Setting: Community. Participants: One hundred and forty-six English-speaking, community dwelling adults, without other neurological or psychiatric disorder that could impact outcome and (1) enrolled in TBI Model Systems sexuality study database or (2) admitted to Rehabilitation Institute of Chicago with primary diagnosis of TBI between 2004-2006. Main outcome measures: Employment status, annual income, Derogatis Interview for Sexual Functioning Self Report (DISF-SR) sum and sub-scale scores, Global Sexual Satisfaction Index (GSSI). Results: No significant difference was found in GSSI scores between employed, unemployed or students/volunteers (p = 0.20); however, lower income marginally correlated with lower GSSI scores (p = 0.09). Marginally significant lower DISF-SR Sexual Cognition sub-group (p = 0.09) scores were found in unemployed vs. employed. Lower annual income also correlated with lower DISF-SR sum scores (p = 0.06), Sexual cognition/fantasy (p = 0.07), Orgasm/ejaculation (p = 0.003) and Sexual drive and relationship (p = 0.01) scores. Conclusions: Lower quality sexual functioning and satisfaction was present in persons with TBI and concomitant unemployment or lower annual income. Efforts are needed to increase awareness amongst the TBI population and rehabilitation professionals of the potential impact unemployment or financial stress has on sexual functioning and satisfaction.	[Bellamkonda, Erica] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55904 USA; [Zollman, Felise] NorthShore Univ Hosp Syst, Dept Neurol, Glenview, IL USA		Bellamkonda, E (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55904 USA.	bellamkonda.erica@mayo.edu			NIDRR, US Department of Education [H133A070043, H133A080044, H133B090023, H133P080007]	The authors report no conflicts of interest. The National Institute on Disability and Rehabilitation Research (NIDRR) Traumatic Brain Injury Model Systems Module Project on Sexuality After TBI was a joint effort involving The Institute for Rehabilitation and Research Memorial Hermann (Principal Investigator [PI]: Angelle Sander), Carolinas Rehabilitation Hospital (Site PI: Flora Hammond), Craig Hospital (site PI: David Ripley), Mayo Clinic (site PI: Anne Moessner), Rehabilitation Institute of Chicago (site PI: Felise Zollman) and Wayne State University (Site PI: Robin Hanks). Supported in part by the NIDRR, US Department of Education Grant nos. H133A070043, H133A080044, H133B090023, H133P080007).	Abdo Carmita Helena Najjar, 2005, Sao Paulo Med. J., V123, P11, DOI 10.1590/S1516-31802005000100003; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; AMRPA, 2009, EREHABDATA; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; [Anonymous], 1999, JAMA, V282, P974; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DeNavas-Walk C, 2007, CURRENT POPULATION R; DeNavas-Walk C, 2004, CURRENT POPULATION R; DEROGATIS LR, 1979, J SEX MARITAL THER, V5, P244, DOI 10.1080/00926237908403732; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Howes H, 2005, BRAIN INJURY, V19, P135, DOI 10.1080/02699050410001720077; Howes HFR, 2005, BRAIN INJURY, V19, P403, DOI 10.1080/02699050400025158; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; MOROKOFF PJ, 1987, HEALTH PSYCHOL, V6, P545, DOI 10.1037/0278-6133.6.6.545; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Office of The Assistant Secretary for Planning and Evaluation, 2011, 2010 HHS GUID; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Tasman A, 2004, PSYCHIATRY, P1471; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Vesney BA, 1994, AM J PHYS MED REHABI, V73, P219	37	8	8	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1063	1069		10.3109/02699052.2014.896473			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200006	24702630				2022-02-06	
J	Caminiti, F; Ciurleo, R; De Salvo, S; Bramanti, P; Marino, S				Caminiti, Fabrizia; Ciurleo, Rosella; De Salvo, Simona; Bramanti, Placido; Marino, Silvia			Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies	BRAIN INJURY			English	Article						Anosmia; olfactory potentials; Sniffin' Sticks test; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ODOR DISCRIMINATION; ORBITOFRONTAL CORTEX; HEAD-INJURY; IDENTIFICATION; TESTS; DYSFUNCTION; THRESHOLDS; ANOSMIA	Background: Traumatic brain injury is one of the main causes of smell disorders. The degree of olfactory loss may vary and depend on the severity, nature and location of injury within the olfactory system. The diagnosis of disorders of the sense of smell is based on medical history and clinical data supported by psychophysical tests of smell, electrophysiological and neuroimaging measures. Methods: This study reports three single clinical cases of post-traumatic anosmia evaluated by Sniffin' Sticks Test, Olfactory Event-Related Potential and Magnetic Resonance Imaging examinations. Results: The Olfactory Event-Related Potential findings confirmed the presence of functional olfactory impairment in all three post-traumatic patients showing a good correlation with results of the psychophysical testing. In particular, Sniffin' Sticks Test and OERPs allowed to demonstrate the functional nature of post-traumatic olfactory loss, while the MRI identified the location and extent of injury compatible with the olfactory disorder. Conclusions: OERPs may have a good clinical application in objective diagnosis of post-traumatic anosmia, especially when the neuroradiological examination does not show lesions compatible with olfactory loss.	[Caminiti, Fabrizia; Ciurleo, Rosella; De Salvo, Simona; Bramanti, Placido; Marino, Silvia] IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy		Caminiti, F (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113,Via Palermo, I-98124 Messina, Italy.	fabriziacaminiti@tiscali.it	Ciurleo, Rosella/T-4590-2019; Marino, Silvia/T-5118-2019; Bramanti, Placido/K-5117-2016; Caminiti, Fabrizia/B-9458-2017; De Salvo, Simona/K-3180-2016	Marino, Silvia/0000-0002-1088-6808; Caminiti, Fabrizia/0000-0002-2527-8063; De Salvo, Simona/0000-0001-9501-3258; Ciurleo, Rosella/0000-0003-0709-5914			Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; Caminiti F, 2013, BRAIN INJURY, V27, P1715, DOI 10.3109/02699052.2013.823667; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Rombaux P, 2006, NEUROPHYSIOL CLIN, V36, P53, DOI 10.1016/j.neucli.2006.03.005; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238	14	8	8	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1776	1780		10.3109/02699052.2014.945960			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600018	25111656				2022-02-06	
J	Carlesimo, GA; di Paola, M; Fadda, L; Caltagirone, C; Costa, A				Carlesimo, Giovanni A.; di Paola, Margherita; Fadda, Lucia; Caltagirone, Carlo; Costa, Alberto			Prospective Memory Impairment and Executive Dysfunction in Prefrontal Lobe Damaged Patients: Is There a Causal Relationship?	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; AGE-DIFFERENCES; NORMATIVE DATA; INTENTIONS; ATTENTION; DEFICITS; CORTEX; COMPONENTS; FAILURE; DELAY	Background. The prospective memory (PM) construct is aimed at capturing cognitive operations involved in the successful accomplishment of delayed intentions. It is generally agreed that PM impairment occurs in patients with prefrontal lobes damage. Objective. To evaluate if there is a causal role of a deficit of executive abilities (failures of planning, set-shifting, selective attention, or working memory) over the PM impairment. Methods. We report a detailed investigation of PM and executive abilities in two patients with posttraumatic damage to prefrontal lobes who complained from a reduced compliance with appointments and daily routines. Results. Laboratory tests confirmed a difficulty in fulfilling delayed intentions in response to the occurrence of critical events and elapsed time. In one patient, PM impairment was associated with poor performance on tests investigating planning, working memory, and mental shifting. The other patient performed in the normal range on all executive tests. Conclusions. Despite the frequent claim of a dependence of PM deficits from executive dysfunction, the reported cases demonstrate that this is not necessarily the case. The results are discussed in the light of current hypotheses relating PM impairment to other deficits that commonly occur as a result of damage to the prefrontal lobes.	[Carlesimo, Giovanni A.; Fadda, Lucia; Caltagirone, Carlo] Univ Roma Tor Vergata, Neurol Clin, Via Orazio Raimondo 18, I-00173 Rome, Italy; [Carlesimo, Giovanni A.; di Paola, Margherita; Fadda, Lucia; Caltagirone, Carlo; Costa, Alberto] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, I-00179 Rome, Italy; [di Paola, Margherita] Dipartimento Med Clin Sanita Pubbl Sci Vita & Amb, Laquila, Italy		Carlesimo, GA (corresponding author), Univ Roma Tor Vergata, Neurol Clin, Via Orazio Raimondo 18, I-00173 Rome, Italy.	memolab@hsantalucia.it	Costa, Alberto/AAA-7038-2019	Fadda, Lucia/0000-0003-0659-9416; COSTA, Alberto/0000-0002-4784-5524			Badzakova-Trajkov G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009682; Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; Bisiacchi PS, 2008, AGING CLIN EXP RES, V20, P569; Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Bortolini V., 1971, FREQUENCY WORDS CONT; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carlesimo G, 2002, NUOVA RIV NEUROLOGIA, V12, P1; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Cockburn J, 1996, J CLIN EXP NEUROPSYC, V18, P304, DOI 10.1080/01688639608408284; Costa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056039; Costa A, 2011, CEREB CORTEX, V21, P2696, DOI 10.1093/cercor/bhr052; Costa A, 2011, NEUROPSYCHOLOGIA, V49, P2209, DOI 10.1016/j.neuropsychologia.2011.03.016; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crescentini C, 2012, NEUROPSYCHOLOGIA, V50, P1521, DOI 10.1016/j.neuropsychologia.2012.03.005; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; GOLDSTEIN LH, 1993, J NEUROL NEUROSUR PS, V56, P274, DOI 10.1136/jnnp.56.3.274; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Koch G, 2005, NEUROIMAGE, V24, P34, DOI 10.1016/j.neuroimage.2004.09.042; Kumar D, 2008, CLIN NEUROPSYCHOL, V22, P497, DOI 10.1080/13854040701396687; Leh SE, 2010, NEUROPSYCHOPHARMACOL, V35, P70, DOI 10.1038/npp.2009.88; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2009, AGING NEUROPSYCHOL C, V16, P563, DOI 10.1080/13825580902866646; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Nocentini U., 2002, NUOVA RIV NEUROLOGIA, V12, P13, DOI DOI 10.1080/00336297.2015.1051236; Okuda J, 2011, NEUROPSYCHOLOGIA, V49, P2258, DOI 10.1016/j.neuropsychologia.2011.02.005; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Pavawalla SP, 2012, NEUROPSYCHOLOGY, V26, P91, DOI 10.1037/a0025866; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shum DHK, 2013, NEUROPSYCHOL REHABIL, V23, P45, DOI 10.1080/09602011.2012.716761; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Spinnler H., 1987, ITALIAN J NEUROLO S8; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Trawley SL, 2011, Q J EXP PSYCHOL, V64, P2181, DOI 10.1080/17470218.2011.584976; Umeda S, 2011, NEUROPSYCHOLOGIA, V49, P2178, DOI 10.1016/j.neuropsychologia.2011.03.036; van den Berg E, 2012, J INT NEUROPSYCH SOC, V18, P706, DOI 10.1017/S1355617712000331; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Wagner M, 2006, J PSYCHIATR RES, V40, P315, DOI 10.1016/j.jpsychires.2005.06.001; Weinborn M, 2011, J CLIN EXP NEUROPSYC, V33, P1119, DOI 10.1080/13803395.2011.614595; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Xiang YT, 2010, ARCH CLIN NEUROPSYCH, V25, P680, DOI 10.1093/arclin/acq062	50	8	8	0	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2014	2014								168496	10.1155/2014/168496			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD5IF	WOS:000333285000001	24825947	Green Submitted, Green Published, gold			2022-02-06	
J	Corradini, PL; Persinger, MA				Corradini, Paula L.; Persinger, Michael A.			Spectral power, source localization and microstates to quantify chronic deficits from 'mild' closed head injury: Correlation with classic neuropsychological tests	BRAIN INJURY			English	Article						Microstate durations; neuropsychological test batteries; quantitative electroencephalogram; source localization (s-LORETA); traumatic brain injury	MAGNETIC-FIELDS; BRAIN-INJURY; EEG; IMPAIRMENT; WEAK; INDICATORS; DEPRESSION; DURATION; SCORES	Primary objective: To explore the quantitative relationship between neuropsychological impairment and spectral QEEG power, source localization (s-LORETA) and microstate duration in patients who 'fail to adapt' years after mild closed head injury. Methods and procedures: Differences in classic psychometric measures, QEEG measures, s-LORETA indicators and microstate durations were compared for three levels of neuropsychological impairment similar to(average) 6 years after injury. Results: Patients who displayed the moderate-to-severe neuropsychological impairments typical of mild TBIs exhibited shorter microstates, less power within the alpha band and lower power within the theta and delta bands within caudal regions. There were conspicuous differences in the configurations of microstates, their source localizations and frequency bands. Conclusions: The systematic relationship between neuropsychological impairment as inferred by classic psychometric measures that can require tens of hours to collect and modern configurational analyses of brain activity that require similar to 30 minutes suggests that the latter might be useful in discerning the area of dysfunction and potential focus of treatment for patients with closed head injury years after the event.	[Corradini, Paula L.; Persinger, Michael A.] Laurentian Univ, Dept Psychol, Behav Neurosci Program, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada		Persinger, MA (corresponding author), Laurentian Univ, Dept Psychol, Behav Neurosci Program, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada.	mpersinger@laurentian.ca					Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Baker-Price L, 2003, PERCEPT MOTOR SKILL, V96, P965, DOI 10.2466/PMS.96.3.965-974; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Cheung KW, 2010, J BIOL SCI, V10, P84; Cooper PR, 1993, HEAD INJURY; Gorham R, 2012, EPILEPSY BEHAV, V23, P152, DOI 10.1016/j.yebeh.2011.11.010; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Lado W. E., 2012, J BEHAV BRAIN SCI, V2, P333; Lado WE, 2008, CENT EUR J BIOL, V3, P422, DOI 10.2478/s11535-008-0041-6; Lehmann D, 2005, PSYCHIAT RES-NEUROIM, V138, P141, DOI 10.1016/j.pscychresns.2004.05.007; Lehmann D, 2010, NEUROIMAGE, V49, P1073, DOI 10.1016/j.neuroimage.2009.07.054; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Martin LJ, 2004, PHARMACOL BIOCHEM BE, V78, P217, DOI 10.1016/j.pbb.2004.03.016; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Niedermeyer E, 1987, ELECTROENCEPHALOGRAP; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Persinger MA, 1997, PERCEPT MOTOR SKILL, V84, P1284, DOI 10.2466/pms.1997.84.3c.1284; Persinger MA, 2003, PERCEPT MOTOR SKILL, V96, P647; PERSINGER MA, 1995, PERCEPT MOTOR SKILL, V80, P1011, DOI 10.2466/pms.1995.80.3.1011; Persinger MA, 1995, PERCEPT MOTOR SKILL, V81, P1283, DOI 10.2466/pms.1995.81.3f.1283; Persinger MA, 2000, PERCEPT MOTOR SKILL, V90, P37, DOI 10.2466/PMS.90.1.37-40; Persinger MA, 1998, PERCEPT MOTOR SKILL, V87, P59, DOI 10.2466/pms.1998.87.1.59; Reitan R, 1985, HALSTEAD REITAN NEUR; Roberts MA, 1994, NEUROPSYCHOLOGY, V1, P45, DOI DOI 10.1080/09084282.1994.9645330; Roll WG, 2002, INT J NEUROSCI, V112, P197, DOI 10.1080/00207450212025; Russell EW, 1970, J CONSULT CLIN PSYCH, V43, P800; St Pierre LS, 2006, INT J NEUROSCI, V116, P1079, DOI 10.1080/00207450600808800; Strik WK, 1997, PSYCHIAT RES-NEUROIM, V75, P183, DOI 10.1016/S0925-4927(97)00054-1; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thatcher RW, 1997, J CLIN NEUROPSYCHIAT, V13, P77; Tiller SG, 2013, J BEHAV BRAIN SCI, V3, P225; Tsang EW, 2004, INT J NEUROSCI, V114, P1183, DOI 10.1080/00207450490475643; Varney N. R., 1992, Brain Injury, V6, P499, DOI 10.3109/02699059209008147; Wackermann J, 1999, INT J PSYCHOPHYSIOL, V34, P65, DOI 10.1016/S0167-8760(99)00038-0; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029	44	8	9	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1317	1327		10.3109/02699052.2014.916819			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900013	24841927				2022-02-06	
J	Edmed, SL; Sullivan, KA				Edmed, Shannon L.; Sullivan, Karen A.			Method of symptom assessment influences cognitive, affective and somatic post-concussion-like symptom base rates	BRAIN INJURY			English	Article						Assessment; diagnosis; head injury; symptom checklists; TBI	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION-LIKE SYMPTOMS; RECOMMENDATIONS; DEPRESSION; PREDICTORS; INTERVIEW; ANXIETY; HISTORY	Primary objective: To investigate whether assessment method influences the type of post-concussion-like symptoms. Methods and procedures: Participants were 73 Australian undergraduate students (M-age = 24.14, SD = 8.84; 75.3% female) with no history of mild traumatic brain injury (mTBI). Participants reported symptoms experienced over the previous 2 weeks in response to an open-ended question (free report), mock interview and standardized checklist (British Columbia Post-concussion Symptom Inventory; BC-PSI). Main outcomes and results: In the free report and checklist conditions, cognitive symptoms were reported significantly less frequently than affective (free report: p<0.001; checklist: p<0.001) or somatic symptoms (free report: p<0.001; checklist: p = 0.004). However, in the mock structured interview condition, cognitive and somatic symptoms were reported significantly less frequently than affective symptoms (both p<0.001). No participants reported at least one symptom from all three domains when assessed by free report, whereas most participants did so when symptoms were assessed by a mock structured interview (75%) or checklist (90%). Conclusions: Previous studies have shown that the method used to assess symptoms affects the number reported. This study shows that the assessment method also affects the type of reported symptoms.	[Edmed, Shannon L.; Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Brisbane, Qld 4001, Australia; [Edmed, Shannon L.; Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, O Block,B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au		Edmed, Shannon/0000-0001-5550-9371			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lovibond P.F., 1995, MANUAL DESPRESSION A; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2004, ICD 10 INT STAT CLAS	25	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1277	1282		10.3109/02699052.2014.915988			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900007	24865110				2022-02-06	
J	Ho, CH; Hsieh, KY; Liang, FW; Li, CJ; Wang, JJ; Chio, CC; Chang, CH; Kuo, JR				Ho, Chung-Han; Hsieh, Kuang-Yang; Liang, Fu-Wen; Li, Chia-Jung; Wang, Jhi-Joung; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung			Pre-existing hyperlipidaemia increased the risk of new-onset anxiety disorders after traumatic brain injury: a 14-year population-based study	BMJ OPEN			English	Article							NATIONAL-COMORBIDITY-SURVEY; PSYCHIATRIC-DISORDERS; UNITED-STATES; HEALTH; PREVALENCE; TAIWAN; INFLAMMATION; ILLNESS; STRESS; ADULTS	Objectives: Anxiety disorders (ADs) are common after traumatic brain injury (TBI). However, the risk factors of new-onset ADs remain unclear. This study was aimed at evaluating the incidence and risk factors for new-onset ADs, including pre-existing hyperlipidaemia and three major comorbidities (diabetes mellitus, hypertension and cardiovascular disease), in patients with TBI. Setting: A matched cohort study was conducted using the Taiwan Longitudinal Health Insurance Database between January 1997 and December 2010. Participants: A total of 3822 participants (1274 patients with TBI with hyperlipidaemia and 2548 age-matched and gender-matched patients with TBI without hyperlipidaemia). Outcome measures: The incidence and HRs for the development of new-onset ADs after TBI were compared between the two groups. Results: The overall incidence rate of new-onset ADs for patients with TBI with hyperlipidaemia is 142.03/10 000 person-years (PYs). Patients with TBI with hyperlipidaemia have a 1.60-fold incidence rate ratio (p<0.0001) and increased HR of ADs (1.58, 95% CI 1.24 to 2.02) compared with those without hyperlipidaemia. The incidence rates of ADs for males and females with hyperlipidaemia, respectively, were 142.12 and 292.32/10 000 PYs, which were higher than those without hyperlipidaemia (93.03 and 171.68/10 000 PYs, respectively). Stratified by age group, hyperlipidaemia is a risk factor of ADs for patients with TBI aged 65 years or younger. Conclusions: Pre-existing hyperlipidaemia is an independent predictor of new-onset ADs in patients with TBI, even when controlling for other demographic and clinical variables. Female patients with pre-existing hyperlipidaemia had significantly higher risk of new-onset ADs than males, especially between the ages of 35 and 65 years.	[Ho, Chung-Han; Wang, Jhi-Joung; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Hsieh, Kuang-Yang] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Hsieh, Kuang-Yang; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Inst Publ Hlth, Tainan 70101, Taiwan; [Li, Chia-Jung] Natl Cheng Kung Univ, Dept Psychiat, Tainan 70101, Taiwan; [Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	kuojinnrung@gmail.com		Liang, Fu-Wen/0000-0002-3396-037X; Ho, Chung-Han/0000-0001-5925-8477			[Anonymous], 1999, JAMA, V282, P974; Bromberger JT, 2013, MENOPAUSE, V20, P488, DOI [10.1097/gme.0b013e3182730599, 10.1097/GME.0b013e3182730599]; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Can OD, 2012, BEHAV PHARMACOL, V23, P582, DOI 10.1097/FBP.0b013e328356c3f2; Chang HY, 2002, CHINESE J PHYSIOL, V45, P187; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Chien IC, 2013, J PSYCHOSOM RES, V75, P270, DOI 10.1016/j.jpsychores.2013.06.003; Chien IC, 2004, PSYCHIAT SERV, V55, P691, DOI 10.1176/appi.ps.55.6.691; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chung SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064630; Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x; Dortland AKBV, 2013, PSYCHONEUROENDOCRINO, V38, P209, DOI 10.1016/j.psyneuen.2012.05.017; Dratva J, 2009, MENOPAUSE, V16, P385, DOI 10.1097/gme.0b013e31818aefef; Einvik G, 2010, J PSYCHOSOM RES, V68, P567, DOI 10.1016/j.jpsychores.2009.11.004; Esmaillzadeh A, 2010, ANN NUTR METAB, V57, P77, DOI 10.1159/000318588; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU, V2, P1; GURURAJ G, 2004, NEUROTRAUMA REGISTRY; HAVEL RJ, 1995, NEW ENGL J MED, V332, P1491, DOI 10.1056/NEJM199506013322207; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Huang CJ, 2011, GEN HOSP PSYCHIAT, V33, P8, DOI 10.1016/j.genhosppsych.2010.10.008; Jensvold MF, 1996, PSYCHOPHARMACOLOGY W; Kawamoto R, 2012, ENDOCRINE, V42, P321, DOI 10.1007/s12020-012-9625-z; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P267; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KLONOFF H, 1971, PERCEPT MOTOR SKILL, V32, P603, DOI 10.2466/pms.1971.32.2.603; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Murray CJ, 1996, GERONTOLOGIST, V36, P773; Olafiranye O, 2011, Mind Brain, V2, P32; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Schmieder RE, 2013, J HYPERTENS, V31, P610, DOI 10.1097/HJH.0b013e32835d6e53; Shear MK, 1997, SEMIN REPROD ENDOCR, V15, P69, DOI 10.1055/s-2008-1067969; Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013; Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P1; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	46	8	8	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2014	4	7							e005269	10.1136/bmjopen-2014-005269			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM2ZS	WOS:000339720900079	25034630	Green Published, gold			2022-02-06	
J	Hohl, A; Ronsoni, MF; Debona, R; Ben, J; Schwarzbold, ML; Diaz, AP; Thais, MERD; Linhares, MN; Latini, A; Prediger, RD; Dal Pizzol, F; Walz, R				Hohl, Alexandre; Ronsoni, Marcelo Fernando; Debona, Rodrigo; Ben, Juliana; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Rodrigues de Oliveira Thais, Maria Emilia; Linhares, Marcelo Neves; Latini, Alexandra; Prediger, Rui Daniel; Dal Pizzol, Felipe; Walz, Roger			Role of hormonal levels on hospital mortality for male patients with severe traumatic brain injury	BRAIN INJURY			English	Article						Hormones; hospital mortality; male; prognosis; severe traumatic brain injury	ISCHEMIA-REPERFUSION INJURY; SEVERE HEAD-INJURY; COMA DATA-BANK; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM; DIAGNOSIS; INSUFFICIENCY; MANAGEMENT	Introduction: Changes in hormone blood levels during the acute phase of traumatic brain injury (TBI) have been described in the literature. The objective was to investigate the association among several hormones plasma levels in the acute phase of severe TBI and the hospital mortality rate of male patients. Methods: The independent association among plasma levels of TSH, LH, FSH, GH, free T-4, cortisol, IGF-1 and total testosterone was measured 10 hours and 30 hours after severe TBI and the hospital mortality of 60 consecutive male patients was evaluated. Results: At least one hormonal level abnormality was demonstrated in 3.6-73.1% of patients. The multiple logistic regressions showed a trend for an independent association among hospital mortality and normal or elevated LH levels measured at 10 hours (OR = 3.7, 95% CI = 0.8-16.3, p = 0.08) and 30 hours (OR = 3.9, 95% CI = 0.9-16.7, p = 0.06). Admission with abnormal pupils and a lower Glasgow Coma Score also were independently associated with hospital mortality. Conclusion: The hormonal changes are frequent in the acute phase of severe TBI. The hormones plasma levels, excepting the LH, are not highly consistent with the hospital mortality of male patients.	[Hohl, Alexandre; Ronsoni, Marcelo Fernando; Debona, Rodrigo; Ben, Juliana; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Rodrigues de Oliveira Thais, Maria Emilia; Linhares, Marcelo Neves; Latini, Alexandra; Prediger, Rui Daniel; Walz, Roger] Univ Fed Santa Catarina, Ctr Neurociencias Aplicadas CeNAP, Florianopolis, SC, Brazil; [Hohl, Alexandre; Ronsoni, Marcelo Fernando; Walz, Roger] Univ Fed Santa Catarina, Dept Clin Med, Florianopolis, SC, Brazil; [Linhares, Marcelo Neves] Univ Fed Santa Catarina, HU, Dept Cirugia, Florianopolis, SC, Brazil; [Linhares, Marcelo Neves; Walz, Roger] HGCR, Ctr Epilepsia Estado Santa Catarina CEPESC, Florianopolis, SC, Brazil; [Latini, Alexandra] Univ Fed Santa Catarina, Ctr Ciencias Biol, Lab Bioenerget & Estresse Oxidat, Florianopolis, SC, Brazil; [Prediger, Rui Daniel] Univ Fed Santa Catarina, Dept Farmacol, Florianopolis, SC, Brazil; [Dal Pizzol, Felipe] Univ Extremo Sul Catarinense UNESC, Lab Fisiopatol Expt, Criciuma, SC, Brazil		Hohl, A (corresponding author), UFSC, Univ Hosp, Dept Clin Med, 3 Andar,Campus Univ, Trindade Florianopolis, SC, Brazil.	alexandrehohl@endocrino.org.br	Diaz, Alexandre Paim/AAD-8323-2019; Hohl, Alexandre/R-9269-2019; Latini, Alexandra/P-2637-2019; Walz, Roger/K-9096-2013; Prediger, Rui D/C-4036-2013; Debona, Rodrigo/M-8317-2014; Diaz, Alexandre Paim/J-9042-2014; Latini, Alexandra/Y-8067-2019; Dal-Pizzol, Felipe/F-2756-2015; Debona, Rodrigo/W-6181-2019; Prediger, Rui Daniel/AAV-3419-2020; Schwarzbold, Marcelo Liborio/J-8960-2014	Diaz, Alexandre Paim/0000-0002-6591-6648; Hohl, Alexandre/0000-0002-8073-5837; Walz, Roger/0000-0002-9875-6687; Prediger, Rui D/0000-0002-7547-6463; Debona, Rodrigo/0000-0002-7316-5450; Latini, Alexandra/0000-0003-4255-3589; Dal-Pizzol, Felipe/0000-0003-3003-8977; Debona, Rodrigo/0000-0002-7316-5450; Prediger, Rui Daniel/0000-0002-7547-6463; 	CNPq (Brazilian Council for Scientific and Technologic Development, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); PRONEX Program of FAPESC/CNPq (NENASC Project); PPSUS Program of FAPESC/MS/CNPq/SES-SC	This work was supported by CNPq (Brazilian Council for Scientific and Technologic Development, Brazil), PRONEX Program of FAPESC/CNPq (NENASC Project) and PPSUS Program of FAPESC/MS/CNPq/SES-SC.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; De Groot LJ, 1999, J CLIN ENDOCR METAB, V84, P151, DOI 10.1210/jc.84.1.151; Thais MERD, 2012, CNS NEUROSCI THER, V18, P606, DOI 10.1111/j.1755-5949.2012.00346.x; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P908, DOI 10.1590/S0004-27302009000800003; Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631, DOI 10.1097/00004647-200004000-00001; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sigwalt AR, 2011, NEUROSCIENCE, V192, P661, DOI 10.1016/j.neuroscience.2011.05.075; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7; Yang SH, 2005, J NEUROBIOL, V62, P341, DOI 10.1002/neu.20103; Yang SH, 2002, J APPL PHYSIOL, V92, P195, DOI 10.1152/jappl.2002.92.1.195	39	8	8	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1262	1269		10.3109/02699052.2014.915986			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900005	24841415				2022-02-06	
J	Jani, MP; Gore, GB				Jani, Mansi Pankaj; Gore, Geeta Bharat			Occurrence of communication and swallowing problems in neurological disorders: Analysis of forty patients	NEUROREHABILITATION			English	Article						Neurological disorders; dysarthria; dysphagia; aphasia; speech language pathologist	MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; APHASIA; DYSARTHRIA; DYSPHAGIA	BACKGROUND: Communication and swallowing problems are common as a result of neurological conditions like stroke, traumatic brain injury, neoplasms of the nervous systems, viral encephalitis, diseases affecting neuromuscular junction and neuro degenerative conditions. The most frequently encountered problems are dysarthria, aphasia, dysphagia and apraxia of speech. OBJECTIVES: Although these disorders are mentioned in literature, very few studies describing the occurrence in different neurological conditions are available in Indian context. Hence, a need was felt to carry out such a study. METHODOLOGY: A heterogenous group of forty patients with neurological conditions were assessed for presence of speech, language and swallowing problems. A percent analysis was carried out to determine the occurrence of aphasia, dysarthria and dysphagia in general, in specific diseases and also to describe type of aphasia and dysarthria according to the characteristics presented. RESULTS: It was seen that the most frequently occurring disorder was dysarthria (60%), followed by dysphagia (55%) and aphasia (18%). It was also noted that dysarthria and dysphagia co-existed in around 45% patients with neurological diseases. CONCLUSIONS: It can be concluded that speech, language and swallowing problems are frequent in individuals with neurological conditions. Speech language pathologist plays an important role as a member of the rehabilitation team in a neurological setup with respect to identifying these problems and initiating intervention at the earliest. Hence, it is necessary for speech language pathologist to be well versed with the features each disorder may present with in terms of communication and swallowing.	[Gore, Geeta Bharat] BYL Nair Charitable Hosp, Dept Audiol & Speech Therapy, Bombay, Maharashtra, India		Jani, MP (corresponding author), 302-A Wing Himgiri Apartment,Lokhandwala Complex, Bombay 400053, Maharashtra, India.	mancyj55@gmail.com					ASHA, 2008, COMM FACTS SPEC POP; Brown J.R., 1975, MOTOR SPEECH DISORDE; Canbaz DH, 2010, J NEUROL SCI-TURK, V27, P20; Channabasavanna S., 1993, EPIDEMIOLOGY OF HEAD; Choi JY, 2007, J NUCL MED, V48, P194; DAMASIO AR, 1992, NEW ENGL J MED, V326, P531, DOI 10.1056/NEJM199202203260806; Darley F., 1982, APHASIA ADJECTIVES, P1; Das SK, 2008, CIRCULATION, V118, P2719, DOI 10.1161/CIRCULATIONAHA.107.743237; Enderby J., 1995, DOES SPEECH LANGUAGE; Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c; HARTELIUS L, 1994, FOLIA PHONIATR LOGO, V46, P9, DOI 10.1159/000266286; Hartelius L, 2000, FOLIA PHONIATR LOGO, V52, P160, DOI 10.1159/000021531; Logemann J., 1983, DISORDERS DEGLUTITIO, P37; Masaki N., 2002, JAPAN J LOGOPEDICS P, V43, P117; Meng NH, 2000, AM J PHYS MED REHAB, V79, P170, DOI 10.1097/00002060-200003000-00010; Paciaroni M, 2004, EUR NEUROL, V51, P162, DOI 10.1159/000077663; Poluska A., 2003, PARKINSONISM RELAT D, V9, P349	17	8	9	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	4					719	727		10.3233/NRE-141165			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW4HK	WOS:000346241600010	25318773				2022-02-06	
J	Kushner, DS; Johnson-Greene, D				Kushner, David S.; Johnson-Greene, Doug			Changes in cognition and continence as predictors of rehabilitation outcomes in individuals with severe traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						fecal incontinence; Functional Independence Measure score; outcomes assessment; postacute change; prediction; prognosis; rehabilitation; TBI; traumatic brain injury; urinary incontinence	POSTTRAUMATIC AMNESIA DURATION; GLASGOW COMA SCALE; HEAD-INJURY; STRESS-DISORDER; MODERATE; RETURN; WORK; TBI; CLASSIFICATION; METAANALYSIS	The study objective was to examine postacute changes in bowel and bladder continence and cognition after severe traumatic brain injury (TBI) in persons with long-term functional recovery to full independence. This case series included nine patients initially admitted to inpatient rehabilitation (IR) with severe TBI who had returned to prior responsibilities and functional independence by 8 to 15 mo. Patients had initial Glasgow Coma Scale scores of 3 to 6, posttraumatic amnesia durations of 18 to 70 d, time-to-follow-commands of 16 to 56 d, initial abnormal brain computed tomography scans, and initial pupil abnormalities. IR Functional Independence Measure (FIM) cognitive and sphincter score improvements were compared with national TBI FIM data from Uniform Data Systems for Medical Rehabilitation (UDSMR) for 2010 (n = 16,368). All patients had IR improvements in cognitive and sphincter FIM scores approximately twice the national UDSMR data for 2010. All patients had combined IR discharge sphincter FIM scores that were 12 or greater, indicating independence to modified independence with bowel and bladder function with no incontinence. Five participants (55%) were admitted to IR with sphincter FIM scores of 11 to 12, indicating recovery of continence during acute care. These findings suggest potential usefulness of IR cognitive FIM score changes and of the recovery of bowel and bladder continence for predicting favorable functional outcomes following severe TBI.	[Kushner, David S.; Johnson-Greene, Doug] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33189 USA		Kushner, DS (corresponding author), Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, 20601 Old Cutler Rd, Miami, FL 33189 USA.	dkushner@med.miami.edu	Kushner, David S./AAW-4951-2020	Kushner, David S./0000-0001-6090-6304	Department of Physical Medicine and Rehabilitation - U.S. Department of Education, National Institute of Disability Research and Rehabilitation [H133A120099]	This material was based on work supported by Department of Physical Medicine and Rehabilitation funding by the U.S. Department of Education, National Institute of Disability Research and Rehabilitation (grant H133A120099, a TBI Model Systems grant).	Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; Akiguchi I, 2008, J NEUROL, V255, P1392, DOI 10.1007/s00415-008-0928-1; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Centers for Disease Control and Prevention National Institutes of Health Department of Defense and Department of Veterans Affairs Leadership Panel, 2013, REPORT TO CONGRESS O; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2012, ANALYSIS OF VA HEALT; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Morris A, 1992, J Gerontol Nurs, V18, P33; Myint PK, 2008, GERONTOLOGY, V54, P202, DOI 10.1159/000126491; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nimgade A, 2003, J HEAD TRAUMA REHAB, V18, P464, DOI 10.1097/00001199-200309000-00008; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reider-Groswasser II, 2002, BRAIN INJURY, V16, P517, DOI 10.1080/02699050110119141; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Starkstein SE, 2012, HAND CLINIC, V106, P53, DOI 10.1016/B978-0-444-52002-9.00004-8; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Tsakanikas D, 2007, SEMIN NEUROL, V27, P58, DOI 10.1055/s-2006-956756; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Walker WC, 2011, PM&R, V3, P6, DOI 10.1016/j.pmrj.2010.11.001; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zhang H, 2005, NEUROIMAGE, V24, P174, DOI 10.1016/j.neuroimage.2004.08.027	60	8	9	1	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	7					1057	1068		10.1682/JRRD.2014.01.0002			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AU8JB	WOS:000345841300005	25436488	Bronze			2022-02-06	
S	McCrea, M; Guskiewicz, K		Niranjan, A; Lunsford, LD		McCrea, Michael; Guskiewicz, Kevin			Evidence-Based Management of Sport-Related Concussion	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							MILD HEAD-INJURY; COLLEGIATE FOOTBALL PLAYERS; ERROR SCORING SYSTEM; POSTURAL STABILITY; POSITION STATEMENT; NCAA CONCUSSION; HIGH-SCHOOL; RECOVERY; METAANALYSIS; RELIABILITY	Concussion is not only one of the most common injuries encountered by athletes participating in contact and collision sports, but also among the most complex injuries to manage in a sports medicine setting. Over the past two decades, we have made great progress in advancing the basic and clinical science of concussion. These advances have had enormous clinical translational value for developing evidence-based guidelines for management of concussion in sports. Applied clinical research has clarified the defining characteristics of sport-related concussion (SRC) that support new diagnostic criteria. At the same time, major advancements have been realized in the development and validation of clinical tools that allow a more objective and accurate assessment of concussion and performance-based measures of recovery. These tools provide clinicians with a more informed basis for determining an athlete's cognitive and physical fitness to return to competition after concussion. Standardized injury management protocols that systematically prescribe rest, graded activity, and return to play have been adopted in nearly all clinical settings. Herein, we briefly summarize the findings and recommendations from several national and international consensus guidelines and position statements on best practice in the evaluation and management of SRC. (C) 2014 S. Karger AG, Basel	[McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [McCrea, Michael] Clement Zablocki VA Med Ctr, Milwaukee, WI USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA		McCrea, M (corresponding author), Med Coll Wisconsin, Brain Injury Res, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu		Guskiewicz, Kevin/0000-0002-8682-2130			Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658	33	8	8	0	13	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						112	127		10.1159/000358769	10.1159/isbn.978-3-318-02649-8		16	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000011	24923397				2022-02-06	
J	Miremami, JD; Talauliker, PM; Harrison, JL; Lifshitz, J				Miremami, Jahan D.; Talauliker, Pooja M.; Harrison, Jordan L.; Lifshitz, Jonathan			Neuropathology in sensory, but not motor, brainstem nuclei of the rat whisker circuit after diffuse brain injury	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Microglial activation; neuropathology; rat; traumatic brain injury; vibrissal circuitry	POST-CONCUSSION SYNDROME; TRAUMATIC AXONAL INJURY; AXOLEMMAL PERMEABILITY; NEUROLOGICAL RECOVERY; SOMATOSENSORY CORTEX; HEAD-INJURIES; LATE-ONSET; RESPONSES; DEGENERATION; ACTIVATION	Neurological dysfunction after traumatic brain injury (TBI) is associated with pathology in cortical, subcortical, and brainstem nuclei. Our laboratory has reported neuropathology and microglial activation in the somatosensory barrel cortex (S1BF) and ventral posterior medial thalamus (VPM) after diffuse TBI in the rat, which correlated with post-injury whisker sensory sensitivity. The present study extends our previous work by evaluating pathology in whisking-associated sensory and motor brainstem nuclei. Brains from adult, male rats were recovered over 1 month after midline fluid percussion or sham injury. The principal trigeminal nucleus (PrV, sensory nucleus) and facial nucleus (VIIN, motor nucleus) were examined for neuropathology (silver histochemistry) and microglial activation (Iba1). Significant neuropathology in PrV was evident at 2 and 7 days post-injury compared to sham. Iba1-labeled microglia showed swollen somata and thickened processes over 1 month post-injury. In contrast, the VIIN showed non-significant neuropathology and reduced labeling of activated Iba1 microglia over 1 month post-injury. Together with our previous data, neuropathology and neuroinflammation in the whisker somatosensory pathway may contribute to post-injury sensory sensitivity more than the motor pathway. Whether these findings are direct results of the mechanical injury or consequences of progressive degeneration remains to be determined.	[Miremami, Jahan D.] Univ Kentucky, Coll Med, Coll Arts & Sci, Dept Biol, Lexington, KY USA; [Miremami, Jahan D.; Talauliker, Pooja M.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Talauliker, Pooja M.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Harrison, Jordan L.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Harrison, Jordan L.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Harrison, Jordan L.; Lifshitz, Jonathan] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA; [Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ USA		Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Translat Neurotrauma Res Program, 1919 E Thomas Rd,Ambulatory Bldg,3rd Fl, Phoenix, AZ 85016 USA.	JLifshitz@email.arizona.edu			University of Kentucky College of Medicine, KSCHIRT [7-11, R01 NS-065052]; Appalachian and Minority Science, Technology, Engineering and Mathematics Majors (AMSTEMM) [NSF-0431552]; Bucks for Brains Presidential Funds for undergraduate research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052] Funding Source: NIH RePORTER	The authors certify that they have no affiliations with any organization or entity with any financial interest in the subject matter discussed in this paper. This study was supported by the University of Kentucky College of Medicine, KSCHIRT # 7-11, R01 NS-065052, the Appalachian and Minority Science, Technology, Engineering and Mathematics Majors (AMSTEMM) grant NSF-0431552, and the Bucks for Brains Presidential Funds for undergraduate research.	Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Baptiste DC, 2009, J NEUROPATH EXP NEUR, V68, P661, DOI 10.1097/NEN.0b013e3181a72605; Bendella H, 2011, EXP BRAIN RES, V212, P65, DOI 10.1007/s00221-011-2697-9; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Dauer DJ, 2011, BRAIN BEHAV IMMUN, V25, P77, DOI 10.1016/j.bbi.2010.08.005; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Johnson IP, 1998, NEUROSCIENCE, V84, P141, DOI 10.1016/S0306-4522(97)00500-9; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Koob Andrew O, 2008, J Biol Eng, V2, P9, DOI 10.1186/1754-1611-2-9; Koob AO, 2006, J NEUROSCI RES, V83, P1558, DOI 10.1002/jnr.20837; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Lifshitz J, 2011, 41 ANN M SOC NEUR WA; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Marzo SJ, 2010, LARYNGOSCOPE, V120, P2264, DOI 10.1002/lary.21077; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Mikics E, 2008, PHYSIOL BEHAV, V94, P341, DOI 10.1016/j.physbeh.2008.01.023; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; Pavlov SP, 2008, EXP NEUROL, V211, P292, DOI 10.1016/j.expneurol.2008.02.019; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosahl SK, 1998, ACT NEUR S, V71, P88; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; WAITE PME, 1984, J PHYSIOL-LONDON, V352, P425, DOI 10.1113/jphysiol.1984.sp015301; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	56	8	8	1	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-0220			SOMATOSENS MOT RES	Somatosens. Mot. Res.		2014	31	3					127	135		10.3109/08990220.2014.897602			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN8BS	WOS:000340827000003	24702476				2022-02-06	
J	Ordek, G; Proddutur, A; Santhakumar, V; Pfister, BJ; Sahin, M				Ordek, Gokhan; Proddutur, Archana; Santhakumar, Vijayalakshmi; Pfister, Bryan J.; Sahin, Mesut			Electrophysiological monitoring of injury progression in the rat cerebellar cortex	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						cerebellar evoked potentials; traumatic injury model; Purkinje cells; multi-electrode arrays; micro-ECoG		The changes of excitability in affected neural networks can be used as a marker to study the temporal course of traumatic brain injury (TBI). The cerebellum is an ideal platform to study brain injury mechanisms at the network level using the electrophysiological methods. Within its crystalline morphology, the cerebellar cortex contains highly organized topographical subunits that are defined by two main inputs, the climbing (CFs) and mossy fibers (MFs). Here we demonstrate the use of cerebellar evoked potentials (EPs) mediated through these afferent systems for monitoring the injury progression in a rat model of fluid percussion injury (FPI). A mechanical tap on the dorsal hand was used as a stimulus, and EPs were recorded from the paramedian lobule (PML) of the posterior cerebellum via multi-electrode arrays (MEAs). Post-injury evoked response amplitudes (EPAs) were analyzed on a daily basis for 1 week and compared with pre-injury values. We found a trend of consistently decreasing EPAs in all nine animals, losing as much as 72 +/- 4% of baseline amplitudes measured before the injury. Notably, our results highlighted two particular time windows; the first 24 h of injury in the acute period and day-3 to day-7 in the delayed period where the largest drops (similar to 50% and 24%) were observed in the EPAs. In addition, cross-correlations of spontaneous signals between electrode pairs declined (from 0.47 +/- 0.1 to 0.35 +/- 0.04, p < 0.001) along with the EPAs throughout the week of injury. In support of the electrophysiological findings, immunohistochemical analysis at day-7 post-injury showed detectable Purkinje cell loss at low FPI pressures and more with the largest pressures used. Our results suggest that sensory evoked potentials (SEPs) recorded from the cerebellar surface can be a useful technique to monitor the course of cerebellar injury and identify the phases of injury progression even at mild levels.	[Ordek, Gokhan; Pfister, Bryan J.; Sahin, Mesut] New Jersey Inst Technol, Dept Biomed Engn, 323 MLK Jr Blvd,Univ Hts, Newark, NJ 07102 USA; [Proddutur, Archana; Santhakumar, Vijayalakshmi] Rutgers Biomed & Hlth Sci, Dept Neurol & Neurosci, Newark, NJ USA		Sahin, M (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, 323 MLK Jr Blvd,Univ Hts, Newark, NJ 07102 USA.	sahin@njit.edu	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187	New Jersey Commission on Brain Injury Research, multi-investigator [CBIR11PJT003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	We thank Luke Fritzky for the technical support on confocal images. We also acknowledge Mathew Long for calibrating the fluid percussion injury device prior to each injury. Study support: New Jersey Commission on Brain Injury Research, multi-investigator grant CBIR11PJT003 to Bryan J, Pfister and Vijayalakshmi San thakumar.	Ai JL, 2007, EXP BRAIN RES, V177, P95, DOI 10.1007/s00221-006-0654-9; Ai JL, 2004, PHARMACOLOGY, V71, P192, DOI 10.1159/000078085; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; ARMSTRON.DM, 1973, BRAIN RES, V54, P365, DOI 10.1016/0006-8993(73)90062-0; ARMSTRONG DM, 1980, J PHYSIOL-LONDON, V309, P357, DOI 10.1113/jphysiol.1980.sp013513; ARMSTRONG DM, 1968, J PHYSIOL-LONDON, V194, P147, DOI 10.1113/jphysiol.1968.sp008399; Atkins MJ, 1997, J COMP NEUROL, V389, P249; Baker MR, 2001, J PHYSIOL-LONDON, V536, P825, DOI 10.1111/j.1469-7793.2001.00825.x; Bengtsson F, 2007, J NEUROPHYSIOL, V98, P1697, DOI 10.1152/jn.00057.2007; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRIHAYE J, 1964, Acta Chir Belg, V63, P299; Burghaus L, 2013, NEUROL SCI, V34, P671, DOI 10.1007/s10072-012-1102-1; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheron G, 2008, NEUROSCIENCE, V153, P1, DOI 10.1016/j.neuroscience.2008.01.074; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; Conti AC, 1998, J NEUROSCI, V18, P5663; Courtemanche R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00125; Culic M, 2005, ACTA NEUROBIOL EXP, V65, P11; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Diwakar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021928; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; ECCLES JC, 1967, EXP BRAIN RES, V3, P58; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P297, DOI 10.1113/jphysiol.1966.sp007825; Fossi S, 2006, NEUROPHYSIOL CLIN, V36, P195, DOI 10.1016/j.neucli.2006.09.001; Fukuda K., 1996, NEUROTRAUMA, V13, P255, DOI [10.1089/neu.1996.13.255, DOI 10.1089/NEU.1996.13.255]; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gross L, 2006, PLOS BIOL, V4, P680, DOI [10.1371/journal.pbio.0040427, 10.1371/journal.pbio.0040042, 10.1371/journal.pbio.0040371, 10.1371/journal.pbio.0040323, 10.1371/journal.pbio.0040048, 10.1371/journal.pbio.0040305, 10.1371/journal.pbio.0040074, 10.1371/journal.pbio.0040043, 10.1371/journal.pbio.0040311, 10.1371/journal.pbio.0040096, 10.1371/journal.pbio.0040191, 10.1371/journal.pbio.0040212]; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hartmann MJ, 1998, J NEUROPHYSIOL, V80, P1598, DOI 10.1152/jn.1998.80.3.1598; Hattori N, 2003, J NUCL MED, V44, P1709; ISHIKAWA K, 1995, J NEUROL SCI, V129, P179, DOI 10.1016/0022-510X(94)00279-W; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Jorntell H, 2000, J PHYSIOL-LONDON, V522, P297, DOI 10.1111/j.1469-7793.2000.00297.x; KUSHNER M, 1987, J NUCL MED, V28, P1667; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lang EJ, 2006, J PHYSIOL-LONDON, V573, P277, DOI 10.1113/jphysiol.2006.571101; LARSON B, 1969, J PHYSIOL-LONDON, V203, P611, DOI 10.1113/jphysiol.1969.sp008882; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Middleton SJ, 2008, NEURON, V58, P763, DOI 10.1016/j.neuron.2008.03.030; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Niimura K, 1999, NEUROLOGY, V52, P792, DOI 10.1212/WNL.52.4.792; Nishiyama H, 2007, NAT NEUROSCI, V10, P675, DOI 10.1038/nn0607-675; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Ordek G, 2013, J NEUROPHYSIOL, V109, P1435, DOI 10.1152/jn.00455.2012; Ordek G, 2012, IEEE ENG MED BIO, P835, DOI 10.1109/EMBC.2012.6346061; OSCARSSON O, 1968, J PHYSIOL-LONDON, V196, P453, DOI 10.1113/jphysiol.1968.sp008518; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Roggeri L, 2008, J NEUROSCI, V28, P6354, DOI 10.1523/JNEUROSCI.5709-07.2008; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Servais L, 2005, NEUROSCIENCE, V134, P1247, DOI 10.1016/j.neuroscience.2005.06.001; Servais L, 2004, NEUROSCI LETT, V367, P171, DOI 10.1016/j.neulet.2004.05.109; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42	65	8	8	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5137			FRONT SYST NEUROSCI	Front. Syst. Neurosci.		2014	8								197	10.3389/fnsys.2014.00197			12	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V19XW	WOS:000214852700195	25346664	Green Published, gold			2022-02-06	
J	Pal, CP; Kumar, B; Dinkar, KS; Singh, P; Kumar, H; Goyal, RK				Pal, Chandra Prakash; Kumar, Binod; Dinkar, Karuna Shankar; Singh, Pulkesh; Kumar, Harish; Goyal, R. K.			Fixation with cancellous screws and fibular strut grafts for neglected femoral neck fractures	JOURNAL OF ORTHOPAEDIC SURGERY			English	Article						bone screws; bone transplantation; femoral neck fractures	SUBTROCHANTERIC VALGUS OSTEOTOMY; NONUNION; HIP	Purpose. To review the outcomes of fixation with cancellous screws and fibular strut grafts for neglected femoral neck fractures. Methods. 44 men and 28 women aged 17 to 50 years with neglected femoral neck fractures of the subcapital (n=12), transcervical (n=57), or basal (n=3) types underwent closed (n=39) or open (n=33) reduction and fixation with a single cancellous screw with double fibular strut grafts (n=24) or fixation with double cancellous screws with a single fibular strut graft (n=48). The mean time from injury to surgery was 10 weeks; the delay was 22 to 35 days in 43 patients and >35 days in 29 patients. Double fibular strut grafts were used for 18 patients with longer delay and resorption of the femoral neck, and 18 patients with posterior comminution of the femoral neck. The outcome was assessed using the Harris hip score. Results. Patients were followed up for a mean of 3 years. The time to bone union was 3 to 4 months in 48 patients, 4 to 5 months in 15, and 5 to 6 months in 5; nonunion was noted in 4 patients. In 18 patients with resorption of the femoral neck, bone union took a longer time. The Harris hip score was excellent (90-100) in 30 patients, good (80-89) in 20, fair (70-79) in 15, and poor (<70) in 7. Of the latter, 4 had nonunion and 3 developed avascular necrosis of the femoral head; they had persistent pain and restriction of hip joint movement. Conclusion. Fixation with cancellous screws and fibular strut grafts for neglected femoral neck fractures is cost-effective and technically less demanding, and associated with good outcomes.	[Pal, Chandra Prakash; Dinkar, Karuna Shankar] SN Med Coll & Hosp, Dept Orthopaed, Agra 282002, Uttar Pradesh, India; [Singh, Pulkesh; Goyal, R. K.] UPRIMS&R, Dept Orthopaed, Saifai, India; [Kumar, Harish] Safdarjang Hosp, Dept Orthopaed, New Delhi, India		Pal, CP (corresponding author), SN Med Coll & Hosp, Dept Orthopaed, Agra 282002, Uttar Pradesh, India.	drcportho@gmail.com	of Chem Phy Sciences, InternationalJournal/C-5864-2016	of Chem Phy Sciences, InternationalJournal/0000-0003-4314-1308			Azam MQ, 2009, INDIAN J ORTHOP, V43, P62, DOI 10.4103/0019-5413.45325; Beris AE, 2004, ORTHOP CLIN N AM, V35, P335, DOI 10.1016/j.ocl.2004.02.008; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Hartford JM, 2005, J ORTHOP TRAUMA, V19, P329; HOU SM, 1993, CLIN ORTHOP RELAT R, P176; LeCroy CM, 2002, J ORTHOP TRAUMA, V16, P464, DOI 10.1097/00005131-200208000-00004; Mathews V, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000118700.22681.50; NAGI ON, 1986, J BONE JOINT SURG BR, V68, P387, DOI 10.1302/0301-620X.68B3.3733802; Wu CC, 1999, J TRAUMA, V46, P312, DOI 10.1097/00005373-199902000-00019; Yadav SS, 2005, INDIAN J ORTHOP, V39, P21	11	8	8	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2309-4990			J ORTHOP SURG-HONG K	J. Orthop. Surg.		2014	22	2					181	185		10.1177/230949901402200213			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AX0GL	WOS:000346631000013	25163951	gold			2022-02-06	
S	Powell, KL; Lukasiuk, K; O'Brien, TJ; Pitkanen, A		Scharfman, HE; Buckmaster, PS		Powell, Kim L.; Lukasiuk, Katarzyna; O'Brien, Terence J.; Pitkanen, Asla			Are Alterations in Transmitter Receptor and Ion Channel Expression Responsible for Epilepsies?	ISSUES IN CLINICAL EPILEPTOLOGY: A VIEW FROM THE BENCH	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	Workshop on Issues in Clinical Epileptology - A View from the Bench held in honor of Phil	MAY 03-05, 2013	Watsonville, CA			Genetic generalized epilepsy; Acquired epilepsy; Voltage-gated ion channels; Ligand-gated ion channels; Animal models of epilepsy	TEMPORAL-LOBE EPILEPSY; CHILDHOOD ABSENCE EPILEPSY; TRAUMATIC BRAIN-INJURY; METABOTROPIC GLUTAMATE RECEPTORS; GABA(A) RECEPTOR; RAT MODEL; SUBUNIT EXPRESSION; CALCIUM-CHANNEL; MOUSE MODEL; PACEMAKER CHANNELS	Neuronal voltage-gated ion channels and ligand-gated synaptic receptors play a critical role in maintaining the delicate balance between neuronal excitation and inhibition within neuronal networks in the brain. Changes in expression of voltage-gated ion channels, in particular sodium, hyperpolarization-activated cyclic nucleotide-gated (HCN) and calcium channels, and ligand-gated synaptic receptors, in particular GABA and glutamate receptors, have been reported in many types of both genetic and acquired epilepsies, in animal models and in humans. In this chapter we review these and discuss the potential pathogenic role they may play in the epilepsies.	[Powell, Kim L.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [Lukasiuk, Katarzyna] Polish Acad Sci, M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, FIN-70211 Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland		O'Brien, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, 4th Floor Clin Sci Bldg, Parkville, Vic 3050, Australia.	kpowell@unimelb.edu.au; k.lukasiuk@nencki.gov.pl; obrientj@unimelb.edu.au; asla.pitkanen@uef.fi	Lukasiuk, Katarzyna/F-4636-2010; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Lukasiuk, Katarzyna/0000-0002-1582-0920; Powell, Kim/0000-0002-9007-4614; O'Brien, Terence/0000-0002-7198-8621	Polish Ministry of Science and EducationMinistry of Science and Higher Education, Poland [DNP/N119/ESF-EuroEPINOMICS/2012]; Academy of FinlandAcademy of FinlandEuropean Commission; Sigrid Juselius FoundationSigrid Juselius Foundation; CURE	This work was supported by a Polish Ministry of Science and Education grant DNP/N119/ESF-EuroEPINOMICS/2012 to K.L. and the Academy of Finland, the Sigrid Juselius Foundation, CURE grant to A.P.	Aronica E, 2009, NEUROBIOL DIS, V36, P81, DOI 10.1016/j.nbd.2009.06.016; Aronica E, 2000, EUR J NEUROSCI, V12, P2333, DOI 10.1046/j.1460-9568.2000.00131.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Broicher T, 2008, MOL CELL NEUROSCI, V39, P384, DOI 10.1016/j.mcn.2008.07.012; Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005; Casillas-Espinosa PM, 2012, EPILEPSIA, V53, P41, DOI 10.1111/epi.12034; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Coenen AML, 2003, BEHAV GENET, V33, P635, DOI 10.1023/A:1026179013847; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cooper EC, 2012, JASPERS BASIC MECH E, P55; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; Dingledine R, 1999, PHARMACOL REV, V51, P7; Eid T, 2002, EUR J NEUROSCI, V15, P517, DOI 10.1046/j.0953-816x.2001.01887.x; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Frasca A, 2011, NEUROBIOL DIS, V43, P507, DOI 10.1016/j.nbd.2011.04.024; Fritschy JM, 1999, NEUROCHEM INT, V34, P435, DOI 10.1016/S0197-0186(99)00040-6; Furtinger S, 2003, NEUROSCI LETT, V352, P141, DOI 10.1016/j.neulet.2003.08.046; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gonzalez MI, 2011, NEUROSCI LETT, V497, P218, DOI 10.1016/j.neulet.2011.02.052; Gorter JA, 2002, EUR J NEUROSCI, V16, P360, DOI 10.1046/j.1460-9568.2002.02078.x; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Hargus NJ, 2011, NEUROBIOL DIS, V41, P361, DOI 10.1016/j.nbd.2010.10.004; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Heron SE, 2007, ANN NEUROL, V62, P560, DOI 10.1002/ana.21169; Kanyshkova T, 2012, NEUROBIOL DIS, V45, P450, DOI 10.1016/j.nbd.2011.08.032; Karimzadeh F, 2013, SYNAPSE, V67, P839, DOI 10.1002/syn.21687; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kennard JTT, 2011, NEUROBIOL DIS, V42, P48, DOI 10.1016/j.nbd.2011.01.003; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200; Kirschstein T, 2007, J NEUROSCI, V27, P7696, DOI 10.1523/JNEUROSCI.4572-06.2007; Klein JP, 2004, BRAIN RES, V1000, P102, DOI 10.1016/j.brainres.2003.11.051; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Kuisle M, 2006, J PHYSIOL-LONDON, V575, P83, DOI 10.1113/jphysiol.2006.110486; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Li JM, 2010, BRAIN RES, V1311, P166, DOI 10.1016/j.brainres.2009.11.024; Liang JM, 2006, NEUROSCI LETT, V406, P27, DOI 10.1016/j.neulet.2006.06.073; Lie AA, 2000, ANN NEUROL, V47, P26, DOI 10.1002/1531-8249(200001)47:1<26::AID-ANA7>3.3.CO;2-G; Liu XB, 2007, P NATL ACAD SCI USA, V104, P12512, DOI 10.1073/pnas.0705320104; Loup F, 2000, J NEUROSCI, V20, P5401, DOI 10.1523/JNEUROSCI.20-14-05401.2000; Lukasiuk K, 2006, PROG BRAIN RES, V158, P223, DOI 10.1016/S0079-6123(06)58011-2; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Mantegazza M, 2012, JASPERS BASIC MECH E, V4th, P41; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; MARESCAUX C, 1995, ITAL J NEUROL SCI, V16, P113, DOI 10.1007/BF02229083; Mathern GW, 1998, EPILEPSY RES, V32, P154, DOI 10.1016/S0920-1211(98)00048-5; Merlo D, 2007, NEUROBIOL DIS, V25, P631, DOI 10.1016/j.nbd.2006.11.005; Monaghan MM, 2008, NEUROSCIENCE, V156, P550, DOI 10.1016/j.neuroscience.2008.07.057; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Munoz A, 2002, J COMP NEUROL, V449, P166, DOI 10.1002/cne.10287; Ngomba RT, 2008, NEUROPHARMACOLOGY, V54, P344, DOI 10.1016/j.neuropharm.2007.10.004; Ngomba RT, 2011, NEUROPHARMACOLOGY, V60, P1281, DOI 10.1016/j.neuropharm.2011.01.007; Ngomba RT, 2011, EPILEPSIA, V52, P1211, DOI 10.1111/j.1528-1167.2011.03082.x; Otalora LFP, 2006, BRAIN RES, V1098, P170, DOI 10.1016/j.brainres.2006.04.124; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; Peloquin JB, 2006, EPILEPSIA, V47, P655, DOI 10.1111/j.1528-1167.2006.00482.x; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Penschuck S, 2005, MOL BRAIN RES, V141, P66, DOI 10.1016/j.molbrainres.2005.08.004; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Pinault Didier, 2005, Thalamus & Related Systems, V3, P181, DOI 10.1017/S1472928807000209; Pirker S, 2003, J NEUROPATH EXP NEUR, V62, P820, DOI 10.1093/jnen/62.8.820; Pisu MG, 2008, J NEUROCHEM, V106, P2502, DOI 10.1111/j.1471-4159.2008.05538.x; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Powell KL, 2014, BRIT J CLIN PHARMACO, V77, P729, DOI 10.1111/bcp.12205; Princivalle AP, 2003, EPILEPSY RES, V55, P39, DOI 10.1016/S0920-1211(03)00090-1; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Reid CA, 2012, BRIT J PHARMACOL, V165, P49, DOI 10.1111/j.1476-5381.2011.01507.x; Remy S, 2003, ANN NEUROL, V53, P469, DOI 10.1002/ana.10473; Rohde J, 2012, NEUROPHARMACOLOGY, V62, P1867, DOI 10.1016/j.neuropharm.2011.12.012; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Schwartzkroin Philip A, 2012, Handb Clin Neurol, V107, P13, DOI 10.1016/B978-0-444-52898-8.00002-1; Schwarzer C, 1997, NEUROSCIENCE, V80, P1001, DOI 10.1016/S0306-4522(97)00145-0; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Solomonia R, 2010, NEUROSCI LETT, V468, P277, DOI 10.1016/j.neulet.2009.11.012; Sperk G, 1998, EPILEPSY RES, V32, P129, DOI 10.1016/S0920-1211(98)00046-1; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; SPREAFICO R, 1993, EPILEPSY RES, V15, P229, DOI 10.1016/0920-1211(93)90060-K; Stewart LS, 2009, EPILEPSY BEHAV, V14, P577, DOI 10.1016/j.yebeh.2009.01.019; Straessle A, 2003, EUR J NEUROSCI, V18, P2213, DOI 10.1046/j.1460-9568.2003.02964.x; Strauss U, 2004, EUR J NEUROSCI, V19, P3048, DOI 10.1111/j.0953-816X.2004.03392.x; Su T, 2008, NEUROSCIENCE, V157, P566, DOI 10.1016/j.neuroscience.2008.09.027; Sun CS, 2007, J NEUROSCI, V27, P12641, DOI 10.1523/JNEUROSCI.4141-07.2007; Sun QJ, 2009, BEHAV BRAIN RES, V201, P292, DOI 10.1016/j.bbr.2009.02.027; Talley EM, 2000, MOL BRAIN RES, V75, P159, DOI 10.1016/S0169-328X(99)00307-1; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; Ulas J, 2000, GLIA, V30, P352, DOI 10.1002/(SICI)1098-1136(200006)30:4<352::AID-GLIA40>3.3.CO;2-Y; Ullal G, 2005, EPILEPSIA, V46, P616, DOI 10.1111/j.1528-1167.2005.49604.x; van de Bovenkamp-Janssen MC, 2006, EPILEPSY RES, V69, P119, DOI 10.1016/j.eplepsyres.2006.01.003; van Gassen KLI, 2009, EPILEPSIA, V50, P957, DOI 10.1111/j.1528-1167.2008.02015.x; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Wu Y, 2007, NEUROBIOL DIS, V26, P439, DOI 10.1016/j.nbd.2007.01.013; Yalcin O, 2012, SEIZURE-EUR J EPILEP, V21, P79, DOI 10.1016/j.seizure.2011.12.002; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	105	8	8	0	9	SPRINGER	DORDRECHT	PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0065-2598	2214-8019	978-94-017-8914-1; 978-94-017-8913-4	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2014	813						211	229		10.1007/978-94-017-8914-1_17			19	Medicine, Research & Experimental; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	BB7UO	WOS:000346021700019	25012379				2022-02-06	
J	Sharp, J; Azar, T; Lawson, D				Sharp, Jody; Azar, Toni; Lawson, David			Effects of a Complex Housing Environment on Heart Rate and Blood Pressure of Rats at Rest and after Stressful Challenges	JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; FEMALE SPRAGUE-DAWLEY; TRAUMATIC BRAIN-INJURY; COGNITIVE FUNCTION; COMMON PROCEDURES; CAGE ENRICHMENT; ADULT RATS; INTERVENTION; PERFORMANCE; RESPONSES	Housing enrichment for rodents continues to be a discussion topic within the animal care community. The objective of this study was to determine the extent to which a complex housing environment affects heart rate, blood pressure, and activity of rats when undisturbed and after exposure to stressful challenges and whether autonomic controls of heart rate would be affected. Male and female Sprague Dawley and Wistar rats with radiotelemetry transmitters were evaluated under nonenriched single-housing conditions and after acclimation to a complex environment of dim light and cohabitation with 3 conspecifics in large cages with hiding, food foraging, and nesting items. Telemetry data were collected when rats were undisturbed, after acute challenges (cage change, intraperitoneal injections, restraint), during a forced running protocol, and after cholinergic or adrenergic blockade. The complex environment reduced heart rate and increased activity in undisturbed rats but did not affect blood pressure. Heart rate responses to challenges were unaffected, decreased, or increased by complex housing, depending on the stock and sex of rats. Forced running was either unaffected or decreased, depending on the stock and sex of rats. Heart rate responses to cholinergic or beta 1-adrenergic blockade were not affected. We conclude that the complex housing did not reduce indices of stress (for example, heart rate) as compared with simpler housing. However, the possibility that some environmental elements interact negatively with each other must be considered in future studies.	[Sharp, Jody; Azar, Toni; Lawson, David] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA		Lawson, D (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.	dlawson@med.wayne.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RR13600]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR013600] Funding Source: NIH RePORTER	Supported by NIH grant RR13600.	Abou-Ismail UA, 2011, LAB ANIM-UK, V45, P145, DOI 10.1258/la.2011.010149; Azar T, 2011, J AM ASSOC LAB ANIM, V50, P175; Azar TA, 2008, J AM ASSOC LAB ANIM, V47, P25; Azar TA, 2012, J AM ASSOC LAB ANIM, V51, P339; Bell JA, 2009, DEV PSYCHOBIOL, V51, P564, DOI 10.1002/dev.20394; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; Brillaud E, 2005, BRAIN RES, V1054, P174, DOI 10.1016/j.brainres.2005.06.069; Chandler MP, 1998, AM J PHYSIOL-REG I, V274, pR510, DOI 10.1152/ajpregu.1998.274.2.R510; Del Arco A, 2007, BEHAV BRAIN RES, V176, P267, DOI 10.1016/j.bbr.2006.10.006; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Gelfo F, 2011, NEUROREHAB NEURAL RE, V25, P243, DOI 10.1177/1545968310380926; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; KLEIN SL, 1994, PHYSIOL BEHAV, V56, P291, DOI 10.1016/0031-9384(94)90197-X; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Koch LG, 1999, PHYSIOL GENOMICS, V1, P63, DOI 10.1152/physiolgenomics.1999.1.2.63; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Pamplona FA, 2009, PROG NEURO-PSYCHOPH, V33, P1153, DOI 10.1016/j.pnpbp.2009.06.012; Pang TYC, 2013, NEUROPHARMACOLOGY, V64, P515, DOI 10.1016/j.neuropharm.2012.06.029; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Saland SK, 2011, PHARMACOL BIOCHEM BE, V98, P455, DOI 10.1016/j.pbb.2011.02.014; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Sharp J, 2005, CONTEMP TOP LAB ANIM, V44, P32; Sharp J, 2003, CONTEMP TOP LAB ANIM, V42, P9; Sharp J, 2002, CONTEMP TOP LAB ANIM, V41, P8; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Swoap SJ, 2004, AM J PHYSIOL-REG I, V287, pR391, DOI 10.1152/ajpregu.00731.2003; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Woodcock EA, 2000, NEUROBIOL LEARN MEM, V73, P1, DOI 10.1006/nlme.1999.3911; Zaias J, 2008, J AM ASSOC LAB ANIM, V47, P30	33	8	8	0	12	AMER ASSOC LABORATORY ANIMAL SCIENCE	MEMPHIS	9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA	1559-6109			J AM ASSOC LAB ANIM	J. Amer. Assoc. Lab. Anim. Sci.	JAN	2014	53	1					52	60					9	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	283UO	WOS:000329272700008	24411780				2022-02-06	
J	Siegert, RJ; Jackson, DM; Playford, ED; Fleminger, S; Turner-Stokes, L				Siegert, Richard J.; Jackson, Diana M.; Playford, E. Diane; Fleminger, Simon; Turner-Stokes, Lynne			A longitudinal, multicentre, cohort study of community rehabilitation service delivery in long-term neurological conditions	BMJ OPEN			English	Article						Rehabilitation Medicine	TRAUMATIC BRAIN-INJURY; PARK DEPENDENCY SCALE; INTEGRATION QUESTIONNAIRE; CAREGIVER BURDEN; NEEDS-ASSESSMENT; FOLLOW-UP; NEUROREHABILITATION; DECISIONS; VALIDITY; STROKE	ObjectivesPart A: To pilot the use of a register to identify and monitor patients with complex needs arising from long-term neurological conditions. Part B: To determine the extent to which patients' needs for health and social services are met following discharge to the community after inpatient rehabilitation; to identify which factors predict unmet needs and to explore the relationship between service provision and outcomes at 12months. Design A multicentre, prospective, cohort study surveying participants at 1, 6 and 12months using postal/online questionnaires and telephone interview. Setting Consecutive discharges to the community from all nine tertiary, specialist, inpatient neurorehabilitation services in London over 18months in 2010-2011. Participants Of 576 admissions 428 patients were recruited at discharge: 256 responded at 4weeks, 212 at 6months and 190 at 12months. Measures Neurological Impairment Scale, The Needs and Provision Complexity Scale, The Northwick Park Dependency Scale, Community Integration Questionnaire, Zarit Burden Inventory. Results n=322 (75%) expressed willingness to be registered, but in practice less than half responded to questionnaires at 6 and 12months (49% and 44%, respectively), despite extensive efforts to contact them, with no significant differences between responders and non-responders. Significant unmet needs were identified within the first year following discharge, particularly in rehabilitation, social work support and provision of specialist equipment. Dependency for basic care and motor and cognitive impairment predicted services received, together accounting for 40% of the variance. Contra to expectation, patients whose rehabilitation needs were met were more dependent and less well integrated at 12months post discharge than those with unmet needs. Conclusions Registration is acceptable to most patients, but questionnaires/telephone interviews may not be the most efficient way to reach them. When community resources are limited, service provision tends to be focused on the most dependent patients. Registration The study was registered with the NIHR Comprehensive Local Research Network: ID number 7503	[Siegert, Richard J.] AUT Univ, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Siegert, Richard J.] AUT Univ, Sch Rehabil & Occupat Studies, Auckland, New Zealand; [Jackson, Diana M.; Turner-Stokes, Lynne] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Playford, E. Diane] UCL, Inst Neurol, London, England; [Fleminger, Simon] South London & Maudsley NHS Fdn Trust, London, England; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, London, England		Siegert, RJ (corresponding author), AUT Univ, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand.	richard.siegert@aut.ac.nz	Turner-Stokes, Lynne/F-4418-2012; Siegert, Richard J./K-2030-2019	Turner-Stokes, Lynne/0000-0002-3302-9462; Siegert, Richard/0000-0002-3074-0929; Playford, E Diane/0000-0001-7314-787X	National Institute for Health Research Health Services and Delivery Research (NIHR HSDR) programmeNational Institute for Health Research (NIHR) [08/1809/235]; Dunhill Medical TrustDunhill Medical Trust; Luff Foundation; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185, 08/1809/235] Funding Source: researchfish	This article presents independent research commissioned by the National Institute for Health Research Health Services and Delivery Research (NIHR HS&DR) programme (project number 08/1809/235). Please visit the HS&DR website for more information. Financial support for this article was also provided by the Dunhill Medical Trust and the Luff Foundation.	Altman IM, 2013, ARCH PHYS MED REHAB, V94, P1837, DOI 10.1016/j.apmr.2013.02.014; Barnes MP, 2001, J REHABIL MED, V33, P244; Barnes MP, 2003, COMMUNITY REHABILITA; Bartolo M, 2010, J REHABIL MED, V42, P818, DOI 10.2340/16501977-0612; British Society of Rehabilitation Medicine, 2010, SPEC NEUR SERV PROV; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; Department of Health, 2005, NAT SERV FRAM LONG T; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Gladman J, 2007, SPECIALIST REHABILIT; Harding KE, 2010, CLIN REHABIL, V24, P928, DOI 10.1177/0269215510370527; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Jackson D, 2011, SUPPORT LTNC CARERS; Jackson D, 2011, DO CARERS PEOPLE LON; Jackson D, 2011, ACQUIRED BRAIN INJUR; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Kendall E, 2011, J INTERPROF CARE, V25, P145, DOI 10.3109/13561820.2010.523651; Kendall E, 2000, DISABIL REHABIL, V22, P435, DOI 10.1080/09638280050045901; Kendall E, 2009, DISABIL REHABIL, V31, P2164, DOI 10.3109/09638280902939734; Koffman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075431; Nancarrow Susan, 2009, Qual Prim Care, V17, P323; Newton J, 2002, DIS REGISTERS ENGLAN; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Siegert RJ, 2010, J REHABIL MED, V42, P936, DOI 10.2340/16501977-0602; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Siegert RJ, 2013, EVALUATION COMMUNITY; Siegert RJ, 2014, CLIN REHABIL; Switzer GE, 2013, BLOOD, V121, P1469, DOI 10.1182/blood-2012-06-437343; Turner-Stokes L, 2005, CLIN MED, V5, P203, DOI 10.7861/clinmedicine.5-3-203; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; Turner-Stokes L, 2013, BMJ OPEN, V3; Turner-Stokes L, 2014, DISABIL REHABIL, V36, P23, DOI 10.3109/09638288.2013.775360; Turner-Stokes L, 2010, CLIN REHABIL, V24, P1112, DOI 10.1177/0269215510371432; Visser-Meily JMA, 2004, CLIN REHABIL, V18, P601, DOI 10.1191/0269215504cr776oa; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Williams R, 1998, BMJ-BRIT MED J, V316, P1379, DOI 10.1136/bmj.316.7141.1379; YOUNG J, 1994, BRIT MED J, V309, P1356, DOI 10.1136/bmj.309.6965.1356; Yu J, 2009, CLIN REHABIL, V23, P408, DOI 10.1177/0269215508091870; Zarit SH, 1990, BURDEN INTERVIEW GER	43	8	9	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2014	4	2								10.1136/bmjopen-2013-004231			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF1FF	WOS:000334459100062	24583762	Green Published, gold			2022-02-06	
J	Stiller, JW; Yu, SS; Brenner, LA; Langenberg, P; Scrofani, P; Pannella, P; Hsu, EB; Roberts, DW; Monsell, RMT; Binks, SW; Guzman, A; Postolache, TT				Stiller, John W.; Yu, Steven S.; Brenner, Lisa A.; Langenberg, Patricia; Scrofani, Phillip; Pannella, Patrick; Hsu, Edbert B.; Roberts, Darryl W.; Monsell, Ray M. T.; Binks, Sidney W., III; Guzman, Alvaro; Postolache, Teodor T.			Sparring and neurological function in professional boxers	FRONTIERS IN PUBLIC HEALTH			English	Article						chronic traumatic brain injury; boxing; cognitive; balance; cumulative sparring index		Despite increased interest regarding the potentially long-term negative impact of chronic traumatic brain injury, limited research has been conducted regarding such injuries and neurological outcomes in real world settings. To increase understanding regarding the relationship between sparring (e.g., training under the tutelage of an experienced boxing coach for the purpose of improving skills and/or fitness) and neurological functioning, professional boxers (n = 237) who competed in Maryland between 2003 and 2008 completed measures regarding sparring exposure (Cumulative Sparring Index, CSI) and performance on tests of cognition (Symbol Digit ModalitiesTest, SDMT) and balance (Sharpened Romberg Test, SRT). Measures were completed prior to boxing matches. Higher scores on the CSI (increased sparring exposure) were associated with poorer performance on both tests of cognition (SDMT) and balance (SRT). A threshold effect was noted regarding performance on the SDMT, with those reporting CSI values greater than about 150 experiencing a decline in cognition. A history of frequent and/or intense sparring may pose a significant risk for developing boxing associated neurological sequelae. Implementing administration of clinically meaningful tests before bouts, such as the CSI, SDMT, and/or the SRT, as well as documentation of results into the boxer's physicals or medical profiles may be an important step for improving boxing safety.	[Stiller, John W.; Scrofani, Phillip; Binks, Sidney W., III] St Elizabeth Hosp, Dept Behav Hlth, Washington, DC USA; [Stiller, John W.; Pannella, Patrick] Maryland State Athlet Commiss, Baltimore, MD USA; [Stiller, John W.; Guzman, Alvaro; Postolache, Teodor T.] Univ Maryland, Sch Med, Dept Psychiat, Mood & Anxiety Program, Baltimore, MD 21201 USA; [Stiller, John W.; Postolache, Teodor T.] Inst Sports Chronobiol, Washington, DC USA; [Yu, Steven S.] Univ Southern Calif, Dept Med, Los Angeles, CA USA; [Brenner, Lisa A.; Postolache, Teodor T.] Mental Illness Res Educ & Clin Ctr, Vet Integrated Serv Network 19, 1055 Clermont St, Denver, CO 80220 USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Aurora, CO USA; [Langenberg, Patricia] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Scrofani, Phillip] Inst Psychol Sci, Arlington, VA USA; [Hsu, Edbert B.] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD USA; [Roberts, Darryl W.] Econometrica Inc, Bethesda, MD USA; [Monsell, Ray M. T.] St Julians Med Ctr, Newport, Shrops, England; [Postolache, Teodor T.] Tuning Inc, Silver Spring, MD USA		Brenner, LA (corresponding author), Mental Illness Res Educ & Clin Ctr, Vet Integrated Serv Network 19, 1055 Clermont St, Denver, CO 80220 USA.	lisa.brenner@va.gov		Postolache, Teodor/0000-0001-6056-4244	University of Maryland	We thank the boxers who participated in the study for making this research possible. We also thank Alex Ramos and Jacquie Richardson of the Retired Boxers Foundation for encouragement in conducting this study. We acknowledge Drs. David Joseph, Aamar Sleemi, and Rajeev Sharma for general support, George Peterson and Emanuel Steward for advice and setting a standard of safety for trainers, Margaret Goodman, MD for advice on medical issues in boxing, and Drs. Laggah and Savchenko for help with recruitment and Joan Pierce and Dr. Smick for continuing recruiting efforts. Many thanks Drs. Daniel Weinberger and Joel Kleinman, Lieber Institute for Brain Development, who commented on conceptual issues, Mr. Bruce Spizler for legal advice and advice on consent procedures, and colleagues of the Association of Ringside Physicians where data were presented on an almost yearly basis. Tuning, Inc., and intramural funds from the University of Maryland supported Dr. Postolache's contribution. The editing by Chantelle Walsh and Ciera Damon is greatly appreciated, as was the assistance with formatting provided by Elizabeth Spitzer, Hassaan Yousufi, and Kelly Stearns.	Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dau N, 2006, ANN C AM SOC BIOM BL; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; FREGLY AR, 1968, AEROSPACE MED, V39, P277; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Ghaffar O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047206; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; Kansagara D., 2013, COMPLICATIONS MILD T; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	27	8	9	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health		2014	2								69	10.3389/fpubh.2014.00069			6	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	VI6AZ	WOS:000498911400067	25101253	Green Published, gold			2022-02-06	
J	Suchy, Y; Euler, M; Eastvold, A				Suchy, Yana; Euler, Matthew; Eastvold, Angela			Exaggerated reaction to novelty as a subclinical consequence of mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; electronic tests; motor planning; neuropsychological assessment; novelty effect; push-turn-taptap task	SUBJECTIVE COGNITIVE COMPLAINTS; SCALE-ELECTRONIC VERSION; TURN-TAPTAP TASK; NEUROPSYCHOLOGICAL ASSESSMENT; ALZHEIMERS-DISEASE; HEAD-INJURY; IMPAIRMENT; MEMORY; MANAGEMENT; ATTENTION	Objectives: To evaluate exaggerated reaction to novelty as a behavioural marker of sub-clinical cognitive dysfunction in individuals with a history of mild traumatic brain injury (mTBI). Background and hypothesis: A sub-set of individuals who sustain mTBIs report persistent cognitive difficulties despite normal performance on traditional neuropsychological measures. Evidence of subtle neuroimaging abnormalities following mTBI lends support to such subjective complaints. However, behavioural evidence is limited. This study examined whether behavioural response to task novelty (`novelty effect' or NE) is exaggerated in mTBI (NE has previously successfully identified pre-clinical cognitive decline among older adults). It was hypothesized that individuals with a history of mTBI would exhibit increased NE relative to controls, despite normal performance on traditional neuropsychological measures. Methods: Thirty-eight male criminal offenders completed semi-structured interviews of their mTBI and other history, conventional neuropsychological testing and a computerized motor planning task that quantified NE. Results: As expected, participants with a history of mTBI exhibited significantly greater NE, despite no group differences in traditional neuropsychological test performance. A greater number of injuries was positively related to NE magnitude and unrelated to traditional measures. Conclusions: Increased NE indexes sub-clinical sequelae of mTBI and may represent a general marker of mild neurological dysfunction.	[Suchy, Yana; Euler, Matthew] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Suchy, Yana] Univ Utah, Utah Brain Inst, Salt Lake City, UT 84112 USA; [Suchy, Yana] Univ Utah, Ctr Aging, Salt Lake City, UT 84112 USA; [Eastvold, Angela] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA		Suchy, Y (corresponding author), Univ Utah, Dept Psychol, 380 S 1530 E,Rm 502, Salt Lake City, UT 84112 USA.	yana.suchy@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			Anderson SW, 2012, J CLIN EXP NEUROPSYC, V34, P895, DOI 10.1080/13803395.2011.630654; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Barr W. B., 2007, NYS PSYCHOL, V19, P24; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bishop CL, 2003, CLIN NEUROPSYCHOL, V17, P468, DOI 10.1076/clin.17.4.468.27944; Bosch B, 2010, CORTEX, V46, P451, DOI 10.1016/j.cortex.2009.05.006; Braun M, 2011, COGN BEHAV NEUROL, V24, P107, DOI 10.1097/WNN.0b013e3182351289; Brovelli A, 2008, CEREB CORTEX, V18, P1485, DOI 10.1093/cercor/bhm198; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Eastvold A, 2011, J INT NEUROPSYCH SOC, V17, P295, DOI 10.1017/S1355617710001669; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fields JA, 2011, NAT REV NEUROL, V7, P677, DOI 10.1038/nrneurol.2011.173; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jones-Gotman M, 2010, EPILEPSY BEHAV, V18, P3, DOI 10.1016/j.yebeh.2010.02.019; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraybill ML, 2013, CLIN NEUROPSYCHOL, V27, P238, DOI 10.1080/13854046.2012.735702; Kraybill ML, 2011, CLIN NEUROPSYCHOL, V25, P210, DOI 10.1080/13854046.2010.542489; Lenzi D, 2011, NEUROBIOL AGING, V32, P1542, DOI 10.1016/j.neurobiolaging.2009.09.006; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miller E, 1999, J FORENSIC PSYCHIATR, V10, P157, DOI 10.1080/09585189908402146; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pillon B, 2002, MOVEMENT DISORD, V17, pS116, DOI 10.1002/mds.10152; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stricker NH, 2010, J INT NEUROPSYCH SOC, V16, P813, DOI 10.1017/S1355617710000652; Suchy Y, 2005, CLIN NEUROPSYCHOL, V19, P4, DOI 10.1080/13854040490888585; Suchy Y, 2007, J CLIN EXP NEUROPSYC, V29, P648, DOI 10.1080/13803390600910506; Suchy Y, 2007, BRAIN INJURY, V21, P69, DOI 10.1080/02699050601149088; Suchy Y, 2011, J INT NEUROPSYCH SOC, V17, P101, DOI 10.1017/S135561771000130X; Suchy Y, 2010, J INT NEUROPSYCH SOC, V16, P26, DOI 10.1017/S1355617709990804; Suchy Y, 2009, J INT NEUROPSYCH SOC, V15, P248, DOI 10.1017/S1355617709090353; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weimer DL, 2009, ALZHEIMERS DEMENT, V5, P215, DOI 10.1016/j.jalz.2009.01.028; Wright DL, 2004, J MOTOR BEHAV, V36, P39, DOI 10.3200/JMBR.36.1.39-50; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; ZACHARY RA, 1985, J CLIN PSYCHOL, V41, P820, DOI 10.1002/1097-4679(198511)41:6<820::AID-JCLP2270410616>3.0.CO;2-X	67	8	8	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					972	979		10.3109/02699052.2014.888766			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600012	24654574				2022-02-06	
J	Wang, YJ; Hsu, YW; Chang, CM; Wu, CC; Ou, JC; Tsai, YR; Chiu, WT; Chang, WC; Chiang, YH; Chen, KY				Wang, Yu-Jia; Hsu, Yu-Wen; Chang, Che-Mai; Wu, Chung-Che; Ou, Ju-Chi; Tsai, Yan-Rou; Chiu, Wen-Ta; Chang, Wei-Chiao; Chiang, Yung-Hsiao; Chen, Kai-Yun			The Influence of BMX Gene Polymorphisms on Clinical Symptoms after Mild Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							POST-CONCUSSION SYMPTOMS; EARLY PREDICTORS; ASSOCIATION; ETK/BMX; BIOMARKERS; INVENTORY; PROGNOSIS; CANCER	Mild traumatic brain injury (mTBI) is one of the most common neurological disorders. Most patients diagnosed with mTBI could fully recover, but 15% of patients suffer from persistent symptoms. In recent studies, genetic factors were found to be associated with recovery and clinical outcomes after TBI. In addition, results from our previous research have demonstrated that the bone marrow tyrosine kinase gene in chromosome X (BMX), a member of the Tec family of kinases, is highly expressed in rats with TBI. Therefore, our aim in this study was to identify the association between genetic polymorphisms of BMX and clinical symptoms following mTBI. Four tagging single nucleotide polymorphisms (tSNPs) of BMX with minimum allele frequency (MAF) > 1% were selected from the HapMap Han Chinese database. Among these polymorphisms, rs16979956 was found to be associated with the Beck anxiety inventory (BAI) and dizziness handicap inventory (DHI) scores within the first week after head injury. Additionally, another SNP, rs35697037, showed a significant correlation with dizziness symptoms. These findings suggested that polymorphisms of the BMX gene could be a potential predictor of clinical symptoms following mTBI.	[Wang, Yu-Jia; Tsai, Yan-Rou; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, Taipei 11031, Taiwan; [Wang, Yu-Jia; Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei 11696, Taiwan; [Hsu, Yu-Wen; Chang, Che-Mai; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei 11031, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 11031, Taiwan; [Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei City 23561, Taiwan; [Chiu, Wen-Ta] Minist Hlth & Welf, Taipei 10341, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei 11031, Taiwan; [Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 11031, Taiwan		Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, Taipei 11031, Taiwan.	chenkathryn@hotmail.com		Chang, Che-Mai/0000-0002-0353-9744; Chang, Wei-Chiao/0000-0002-8573-5924	Center of Excellence for Clinical Trial and Research in Neuroscience [DOH 101-TD-B-111-003]; National Science Council Grant [NSC 98-2321-B-038- 003-MY3, NSC 102-2314-B-038-023-MY3]	This study was supported by the Center of Excellence for Clinical Trial and Research in Neuroscience DOH 101-TD-B-111-003 and National Science Council Grant NSC 98-2321-B-038- 003-MY3, NSC 102-2314-B-038-023-MY3.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chen KY, 2012, CELL TRANSPLANT, V21, P345, DOI 10.3727/096368911X582741; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jasielska M, 2010, INVEST OPHTH VIS SCI, V51, P3874, DOI 10.1167/iovs.09-5003; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palmer C. D., BLOOD, V111; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029; Wu JCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039226; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	37	8	8	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								293687	10.1155/2014/293687			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AG2FX	WOS:000335232800001	24860816	Green Published, gold, Green Submitted			2022-02-06	
J	Wee, HY; Kuo, JR				Wee, Hsiao-Yue; Kuo, Jinn-Rung			Never neglect the atmospheric pressure effect on a brain with a skull defect	INTERNATIONAL MEDICAL CASE REPORTS JOURNAL			English	Article						traumatic brain injury; decompressive craniectomy; hydrocephalus; cranioplasty		Herein, we report an unusual case of a patient who presented with a severe, sinking skin flap after a decompressive craniectomy and ventriculoperitoneal shunt surgery due to a traumatic brain injury. After cranioplasty, the patient's neurological deficiency improved and was confirmed by transcranial Doppler sonography. In addition to discussing the pathogenesis of the sinking skin flap, we emphasize the importance of cranioplasty for neurological improvement and remind the surgeon to "never neglect the atmospheric pressure effect on a brain with a skull defect".	[Wee, Hsiao-Yue; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan 710, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan 710, Taiwan.	kuojinnrung@gmail.com					CARVI Y, 2006, NEUROL RES, V28, P139, DOI DOI 10.1179/016164106X98008; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; Kelley GR, 2004, NEUROLOGY, V62, P157, DOI 10.1212/WNL.62.1.157; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Schaller B, 2005, J TRAUMA, V59, P1521, DOI 10.1097/01.ta.0000197402.20180.6b; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Yamamura A, 1997, NO SHINKEI GEKA, V5, P345	11	8	9	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-142X			INT MED CASE REP J	INT. MED. CASE REP. J.		2014	7						67	69		10.2147/IMCRJ.S59410			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V26PR	WOS:000215304600015	24741332	Green Published, gold, Green Submitted			2022-02-06	
J	Wiltshire, GE; Ehrlich, C				Wiltshire, Gilly-Elle; Ehrlich, Carolyn			Is conversation partner training effective in assisting individuals with a traumatic brain injury to display improved communication outcomes	JOURNAL OF SOCIAL INCLUSION			English	Article						Traumatic brain injury; conversation partner training; rehabilitation; measurement tool	PEOPLE; REHABILITATION; ABILITIES; DISCOURSE; IMPACT; DEFICITS; APHASIA; RETURN; WORK; TBI	Background: People who experience Traumatic Brain Injury (TBI) often exhibit a range of communication difficulties following their injury. Conversation is a vital component of communication that can have wide-ranging effects on social and vocational roles. Conversation ability is often negatively affected by a brain injury. It has been suggested that training the conversation partners of people with TBI can be effective in improving communication outcomes, therefore, positively affecting quality of life. This is the first systematic review investigating the efficacy and effectiveness of conversation partner training with this population. Method: After appropriate search terms were chosen, Medline, Psychinfo, CINAHL and Speechbite databases were searched to find appropriate articles for inclusion in the review. Papers underwent a three step screening process (title, abstract and full text) to be included in the study. Data were extracted and summarised. Results: Although only four studies were included in the final review, all showed positive effects of training in relation to a range of conversation partners for people with TBI, including family, carers and shop assistants. Training programs varied in method and outcome measures, but all provided support for the inclusion of communication partner training in TBI rehabilitation. Conclusion: Conversation partner training can be an effective intervention for people with TBI. More studies with larger sample sizes would add strength to conclusions and provide more informed basis for clinical practice. Recommendations for future research and practice are provided.	[Wiltshire, Gilly-Elle; Ehrlich, Carolyn] Griffith Univ, CONROD, Nathan, Qld, Australia		Wiltshire, GE (corresponding author), Griffith Univ, CONROD, Nathan, Qld, Australia.						Access Economics , 2009, EC COST SPIN CORD IN; Armstrong E., 2006, BRAIN IMPAIR, V7, P175, DOI DOI 10.1375/BRIM.7.3.175; Australian Institute of Health and Welfare (AIHW), 2007, BULLETIN, V55; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Chan J., 2009, AUSTR E J ADV MENTAL, V8; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Durham C., 2014, UNLOCKING MY BRAIN L; Goldblum G, 2009, APHASIOLOGY, V23, P87, DOI 10.1080/02687030802024094; Granlund M, 2008, AUGMENT ALTERN COMM, V24, P207, DOI 10.1080/08990220802387935; Grant JS, 2006, ARCH PHYS MED REHAB, V87, P343, DOI 10.1016/j.apmr.2005.09.019; Hepburn KW, 2001, J AM GERIATR SOC, V49, P450, DOI 10.1046/j.1532-5415.2001.49090.x; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McCarthy JW, 2010, AUGMENT ALTERN COMM, V26, P61, DOI 10.3109/07434618.2010.481562; Moran CA, 2006, BRAIN INJURY, V20, P417, DOI 10.1080/02699050500488223; Muenchberger H, 2011, J PRIM CARE COMMUNIT, V2, P60, DOI 10.1177/2150131910383578; Rietdijk R., J REHABILIT IN PRESS; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L., 2014, INQUIRY PREVALENCE D; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Wallace T, 2011, NEUROREHABILITATION, V28, P199, DOI 10.3233/NRE-2011-0649; WELCHWEST P, 2007, COMMUNICATION DEFICI; Wilkinson R, 2010, APHASIOLOGY, V24, P869, DOI 10.1080/02687030903501958; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]	43	8	8	0	1	GRIFFITH UNIV, SCH HUMAN SERVICES & SOCIAL WORK	MEADOWBROOK	RM 2 32, ACADEMIC 1-L05, LOGAN CAMPUS, UNIVERSITY DR, MEADOWBROOK, QLD 4131, AUSTRALIA	1836-8808			J SOC INCL	J. Soc. Incl.		2014	5	2					9	26		10.36251/josi.73			18	Social Issues	Emerging Sources Citation Index (ESCI)	Social Issues	V08OF	WOS:000214084000002		Green Published, Green Submitted, gold			2022-02-06	
J	Yadav, NK; Ciuffreda, KJ				Yadav, Naveen K.; Ciuffreda, Kenneth J.			Effect of binasal occlusion (BNO) and base-in prisms on the visual-evoked potential (VEP) in mild traumatic brain injury (mTBI)	BRAIN INJURY			English	Article						Base-in prism; binasal occlusion (BNO); mild traumatic brain injury (mTBI); objective mTBI biomarker; visual-evoked potential amplitude; visual-evoked potential latency; visual motion sensitivity (VMS)	REHABILITATION; MOTION; FIXATION; PROTOCOL; TBI	Purpose: To assess quantitatively the effect and relative contribution of binasal occlusion (BNO) and base-in prisms (BI) on visually-evoked potential (VEP) responsivity in persons with mild traumatic brain injury (mTBI) and the symptom of visual motion sensitivity (VMS), as well as in visually-normal (VN) individuals. Research design and methods: Subjects were comprised of 20 VN adults and 15 adults with mTBI and VMS. There were four test conditions: (1) conventional pattern VEP, which served as the baseline comparison condition; (2) VEP with BNO alone; (3) VEP with 2 pd BI prisms before each eye; and (4) VEP with the above BNO and BI prism combination. Results: In mTBI, the mean VEP amplitude increased significantly in nearly all subjects (similar to 90%) with BNO alone. In contrast, in VN, it decreased significantly with BNO alone in all subjects (100%), as compared to the other test conditions. These objective findings were consistent with improvements in visual impressions and sensorimotor tasks in the group with mTBI. Latency remained within normal limits under all test conditions in both groups. Conclusions: Only the BNO condition demonstrated significant, but opposite and consistent, directional effects on the VEP amplitude in both groups. The BNO-VEP test condition may be used clinically for the objectively-based, differential diagnosis of persons suspected of having mTBI and VMS from the VNs.	[Yadav, Naveen K.; Ciuffreda, Kenneth J.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Yadav, NK (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	nyadav@sunyopt.edu					Abdi Herve., 2010, ENCY RES DESIGN, V1, P169; [Anonymous], 2006, J CLIN NEUROPHYSIOL, V23, P107, DOI DOI 10.1097/00004691-200604000-00006; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2012, OPTOMETRY, V83, P10; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda KJ, 1999, CLIN EYE VIS CARE, V11, P41, DOI DOI 10.1016/S0953-4431(99)00010-7; Ciuffreda KJ, 2009, OPTOMETRY VISION DEV, V6, P16; Faul M, 2010, TRAUMATIC BRAIN INJU; Gallop S, 1998, J BEHAV OPTOM, V9, P31; Gibson JJ., 1950, PERCEPTION VISUAL WO; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; HERAVIANSHANDIZ J, 1993, OPHTHAL PHYSL OPT, V13, P295, DOI 10.1111/j.1475-1313.1993.tb00472.x; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Hudac CM, 2012, EYE BRAIN, V4, P1, DOI 10.2147/EB.S27290; JAMPOLSKY A, 1955, ARCH OPHTHALMOL-CHIC, V54, P683; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KAUFMAN LLOYD, 1963, VISION RES, V3, P401, DOI 10.1016/0042-6989(63)90092-0; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Li CSR, 2002, PROG NEURO-PSYCHOPH, V26, P929, DOI 10.1016/S0278-5846(02)00207-5; Marr AL, 2004, CENTRAL NERVOUS SYST, P20; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Padula WV, 2012, NEUROVISUAL PROCESSI, P67; Padula WV, 1988, BEHAV VISION APPROAC, P167; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Proctor A, 1974, OPTOMETRY VISION DEV, V40, P45; READING RW, 1983, BINOCULAR VISION FDN; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; Shushtarian SM, 2009, IFMBE PROC, V22, P2640; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Tello C, 2010, DOC OPHTHALMOL, V120, P219, DOI 10.1007/s10633-010-9216-3; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Winkler PA, 2009, OPTOMETRY, V80, P502, DOI 10.1016/j.optm.2009.01.014; Yadav NK, 2014, BRAIN INJURY, V28, P922, DOI 10.3109/02699052.2014.887227; Yadav NK, 2013, BRAIN INJURY, V27, P1631, DOI 10.3109/02699052.2013.844856; Yadav NK, 2012, DOC OPHTHALMOL, V124, P177, DOI 10.1007/s10633-012-9319-0	47	8	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1568	1580		10.3109/02699052.2014.939718			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700008	25058498				2022-02-06	
J	Zaninotto, AL; Guirado, VMD; Baldivia, B; Nunes, MD; Amorim, RLO; Teixeira, MJ; de Lucia, MCS; de Andrade, AF; Paiva, WS				Zaninotto, Ana Luiza; de Paula Guirado, Vinicius Monteiro; Baldivia, Beatriz; Nunes, Monica Domiano; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Souza de Lucia, Mara Cristina; de Andrade, Almir Ferreira; Paiva, Wellingson Silva			Improvement of verbal fluency in patients with diffuse brain injury over time	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						traumatic brain injury; neuropsychological tests; diffuse axonal injury; prognosis; executive function	COMPONENT ANALYSIS; HEALTHY-ADULTS; NORMATIVE DATA; PERFORMANCE; MODERATE; LESIONS; TASKS; DISEASE; SCORES	Background: Diffuse axonal injury (DAI), a common cause of neurological sequelae in patients with traumatic brain injury (TBI), is considered one of the most prevalent forms of primary neuronal injury in patients with severe TBI. Cognitive deficits induced by DAI can persist over time, especially following moderate or severe injuries. The aim of the present study was to compare verbal fluency (VF) performance at 6 and 12 months after the trauma in a same group of patients with DAI. Methods: Eighteen patients with moderate to severe DAI and 17 healthy volunteers were enrolled. All DAI participants had sustained a TBI at least 6 months prior to the start of the study, were between 18 and 50 years of age, and had at least 4 years of education. The VF test was administered within an extensive neuropsychological test battery. We evaluated the same patients at 6 months (DAI1 group) and 12 months (DAI2 group) and compared the results of neuropsychological tests with a control group of healthy volunteers who were matched to patients for sex, age, and educational level. Results: In comparison to controls, the DAI1 group produced significantly fewer words. The DAI2 group produced significantly more semantic words than DAI1 (P<0.05) and demonstrated a trend towards the production of more clusters for letter A (P=0.09) and total words generated in a phonemic test (P=0.09). No significant differences were observed between DAI2 and the control group in the total number of words generated in phonetic FAS or semantic fluency scores. Conclusion: The present findings may be useful in the construction of a management plan for long-term TBI rehabilitation that considers the trauma of each patient. Further, our results suggest the VF test is a suitable instrument for the assessment of cognitive difficulties following TBI.	[Zaninotto, Ana Luiza; Baldivia, Beatriz; Nunes, Monica Domiano; Souza de Lucia, Mara Cristina] Univ Sao Paulo, Sch Med, Div Psychol, Hosp Clin, BR-05410000 Sao Paulo, Brazil; [de Paula Guirado, Vinicius Monteiro; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; de Andrade, Almir Ferreira; Paiva, Wellingson Silva] Univ Sao Paulo, Sch Med, Div Neurosurg, BR-05410000 Sao Paulo, Brazil		Paiva, WS (corresponding author), Univ Sao Paulo, Sch Med, 470 Alves Guimaraes St,Ap 93, BR-05410000 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013; Amorim, Robson/AAK-1368-2021; Zaninotto, Ana Luiza C./I-4095-2016	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519; Zaninotto, Ana Luiza C./0000-0003-0639-0612			Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; de Andrade AF, 2011, ARQ NEURO-PSIQUIAT, V69, P79, DOI 10.1590/S0004-282X2011000100016; de Andrade AF, 2009, REV ASSOC MED BRAS, V55, P75, DOI 10.1590/S0104-42302009000100020; De Capitani EM, 2005, CLIN TOXICOL, V43, P287, DOI 10.1081/CLT-200058934; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Rich JB, 1999, NEUROPSYCHOLOGY, V13, P525, DOI 10.1037/0894-4105.13.4.525; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Troster AI, 1998, NEUROPSYCHOLOGIA, V36, P295, DOI 10.1016/S0028-3932(97)00153-X; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	26	8	9	0	6	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2014	10						1155	1160		10.2147/NDT.S62728			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	AK4YE	WOS:000338429700001	25028551	Green Published, Green Submitted, gold			2022-02-06	
J	Zhang, XY; Gu, CG; Gu, JW; Zhang, JH; Zhu, H; Zhang, YC; Cheng, JM; Li, YM; Yang, T				Zhang, X. -Y.; Gu, C. -G.; Gu, J. -W.; Zhang, J. -H.; Zhu, H.; Zhang, Y. -C.; Cheng, J. -M.; Li, Y. -M.; Yang, T.			Analysis of key genes and modules during the courses of traumatic brain injury with microarray technology	GENETICS AND MOLECULAR RESEARCH			English	Article						Traumatic brain injury; Time series; Risk genes; Network modules	CARCINOGENESIS IN-VIVO; CONSTITUTIVE ACTIVATION; EXPRESSION DATA; SCAR FORMATION; APOPTOSIS; CELLS; INHIBITION; RECEPTORS; NETWORKS; NEUROPROTECTION	Gene expression data acquired at different times after traumatic brain injury (TBI) were analyzed to identify differentially expressed genes (DEGs). Interaction network analysis and functional enrichment analysis were performed to extract valuable information, which may benefit diagnosis and treatment of TBI. Microarray data were downloaded from Gene Expression Omnibus and pre-treated with MATLAB. DEGs were screened out with the SAM method. Interaction networks of the DEGs were established, followed by module analysis and functional enrichment analysis to obtain insight into the molecular mechanisms. A total of 39 samples at six time points (30 min, 4, 8, 24, 72 h, and 21 days) were analyzed and generated 377 DEGs. Eight modules were identified from the networks and network ontology analysis revealed that cell surface receptor-linked signaling pathway, response to wounding and signaling pathway were significantly overrepresented. Altered risk genes and modules in TBI were uncovered through comparing the gene expression data acquired at various time points. These genes or modules could be potential biomarkers for diagnosis and treatment of TBI.	[Zhang, X. -Y.; Zhang, J. -H.; Zhu, H.; Zhang, Y. -C.; Cheng, J. -M.; Li, Y. -M.; Yang, T.] ChengDu Mil Gen Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Gu, C. -G.] 452 Hosp PLA, Clin Lab Dept, Chengdu, Sichuan, Peoples R China; [Gu, J. -W.] Air Force Gen Hosp PLA, Dept Neurosurg, Beijing, Peoples R China		Gu, JW (corresponding author), Air Force Gen Hosp PLA, Dept Neurosurg, Beijing, Peoples R China.	jian-wengu@hotmail.com		Li, Yunming/0000-0001-6363-4869	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC: 81000859]	Research supported by the National Natural Science Foundation of China (NSFC: 81000859).	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bhardwaj A, 2000, AM J PHYSIOL-HEART C, V279, pH1616, DOI 10.1152/ajpheart.2000.279.4.H1616; Bing M, 2006, J IMMUNOL, V176, P4968; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; Costa IG, 2005, BIOINFORMATICS, V21, P2544, DOI 10.1093/bioinformatics/bti311; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Galasso JM, 1998, AM J PATHOL, V153, P1631, DOI 10.1016/S0002-9440(10)65752-5; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Kunigal S, 2009, INT J ONCOL, V34, P1209, DOI 10.3892/ijo_00000249; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Liang QC, 2009, CANCER LETT, V273, P164, DOI 10.1016/j.canlet.2008.08.011; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McPherson RJ, 2007, GROWTH HORM IGF RES, V17, P424, DOI 10.1016/j.ghir.2007.05.006; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Mora LB, 2002, CANCER RES, V62, P6659; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang JG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr251; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Xi SC, 2003, CANCER RES, V63, P6763; Zhou BY, 2010, P NATL ACAD SCI USA, V107, P9923, DOI 10.1073/pnas.1002757107	44	8	8	1	4	FUNPEC-EDITORA	RIBEIRAO PRETO	RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL	1676-5680			GENET MOL RES	Genet. Mol. Res.		2014	13	4					9220	9228		10.4238/2014.November.7.9			9	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	AT7LX	WOS:000345119600042	25501144	Bronze			2022-02-06	
J	Covassin, T; Elbin, RJ; Crutcher, B; Burkhart, S; Kontos, A				Covassin, Tracey; Elbin, R. J.; Crutcher, Bryan; Burkhart, Scott; Kontos, Anthony			The Relationship Between Coping, Neurocognitive Performance, and Concussion Symptoms in High School and Collegiate Athletes	SPORT PSYCHOLOGIST			English	Article						ImPACT; Brief Cope; sport injury; approach; avoidance	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; EMOTIONAL RESPONSE; BRIEF-COPE; SPORT; RECOVERY; REHABILITATION; AVOIDANCE; STRESS	The present study explored the relationship of neurocognitive performance and symptoms to coping responses at 3 and 8 days postconcussion. A total of 104 concussed athletes (M = 16.41, SD = 2.19 years) completed the Immediate Post Concussion Assessment Cognitive Testing (ImPACT) at baseline and the ImPACT and Brief Cope inventory at 3 and 8 days postconcussion. Concussed athletes reported more frequent use of self-distraction, behavioral disengagement, religion, and self-blame 3 days postconcussion compared with 8 days. Concussed athletes reported more use of avoidance coping at 3 days than 8 days (Wilks's Lambda =.95, F [1, 100] =4.71, p =.032, eta(2)=.046) post-injury. Total symptoms were also a significant (p =.001) predictor of avoidance coping 3 days postconcussion and decreased visual memory was associated with increased avoidance coping (p =.03) 8 days post-injury. Time since injury likely impacts neurocognitive perfoimance, symptomology, and coping. Clinicians should be aware of higher reported symptoms early and lingering visual memory deficits 1-week post-injury.	[Covassin, Tracey; Crutcher, Bryan] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Burkhart, Scott; Kontos, Anthony] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA.			Kontos, Anthony/0000-0002-3749-4310			Anshel M, 1996, J SOC PSYCHOL, V136, P311, DOI 10.1080/00224545.1996.9714010; Anshel M. H., 2001, Journal of Sport Behavior, V24, P128; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Carson F, 2010, SCAND J MED SCI SPOR, V20, P235, DOI 10.1111/j.1600-0838.2009.00890.x; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; Garcia C, 2010, J NURS SCHOLARSHIP, V42, P166, DOI 10.1111/j.1547-5069.2009.01327.x; Gould D, 1997, SPORT PSYCHOL, V11, P379, DOI 10.1123/tsp.11.4.379; [黄峥 HUANG Zheng], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P5; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Kapsou M, 2010, J HEALTH PSYCHOL, V15, P215, DOI 10.1177/1359105309346516; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2000, IMMEDIATE POSTCONCUS; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; ROTH S, 1986, AM PSYCHOL, V41, P813, DOI 10.1037/0003-066X.41.7.813; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700	33	8	8	0	15	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0888-4781	1543-2793		SPORT PSYCHOL	Sport Psychol.	DEC	2013	27	4					372	379		10.1123/tsp.27.4.372			8	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	289LI	WOS:000329683600006					2022-02-06	
J	Elder, H				Elder, Hinemoa			Te Waka Oranga: An Indigenous Intervention for Working with Maori Children and Adolescents with Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						indigenous; traumatic brain injury; child and adolescent; framework; Maori	OUTCOMES; REHABILITATION; HEALTH	Background: Application of salient cultural knowledge held by families following child and adolescent traumatic brain injury (TBI) has yet to be documented in the literature. While the importance of the family is a well-established determinant of enhanced outcomes in child and adolescent TBI, the emphasis to date has been on the leading role of professional knowledge. The role of whanau (extended family) is recognised as an essential aspect of hauora (wellbeing) for Maori, who are overrepresented in TBI populations. However, whanau knowledge systems as a potent resource for enhancing recovery outcomes have not previously been explored. This paper describes the development of an indigenous intervention, Te Waka Oranga. Method: Rangahau Kaupapa Maori (Maori determined research methods) theory building was used to develop a TBI intervention for working with Maori. The intervention emerged from the findings and analysis of data from 18 wananga (culturally determined fora) held on rural, remote and urban marae (traditional meeting houses). Results: The intervention framework, called Te Waka Oranga, describes a process akin to teams of paddlers working together to move a waka (canoe, vessel) in a desired direction of recovery. This activity occurs within a Maori defined space, enabling both world views, that of the whanau and the clinical world, to work together. Whanau knowledge therefore has a vital role alongside clinical knowledge in maximising outcomes in mokopuna (infants, children, adolescents and young adults) with TBI. Conclusion: Te Waka Oranga provides for the equal participation of two knowledge systems, that of whanau and of clinical staff in their work in the context of mokopuna TBI. This framework challenges the existing paradigm of the role of families in child and adolescent TBI rehabilitation by highlighting the essential role of cultural knowledge and practices held within culturally determined groups. Further research is needed to test the intervention.	[Elder, Hinemoa] Whare Wananga Awanuiarangi, Bay Of Plenty, New Zealand		Elder, H (corresponding author), POB 334, Oneroa, Waiheke Island, New Zealand.	hinemoa@xtra.co.nz					Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Barlow C, 2005, TIKANGA WHAKAARO KEY; Blackmer J, 1999, BRAIN INJURY, V13, P627; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brown D., 2009, MAORI AGR FALE WHARE; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Cheung M., 2010, CELLULAR CULTURAL ST; Collins A., 2006, ROLE WHANAU LIVES MA; Durie M, 2004, INT J EPIDEMIOL, V33, P1138, DOI 10.1093/ije/dyh250; Durie M., 2002, NAT MAOR GRAD PSYCH; Durie M., 2001, MAURI ORA DYNAMICS M; Durie M., 1995, HUI WHAK; Durie M, 2011, TRANSCULT PSYCHIATRY, V48, P24, DOI 10.1177/1363461510383182; Durie MH, 1995, J POLYNESIAN SOC, V104, P461; Elder H, 2013, BRAIN IMPAIR, V14, P406, DOI 10.1017/BrImp.2013.28; Elder H, 2012, AUSTRALAS PSYCHIATRY, V20, P20, DOI 10.1177/1039856211430147; Glavish N., 2007, TIKANGA BEST PRACTIC; Kingi, 1997, FRAMEWORK MEASURING; Kingi J., 1999, MAORI CONCEPTS DISAB; Langlois J., 2003, MORBIDITY MORTALITY, V52, pSS; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Marsden M., 2003, WOVEN UNIVERSE SELEC; McClintock K, 2012, INT J SOC PSYCHIATR, V58, P96, DOI 10.1177/0020764010387067; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Statistics New Zealand & Ministry of Culture and Heritage, 2003, MEAS CULT CULT EXP C; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Taylor H.G., 1999, NEUROPSYCHOLOGY, V7, P755; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TAYLOR HG, 1995, TRAUMATIC HEAD INJUR; Te Puni Kokiri, 2010, 2009 RANGAHAU NGA WA; Te Puni Kokiri, 2007, TIROHANGA KI REO MAO; Uomoto J.M., 2005, REHABILITATION TRAUM, P247; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; [No title captured]	41	8	8	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2013	14	3					415	424		10.1017/BrImp.2013.29			10	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	300MD	WOS:000330467100004					2022-02-06	
J	Lefebvre, H; Levert, MJ; Le Dorze, G; Croteau, C; Gelinas, I; Therriault, PY; Michallet, B; Samuelson, J				Lefebvre, Helene; Levert, Marie-Josee; Le Dorze, Guylaine; Croteau, Claire; Gelinas, Isabelle; Therriault, Pierre-Yves; Michallet, Bernard; Samuelson, Jacinthe			Personalized citizen accompaniment for community integration of people with traumatic brain injury : a step towards resilience ?	RECHERCHE EN SOINS INFIRMIERS			French	Article						Personalised citizen accompaniment; traumatic brain injury; community integration; resilience		Introduction : most people with a traumatic brain injury (TBI) live with physical, sensory, or psychological sequelae that affect their day-to-day functioning and prevent them from performing their regular activities. Context : a Citizen Accompaniment for Community Integration project (APIC) was implemented for people with TBI to fulfill the lack of access to resources and gives them support to redefine their life projects. Objectives : this study's aim is to evaluate the APIC's impacts on the participants' wellbeing and their ability to participate in recreational and day-to-day living activities. Methods : it uses a mixed research design of multiple case studies supported by a participative and collaborative research approach. Qualitative and quantitative datas were collected from 9 participants with TBI in 2 stages, at the beginning of the APIC after 6 months and at the end, after 12 months, using semi-structured interviews. Results : this study shows the APIC's positive impacts in the development of the participant's autonomy and satisfaction with their social participation. Discussion and conclusion : it tends to reveal that the APIC is a safe space for experimentation, founded on a reciprocal relationship between accompanied and accompanier, and promoting the commitment to the resilience process.	[Lefebvre, Helene] Univ Montreal, Fac Sci Infirmieres, Rech & Dev Int, Montreal, PQ, Canada; [Lefebvre, Helene; Levert, Marie-Josee; Le Dorze, Guylaine; Croteau, Claire; Gelinas, Isabelle; Therriault, Pierre-Yves; Michallet, Bernard] CRIR, Grp Interreseaux Rech Adaptat Famille & Son Envir, Montreal, PQ, Canada; [Levert, Marie-Josee] Univ Montreal, Fac Sci Infirmieres, Montreal, PQ, Canada; [Le Dorze, Guylaine; Croteau, Claire] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada; [Gelinas, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Therriault, Pierre-Yves] Univ Montreal, Ecole Readaptat, Montreal, PQ, Canada; [Michallet, Bernard] Univ Quebec Trois Rivieres, Dept Orthophonie, Trois Rivieres, PQ, Canada; [Samuelson, Jacinthe] Grp Interreseaux Rech Adaptat Famille & Son Envir, Profess Rech, Psychol, Montreal, PQ, Canada		Lefebvre, H (corresponding author), Univ Montreal, Fac Sci Infirmieres, Rech & Dev Int, Montreal, PQ, Canada.	helene.lefebvre@umontreal.ca	Le Dorze, Guylaine/A-1790-2014				Bourque D., 2005, EC SOLIDARITES, V36, P13; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Christiansen C. H., 2005, OCCUPATIONAL THERAPY; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Desgagnu S., 2001, REV SCI ED, V27, DOI [10.7202/000305ar, DOI 10.7202/000305AR]; Dumont Claire, 2005, Can J Occup Ther, V72, P222; DUTIL E, 1995, EXPERIENCES ERGOTHER, V8, P52; DUTIL E, 2006, REV CANADIENNE ERGOT, V4, P326; Gadoury M, 2001, CADRE REFERENCE CLIN; GIRAUD-BARO E, 2006, INFORM PSYCHIAT, V82, P281; Guba EG., 1989, 4 GENERATION EVALUAT; Ionescu, 2011, TRAITE RESILIENCE AS; Johnson NG, 2003, J CLIN PSYCHOL, V59, P1193, DOI 10.1002/jclp.10210; Jourdan-Ionescu C., 2001, REV QUEBECOISE PSYCH, V22, P163; Khelia I, 2011, DEV HUMAIN HANDICAP, V19, P103; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; LEFEBVRE H, 2007, ADEQUATION ENTRE BES; Lefebvre H., 2006, ILLNESS CRISIS LOSS, V14, P337, DOI DOI 10.1177/105413730601400403; LEFEBVRE H, 2010, MODELES PRATIQUES ED; LEFEBVRE H, 2010, 13 C INT ED FAM SERV; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; MANCIAUX M, 2001, RESILIENCE RESISTER; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; MICHALLET B, 2013, REV QUEBECOISE PSYCH; MINISTERE DE LA SANTE ET DES SERVICES SOCIAUX, 2005, CONT SERV PERS AYANT; Patterson JM, 2002, J CLIN PSYCHOL, V58, P233, DOI 10.1002/jclp.10019; Peterson C., 2004, CHARACTER STRENGTHS; PIRES A, 1997, RECHERCHE QUALITATIV, P173; POURTOIS JP, 2011, TRAITE RESILIENCE AS, P37; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Richardson G.E., 1990, HEALTH EDUC J, V21, P33, DOI [10.1080/00970050.1990.10614589, DOI 10.1080/00970050.1990.10614589]; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; SALTER K, 2008, COMMUNITY REINTEGRAT; Schepers VP, 2005, ARCH PHYS MED REHAB, V86, P1472, DOI 10.1016/j.apmr.2004.11.039; Schipper K, 2011, BRAIN INJURY, V25, P832, DOI 10.3109/02699052.2011.589796; Seligman M. E. P., 2002, HDB POSITIVE PSYCHOL; SYLVESTRE A, 1994, REV FRANCOPHONE DEFI, V5, P155; Sylvestre A, 1999, LANGAGE PRATIQUES, V24, P13; TESSIER R, 1987, MANUEL QUEBECOIS PSY, P165; Tisseron S, 2007, LA RESILIENCE; [No title captured], DOI DOI 10.1375/BRIM.7.2.107; [No title captured]	44	8	8	0	3	ASSOC RECHERCHE & SOINS INFIRMIERS	TOULOUSE	109 RUE NEGRENEYS, TOULOUSE, 31200, FRANCE	2271-8362			RECH SOINS INFIRM	Rech. Soins Infirm.	DEC	2013		115					107	123		10.3917/rsi.115.0107			17	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF6OD	WOS:000443350800010	24490458				2022-02-06	
J	McHugh, L; Wood, R				McHugh, Louise; Wood, Rodger			Stimulus over-selectivity in temporal brain injury: Mindfulness as a potential intervention	BRAIN INJURY			English	Article						Mindfulness; over-selectivity; traumatic head injury	ATTENTION AWARENESS SCALE; HEAD-INJURY; OVERSELECTIVITY; VALIDATION; REDUCTION; FATIGUE	Objective: The current study aimed to investigate the impact of brief mindfulness training on the performance of a sample of patients with TBI in an over-selectivity task. Participants: Twenty-four patients who had suffered TBI and reported problems with focused or sustained attention. Method: The study was a between-subjects design (mindfulness intervention vs control) with difference between number of most and least chosen stimulus selections on an over-selectivity task as the dependent measure. Results: The results of this study indicated that stimulus over-selectivity was present in a group of patients with TBI. However, the level of emergent over-selectivity was significantly reduced by a mindfulness induction when compared to a no-intervention control group. Conclusions: The findings are discussed in terms of the efficacy of mindfulness training in reducing TBI-related cognitive deficits.	[McHugh, Louise] Univ Coll Dublin, Dublin 2, Ireland; [Wood, Rodger] Swansea Univ, Swansea, W Glam, Wales		McHugh, L (corresponding author), Univ Coll Dublin, Sch Psychol, Newman Bldg, Dublin 2, Ireland.	louise.mchugh@ucd.ie		McHugh, Louise/0000-0002-2526-4649			Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Carlson LE, 2005, J PSYCHOSOM RES, V58, P29, DOI 10.1016/j.jpsychores.2004.04.366; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cumming W. W., 1965, STIMULUS GEN, P284; Dickinson A, 1996, Q J EXP PSYCHOL-B, V49, P60, DOI 10.1080/713932614; Dube WV, 1999, J APPL BEHAV ANAL, V32, P25, DOI 10.1901/jaba.1999.32-25; Fletcher LB., 2010, MINDFULNESS, V1, P41, DOI [10.1007/s12671-010-0006-5, DOI 10.1007/S12671-010-0006-5]; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Kabat-Zinn, 1994, WHEREVER YOU GO THER; KAUFMAN MA, 1981, B PSYCHONOMIC SOC, V18, P318; Lau MA, 2006, J CLIN PSYCHOL, V62, P1445, DOI 10.1002/jclp.20326; Lombard K.M., 1999, EXPT ANAL HUMAN BEHA, V17, P8; LOVAAS OI, 1971, BEHAV RES THER, V9, P305, DOI 10.1016/0005-7967(71)90042-8; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; MacKillop J, 2007, J PSYCHOPATHOL BEHAV, V29, P289, DOI 10.1007/s10862-007-9045-1; MACKINTOSH NJ, 1971, Q J EXP PSYCHOL, V23, P118, DOI 10.1080/00335557143000121; McHugh L, 2010, RES DEV DISABIL, V31, P178, DOI 10.1016/j.ridd.2009.08.009; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Reed P, 2005, J AUTISM DEV DISORD, V35, P601, DOI 10.1007/s10803-005-0004-y; Rescorla RobertA., 1972, CLASSICAL CONDITION, P64; Schlund MW, 2001, BRAIN INJURY, V15, P1061, DOI 10.1080/02699050110086887; Spreen O, 1998, COMPENDIUM NEUROPSYC, P4; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Sutherland N. S., 1971, MECH ANIMAL DISCRIMI; TEASDALE G, 1974, LANCET, V2, P81; WAYLAND S, 1985, BRAIN COGNITION, V4, P338, DOI 10.1016/0278-2626(85)90026-0; Wechsler D., 1997, WECHSLER MEMORY SCAL	30	8	8	0	28	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1595	1599		10.3109/02699052.2013.834379			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400014	24266796				2022-02-06	
J	Perez-Bovet, J; Garcia-Armengol, R; Ferrer, SM				Perez-Bovet, J.; Garcia-Armengol, R.; Martin Ferrer, S.			Traumatic epidural retroclival hematoma with odontoid fracture and cardiorespiratory arrest	SPINAL CORD			English	Article						retroclival hematoma; odontoid fracture; cervical epidural hematoma; cervical injury; cervical trauma		Study design: Case report. Objectives: To describe a case or traumatic retroclival hematoma with features not previously reported. Setting: Single center. Methods: Description of a case, in the context of relevant literature on the subject. Results: Traumatic retroclival hematomas are a rare, typically pediatric, entity. Only four cases of epidural hematoma in adult patients have been reported. We describe an additional case, the first with a fatal course in the acute setting. It is also the first retroclival hematoma associated to an odontoid base fracture. Conclusion: Retroclival hematomas are a rare diagnosis, to be considered in pediatric patients with flexion-extension, high-energy injuries. Morphology is typically epidural. Brain stem and cranial nerve symptoms are typical. Treatment is usually conservative. Outcome is regarded as favorable, with partial recovery and neurologic sequelae. Adult cases are extremely rare. The case we describe adds new characteristics to the scarcity of cases.	[Perez-Bovet, J.; Garcia-Armengol, R.; Martin Ferrer, S.] Univ Hosp Dr Josep Trueta, Dept Neurosurg, Girona 17007, Spain		Perez-Bovet, J (corresponding author), Univ Hosp Dr Josep Trueta, Dept Neurosurg, Avinguda Franca S-N, Girona 17007, Spain.	sgf_39@hotmail.com					Fuentes S, 2000, NEUROCHIRURGIE, V46, P563; Khan N, 2000, SURG NEUROL, V54, P171, DOI 10.1016/S0090-3019(00)00284-6; Oliviero A, 2000, SPINE, V25, P888, DOI 10.1097/00007632-200004010-00020; Ratilal B, 2006, SURG NEUROL, V66, P200, DOI 10.1016/j.surneu.2005.11.030; Tubbs RS, 2010, NEUROSURGERY, V67, P404, DOI 10.1227/01.NEU.0000372085.70895.E7	5	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	DEC	2013	51	12					926	928		10.1038/sc.2013.53			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	269PB	WOS:000328252700011	23752261				2022-02-06	
J	Ishii, Y; Shintani-Ishida, K; Yoshida, K				Ishii, Yasuhiro; Shintani-Ishida, Kaori; Yoshida, Ken-ichi			Connexin-43 hemichannels contribute to the propagation of mu-calpain-mediated neuronal death in a cortical ablation injury model	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury; Calpain; Hemichannel; Astrocyte; Connexin-43; Neuronal death	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; GAP-JUNCTIONS; FODRIN PROTEOLYSIS; MIMETIC PEPTIDES; ATP RELEASE; RAT-BRAIN; ASTROCYTES; ISCHEMIA; CHANNELS	We investigated the role of the astrocytic and neuronal hemichannels (HCs) in the spread of cortical neuronal death in a rat cortical injury model. Over time (by 6 h), propidium iodide (PI)-positive cells with labeling either with anti-neuron specific enolase or anti-parvalbumin (indicating GABAnergic interneurons) antibody spread in the deep cortical layers adjacent to the injury and co-localized with activated mu-calpain. Connexin (Cx)-43, glial fibrillary acidic protein (GFAP), activated mu-calpain and alpha-fodrin breakdown product (FBP) increased post-injury, peaking at 1 h, in the injury and adjacent areas. GFAP-Cx43-positive reactivated astrocytes exhibited similar distribution to the dead neurons. Cx43 and Cx36 primarily comprise HCs in the astrocyte and neuron, respectively. Ethidium bromide (EtBr) uptake was enhanced post-injury, and confirmed in the Cx43- and Cx36-positive cells. A Cx43-HC inhibitor Gap26 prevented the opening of the Cx43-HC and Cx36-HC, mu-calpain activation, alpha-fodrin proteolysis and death in the deep cortical neurons. Collectively, opening of the astrocytic Cx43-HC and neuronal Cx36-HC would induce the regional spread of cortical neuronal death through mu-calpain activation in the rat brain injury model. (C) 2013 Elsevier Inc. All rights reserved.	[Ishii, Yasuhiro; Shintani-Ishida, Kaori; Yoshida, Ken-ichi] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan		Yoshida, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kyoshida@m.u-tokyo.ac.jp			JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22590628, 24659334]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24659334] Funding Source: KAKEN	This study was supported by JSPS KAKENHI Grant Numbers 22590628, 24659334.	Bartus RT, 1999, EXP NEUROL, V155, P315, DOI 10.1006/exnr.1998.7001; Belousov AB, 2012, NEUROSCI LETT, V524, P16, DOI 10.1016/j.neulet.2012.06.065; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Fukuda S, 1998, J NEUROCHEM, V70, P2526; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Huang CL, 2012, J NEUROSCI, V32, P3333, DOI 10.1523/JNEUROSCI.1216-11.2012; Kawamura M, 2004, J NEUROSCI, V24, P10835, DOI 10.1523/JNEUROSCI.3028-04.2004; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Ma YF, 2011, CEREB CORTEX, V21, P2639, DOI 10.1093/cercor/bhr051; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Nakase T, 2006, GLIA, V54, P369, DOI 10.1002/glia.20399; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Zundorf G, 2007, J NEUROCHEM, V102, P508, DOI 10.1111/j.1471-4159.2007.04509.x	32	8	8	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	NOV 15	2013	441	2					457	462		10.1016/j.bbrc.2013.10.091			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	256DO	WOS:000327290100031	24383076				2022-02-06	
J	Prima, V; Serebruany, VL; Svetlov, A; Hayes, RL; Svetlov, SI				Prima, Victor; Serebruany, Victor L.; Svetlov, Artem; Hayes, Ronald L.; Svetlov, Stanislav I.			Impact of Moderate Blast Exposures on Thrombin Biomarkers Assessed by Calibrated Automated Thrombography in Rats	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; biomarkers; cerebral vascular disease; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ADHESION MOLECULES; HEAD-INJURY; IN-VITRO; GENERATION; MATRIX; METALLOPROTEINASE; EXPRESSION; ACTIVATION; MODEL	Severe blast exposures are frequently complicated with fatal intracranial hemorrhages. However, many more sustain low level blasts without tissue damage detectable by brain imaging. To investigate effects of nonlethal blast on thrombin-related biomarkers, rats were subjected to two different types of head-directed blast: 1) moderate composite blast with strong head acceleration or 2) moderate primary blast, without head acceleration. Thrombin generation (TG) ex vivo after blast was studied by calibrated automated thrombography (CAT). In the same blood samples, we assessed maximal concentration of TG (TG(max)), start time, peak time, mean time, and concentrations of protein markers for vascular/hemostatic dysfunctions: integrin /, soluble endothelial selectin (sE-selectin), soluble intercellular cell adhesion molecule-1 (sICAM-1), and matrix metalloproteinases (MMP)-2, MMP-8, and MMP-13. Blast remarkably affected all TG indices. In animals exposed to composite blast, TG(max) peaked at 6h (approximate to 4.5-fold vs. control), sustained at day 1 (approximate to 3.8-fold increase), and declined to a 2-fold increase over control at day 7 post-blast. After primary blast, TG(max) also rose to approximate to 4.2-fold of control at 6h, dropped to approximate to 1.7-fold of control at day 1, and then exhibited a slight secondary increase at 2-fold of control at day 7. Other TG indices did not differ significantly between two types of blast exposure. The changes were also observed in other microvascular/inflammatory/hemostatic biomarkers. Integrin / and sICAM-1 levels were elevated after both composite and primary blast at 6h, 1 day, and 7 days. sE-selectin exhibited near normal levels after composite blast, but increased significantly at 7 days after primary blast; MMP-2, MMP-8, and MMP-13 slightly rose after composite blast and significantly increased (approximate to 2-4-fold) after primary blast. In summary, CAT may have a clinical diagnostic utility in combination with selected set of microvascular/inflammatory biomarkers in patients subjected to low/moderate level blast exposures.	[Prima, Victor; Svetlov, Artem; Hayes, Ronald L.; Svetlov, Stanislav I.] Banyan Labs Inc, Alachua, FL 32615 USA; [Prima, Victor; Svetlov, Stanislav I.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Prima, Victor; Svetlov, Stanislav I.] Univ Florida, Dept Urol, Gainesville, FL 32610 USA; [Serebruany, Victor L.] Heart Drug Res LLC, Towson, MD USA		Svetlov, SI (corresponding author), Banyan Labs Inc, 12085 Res Dr, Alachua, FL 32615 USA.	vprima@ufl.edu; ssvetlov@banyanbio.com	Goto, Shinya/AAU-6045-2020	Goto, Shinya/0000-0002-6821-1504	Department of DefenseUnited States Department of Defense [W81XWH-8-1-0376, W81XWH-07-0-0701]	The authors thank Danny Johnson for his expert technical assistance. This work was supported by grants W81XWH-8-1-0376 and W81XWH-07-01-0701 from the Department of Defense.	Alabanza LM, 2012, J NEUROIMMUNOL, V245, P48, DOI 10.1016/j.jneuroim.2012.02.004; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Coupland RM, 1999, BRIT MED J, V319, P410, DOI 10.1136/bmj.319.7207.410; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GROVES HM, 1982, LAB INVEST, V46, P605; Guy R J, 1998, J R Nav Med Serv, V84, P79; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Kang DW, 2009, STROKE, V40, P1653, DOI 10.1161/STROKEAHA.108.539429; Kanof M., 2008, VA HEALTH CARE MILD; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Krave U, 2005, EUR J NEUROSCI, V21, P2876, DOI 10.1111/j.1460-9568.2005.04115.x; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lockard MM, 2010, J APPL PHYSIOL, V108, P1682, DOI 10.1152/japplphysiol.00884.2009; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; Miho N, 2005, CARDIOVASC RES, V68, P289, DOI 10.1016/j.cardiores.2005.05.029; Morancho A, 2010, ANN NY ACAD SCI, V1207, P123, DOI 10.1111/j.1749-6632.2010.05734.x; Ni HY, 2003, TRANSFUS APHER SCI, V28, P257, DOI 10.1016/S1473-0502(03)00044-2; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Serebruany V, 2012, J THROMB THROMBOLYS, V33, P22, DOI 10.1007/s11239-011-0654-x; Sossdorf M, 2008, PLATELETS, V19, P476, DOI 10.1080/09537100802210337; Stouffer GA, 1998, CIRCULATION, V97, P907, DOI 10.1161/01.CIR.97.9.907; Stouffer GA, 2003, ARTERIOSCL THROM VAS, V23, P1971, DOI 10.1161/01.ATV.0000093470.51580.0F; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; WALTERS TK, 1994, J VASC RES, V31, P173, DOI 10.1159/000319584; Wang HC, 2011, CRIT CARE, V15, DOI 10.1186/cc10568; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yilmaz G, 2008, NEUROL RES, V30, P783, DOI 10.1179/174313208X341085; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	53	8	8	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2013	30	22					1881	1887		10.1089/neu.2012.2758			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	243PH	WOS:000326328400006	23805797	Green Published			2022-02-06	
J	Brownell, H; Lundgren, K; Cayer-Meade, C; Milione, J; Katz, DI; Kearns, K				Brownell, Hiram; Lundgren, Kristine; Cayer-Meade, Carol; Milione, Janet; Katz, Douglas I.; Kearns, Kevin			Treatment of Metaphor Interpretation Deficits Subsequent to Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						language and communication impairment; metaphor; treatment	REHABILITATION; APHASIA; MEMORY	Objective: To improve oral interpretation of metaphors by patients with traumatic brain injury (TBI). Design: Both single subject experimental design and group analysis. Setting: Patients' homes. Participants: Eight adult patients with moderate to severe traumatic brain injury sustained 3 to 20 years before testing. Intervention: The Metaphor Training Program consisted typically of 10 baseline sessions, 3 to 9 1-hour sessions of structured intervention, and 10 posttraining baseline sessions. Training used extensive practice with simple graphic displays to illustrate semantic associations. Main Outcome Measures: Quality of orally produced metaphor interpretation and accuracy of line orientation judgments served as dependent measures obtained during baseline, training, posttraining, and at a 3- to 4-month follow-up. Untrained line orientation judgments provided a control measure. Results: Group data showed significant improvement in metaphor interpretation but not in line orientation. Six of 8 patients individually demonstrated significant improvement in metaphor interpretation. Gains persisted for 3 of the 6 patients at the 3- to 4-month follow-up. Conclusion: The Metaphor Training Program can improve cognitive-communication performance for individuals with moderate to severe traumatic brain injury. Results support the potential for treating patients' residual cognitive-linguistic deficits.	[Brownell, Hiram] Boston Coll, Chestnut Hill, MA 02467 USA; [Brownell, Hiram; Lundgren, Kristine; Cayer-Meade, Carol; Milione, Janet; Katz, Douglas I.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Brownell, Hiram; Lundgren, Kristine; Cayer-Meade, Carol; Milione, Janet] VA Boston Healthcare Syst, West Roxbury, MA USA; [Lundgren, Kristine] Univ N Carolina, Greensboro, NC 27412 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Kearns, Kevin] SUNY Coll Fredonia, Fredonia, NY 14063 USA		Brownell, H (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02467 USA.	hiram.brownell@bc.edu			National Institute of Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R21 DC007165, P30 DC05432, RO1DC0520702]; Research Service of the Boston VA Healthcare System; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC005432, R21DC007165] Funding Source: NIH RePORTER	The study was supported by the National Institute of Deafness and Other Communication Disorders grants R21 DC007165, P30 DC05432, and RO1DC0520702 as well as the Research Service of the Boston VA Healthcare System.	Beeman M, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P255; Borckardt JJ, 2008, AM PSYCHOL, V63, P77, DOI 10.1037/0003-066X.63.2.77; Brownell H, 2007, ANN CONV AM SPEECH L; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Frattali C, 2003, J MED SPEECH-LANG PA, V11, pIX; GLUCKSBERG S, 1982, J VERB LEARN VERB BE, V21, P85, DOI 10.1016/S0022-5371(82)90467-4; HELMESTABROOKS N, 2001, CLQT COGNITIVE LINGU; Hilari K, 2003, STROKE, V34, P1944, DOI 10.1161/01.STR.0000081987.46660.ED; Hyerle D., 1995, THINKING MAPS TOOLS; Kearns KP, 2000, SCI PRACT NEUROPSYCH, P421; Kempler D., 1996, FORMULAIC NOVEL LANG; Kempler D., 2005, NEUROCOGNITIVE DISOR; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lundgren K, 2011, APHASIOLOGY, V25, P456, DOI 10.1080/02687038.2010.500809; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; Mills VM, 1997, NEUROLOGIC REHABILIT; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Myers PS, 1999, RIGHT HEMISHPERE DAM; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Porch BE, 2007, AM J SPEECH-LANG PAT, V16, P84, DOI 10.1044/1058-0360(2007/011); Qualls CE, 2000, ARCH CLIN NEUROPSYCH, V15, P159, DOI 10.1016/S0887-6177(98)00043-2; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Tompkins C.A., 1995, RIGHT HEMISPHERE COM; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; [No title captured]	32	8	8	2	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					446	452		10.1097/HTR.0b013e31825b5e85			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200009	22832370				2022-02-06	
J	Hagel, BE; Yanchar, NL				Hagel, Brent E.; Yanchar, Natalie L.		Canadian Paediatric Soc Injury Pre	Bicycle helmet use in Canada: The need for legislation to reduce the risk of head injury	PAEDIATRICS & CHILD HEALTH			English	Article						Bicycle helmet; Head injuries; Legislation	SAFETY GEAR; CHILDREN; COMPENSATION; TRENDS; BEHAVIOR; DEATHS; TRAUMA; IMPACT	Bicycling is a popular activity and a healthy, environmentally friendly form of transportation. However, it is also a leading cause of sport and recreational injury in children and adolescents. Head injuries are among the most severe injuries sustained while bicycling, justifying the implementation of bicycle helmet legislation by many provinces. There is evidence that bicycle helmet legislation increases helmet use and reduces head injury risk. Evidence for unintended consequences of helmet legislation, such as reduced bicycling and greater risk-taking, is weak and conflicting. Both research evidence to date and recognition of the substantial impact of traumatic brain injuries support the recommendation for all-ages bicycle helmet legislation.					Hagel, Brent/AAK-3319-2020				Adams J, 2001, Inj Prev, V7, P89, DOI 10.1136/ip.7.2.89; Alberta Centre for Injury Control and Research, 2008, INJURY CONTROL ALBER, V11, P4; Alberta Transportation. Office of Traffic Safety, 2010, ALB TRAFF COLL STAT; [Anonymous], 2013, BMJ, V346, pf2674; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bonyun M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001049; Canadian Institute for Health Information, 2004, INJ HOSP 2001 2002, P21; Canadian Paediatric Society, 2012, AR WE DOING EN STAT; Carpenter CS, 2009, INTENDED UNINTENDED; COTE TR, 1992, PEDIATRICS, V89, P1216; Craig CL, 2001, INCREASING PHYS ACTI; CUSHMAN R, 1990, CAN MED ASSOC J, V143, P108; Dennis J, HELMET LEGISLATION A; Dennis J, 2010, INJURY PREV, V16, P219, DOI 10.1136/ip.2009.025353; DiLillo D, 2001, J PEDIATR PSYCHOL, V26, P175, DOI 10.1093/jpepsy/26.3.175; Dowd MD, 2002, CRIT CARE MED, V30, pS385, DOI 10.1097/00003246-200211001-00002; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Farris C, 1997, ANN EMERG MED, V29, P625, DOI 10.1016/S0196-0644(97)70251-8; Finch C.F., 1993, 45 MON U ACC RES CTR; Finvers KA, 1996, CLIN J SPORT MED, V6, P102, DOI 10.1097/00042752-199604000-00007; Fischer CM, 2012, ANN EMERG MED, V60, P228, DOI 10.1016/j.annemergmed.2012.03.018; Foss R, 2000, BICYCLE HELMET USE B; Gilchrist J, 2000, PEDIATRICS, V106, P6, DOI 10.1542/peds.106.1.6; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Health Canada, 1997, SAF CAN CHILDR YOUTH, P291; Hedlund J, 2000, Inj Prev, V6, P82, DOI 10.1136/ip.6.2.82; HU XH, 1995, ARCH PEDIAT ADOL MED, V149, P437, DOI 10.1001/archpedi.1995.02170160091013; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; Karkhaneh M, 2011, ACCIDENT ANAL PREV, V43, P788, DOI 10.1016/j.aap.2010.10.026; Karkhaneh M, 2010, CAN J EMERG MED, V12, P266; Karkhaneh M, 2013, ACCIDENT ANAL PREV, V59, P206, DOI 10.1016/j.aap.2013.05.027; Khambalia A, 2005, PEDIATRICS, V116, P939, DOI 10.1542/peds.2005-0518; Lardelli-Claret P, 2003, INJURY PREV, V9, P128, DOI 10.1136/ip.9.2.128; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; Leitch K. K., 2007, REACHING TOP REPORT; Linn S, 1998, Inj Prev, V4, P122; Macpherson A K, 2001, Inj Prev, V7, P228, DOI 10.1136/ip.7.3.228; Macpherson AK, 2006, INJURY PREV, V12, P231, DOI 10.1136/ip.2005.011379; Macpherson AK, 2004, ACCIDENT ANAL PREV, V36, P649, DOI 10.1016/S0001-4575(03)00086-1; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Manitoba Finance Taxation Division, 2013, BULLETIN, V113; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; Mehan TJ, 2009, CLIN PEDIATR, V48, P166, DOI 10.1177/0009922808324952; Morrongiello BA, 2002, INJ PREV, V8, P27, DOI 10.1136/ip.8.1.27; Morrongiello BA, 2007, ACCIDENT ANAL PREV, V39, P618, DOI 10.1016/j.aap.2006.10.006; Morrongiello BA, 2007, J APPL DEV PSYCHOL, V28, P56, DOI 10.1016/j.appdev.2006.10.005; NIXON J, 1987, BRIT MED J, V294, P1267, DOI 10.1136/bmj.294.6582.1267; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Owen R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003985.pub3; Parkin PC, 2003, PEDIATRICS, V112, pE192, DOI 10.1542/peds.112.3.e192; Phillips RO, 2011, RISK ANAL, V31, P1187, DOI 10.1111/j.1539-6924.2011.01589.x; Pless IB, 2006, ARCH PEDIAT ADOL MED, V160, P610, DOI 10.1001/archpedi.160.6.610; Puranik S, 1998, SOUTHERN MED J, V91, P1033, DOI 10.1097/00007611-199811000-00008; ROWE BH, 1995, CAN MED ASSOC J, V152, P45; Safe Kids Canada, 2007, CHILD YOUTH UN INJ 1; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Sosin DM, 1996, PEDIATRICS, V98, P868; SPAITE DW, 1991, J TRAUMA, V31, P1510, DOI 10.1097/00005373-199111000-00008; Thakore S, 2009, PAED CHILD HEALT-CAN, V14, P509, DOI 10.1093/pch/14.8.509; Thompson D C, 2001, Inj Prev, V7, P86, DOI 10.1136/ip.7.2.86; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Wilde G. J. S., 2001, TARGET RISK; Yanchar NL, 2006, INJURY PREV, V12, P30, DOI 10.1136/ip.2005.008466	66	8	8	0	18	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	NOV	2013	18	9					475	480					8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	247AE	WOS:000326583600011					2022-02-06	
J	Donders, J; Strong, CAH				Donders, Jacobus; Strong, Carrie-Ann H.			Does Green's Word Memory Test really measure memory?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Memory; Traumatic brain injury; Injury severity; Assessment; Validity	TRAUMATIC BRAIN-INJURY; EDITION CVLT-II; VALIDITY; SAMPLE	This study investigated whether the Multiple Choice, Paired Associates, Free Recall, and Long Delayed Free Recall subtests of Green's Word Memory Test (WMT) were sensitive to memory impairment after traumatic brain injury (TBI) in 107 persons who passed performance validity criteria on the same instrument. Whereas several of the California Verbal Learning Test-Second Edition indices demonstrated a statistically significant correlation with coma duration, and also showed statistically significant mean differences between TBI severity groups, none of the four WMT memory subtests did so. It is concluded that, although the WMT is an excellent performance validity test, it is not sensitive to memory impairment after TBI.	[Donders, Jacobus; Strong, Carrie-Ann H.] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone Dominic A, 2009, Appl Neuropsychol, V16, P309, DOI 10.1080/09084280903297883; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cullen B, 2005, INT J GERIATR PSYCH, V20, P371, DOI 10.1002/gps.1291; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Faul M, 2010, TRAUMATIC BRAIN INJU; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2003, GREENS MED SYMPTOM V; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve K.W., 2013, NEUROPSYCHOLOGY SCI, VI, P61; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Rienstra A, 2009, ARCH CLIN NEUROPSYCH, V24, P255, DOI 10.1093/arclin/acp035; Roebuck-Spencer T., 2012, PRINCIPLES PRACTICE, P329; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Tschanz JT, 2002, NEUROPSY NEUROPSY BE, V15, P28	23	8	8	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 1	2013	35	8					827	834		10.1080/13803395.2013.824557			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226TQ	WOS:000325059300004	23957844				2022-02-06	
J	Fan, XF; Chen, ZH; Huang, Q; Dai, WM; Jie, YQ; Yu, GF; Wu, A; Yan, XJ; Li, YP				Fan, Xiao-Feng; Chen, Zhen-Hong; Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Yu, Guo-Feng; Wu, An; Yan, Xin-Jiang; Li, Yun-Ping			Leptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage	PEPTIDES			English	Article						Leptin; Aneurysmal subarachnoid hemorrhage; Functional outcome; Mortality	CLINICAL-OUTCOMES	Leptin has been identified as a plasma marker for outcomes in traumatic brain injury and intracerebral hemorrhage. We further investigated whether leptin might serve as a marker for severity and prognosis in aneurysmal subarachnoid hemorrhage. One hundred and eight consecutive patients and 108 sex and age - matched healthy subjects were recruited. Plasma leptin levels were measured by enzyme-linked immunosorbent assay. Clinical severity was assessed using World Federation of Neurological Surgeons score and Fisher score. Mortality and poor long-term outcome (Glasgow outcome scale scores of 1-3) at 6 months were recorded. Plasma leptin levels on admission were substantially higher in patients than in healthy controls, and were significantly associated with the clinical severity. There was also a significant association between leptin levels and clinical outcomes at 6 months in multivariate logistic regression analysis. Using receiver operating characteristic curves, we calculated areas under the curve for clinical outcomes at 6 months. The predictive performance of leptin was similar to, but did not obviously improve those of World Federation of Neurological Surgeons score and Fisher score. Thus, leptin may indicate clinical severity of the initial bleeding and also have prognostic value for clinical outcomes in aneurysmal subarachnoid hemorrhage and may therefore help in guiding treatment decisions in the setting of aneurysmal subarachnoid hemorrhage. (C) 2013 Elsevier Inc. All rights reserved.	[Fan, Xiao-Feng; Chen, Zhen-Hong; Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Yu, Guo-Feng; Wu, An; Yan, Xin-Jiang; Li, Yun-Ping] Quzhou Peoples Hosp, Dept Neurosurg, Kecheng Dist 324000, Quzhou, Peoples R China		Chen, ZH (corresponding author), Quzhou Peoples Hosp, Dept Neurosurg, 2 Zhongloudi Rd, Kecheng Dist 324000, Quzhou, Peoples R China.	xffqzmd@163.com					Behnes M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-217; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Dong XQ, 2010, WORLD NEUROSURG, V74, P286, DOI 10.1016/j.wneu.2010.02.019; DRAKE CG, 1988, J NEUROSURG, V68, P985; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Kim CK, 2013, J CEREBR BLOOD F MET, V33, P944, DOI 10.1038/jcbfm.2013.35; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Maimaitili A, 2013, EXP THER MED, V5, P1657, DOI 10.3892/etm.2013.1068; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Soderberg S, 1999, STROKE, V30, P328, DOI 10.1161/01.STR.30.2.328; Vernooy JHJ, 2013, PULM PHARMACOL THER, V26, P464, DOI 10.1016/j.pupt.2013.03.016; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Zhang X, 2013, PEPTIDES, V43, P133, DOI 10.1016/j.peptides.2013.03.010; Zhao QJ, 2012, CLIN EXP HYPERTENS, V34, P161, DOI 10.3109/10641963.2011.561902	19	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0196-9781	1873-5169		PEPTIDES	Peptides	OCT	2013	48						70	74		10.1016/j.peptides.2013.08.002			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	225XK	WOS:000324998300009	23954475				2022-02-06	
J	O'Phelan, K; Ernst, T; Park, D; Stenger, A; Denny, K; Green, D; Chang, C; Chang, LD				O'Phelan, Kristine; Ernst, Thomas; Park, Dalnam; Stenger, Andrew; Denny, Katherine; Green, Deborah; Chang, Cherylee; Chang, Linda			Impact of Methamphetamine on Regional Metabolism and Cerebral Blood Flow After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Adult brain injury; MRI; Blood flow; Metabolism; Alcohol and drug abuse	POSITRON-EMISSION-TOMOGRAPHY; MAGNETIC-RESONANCE SPECTROSCOPY; SUBSTANCE-ABUSE; HEAD-INJURY; LONG-TERM; PERFUSION; USERS; ABNORMALITIES; PRESSURE; RECOVERY	Substance abuse is a frequent comorbid condition among patients with traumatic brain injury (TBI), but little is known about its potential additive or interactive effects on tissue injury or recovery from TBI. This study aims to evaluate changes in regional metabolism and cerebral perfusion in subjects who used methamphetamine (METH) prior to sustaining a TBI. We hypothesized that METH use would decrease pericontusional cerebral perfusion and markers of neuronal metabolism, in TBI patients compared to those without METH use. This is a single center prospective observational study. Adults with moderate and severe TBI were included. MRI scanning was performed on a 3 Tesla scanner. MP-RAGE and FLAIR sequences as well as Metabolite spectra of NAA and lactate in pericontusional and contralateral voxels identified on the MP-RAGE scans. A spiral-based FAIR sequence was used for the acquisition of cerebral blood flow (CBF) maps. Regional CBF images were analyzed using ImageJ open source software. Pericontusional and contralateral CBF, NAA, and lactate were assessed in the entire cohort and in the METH and non-METH groups. Seventeen subjects completed the MR studies. Analysis of entire cohort: pericontusional NAA concentrations (5.81 +/- A 2.0 mM/kg) were 12 % lower compared to the contralateral NAA (6.98 +/- A 1.2 mM/kg; p = 0.03). Lactate concentrations and CBF were not significantly different between the two regions; however, regional CBF was equally reduced in the two regions. Subgroup analysis: 41 % of subjects tested positive for METH. The mean age, Glasgow Coma Scale, and time to scan did not differ between groups. The two subject groups also had similar regional NAA and lactate. Pericontusional CBF was 60 % lower in the METH users than the non-users, p = 0.04; contralateral CBF did not differ between the groups. This small study demonstrates that tissue metabolism is regionally heterogeneous after TBI and pericontusional perfusion was significantly reduced in the METH subgroup.	[O'Phelan, Kristine] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Ernst, Thomas; Stenger, Andrew; Chang, Cherylee; Chang, Linda] Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Neurosci & MR Res Program, Honolulu, HI 96813 USA; [Park, Dalnam] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA; [Denny, Katherine] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Green, Deborah] Boston Univ, Sch Med, Dept Neurol, Boston Med Ctr, Boston, MA 02118 USA; [Chang, Cherylee] Queens Med Ctr, Inst Neurosci, Honolulu, HI 96813 USA		O'Phelan, K (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1120 NW 14th St, Miami, FL 33136 USA.	kophelan@med.miami.edu; tmernst@hawaii.edu; dpark@ohsu.edu; stenger@hawaii.edu; kdenny@med.miami.edu; deborah.green@bmc.org; cchang@queens.org; lchang@hawaii.edu	Chang, Cherylee/ABG-2080-2020; Chang, Cherylee/Y-8450-2019	Green-LaRoche, MD, Deborah/0000-0001-8158-0788	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03DA24199]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R03DA024199, K02DA020569] Funding Source: NIH RePORTER	This work was supported by NIH R03DA24199 (I START).	Ali SF, 1996, ANN NY ACAD SCI, V801, P187, DOI 10.1111/j.1749-6632.1996.tb17441.x; Andelic N, 2012, J TRAUMA MANAGEMENT, V4, P6; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brain Trauma Foundation & American Association of Neurological Surgeons, 2000, MANAGEMENT PROGNOS 1, V17, P286; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; CHAN P, 1994, J TOXICOL-CLIN TOXIC, V32, P147, DOI 10.3109/15563659409000444; Chang L, 2002, PSYCHIAT RES-NEUROIM, V114, P65, DOI 10.1016/S0925-4927(02)00004-5; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dautry W, 2000, J CEREBR BLOOD F MET, V20, P789, DOI 10.1097/00004647-200005000-00005; Giza CC, 2001, J ATHL TRAINING, V36, P228; Harvey DC, 2000, BRAIN RES, V871, P259, DOI 10.1016/S0006-8993(00)02439-2; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hattori N, 2004, J NUCL MED, V45, P775; Hwang J, 2006, DRUG ALCOHOL DEPEN, V82, P177, DOI 10.1016/j.drugalcdep.2005.09.011; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KETY SS, 1945, AM J PHYSIOL, V143, P53, DOI 10.1152/ajplegacy.1945.143.1.53; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Nordahl TE, 2005, ARCH GEN PSYCHIAT, V62, P444, DOI 10.1001/archpsyc.62.4.444; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rasband R. W.S., 1997, IMAGEJ; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Villemagne V, 1998, J NEUROSCI, V18, P419; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yang YH, 2002, MAGN RESON MED, V48, P278, DOI 10.1002/mrm.10196	38	8	8	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2013	19	2					183	191		10.1007/s12028-013-9871-9			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	221GB	WOS:000324644800008	23836426	Green Accepted			2022-02-06	
J	Wang, WH; Lin, JM; Luo, F; Hu, LS; Li, J; Huang, W				Wang, Wen-hao; Lin, Jun-ming; Luo, Fei; Hu, Lian-shui; Li, Jun; Huang, Wei			Early Diagnosis and Management of Cerebral Venous Flow Obstruction Secondary to Transsinus Fracture after Traumatic Brain Injury	JOURNAL OF CLINICAL NEUROLOGY			English	Article						traumatic brain injury; transsinus fracture; transsinus epidural hematoma; cerebral venous flow obstruction; urokinase; two-dimensional time-of-flight magnetic resonance venography	DEPRESSED SKULL FRACTURE; OF-THE-LITERATURE; SAGITTAL SINUS THROMBOSIS; INTRACRANIAL HYPERTENSION; MR VENOGRAPHY; RISK-FACTORS; UROKINASE; CT; INFUSION; UPDATE	Background and Purpose Cerebral venous flow obstruction (CVFO) is a fatal complication of traumatic brain injury To compare the outcomes of patients with CVFO secondary to traumatic-brain-injury-induced transsinus fracture who were diagnosed early versus those diagnosed late in the therapeutic course. Methods In total, 403 patients with transsinus fracture were reviewed retrospectively. The patients were divided into an early-diagnosis group (n=338) and a delayed-diagnosis group (n=65). The patients submitted to 2D time-of-flight magnetic resonance venography (2D-TOF MRV) and/or CT venography (CTV), depending upon the findings of intracranial pressure monitoring, in order to identify potentially complicated CVFO. These examinations took place within 3 days of the onset of malignant intracranial hypertension symptoms in the early-diagnosis group, and after an average of 7 days in the delayed-diagnosis group. Once diagnosed, patients received intravenous thrombolytic therapy with low-dose urokinase. Patients with massive transsinus epidural hematoma, depressed fracture, or cerebral hernia were treated surgically to relieve the compression and repair any damage to the venous sinuses. Results Cerebral venous flow obstruction was much more severe in the delayed-diagnosis group than in the early-diagnosis group (p<0.001), and hence patients in the former group were given a higher dose of urokinase (p<0.001) for thrombolytic therapy. They were also significantly more likely to need surgery (48.1% vs. 20.6%,p=0.003) and had a higher mortality rate (37.0% vs. 4.1%, p<0.001). However, patients in both groups experienced a similarly favorable prognosis, not only with regard to functional outcome but also with respect to neuroradiological improvement, as evaluated by 2D-TOF MRV/CTV at the final follow-up (p=0.218). Conclusions Delayed diagnosis can result in increased risk of surgery and death in the acute phase. Thrombolytic therapy with low-dose urokinase resulted in promising improvements in both functional and neuroradiological outcomes in all of the patients in this study, regardless of the time to diagnosis.	[Wang, Wen-hao; Lin, Jun-ming; Luo, Fei; Hu, Lian-shui; Li, Jun; Huang, Wei] Xiamen Univ, Affiliated Southeast Hosp, Dept Neurosurg, Hosp PLA 175, Zhangzhou 363000, Fujian, Peoples R China		Wang, WH (corresponding author), Xiamen Univ, Affiliated Southeast Hosp, Dept Neurosurg, Hosp PLA 175, 269th Zhanghua Rd, Zhangzhou 363000, Fujian, Peoples R China.	wenhao_wang0712@126.com		Wang, Wen-Hao/0000-0001-9568-3876			Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Alper F, 2004, CEREBROVASC DIS, V18, P236, DOI 10.1159/000079960; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; Dabscheck G, 2007, J CHILD NEUROL, V22, P344, DOI 10.1177/0883073807300532; ElSankari S, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.99158; Fuentes S, 2005, BRIT J NEUROSURG, V19, P438, DOI 10.1080/02688690500390193; Fukusumi A, 2010, ACAD RADIOL, V17, P1103, DOI 10.1016/j.acra.2010.04.020; Gosk-Bierska I, 2006, NEUROLOGY, V67, P814, DOI 10.1212/01.wnl.0000233887.17638.d0; GROSMAN H, 1987, J CAN ASSOC RADIOL, V38, P183; Guenther G, 2011, NEUROLOGIA, V26, P488, DOI 10.1016/j.nrl.2010.09.013; Haghighi AB, 2012, STROKE, V43, P262, DOI 10.1161/STROKEAHA.111.635664; LEWIN JS, 1994, AM J NEURORADIOL, V15, P1657; Linn J, 2009, AM J NEURORADIOL, V30, P728, DOI 10.3174/ajnr.A1451; McBane RD, 2010, THROMB RES, V126, P81, DOI 10.1016/j.thromres.2010.04.015; Nimjee SM, 2011, J NEUROINTERV SURG, V3, P30, DOI 10.1136/jnis.2010.002469; Novak Z, 2000, AM J NEURORADIOL, V21, P143; Qu H, 2013, EXP THER MED, V5, P233, DOI 10.3892/etm.2012.796; Saadatnia M, 2009, INT J STROKE, V4, P111, DOI 10.1111/j.1747-4949.2009.00260.x; Wasay M, 2001, STROKE, V32, P2310, DOI 10.1161/hs1001.096192; Widjaja E, 2006, AM J NEURORADIOL, V27, P1913; Yigit H, 2012, EUR RADIOL, V22, P980, DOI 10.1007/s00330-011-2330-0; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351	24	8	8	0	7	KOREAN NEUROLOGICAL ASSOC	SEOUL	1111 DAEIL BLD, 43 INSA-DONG, JONGNO-GU, SEOUL, 110-741, SOUTH KOREA	1738-6586	2005-5013		J CLIN NEUROL	J. Clin. Neurol.	OCT	2013	9	4					259	268		10.3988/jcn.2013.9.4.259			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	232TJ	WOS:000325517000008	24285968	Green Submitted, Green Published			2022-02-06	
J	Zurita, M; Aguayo, C; Bonilla, C; Rodriguez, A; Vaquero, J				Zurita, Mercedes; Aguayo, Concepcion; Bonilla, Celia; Rodriguez, Alicia; Vaquero, Jesus			Perilesional intrathecal administration of autologous bone marrow stromal cells achieves functional improvement in pigs with chronic paraplegia	CYTOTHERAPY			English	Article						bone marrow stromal cells; spinal cord repair; paraplegia; nervous system transplantation	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; TRANSPLANTATION; RATS; THERAPY; CHALLENGE; RECOVERY; MODEL	Background aims. At present, on the basis of the great number of preclinical studies and preliminary clinical trials in humans, bone marrow stromal cell (BMSC) transplantation offers promise in the treatment of paraplegia. Nevertheless, there is not enough experience in humans about the best candidates for this type of cell therapy or details about the best parameters or best route of administration. Methods. Two adult paraplegic pigs with chronic paraplegia were treated only with perilesional intrathecal administration of 40 x 10(6) autologous BMSC suspended in autologous plasma and followed for 1 year after cell transplantation. Results. Our study showed clinical improvement, starting at 2 mo after BMSC administration and reaching stabilization at 10 mo. This was associated with recovery of previously abolished somatosensory-evoked potentials. At the end of the study, histological images suggested spinal cord regeneration. Conclusions. Our present findings suggest the possible utility of perilesional intrathecal administration of autologous BMSC in patients with chronic paraplegia.	[Zurita, Mercedes; Aguayo, Concepcion; Bonilla, Celia; Rodriguez, Alicia; Vaquero, Jesus] Hosp Puerta de Hierro Majadahonda, Neurosci Res Unit, Dept Neurosurg, Madrid 28222, Spain		Zurita, M (corresponding author), Hosp Puerta de Hierro Majadahonda, Unidad Invest Neurociencias, Joaquin Rodrigo 2, Madrid 28222, Spain.	zuritac@telefonica.net			Rafael del Pino Foundation; Ramon Areces Foundation; Neuroscience Institute of Los Madronos Hospital; Carlos III InstituteInstituto de Salud Carlos III [FIS 04/1281FIS 07/0621, FIS PS09/01105]	This work was supported by grants from Rafael del Pino Foundation, Ramon Areces Foundation, Neuroscience Institute of Los Madronos Hospital and Carlos III Institute (FIS 04/1281FTS 07/0621, FIS PS09/01105).	de Haro J, 2005, NEUROSCI LETT, V377, P7, DOI 10.1016/j.neulet.2004.11.060; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Hu DZ, 2004, CHINESE MED J-PEKING, V117, P1576; Kishk NA, 2010, NEUROREHAB NEURAL RE, V24, P702, DOI 10.1177/1545968310369801; Kuluz J, 2010, J SPINAL CORD MED, V33, P43, DOI 10.1080/10790268.2010.11689673; Kumar AA, 2009, EXP CLIN TRANSPLANT, V7, P241; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Li Huiying, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P180; Liu WP, 2008, NEUROSCI LETT, V434, P160, DOI 10.1016/j.neulet.2007.12.067; Nishida H, 2011, AM J VET RES, V72, P1118, DOI 10.2460/ajvr.72.8.1118; Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857; Saito F, 2008, J TRAUMA, V64, P53, DOI 10.1097/TA.0b013e31815b847d; Saito F, 2012, RESTOR NEUROL NEUROS, V30, P127, DOI 10.3233/RNN-2011-0629; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Zurita M, 2004, NEUROREPORT, V15, P1105, DOI 10.1097/00001756-200405190-00004; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069; Zurita M, 2012, PROG NEUROBIOL, V97, P288, DOI 10.1016/j.pneurobio.2012.04.005	21	8	8	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	OCT	2013	15	10					1218	1227		10.1016/j.jcyt.2013.05.012			10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	217JJ	WOS:000324355500005	23849974				2022-02-06	
J	Amini, A; Eghtesadi, R; Feizi, AM; Mansouri, B; Kariman, H; Dolatabadi, AA; Hatamabadi, H; Kabir, A				Amini, Afshin; Eghtesadi, Razieh; Feizi, Ali Mohammad; Mansouri, Behnam; Kariman, Hamid; Dolatabadi, Ali Arhami; Hatamabadi, Hamidreza; Kabir, Ali			Sonographic Optic Nerve Sheath Diameter as a Screening Tool for Detection of Elevated Intracranial Pressure	EMERGENCY			English	Article						Intracranial pressure; traumatic brain injury; ultrasonography; optic nerve; tomography		Introduction: Timely diagnosis and treatment of post-traumatic elevated intracranial pressure (EICP) could be reduced morbidity and mortality, and improved patients' outcome. This study is trying to evaluate the diagnostic accuracy of sonographic optic nerve sheath diameter (ONSD) in detection of EICP. Methods: Sonographic ONSD of patients with head trauma or cerebrovascular accident suspicious for EICP were evaluated by a trained chief resident of emergency medicine, who was blind to the clinical and brain computed tomography scan (BCT) findings of patients. Immediately after ultrasonography, BCT was performed and reported by an expert radiologist without awareness from other results of the patients. Finally, ultrasonographic and BCT findings regarding EICP were compared. To evaluate the ability of sonographic ONSD in predicting the BCT findings and obtain best cutoff level, receiver operating characteristic (ROC) curve were used. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) of sonographic ONSD in determining of EICP was calculated. P < 0.05 was considered as statistically significant. Results: There were 222 patients (65.3% male), with mean age of 42.2 +/- 19.5 years (range: 16-90 years). BCT showed signs of EICP, in 28 cases (12.6%). The means of the ONSD in the patients with EICP and normal ICP were 5.5 +/- 0.56 and 3.93 +/- 0.53 mm, respectively (P < 0.0001). ROC curve demonstrated that the best cut off was 4.85 mm. Sensitivity, specificity, PPV, NPV, PLR, and NLR of ONSD for prediction of EICP were 96.4%, 95.3%, 72.2%, 98.9%, 20.6, and 0.04, respectively. Conclusion: Sonographic diameter of optic nerve sheath could be considered as an available, accurate, and noninvasive screening tool in determining the elevated intracranial pressure in cases with head trauma or cerebrovascular accident.	[Amini, Afshin; Eghtesadi, Razieh; Kariman, Hamid; Dolatabadi, Ali Arhami; Hatamabadi, Hamidreza; Kabir, Ali] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Dept Emergency Med, Tehran, Iran; [Feizi, Ali Mohammad] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Dept Radiol, Tehran, Iran; [Mansouri, Behnam] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Dept Neurol, Tehran, Iran		Eghtesadi, R (corresponding author), Imam Hossein Hosp, Dept Emergency Med, Shahid Madani Ave, Tehran, Iran.	razieeqtesadi@yahoo.com	Amini, Afshin/AAN-5713-2020; Kariman, Hamid/AAK-1103-2020; Mansouri, Behnam/AAE-4549-2020; Hatamabadi, Hamid Reza/B-9715-2016	Kariman, Hamid/0000-0001-8082-0356; Eghtesadi, razie/0000-0002-1673-3263			Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Bauerle J, 2011, J NEUROL, V258, P2014, DOI 10.1007/s00415-011-6059-0; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; GANGEMI M, 1987, NEUROCHIRURGIA, V30, P53; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Hamilton DR, 2011, J ULTRAS MED, V30, P651, DOI 10.7863/jum.2011.30.5.651; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Karim S, 2004, INVEST OPHTH VIS SCI, V45, P1047, DOI 10.1167/iovs.03-1246; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lagreze WA, 2007, INVEST OPHTH VIS SCI, V48, P1913, DOI 10.1167/iovs.06-1075; Le A, 2009, ANN EMERG MED, V53, P785, DOI 10.1016/j.annemergmed.2008.11.025; Major R, 2011, EMERG MED J, V28, P679, DOI 10.1136/emj.2009.087353; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; Montazeri A, 2004, PUBLIC HEALTH, V118, P110, DOI 10.1016/S0033-3506(03)00173-2; Sankhyan N, 2010, INDIAN J PEDIATR, V77, P1409, DOI 10.1007/s12098-010-0190-2; SKALKA HW, 1978, SOUTHERN MED J, V71, P399, DOI 10.1097/00007611-197804000-00017; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tuite GF, 1996, NEUROSURGERY, V38, P272, DOI 10.1097/00006123-199602000-00009; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	25	8	8	0	0	SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED	TEHRAN	SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN	2345-4571			EMERGENCY	Emergency	FAL	2013	1	1					15	19					5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V9Z4T	WOS:000409491600004	26495330				2022-02-06	
J	Olson, DM; McNett, MM; Lewis, LS; Riemen, KE; Bautista, C				Olson, DaiWai M.; McNett, Molly M.; Lewis, Lisa S.; Riemen, Kristina E.; Bautista, Cynthia			EFFECTS OF NURSING INTERVENTIONS ON INTRACRANIAL PRESSURE	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; CHEST PERCUSSION; HYPERVENTILATION; PATIENT; ADULTS; CARE	Background Intracranial pressure is a frequent target for goaldirected therapy to prevent secondary brain injury. In critical care settings, nurses deliver many interventions to patients having intracranial pressure monitored, yet few data documenting the immediate effect of these interventions on intracranial pressure are available. Objective To examine the relationship between intracranial pressure and specific nursing interventions observed during routine care. Methods Secondary analysis of prospectively collected observational data. Results During 3118 minutes of observation, 11 specific nursing interventions were observed for 28 nurse-patient dyads from 16 hospitals. Family members talking in the room, administering sedatives, and repositioning the patient were associated with a significantly lower intracranial pressure. However, intracranial pressure was sometimes higher, lower, or unchanged after each intervention observed. Conclusion Response of intracranial pressure to nursing interventions is inconsistent. Most interventions were associated with inconsistent changes in intracranial pressure at 1 or 5 minutes after the intervention.	[Olson, DaiWai M.; Riemen, Kristina E.] Duke Univ, Med Ctr, Durham, NC USA; [McNett, Molly M.] Metrohlth Med Ctr, Cleveland, OH USA; [Lewis, Lisa S.] Watts Sch Nursing, Durham, NC USA; [Bautista, Cynthia] Yale New Haven Med Ctr, New Haven, CT 06504 USA		Olson, DM (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	DaiWai.Olson@UTSouthwestern.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Lewis, Lisa/0000-0001-5330-9747			Amato A, 2011, NURS CRIT CARE, V16, P252, DOI 10.1111/j.1478-5153.2010.00444.x; Biley F C, 1993, Intensive Crit Care Nurs, V9, P75, DOI 10.1016/0964-3397(93)90047-2; Crosby L J, 1992, J Neurosci Nurs, V24, P40; de Andrade AF, 2011, ARQ NEURO-PSIQUIAT, V69, P79, DOI 10.1590/S0004-282X2011000100016; Fields L, 2004, GUIDE CARE PATIENT I; Hickey JV, 2009, BIOL RES NURS, V11, P174, DOI 10.1177/1099800409332902; Hickey JV, 2009, CLIN PRACTICE NEUROL, P270; Hugo M, 1987, Intensive Care Nurs, V3, P78, DOI 10.1016/0266-612X(87)90029-0; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Kirkness CJ, 2009, AM J CRIT CARE, V18, P241, DOI 10.4037/ajcc2009743; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Lombardi F., 2002, COCHRANE DB SYST REV, V2002, DOI DOI 10.1002/14651858.CD001427; March K, 1990, J Neurosci Nurs, V22, P375; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; Miller CM, 2012, CURR NEUROL NEUROSCI, V12, P474, DOI 10.1007/s11910-012-0274-7; MITCHELL PH, 1981, NURS RES, V30, P212; MITCHELL PH, 1978, NURS RES, V27, P4; Olson DM, 2007, NEUROCRIT CARE, V6, P100, DOI 10.1007/s12028-007-0015-y; Olson DM, 2013, J NEUROSCI NURS, V45, P186, DOI 10.1097/JNN.0b013e3182986400; Olson DM, 2010, J NEUROSCI NURS, V42, P119, DOI 10.1097/JNN.0b013e3181d4a3aa; Olson DM, 2009, AM J CRIT CARE, V18, P330, DOI 10.4037/ajcc2009523; PARSONS LC, 1984, HEART LUNG, V13, P372; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Prendergast V, 2011, NEUROCRIT CARE, V14, P281, DOI 10.1007/s12028-011-9502-2; Prendergast V, 2009, AM J CRIT CARE, V18, P368, DOI 10.4037/ajcc2009621; Rising C J, 1993, J Neurosci Nurs, V25, P302; RUDY EB, 1991, HEART LUNG, V20, P667; SNYDER M, 1983, J ADV NURS, V8, P273; Szabo CM, 2011, J NEUROSCI NURS, V43, pE1, DOI 10.1097/JNN.0b013e318227f1e5; Treloar D M, 1991, J Neurosci Nurs, V23, P295; Villanueva N E, 1999, J Neurosci Nurs, V31, P216; Wuchner SS, 2012, J NEUROSCI NURS, V44, P177, DOI 10.1097/JNN.0b013e318252763f	34	8	8	0	11	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	SEP 1	2013	22	5					431	438		10.4037/ajcc2013751			8	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	219UM	WOS:000324536100010	23996423				2022-02-06	
J	Williams, G; Schache, AG; Morris, ME				Williams, Gavin; Schache, Anthony G.; Morris, Meg E.			Self-Selected Walking Speed Predicts Ability to Run Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain trauma; gait disorders; rehabilitation; running	HIGH-LEVEL; POWER-GENERATION; RUNNING ABILITY; STROKE; GAIT; HIP; BIOMECHANICS; VALIDITY	Objective: To identify factors that predict running ability following traumatic brain injury (TBI), and to quantify performance thresholds for these predictors. Design: Cross-sectional cohort study. Participants: One hundred fourteen people with TBI. Outcome Measures: Self-selected walking speed, the high-level mobility assessment tool, postural stability (lateral center of mass displacement), ankle power generation at push-off and quality of gait performance (Gait Profile Score). Results: All predictor variables were all strongly associated with the ability to run. However, only self-selected walking speed contributed significantly to the final result. Investigation of performance thresholds for self-selected walking speed indicated that following TBI, people who walk at speeds of 1.0 m/s or higher are 16.9 times more likely of being able to run than for those who walk at speeds of less than 1.0 m/s. Conclusions: Self-selected walking speeds higher than 1.0 m/s greatly increase the likelihood of running following brain injury. The 1.0 m/s threshold, although slower than able-bodied self-selected walking speeds, may be an important indicator of the ability to run in this population.	[Williams, Gavin] Epworth Med Fdn, Physiotherapy Dept, Melbourne, Vic 3121, Australia; [Williams, Gavin; Morris, Meg E.] Univ Melbourne, Sch Physiotherapy, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Schache, Anthony G.] Univ Melbourne, Dept Mech Engn, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Melbourne, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Williams, Gavin/0000-0003-2758-7473; Morris, Meg/0000-0002-0114-4175			Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beynon S, 2010, GAIT POSTURE, V32, P129, DOI 10.1016/j.gaitpost.2010.01.010; Brandt T, 1999, LANCET, V354, P746, DOI 10.1016/S0140-6736(99)03179-7; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Collen F M, 1991, Int Disabil Stud, V13, P50; De Smet K, 2009, GAIT POSTURE, V29, P54, DOI 10.1016/j.gaitpost.2008.06.005; Fatar M, 2003, STROKE, V34, pE178, DOI 10.1161/01.STR.0000092200.70438.C0; Gardner M.J, 2000, STAT CONFIDENCE; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; MANN RA, 1980, AM J SPORT MED, V8, P345, DOI 10.1177/036354658000800510; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Moriello G, 2009, J NEUROL PHYS THER, V33, P111, DOI 10.1097/NPT.0b013e3181a6ab6b; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; OUNPUU S, 1994, CLIN SPORT MED, V13, P843; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Segers V, 2007, GAIT POSTURE, V26, P349, DOI 10.1016/j.gaitpost.2006.10.013; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Williams G, 2001, BRAIN INJURY, V15, P831; Williams G, J HEAD TRAU IN PRESS; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams G, 2011, J NEUROTRAUM, V28, P281, DOI 10.1089/neu.2010.1649; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2011, PHYSIOTHER CAN, V63, P58, DOI 10.3138/ptc.2009-53; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	36	8	8	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					379	385		10.1097/HTR.0b013e3182575f80			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600084	22647966				2022-02-06	
J	Hofer, H; Frigerio, S; Frischknecht, E; Gassmann, D; Gutbrod, K; Muri, RM				Hofer, Helene; Frigerio, Susanna; Frischknecht, Eveline; Gassmann, Daniel; Gutbrod, Klemens; Mueri, Rene M.			Diagnosis and treatment of an obsessive-compulsive disorder following traumatic brain injury: A single case and review of the literature	NEUROCASE			English	Article						Traumatic brain injury; Obsessive-compulsive disorder; Diagnostic; Treatment; Medication; Single case	COGNITIVE-BEHAVIORAL THERAPY; HEAD-INJURY; ANXIETY DISORDERS; PREDICTORS; NEUROPSYCHIATRY; REHABILITATION; INDIVIDUALS; DEPRESSION; EXPOSURE; SEQUELAE	A 27-year-old patient with traumatic brain injury and neuropsychiatric symptoms fitting the obsessive-compulsive disorder was investigated. Brain CT-scan revealed left temporal and bilateral fronto-basal parenchymal contusions. Main Outcome Measure was the Yale-Brown Obsessive Compulsive Scale at pre- and post-treatment and at 6 months follow-up. The combination of pharmacotherapy and psychotherapy resulted in lower intensity and frequency of symptoms. Our case illustrates the importance of a detailed diagnostic procedure in order to provide appropriate therapeutic interventions. Further studies are needed to guide the clinician in determining which patients are likely to benefit from a psychotherapeutic intervention in combination with pharmacotherapy.	[Hofer, Helene; Gutbrod, Klemens; Mueri, Rene M.] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Frigerio, Susanna] Hosp Olten, Dept Neurol, Olten, Switzerland; [Frischknecht, Eveline; Gassmann, Daniel] Univ Bern, Dept Psychol, Bern, Switzerland		Hofer, H (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland.	helene.hofer@insel.ch	Muri, Rene M/E-9320-2012	Muri, Rene M/0000-0001-6990-4188; Gutbrod, Klemens/0000-0002-5723-3468			Abramowitz J. S., 2006, CONCEPT CONTROVERSIE; Abramowitz J.S., 2002, ROMANIAN J COGNITIVE, V2, P89, DOI DOI 10.1016/J.CPR.2005.07.003; American Psychiatric Association, 2007, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arco L, 2008, NEUROPSYCHOL REHABIL, V18, P109, DOI 10.1080/09602010701656706; Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN, P59; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Bilgic Basar, 2004, Cogn Behav Neurol, V17, P118, DOI 10.1097/01.wnn.0000117862.44205.ea; Bjorgvinsson Throstur, 2007, J Psychiatr Pract, V13, P362; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carota A, 2005, NEUROLOGY, V64, P428, DOI 10.1212/01.WNL.0000150935.05940.2D; Carota A, 2002, CURR OPIN NEUROL, V15, P57, DOI 10.1097/00019052-200202000-00010; Childers MK, 1998, BRAIN INJURY, V12, P613; CHRISTENSEN AL, 1991, J HEAD TRAUMA REHAB, V6, P56; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coetzer BR, 2004, INT J PSYCHIAT MED, V34, P363, DOI 10.2190/XENN-NNWT-7N2K-R26A; Coetzer R, 2001, PSYCHIAT CLIN NEUROS, V55, P83, DOI 10.1046/j.1440-1819.2001.00792.x; Coetzer R., 2003, J COGNITIVE REHA WIN, P4; Coetzer R., 2010, ANXIETY MOOD DISORDE; CRUM RM, 1993, DRUG ALCOHOL DEPEN, V31, P281, DOI 10.1016/0376-8716(93)90010-N; Cummings J., 2003, NEUROPSYCHIATRY BEHA; Derogatis L.R., 1992, SCL 90 R ADM SCORING; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Emmelkamp PM, 2000, ZWANGSSTORUNGEN; Emmelkamp PMG, 2002, DIAGNOSIS CONCEPTUALIZATION, AND TREATMENT PLANNING FOR ADULTS, P167; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fisher PL, 2005, BEHAV RES THER, V43, P1543, DOI 10.1016/j.brat.2004.11.007; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Foa EB, 2005, AM J PSYCHIAT, V162, P151, DOI 10.1176/appi.ajp.162.1.151; Foa Edna B, 2010, Dialogues Clin Neurosci, V12, P199; Gauggel S., 2003, Z NEUROPSYCHOL, V14, P217; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Goodwin RD, 2002, COMPR PSYCHIAT, V43, P245, DOI 10.1053/comp.2002.33500; Grace J, 2001, FRSBE FRONTAL SYSTEM; Grados MA, 2003, INT REV PSYCHIATR, V15, P350, DOI 10.1080/09540260310001606737; Grawe K, 2007, NEUROPSYCHOTHERAPY N; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Huey ED, 2008, J NEUROPSYCH CLIN N, V20, P390, DOI 10.1176/appi.neuropsych.20.4.390; Kant R, 1996, BRAIN INJURY, V10, P55; Keeley ML, 2008, CLIN PSYCHOL REV, V28, P118, DOI 10.1016/j.cpr.2007.04.003; Kellner Michael, 2010, Dialogues Clin Neurosci, V12, P187; Koran LM, 2007, AM J PSYCHIAT, V164, P5; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kuelz AK, 2006, J CLIN EXP NEUROPSYC, V28, P1273, DOI 10.1080/13803390500507246; Lakatos A, 1999, KOGNITIVE VERHALTENS; LAPLANE D, 1982, REV NEUROL, V138, P137; Maher MJ, 2010, PSYCHOL MED, V40, P2013, DOI 10.1017/S0033291710000620; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; Michael AJ, 1988, J ANXIETY DISORD, V4, P353, DOI DOI 10.1016/0887-6185(88)90030-8; Paine TA, 2002, BEHAV PHARMACOL, V13, P511, DOI 10.1097/00008877-200211000-00001; Pallanti S, 2006, PROG NEURO-PSYCHOPH, V30, P400, DOI 10.1016/j.pnpbp.2005.11.028; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PRIGATANO GP, 1999, PRINCIPLE NEUROPSYCH; Prigatano GP, 1994, BRAIN INJURY NEUROPS, P173; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reinecker H., 1994, LANGZEITEFFEKTE BEI; Ring HA, 2002, J NEUROL NEUROSUR PS, V72, P12, DOI 10.1136/jnnp.72.1.12; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; SALKOVSKIS PM, 1989, BEHAV RES THER, V27, P677, DOI 10.1016/0005-7967(89)90152-6; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sohlberg M., 2001, COGNITIVE REHABILITA; Stein DJ, 2002, LANCET, V360, P397, DOI 10.1016/S0140-6736(02)09620-4; Stengler-Wenzke K, 2003, PSYCHIAT PRAX, V30, P37, DOI 10.1055/s-2003-36625; Stewart SE, 2006, J PSYCHIATR RES, V40, P511, DOI 10.1016/j.jpsychires.2005.08.007; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Whittal ML, 2005, BEHAV RES THER, V43, P1559, DOI 10.1016/j.brat.2004.11.012; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; Wilson BA, 2003, NEUROPSYCHOLOG REHAB, P1; Wilson KA, 2005, BEHAV RES THER, V43, P1645, DOI 10.1016/j.brat.2005.01.002; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432	77	8	8	0	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	AUG 1	2013	19	4					390	400		10.1080/13554794.2012.690423			11	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	192SO	WOS:000322505800010	22784309				2022-02-06	
J	Yuan, Q; Liu, H; Wu, X; Sun, Y; Hu, J				Yuan, Q.; Liu, H.; Wu, X.; Sun, Y.; Hu, J.			Comparative study of decompressive craniectomy in traumatic brain injury with or without mass lesion	BRITISH JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; mess lesion; outcome; traumatic brain injury	SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; SURGICAL-MANAGEMENT; PRESSURE	Objective. Decompressive craniectomy (DC) is one of the most ardently debated topics in traumatic brain injury (TBI) treatment. The aim of this study is to compare the differences between DC with and without mass evacuation in patients with TBI. Methods. From January 2005 to December 2009, 164 patients underwent DC at our centre. Seventy-one of the 164 patients underwent DC for diffuse injury (group B). Ninety-three patients underwent DC as part of an operation to treat a mass lesion (group A). Patient characteristics and post-operative outcomes were compared between the two groups. Results. Thirty-six patients died during this study (22.0%). Fifty-nine of these patients (36.0%) remained either vegetative (n = 30) or severely disabled (n = 29). Sixty-nine patients (42%) had a Glasgow Outcome Scale (GOS) score of 4 to 5. Three predictors were significantly related to 60-day mortality: age older than 50 years (odds ratio [OR], 2.36; 95% confidence interval [CI], 1.01-5.52), abnormal pupillary response to light (OR, 3.79; 95% CI, 1.29-11.14), and DC with mass evacuation (OR, 0.31; 95% CI, 0.12-0.79). Mortality differed substantially between patients with (group A) and without (group B) mass evacuation (14.0% versus 32.4%). Only one predictor was significantly related to good outcome: Glasgow Coma Scale (GCS) score at admission: (OR, 2.43; and 95% CI, 1.39-4.24). Conclusions. DC for patients with or without mass lesion has different patient characteristics. DC with mass evacuation has lower mortality than DC without mass evacuation. Outcome prediction following DC should be adjusted according to mass evacuation.	[Yuan, Q.] Jiao Tong Univ, Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China; [Liu, H.] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China; [Yuan, Q.; Wu, X.; Sun, Y.; Hu, J.] Fudan Univ, Dept Neurosurg, Shanghai 200433, Peoples R China		Hu, J (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	297260090@qq.com					Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Boret H, 2006, ACTA ANAESTH SCAND, V50, P252, DOI 10.1111/j.1399-6576.2005.00862.x; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Munch EC, 2001, CRIT CARE MED, V29, P976; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Poca MA, 1998, ACT NEUR S, V71, P27; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schneider GH, 2002, ACT NEUR S, V81, P77; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Ucar T, 2001, NEUROSURGERY, V49, P1022; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214	24	8	8	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	2013	27	4					483	488		10.3109/02688697.2013.763897			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	190DP	WOS:000322319000017	23384251				2022-02-06	
J	Barbieri, A; Giuliani, E; Carone, C; Pederzoli, F; Mascheroni, G; Greco, G; Stucchi, C; Genedani, S				Barbieri, A.; Giuliani, E.; Carone, C.; Pederzoli, F.; Mascheroni, G.; Greco, G.; Stucchi, C.; Genedani, S.			Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study	MINERVA ANESTESIOLOGICA			English	Article						Stroke; Biological markers; Matrix Metalloproteinase 9; S-100 calcium-binding protein beta subunit; Pro-brain natriuretic peptide (1-76); Fibrin fragment D	TRAUMATIC BRAIN-INJURY; CEREBRAL INFARCTION; DIAGNOSIS; BLOOD; METALLOPROTEINASES; PREVALENCE; MEDIATORS; MORTALITY; PATHOLOGY; SUBTYPES	Background. Stroke is a leading cause of long-term morbidity and mortality affecting several hundred-thousand people annually in the Western Countries. Various panels of biomarkers of neural damage have been developed and validated. The primary objective of this investigation was to measure the correlation between the clinical severity of stroke and the serum/plasma concentrations of neural damage biomarkers. Methods. A prospective investigation was conducted on a panel of biomarkers composed of S10013, matrix metalloproteinase-9 (MMP-9), N-terminal pro-B-type natriuretic peptide (NT pro-BNP) and D-dimer at admission and after 24 hours, in a cohort patients with a confirmed diagnosis of stroke in an emergency setting (STROke-MArkers STROMA). Results. A total of 58 consecutive patients were enrolled, no participant was excluded; according to clinical severity measured by National Institute of Health Stroke Scale (NIHSS) there were 29 minor strokes, 24 moderate, 3 moderate-severe, 2 severe. The Spearman's rank correlation test was used to assess the relationship between the baseline NIHSS value and the concentrations of the four biomarkers: all the studied biomarkers showed a statistically significant correlation with baseline NIHSS at 24 hours. A multivariate ordinal regression model was used to analyze the correlation of markers with stroke severity, stratified, according to NIHSS score: MMP-9 and S10013 showed a statistically significant correlation after 24 hours. Conclusion. MMP-9, S10013, NT pro-BNP and D-dimer showed a good correlation with the clinical severity of stroke which may become an additional resource in the acute patient evaluation and potentially follow-up.	[Barbieri, A.] Univ Modena & Reggio Emilia, Intens Care Unit, Policlin Teaching Hosp, Modena, Italy; [Giuliani, E.; Mascheroni, G.] Univ Modena & Reggio Emilia, Policlin Teaching Hosp, Modena, Italy; [Carone, C.; Pederzoli, F.; Genedani, S.] Univ Modena & Reggio Emilia, Dept Pharmacol, Modena, Italy; [Greco, G.; Stucchi, C.] Ramazzini Hosp, Dept Neurol, Modena, Italy		Barbieri, A (corresponding author), Via Pozzo 71, I-41124 Modena, Italy.	alberto.barbieri@unimore.it	Giuliani, Enrico/L-2158-2016; Barbieri, Alberto/L-1427-2016; Genedani, Susanna/K-4370-2016	Giuliani, Enrico/0000-0001-7140-7850; Barbieri, Alberto/0000-0002-3904-1323; Genedani, Susanna/0000-0003-1526-153X; Carone, Chiara/0000-0002-3833-3690	Italian Ministry of Education and ResearchMinistry of Education, Universities and Research (MIUR); University of Modena; Reggio Emilia	The authors wish to thank Dr. P. Coppolecchia, G. Madella, the medical and nursing staff of the Department of Neurology at the Ramazzini Hospital (Carpi, Italy) and Prof. M. Rocchi for their precious collaboration to the study. Authors wish to aknowledge PRIN-2008 institutional grant (Italian Ministry of Education and Research) and University of Modena and Reggio Emilia Institutional funds for the financial support.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Amar AP, 2011, WORLD NEUROSURG, V76, pS3, DOI 10.1016/j.wneu.2011.07.002; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Fang Jing, 2012, Morbidity and Mortality Weekly Report, V61, P379; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Haapaniemi E, 2009, ACTA NEUROL SCAND, V119, P141, DOI 10.1111/j.1600-0404.2008.01081.x; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Koh SH, 2011, EUR J NEUROL, V18, P158, DOI 10.1111/j.1468-1331.2010.03100.x; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; Montaner J, 2012, CEREBROVASC DIS, V34, P240, DOI 10.1159/000341858; Powner DJ, 2007, NEUROCRIT CARE, V7, P119, DOI 10.1007/s12028-007-0079-8; Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588; Sibon I, 2009, AM J EMERG MED, V27, P558, DOI 10.1016/j.ajem.2008.05.001; Skoloudik D, 2010, J THROMB THROMBOLYS, V29, P477, DOI 10.1007/s11239-009-0372-9; Vanni S, 2011, J EMERG MED, V40, P499, DOI 10.1016/j.jemermed.2008.09.028; Vukasovic I, 2006, CLIN CHEM LAB MED, V44, P428, DOI 10.1515/CCLM.2006.079; Wang DZ, 2000, STROKE, V31, P77, DOI 10.1161/01.STR.31.1.77; Whiteley W, 2008, STROKE, V39, P2902, DOI 10.1161/STROKEAHA.107.511261; Whiteley W, 2011, CEREBROVASC DIS, V32, P141, DOI 10.1159/000328517; Worthmann H, 2010, CEREBROVASC DIS, V30, P85, DOI 10.1159/000314624; Yiadom MYAB, 2011, EMERG MED CLIN N AM, V29, P689, DOI 10.1016/j.emc.2011.08.006; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	28	8	9	0	4	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUL	2013	79	7					750	757					8	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	298MH	WOS:000330327500009	23511364				2022-02-06	
J	Dvorkin, AY; Pacini, S; Hsu, N; Larson, EB				Dvorkin, Assaf Y.; Pacini, Sonia; Hsu, Nancy; Larson, Eric B.			Treatment challenges with profound behaviour disturbance after traumatic brain injury: A case report	BRAIN INJURY			English	Article						Agitation; attention; brain injury; rehabilitation; virtual reality	VIRTUAL-REALITY; REHABILITATION; ATTENTION; MANAGEMENT; AGITATION; PROGRAMS	Background: Severe behavioural disturbances exhibited during the earliest stages of recovery from severe traumatic brain injury often limit the ability to provide standard care. Studies that focus on treatment options for inpatients with such behaviours are scarce. There is limited guidance on how to approach therapy that will maximize the patient's tolerance and participation and how to measure meaningful progress. Case report: This case study describes how the use of an innovative treatment approach to improve attention was beneficial in rehabilitation of a patient with severe traumatic brain injury whose profound behaviour disturbances substantially precluded participation in traditional therapies. The study shows how rehabilitation utilizing an interactive virtual reality-robotics environment that minimized distractions was associated with improved engagement in therapy, decreased disruptive behaviour during treatment and more sensitive measurement of progress. Conclusion: These results may be instructive in how technology can be used to modify therapy sessions to make them accessible to patients with profound behaviour disturbance and how meaningful progress can be measured even in the absence of gains in traditional metrics.	[Dvorkin, Assaf Y.; Pacini, Sonia; Hsu, Nancy; Larson, Eric B.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Dvorkin, Assaf Y.; Larson, Eric B.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA		Dvorkin, AY (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, 345 East Super St, Chicago, IL 60611 USA.	sasaf@vms.huji.ac.il	Larson, Eric/AAD-9567-2021		US Department of Education, National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133A080045A]	The authors report no conflicts of interest. This work was supported by the US Department of Education, National Institute on Disability and Rehabilitation Research (Grant #H133A080045A). The opinions expressed here do not necessarily represent the policy of the Department of Education.	Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Dvorkin Assaf Y, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P962, DOI 10.1109/ICORR.2009.5209629; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; Granger CV, 1993, GUIDE UNIFORM DATA S; Larson EB, 2011, BRAIN INJURY, V25, P274, DOI 10.3109/02699052.2010.551648; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Michel J A, 2006, Eura Medicophys, V42, P59; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Rizzo A, 2011, J CLIN PSYCHOL MED S, V18, P176, DOI 10.1007/s10880-011-9247-2; Saout V., 2011, Annals of Physical and Rehabilitation Medicine, V54, P259, DOI 10.1016/j.rehab.2011.04.003; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Stewart I, 2010, BRAIN INJURY, V24, P1616, DOI 10.3109/02699052.2010.523050; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Wang M, 2011, NEUROEPIDEMIOLOGY, V36, P2, DOI 10.1159/000320847; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; Zoccolotti P, 2011, EUR J PHYS REHAB MED, V47, P123	21	8	9	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					957	961		10.3109/02699052.2013.793399			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200026	23758543				2022-02-06	
J	Jonsson, CA; Catroppa, C; Godfrey, C; Smedler, AC; Anderson, V				Jonsson, Catherine Aaro; Catroppa, Cathy; Godfrey, Celia; Smedler, Ann-Charlotte; Anderson, Vicki			Individual profiles of predictors and their relations to 10 years outcome after childhood traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; paediatric; cluster analysis; follow-up studies; cognition; adaptive behaviour; educational measurement; cognitive reserve	TEST-CHILDRENS VERSION; QUALITY-OF-LIFE; HEAD-INJURY; COGNITIVE RESERVE; YOUNG-ADULTS; MEMORY; GENDER; VULNERABILITY; MODERATOR; PATTERNS	Background: Outcome after childhood traumatic brain injury (CTBI) is heterogeneous, with several predictors influencing long-term outcome. Method: This exploratory study used person-oriented cluster analysis to investigate individual profiles of medical, psychological and social predictors and their relation to longitudinal development in a sample of 127 participants with mild, moderate and severe CTBI. Outcome of cognitive, adaptive and academic function was measured at 30 months and 10 years post-injury. Results: A nine-cluster solution, explaining 67% of the variance in the sample, resulted in two clusters with individuals with mostly mild injuries, five with mostly moderate injured individuals and two clusters with severely injured individuals. Best outcome at 10 years post-injury had a cluster with individuals with moderate injuries, young age at injury, average socioeconomic status (SES) and high pre-injury adaptive function. Worst outcome had a small cluster with severely injured individuals, young age at injury, average SES and average pre-injury adaptive function. Conclusions: The findings suggest that pre-injury adaptive function is an influential predictor of outcome following moderate CTBI. Age at injury in the severe group appears to have increased influence over time, with younger age at injury associated with reduced outcome at 10 years after severe CTBI.	[Jonsson, Catherine Aaro; Catroppa, Cathy; Godfrey, Celia; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne, Vic 3010, Australia; [Smedler, Ann-Charlotte] Stockholm Univ, Stockholm, Sweden		Jonsson, CA (corresponding author), Ostersunds Hosp, Ostersund, Sweden.	catherine.aaro.jonsson@jll.se	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [2010-1390]; Victorian Government's Operational Infrastructure Support Program; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This article was supported by grants of Swedish Council for Working Life and Social Research (C.A.J., grant number 2010-1390), the Victorian Government's Operational Infrastructure Support Program and the Australian National Health and Medical Research Council. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bergman L. R., 2003, STUDYING INDIVIDUAL; Bergman LR, 2006, DEV PSYCHOPATHOLOGY, V1; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; BRESLAU N, 1990, ARCH GEN PSYCHIAT, V47, P15; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cohen J., 2013, STAT POWER ANAL BEHA; Daniel A., 1983, POWER PRIVILEGE PRES; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; DENNIS M, 2007, COGNITIVE RESERVE TH, P53; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Emanuelson I, 1998, PEDIAT REHABILITATIO, V65, P70; Ensign J., 2009, PSYCHOSOCIAL SUBTYPE; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P449; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Morris RD, 1998, J EDUC PSYCHOL, V90, P347, DOI 10.1037/0022-0663.90.3.347; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Rogers E, 2006, J HEAD TRAUMA REHAB, V21, P279, DOI 10.1097/00001199-200605000-00008; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Warschausky S, 2005, NEUROPSYCHOLOGY, V19, P193, DOI 10.1037/0894-4105.19.2.193; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D., 1989, MANUAL PRESCHOOL PRI; Wilkingson GS., 1993, WRAT3 WIDE RANGE ACH; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; [No title captured]	55	8	8	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					831	838		10.3109/02699052.2013.775493			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200009	23789862				2022-02-06	
J	Snedden, TR				Snedden, Traci R.			Concept analysis of concussion	JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING			English	Article						Adolescent; concept analysis; concussion; nursing; pediatric	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; YOUTH; MANAGEMENT; STATEMENT; RECOVERY; PLAY	Purpose. Concussion has been estimated to occur in 1.6-3.8 million adolescent athletes in the United States each year. However, because of conceptual ambiguity regarding its definition, the true incidence is estimated to be significantly higher. This article seeks to identify and support a single definition for the term concussion. Conclusions. Defining attributes, antecedents, and consequences of concussion allow for a better understanding of this concept. Sample cases from pediatric clinical practice further clarify the concept as it applies to pediatric nursing. Practice Implications. A clear definition has the potential to increase knowledge and recognition of concussion injury, leading to strategies that would decrease the risk of long-term effects and devastating outcomes.	Univ Colorado, Coll Nursing, Aurora, CO USA		Snedden, TR (corresponding author), Univ Colorado, Coll Nursing, Aurora, CO USA.	Traci.Snedden@ucdenver.edu		Snedden, Traci/0000-0002-1550-2340			[Anonymous], 2011, COLLINS THESAURUS EN; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bey T, 2009, WEST J EMERG MED, V10, P6; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention (CDC), 2011, INJ PREV CONTR TRAUM; Concussion, MERRIAM WEBSTERS MED; Concussion, COLLINS ENGLISH DICT; Concussion, AM HERITAGE SCI DICT; Concussion, STEDMANS MED DICT; Cook AW, 1966, CLIN NEUROSURG, V12, P386; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Federation of American Scientists, 2011, MK3A2 CONC OFF HAND; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Flamm E., 1996, HIST NEUROSURGERY, P65; Garrison M. L., 1969, ML GARRISONS HIST NE; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia G. A., 2008, J HEAD TRAUMA REH S1, V14, P230; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hippocrates, 1950, HIPPOCRATIC WRITINGS; ICD-9, 2012, CONC; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Olario S., 2001, J ATHL TRAINING, V6, P257; Pardini D., 2004, BR J SPORTS MED, V38, P661; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Trotter W, 1924, LANCET, V1, P935; Walker LO., 2011, STRATEGIES THEORY CO, V5. ed; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	48	8	8	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1539-0136	1744-6155		J SPEC PEDIATR NURS	J. Spec. Pediatr. Nurs.	JUL	2013	18	3					211	220		10.1111/jspn.12038			10	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	176HZ	WOS:000321296100006	23822845				2022-02-06	
J	Vandresen, S; Hoeller, AA; Herculano, BA; Duzzioni, M; Duarte, FS; Piermartiri, TCB; Boeck, CC; de Lima, TCM; Marino-Neto, J; Tasca, CI				Vandresen-Filho, Samuel; Hoeller, Alexandre A.; Herculano, Bruno A.; Duzzioni, Marcelo; Duarte, Filipe S.; Piermartiri, Tetsade C. B.; Boeck, Carina C.; de Lima, Thereza C. M.; Marino-Neto, Jose; Tasca, Carla I.			NMDA Preconditioning Attenuates Cortical and Hippocampal Seizures Induced by Intracerebroventricular Quinolinic Acid Infusion	NEUROTOXICITY RESEARCH			English	Article						NMDA preconditioning; Quinolinic acid; Seizures; Electroencephalography	EXCITOTOXIC NEURONAL DEATH; ASPARTATE-INDUCED SEIZURES; INHIBITS GLUTAMATE UPTAKE; STATUS EPILEPTICUS; ISCHEMIC TOLERANCE; RAT-BRAIN; MICE; DAMAGE; RECEPTORS; NEUROPROTECTION	Searching for new therapeutic strategies through modulation of glutamatergic transmission using effective neuroprotective agents is essential. Glutamatergic excitotoxicity is a common factor to neurodegenerative diseases and acute events such as cerebral ischemia, traumatic brain injury, and epilepsy. This study aimed to evaluate behavioral and electroencephalographic (EEG) responses of mice cerebral cortex and hippocampus to subconvulsant and convulsant application of NMDA and quinolinic acid (QA), respectively. Moreover, it aimed to evaluate if EEG responses may be related to the neuroprotective effects of NMDA. Mice were preconditioned with NMDA (75 mg/kg, i.p.) and EEG recordings were performed for 30 min. One day later, QA was injected (36.8 nmol/site) and EEG recordings were performed during 10 min. EEG analysis demonstrated NMDA preconditioning promotes spike-wave discharges (SWDs), but it does not display behavioral manifestation of seizures. Animals that were protected by NMDA preconditioning against QA-induced behavioral seizures, presented higher number of SWD after NMDA administration, in comparison to animals preconditioned with NMDA that did display behavioral seizures after QA infusion. No differences were observed in latency for the first seizure or duration of seizures. EEG recordings after QA infusion demonstrated there were no differences in the number of SWD, latency for the first seizure or duration of seizures in animals pretreated with saline or in animals preconditioned by NMDA that received QA. A negative correlation was identified between the number of NMDA-induced SWD and QA-induced seizures severity. These results suggest a higher activation during NMDA preconditioning diminishes mice probability to display behavioral seizures after QA infusion.	[Vandresen-Filho, Samuel; Herculano, Bruno A.; Piermartiri, Tetsade C. B.; Tasca, Carla I.] Univ Fed Santa Catarina, CCB, Dept Bioquim, BR-88040900 Florianopolis, SC, Brazil; [Hoeller, Alexandre A.; Duzzioni, Marcelo; Duarte, Filipe S.; de Lima, Thereza C. M.] Univ Fed Santa Catarina, Dept Farmacol, Florianopolis, SC, Brazil; [Boeck, Carina C.] Univ Extremo Sul Catarinense, Programa Posgrad Ciencias Saude, Criciuma, SC, Brazil; [Marino-Neto, Jose] Univ Fed Santa Catarina, Dept Ciencias Fisiol, Florianopolis, SC, Brazil; [Marino-Neto, Jose] Univ Fed Santa Catarina, Inst Biomed Engn, Florianopolis, SC, Brazil		Vandresen, S (corresponding author), Univ Fed Santa Catarina, CCB, Dept Bioquim, BR-88040900 Florianopolis, SC, Brazil.	samuelvandresen@yahoo.com.br	Duzzioni, Marcelo/C-6797-2015; Boeck, Carina Rodrigues/E-9472-2011; Tasca, Carla Ines/AAB-8287-2019; Lima, Thereza CM/C-6812-2015; Herculano, Bruno/N-4587-2019; de Lima, Thereza Christina Monteiro/AAH-9402-2019; Herculano, Bruno/F-8917-2018; Hoeller, Alexandre Ademar/F-2823-2013	Boeck, Carina Rodrigues/0000-0002-6828-5634; Tasca, Carla Ines/0000-0002-3414-6150; Lima, Thereza CM/0000-0002-3253-7350; Herculano, Bruno/0000-0003-0095-3381; Herculano, Bruno/0000-0003-0095-3381; Hoeller, Alexandre Ademar/0000-0001-7526-1502; Piermartiri, Tetsade/0000-0002-9773-6983	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPESCFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC); FINEP-IBN/NetFinanciadora de Inovacao e Pesquisa (Finep) [01.06.0842-00]; INCT for Excitotoxicity and Neuroprotection	This work was supported by grants from CNPq, CAPES, FAPESC (NENASC Project-PRONEX-CNPq/FAPESC), FINEP-IBN/Net (01.06.0842-00), and INCT for Excitotoxicity and Neuroprotection to C.I. Tasca. C.I.T., J.M.N., and T.C.M.L. are recipients of CNPq productivity fellowship.	Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Boeck CR, 2004, EPILEPSIA, V45, P745, DOI 10.1111/j.0013-9580.2004.65203.x; Borges K, 2007, NEUROBIOL DIS, V26, P66, DOI 10.1016/j.nbd.2006.12.001; Cruz SL, 2003, BEHAV BRAIN RES, V140, P195, DOI 10.1016/S0166-4328(02)00323-6; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Geocadin RG, 2005, BRAIN RES, V1064, P146, DOI 10.1016/j.brainres.2005.04.046; Hatazaki S, 2007, NEUROSCIENCE, V150, P467, DOI 10.1016/j.neuroscience.2007.09.020; Herculano BD, 2011, BEHAV BRAIN RES, V219, P92, DOI 10.1016/j.bbr.2010.12.025; HEYES MP, 1989, ANN NEUROL, V26, P275; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jimenez-Mateos EM, 2010, NEUROSCIENCE, V171, P556, DOI 10.1016/j.neuroscience.2010.09.003; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Kabova R, 1999, EPILEPSIA, V40, P1357, DOI 10.1111/j.1528-1157.1999.tb02006.x; Leung LS, 2004, HIPPOCAMPUS, V14, P510, DOI 10.1002/hipo.10199; Marganella C, 2005, EUR J PHARMACOL, V518, P111, DOI 10.1016/j.ejphar.2005.06.022; Miao B, 2005, J BIOL CHEM, V280, P21693, DOI 10.1074/jbc.M500003200; Najm IM, 1998, BRAIN RES, V810, P72, DOI 10.1016/S0006-8993(98)00886-5; Ogita K, 2003, J NEUROCHEM, V85, P1336, DOI 10.1046/j.1471-4159.2003.01778.x; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; POLI A, 1991, J NEUROCHEM, V57, P298, DOI 10.1111/j.1471-4159.1991.tb02128.x; Ralevic V, 1998, PHARMACOL REV, V50, P413; Sanchez AME, 2008, ARCH MED RES, V39, P265, DOI 10.1016/j.arcmed.2007.11.011; Sawant PM, 2010, HIPPOCAMPUS, V20, P994, DOI 10.1002/hipo.20698; Schmidt AP, 2000, BRAIN RES, V864, P40, DOI 10.1016/S0006-8993(00)02106-5; Sommer C, 2002, STROKE, V33, P1093, DOI 10.1161/01.STR.0000014205.05597.45; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; Stone TW, 2000, AMINO ACIDS, V19, P275, DOI 10.1007/s007260070059; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P2362, DOI 10.1073/pnas.261713299; Tavares RG, 2000, NEUROREPORT, V11, P249, DOI 10.1097/00001756-200002070-00005; Tavares RG, 2002, NEUROCHEM INT, V40, P621, DOI 10.1016/S0197-0186(01)00133-4; Torres FV, 2010, EXP NEUROL, V221, P296, DOI 10.1016/j.expneurol.2009.11.013; Vandresen S, 2007, BRAIN RES, V1184, P38, DOI 10.1016/j.brainres.2007.09.091; Vega-Naredo I, 2005, J PINEAL RES, V39, P266, DOI 10.1111/j.1600-079X.2005.00243.x	35	8	8	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428			NEUROTOX RES	Neurotox. Res.	JUL	2013	24	1					55	62		10.1007/s12640-012-9359-y			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154NK	WOS:000319682500005	23184648				2022-02-06	
J	Arbour, RB				Arbour, Richard B.			Traumatic Brain Injury Pathophysiology, Monitoring, and Mechanism-Based Care	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Brain trauma; Primary and secondary injury; Intracranial hypertension; Osmotherapy; Metabolic suppression; Neurological assessment; Neurodiagnostics; Hypothermia	REFRACTORY INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; HYPERTONIC SALINE; TISSUE OXYGEN; MANAGEMENT; PRESSURE; INFUSION; MILD; COMA	Traumatic brain injury, which may be blunt or penetrating, begins altering intracranial physiology at the moment of impact as primary brain trauma. This article differentiates blunt versus penetrating brain trauma, primary versus secondary brain injury, and subsequent intracranial pathophysiology. Discussion and case study correlate intracranial pathophysiology and multisystem influences on evolving brain injury with mechanism-based interventions to modulate brain components (brain, blood, and cerebrospinal fluid volumes). The discussion also explores the effects of controlled ventilation, cardiopulmonary physiology, and global physiologic state on secondary injury, control of intracranial pressure, and recovery.	[Arbour, Richard B.] La Salle Univ, Philadelphia, PA 19141 USA; [Arbour, Richard B.] Holy Family Univ, Philadelphia, PA 19114 USA; [Arbour, Richard B.] Sch Nursing & Hlth Sci, Philadelphia, PA 19141 USA		Arbour, RB (corresponding author), La Salle Univ, 1900 West Olney Ave, Philadelphia, PA 19141 USA.	RichNrs@aol.com					Arbour Richard, 2004, Crit Care Nurse, V24, P19; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Bader Mary Kay, 2006, Crit Care Nurs Clin North Am, V18, P243, DOI 10.1016/j.ccell.2006.01.003; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Barazangi N, 2008, NEUROL INDIA, V56, P405; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS55, DOI DOI 10.1089/NEU.2007.9988; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS45; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS77, DOI DOI 10.1089/NEU.2006.9984; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J NEUROTRAUMA S1, V24, P571; Brain Trauma Foundation: American association of Neurological surgeons, 2007, J NEUROTRAUMA S1, V24, pS59; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cianchi Giovanni, 2012, J Trauma Manag Outcomes, V6, P8, DOI 10.1186/1752-2897-6-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dawodu ST, TRAUMATIC BRAIN INJU; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Diedrich Daniel A, 2011, J Intensive Care Med, V26, P59, DOI 10.1177/0885066610384195; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Faridar A, 2011, FRONT NEUROL, V2, P1; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Griffin LJ, 2012, CRIT CARE NURS Q, V35, P144, DOI 10.1097/CNQ.0b013e31824565b0; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Harris T, 2012, POSTGRAD MED J, V88, P588, DOI 10.1136/postgradmedj-2010-74245; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Honeybul S, 2011, J NEUROSURG SCI, V55, P343; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Ilyas MIM, 2009, ANN THORAC SURG, V87, pE1, DOI 10.1016/j.athoracsur.2008.07.055; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Mcilvoy L, 2012, AACN ADV CRIT CARE, V23, P204, DOI 10.1097/NCI.0b013e31824db1c6; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Pangilinan PH, CLASSIFICATION COMPL; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Protheroe RT, 2011, ANAESTHESIA, V66, P1035, DOI 10.1111/j.1365-2044.2011.06874.x; Rangel-Castilla L., CLOSED HEAD TRAUMA; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rupich K, 2009, J NEUROSCI NURS, V41, P159, DOI 10.1097/JNN.0b013e3181a23ec1; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Schimpf Melissa M, 2012, J Trauma Nurs, V19, P160, DOI 10.1097/JTN.0b013e318261cfb4; Sessler DI, 2009, CRIT CARE MED, V37, pS203, DOI 10.1097/CCM.0b013e3181aa5568; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stewart C, 2008, NEUROSURGERY, V63, P1159, DOI 10.1227/01.NEU.0000333265.19131.7C; Stirer SI, 2009, NEUROSURG FOCUS, V26, P1; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; TEASDALE G, 1974, LANCET, V2, P81; The Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons. 2007; Joint Section on Neurotrauma and Critical Care; AANS/CNS, 2007, J NEUROTRAUMA S1, V24, pS87; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Tsang KKT, 2012, BRIT J ORAL MAX SURG, V50, P298, DOI 10.1016/j.bjoms.2011.03.004; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50; Yetman Linda, 2009, Can J Neurosci Nurs, V31, P22; Zaccheo MA, 2008, CRIT CARE NURSE, V28, P18; Zhang XY, 2011, AM J EMERG MED, V29, P699, DOI 10.1016/j.ajem.2010.01.042	81	8	8	5	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	JUN	2013	25	2					297	+		10.1016/j.ccell.2013.02.010			24	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	161QV	WOS:000320209300014	23692946				2022-02-06	
J	Ma, CK; He, XG; Wang, L; Wang, BC; Li, QF; Jiang, F; Ma, J				Ma, Chenkai; He, Xiaoguang; Wang, Lin; Wang, Baocheng; Li, Qifeng; Jiang, Feng; Ma, Jie			Is therapeutic hypothermia beneficial for pediatric patients with traumatic brain injury? A meta-analysis	CHILDS NERVOUS SYSTEM			English	Article						Hypothermia; Traumatic brain injury; Children; Meta-analysis	CEREBRAL PERFUSION-PRESSURE; CONTROLLED CORTICAL IMPACT; SEVERE HEAD TRAUMA; MODERATE HYPOTHERMIA; INTRACRANIAL-PRESSURE; CHILDREN; HYPOTENSION; RATS; PNEUMONIA; MORTALITY	Hypothermia therapy shows its unique potential for reducing mortality in animal study and improving neurologic outcome in patients with traumatic brain injury. However, therapeutic hypothermia for pediatric traumatic brain injury remains a controversial issue. To determine the effectiveness and safety of hypothermia treatment for pediatric traumatic brain injury patients, we conducted this meta-analysis. We analyzed the data from MEDLINE, Pubmed, EMBASE, and Cochrane Library by electronic searching. No limitation of language was selected for analysis. We extracted the mortality and adverse events from the published trials. Six clinical trials and 366 pediatric patients met our inclusion criteria. Pediatric patients with traumatic brain injury treated with hypothermia had more unfavorable outcome than those in the normothermia group (RR 1.73, 95 % CI 1.06 to 2.84), and this increased risk is statistically significant. Patients with therapeutic hypothermia are slightly likely to be induced by cardiac arrhythmia, and the likelihood is also significant (RR 2.57, 95 % CI 1.01 to 6.54). Risk of pneumonia has no statistical difference between normothermia and hypothermia arms (RR 0.90, 95 % CI 0.73 to 1.12). Two of the included trials have reported their detail randomization assignment. Hypothermia may slightly increase the risk of mortality in children with traumatic brain injury and the ratio of cardiac arrhythmia after this hypothermia therapy is slightly higher than that in normothermia groups. In the future, more randomized controlled trials and multicenter studies on the mechanism of therapeutic hypothermia are required.	[Ma, Chenkai; He, Xiaoguang; Wang, Lin; Wang, Baocheng; Li, Qifeng; Jiang, Feng; Ma, Jie] Shanghai Jiao Tong Univ, Dept Pediat Neurosurg, Shanghai Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China		Ma, J (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat Neurosurg, Shanghai Xinhua Hosp, Sch Med, 1665 Kongjiang Rd, Shanghai 200030, Peoples R China.	majie365@hotmail.com	Ma, Chenkai/AAK-4261-2020	Ma, Chenkai/0000-0003-2172-7332	National Key Basic Research Program (NKBRP)National Basic Research Program of China [2010CB945203]; The National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271382]; Program of Shanghai Subject Chief Scientist [09XD1403300]	This study was supported by the National Key Basic Research Program (NKBRP) (2010CB945203), The National Natural Science Foundation of China (81271382), and the Program of Shanghai Subject Chief Scientist (09XD1403300). The authors also acknowledge Dr. Lianming Wu and Prof. Xucheng Jiang for their critical suggestion.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Beurskens CJP, 2012, CRIT CARE MED, V40, P919, DOI 10.1097/CCM.0b013e3182373174; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Jones PA, 2005, ACT NEUR S, V95, P29; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS3, DOI 10.1097/PCC.0b013e31823f437e; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI [10.1089/neu.2008.0828, 10.1089/neu.2008-0828]; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Mongardon N, 2010, INTENS CARE MED, V36, P92, DOI 10.1007/s00134-009-1681-3; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5	26	8	8	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUN	2013	29	6					979	984		10.1007/s00381-013-2076-x			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	148FE	WOS:000319227800015	23503613				2022-02-06	
J	Mannix, RC; Zhang, J; Berglass, J; Qui, JH; Whalen, MJ				Mannix, Rebekah C.; Zhang, Jimmy; Berglass, Jacqueline; Qui, Jianhua; Whalen, Michael J.			Beneficial effect of amyloid beta after controlled cortical impact	BRAIN INJURY			English	Article						Traumatic brain injury; beta amyloid	TRAUMATIC BRAIN-INJURY; PROTEIN DEPOSITION; TRANSMISSION; INHIBITION; MODULATION; SECRETASE; DEATH	Background: Worse functional outcomes after controlled cortical impact (CCI) in Bace1(-/-) mice have previously been demonstrated. This study investigated whether reconstitution of amyloid-beta (A beta) after CCI in Bace1(-/-) animals would reverse the detrimental effect of Bace1 deletion. Methods: Bace1(-/-) and wild type Bace1(+/+) (C57Bl/ 6) mice were subjected to CCI (n = 14-23/ group) or sham injury (n= 6/ group). After injury, mice underwent intracerebroventricular injections of A beta(40) (n=23 Bace1(-/-) and 17 Bace1(+/+) per group) or vehicle (n=14 Bace1(-/-) and 22 Bace1(+/+) per group). Functional outcomes were assessed with wire grip (motor) and Morris water maze (spatial memory). Soluble A beta levels were assessed at 24 hours and 21 days after CCI. Lesion volume was assessed 21 days after injury. Results: At 24 hours after injury, A beta-treated Bace1(-/-) mice had A beta(40) levels similar to vehicle-treated Bace1(+/+) mice, but by 21 days after injury there were no differences between A beta-treated versus vehicle-treated Bace1(-/-) mice. Reconstitution with A beta(40) improved motor but not spatial memory or histopathological outcome in injured Bace1(-/-) mice. In contrast, treatment with A beta(40) worsened motor performance in Bace1(+/+) mice. Conclusions: The data suggest A beta(40) may have some beneficial effects after CCI in young adult mice and that therapies targeting BACE should be approached cautiously.	[Mannix, Rebekah C.; Berglass, Jacqueline] Harvard Univ, Sch Med, Dept Med, Div Emergency Med,Childrens Hosp Boston, Boston, MA 02115 USA; [Mannix, Rebekah C.; Zhang, Jimmy; Berglass, Jacqueline; Qui, Jianhua; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA USA; [Zhang, Jimmy; Qui, Jianhua; Whalen, Michael J.] Harvard Univ, Dept Pediat, Massachusetts Gen Hosp, Sch Med, Charlestown, MA USA		Mannix, RC (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	rebekah.mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		Charles Hood Foundation (RCM); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5RO1NS047447]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047447] Funding Source: NIH RePORTER	This work was supported by grants from Charles Hood Foundation (RCM) and NINDS 5RO1NS047447 (MJW).	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Preda S, 2008, NEUROPSYCHOPHARMACOL, V33, P1062, DOI 10.1038/sj.npp.1301485; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Zhong P, 2003, J BIOL CHEM, V278, P26888, DOI 10.1074/jbc.M302789200	21	8	8	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					743	748		10.3109/02699052.2013.771797			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500012	23672448				2022-02-06	
J	Sahoo, SS; Agrawal, D				Sahoo, Siddhartha Shankar; Agrawal, Deepak			Correlation of optic nerve sheath diameter with intracranial pressure monitoring in patients with severe traumatic brain injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Intracranial pressure; Ultrasound; TBI; Optic nerve sheath diameter; Severe traumatic brain injury		Aims and objectives: To assess the feasibility and reliability of using optic nerve sheath diameter (ONSD) as an objective measure of intracranial pressure (ICP) in patients of severe head injury. Methods and materials: This prospective study was carried out in Neurosurgery ICU over a 3month period (April-June 2012). All patients with severe traumatic brain injury (admission GCS <= 8) who had ICP monitoring using Codman (R) intraparenchymal transducer had serial bedside ONSD measurements taken by a single neurosurgeon using a 7.5 MHz linear probe on the same ultrasound machine (Sonosite Micromaxx (R)) were enrolled in the study. Patients with significant ocular trauma to either eye were excluded. Results: A total of 20 patients were enrolled during the study period. The mean age was 27 years (range 2-43 years) with M:F ratio of 3:1 and mean GCS of 6 (range 4-8). The mean ONSD in patients with ICP >20 was 6.6 + 0.45mm as compared to 5.9 + 0.57mm in patients with ICP <20 (p = 0.028). The Pearson Correlation Coefficient between ONSD (average of both eyes) and ICP was 0.499 (p = 0.041). A cutoff of 6.3 mm detected ICP >20 mmHg with 100% sensitivity and 72.7% specificity. Conclusion: ONSD is a technically simple, non-invasive method of assessing ICP and correlates well with actual ICP in patients of severe traumatic brain injury. A cutoff of 6.3 mm can be used to plan therapeutic interventions when ICP monitoring is unavailable or contraindicated. Copyright (C) 2013, Neurotrauma Society of India. All rights reserved.	[Sahoo, Siddhartha Shankar; Agrawal, Deepak] All India Inst Med Sci, JPNA Trauma Ctr, Dept Neurosurg, New Delhi 110029, India		Agrawal, D (corresponding author), All India Inst Med Sci, JPNA Trauma Ctr, Dept Neurosurg, New Delhi 110029, India.	drdeepak@gmail.com	/AAG-3032-2021	/0000-0002-5499-0746			Blaivas M, 2005, ACAD EMERG MED, V45, P336; Cennamo G., 1987, OPHTHALM ECHOGR, V7, P603, DOI [10.1007/978-94-009-3315-6_99, DOI 10.1007/978-94-009-3315-6_99]; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; GANGEMI M, 1987, NEUROCHIRURGIA, V30, P53; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; HASSLER W, 1988, J NEUROSURG, V68, P745; HAYREH S S, 1964, Br J Ophthalmol, V48, P522, DOI 10.1136/bjo.48.10.522; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; OSSOINIG K C, 1979, International Ophthalmology Clinics, V19, P127, DOI 10.1097/00004397-197901940-00007; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Steffen H, 1996, OPHTHALMOLOGY, V103, P1229, DOI 10.1016/S0161-6420(96)30518-6; Tamburrelli C., 1993, OPHTHALMIC ECHOGRAPH, P101; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tsung JW, 2005, PEDIATR EMERG CARE, V21, P94, DOI 10.1097/01.pec.0000159052.64930.64	18	8	8	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2013	10	1					9	12		10.1016/j.ijnt.2013.05.010			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M4K	WOS:000218388900003					2022-02-06	
J	Kunz, SN; Brandtner, H; Meyer, H				Kunz, S. N.; Brandtner, H.; Meyer, H.			Unusual blood spatter patterns on the firearm and hand: A backspatter analysis to reconstruct the position and orientation of a firearm	FORENSIC SCIENCE INTERNATIONAL			English	Article						Forensic science; Blood stain pattern analysis; Backspatter; Firearm fatality; Suicide; Reconstruction	CLOSE-RANGE SHOTS; HEAD	When it comes to firearm fatalities, the main goal of forensic analysis is to distinguish firearm suicides from homicides and accidents. Apart from the location of the entrance wound, wound path trajectory and gunshot residue, blood stain pattern analysis of gunshot-related backspatter on the hands of the victim can be an essential tool not only to determine which hand was holding the firearm, but also to reconstruct the position from which a weapon was fired. We present a case of a 90-year-old man, who was found dead in his house. Because of unclear circumstances and an unusual position of the deceased with a gunshot entrance wound to the right temporal region and a firearm found on the left side of his body, an autopsy was performed. Due to the unusual bloodspatter stains on the hands and the firearm, it was possible to deduce the position and orientation of the hands and the firearm of the deceased. We could reconstruct that the man held the weapon in his right hand, using the left hand to stabilise the firearm and the right thumb to pull the trigger. A contact shot to the right temple led to central regulatory failure due to extensive brain injury. The manner of death was concluded to be a suicide. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Kunz, S. N.; Brandtner, H.; Meyer, H.] Paris Lodron Univ Salzburg, IFFB Gerichtsmed & Forens Neuropsychiat, Salzburg, Austria		Kunz, SN (corresponding author), Paris Lodron Univ Salzburg Linz, IFFB Gerichtsmed & Forens Neuropsychiat, Ignaz Harrer Str 79, A-5020 Salzburg, Austria.	sebastian.kunz@sbg.ac.at	Meyer, Harald/F-9926-2013				Davidson PL, 2012, J FORENSIC SCI, V57, P1339, DOI 10.1111/j.1556-4029.2012.02143.x; Druid H, 1997, FORENSIC SCI INT, V88, P147, DOI 10.1016/S0379-0738(97)00104-7; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 2008, FORENSIC SCI INT, V181, P15, DOI 10.1016/j.forsciint.2008.07.010; Karger B, 1997, INT J LEGAL MED, V110, P27; KLAGES U, 1975, Z RECHTSMED, V76, P307, DOI 10.1007/BF02114691; Peschel O, 2011, FORENSIC SCI MED PAT, V7, P257, DOI 10.1007/s12024-010-9198-1; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; Verhoff MA, 2003, INT J LEGAL MED, V117, P229, DOI 10.1007/s00414-003-0383-6; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f	11	8	8	1	92	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	MAY 10	2013	228	1-3					E54	E57		10.1016/j.forsciint.2013.02.012			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	129HF	WOS:000317829100011	23477802				2022-02-06	
J	Martinez, RJA; Voth, AH; Fernandez, CM; Alarza, FH; Serna, IM; de Alba, AM; Bedoya, MZ; Trujillo, MD; Pardo, JCM; Hellin, VD; Cabrero, EL; Garcia, APG				Avila Martinez, Regulo Jose; Hernandez Voth, Ana; Marron Fernandez, Carmen; Hermoso Alarza, Fatima; Martinez Serna, Ivan; Mariscal de Alba, Andrea; Zuluaga Bedoya, Mauricio; Dolores Trujillo, Maria; Meneses Pardo, Jose Carlos; Diaz Hellin, Vicente; Larru Cabrero, Emilio; Gamez Garcia, A. Pablo			Evolution and Complications of Chest Trauma	ARCHIVOS DE BRONCONEUMOLOGIA			Spanish	Article						Thoracic injuries; Comorbidities; Complications	RIB FRACTURES; BLUNT; MANAGEMENT; MORTALITY; OUTCOMES; VICTIMS	Objective: To describe the clinical characteristics and risk factors of patients with chest trauma, and to evaluate their correlation with the development of complications. Methods: Descriptive, prospective and analytical study of a patient cohort with chest trauma who underwent follow-up for a period of 30 days. Excluded from the study were those patients with moderate to severe traumatic brain injury, long-bone fractures, abdominal trauma and patients requiring mechanical ventilation. Results: A total of 376 patients met the inclusion criteria, 220 of whom were males (58.5%). The most frequent causes of trauma were falls (218 cases; 57.9%) and motor vehicle accidents (57 cases; 15.1%). The most frequent type of trauma was rib contusion (248 cases; 65.9%) and rib fractures (61 cases; 16.2%). Complications were observed in 43 patients (11.4%), mainly hemothorax (13 cases), pneumothorax (9 cases), pneumonia (6 cases) and acute renal failure (4 cases). Four patients died due to pneumonia and hemothorax. Thirty-three patients were hospitalized (8.7%) and 10 (2.6%) required later re-admittance.The risk for complications increased significantly in patients with more than 2 rib fractures, in those over the age of 85 and in the presence of certain comorbidities, such as COPD and pathologies requiring anticoagulation therapy. The risk for re-admittance is higher in patients over the age of 60. Conclusions: Patients with chest trauma who present certain comorbidities, are over the age of 85 and have more than 2 rib fractures may present more complications. These factors should be contemplated in the evaluation, management and follow-up of these subjects. (C) 2012 SEPAR. Published by Elsevier Espana, S.L. All rights reserved.	[Avila Martinez, Regulo Jose; Marron Fernandez, Carmen; Hermoso Alarza, Fatima; Martinez Serna, Ivan; Mariscal de Alba, Andrea; Zuluaga Bedoya, Mauricio; Dolores Trujillo, Maria; Meneses Pardo, Jose Carlos; Diaz Hellin, Vicente; Larru Cabrero, Emilio; Gamez Garcia, A. Pablo] Hosp Univ 12 Octubre, Serv Cirugia Torac, Madrid, Spain; [Hernandez Voth, Ana] Hosp Univ 12 Octubre, Serv Neumol, Madrid, Spain		Martinez, RJA (corresponding author), Hosp Univ 12 Octubre, Serv Cirugia Torac, Madrid, Spain.	reguloavila@gmail.com					Aschkenasy MT, 2006, EMERG MED CLIN N AM, V24, P413, DOI 10.1016/j.emc.2006.01.005; ATLS. Comite de Trauma del Colegio Americano de Cirujanos, 1997, PROGR AV AP VIT TRAU; Bamvita JM, 2007, J TRAUMA, V63, P135, DOI 10.1097/TA.0b013e318068651d; Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Chang TT, 2007, SURG CLIN N AM, V87, P229, DOI 10.1016/j.suc.2006.09.010; Gilart JF, 2011, ARCH BRONCONEUMOL, V47, P41, DOI 10.1016/j.arbres.2010.05.014; Freixinet J, 2008, ARCH BRONCONEUMOL, V44, P257, DOI 10.1016/S1579-2129(08)60041-5; Gowing R, 2007, CAN J SURG, V50, P437; Grossman M, 2003, J TRAUMA, V55, P26, DOI 10.1097/01.TA.0000072109.52351.0D; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; HELLING TS, 1989, J TRAUMA, V29, P1367, DOI 10.1097/00005373-198910000-00013; Institut Nacional de Estadistica de Espana, DEM POBL; LEE RB, 1989, J TRAUMA, V29, P795, DOI 10.1097/00005373-198906000-00016; Myint KS, 2012, W INDIAN MED J, V61, P64; Robert B, 2009, INJURIES EUROPEAN UN; Sirmali M, 2003, EUR J CARDIO-THORAC, V24, P133, DOI 10.1016/S1010-7940(03)00256-2; Smith N, 2009, EUR J CARDIO-THORAC, V36, P340, DOI 10.1016/j.ejcts.2009.03.048; Testerman GM, 2006, SOUTH MED J, V99, P335, DOI 10.1097/01.smj.0000203815.29757.d3; Virgos S, 2004, ARCH BRONCONEUMOL, V40, P489	19	8	8	0	5	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0300-2896	1579-2129		ARCH BRONCONEUMOL	Arch. Bronconeumol.	MAY	2013	49	5					177	180		10.1016/j.arbres.2012.12.005			4	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	145ON	WOS:000319026500001	23415575				2022-02-06	
J	Burke, DA; Whittemore, SR; Magnuson, DSK				Burke, Darlene A.; Whittemore, Scott R.; Magnuson, David S. K.			Consequences of Common Data Analysis Inaccuracies in CNS Trauma Injury Basic Research	JOURNAL OF NEUROTRAUMA			English	Article						data analysis; mice; rats; spinal cord injury; statistics; traumatic brain injury	AMERICAN-PHYSIOLOGICAL-SOCIETY; SPINAL-CORD-INJURY; REPORTING STATISTICS; JOURNALS; GUIDELINES; PHARMACOLOGY; MANUSCRIPTS; PRECISE; TESTS; REACH	The development of successful treatments for humans after traumatic brain or spinal cord injuries (TBI and SCI, respectively) requires animal research. This effort can be hampered when promising experimental results cannot be replicated because of incorrect data analysis procedures. To identify and hopefully avoid these errors in future studies, the articles in seven journals with the highest number of basic science central nervous system TBI and SCI animal research studies published in 2010 (N = 125 articles) were reviewed for their data analysis procedures. After identifying the most common statistical errors, the implications of those findings were demonstrated by reanalyzing previously published data from our laboratories using the identified inappropriate statistical procedures, then comparing the two sets of results. Overall, 70% of the articles contained at least one type of inappropriate statistical procedure. The highest percentage involved incorrect post hoc t-tests (56.4%), followed by inappropriate parametric statistics (analysis of variance and t-test; 37.6%). Repeated Measures analysis was inappropriately missing in 52.0% of all articles and, among those with behavioral assessments, 58% were analyzed incorrectly. Reanalysis of our published data using the most common inappropriate statistical procedures resulted in a 14.1% average increase in significant effects compared to the original results. Specifically, an increase of 15.5% occurred with Independent t-tests and 11.1% after incorrect post hoc t-tests. Utilizing proper statistical procedures can allow more-definitive conclusions, facilitate replicability of research results, and enable more accurate translation of those results to the clinic.	[Burke, Darlene A.; Whittemore, Scott R.; Magnuson, David S. K.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40202 USA		Burke, DA (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, 511 S Floyd St, Louisville, KY 40202 USA.	darlene.burke@louisville.edu		Magnuson, David/0000-0003-3816-3676	COBRE; GMS [NIH1P30 RR031159-01A1, GM-8P30GM103507-02]; Kentucky Spinal Cord and Head Injury Research Trust [8-7A]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015576, P30RR031159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103507] Funding Source: NIH RePORTER	This work was supported by grants from COBRE and GMS (NIH1P30 RR031159-01A1 and GM-8P30GM103507-02; to S.R.W., D.S.K.M., and D.A.B.) and Kentucky Spinal Cord and Head Injury Research Trust (8-7A; to D.S.K.M.).	Altman DG, 2000, STAT MED, V19, P3275, DOI 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M; Berger E, 2006, ANN EMERG MED, V47, P157, DOI 10.1016/j.annemergmed.2005.12.015; Castellan N. J, 1988, NONPARAMETRIC STAT B; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Curran-Everett D, 2004, AM J PHYSIOL-ENDOC M, V287, pE189, DOI 10.1152/ajpendo.00213.2004; Curran-Everett D, 1998, J APPL PHYSIOL, V85, P775, DOI 10.1152/jappl.1998.85.3.775; Curran-Everett D, 2007, ADV PHYSIOL EDUC, V31, P295, DOI 10.1152/advan.00022.2007; Doherty ME, 2009, BEHAV RES METHODS, V41, P55, DOI 10.3758/BRM.41.1.55; Drummond GB, 2011, J PHYSIOL-LONDON, V589, P5007, DOI 10.1113/jphysiol.2011.221093; Drummond GB, 2011, ADV PHYSIOL EDUC, V35, P129, DOI 10.1152/advan.00029.2011; Evans RG, 2008, CLIN EXP PHARMACOL P, V35, P1274, DOI 10.1111/j.1440-1681.2008.05023.x; Evans RG, 2011, CLIN EXP PHARMACOL P, V38, P285, DOI 10.1111/j.1440-1681.2011.05508.x; Hays WL, 1981, STATISTICS; Hill RL, 2009, J NEUROTRAUM, V26, P1, DOI 10.1089/neu.2008.0543; Kurusz M, 2010, PERFUSION-UK, V25, P55, DOI 10.1177/0267659110369740; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lenth RV, 2006, JAVA APPLETS POWER S; Ludbrook J, 2005, CLIN EXP PHARMACOL P, V32, P324, DOI 10.1111/j.1440-1681.2005.04221.x; Ludbrook J, 2003, J CLIN NEUROSCI, V10, P540, DOI 10.1016/S0967-5868(03)00091-2; Ludbrook J, 2001, CLIN EXP PHARMACOL P, V28, P488, DOI 10.1046/j.1440-1681.2001.3474.x; Ludbrook J, 2000, CLIN EXP PHARMACOL P, V27, P212, DOI 10.1046/j.1440-1681.2000.03223.x; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Morton JP, 2009, ADV PHYSIOL EDUC, V33, P7, DOI 10.1152/advan.90207.2008; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Schriger DL, 2006, ANN EMERG MED, V48, P743, DOI 10.1016/j.annemergmed.2006.03.028; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; WRATHALL JR, 1992, J NEUROTRAUM, V9, P165, DOI 10.1089/neu.1992.9.165; Zhang YP, 2008, J NEUROTRAUM, V25, P1227, DOI 10.1089/neu.2007.0388	30	8	8	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	10					797	805		10.1089/neu.2012.2704			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	149QM	WOS:000319336100001	23186206	Green Published			2022-02-06	
J	Takeuchi, S; Wada, K; Nawashiro, H; Uozumi, Y; Otani, N; Nagatani, K; Kobayashi, H; Shima, K				Takeuchi, Satoru; Wada, Kojiro; Nawashiro, Hiroshi; Uozumi, Yoichi; Otani, Naoki; Nagatani, Kimihiro; Kobayashi, Hiroaki; Shima, Katsuji			Decrease in Plasma Adiponectin Level and Increase in Adiponectin Immunoreactivity in Cortex and Hippocampus After Traumatic Brain Injury in Rats	TURKISH NEUROSURGERY			English	Article						Adiponectin; Traumatic brain injury; Lateral fluid percussion; Rat	INSULIN-RESISTANCE; PROTEIN; SERUM	AIM: Adiponectin plays an important role in the regulation of tissue inflammation. Recently, it has been reported that the plasma adiponectin levels in several acute illnesses decrease periodically, thus indicating that adiponectin may play a role in the inflammatory response in patients with acute illness. However, little is known about the effects of adiponectin following TBI. The aim of the present study was to examine the changes in the plasma adiponectin levels and the immunoreactivity of adiponectin in the brain after TBI. MATERIAL and METHODS: Adult male Sprague-Dawley rats were subjected to lateral fluid percussion injury using the Dragonfly device. Plasma adiponectin levels were determined by ELISA kit. Immunohistochemistry and Western blot analysis were performed to assess the immunoreactivity of adiponectin. RESULTS: The plasma adiponectin levels gradually decreased and were significantly lower at 48 h and 72h after injury than before injury. Immunohistochemistry and Western blot analysis showed that the adiponectin immunoreactivity was increased in the cerebral cortex at 24 hours after injury and in the hippocampus at 72 hours after injury. CONCLUSION: Our findings suggest that adiponectin might participate in the pathophysiological process occurring after TBI.	[Takeuchi, Satoru; Wada, Kojiro; Nawashiro, Hiroshi; Uozumi, Yoichi; Otani, Naoki; Nagatani, Kimihiro; Kobayashi, Hiroaki; Shima, Katsuji] Natl Def Med Coll, Dept Neurosurg, Saitama, Japan		Takeuchi, S (corresponding author), Natl Def Med Coll, Dept Neurosurg, Saitama, Japan.	drne776@ndmc.ac.jp		Uozumi, Yoichi/0000-0002-5985-2764			Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Conti AC, 1998, J NEUROSCI, V18, P5663; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Gil-Campos M, 2004, CLIN NUTR, V23, P963, DOI 10.1016/j.clnu.2004.04.010; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Hickman IJ, 2007, DIABETES OBES METAB, V9, P438, DOI 10.1111/j.1463-1326.2006.00604.x; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Marousi S, 2010, ACTA NEUROL SCAND, V121, P277, DOI 10.1111/j.1600-0404.2009.01231.x; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Nishimura M, 2008, CIRCULATION, V117, P216, DOI 10.1161/CIRCULATIONAHA.107.725044; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Soares HD, 1995, J NEUROSCI, V15, P8223; Stahel PF, 2008, PPAR RES, V2008, DOI 10.1155/2008/538141; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Thundyil John, 2010, Exp Transl Stroke Med, V2, P15, DOI 10.1186/2040-7378-2-15; Venkatesh B, 2009, CRIT CARE, V13, DOI 10.1186/cc7941; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yatomi K, 2009, BRAIN RES, V1297, P169, DOI 10.1016/j.brainres.2009.08.039	24	8	8	0	2	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAY	2013	23	3					349	354		10.5137/1019-5149.JTN.7023-12.1			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	178WD	WOS:000321477200009	23756974	Bronze			2022-02-06	
J	Tsaousides, T; Ashman, TA; Gordon, WA				Tsaousides, Theodore; Ashman, Teresa A.; Gordon, Wayne A.			Diagnosis and Treatment of Depression Following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						depression; traumatic brain injury; interventions; pharmacological; psychotherapeutic; neurorehabilitation	RANDOMIZED CONTROLLED-TRIAL; SCHEDULED TELEPHONE INTERVENTION; COGNITIVE-BEHAVIORAL THERAPY; II PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; HEAD-INJURY; AXIS-I; MAGNETIC-FIELDS; DSM-IV; REHABILITATION	Depression is one of the most common psychiatric diagnoses among individuals with traumatic brain injury (TBI). Prevalence of post-TBI depression (PTBID) ranges from 12 to 60% and is generally higher than rates reported in the general population. The wide range in reported rates is attributed to methodological variability across studies, including measurement and sampling differences. Several systematic reviews have been published in the past 5 years, reporting on outcomes for depression across different classes of interventions, including pharmacological, biomedical and behavioural. The consensus across reviews is that more research is necessary to develop evidence-based practice guidelines. The present narrative review synthesises the findings of previous studies, focusing on the nature of the interventions, the eligibility criteria for inclusion and the assessment of outcome. Pharmacological studies are generally more rigorous methodologically, but provide mixed findings. Other biomedical interventions are only at the initial stages of research development, including case and pilot studies. The results of behavioural studies are positive regarding improvements in mood. However, the number of efficacy studies of behavioural interventions for depression is extremely limited. Recommendations for designing interventions are provided.	[Tsaousides, Theodore; Gordon, Wayne A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ashman, Teresa A.] NYU, Langone Med Ctr, New York, NY USA		Tsaousides, T (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	theodore.tsaousides@mountsinai.org					Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Ashman T. A., 2011, AM C REH MED OCT ATL; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Baker-Price L, 2003, PERCEPT MOTOR SKILL, V96, P965, DOI 10.2466/PMS.96.3.965-974; BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard Michel, 2012, Adv Mind Body Med, V26, P14; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; Derogatis L., 1994, ADM SCORING PROCEDUR; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Doering B, 2011, CURR OPIN PSYCHIATR, V24, P156, DOI 10.1097/YCO.0b013e328343804e; Donnellan Clare P, 2006, Acupunct Med, V24, P129; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Gertler P., 2012, COCHRANE DB SYST REV, DOI 0.1002/14651858.CD009871; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Guillamondegui OD, 2011, AHRQ PUBLICATION; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kanetani Kouichi, 2003, Journal of Nippon Medical School, V70, P313; Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32, DOI 10.1176/jnp.11.1.32; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Li XH, 2012, NEUROPSYCHOPHARMACOL, V37, P77, DOI 10.1038/npp.2011.198; Martino C, 2008, J ECT, V24, P92, DOI 10.1097/YCT.0b013e31814faae5; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mulder RT, 2006, AM J PSYCHIAT, V163, P95, DOI 10.1176/appi.ajp.163.1.95; Newburn G, 1999, BRAIN INJURY, V13, P637; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Pettit JW, 2006, PSYCHIAT RES, V141, P271, DOI 10.1016/j.psychres.2005.07.022; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Taylor D, 2011, BRIT J PSYCHIAT, V198, P179, DOI 10.1192/bjp.bp.110.077610; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	89	8	8	0	16	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2013	14	1			SI		63	76		10.1017/BrImp.2013.8			14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	189EY	WOS:000322251300007		Bronze			2022-02-06	
J	Tseng, YJ; Hung, YC; Hu, WL				Tseng, Ying-Jung; Hung, Yu-Chiang; Hu, Wen-Long			Acupuncture Helps Regain Postoperative Consciousness in Patients with Traumatic Brain Injury: A Case Study	JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE			English	Article								Objective: This report of one case illustrates the potential effect of acupuncture therapy in addition to Western medicine for regaining postoperative consciousness in patients with traumatic brain injury (TBI). Clinical features: A 65-year-old man experienced a TBI after being involved in a motor vehicle accident. His initial Glasgow Coma Scale (GCS) score was E1V1M2, and brain computerized tomography showed a right-sided subdural hemorrhage. He received emergency medical treatment and underwent craniotomy to remove the lacerated portions of brain as well as subtemporal decompression, followed by a decompressive craniectomy the following day to remove an intracerebral hematoma due to late-onset temporo-parietal rebleeding. Twelve days after surgery, the patient remained in poor condition due to serious complications and the GCS was E2VeM4. His family then underwent counseling and he subsequently received acupuncture treatment. Intervention and outcome: This patient was treated with acupuncture three times each week, consisting of strong stimulation at GV26 (Shuigou) and the 12 Well points using the half-needling technique. After 3 weeks of consecutive treatment, his GCS score improved to E4VtM6. In addition, he regained consciousness and could tolerate rehabilitation programs. Conclusions: We believe that an experienced physician may use acupuncture as complementary therapy in patients with TBI who fail to regain consciousness postoperatively.	[Tseng, Ying-Jung; Hung, Yu-Chiang; Hu, Wen-Long] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Tseng, Ying-Jung; Hung, Yu-Chiang; Hu, Wen-Long] Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan; [Hu, Wen-Long] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Hu, Wen-Long] Fooyin Univ, Coll Nursing, Kaohsiung, Taiwan		Hu, WL (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Chinese Med, 123 Dapi Rd, Kaohsiung 833, Taiwan.	oolonghu@gmail.com	Hu, Wen-Long/N-1660-2014; Hung, yu-chiang/ABE-7636-2020	Hu, Wen-Long/0000-0001-9549-6202; 			Cao Ben-Fang, 2011, Zhongguo Zhen Jiu, V31, P121; Chen Jian-Hua, 2007, Zhongguo Zhen Jiu, V27, P907; Chen Xiao-yun, 2009, Zhongguo Zhen Jiu, V29, P619; Fu Ying-ying, 2009, Zhongguo Zhen Jiu, V29, P107; He Jing, 2005, J Tradit Chin Med, V25, P171; Hu WL, 2011, ACUPUNCTURE CLIN PRA, P3; Kuo CY, 1995, TAIPEI J MED, V24, P36; Liu Jian-ping, 2010, Zhongguo Zhen Jiu, V30, P206; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Misulis KE, TRAUMATIC BRAIN INJU; Peng Fan, 2010, Zhongguo Zhen Jiu, V30, P465; Tamai Hideaki, 2009, Masui, V58, P349; Wong V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007700.pub2; Yi Guo, 2005, J Tradit Chin Med, V25, P85; Zheng Lu, 2005, Zhongguo Zhen Jiu, V25, P82	15	8	8	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1075-5535	1557-7708		J ALTERN COMPLEM MED	J. Altern. Complement Med.	MAY	2013	19	5					474	477		10.1089/acm.2012.0163			4	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	140VZ	WOS:000318685700015	23210471				2022-02-06	
J	Boyko, M; Kuts, R; Gruenbaum, BF; Melamed, I; Gruenbaum, SE; Klein, M; Shapira, Y; Zlotnik, A				Boyko, Matthew; Kuts, Ruslan; Gruenbaum, Benjamin F.; Melamed, Israel; Gruenbaum, Shaun E.; Klein, Moti; Shapira, Yoram; Zlotnik, Alexander			The Role of Hypothermia in the Regulation of Blood Glutamate Levels in Naive Rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						glutamate; glutamate oxaloacetate transaminase (GOT); glutamate pyruvate transaminase (GPT); hypothermia; neuroprotection	EXCITATORY AMINO-ACIDS; ACUTE ISCHEMIC-STROKE; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; OXALOACETATE TRANSAMINASE; CEREBRAL-ISCHEMIA; MILD HYPOTHERMIA; BRAIN-BARRIER	Background: The exact mechanism of hypothermia-induced neuroprotection has not been determined yet; however, we hypothesized that it may be mediated by a blood glutamate-scavenging effect. Here, we examine the effect of hypothermic conditions (mild, moderate, and deep) on blood glutamate levels in naive rats. To identify the mechanism of hypothermia-induced glutamate reduction, we also measured concentrations of glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT), the primary regulators of glutamate concentration in blood. Methods: Rats were anesthetized with isoflurane, and their rectal temperature was maintained for 6 hours at 36 to 37 degrees C, 33 to 36 degrees C, 30 to 32 degrees C, 18 to 22 degrees C, or was not maintained artificially. At 6 hours, active cooling was discontinued and rats were allowed to rewarm. There were 12 rats in each group for a total of 60 rats. Blood samples were drawn at 0, 3, 6, 12, 24, and 48 hours for the determination of blood glutamate, GOT, and GPT levels. Results: A strong correlation between body temperature and blood glutamate levels was observed (P < 0.001). Mild (33 to 36 degrees C) and moderate (30 to 32 degrees C) hypothermia led to reduced blood glutamate levels (P < 0.001). Deep hypothermia (18 to 22 degrees C) was associated with significant elevations in blood glutamate levels (P < 0.001). Hypothermia, irrespective of the degree, led to elevations in GOT in plasma (P < 0.001). Conclusions: Mild and moderate hypothermia led to a reduction in blood glutamate levels in rats, whereas deep hypothermia was associated with a significant elevation in blood glutamate levels. We further demonstrated an elevation of GOT and GPT levels, supporting their involvement in reducing blood glutamate by the conversion of glutamate to 2-ketoglutarate. We suggest that the neuroprotective properties of hypothermia may be partially because of a blood glutamate-scavenging mechanism.	[Boyko, Matthew; Kuts, Ruslan; Gruenbaum, Benjamin F.; Klein, Moti; Shapira, Yoram; Zlotnik, Alexander] Soroka Univ, Med Ctr, Dept Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel; [Melamed, Israel] Soroka Univ, Med Ctr, Dept Neurosurg, IL-84105 Beer Sheva, Israel; [Zlotnik, Alexander] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA		Zlotnik, A (corresponding author), Soroka Univ, Med Ctr, Dept Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	klein, moti/AAR-6552-2021	Boyko, Matthew/0000-0003-3116-1643			ALTLAND PD, 1974, CRYOBIOLOGY, V11, P296, DOI 10.1016/0011-2240(74)90005-4; Arakawa H, 1997, J PHARMACOL EXP THER, V280, P1296; Berger C, 2004, EXP NEUROL, V185, P305, DOI 10.1016/j.expneurol.2003.10.008; Berger C, 2002, STROKE, V33, P519, DOI 10.1161/hs0102.100878; Bissonnette B, 1999, ANESTHESIOLOGY, V91, P1763, DOI 10.1097/00000542-199912000-00030; BLAIR E, 1961, SCIENCE, V133, P105, DOI 10.1126/science.133.3446.105; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; Campos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044191; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castellanos M, 2008, NEUROLOGY, V71, P1862, DOI 10.1212/01.wnl.0000326064.42186.7e; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Divino JC, 1999, AM J PHYSIOL-ENDOC M, V277, pE693, DOI 10.1152/ajpendo.1999.277.4.E693; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kentner R, 2002, SHOCK, V17, P521, DOI 10.1097/00024382-200206000-00014; Koura SS, 1998, ACT NEUR S, V71, P244; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Roti JLR, 2008, INT J HYPERTHER, V24, P3, DOI 10.1080/02656730701769841; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Tang XN, 2009, J NEUROTRAUM, V26, P325, DOI 10.1089/neu.2008.0594; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2007, P NATL ACAD SCI USA, V104, P7315, DOI 10.1073/pnas.0702450104; Teichberg VI, 2011, J CEREBR BLOOD F MET, V31, P1376, DOI 10.1038/jcbfm.2011.46; Tisherman Samuel A, 2004, Curr Opin Crit Care, V10, P512; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2010, ANESTH ANALG, V111, P1497, DOI 10.1213/ANE.0b013e3181fc0112; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b; ZORNOW MH, 1995, J NEUROSURG ANESTH, V7, P148, DOI 10.1097/00008506-199504000-00022	42	8	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2013	25	2					174	183		10.1097/ANA.0b013e31827ee0ac			10	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	103XN	WOS:000315952900009	23295267				2022-02-06	
J	DeLoughery, EP; Lenfesty, B; DeLoughery, TG				DeLoughery, Emma P.; Lenfesty, Barbara; DeLoughery, Thomas G.			The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						intracranial haemorrhage; plasma; recombinant factor VIIa; warfarin	PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; MANAGEMENT; REVERSAL	Patients on warfarin who have traumatic intracranial haemorrhage have a high mortality. The procoagulant recombinant factor VIIa (rFVIIa) is widely used off-label to treat intracranial haemorrhaging in patients taking warfarin to try to improve these adverse outcomes, but its effectiveness is unknown. In this study, medical records from 2002 to 2010 were reviewed for 27 warfarin patients who received rFVIIa for their traumatic intracranial haemorrhage and were compared with a matched control group of 27 warfarin patients who did not receive rFVIIa. The two groups were matched for sex, age and Injury Severity Score. The rFVIIa patients had 33.3% mortality compared with the 37% for the control patients, but this was not a statistically significant difference. There was also no significant difference in plasma unit use between the groups. However, the rFVIIa group had a significantly higher number of subdural haemorrhages, which carry a better prognosis. The initial international normalized ratios (INRs) of the rFVIIa patients were higher, and the decrease of INR was more pronounced than in the control patients. From the data, it appears that although the INRs of rFVIIa patients did improve compared with the control group, there was no reduction in plasma use or mortality. Blood Coagul Fibrinolysis 24:317-320 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[DeLoughery, Emma P.; DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Med Oncol, Portland, OR 97201 USA; [Lenfesty, Barbara] Oregon Hlth & Sci Univ, Dept Surg, Trauma Serv, Portland, OR 97201 USA; [DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Dept Pathol, Div Lab Med, Portland, OR 97201 USA; [DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Dept Pediat, Div Hematol Med Oncol, Portland, OR 97201 USA		DeLoughery, TG (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Hematol L586, Portland, OR 97201 USA.	delought@ohsu.edu					Brown CVR, 2012, AM SURGEON, V78, P57; Dager WE, 2006, PHARMACOTHERAPY, V26, P1091, DOI 10.1592/phco.26.8.1091; Elliott J, 2010, ANESTH ANALG, V110, P1419, DOI 10.1213/ANE.0b013e3181d568c8; Illanes S, 2011, STROKE, V42, P191, DOI 10.1161/STROKEAHA.110.593541; Logan AC, 2011, ANN INTERN MED, V154, P516, DOI 10.7326/0003-4819-154-8-201104190-00002; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Nishijima DK, 2010, ACAD EMERG MED, V17, P244, DOI 10.1111/j.1553-2712.2010.00666.x; Nyquist P, 2010, CRIT CARE MED, V38, P946, DOI 10.1097/CCM.0b013e3181d16a04; Pinner NA, 2010, WORLD NEUROSURG, V74, P631, DOI 10.1016/j.wneu.2010.06.030; Sarode R, 2012, J NEUROSURG, V116, P491, DOI 10.3171/2011.11.JNS11836; Skolnick BE, 2010, BLOOD, V116, P693, DOI 10.1182/blood-2009-11-253492	11	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0957-5235			BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	APR	2013	24	3					317	320		10.1097/MBC.0b013e32835cc16b			4	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	114KN	WOS:000316739900016	23429251				2022-02-06	
J	Jain, SK; Sundar, IV; Sharma, V; Prasanna, KL; Kulwal, G; Tiwari, RN				Jain, S. K.; Sundar, I. Vijay; Sharma, Vinod; Prasanna, K. L.; Kulwal, Gaurav; Tiwari, Rahul Nath			Bilateral large traumatic basal ganglia haemorrhage in a conscious adult: A rare case report	BRAIN INJURY			English	Article						Bilateral; traumatic basal ganglia haemorrhage; adult	HEMATOMAS	Background: Bilateral traumatic basal ganglia haematoma is an extremely rare event in traumatic brain injuries, with only five reported cases. The presumed mechanism is due to shearing forces leading to haemorrhage from the lenticulostriate or anterior choroidal artery. The prognosis appears to be dependent on the extent and severity of underlying brain injury. Case study: A case of a 38 year old fully conscious male, who presented with bilateral basal ganglia haematoma and extradural haematoma, is presented and the relevant literature is briefly reviewed.	[Jain, S. K.; Sundar, I. Vijay; Sharma, Vinod; Prasanna, K. L.; Kulwal, Gaurav; Tiwari, Rahul Nath] SMS Med Coll & Hosp, Dept Neurosurg, Jaipur 302004, Rajasthan, India		Jain, SK (corresponding author), 230 Himmat Nagar,Tonk Rd, Jaipur 302018, Rajasthan, India.	shashi_neelu@yahoo.com	ILANGOVAN, VIJAY SUNDAR/AAV-7056-2020	ILANGOVAN, VIJAY SUNDAR/0000-0003-1902-737X			ADAMS JH, 1986, J NEUROL NEUROSUR PS, V49, P1039, DOI 10.1136/jnnp.49.9.1039; Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; Graham D.I., 1996, NEUROTRAUMA, P43; Jang KJ, 2007, J KOREAN NEUROSURG S, V41, P272, DOI 10.3340/jkns.2007.41.4.272; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; Kaushal R, 2011, INDIAN J NEUROTRAUM, V8, P109, DOI 10.1016/S0973-0508(11)80010-9; Kumar D, 2009, THE INTERNET JOURNAL, V6; LEE JP, 1991, J TRAUMA, V31, P376, DOI 10.1097/00005373-199103000-00011; MACPHERSON P, 1986, J NEUROL NEUROSUR PS, V49, P29, DOI 10.1136/jnnp.49.1.29; MOSBERG WH, 1959, J NEUROSURG, V16, P209, DOI 10.3171/jns.1959.16.2.0209; YAMAMOTO F, 1990, Neurological Surgery, V18, P563; Yanagawa Y, 1997, NEUROL SURG TOKYO, V25, P1105; YANAKA K, 1991, Neurological Surgery, V19, P369	13	8	8	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2013	27	4					500	503		10.3109/02699052.2013.765597			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	117LG	WOS:000316954300015	23472761				2022-02-06	
J	Mann, V; Mann, ST; Alejandre-Lafont, E; Rohrig, R; Weigand, MA; Muller, M				Mann, V.; Mann, S. T.; Alejandre-Lafont, E.; Roehrig, R.; Weigand, M. A.; Mueller, M.			Supraglottic airway devices in emergency medicine. Impact of gastric drainage	ANAESTHESIST			German	Article						Laryngeal tube; Gastric dilatation; Respiratory aspiration; Airway management; Emergency medicine	LARYNGEAL MASK AIRWAY; ENDOTRACHEAL INTUBATION; PREHOSPITAL AIRWAY; BADEN-WUERTTEMBERG; STOMACH INFLATION; DIFFICULT AIRWAY; MEDICAL SYSTEM; TUBE SUCTION; MANAGEMENT; EQUIPMENT	This case report describes a life-saving use of a supraglottic airway device (LT-D (TM)-Larynxtubus, VBM Medizintechnik, Sulz, Germany) in an out-of-hospital emergency patient suffering from severe traumatic brain injury. Mechanical ventilation with the laryngeal tube was complicated by repeated airway obstructions and pronounced gastric distension with air as a consequence of oropharyngeal leakage. In this situation pulmonary ventilation of the patient was compromised so that emergency endotracheal intubation became necessary in the resuscitation area with vital indications. In this context the status of supraglottic airway devices in emergency medicine is discussed as well as the reasons for the gastric distension. Besides the immediate drastic consequences of gastric distension with respect to pulmonary ventilation, potential deleterious non-pulmonary consequences of this complication are highlighted. The clinical relevance of the described complications as well as the associated possibility of an optimized position control necessitate the recommendation only to use second generation supraglottic airway devices with integrated gastric access in (out-of-hospital) emergency medicine.	[Mann, V.; Roehrig, R.; Weigand, M. A.; Mueller, M.] Univ Klinikum Giessen & Marburg GmbH, Klin Anaesthesiol, D-35382 Giessen, Germany; [Alejandre-Lafont, E.] Univ Klinikum Giessen & Marburg GmbH, Radiol, D-35382 Giessen, Germany		Muller, M (corresponding author), Univ Klinikum Giessen & Marburg GmbH, Klin Anaesthesiol, Campus Giessen,Rudolf Buchheim Str 7, D-35382 Giessen, Germany.	matthias.f.mueller@chiru.med.uni-giessen.de	Rohrig, Rainer/D-8581-2013; Rohrig, Rainer/G-7238-2015; Mueller, Matthias F/D-8560-2013	Rohrig, Rainer/0000-0002-0032-5118; 			Adnet F, 1998, ANN EMERG MED, V32, P454, DOI 10.1016/S0196-0644(98)70175-1; Asai T, 2002, RESUSCITATION, V55, P171, DOI 10.1016/S0300-9572(02)00170-3; Bercker S, 2008, ANESTH ANALG, V106, P445, DOI 10.1213/ane.0b013e3181602ae1; Berlac P, 2008, ACTA ANAESTH SCAND, V52, P897, DOI 10.1111/j.1399-6576.2008.01673.x; BRAIN AIJ, 1983, BRIT J ANAESTH, V55, P801, DOI 10.1093/bja/55.8.801; Braun P, 2010, CURR OPIN ANESTHESIO, V23, P500, DOI 10.1097/ACO.0b013e32833bc135; Breckwoldt J, 2011, RESUSCITATION, V82, P1519, DOI 10.1016/j.resuscitation.2011.06.028; Brimacombe J, 2003, ANESTH ANALG, V97, P1192, DOI 10.1213/01.ANE.0000078818.64971.44; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Cook T, 2011, BJA EDUC, V11, P56, DOI 10.1093/bjaceaccp/mkq058; Deakin CD, 2005, EMERG MED J, V22, P64, DOI 10.1136/emj.2004.017178; Deakin CD, 2010, RESUSCITATION, V81, P539, DOI 10.1016/j.resuscitation.2010.02.001; Dengler V, 2011, ANAESTHESIST, V60, P135, DOI 10.1007/s00101-010-1774-y; Do Shin S, 2012, RESUSCITATION, V83, P313, DOI 10.1016/j.resuscitation.2011.10.028; FRASS M, 1987, ANN EMERG MED, V16, P768, DOI 10.1016/S0196-0644(87)80571-1; Gaitini LA, 2004, ANESTHESIOLOGY, V101, P316, DOI 10.1097/00000542-200408000-00011; Genzwurker H, 2007, ANAESTHESIST, V56, P665, DOI 10.1007/s00101-007-1194-9; Genzwurker HV, 2010, ANASTH INTENSIVMED, V51, P202; Genzwurker H, 2002, ANAESTHESIST, V51, P367, DOI 10.1007/s00101-002-0303-z; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Heidegger T, 2003, ANAESTHESIST, V52, P381, DOI 10.1007/s00101-003-0501-3; Jackson KM, 2007, ANAESTHESIA, V62, P388, DOI 10.1111/j.1365-2044.2007.04983.x; Johnston BD, 2006, ACAD EMERG MED, V13, P1051, DOI 10.1197/j.aem.2006.06.031; Keller C, 2000, ANESTH ANALG, V91, P1017, DOI 10.1097/00000539-200010000-00046; Klaver NS, 2007, ANAESTHESIA, V62, P723, DOI 10.1111/j.1365-2044.2007.05073.x; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Mann V, 2012, NOTFALL RETTUNGSMED, V15, P136, DOI 10.1007/s10049-011-1413-4; Mann V, 2011, ANASTH INTENSIVMED, V52, P824; Paal P, 2009, RESUSCITATION, V80, P365, DOI 10.1016/j.resuscitation.2008.12.001; Paal P, 2009, RESUSCITATION, V80, P142, DOI 10.1016/j.resuscitation.2008.09.005; Russo SG, 2010, ANAESTHESIST, V59, P929, DOI 10.1007/s00101-010-1782-y; Schmid M, 2011, ACTA ANAESTH SCAND, V55, P583, DOI 10.1111/j.1399-6576.2011.02418.x; Schmid M, 2009, ANAESTHESIA, V64, P625, DOI 10.1111/j.1365-2044.2008.05859.x; Schmid MC, 2006, ANAESTHESIST, V55, P1051, DOI 10.1007/s00101-006-1078-4; Schmid MC, 2009, ANAESTHESIST, V58, P884, DOI 10.1007/s00101-009-1584-2; Sharma V, 2010, BRIT J ANAESTH, V105, P228, DOI 10.1093/bja/aeq118; Timmermann A, 2007, ANAESTHESIST, V56, P328, DOI 10.1007/s00101-007-1153-5; Timmermann A, 2012, ANASTH INTENSIVMED, V53, P294; Timmermann A, 2011, ANAESTHESIA, V66, P45, DOI 10.1111/j.1365-2044.2011.06934.x; Timmermann A, 2006, RESUSCITATION, V70, P179, DOI 10.1016/j.resuscitation.2006.01.010; von Goedecke A, 2007, ANESTH ANALG, V104, P481, DOI 10.1213/01.ane.0000255964.86086.63; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156; Wang HE, 2012, RESUSCITATION, V83, P1061, DOI 10.1016/j.resuscitation.2012.05.018; Wenzel V, 1998, RESUSCITATION, V38, P113, DOI 10.1016/S0300-9572(98)00095-1; Wirtz DD, 2007, PREHOSP EMERG CARE, V11, P213, DOI 10.1080/10903120701205935	46	8	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	APR	2013	62	4					285	+		10.1007/s00101-013-2154-1			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	130EH	WOS:000317895000006	23494024				2022-02-06	
J	Schmidt, K; Jakubietz, M; Harenberg, P; Holzapfel, BM; Rudert, M; Meffert, R; Jakubietz, R				Schmidt, K.; Jakubietz, M.; Harenberg, P.; Holzapfel, B. M.; Rudert, M.; Meffert, R.; Jakubietz, R.			The distally based adipofascial sural artery flap for the reconstruction of distal lower extremity defects	OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE			German	Article						Arteria suralis flap; Island flap; Adipofascial flap; Leg injuries; Operative procedures	SOFT-TISSUE DEFECTS; ISLAND FLAP; LOWER-LEG; COVERAGE; ANKLE; FOOT	Problematic tissue defects in the distal one-third of the lower leg represent a special challenge for the operative therapy. The distally based adipofascial sural artery flap is a safe and effective modification of the classical fasciocutaneous sural artery flap technique and makes the reconstruction in this problematic area more feasible. The surgical aim is soft tissue reconstruction with local tissue avoiding free tissue transfer. Complex or chronic wounds (maximum width of 8 cm) of the distal lower leg with exposed bone, joints, tendons, and/or neurovascular structures, especially in cases of missing skin perforators. Arterial vascular disease (stage III-IV), especially peroneal artery occlusion. Postthrombotic syndrome with occlusion of the small saphenous vein. Chronic lymphedema. Preparation of the vascular pedicle of the distally based flap (including small saphenous vein, sural artery and nerve), the adjacent crural fascia and the subcutaneous fat without a skin island. The pivot point is about 6 cm cranial to the malleolus lateralis. The flap can be raised proximally up to the heads of the gastrocnemius muscle. After harvesting the flap there will be a change in blood flow direction in the small saphenous vein. The donor site can be closed primarily. The flap is covered with meshed split skin graft at the end of surgery. Strict elevation of the extremity for 5 days, then flap conditioning. Between 1997 and 2012, this technique was used in 104 consecutive patients with soft tissue defects in the distal one-third of the lower leg. Flap survival was achieved 91 patients. In 2 patients amputation of the lower leg was necessary at the mid tibia level. In 3 cases flap necrosis occurred, requiring free tissue transfer.	[Schmidt, K.; Jakubietz, M.; Harenberg, P.; Jakubietz, R.] Univ Wurzburg, Div Plast & Aesthet Surg & Handsurg, Dept Traumatol, D-97080 Wurzburg, Germany; [Holzapfel, B. M.; Rudert, M.] Univ Wurzburg, Dept Orthoped Surg, D-97080 Wurzburg, Germany; [Meffert, R.] Univ Wurzburg, Dept Traumatol, D-97080 Wurzburg, Germany		Schmidt, K (corresponding author), Univ Wurzburg, Div Plast & Aesthet Surg & Handsurg, Dept Traumatol, Oberduerrbacher Str 6, D-97080 Wurzburg, Germany.	schmidt_k@klinik.uni-wuerzburg.de		Rudert, Maximilian/0000-0003-4982-6594; Harenberg, Patrick/0000-0002-2069-2855			Baumeister SP, 2003, PLAST RECONSTR SURG, V112, P129, DOI 10.1097/01.PRS.0000066167.68966.66; Bocchi A, 2000, ANN PLAS SURG, V45, P284, DOI 10.1097/00000637-200045030-00011; Colen LB, 2003, PLAST RECONSTR SURG, V112, P141, DOI 10.1097/01.PRS.0000066168.31011.9F; Colson P, 1970, Chirurgie, V96, P639; DONSKI PK, 1983, SCAND J PLAST RECONS, V17, P191, DOI 10.3109/02844318309013118; Egozi D, 2011, MICROSURG, V31, P109, DOI 10.1002/micr.20852; Francesco G, 2007, ANN PLAS SURG, V59, P563, DOI 10.1097/01.sap.0000258452.55695.aa; Hollenbeck ST, 2010, PLAST RECONSTR SURG, V125, P924, DOI 10.1097/PRS.0b013e3181cc9630; Jakubietz RG, 2010, MICROSURG, V30, P608, DOI 10.1002/micr.20798; Kneser U, 2005, PLAST RECONSTR SURG, V116, P1910, DOI 10.1097/01.prs.0000189204.71906.c2; LAMBERTY BGH, 1990, WORLD J SURG, V14, P776, DOI 10.1007/BF01670524; MASQUELET AC, 1992, PLAST RECONSTR SURG, V89, P1115, DOI 10.1097/00006534-199206000-00018; Mueller JE, 2001, ARCH ORTHOP TRAUM SU, V121, P350, DOI 10.1007/s004020000238; Rudig LLJ, 2008, OPER ORTHOP TRAUMATO, V20, P252, DOI 10.1007/s00064-008-1307-x; Schmidt K, 2012, PLAST RECONSTR SURG, V130, P360, DOI 10.1097/PRS.0b013e3182589b0e; Teo TC, 2010, CLIN PLAST SURG, V37, P615, DOI 10.1016/j.cps.2010.06.003	16	8	8	0	4	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	0934-6694	1439-0981		OPER ORTHOP TRAUMATO	Oper. Orthopade Traumatol.	APR	2013	25	2					162	169		10.1007/s00064-012-0203-6			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	129RG	WOS:000317859000006	23525492				2022-02-06	
J	Zhong, WY; Sima, XT; Huang, SQ; Chen, HF; Cai, BW; Sun, H; Hu, Y; Liu, Y; You, C				Zhong, Weiying; Sima, Xiutian; Huang, Siqing; Chen, Haifeng; Cai, Bowen; Sun, Hong; Hu, Yu; Liu, Yi; You, Chao			Traumatic extradural hematoma in childhood	CHILDS NERVOUS SYSTEM			English	Article						Children; Extradural hematoma; Head injury; Outcome	SUPRATENTORIAL EPIDURAL HEMATOMA; CONSERVATIVE MANAGEMENT; CHILDREN; AGE	This study was undertaken to assess the clinical and radiological characteristics of children with traumatic extradural hematoma (TEDH), and factors affecting the initial neurological status and outcome. Medical records of 269 consecutive children with TEDH from 2005 to 2012 were retrospectively reviewed, factors affecting the initial neurological status and outcomes were explored using univariate and multivariate analysis. There were 166 boys and 103 girls (average age: 7.0 years). Fall from a height (59 %) was the most common mechanism of head injury. With increasing age, an increase of motor-vehicle accident and assault was noted. Among the children 85.5 % experienced a Glasgow Coma Scale (GCS) of 13-15, 9.7 % with GCS 9-12, and 4.8 % with GCS 3-8. The main clinical manifestations were headache, vomiting and nausea, and conscious disturbance. The main locations were the temporal, temporoparietal, and frontal regions. The 97.4 % saw a favorable outcome, whereas 2.6 % had a poor outcome (overall mortality: 1.1 %). Many factors influenced the prognosis; the most important factors affecting prognosis were the initial neurological condition and secondary brain edema, while the initial neurological status were associated with pupillary abnormality, clinical progression, the number and volume of TEDH, and midline shift. Although the outcome was excellent in most cases, early diagnosis and surgical evacuation before irreversible brain damage was important to lower mortality for those massive TEDHs.	[Zhong, Weiying; Sima, Xiutian; Huang, Siqing; Chen, Haifeng; Cai, Bowen; Sun, Hong; Hu, Yu; Liu, Yi; You, Chao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan Provinc, Peoples R China		You, C (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu 610041, Sichuan Provinc, Peoples R China.	chendoubo@163.com					Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Ben Abraham R, 2000, PEDIATR NEUROSURG, V33, P70, DOI 10.1159/000028990; Beni-Adani L, 1999, J TRAUMA, V46, P306, DOI 10.1097/00005373-199902000-00018; Bozbuga M, 1999, NEUROSURG REV, V22, P34, DOI 10.1007/s101430050006; Browne GJ, 2002, PEDIATR EMERG CARE, V18, P86, DOI 10.1097/00006565-200204000-00006; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; Ciurea AV, 2007, CHILD NERV SYST, V23, P335, DOI 10.1007/s00381-006-0230-4; Dubey A, 2004, NEUROL INDIA, V52, P443; ERSAHIN Y, 1993, CHILD NERV SYST, V9, P96, DOI 10.1007/BF00305316; Flannery AM, 2009, PEDIATR NEUROSURG, V45, P185, DOI 10.1159/000222667; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hanci M, 1994, TURK NEUROSURG, V4, P73; Herrera EJ, 2000, CHILD NERV SYST, V16, P585, DOI 10.1007/s003810000340; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; JAMJOOM A, 1994, NEUROSURG REV, V17, P277, DOI 10.1007/BF00306818; Jamjoom AB, 1997, NEUROSURG REV, V20, P227, DOI 10.1007/BF01105892; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Koc RK, 1998, NEUROSURG REV, V21, P52, DOI 10.1007/BF01111486; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; PASAOGLU A, 1990, ACTA NEUROCHIR, V106, P136, DOI 10.1007/BF01809456; POON WS, 1992, NEUROSURGERY, V30, P681; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SENGUPTA RP, 1972, J NEUROL NEUROSUR PS, V35, P297, DOI 10.1136/jnnp.35.3.297	28	8	10	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2013	29	4					635	641		10.1007/s00381-012-1971-x			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	106FI	WOS:000316127800015	23239253				2022-02-06	
J	Bingham, D; John, CM; Levin, J; Panter, SS; Jarvis, GA				Bingham, Deborah; John, Constance M.; Levin, Jack; Panter, S. Scott; Jarvis, Gary A.			Post-injury conditioning with lipopolysaccharide or lipooligosaccharide reduces inflammation in the brain	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury; Inflammation; Neuroprotection; LPS; LOS; Microglia	NERVOUS-SYSTEM; INTERFERON-GAMMA; BARRIER PERMEABILITY; ADULT NEUROGENESIS; INJURED BRAIN; INTERLEUKIN-1; CYTOKINES; CELLS; RAT; ACTIVATION	Background: Traumatic brain injury (TBI) is a leading cause of mortality and disability in the Western world. The first stage of TBI results from the mechanical damage from an impact or blast. A second stage occurs as an inflammatory response to the primary injury and presents an opportunity for clinical intervention. In this study, we investigated the effect of pre- and post-injury treatment with lipopolysaccharide (LPS) from Escherichia coli and lipooligosaccharide (LOS) from Neisseria meningitidis on levels of cerebral inflammatory cells, circulating blood cells, and pro- and anti-inflammatory cytokine levels in a rat model of neuroinflammation induced by intrastriatal injection of IL-1 beta to mimic the second stage of TBI. Methods: LPS or LOS was administered intravenously (IV) or intranasally (IN) 2 h pre- or post-injection of IL-1 beta. The rats were euthanized 12 h following IL-1 beta injection. Brain sections were immunostained with antibody to ED-1, a microglia cell marker. Cells in whole blood were assessed with a VetScan HM2 analyzer, and cytokine levels in sera were analyzed with a Bio-Plex system. Results: Pre- and post-injury IV administration of LPS or LOS significantly reduced microglia in the brain, and IN pre-treatment with LPS or LOS showed a statistical trend towards reducing microglia. Pre- and post-treatment IV with LOS increased circulating levels of IL-2 and IL-4, whereas IN post-treatment with LPS reduced levels of the inflammatory cytokines, TNF-alpha and IFN-gamma. Conclusions: The findings strongly support continued investigation of post-conditioning with LPS or LOS as potential neuroprotective treatments for neuroinflammation from TBI. Published by Elsevier B.V.	[Bingham, Deborah; John, Constance M.; Jarvis, Gary A.] Vet Affairs Med Ctr, Ctr Immunochem, San Francisco, CA 94121 USA; [John, Constance M.; Levin, Jack; Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [John, Constance M.; Levin, Jack; Panter, S. Scott; Jarvis, Gary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Panter, S. Scott] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Jarvis, GA (corresponding author), Vet Affairs Med Ctr, Ctr Immunochem, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Jarvis@ucsf.edu		Jarvis, Gary/0000-0002-7576-3702	U.S. Department of Veterans Affairs, Office of Biomedical Laboratory Research and DevelopmentUS Department of Veterans Affairs; U.S. Department of DefenseUnited States Department of Defense [W81XWH-05-2-0094]; Northern California Institute for Research and Education	This work was supported by the U.S. Department of Veterans Affairs, Office of Biomedical Laboratory Research and Development, and by the U.S. Department of Defense under contract number W81XWH-05-2-0094. Grant administration support was provided by the Northern California Institute for Research and Education. We thank Courtney R. Funk for assistance with the quantification of the microglia cells in the brain and Nadine E. Walas for timely and valuable research assistance. This is paper number 112 from the Center for Immunochemistry.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aden U, 2010, BRAIN BEHAV IMMUN, V24, P747, DOI 10.1016/j.bbi.2009.10.010; Ajmone-Cat MA, 2008, CURR PHARM DESIGN, V14, P1435, DOI 10.2174/138161208784480199; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Antony PA, 2005, J IMMUNOTHER, V28, P120, DOI 10.1097/01.cji.0000155049.26787.45; APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Bastide M, 2003, J CEREBR BLOOD F MET, V23, P399, DOI 10.1097/01.WCB.0000050064.57184.F2; Bingham D, 2011, BRAIN RES BULL, V85, P403, DOI 10.1016/j.brainresbull.2011.04.007; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bohatschek M, 2001, EXP NEUROL, V172, P137, DOI 10.1006/exnr.2001.7764; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Conlon P J, 1989, Biotechnol Ther, V1, P31; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Davis AEM, 2005, EUR J NEUROSCI, V22, P2441, DOI 10.1111/j.1460-9568.2005.04447.x; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; Folkerth RD, 2004, BRAIN PATHOL, V14, P265; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gennarelli T A, 1993, Acta Neurochir Suppl (Wien), V57, P49; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; Graff CL, 2005, J PHARM SCI-US, V94, P1187, DOI 10.1002/jps.20318; GRANOWITZ EV, 1993, J IMMUNOL, V151, P1637; Hackett SJ, 2001, J MED MICROBIOL, V50, P847, DOI 10.1099/0022-1317-50-10-847; Hansen-Pupp I, 2005, PEDIATR RES, V58, P946, DOI 10.1203/01.PDR.0000182592.76702.E8; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; He Fang, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P1129, DOI 10.3969/j.issn.1672-7347.2010.11.003; Hellewell SC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/356494; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kedar E, 1997, J IMMUNOTHER, V20, P180, DOI 10.1097/00002371-199705000-00003; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lehotsky J, 2009, ANAT REC, V292, P2002, DOI 10.1002/ar.20970; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; McIntosh TK, 1996, LAB INVEST, V74, P315; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Patrone JB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Pietropaoli A, 2009, J CLIN INVEST, V119, P2891, DOI 10.1172/JCI40880; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Pridmore AC, 2003, INFECT IMMUN, V71, P3901, DOI 10.1128/IAI.71.7.3901-3908.2003; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Semple JW, 2007, BLOOD, V109, P4803, DOI 10.1182/blood-2006-12-062695; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; Vedder H, 1999, INFLAMM RES, V48, P67, DOI 10.1007/s000110050408; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	71	8	8	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	MAR 15	2013	256	1-2					28	37		10.1016/j.jneuroim.2012.12.009			10	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	111FN	WOS:000316507100005	23333234				2022-02-06	
J	Ahmed, O; Sullivan, SJ; Schneiders, A; Moon, S; McCrory, P				Ahmed, Osman; Sullivan, S. John; Schneiders, Anthony; Moon, Sam; McCrory, Paul			Exploring the opinions and perspectives of general practitioners towards the use of social networking sites for concussion management	JOURNAL OF PRIMARY HEALTH CARE			English	Article						Brain concussion; general practitioners; health education; internet; social networking		INTRODUCTION: Social networking sites (SNSs) are increasingly being used for health-related purposes. Many patients now use sites such as Facebook to discuss symptoms, seek support, and search for advice on health conditions, including concussion. Innovative methods of delivering health information using these technologies are starting to emerge and it is important to seek the input of key stakeholder groups (including general practitioners) to establish their feasibility and to highlight areas of concern. AIM: This study aimed to seek the opinions of general practitioners towards the use of SNSs in concussion management. METHODS: Semi-structured interviews were captured with a digital voice recorder and analysed using interpretative description methodology. Participants were general practitioners whose caseload included persons with a concussion between the ages of 16 and 30 years, and who had treated a patient with a concussion in the past 12 months. FINDINGS: The clinical experience of the participants ranged from 3 to 35 years and 50% of the participants had a Facebook account themselves. While all participants were positive towards the use of SNSs for this purpose, concerns were raised regarding the issues of privacy and moderation. CONCLUSION: SNSs, particularly Facebook, have the potential (if correctly utilised) to be a viable adjunct to traditional concussion management programmes. In order for SNSs to be successfully used in this manner, the quality of information shared needs to be accurate and patients using them need to ensure that they get adequate cognitive rest.	[Ahmed, Osman; Sullivan, S. John; Schneiders, Anthony] Univ Otago, Ctr Physiotherapy Res, Sch Physiotherapy, Dunedin, New Zealand; [Moon, Sam] Univ Otago, Student Hlth Serv, Dunedin, New Zealand; [McCrory, Paul] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia; [McCrory, Paul] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [McCrory, Paul] Monash Univ, Australian Ctr Res Sports Injury & Its Prevent, Melbourne, Vic, Australia		Ahmed, O (corresponding author), Univ Otago, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	osman.ahmed@otago.ac.nz	McCrory, Paul/Q-8688-2019; Schneiders, Anthony/F-4212-2015	Schneiders, Anthony/0000-0002-1583-3879; McCrory, Paul/0000-0003-4850-0568			Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Bender JL, 2011, J MED INTERNET RES, V13, P165, DOI 10.2196/jmir.1560; Broom A, 2005, QUAL HEALTH RES, V15, P325, DOI 10.1177/1049732304272916; Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249; Chu LF, 2010, CURR OPIN ANESTHESIO, V23, P218, DOI 10.1097/ACO.0b013e328337339c; Eysenbach G, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1030; Eytan Ted, 2011, Perm J, V15, P71; Farmer AD, 2009, POSTGRAD MED J, V85, P455, DOI 10.1136/pgmj.2008.074674; Gajaria A, 2011, J ADOLESCENT HEALTH, V49, P15, DOI 10.1016/j.jadohealth.2010.09.004; Giveon S, 2009, ISR MED ASSOC J, V11, P537; Greene JA, 2011, J GEN INTERN MED, V26, P287, DOI 10.1007/s11606-010-1526-3; Gualtieri LN, 2009, P 27 INT C HUM FACT; Hoppe KM, PMR; Khan KM, 2010, BRIT J SPORT MED, V44, P911, DOI 10.1136/bjsm.2010.079269; Kim J, 2009, INFORM HEALTH SOC CA, V34, P136, DOI 10.1080/17538150903102422; Lindsay S, 2009, HEALTH EDUC RES, V24, P646, DOI 10.1093/her/cyp001; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Pew Internet & American Life Project, 2011, SOCIAL LIFE HLTH INF; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Sullivan SJ, 2012, PHYS THER SPORT, V13, P209, DOI 10.1016/j.ptsp.2011.10.004; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Thorne S, 2013, INT J QUAL METH, V5, P36; van Uden-Kraan CF, 2010, CLIN RHEUMATOL, V29, P1229, DOI 10.1007/s10067-010-1435-1; Williams D, BIG HITS SMALL SCREE; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	29	8	8	0	4	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	1172-6164	1172-6156		J PRIM HEALTH CARE	J. Prim. Health Care	MAR	2013	5	1					36	42		10.1071/HC13036			7	Primary Health Care	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V50KV	WOS:000210154400007	23457693	Green Submitted, gold			2022-02-06	
J	Gaetani, P; Pisano, P; Solinas, G; Colombo, P; Destro, A; Levi, D; Aimar, E; Baena, RRY; Allavena, P				Gaetani, P.; Pisano, P.; Solinas, G.; Colombo, P.; Destro, A.; Levi, D.; Aimar, E.; Rodriguez Y Baena, R.; Allavena, P.			Immunohistohemical expression of the chemokine fractalkine and its receptor in the human brain cortex after severe traumatic brain injury and brain hemorrhage	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Chemokines; Brain injury; Brain	HEAD-INJURY; BARRIER DYSFUNCTION; CELL-DEATH; RAT-BRAIN; INFLAMMATION; MICROGLIA; CX(3)CR1; NEURONS; ISCHEMIA; RELEASE	Aim. Recent experimental studies have suggested that chemokines, a subclass of chemoattractant cytokines which play an important role in regulating leukocyte migration and intercellular communication, participate in brain responses of traumatic injury. Fractalkine (CX3CL1) is a peculiar chemokine, the only one with a CX3C motif, existing both as a soluble and a membrane-anchored molecule. In the brain, Fractalkine has been suggested to have a role in neuroprotection under experimental conditions of brain injury. Methods. Eighteen human brain samples were obtained during surgery of decompressive craniotomy for severe traumatic brain injury (TBI) or after spontaneous intracranial haemorrhage (ICH). Five normal brain samples were obtained during surgery for unruptured intracranial aneurysms (standard gyrectomy). Immunohistochemistry of formalin fixed and paraffin embedded tissues was performed in order to verify the expression of fractalkine and its receptor (CX3CR1). The values of chemokine and receptor expression were correlated with the clinical parameters of the patients. Results. The chemokine fractalkine was significantly upregulated in the neural compartment after brain injury, compared to normal brain samples. Intensity scores were significantly higher when the interval between injury and surgery was >5 h, (P=0.015). In the glial compartment, Fractalkine expression was significantly associated with less severe clinical conditions and lower intracranial pressure at surgery (P=0.014). Expression of the receptor CX3CR1 was detected, at low intensity, on both glial and neurons. Higher expression in neurons was associated with better clinical conditions (Glasgow score) of patients at admission (P=0.037). Conclusion. The results of this study highlights for the first time that fractalkine and its receptor CX3CR1 are expressed in the human brain after TBI and ICH and may be involved in the limitation of tissue damage.	[Gaetani, P.; Pisano, P.; Levi, D.; Aimar, E.; Rodriguez Y Baena, R.] IRCCS Ist Clin Humanitas, Dept Neurosurg, I-20089 Milan, Italy; [Solinas, G.; Allavena, P.] IRCCS Ist Clin Humanitas, Dept Immunol & Cell Biol, Rozzano Milan, Italy; [Colombo, P.; Destro, A.] Univ Milan, IRCCS Ist Clin Humanitas, Sch Med, Dept Pathol, I-20089 Milan, Italy		Gaetani, P (corresponding author), IRCCS Ist Clin Humanitas, Dept Neurosurg, Via Manzoni 56, I-20089 Milan, Italy.	paolo.gaetani@humanitas.it	Colombo, Piergiuseppe/AAA-9176-2019	Colombo, Piergiuseppe/0000-0002-6161-6138; Gaetani, Paolo/0000-0003-0662-5872; Allavena, Paola/0000-0002-6697-6028			Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beck GC, 1999, CLIN EXP IMMUNOL, V118, P298; Berangere Re DB, 2006, NAT NEUROSCI, V9, P859; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Fujimura M, 1999, J NEUROSCI, V19, P3414; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hainsworth AH, 2005, J CEREBR BLOOD F MET, V25, P1030, DOI 10.1038/sj.jcbfm.9600104; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kastenbauer S, 2003, J NEUROIMMUNOL, V137, P210, DOI 10.1016/S0165-5728(03)00085-7; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Maciejewski-Lenoir D, 1999, J IMMUNOL, V163, P1628; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Qiu JH, 2002, J NEUROSCI, V22, P3504; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Schwaeble WJ, 1998, FEBS LETT, V439, P203, DOI 10.1016/S0014-5793(98)01384-2; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Tarozzo G, 2002, EUR J NEUROSCI, V15, P1663, DOI 10.1046/j.1460-9568.2002.02007.x; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	29	8	8	0	9	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616			J NEUROSURG SCI	J. Neurosurg. Sci.	MAR	2013	57	1					55	62					8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	160TN	WOS:000320143500005	23584220				2022-02-06	
J	He, YL; Yang, GT; Wang, YG; Ren, Y; He, XS; Zhang, X; Fei, Z				He, Yalong; Yang, Guitao; Wang, Yangang; Ren, Yi; He, Xiaosheng; Zhang, Xiang; Fei, Zhou			Expression of candidate plasticity-related gene 15 is increased following traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Candidate plasticity-related gene 15; Lateral rotational acceleration; Rats; Traumatic brain injury	SUBVENTRICULAR ZONE; CPG15; NEUROGENESIS; NEURITIN; RAT; PROLIFERATION; REGENERATION; NEURONS; GROWTH; CORTEX	Objectives: Candidate plasticity-related gene 15 (cpg15) is an activity-regulated gene that mediates synaptic plasticity; this study assesses the potential link between cpg15 expression levels and repair and regeneration following traumatic brain injury (TBI). Methods: We investigated the expression of cpg15 in the frontal lobe of rats subjected to TBI and sham rats, using the following methods: immunohistochemical analysis, Western blotting, and reverse transcription-polymerase chain reaction. Results: CPG15(+) neurons were present in coronal sections of the frontal lobe at Day 1, reached the highest level around Day 14, and maintained elevated levels through Day 21. CPG15 protein and mRNA levels were noticed to increase in a similar temporal pattern. In contrast, rats in the sham group had undetectable levels of CPG15. Conclusions: Elevated cpg15 expression in the frontal cortex suggests its possible involvement in regenerative and reparative processes that follow TBI.	[He, Yalong; Wang, Yangang; He, Xiaosheng; Zhang, Xiang; Fei, Zhou] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; [Yang, Guitao] Fourth Mil Med Univ, Dept Med Teaching & Res Adm, Xijing Hosp, Xian 710032, Peoples R China; [Ren, Yi] Univ Rochester, Med Ctr, Grad Program Neurosci, Rochester, NY 14642 USA		He, YL (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 15 West Changle Rd, Xian 710032, Peoples R China.	hexiaos@fmmu.edu.cn		He, yalong/0000-0002-4669-5384	NSFCNational Natural Science Foundation of China (NSFC) [C140301/30971173]	(Sources of grants: NSFC, no. C140301/30971173).	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Cantallops I, 2008, DEV NEUROBIOL, V68, P744, DOI 10.1002/dneu.20529; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; Han Y, 2007, J NEUROTRAUM, V24, P722, DOI 10.1089/neu.2006.0174; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Neary JT, 2005, IUBMB LIFE, V57, P711, DOI 10.1080/15216540500319143; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; Sharma N, 2010, EXP NEUROL, V223, P183, DOI 10.1016/j.expneurol.2009.04.031; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65	24	8	9	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2013	35	2					174	180		10.1179/1743132812Y.0000000134			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	101KL	WOS:000315773800014	23336599				2022-02-06	
J	Cheng, G; Fu, L; Zhang, HY; Wang, YM; Zhang, LM; Zhang, JN				Cheng, Gang; Fu, Luo'an; Zhang, Hang-yu; Wang, Ya-ming; Zhang, Lei-ming; Zhang, Jian-ning			The role of mitochondrial calcium uniporter in neuroprotection in traumatic brain injury	MEDICAL HYPOTHESES			English	Article							PERMEABILITY TRANSITION; APOPTOSIS; HEART; MECHANISMS; MEMBRANE; PREVENTS; BAX	The alteration in cellular Ca2+ homeostasis is one of the key mechanisms contributing to secondary neuronal damage and altered physiology during the process of traumatic brain injury (TBI). However, there is considerable uncertainty about the efficacy of calcium channel blockers in randomized, controlled, clinical trials. In the physiological condition, cellular Ca2+ homeostasis occurs through repetitive bursts of rising intracellular Ca2+ that, sometimes are referred to as Ca2+ oscillations. Mitochondria are intimately involved in the spatiotemporal tuning of cellular Ca2+ signaling mainly through mitochondrial Ca2+ uniporter (MCU). Excessive Ca2+ uptake by the mitochondria through MCU is a key event in mitochondrial dysfunction and cell death in TBI. Selective inhibition of MCU has showed a promising cardioprotection and neuroprotection effect in many preclinical studies. Based on these preclinical results, the selective inhibition of MCU may be a new strategy for neuroprotection in TBI patients. (c) 2012 Elsevier Ltd. All rights reserved.	[Cheng, Gang; Wang, Ya-ming; Zhang, Lei-ming; Zhang, Jian-ning] PLA Navy Gen Hosp, Dept Neurosurg, Beijing 100048, Peoples R China; [Fu, Luo'an] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Zhang, Hang-yu] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China		Zhang, JN (corresponding author), PLA Navy Gen Hosp, Dept Neurosurg, Beijing 100048, Peoples R China.	jnzhang2005@gmail.com					Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Correa F, 2007, INT J BIOCHEM CELL B, V39, P787, DOI 10.1016/j.biocel.2007.01.013; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Garcia-Rivas GD, 2005, FEBS J, V272, P3477, DOI 10.1111/j.1742-4658.2005.04771.x; Kambe Y, 2011, NEUROCHEM INT, V59, P10, DOI 10.1016/j.neuint.2011.03.018; Langham J, 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD000565, DOI 10.1002/14651858.CD000565]; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Nutt LK, 2002, J BIOL CHEM, V277, P9219, DOI 10.1074/jbc.M106817200; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Putney JW, 2006, CURR BIOL, V16, pR812, DOI 10.1016/j.cub.2006.08.040; Roy SS, 2008, METHODS, V46, P213, DOI 10.1016/j.ymeth.2008.09.024; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Sloan RC, 2012, J MOL CELL CARDIOL, V52, P1009, DOI 10.1016/j.yjmcc.2012.02.009; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Sun YG, 2010, BIOMED PHARMACOTHER, V64, P170, DOI 10.1016/j.biopha.2009.09.024; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Tirosh O, 2000, NEUROSCIENCE, V97, P531, DOI 10.1016/S0306-4522(00)00028-2; Vanderluit JL, 2003, CELL DEATH DIFFER, V10, P969, DOI 10.1038/sj.cdd.4401258; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; Thu VT, 2012, CARDIOVASC RES, V94, P342, DOI 10.1093/cvr/cvs122; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Yarana C, 2012, LIFE SCI, V90, P808, DOI 10.1016/j.lfs.2012.04.004; Ye Ting-Mei, 2006, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V22, P136; Zhang SZ, 2006, LIFE SCI, V78, P738, DOI 10.1016/j.lfs.2005.05.076; Zhou J, 2011, MED HYPOTHESES, V76, P1, DOI 10.1016/j.mehy.2010.07.049	29	8	8	1	15	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	FEB	2013	80	2					115	117		10.1016/j.mehy.2012.11.004			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	083SO	WOS:000314485700003	23200456				2022-02-06	
J	Coy, AE; Perrin, PB; Stevens, LF; Hubbard, R; Sosa, DMD; Jove, IGE; Arango-Lasprilla, JC				Coy, Anthony E.; Perrin, Paul B.; Stevens, Lillian F.; Hubbard, Rebecca; Diaz Sosa, Dulce Maria; Espinosa Jove, Irma Guadalupe; Carlos Arango-Lasprilla, Juan			Moderated Mediation Path Analysis of Mexican Traumatic Brain Injury Patient Social Functioning, Family Functioning, and Caregiver Mental Health	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Caregivers; Depression; Family; Mexico; Rehabilitation	QUALITY-OF-LIFE; PUERTO-RICAN; SURVEY QUESTIONNAIRE; HEAD-INJURY; DISTRESS; INDIVIDUALS; OUTCOMES; BURDEN; REHABILITATION; PREDICTORS	Objective: To examine the system of connections among traumatic brain injury (TBI) patient social functioning, family functioning, and caregiver depression and burden in Mexico. Design: Cross-sectional survey. Setting: A public medical facility. Participants: Mexican TBI patient-caregiver dyads (N=84) participated in this study. Most of the patients with TBI were men (81%), with an average age +/- SD of 38.83 +/- 13.44 years. The majority of caregivers (86%) were women, with an average age +/- SD of 51.74 +/- 11.29. Intervention: Not applicable. Main Outcome Measures: Outcomes assessed included family functioning (Family Satisfaction Scale), patient social functioning (Medical Outcomes Study 36-Item Short-Form Health Survey), and caregiver mental health (Patient Health Questionnaire-9 and Zarit Burden Interview). Results: A moderated mediation path model found that patient social functioning and family functioning predicted caregiver burden, and caregiver burden mediated the effect of family functioning on caregiver depression. Caregivers with strong family functioning tended to have low burden, no matter the level of patient social functioning. This path model provided an excellent fit and explained 47% of the variance in caregiver burden and 36% of the variance in caregiver depression. Conclusions: In Mexico, strong family functioning is an important buffer in the relationship between TBI patient social functioning deficits and caregiver mental health, especially because familism is a core value in Latino culture. Rehabilitation interventions designed to strengthen family functioning may improve caregiver mental health, thereby influencing the quality of informal care that caregivers are able to provide. Archives of Physical Medicine and Rehabilitation 2013;94:362-8 (C) 2013 by the American Congress of Rehabilitation Medicine	[Coy, Anthony E.; Perrin, Paul B.; Hubbard, Rebecca] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian F.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Diaz Sosa, Dulce Maria] Univ Nacl Autonoma Mexico, Dept Psychol, Mexico City 04510, DF, Mexico; [Espinosa Jove, Irma Guadalupe] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, Ikerbasque, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X; Coy, Anthony/0000-0002-3644-4151			Anderson M. I., 2006, STRESS ITS IMPACT SO, P23; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Ayuso-Mateos JL, 1999, ACTA PSYCHIAT SCAND, V99, P26, DOI 10.1111/j.1600-0447.1999.tb05381.x; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Gonz?lez, 2002, INSTRUMENTOS EVALUAC, P403; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; Hinojosa MS, 2009, ETHNIC HEALTH, V14, P591, DOI 10.1080/13557850903165403; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Marin G, 1991, RES HISPANIC POPULAT; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; MORTON VM, 1995, BRAIN INJURY, V9, P81; Moules S, 1999, BRAIN INJURY, V13, P983; Olson DH, 2010, FACES 4 MANUAL; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Sanchez-Ayendez M, 1998, J GERONTOL SOC WORK, V30, P75, DOI 10.1300/J083v30n01_06; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Scharlach A, 2006, FAM RELAT, V55, P625, DOI 10.1111/j.1741-3729.2006.00431.x; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Teasdate G, 1974, LANCET, V304, P81; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Villarreal R, 2005, HISPANIC J BEHAV SCI, V27, P409, DOI 10.1177/0739986305281125; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zea MC, 1994, J SOCIAL BEHAV, V9, P1; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	52	8	9	0	30	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2013	94	2					362	368		10.1016/j.apmr.2012.08.210			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	084TZ	WOS:000314563300016	22940090				2022-02-06	
J	Gouse, H; Thomas, KGF; Solms, M				Gouse, Hetta; Thomas, Kevin G. F.; Solms, Mark			Neuropsychological, Functional, and Behavioral Outcome in South African Traumatic Brain Injury Litigants	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Litigation; Malingering; Neuropsychological assessment; Activities of daily living	HEAD-INJURY; FOLLOW-UP; PERFORMANCE; SYMPTOMATOLOGY; COMPENSATION; PREDICTORS; LITIGATION; MODERATE	Few studies address the extent to which, during the process of litigation, individuals with moderate-to-severe traumatic brain injury might malinger in their performance on neuropsychological assessment batteries. This study explored whether financial settlement influenced neuropsychological test performance and activities of daily living in litigants (N 31) who were tested and interviewed both during litigation and 1 year or more after case settlement. Results showed that neuropsychological test scores did not change from assessment during forensic proceedings to assessment after settlement. Although some improvement was evident in activities of daily living, the gains were small and their clinical significance questionable. We found no evidence that individuals with moderate-to-severe TBI, despite clear potential for secondary gain, malingered or delivered sub-optimal effort during neuropsychological evaluation taking place in the context of litigation.	[Gouse, Hetta; Thomas, Kevin G. F.; Solms, Mark] Univ Cape Town, Dept Psychol, ZA-7925 Cape Town, South Africa; [Gouse, Hetta] Groote Schuur Hosp, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa		Gouse, H (corresponding author), Groote Schuur Hosp, Dept Psychiat & Mental Hlth, Anzio Rd, ZA-7925 Cape Town, South Africa.	hetta.gouse@uct.ac.za	Thomas, Kevin Garth Flusk/AAA-8655-2020; Gouse, Hetta/H-1461-2015	Thomas, Kevin Garth Flusk/0000-0002-0807-6101; Gouse, Hetta/0000-0001-7885-8363	Deutscher Akademischer Austausch DienstDeutscher Akademischer Austausch Dienst (DAAD); National Research Foundation of South AfricaNational Research Foundation - South Africa	This work was supported by the Deutscher Akademischer Austausch Dienst and the National Research Foundation of South Africa.	Benton A., 1976, MULTILINGUAL APHASIA; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bianchini KJ, 2003, CLIN NEUROPSYCHOL, V17, P574, DOI 10.1076/clin.17.4.574.27946; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Cohen J., 2013, STAT POWER ANAL BEHA; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Department of Basic Education, 2010, 2009 COUNTR REP S AF; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Evans C, 1998, RELIABLE CHANGE CRIT; Evans R. W., 1994, AM J FORENSIC PSYCH, V4, P19; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Foxcroft C., 2004, PSYCHOL ASSESSMENT S; Goosen J, 2003, INJURY, V34, P704, DOI 10.1016/S0020-1383(03)00153-0; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hugo F. J., 2001, SAJP-S AFR J PSYCHI, V7, P110; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Lafayette Instrument Company, 1999, PURD PEGB TEST EX MA; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McKinlay W. M., 1983, J NEUROL NEUROSUR PS, V46, P1054; Meyers J. E., 1995, CLIN NEUROPSYCHOL, V8, P153; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paterson H, 2005, SA J IND PSYCHOL, V31, P12; Prigatano G., 1990, CLIN NEUROPSYCHOL, V4, P1; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Rogers R., 1997, CLIN ASSESSMENT MALI; ShuttleworthJordan AB, 1996, S AFR J PSYCHOL, V26, P96, DOI 10.1177/008124639602600205; *STAT S AFR, 2001, CENS 2001; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D.T., 2001, FRONTAL LOBES NEUROP, P101; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; TEASDALE G, 1974, LANCET, V2, P81; Theron FH., 2001, SAJP-S AFR J PSYCHI, V7, P96; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P239, DOI 10.1016/j.acn.2005.12.004; World Bank, 2009, WORLD DEV IND DAT	51	8	8	0	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2013	28	1					38	51		10.1093/arclin/acs100			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	073EP	WOS:000313726600005	23151324	Bronze			2022-02-06	
J	Thompson, JN; Majumdar, J; Sheldrick, R; Morcos, F				Thompson, James N.; Majumdar, Jaydip; Sheldrick, Russell; Morcos, Fayez			Acute neurorehabilitation versus treatment as usual	BRITISH JOURNAL OF NEUROSURGERY			English	Article						acute; comparison; head injury; neurorehabilitation; outcomes	TRAUMATIC BRAIN-INJURY; FUNCTIONAL ASSESSMENT MEASURE; SEVERE HEAD-INJURY; LENGTH-OF-STAY; EARLY REHABILITATION; RECOVERY; OUTCOMES; PROGRAM; STROKE; PLASTICITY	Several clinical and government reviews have recommended specialised rehabilitation services for those recovering from neurological insult or neurosurgical intervention. Despite this, provision of 'rapid access'/acute neurorehabilitation units is extremely limited in the UK. In some areas, millions of people have no access to such facilities. Numerous articles have indicated that delayed access to neurorehabilitation in the acute recovery stage may worsen clinical outcomes and increase length of stay for patients. However, there has been a lack of studies directly comparing clinical outcomes between matched samples of patients in acute neurorehabilitation units versus patients receiving treatment-as-usual. In a study believed to be the first of its kind, this paper: (A) Describes the rationale and evidence base for acute neurorehabilitation. (B) Provides a comparison of clinical outcome scores Functional Independence Measure/Functional Assessment Measure (FIM-FAM) and also length of stay times for both of the aforementioned groups. The results show that all outcome areas except the 'communication' domain saw clinically and statistically significant improvements in the acute neurorehabilitation group. Length of stay was significantly reduced in the acute neurorehabilitation group. The case for reviewing the provision of acute neurorehabilitation units is now even more urgent and difficult to ignore.	[Thompson, James N.; Majumdar, Jaydip; Sheldrick, Russell] Salford Royal Hosp NHS Fdn Trust, Manchester, Lancs, England; [Morcos, Fayez] Pennine Acute Hosp NHS Trust, Manchester, Lancs, England		Thompson, JN (corresponding author), Salford Royal Hosp NHS Fdn Trust, Salford M6 8HD, Lancs, England.	jamest33@hotmail.co.uk					Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Bradley LJ, 2006, BRIT J NEUROSURG, V20, P36, DOI 10.1080/02688690600600855; Brandtlow CE, 2003, EXP GERONTOL, V38, P79; Butefisch CM, 2006, J PHYSIOL-PARIS, V99, P437, DOI 10.1016/j.jphysparis.2006.03.001; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Greenwood R, 2004, BRIT J NEUROSURG, V18, P573, DOI 10.1080/02688690400022888; Greenwood RJ, 2004, BRIT J NEUROSURG, V18, P462, DOI 10.1080/02688690400012327; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; House of Commons, 2001, 3 HOUS COMM HLTH COM; Hu MH, 2010, DISABIL REHABIL, V32, P1251, DOI 10.3109/09638280903464448; Irdesel J, 2007, NEUROCIRUGIA, V18, P5; Komitova M, 2006, EXP NEUROL, V199, P42, DOI 10.1016/j.expneurol.2006.03.010; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Moon Lawrence, 2005, J Neurol Phys Ther, V29, P55; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; Pickard JD, 2004, J ROY SOC MED, V97, P384, DOI 10.1258/jrsm.97.8.384; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rollnik JD, 2010, DTSCH ARZTEBL INT, V107, P286, DOI 10.3238/arztebl.2010.0286; *ROYAL COLL SURG E, 1999, REP WORK PART MAN PA; Royal College of Physicians, 2000, MED REH PEOPL PHYS C; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schwab ME, 2007, INT C SERIES, V1302, P131; Seeley HM, 2009, BRIT J NEUROSURG, V23, P530, DOI 10.1080/02688690903078874; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Taricco M, 2006, Eura Medicophys, V42, P69; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Wilson FC, 2009, NEUROREHABILITATION, V24, P377, DOI 10.3233/NRE-2009-0492; Wittenberg GF, 2010, NEUROBIOL DIS, V37, P252, DOI 10.1016/j.nbd.2009.09.007	33	8	8	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2013	27	1					24	29		10.3109/02688697.2012.714818			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	072MT	WOS:000313676500007	22938594				2022-02-06	
J	Tee, JW; Chan, PCH; Gruen, RL; Fitzgerald, MCB; Liew, SM; Cameron, PA; Rosenfeld, JV				Tee, Jin W.; Chan, Patrick C. H.; Gruen, Russell L.; Fitzgerald, Mark C. B.; Liew, Susan M.; Cameron, Peter A.; Rosenfeld, Jeffrey V.			Early Predictors of Mortality After Spine Trauma A Level 1 Australian Trauma Center Study	SPINE			English	Article						early; mortality predictors; spine trauma; outcome; elderly; coagulation	INJURY SEVERITY SCORE; CORD-INJURY; RISK-FACTORS; EPIDEMIOLOGY; CLASSIFICATION; HYPERGLYCEMIA; PREVALENCE; DEATH; HEAD; CARE	Study Design. Retrospective cohort study. Objective. To identify early independent mortality predictors after spine trauma. Summary of Background Data. Spine trauma consists of spinal cord and spine column injury. The ability to identify early (within 24 hours) risk factors predictive of mortality in spine trauma has the potential to reduce mortality and improve spine trauma management. Methods. Analysis was performed on 215 spine column and/or spinal cord injured patients from July 2008 to August 2011. Univariate and multivariate logistic regression models were applied to investigate the effects of the Injury Severity Score, age, mechanism of injury, blood glucose level, vital signs, brain trauma severity, morbidity before trauma, coagulation profile, neurological status, and spine injuries on the risk of in-hospital death. Results. Applying a multivariate logistic regression model, there were 7 independent early predictive factors for mortality after spine injury. They were (1) Injury Severity Score more than 15 (odds ratio [OR] = 3.67; P = 0.009), (2) abnormal coagulation profile (OR = 6; P < 0.0001), (3) patients 65 years or older (OR = 3.49; P = 0.007), (4) hypotension (OR = 2.9; P = 0.033), (5) tachycardia (OR = 4.04; P = 0.005), (6) hypoxia (OR = 2.9; P = 0.033), and (7) multiple comorbidities (OR = 3.49; P = 0.007). Severe traumatic brain injury was also associated with mortality but was excluded from multivariate analysis because there were no patients with this variable in the comparison group. Conclusion. Mortality predictors for spine trauma patients are similar to those for general trauma patients. Spine injury variables were shown not to be independent predictors of spine trauma mortality.	[Tee, Jin W.; Chan, Patrick C. H.; Rosenfeld, Jeffrey V.] Alfred, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Tee, Jin W.; Gruen, Russell L.; Fitzgerald, Mark C. B.] Alfred, Trauma Serv, Melbourne, Vic 3004, Australia; [Liew, Susan M.] Alfred, Dept Orthopaed, Melbourne, Vic 3004, Australia; [Fitzgerald, Mark C. B.; Cameron, Peter A.] Alfred, Dept Emergency Med, Melbourne, Vic 3004, Australia; [Tee, Jin W.; Chan, Patrick C. H.; Gruen, Russell L.; Fitzgerald, Mark C. B.; Liew, Susan M.; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Gruen, Russell L.; Rosenfeld, Jeffrey V.] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Inst Brain Dev & Repair, Melbourne, Vic, Australia; [Cameron, Peter A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia		Tee, JW (corresponding author), Alfred, Dept Neurosurg, Level 1,Old Baker Bldg,Commercial Rd, Melbourne, Vic 3004, Australia.	Jin_Wee@hotmail.com	Rosenfeld, Jeffrey V/B-7249-2011	Cameron, Peter/0000-0002-1443-557X; Fitzgerald, Mark/0000-0003-0183-7761			ANDERSEN J, 1992, J TRAUMA, V33, P219, DOI 10.1097/00005373-199208000-00009; Australian Bureau of Statistics, 2006, 32220 AUSTR BUR STAT; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BLUMER CE, 1995, NEUROEPIDEMIOLOGY, V14, P258, DOI 10.1159/000109801; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Cotton BA, 2005, J TRAUMA, V59, P1400, DOI 10.1097/01.ta.0000196005.49422.e6; Custer RL., 1999, CTE J, V15, DOI [10.21061/jcte.v15i2.702, DOI 10.21061/JCTE.V15I2.702]; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Fisher CG, 2006, SPINE, V31, pS2, DOI 10.1097/01.brs.0000217948.02567.3a; Hebert JS, 2000, SPINE, V25, P55, DOI 10.1097/00007632-200001010-00011; Hill DA, 1997, J TRAUMA, V42, P62, DOI 10.1097/00005373-199701000-00011; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Jackson G, 2001, MAJOR TRAUMA DATA RE; KRAUS JF, 1980, J NEUROSURG, V53, pS3; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lichtveld RA, 2007, EUR J TRAUMA EMERG S, V33, P46, DOI 10.1007/s00068-007-6097-6; Lu J, 2005, ACT NEUR S, V95, P281; MacLeod JBA, 2004, AM SURGEON, V70, P805; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Martin ND, 2011, J TRAUMA, V71, P380, DOI 10.1097/TA.0b013e318228221f; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Neumann CR, 2009, J TRAUMA, V67, P67, DOI 10.1097/TA.0b013e3181aa63f3; Olerud C, 1999, ACTA ORTHOP SCAND, V70, P509, DOI 10.3109/17453679909000990; Pickett W, 2003, J TRAUMA, V30, P113; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TRAN DD, 1993, SURGERY, V114, P21; United Nations. Department of Economic and Social Affairs. Population Division, 2009, ESAPWP210 UN DEP EC; Vaccaro AR, 2007, SPINE, V32, P2365, DOI 10.1097/BRS.0b013e3181557b92; Vaccaro AR, 2005, SPINE, V30, P2325, DOI 10.1097/01.brs.0000182986.43345.cb; van Middendorp JJ, 2010, SPINE, V35, P1079, DOI 10.1097/BRS.0b013e3181bc9fd2; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; Victorian State Trauma System, 2010, VICT GOV HLTH INF; World Health Organization, PROP WORK DEF OLD PE; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	37	8	9	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JAN 15	2013	38	2					169	177		10.1097/BRS.0b013e3182634cbf			9	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	070YN	WOS:000313550900019	22691920				2022-02-06	
J	Anderson, GD; Peterson, TC; Vonder Haar, C; Kantor, ED; Farin, FM; Bammler, TK; MacDonald, JW; Hoane, MR				Anderson, Gail D.; Peterson, Todd C.; Vonder Haar, Cole; Kantor, Eric D.; Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.; Hoane, Michael R.			Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; recovery of function; cortical contusion impact; gene expression; erythropoietin; anakinra	INTERLEUKIN-1 RECEPTOR ANTAGONIST; RECOMBINANT-HUMAN-ERYTHROPOIETIN; FLUID PERCUSSION INJURY; CORTICAL CONTUSION INJURY; INFLAMMATORY RESPONSE; NICOTINAMIDE TREATMENT; CEREBRAL-ISCHEMIA; NEURONAL DAMAGE; NERVOUS-SYSTEM; RODENT MODEL	The goal of this study was to compare the effects of two inflammatory modulators, erythropoietin (EPO) and anakinra, on functional recovery and brain gene expression following a cortical contusion impact (CCI) injury. Dosage regimens were designed to provide serum concentrations in the range obtained with clinically approved doses. Functional recovery was assessed using both motor and spatial learning tasks and neuropathological measurements conducted in the cortex and hippocampus. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24h, 72h, and 7 days post-CCI. Ingenuity Pathway Analysis was used to evaluate the effect on relevant functional categories. EPO and anakinra treatment resulted in significant changes in brain gene expression in the CCI model demonstrating acceptable brain penetration. At all three time points, EPO treatment resulted in significantly more differentially expressed genes than anakinra. For anakinra at 24h and EPO at 24h, 72 h, and 7 days, the genes in the top 3 functional categories were involved in cellular movement, inflammatory response and cell-to-cell signaling. For EPO, the majority of the genes in the top 10 canonical pathways identified were associated with inflammatory and immune signaling processes. This was true for anakinra only at 24 h post-traumatic brain injury (TBI). The immunomodulation effects of EPO and anakinra did not translate into positive effects on functional behavioral and lesion studies. Treatment with either EPO or anakinra failed to induce significant beneficial effects on recovery of function or produce any significant effects on the prevention of injury induced tissue loss at 30 days post-injury. In conclusion, treatment with EPO or anakinra resulted in significant effects on gene expression in the brain without affecting functional outcome. This suggests that targeting these inflammatory processes alone may not be sufficient for preventing secondary injuries after TBI.	[Anderson, Gail D.; Kantor, Eric D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Peterson, Todd C.; Vonder Haar, Cole; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Box 357630,Hlth Sci Complex H-361A, Seattle, WA 98195 USA.	gaila@washington.edu		Vonder Haar, Cole/0000-0001-7949-2068	National Institutes of Health/National Institute of Child, Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; NIEHS Center for Ecogenetics & Environmental Health [P30ES007033]	The research was supported by a grant from the National Institutes of Health/National Institute of Child, Health and Development (R01 HD061944-01) and by the NIEHS Center for Ecogenetics & Environmental Health (P30ES007033)	Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Boogaerts M, 2006, CURR MED RES OPIN S4, V22, pS15, DOI DOI 10.1185/030079906X159588; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cerami A, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_1.8; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Faul M, 2010, TRAUMATIC BRAIN INJU; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hagan P, 1996, NEUROSCIENCE, V75, P1033, DOI 10.1016/0306-4522(96)00225-4; Hailer NP, 2005, EUR J NEUROSCI, V21, P2347, DOI 10.1111/j.1460-9568.2005.04067.x; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Juliet P. A., 2008, NEUROSCI LETT, V289, P5; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Loddick SA, 1997, BIOCHEM BIOPH RES CO, V234, P211, DOI 10.1006/bbrc.1997.6436; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MATHEW P, 1994, ACTA NEUROCHIR, P428; McCluskey S, 2009, EUR J CLIN PHARMACOL, V65, P273, DOI 10.1007/s00228-008-0575-6; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Rizzo JD, 2010, BLOOD, V116, P4045, DOI 10.1182/blood-2010-08-300541; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Touzani O, 1999, J NEUROIMMUNOL, V100, P203, DOI 10.1016/S0165-5728(99)00202-7; Vezzani A, 2004, ADV EXP MED BIOL, V548, P123; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	60	8	8	0	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.		2013	4								129	10.3389/fphar.2013.00129			14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AX6CS	WOS:000347011700127	24151467	Green Published, gold			2022-02-06	
J	Chandrasekhar, SS				Chandrasekhar, Sujana S.			The assessment of balance and dizziness in the TBI patient	NEUROREHABILITATION			English	Article						Dizziness; balance disorders; vertigo; gait ataxia; TBI; vestibular dysfunction	VERTIGO	OBJECTIVES: All degrees of traumatic brain injury (TBI) are associated with balance dysfunction and/or dizziness. The clinician assessing and managing patients with TBI should become familiar with vestibular and non-vestibular causes of dizziness and imbalance, and be able to perform screening tests to determine when referral to a vestibular specialist is warranted. This chapter outlines the clinical pathways to be followed in history-taking, physical examination, and assessment. INTRODUCTION: Dizziness, vertigo, balance dysfunction and gait ataxia can have their origin in the vestibular system, elsewhere, or be multifactorial. The complex anatomy and physiology of the balance canals, otolithic organs, and vestibular nerves peripherally, and the vestibular nuclei centrally, as well as the neural connections between vestibular, oculomotor, and proprioceptive systems will be covered in clinically pertinent detail. METHODS: A majority of diagnosis of dizziness/vertigo can be made after a proper history has been obtained. This can be challenging in all dizzy patients, and more so in the TBI patient in whom memory and recall may be impaired. The reader will learn how to use tools such as dizziness questionnaires as well as targeted history taking to elicit the information. Similarly, the addition of a programmatic, targeted physical examination of the dizzy patient will allow the clinician to fine-tune the diagnosis between peripheral and central causes. RESULTS: Once history and examination have narrowed the diagnostic possibilities, appropriate testing - in the vestibular laboratory and radiologic testing - is indicated. The reader will learn when these tests should be considered, and what the findings will show. Treatment can then be targeted for maximal outcome. CONCLUSION: Managing TBI is challenging; the addition of dizziness or balance complaints in these individuals makes it even more so. This paper seeks to provide a useful roadmap clinical pathway for assessment of these patients with appropriate and timely referral for treatment.	New York Otol New York Head & Neck Inst, New York, NY 10028 USA		Chandrasekhar, SS (corresponding author), New York Otol New York Head & Neck Inst, 1421 3rd Ave,4th Floor, New York, NY 10028 USA.	sujana1@gmail.com					Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Bronstein AM, 2010, RESTOR NEUROL NEUROS, V28, P83, DOI 10.3233/RNN-2010-0530; Cianfrone G, 2011, EUR REV MED PHARMACO, V15, P601; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Fishman JM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008607.pub2; Goebel JA, 2001, SEMIN NEUROL, V21, P391, DOI 10.1055/s-2001-19410; Hain TC, 2003, CNS DRUGS, V17, P85, DOI 10.2165/00023210-200317020-00002; Hain TC, 2011, NEUROREHABILITATION, V29, P127, DOI 10.3233/NRE-2011-0687; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Harris LR, 2011, PROG BRAIN RES, V191, P133, DOI 10.1016/B978-0-444-53752-2.00008-4; Hillier SL, 2011, COCHRANE DB SYST REV, P1, DOI [10.1002/14651858, DOI 10.1002/14651858.CD005397.PUB4]; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Huppert D, 2011, ACTA OTO-LARYNGOL, V131, P228, DOI 10.3109/00016489.2010.531052; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kerber KA, 2009, EMERG MED CLIN N AM, V27, P39, DOI 10.1016/j.emc.2008.09.002; King WM, 2011, ANN NY ACAD SCI, V1233, P219, DOI 10.1111/j.1749-6632.2011.06165.x; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Rubin DI, 2011, SEMIN NEUROL, V31, P29, DOI 10.1055/s-0031-1271306; Rutka J. A., 2004, OTOTOXICITY, P24; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Uchino Y, 2011, NEUROSCI RES, V71, P315, DOI 10.1016/j.neures.2011.09.001; Wolff JL, 2012, J AM GERIATR SOC, V60, P106, DOI 10.1111/j.1532-5415.2011.03770.x	23	8	8	2	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2013	32	3					445	454		10.3233/NRE-130867			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200003	23648599				2022-02-06	
J	Gardner, A				Gardner, Andrew			The complex clinical issues involved in an athlete's decision to retire from collision sport due to multiple concussions: a case study of a professional athlete	FRONTIERS IN NEUROLOGY			English	Article						case study; brain concussion; athlete; sport; retirement		The issue of retirement from athletic participation due to repetitive concussive injuries remains controversial. The complexity of providing recommendations to elite athletes is highlighted by the prospect that offering inappropriate advice may foreseeably lead to engagement in a medico-legal challenge. Currently no evidenced-based, scientifically validated guidelines for forming the basis of such a decision exist. The current paper discusses the complexities of this challenge in addition to presenting a case study of a professional athlete. A number of central issues to consider when discussing athlete retirement revolve around the player's medical and concussion histories, the current clinical profile, the athlete's long-term life goals, and understanding of the potential long-term risks. Ensuring that thorough investigations of all possible differential diagnosis, that may explain the presenting symptoms, are conducted is also essential. Discussion pertaining to recommendations for guiding the clinical approach to the retirement issue for athletes with a history of multiple concussions is presented.	[Gardner, Andrew] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Sch Med & Publ Hlth, Bowman Bldg,Univ Dr, Callaghan, NSW 2308, Australia		Gardner, A (corresponding author), Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Sch Med & Publ Hlth, Bowman Bldg,Univ Dr, Callaghan, NSW 2308, Australia.	andrew.gardner@neurogard.com.au	Gardner, Andrew/J-5162-2013	Gardner, Andrew/0000-0001-5031-5586			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bauman J, 2005, CLIN J SPORT MED, V15, P432, DOI 10.1097/01.jsm.0000186682.21040.82; Brewer TL, 1998, ATTENTIONAL IMPAIRME; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gissane C, 1997, Aust J Sci Med Sport, V29, P91; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hecht AN, 2002, SENTON HALL J SPORTS, V12, P17; Johnson R, 2004, CLIN SPORT MED, V23, P175, DOI 10.1016/j.csm.2004.01.003; Kaye AH, 2012, MED J AUSTRALIA, V196, P547, DOI 10.5694/mja12.10539; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x	29	8	8	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2013	4								141	10.3389/fneur.2013.00141			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QT	WOS:000209629000140	24098296	gold, Green Published			2022-02-06	
B	Glang, A; Ettel, D; Tyler, JS; Todis, B		Zasler, ND; Katz, DI; Zafonte, RD		Glang, Ann; Ettel, Debbie; Tyler, Janet Siantz; Todis, Bonnie			Educational Issues and School Reentry for Students With Traumatic Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							POST-CONCUSSION SYNDROME; HEAD-INJURY; COGNITIVE REHABILITATION; FUNCTIONAL RECOVERY; BEHAVIOR PROBLEMS; EARLY-CHILDHOOD; YOUNG-CHILDREN; PROFESSIONAL-DEVELOPMENT; PSYCHOSOCIAL OUTCOMES; ACADEMIC-PERFORMANCE		[Glang, Ann] Ctr Brain Injury Res & Training, Eugene, OR USA; [Glang, Ann] ORCAS, Eugene, OR USA; [Ettel, Debbie; Todis, Bonnie] Western Oregon Univ, Ctr Brain Injury Res & Training, Teaching Res Inst, Eugene, OR USA		Glang, A (corresponding author), Ctr Brain Injury Res & Training, Eugene, OR USA.						Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alderman N, 2011, BRAIN INJURY, V25, P83, DOI 10.3109/02699052.2010.532849; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Army Individual Test Battery, 1944, MAN DIR SCOR TRAIL B; Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BATAVIA A, 1990, ARCH PHYS MED REHAB, V71, P1014; Begali V., 1992, HEAD INJURY CHILDREN; Benedict EA, 2007, TOP EARLY CHILD SPEC, V27, P174, DOI 10.1177/02711214070270030801; Benton AL, 1994, MULTILINGUAL APHASIA; Bersani H, WHAT IS TAU IN PRESS; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Bohmann J, 2007, PRINCIPAL LEADERSHIP, P12; BOLL T, 1993, CHILDRENS CATEGORY T; Borko H., 2004, ED RES, V33, P3, DOI DOI 10.3102/0013189X033008003; Borkowski JG, 2000, ISSUES MEASUREMENT M, P1; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bruininks R. H., 1984, SCALES INDEPENDENT B; BULGREN JA, 2006, TEACHING ADOLESCENTS, P79; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; CARNINE D, 1980, J EDUC RES, V74, P106, DOI 10.1080/00220671.1980.10885292; Carnine D., 1990, DIRECT INSTRUCTION R; Carnine D. W., 2006, DESIGNING EFFECTIVE; CARNINE DW, 1976, J APPL BEHAV ANAL, V9, P199, DOI 10.1901/jaba.1976.9-199; CARPENTER TP, 1989, AM EDUC RES J, V26, P499, DOI 10.2307/1162862; Carr E. G., 1999, POSITIVE BEHAV SUPPO; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2010, STUD NEUROPSYCHOL NE, P439; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Champagne J., 1993, EDLAW BRIEFING PAPER; Chapman J, 2005, PHYS WORLD, V18, P17; Chapman J. K., 2000, RURAL SPECIAL ED Q, V19, P3; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Charles N., 2008, GRIEF MATTERS AUSTR, V11, P64; Cheatham GA, 2012, TEACH EXCEPT CHILD, V44, P50, DOI 10.1177/004005991204400306; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clang A, 1996, STUDENTS ACQUIRED BR; Cleary M., 2010, J SCH HLTH, V81, P1; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; CONNERS CK, 2000, CONNERS CONTINUOUS P, V2; Connolly A. J., 2007, KEY MATH 3 DIAGNOSTI; Conoley JC, 1996, J LEARN DISABIL-US, V29, P662, DOI 10.1177/002221949602900610; Darling RB, 1983, FAMILY HANDICAPPED C, P175; Darling-Hammond L, 2009, EDUC LEADERSHIP, V66, P46; Davis AS, 2004, J SCHOOL PSYCHOL, V42, P87, DOI 10.1016/j.jsp.2003.11.001; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dettmer JL, 2007, J HEAD TRAUMA REHAB, V22, P339, DOI 10.1097/01.HTR.0000300229.13490.c7; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Dise-Lewis JE, 2006, BRAINSTARS BRAIN INJ; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 1997, Pediatr Rehabil, V1, P179; Elliott C.D., 2007, DIFFERENTIAL ABILITY; ENGLERT CS, 1984, REM SPEC EDUC, V5, P38, DOI DOI 10.1177/074193258400500208; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Faul M, 2010, TRAUMATIC BRAIN INJU; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Fiorello C. A., 2009, HDB ED TRAINING SUPE, V1, P213; Fixsen D.L., 2005, IMPLEMENTATION RES S; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Forest M., 1989, ED ALL STUDENTS MAIN; FUCHS LS, 1992, EXCEPT CHILDREN, V58, P436, DOI 10.1177/001440299205800507; Functional Independence Measure (FIM), 1996, UN DAT SYST MED REH; FUNK P, 1996, PHYS DISABILITIES ED, V15, P49; Gardner MF., 1996, TEST VISUAL PERCEPTU; Gersten R. M., 1982, EDUC EVAL POLICY AN, V4, P67; GERSTEN RM, 1982, ANAL INTERVEN DEVEL, V2, P305, DOI 10.1016/0270-4684(82)90026-X; Gersten R, 2009, REV EDUC RES, V79, P1202, DOI 10.3102/0034654309334431; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A., 2011, EMPIRICALLY BASED IN; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Goldberg E., 2000, EXECUTIVE CONTROL BA; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grant D. A., 1948, WISCONSIN CARD SORTI; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Grossman P, 2001, TEACH COLL REC, V103, P942, DOI 10.1111/0161-4681.00140; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hale J. B., 2004, SCH NEUROPSYCHOLOGY; Hammill D., 2009, COMPREHENSIVE TEST N, V2nd ed.; Hammill D.D., 1993, DEV TEST VISUAL PERC, V2nd; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Harvey VS, 2002, BEST PRACTICES SCH P, V1, p:831; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; HIBBARD M, 2001, STUDENTS TRAUMATIC B; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; HOSACK KR, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199504000-00007; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Jones HA, 2008, PSYCHOL SCHOOLS, V45, P918, DOI 10.1002/pits.20342; Kaufman AS., 2004, KAUFMAN ASSESSMENT B, V2; Kaufman N.L., 2004, KAUFMAN TEST ED ACHI; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kluth P, 2001, EDUC LEADERSHIP, V59, P24; Kohn SE, 1983, BOSTON NAMING TEST; Korkman M., 2007, NEPSY, VII; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRYZANOWSKI J, 1980, J READING BEHAV, V12, P225, DOI 10.1080/10862968009547373; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Lane SJ, 2010, AM J OCCUP THER, V64, P375, DOI 10.5014/ajot.2010.09069; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lerman DC, 2008, J APPL BEHAV ANAL, V41, P243, DOI 10.1901/jaba.2008.41-243; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Little JW, 2002, TEACH TEACH EDUC, V18, P917; Lovell M, 2000, IMPACT IMMEDIATE POS; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Markwardt F.C., 1989, PEABODY INDIVIDUAL A; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Mather N., 2001, WOODCOCK JOHNSON 3 T; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1998, J AM ACAD CHILD ADOL, V37, P83; McCaleb KN, 2006, PHYS DISABILITIES ED, V25, P61; McCutchen D, 2002, J LEARN DISABIL-US, V35, P69, DOI 10.1177/002221940203500106; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Merrell KW, 2002, SCH SOCIAL BEHAV SCA; Merrell KW, 2003, BEHAV SOCIAL EMOTION, P52; Miller DC, 2007, ESSENTIALS SCH NEURO, P351; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; MISCHEL W, 1972, J PERS SOC PSYCHOL, V21, P204, DOI 10.1037/h0032198; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Naglieri J. A., 1997, COGNITIVE ASSESSMENT; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; National Secondary Training and Technical Assistance Center (NSTTAC), EV BAS SEC TRANS PRA; Noell GH, 1997, SCHOOL PSYCHOL QUART, V12, P77, DOI 10.1037/h0088949; Novack TA, 2000, BRAIN INJURY, V14, P987; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Odom SL, 2009, TOP EARLY CHILD SPEC, V29, P53, DOI 10.1177/0271121408329171; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Randolph C., 1998, REPEATABLE BATTERY A; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Robinson TR, 1999, J EDUC PSYCHOL, V91, P195, DOI 10.1037/0022-0663.91.2.195; Roid G., 2003, STANFORD BINET INTEL, V5th ed.; ROSENSHINE B, 1986, HDB RES TEACHING, P376; Rozalski M, 2010, EXCEPTIONALITY, V18, P151, DOI 10.1080/09362835.2010.491991; Sailors M, 2010, ELEM SCHOOL J, V110, P301, DOI 10.1086/648980; Sample PL, 2007, SUBST USE MISUSE, V42, P705, DOI 10.1080/10826080701202536; Savage RC, 1995, PERSPECTIVES NETWORK, pV; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Savage RC, 2005, PREV SCH FAIL, V49, P43, DOI 10.3200/PSFL.49.4.43-52; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sharp GK, 2002, CURRENT LEGAL STATUS; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Shigaki CL, 2002, REHABIL PSYCHOL, V47, P204, DOI 10.1037//0090-5550.47.2.204; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M, 2007, BRAIN INJ ASS OR OCT; Sohlberg McKay Moore, 2005, Seminars in Speech and Language, V26, P268, DOI 10.1055/s-2005-922105; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Spellacy F. J., 1969, CORTEX, V5, P390, DOI [10.1016/S0010-9452(69)80015-8, DOI 10.1016/S0010-9452(69)80015-8]; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Talley J., 1993, CHILDRENS AUDTORY VE CHILDRENS AUDITORY V; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; TELZROW CF, 1991, SEMIN NEUROL, V11, P50, DOI 10.1055/s-2008-1041205; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; The University of the State of New York, 1997, TRAUM BRAIN INJ GUID; Thickbroom GW, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-4; Tiffin J, 1968, PURDUE GROOVED PEGBO; Todis B, 1996, STUDENTS ACQUIRED BR, P33; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tonks J, 2010, NEUROPSYCHOL REHABIL, V20, P922, DOI 10.1080/09602011.2010.519209; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; TURNBULL AP, 1986, FAMILIES PROFESSIONA; TURNBULL H. R., 2004, EXCEPTIONAL LIVES SP; Tyler J. S., 1997, STUDENTS ACQUIRED BR, P323; Tyler JS, 2003, ADV SPEC EDUC, V15, P299; US Bureau of Labor Statistics, 2006, CURR POP SURV EMPL P; US Department of Education, 2004, NAT LONG TRANS STUD; US Department of Education, 2007, 29 US DEP ED, V2; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Walker B.R., 1996, STUDENTS ACQUIRED BR, P295; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wechsler D., 2009, WECHSLER INDIVIDUAL; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D, 2004, DIGIT SPAN FORWARD R; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Wechsler D, 2009, LOGICAL MEMORY 1 2 S; Wechsler D., 2002, WECHSLER PRIMARY PRE; WEEKS M, 1981, J APPL BEHAV ANAL, V14, P449, DOI 10.1901/jaba.1981.14-449; Wetherington C. E., 2006, EXCEPTIONALITY, V14, P155, DOI [10.1207/s15327035-x1403_4, DOI 10.1207/S15327035-X1403_4]; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; White, 1982, EDUC TREAT CHILD, V5, P93; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Woodcock, 2011, WOODCOCK READING MAS; Woodcock R.W., 2007, WOODCOCK JOHNSON TES; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, STUD NEUROPSYCHOL NE, P243; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker M, 2007, PHYS MED REH CLIN N, V18, pvii; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; Yoon KS., 2007, REV EVIDENCE TEACHER; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	261	8	8	0	9	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							602	620					19	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100037					2022-02-06	
B	Iverson, GL; Lange, RT; Gaetz, MB; Zasler, ND		Zasler, ND; Katz, DI; Zafonte, RD		Iverson, Grant L.; Lange, Rael T.; Gaetz, Michael B.; Zasler, Nathan D.			Mild Traumatic Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; WHITE-MATTER HYPERINTENSITIES; CREATINE-KINASE-BB; POST-CONCUSSION SYNDROME; DIFFUSE AXONAL INJURY; COMPUTED-TOMOGRAPHY FINDINGS; SPECTRIN BREAKDOWN PRODUCTS; S-100 PROTEIN MEASUREMENTS		[Iverson, Grant L.; Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lange, Rael T.] Walter Reed Natl Mil Med, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Gaetz, Michael B.] Univ Fraser Valley, Dept Kinesiol & Phys Educ, Chilliwack, BC, Canada; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Sheltering Arms Hosp, iWalk Program, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.						Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Agid R, 2003, INT J NEUROPSYCHOPH, V6, P215, DOI 10.1017/S146114570300347X; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alzate O, 2010, NEUROPROTEOMICS, P1; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersen K, 2005, EPIDEMIOLOGY, V16, P233, DOI 10.1097/01.ede.0000152116.32580.24; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; [Anonymous], 1998, NIH Consens Statement, V16, P1; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Atalay B, 2007, BRIT J NEUROSURG, V21, P281, DOI 10.1080/02688690701364781; ATKINSON JH, 1991, PAIN, V45, P111, DOI 10.1016/0304-3959(91)90175-W; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Balut M, 2006, ADV THER, V23, P12; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2010, J HEAD TRAUMA REHAB, V25, P225, DOI 10.1097/HTR.0b013e3181e7f784; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berube J, 2001, J HEAD TRAUMA REHAB, V16, P210, DOI 10.1097/00001199-200104000-00009; Biberthaler P, 2000, ACT NEUR S, V76, P177; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BIJUR PE, 1990, PEDIATRICS, V86, P337; Binder EB, 2009, MOL PSYCHIAT; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1997, CRASH PSYCHOL ASSESS; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonatz H, 2000, J NEUROSCI METH, V100, P105, DOI 10.1016/S0165-0270(00)00238-7; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 2000, NEUROLOGY, V54, P308, DOI 10.1212/WNL.54.2.308; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Bryant RA, 1998, APPL COGNITIVE PSYCH, V12, P81, DOI 10.1002/(SICI)1099-0720(199802)12:1<81::AID-ACP507>3.0.CO;2-8; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Buckley TC, 1996, J ABNORM PSYCHOL, V105, P617, DOI 10.1037/0021-843X.105.4.617; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Cao QJ, 2010, BRAIN RES, V1310, P172, DOI 10.1016/j.brainres.2009.10.031; Cardali S, 2006, J Neurosurg Sci, V50, P25; Carr ME, 2009, MIL MED, V174, P622, DOI 10.7205/MILMED-D-02-4708; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carter JC, 2009, PSYCHIAT RES-NEUROIM, V172, P215, DOI 10.1016/j.pscychresns.2008.09.005; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Cooney BS, 1996, HEADACHE, V36, P616, DOI 10.1046/j.1526-4610.1996.3610616.x; COOPER PR, 1983, NEUROSURGERY, V12, P536, DOI 10.1227/00006123-198305000-00010; CORRADA M, 1995, INT J EPIDEMIOL, V24, P1000, DOI 10.1093/ije/24.5.1000; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Dal Forno G, 2005, ANN NEUROL, V57, P381, DOI 10.1002/ana.20405; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; DAUBERSCHMIDT R, 1983, CLIN CHIM ACTA, V131, P165, DOI 10.1016/0009-8981(83)90085-2; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Ehrlich S, 2005, J AFFECT DISORDERS, V86, P281, DOI 10.1016/j.jad.2005.01.007; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Ergun R, 1998, NEUROL RES, V20, P418; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Farmer AE, 2003, PSYCHOL MED, V33, P1169, DOI 10.1017/S0033291703008419; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; Ferguson RJ, 1996, SOURCEBOOK PSYCHOL T, P615; FERINISTRAMBI L, 1990, NEUROEPIDEMIOLOGY, V9, P39, DOI 10.1159/000110750; Finsterer J, 2004, SCAND J CLIN LAB INV, V64, P553, DOI 10.1080/00365510410007035; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Franklin CL, 2001, J NERV MENT DIS, V189, P548, DOI 10.1097/00005053-200108000-00008; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; FRENCH BN, 1977, SURG NEUROL, V7, P171; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Friis RH, 2002, EUR PSYCHIAT, V17, P241, DOI 10.1016/S0924-9338(02)00682-X; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Giehl KM, 1997, EUR J NEUROSCI, V9, P2479, DOI 10.1111/j.1460-9568.1997.tb01665.x; Gieron MA, 1998, PEDIATR NEUROL, V19, P382, DOI 10.1016/S0887-8994(98)00072-1; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Grant I, 2003, J INT NEUROPSYCH SOC, V9, P679, DOI 10.1017/S1355617703950016; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Gray MJ, 2004, J CONSULT CLIN PSYCH, V72, P909, DOI 10.1037/0022-006X.72.5.909; Greenwald BS, 2001, J AM GERIATR SOC, V49, P1218, DOI 10.1046/j.1532-5415.2001.49240.x; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Grieger TA, 2003, PSYCHIAT SERV, V54, P1380, DOI 10.1176/appi.ps.54.10.1380; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Guez M, 2005, J CLIN EXP NEUROPSYC, V27, P151, DOI 10.1080/13803390490515487; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Harvey AG, 2001, J TRAUMA STRESS, V14, P277, DOI 10.1023/A:1011108816888; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Heilbronner RL, 1993, TRIAL DIPLOMACY J, V16, P161; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Heininger K, 2000, HUM PSYCHOPHARM CLIN, V15, P1, DOI 10.1002/(SICI)1099-1077(200001)15:1<1::AID-HUP153>3.0.CO;2-1; Henry G K, 2000, Appl Neuropsychol, V7, P65, DOI 10.1207/S15324826AN0702_1; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hung CI, 2006, CEPHALALGIA, V26, P26, DOI 10.1111/j.1468-2982.2005.00985.x; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; IVERSON GL, 2001, J FORENSIC NEUROPSYC, V2, P19, DOI DOI 10.1300/J151v02n01_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jacobus J, 2009, NEUROTOXICOL TERATOL, V31, P349, DOI 10.1016/j.ntt.2009.07.006; JAMISON RN, 1988, INT J PSYCHIAT MED, V18, P183; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Kalish H, 2010, J CHROMATOGR B, V878, P194, DOI 10.1016/j.jchromb.2009.10.022; KASTE M, 1981, J NEUROSURG, V55, P511, DOI 10.3171/jns.1981.55.4.0511; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendler KS, 2000, AM J PSYCHIAT, V157, P1243, DOI 10.1176/appi.ajp.157.8.1243; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Korfias S, 2009, MINI-REV MED CHEM, V9, P227, DOI 10.2174/138955709787315994; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lahiri DK, 2004, J MOL NEUROSCI, V23, P225, DOI 10.1385/JMN:23:3:225; LAHMEYER HW, 1987, J PSYCHIAT RES, V21, P1, DOI 10.1016/0022-3956(87)90004-5; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P123, DOI 10.1097/HTR.0b013e31820e6840; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2010, J TRAUMA, V68, P1065, DOI 10.1097/TA.0b013e3181bb9890; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lehmann C, 2009, BRAIN RES, V1297, P1, DOI 10.1016/j.brainres.2009.08.070; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; LEVITT MA, 1995, ACAD EMERG MED, V2, P675, DOI 10.1111/j.1553-2712.1995.tb03617.x; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Lyoo IK, 2002, COMPR PSYCHIAT, V43, P361, DOI 10.1053/comp.2002.34636; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; MAXWELL WL, 1988, ACTA NEUROPATHOL, V76, P395, DOI 10.1007/BF00686977; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; McKeating EG, 1998, ACT NEUR S, V71, P117; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Missler U, 1999, CLIN CHEM, V45, P138; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore PB, 2001, BRIT J PSYCHIAT, V178, P172, DOI 10.1192/bjp.178.2.172; MORAN SG, 1994, AM SURGEON, V60, P533; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nielsen AS, 2003, J ALZHEIMERS DIS, V5, P119, DOI 10.3233/JAD-2003-5206; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; NORDBY HK, 1984, ACTA NEUROCHIR, V71, P205, DOI 10.1007/BF01401315; NORDBY HK, 1985, ACTA NEUROCHIR, V76, P131, DOI 10.1007/BF01418475; North C S, 2001, Mil Med, V166, P51; North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034; North CS, 1997, AM J PSYCHIAT, V154, P1696, DOI 10.1176/ajp.154.12.1696; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; North CS, 2002, J URBAN HEALTH, V79, P383, DOI 10.1093/jurban/79.3.383; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Ohayon MM, 2004, ENCEPHALE, V30, P222; Olvey SE, 2004, NEUROSURGERY, V54, P672, DOI 10.1227/01.NEU.0000108782.68099.29; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paniak C, 2000, BRAIN INJURY, V14, P219; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PHILLIPS JP, 1980, BRIT MED J, V281, P777, DOI 10.1136/bmj.281.6243.777; Pillai JJ, 2002, PSYCHIAT RES-NEUROIM, V114, P51, DOI 10.1016/S0925-4927(01)00129-9; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Rabow L, 1979, Acta Neurochir Suppl (Wien), V28, P108; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Sassi RB, 2003, J AFFECT DISORDERS, V77, P237, DOI 10.1016/S0165-0327(02)00170-2; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; SCHWARTZ JH, 1991, PRINCIPLES NEURAL SC, P49; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sergeant N, 2005, BBA-MOL BASIS DIS, V1739, P179, DOI 10.1016/j.bbadis.2004.06.020; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Sheftell FD, 2002, HEADACHE, V42, P934, DOI 10.1046/j.1526-4610.2002.02217.x; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Son BC, 2000, ACT NEUR S, V76, P13; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sullivan Michael J L, 2002, Pain Res Manag, V7, P120; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tellier A, 1999, BRAIN INJURY, V13, P463; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; THOMAS D G T, 1978, Lancet, V1, P113; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Varney N R, 1995, Appl Neuropsychol, V2, P47, DOI 10.1207/s15324826an0202_1; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Vos PE, 2002, SHOCK, V18, P481, DOI 10.1097/00024382-200211000-00017; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson KG, 2002, CLIN J PAIN, V18, P77, DOI 10.1097/00002508-200203000-00002; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; WRIGHTSON P, 1989, MILD HEAD INJURY, P245; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yao CP, 2008, BRAIN INJURY, V22, P723, DOI 10.1080/02699050802304706; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zafonte RD, 2002, J HEAD TRAUMA REHAB, V17, P322, DOI 10.1097/00001199-200208000-00006; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang Z, 2009, CELL MOL LIFE SCI, V66, P526, DOI 10.1007/s00018-008-8362-1; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zurek J, 2010, CESK SLOV NEUROL N, V73, P37	522	8	8	0	14	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							434	469					36	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100029					2022-02-06	
J	Kahle, KT; Walcott, BP; Simard, JM				Kahle, Kristopher T.; Walcott, Brian P.; Simard, J. Marc			Continuous hyperosmolar therapy for traumatic brain injury-associated cerebral edema: As good as it gets, or an iatrogenic secondary insult?	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Edema; Hypernatremia; Hyperosmolar; Hypertonic; Trauma; Tumor; Vasogenic		Cerebral edema is a heterogeneous condition that is present in almost every type of neurological disease process - ranging from tumor, to cerebrovascular disease, to infection, to trauma, among others. It is associated with a high rate of morbidity and mortality. The pathophysiologic mechanisms of edema formation are distinct for the different conditions, thereby defining the various classifications. A relatively new treatment practice for cerebral edema is known as induced, sustained hypernatremia. This practice is highly controversial, is in widespread use, and lacks robust evidence for efficacy. Herein, we review details of the controversy regarding this practice. (C) 2012 Elsevier Ltd. All rights reserved.	[Kahle, Kristopher T.; Walcott, Brian P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Kahle, Kristopher T.; Walcott, Brian P.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MA USA		Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St,White Bldg,Room 502, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061808] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL082517] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS061808] Funding Source: Medline		BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; LIEN YHH, 1990, J CLIN INVEST, V85, P1427, DOI 10.1172/JCI114587; LUNDBERG N, 1959, Acta Psychiatr Scand Suppl, V34, P1; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4	10	8	10	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2013	20	1					30	31		10.1016/j.jocn.2012.10.004			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	072JR	WOS:000313667700006	23200533	Green Accepted			2022-02-06	
J	Kave, G; Shalmon, M; Knafo, A				Kave, Gitit; Shalmon, Moran; Knafo, Ariel			Environmental contributions to preschoolers' semantic fluency	DEVELOPMENTAL SCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; SCHOOL-AGED CHILDREN; VERBAL FLUENCY; EXECUTIVE FUNCTIONS; COGNITIVE-DEVELOPMENT; EXPRESSIVE VOCABULARY; SOCIOECONOMIC-STATUS; LANGUAGE IMPAIRMENT; WORD-RETRIEVAL; FRONTAL-LOBE	Semantic fluency was examined in Hebrew-speaking 5-year-old monozygotic and dizygotic twins (N = 396, 198 pairs), 22% of them with mother-reported speech-related problems. There were positive correlations of similar magnitudes among monozygotic, same-sex dizygotic, and opposite-sex dizygotic twins. Analyses showed no genetic effects, alongside significant shared (39%) and non-shared environmental (61%) effects on fluency scores. The presence of speech-related problems in one twin affected the fluency score of the co-twin. A multivariate regression analysis revealed that parental education and length of stay at daycare significantly predicted fluency scores. We suggest that semantic fluency performance is highly affected by environmental factors at age 5 although genetic effects might emerge later on.	[Kave, Gitit] Open Univ, Dept Educ & Psychol, Raanana, Israel; [Shalmon, Moran; Knafo, Ariel] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel		Knafo, A (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	msarielk@mscc.huji.ac.il	Knafo-Noam, Ariel/E-8067-2011	Knafo-Noam, Ariel/0000-0003-0613-1960; Kave, Gitit/0000-0002-4950-5507			Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Ardila A, 2006, INT J PSYCHOL, V41, P324, DOI 10.1080/00207590500345542; Bishop DVM, 2008, GENES BRAIN BEHAV, V7, P365, DOI 10.1111/j.1601-183X.2007.00360.x; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Byrne B, 2009, J NEUROLINGUIST, V22, P219, DOI 10.1016/j.jneuroling.2008.09.003; Chilosi AM, 2009, CHILD NEUROPSYCHOL, V15, P582, DOI 10.1080/09297040902927614; de Guibert C, 2010, NEUROIMAGE, V51, P897, DOI 10.1016/j.neuroimage.2010.02.054; DELIS DC, 2001, DELISKAPLAN EXECUTIV; DeThorne LS, 2008, J SPEECH LANG HEAR R, V51, P423, DOI 10.1044/1092-4388(2008/031); Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Gagliano A, 2007, J CLIN EXP NEUROPSYC, V29, P488, DOI 10.1080/13803390600788142; Galsworthy MJ, 2000, DEVELOPMENTAL SCI, V3, P206, DOI 10.1111/1467-7687.00114; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Hammond SI, 2012, DEV PSYCHOL, V48, P271, DOI 10.1037/a0025519; Hart SA, 2009, J CHILD PSYCHOL PSYC, V50, P911, DOI 10.1111/j.1469-7610.2009.02074.x; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Hayiou-Thomas ME, 2006, J CHILD LANG, V33, P339, DOI 10.1017/S0305000906007331; Henry LA, 2012, J CHILD PSYCHOL PSYC, V53, P37, DOI 10.1111/j.1469-7610.2011.02430.x; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Hoekstra RA, 2009, DEVELOPMENTAL SCI, V12, P1041, DOI 10.1111/j.1467-7687.2009.00843.x; Hurks PPM, 2010, CHILD NEUROPSYCHOL, V16, P366, DOI 10.1080/09297041003671184; Hurks PPM, 2006, J CLIN EXP NEUROPSYC, V28, P684, DOI 10.1080/13803390590954191; Kave G, 2006, DEV NEUROPSYCHOL, V29, P493, DOI 10.1207/s15326942dn2903_7; Kave G, 2008, J CLIN EXP NEUROPSYC, V30, P349, DOI 10.1080/13803390701416197; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kave G, 2010, CHILD NEUROPSYCHOL, V16, P549, DOI 10.1080/09297049.2010.485124; Kave G, 2010, PSYCHOL AGING, V25, P719, DOI 10.1037/a0018927; Kishiyama MM, 2009, J COGNITIVE NEUROSCI, V21, P1106, DOI 10.1162/jocn.2009.21101; Knafo A, 2006, TWIN RES HUM GENET, V9, P791, DOI 10.1375/twin.9.6.791; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Kovas Y, 2005, CHILD DEV, V76, P632, DOI 10.1111/j.1467-8624.2005.00868.x; Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nash HM, 2008, COGN NEUROPSYCHOL, V25, P690, DOI 10.1080/02643290802274064; NEALE MC, 1999, MX STAT MODELING; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Olson RK, 2011, SCI STUD READ, V15, P26, DOI 10.1080/10888438.2011.536128; Pineda D, 1998, INT J NEUROSCI, V96, P177, DOI 10.3109/00207459808986466; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; PLOMIN R, 2008, BEHAV GENETICS; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/twin.3.3.129; Prigatano GP, 2008, J INT NEUROPSYCH SOC, V14, P143, DOI 10.1017/S1355617708080089; Prigatano GP, 2008, BRAIN INJURY, V22, P491, DOI 10.1080/02699050802084902; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Rodriguez ET, 2009, J APPL DEV PSYCHOL, V30, P677, DOI 10.1016/j.appdev.2009.01.003; Samuelsson S, 2008, LEARN INDIVID DIFFER, V18, P289, DOI 10.1016/j.lindif.2008.03.004; Sauzeon H, 2004, BRAIN LANG, V89, P192, DOI 10.1016/S0093-934X(03)00367-5; Schachar RJ, 2011, J INT NEUROPSYCH SOC, V17, P238, DOI 10.1017/S1355617710001463; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Stromswold K, 2001, LANGUAGE, V77, P647, DOI 10.1353/lan.2001.0247; Tallberg IM, 2011, SCAND J PSYCHOL, V52, P35, DOI 10.1111/j.1467-9450.2010.00842.x; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Westerlund M, 2008, CHILD CARE HLTH DEV, V34, P257, DOI 10.1111/j.1365-2214.2007.00801.x	62	8	8	1	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1363-755X			DEVELOPMENTAL SCI	Dev. Sci.	JAN	2013	16	1					124	135		10.1111/desc.12010			12	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	096DD	WOS:000315383300013	23278934				2022-02-06	
J	Kieffer-Kristensen, R; Siersma, VD; Teasdale, TW				Kieffer-Kristensen, Rikke; Siersma, Volkert D.; Teasdale, Thomas W.			Family matters: Parental-acquired brain injury and child functioning	NEUROREHABILITATION			English	Article						Family health; parental ABI; child problems; parent's functioning; illness-related variables	EVENT SCALE; PHYSICAL ILLNESS; SOCIAL SUPPORT; FOLLOW-UP; ADJUSTMENT; STRESS; IMPACT; POPULATION; CANCER; REHABILITATION	OBJECTIVES: To relate illness and family factors to emotional and behavioural problems in school-age children (7-14 years old) of parents with acquired brain injury and their healthy spouses. PARTICIPANTS, MATERIALS/METHODS: Members of 35 families in which a parent had been diagnosed with acquired brain injury participated. Family and brain injury characteristics were reported by the ill and healthy parents. Children self-reported post-traumatic stress symptoms (PSS) using the Child Impact of Events revised (CRIES). Emotional and behavioural problems among the children were also identified by the parents using the Achenbach's Child Behaviour Checklist (CBCL). RESULTS: The family stress variables relating to the healthy spouse in all six comparisons were significant (p< = 0.05) or nearly so (p = 0.07) in each case showing higher scores for spouses to be associated with higher CRIES and CBCL total scores for the children. For the adjusted associations, we again found the family stress variables in the healthy spouse to be related to the risk of emotional and behavioral problems in the children. CONCLUSIONS: The present results suggest that in ABI families, the children's emotional functioning depends upon family factors and primarily on the level of parental stress in the healthy parent.	[Kieffer-Kristensen, Rikke; Teasdale, Thomas W.] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Siersma, Volkert D.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark		Kieffer-Kristensen, R (corresponding author), Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	rikke.kieffer@psy.ku.dk	Siersma, Volkert D/G-6867-2016	Siersma, Volkert D/0000-0003-1941-2681			Abidin RR., 1983, PARENTING STRESS IND; ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; ARMISTEAD L, 1995, CLIN PSYCHOL REV, V15, P409, DOI 10.1016/0272-7358(95)00023-I; Bilenberg N, 1999, ACTA PSYCHIAT SCAND, V100, P2, DOI 10.1111/j.1600-0447.1999.tb10703.x; Boss P, 2002, J CLIN PSYCHOL, V58, P1351, DOI 10.1002/jclp.10083; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Dyregrov A, 1996, SCAND J PSYCHOL, V37, P339, DOI 10.1111/j.1467-9450.1996.tb00667.x; Emery R E, 1995, Pediatr Rev, V16, P306, DOI 10.1542/pir.16-8-306; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Haskett ME, 2006, J CLIN CHILD ADOLESC, V35, P302, DOI 10.1207/s15374424jccp3502_14; HETHERINGTON EM, 1989, AM PSYCHOL, V44, P303, DOI 10.1037/0003-066X.44.2.303; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kelly JB, 2000, J AM ACAD CHILD PSY, V39, P963, DOI 10.1097/00004583-200008000-00007; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kobak R., 2006, DEV PSYCHOL, V2nd ed.), P333; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LECLERE FB, 1994, J MARRIAGE FAM, V56, P457, DOI 10.2307/353112; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rolland JS, 2005, CANCER-AM CANCER SOC, V104, P2584, DOI 10.1002/cncr.21489; ROLLAND JS, 1990, FAM PROCESS, V29, P229, DOI 10.1111/j.1545-5300.1990.00229.x; ROLLAND JS, 1987, FAM PROCESS, V26, P203, DOI 10.1111/j.1545-5300.1987.00203.x; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Steele RG, 1997, J ABNORM CHILD PSYCH, V25, P83, DOI 10.1023/A:1025771210350; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Visser A, 2006, CANCER-AM CANCER SOC, V106, P1178, DOI 10.1002/cncr.21691; Visser A, 2004, CANCER TREAT REV, V30, P683, DOI 10.1016/j.ctrv.2004.06.001; Visser-Meily A, 2005, J REHABIL MED, V37, P236, DOI 10.1080/16501970510025990	44	8	8	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	1					59	68		10.3233/NRE-130823			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	095MR	WOS:000315339100007	23422459				2022-02-06	
J	Lima, AAM; Kvalsund, MP; de Souza, PPE; Figueiredo, IL; Soares, AM; Mota, RMS; Lima, NL; Pinkerton, RC; Patrick, PP; Guerrant, RL; Oria, RB				Lima, Aldo A. M.; Kvalsund, Michelle P.; de Souza, Paula P. E.; Figueiredo, Italo L.; Soares, Alberto M.; Mota, Rosa M. S.; Lima, Noelia L.; Pinkerton, Relana C.; Patrick, Peter P.; Guerrant, Richard L.; Oria, Reinaldo B.			Zinc, vitamin A, and glutamine supplementation in Brazilian shantytown children at risk for diarrhea results in sex-specific improvements in verbal learning	CLINICS			English	Article						Malnutrition; Cognition; Zinc; Vitamin A; Glutamine; Child	EARLY-CHILDHOOD DIARRHEA; INTESTINAL BARRIER FUNCTION; GENDER-DIFFERENCES; BRAIN; GROWTH; MEMORY; ESTROGEN; HEALTH; INJURY; MICE	OBJECTIVE: To identify the impact of supplemental zinc, vitamin A, and glutamine, alone or in combination, on long-term cognitive outcomes among Brazilian shantytown children with low median height-for-age z-scores. METHODS: A randomized, double-blind, placebo-controlled trial was conducted in children aged three months to nine years old from the urban shanty compound community of Fortaleza, Brazil. Demographic and anthropometric information was assessed. The random treatment groups available for cognitive testing (total of 167 children) were: (1) placebo, n = 25; (2) glutamine, n = 23; (3) zinc, n = 18; (4) vitamin A, n = 19; (5) glutamine+zinc, n = 20; (6) glutamine+vitamin A, n = 21; (7) zinc+vitamin A, n = 23; and (8) glutamine+zinc+vitamin A, n = 18. Neuropsychological tests were administered for the cognitive domains of non-verbal intelligence and abstraction, psychomotor speed, verbal memory and recall ability, and semantic and phonetic verbal fluency. Statistical analyses were performed using SPSS, version 16.0. ClinicalTrials.gov: NCT00133406. RESULTS: Girls receiving a combination of glutamine, zinc, and vitamin A had higher mean age-adjusted verbal learning scores than girls receiving only placebo (9.5 versus 6.4, p = 0.007) and girls receiving zinc+vitamin A (9.5 versus 6.5, p = 0.006). Similar group differences were not found between male study children. CONCLUSIONS: The findings suggest that combination therapy offers a sex-specific advantage on tests of verbal learning, similar to that seen among female patients following traumatic brain injury.	[Lima, Aldo A. M.; de Souza, Paula P. E.; Figueiredo, Italo L.; Soares, Alberto M.; Mota, Rosa M. S.; Lima, Noelia L.; Pinkerton, Relana C.; Guerrant, Richard L.; Oria, Reinaldo B.] Univ Fed Ceara, Sch Med, Clin Res Unit, Fortaleza, Ceara, Brazil; [Lima, Aldo A. M.; de Souza, Paula P. E.; Figueiredo, Italo L.; Soares, Alberto M.; Mota, Rosa M. S.; Lima, Noelia L.; Pinkerton, Relana C.; Guerrant, Richard L.; Oria, Reinaldo B.] Ctr Global Hlth, Inst Biomed, Fortaleza, Ceara, Brazil; [Lima, Aldo A. M.; de Souza, Paula P. E.; Figueiredo, Italo L.; Soares, Alberto M.; Mota, Rosa M. S.; Lima, Noelia L.; Pinkerton, Relana C.; Guerrant, Richard L.; Oria, Reinaldo B.] Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Kvalsund, Michelle P.; Guerrant, Richard L.] Univ Virginia, Sch Med, Ctr Global Hlth, Div Infect Dis, Charlottesville, VA 22908 USA; [Patrick, Peter P.] Univ Virginia, Sch Med, Kluge Childrens Hosp, Dept Pediat, Charlottesville, VA 22908 USA		Lima, AAM (corresponding author), Univ Fed Ceara, Sch Med, Clin Res Unit, Fortaleza, Ceara, Brazil.	rbo5u@virginia.edu	Oria, Reinaldo B/D-6440-2014; Lima, Aldo AM/D-8251-2018	Lima, Aldo AM/0000-0002-0299-1747; Oria, Reinaldo/0000-0002-6914-5481; Soares, Alberto Melo/0000-0002-3359-6109	Brazilian funding agency, CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); ICIDR program from the NIH, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 U01 AI026512]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U01AI026512] Funding Source: NIH RePORTER	The authors would like to thank Sayonara Bezerra de Alencar, Fatima Alves, Rosiana Maria de Paula Silva, and Maria Luzia F. Melo for all of their hard work and dedication to the Parque Universitario community and the Clinical Research Unit of the Federal University of Ceara. The study was supported by a Brazilian funding agency, CNPq, and an ICIDR program grant, #5 U01 AI026512, from the NIH, USA.	Albrecht J, 2010, NEURON GLIA BIOL, V6, P263, DOI 10.1017/S1740925X11000093; Ardila A, 2011, DEV PSYCHOL, V47, P984, DOI 10.1037/a0023819; Azcoitia I, 2011, TRENDS ENDOCRIN MET, V22, P467, DOI 10.1016/j.tem.2011.08.002; Benton D, 2008, EUR J NUTR, V47, P38, DOI 10.1007/s00394-008-3004-9; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Black MM, 2003, J NUTR, V133, p3927S, DOI 10.1093/jn/133.11.3927S; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Brown L., 1997, TEST NONVERBAL INTEL, V3rd; Carneiro-Filho BA, 2004, NUTRITION, V20, P934, DOI 10.1016/j.nut.2004.06.016; Carneiro-Filho Benedito A., 2003, Curr Infect Dis Rep, V5, P114, DOI 10.1007/s11908-003-0046-2; Colvin RA, 2000, J NUTR, V130, p1484S, DOI 10.1093/jn/130.5.1484S; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Ladd FVL, 2010, NUTRITION, V26, P662, DOI 10.1016/j.nut.2009.11.020; Lazzerini M, 2012, COCHRANE DB SYST REV, V6; Lima AAM, 2005, J PEDIATR GASTR NUTR, V40, P28, DOI 10.1097/00005176-200501000-00006; Lima AAM, 2010, J PEDIATR GASTR NUTR, V50, P309, DOI 10.1097/MPG.0b013e3181a96489; Lorntz B, 2006, PEDIATR INFECT DIS J, V25, P513, DOI 10.1097/01.inf.0000219524.64448.90; Patrick PD, 2005, CHILD NEUROPSYCHOL, V11, P233, DOI 10.1080/092970490911252; ROBISON LL, 1984, AM J PEDIAT HEMATOL, V6, P115; Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; SODERBERG TA, 1990, SCAND J PLAST RECONS, V24, P193; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Vazir S, 2006, NUTRITION, V22, pS26, DOI 10.1016/j.nut.2004.07.021; WABER DP, 1990, DEV MED CHILD NEUROL, V32, P238; Wilson ME, 2011, HORM BEHAV, V59, P353, DOI 10.1016/j.yhbeh.2010.08.004; Wu GH, 2004, WORLD J GASTROENTERO, V10, P2592, DOI 10.3748/wjg.v10.i17.2592; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0	34	8	10	0	11	HOSPITAL CLINICAS, UNIV SAO PAULO	SAO PAULO	FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL	1807-5932	1980-5322		CLINICS	Clinics		2013	68	3					351	358		10.6061/clinics/2013(03)OA11			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158VC	WOS:000320000800012	23644855	Green Published, Green Submitted, gold			2022-02-06	
J	Liu, Y; Jolly, S; Pokala, K				Liu, Yan; Jolly, Suneil; Pokala, Krishna			Prolonged Paroxysmal Sympathetic Storming Associated with Spontaneous Subarachnoid Hemorrhage	CASE REPORTS IN MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; AUTONOMIC DYSFUNCTION; SUDDEN-DEATH; INSTABILITY; HYPERACTIVITY; DYSAUTONOMIA; PULMONARY; DYSTONIA	Paroxysmal sympathetic storming (PSS) is a rare disorder characterized by acute onset of nonstimulated tachycardia, hypertension, tachypnea, hyperthermia, external posturing, and diaphoresis. It is most frequently associated with severe traumatic brain injuries and has been reported in intracranial tumors, hydrocephalous, severe hypoxic brain injury, and intracerebral hemorrhage. Although excessive release of catecholamine and therefore increased sympathetic activities have been reported in subarachnoid hemorrhage (SAH), there is no descriptive report of PSS primarily caused by spontaneous SAH up to date. Here, we report a case of prolonged PSS in a patient with spontaneous subarachnoid hemorrhage and consequent vasospasm. The sympathetic storming started shortly after patient was rewarmed from hypothermia protocol and symptoms responded to Labetalol, but intermittent recurrence did not resolve until 3 weeks later with treatment involving Midazolam, Fentanyl, Dexmedetomidine, Propofol, Bromocriptine, and minimizing frequency of neurological and vital checks. In conclusion, prolonged sympathetic storming can also be caused by spontaneous SAH. In this case, vasospasm might be a precipitating factor. Paralytics and hypothermia could mask the manifestations of PSS. The treatment of the refractory case will need both timely adjustment of medications and minimization of exogenous stressors or stimuli.	[Liu, Yan] Univ Texas Southwestern, Univ Med Ctr Brackenridge, Dept Internal Methane, Med Sch Residency Program, 601 East 15th St, Austin, TX 78701 USA; [Jolly, Suneil] Univ Texas Southwestern, Univ Med Ctr Brackenridge, Transit Program, Med Sch Residency Program, Austin, TX 78701 USA; [Pokala, Krishna] Univ Texas Southwestern, Univ Med Ctr Brackenridge, Dept Neurol, Med Sch Residency Program, Austin, TX 78701 USA		Liu, Y (corresponding author), Univ Texas Southwestern, Univ Med Ctr Brackenridge, Dept Internal Methane, Med Sch Residency Program, 601 East 15th St, Austin, TX 78701 USA.	yan.liu@utsouthwestern.edu					Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; BHIGJEE AI, 1985, J NEUROL SCI, V71, P77, DOI 10.1016/0022-510X(85)90038-3; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Bower RS, 2010, NEUROCRIT CARE, V13, P233, DOI 10.1007/s12028-010-9381-y; Bruder N, 2011, NEUROCRIT CARE, V15, P257, DOI 10.1007/s12028-011-9598-4; de Chazal I, 2005, ANESTH ANALG, V100, P1147, DOI 10.1213/01.ANE.0000147704.90285.2A; Diamond AL, 2005, NEUROCRIT CARE, V2, P288, DOI 10.1385/NCC:2:3:288; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Lee VH, 2006, NEUROCRIT CARE, V5, P243, DOI 10.1385/NCC:5:3:243; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Moussouttas M, 2012, NEUROCRIT CARE, V16, P381, DOI 10.1007/s12028-012-9673-5; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; Sakr YL, 2002, PROG CARDIOVASC DIS, V45, P67, DOI 10.1053/pcad.2002.124633; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; Scott JS, 1997, AM J PHYS MED REHAB, V76, P200, DOI 10.1097/00002060-199705000-00007; Sheikhazadi A, 2009, AM J FOREN MED PATH, V30, P358, DOI 10.1097/PAF.0b013e3181bfcd64; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738	24	8	8	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.		2013	2013								358182	10.1155/2013/358182			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V25ZF	WOS:000215261800088	23476663	Green Submitted, Green Published, gold			2022-02-06	
J	Perrin, PB; Stevens, LF; Cabrera, TV; Jimenez-Maldonado, M; Martinez-Cortes, ML; Arango-Lasprilla, JC				Perrin, Paul B.; Stevens, Lillian Flores; Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Luisa Martinez-Cortes, Maria; Carlos Arango-Lasprilla, Juan			Just how bad is it? Comparison of the mental health of Mexican traumatic brain injury caregivers to age-matched healthy controls	NEUROREHABILITATION			English	Article						TBI caregivers; Latin America; mental health	QUALITY-OF-LIFE; ROSENBERG SELF-ESTEEM; PUERTO-RICAN; PSYCHOMETRIC PROPERTIES; INDIVIDUALS; BURDEN; REHABILITATION; FAMILY; DEPRESSION; NEEDS	OBJECTIVE: To compare the mental health of family caregivers of individuals with traumatic brain injury (TBI) to an age-matched healthy control from Guadalajara, Mexico. SETTING: Hospital Civil Fray Antonio Alcade, a public medical facility in Guadalajara, Mexico. PARTICIPANTS: Ninety family caregivers of individuals with TBI and 89 healthy controls (n = 179) did not differ with respect to age, sex, marital status, education, or household income. MAIN OUTCOME MEASURES: Outcome measures assessed satisfaction with life (Satisfaction with Life Scale), depression (Patient Health Questionnaire-9), social support (Interpersonal Support Evaluation List), self-esteem (Rosenberg Self-Esteem Scale), and anxiety (State-Trait Anxiety Inventory). RESULTS: A multivariate analysis of variance found that in comparison to controls, TBI caregivers reported substantially lower mental health scores across all indices, as well as lower social support in two out of three comparisons. The effect sizes of the social support differences were small; two out of five mental health differences reached medium-sized effects; and the other three reached large-sized effects. CONCLUSIONS: Because TBI caregivers' mental health influences the quality of informal care they can provide, mental health interventions for family caregivers are an extremely important part of TBI rehabilitation in Latin America, especially considering familism as a core value in Latino culture.	[Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Luisa Martinez-Cortes, Maria] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, IKERBASQUE, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Basque Fdn Sci, IKERBASQUE, Dept Psychol, Bilbao, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Atienza FL, 2000, PSICOTHEMA, V12, P314; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Cavallo M.M., 2011, TXB TRAUMATIC BRAIN, P483; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hinojosa MS, 2009, ETHNIC HEALTH, V14, P591, DOI 10.1080/13557850903165403; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Leipziger D. M., 2001, FIN DEV, V38; Marin G., 1991, RES HISPANIC POUPLAT; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; NOVY DM, 1995, HISPANIC J BEHAV SCI, V17, P209, DOI 10.1177/07399863950172005; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rosenberg M., 1965, SOC ADOLSECENT CHILD; Sanchez-Ayendez M, 1998, J GERONTOL SOC WORK, V30, P75, DOI 10.1300/J083v30n01_06; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Spielberger C. D., 2010, CORSINI ENCY PSYCHOL, P1; Spielberger C. D, 1975, IDARE INVENTARIO ANI; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Villarreal R, 2005, HISPANIC J BEHAV SCI, V27, P409, DOI 10.1177/0739986305281125; VIRELLA B, 1994, J PERS ASSESS, V63, P401, DOI 10.1207/s15327752jpa6303_1; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZEA MC, 1994, J SOC BEHAV PERS, V9, P185; Zniga Carrasco, 2008, VIGILANCIA EPIDEMIOL, V26, P1; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	57	8	8	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	3					679	686		10.3233/NRE-130891			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200027	23648623				2022-02-06	
J	Rendell, S; Batchelor, JS				Rendell, Simon; Batchelor, John S.			An analysis of predictive markers for intracranial haemorrhage in warfarinised head injury patients	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; ANTICOAGULATED PATIENTS; COMPUTED-TOMOGRAPHY; RISK; CT	Introduction Minor head injury in older patients on warfarin may present in a variety of ways that often fall outside the remit of conventional guidelines. The aim of this study was to determine the relative risks for intracranial haemorrhage (ICH) in patients with subtherapeutic, therapeutic and supratherapeutic INR levels, in addition to the relative risks for the common symptoms at presentation. Methods The notes were retrospectively reviewed of all patients who had a CT scan requested by the emergency department over a 2-year period (January 2008 to December 2009) and from these warfarinised head injuries were identified. Results 82 warfarinised head injury patients were identified from 3338 requested CT scans. 12 of these patients (15%) had evidence of ICH on the CT. 72 patients had their INR checked (88%) and the RR of ICH for the INR subgroups were calculated: INR <2 (RR 1.89; 95% CI 0.65 to 5.55); INR 2-3 (RR 0.84; 95% CI 0.27 to 2.64); and INR >3 (RR 0.53; 95% CI 0.13 to 2.29). The greatest proportion of those with ICH (42%) had a subtherapeutic INR. 2 out of the 12 patients (17%) were found to have intracranial bleeding despite not meeting the criteria for a CT scan according to the NICE guidelines. Conclusion The results of the INR subgroup analysis suggest that a subtherapeutic INR may not be protective against ICH in patients with minor head injury.	[Rendell, Simon; Batchelor, John S.] Manchester Royal Infirm, Dept Emergency Med, Manchester M13 9WL, Lancs, England		Batchelor, JS (corresponding author), Manchester Royal Infirm, Dept Emergency Med, Oxford Rd, Manchester M13 9WL, Lancs, England.	johnbatchelor@msn.com					Berwaerts J, 2000, QJM-MON J ASSOC PHYS, V93, P513, DOI 10.1093/qjmed/93.8.513; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P1787, DOI 10.1136/jnnp.2004.041384; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Karni A, 2001, AM SURGEON, V67, P1098; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Singer DE, 2009, CIRC-CARDIOVASC QUAL, V2, P297, DOI 10.1161/CIRCOUTCOMES.108.830232; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Volans AP, 1998, J ACCID EMERG MED, V15, P159	19	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2013	30	1					28	31		10.1136/emermed-2011-200176			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	062CN	WOS:000312896800012	22362648				2022-02-06	
J	Zare, MA; Ahmadi, K; Zadegan, SA; Farsi, D; Rahimi-Movaghar, V				Zare, Mohammad Amin; Ahmadi, Koorosh; Zadegan, Shayan Abdollah; Farsi, Davood; Rahimi-Movaghar, Vafa			Effects of Brain Contusion on Mild Traumatic Brain-Injured Patients	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						computed tomography; contusion; mild traumatic brain injury; outcome; rehospitalization	MINOR HEAD-INJURY; UNITED-STATES; AGREEMENT STATEMENT; CONCUSSION; PREVALENCE; RECOMMENDATIONS; POPULATION; RECOVERY; SEQUELAE; HEALTH	Traumatic brain injury (TBI) is an important health issue with high prevalence. The most common type of TBI is mild TBI (MTBI). MTBI is known as a condition with self-limited symptoms; however, it could cause some structural abnormalities of brain and become complicated. Visible structural brain damage could have an important effect on recovery after MTBI, but the outcome is not fully understood. This study investigated the clinical course of MTBI patients with the existence of contusion in computed tomography (CT) imaging. Fifty patients with MTBI and simultaneous brain contusion in CT scan were enrolled according to specific exclusion criteria in 14 month. Patients were followed up for two weeks after their first arrival for neurosurgical interventions, decreased level of consciousness, and other neurological complications. Presence of neurological symptoms increased duration of hospital stay and number of CT scans. Forty-two percent of MTBI patients with contusion did not have any objective neurological signs. Fifty percent returned to the hospital with neurologic symptoms and signs. Leading causes were headache followed by seizure and dizziness. Rehospitalization was increased in the patients with altered level of consciousness. The size of brain contusion increased in two patients without further need for neurosurgical intervention. Contusion alone did not worsen the prognosis of patients in short-term follow-up and did not cause neurosurgical interventions.	[Zare, Mohammad Amin; Farsi, Davood] Univ Tehran Med Sci, Dept Emergency Med, Tehran, Iran; [Ahmadi, Koorosh] Alborz Univ Med Sci, Dept Emergency Med, Alborz, Iran; [Zadegan, Shayan Abdollah; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Sina Gen Hosp, Tehran, Iran		Rahimi-Movaghar, V (corresponding author), Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Sina Gen Hosp, Hassan Abad SQ,Imam Khomeini St,POB 11365-3876, Tehran, Iran.	v_rahimi@sina.tums.ac.ir	Zadegan, Shayan Abdollah/AAU-9866-2020; Rahimi-Movaghar, Vafa/L-6339-2019; Farsi, Davood/Q-5092-2018; Ahmadi, Koorosh/AAF-7559-2020	Zadegan, Shayan Abdollah/0000-0002-6517-0567; Farsi, Davood/0000-0002-8366-2477; 			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Biros MH, 2010, ROSENS EMERGENCY MED, P295; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; CLINE DM, 1988, ANN EMERG MED, V17, P127, DOI 10.1016/S0196-0644(88)80297-X; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Hamilton NA, 2010, SEMIN PEDIATR SURG, V19, P271, DOI 10.1053/j.sempedsurg.2010.06.005; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Neal Matthew T, 2012, Surg Neurol Int, V3, P16, DOI 10.4103/2152-7806.92930; Rahimi-Movaghar V, 2011, AM SURGEON, V77, pE112; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saadat S, 2011, ULUS TRAVMA ACIL CER, V17, P149, DOI 10.5505/tjtes.2011.26043; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shorooei MH, 2010, CHIN J TRAUMATOL, V13, P345, DOI 10.3760/cma.j.issn.1008-1275.2010.06.005; Tellier A, 1999, BRAIN INJURY, V13, P463; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	49	8	8	0	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	JAN	2013	123	1					65	69		10.3109/00207454.2012.728653			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	062WR	WOS:000312955300011	23005920	Green Published			2022-02-06	
J	Senapati, SB; Mishra, SS; Das, S; Satpathy, PC				Senapati, Satya Bhusan; Mishra, Sudhansu Sekhar; Das, Srikanta; Satpathy, Pratap Chandra			Cranioplasty after decompressive craniectomy	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Decompressive craniectomy; Early cranioplasty; Delayed cranioplasty		Decompressive craniectomy is a well accepted procedure for management of refractory intracranial hypertension after head trauma. All cases of decompressive craniectomy eventually require second surgery for cranioplasty. Most people believe that cranioplasty is for cosmetic purpose only, where as it has a definitive impact on restoration of normal intracranial physiology and improvement of patient neurological condition. There is conflicting opinion regarding timing for cranioplasty even in text books. In this article we describe operative procedure adopted by us for cranioplasty and simultaneously review the literature regarding appropriate timing for cranioplasty after decompressive craniectomy. We found there are definitive advantages of early cranioplasty over delayed cranioplasty. Points in favor of early cranioplasty are highlighted. Copyright (C) 2012, Neurotrauma Society of India. All rights reserved.	[Senapati, Satya Bhusan; Mishra, Sudhansu Sekhar; Das, Srikanta; Satpathy, Pratap Chandra] SCB Med Coll & Hosp, Dept Neuro Surg, Cuttack 753007, Orissa, India		Senapati, SB (corresponding author), SCB Med Coll & Hosp, Dept Neuro Surg, Cuttack 753007, Orissa, India.	satya.bhusan.senapati@gmail.com; drssmishra@gmail.com; drsrikantadas@gmail.com; senapati2k@yahoo.com					Cohen JE, 2004, NEUROL RES, V26, P763, DOI 10.1179/016164104225015930; FOSTER R.D., 2000, SCHMIDEK SWEET OPERA, P29; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; SHAFFREY ME, 1993, BRAIN SURG COMPLICAT, P1373	9	8	8	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2012	9	2					136	139		10.1016/j.ijnt.2012.10.006			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M3Y	WOS:000218387700012					2022-02-06	
J	Sogut, O; Kaya, H; Gokdemir, MT; Solduk, L; Dokuzoglu, MA; Sayhan, MB; Kaya, A; Kocyigit, A				Sogut, Ozgur; Kaya, Halil; Gokdemir, Mehmet Tahir; Solduk, Leyla; Dokuzoglu, Mehmet Akif; Sayhan, Mustafa Burak; Kaya, Atilhan; Kocyigit, Abdurrahim			Early oxidative status in adult patients with isolated traumatic brain injury	TURKISH JOURNAL OF MEDICAL SCIENCES			English	Article; Proceedings Paper	6th European Congress on Emergency Medicine / 12th Annual Meeting of SweSEM	OCT 11-14, 2010	Stockholm, SWEDEN			Head injury; clinical outcome; oxidative stress index; total oxidant status; total antioxidant status	TOTAL OXIDANT STATUS; CRITICALLY-ILL PATIENTS; HEAD-INJURY; FREE-RADICALS; STRESS; RATS; CLASSIFICATION; MORTALITY; SEVERITY	Aim: To investigate oxidative and antioxidative status, as well as the Glasgow Coma Scale (GCS) and Revised Trauma Score (RTS), reflecting injury severity and neurological outcome during the early posttraumatic period in patients with isolated traumatic brain injury (TBI). Materials and methods: Fifty-one adult patients with TB! and 45 eligible healthy volunteers as control subjects were enrolled. Plasma total oxidant status (TOS), total antioxidant status (TAS), and the oxidative stress index (OSI) were calculated as biomarkers of early oxidative changes in serum using a novel automated method. Results: TOS levels and OSI values were significantly higher in nonsurvivors compared with those in survivors. However, there was no significant difference in TAS levels between survivors and nonsurvivors. GCS and RTS showed negative correlations with TOS levels, but neither was significantly related to OSI levels. Furthermore, GCS scores were negatively correlated with TAS levels, whereas RTS scores were not significantly related to TAS levels. Conclusion: Patients with isolated TBI are exposed to potent oxidative stress. TOS, as an early oxidative stress biomarker, might reflect the severity of cerebral insult in those patients.	[Sogut, Ozgur; Kaya, Halil; Gokdemir, Mehmet Tahir; Solduk, Leyla; Dokuzoglu, Mehmet Akif] Harran Univ, Fac Med, Dept Emergency Med, Sanliurfa, Turkey; [Sayhan, Mustafa Burak] Trakya Univ, Fac Med, Dept Emergency Med, Edirne, Turkey; [Kaya, Atilhan] Harran Univ, Fac Med, Dept Forens Med, Sanliurfa, Turkey; [Kocyigit, Abdurrahim] Harran Univ, Fac Med, Dept Biochem, Sanliurfa, Turkey		Sogut, O (corresponding author), Harran Univ, Fac Med, Dept Emergency Med, Sanliurfa, Turkey.	drosogut@harran.edu.tr	Kocyigit, Abdurrahim/P-8685-2019; Kaya, Halil/ABH-5489-2020	Kocyigit, Abdurrahim/0000-0003-2335-412X; Kaya, Halil/0000-0003-2005-6100			Aslan M, 2007, NUTR METAB CARDIOVAS, V17, P734, DOI 10.1016/j.numecd.2006.08.005; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Emecen O, 2010, TURK J MED SCI, V40, P889, DOI 10.3906/sag-0906-6; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee YB, 2009, J KOREAN NEUROSURG S, V46, P451, DOI 10.3340/jkns.2009.46.5.451; Lemineur T, 2006, CURR OPIN CLIN NUTR, V9, P704, DOI 10.1097/01.mco.0000247467.41661.f3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nayak CD, 2008, NEUROL INDIA, V56, P31, DOI 10.4103/0028-3886.39309; Ozaydin M, 2011, TURK J MED SCI, V41, P755, DOI 10.3906/sag-1003-691; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; ROSS D, 1988, PHARMACOL THERAPEUT, V37, P231, DOI 10.1016/0163-7258(88)90027-7; Roth E, 2004, CURR OPIN CLIN NUTR, V7, P161, DOI 10.1097/00075197-200403000-00010; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Selek S, 2008, CLIN BIOCHEM, V41, P140, DOI 10.1016/j.clinbiochem.2007.11.018; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sogut O, 2010, J INT MED RES, V38, P1708, DOI 10.1177/147323001003800516; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Vagnozzi R, 1997, EXP BRAIN RES, V117, P411, DOI 10.1007/s002210050235	34	8	8	0	11	TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY	ANKARA	ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY	1300-0144	1303-6165		TURK J MED SCI	Turk. J. Med. Sci.	DEC	2012	42	6					1010	1019		10.3906/sag-1109-35			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	020GF	WOS:000309796300010					2022-02-06	
J	Tate, RL; Aird, V; Taylor, C				Tate, Robyn L.; Aird, Vanessa; Taylor, Christine			Bringing Single-case Methodology into the Clinic to Enhance Evidence-based Practices	BRAIN IMPAIRMENT			English	Article						rehabilitation; treatment; evidence-based practice; single-subject design; n-of-1 trial; methodology	TRAUMATIC BRAIN-INJURY; INTERNATIONAL CLASSIFICATION; SUBJECT RESEARCH; REHABILITATION; DISABILITY; PEOPLE; HEALTH; SKILLS; INDIVIDUALS; DEFICITS	There are many challenges in incorporating an evidence-based approach into clinical practice and a large literature exists on various barriers and facilitators. Within this context, we have developed a framework to advocate an empirical approach to therapeutic interventions, using our Model to Assess Treatment Effect (MATE). The MATE is designed to characterise how an intervention is delivered to an individual patient/client. It is organised hierarchically into seven levels, from low levels of capacity to demonstrate treatment effect (e. g., Level 1: treatment commenced without pre-intervention assessment) to high levels where cause-effect relationships can be established between the intervention and the behaviour being treated (e. g., Level 6: implementation of a well-designed single-case experimental design). Consequently, the MATE captures all levels of clinical intervention and can be applied readily to an individual patient, as well as an entire clinical setting. In this paper, we present a decision tree in the form of a detailed flow-chart which assists the clinician to classify treatment delivery on the MATE. We believe that the MATE has the capacity not only to document current clinical practice, but also to provide a model whereby future treatments can be planned and implemented with greater scientific rigour and hence accountability in relation to treatment outcomes.	[Tate, Robyn L.] Univ Sydney, Sydney Med Sch, No Clin Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Tate, Robyn L.] Royal Rehabil Ctr Sydney, Rehabil Studies Unit, Ryde, NSW 1680, Australia; [Aird, Vanessa; Taylor, Christine] Cortex Commun Partners, Sydney, NSW, Australia; [Taylor, Christine] Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW 2109, Australia		Tate, RL (corresponding author), Royal Rehabil Ctr Sydney, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	rtate@med.usyd.edu.au					Backman CL, 1997, ARCH PHYS MED REHAB, V78, P1145, DOI 10.1016/S0003-9993(97)90142-8; Barlow DH, 1984, SINGLE CASE EXPT DES; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bovend'Eerdt TJH, 2011, J REHABIL MED, V43, P46, DOI 10.2340/16501977-0624; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Callahan CD, 2005, REHABIL PSYCHOL, V50, P24, DOI 10.1037/0090-5550.50.1.24; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Davis D, 2003, BMJ-BRIT MED J, V327, P33, DOI 10.1136/bmj.327.7405.33; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Fucetola R, 2005, APHASIOLOGY, V19, P411, DOI 10.1080/02687030444000859; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Grimshaw Jeremy, 2004, J Contin Educ Health Prof, V24 Suppl 1, pS31, DOI 10.1002/chp.1340240506; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Haynes B, 1998, BMJ-BRIT MED J, V317, P273, DOI 10.1136/bmj.317.7153.273; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Hersh D, 2012, APHASIOLOGY, V26, P220, DOI 10.1080/02687038.2011.640392; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Kazdin AE., 2011, SINGLE CASE RES DESI; Kratochwill T.R., 2010, SINGLE CASE DESIGNS; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; McMillan TM, 1999, NEUROPSYCHOL REHABIL, V9, P241, DOI 10.1080/096020199389356; Metcalfe C, 2001, PHYSIOTHERAPY, V11, P433, DOI DOI 10.1016/S0031-9406(05)65462-4; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; STINEMAN MG, 2005, PHYS MED REHABILITAT, P1099; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Tate R.L., SOCIAL COMMUNICATION; Tate RL, 2013, J HEAD TRAUMA REHAB, V28, P77, DOI 10.1097/HTR.0b013e31824e103e; Tate RL, 2008, BRAIN IMPAIR, V9, P282, DOI 10.1375/brim.9.3.282; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Turner-Stokes L, 2010, CLIN REHABIL, V24, P66, DOI 10.1177/0269215509343846; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Wade D. T., 2005, EFFECTIVENESS REHABI, P31, DOI [10.1093/acprof:oso/9780198526544.003.0004, DOI 10.1093/ACPROF:OSO/9780198526544.003.0004]; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; WILSON BA, 2003, BRAIN IMPAIR, V4, P25, DOI DOI 10.1375/BRIM.4.1.25.27030; World Health Organization, 2007, INT CLASS FUNCT DIS; Worrall LE, 2008, INT J SPEECH-LANG PA, V10, P72, DOI 10.1080/17549500701852148; Youse KM, 2009, NEUROREHABILITATION, V24, P355, DOI 10.3233/NRE-2009-0490	52	8	8	0	21	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2012	13	3					347	359		10.1017/BrImp.2012.32			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	072HI	WOS:000313660300005					2022-02-06	
J	Thomas, MD; McGrath, A; Skilbeck, CE				Thomas, Matt D.; McGrath, Andrew; Skilbeck, Clive E.			The psychometric properties of the Quality of Life Inventory in an Australian community sample	AUSTRALIAN JOURNAL OF PSYCHOLOGY			English	Article						Australian normative research; confirmatory factor analysis; psychometric properties; quality of life; quality of life inventory	TRAUMATIC BRAIN-INJURY; DEPRESSION; VALIDITY; HEALTH; SATISFACTION; CONSTRUCT; THERAPY	The Quality of Life Inventory (QOLI, Frisch) is an importance-weighted measure of life satisfaction that has been found to possess adequate psychometric properties in US and clinically-based samples. The current study aimed to investigate the normative distribution, factor structure and key psychometric properties of the QOLI in an Australian general community sample. Results indicated that the Australian sample (n?=?259) reported slightly better quality of life than the US-based standardisation sample. Confirmatory factor analyses showed that a three-factor model provided the best fit for the data. Psychometric properties were all generally found to be adequate and close to Frisch's reported levels. In conclusion, this study indicated that the QOLI may be used in the Australian context with confidence. Future research could examine the clinical utility of the three-factor model.	[Thomas, Matt D.; McGrath, Andrew] Charles Sturt Univ, Sch Psychol, Bathurst, NSW 2795, Australia; [Skilbeck, Clive E.] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia		Thomas, MD (corresponding author), Charles Sturt Univ, Sch Psychol, Panorama Ave, Bathurst, NSW 2795, Australia.	mathomas@csu.edu.au	McGrath, Andrew/AAJ-1648-2020	McGrath, Andrew/0000-0001-9249-0219			AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Anderson KL, 1999, J ADV NURS, V29, P298, DOI 10.1046/j.1365-2648.1999.00889.x; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andrews F. M., 1976, SOCIAL INDICATORS WE; Arbuckle J.L., 2007, AMOS 16 0 USERS GUID; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bourland SL, 2000, AGING MENT HEALTH, V4, P315, DOI 10.1080/713649960; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown M, 1999, MT SINAI J MED, V66, P160; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Browne MW, 1993, ALTERNATIVE WAYS ASS; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Carlbring P, 2009, BEHAV RES THER, V47, P848, DOI 10.1016/j.brat.2009.06.012; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Cummins R., 2010, ACQOL INSTRUMENTS; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; Frisch M. B., 2003, ANN M ASS ADV BEH TH; Frisch M.B., 1994, QUALITY LIFE INVENTO; Frisch MB, 2005, ASSESSMENT, V12, P66, DOI 10.1177/1073191104268006; Frisch MB, 1998, CLIN PSYCHOL-SCI PR, V5, P19, DOI 10.1111/j.1468-2850.1998.tb00132.x; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jakupcak M, 2010, J TRAUMA STRESS, V23, P491, DOI 10.1002/jts.20543; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Leathard HL, 2009, J ADV NURS, V65, P1318, DOI 10.1111/j.1365-2648.2008.04949.x; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Lunney CA, 2007, J TRAUMA STRESS, V20, P955, DOI 10.1002/jts.20269; McAlinden NM, 2006, COMPR PSYCHIAT, V47, P309, DOI 10.1016/j.comppsych.2005.09.003; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; Tabachnick L.S., 2001, USING MULTIVARIATE S; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Trauer T, 2001, QUAL LIFE RES, V10, P579, DOI 10.1023/A:1013159414364; Ullman JB., 2001, USING MULTIVARIATE S, V4, P653; Zucchini W., 1986, MODEL SELECTION	40	8	8	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-9530	1742-9536		AUST J PSYCHOL	Aust. J. Psychol.	DEC	2012	64	4					225	234		10.1111/j.1742-9536.2012.00054.x			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	040AZ	WOS:000311292600007					2022-02-06	
J	Beseler, MR; Grao, CM; Gil, A; Lozano, MDM				Beseler, M. R.; Grao, C. M.; Gil, A.; Martinez Lozano, M. D.			Walking assessment with instrumented insoles in patients with lower limb spasticity after botulinum toxin infiltration	NEUROLOGIA			Spanish	Article						Botulinum toxin; Instrumented insoles; Spasticity; Spinal cord injury; Stroke; Traumatic brain injury	STIFF-KNEE GAIT; INJECTION; RELIABILITY; INJURY; SYSTEM; ADULTS; SCALE	Introduction: Botulinum toxin A (BTA) improves the kinematic parameters of gait in patients with spasticity of lower limbs, but there are no studies in which kinetic parameters are measured with instrumented insoles. We therefore used instrumented insoles to perform a functional assessment of therapeutic results in patients with lower limb spasticity after brain injury or spinal cord infiltration indicating BTA. Material and methods: Ten patients (11 lower limbs) seen in a Neurorehabilitation Unit. The tests carried out included clinical examination, gait assessment (Functional Ambulation Categories (FAC); Hospital de Sagunto Gait Scale), and biomechanical assessment (Biofoot / IBV version 5.0), before and three weeks after infiltration with BTA. Statistics: t-test for related samples of clinical variables, functional variables and biomechanical variables before and after infiltration. Level of significance P<.05. Qualitative method to assess whether changes in the biomechanical variables tended toward normal values. Results: BTA improves muscle tone, joint arch and frequency of spasms (P<.01). The patient sample showed a high level of satisfaction with the improvement in symptoms. There were no changes in walking ability after injection. There were no statistically significant changes in biomechanical parameters, but there was improved gait cadence. The relatively small statistical significance close to P=.1 of the peak pressure in the heel after injection indicates the need for further studies with instrumented insoles in people with spasticity due to central nervous system injury. Conclusions: With the decrease in muscle tone after infiltration with BTA the clinical symptoms associated with muscle tone improved without any functional changes in gait scales. The changes in the biomechanical parameters show that larger studies using instrumented insoles should be performed in the population with spasticity after a central nervous system injury treated with BTA infiltration. (C) 2011 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L. All rights reserved.	[Beseler, M. R.; Grao, C. M.; Martinez Lozano, M. D.] Hosp La Magdalena, Serv Neurol, Castellon de La Plana, Spain; [Gil, A.] Hosp Nacl Paraplej, Serv Neurol, Toledo, Spain		Beseler, MR (corresponding author), Hosp La Magdalena, Serv Neurol, Castellon de La Plana, Spain.	beseler_ros@gva.es					Bleyenheuft C, 2009, GAIT POSTURE, V30, P168, DOI 10.1016/j.gaitpost.2009.04.003; Bobain G, 2006, ANN READAPT MED PHYS, V49, P609; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bryant AR, 2000, J AM PODIAT MED ASSN, V90, P295, DOI 10.7547/87507315-90-6-295; Caty GD, 2008, STROKE, V39, P2803, DOI 10.1161/STROKEAHA.108.516153; Chambers CT, 1998, PAIN, V78, P27, DOI 10.1016/S0304-3959(98)00112-2; Fheodoroff K, 2001, WIEN KLIN WOCHENSCHR, V113, P11; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, P9, DOI 10.1016/j.apmr.2008.04.030; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Hoyos JV, 1993, BIOMECANICA MARCHA H, P321; Kimura J, 1997, PATIENTS VISIT FO S6; Lance J.W., 1980, SPASTICITY DISORDERE, P485; LEAVITT LA, 1971, SOUTH MED J, V64, P1131, DOI 10.1097/00007611-197109000-00022; Marciniak C, 2008, AM J PHYS MED REHAB, V87, P312, DOI 10.1097/PHM.0b013e318168ceaf; Martinez Nova A, 2007, FOOT, V17, P190; Mayer H, 2002, SPASTICITY ETIOLOGY, P16; Papadonikolakis AS, 2003, ACTA ORTHOP SCAND, V74, P749, DOI 10.1080/00016470310018315; Perry J, 1992, GAIT ANAL NORMAL PAT; Randolph AL, 2000, ARCH PHYS MED REHAB, V81, P573, DOI 10.1016/S0003-9993(00)90037-6; Robertson JVG, 2009, GAIT POSTURE, V29, P108, DOI 10.1016/j.gaitpost.2008.07.005; Rosales RL, 2008, J NEURAL TRANSM, V115, P617, DOI 10.1007/s00702-007-0869-3; Rousseaux M, 2007, EUR J NEUROL, V14, P206, DOI 10.1111/j.1468-1331.2006.01617.x; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1234, DOI 10.1016/j.apmr.2004.11.016	24	8	9	0	8	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0213-4853			NEUROLOGIA	Neurologia	NOV-DEC	2012	27	9					519	530		10.1016/j.nrl.2011.07.007			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	050KZ	WOS:000312053500001	22088852	Bronze			2022-02-06	
J	Billeter, AT; Sklare, S; Franklin, GA; Wright, J; Morgan, G; O'Flynn, PE; Polk, HC				Billeter, Adrian T.; Sklare, Seth; Franklin, Glen A.; Wright, Jerry; Morgan, Gary; O'Flynn, Paul E.; Polk, Hiram C.			Sequential improvements in organ procurement increase the organ donation rate	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Organ donation; Organ donor; Organ procurement; Transplantation; Intensivist programme; Liaison programme	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; LIVER-TRANSPLANTATION; DONOR CONVERSION; CONSENT; MANAGEMENT; FAMILIES; PROTECTS; PROTOCOL	Purpose: Organ demand exceeds availability of transplantable organs. Organ procurement continues to suffer from failures to identify potential donors, inability to obtain consent for donation, as well as failures to retrieve certain organs as donor demographics change. The purpose of this article is to propose how sequentially introduced measures can increase organ donation rates as well as improve organ procurement. Methods: We analysed the effect of stepwise improvements in the organ procurement process patients in a university-based surgical intensive care unit over a 20-year period. We related newly introduced measures in the organ retrieval process with changes in donation rates. We specifically targeted these three main steps in the donation process: donor identification, conversion of potential donors to actual donors, and organ protection during the procurement process. Finally, we assessed the effect of the same measures on organ procurement after introduction in other hospitals of the same organ procurement region. Results: Introduction of quality improvement steps increased all of the observed parameters. The number of organ donors was stabilised due to a better identification of potential donors, a major increase in conversion from potential to actual donors, and an increase in extended criteria donor. Improvements in organ protection led to higher rates of organs transplanted per donor and increased recovery of lungs and hearts despite increasing donor age. The same measures were introduced successfully in other hospitals in our organ procurement region. Conclusion: Sequential improvements in organ procurement can increase the yield of retrieved organs. The same measures can be applied to other hospitals and lead to comparable improvements in organ donation. Published by Elsevier Ltd.	[Wright, Jerry; Morgan, Gary; O'Flynn, Paul E.] Kentucky Organ Donor Affiliates, Louisville, KY 40202 USA; [Billeter, Adrian T.; Sklare, Seth; Franklin, Glen A.; Polk, Hiram C.] Univ Louisville, Sch Med, Dept Surg, Price Inst Surg Res, Louisville, KY 40202 USA		Billeter, AT (corresponding author), Univ Louisville, Sch Med, Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA.	adrianbilleter@bluewin.ch	Billeter, Adrian/O-2185-2019	Billeter, Adrian/0000-0001-8724-4793	Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship; Price Trust Fund; Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship Trust	Dr. Billeter holds the Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship.; This work was funded in part by the Price Trust Fund and by the Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship Trust. The funding source had no role in the production of the manuscript.	Buchholz BM, 2011, TRANSPLANTATION, V92, P985, DOI 10.1097/TP.0b013e318230159d; Chamberlain K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e341; Christmas AB, 2008, J TRAUMA, V65, P1507, DOI 10.1097/TA.0b013e31818a5cf0; de Groot YJ, 2011, INTENS CARE MED, V37, P665, DOI 10.1007/s00134-011-2131-6; Franklin GA, 2010, AM SURGEON, V76, P587; Franklin GA, 2009, AM SURGEON, V75, P537; GARRISON RN, 1991, SURG GYNECOL OBSTET, V173, P391; Harrison TR, 2011, J HEALTH COMMUN, P1; Jaeschke H, 2012, TRANSPLANT REV-ORLAN, V26, P103, DOI 10.1016/j.trre.2011.10.006; Kemp CD, 2008, J TRAUMA, V64, P1573, DOI 10.1097/TA.0b013e318068fc2f; Kirby J, 2008, J TRAUMA, V65, P1509, DOI 10.1097/TA.0b013e318160e1f0; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; Kugler C, 2011, J HEART LUNG TRANSPL, V30, P204, DOI 10.1016/j.healun.2010.08.030; Kugler C, 2010, TRANSPLANTATION, V90, P451, DOI 10.1097/TP.0b013e3181e72863; Li W, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/635179; Liu CL, 2006, J HEPATO-BILIARY-PAN, V13, P110, DOI 10.1007/s00534-005-1016-x; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Ozaki KS, 2012, TRANSPL INT, V25, P107, DOI 10.1111/j.1432-2277.2011.01363.x; Pinson CW, 2000, ANN SURG, V232, P597, DOI 10.1097/00000658-200010000-00015; Reilly P, 2006, J TRAUMA, V61, P433; Rithalia A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3162; Rodriguez-Arias D, 2010, LANCET, V376, P1109, DOI 10.1016/S0140-6736(10)61342-6; Salim A, 2007, J TRAUMA, V62, P1411, DOI 10.1097/TA.0b013e3180479876; Salim A, 2006, J TRAUMA, V61, P429, DOI 10.1097/01.ta.0000228968.63652.c1; SIMINOFF LA, 1995, J TRAUMA, V39, P553; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Singbartl K, 2011, AM J TRANSPLANT, V11, P1517, DOI 10.1111/j.1600-6143.2011.03485.x; Slaughter MS, 2010, J CARDIAC SURG, V25, P490, DOI 10.1111/j.1540-8191.2010.01075.x; Tanabe M, 2010, EUR J CLIN INVEST, V40, P943, DOI 10.1111/j.1365-2362.2010.02339.x; Van De Wauwer C, 2011, EUR J CARDIO-THORAC, V39, pE175, DOI 10.1016/j.ejcts.2011.01.035; Vane DW, 2001, J TRAUMA, V51, P329, DOI 10.1097/00005373-200108000-00017; Vincent A, 2012, BRIT J ANAESTH, V108, pI80, DOI 10.1093/bja/aer353; Weireter LJ, 2007, J TRAUMA, V62, P1414; Yeung Jonathan C, 2009, Thorac Surg Clin, V19, P261, DOI 10.1016/j.thorsurg.2009.02.006; Zeng Z, 2012, WORLD J GASTROENTERO, V18, P1765, DOI 10.3748/wjg.v18.i15.1765	36	8	10	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2012	43	11					1805	1810		10.1016/j.injury.2012.08.012			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	014VR	WOS:000309404300005	22920088				2022-02-06	
J	Hoffman, SN; Zhang, XP; Erlich, PM; Boscarino, JA				Hoffman, Stuart N.; Zhang, Xiaopeng; Erlich, Porat M.; Boscarino, Joseph A.			Grapheme-Color Synesthesia and Posttraumatic Stress Disorder: Preliminary Results From the Veterans Health Study	PSYCHOSOMATIC MEDICINE			English	Article						posttraumatic stress disorder; depression; synesthesia; veterans; risk factors; trauma exposure	TRADE-CENTER DISASTER; MENTAL-HEALTH; TRAUMA EXPOSURE; NATIONAL-SURVEY; SUBSTANCE USE; RISK-FACTORS; SERVICE USE; PTSD; COMORBIDITY; AFGHANISTAN	Objective: Posttraumatic stress disorder (PTSD) is associated with altered neuropsychological function, possibly including complex visual information processing. Grapheme-color synesthesia refers to the phenomenon that a particular letter or number elicits the visual perception of a specific color. The study objective was to assess if grapheme-color synesthesia was associated with PTSD among US veterans. Method: We surveyed 700 veterans who were outpatients in a multihospital system in Pennsylvania. All veterans had served at least one warzone deployment. PTSD and grapheme-color synesthesia were assessed using validated research instruments. Results: The mean age of veterans was 59 years, and 96% were men. The prevalence of current PTSD was 7% (95% confidence interval [CI] = 5.1-8.8), and current partial PTSD was 11% (95% CI = 9.3-14.0). The prevalence of current depression was 6% (95% CI = 4.7-8.3). Altogether, 6% (95% CI = 4.8-8.5) of veterans screened positive for grapheme-color synesthesia. Bivariate analyses suggested that grapheme-color synesthesia was associated with current PTSD (odds ratio [OR] = 3.4, p = .004) and current partial PTSD (OR = 2.4, p = .013), but not current depression (OR = 1.1, p = .91). Multivariate logistic regression results, adjusting for age, sex, marital status, level of education, current psychotropic medication use, and concussion history, confirmed these results. Conclusions: Grapheme-color synesthesia seems to be associated with PTSD among veterans who had been deployed. This finding may have implications for PTSD diagnostic screening and treatment. Research is recommended to confirm this finding and to determine if synesthesia is a risk indicator for PTSD among nonveterans.	[Erlich, Porat M.; Boscarino, Joseph A.] Geisinger Med Clin, Ctr Hlth Res, Danville, PA 17822 USA; [Hoffman, Stuart N.] Geisinger Med Clin, Dept Neurol, Danville, PA 17822 USA; [Zhang, Xiaopeng] Geisinger Med Clin, Dept Anesthesiol, Danville, PA 17822 USA; [Erlich, Porat M.] Temple Univ, Dept Med, Sch Med, Philadelphia, PA 19122 USA; [Boscarino, Joseph A.] Temple Univ, Dept Psychiat, Sch Med, Philadelphia, PA 19122 USA		Boscarino, JA (corresponding author), Geisinger Med Clin, Ctr Hlth Res, 100 N Acad Ave, Danville, PA 17822 USA.	jaboscarino@geisinger.edu			Geisinger Auxiliary Fund; Kline & Ditty Health Fund; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21-MH-086317]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH066403, R21MH086317] Funding Source: NIH RePORTER	Support for this study was provided, in part, by the Geisinger Auxiliary Fund, the Kline & Ditty Health Fund, and the National Institute of Mental Health (Grant No. R21-MH-086317; to Dr. Boscarino).	Acierno R, 2000, J TRAUMA STRESS, V13, P381, DOI 10.1023/A:1007772905696; Alstadhaug KB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-121; American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; Asher JE, 2009, AM J HUM GENET, V84, P279, DOI 10.1016/j.ajhg.2009.01.012; Banissy MJ, 2009, EXP BRAIN RES, V196, P565, DOI 10.1007/s00221-009-1888-0; Barnett KJ, 2008, NEUROIMAGE, V43, P605, DOI 10.1016/j.neuroimage.2008.07.028; Boscarino JA, 2004, GEN HOSP PSYCHIAT, V26, P346, DOI 10.1016/j.genhosppsych.2004.05.001; Boscarino JA, 2007, ENCY STRESS, V3, P830; Boscarino JA, 2007, PSYCHOSOM MED, V69, P365, DOI 10.1097/PSY.0b013e31805fe2bc; Boscarino Joseph A, 2012, Minerva Psichiatr, V53, P47; Boscarino JA, 2012, NEUROPSYCH DIS TREAT, V8, P131, DOI 10.2147/NDT.S29508; Boscarino JA, 2011, J TRAUMA STRESS, V24, P515, DOI 10.1002/jts.20673; Boscarino JA, 2011, J NERV MENT DIS, V199, P91, DOI 10.1097/NMD.0b013e3182043b39; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Boscarino JA, 2009, SOC PSYCH PSYCH EPID, V44, P887, DOI 10.1007/s00127-009-0011-y; Brang D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001205; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Carruthers HR, 2012, DIGEST DIS SCI, V57, P1619; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Galea S, 2008, EPIDEMIOLOGY, V19, P47, DOI 10.1097/EDE.0b013e31815c1dbf; Gurvits TV, 2006, ARCH GEN PSYCHIAT, V63, P571, DOI 10.1001/archpsyc.63.5.571; Hedtke KA, 2008, J CONSULT CLIN PSYCH, V76, P633, DOI 10.1037/0022-006X.76.4.633; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick D. G., 1998, DSM 4 SOURCEBOOK, V4, P803; Kilpatrick DG, 1997, J CONSULT CLIN PSYCH, V65, P834, DOI 10.1037/0022-006X.65.5.834; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; Koenen KC, 2007, J TRAUMA STRESS, V20, P737, DOI 10.1002/jts.20205; Mattingley JB, 2009, ANN NY ACAD SCI, V1156, P141, DOI 10.1111/j.1749-6632.2009.04422.x; Niccolai V, 2012, AM J PSYCHOL, V125, P81; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Schwab KA, 2006, NEUROLOGY, V66, pA235; Smilek D, 2002, PSYCHOL SCI, V13, P548, DOI 10.1111/1467-9280.00496; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; US Department of Veterans Affairs, 2002, 2001 NAT SURV VET NV; Yaro C, 2007, Q J EXP PSYCHOL, V60, P681, DOI 10.1080/17470210600785208	38	8	8	2	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	NOV-DEC	2012	74	9					912	915		10.1097/PSY.0b013e3182731007			4	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	037UK	WOS:000311131800007	23115347	Green Accepted			2022-02-06	
J	Jia, XX; Cong, B; Wang, SJ; Dong, LR; Ma, CL; Li, YM				Jia, Xianxian; Cong, Bin; Wang, Songjun; Dong, Liru; Ma, Chunling; Li, Yingmin			Secondary damage caused by CD11b(+) microglia following diffuse axonal injury in rats	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Diffuse axonal injury; microglia; beta-amyloid peptide precursor; CD11b; interleukin-6	TRAUMATIC BRAIN-INJURY; PATHOPHYSIOLOGY; MODEL	BACKGROUND: Diffuse axonal injury (DAI) is one of the most common and important pathologic features of human traumatic brain injury, accounting for high mortality and the development of persistent posttraumatic neurologic sequelae. Secondary damage resulting, e.g., from mass compressive effects through edema or inflammation can exacerbate morphologic changes in injured axons. METHODS: In this study, DAI was induced in Sprague-Dawley rats by subjecting the animals to a midline closed-skull strike. Experimental rats and control animals subjected to sham operation were killed at 0 hour, 1 hour, 3 hour, 6 hour, 12 hour, 24 hour, 72 hour, 5 days, or 7 days later. Brains were harvested and paraffin-embedded sections of brain tissue (5 mu m thick) were processed for hematoxylin and eosin staining, Bielschowsky silver staining, cresyl violet staining of Nissl bodies, Weil staining of myelin sheaths, or TUNEL assay to verify neuronal changes. Immunocytochemistry was used to examine the expression of beta-amyloid precursor protein, CD11b, and interleukin (IL)-6. RESULTS: CD11b/IL-6 expression was higher at 6 hour and peaked at 12 hour after injury. Pathologic changes in neurons were greater at 24 and 48 hour after injury. The results indicate that DAI can induce activation of microglia to express IL-6 in the early stages after injury. CONCLUSIONS: This suggests that microglia play an important role in secondary pathologic changes in brain tissue that are mediated, at least in part, by IL-6. (J Trauma Acute Care Surg. 2012;73:1168-1174. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Jia, Xianxian; Cong, Bin; Wang, Songjun; Ma, Chunling; Li, Yingmin] Hebei Med Univ, Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang 050017, Hebei, Peoples R China; [Dong, Liru] Hebei United Univ, Affiliated Hosp, Dept Pathol, Tangshan, Hebei, Peoples R China		Cong, B (corresponding author), Hebei Med Univ, Dept Forens Med, Hebei Key Lab Forens Med, 361 Zhong Shan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	hbydcongbin@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872919]; Natural Science Foundation of Hebei Province of the Chinese government [C2008001038]	Supported in part by the National Natural Science Foundation of China (30872919) and the Natural Science Foundation of Hebei Province (C2008001038) of the Chinese government.	Aarli JA, 2003, CURR MED CHEM, V10, P1931, DOI 10.2174/0929867033456918; Choucair-Jaafar N, 2011, FUND CLIN PHARMACOL, V25, P115, DOI 10.1111/j.1472-8206.2010.00811.x; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Keightley M, 2011, J VIS EXP; Kondo K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-147; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; Mima T, 2009, CURR OPIN RHEUMATOL, V21, P224, DOI 10.1097/BOR.0b013e3283295fec; Schroeter M, 1997, STROKE, V28, P382, DOI 10.1161/01.STR.28.2.382; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yanagawa Y, 2010, AM J EMERG MED, V28, DOI 10.1016/j.ajem.2009.09.017	24	8	10	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2012	73	5					1168	1174		10.1097/TA.0b013e318246eaf4			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	043VF	WOS:000311577100024	22710781				2022-02-06	
J	Sambuco, M; Brookes, N; Catroppa, C; Lah, S				Sambuco, Melissa; Brookes, Naomi; Catroppa, Cathy; Lah, Suncica			Predictors of Long-Term Sibling Behavioral Outcome and Self-Esteem Following Pediatric Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior; brain injuries; child; self-esteem; siblings	PERCEIVED SOCIAL SUPPORT; CHRONIC ILLNESS; GROUP INTERVENTION; CANCER-PATIENTS; CHILDREN; ADOLESCENTS; DISABILITY; ADJUSTMENT; STRESS; MISCONCEPTIONS	Objectives: To determine predictors of self-esteem and behavioral outcome among siblings of children with traumatic brain injury (TBI). Design: Cross-sectional. Participants: Thirty-nine siblings closest in age to a child who sustained moderate to severe TBI. Measures: Outcome variables: sibling behavior (Child Behavior Checklist-Revised) and self-esteem (The Self-Perception Profile for Children-Global Self-Worth). Predictor variables: social support (The Social Support Scale for Children), knowledge (The Child TBI Knowledge Questionnaire), injured child behavior (Child Behavior Checklist-Revised), injured child adaptive skills (Adaptive Behavior Assessment System II-Practical Component), severity of injury (Glasgow Coma Scale), injured child age at injury, time since injury, family functioning (The Family Adaptability and Cohesion Evaluation Scales II-Cohesion Subscale), and socio economic status. Results: Significantly reduced self-esteem, but no evidence of behavioral difficulties, were found in siblings of children who had sustained TBI. Sibling self-esteem did not correlate with any other study variables. Behavioral outcome correlated with: sense of social support, knowledge about TBI and injured child behavior. Nevertheless, simultaneous regression analyses revealed that only knowledge about TBI and sense of social support made significant independent contributions to behavioral outcome. Conclusions: Educating uninjured siblings about TBI and raising awareness of their needs in members of their social support network may be important in facilitating sibling behavioral outcome.	[Sambuco, Melissa; Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Brookes, Naomi] Sydney Childrens Hosp, Brain Injury Rehabil Program, Randwick, NSW, Australia; [Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy] Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Inst, Melbourne, Vic, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Mungo Mac Callum Bldg A19, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Lah, Suncica/0000-0003-2282-4812	University of SydneyUniversity of Sydney	This research was in part supported by the research scholarship, University of Sydney Postgraduate Award (UPA), awarded to Melissa Sambuco.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Australian Bureau of Statistics, 2008, FAM CHAR TRANS; Barlow JH, 2006, CHILD CARE HLTH DEV, V32, P19, DOI 10.1111/j.1365-2214.2006.00591.x; Barrera M, 2002, CHILD HEALTH CARE, V31, P131, DOI 10.1207/S15326888CHC3102_4; Brooks ND, 1991, J CLIN EXP NEUROPSYC, V13, P155; CARPENTER PJ, 1991, ADVANCES IN CHILD HEALTH PSYCHOLOGY, P193; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Demaray MK, 2005, PSYCHOL SCHOOLS, V42, P691, DOI 10.1002/pits.20120; Demaray MK, 2002, PSYCHOL SCHOOLS, V39, P305, DOI 10.1002/pits.10018; EYBERG SM, 1983, J CLIN CHILD PSYCHOL, V12, P347, DOI 10.1207/s15374424jccp1203_19; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; FAY T, 2003, BRAIN IMPAIR, V4, P91; Franklin J, 2006, PEDIATRICS, V118, P2481, DOI 10.1542/peds.2006-0511; Giallo R, 2006, J INTELL DISABIL RES, V50, P937, DOI 10.1111/j.1365-2788.2006.00928.x; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; Gold JI, 2008, CHILD CARE HLTH DEV, V34, P491, DOI 10.1111/j.1365-2214.2008.00810.x; Good S, 2003, THESIS FACULTY SAYBR; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Harter S, 1985, MANUAL SOCIAL SUPPOR; Harter S., 1985, MANUAL SELF PERCEPTI; Higgins DJ, 2005, AUTISM, V9, P125, DOI 10.1177/1362361305051403; Houtzager BA, 2004, J PEDIATR PSYCHOL, V29, P591, DOI 10.1093/jpepsy/jsh061; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Lancaster S., 2004, OVERVIEW USE CHILD B; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lobato DJ, 2005, J PEDIATR PSYCHOL, V30, P678, DOI 10.1093/jpepsy/jsi054; Lobato DJ, 2002, J PEDIATR PSYCHOL, V27, P711, DOI 10.1093/jpepsy/27.8.711; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; Miller HM, 2000, SOC BEHAV PERSONAL, V28, P105, DOI 10.2224/sbp.2000.28.2.105; Muris P, 2003, PERS INDIV DIFFER, V35, P1791, DOI 10.1016/S0191-8869(03)00004-7; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Newman BM, 2007, ADOLESCENCE, V42, P441; O'Hara C, 1991, COGNITIVE REHABILITA, V9, P8; Olson D, 1985, FAMILY ADAPTABILITY; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Peretti PO, 1995, INDIAN J CLIN PSYCHO, V22, P23; Pike L. T., 2000, FAMILY MATTERS, V5, P40; Printz BL, 1999, ADOLESCENCE, V34, P715; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Robson T., 2005, BRAIN IMPAIR, V6, P45, DOI [10.1375/brim.6.1.45.65477, DOI 10.1375/BRIM.6.1.45.65477]; SAHLER OJZ, 1989, AM J DIS CHILD, V143, P690, DOI 10.1001/archpedi.1989.02150180068023; Sambuco M, 2008, BRAIN INJURY, V22, P7, DOI 10.1080/02699050701822022; Shute R, 2007, INT J CLIN HLTH PSYC, V7, P595; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Stewart D, 2004, Asia Pac J Public Health, V16 Suppl, pS37; Swift EE, 2003, J DEV BEHAV PEDIATR, V24, P24, DOI 10.1097/00004703-200302000-00007; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; THOMPSON RJ, 1994, J PEDIATR PSYCHOL, V19, P189, DOI 10.1093/jpepsy/19.2.189; Torsheim T, 2003, SCAND J PSYCHOL, V44, P153, DOI 10.1111/1467-9450.00333; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Weigel DJ, 1998, J ADOLESCENT RES, V13, P158, DOI 10.1177/0743554898132004; Williams, 1997, INT J NURS STUD, V34, P312; Williams PD, 2003, J PEDIATR-US, V143, P386, DOI 10.1067/S0022-3476(03)00391-3; Williams PD, 2002, J BEHAV MED, V25, P411, DOI 10.1023/A:1020401122858; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ystgaard M, 1997, SOC PSYCH PSYCH EPID, V32, P277, DOI 10.1007/BF00789040	67	8	8	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					413	423		10.1097/HTR.0b013e3182274162			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200012	21912276				2022-02-06	
J	Takeuchi, S; Takasato, Y; Suzuki, G; Maeda, T; Masaoka, H; Hayakawa, T; Otani, N; Yatsushige, H; Shigeta, K; Momose, T; Nawashiro, H; Mori, K				Takeuchi, Satoru; Takasato, Yoshio; Suzuki, Go; Maeda, Takuya; Masaoka, Hiroyuki; Hayakawa, Takanori; Otani, Naoki; Yatsushige, Hiroshi; Shigeta, Keigo; Momose, Toshiya; Nawashiro, Hiroshi; Mori, Kentaro			Postoperative computed tomography after surgery for head trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; computed tomographic scan; new findings; decompressive craniectomy; surgery	ACUTE SUBDURAL-HEMATOMA; DECOMPRESSIVE CRANIECTOMY; BRAIN-INJURY; EPIDURAL HEMATOMA; MANAGEMENT; HEMICRANIECTOMY; HYPERTENSION; EVACUATION; HEMORRHAGE	BACKGROUND: It is well known that intracranial lesions, which are already diagnosed on preoperative computed tomography, often expand after surgery, and the risk factors have been investigated. On the other hand, we have experienced cases in which new lesions, which were not detected on preoperative computed tomography, were found on postoperative computed tomography. However, little is known about the factors associated with such new postoperative lesions. Here, we investigated the predictive factors of new findings (NFs) on computed tomography early after surgery. METHODS: We conducted a retrospective registry-based review of 186 consecutive patients who underwent surgery for traumatic brain injury and investigated the prognostic factors of NFs on computed tomography early after surgery. RESULTS: Mean age was 51 years, and 67.2% were males among the 186 patients. NFs on postoperative computed tomography were observed in 29 patients (15.6%). A univariate analysis showed that Glasgow Coma Scale (GCS) score of 8 or less (p < 0.001), subdural hematoma as the primary indication for surgery (p = 0.012), midline shift (p < 0.001), absence of basal cistern (p < 0.001), and decompressive craniectomy and craniotomy as the surgical procedures (p < 0.001, p = 0.004, respectively) were significantly associated with NFs on postoperative computed tomography. A logistic regression analysis demonstrated that decompressive craniectomy as the surgical procedure (p = 0.001; odds ratio [OR], 8.1; 95% confidence interval [CI], 2.23-28.82), GCS score of 8 or less (p = 0.019; OR, 3.4; 95% CI, 1.23-9.52), and absence of basal cistern (p = 0.023; OR, 3.5; 95% CI, 1.19-10.35) were significant factors. CONCLUSION: Early postoperative computed tomography after surgery for head trauma seems to be warranted in patients presenting with the indicated predictive factors of NFs. (J Trauma Acute Care Surg. 2012;73:254-1260. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Takeuchi, Satoru; Otani, Naoki; Nawashiro, Hiroshi; Mori, Kentaro] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan; [Takasato, Yoshio; Maeda, Takuya; Masaoka, Hiroyuki; Hayakawa, Takanori; Yatsushige, Hiroshi; Shigeta, Keigo; Momose, Toshiya] Nippon Med Sch, Natl Hosp Org Disaster Med Ctr, Dept Neurosurg, Tokyo 113, Japan; [Suzuki, Go] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan		Takeuchi, S (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	s.takeuchi@room.ocn.ne.jp		Maeda, Takuya/0000-0003-0912-4643			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cohen JE, 2004, NEUROL RES, V26, P763, DOI 10.1179/016164104225015930; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; Khaldi A, 2010, J NEUROSURG, V113, P1021, DOI 10.3171/2009.11.JNS081048; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Paci GM, 2008, J TRAUMA, V64, P326, DOI 10.1097/TA.0b013e318163358a; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	27	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2012	73	5					1254	1260		10.1097/TA.0b013e318265cc14			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	043VF	WOS:000311577100039	22922972				2022-02-06	
J	Heuer, JF; Sauter, P; Barwing, J; Herrmann, P; Crozier, TA; Bleckmann, A; Beissbarth, T; Moerer, O; Quintel, M				Heuer, Jan Florian; Sauter, Philip; Barwing, Juergen; Herrmann, Peter; Crozier, Thomas A.; Bleckmann, Annalen; Beissbarth, Tim; Moerer, Onnen; Quintel, Michael			Effects of High-frequency Oscillatory Ventilation on Systemic and Cerebral Hemodynamics and Tissue Oxygenation: An Experimental Study in Pigs	NEUROCRITICAL CARE			English	Article						Volume controlled ventilation; HFOV; Cerebral blood flow; Cerebral tissue oxygenation; Hemodynamics	RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; TRAUMATIC BRAIN-INJURY; ACUTE LUNG INJURY; LEFT-VENTRICULAR DYSFUNCTION; MECHANICAL VENTILATION; INTRACRANIAL-PRESSURE; ADULTS; VOLUME; EDEMA	In this study, we compare the effects of high frequency oscillatory ventilation (HFOV) with those of lung-protective volume-controlled ventilation (VCV) on cerebral perfusion, tissue oxygenation, and cardiac function with and without acute intracranial hypertension (AICH). Eight pigs with healthy lungs were studied during VCV with low tidal volume (V-T: 6 ml kg(-1)) at four PEEP levels (5, 10, 15, 20 cmH(2)O) followed by HFOV at corresponding transpulmonary pressures, first with normal ICP and then with AICH. Systemic and pulmonary hemodynamics, cardiac function, cerebral perfusion pressure (CPP), cerebral blood flow (CBF), cerebral tissue oxygenation, and blood gases were measured after 10 min at each level. Transpulmonary pressures (TPP) were calculated at each PEEP level. The measurements were repeated with HFOV using continuous distending pressures (CDP) set at TPP plus 5 cmH(2)O for the corresponding PEEP level. Both measurement series were repeated after intracranial pressure (ICP) had been raised to 30-40 cmH(2)O with an intracranial balloon catheter. Cardiac output, stroke volume, MAP, CPP, and CBF were significantly higher during HFOV at normal ICP. Systemic and cerebral hemodynamics was significantly altered by AICH, but there were no differences attributable to the ventilatory mode. HFOV is associated with less hemodynamic compromise than VCV, even when using small tidal volumes and low mean airway pressures. It does not impair cerebral perfusion or tissue oxygenation in animals with AICH, and could, therefore, be a useful ventilatory strategy to prevent lung failure in patients with traumatic brain injury.	[Heuer, Jan Florian; Sauter, Philip; Barwing, Juergen; Herrmann, Peter; Crozier, Thomas A.; Moerer, Onnen; Quintel, Michael] Univ Gottingen, Sch Med, Dept Anaesthesiol Emergency & Intens Care Med, Gottingen, Germany; [Bleckmann, Annalen; Beissbarth, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Bleckmann, Annalen] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany		Heuer, JF (corresponding author), Univ Gottingen, Sch Med, Dept Anaesthesiol Emergency & Intens Care Med, Gottingen, Germany.	jheuer@med.uni-goettingen.de; philip.sauter@med.uni-goettingen.de; jbarwing@med.uni-goettingen.de; pherrmann@med.uni-goettingen.de; tcrozier@med.uni-goettingen.de; a.bleckmann@med.uni-goettingen.de; tim.beissbarth@med.uni-goettingen.de; omoerer@gwdg.de; mquintel@med.uni-goettingen.de	Moerer, Onnen/K-6349-2019; Beissbarth, Tim/B-3129-2013	Beissbarth, Tim/0000-0001-6509-2143; Herrmann, Peter/0000-0002-0348-2573			AMATO MBP, 1995, AM J RESP CRIT CARE, V152, P1835, DOI 10.1164/ajrccm.152.6.8520744; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Bennett SS, 2007, NEUROCRIT CARE, V7, P221, DOI 10.1007/s12028-007-0084-y; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Courtney SE, 2002, NEW ENGL J MED, V347, P643, DOI 10.1056/NEJMoa012750; DAUBER IM, 1983, J CLIN INVEST, V72, P1977, DOI 10.1172/JCI111162; David M, 2003, INTENS CARE MED, V29, P1656, DOI 10.1007/s00134-003-1897-6; David M, 2006, BRIT J ANAESTH, V97, P525, DOI 10.1093/bja/ael215; David M, 2005, ACTA ANAESTH SCAND, V49, P209, DOI 10.1111/j.1399-6576.2004.00570.x; David M, 2004, EUR J ANAESTH, V21, P944, DOI 10.1017/S0265021504000328; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; Fort P, 1997, CRIT CARE MED, V25, P937, DOI 10.1097/00003246-199706000-00008; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Hall SRR, 2005, J HEART LUNG TRANSPL, V24, P1639, DOI 10.1016/j.healun.2004.11.004; HUSEBY JS, 1978, J APPL PHYSIOL, V44, P25, DOI 10.1152/jappl.1978.44.1.25; HUSEBY JS, 1981, J NEUROSURG, V55, P704, DOI 10.3171/jns.1981.55.5.0704; Huttemann E, 2002, INTENS CARE MED, V28, P1084, DOI 10.1007/s00134-002-1355-x; Krishnan JA, 2000, CHEST, V118, P795, DOI 10.1378/chest.118.3.795; Malhotra A, 2007, NEW ENGL J MED, V357, P1113, DOI 10.1056/NEJMct074213; Mehta S, 2001, CRIT CARE MED, V29, P1360, DOI 10.1097/00003246-200107000-00011; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Nelle M, 1997, INTENS CARE MED, V23, P671, DOI 10.1007/s001340050392; Rohde V, 2002, J NEUROSURG, V97, P954, DOI 10.3171/jns.2002.97.4.0954; Szabo G, 2001, EUR J CARDIO-THORAC, V20, P170, DOI 10.1016/S1010-7940(01)00722-9; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; TRAVERSE JH, 1988, PEDIATR RES, V23, P628, DOI 10.1203/00006450-198806000-00020; Wiesenack C, 2001, J CARDIOTHOR VASC AN, V15, P584, DOI 10.1053/jcan.2001.26536; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	29	8	9	0	12	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	OCT	2012	17	2					281	292		10.1007/s12028-011-9566-z			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	002QU	WOS:000308548800022	21647845				2022-02-06	
J	Jin, Y; Li, BY; Qiu, LL; Ling, YR; Bai, ZQ				Jin, Yong; Li, Bo-You; Qiu, Ling-Li; Ling, Yuan-Ren; Bai, Zhi-Qiang			Decreased plasma gelsolin is associated with 1-year outcome in patients with traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Gelsolin; Traumatic brain injury; 1-year outcome	LYSOPHOSPHATIDIC ACID; SCAVENGER SYSTEM; HEAD-INJURY; ACTIN; MICE; PROTEIN; MORTALITY; RESPONSES; DISEASE; STROKE	Purpose: Decreased plasma gelsolin level has been associated with 1-month mortality after traumatic brain injury (TBI). Thus, we investigated the ability of gelsolin to predict 1-year mortality and functional outcome in these patients. Methods: One hundred fourteen healthy controls and 114 patients with acute severe TBI were included in this study. Plasma gelsolin concentration on admission was measured by ELISA. Results: Fifty-five patients (48.2%) had unfavorable outcome (Glasgow Outcome Scale score of 1-3) and 38 patients (33.3%) died in 1 year after TBI. Upon admission, plasma gelsolin level in patients was substantially lower than that in healthy controls. A multivariate analysis selected plasma gelsolin level as an independent predictor for 1-year unfavorable outcome and mortality of patients. A receiver operating characteristic curve analysis showed plasma gelsolin level predicted 1-year unfavorable outcome and mortality statistically significantly. The predictive value of the gelsolin concentration was thus similar to that of Glasgow Coma Scale (GCS) score. In a combined logistic-regression model, gelsolin did not statistically significantly improve the area under curve of GCS score. Conclusions: Plasma gelsolin level is a useful, complementary tool to predict functional outcome and mortality 1 year after TBI. (C) 2012 Elsevier Inc. All rights reserved.	[Jin, Yong; Li, Bo-You; Qiu, Ling-Li; Ling, Yuan-Ren; Bai, Zhi-Qiang] Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Neurosurg, Jiaojiang Dist 318000, Taizhou, Peoples R China		Jin, Y (corresponding author), Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Neurosurg, Jiaojiang Dist 318000, Taizhou, Peoples R China.	taizhoujinyong@163.com					Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Christofidou-Solomidou M, 2002, LUNG, V180, P91, DOI 10.1007/s004080000084; Christofidou-Solomidou M, 2002, J INVEST MED, V50, P54, DOI 10.2310/6650.2002.33518; Dahl B, 1999, SHOCK, V12, P102, DOI 10.1097/00024382-199908000-00002; DiNubile MJ, 2002, BLOOD, V100, P4367, DOI 10.1182/blood-2002-06-1672; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Guntert A, 2010, J ALZHEIMERS DIS, V21, P585, DOI 10.3233/JAD-2010-100279; Guo XC, 2011, J CRIT CARE, V26, P608, DOI 10.1016/j.jcrc.2011.02.007; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; Huang S, 1997, CLIN INFECT DIS, V24, P951, DOI 10.1093/clinids/24.5.951; ITO H, 1992, GASTROENTEROLOGY, V102, P1686, DOI 10.1016/0016-5085(92)91731-I; JANMEY PA, 1987, BLOOD, V70, P524; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P8239; KWIATKOWSKI DJ, 1988, J CELL BIOL, V106, P375, DOI 10.1083/jcb.106.2.375; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; LIND SE, 1986, J CLIN INVEST, V78, P736, DOI 10.1172/JCI112634; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; Rosengart MR, 2002, SHOCK, V17, P109, DOI 10.1097/00024382-200202000-00005; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cb.11.110195.002433; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; TANAKA J, 1993, DEV BRAIN RES, V76, P268, DOI 10.1016/0165-3806(93)90217-X; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Xu JF, 2012, J TRAUMA ACUTE CARE, V72, P491, DOI 10.1097/TA.0b013e318226ec39; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0	39	8	9	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	OCT	2012	27	5							527.e1	10.1016/j.jcrc.2012.01.002			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025PP	WOS:000310204300032	22386223				2022-02-06	
J	Matsui, T; Motoki, Y; Inomoto, T; Miura, D; Kato, Y; Suenaga, H; Hino, K; Nojima, J				Matsui, Tomohiro; Motoki, Yukari; Inomoto, Takafumi; Miura, Daisuke; Kato, Yukiko; Suenaga, Hiromi; Hino, Keisuke; Nojima, Junzo			Temperature-Related Effects of Adenosine Triphosphate-Activated Microglia on Pro-Inflammatory Factors	NEUROCRITICAL CARE			English	Article						Adenosine triphosphate; Hyperthermia; Hypothermia; Tumor necrosis factor-alpha; Nitric oxide; Microglia; p38 mitogen-activated protein kinase; Incubation temperature	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; CEREBROSPINAL-FLUID; MODERATE HYPOTHERMIA; HEAD-INJURY; INTERLEUKIN-6; RELEASE; CYTOKINE; HYPERTHERMIA	Therapeutic hypothermia protects neurons after severe brain injury. Activated microglia produce several neurotoxic factors, such as pro-inflammatory cytokines and nitric oxide (NO), during neuron destruction. Hence, suppression of microglial release of these factors is thought to contribute partly to the neuroprotective effects of hypothermia. After brain insults, adenosine triphosphate (ATP) is released from injured cells and activates microglia. Here, we examined the acute effects of temperature on ATP-activated microglial production of inflammatory factors, and the possible involvement of p38 mitogen-activated protein kinase (p38) underlying such effects. Microglia were cultured with ATP at 33, 37, and 39A degrees C, or with ATP in the presence of a p38 inhibitor, SB203580, at 37A degrees C. Cytokine and NO levels, and p38 activation were measured. Compared to 37A degrees C, TNF-alpha was reduced at 33A degrees C and augmented at 39A degrees C for 1.5 h. IL-6 was reduced at 33A degrees C for 6 h. NO was reduced at 33A degrees C, but augmented at 39A degrees C for 6 h. p38 was reduced at 33A degrees C for 1 min. SB203580 inhibited ATP-induced TNF-alpha, IL-6, and NO production. Lowering temperature rapidly reduced p38 activation and the subsequent p38-regulated production of pro-inflammatory cytokines and NO in ATP-activated microglia, suggesting that attenuation of early phase inflammatory responses via suppression of p38 in microglia is one possible neuroprotective mechanism of therapeutic hypothermia. Temperature elevation increased TNF-alpha and NO production in these cells. These temperature-dependent changes imply that monitoring of TNF-alpha and NO in the cerebrospinal fluid during the early phase might be useful as biomarkers for responses to therapeutic hypothermia and hyperthermia.	[Matsui, Tomohiro; Motoki, Yukari; Inomoto, Takafumi; Miura, Daisuke; Kato, Yukiko; Suenaga, Hiromi; Nojima, Junzo] Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, Ube, Yamaguchi 7558505, Japan; [Hino, Keisuke] Kawasaki Med Sch, Dept Hepatol & Pancreatol, Kurashiki, Okayama, Japan		Matsui, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [20791077]	This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Young Scientists (B), No. 20791077 to T. M.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Goldring CEP, 2000, FASEB J, V14, P2393; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lancelot E, 1998, NEUROSCI LETT, V242, P131, DOI 10.1016/S0304-3940(98)00095-0; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/00003246-200212000-00014; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Matsui T, 2010, ANESTH ANALG, V111, P554, DOI 10.1213/ANE.0b013e3181e3a2a2; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Ohtani Y, 2000, NEUROSCI LETT, V293, P72, DOI 10.1016/S0304-3940(00)01478-6; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Shigemoto-Mogami Y, 2001, J NEUROCHEM, V78, P1339, DOI 10.1046/j.1471-4159.2001.00514.x; Si QS, 1997, NEUROSCIENCE, V81, P223, DOI 10.1016/S0306-4522(97)00172-3; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Yamaguchi S, 2000, NEUROL RES, V22, P657	41	8	9	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2012	17	2					293	300		10.1007/s12028-011-9639-z			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	002QU	WOS:000308548800023	21979577				2022-02-06	
J	Nalder, E; Fleming, J; Cornwell, P; Foster, M; Haines, T				Nalder, Emily; Fleming, Jennifer; Cornwell, Petrea; Foster, Michele; Haines, Terry			FACTORS ASSOCIATED WITH THE OCCURRENCE OF SENTINEL EVENTS DURING TRANSITION FROM HOSPITAL TO HOME FOR INDIVIDUALS WITH TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; life change event; community integration	COMMUNITY INTEGRATION; PSYCHOMETRIC PROPERTIES; OUTCOMES; NEEDS; REHABILITATION; MULTICENTER; EXPERIENCES; POSTSTROKE; CAREGIVERS; EMPLOYMENT	Objective: To describe the timing and factors associated with the occurrence of sentinel events (financial strain, difficulty accessing therapy, return to work, accommodation change and independent transport use) during transition to the community for individuals with traumatic brain injury. Design: Longitudinal cohort design with data collected pre discharge and at 1, 3 and 6-month follow-ups. Subjects: Individuals with moderate to severe traumatic brain injury (n=127), discharged home from acute care and inpatient rehabilitation. Methods: Data were collected using self-report questionnaires (sentinel events questionnaire, Mayo Portland Adaptability Inventory-4, Sydney Psychosocial Reintegration Scale, Depression Anxiety Stress Scale). Logistic regression was used to identify factors associated with sentinel events. Results: The most commonly reported events were independent transport use and return to work, reported on 104 and 90 occasions, respectively. A longer hospital stay and poorer community integration were related to negative events (e.g. reduced therapy). The inverse relationship was seen for positive events. Links existed between sentinel events (e.g. previous financial strain increased the likelihood of this event in transition). Conclusion: This paper highlights the interplay between personal and environmental factors and life events in shaping transition experiences. Individualised service planning and monitoring of sentinel events is important to promote successful community transition.	[Nalder, Emily; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Nalder, Emily; Fleming, Jennifer] Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Griffith Hlth Inst, Nathan, Qld 4111, Australia; [Cornwell, Petrea] Metro N Hlth & Hlth Serv, Brisbane, Qld, Australia; [Foster, Michele] Univ Queensland, Sch Social Work & Human Serv, Brisbane, Qld 4072, Australia; [Haines, Terry] Monash Univ, So Physiotherapy Clin Sch, Clayton, Vic 3800, Australia; [Haines, Terry] Allied Hlth Res Unit, So Hlth, Vic, Australia		Nalder, E (corresponding author), Ctr Functioning & Hlth Res, POB 6053, Buranda, Qld, Australia.	e.nalder@uq.edu.au	Haines, Terrence/E-9372-2015; Cornwell, Petrea/AAE-5547-2019	Haines, Terrence/0000-0003-3150-6154; 	Australian Research Council LinkageAustralian Research Council [LP0776294]; Department of Communities (Disability Services); Acquired Brain Injury Outreach Service	Funding support has been received by way of an Australian Research Council Linkage grant (LP0776294) with partner organisations Department of Communities (Disability Services) and the Acquired Brain Injury Outreach Service. Funding agencies had no influence on data interpretation and conclusions drawn.	Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bradshaw J., 1972, PROBLEMS PROGR MED C, P71; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P356; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Cott CA, 2007, DISABIL REHABIL, V29, P1566, DOI 10.1080/09638280701618588; Elder G.H., 2009, CRAFT LIFE COURSE RE; Elder G.H., 1995, LIFE COURSE PARADIGM, P101, DOI DOI 10.1037/10176-003; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P643, DOI 10.3109/02688699308995093; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Hosmer DW, 2005, APPL LOGISTIC REGRES; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Nalder E, 2012, BRAIN INJ; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; OTOOLE BI, 1986, AM J EPIDEMIOL, V124, P317, DOI 10.1093/oxfordjournals.aje.a114390; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Rittman M, 2007, TOP STROKE REHABIL, V14, P21, DOI 10.1310/tsr1402-21; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wendel K, 2010, SCAND J OCCUP THER, V17, P162, DOI [10.3109/11038120902964450, 10.1080/11038120902964450]; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; [No title captured]	41	8	9	1	17	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	OCT	2012	44	10					837	844		10.2340/16501977-1033			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	025LD	WOS:000310189800005	22960731	Green Published, gold			2022-02-06	
J	Xing, GQ; Ren, M; O'Neill, JT; Sharma, P; Verma, A; Watson, WD				Xing, Guoqiang; Ren, Ming; O'Neill, J. Timothy; Sharma, Pushpa; Verma, Ajay; Watson, William D.			Pyruvate dehydrogenase phosphatase1 mRNA expression is divergently and dynamically regulated between rat cerebral cortex, hippocampus and thalamus after traumatic brain injury: A potential biomarker of TBI-induced hyper- and hypo-glycaemia and neuronal vulnerability	NEUROSCIENCE LETTERS			English	Article						PDP1; GFAP; mRNA; Brain injury; Apoptosis; Cerebral cortex; Hippocampus; Thalamus; Rat; Mitochondria; PDH activity; Oxidative phosphorylation	MITOCHONDRIAL DYSFUNCTION; NEUTROPHIL ACCUMULATION; GLUCOSE-METABOLISM; FDG-PET; IMPACT; MICRODIALYSIS; HYPERGLYCEMIA; ENERGY; DISTURBANCE; CONCUSSION	Cerebral pyruvate depletion and lactate acidosis are common metabolic characteristics of patients with traumatic brain injury (TBI) and are associated with poor prognosis. Pyruvate dehydrogenase (PDH) is the rate-limiting enzyme coupling glycolysis to mitochondrial tricarboxylic acid (TCA) cycle. Brain PDH activity is regulated by its phosphorylation status and other effectors. Phosphorylation of PDH E1 alpha 1 subunit by PDH kinase inhibits PDH activity while dephosphorylation of phosphorylated PDHE1 alpha 1 by PDH phosphatase (PDP1) restores PDH activity. In situ hybridization showed that PDP1 mRNA is highly expressed in the cerebral cortex, hippocampus and thalamus of rat. Controlled cortical impact (CCI) induced a significant increase in PDP1 mRNA expression in ipsilateral cerebral cortex at 4h (P<0.05) and 24h post CCI (P<0.01) that returned to basal level 72h post CCI. PDP1 mRNA level increased transiently in ipsilateral hippocampal dentate gyrus and CA1-3 subfields 4 h post CCI (P<0.01) but decreased significantly 24 h and 72 h (P<0.01) post CCI, coinciding with a marked increase in neuronal apoptosis in ipsilateral hippocampus 24 h post CCI. PDP1 mRNA expression in thalamus and other subcortical regions decreased persistently post CCI. Contralateral CCI and craniotomy showed similar effects on PDP1 mRNA expression as ipsilateral CCI. Because GFAP mRNA expression was induced in brain regions where PDP1 expression was altered, further study should determine the potential relationship between astrocyte activation, PDP1 alteration, and pyruvate metabolism following TBI. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Xing, Guoqiang; Ren, Ming; Verma, Ajay; Watson, William D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Xing, Guoqiang] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [O'Neill, J. Timothy] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Sharma, Pushpa] Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA; [Xing, Guoqiang] Friends Res Inst, Baltimore, MD 21201 USA; [Xing, Guoqiang] Lotus Biotech Com, Gaithersburg, MD 20878 USA		Xing, GQ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gxing99@yahoo.com	Sharma, Pushpa/AAY-8756-2020; Xing, Guoqiang/ABA-8450-2020		Henry Jackson Foundation; Comprehensive National Neuroscience Program (CNNP)	This work was supported, in part, by the Henry Jackson Foundation's DBSCIP and TRP grants, GEMI Funds, Lotus Biotech.com, as well as the Comprehensive National Neuroscience Program (CNNP). Ms. Jillian Wen proofread this manuscript.	Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Chowdhury GMI, 2003, NEUROSCI RES, V45, P149, DOI 10.1016/S0168-0102(02)00207-9; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; de Graaf RA, 2004, P NATL ACAD SCI USA, V101, P12700, DOI 10.1073/pnas.0405065101; de la Cueva-Barrao L, 2009, REV NEUROLOGIA, V49, P58, DOI 10.33588/rn.4902.2008676; Grossman E.J., 2011, J NEUROTRAUM; Hattori N, 2004, J NUCL MED, V45, P775; Hattori N, 2003, J NUCL MED, V44, P1709; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Reed L.J., 1996, PYRUVATE DEHYDROGENA; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Ren M., 2006, 36 ANN M SOC NEUR; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Samii A., 2001, CONTRIBUTION IONIC A; Samii A., 1998, J NEUROTRAUMA, V15; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Weinzierl MR, 2002, J MOL NEUROSCI, V18, P247, DOI 10.1385/JMN:18:3:247; Xing GQ, 2012, EXP NEUROL, V234, P31, DOI 10.1016/j.expneurol.2011.12.007; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c	41	8	9	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	SEP 13	2012	525	2					140	145		10.1016/j.neulet.2012.07.055			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	009HA	WOS:000309015600011	22884618				2022-02-06	
J	Alosco, ML; Knecht, K; Glickman, E; Gunstad, J; Bergeron, M				Alosco, Michael L.; Knecht, Krysten; Glickman, Ellen; Gunstad, John; Bergeron, Michael			History of Concussion and Exertional Heat Illness Symptoms Among College Athletes	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article							TRAUMATIC BRAIN-INJURY; RATE-VARIABILITY; EPIDEMIOLOGY		[Alosco, Michael L.; Knecht, Krysten; Gunstad, John] Kent State Univ, Dept Psychol, Kent, OH 44242 USA; [Glickman, Ellen] Kent State Univ, Dept Hlth Sci, Kent, OH 44242 USA; [Bergeron, Michael] Univ S Dakota, Dept Pediat, Sanford Sch Med, Sioux Falls, SD USA		Alosco, ML (corresponding author), Kent State Univ, Dept Psychol, Kent, OH 44242 USA.						Allan L, 2010, NEUROPSYCHOLOGY CARD, P294; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; ARMSTRONG LE, 1990, MED SCI SPORT EXER, V22, P36; ARMSTRONG LE, 1988, ANN SPORTS MED, V3, P182; Binkley HM, 2002, J ATHL TRAINING, V37, P329; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Crandall CG, 2010, ACTA PHYSIOL, V199, P407, DOI 10.1111/j.1748-1716.2010.02119.x; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Donoghue AM, 2000, OCCUP MED-OXFORD, V50, P259, DOI 10.1093/occmed/50.4.259; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P977; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Kanjwal K, 2010, CARDIOL J, V17, P482; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; La Fountaine M, 2009, J ATHL TRAINING, V46, P230; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; National Collegiate Athletic Association, 2011, 2011 2012 NCAA SPORT; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Wilson TE, 2011, EXERC SPORT SCI REV, V39, P12, DOI 10.1097/JES.0b013e318201eed6; Yard EE, 2010, J SAFETY RES, V41, P471, DOI 10.1016/j.jsr.2010.09.001	29	8	8	0	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	SEP	2012	17	5					22	27		10.1123/ijatt.17.5.22			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	005UD	WOS:000308774700005					2022-02-06	
J	Archambault, P; Dionne, CE; Lortie, G; LeBlanc, F; Rioux, A; Larouche, G				Archambault, Patrick; Dionne, Clermont E.; Lortie, Gilles; LeBlanc, Francois; Rioux, Anik; Larouche, Genevieve			Adrenal inhibition following a single dose of etomidate in intubated traumatic brain injury victims	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						adrenal insufficiency; etomidate; traumatic brain injury	CRITICALLY-ILL PATIENTS; ENDOTRACHEAL INTUBATION; ADRENOCORTICAL FUNCTION; CORTISOL RESPONSE; AIRWAY MANAGEMENT; INSUFFICIENCY; INDUCTION; EMERGENCY; HYPOPITUITARISM; HYDROCORTISONE	Background: Etomidate is frequently used to intubate traumatic brain injury (TBI) victims, even though it has been linked to adrenal insufficiency (AI) in some populations. Few studies have explored the risk of prolonged etomidate-induced AI among TBI victims. Objective: To determine the risk and the length of AI induced by etomidate in patients intubated for moderate and severe TBI. Methods: Participants in this observational study were moderate to severe intubated TBI victims aged > 16 years. The anesthetic used (etomidate versus others) was determined solely by the treating emergency physician. Adrenocorticotropic hormone (ACTH) stimulation tests (250 mu g) were performed 24, 48, and 168 hours after intubation. AI was defined as an increase in serum cortisol 1 hour post-ACTH test (delta cortisol) of less than 248.4 nmol/L. Results: Forty subjects (participation 42.6%) underwent ACTH testing. Fifteen received etomidate, and 25 received another anesthetic. There were no statistically significant differences between groups as to the cumulative incidence of AI at any measurement time. However, at 24 hours, exploratory post hoc analyses showed a significant decrease in delta cortisol (adjusted means: etomidate group: 305.1 nmol/L, 95% CI 214.7-384.8 versus other anesthetics: 500.5 nmol/L, 95% CI 441.8-565.7). This decrease was not present at 48 and 168 hours. Conclusion: In TBI victims, although a single dose of etomidate does not increase the cumulative incidence of AI as defined, it seems to decrease the adrenal response to an ACTH test for 24 hours. The clinical impacts of this finding remain to be determined.	[Archambault, Patrick] CSSS Alphonse Desjardins CHAU Levis, Dept Emergency Med, Levis, PQ G6V 3Z1, Canada; [Archambault, Patrick] CSSS Alphonse Desjardins CHAU Levis, Dept Anesthesiol, Levis, PQ G6V 3Z1, Canada; [Dionne, Clermont E.] CHA Univ Quebec, Ctr Rech FRSQ, URESP, Quebec City, PQ, Canada; [Lortie, Gilles] Univ Laval, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada; [Lortie, Gilles] Univ Hotel Dieu Levis, Ctr Hosp, Ctr Sante & Serv Sociaux Alphonse Desjardins, Dept Emergency Med, Levis, PQ, Canada; [LeBlanc, Francois] CHA Univ Quebec, Hop Enfant Jesus, Dept Med, Quebec City, PQ, Canada; [LeBlanc, Francois] CHA Univ Quebec, Hop Enfant Jesus, Div Crit Care, Quebec City, PQ, Canada; [Rioux, Anik] Hop Gatineau, Dept Pharm, Gatineau, PQ, Canada; [Larouche, Genevieve] Univ Quebec, Ctr Hosp, Dept Pharm, Quebec City, PQ, Canada		Archambault, P (corresponding author), CSSS Alphonse Desjardins CHAU Levis, Dept Emergency Med, 143 Rue Wolfe, Levis, PQ G6V 3Z1, Canada.	patrick.m.archambault@gmail.com	Dionne, Clermont/U-6507-2019	DIONNE, Clermont/0000-0003-0806-5573	Association des medecins d'urgence du Quebec; Programme national de recherche en traumatologie; Fondation des hopitaux Enfant-Jesus et Saint-Sacrement; Universite Laval/CHAU Hotel-Dieu de Levis Emergency Medicine Research Chair; Universite Laval McLaughlin Fellowship Fund; Fonds academique de recherche en soins intensifs de Quebec	Funding was provided by the following: Association des medecins d'urgence du Quebec, Programme national de recherche en traumatologie, Fondation des hopitaux Enfant-Jesus et Saint-Sacrement, Universite Laval/CHAU Hotel-Dieu de Levis Emergency Medicine Research Chair, Universite Laval McLaughlin Fellowship Fund, and Fonds academique de recherche en soins intensifs de Quebec.	Absalom A, 1999, ANAESTHESIA, V54, P861; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; ALLOLIO B, 1985, CLIN ENDOCRINOL, V22, P281, DOI 10.1111/j.1365-2265.1985.tb03241.x; Annane D, 2005, INTENS CARE MED, V31, P325, DOI 10.1007/s00134-005-2560-1; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Bloomfield R, 2006, BRIT J ANAESTH, V97, P116, DOI 10.1093/bja/ael124; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CROZIER TA, 1987, ANESTHESIOLOGY, V66, P628, DOI 10.1097/00000542-198705000-00006; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; DUTHIE DJR, 1985, BRIT J ANAESTH, V57, P156, DOI 10.1093/bja/57.2.156; Edwards P, 2005, LANCET, V365, P1957; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FRAGEN RJ, 1984, ANESTHESIOLOGY, V61, P652, DOI 10.1097/00000542-198412000-00004; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Hohl CM, 2010, ANN EMERG MED, V56, P105, DOI 10.1016/j.annemergmed.2010.01.030; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jackson WL, 2005, CHEST, V127, P1031, DOI 10.1378/chest.127.3.1031; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Marx J.A., 2006, ROSENS EMERGENCY MED; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Morris C, 2005, ANAESTHESIA, V60, P737, DOI 10.1111/j.1365-2044.2005.04325.x; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Payen JF, 2012, CRIT CARE MED, V40, P29, DOI 10.1097/CCM.0b013e31822d7938; Price K, 2005, CRIT CARE S1, V9, pP392, DOI [10.1186/cc3455, DOI 10.1186/CC3455]; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Sakles JC, 1998, ANN EMERG MED, V31, P325, DOI 10.1016/S0196-0644(98)70342-7; SanoFi Diagnostics Pasteur, 1995, ACC IMM SYST MAN OP; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Sehdev Rajesh S, 2006, Emerg Med Australas, V18, P37; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; WAGNER RL, 1984, ANESTHESIOLOGY, V61, P647, DOI 10.1097/00000542-198412000-00003; WALLS RM, 2004, MANUAL EMERGENCY AIR; Weant KA, 2008, NEUROSURGERY, V63, P645, DOI 10.1227/01.NEU.0000325728.50939.15	42	8	9	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	SEP	2012	14	5					270	282		10.2310/8000.2012.120453			13	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	016RF	WOS:000309536200002	22967694				2022-02-06	
J	Avesani, R; Carraro, E; Armani, G; Masiero, S				Avesani, R.; Carraro, E.; Armani, G.; Masiero, S.			Exploring variables associated with rehabilitation length of stay in brain injuries patients	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Length of stay; Treatment Outcome; Rehabilitation	SEVERE HEAD-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; MULTICENTER ANALYSIS; INPATIENT REHABILITATION; MODEL SYSTEMS; OLDER-ADULTS; COMPLICATIONS; COMMUNITY	Background. The impact of outcome measure as early variables on rehabilitation length of stay (LOS) in traumatic brain injury (TB!) patients remains poorly investigated. Aim. To investigate: 1) the association between LOS and motor and functional outcomes; 2) the predictive factors of LOS in TBI patients admitted to a rehabilitation center. Design. Retrospective study. Setting. Inpatient TBI Rehabilitation Centre. Populations. 241 TBI patients (190 males and 51 females, mean age 43.61 +/- 19.4 years, initial Glasgow Coma Scale of 6.96 +/- 3.39). Methods. We recorded demographic characteristics (age, sex, setting and LOS in the acute phase, rehabilitation LOS) and outcome measures (Glasgow Outcome Scale, Disability Rating Scale, Levels of Cognitive Functioning, Functional Independence Measure). Results. Average rehabilitation LOS was 58.82 +/- 58 days; 191 (79%) subjects were discharged from the rehabilitation center within 90 days. Rehabilitation LOS was significantly correlated with acute-care LOS (P=0.001) and Glasgow Coma Scale, but not with patients' age (P=0.250) or sex (P=0.348). Rehabilitation LOS was significantly correlated with functional and cognitive admission outcome scores but not with gains during rehabilitation. Rehabilitation LOS was significantly less in the group of patients that returned back home respect to others. Regression analysis also illustrated that longer acute-care LOS was independently associated with significantly increased rehabilitation LOS (P<0.001). Conclusion. Our retrospective study suggests that rehabilitation LOS in TBI patients is correlated with timing of and score at admission to the rehabilitation setting rather than with gains in functional outcome. Clinical Rehabilitation Impact. This result may help to optimize inpatient service utilization, especially in term of LOS.	[Avesani, R.; Carraro, E.; Armani, G.] Sacro Cuore Don Calabria Hosp, Dept Rehabil, Verona, Italy; [Carraro, E.; Masiero, S.] Univ Padua, Dept Rehabil Med, Padua, Italy		Masiero, S (corresponding author), Azienda Osped, Dept Rehabil, Via Giustiniani 2, I-35128 Padua, Italy.	stef.masiero@unipd.it	Masiero, Stefano/K-6473-2016; Carraro, Elena/A-1924-2011	Masiero, Stefano/0000-0002-0361-4898; Carraro, Elena/0000-0002-1259-1050			Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; [Anonymous], 1992, RICERCA RIABIL S, V2, P1; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Armitage P, 2002, STAT METHODS MED RES, P817; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Development Core Team, 2009, LANG ENV STAT COMP; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hagen C, 1979, REHABILITATION HEAD, P8; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Masiero S, 2011, AGING CLIN EXP RES, V23, P74, DOI 10.3275/6798; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ottenbacher KJ, 2000, AM J PUBLIC HEALTH, V90, P1920, DOI 10.2105/AJPH.90.12.1920; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwartz I, 2007, ARCH PHYS MED REHAB, V88, P440, DOI 10.1016/j.apmr.2007.01.001; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tesio L, 2002, AM J PHYS MED REHAB, V81, P168, DOI 10.1097/00002060-200203000-00003; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Zampolini M, 2009, EUR MED PHYS, V45, P1	44	8	8	1	12	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	SEP	2012	48	3					433	441					9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	024EY	WOS:000310093000011	22820827				2022-02-06	
J	Baykara, B; Cetin, F; Baykara, B; Aksu, I; Dayi, A; Kiray, M; Sisman, AR; Ozdemir, D; Arda, MN; Uysal, N				Baykara, Basak; Cetin, Ferihan; Baykara, Burak; Aksu, Ilkay; Dayi, Ayfer; Kiray, Muge; Sisman, Ali Riza; Ozdemir, Durgul; Arda, Mehmet Nuri; Uysal, Nazan			Anxiety Caused by Traumatic Brain Injury Correlates to Decreased Prefrontal Cortex VEGF Immunoreactivity and Neuron Density in Immature Rats	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Immature rat; Anxiety; VEGF; Prefrontal cortex	INDUCED HIPPOCAMPAL DAMAGE; ADRENOCORTICAL-RESPONSE; CRANIOCEREBRAL TRAUMA; DOPAMINERGIC ACTIVITY; MATERNAL SEPARATION; STRESS; NEUROENDOCRINE; DYSFUNCTION; DEPRESSION; SEVERITY	AIM: Traumatic brain injury (TBI) may cause neuropsychiatric disorders such as anxiety disorder which has negative effects on cognitive functions and behavior. The aim of this study is to investigate the effects of TBI on anxiety and vascular endothelial growth factor (VEGF) immunoreactivity on the prefrontal cortex of immature rats, which is one of the anxiety-related regions of the brain in 7-day-old immature rats subjected to contusion injury. MATERIAL and METHODS: Rats were divided into three groups: Control (n=7), Sham (n=7) and TBI (n=7). Anxiety levels were assessed with open field activity and elevated plus maze in postnatal 27 days. Prefrontal cortex damage related to TBI was examined by cresyl violet staining and VEGF immunostaining. Prefrontal cortex neuronal density was calculated. Serum corticosterone levels were determined. RESULTS: The anxiety level in the TBI group was significantly greater than the control and sham groups. The prefrontal cortex VEGF immunostaining score and neuron density were decreased in the TBI group compared to control and sham group. Serum corticosterone levels were significantly increased in the TBI group. CONCLUSION: These results indicate that TBI decreases VEGF immunoreactivity in prefrontal cortex neurons and increases the anxiety levels of immature rats.	[Baykara, Basak] Dokuz Eylul Univ, Fac Phys Therapy & Rehabil, Dept Histol & Embryol, Izmir, Turkey; [Cetin, Ferihan; Aksu, Ilkay; Dayi, Ayfer; Kiray, Muge; Uysal, Nazan] Dokuz Eylul Univ, Fac Med, Dept Physiol, Izmir, Turkey; [Baykara, Burak] Dokuz Eylul Univ, Fac Med, Dept Child & Adolescent Psychiat, Izmir, Turkey; [Sisman, Ali Riza] Dokuz Eylul Univ, Fac Med, Dept Biochem, Izmir, Turkey; [Ozdemir, Durgul] Dokuz Eylul Univ, Fac Med, Dept Pediat, Izmir, Turkey; [Arda, Mehmet Nuri] Dokuz Eylul Univ, Fac Med, Dept Neurosurg, Izmir, Turkey		Baykara, B (corresponding author), Dokuz Eylul Univ, Fac Phys Therapy & Rehabil, Dept Histol & Embryol, Izmir, Turkey.	basak.baykara@deu.edu.tr	Baykara, Huseyin Burak/AAH-4898-2020; Baykara, Basak/AAC-6504-2019; dayi, ayfer/O-9503-2019	Baykara, Huseyin Burak/0000-0002-1530-0159; Baykara, Basak/0000-0002-4178-2235; dayi, ayfer/0000-0002-4102-1399; Uysal, Nazan/0000-0002-2348-7427			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; BOUZARTH WF, 1968, SURG GYNECOL OBSTETR, V126, P995; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Cernak I, 1999, BRAIN INJURY, V13, P1005; Conte V., 2003, EUR J TRAUMA, V7, P335; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Jahng JW, 2010, NEUROSCIENCE, V171, P144, DOI 10.1016/j.neuroscience.2010.08.063; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McIntosh LJ, 1998, BRAIN RES, V791, P209, DOI 10.1016/S0006-8993(98)00115-2; Moore E, 2006, PARIS REV, P117; Ognibene E, 2008, PROG NEURO-PSYCHOPH, V32, P1269, DOI 10.1016/j.pnpbp.2008.03.023; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Porritt MJ, 2005, EXP NEUROL, V192, P226, DOI 10.1016/j.expneurol.2004.11.030; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; STEINBOK P, 1979, NEUROSURGERY, V5, P559, DOI 10.1227/00006123-197911000-00003; Tata DA, 2010, PHYSIOL BEHAV, V99, P186, DOI 10.1016/j.physbeh.2009.09.008; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Uysal N, 2011, NEUROSCI LETT, V505, P273, DOI 10.1016/j.neulet.2011.10.039; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x	41	8	8	0	7	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	SEP	2012	22	5					604	610		10.5137/1019-5149.JTN.5633-11.1			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	024ON	WOS:000310118600012	23015338	Bronze			2022-02-06	
J	Heuer, JF; Selke, M; Crozier, TA; Pelosi, P; Herrmann, P; Perske, C; Quintel, M				Heuer, Jan Florian; Selke, Maren; Crozier, Thomas A.; Pelosi, Paolo; Herrmann, Peter; Perske, Christina; Quintel, Michael			Effects of Acute Intracranial Hypertension on Extracerebral Organs: A Randomized Experimental Study in Pigs	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						acute intracranial hypertension; multiple organ dysfunction; organ cross-talk	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ENHANCED PULMONARY INFLAMMATION; SEVERE HEAD-INJURY; CARDIAC-ARRHYTHMIAS; LUNG INFLAMMATION; DYSFUNCTION; DONORS; COMPLICATIONS	Background The study was conducted to determine the effects of isolated acute intracranial hypertension (AICH) on extracerebral organs. Design A total of 14 mechanically ventilated pigs were randomized to two groups of seven each: (1) control and (2) AICH. Methods AICH was induced by inflating an intracranial balloon catheter. The inflation volume was adjusted to keep intracranial pressure between 30 and 40 cm H2O. Hemodynamics, gas-exchange, and global oxygen delivery parameters were observed over a 4-hour period. At the end of the 4-hour period, tissue samples of heart, lungs, liver, and kidneys were collected and histologically graded for inflammation, edema, and cell damage (necrosis) using semiquantitative scores. Results Animals with AICH had increased heart rate and cardiac output, and higher scores for inflammation, edema, and necrosis in heart, lung, kidney, and liver tissues (all p < 0.05). Peripheral and mixed-venous oxygen saturations were unaffected. Conclusions Isolated AICH induces injury to multiple extracerebral organs, even in the absence of hypoperfusion or hypoxemia.	[Heuer, Jan Florian; Crozier, Thomas A.; Herrmann, Peter; Quintel, Michael] Univ Hosp Gottingen, Dept Anaesthesiol Emergency & Intens Care Med, D-37075 Gottingen, Germany; [Selke, Maren] Univ Hosp Gottingen, Dept Cardiol, D-37075 Gottingen, Germany; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Perske, Christina] Univ Hosp Gottingen, Dept Pathol, D-37075 Gottingen, Germany		Heuer, JF (corresponding author), Univ Hosp Gottingen, Dept Anaesthesiol Emergency & Intens Care Med, Robert Koch Str 40, D-37075 Gottingen, Germany.	jheuer@med.uni-goettingen.de	Rocco, Patricia/I-7460-2012	Rocco, Patricia/0000-0003-1412-7136; Herrmann, Peter/0000-0002-0348-2573; Pelosi, Paolo/0000-0001-5055-3023			Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; BUSSON M, 1995, J UROLOGY, V154, P356, DOI 10.1016/S0022-5347(01)67046-0; Calzia E, 2010, CRIT CARE MED, V38, pS559, DOI 10.1097/CCM.0b013e3181f1fe70; Cobelens PM, 2010, CRIT CARE, V14, DOI 10.1186/cc9232; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; Daniele Ornella, 2002, J Stroke Cerebrovasc Dis, V11, P28, DOI 10.1053/jscd.2002.123972; Quilez ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10230; Fisher AJ, 1999, LANCET, V353, P1412, DOI 10.1016/S0140-6736(99)00494-8; Fu YC, 2004, ARCH DIS CHILD, V89, P368, DOI 10.1136/adc.2003.029645; Grosse-Wortmann L, 2006, PEDIATR CARDIOL, V27, P286, DOI 10.1007/s00246-005-1248-1; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Heuer JF, 2011, INTENS CARE MED, V37, P1182, DOI 10.1007/s00134-011-2232-2; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; LEFER AM, 1993, ANNU REV PHARMACOL, V33, P71, DOI 10.1146/annurev.pa.33.040193.000443; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; Nathan C, 2003, NATURE, V422, P675, DOI 10.1038/422675a; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pelosi P, 2011, CRIT CARE, V15, DOI 10.1186/cc10259; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Pratschke J, 2000, ANN SURG, V232, P263, DOI 10.1097/00000658-200008000-00017; Rohde V, 2002, J NEUROSURG, V97, P954, DOI 10.3171/jns.2002.97.4.0954; SEN S, 1984, DEUT MED WOCHENSCHR, V109, P817, DOI 10.1055/s-2008-1069279; Silverberg J, 2010, BRAIN BEHAV IMMUN, V24, P263, DOI 10.1016/j.bbi.2009.10.006; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	37	8	8	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315			J NEUROL SURG PART A	J. Neurol. Surg. Part A	SEP	2012	73	5					289	295		10.1055/s-0032-1304813			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	175VA	WOS:000321260500004	22899228				2022-02-06	
J	Muthuraju, S; Pati, S; Rafiqul, M; Abdullah, JM; Jaafar, H				Muthuraju, Sangu; Pati, Soumya; Rafiqul, Mohammad; Abdullah, Jafri Malin; Jaafar, Hasnan			IntelliCage provides voluntary exercise and an enriched environment, improving locomotive activity in mice following fluid percussion injury	BASAL GANGLIA			English	Article						IntelliCage; Fluid percussion injury; Neurobehavioral recovery; Enrich environment; Locomotors activity; Motivated voluntary movement	TRAUMATIC BRAIN-INJURY; SUBVENTRICULAR ZONE; NEUROGENESIS; CELLS; INHIBITION; DISRUPTION; MIGRATION; ISCHEMIA; SYSTEMS; MODELS	Considerable evidence suggests that brain damage can lead to impairments in locomotive activity in human beings. However, no study has thoroughly investigated the locomotion and morphological changes in animals after IntelliCage Exposure (IE). Therefore, to elucidate the locomotive activity and morphological changes in striatum of mice models of fluid percussion injury (FPI), we designed a novel strategy and utilised an advanced neurobehavioral monitoring device known as the IE system. We observed locomotive functioning, from the induction of injury until complete recovery. To achieve the objectives, mice were divided into four groups, the (i) sham group (n = 8), (ii) FPI group (n = 8), and not subjected to acclimatisation in the IE, (iii) sham group (n = 11) and (iv) FPI group (n = 11), and subjected to acclimatisation in the IE. Locomotive activity was monitored for each group for 5 days. Results suggested that the neuronal damage associated with locomotive impairment could occur in the early hours (3-6 h) post-FPI. The process of recovery started significantly at 24 h and continued. Results showed a complete restoration in locomotive activity by the FPI mice at 72 h post-trauma. Morphological results suggested that FPI mice with IE showed less dead cells as compared to FPI mice without IE. Our data also suggested a new dimension for the factors influencing FPI recovery. We hypothesise that IE to FPI animals may provide the necessary enriched environment, induce motivated voluntary physical exercises, and enhance social interactions to accelerate striatum-derived neurogenesis. These factors could be beneficial in TBI-related therapeutic strategies. (C) 2012 Published by Elsevier GmbH.	[Muthuraju, Sangu; Pati, Soumya; Rafiqul, Mohammad; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kota Baharu 16150, Kelantan, Malaysia; [Jaafar, Hasnan] Univ Sains Malaysia, Sch Med Sci, Dept Pathol, Kota Baharu 16150, Kelantan, Malaysia		Abdullah, JM (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kota Baharu 16150, Kelantan, Malaysia.	brainsciences@gmail.com	SANGU, MUTHURAJU/C-3200-2011; Abdullah, J/C-2828-2011	SANGU, MUTHURAJU/0000-0002-7949-2110; Abdullah, J/0000-0002-0258-7410			Barlind A, 2010, EXP BRAIN RES, V201, P781, DOI 10.1007/s00221-009-2095-8; Baunez C, 2010, PROG BRAIN RES, V183, P235, DOI 10.1016/S0079-6123(10)83012-2; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CHOPP M, 1991, ACTA NEUROPATHOL, V83, P66, DOI 10.1007/BF00294432; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Dunnett SB, 2006, EXP NEUROL, V199, P479, DOI 10.1016/j.expneurol.2006.01.013; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Endo T, 2011, BEHAV BRAIN RES, V221, P172, DOI 10.1016/j.bbr.2011.02.037; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Frink M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/797383; Haruddin FA, 2010, ORIENT NEURON NEXUS, V1, P13; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Iyengar S, 2002, J NEUROSCI, V22, P946, DOI 10.1523/JNEUROSCI.22-03-00946.2002; Knab AM, 2010, INT J BIOL SCI, V6, P133; Kristian P, 2010, J NEUROINFLAMM, V7, P62; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; MacDonald P.A., 2011, PARKINSONS DIS-US, V2011, DOI DOI 10.4061/2011/572743; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Nishi A, 2010, J PHARMACOL SCI, V114, P6, DOI 10.1254/jphs.10R01FM; Nygren J, 2006, STROKE, V37, P2824, DOI 10.1161/01.STR.0000244769.39952.90; OAKLEY NR, 1991, PSYCHOPHARMACOLOGY, V105, P204, DOI 10.1007/BF02244310; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Plane JM, 2008, EXP NEUROL, V214, P125, DOI 10.1016/j.expneurol.2008.08.006; Rao RPN, 2003, PHILOS T ROY SOC A, V361, P1149, DOI 10.1098/rsta.2003.1190; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schneier FR, 2000, AM J PSYCHIAT, V157, P457, DOI 10.1176/appi.ajp.157.3.457; Shohamy D., 2011, CURR OPIN NEUROBIOL; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; Tiihonen J, 1997, AM J PSYCHIAT, V154, P239; Wei B, 2011, EUR J NEUROSCI, V33, P819, DOI 10.1111/j.1460-9568.2010.07570.x; Xu JY, 2010, BLOOD, V115, P2709, DOI 10.1182/blood-2009-05-223776; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046	35	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2210-5336	2210-5344		BASAL GANGLIA	Basal Ganglia	SEP	2012	2	3					143	151		10.1016/j.baga.2012.06.004			9	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V4H2I	WOS:000218929500005					2022-02-06	
J	Ouckama, R; Pearsall, DJ				Ouckama, Ryan; Pearsall, David J.			Impact performance of ice hockey helmets: head acceleration versus focal force dispersion	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Impact biomechanics; load distribution; head injury; helmets; concussion	TRAUMATIC BRAIN-INJURY; CONCUSSION; FOOTBALL; SPORT	Modern sport helmets certified to various international safety standards have virtually eliminated the incidence of cranial fracture and fatal brain injury in contact sports; however, the occurrence of diffuse brain injuries (mTBI) are still prevalent. Local contact mechanics between the colliding surface (helmet/head) need to be considered as global measures of acceleration and are insensitive to load distribution measures which are indicative of helmet performance. The purpose of this study was to demonstrate the ability to capture localized load distribution response between the helmet and headform and to examine factors that may influence these measures. Twenty-five flexible force sensors were arranged in a 5 x 5 array about three impact sites (front, side, rear) of a 575 mm EN960 headform. Test factors included helmet model (5), impact location (3) and temperature (21 degrees C, -25 degrees C) as well as repeated impacts (3). Testing procedure followed the CSA Z262.1-09 standard at the defined locations. Average error calculated during sensor calibration was 2.8 +/- 1% with an R-2 value of 0.987 +/- 0.009. As expected, peak global force correlated well to peak acceleration (R-2 = 0.98) but weakly corresponded to peak focal force (R-2 = 0.22). Furthermore, both load distribution magnitudes and patterns were found to vary substantially with mixed effects between helmet models, impact locations, and temperatures. Given these findings, this novel approach may be used to quantify local contact mechanics between the colliding surface/helmet/head.	[Ouckama, Ryan; Pearsall, David J.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada		Ouckama, R (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	ryan.ouckama@mail.mcgill.ca	Pearsall, David/C-9353-2014	Pearsall, David/0000-0002-4382-3504	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)FQRNT; Bauer Hockey Corporation in St-Jerome, Quebec, Canada	This study was supported by the Industrial Innovation Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC), Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) and the Bauer Hockey Corporation in St-Jerome, Quebec, Canada.	[Anonymous], 2009, Z262109 CSA; ASTM, 2007, F104507 ASTM INT; Bishop PJ, 1993, SAFETY ICE HOCKEY, P175; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; ISO, 2003, 102562003 ISO; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; NOCSAE, 2004, 03004M04A NOCSAE ND; Ouckama R, 2011, J BIOMECH, V44, P904, DOI 10.1016/j.jbiomech.2010.11.035; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	18	8	8	2	27	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371			P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		185	192		10.1177/1754337111435625			8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000005					2022-02-06	
J	Upshaw, JE; Gosserand, JK; Williams, N; Edwards, JC				Upshaw, Jana E.; Gosserand, Jaime Kaye; Williams, Nolan; Edwards, Jonathan C.			Sports-Related Concussions	PEDIATRIC EMERGENCY CARE			English	Article						concussion; mild traumatic brain injury; sports; adolescents	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL SPORTS; STANDARDIZED ASSESSMENT; FOOTBALL PLAYERS; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURIES; MILD HEAD; MANAGEMENT; ATHLETE; RECOVERY	During the past decade, awareness of concussions has exploded as both the media and the medical literature have given more focus to this common problem. Concussions after recreational activities, especially athletics, are a frequent complaint in the emergency department. In the past few years, care of these patients has been simplified as grading systems and classifications have been abandoned. However, questions remain as to the best way to rehabilitate these patients to avoid long-term sequelae, especially in children and adolescents. The purpose of this review is to discuss the demographic characteristics, the pathophysiology, definition, clinical characteristics, and management of concussions in children and adolescents.	[Upshaw, Jana E.; Gosserand, Jaime Kaye] Med Univ S Carolina, Dept Pediat, Div Pediat Emergency Med, Charleston, SC 29425 USA; [Williams, Nolan; Edwards, Jonathan C.] Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA		Upshaw, JE (corresponding author), Med Univ S Carolina, Dept Pediat, Div Pediat Emergency Med, 135 Rutledge Ave, Charleston, SC 29425 USA.	upshawje@musc.edu		Williams, Nolan/0000-0003-4368-3203			[Anonymous], 2010, MED SCI SPORT EXER, V42, P820, DOI 10.1249/MSS.0b013e3181d19a0b; Ashton DJ, 2010, CHILD CONCUSSIONS RI; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; Gessel L, 2007, J ATHL TRAINING, V42, P8; Gordon K, 2010, PEDIATR NEUROL, V43, P5; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Grossi T, 2009, CLEVELAND; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Keating P, 2010, IS CONCUSSION TESTIN; Kelly JP, 1997, NEUROLOGY, V48, P581; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marshal J, 2010, CONCUSSIONS RISE COL; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Quarstad B, 2010, IM SOCCER NEWS; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sports NCoY, 2008, REP TRENDS PART ORG; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wesolowski K, 2010, NEUROLOGY TODAY, V10, P32; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	71	8	8	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2012	28	9					926	935		10.1097/PEC.0b013e318267f674			10	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	004HZ	WOS:000308673600023	22940896				2022-02-06	
J	Williams, G; Hill, B; Pallant, JF; Greenwood, K				Williams, Gavin; Hill, Bridget; Pallant, Julie F.; Greenwood, Ken			Internal validity of the revised HiMAT for people with neurological conditions	CLINICAL REHABILITATION			English	Article						Mobility limitation; neurological disorder; reproducibility of results	HIGH-LEVEL MOBILITY; ASSESSMENT-TOOL HIMAT; RASCH MEASUREMENT MODEL; TRAUMATIC BRAIN-INJURY; MANUAL ABILITY; ABILHAND; STROKE; SCALE; QUESTIONNAIRE; RELIABILITY	Objective: The High-level Mobility Assessment Tool (HiMAT) was developed to measure high-level mobility limitations following traumatic brain injury. The aim of this study was to investigate if the revised HiMAT is valid for use with adults with neurological conditions other than traumatic brain injury. Design: Cross-sectional study. Subjects: Ninety-five participants with neurological conditions. Methods: HiMAT score sheets were retrieved from the central medical files of people who had attended a major rehabilitation facility for a neurological condition from January 2006 to October 2007. Additional HiMAT score sheets were submitted by therapists who participated in the HiMAT User's Group. Rasch analysis (RUMM2030 software) was used to determine the overall fit of the model, individual item fit and differential item functioning. Results: Rasch analysis supported the internal validity of the revised eight-item HiMAT for individuals with neurological conditions. It showed good overall fit (P = 0.74), no misfitting items and excellent internal consistency (Person Separation Index = 0.91). The HiMAT is unidimensional with no evidence of response dependency and no differential item functioning for age or sex. Conclusion: Further development of the revised HiMAT is required to investigate other aspects of validity, reliability and responsiveness in different neurological populations. However, the results support the internal validity of the revised HiMAT when used for people with neurological conditions who are able to walk without gait aids.	[Williams, Gavin; Hill, Bridget] Epworth Med Fdn, Physiotherapy Dept, Richmond, Vic 3121, Australia; [Williams, Gavin] Univ Melbourne, Sch Physiotherapy, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Pallant, Julie F.] Univ Melbourne, Rural Hlth Acad Ctr, Melbourne, Vic, Australia; [Greenwood, Ken] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Greenwood, Kenneth M/J-8993-2015	Greenwood, Kenneth M/0000-0002-8420-6588; Hill, Bridget/0000-0002-8632-094X; Williams, Gavin/0000-0003-2758-7473			Andrich D., 2003, RUMM2020; Arnould C, 2004, NEUROLOGY, V63, P1045, DOI 10.1212/01.WNL.0000138423.77640.37; Belvedere SL, 2010, J CLIN EPIDEMIOL, V63, P1287, DOI 10.1016/j.jclinepi.2010.02.012; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Granger CV, 1983, GUIDE USE UNIFORM DA; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; MAHONEY F I, 1965, Md State Med J, V14, P61; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Penta M, 2001, STROKE, V32, P1627, DOI 10.1161/01.STR.32.7.1627; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TEASDALE G, 1974, LANCET, V2, P81; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tyson S, 2009, CLIN REHABIL, V23, P1018, DOI 10.1177/0269215509339004; Vanthuyne M, 2009, ARTHRIT RHEUM-ARTHR, V61, P695, DOI 10.1002/art.24426; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams G, 2004, HIGH LEVEL MOBILITY; Williams G, 2009, INT J THER REHABIL, V16, P188, DOI 10.12968/ijtr.2009.16.4.41186; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	27	8	8	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	AUG	2012	26	8					741	747		10.1177/0269215511429163			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	975CN	WOS:000306484500009	22172924				2022-02-06	
J	Elias, PZ; Spector, M				Elias, Paul Z.; Spector, Myron			Characterization of a Bilateral Penetrating Brain Injury in Rats and Evaluation of a Collagen Biomaterial for Potential Treatment	JOURNAL OF NEUROTRAUMA			English	Article						collagen; penetrating brain injury; rat brain; scaffold; traumatic brain injury	MESENCHYMAL STEM-CELLS; GUNSHOT WOUNDS; CEREBRAL-CORTEX; IN-VITRO; REGENERATION; HEAD; INFLAMMATION; MIGRATION; HYDROGELS; MODEL	Penetrating brain injury (PBI) encountered in both the military and civilian sectors results in high morbidity and mortality due to the absence of effective treatment options for survivors of the initial trauma. Developing therapies for such injuries requires a better understanding of the complex pathology involved when projectiles enter the skull and disrupt the brain parenchyma. This study presents a histological characterization of bilateral PBI using a relatively new injury model in the rat, and also investigates the implantation of a collagen scaffold into the PBI lesion as a potential treatment option. At 1 week post-PBI, the lesion was characterized by dense macrophage infiltration, evolving astrogliosis, hypervascularity, and an absence of viable neurons, oligodendrocytes, and myelinated axons. Histomorphometric analysis revealed that the PBI lesion volume expanded by 29% between 1 week and 5 weeks post-injury, resulting in formation of a large acellular cavity. Immunohistochemistry showed a decrease in the presence of CD68-positive macrophages from 1 to 5 weeks post-PBI as the necrotic tissue in the lesion was cleared, while persistent glial scarring remained in the form of upregulated GFAP expression surrounding the PBI cavity. Implanted type I collagen scaffolds remained intact with open pores after time periods of 1 week and 4 weeks in vivo, and were found to be sparsely infiltrated with macrophages, astrocytes, and endothelial cells. Collagen scaffolds appear to be an appropriate delivery vehicle for cellular and pharmacological therapeutic agents in future studies of PBI.	[Elias, Paul Z.; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA; [Elias, Paul Z.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Spector, Myron] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA		Elias, PZ (corresponding author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151,Room D1-151,150 S Huntington Ave, Boston, MA 02130 USA.	pzelias@alum.mit.edu		Spector, Myron/0000-0003-3328-4858	U.S. Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs	The research reported here was supported by the U.S. Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service. M. S. is a VA Research Career Scientist.	ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493; ALLEN IV, 1982, INJURY, V14, P183, DOI 10.1016/0020-1383(82)90057-2; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bolliet C, 2008, TISSUE ENG PART C-ME, V14, P207, DOI 10.1089/ten.tec.2008.0168; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0; Chang YC, 2007, CELL TRANSPLANT, V16, P171; Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028; Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275; Elias PZ, 2012, J MECH BEHAV BIOMED, V12, P63, DOI 10.1016/j.jmbbm.2012.03.014; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035; Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.actbio.2006.12.009; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; HUNT TK, 1984, SURGERY, V96, P48; Izci Y, 2005, EMERG MED J, V22, P409, DOI 10.1136/emj.2004.014704; Izci Y, 2003, TOHOKU J EXP MED, V201, P39, DOI 10.1620/tjem.201.39; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jankovic S, 2000, ACTA NEUROCHIR, V142, P101, DOI 10.1007/s007010050014; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; KNOWLSON GT, 1974, J NEUROL NEUROSUR PS, V37, P971, DOI 10.1136/jnnp.37.8.971; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Murano T, 2005, AM SURGEON, V71, P1009; Nakada A, 2009, CELLS TISSUES ORGANS, V190, P326, DOI 10.1159/000223233; Novozhilova A P, 1997, Neurosci Behav Physiol, V27, P183, DOI 10.1007/BF02461951; O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6; Pabuscu Y, 2003, COMPUT MED IMAG GRAP, V27, P397, DOI 10.1016/S0895-6111(03)00015-6; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pataquiva-Mateus A.Y., 2012, J BIOMED MAT RES B; Pek YS, 2004, BIOMATERIALS, V25, P473, DOI 10.1016/S0142-9612(03)00541-6; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sapsford W, 2003, J R Army Med Corps, V149, P5; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SOBLOSKY JS, 1992, J NEUROSURG, V76, P119, DOI 10.3171/jns.1992.76.1.0119; Spilker MH, 1997, TISSUE ENG, V3, P309, DOI 10.1089/ten.1997.3.309; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Sun XD, 2009, BIOMATERIALS, V30, P1222, DOI 10.1016/j.biomaterials.2008.10.020; Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974; Tian WM, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015010; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345; Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; WOERLY S, 1992, J NEURAL TRANSP PLAS, V3, P21, DOI 10.1155/NP.1992.21; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yannas IV, 2005, J R SOC INTERFACE, V2, P403, DOI 10.1098/rsif.2005.0062; Zhang C, 2005, J NEUROTRAUM, V22, P1456, DOI 10.1089/neu.2005.22.1456; Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335	77	8	8	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	11					2086	2102		10.1089/neu.2011.2181			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	983CX	WOS:000307095800009	22519932				2022-02-06	
J	Granget, E; Milh, M; Pech-Gourg, G; Paut, O; Girard, N; Lena, G; Scavarda, D				Granget, Emilie; Milh, Mathieu; Pech-Gourg, Gregoire; Paut, Olivier; Girard, Nadine; Lena, Gabriel; Scavarda, Didier			Life-saving decompressive craniectomy for acute disseminated encephalomyelitis in a child: a case report	CHILDS NERVOUS SYSTEM			English	Article							TRAUMATIC BRAIN-INJURY; HEMICRANIECTOMY; FEATURES		[Granget, Emilie; Pech-Gourg, Gregoire; Lena, Gabriel; Scavarda, Didier] CHU Timone Enfants, Dept Pediat Neurosurg, Marseille, France; [Milh, Mathieu] CHU Timone Enfants, Dept Pediat Neurol, Marseille, France; [Paut, Olivier] CHU Timone Enfants, Dept Pediat Anesthesiol & Intens Care, Marseille, France; [Girard, Nadine] CHU Timone, Dept Neuroradiol, Marseille, France		Scavarda, D (corresponding author), CHU Timone Enfants, Dept Pediat Neurosurg, Marseille, France.	didier.scavarda@ap-hm.fr	Girard, Nadine/B-7109-2017; , Girard/E-8537-2013	, Girard/0000-0001-8639-9275			Ahmed AI, 2010, NEUROCRIT CARE, V13, P393, DOI 10.1007/s12028-010-9420-8; Alexander M, 2011, ANN INDIAN ACAD NEUR, V14, pS60, DOI 10.4103/0972-2327.83095; Borlot F, 2011, J PEDIATR NEUROSCI, V6, P48, DOI 10.4103/1817-1745.84408; Dale RC, 2000, BRAIN, V123, P2407, DOI 10.1093/brain/123.12.2407; Dombrowski KE, 2011, BRIT J NEUROSURG, V25, P249, DOI 10.3109/02688697.2010.544784; Guresir E, 2011, NEUROSURGER IN PRESS; Hashim HZ, 2011, ANN ACAD MED SINGAP, V40, P197; Hoche F, 2011, J NEURAL TRANSM, V118, P1311, DOI 10.1007/s00702-011-0609-6; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308; Jacob AT, 2011, PEDIATR NEUROSURG, V47, P81, DOI 10.1159/000329624; Ketelslegers IA, 2011, MULT SCLER J, V17, P441, DOI 10.1177/1352458510390068; Leake JAD, 2004, PEDIATR INFECT DIS J, V23, P756, DOI 10.1097/01.inf.0000133048.75452.dd; Menge T, 2007, CURR OPIN NEUROL, V20, P247, DOI 10.1097/WCO.0b013e3280f31b45; Murthy SNK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e21; Nguyen Ha Son, 2011, Childs Nerv Syst, V27, P657, DOI 10.1007/s00381-010-1285-9; Nilsson P, 2009, EUR J NEUROL, V16, P639, DOI 10.1111/j.1468-1331.2009.02547.x; Pavone P, 2010, NEUROPEDIATRICS, V41, DOI 10.1055/s-0031-1271656; Refai D, 2005, NEUROSURGERY, V56, P872, DOI 10.1227/01.NEU.0000156201.46473.A8; Rust R S, 2000, Semin Pediatr Neurol, V7, P66, DOI 10.1053/pb.2000.6693; Singh S, 1999, AM J ROENTGENOL, V173, P1101, DOI 10.2214/ajr.173.4.10511187; Tenembaum S, 2007, NEUROLOGY, V68, pS23, DOI 10.1212/01.wnl.0000259404.51352.7f; von Stuckrad-Barre S, 2003, NEUROLOGY, V61, P420, DOI 10.1212/01.WNL.0000073540.35919.AE	23	8	8	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2012	28	7					1121	1124		10.1007/s00381-012-1733-9			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	961LM	WOS:000305465900025	22399246				2022-02-06	
J	Tamashiro, M; Cozzo, D; Mattei, M; Salierno, F; Rivas, ME; Alzua, O; Olmos, L; Bonamico, L; Leiguarda, R				Tamashiro, Mercedes; Cozzo, Diego; Mattei, Martin; Salierno, Fernando; Elisa Rivas, Maria; Alzua, Oscar; Olmos, Lisandro; Bonamico, Lucas; Leiguarda, Ramon			Early motor predictors of recovery in patients with severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; vegetative state; rehabilitation	HEAD-INJURY; PROFILE; SCALE; STATE	Research design: Retrospective observational study. Objective: To compare motor variables between patients with severe traumatic brain injury who emerge and patients who do not emerge from vegetative state, in an attempt to identify early motor manifestations associated with consistent patient improvement. Methods and procedures: Patients were divided into two groups: group 1, patients who emerged from vegetative state attaining at least a state of functional interactive communication and/or functional use of two different objects (n = 8); and group 2, patients who did not emerge (n = 7). Twenty-one motor variables were compared weekly between groups until the end of the treatment programme. Results: Significant differences were observed in head control (p = 0.051) and head turning (p = 0.002) variables, as well as in visual fixation and pursuit (p = 0.051) after a median of 41 days of therapy; and in head control and head turning; visual fixation and pursuit; phonation; pain localization, reach and grasp, and trunk movement (p <= 0.051) after a median of 212 days of programme duration. Conclusions: Head turning, together with or immediately followed by visual pursuit and fixation, proved to be clinically significant variables associated with recovery from vegetative state to higher states of consciousness beyond minimally conscious state.	[Tamashiro, Mercedes; Cozzo, Diego; Mattei, Martin; Salierno, Fernando; Elisa Rivas, Maria; Alzua, Oscar] FLENI Rehabil Inst, Dept Phys Therapy, Escobar, Argentina; [Bonamico, Lucas; Leiguarda, Ramon] FLENI Rehabil Inst, Dept Neurol, Escobar, Argentina		Tamashiro, M (corresponding author), FLENI Inst, Ruta 9 Km 52,5 B1625XAF, Escobar, Pcia De Buenos, Argentina.	mtamashiro@fleni.org.ar					Andrew K, 1993, NEUROPSYCHOL REHABIL, V3, P109; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Jeannerod M., 1988, OXFORD PSYCHOL SERIE, P41; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Martins GF, 1982, DESCENDING PATHWAYS, P1; Mazaux JM, 1986, REEDUCATION READAPTA, P32; Pelissier J, 1992, TRAUMATISME CRANIEN, P15; Pilon M, 1996, BRAIN INJURY, V10, P421, DOI 10.1080/026990596124287; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shunmway-Cook A, 2001, MOTOR CONTROL THEORY, P447; Winkler P. A., 2001, NEUROLOGICAL REHABIL, P416	19	8	8	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					921	926		10.3109/02699052.2012.661911			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100003	22571420				2022-02-06	
J	Var, FA; Rajeswaran, J				Var, Firdous Ahmad; Rajeswaran, Jamuna			Perception of Illness in Patients with Traumatic Brain Injury	INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE			English	Article						Demographics; illness; perception; traumatic brain injury		Background: Perception of illness plays an important role in recovery process. It affects our coping behaviors, adherence to treatment and preventive measures taken for healthy recovery. Aims: The aim of the study is to examine perception of illness in patients with traumatic brain injury (TBI). Materials and Methods: This was a cross sectional study design done on sample of 31 patients with mild to moderate TBI. Depression anxiety stress scales-21 (DASS-21), Brief illness perception questionnaire (IPQ) and Rivermead Post Concussion Symptoms Questionnaire (RPQ) was used. Statistical Analysis: Descriptive and correlational statistics was used. Results: The results indicated that overall higher percentage falls within low and medium range of IPQ. However higher percentage falls within higher range, on coherence and emotional response subscales of IPQ. Consequence, timeline, personal control, treatment control, concern, emotional control, and total of the subscales of IPQ were positively correlated with RPQ3 and RPQ13 at 0.01 and 0.05 level of significance. A significant correlation was found between demographic variables and subscales of IPQ at 0.01 and 0.05 level of significance. Conclusion: The study shows one to one relationship between symptoms experienced by patients, how they perceive their illness and socio demographic variables.	[Var, Firdous Ahmad; Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore, Karnataka, India		Var, FA (corresponding author), Beyond Counselling Clin, 2nd Floor Hadika Complex, Srinagar, Jammu & Kashmir, India.	mailfaw@gmail.com					Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leventhal H., 1980, CONTRIB MED PSYCHOL, V2, P7; Lewin K., 1944, PERSONALITY BEHAV DI, V70, P333; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; Rajkumari K, 2011, THESIS NATL I MENTAL; Rogers RW., HDB HLTH BEHAV RES, V1, P113; Sankla SK., 1998, P NEUR C, P1; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	15	8	8	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0253-7176	0975-1564		INDIAN J PSYCHOL MED	Indian J. Psychol. Med.	JUL	2012	34	3					223	226		10.4103/0253-7176.106014			4	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	QA9WX	WOS:000613796300004	23441077	Green Published			2022-02-06	
J	Chan, J; Merriman, B; Parmenter, T; Stancliffe, R				Chan, Jeffrey; Merriman, Brian; Parmenter, Trevor; Stancliffe, Roger			Rethinking Respite Policy for People With Intellectual and Developmental Disabilities	JOURNAL OF POLICY AND PRACTICE IN INTELLECTUAL DISABILITIES			English	Article						carers; family; intellectual disabilities; policy; respite	TRAUMATIC BRAIN-INJURY; CARE; CHILDREN; SERVICES; NEEDS; PARENTS; SUPPORT; HOME; DEPRESSION; PROVISION	Respite care is one of a range of support services typically available to carers of people with dependencies who need a break from caring, and the factors that influence the need for respite care are generally similar irrespective of the nature of the dependencies. Hence, the expectations of families potentially have policy and service provision implications regardless of the jurisdiction. However, there is considerable variability in the provision of services, not only between jurisdictions, with differing levels of service development, but also within jurisdictions. The history of disjointed service provision suggests the need for a rethink of respite policy. The authors discuss the conceptual framework and prevalent thinking on respite policy such as a shared understanding of respite care among stakeholders. In turn, this shared understanding is seen as generating a move toward integrated service development, recasting respite as part of a continuum of family support services in which funding policies give families more control. The authors conclude that respite care provided in an integrated framework moves beyond the basic function of a break in caring to one of supporting family coping and resilience.	[Chan, Jeffrey] Off Chief Practitioner, Dept Communities, Brisbane, Qld, Australia; [Merriman, Brian] Trinity Coll Dublin, Childrens Res Ctr, Dublin, Ireland; [Parmenter, Trevor] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Stancliffe, Roger] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia		Chan, J (corresponding author), Off Chief Practitioner Disabil, Dept Communities, Level 3B Neville Bonner Bldg,75 Williams St, Brisbane, Qld 4000, Australia.	jeffrey.chan@communities.qld.gov.au	Stancliffe, Roger/C-3430-2008	Stancliffe, Roger/0000-0003-4265-7433			Australian Institute of Health and Welfare, 2011, DIS SUPP SERV 2008 0; Australian Institute of Health and Welfare, 2007, CURR FUT DEM SPEC DI; Brown JB, 2000, CAN FAM PHYSICIAN, V46, P1793; Brown S. L, 2007, ALZHEIMERS CARE TODA, V8, P235; Caldwell J, 2003, J INTELL DISABIL RES, V47, P352, DOI 10.1046/j.1365-2788.2003.00496.x; Chan J. B., 2000, CHILD YOUTH CARE FOR, V29, P27, DOI DOI 10.1023/A:1009420206722; Chan JB, 2001, J INTELLECT DEV DIS, V26, P339, DOI 10.1080/13668250120087344; Chan JB., 2001, CHILD YOUTH CARE FOR, V30, P253, DOI [DOI 10.1023/A:1014467226528, 10.1023/A:1014467226528]; Chan J, 2008, INT J REHABIL RES, V31, P3, DOI 10.1097/MRR.0b013e3282f45215; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Chan JB, 2008, INT J DISABIL DEV ED, V55, P289, DOI 10.1080/10349120802489448; CHESSON R, 2004, MAKING BREAK DEV MET; Chiu L, 1999, HEALTH POLICY, V46, P239, DOI 10.1016/S0168-8510(98)00062-1; Cotterill L, 1997, DISABIL SOC, V12, P775, DOI 10.1080/09687599727047; Cramer H, 2008, BRIT J SOC WORK, V38, P1060, DOI 10.1093/bjsw/bcl393; Cummins RA, 2001, J INTELLECT DEV DIS, V26, P83, DOI 10.1080/13668250020032787; Daisychain Foundation, 2006, TIM YOU PROGR; Damiani G, 2004, CHILD CARE HLTH DEV, V30, P77, DOI 10.1111/j.1365-2214.2004.00391.x; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Dowse L., 2003, WAY FORWARD SUPPORTI; Hanrahan D., 2004, NATL HOME SHARING NE; Herman SE, 1997, MENT RETARD, V35, P458, DOI 10.1352/0047-6765(1997)035<0458:POSARA>2.0.CO;2; Hughes J, 2007, FAMILY MATTERS, P32; Jeon YH, 2005, J ADV NURS, V49, P297, DOI 10.1111/j.1365-2648.2004.03287.x; Jeon YH, 2007, INT J MENT HEALTH NU, V16, P96, DOI 10.1111/j.1447-0349.2007.00452.x; Kelly C, 2010, ANN REPORT NATL DISA; Kersten P, 2001, HEALTH SOC CARE COMM, V9, P235, DOI 10.1046/j.1365-2524.2001.00297.x; KOSLOSKI K, 1995, GERONTOLOGIST, V35, P67, DOI 10.1093/geront/35.1.67; Maarbjerg A. W., 2006, 4 QUAL C 2006 BUILD; MacDonald H, 2004, CHILD CARE HLTH DEV, V30, P279, DOI 10.1111/j.1365-2214.2004.00392.x; McConkey R, 2005, J INTELL DISABIL RES, V49, P600, DOI 10.1111/j.1365-2788.2005.00697.x; McConkey R., 2006, J SOC WORK, V6, P65, DOI [10.1177/1468017306062224, DOI 10.1177/1468017306062224]; McConkey R, 2010, J APPL RES INTELLECT, V23, P85, DOI 10.1111/j.1468-3148.2009.00547.x; McCubbin, 1996, FAMILY ASSESSMENT RE, P1; McNally S, 1999, DISABIL REHABIL, V21, P1, DOI 10.1080/096382899298043; Merriman B., 2007, BEST PRACTICE PROVIS; Montoro-Rodriguez J, 2003, GERONTOLOGIST, V43, P916, DOI 10.1093/geront/43.6.916; Neufeld S M, 2001, J Pediatr Nurs, V16, P234, DOI 10.1053/jpdn.2001.24183; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Olsen R, 2001, J ADV NURS, V34, P603, DOI 10.1046/j.1365-2648.2001.01789.x; Perry J, 2001, Can J Nurs Res, V33, P81; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Post S. G., 2007, ALZHEIMERS CARE TODA, V8, P247; Quin S., 1999, CONT IRISH SOCIAL PO, P146; RIDLEY G, 2004, APPROPRIATE EFFECTIV; Robinson C, 2001, CHILD FAMILY SOCIAL, V6, P67; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Spicer I, 2007, FAMILY MATTERS, P30	48	8	8	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1741-1122	1741-1130		J POLICY PRACT INTEL	J. Policy Pract. Intellect. Disabil.	JUN	2012	9	2					120	126		10.1111/j.1741-1130.2012.00332.x			7	Health Policy & Services; Rehabilitation	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Rehabilitation	952QV	WOS:000304808200005					2022-02-06	
J	Chen, XW; Lin, WP; Lin, JH; Wu, CY; Zhang, LQ; Huang, ZD; Lai, JM				Chen, X-W; Lin, W-P; Lin, J-H; Wu, C-Y; Zhang, L-Q; Huang, Z-D; Lai, J-M			The protective effects of the lentivirus-mediated neuroglobin gene transfer on spinal cord injury in rabbits	SPINAL CORD			English	Article						spinal cord injury; neuroglobin; gene transfer; malondialdehyde; apoptosis	NITRIC-OXIDE; CELLS; APOPTOSIS; BRAIN; RATS; PATHWAYS; NEURONS	Study design: We introduced a lentiviral vector containing the neuroglobin (Ngb) gene into the injured spinal cords to evaluate the therapeutic potential of Ngb in a rabbit model of spinal cord injury (SCI). Objectives: It is not clear whether Ngb has the neuroprotective role to SCI. The purpose of this study was to investigate the possible protective effects of the Ngb overexpression on traumatic SCI in rabbits. Setting: Department of Orthopedic Surgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, People's Republic of China. Methods: A lentiviral vector containing Ngb gene was constructed and injected at the SCI sites 24 h after SCI. The rabbits' motor functions were evaluated by the Basso-Beattie-Bresnahan rating scale. Quantitative real-time PCRs, western blots, malondialdehyde (MDA) tests and terminal deoxynucleotidyl transferase-mediated UTP end labeling assays were also performed. Results: The Ngb expression in the LV-Ngb group increased significantly at days 7, 14 and 21. A more significant functional improvement was observed in the LV-Ngb group compared with the improvements in all other groups at days 14 and 21. The traumatic SCI seemed to lead to an increase in the levels of MDA and in the number of the apoptotic cells, which could be prevented by the LV-Ngb treatment. Conclusion: This study demonstrated that the Ngb overexpression may have potential therapeutic benefits for both reducing secondary damages and improving the outcomes after traumatic SCI. Spinal Cord (2012) 50, 467-471; doi:10.1038/sc.2011.138; published online 22 November 2011	[Chen, X-W; Lin, J-H; Wu, C-Y; Zhang, L-Q; Huang, Z-D; Lai, J-M] Fujian Med Univ, Dept Orthoped Surg, Affiliated Hosp 1, Fuzhou 350005, Peoples R China; [Lin, W-P] Fujian Med Univ, Dept Orthoped Surg, Affiliated Hosp 2, Quanzhou, Peoples R China		Lin, JH (corresponding author), Fujian Med Univ, Dept Orthoped Surg, Affiliated Hosp 1, 20 Chazhong Rd, Fuzhou 350005, Peoples R China.	jianhua0918@126.com		Lin, Jianhua/0000-0003-0698-0292; Zhang, Liqun/0000-0002-2937-2743	Specialized Research Fund for the Doctoral Program of Higher Education of ChinaSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20060392003]	We would like to thank Dr Yu Su for editorial assistance in preparing this paper. This study was supported by a grant from the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20060392003).	Ates O, 2006, ACTA PHARMACOL SIN, V27, P1317, DOI 10.1111/j.1745-7254.2006.00416.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Fago A, 2008, IUBMB LIFE, V60, P398, DOI 10.1002/iub.35; Fago A, 2006, J INORG BIOCHEM, V100, P1339, DOI 10.1016/j.jinorgbio.2006.03.009; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Weber T, 2003, BIOCHEMISTRY-US, V42, P4277, DOI 10.1021/bi020527j	19	8	8	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	JUN	2012	50	6					467	471		10.1038/sc.2011.138			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	951LC	WOS:000304721100015	22105458	Bronze			2022-02-06	
J	Rahman, RA; George, D; Baumgartner, D; Nierenberger, M; Remond, Y; Ahzi, S				Rahman, Rania Abdel; George, Daniel; Baumgartner, Daniel; Nierenberger, Mathieu; Remond, Yves; Ahzi, Said			AN ASYMPTOTIC METHOD FOR THE PREDICTION OF THE ANISOTROPIC EFFECTIVE ELASTIC PROPERTIES OF THE CORTICAL VEIN: SUPERIOR SAGITTAL SINUS JUNCTION EMBEDDED WITHIN A HOMOGENIZED CELL ELEMENT	JOURNAL OF MECHANICS OF MATERIALS AND STRUCTURES			English	Article						homogenization; mechanical behavior; bridging veins; brain-skull interface; elastic properties; biological material	BRIDGING VEINS; MECHANICAL RESPONSE; DYNAMIC-RESPONSE; IN-VIVO; BRAIN; DEFORMATION; BIOMECHANICS; GLUCOSE; IMPACT; INJURY	Bridging veins (BVs) are frequently damaged in traumatic brain injury due to brain-skull relative motion. These veins, connected to the superior sagittal sinus (SSS), are prone to rupture upon head impact giving rise to an acute subdural hematoma (ASDH). We modeled the biomechanical characteristics of ASDH to study the behavior of the SSS-BVs compound with its surrounding medium. The almost periodic distribution of the BVs along the SSS allowed the use of the homogenization method based on asymptotic expansion to calculate the effective elastic properties of the brain-skull interface region. The representative volume element (RVE) under study is an anisotropic equivalent medium with homogenized elastic properties, accounting for the variations of each constituent's mechanical properties. It includes the sinus, the BVs and blood, and the surrounding cerebrospinal fluid and tissue. The results show large variations in the RVE anisotropic properties depending on each constituent of the BV and, to a certain extent, on the variability of the surrounding constituents' mechanical properties.	French Univ Egypt, Fac Engn, Cairo, Egypt; [George, Daniel; Baumgartner, Daniel; Nierenberger, Mathieu; Remond, Yves; Ahzi, Said] Univ Strasbourg, CNRS, Inst Fluids & Solid Mech, F-67000 Strasbourg, France		Rahman, RA (corresponding author), French Univ Egypt, Fac Engn, BP 21 Chorouk City,Km 37,Highway Cairo Ismailia, Cairo, Egypt.	rania.elanwar@gmail.com; george@unistra.fr; daniel.baumgartner@unistra.fr; mathieu.nierenberger@etu.unistra.fr; remond@unistra.fr; ahzi@unistra.fr	Remond, Yves/G-8954-2011	Remond, Yves/0000-0003-3312-8361; george, daniel/0000-0003-3310-8141; Nierenberger, Mathieu/0000-0002-6412-0218; Ahzi, Said/0000-0002-0353-9234			Bashkatov AN, 2003, BIOPHYS J, V85, P3310, DOI 10.1016/S0006-3495(03)74750-X; Baumgartner D, 2005, EUR J COMPUT MECH, V14, P421; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bertaud J, 2010, ACTA BIOMATER, V6, P2457, DOI 10.1016/j.actbio.2010.01.028; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; Chatziprodromou I, 2007, J BIOMECH, V40, P412, DOI 10.1016/j.jbiomech.2005.12.009; Delye Hans, 2006, Stapp Car Crash J, V50, P625; DEVRIES F, 1989, INT J NUMER METH ENG, V27, P285, DOI 10.1002/nme.1620270206; DUMONT JP, 1987, COMPOS STRUCT, V8, P119, DOI 10.1016/0263-8223(87)90008-0; Fenderson B. A., 2007, LINPPINCOTTS REV PAT; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; Henrikson RC, 1997, NATL MED SERIES INDE, V1st; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Horgan T. J., 2005, THESIS NATL U IRELAN; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Ji Songbai, 2004, Stapp Car Crash J, V48, P227; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; KLEIVEN S, 2002, THESIS ROYAL I TECHN; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kumaresan S, 1996, MED BIOL ENG COMPUT, V34, P27, DOI 10.1007/BF02637019; Ladeveze P., 1985, P ICCM 5 SAN DIEG AU, P1025; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Li MX, 2007, J BIOMECH, V40, P3715, DOI 10.1016/j.jbiomech.2007.06.023; Mahmoud R. A. R., 2010, THESIS U STRASBOURG; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; Melvin J. W., 1970, 700903 SAE U MICH; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Mukherjee S., 2006, J I ENG, V87, P10; Paka P, 2011, PROCEDIA ENGINEER, V13, P409, DOI 10.1016/j.proeng.2011.05.106; Park J. B., 2007, BIOMATERIALS INTRO, P245; Pham T, 2010, ACTA BIOMATER, V6, P4336, DOI 10.1016/j.actbio.2010.05.028; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rhoton AL, 2002, NEUROSURGERY, V51, pS1, DOI 10.1227/01.NEU.0000028086.48597.4F; Ruan J. S., 1993, 933114 SAE WAYN STAT; Ruan J. S., 1996, 1996 INT C BIOM IMP, P63; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Samet M. M., 1999, ENDOTHELIAL CELL RES, V6, P8; SANCHEZP.E, 1974, INT J ENG SCI, V12, P331, DOI 10.1016/0020-7225(74)90062-7; Sanz-Herrera JA, 2009, ACTA BIOMATER, V5, P219, DOI 10.1016/j.actbio.2008.06.021; Sarkar S, 2004, TRENDS BIOMATER ARTI, V17, P130; Soliman S, 2010, ACTA BIOMATER, V6, P1227, DOI 10.1016/j.actbio.2009.10.051; Vignes JR, 2007, J NEUROSURG, V107, P1205, DOI 10.3171/JNS-07/12/1205; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Willinger R., 1990, 1990 INT C BIOM IMP, P203; Willinger R., 1992, 1992 P INT IRCOBI C, P283; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021; Yoon YJ, 2002, BIOMECH MODEL MECHAN, V1, P83, DOI 10.1007/s10237-002-0008-x; Yue XF, 2008, AFR J BIOTECHNOL, V7, P689; Zhou C., 1995, 952714 SAE WAYN STAT; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]	56	8	8	0	8	MATHEMATICAL SCIENCE PUBL	BERKELEY	UNIV CALIFORNIA, DEPT MATHEMATICS, BERKELEY, CA 94720-3840 USA	1559-3959			J MECH MATER STRUCT	J. Mech. Mater. Struct.	JUN	2012	7	6					593	611		10.2140/jomms.2012.7.593			19	Materials Science, Multidisciplinary; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics	059NK	WOS:000312712000004		Bronze			2022-02-06	
J	Tate, DF; Shenton, ME; Bigler, ED				Tate, D. F.; Shenton, M. E.; Bigler, E. D.			Introduction to the brain imaging and behavior special issue on neuroimaging findings in mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Neuroimaging; Neuropsychological testing; Heterogeneity	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT SYMPTOMS; HEAD-INJURY; ENCEPHALOPATHY; LESIONS; IRAQ	Contemporary neuroimaging methods and research findings in mild traumatic brain injury (mTBI) are reviewed in this special issue. Topics covered include structural and functional neuroimaging techniques with a particular emphasis on the most contemporary research involving magnetic resonance imaging (MRI). Future research directions as well as applied applications of using neuroimaging techniques to define biomarkers of brain injury are covered.	[Tate, D. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, Res Imaging Inst, San Antonio, TX 78229 USA; [Tate, D. F.] Henry M Jackson Fdn Adv Mil Med, Def Ctr, San Antonio, TX USA; [Tate, D. F.] Henry M Jackson Fdn Adv Mil Med, Vet Brain Injury Ctr, San Antonio, TX USA; [Shenton, M. E.] Harvard Univ, Sch Med, Dept Psychiat & Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Shenton, M. E.] Harvard Univ, VA Boston Healthcare Syst, Sch Med, Brockton, MA 02401 USA; [Bigler, E. D.] Brigham Young Univ, Dept Psychol Sci, Provo, UT 84602 USA; [Bigler, E. D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Bigler, E. D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, E. D.] Utah Brain Inst, Salt Lake City, UT USA		Tate, DF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, Res Imaging Inst, San Antonio, TX 78229 USA.	tatedf@uthscsa.edu	Shenton, Martha/V-8780-2019; Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [L30 NS063444] Funding Source: Medline		Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, LANCET, V368, P837, DOI 10.1016/S0140-6736(06)69315-X; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511	29	8	8	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2012	6	2			SI		103	107		10.1007/s11682-012-9185-0			5	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967LI	WOS:000305908900001	22706729				2022-02-06	
J	Guthrie, DB; Stein, DG; Liotta, DC; Lockwood, MA; Sayeed, I; Atif, F; Arrendale, RF; Reddy, GP; Evers, TJ; Marengo, JR; Howard, RB; Culver, DG; Natchus, MG				Guthrie, David B.; Stein, Donald G.; Liotta, Dennis C.; Lockwood, Mark A.; Sayeed, Iqbal; Atif, Fahim; Arrendale, Richard F.; Reddy, G. Prabhakar; Evers, Taylor J.; Marengo, Jose R.; Howard, Randy B.; Culver, Deborah G.; Natchus, Michael G.			Water-Soluble Progesterone Analogues Are Effective, Injectable Treatments in Animal Models of Traumatic Brain Injury	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Traumatic brain injury; traumatic brain injury; progesterone; neurosteroid; progesterone analogues	EDEMA; HYDROLYSIS; EXPRESSION; ISCHEMIA; AGENTS; BLOOD	After more than 30 years of research and 30 failed clinical trials with as many different treatments, progesterone is the first agent to demonstrate robust clinical efficacy as a treatment for traumatic brain injuries. It is currently being investigated in two, independent phase III clinical trials in hospital settings; however, it presents a formidable solubility challenge that has so far prevented the identification of a formulation that would be suitable for emergency field response use or battlefield situations. Accordingly, we have designed and tested a novel series of water-soluble analogues that address this critical need. We report here the synthesis of C-20 oxime conjugates of progesterone as therapeutic agents for traumatic brain injuries with comparable efficacy in animal models of traumatic brain injury and improved solubility and pharmacokinetic profiles. Pharmacodynamic analysis reveals that a nonprogesterone steroidal analogue may be primarily responsible for the observed activity.	[Guthrie, David B.; Liotta, Dennis C.; Lockwood, Mark A.; Arrendale, Richard F.; Reddy, G. Prabhakar; Evers, Taylor J.; Marengo, Jose R.; Howard, Randy B.; Culver, Deborah G.; Natchus, Michael G.] Emory Univ, EIDD, Atlanta, GA 30322 USA; [Stein, Donald G.; Sayeed, Iqbal; Atif, Fahim] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Liotta, Dennis C.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA		Natchus, MG (corresponding author), Emory Univ, EIDD, 1515 Dickey Dr, Atlanta, GA 30322 USA.	mnatchu@emory.edu	Stein, Donald/AAJ-5139-2020		Emory Institute for Drug Discovery, Emory University	We gratefully acknowledge financial support from The Emory Institute for Drug Discovery, Emory University.	[Anonymous], PROG TRAUM BRAIN INJ; BHR Pharma SyNAPSe, 2011, SYNAPSE PHAS 3 STUD; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jiang C, 2009, INFLAMM RES, V58, P619, DOI 10.1007/s00011-009-0032-8; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; LI QG, 1992, EUR J DRUG METAB PH, V17, P281, DOI 10.1007/BF03190161; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; MacNevin CJ, 2009, J MED CHEM, V52, P6012, DOI 10.1021/jm900712n; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein DG, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P2223; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; THIJSSEN JH, 1966, ACTA ENDOCRINOL-COP, V51, P563, DOI 10.1530/acta.0.0510563; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VARIA SA, 1984, J PHARM SCI, V73, P1074, DOI 10.1002/jps.2600730813; Wang JP, 2011, MOL MED REP, V4, P319, DOI 10.3892/mmr.2011.418; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	27	8	8	0	14	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	MAY	2012	3	5					362	366		10.1021/ml200303r			5	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	939DC	WOS:000303786400004	24900479	Green Published			2022-02-06	
J	Tyson, BT; Pham, MT; Brown, NT; Mayer, TR				Tyson, Brad T.; Pham, Martha T.; Brown, Natashia T.; Mayer, Thomas R.			Patient Safety Considerations in the Rehabilitation of the Individual with Cognitive Impairment	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Cognitive impairment; Patient safety; Rehabilitation; Activities of daily living; Executive functioning	TRAUMATIC BRAIN-INJURY; PREDICTORS; POPULATION; DEMENTIA; PERFORMANCE; ALCOHOL; DISEASE; SUICIDE; HEALTH; RATES	Deficits in cognitive functioning are associated with many safety concerns, including difficulties performing activities of daily living, medication errors, motor vehicle accidents, impaired awareness of deficits, decision-making capacity, falls, and travel away from home. Preventing adverse safety outcomes is particularly relevant in rehabilitation patients. Integration of information and recommendations stemming from allied disciplines, such as rehabilitation medicine, physical therapy, occupational therapy, speech therapy, and neuropsychology, is the most effective way to limit poor outcomes. Education and prevention counseling by health care professionals is an important approach in limiting adverse safety outcomes in patients with cognitive impairment.	[Tyson, Brad T.; Pham, Martha T.; Brown, Natashia T.; Mayer, Thomas R.] Kingsbrook Jewish Med Ctr, Dept Phys Med & Rehabil, Traumat Brain Injury & Coma Recovery Unit, Kingsbrook Rehabil Inst, Brooklyn, NY 11203 USA		Mayer, TR (corresponding author), Kingsbrook Jewish Med Ctr, Dept Phys Med & Rehabil, Traumat Brain Injury & Coma Recovery Unit, Kingsbrook Rehabil Inst, 585 Schenectady Ave, Brooklyn, NY 11203 USA.	tmayer@kingsbrook.org					American Psychological Association and American Bar Association, 2008, ASS OLD AD DIM CAP; Baier B, 2005, J NEUROL NEUROSUR PS, V76, P358, DOI 10.1136/jnnp.2004.036731; Barclay T. R., 2010, NEUROPSYCHOLOGY EVER, P136; Blumenfeld H, 2003, NEUROANATOMY CLIN CA, P821; Boyle PA, 2004, CLIN NEUROPSYCHOL, V18, P75, DOI 10.1080/13854040490507172; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Cahn-Weiner DA, 2003, J GERIATR PSYCH NEUR, V16, P84, DOI 10.1177/0891988703016002004; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen RA, 2009, NEUROPSYCHOLOGY CARD; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; Corrigan J.D., 2005, REHABILITATION TRAUM, P133; Curry ML, 2000, MONITOR PSYCHOL, V31, P2; DILLER L, 1970, Archives of Physical Medicine and Rehabilitation, V51, P358; Dunbar-Jacob J, 2000, Annu Rev Nurs Res, V18, P48; ELOVIC E, 2005, TXB TRAUMATIC BRAIN, P727; Farmer J E, 1995, Appl Neuropsychol, V2, P107, DOI 10.1207/s15324826an0203&4_2; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Flashman L., 2005, TXB TRAUMATIC BRAIN, P353; Freeland J, 1996, MAGAZINE, V4, P32; Ganguli M, 2002, ARCH GEN PSYCHIAT, V59, P1046, DOI 10.1001/archpsyc.59.11.1046; Gould ON, 1999, AGING NEUROPSYCHOL C, V6, P141, DOI 10.1076/anec.6.2.141.788; Grant I., 2010, NEUROPSYCHOLOGY EVER, P93; GRYFE CI, 1984, J AM GERIATR SOC, V32, P301, DOI 10.1111/j.1532-5415.1984.tb02026.x; Heaton, 2010, NEUROPSYCHOLOGY EVER, P5; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Herzog L, 1990, MEDICATION REGIMENS; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; JACKSON JE, 1989, J GEN INTERN MED, V4, P39, DOI 10.1007/BF02596489; Jeste SD, 2003, SCHIZOPHR RES, V63, P49, DOI 10.1016/S0920-9964(02)00314-6; Kattin K, 2005, AM J GERIAT PSYCHIAT, V13, P501; KEWMAN DG, 1991, INT J PSYCHIAT MED, V21, P253, DOI 10.2190/FRYK-TMGA-AULW-BM5G; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Kuzis G, 1999, NEUROPSY NEUROPSY BE, V12, P265; Lamy PP, 1992, CLIN GERIATRIC PSYCH, P15; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; LEZAK MD, 2004, NEUROPSYCHOLOGICAL A, P611; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Marson D. C., 2005, FORENSIC NEUROPSYCHO, P334; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; Miller KE, 2000, AM FAM PHYSICIAN, V61, P1089; Novack TA., 2010, HDB REHABILITATION P, P165; O'Bryant SE, 2006, HEADACHE, V46, P1364, DOI 10.1111/j.1526-4610.2006.00579.x; Pereira J, 1997, CANCER-AM CANCER SOC, V79, P835; Plautz B, 1996, AM J PREV MED, V12, P33, DOI 10.1016/S0749-3797(18)30256-3; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 2009, STUDY ANOSAGNOSIA, P495; Putzke JD, 2000, J HEART LUNG TRANSPL, V19, P995, DOI 10.1016/S1053-2498(00)00183-2; Rizzo M., 2010, NEUROPSYCHOLOGY EVER, P168; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Rowe Meredeth A, 2003, Am J Alzheimers Dis Other Demen, V18, P343; Royall DR, 2005, J INT NEUROPSYCH SOC, V11, P899, DOI 10.1017/S135561770505109X; SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304; Schuler M, 2004, PAIN MED, V5, P253, DOI 10.1111/j.1526-4637.2004.04040.x; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Solhberg MM, 2001, COGNITIVE REHABILITA, P296; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vance DE, 2006, J AGING PHYS ACTIV, V14, P254, DOI 10.1123/japa.14.3.254; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; Worringham C, 2003, MOVEMENT DISORD, V21, P230; [No title captured]	63	8	8	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2012	23	2					315	+		10.1016/j.pmr.2012.02.007			21	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	949KO	WOS:000304575300008	22537695				2022-02-06	
J	Rachubinski, AL; Crowley, SK; Sladek, JR; Maclean, KN; Bjugstad, KB				Rachubinski, Angela L.; Crowley, Shannon K.; Sladek, John R., Jr.; Maclean, Kenneth N.; Bjugstad, Kimberly B.			Effects of Neonatal Neural Progenitor Cell Implantation on Adult Neuroanatomy and Cognition in the Ts65Dn Model of Down Syndrome	PLOS ONE			English	Article							AGE-RELATED IMPAIRMENTS; TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; STEM-CELLS; MOUSE MODEL; ALZHEIMERS-DISEASE; DENTATE GYRUS; MICE; TRANSPLANTATION; MEMORY	As much of the aberrant neural development in Down syndrome (DS) occurs postnatally, an early opportunity exists to intervene and influence life-long cognitive development. Recent success using neural progenitor cells (NPC) in models of adult neurodegeneration indicate such therapy may be a viable option in diseases such as DS. Murine NPC (mNPC, C17.2 cell line) or saline were implanted bilaterally into the dorsal hippocampus of postnatal day 2 (PND 2) Ts65Dn pups to explore the feasibility of early postnatal treatment in this mouse model of DS. Disomic littermates provided karyotype controls for trisomic pups. Pups were monitored for developmental milestone achievement, and then underwent adult behavior testing at 14 weeks of age. We found that implanted mNPC survived into adulthood and migrated beyond the implant site in both karyotypes. The implantation of mNPC resulted in a significant increase in the density of dentate granule cells. However, mNPC implantation did not elicit cognitive changes in trisomic mice either neonatally or in adulthood. To the best of our knowledge, these results constitute the first assessment of mNPC as an early intervention on cognitive ability in a DS model.	[Rachubinski, Angela L.; Maclean, Kenneth N.; Bjugstad, Kimberly B.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Crowley, Shannon K.] Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Crowley, Shannon K.] Univ S Carolina, Dept Neuropsychiat & Behav Sci, Columbia, SC 29208 USA; [Sladek, John R., Jr.] Univ Colorado Denver, Sch Med, Dept Neurol, Aurora, CO USA; [Sladek, John R., Jr.] Univ Colorado Denver, Sch Med, Ctr Neurosci, Aurora, CO USA; [Maclean, Kenneth N.; Bjugstad, Kimberly B.] Univ Colorado Denver, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO USA		Rachubinski, AL (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	kimberly.bjugstad@ucdenver.edu		Bjugstad, Kimberly/0000-0002-0473-5413	Ruth L. Kirschstein National Research Service Award (NRSA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31NS060517]; Anna and John J. Sie Foundation; National Institutes of Health/NCRR Colorado CTSI [TL1 RR025778]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045224-03]; Linda Crnic Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045224] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS060517] Funding Source: NIH RePORTER	This work was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) (F31NS060517), The Anna and John J. Sie Foundation, The Linda Crnic Institute, and was supported by National Institutes of Health/NCRR Colorado CTSI Grant Number TL1 RR025778. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. KNM gratefully acknowledges support from the NICHD (R01HD045224-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson EC, 2001, CYTOGENET CELL GENET, V93, P270, DOI 10.1159/000056997; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Bautista A, 2010, DEV PSYCHOBIOL, V52, P35, DOI 10.1002/dev.20409; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Bimonte-Nelson HA, 2003, BEHAV BRAIN RES, V139, P47, DOI 10.1016/S0166-4328(02)00082-7; Bjugstad KB, 2006, EXP NEUROL, V198, P561, DOI 10.1016/j.expneurol.2006.02.023; Bjugstad KB, 2004, EXP NEUROL, V187, P204; Bjugstad KB, 2005, CELL TRANSPLANT, V14, P183, DOI 10.3727/000000005783983098; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Chang Q, 2008, NEUROBIOL LEARN MEM, V89, P167, DOI 10.1016/j.nlm.2007.05.007; Contestabile A, 2009, CELL PROLIFERAT, V42, P171, DOI 10.1111/j.1365-2184.2009.00587.x; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Down JL, 1866, CLIN LECT REPORTS LO, V3, P259; Feng ZQ, 2009, NEUROSCI LETT, V462, P213, DOI 10.1016/j.neulet.2009.07.008; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Frotscher M., 2007, HIPPOCAMPUS BOOK, P115; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Hattiangady B, 2007, STEM CELLS, V25, P2104, DOI 10.1634/stemcells.2006-0726; Heyser CJ, 2001, ASSESSMENT DEV MILES; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; Hunter CL, 2003, BEHAV BRAIN RES, V138, P121, DOI 10.1016/S0166-4328(02)00275-9; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; Jucker Mathias, 1994, V719, P238; Kern DS, 2011, CELL TRANSPLANT, V20, P371, DOI 10.3727/096368910X528085; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Miranda MI, 2003, NEUROBIOL LEARN MEM, V80, P211, DOI 10.1016/S1074-7427(03)00061-3; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Park KI, 2000, YONSEI MED J, V41, P825, DOI 10.3349/ymj.2000.41.6.825; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rueda N, 2005, NEUROSCI LETT, V380, P197, DOI 10.1016/j.neulet.2005.01.039; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Schmitz C, 1998, ANAT EMBRYOL, V198, P371, DOI 10.1007/s004290050191; Snyder EY, 1996, CURR OPIN NEUROL, V9, P126, DOI 10.1097/00019052-199604000-00013; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Stasko MR, 2004, BEHAV BRAIN RES, V154, P1, DOI 10.1016/j.bbr.2004.01.012; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Toso L, 2008, OBSTET GYNECOL, V112, P1242, DOI 10.1097/AOG.0b013e31818c91dc; UECKER A, 1993, J CLIN CHILD PSYCHOL, V22, P266, DOI 10.1207/s15374424jccp2202_12; Wainwright PE, 1998, J NUTR, V128, P661, DOI 10.1093/jn/128.3.661; Watson DJ, 2006, HUM GENE THER, V17, P693, DOI 10.1089/hum.2006.17.693; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163; Zorrilla EP, 1997, DEV PSYCHOBIOL, V30, P141, DOI 10.1002/(SICI)1098-2302(199703)30:2<141::AID-DEV5>3.0.CO;2-Q	64	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36082	10.1371/journal.pone.0036082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	WOS:000305345200114	22558337	Green Published, gold, Green Submitted			2022-02-06	
J	Jung, SW; Kim, DW				Jung, Sang-Won; Kim, Dong-Won			Our Experience with Surgically Treated Epidural Hematomas in Children	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic epidural hematomas (EDHs); Children; Cause; Outcome	EXTRADURAL HEMATOMA; MANAGEMENT	Objective : Traumatic epidural hematomas (EDHs) in children are a relatively unusual occurrence. The cause and outcome vary depending on period and region of study. The aims of this analysis were to review the cause and outcome of pediatric EDHs nowadays and to discuss outcome-related variables in a large consecutive series of surgically treated EDH in children. Methods : This is a retrospective review of 29 patients with surgically treated EDHs between Jan 2000 and February 2010. Patients' medical records, computed tomographic (CT) scans, and, if performed, magnetic resonance imaging (MRI) were reviewed to define variables associated with outcome. Variables included in the analysis were age, associated severe extracranial injury, abnormal pupillary response, hematoma thickness, severity of head injury (Glasgow Coma Scale score), parenchymal brain injury, and diffuse axonal injury. Results : The mean (SD) age of the patients was 109 months (0-185 months). Most of the injuries with EDHs occurred in traffic accident (14 cases, 48.2%) and followed by slip down in 6 cases and falls in 6 cases. There were one birth injury and one unknown cause. EDHs in traffic accidents occurred in pedestrians hit by a motor vehicle, 9 cases; motorbike and car accidents, 5 cases and bicycle accidents, 1 case. The locations of hematoma were almost same in both sides (left side in 15 cases). Temporal lobe is the most common site of hematomas (13 cases, 44%). The mean size of the EDHs was 18 mm (range, 5-40 mm). Heterogeneous hematomas in CT scans were 20 cases (67%). Two patients were referred with unilateral or bilateral dilated pupil(s). There was enlargement of EDH in 5 patients (17%). All of them were heterogeneous hematomas in CT scans. Except for 4 patients, all EDHs were associated with skull fracture(s) (87%). There was no case of patient with major organ injury. CT or MRI revealed brain contusion in 5 patients, and diffuse axonal injury in one patient. The mortality was zero, and the outcomes were excellent in 26 and good in 2 patients. None of the tested variables were found to have a prognostic relevance. Conclusion : Regardless of the EDH size, the clinical status of the patients, the abnormal pupillary findings, or the cause of injury, the outcome and prognosis of the patients with EDH were excellent.	[Jung, Sang-Won; Kim, Dong-Won] Keimyung Univ, Sch Med, Dept Neurosurg, Taegu 700712, South Korea		Kim, DW (corresponding author), Keimyung Univ, Sch Med, Dept Neurosurg, 56 Dalseong Ro, Taegu 700712, South Korea.	dongwon@dsmc.or.kr					Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Barras CD, 2009, STROKE, V40, P1325, DOI 10.1161/STROKEAHA.108.536888; Ben Abraham R, 2000, PEDIATR NEUROSURG, V33, P70, DOI 10.1159/000028990; Browne GJ, 2002, PEDIATR EMERG CARE, V18, P86, DOI 10.1097/00006565-200204000-00006; Bullock M Ross, 2006, Neurosurgery, V58, pS7; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; DHELLEMMES P, 1985, J NEUROSURG, V62, P861, DOI 10.3171/jns.1985.62.6.0861; Ersahin Y, 2010, BRIT J NEUROSURG, V24, P503, DOI 10.3109/02688697.2010.487136; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; JAMJOOM A, 1994, NEUROSURG REV, V17, P277, DOI 10.1007/BF00306818; Maggi G, 1998, J Neurosurg Sci, V42, P95; Marion DW, 2006, NEUROSURGERY, V58, P655; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501	14	8	8	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	APR	2012	51	4					215	218		10.3340/jkns.2012.51.4.215			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	959NQ	WOS:000305319900005	22737301	Green Submitted, Green Published, gold			2022-02-06	
J	Semenova, NA; Akhadov, TA; Petryaykin, AV; Sidorin, SS; Lukovenkov, AV; Varfolomeev, SD				Semenova, N. A.; Akhadov, T. A.; Petryaykin, A. V.; Sidorin, S. S.; Lukovenkov, A. V.; Varfolomeev, S. D.			Metabolic Dysfunction and Relationship in Human Frontoparietal Cortex in Severe Traumatic Brain Injury: Single-Voxel H-1 Magnetic Resonance Spectroscopy Study	BIOCHEMISTRY-MOSCOW			English	Article						magnetic resonance spectroscopy; severe traumatic brain injury; frontoparietal cortex	PROTON MR SPECTROSCOPY; N-ACETYLASPARTATE; AXONAL INJURY; CHILDREN; DAMAGE	H-1-magnetic resonance spectroscopy revealed that apparently normal (from the data of magnetic resonance imaging) human brain frontoparietal cortex in the subacute stage of traumatic brain injury is characterized by decreased level of N-acetylaspartate (NAA) and increase in levels of myoinositol, choline-containing compounds (Cho), and creatine/phosphocreatine (Cr). Correlations between Cr, Cho, and NAA were established. We propose a scheme of neuronal metabolic processes that joins these substances.	[Semenova, N. A.; Sidorin, S. S.; Lukovenkov, A. V.; Varfolomeev, S. D.] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow 119334, Russia; [Akhadov, T. A.; Petryaykin, A. V.; Sidorin, S. S.] Childrens Clin & Res Inst Emergency Surg & Trauma, Moscow 119180, Russia		Semenova, NA (corresponding author), Russian Acad Sci, Emanuel Inst Biochem Phys, Ul Kosygina 4, Moscow 119334, Russia.	nmr-semen@mail.ru; akhadov@mail.ru	Varfolomeev, Sergei D./L-7499-2018; Akhadov, Tolib/AAD-2906-2022				Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Akhadov T. A., 2009, MED VIZUALIZATSIYA, V2, P117; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Baslow MH, 2006, ADV EXP MED BIOL, V576, P95; Baslow MH, 2007, J MOL NEUROSCI, V32, P235, DOI 10.1007/s12031-007-0049-9; Bonavita S, 1999, EUR J RADIOL, V30, P125, DOI 10.1016/S0720-048X(99)00051-0; Braissant Olivier, 2007, V46, P67; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Chadi G, 1998, BRAZ J MED BIOL RES, V31, P231, DOI 10.1590/S0100-879X1998000200007; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; GUIMARAES AR, 1995, NEUROSCIENCE, V69, P1095, DOI 10.1016/0306-4522(95)00300-8; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Karp G., 2009, CELL MOL BIOL CONCEP, P180; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Marret V., 1996, BIOCHEM J, V316, P805; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Ross BD, 1997, BIOPHYS CHEM, V68, P161, DOI 10.1016/S0301-4622(97)00032-X; SATO H, 1988, BIOCHEM BIOPH RES CO, V150, P491, DOI 10.1016/0006-291X(88)90547-5; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Semenova NA, 2011, DOKL BIOCHEM BIOPHYS, V436, P49, DOI 10.1134/S1607672911010157; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Tran T, 2009, NEUROL CLIN, V27, P21, DOI 10.1016/j.ncl.2008.09.007; Xin LJ, 2009, MAGN RESON MED, V61, P260, DOI 10.1002/mrm.21829	34	8	8	0	7	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0006-2979	1608-3040		BIOCHEMISTRY-MOSCOW+	Biochem.-Moscow	APR	2012	77	4					388	394		10.1134/S0006297912040104			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925ZL	WOS:000302801000010	22809158				2022-02-06	
J	Taub, E				Taub, Edward			Parallels between use of constraint-induced movement therapy to treat neurological motor disorders and amblyopia training	DEVELOPMENTAL PSYCHOBIOLOGY			English	Article						motor deficit; amblyopia; learned nonuse; developmental disregard; CI therapy; amblyopia training; neuroplasticity	UPPER EXTREMITY FUNCTION; UPPER-LIMB FUNCTION; MIDDLE-AGED MEN; CORTICAL REORGANIZATION; SOMATOSENSORY CORTEX; CHRONIC STROKE; CI THERAPY; LEARNED NONUSE; VISUAL-ACUITY; FORCED-USE	There are striking similarities between the visual defect of amblyopia and the motor deficit of the extremities produced by such types of damage to the central nervous system (CNS) as stroke and traumatic brain injury, both after and before maturity. Part of the motor deficit of the extremities following CNS injury can be attributed to a learning phenomenon termed learned nonuse or if present from birth, developmental disregard. The same mechanism is hypothesized to be involved in the development of amblyopia. Treatments that are efficacious in the remediation of these defects, Constraint-Induced Movement therapy and amblyopia training, also share a number of strong similarities. In addition, plastic brain changes are produced by CI therapy and are hypothesized to occur during amblyopia training. (C) 2010 Wiley Periodicals, Inc. Dev Psychobiol 54:274-292, 2012.	Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA		Taub, E (corresponding author), Univ Alabama Birmingham, Dept Psychol, 1530 3rd Ave S,CPM 712, Birmingham, AL 35294 USA.				National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD34273]; U.S. Department of Veterans Affairs, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B93-629AP, B95-975R, W98-0410]; Retirement Research Foundation [94-172]; Alabama Health Services Foundation; Center for Aging, University of Alabama at Birmingham; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD034273] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health; Contract grant number: HD34273; Contract grant sponsor: U.S. Department of Veterans Affairs, Rehabilitation Research and Development Service; Contract grant number: B93-629AP, B95-975R, W98-0410; Contract grant sponsor: Retirement Research Foundation; Contract grant number: 94-172; Contract grant sponsor: Alabama Health Services Foundation and the Center for Aging, University of Alabama at Birmingham	Arnold RW, 2008, ARCH OPHTHALMOL-CHIC, V126, P891, DOI 10.1001/archopht.126.7.891; Azrin N.H., 1966, OPERANT BEHAV AREAS, P380; Bara-Jimenez W, 1998, ANN NEUROL, V44, P828, DOI 10.1002/ana.410440520; Bowman MH, 2006, NEUROREHABILITATION, V21, P167; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Candia V, 1999, LANCET, V353, P42, DOI 10.1016/S0140-6736(05)74865-0; Castro CM, 2001, HEALTH PSYCHOL, V20, P438, DOI 10.1037//0278-6133.20.6.438; CATANIA A. C., 1998, LEARNING; Chekitaan, 2009, International Ophthalmology, V29, P231, DOI 10.1007/s10792-008-9232-4; Cleary M, 2000, BRIT J OPHTHALMOL, V84, P572, DOI 10.1136/bjo.84.6.572; Coffins RS, 2008, J AAPOS, V12, P565, DOI 10.1016/j.jaapos.2008.04.008; Cohen J., 2013, STAT POWER ANAL BEHA; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dettmers C, 2005, ARCH PHYS MED REHAB, V86, P204, DOI 10.1016/j.apmr.2004.05.007; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Elbert T, 2002, J NEUROSCI, V22, P9941; Elbert T, 1997, EXP BRAIN RES, V117, P161, DOI 10.1007/s002210050210; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; Elbert T, 1998, NEUROREPORT, V9, P3571, DOI 10.1097/00001756-199811160-00006; Elbert T., 1995, SCIENCE, V220, P21; EPSTEIN LH, 1980, BEHAV MODIF, V4, P465, DOI 10.1177/014544558044003; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Estes WK., 1944, PSYCHOL MONOGR, P57; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Friedman RH, 1998, J MED SYST, V22, P95, DOI 10.1023/A:1022695119046; Gauthier L.Y., 2010, DECREASED GREY UNPUB; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Hallam J, 1998, AM J HEALTH PROMOT, V13, P4, DOI 10.4278/0890-1171-13.1.4; Harnish S, 2009, ARCH PHYS MED REHAB, V90, pE16; Huang CB, 2008, P NATL ACAD SCI USA, V105, P4068, DOI 10.1073/pnas.0800824105; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Jones TA, 2009, STROKE, V40, pS136, DOI 10.1161/STROKEAHA.108.533653; JUNEAU M, 1987, AM J CARDIOL, V60, P66, DOI 10.1016/0002-9149(87)90986-6; KING AC, 1988, AM J CARDIOL, V61, P628, DOI 10.1016/0002-9149(88)90778-3; King AC, 2000, J GERONTOL A-BIOL, V55, pM74; KNAPP HD, 1963, EXP NEUROL, V7, P305, DOI 10.1016/0014-4886(63)90077-3; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; KUPFER C, 1957, AM J OPHTHALMOL, V43, P918, DOI 10.1016/0002-9394(57)91795-6; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; Levi DM, 1996, P NATL ACAD SCI USA, V93, P6830, DOI 10.1073/pnas.93.13.6830; Li R. W., 2007, INVEST OPHTH VIS SCI, V48, P4889; Li RW, 2007, INVEST OPHTH VIS SCI, V48, P5046, DOI 10.1167/iovs.07-0324; Li RW, 2004, J VISION, V4, P476, DOI 10.1167/4.6.7; Liepert J, 1998, NEUROSCI LETT, V250, P5, DOI 10.1016/S0304-3940(98)00386-3; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lum PS, 2004, J REHABIL RES DEV, V41, P249, DOI 10.1682/JRRD.2003.06.0092; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Mark V., 2003, PERCEPTUAL COMPLETIO, P281; Mark VW, 2008, MULT SCLER J, V14, P992, DOI 10.1177/1352458508090223; Mark V W, 2006, Eura Medicophys, V42, P269; MARTIN JE, 1984, J CONSULT CLIN PSYCH, V52, P795, DOI 10.1037/0022-006X.52.5.795; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; Morris D M, 2006, Eura Medicophys, V42, P257; Morris DM, 2006, NEUROREHABILITATION, V21, P131; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Mott F.W., 1895, P ROY SOC LOND, V57, P481, DOI DOI 10.1098/RSP1.1894.0179; NOLAND MP, 1989, RES Q EXERCISE SPORT, V60, P216, DOI 10.1080/02701367.1989.10607443; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OSullivan S., 2007, PHYS REHABILITATION, VFifth; OWEN N, 1987, J SPORT PSYCHOL, V9, P346, DOI 10.1123/jsp.9.4.346; Ploughman M, 2004, ARCH PHYS MED REHAB, V85, P1417, DOI 10.1016/j.apmr.2004.01.018; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Polat U, 2008, RESTOR NEUROL NEUROS, V26, P413; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Rejeski WJ, 2003, HEALTH PSYCHOL, V22, P414, DOI 10.1037/0278-6133.22.4.414; Repka MX, 2008, ARCH OPHTHALMOL-CHIC, V126, P990, DOI 10.1001/archopht.126.7.990; ROBISON JI, 1992, MED SCI SPORT EXER, V24, P85; Rubab S, 2008, ARCH OPHTHALMOL-CHIC, V126, P133, DOI 10.1001/archophthalmol.2007.27; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Skinner B.F., 1968, TECHNOLOGY TEACHING; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Sterr A, 1998, J NEUROSCI, V18, P4417; Sterr A, 1998, NATURE, V391, P134, DOI 10.1038/34322; Stewart CE, 2004, INVEST OPHTH VIS SCI, V45, P3048, DOI 10.1167/iovs.04-0250; STOFFELMAYR BE, 1992, J OCCUP ENVIRON MED, V34, P156, DOI 10.1097/00043764-199202000-00015; Sullivan T, 1998, ARTHRIT CARE RES, V11, P228, DOI 10.1002/art.1790110403; Taub E, 2006, Eura Medicophys, V42, P241; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; Taub E, 2005, STROKE, V36, P1301, DOI 10.1161/01.STR.0000166043.27545.e8; Taub E, 2004, PEDIATRICS, V113, P305, DOI 10.1542/peds.113.2.305; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 1999, J REHABIL RES DEV, V36, P237; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E., 2009, SOC NEUR CHIC IL; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Taub E, 1968, NEUROPSYCHOLOGY SPAT, P173; Taub Edward, 2007, Dev Neurorehabil, V10, P3, DOI 10.1080/13638490601151836; Umphred D., 2001, NEUROLOGICAL REHABIL, V4, P56; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Uswatte G, 2000, STROKE, V31, P662, DOI 10.1161/01.STR.31.3.662; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G., 2002, RELATION CI TH UNPUB; Uswatte G, 2008, ARCH PHYS MED REHAB, V89, pE9; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; Uswatte G, 2006, NEUROREHABILITATION, V21, P147; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wolf SL, 2008, LANCET NEUROL, V7, P33, DOI 10.1016/S1474-4422(07)70294-6; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; WYSOCKI T, 1979, J APPL BEHAV ANAL, V12, P55, DOI 10.1901/jaba.1979.12-55; Yamashima T, 2004, HIPPOCAMPUS, V14, P861, DOI 10.1002/hipo.20001; YANG TT, 1994, NATURE, V368, P592, DOI 10.1038/368592b0; Zhou YF, 2006, VISION RES, V46, P739, DOI 10.1016/j.visres.2005.07.031; Zinn S., 2006, PATIENT TREATMENT AD; [No title captured]	117	8	9	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1630	1098-2302		DEV PSYCHOBIOL	Dev. Psychobiol.	APR	2012	54	3			SI		274	292		10.1002/dev.20514			19	Developmental Biology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Psychology	907RP	WOS:000301435600006	22415916				2022-02-06	
J	Detweiler, MB; Arif, S; Candelario, J; Altman, J; Murphy, PF; Halling, MH; Vasudeva, S; Detweiler, JG				Detweiler, Mark B.; Arif, Saira; Candelario, Joseph; Altman, Joanne; Murphy, Pamela F.; Halling, Mary H.; Vasudeva, Sachinder; Detweiler, Jonna G.			Salem VAMC-US Army Fort Bragg Warrior Transition Clinic Telepsychiatry Collaboration: 12-Month Operation Clinical Perspective	TELEMEDICINE AND E-HEALTH			English	Article						telepsychiatry; military medicine; telehealth	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; SECONDARY TRAUMATIZATION; DEPRESSION; VETERANS; PTSD; PREVALENCE; PAIN; DEPLOYMENT	Objective: To describe the clinical experience in the first Veterans Affairs (VA)-U. S. Army Warrior Transition Clinic (WTC) telepsychiatry operation (September 2008-August 2009). Materials: Joint VA and U.S. Army records. Methods: Analysis of intake, follow-up, and last visit records. Results: One hundred twenty active-duty U.S. Army soldiers were seen (394 clinic visits). Ninety-eight soldiers had one or more combat tours, principally in Iraq and Afghanistan. Posttraumatic stress disorder was diagnosed in 50.0% of the cases by the WTC telepsychiatrists. The majority of the soldiers had medical comorbidities, especially chronic pain (75.0%), in addition to mental health problems. Several of the soldiers were recovering from trauma (20.8%) and/or surgery (23.3%), 11.7% exhibited traumatic brain injuries, and 17.5% had headaches. Disrupted relationships (74.2%) were notable for non-family members, especially military cohorts such as other persons in the same WTC squad or platoon. Conclusion: The observations in this report come from a cross-section of soldiers who were triaged to meet WTC admission criteria. As this is the prototype VA-U.S. Army telepsychiatry collaboration, there are no comparative data at this time. The nature of the medical and psychiatric problems treated in the military WTC represents an index of the more severe combat trauma treated on military bases from ongoing combat operations and may predict future VA-U. S. Army collaborative telepsychiatry clinic experiences.	[Detweiler, Mark B.; Murphy, Pamela F.; Halling, Mary H.; Detweiler, Jonna G.] Salem VAMC, Geriatr Res Grp, Salem, VA USA; [Arif, Saira] Univ Virginia Roanoke, Caril Clin, Salem Psychiat Med Residency Program, Salem, VA USA; [Candelario, Joseph] Salem VAMC, Emergency Dept, Salem, VA USA; [Altman, Joanne] USA, Warrior Transit Clin, Ft Bragg, NC USA; [Murphy, Pamela F.] Virginia Tech, Adjunct Fac, Blacksburg, VA USA		Detweiler, MB (corresponding author), Vet Affairs Med Ctr, 1970 Roanoke Blvd, Salem, VA 24153 USA.	mark.detweiler1@va.gov					Andary MT, 1997, CLIN J PAIN, V13, P244, DOI 10.1097/00002508-199709000-00010; ATKINSON JH, 1991, PAIN, V45, P111, DOI 10.1016/0304-3959(91)90175-W; Balzac F, 2008, NEUROPSYCHIATRY REV, V9, P28; Balzac F., 2008, NEUROPSYCHIATRY REV, V9, P1; Balzac F, 2008, NEUROPSYCHIATRY REV, V9, P26; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; BLUM MD, 1984, HOSP COMMUNITY PSYCH, V35, P691; BOSCARINO J, 1980, INT J SOC PSYCHIATR, V27, P204, DOI 10.1177/002076408102700307; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chemtob CM, 1997, J TRAUMA STRESS, V10, P17, DOI 10.1002/jts.2490100104; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Detweiler MB, 2011, J TELEMED TELECARE, V17, P293, DOI 10.1258/jtt.2011.100804; Dirkzwager AJE, 2005, J FAM PSYCHOL, V19, P217, DOI 10.1037/0893-3200.19.2.217; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Germain A, 2009, PSYCHIAT ANN, V39, P335, DOI 10.3928/00485713-20090514-02; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hall-Flavin DK, IS THERE LINK PAIN D; Hamblen JL, 2009, PSYCHIAT ANN, V39, P348, DOI 10.3928/00485713-20090515-02; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Houston JB, 2009, PSYCHIAT ANN, V39, P805, DOI 10.3928/00485713-20090728-03; Johnson J, 2009, PSYCHIAT ANN, V39, P326, DOI 10.3928/00485713-20090514-01; Joiner T, 1999, INTERACTIONAL NATURE OF DEPRESSION, P3, DOI 10.1037/10311-013; Kessler RC, 1998, AM J PSYCHIAT, V155, P1092, DOI 10.1176/ajp.155.8.1092; Kibler JL, 2009, BEHAV MED, V34, P125, DOI 10.3200/BMED.34.4.125-132; Kim DG, 2009, NEUROREHABILITATION, V25, P117, DOI 10.3233/NRE-2009-0506; Kozminski M, 2010, J AM OSTEOPATH ASSOC, V110, P514; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; MacDonald C, 1999, J TRAUMA STRESS, V12, P701, DOI 10.1023/A:1024729520686; Magruder KM, 2009, PSYCHIAT ANN, V39, P778, DOI 10.3928/00485713-20090728-04; Marlow RA, 2009, J AM BOARD FAM MED, V22, P633, DOI 10.3122/jabfm.2009.06.070098; McAllister TW, 2010, PSYCHIAT ANN, V40, P533, DOI 10.3928/00485713-20101018-04; McFarlane AC, 2009, PSYCHIAT ANN, V39, P81, DOI 10.3928/00485713-20090201-05; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; NACE EP, 1977, AM J PSYCHIAT, V134, P167; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; PAN HS, 1994, J CONSULT CLIN PSYCH, V62, P975, DOI 10.1037/0022-006X.62.5.975; Rand Corporation Objective Analysis, EFF SOL ON 5 IR AFH; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; Schudlich TDD, 2004, J FAM PSYCHOL, V18, P171, DOI 10.1037/0893-3200.18.1.171; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Stinson FS, 1998, NIH PUBLICATION, V6; Sullivan GM, 2009, PSYCHIAT ANN, V39, P342, DOI 10.3928/00485713-20090515-01; Sullivan LE, 2005, AM J MED, V118, P330, DOI 10.1016/j.amjmed.2005.01.007; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Treadway KK, 2009, PRIMARY CARE MED OFF, P102; Warner CH, 2009, PSYCHIAT ANN, V39, P56, DOI 10.3928/00485713-20090201-11; Workman Edward A., 2002, Prim Care Companion J Clin Psychiatry, V4, P137	53	8	8	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	MAR	2012	18	2					81	86		10.1089/tmj.2011.0064			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	902MB	WOS:000301041200002	22283361				2022-02-06	
J	Bajaj, JS; Thacker, LR; Heuman, DM; Gibson, DP; Sterling, RK; Stravitz, RT; Fuchs, M; Sanyal, AJ; Wade, JB				Bajaj, Jasmohan S.; Thacker, Leroy R.; Heuman, Douglas M.; Gibson, Douglas P.; Sterling, Richard K.; Stravitz, R. Todd; Fuchs, Michael; Sanyal, Arun J.; Wade, James B.			Driving Simulation Can Improve Insight into Impaired Driving Skills in Cirrhosis	DIGESTIVE DISEASES AND SCIENCES			English	Article						Driving skills; Minimal hepatic encephalopathy; Insight; Cognitive rehabilitation; Cirrhosis	MINIMAL HEPATIC-ENCEPHALOPATHY; TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; ANOSOGNOSIA; DIAGNOSIS; VEHICLE; REALITY	Minimal hepatic encephalopathy (MHE) is associated with poor driving skills and insight. Increasing insight may improve receptiveness for therapy or driving restrictions. To evaluate the change in the self-assessment of driving skills (SADS) using a driving simulator. Cirrhotic patients and age/education-matched controls underwent MHE testing with inhibitory control (ICT) and the psychometric hepatic encephalopathy score (PHES). SADS, a Likert scale from 0 to 10, was administered just before and after a standardized driving simulation comprising testing and navigation tasks. The percentage SADS change from baseline was compared within/between groups. A total of 84 patients (60% men, age 55 years) and 12 controls were included. Controls were significantly better than cirrhotics on cognitive/simulator testing. The baseline SADS was similar between the groups. The baseline patient SADS was only correlated with ICT lures (r = -0.4, P = 0.001). Post-simulation, 60% of patients improved their insight, i.e., reduced SADS (from 8 to 6.5, P = 0.0001) compared to 25% of controls (P = 0.02). The mean percentage SADS reduction was also higher in cirrhotics (18% vs. 8%, P = 0.03). MHE on ICT patients had a significantly higher SADS improvement (P = 0.004) compared to the other patients; no difference was seen in those with/without MHE due to the PHES. The percentage SADS reduction in patients was correlated with getting lost (r = 0.468, P < 0.0001), crashes (P = 0.002), and centerline/road-edge excursions (P = 0.01). There was a significantly higher percentage SADS reduction in cirrhotics who got lost (25%) compared to those who did not get lost (12%) and controls (8%, P = 0.014). Insight into driving skills in cirrhosis improves after driving simulation and is highest in those with navigation errors and MHE on ICT. Driving simulator-associated insight improvement may be the first step towards the cognitive rehabilitation of driving skills in cirrhosis.	[Bajaj, Jasmohan S.; Heuman, Douglas M.; Sterling, Richard K.; Stravitz, R. Todd; Fuchs, Michael; Sanyal, Arun J.] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23249 USA; [Bajaj, Jasmohan S.; Thacker, Leroy R.; Heuman, Douglas M.; Gibson, Douglas P.; Sterling, Richard K.; Stravitz, R. Todd; Fuchs, Michael; Sanyal, Arun J.; Wade, James B.] McGuire VA Med Ctr, Richmond, VA 23249 USA; [Thacker, Leroy R.] Virginia Commonwealth Univ, Div Biostat, Richmond, VA 23249 USA; [Gibson, Douglas P.; Wade, James B.] Virginia Commonwealth Univ, Div Psychol, Richmond, VA 23249 USA		Bajaj, JS (corresponding author), Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	jsbajaj@vcu.edu	Sterling, Richard/AAV-1598-2020		American College of Gastroenterology (ACG); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK087913]; National Center for Research Resources (NCRR), NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031990]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK087913] Funding Source: NIH RePORTER	This study was partly supported by the American College of Gastroenterology (ACG) Junior Faculty Development Award, R01DK087913 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), and award UL1RR031990 from the National Center for Research Resources (NCRR), NIH.	Antoine C, 2004, ENCEPHALE, V30, P570; Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; Bajaj JS, 2008, CLIN GASTROENTEROL H, V6, P1135, DOI 10.1016/j.cgh.2008.05.025; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P1903, DOI 10.1111/j.1572-0241.2007.01424.x; Bajaj JS, 2011, GASTROENTEROLOGY, V140, P478, DOI 10.1053/j.gastro.2010.08.061; Bajaj JS, 2011, CLIN GASTROENTEROL H, V9, P97, DOI 10.1016/j.cgh.2010.10.031; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; Bajaj JS, 2009, AM J GASTROENTEROL, V104, P898, DOI 10.1038/ajg.2009.7; Bajaj JS, 2011, GASTROENTEROLOGY, V140, pe1; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Cohen SM, 2011, CLIN GASTROENTEROL H, V9, P156, DOI 10.1016/j.cgh.2010.08.002; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Iachini Ina, 2009, Curr Aging Sci, V2, P43; Kircheis G, 2009, GASTROENTEROLOGY, V137, P1706, DOI 10.1053/j.gastro.2009.08.003; Kurz A, 2009, INT J GERIATR PSYCH, V24, P163, DOI 10.1002/gps.2086; Marcotte TD, 2004, NEUROLOGY, V63, P1417, DOI 10.1212/01.WNL.0000141920.33580.5D; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Weniger G, 2011, NEUROPSYCHOLOGIA, V49, P518, DOI 10.1016/j.neuropsychologia.2010.12.031; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038	30	8	8	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	FEB	2012	57	2					554	560		10.1007/s10620-011-1888-3			7	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	881LS	WOS:000299487500041	21901255	Green Accepted			2022-02-06	
J	Asano, Y; Shinoda, J; Okumura, A; Aki, T; Takenaka, S; Miwa, K; Yamada, M; Ito, T; Yokoyama, K				Asano, Yoshitaka; Shinoda, Jun; Okumura, Ayumi; Aki, Tatsuki; Takenaka, Shunsuke; Miwa, Kazuhiro; Yamada, Mikito; Ito, Takeshi; Yokoyama, Kazutoshi			Utility of Fractional Anisotropy Imaging Analyzed by Statistical Parametric Mapping for Detecting Minute Brain Lesions in Chronic-Stage Patients Who Had Mild or Moderate Traumatic Brain Injury	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						diffuse brain injury; diffusion tensor magnetic resonance imaging; fractional anisotropy; statistical parametric mapping; cognitive impairment	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; TENSOR MRI; DAMAGE; METABOLISM; RECOVERY; CT	Diffusion tensor imaging (DTI) has recently evolved as valuable technique to investigate diffuse axonal injury (DAI). This study examined whether fractional anisotropy (FA) images analyzed by statistical parametric mapping (FA-SPM images) are superior to T-2*-weighted gradient recalled echo (T2*GRE) images or fluid-attenuated inversion recovery (FLAIR) images for detecting minute lesions in traumatic brain injury (TB!) patients. DTI was performed in 25 patients with cognitive impairments in the chronic stage after mild or moderate TBI. The FA maps obtained from the DTI were individually compared with those from age-matched healthy control subjects using voxel-based analysis and FA-SPM images (p < 0.001). Abnormal low-intensity areas on T2*GRE images (T2* lesions) were found in 10 patients (40.0%), abnormal high-intensity areas on FLAIR images in 4 patients (16.0%), and areas with significantly decreased FA on FA-SPM image in 16 patients (64.0%). Nine of 10 patients with T2* lesions had FA-SPM lesions. FA-SPM lesions topographically included most T2* lesions in the white matter and the deep brain structures, but did not include T2* lesions in the cortex/near-cortex or lesions containing substantial hemosiderin regardless of location. All 4 patients with abnormal areas on FLAIR images had FA-SPM lesions. FA-SPM imaging is useful for detecting minute lesions because of DAI in the white matter and the deep brain structures, which may not be visualized on T2*GRE or FLAIR images, and may allow the detection of minute brain lesions in patients with post-traumatic cognitive impairment.	[Asano, Yoshitaka; Shinoda, Jun] Gifu Univ, Dept Clin Brain Sci, Grad Sch Med, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Gifu 5050034, Japan; [Asano, Yoshitaka; Shinoda, Jun; Okumura, Ayumi; Aki, Tatsuki; Takenaka, Shunsuke; Miwa, Kazuhiro] Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Dept Neurosurg, Gifu, Japan; [Yamada, Mikito; Ito, Takeshi; Yokoyama, Kazutoshi] Kizawa Mem Hosp, Dept Neurosurg, Gifu, Japan		Asano, Y (corresponding author), Gifu Univ, Dept Clin Brain Sci, Grad Sch Med, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, 630 Shimokobi,Kobi Cho, Gifu 5050034, Japan.	yoasano-nsu@umin.ac.jp					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Konishi J, 2005, NEUROLOGY, V64, P108, DOI 10.1212/01.WNL.0000148477.65273.0C; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Okumura Ayumi, 2005, No To Shinkei, V57, P115; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; STRICH SJ, 1961, LANCET, V2, P443; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	30	8	9	0	7	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2012	52	1					31	40		10.2176/nmc.52.31			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	879SE	WOS:000299351700002	22278025	Bronze			2022-02-06	
J	Colomer, CB; Vergara, FS; Perez, FT; Vasquez, FM; Kunstmann, AH; Fierro, GP; Zenkovich, CS				Bennett Colomer, Carlos; Solari Vergara, Felipe; Tapia Perez, Felipe; Miranda Vasquez, Francisca; Horlacher Kunstmann, Andres; Parra Fierro, Gilda; Salazar Zenkovich, Cristin			Delayed Intracranial Hypertension and Cerebral Edema in Severe Pediatric Head Injury: Risk Factor Analysis	PEDIATRIC NEUROSURGERY			English	Article						Pediatric brain trauma; Diffuse brain edema; Intracranial hypertension	TRAUMATIC BRAIN-INJURY; CHILDREN; AUTOREGULATION; CRANIECTOMY; PRESSURE	Introduction: Diffuse brain edema has been described as a major cause of intracranial hypertension (IH) following traumatic brain injury (TBI), and several studies suggest that it may be more frequent in children than in adults. While most cases of IH following TBI are present from the beginning, several studies have described a subgroup of patients with delayed elevations in intracranial pressure (ICP). Methods: Retrospective review of severe pediatric TBI cases admitted to a single institution during a 6-year period. Patients were classified into three groups, based on the temporal evolution of ICP: patients who evolved without IH, patients who had IH at admission and patients with delayed IH. A risk factor analysis was performed to find differences between these groups. Results: 31 cases of severe pediatric TBI were analyzed. 13 patients were female and 18 male, with an average age of 8.9 years. 4 patients met the described criteria for delayed IH; the only significant risk factor was presence of edema at the initial brain CT (p = 0.008). 3 additional patients presented clinical deterioration after 48 h and signs of brain edema in the CT, after ICP monitoring had been discontinued. Conclusions: Late-onset IH is a relatively common clinical condition in the pediatric population with severe TBI (present in 13% of the cases in our series), and the presence of a Marshall III CT scan at admission is a significant risk factor for this condition. Pediatric patients may benefit from a more prolonged period of ICP monitoring than adults, and the lack of amelioration of brain edema at follow-up brain CT (even with normal ICP values) may be an indication that more prolonged monitoring is needed. Copyright (C) 2013 S. Karger AG, Basel	Valparaiso Univ Valparasio, Sch Med, Hosp Carlos Van Buren, Dept Neurosurg, FR-75011 Paris, France; [Bennett Colomer, Carlos; Solari Vergara, Felipe; Tapia Perez, Felipe; Miranda Vasquez, Francisca; Salazar Zenkovich, Cristin] Univ Valparaiso, Sch Med, Vina Del Mar, Chile; [Bennett Colomer, Carlos; Horlacher Kunstmann, Andres; Parra Fierro, Gilda; Salazar Zenkovich, Cristin] Hosp Carlos Van Buren, Dept Neurosurg, Valparaiso, Chile		Colomer, CB (corresponding author), Valparaiso Univ Valparasio, Sch Med, Hosp Carlos Van Buren, Dept Neurosurg, Blvd Voltaire 30, FR-75011 Paris, France.	Carlos.Bennett@gmail.com					ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Caceres A, 2007, TEC PACIENTES PEDIAT, P23; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; Dias MS, 2004, PEDIATR CLIN N AM, V51, P271, DOI 10.1016/S0031-3955(03)00211-6; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; Souter MJ, 1999, CRIT CARE MED, V27, P177, DOI 10.1097/00003246-199901000-00048; Tasker R.C, 2008, ROGERS TXB PEDIAT IN, P888; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	17	8	8	1	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2012	48	4					205	209		10.1159/000343385			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	220PI	WOS:000324596900001	23571484				2022-02-06	
J	Bhambhani, Y; Forbes, S; Forbes, J; Craven, B; Matsuura, C; Rodgers, C				Bhambhani, Yagesh; Forbes, Scott; Forbes, Janet; Craven, Bruce; Matsuura, Cristiane; Rodgers, Carol			Physiologic Responses of Competitive Canadian Cross-Country Skiers With Disabilities	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						paralympic sport; sitting and standing skiing; oxygen uptake; heart rate; blood lactate	PEAK OXYGEN-UPTAKE; VENTILATORY RESPONSE; BODY-COMPOSITION; EXERCISE; RECOVERY; ERGOMETER; INJURY	Objective: To examine the acute cardiorespiratory and metabolic responses in competitive cross-country skiers with disabilities. Design: Cross-sectional comparisons using a select group of Canadian athletes training for the Vancouver 2010 Paralympic Winter Games. Setting: Canmore Nordic Centre Provincial Park, Canmore, Alberta. Participants: Nine competitive cross-country skiers (4 with visual impairment; 1 with traumatic brain injury, 3 with spinal cord injury, and 1 with cerebral palsy). Interventions: Three-minute and 12-minute exercise tests in the standing or sitting skiing position to voluntary fatigue. Main Outcome Measures: Cardiorespiratory responses using a telemetric system to compare the physiologic responses among the athletes with different disabilities. Heart rate (HR) and capillary lactate were measured at 2, 5, and 10 minutes of recovery. Results: The t test results indicated that the peak values of the absolute and relative oxygen uptake ((V) over dotO(2)peak), HR, and ventilation rate were significantly higher during the 12-minute compared with the 3-minute protocol during standing skiing. However, the oxygen pulse and ventilatory equivalent for oxygen ratio were not significantly (P > 0.05) different between the 2 protocols. Analysis of variance revealed no significant (P > 0.05) differences among the 3 trials for these peak physiologic responses during sitting skiing. Cross-sectional comparisons of the peak physiologic responses between the standing and sitting skiers indicated significantly (P < 0.05) higher values in the standing compared with the sitting position. Cardiorespiratory respiratory efficiency was significantly (P < 0.05) lower in the sitting compared with the standing position. HR during 10 minutes of recovery was significantly correlated with (V) over dotO(2)peak. Pearson correlations were not significant between (V) over dotO(2)peak and lactate removal during recovery. Conclusion: These descriptive findings during the standing and sitting skiing protocols provide preliminary data that would be useful in testing, training, and classification of competitive skiers with disabilities.	[Bhambhani, Yagesh; Forbes, Janet] Univ Alberta, Fac Rehabil Med, Edmonton, AB T6G 2G4, Canada; [Forbes, Scott] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB T6G 2G4, Canada; [Craven, Bruce] Sports Med Council Saskatchewan, Saskatoon, SK, Canada; [Matsuura, Cristiane] Brazilian Anny, Army Sch Phys Educ, Rio De Janeiro, Brazil; [Rodgers, Carol] Univ Saskatchewan, Coll Kinesiol, Saskatoon, SK, Canada		Bhambhani, Y (corresponding author), Univ Alberta, Fac Rehabil Med, Room 373,Corbett Hall, Edmonton, AB T6G 2G4, Canada.	yagesh.bhambhani@ualberta.ca		Matsuura, Cristiane/0000-0002-2317-5781	Own The Podium, Canadian Olympic Committee	Supported by Own The Podium, Canadian Olympic Committee.	American College of Sports Medicine, 2001, ACSMS RES MAN GUID E; Armstrong N, 2011, MED SPORT SCI, V56, P59, DOI 10.1159/000320633; Bernardi M, 2010, MED SCI SPORT EXER, V42, P1200, DOI 10.1249/MSS.0b013e3181c67d82; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bhambhani Y, 1985, Can J Appl Sport Sci, V10, P44; Bhambhani Y., 2011, PARALYMPIC ATHLETE, P51; BHAMBHANI YN, 1995, ARCH PHYS MED REHAB, V76, P713, DOI 10.1016/S0003-9993(95)80524-9; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bortolan L, 2008, J SPORT MED PHYS FIT, V48, P177; Brown J K, 2000, Clin Nurs Res, V9, P84, DOI 10.1177/10547730022158456; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Calbet JAL, 2004, J PHYSIOL-LONDON, V558, P319, DOI 10.1113/jphysiol.2003.059287; Desport JC, 2000, CLIN NUTR, V19, P185, DOI 10.1054/clnu.1999.0122; Doyon KH, 2001, CAN J APPL PHYSIOL, V26, P1, DOI 10.1139/h01-001; Du N, 2005, J SPORT SCI MED, V4, P9; FARIA IE, 1994, J SPORT SCI, V12, P255, DOI 10.1080/02640419408732171; Faria IE, 1996, J SPORT MED PHYS FIT, V36, P1; Forbes Scott C, 2010, N Am J Sports Phys Ther, V5, P40; Haug RC, 1999, MED SCI SPORT EXER, V31, P619, DOI 10.1097/00005768-199904000-00021; Larsson P, 2002, SCAND J MED SCI SPOR, V12, P347, DOI 10.1034/j.1600-0838.2002.01161.x; Mojtahedi MC, 2009, SPINAL CORD, V47, P698, DOI 10.1038/sc.2009.20; Nilsson JE, 2004, EUR J APPL PHYSIOL, V92, P121, DOI 10.1007/s00421-004-1042-4; Pernot HFM, 2011, SPINAL CORD, V49, P935, DOI 10.1038/sc.2011.30; Pyne DB, 2000, EUR J APPL PHYSIOL, V82, P112, DOI 10.1007/s004210050659; Rusko H., 2003, HDB SPORTS MED SCI C; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Wecht JM, 2006, MED SCI SPORT EXER, V38, P1223, DOI 10.1249/01.mss.0000227306.34149.ba; Wisloff U, 1998, MED SCI SPORT EXER, V30, P963, DOI 10.1097/00005768-199806000-00029; Wisloff U, 1998, MED SCI SPORT EXER, V30, P1314, DOI 10.1097/00005768-199808000-00021	29	8	9	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2012	22	1					31	38					8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	878ZS	WOS:000299297700006	22222595				2022-02-06	
J	Bye, N; Turnley, AM; Morganti-Kossmann, MC				Bye, Nicole; Turnley, Ann M.; Morganti-Kossmann, M. Cristina			Inflammatory Regulators of Redirected Neural Migration in the Injured Brain	NEUROSIGNALS			English	Article						Adult neurogenesis; Brain injuries; Cell migration; Chemokines; Growth factors; Inflammation; Neural precursor cells	ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE CELLS; COLONY-STIMULATING FACTOR; OLFACTORY-BULB NEUROGENESIS; CEREBRAL-ARTERY OCCLUSION; P75 NEUROTROPHIN RECEPTOR; RADIAL GLIAL-CELLS; PROGENITOR CELLS; STEM-CELLS	Brain injury following stroke or trauma induces the migration of neuroblasts derived from subventricular zone neural precursor cells (NPCs) towards the damaged tissue, where they then have the potential to contribute to repair. Enhancing the recruitment of new cells thus presents an enticing prospect for the development of new therapeutic approaches to treat brain injury; to this end, an understanding of the factors regulating this process is required. During the neuro-inflammatory response to ischemic and traumatic brain injuries, a plethora of pro- and anti-inflammatory cytokines, chemokines and growth factors are released in the damaged tissue, and recent work indicates that a variety of these are able to influence injury-induced migration. In this review, we will discuss the contribution of specific chemokines and growth factors towards stimulating NPC migration in the injured brain. Copyright (C) 2012 S. Karger AG, Basel	[Bye, Nicole; Morganti-Kossmann, M. Cristina] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Bye, Nicole; Morganti-Kossmann, M. Cristina] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Turnley, Ann M.] Univ Melbourne, Melbourne Brain Ctr, Ctr Neurosci, Melbourne, Vic, Australia		Bye, N (corresponding author), Alfred Hosp, Natl Trauma Res Inst, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	nicole.bye@monash.edu		Turnley, Ann/0000-0002-8442-127X; Morganti-Kossmann, Cristina/0000-0002-0807-2063	Victorian Neurotrauma Initiative and Transport Accident Commission; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was supported by research grants and fellowships to N.B. and C.M.K. by the Victorian Neurotrauma Initiative and Transport Accident Commission, and by a National Health and Medical Research Council Fellowship to A.M.T.	Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Agasse F, 2007, EUR J NEUROSCI, V26, P3036, DOI 10.1111/j.1460-9568.2007.05915.x; Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bagley JA, 2010, NEUROSCIENCE, V169, P1449, DOI 10.1016/j.neuroscience.2010.05.075; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Baldauf K, 2005, BRAIN RES, V1056, P158, DOI 10.1016/j.brainres.2005.07.035; Barrett GL, 2005, NEUROSCIENCE, V133, P381, DOI 10.1016/j.neuroscience.2005.01.067; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Bath KG, 2010, DEV NEUROBIOL, V70, P339, DOI 10.1002/dneu.20781; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Berman JW, 1996, J IMMUNOL, V156, P3017; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Catts VS, 2008, EUR J NEUROSCI, V28, P883, DOI 10.1111/j.1460-9568.2008.06390.x; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; Craig CG, 1996, J NEUROSCI, V16, P2649; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dayer AG, 2007, BRAIN, V130, P2962, DOI 10.1093/brain/awm200; DEMETRI GD, 1991, BLOOD, V78, P2791; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Donovan MH, 2008, HIPPOCAMPUS, V18, P435, DOI 10.1002/hipo.20410; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Fallon J, 2001, P NATL ACAD SCI USA, V98, P8157; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; Ganat Y, 2002, NEUROSCIENCE, V112, P977, DOI 10.1016/S0306-4522(02)00060-X; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; GOMEZPINILLA F, 1995, J NEUROSCI, V15, P2021, DOI 10.1523/JNEUROSCI.15-03-02021.1995; Gonzalez-Perez O, 2009, STEM CELLS, V27, P3122, DOI 10.1002/stem.267; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Gordon RJ, 2012, EXP NEUROL, V233, P587, DOI 10.1016/j.expneurol.2011.11.029; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Grimm I, 2010, ACTA PHYSIOL, V199, P181, DOI 10.1111/j.1748-1716.2010.02092.x; Gritti A, 1999, J NEUROSCI, V19, P3287; Hagihara K, 2009, DEV BIOL, V334, P276, DOI 10.1016/j.ydbio.2009.07.029; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hastings NB, 1999, J COMP NEUROL, V415, P144; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Killian ECO, 2009, DEV BIOL, V333, P161, DOI 10.1016/j.ydbio.2009.06.031; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008122; Knerlich-Lukoschus F, 2010, GLIA, V58, P916, DOI 10.1002/glia.20974; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lalor SJ, 2010, J NEUROIMMUNOL, V224, P56, DOI 10.1016/j.jneuroim.2010.05.017; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Leong SY, 2011, NEUROCHEM INT, V59, P382, DOI 10.1016/j.neuint.2010.12.024; Li MZ, 2011, GLIA, V59, P108, DOI 10.1002/glia.21080; Li SF, 2009, NEUROSURGERY, V65, P771, DOI 10.1227/01.NEU.0000349931.61771.52; Li SY, 2010, NEUROSCI RES, V67, P293, DOI 10.1016/j.neures.2010.04.006; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Liu XS, 2008, BRAIN RES, V1226, P18, DOI 10.1016/j.brainres.2008.06.013; Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Magge SN, 2009, J NEUROSCI RES, V87, P1547, DOI 10.1002/jnr.21983; Mahmood A., 2009, NEUROSURGERY, V65, P191, DOI DOI 10.1227/01.NEU.0000343540.24780.D6; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Marti HH, 1997, KIDNEY INT, V51, P416, DOI 10.1038/ki.1997.55; Martinez R, 2011, EUR J NEUROSCI, V33, P26, DOI 10.1111/j.1460-9568.2010.07490.x; Masumura M, 1996, NEUROSCI LETT, V213, P119, DOI 10.1016/0304-3940(96)12841-X; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Monfils MH, 2006, EUR J NEUROSCI, V24, P739, DOI 10.1111/j.1460-9568.2006.04939.x; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Ni HT, 2004, DEV BRAIN RES, V152, P159, DOI 10.1016/j.devbrainres.2004.06.015; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Ohab JJ, 2008, NEUROSCIENTIST, V14, P369, DOI 10.1177/1073858407309545; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Petraglia AL, 2010, NEUROSURGERY, V66, P165, DOI 10.1227/01.NEU.0000363148.49779.68; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Ransome MI, 2007, J NEUROCHEM, V102, P1953, DOI 10.1111/j.1471-4159.2007.04684.x; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ridet JL, 1998, TRENDS NEUROSCI, V21, P80; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Robinson CJ, 2001, J CELL SCI, V114, P853; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Smith C, 2001, EUR J NEUROSCI, V13, P443, DOI 10.1046/j.1460-9568.2001.01400.x; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; TAKAMI K, 1992, EXP BRAIN RES, V90, P1; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tiveron MC, 2010, J NEUROIMMUNOL, V224, P72, DOI 10.1016/j.jneuroim.2010.05.011; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033; Vrotsos EG, 2009, CELL MOL NEUROBIOL, V29, P373, DOI 10.1007/s10571-008-9329-3; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; WOODWARD WR, 1992, J NEUROSCI, V12, P142; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Yu T, 2010, J NEUROSCI RES, V88, P2775, DOI 10.1002/jnr.22454; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	212	8	8	0	12	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1424-862X	1424-8638		NEUROSIGNALS	Neurosignals		2012	20	3					132	146		10.1159/000336542			15	Biochemistry & Molecular Biology; Biophysics; Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology; Neurosciences & Neurology	953TC	WOS:000304895100002	22456466	gold			2022-02-06	
J	Chen, J; Jin, H; Zhang, Y; Liang, QZ; Liao, HY; Guo, ZY; Han, XJ				Chen, Jing; Jin, Hu; Zhang, Ying; Liang, Qizhou; Liao, Haiyan; Guo, Ziyi; Han, Xiangjun			MRS and diffusion tensor image in mild traumatic brain injuries	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Mild trauma brain injures; Magnetic resonance spectroscopy; Diffusion tensor image; Fractional anisotropic mapping		Objective: To analyze characters of magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) in the diagnosis of mild trauma brain injuries (MTBI) in frontal lobe and to compare with conventional magnetic resonance imaging (MRI). Methods: A total of 21 patients were selected, who all aged 12-51 years old and had injury within 24 hours. Computer tomography (CT) and the Glasgow Coma Scale were used to evaluate the degree of injury. All patients were diagnosed as MTBI, and 19 had conventional MRI, MRS and DTI. The major parameters of MRS weir Probe-P sequence, TE = 144 or 35 ms, and both single voxel spectrum and chemical shift imging were included. The major parameters of DTI were diffusion directions =15, b value = 1.000 s/mm(2). Frational anisotropic (FA) map and average ADC map were obtained to evaluate DTI result. Positive detetion ratio was observed and the imaging changes were compared between injured side and normal side. Results: All 21 patients had CT scan and Glasgow scale. A total of 19 patients had conventional MRI. DTI and MRS. Results of CT and conventional MRI showed no significant abnormality in lobe, and Glasgow scale showed mild type. MRS result showed significant decrease in N-acetyl aspartate (NAA) and NAA/creatine (Cr) in 13 eases (68.4%) (P < 0.001), and increase in lactic acid (Lac) in 7 cases (36.8%). FA mapping of the frontal lobe displayed significant changes in 7 cases (36.8%), with 5 out of the 7 cases having increase in FA value. And there was no significant difference in average ADC. Conclusions: MRS and DTI might be more sensible than other methods, such as CT and conventional MRI in diagnosis of MTBI. The particular changes were reduced NAA and increased Lac for MRS, and increased FA values for DTI.	[Chen, Jing; Jin, Hu; Zhang, Ying; Liang, Qizhou; Liao, Haiyan; Guo, Ziyi; Han, Xiangjun] Municipal Hosp HaiKou, Dept Radiol, Haikou 570208, Hainan Province, Peoples R China		Han, XJ (corresponding author), Municipal Hosp HaiKou, Dept Radiol, Haikou 570208, Hainan Province, Peoples R China.	jilinhxj@163.com			Science Foundation of Haikou Health Bureau [2010-SWY-13-058]; Haikou Science Technology Information Bureu [2009-049-1]	This work was supported by the Science Foundation of Haikou Health Bureau (2010-SWY-13-058) and Haikou Science Technology Information Bureu (2009-049-1).	Abhiram Chakraborty, 2011, Asian Pacific Journal of Tropical Disease, V1, P206, DOI 10.1016/S2222-1808(11)60029-7; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	11	8	12	0	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1995-7645	2352-4146		ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	JAN	2012	5	1					67	70		10.1016/S1995-7645(11)60248-4			4	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	878NU	WOS:000299264600013	22182647	gold			2022-02-06	
J	Hopkins, RO; Jackson, JC				Hopkins, Ramona O.; Jackson, James C.			Neuroimaging after critical illness: Implications for neurorehabilitation outcome	NEUROREHABILITATION			English	Article						Critical illness; cognitive impairment; neuroimaging; ICU; lesions	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; CARE-UNIT SURVIVORS; QUALITY-OF-LIFE; PROLONGED MECHANICAL VENTILATION; COGNITIVE IMPAIRMENT; SEPTIC ENCEPHALOPATHY; DELIRIUM DURATION; FUNCTIONAL STATUS; IMAGING FINDINGS	Survivors of critical illness frequently have severe and long-lasting cognitive impairments and psychiatric disorders, which adversely affect functional outcomes including return to work, and quality of life. While data regarding cognitive outcomes has increased over the last 15 years, neuroimaging data in medical and surgical critical populations is extremely limited. The abrupt development of new significant cognitive impairments after critical illness along with abnormalities on neuroimaging suggest that critical illness results in new acquired brain injury, similar to that observed in other acquired brain injuries. Abnormalities on neuroimaging including cortical and subcortical lesions, brain atrophy, and white matter hyperintensities (WMH) which occur in widely distributed brain regions. Patients admitted to neurorehabilitation who received critical care related to their primary diagnosis may have sustained neurological injury from the nonspecific effects of their critical illness and as demonstrated in this review, generalized, non-specific neuroimaging findings may be observed and quantified. Given the high prevalence rate of cognitive impairments in this population, neuroimaging is important to help elucidate neuropathology of critical illness acquired brain injury and may be beneficial in guiding rehabilitation outcomes in this population.	[Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84093 USA; [Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84093 USA; [Hopkins, Ramona O.] Intermt Med Ctr, Murray, UT USA; [Jackson, James C.] Vanderbilt Univ, Sch Med, Div Allergy Pulm Crit Care Med, Nashville, TN 37212 USA; [Jackson, James C.] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA		Hopkins, RO (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84093 USA.	mona_hopkins@byu.edu			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG031322] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23 AG031322] Funding Source: Medline		Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bozza FA, 2010, J CEREBR BLOOD F MET, V30, P440, DOI 10.1038/jcbfm.2009.215; Breteler MMB, 2011, JAMA-J AM MED ASSOC, V305, P304, DOI 10.1001/jama.2010.2017; Chen SY, 2011, J FORMOS MED ASSOC, V110, P572, DOI 10.1016/j.jfma.2011.07.008; Chiang LL, 2006, PHYS THER, V86, P1271, DOI 10.2522/ptj.20050036; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Finelli PF, 2004, J NEUROL NEUROSUR PS, V75, P1189, DOI 10.1136/jnnp.2003.030833; Grimmer T., 2012, NEUROBIOLOGY AGING; Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0; Guo JT, 2002, J NEUROSCI, V22, P5900; Hollinger P, 2000, J NEUROL, V247, P232, DOI 10.1007/s004150050573; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hopkins RO, 2010, BRAIN INJURY, V24, P1478, DOI 10.3109/02699052.2010.506861; Hopkins RO, 2009, CLIN CHEST MED, V30, P143, DOI 10.1016/j.ccm.2008.11.001; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 2006, BRAIN INJURY, V20, P263, DOI 10.1080/02699050500488199; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P1005, DOI 10.1017/S135561770410711X; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; JACKSON AC, 1985, CAN J NEUROL SCI, V12, P303, DOI 10.1017/S0317167100035381; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Jackson JC, 2009, SOUTH MED J, V102, P1150, DOI 10.1097/SMJ.0b013e3181b6a592; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KISHI Y, 1995, GEN HOSP PSYCHIAT, V17, P371, DOI 10.1016/0163-8343(95)00056-W; Lerner D M, 2000, Semin Clin Neuropsychiatry, V5, P98; Little DM, 2010, NEUROREHABILITATION, V26, P15, DOI 10.3233/NRE-2010-0532; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Morandi A, 2012, CRIT CARE MED, V40, P2182, DOI 10.1097/CCM.0b013e318250acdc; Morandi Alessandro, 2010, Psychiatry (Edgmont), V7, P28; Piazza O, 2009, NEUROCHEM RES, V34, P1289, DOI 10.1007/s11064-008-9907-2; Senthilkumar S, 2008, BIOCHEM J, V415, P207, DOI 10.1042/BJ20071696; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Suchyta MR, 2010, BRAIN IMAGING BEHAV, V4, P22, DOI 10.1007/s11682-009-9082-3; Wadghiri YZ, 2012, METHODS MOL BIOL, V849, P435, DOI 10.1007/978-1-61779-551-0_30; Warren DE, 2012, CLIN NEUROPSYCHOL, V26, P335, DOI 10.1080/13854046.2012.655781; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; YOUNG GB, 1990, CLIN INVEST MED, V13, P297	42	8	8	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	31	3					311	318		10.3233/NRE-2012-0798			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	028QC	WOS:000310436200007	23093457	Green Accepted			2022-02-06	
J	Jezierski, A; Rennie, K; Tremblay, R; Zurakowski, B; Gruslin, A; Sikorska, M; Bani-Yaghoub, M				Jezierski, Anna; Rennie, Kerry; Tremblay, Roger; Zurakowski, Bogdan; Gruslin, Andree; Sikorska, Marianna; Bani-Yaghoub, Mahmud			Human Amniotic Fluid Cells Form Functional Gap Junctions with Cortical Cells	STEM CELLS INTERNATIONAL			English	Article							NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; IN-VITRO; NEURONAL DIFFERENTIATION; CONNEXIN EXPRESSION; CULTURED ASTROCYTES; SCIATIC-NERVE; RAT MODEL; TRANSPLANTATION; MOUSE	The usage of stem cells is a promising strategy for the repair of damaged tissue in the injured brain. Recently, amniotic fluid (AF) cells have received a lot of attention as an alternative source of stem cells for cell-based therapies. However, the success of this approach relies significantly on proper interactions between graft and host tissue. In particular, the reestablishment of functional brain networks requires formation of gap junctions, as a key step to provide sufficient intercellular communication. In this study, we show that AF cells express high levels of CX43 (GJA1) and are able to establish functional gap junctions with cortical cultures. Furthermore, we report an induction of Cx43 expression in astrocytes following injury to the mouse motor cortex and demonstrate for the first time CX43 expression at the interface between implanted AF cells and host brain cells. These findings suggest that CX43-mediated intercellular communication between AF cells and cortical astrocytes may contribute to the reconstruction of damaged tissue by mediating modulatory, homeostatic, and protective factors in the injured brain and hence warrants further investigation.	[Jezierski, Anna; Rennie, Kerry; Tremblay, Roger; Zurakowski, Bogdan; Sikorska, Marianna; Bani-Yaghoub, Mahmud] Natl Res Council Canada, Inst Biol Sci, Neurobiol Program, Neurogenesis & Brain Repair Grp, Ottawa, ON K1A 0R6, Canada; [Jezierski, Anna; Gruslin, Andree; Bani-Yaghoub, Mahmud] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Gruslin, Andree] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, Ottawa, ON K1H 8M5, Canada		Bani-Yaghoub, M (corresponding author), Natl Res Council Canada, Inst Biol Sci, Neurobiol Program, Neurogenesis & Brain Repair Grp, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	mahmud.bani@nrc.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ontario Graduate Scholarship (OGS)Ontario Graduate Scholarship	The authors would like to thank Julie Haukenfrers, Amy Aylsworth, Maria Ribecco, Brandon Smith, and John Bechberger for their technical assistance. A. Jezierski has been funded by the Canadian Institutes of Health Research (CIHR) and the Ontario Graduate Scholarship (OGS).	Bani-Yaghoub M, 1999, DEV GENET, V24, P69, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<69::AID-DVG8>3.0.CO;2-M; Bani-Yaghoub M, 1999, EXP NEUROL, V156, P16, DOI 10.1006/exnr.1998.6950; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bani-Yaghoub M, 2008, BIOCHEM CELL BIOL, V86, P361, DOI [10.1139/O08-116, 10.1139/o08-116]; BaniYaghoub M, 1997, J NEUROSCI RES, V49, P19, DOI 10.1002/(SICI)1097-4547(19970701)49:1<19::AID-JNR3>3.0.CO;2-G; Belliveau DJ, 1997, DEV GENET, V21, P187, DOI 10.1002/(SICI)1520-6408(1997)21:3<187::AID-DVG2>3.0.CO;2-3; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Chitty DW, 2012, J NEUROSCI METH, V205, P17, DOI 10.1016/j.jneumeth.2011.12.007; Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; DERMIETZEL R, 1991, INT REV CYTOL, V127, P57; Dermietzel R, 1998, BRAIN RES REV, V26, P176, DOI 10.1016/S0165-0173(97)00031-3; Di WL, 2001, J INVEST DERMATOL, V117, P958, DOI 10.1046/j.0022-202x.2001.01468.x; Donaldson AE, 2009, STEM CELLS DEV, V18, P1003, DOI 10.1089/scd.2008.0300; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Gekas J, 2010, CLIN EXP MED, V10, P1, DOI 10.1007/s10238-009-0060-2; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Giaume C, 1997, GLIA, V21, P114; Guan XA, 2011, J TISSUE ENG REGEN M, V5, P220, DOI 10.1002/term.308; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Homkajorn B, 2010, NEUROSCI LETT, V486, P197, DOI 10.1016/j.neulet.2010.09.051; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jaderstad J, 2011, EXP CELL RES, V317, P70, DOI 10.1016/j.yexcr.2010.07.011; Jaderstad J, 2010, P NATL ACAD SCI USA, V107, P5184, DOI 10.1073/pnas.0915134107; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945; Kim J, 2007, CELL PROLIFERAT, V40, P75; Kirchhoff F, 2001, EUR ARCH PSY CLIN N, V251, P159, DOI 10.1007/s004060170036; Kornyei Z, 2000, J NEUROSCI RES, V61, P421, DOI 10.1002/1097-4547(20000815)61:4<421::AID-JNR8>3.0.CO;2-4; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Maeda S, 2011, CELL MOL LIFE SCI, V68, P1115, DOI 10.1007/s00018-010-0551-z; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Pan HC, 2006, J CLIN NEUROSCI, V13, P570, DOI 10.1016/j.jocn.2005.06.007; Pan HC, 2009, NEUROCHEM RES, V34, P518, DOI 10.1007/s11064-008-9815-5; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Rosner M, 2012, AMINO ACIDS, V42, P1591, DOI 10.1007/s00726-011-0929-8; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shurman DL, 2005, INVEST OPHTH VIS SCI, V46, P1957, DOI 10.1167/iovs.04-1364; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Tay LL, 2011, ANALYST, V136, P1620, DOI 10.1039/c0an00897d; Toselli M, 2008, NAT BIOTECHNOL, V26, P269, DOI 10.1038/nbt0308-269; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Valli A, 2010, ONCOGENE, V29, P966, DOI 10.1038/onc.2009.405; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Yeh YC, 2010, TISSUE ENG PT A, V16, P1925, DOI [10.1089/ten.tea.2009.0728, 10.1089/ten.TEA.2009.0728]; Zhang P, 2009, STEM CELLS DEV, V18, P1299, DOI 10.1089/scd.2008.0331; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	67	8	8	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-966X	1687-9678		STEM CELLS INT	Stem Cells Int.		2012	2012								607161	10.1155/2012/607161			16	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	209QP	WOS:000323774900001	22792116	Green Published, gold, Green Submitted			2022-02-06	
J	Oliviero, A; Arevalo-Martin, A; Rotondi, M; Garcia-Ovejero, D; Mordillo-Mateos, L; Lozano-Sicilia, A; Panyavin, I; Chiovato, L; Aguilar, J; Foffani, G; Di Lazzaro, V; Molina-Holgado, E				Oliviero, A.; Arevalo-Martin, A.; Rotondi, M.; Garcia-Ovejero, D.; Mordillo-Mateos, L.; Lozano-Sicilia, A.; Panyavin, I.; Chiovato, L.; Aguilar, J.; Foffani, G.; Di Lazzaro, V.; Molina-Holgado, E.			CB1 receptor antagonism/inverse agonism increases motor system excitability in humans	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article						Transcranial magnetic stimulation; Motor cortex; CB1; Rimonabant; Spinal cord	TRANSCRANIAL MAGNETIC STIMULATION; SPINAL LOCOMOTOR CIRCUITRY; I-WAVE INTERACTION; CONSCIOUS HUMANS; CANNABINOID RECEPTOR; CORTICOCORTICAL INHIBITION; ENDOCANNABINOID SYSTEM; VOLUNTARY CONTRACTION; CORTICAL EXCITABILITY; SYNAPTIC PLASTICITY	CB1 receptor is highly expressed in cerebral structures related to motor control, such as motor cortex, basal ganglia and cerebellum. In the spinal cord, the expression of CB1 receptors has also been observed in ventral motor neurons, interneurons and primary afferents, i.e., in the cells that may be part of the circuits involved in motor control. It is known that the antagonist/inverse agonist of CB1 receptors Rimonabant penetrates the blood brain barrier and produces a broad range of central psychoactive effects in humans. Based on the occurrence of central effects in humans treated with Rimonabant and on the location of CB1 receptors, we hypothesized that the application of Rimonabant can also affect the motor system. We tested the effects of a single dose of 20 mg of Rimonabant on the excitability of motor cortex and of spinal motor neurons in order to detect a possible drug action on motor system at cortical and spinal levels. For this purpose we use classical protocols of transcranial magnetic and electrical stimulation (TMS and TES). Single and paired pulse TMS and TES were used to assess a number of parameters of cortical inhibition and cortical excitability as well as of the excitability of spinal motor neurons. We demonstrated that a single oral dose of 20 mg of Rimonabant can increase motor system excitability at cortical and spinal levels. This opens new avenues to test the CB1R antagonists/inverse agonists for the treatment of a number of neurological dysfunctions in which can be useful to increase the excitability levels of motor system. Virtually all the disorders characterized by a reduced output of the motor cortex can be included in the list of the disorders that can be treated using CB1 antagonists/reverse agonists (e.g. stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, fatigue syndromes, parkinsonisms, etc.). (C) 2011 Elsevier B.V. and ECNP. All rights reserved.	[Oliviero, A.; Mordillo-Mateos, L.; Lozano-Sicilia, A.; Panyavin, I.] Hosp Nacl Paraplejicos, FENNSI Grp, SESCAM, Toledo 45071, Spain; [Arevalo-Martin, A.; Garcia-Ovejero, D.; Molina-Holgado, E.] Hosp Nacl Paraplejicos, Lab Neuroinflammat, SESCAM, Unidad Neurol Expt, Toledo 45071, Spain; [Rotondi, M.; Chiovato, L.] Univ Pavia, Unit Internal Med & Endocrinol, Fdn Salvatore Maugeri IRCCS, I-27100 Pavia, Italy; [Aguilar, J.; Foffani, G.] Hosp Nacl Paraplejicos, Neurosignals Grp, SESCAM, Toledo 45071, Spain; [Di Lazzaro, V.] Univ Cattolica, Inst Neurol, Rome, Italy		Oliviero, A (corresponding author), Hosp Nacl Paraplejicos, FENNSI Grp, SESCAM, Finca La Peraleda S-N, Toledo 45071, Spain.	antonioo@sescam.jccm.es	Chiovato, Luca/K-6617-2016; Mordillo-Mateos, Laura/M-2548-2014; Aguilar, Juan/N-3850-2019; Oliviero, Antonio/ABH-4485-2020; Foffani, Guglielmo/ABD-5897-2020; Rotondi, Mario/K-5250-2016; Arevalo-Martin, Angel/A-5376-2011; Molina-Holgado, Eduardo/C-2714-2008; Garcia-Ovejero, Daniel/H-9090-2019; Aguilar, Juan/Q-2206-2015; Di Lazzaro, Vincenzo/L-3731-2018; chiovato, luca/AAC-9003-2019	Chiovato, Luca/0000-0001-7457-7353; Mordillo-Mateos, Laura/0000-0003-3754-2279; Aguilar, Juan/0000-0002-8070-3923; Oliviero, Antonio/0000-0001-7723-0478; Rotondi, Mario/0000-0001-6464-2334; Molina-Holgado, Eduardo/0000-0001-6693-1682; Garcia-Ovejero, Daniel/0000-0002-7479-5104; Aguilar, Juan/0000-0002-8070-3923; Di Lazzaro, Vincenzo/0000-0002-9113-5925; Foffani, Guglielmo/0000-0001-7289-6668; Arevalo-Martin, Angel/0000-0002-0549-6098	Fundacion Hospital Nacional de Paraplejicos	This study was funded by the Fundacion Hospital Nacional de Paraplejicos. The Fundacion Hospital Nacional de Paraplejicos had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the paper for publication.	Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clarke RW, 2001, NEUROPHARMACOLOGY, V40, P570, DOI 10.1016/S0028-3908(00)00179-9; Di Lazzaro V, 1999, EXP BRAIN RES, V129, P494, DOI 10.1007/s002210050919; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P525, DOI 10.1007/s002210050649; Di Lazzaro V, 2003, J PHYSIOL-LONDON, V547, P485, DOI 10.1113/jphysiol.2002.030486; Di Lazzaro V, 2002, CLIN NEUROPHYSIOL, V113, P1673, DOI 10.1016/S1388-2457(02)00264-X; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Di Marzo F, 2008, DRUG DISCOVERY, V7, P438; El Manira A, 2008, BRAIN RES REV, V57, P29, DOI 10.1016/j.brainresrev.2007.06.020; Farquhar-Smith WP, 2000, MOL CELL NEUROSCI, V15, P510, DOI 10.1006/mcne.2000.0844; Fernandez-Ruiz J, 2009, BRIT J PHARMACOL, V156, P1029, DOI 10.1111/j.1476-5381.2008.00088.x; Fitzgerald PB, 2009, NEUROPSYCHOPHARMACOL, V34, P2368, DOI 10.1038/npp.2009.71; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; GILBERT PE, 1981, J CLIN PHARMACOL, V21, pS311, DOI 10.1002/j.1552-4604.1981.tb02609.x; GOUGH AL, 1977, PSYCHOPHARMACOLOGY, V54, P87, DOI 10.1007/BF00426547; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hegyi Z, 2009, EUR J NEUROSCI, V30, P251, DOI 10.1111/j.1460-9568.2009.06816.x; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Kyriakatos A, 2007, J NEUROSCI, V27, P12664, DOI 10.1523/JNEUROSCI.3174-07.2007; Moreira F., 2009, REV BRASILEIRA PSIQU, V31; Ong WY, 1999, J NEUROCYTOL, V28, P39, DOI 10.1023/A:1007011700677; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Petro D. J., 1981, J CLIN PHARMACOL, P413; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Romero J, 2002, MOL BRAIN RES, V100, P85; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; TRAMPOSCH A, 1981, NEUROPHARMACOLOGY, V20, P617, DOI 10.1016/0028-3908(81)90217-3; Turkanis A., 1983, LIFE SCI, V32, P1675; Turkanis A., 1983, BRAIN RES, V288, P283; Turkanis A., 1986, PHARM BIOCH BEHAV, V25, P89; VALLSSOLE J, 1992, ELECTROEN CLIN NEURO, V85, P355, DOI 10.1016/0168-5597(92)90048-G; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Ziemann U, 1998, J PHYSIOL-LONDON, V511, P181, DOI 10.1111/j.1469-7793.1998.181bi.x; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 1998, ELECTROMYOGR MOTOR C, V109, P321, DOI 10.1016/S0924-980X(98)00023-X; Ziemann U, 1996, EXP BRAIN RES, V109, P127	49	8	8	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-977X			EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	JAN	2012	22	1					27	35		10.1016/j.euroneuro.2011.04.004			9	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	881DO	WOS:000299460900003	21571507				2022-02-06	
J	Omu, O; Reynolds, F				Omu, Onutobor; Reynolds, Frances			Health professionals' perceptions of cultural influences on stroke experiences and rehabilitation in Kuwait	DISABILITY AND REHABILITATION			English	Article						culture; stroke; Kuwait; Middle East; rehabilitation	TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; MENTAL-HEALTH; BELIEFS; ETHNICITY; MEDICINE; PEOPLE; NEEDS	Purpose: The aim of this study was to investigate the perceptions of health professionals who treat stroke patients in Kuwait regarding cultural influences on the experience of stroke and rehabilitation in Kuwait. Health professionals interviewed were from a variety of cultural backgrounds thus providing an opportunity to investigate how they perceived the influence of culture on stroke recovery and rehabilitation in Kuwait. Method: Semi-structured interviews were carried out with 12 health professionals with current/recent stroke rehabilitation experience in Kuwait, followed by thematic analysis of the verbatim transcripts. Results: The health professionals identified several features of the Kuwaiti culture that they believed affected the experiences of stroke patients. These were religious beliefs, family involvement, limited education and public information about stroke, prevailing negative attitudes toward stroke, access to finances for private treatment, social stigma and the public invisibility of disabled people, difficulties identifying meaningful goals for rehabilitation, and an acceptance of dependency linked with the widespread presence of maids and other paid assistants in most Kuwaiti homes. Conclusion: To offer culturally sensitive care, these issues should be taken into account during the rehabilitation of Kuwaiti stroke patients in their home country and elsewhere.	[Omu, Onutobor; Reynolds, Frances] Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge UB8 3PH, Middx, England		Reynolds, F (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge UB8 3PH, Middx, England.	frances.reynolds@brunel.ac.uk		Reynolds, Frances/0000-0001-7228-6931			Aflakseir A, 2009, MENT HEALTH RELIG CU, V12, P175, DOI 10.1080/13674670802428563; Al-Jarallah KF, 2009, INT NURS REV, V56, P65, DOI 10.1111/j.1466-7657.2008.00654.x; Al-Krenawi A, 2000, HEALTH SOC WORK, V25, P9, DOI 10.1093/hsw/25.1.9; ANDERSON JM, 1993, ARCH PHYS MED REHAB, V74, P574, DOI 10.1016/0003-9993(93)90154-3; [Anonymous], 2011, ENCY BRITANNICA; Crabtree SA, 2007, DISABIL SOC, V22, P49, DOI 10.1080/09687590601056618; Balcazar F, 2010, CULTURE DISABILITY R; Bham Z, 2005, ETHNIC DIS, V15, P548; Bhui K, 2008, J MENT HEALTH, V17, P141, DOI 10.1080/09638230701498408; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cardol M, 2002, DISABIL REHABIL, V24, P970, DOI 10.1080/09638280210151996; Coyne C, 2001, PT MAGAZINE PHYS THE, V10, P49; Coyne C, 2001, PT MAGAZINE PHYS THE, V10, P44; Dean E, 2006, DEV CULTURAL COMPETE, P260; Dressler D, 2009, DISABIL REHABIL, V31, P1181, DOI 10.1080/09638280902773786; Endrawes G, 2007, INT J MENT HEALTH NU, V16, P178, DOI 10.1111/j.1447-0349.2007.00465.x; Gallagher E, 2001, CURR SOCIOL, V49, P231; Gallaher CK, 2001, REHABIL PSYCHOL, V46, P312, DOI 10.1037/0090-5550.46.3.312; Gard G, 2005, EUR J PHYSIOTHER, V7, P20, DOI 10.1080/14038190510009432; Goffman E., 1963, STIGMA NOTES MANAGEM; Haggstrum T M, 1995, J Transcult Nurs, V7, P15, DOI 10.1177/104365969500700103; Loewenthal KM, 2001, BRIT J MED PSYCHOL, V74, P293, DOI 10.1348/000711201160993; LOEWENTHAL KM, 1999, TRANSCULT PSYCHIATRY, V36, P491, DOI DOI 10.1177/136346159903600408; Mason J., 2002, QUALITATIVE RES; Matheson D, 2009, DISABIL REHABIL, V31, P1191, DOI 10.1080/09638280902773794; Meyer M, 2007, DISABIL SOC, V22, P595, DOI 10.1080/09687590701560204; Murray CD, 2004, DISABIL REHABIL, V26, P808, DOI 10.1080/09638280410001696746; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Norris Meriel, 2008, DIVERSITY HLTH SOCIA, V5, P151; O'Connell B, 2001, J Qual Clin Pract, V21, P120, DOI 10.1046/j.1440-1762.2001.00426.x; Pargament KI, 2001, ARCH INTERN MED, V161, P1881, DOI 10.1001/archinte.161.15.1881; Rhodes PJ, 2008, ETHNIC HEALTH, V13, P1, DOI 10.1080/13557850701803031; Shah M A, 1990, J Allied Health, V19, P117; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Subgranon R, 2000, J Transcult Nurs, V11, P166, DOI 10.1177/104365960001100302; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Wickford J, 2008, DISABIL REHABIL, V30, P305, DOI 10.1080/09638280701257205; Yamey G, 2004, DISABIL REHABIL, V26, P455, DOI 10.1080/09638280410001663021; Zou X, 2009, J PERS SOC PSYCHOL, V97, P579, DOI 10.1037/a0016399	39	8	13	4	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2012	34	2					119	127		10.3109/09638288.2011.591883			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	855UR	WOS:000297591400004	21951231	Green Accepted			2022-02-06	
J	Rackley, C; Allen, DN; Fuhrman, LJ; Mayfield, J				Rackley, Christopher; Allen, Daniel N.; Fuhrman, Laura J.; Mayfield, Joan			Generalizability of WISC-IV index and subtest score profiles in children with traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						WISC-IV; Traumatic brain injury; Processing speed index; Children; Assessment; Neuropsychology	WECHSLER INTELLIGENCE SCALE; HEAD-INJURY; CRITERION VALIDITY; PATTERNS; SUBTYPES; EDITION; SIMILARITIES; MEMORY	The Wechsler Intelligence Scale for Children, 4th edition (WISC-IV) is often used to assess children with traumatic brain injury (TBI); although limited information is available regarding its psychometric properties in these children. Two recent reports suggest that the Perceptual Reasoning Index is not uniquely sensitive to TBI, which differs from the Perceptual Organization Index of the WISC-III. The current study examined WISC-IV profiles in two independently gathered samples of children with TBI. Examination of profiles indicated similarities between the current findings and those reported in other studies, in that the greatest deficits were present on the Processing Speed Index and its component subtests of Coding and Symbol Search, while the Perceptual Reasoning index score was comparable to the Verbal Comprehension Index. Also, no significant index or subtest score differences were present when the current sample was compared to the children with TBI reported by Allen, Thaler, Donohue and Mayfield (2010). The present findings are consistent with two prior studies of the WISC-IV in children with TBI, providing additional evidence for profile differences between the WISC-III and WISC-IV. The results also suggest that WISC-IV profiles reported in prior studies are generalizable across TBI samples and study sites.	[Rackley, Christopher] Blythedale Childrens Hosp, Dept Psychiat Psychol, Valhalla, NY 10595 USA; [Allen, Daniel N.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Fuhrman, Laura J.] Ferkauf Grad Sch Psychol, Bronx, NY USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Rackley, C (corresponding author), Blythedale Childrens Hosp, Dept Psychiat Psychol, 95 Bradhurst Ave, Valhalla, NY 10595 USA.	Christopherr@blythedale.org		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 2008, J CLIN EXP NEUROPSYC, V30, P741, DOI 10.1080/13803390701689595; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Fiorello CA, 2007, APPL NEUROPSYCHOL, V14, P2, DOI 10.1080/09084280701280338; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Kay JB, 1999, J CLIN EXP NEUROPSYC, V21, P186, DOI 10.1076/jcen.21.2.186.927; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Wechsler D., 2003, WISC 4 TECHNICAL INT	22	8	8	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.		2012	18	5					512	519		10.1080/09297049.2011.628308			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	984ZF	WOS:000307231800007	22103451				2022-02-06	
J	Rivara, FP				Rivara, Frederick P.			Prevention of death and disability from injuries to children and adolescents	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						epidemiologic transition; injuries; children; adolescents	TRAUMATIC BRAIN-INJURY; SYSTEMATIC ANALYSIS; CENTER CARE; COUNTRIES; HEALTH; CHILDHOOD; MORTALITY; REHABILITATION; EXPERIENCE; OBESITY	One million children and adolescents die each year from injuries and many-fold more suffer long-term disability. While there have been substantial reductions in injury mortality over the last 50 years, further decreases in morbidity and mortality will require consideration of additional factors. This article discusses five different components to further reduce the injury burden: consideration of the epidemiologic transition occurring in both high-income as well as low- and middle-income countries; expanding the concept of injury prevention to that of injury control, with substantial emphasis on acute care and rehabilitation of the injured child; inclusion of adolescents in paediatric injury control; improving the quality of research conducted; and changing the way priorities are determined in the injury field.	[Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Rivara, FP (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	fpr@uw.edu					Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; BERGMAN AB, 1991, PEDIATRICS, V88, P69; Berra S, 2009, MED CARE, V47, P161, DOI 10.1097/MLR.0b013e3181844e09; Blum LS, 2009, SOC SCI MED, V68, P1720, DOI 10.1016/j.socscimed.2009.01.020; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; DiGuiseppi C, 2002, BRIT MED J, V325, P995, DOI 10.1136/bmj.325.7371.995; Gauld S, 2011, DISABIL REHABIL, V33, P1901, DOI 10.3109/09638288.2010.550382; Haig AJ, 2009, DISABIL REHABIL, V31, P1031, DOI 10.1080/09638280902803765; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hettiaratchy S, 2010, LANCET, V376, P149, DOI 10.1016/S0140-6736(10)60622-8; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Lopez A, 2008, LANCET, V372, P1525, DOI 10.1016/S0140-6736(08)61632-3; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Peden, 2004, GUIDELINES ESSENTIAL; Peltzer K, 2008, INJURY PREV, V14, P381, DOI 10.1136/ip.2008.018598; Pritchard-Jones K, 2006, EUR J CANCER, V42, P2183, DOI 10.1016/j.ejca.2006.06.006; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; Walker IA, 2010, B WORLD HEALTH ORGAN, V88, P897, DOI 10.2471/BLT.10.076703; *WHO, 2002, GLOB BURD DIS PROJ V	26	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1745-7300			INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.		2012	19	3			SI		226	230		10.1080/17457300.2012.686919			5	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	996ZJ	WOS:000308133200008	22620977				2022-02-06	
J	Smith, GST; Voyer-Grant, JAM; Harauz, G				Smith, Graham S. T.; Voyer-Grant, Janine A. M.; Harauz, George			Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 59; myelin basic protein; apoptosis; neuroprotection; caspase-3; live-cell imaging; glia; oligodendrocytes		The central nervous system can experience a number of stresses and neurological insults, which can have numerous adverse effects that ultimately lead to a reduction in neuronal population and function. Damaged axons can release excitatory molecules including potassium or glutamate into the extracellular matrix, which in turn, can produce further insult and injury to the supporting glial cells including astrocytes and oligodendrocytes (8, 16). If the insult persists, cells will undergo programmed cell death (apoptosis), which is regulated and activated by a number of well-established signal transduction cascades (14). Apoptosis and tissue necrosis can occur after traumatic brain injury, cerebral ischemia, and seizures. A classical example of apoptotic regulation is the family of cysteine-dependent aspartate-directed proteases, or caspases. Activated proteases including caspases have also been implicated in cell death in response to chronic neurodegenerative diseases including Alzheimer's, Huntington's, and Multiple Sclerosis (4, 14, 3, 11, 7). In this protocol we describe the use of the NucView 488 caspase-3 substrate to measure the rate of caspase-3 mediated apoptosis in immortalized N19-oligodendrocyte (OLG) cell cultures (15, 5), following exposure to different extracellular stresses such as high concentrations of potassium or glutamate. The conditionally-immortalized N19-OLG cell line (representing the O2A progenitor) was obtained from Dr. Anthony Campagnoni (UCLA Semel Institute for Neuroscience) (15, 5), and has been previously used to study molecular mechanisms of myelin gene expression and signal transduction leading to OLG differentiation (e. g. (6, 10)). We have found this cell line to be robust with respect to transfection with exogenous myelin basic protein (MBP) constructs fused to either RFP or GFP (red or green fluorescent protein) (13, 12). Here, the N19-OLG cell cultures were treated with either 80 mM potassium chloride or 100 mM sodium glutamate to mimic axonal leakage into the extracellular matrix to induce apoptosis (9). We used a bi-functional caspase-3 substrate containing a DEVD (Asp-Glu-Val-Asp) caspase-3 recognition subunit and a DNA-binding dye (2). The substrate quickly enters the cytoplasm where it is cleaved by intracellular caspase-3. The dye, NucView 488 is released and enters the cell nucleus where it binds DNA and fluoresces green at 488 nm, signaling apoptosis. Use of the NucView 488 caspase-3 substrate allows for live-cell imaging in real-time (1, 10). In this video, we also describe the culturing and transfection of immortalized N19-OLG cells, as well as live-cell imaging techniques.	[Smith, Graham S. T.; Voyer-Grant, Janine A. M.; Harauz, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada		Smith, GST (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.			Harauz, George/0000-0002-6114-9947	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Multiple Sclerosis Society of Canada (MSSC); MSSC	This laboratory has been supported by the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Multiple Sclerosis Society of Canada (MSSC). GSTS was the recipient of a Doctoral Studentship from the MSSC. We are grateful to Dr. Joan Boggs (Hospital for Sick Children, Toronto) for many helpful discussions and comments on this manuscript. We are grateful to Biotium for their generous gift of additional NucView 488 caspase-3.	Antczak C, 2009, J BIOMOL SCREEN, V14, P956, DOI 10.1177/1087057109343207; Cen H, 2008, FASEB J, V22, P2243, DOI 10.1096/fj.07-099234; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; FOSTER LM, 1993, DEV NEUROSCI-BASEL, V15, P100, DOI 10.1159/000111322; Fulton D, 2010, GLIA, V58, P1292, DOI 10.1002/glia.21008; Hisahara S, 2003, NEUROSCI RES, V46, P387, DOI 10.1016/S0168-0102(03)00127-5; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lawrence MS, 1996, J NEUROSCI, V16, P486; Mejia ROS, 2001, NEUROSCIENTIST, V7, P480, DOI 10.1177/107385840100700604; Paez PM, 2007, J NEUROSCI, V27, P12690, DOI 10.1523/JNEUROSCI.2381-07.2007; Smith G.S.T., 2011, J NEUROSCI IN PRESS; Smith GST, 2011, J NEUROSCI RES, V89, P467, DOI 10.1002/jnr.22570; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; VERITY AN, 1993, J NEUROCHEM, V60, P577, DOI 10.1111/j.1471-4159.1993.tb03188.x; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X	16	8	8	0	5	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JAN	2012		59							e3422	10.3791/3422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36PD	WOS:000209222600022	22294086	Green Published, Green Submitted, Bronze			2022-02-06	
J	Sullivan, KA; Edmed, SL				Sullivan, Karen A.; Edmed, Shannon L.			Systematic Variation of the Severity of Motor Vehicle Accident-related Traumatic Brain Injury Vignettes Produces Different Post-Concussion Symptom Reports	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild traumatic brain injury; Expectation-as-etiology; Neurobehavioral Symptom Inventory; Post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION SYNDROME; SERVICE MEMBERS; HEAD-INJURY; BASE RATES; EXPECTATION; RECOMMENDATIONS; KNOWLEDGE	This study investigated the specificity of the post-concussion syndrome (PCS) expectation-as-etiology hypothesis. Undergraduate students (n = 551) were randomly allocated to one of three vignette conditions. Vignettes depicted either a very mild (VMI), mild (MI), or moderate-to-severe (MSI) motor vehicle-related traumatic brain injury (TBI). Participants reported the PCS and PTSD symptoms that they imagined the depicted injury would produce. Secondary outcomes (knowledge of mild TBI, and the perceived undesirability of TBI) were also assessed. After data screening, the distribution of participants by condition was: VMI (n = 100), MI (n = 96), and MSI (n = 71). There was a significant effect of condition on PCS symptomatology, F(2, 264) = 16.55, p < .001. Significantly greater PCS symptomatology was expected in the MSI condition compared to the other conditions (MSI>VMI; medium effect, r = .33; MSI>MI; small-to-medium effect, r = .22). The same pattern of group differences was found for PTSD symptoms, F(2, 264) = 17.12, p < .001. Knowledge of mild TBI was not related to differences in expected PCS symptoms by condition; and the perceived undesirability of TBI was only associated with reported PCS symptomatology in the MSI condition. Systematic variation in the severity of a depicted TBI produces different PCS and PTSD symptom expectations. Even a very mild TBI vignette can elicit expectations of PCS symptoms.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, O Block,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC #1000000311) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. The authors would like to thank Lauren Cunningham who was employed as a research assistant on this project.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carr J, 2007, TRAUMA, V9, P21, DOI 10.1177/1460408607082845; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Field A., 2017, DISCOVERING STAT USI, V5th; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King P.R., 2011, THESIS STATE U NEW Y; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sullivan K. A., BRAIN INJUR IN PRESS; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; [No title captured]	38	8	8	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	8					1255	1277		10.1080/13854046.2012.735254			23	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	045LG	WOS:000311696700002	23186297				2022-02-06	
J	Waydhas, C				Waydhas, C.			Preclinical management of multiples injuries: S3 guideline	UNFALLCHIRURG			German	Article						Polytrauma; Emergency physician; Guidelines; Intubation; Volume replacement	RAPID-SEQUENCE INTUBATION; TRAUMA; ETOMIDATE; INSUFFICIENCY	The guidelines follow the priorities established by the A-B-C-D-E scheme. They focus on the treatment of actual disturbances of vital functions and not so much on their anticipated development. Important recommendations with regard to the indication for intubation and ventilation, fluid therapy, diagnosis and treatment of severe chest injuries (tension pneumothorax in particular), management of severe traumatic brain injury, pelvic and vertebral injuries, priorities in the management of extremity fractures as well as indications for the choice of the receiving hospital are given. The recommendations are discussed in view of future concerns and developments.	Univ Klinikum Essen, Unfallchirurg Klin, D-45147 Essen, Germany		Waydhas, C (corresponding author), Univ Klinikum Essen, Unfallchirurg Klin, Hufelandstr 55, D-45147 Essen, Germany.	christian.waydhas@uk-essen.de					Ahnefeld FW, 2008, NOTFALL RETTUNGSMED, V11, P421; Albert SG, 2011, INTENS CARE MED, V37, P901, DOI 10.1007/s00134-011-2160-1; Beck A, 2001, UNFALLCHIRURG, V104, P1082, DOI 10.1007/s001130170024; Beck A., 2005, J HIGH ENERGY PHYS, V8, P466, DOI [10.1007/s10049-005-0769-8, DOI 10.1007/S10049-005-0769-8]; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; DeAngelis NA, 2008, INJURY, V39, P903, DOI 10.1016/j.injury.2007.12.008; Deutsche Gesellschaft fur Unfallchirurgie e. V, 2006, WEISSB SCHWERV VERS; Dulchavsky SA, 2001, J TRAUMA, V50, P201, DOI 10.1097/00005373-200102000-00003; Ficke JR, 2007, J AM ACAD ORTHOP SUR, V15, P590, DOI 10.5435/00124635-200710000-00003; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Hussmann B, 2011, CRIT CARE, V15, DOI 10.1186/cc10442; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Kirkpatrick AW, 2007, CRIT CARE MED, V35, pS162, DOI 10.1097/01.CCM.0000260627.97284.5D; Lee C, 2007, EMERG MED J, V24, P584, DOI 10.1136/emj.2007.046359; Lee C, 2005, EMERG MED J, V22, P660, DOI 10.1136/emj.2005.024489; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; Lyon M, 2011, AM J EMERG MED; Muakkassa FF, 2010, J TRAUMA, V68, P1305, DOI 10.1097/TA.0b013e3181dcd137; Plurad DS, 2011, J TRAUMA, V71, P565, DOI 10.1097/TA.0b013e3182213d52; Probst C, 2007, CHIRURG, V78, P875, DOI 10.1007/s00104-007-1410-9; Rowan KR, 2002, RADIOLOGY, V225, P210, DOI 10.1148/radiol.2251011102; Ruchholtz S, 2002, J TRAUMA, V52, P879, DOI 10.1097/00005373-200205000-00010; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sperry JL, 2008, J TRAUMA, V64, P9, DOI 10.1097/TA.0b013e31815dd029; Volpicelli G, 2011, INTENS CARE MED, V37, P224, DOI 10.1007/s00134-010-2079-y; Warner KJ, 2009, J TRAUMA, V67, P45, DOI 10.1097/TA.0b013e3181a92a70; Waydhas C, 2007, RESUSCITATION, V72, P11, DOI 10.1016/j.resuscitation.2006.06.025; Worsing R A Jr, 1984, Emerg Med Clin North Am, V2, P205; Xirouchaki N, 2011, INTENS CARE MED, V37, P1488, DOI 10.1007/s00134-011-2317-y	30	8	9	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	JAN	2012	115	1					8	13		10.1007/s00113-011-2102-y			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	881WS	WOS:000299522800005	22274598				2022-02-06	
J	Wong, GKC; Ngai, K; Wong, A; Lam, SW; Mok, VCT; Yeung, J; Rainer, T; Wong, R; Poon, WS				Wong, George Kwok Chu; Ngai, Karine; Wong, Adrian; Lam, Sandy Wai; Mok, Vincent C. T.; Yeung, Janice; Rainer, Timothy; Wong, Rosanna; Poon, Wai Sang			Long-term cognitive dysfunction in patients with traumatic subarachnoid hemorrhage: prevalence and risk factors	ACTA NEUROCHIRURGICA			English	Article						Subarachnoid hemorrhage; Traumatic brain injury; Cognitive impairment	QUALITY-OF-LIFE; COMMUNICATING ARTERY ANEURYSM; GERIATRIC DEPRESSION SCALE; BRAIN-INJURY; CHINESE POPULATION; SF-36; IMPAIRMENT; VALIDATION; EQUIVALENT; VALIDITY	Cognition had recently been suggested as a supplement to traditional measures of neurological outcome. However, no data were available in the literature on long-term cognitive outcomes in patients with traumatic subarachnoid hemorrhage (tSAH). We explored the long-term cognitive profiles of patients with tSAH who had returned to the community, and the risk factors associated with this event. Patients with tSAH were contacted to obtain their consent to participate in the study of cognitive profiles and outcome. Forty-seven (42%) of 111 eligible patients completed all the assessments. Time from ictus to assessment ranged from 3 to 5 years. No difference in patient characteristics was observed between those who participated and those who did not. In patients with tSAH who had returned to the community, domain deficits and cognitive impairment were correlated with the extended Glasgow outcome scale (GOS-E), and were predicted by age and Glasgow coma scale (GCS) on admission. The accuracies of classifications were 79% and 81%, respectively. The number of domain deficits was also correlated with GOS-E, and was predicted by age, GCS on admission, and the extent of tSAH, with a total R (2) value of 50%. Long-term cognitive dysfunction is common after tSAH. In addition to GCS on admission and follow-up GOS-E, the extent of tSAH is an independent risk factor for the number of cognitive domain deficits that occur.	[Wong, George Kwok Chu] Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Wong, Rosanna] Prince Wales Hosp, Dept Occupat Therapy, Shatin, Hong Kong, Peoples R China; [Yeung, Janice; Rainer, Timothy] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China; [Wong, Adrian; Mok, Vincent C. T.] Chinese Univ Hong Kong, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Wong, George Kwok Chu; Ngai, Karine; Lam, Sandy Wai; Poon, Wai Sang] Chinese Univ Hong Kong, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China		Wong, GKC (corresponding author), Prince Wales Hosp, Dept Surg, 4-F Clin Sci Bldg,1 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	; Wong, Adrian/K-4859-2014; Rainer, Timothy/I-2591-2013; Mok, Vincent/N-6421-2015	Wong, George Kwok Chu/0000-0002-6078-2548; Wong, Adrian/0000-0002-7859-3956; Rainer, Timothy/0000-0003-3355-3237; Mok, Vincent/0000-0002-8102-8835	Chinese University of Hong Kong, Hong KongChinese University of Hong Kong	This study was supported by the Research and Training Fund for Neurosurgery, The Chinese University of Hong Kong, Hong Kong.	Alfieri A, 2008, J NEUROSURG, V109, P1019, DOI 10.3171/JNS.2008.109.12.1019; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Brown PJ, 2007, PSYCHOL AGING, V22, P372, DOI 10.1037/0882-7974.22.2.372; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Chahal N, 2011, NEUROEPIDEMIOLOGY, V37, P31, DOI 10.1159/000328647; Chan A, 2002, EUR NEUROL, V47, P37, DOI 10.1159/000047945; Chan A.S., 1999, HONG KONG LIST LEARN; Chung WS., 1994, J HONG KONG COLL PSY, V4, P25, DOI DOI 10.12809/HKMJ154737; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Debruyne H, 2009, INT J GERIATR PSYCH, V24, P556, DOI 10.1002/gps.2154; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fontanella M, 2003, ACTA NEUROCHIR, V145, P867, DOI 10.1007/s00701-003-0111-5; Lam C, 1999, HONG KONG PRACTITION; Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008; Lam CLK, 1998, J CLIN EPIDEMIOL, V51, P1139, DOI 10.1016/S0895-4356(98)00105-X; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Lim PPJ, 2000, INT J GERIATR PSYCH, V15, P824, DOI 10.1002/1099-1166(200009)15:9<824::AID-GPS207>3.0.CO;2-C; Owolabi MO, 2010, CEREBROVASC DIS, V29, P105, DOI 10.1159/000262305; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rey A, 1941, ARCH PSYCHOL, V28, P296; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Smith A., 1982, SYMBOL DIGIT MODALIT; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taft C, 2001, QUAL LIFE RES, V10, P395, DOI 10.1023/A:1012552211996; Tang WK, 2004, J AFFECT DISORDERS, V81, P153, DOI 10.1016/S0165-0327(03)00163-0; TEASDALE G, 1974, LANCET, V2, P81; Tham W, 2002, J NEUROL SCI, V203, P49, DOI 10.1016/S0022-510X(02)00260-5; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Wechsler D., 2005, WECHSLER MEMORY SCAL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong GK, 2009, BRIT J NEUROSURG, V23, P601, DOI 10.3109/02688690902948184; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d; Wong GKC, 2011, ACTA NEUROCHIR, V153, P107, DOI 10.1007/s00701-010-0855-7; Wong GKC, 2009, ACTA NEUROCHIR, V151, P1601, DOI 10.1007/s00701-009-0425-z; Wong GKC, 2010, J NEUROL SCI, V299, P5, DOI 10.1016/j.jns.2010.08.059	40	8	9	1	10	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JAN	2012	154	1					105	111		10.1007/s00701-011-1198-8			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	870BE	WOS:000298643300017	22002505				2022-02-06	
J	Yoon, SH; Kwon, SK; Park, SR; Min, BH				Yoon, Soo Han; Kwon, Soon Keun; Park, So Ra; Min, Byoung-Hyun			Effect of Ultrasound Treatment on Brain Edema in a Traumatic Brain Injury Model with the Weight Drop Method	PEDIATRIC NEUROSURGERY			English	Article							LOW-FREQUENCY ULTRASOUND; FOCUSED ULTRASOUND; BARRIER DISRUPTION; DECOMPRESSIVE CRANIECTOMY; DRUG-DELIVERY; HEAD-INJURY; RATS; AQUAPORIN-4; WATER; MANAGEMENT	Background: For the treatment of traumatic brain edema, an efficient modality has not yet emerged. There have been many studies to date which have reported the employment of low-frequency ultrasound for blood-brain barrier disruption (BBBD). However, the authors have observed that low-intensity ultrasound increases water permeability without cellular damage in cartilage cells. We have therefore attempted to observe the effects of applying this low-intensity ultrasound to an experimental animal model. Methods: A traumatic brain injury rat model was established according to the weight drop method developing the traumatic brain edema. The degree of BBBD was measured by the changes in the water content and spectrophotometric absorbance of Evans blue dye in the cerebrum after low-frequency ultrasound. Results: The cerebral water content levels showed that the BBBD gradually increased after impact and thereafter decreased after 6 h. After low-frequency ultrasound exposure, the values of water content and spectrophotometric absorbance of Evans blue dye were the lowest at 0 h, and were increased at 2 and 5 h of ultrasonic exposure (after impact). Conclusion: We suggest that traumatic brain edema in the rat model may be alleviated by low-frequency ultrasound, and low-frequency ultrasound might be proposed as a novel treatment modality for brain edema. Copyright (C) 2012 S. Karger AG, Basel	[Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Orthoped Surg, Suwon 443721, South Korea; [Yoon, Soo Han] Ajou Univ, Sch Med, Dept Neurosurg, Suwon 443721, South Korea; [Kwon, Soon Keun; Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Mol Sci & Technol, Suwon 443721, South Korea; [Park, So Ra; Min, Byoung-Hyun] Inha Univ, Coll Med, Dept Physiol, Inchon, South Korea		Min, BH (corresponding author), Ajou Univ, Sch Med, Dept Orthoped Surg, San 5, Suwon 443721, South Korea.	ee802000@yahoo.co.kr		Min, Byoung-Hyun/0000-0001-8928-414X			ARTRU F, 1976, EUR NEUROL, V14, P310, DOI 10.1159/000114753; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Dhillon HS, 1999, J NEUROTRAUM, V16, P455, DOI 10.1089/neu.1999.16.455; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Feng Y, 2010, J ULTRAS MED, V29, P963, DOI 10.7863/jum.2010.29.6.963; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; HOLLIS PH, 1988, EXP NEUROL, V99, P428, DOI 10.1016/0014-4886(88)90159-8; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kempski O, 2001, SEMIN NEPHROL, V21, P303, DOI 10.1053/snep.2001.21665; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Park SR, 2005, ULTRASOUND MED BIOL, V31, P1551, DOI 10.1016/j.ultrasmedbio.2005.07.002; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Reinhard M, 2006, STROKE, V37, P1546, DOI 10.1161/01.STR.0000221813.27519.0b; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taniguchi M, 2002, BRAIN RES MOL BRAIN, V78, P131; Venero JL, 2004, CURR PHARM DESIGN, V10, P2153, DOI 10.2174/1381612043384150; Vykhodtseva N, 2008, ULTRASONICS, V48, P279, DOI 10.1016/j.ultras.2008.04.004; WATTS RG, 1989, NEUROSURGERY, V25, P202, DOI 10.1227/00006123-198908000-00008; Yoshino SI, 2009, ANTICANCER RES, V29, P889; Zderic V, 2004, CORNEA, V23, P804, DOI 10.1097/01.ico.0000134189.33549.cc	40	8	8	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2012	48	2					102	108		10.1159/000343011			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	049TB	WOS:000312005200006	23154513				2022-02-06	
J	Dagenais, PA; Adlington, LM; Evans, KJ				Dagenais, Paul A.; Adlington, Laura M.; Evans, Kelli J.			Intelligibility, Comprehensibility, and Acceptability of Dysarthric Speech by Older and Younger Listeners	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article						dysarthria; intelligibility; comprehensibility; acceptability; aging		The purpose of this study was to determine if any relationships exist across the measures of intelligibility, comprehensibility, and acceptability when used to assess dysarthric speech. Intelligibility, an objective measure, was defined as percent of words heard correctly; comprehensibility, also an objective measure, as the ability to understand what is being said; and acceptability, a subjective measure, as how the listener rates the person's naturalness and overall speaking ability. Four young men with traumatic brain injury and one control participant were recorded reading sentences from the Assessment of Intelligibility of Dysarthric Speech. Speakers repeated sentences until they had attempted all words (a "best" speech condition). Younger and older normal-hearing adults acted as listeners. Sentences were presented to the listeners, who typed what they heard (intelligibility), answered questions (comprehensibility), and rated naturalness (acceptability). All ratings were high for intelligibility and comprehensibility. Older listeners rated acceptability similar to intelligibility and comprehensibility, but younger listeners rated acceptability significantly lower. Listeners of different ages appear to rate dysarthric speech differently. Young listeners show better skills at understanding words and meaning but find the speech itself unacceptable. Older listeners are more accepting. Further work is needed using samples of dysarthric speech recorded without repetitions to correct word errors.	[Dagenais, Paul A.; Adlington, Laura M.; Evans, Kelli J.] Univ S Alabama, Mobile, AL 36688 USA		Dagenais, PA (corresponding author), Univ S Alabama, 5721 USA Dr N,Room 1119, Mobile, AL 36688 USA.	pdagenais@usouthal.edu					Adamovich B. B., 1992, SCALES COGNITIVE ABI; Bressmann T, 2009, CAN J SPEECH-LANG PA, V33, P204; Dabul B. L., 2000, APRAXIA BATTERY ADUL; Dagenais PA, 2006, CLIN LINGUIST PHONET, V20, P141, DOI 10.1080/02699200400026843; Dagenais PA, 1999, J MED SPEECH-LANG PA, V7, P91; Dagenais PA, 2010, J MED SPEECH-LANG PA, V18, P27; Fletcher SG., 1978, DIAGNOSING SPEECH DI; Henningsson G, 2008, CLEFT PALATE-CRAN J, V45, P1, DOI 10.1597/06-086.1; Hustad KC, 2008, J SPEECH LANG HEAR R, V51, P562, DOI 10.1044/1092-4388(2008/040); Hustad KC, 2002, J SPEECH LANG HEAR R, V45, P545, DOI 10.1044/1092-4388(2002/043); TIKOFSKY RS, 1964, J SPEECH HEAR RES, V7, P325, DOI 10.1044/jshr.0704.325; Walshe M, 2008, INT J LANG COMM DIS, V43, P633, DOI 10.1080/13682820801887117; Weinstein B., 1983, AM SPEECH LANGUAGE H, V25, P37; Whitehill TL, 2004, J MED SPEECH-LANG PA, V12, P229; Whitehill TL, 2002, CLEFT PALATE-CRAN J, V39, P50, DOI 10.1597/1545-1569(2002)039<0050:AIISWC>2.0.CO;2; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Yorkston K. M., 1998, NEUROMOTOR SPEECH DI; Yorkston K. M., 1996, J SPEECH LANGUAGE PA, V5, P55	18	8	8	0	13	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	2011	19	4					37	48					12	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	V34SU	WOS:000209106800004					2022-02-06	
J	Dorfman, JD; Burns, JD; Green, DM; DeFusco, C; Agarwal, S				Dorfman, Jon D.; Burns, Joseph D.; Green, Deborah M.; DeFusco, Christina; Agarwal, Suresh			Decompressive Laparotomy for Refractory Intracranial Hypertension After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Intracranial hypertension; Intra-abdominal hypertension	ABDOMINAL COMPARTMENT SYNDROME; PRESSURE	Intracranial hypertension is a crucial modifiable risk factor for poor outcome after traumatic brain injury (TBI). Limited evidence suggests that decompressive laparotomy may be an effective treatment for refractory ICH in patients who have elevated intra-abdominal pressure. Case report. We present a multi-trauma patient who sustained severe TBI in a motor vehicle collision. Intracranial pressure (ICP) was initially medically managed but became refractory to standard therapies. Emergent decompressive laparotomy performed in the surgical intensive care unit for abdominal compartment syndrome concomitantly improved the patient's ICP. Elevated intra-abdominal pressure can exacerbate intracranial hypertension in patients with TBI. Recognition of this condition and treatment with decompressive laparotomy may be useful in patients with intracranial hypertension refractory to optimal medical therapy.	[Burns, Joseph D.; Green, Deborah M.; DeFusco, Christina] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02119 USA; [Dorfman, Jon D.; Burns, Joseph D.; Green, Deborah M.; DeFusco, Christina; Agarwal, Suresh] Boston Med Ctr, Boston, MA 02119 USA; [Dorfman, Jon D.; Agarwal, Suresh] Boston Univ, Sch Med, Dept Surg, Boston, MA 02119 USA; [Burns, Joseph D.; Green, Deborah M.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02119 USA		Burns, JD (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,Collamore Bldg C-3, Boston, MA 02119 USA.	joseph.burns@bmc.org		Green-LaRoche, MD, Deborah/0000-0001-8158-0788; Burns, Joseph/0000-0003-4158-616X			Bloomfield GL, 1996, J TRAUMA, V40, P936, DOI 10.1097/00005373-199606000-00012; Bloomfield GL, 1995, J TRAUMA, V39, P1168, DOI 10.1097/00005373-199512000-00028; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Deeren DH, 2005, INTENS CARE MED, V31, P1577, DOI 10.1007/s00134-005-2802-2; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; Maerz L, 2008, CRIT CARE MED, V36, pS212, DOI 10.1097/CCM.0b013e318168e333; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542	9	8	8	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2011	15	3					516	518		10.1007/s12028-011-9549-0			3	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	852NT	WOS:000297365400023	21519956				2022-02-06	
J	Shafer, R; Brown, A; Taylor, C				Shafer, Robert; Brown, Alice; Taylor, Christopher			Correlation between cerebral blood flow and oxygen saturation in patients with subarachnoid hemorrhage and traumatic brain injury	JOURNAL OF NEUROINTERVENTIONAL SURGERY			English	Article							NEAR-INFRARED SPECTROSCOPY; XENON-CT; STABLE-XENON; CLINICAL-EXPERIENCE; COMPUTED-TOMOGRAPHY; PERFUSION CT; STROKE; PERFORMANCE; VASOSPASM; OXIMETRY	The INVOS cerebral oximeter and portable xenon enhanced CT (Xe/CT) scan are two commonly used diagnostic devices in patients who have experienced neurologic insults such as traumatic brain injury and subarachnoid hemorrhage. While the INVOS device is a relatively inexpensive, non-invasive measure of cerebral blood oxygen saturation, Xe/CT is a more complex costly diagnostic test that is the current gold standard for assessing cerebral perfusion in patients in the neurosciences intensive care unit (NSI) at the University of New Mexico Hospital. The purpose of this research was to investigate a possible relationship between these two diagnostic devices that might enable clinicians to better determine the appropriate timing and necessity of Xe/CT scans by evaluating trends in cerebral oximetry. The research was conducted in the University of New Mexico Hospital NSI over 18 months, with 25 imaging studies being collected from among 22 patients. Computer generated cortical segments obtained from the Xe/CT scans were correlated to INVOS cerebral oximeter pad placement on each patient's forehead, and the values were then compared using Spearman correlation coefficients. In this study, no statistically significant relationship between the devices was found although expansion of the study to a greater number of patients may uncover such a relationship.	Univ New Mexico Hosp, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA; Univ New Mexico Hosp, Sch Med, Dept Neurointervent Radiol, Albuquerque, NM 87131 USA		Shafer, R (corresponding author), Univ New Mexico, Dept Neurosurg, 3901 Indian Sch Rd NE,Apt A308, Albuquerque, NM 87110 USA.	rshafer@salud.unm.edu					DEWITT DS, 1989, STROKE, V20, P1716, DOI 10.1161/01.STR.20.12.1716; Fainardi E, 2006, NEURORADIOLOGY, V48, P685, DOI 10.1007/s00234-006-0111-2; Firlik AD, 1998, J NEUROSURG, V89, P243, DOI 10.3171/jns.1998.89.2.0243; Firlik Andrew D., 2000, Keio Journal of Medicine, V49, pA129; Gupta R, 2008, NEUROCRIT CARE, V9, P27, DOI 10.1007/s12028-007-9004-4; Hashimoto K, 2007, DIGEST DIS SCI, V52, P943, DOI 10.1007/s10620-006-9327-6; Hillman J, 2005, BRIT J NEUROSURG, V19, P395, DOI 10.1080/02688690500389898; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; LATCHAW RE, 1987, RADIOLOGY, V163, P251, DOI 10.1148/radiology.163.1.3823444; Lee TS, 2008, ANN VASC SURG, V22, P58, DOI 10.1016/j.avsg.2007.07.022; Nemoto EM, 2000, CRIT CARE MED, V28, P1052, DOI 10.1097/00003246-200004000-00023; Olsson C, 2006, J THORAC CARDIOV SUR, V131, P371, DOI 10.1016/j.jtcvs.2005.08.068; SEIFERT H, 1995, BRIT J RADIOL, V68, P301, DOI 10.1259/0007-1285-68-807-301; Shah N, 2000, J NEUROSURG ANESTH, V12, P201, DOI 10.1097/00008506-200007000-00001; Thavasothy M, 2002, ANAESTHESIA, V57, P999, DOI 10.1046/j.1365-2044.2002.02826.x; Torella F, 2002, SHOCK, V18, P440, DOI 10.1097/00024382-200211000-00009; Torella F, 2002, COMP BIOCHEM PHYS A, V132, P199, DOI 10.1016/S1095-6433(01)00548-7; Torella F, 2002, VOX SANG, V83, P254, DOI 10.1046/j.1423-0410.2002.00223.x; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Yonas H, 1996, NEUROSURG CLIN N AM, V7, P605; YONAS H, 1984, RADIOLOGY, V152, P435, DOI 10.1148/radiology.152.2.6739811; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010; Yonas H, 1998, NEUROSURGERY, V42, P1005, DOI 10.1097/00006123-199805000-00030	23	8	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1759-8478			J NEUROINTERV SURG	J. NeuroInterventional Surg.	DEC	2011	3	4					395	398		10.1136/jnis.2010.004184			4	Neuroimaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	844ZU	WOS:000296793400024	21990444				2022-02-06	
J	Williams, GP; Morris, ME				Williams, Gavin P.; Morris, Meg E.			Tests of Static Balance Do Not Predict Mobility Performance Following Traumatic Brain Injury	PHYSIOTHERAPY CANADA			English	Article						balance; gait; mobility; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; STROKE REHABILITATION; STANDING BALANCE; ASSESSMENT-TOOL; GAIT; PEOPLE; VALIDITY; SCALE; AMBULATION; WALKING	Purpose: To investigate the extent to which different single-limb support (SLS) parameters predict mobility performance following traumatic brain injury (TBI). Methods: Seventy-one people with mobility limitations following TBI were assessed for balance and mobility performance in a human movement laboratory. Participants performed a clinical test of static balance that involved balancing in SLS on each leg with eyes open and eyes closed. Mobility performance was measured by self-selected gait speed and performance on the High Level Mobility Scale (HiMAT). Dynamic stability during walking was measured by quantifying lateral centre of mass (COM) displacement, width of base of support, and proportion of double-support stance time. Results: Total static balance scores were strongly correlated with HiMAT scores (r = 0.57, p < 0.001) and lateral COM displacement (r = -0.51, p < 0.001). Despite these strong correlations, however, balance scores explained only 32% of the variance in advanced mobility skills (r(2) = 0.32) and 26% of the variance in lateral COM displacement (r(2) = 0.26). Conclusions: Since mobility performance varied widely for people with similar levels of balance, SLS time was not able to predict dynamic stability during gait, self-selected gait speed, or advanced mobility skills in people with TBI.	[Williams, Gavin P.] Epworth Med Fdn, Melbourne, Vic, Australia; [Morris, Meg E.] Univ Melbourne, Melbourne Sch Hlth Sci, Melbourne, Vic, Australia		Williams, GP (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au		Williams, Gavin/0000-0003-2758-7473; Morris, Meg/0000-0002-0114-4175	Victorian Neurotrauma Initiative	This project was funded by the Victorian Neurotrauma Initiative as part of a post-doctoral fellowship.	Alzayer L, 2009, J NEUROL PHYS THER, V33, P136, DOI 10.1097/NPT.0b013e3181b51307; Ashburn A, 2008, AGE AGEING, V37, P270, DOI 10.1093/ageing/afn066; Au-Yeung SSY, 2009, NEUROREHAB NEURAL RE, V23, P515, DOI 10.1177/1545968308326425; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; BERG K, 1989, Physiotherapy Canada, V41, P304; Berkovits, 1996, PHYSIOTHER CAN, V48, P257, DOI [10.3138/ptc.48.4.257, DOI 10.3138/PTC.48.4.257]; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cohen J, 1977, STAT POWER ANAL BEHA; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; Eser F, 2008, EUR J PHYS REHAB MED, V44, P19; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; JOHANSSON G, 1991, Physiotherapy Theory and Practice, V7, P121, DOI 10.3109/09593989109106962; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KEENAN MA, 1984, CLIN ORTHOP RELAT R, P165; Kerrigan DCC, 1999, J HEAD TRAUMA REHAB, V14, P136, DOI 10.1097/00001199-199904000-00004; Korner-Bitensky N, 2006, STROKE, V37, P631; Maeda N, 2009, J INT MED RES, V37, P697, DOI 10.1177/147323000903700313; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2001, BRAIN INJURY, V15, P831; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; WINSTEIN CJ, 1989, ARCH PHYS MED REHAB, V70, P755; Yavuzer G, 2006, CLIN REHABIL, V20, P960, DOI 10.1177/0269215506070315	33	8	8	0	10	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA	0300-0508			PHYSIOTHER CAN	Physiother. Can.	WIN	2011	63	1					58	64		10.3138/ptc.2009-53			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	843MY	WOS:000296677200007	22210980	Green Published			2022-02-06	
J	Colantonio, A; Moldofsky, B; Escobar, M; Vernich, L; Chipman, M; McLellan, B				Colantonio, Angela; Moldofsky, Byron; Escobar, Michael; Vernich, Lee; Chipman, Mary; McLellan, Barry			Using geographical information systems mapping to identify areas presenting high risk for traumatic brain injury	EMERGING THEMES IN EPIDEMIOLOGY			English	Article						traumatic brain injury; geographic information systems; geographic visualization; spatial analysis	EPIDEMIOLOGY; PREVENTION; EXPOSURE; CHILDREN; HEALTH; GIS	Background: The aim of this study is to show how geographical information systems (GIS) can be used to track and compare hospitalization rates for traumatic brain injury (TBI) over time and across a large geographical area using population based data. Results & Discussion: Data on TBI hospitalizations, and geographic and demographic variables, came from the Ontario Trauma Registry Minimum Data Set for the fiscal years 1993-1994 and 2001-2002. Various visualization techniques, exploratory data analysis and spatial analysis were employed to map and analyze these data. Both the raw and standardized rates by age/gender of the geographical unit were studied. Data analyses revealed persistent high rates of hospitalization for TBI resulting from any injury mechanism between two time periods in specific geographic locations. Conclusions: This study shows how geographic information systems can be successfully used to investigate hospitalizaton rates for traumatic brain injury using a range of tools and techniques; findings can be used for local planning of both injury prevention and post discharge services, including rehabilitation.	[Colantonio, Angela] Univ Toronto, Toronto Rehabil Inst UHN, Saunderson Family Chair Acquired Brain Injury Res, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela; Escobar, Michael; Vernich, Lee; Chipman, Mary] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Moldofsky, Byron] Univ Toronto, Dept Geog, Toronto, ON, Canada; [McLellan, Barry] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst UHN, Saunderson Family Chair Acquired Brain Injury Res, Toronto, ON, Canada.	angela.colantonio@utoronto.ca		Escobar, Michael/0000-0001-9055-4709	Ontario Neurotrauma Foundation; Toronto Rehabilitation Institute Foundation; Ontario Ministry of Health and Long Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario	We would like to acknowledge and thank the the Ontario Neurotrauma Foundation and the Toronto Rehabilitation Institute Foundation for financial support for this project. The Toronto Rehabilitation Institute acknowledges a grant from the Ontario Ministry of Health and Long Term Care (MOHLTC). We thank Justin Ngan for his work with the geographic analysis and Sandra Sokoloff for her assistance with copyediting and manuscript preparation. We wish to thank Greg Webster and the staff of the Canadian Institute for Health Information for providing the data and reviewing our data with respect to privacy issues. The views of the authors do not necessarily reflect the views of the Ontario MOHLTC.	Altmayer Chris A, 2003, Int J Health Geogr, V2, P7, DOI 10.1186/1476-072X-2-7; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Aultman-Hall L, 1999, ACCIDENT ANAL PREV, V31, P675, DOI 10.1016/S0001-4575(99)00028-7; BAKER SP, 1991, ACCIDENT ANAL PREV, V23, P19, DOI 10.1016/0001-4575(91)90031-Y; BRADDOCK M, 1994, AM J PUBLIC HEALTH, V84, P1158, DOI 10.2105/AJPH.84.7.1158; Centers for Disease Control and Prevention, 2005, INJ MAPS; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cressie N.A.C., 2004, APPL SPATIAL STAT PU, Vfirst; Cromley EK, 2003, ANNU REV PUBL HEALTH, V24, P7, DOI 10.1146/annurev.publhealth.24.012902.141019; Cusimano MD, 2007, INJURY PREV, V13, P51, DOI 10.1136/ip.2006.012468; Das-Gupta R, 2002, DISABIL REHABIL, V24, P654, DOI 10.1080/09638280110109282; Dragioevio S, 2004, CARTOGRAPHICA, V39, P29, DOI [10.3138/6338-8M7X-4H12-30T9, DOI 10.3138/6338-8M7X-4H12-30T9]; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Getis A., 1996, SPATIAL ANAL MODELIN, P261; Gotway-Crawford C, 2004, ECOLOGICAL INFERENCE; Hijar M, 2003, SOC SCI MED, V57, P2149, DOI 10.1016/S0277-9536(03)00067-4; Jarup L, 2004, ENVIRON HEALTH PERSP, V112, P995, DOI 10.1289/ehp.6736; Kistemann T, 2002, INT J HYG ENVIR HEAL, V205, P169, DOI 10.1078/1438-4639-00145; LaScala EA, 2000, ACCIDENT ANAL PREV, V32, P651, DOI 10.1016/S0001-4575(99)00100-1; McLafferty SL, 2003, ANNU REV PUBL HEALTH, V24, P25, DOI 10.1146/annurev.publhealth.24.012902.141012; Moldofsky B, 2008, GCUT GIS CARTOGRAPHY; National Cancer Institute:, 2005, CANC MORT MAPS GRAPH; Nuckols JR, 2004, ENVIRON HEALTH PERSP, V112, P1007, DOI 10.1289/ehp.6738; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Parsons D, LOCAL HLTH INTEGRATI; Robinson TP, 2000, ADV PARASIT, V47, P81, DOI 10.1016/S0065-308X(00)47007-7; WANG S, 1997, PLANNING PERSPECTIVE, V12, P225; Wei WL, 2010, BRAIN INJURY, V24, P1358, DOI 10.3109/02699052.2010.506635; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x; World Health Organization, 2005, EUR HLTH ENV INF SYS; Yiannakoulias N, 2003, SOC SCI MED, V57, P2065, DOI 10.1016/S0277-9536(03)00081-9	34	8	8	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-7622		EMERG THEMES EPIDEMI	Emerg. Themes Epidemiol.	NOV 4	2011	8								7	10.1186/1742-7622-8-7			11	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	V51OL	WOS:000210231400001	22054220	gold, Green Published			2022-02-06	
J	Aravamudhan, S; Bellamkonda, RV				Aravamudhan, Shyam; Bellamkonda, Ravi V.			Toward a Convergence of Regenerative Medicine, Rehabilitation, and Neuroprosthetics	JOURNAL OF NEUROTRAUMA			English	Article						electrical stimulation; nervous system; neural injury; stem cells; tissue engineering	SPINAL-CORD-INJURY; PERIPHERAL-NERVE REGENERATION; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; PROMOTES AXONAL REGENERATION; OLFACTORY ENSHEATHING CELLS; HINDLIMB-STEPPING ABILITY; NEURITE GROWTH-INHIBITORS; SCHWANN-CELLS	No effective therapeutic interventions exist for severe neural pathologies, despite significant advances in regenerative medicine, rehabilitation, and neuroprosthetics. Our current hypothesis is that a specific combination of tissue engineering, pharmacology, cell replacement, drug delivery, and electrical stimulation, together with plasticity-promoting and locomotor training (neurorehabilitation) is necessary to interact synergistically in order to activate and enable all damaged circuits. We postulate that various convergent themes exist among the different therapeutic fields. Therefore, the objective of this review is to highlight the convergent themes, which we believe have a common goal of restoring function after neural damage. The convergent themes discussed in this review include modulation of inflammation and secondary damage, encouraging endogenous repair/regeneration (using scaffolds, cell transplantation, and drug delivery), application of electrical fields to modulate healing and/or activity, and finally modulation of plasticity.	[Aravamudhan, Shyam; Bellamkonda, Ravi V.] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA		Bellamkonda, RV (corresponding author), Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr NE, Atlanta, GA 30332 USA.	ravi@gatech.edu					Abbott A, 2006, NATURE, V442, P125, DOI 10.1038/442125a; AEBISCHER P, 1988, BRAIN RES, V448, P364, DOI 10.1016/0006-8993(88)91278-4; AGNEW WF, 1990, EPILEPSIA, V31, pS27, DOI 10.1111/j.1528-1157.1990.tb05845.x; Ahmed Z, 2003, TISSUE ENG, V9, P219, DOI 10.1089/107632703764664693; Al-Majed AA, 2004, CELL MOL NEUROBIOL, V24, P379, DOI 10.1023/B:CEMN.0000022770.66463.f7; Aldini NN, 1996, BIOMATERIALS, V17, P959, DOI 10.1016/0142-9612(96)84669-2; ANSSELIN A D, 1988, Microsurgery, V9, P103, DOI 10.1002/micr.1920090210; ANTAL EJ, 1983, J PHARMACOKINET BIOP, V11, P561, DOI 10.1007/BF01059057; Antri M, 2003, EUR J NEUROSCI, V18, P1963, DOI 10.1046/j.1460-9568.2003.02916.x; Bareyre FM, 2008, J NEUROL SCI, V265, P63, DOI 10.1016/j.jns.2007.05.004; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Becker D, 2003, NEUROLOGIST, V9, P1, DOI 10.1097/01.nrl.0000038587.58012.05; Belkas JS, 2005, RESTOR NEUROL NEUROS, V23, P19; Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798; Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156; Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012; Borgens R.B., 2003, ADV ANAT EMBRYOL CEL, V171, P1; Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3; Borgens RB, 2002, J EXP BIOL, V205, P1; BORGENS RB, 1982, INT REV CYTOL, V76, P245, DOI 10.1016/S0074-7696(08)61793-3; Borgens Richard Ben, 2003, Adv Anat Embryol Cell Biol, V171, pIII; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1990, MED J AUSTRALIA, V153, P368, DOI 10.5694/j.1326-5377.1990.tb136976.x; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bregman B S, 1983, Brain Res, V285, P119; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; BUNGE MB, 1994, J NEUROL, V242, pS36, DOI 10.1007/BF00939240; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; CARONI P, 1988, PROG BRAIN RES, V78, P363; Carter LM, 2008, J NEUROSCI, V28, P14107, DOI 10.1523/JNEUROSCI.2217-08.2008; Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chau C, 1998, J NEUROPHYSIOL, V79, P392, DOI 10.1152/jn.1998.79.1.392; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149; Chuah MI, 2004, EXP NEUROL, V185, P15, DOI 10.1016/j.expneurol.2003.09.008; Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002; Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022; Cote MP, 2004, J NEUROSCI, V24, P11317, DOI 10.1523/JNEUROSCI.1486-04.2004; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Daar AS, 2007, J TISSUE ENG REGEN M, V1, P179, DOI 10.1002/term.20; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dawson J, 2008, SPINAL CORD, V46, P768, DOI 10.1038/sc.2008.50; de Leon RD, 1999, J NEUROPHYSIOL, V81, P85, DOI 10.1152/jn.1999.81.1.85; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Deer TR, 2007, PAIN MED, V8, P259, DOI 10.1111/j.1526-4637.2006.00150.x; Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47; Dunlop SA, 2008, TRENDS NEUROSCI, V31, P410, DOI 10.1016/j.tins.2008.05.004; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18; Fawcett JW, 2009, BRAIN, V132, P1417, DOI 10.1093/brain/awp121; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEHLINGS MG, 1992, BRAIN RES, V579, P32, DOI 10.1016/0006-8993(92)90738-U; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; FoidartDessalle M, 1997, EXP NEUROL, V148, P236, DOI 10.1006/exnr.1997.6542; Fong AJ, 2009, PROG BRAIN RES, V175, P393, DOI 10.1016/S0079-6123(09)17526-X; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Freehafer AA, 1998, SPINAL CORD, V36, P315, DOI 10.1038/sj.sc.3100475; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Galvin J, 2009, DEV NEUROREHABIL, V12, P352, DOI 10.3109/17518420903087293; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gazula VR, 2004, J COMP NEUROL, V476, P130, DOI 10.1002/cne.20204; Gerndt SJ, 1997, J TRAUMA, V42, P279, DOI 10.1097/00005373-199702000-00017; Giles GM, 2009, ARCH PHYS MED REHAB, V90, P530, DOI 10.1016/j.apmr.2009.01.004; Giszter SF, 2008, NEUROTHERAPEUTICS, V5, P147, DOI 10.1016/j.nurt.2007.10.062; Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243; Gordon T, 2007, ACTA NEUROCHIR SUPPL, V100, P3; Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412; Gottlieb DI, 2002, ANNU REV NEUROSCI, V25, P381, DOI 10.1146/annurev.neuro.25.112701.142904; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Graupe D, 2002, NEUROL RES, V24, P431, DOI 10.1179/016164102101200302; Grill R, 1997, J NEUROSCI, V17, P5560; Grill WM, 2001, J REHABIL RES DEV, V38, P633; Grill WM, 2000, ASSIST TECHNOL, V12, P6, DOI 10.1080/10400435.2000.10132006; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748; Hadlock TA, 2001, MICROSURG, V21, P96, DOI 10.1002/micr.1016; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; HALL ED, 1993, CELL MOL NEUROBIOL, V13, P415, DOI 10.1007/BF00711581; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hamid S, 2008, EUR SPINE J, V17, P1256, DOI 10.1007/s00586-008-0729-3; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Hobby J, 2001, J HAND SURG-BRIT EUR, V26, P459, DOI 10.1054/jhsb.2001.0587; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hsu SH, 2007, BIOMED MICRODEVICES, V9, P665, DOI 10.1007/s10544-007-9068-0; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Keirstead HS, 2005, TRENDS NEUROSCI, V28, P677, DOI 10.1016/j.tins.2005.09.008; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Kennedy P, 2009, SPINAL CORD, V47, P290, DOI 10.1038/sc.2008.116; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042; Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077; Koshimune M, 2003, BIO-MED MATER ENG, V13, P223; Koszdin KL, 2000, ANESTHESIOLOGY, V92, P156, DOI 10.1097/00000542-200001000-00027; Kotani N, 2000, NEW ENGL J MED, V343, P1514, DOI 10.1056/NEJM200011233432102; Kubasak MD, 2008, BRAIN, V131, P264, DOI 10.1093/brain/awm267; Landry ES, 2006, EUR J NEUROSCI, V24, P535, DOI 10.1111/j.1460-9568.2006.04917.x; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leach Jennie B, 2010, Front Neuroeng, V2, P18, DOI 10.3389/neuro.16.018.2009; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192; Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Liu Y, 1999, J NEUROSCI, V19, P4370; Lohmeyer JA, 2007, INT J ARTIF ORGANS, V30, P64, DOI 10.1177/039139880703000109; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927; LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1; Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P100, DOI 10.1016/j.jhsb.2003.09.018; Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Marchesi C, 2007, GLIA, V55, P425, DOI 10.1002/glia.20470; Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.200701089; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; McCaig CD, 2000, DEV DYNAM, V217, P299, DOI 10.1002/(SICI)1097-0177(200003)217:3<299::AID-DVDY8>3.0.CO;2-G; MCCAIG CD, 1986, J EMBRYOL EXP MORPH, V94, P245; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mensinger AF, 2000, J NEUROPHYSIOL, V83, P611, DOI 10.1152/jn.2000.83.1.611; MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213; Mimura T, 2004, J NEUROSURG, V101, P806, DOI 10.3171/jns.2004.101.5.0806; Mohanna PN, 2003, J ANAT, V203, P553, DOI 10.1046/j.1469-7580.2003.00243.x; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Moriarty LJ, 2001, J NEUROCYTOL, V30, P45, DOI 10.1023/A:1011917424450; Mukhatyar V, 2009, ADV MATER, V21, P4670; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Musienko P, 2009, IEEE T BIO-MED ENG, V56, P2707, DOI 10.1109/TBME.2009.2027226; Navarro X, 2005, J PERIPHER NERV SYST, V10, P229, DOI 10.1111/j.1085-9489.2005.10303.x; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Ngo TTB, 2003, J NEUROSCI RES, V72, P227, DOI 10.1002/jnr.10570; Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003; Nie X, 2007, INT J ORAL MAX SURG, V36, P32, DOI 10.1016/j.ijom.2006.06.005; Ogawa M, 2002, EXP HEMATOL, V30, P3, DOI 10.1016/S0301-472X(01)00770-6; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Oudega M, 1996, EXP NEUROL, V140, P218, DOI 10.1006/exnr.1996.0131; Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6; PATEL N, 1982, J NEUROSCI, V2, P483; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; PINE J, 1980, J NEUROSCI METH, V2, P19, DOI 10.1016/0165-0270(80)90042-4; Piper NA, 2006, PEDIATR ANESTH, V16, P989, DOI 10.1111/j.1460-9592.2006.01908.x; Protas EJ, 2001, ARCH PHYS MED REHAB, V82, P825, DOI 10.1053/apmr.2001.23198; Qian T, 2005, SPINAL CORD, V43, P199, DOI 10.1038/sj.sc.3101681; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Raineteau O, 2002, EUR J NEUROSCI, V16, P1761, DOI 10.1046/j.1460-9568.2002.02243.x; Raineteau O, 2001, P NATL ACAD SCI USA, V98, P6929, DOI 10.1073/pnas.111165498; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; Rutkowski GE, 2004, J NEURAL ENG, V1, P151, DOI 10.1088/1741-2560/1/3/004; Sadowsky CL, 2001, NEUROREHABILITATION, V16, P165; SAHENK Z, 1994, BRAIN RES, V655, P246, DOI 10.1016/0006-8993(94)91621-7; Schlosshauer B, 2001, BRAIN RES, V903, P237, DOI 10.1016/S0006-8993(01)02391-5; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Scott SH, 2008, NAT NEUROSCI, V11, P1245, DOI 10.1038/nn1108-1245; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SISKEN BF, 1993, J CELL BIOCHEM, V51, P404, DOI 10.1002/jcb.2400510404; Snoek GJ, 2000, SPINAL CORD, V38, P244, DOI 10.1038/sj.sc.3100980; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; Su Y, 2007, BRAIN RES, V1145, P41, DOI 10.1016/j.brainres.2007.01.138; Tatagiba M, 1997, NEUROSURGERY, V40, P541, DOI 10.1097/00006123-199703000-00023; Tatard VM, 2005, CURR DRUG TARGETS, V6, P81, DOI 10.2174/1389450053344885; Taylor P, 2001, SPINAL CORD, V39, P156, DOI 10.1038/sj.sc.3101126; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Thompson DM, 2004, ANN BIOMED ENG, V32, P1120; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tseng CY, 2003, J RECONSTR MICROSURG, V19, P331; Udina E, 2008, EXP NEUROL, V210, P238, DOI 10.1016/j.expneurol.2007.11.007; Valero-Cabre A, 2001, J NEUROSCI RES, V63, P214, DOI 10.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; WALLACE MC, 1987, NEUROSURGERY, V20, P878; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang SG, 2003, J BIOMED MATER RES A, V66A, P522, DOI 10.1002/jbm.a.10008; Weddell G, 1942, J ANAT, V77, P49; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; WEISS PAUL, 1941, SCIENCE, V93, P67, DOI 10.1126/science.93.2403.67; Westergren H, 2001, SPINAL CORD, V39, P74, DOI 10.1038/sj.sc.3101127; Wickelgren I, 2004, SCIENCE, V306, P1878; WILLIAMS LR, 1985, J COMP NEUROL, V231, P209, DOI 10.1002/cne.902310208; WILLIAMS LR, 1987, J COMP NEUROL, V264, P284, DOI 10.1002/cne.902640211; WOOD MR, 1979, SCIENCE, V206, P344, DOI 10.1126/science.482943; Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Yoshii S, 2002, BRAIN RES, V949, P202, DOI 10.1016/S0006-8993(02)03149-9; Yoshii S, 2001, BRAIN RES, V888, P158, DOI 10.1016/S0006-8993(00)03025-0; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zasler ND, 2009, PROG BRAIN RES, V177, P111, DOI 10.1016/S0079-6123(09)17709-9; Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009; Zhang PX, 2004, ARTIF CELL BLOOD SUB, V32, P509, DOI 10.1081/BIO-200039608	240	8	8	0	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2329	2347		10.1089/neu.2010.1542			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600011	21663399				2022-02-06	
J	Bendikas, EA; Wade, SL; Cassedy, A; Taylor, HG; Yeates, KO				Bendikas, Emily A.; Wade, Shari L.; Cassedy, Amy; Taylor, H. Gerry; Yeates, Keith Owen			Mothers Report More Child-Rearing Disagreements Following Early Brain Injury Than Do Fathers	REHABILITATION PSYCHOLOGY			English	Article						brain injury; family functioning; marital relationship; parental perceptions	BEHAVIOR PROBLEMS; MARITAL ADJUSTMENT; TRANSITION; PREDICTORS; CAREGIVER; HOME	Objective: To investigate differences between mother's and father's perceptions of marital relationship quality, child rearing disagreements, and family functioning over the initial 18 months following traumatic brain injury (TBI) in early childhood relative to an orthopedic-injury comparison group. Methods: Participants included 147 parent-dyads of children with TBI (n = 53) and orthopedic injuries (OL n = 94) who were between the ages of 3 and 7 years at injury. Family functioning, marital quality, and child-rearing disagreements were assessed shortly after injury and at 6, 12, and 18-month follow-ups, with ratings at the initial assessment completed to reflect preinjury functioning. Mixed model analyses were used to examine mother and father's reports of family functioning, marital quality, and child-rearing disagreements over time as a function of injury severity and parent gender. Results: We found a significant Group x Gender interaction for ratings of love and parenting disagreements. As hypothesized, mothers of children with severe TBI rated the relationship as significantly less loving than did their partners, and mothers of children with both moderate and severe TBI endorsed more parenting disagreements than did their partners. However, fathers reported higher levels of family dysfunction than their partners, regardless of injury type or severity. Conclusions: Implications for treatment based on differences in mothers' and fathers' perceptions of family and marital functioning, and future directions for research, are discussed.	[Bendikas, Emily A.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Wade, Shari L.; Cassedy, Amy] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Wade, Shari L.] Cincinnati Childrens Hosp, Med Ctr, Div Pediat Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pediat Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1UL1RR026314, UL1 RR026314] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729, R01 HD042729] Funding Source: Medline		BELSKY J, 1985, J MARRIAGE FAM, V47, P855, DOI 10.2307/352329; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BRADFORD K, 2005, J EMOTIONAL ABUSE, V5, P143, DOI DOI 10.1300/J135V05N02_; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Chaney JM, 1997, J PEDIATR PSYCHOL, V22, P229; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Conoley JC, 1996, J LEARN DISABIL-US, V29, P662, DOI 10.1177/002221949602900610; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; GRYL FE, 1991, J SOC PERS RELAT, V8, P243, DOI 10.1177/0265407591082005; Holmbeck GN, 1997, J PEDIATR PSYCHOL, V22, P167; Huston T.L., 1979, SOCIAL EXCHANGE DEV, P168, DOI [DOI 10.1016/B978-0-12-143550-9.50011-2, 10.1016/B978-0-12-143550-9.50011-2]; Johnson EM, 1998, J MARRIAGE FAM, V60, P195, DOI 10.2307/353451; JOURILES EN, 1991, CHILD DEV, V62, P1424, DOI 10.2307/1130816; Kazak AE, 1997, J PEDIATR PSYCHOL, V22, P141, DOI 10.1093/jpepsy/22.2.141; Keogh BK, 2000, AM J MENT RETARD, V105, P32, DOI 10.1352/0895-8017(2000)105<0032:MOCIFC>2.0.CO;2; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; LANDRY SH, 1990, CHILD DEV, V61, P1605, DOI 10.2307/1130768; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; O'Leary SG, 2005, J FAM PSYCHOL, V19, P208, DOI 10.1037/0893-3200.19.2.208; Papp LM, 2002, DEV PSYCHOL, V38, P774, DOI 10.1037//0012-1649.38.5.774; QUITTNER AL, 1992, REHABIL PSYCHOL, V37, P275, DOI 10.1037/h0079107; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112	33	8	8	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2011	56	4					374	382		10.1037/a0025634			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	862AQ	WOS:000298062600011	22121941	Green Accepted			2022-02-06	
J	Elkin, BS; Shaik, MA; Morrison, B				Elkin, Benjamin S.; Shaik, Mohammed A.; Morrison, Barclay, III			Chondroitinase ABC Reduces Brain Tissue Swelling In Vitro	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; chondroitinase; chond2roitin sulfate; Donnan effect; edema; porcine brain; proteoglycans; rat brain	INTRACRANIAL-PRESSURE; SULFATE PROTEOGLYCANS; MATHEMATICAL-MODEL; RAT-BRAIN; EDEMA; MANAGEMENT; SODIUM; CELLS; GLYCOSAMINOGLYCANS; HOMEOSTASIS	Increased intracranial pressure (ICP) caused by edema following severe traumatic brain injury (TBI) or stroke contributes to high rates of mortality and morbidity. The search continues for more effective treatments that target the edema that contributes to increased ICP. We previously described the effect of the fixed charge density (FCD) of brain on its swelling behavior according to the Donnan effect. Here we show that reduction of brain tissue FCD is an effective means of reducing brain tissue swelling and edema in rat and porcine cortical brain tissue in vitro. The effect of enzymes directed at digesting candidate contributors to cellular FCD such as chondroitin sulfate proteoglycans (CSPGs), heparin sulfate proteoglycans (HSPGs), and DNA was examined in slices of the adult rat cortex. All enzymes were capable of decreasing FCD in the tissue by similar to 20%, and reducing tissue swelling over a 24 h period following dissection from similar to 60% to similar to 30%. Chondroitinase ABC (ChABC) was most effective at reducing dead brain tissue swelling in response to changes in ionic osmotic environments. ChABC reduced swelling in live slices of tissue even within the first 2 h following dissection. It also significantly reduced the FCD, initial tissue swelling, and volume change in response to hypotonic bathing solution in porcine cortical brain tissue. The use of ChABC to reduce tissue FCD may be an effective method for reducing brain edema and controlling ICP following injury.	[Elkin, Benjamin S.; Shaik, Mohammed A.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,1210 Amsterdam Ave,MC 8904, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	The authors thank Drs. Alexander Romanov, Manu Sebastien, and Peter Pak at the Columbia University Medical Center (CUMC) for assistance with the procurement of porcine brain tissue. This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship (BSE).	Amorini AM, 2003, ACT NEUR S, V86, P261; AQUINO DA, 1984, J CELL BIOL, V99, P1117, DOI 10.1083/jcb.99.3.1117; Asher RA, 2000, J NEUROSCI, V20, P2427; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dronne MA, 2006, J THEOR BIOL, V240, P599, DOI 10.1016/j.jtbi.2005.10.023; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Elkin BS, 2010, PHILOS T R SOC A, V368, P585, DOI 10.1098/rsta.2009.0223; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HITCHCOCK SE, 1980, J BIOL CHEM, V255, P5668; JENKINS HG, 1988, J NEUROCHEM, V51, P1634, DOI 10.1111/j.1471-4159.1988.tb01134.x; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Kurbel S, 2008, J THEOR BIOL, V252, P769, DOI 10.1016/j.jtbi.2008.02.022; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; MARGOLIS RK, 1979, P NATL ACAD SCI USA, V76, P1711, DOI 10.1073/pnas.76.4.1711; MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Nguyen MK, 2006, J APPL PHYSIOL, V100, P1293, DOI 10.1152/japplphysiol.01274.2005; OVERBEEK JTG, 1956, PROG BIOPHYS MOL BIO, V6, P58; Papageorgakopoulou N, 2001, BIOCHIMIE, V83, P973, DOI 10.1016/S0300-9084(01)01324-4; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Rangel-Castilla L, 2008, NEUROL CLIN, V26, px; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; RAPOPORT SI, 1978, J THEOR BIOL, V74, P439, DOI 10.1016/0022-5193(78)90224-2; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sun DD, 2004, J BIOMECH ENG-T ASME, V126, P6, DOI 10.1115/1.1644562; TOMITA M, 1988, BRAIN RES, V474, P165, DOI 10.1016/0006-8993(88)90679-8; TOMITA M, 1992, AM J PHYSIOL, V262, pH603, DOI 10.1152/ajpheart.1992.262.2.H603; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Young W, 1986, Cent Nerv Syst Trauma, V3, P215; YOUNG W, 1987, STROKE, V18, P751, DOI 10.1161/01.STR.18.4.751; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1	47	8	8	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2277	2285		10.1089/neu.2010.1603			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600007	21381883				2022-02-06	
J	Zhao, XD; Zhou, YT				Zhao, Xu-dong; Zhou, Yi-ting			Effects of Progesterone on Intestinal Inflammatory Response and Mucosa Structure Alterations Following SAH in Male Rats	JOURNAL OF SURGICAL RESEARCH			English	Article						subarachnoid hemorrhage; intestine; inflammation; progesterone	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; NECROSIS-FACTOR-ALPHA; BARRIER FUNCTION; CYTOKINE; EXPRESSION; STROKE; MODEL; GUT; LEUKOCYTOSIS	Background. Subarachnoid hemorrhage (SAH) can induce a persistent inflammatory response, histopathologic changes in the gut. This study investigated whether progesterone administration modulates intestinal proinflammatory cytokine expression and structure alternations following SAH in male rats. Materials and Methods. A total of 48 male rats were randomly divided into four groups: control group (n = 12), SAH group (n = 12), SAH + vehicle group (n = 12) and SAH + progesterone group (n = 12). We measured intestinal wet/dry weight ratio; the concentrations of IL-1 beta, TNF-alpha, and IL-6 by enzyme-linked immunosorbent assay; intestinal mucosal morphologic changes by histopathologic study and electron microscopy. Results. Administration of progesterone following SAH could increase the appetite scores of SAH rats and decrease concentrations of proinflammatory cytokines and wet/dry weight ratio in the gut. SAH-induced damage of gut structure was ameliorated after progesterone supplementation. Conclusions. The results of the present study suggest that the therapeutic benefit of post-SAH progesterone supplementation might be due to its inhibitory effects on intestinal proinflammatory cytokine expression and gut structure amelioration. (C) 2011 Elsevier Inc. All rights reserved.	[Zhao, Xu-dong] Nanjing Med Univ, Wuxi Hosp Affiliated 2, Dept Neurosurg, Wuxi 214002, Jiangsu Provinc, Peoples R China; [Zhou, Yi-ting] Wuxi Integrated Tradit Chinese & Western Med Hosp, Dept Radiol, Wuxi, Jiangsu Provinc, Peoples R China		Zhao, XD (corresponding author), Nanjing Med Univ, Wuxi Hosp Affiliated 2, Dept Neurosurg, 68 Zhong Shan Rd, Wuxi 214002, Jiangsu Provinc, Peoples R China.	zhaoxudong623@yahoo.cn					Amasheh M, 2009, SCAND J GASTROENTERO, V44, P1226, DOI 10.1080/00365520903131973; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Davenport RJ, 1996, STROKE, V27, P421, DOI 10.1161/01.STR.27.3.421; Dooling Ellen, 2004, J Neurosci Nurs, V36, P130; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Gambhir S, 2009, J CLIN NEUROSCI, V16, P921, DOI 10.1016/j.jocn.2008.10.009; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Gotkin JL, 2006, AM J OBSTET GYNECOL, V195, P1015, DOI 10.1016/j.ajog.2006.07.002; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Kurachi O, 2001, J CLIN ENDOCR METAB, V86, P2275, DOI 10.1210/jc.86.5.2275; MARION DW, 1986, NEUROSURGERY, V18, P101, DOI 10.1227/00006123-198601000-00019; Neuder LE, 2009, VET IMMUNOL IMMUNOP, V129, P192, DOI 10.1016/j.vetimm.2008.11.006; PARKINSON D, 1984, SURG NEUROL, V21, P132, DOI 10.1016/0090-3019(84)90330-6; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; SCHELL AR, 1987, ARCH INTERN MED, V147, P591, DOI 10.1001/archinte.147.3.591; Schroeder JE, 2009, INJURY, V40, pS82, DOI 10.1016/j.injury.2009.10.041; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Shields AD, 2005, AM J OBSTET GYNECOL, V193, P1144, DOI 10.1016/j.ajog.2005.05.046; SPALLONE A, 1987, SURG NEUROL, V27, P253, DOI 10.1016/0090-3019(87)90038-3; Svigelj V, 1996, ACTA NEUROL SCAND, V94, P120, DOI 10.1111/j.1600-0404.1996.tb07041.x; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; TANAKA S, 1979, ACTA NEUROCHIR, V48, P223, DOI 10.1007/BF02056970; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; WEIR BK, 1978, J NEUROSURG, V49, P502, DOI 10.3171/jns.1978.49.4.0502; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	35	8	9	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	NOV	2011	171	1					E47	E53		10.1016/j.jss.2011.07.018			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	839LS	WOS:000296368000007	21924739				2022-02-06	
J	Hasler, RM; Benz, J; Benneker, LM; Kleim, B; Dubler, S; Zimmermann, H; Exadaktylos, AK				Hasler, Rebecca M.; Benz, Judith; Benneker, Lorin M.; Kleim, Birgit; Dubler, Simon; Zimmermann, Heinz; Exadaktylos, Aristomenis K.			Do alpine skiers and snowboarders wear protective equipment more often after an accident?	SWISS MEDICAL WEEKLY			English	Article						alpine skiing; snowboarding; helmet; back protector; behaviour after injury	TRAUMATIC-BRAIN-INJURY; SWITZERLAND	QUESTIONS UNDER STUDY/PRINCIPLES: Analysis of changes in the behaviour of wearing protective equipment by alpine skiers and snowboarders after injury, performed at a level I trauma centre in Switzerland. METHODS: We present a study, using a standardised questionnaire, assessing behaviour on ski slopes by adult patients admitted between Oct 2007 and April 2008. Patients were re-interviewed after the 2008/2009 season. McNemar tests were used to analyse differences in protective clothing wearing rates between the two seasons. Multiple logistic regression with age, gender and injury severity score (ISS) as predictors, was used to compare findings in those who started wearing protective equipment and those who did not. RESULTS: A total of 104/132 patients from the 2007/2008 season were questioned about wearing protective equipment in 2008/2009. 20 patients could not be reassessed (7 declined, 13 had abandoned winter sports). A total of 84 patients were reassessed (61 alpine skiers and 23 snowboarders). The median age of participants was 39 years and 70.2% were male. Helmet and back protector wearing rates increased from 40.5% to 78.6% (p <0.001) and from 14.3% to 23.8% (p = 0.021), respectively. Snowboarders more than doubled their helmet wearing rate (39.1% to 82.6%, p = 0.002). Skiers showed a trend towards doubling their back protector wearing rate (6.6% to 14.8%, p = 0.063). Younger skiers started wearing back protectors more often than older skiers. CONCLUSIONS: Sustained injury might provide skiers and snowboards with a potent trigger to change their attitude towards the use of protective equipment. The psychological processes influencing the use of protective equipment require further investigation.	[Hasler, Rebecca M.] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Benneker, Lorin M.] Univ Hosp Bern, Dept Orthopaed Surg, CH-3010 Bern, Switzerland; [Kleim, Birgit] Univ Zurich, Dept Psychol, CH-8006 Zurich, Switzerland		Hasler, RM (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, Freiburgstr, CH-3010 Bern, Switzerland.	rebecca.hasler@gmail.com	Kleim, Birgit/AAM-5309-2021				*AAAM COMM INJ SCA, 2008, ABBR INJ SCAL 2008 R; Clarke VA, 2000, J BEHAV MED, V23, P367, DOI 10.1023/A:1005500917875; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Hasler RM, 2009, BRIT J SPORT MED, V43, P1020, DOI 10.1136/bjsm.2009.064741; Hasler RM, 2010, BRIT J SPORT MED, V44, P816, DOI 10.1136/bjsm.2010.071357; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Schmitt KU, 2010, BRIT J SPORT MED, V44, P822, DOI 10.1136/bjsm.2010.072728; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633	11	8	8	0	1	E M H SWISS MEDICAL PUBLISHERS LTD	MUTTENZ	FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND	1424-7860			SWISS MED WKLY	Swiss Med. Wkly.	OCT 27	2011	141								w13283	10.4414/smw.2011.13283			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	841RV	WOS:000296531500001	22030562	Green Submitted, gold			2022-02-06	
J	Asehnoune, K; Roquilly, A; Sebille, V				Asehnoune, Karim; Roquilly, Antoine; Sebille, Veronique		Corti-TC Trial Grp	Corticotherapy for traumatic brain-injured Patients - The Corti-TC trial: study protocol for a randomized controlled trial	TRIALS			English	Article						Trauma; Traumatic brain injury; corticosteroid insufficiency; glucocorticoid; mineralocorticoid; pneumonia; nosocomial infection; intensive care unit	VENTILATOR-ASSOCIATED PNEUMONIA; ADRENAL INSUFFICIENCY; SEVERE SEPSIS; SEPTIC SHOCK; RISK-FACTORS; HYDROCORTISONE; MANAGEMENT; CORTICOSTEROIDS; PREVENTION; MORTALITY	Background: Traumatic brain injury (TBI) is a main cause of severe prolonged disability of young patients. Hospital acquired pneumonia (HAP) add to the morbidity and mortality of traumatic brain-injured patients. In one study, hydrocortisone for treatment of traumatic-induced corticosteroid insufficiency (CI) in multiple injured patients has prevented HAP, particularly in the sub-group of patients with severe TBI. Fludrocortisone is recommended in severe brain-injured patients suffering from acute subarachnoid hemorrhage. Whether an association of hydrocortisone with fludrocortisone protects from HAP and improves neurological recovery is uncertain. The aim of the current study is to compare corticotherapy to placebo for TBI patients with CI. Methods: The CORTI-TC (Corticotherapy in traumatic brain-injured patients) trial is a multicenter, randomized, placebo controlled, double-blind, two-arms study. Three hundred and seventy six patients hospitalized in Intensive Care Unit with a severe traumatic brain injury (Glasgow Coma Scale <= 8) are randomized in the first 24 hours following trauma to hydrocortisone (200 mg. day(-1) for 7 days, 100 mg on days 8-9 and 50 mg on day-10) with fludrocortisone (50 mu g for 10 days) or double placebo. The treatment is stopped if patients have an appropriate adrenal response. The primary endpoint is HAP on day-28. The endpoint of the ancillary study is the neurological status on 6 and 12 months. Discussion: The CORTI-TC trial is the first randomized controlled trial powered to investigate whether hydrocortisone with fludrocortisone in TBI patients with CI prevent HAP and improve long term recovery.	[Asehnoune, Karim] CHU Nantes, Serv Anesthesie Reanimat Chirurg, Hotel Dieu HME, F-44035 Nantes 01, France; [Roquilly, Antoine; Corti-TC Trial Grp] Hop Hotel Dieu, Intens Care Unit, F-44093 Nantes, France; [Sebille, Veronique] Pharm Univ Nantes, EA 4275, Biostat Unit, F-44000 Nantes, France		Asehnoune, K (corresponding author), CHU Nantes, Serv Anesthesie Reanimat Chirurg, Hotel Dieu HME, F-44035 Nantes 01, France.	karim.asehnoune@chu-nantes.fr	Roquilly, Antoine/P-9826-2017; Sebille, Veronique/L-8761-2015; Sebille, Veronique/I-3309-2015; Seguin, Philippe/P-9487-2019	Seguin, Philippe/0000-0002-7774-4257; mimoz, olivier/0000-0003-1737-7915; Sebille, Veronique/0000-0002-0780-7742; Malledant, yannick/0000-0001-6680-5184; hanouz, jean-luc/0000-0003-1845-8610	Societe Francaise d'Anesthesie Reanimation (SFAR)	This study is an investigator-initiated trial, funded by the Societe Francaise d'Anesthesie Reanimation (SFAR).	Albert SG, 2011, INTENS CARE MED, V37, P901, DOI 10.1007/s00134-011-2160-1; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bandiera GW, 1999, J TRAUMA, V47, P932, DOI 10.1097/00005373-199911000-00020; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Czaja AS, 2009, J TRAUMA, V67, P805, DOI 10.1097/TA.0b013e318185e1fb; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Klompas M, 2009, CRIT CARE, V13, DOI 10.1186/cc8036; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Reynolds SF, 2005, CHEST, V127, P1397, DOI 10.1378/chest.127.4.1397; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Seguin P, 2006, CRIT CARE MED, V34, P1514, DOI 10.1097/01.CCM.0000214516.73076.82; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051	34	8	9	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	OCT 14	2011	12								228	10.1186/1745-6215-12-228			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	853IZ	WOS:000297420700001	21999663	Green Published, gold			2022-02-06	
J	Larson, MJ; Fair, JE; Farrer, TJ; Perlstein, WM				Larson, Michael J.; Fair, Joseph E.; Farrer, Thomas J.; Perlstein, William M.			Predictors of performance monitoring abilities following traumatic brain injury: The influence of negative affect and cognitive sequelae	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Depression; Anxiety; Negative affect; Traumatic brain injury; Error related negativity; Event-related potential	ERROR-RELATED-NEGATIVITY; HEAD-INJURY; DEPRESSION; DYSFUNCTION; AWARENESS; MILD; PREVALENCE; COMPONENTS; POSITIVITY; FEEDBACK	Performance monitoring is a cognitive control process modulated by both cognitive and affective variables. This study examined the relative contributions of negative affect (NA) and cognitive sequelae to performance monitoring dysfunction following severe traumatic brain injury (TBI). We used the error-related negativity (ERN) and post-error positivity (Pe) components of the event-related potential (ERP) to test the hypothesis that NA and cognitive sequelae would predict performance monitoring dysfunction beyond time since injury, and injury severity. Nineteen survivors of severe TBI completed neuropsychological tests, measures of NA, and a computerized Stroop task. Scores on NA and neuropsychological measures were standardized to form magnitude of cognitive sequelae and negative affect composite scores. Separate hierarchical regression analyses with ERN and Pe amplitudes as dependent variables and injury severity, time since injury, magnitude of cognitive sequelae, and NA as independent variables indicated that NA and cognitive sequelae significantly predicted ERN amplitude, with a larger relative contribution of NA than cognitive sequelae. Increased levels of NA were associated with decreased amplitude ERN. Cognitive sequelae, but not NA, predicted Pe amplitude. Injury severity and time since injury were not significant predictors. Results suggest that both NA and cognitive sequelae play critical roles in performance monitoring decrements following TBI and indicate a possible dissociation between the ERN and Pe, with the ERN more related to affective processes and the Pe to cognitive processes. (C) 2011 Elsevier B.V. All rights reserved.	[Larson, Michael J.; Fair, Joseph E.; Farrer, Thomas J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Perlstein, William M.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Perlstein, William M.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065; Farrer, Thomas J./0000-0001-8092-6214	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS053335, K01 MH01857, R21 MH073076]; Evelyn F. McKnight Brain Research Grant Program; Florida Brain and Spinal Cord Injury Research Trust; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH073076, K01MH001857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS053335] Funding Source: NIH RePORTER	This research was supported by a National Institute of Health (NIH) Fellowship to MJL (F31 NS053335) and grants from the Evelyn F. McKnight Brain Research Grant Program, the Florida Brain and Spinal Cord Injury Research Trust Fund, and the NIH to WMP (K01 MH01857; R21 MH073076). The authors report no conflicts of interest.	Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Benton A., 1976, MULTILINGUAL APHASIA; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bressan RA, 2005, ACTA PSYCHIAT SCAND, V111, P14, DOI 10.1111/j.1600-0447.2005.00540.x; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chiu PH, 2007, AM J PSYCHIAT, V164, P608, DOI 10.1176/appi.ajp.164.4.608; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Compton RJ, 2007, BRAIN COGNITION, V64, P247, DOI 10.1016/j.bandc.2007.03.006; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Emerson CS, 2005, ARCH CLIN NEUROPSYCH, V20, P539, DOI 10.1016/j.acn.2004.10.003; Emerson CS, 2001, NEUROPSY NEUROPSY BE, V14, P130; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Heaton R. K., 2004, REVISED COMPREHENSIV; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim MS, 2006, PSYCHIAT CLIN NEUROS, V60, P303, DOI 10.1111/j.1440-1819.2006.01506.x; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Ladouceur CD, 2010, DEV NEUROPSYCHOL, V35, P194, DOI 10.1080/87565640903526553; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P595, DOI 10.1017/S1355617707070749; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2011, COGN AFFECT BEHAV NE, V11, P159, DOI 10.3758/s13415-010-0018-6; Larson MJ, 2010, PSYCHOPHYSIOLOGY, V47, P415, DOI 10.1111/j.1469-8986.2009.00949.x; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Larson MJ, 2006, NEUROREPORT, V17, P329, DOI 10.1097/01.wnr.0000199461.01542.db; Leon-Carrion J, 1997, NEUROPSYCHOL REHABIL, P415; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Levine B., 2002, PRINCIPLES FRONTAL L, P448; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Liotti M, 2001, J CLIN EXP NEUROPSYC, V23, P121, DOI 10.1076/jcen.23.1.121.1223; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Luu P, 2000, J EXP PSYCHOL GEN, V129, P43, DOI [10.1037/0096-3445.129.1.43, 10.1037//0096-3445.129.1.43]; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; MARX EM, 1992, J ABNORM PSYCHOL, V101, P78, DOI 10.1037/0021-843X.101.1.78; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mialet JP, 1996, PSYCHOL MED, V26, P1009, DOI 10.1017/S0033291700035339; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mitchell RA, 2011, CNS NEUROSCI THER, V17, P411, DOI 10.1111/j.1755-5949.2010.00161.x; Mohanty A., 2002, TXB BIOL PSYCHIAT, P791; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nizam, 2007, APPL REGRESSION ANAL; O'Connell RG, 2009, NEUROPSYCHOLOGIA, V47, P1149, DOI 10.1016/j.neuropsychologia.2009.01.011; Olvet DM, 2010, PSYCHIAT RES, V179, P30, DOI 10.1016/j.psychres.2010.06.008; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Prigatano G.P, 2005, REHABILITATION TRAUM, P383; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robinson RG, 2005, TXB TRAUMATIC BRAIN, P201; Ruchsow M, 2006, J PSYCHIATR RES, V40, P37, DOI 10.1016/j.jpsychires.2005.02.002; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Shenal BV, 2003, NEUROPSYCHOL REV, V13, P33, DOI 10.1023/A:1022300622902; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Speilberger C, 1983, MANUAL STATE TRAIT A; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; TEASDALE G, 1974, LANCET, V2, P81; Tops M, 2006, PSYCHONEUROENDOCRINO, V31, P847, DOI 10.1016/j.psyneuen.2006.04.001; TRICHARD C, 1995, PSYCHOL MED, V25, P79, DOI 10.1017/S0033291700028105; Tucker DM, 2003, J ABNORM PSYCHOL, V112, P667, DOI 10.1037/0021-843X.112.4.667; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiswede D, 2009, SOC COGN AFFECT NEUR, V4, P227, DOI 10.1093/scan/nsp015; Wiswede D, 2009, NEUROPSYCHOLOGIA, V47, P83, DOI 10.1016/j.neuropsychologia.2008.08.016; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	83	8	8	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		61	68		10.1016/j.ijpsycho.2011.02.001			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600007	21315777				2022-02-06	
J	Putukian, M				Putukian, Margot			Neuropsychological Testing as It Relates to Recovery From Sports-related Concussion	PM&R			English	Article							COMPUTERIZED COGNITIVE ASSESSMENT; TEST-RETEST RELIABILITY; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; HEAD-INJURY; SYMPTOMS; IMPAIRMENT; MANAGEMENT; IMPACT; RETURN	Concussion is a challenging injury for the sports medicine team, and neuropsychological testing has been used as an adjunct to other clinical measures for assessment and management, and to guide return-to-play decisions. Understanding the limitations as well as the role of neuropsychological testing in the evaluation and management of sports-related concussion is important for the sports medicine team. This article will review the evidence regarding the utility of neuropsychological testing as it relates to concussion in sports. PM R 2011;3:S425-S432	[Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Putukian, Margot] Univ Med & Dent New Jersey, Newark, NJ 07103 USA		Putukian, M (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	putukian@princeton.edu					[Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB., 2003, ARCH CLIN NEUROPSYCH, V17, P460; Barth JT, 2001, J ATHL TRAINING, V36, P253; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Grindel Scott H, 2006, Curr Sports Med Rep, V5, P9; Gronwall D, 1989, J NEUROL NEUROSUR PS, P153; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hecht S, 2004, CLIN J SPORT MED, V14, P310; Herring SA, MED SCI SPO IN PRESS; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2006, BRAIN INJURY, P1; IVERSON GL, 2009, BR J SPORTS MED S1, V43, P100; Iverson GL, 2009, CAN AC SPORTS MED M; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Lovell MR., 2000, NEUROLOGIC ATHLETIC, P32; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Maddocks DL, 1993, INFORMATION PROCESSI, P1; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P255; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2005, BRIT J SPORT MED, V39, P63; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Nassiri JD, 2002, MIL MED, V167, P873, DOI 10.1093/milmed/167.10.873; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Putukian Margot, 2006, Curr Sports Med Rep, V5, P15; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Shuttleworth-Edwards AB, 2002, BRIT J SPORT MED, V36, P473, DOI 10.1136/bjsm.36.6.473-a; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Turner M., 1998, JOCK CLUB C HEAD INJ; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	87	8	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S425	S432		10.1016/j.pmrj.2011.08.003			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100010	22035685				2022-02-06	
J	El-Alfy, BS				El-Alfy, Barakat Sayed			Results of the percutaneous pinning of proximal humerus fractures with a modified palm tree technique	INTERNATIONAL ORTHOPAEDICS			English	Article							INTERNAL-FIXATION; 3-PART FRACTURES; EPIDEMIOLOGY; CHILDREN; PINS	Many techniques are available for closed reduction and percutaneous fixation of proximal humeral fractures. The palm tree technique was described by Kapandji in 1989. In that technique three curved wires are inserted through one hole at the V-shaped insertion of the deltoid muscle. It is a good technique but it has some disadvantages. In this study we introduced some modifications for the technique, and we evaluated the clinical results of the modified technique in treatment of 18 cases. Eighteen patients with displaced proximal humeral fractures were treated by closed reduction and percutaneous fixation with the palm tree technique after minor modifications. The age of the patients ranged from 38 to 75 years with an average of 56 years. Eleven were females and seven were males. The fractures were two-part in 13 cases and three-part fractures in five cases. The average time of healing was seven weeks. The follow-up period ranged from 14 months to 39 months with an average of 22 months. The Constant score ranged from 45 to 88 with a mean of 73. The results were satisfactory in 77% and unsatisfactory in 23% of the cases. The complications included pin tract infection in two cases, intraarticular wire migration in one case, skin necrosis around the wires in three cases and malunion with varus deformity in one case. No cases were complicated by neurovascular injury, loss of fixation or avascular necrosis of the humeral head. The palm tree technique is a good method for fixation of proximal humeral fractures. It produces good grip in both of the proximal and distal fragments and allows for early joint movements. Our modifications allow for easy insertion of the wires, increase the stability of fixation and minimize the risk of complications.	Al Razi Orthopaed Hosp, Safat 13043, Kuwait		El-Alfy, BS (corresponding author), Al Razi Orthopaed Hosp, POB 4235, Safat 13043, Kuwait.	barakatelalfy@yahoo.com					Baron JA, 1996, BONE, V18, pS209, DOI 10.1016/8756-3282(95)00504-8; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Descamps P Y, 2001, Acta Orthop Belg, V67, P219; Fenichel I, 2006, INT ORTHOP, V30, P153, DOI 10.1007/s00264-005-0058-7; Gerber C, 2004, J BONE JOINT SURG BR, V86B, P848, DOI 10.1302/0301-620X.86B6.14577; Herscovici D, 2000, CLIN ORTHOP RELAT R, P97; Jiang CY, 2007, J SHOULDER ELB SURG, V16, P235, DOI 10.1016/j.jse.2006.05.011; KAPANDJI A, 1989, Annales de Chirurgie de la Main, V8, P39, DOI 10.1016/S0753-9053(89)80044-4; LASCOMBES P, 1990, J PEDIATR ORTHOPED, V10, P167; Le Bellec Y, 2002, REV CHIR ORTHOP, V88, P342; LIND T, 1989, ARCH ORTHOP TRAUM SU, V108, P285, DOI 10.1007/BF00932316; Metaizeau JP, 2004, J BONE JOINT SURG BR, V86B, P954, DOI 10.1302/0301-620X.86B7.15620; Naidu SH, 1997, ORTHOPEDICS, V20, P1073; Naranja R J Jr, 2000, J Am Acad Orthop Surg, V8, P373; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Pospula W, 2009, MED PRIN PRACT, V18, P284, DOI 10.1159/000215725; Rowles DJ, 2001, J BONE JOINT SURG AM, V83A, P1695, DOI 10.2106/00004623-200111000-00012; Vogel G, 2007, INT ORTHOP, V31, P811, DOI 10.1007/s00264-006-0266-9	19	8	9	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	SEP	2011	35	9					1343	1347		10.1007/s00264-011-1231-9			5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	809OS	WOS:000294067200011	21409369	Green Published			2022-02-06	
J	Hawkeswood, J; Finlayson, H; O'Connor, R; Anton, H				Hawkeswood, Jonathan; Finlayson, Heather; O'Connor, Russ; Anton, Hugh			A PILOT SURVEY ON INJURY AND SAFETY CONCERNS IN INTERNATIONAL SLEDGE HOCKEY	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Disabled athlete; Paralympic; sledge hockey		Objective: To describe sledge hockey injury patterns, safety issues and to develop potential injury prevention strategies. Design: Pilot survey study of international sledge hockey professionals, including trainers, physiotherapists, physicians, coaches and/or general managers. Setting: Personal encounter or online correspondence. Respondents: Sledge hockey professionals; a total of 10 respondents from the 5 top-ranked international teams recruited by personal encounter or online correspondence. Main Outcome Measurements: Descriptive Data reports on sledge athlete injury characteristics, quality of rules and enforcement, player equipment, challenges in the medical management during competition, and overall safety. Results: Muscle strains and concussions were identified as common, and injuries were reported to affect the upper body more frequently than the lower body. Overuse and body checking were predominant injury mechanisms. Safety concerns included excessive elbowing, inexperienced refereeing and inadequate equipment standards. Conclusions: This paper is the first publication primarily focused on sledge hockey injury and safety. This information provides unique opportunity for the consideration of implementation and evaluation of safety strategies. Safety interventions could include improved hand protection, cut-resistant materials in highrisk areas, increased vigilance to reduce intentional head-contact, lowered rink boards and modified bathroom floor surfacing.	[Hawkeswood, Jonathan; Finlayson, Heather; O'Connor, Russ; Anton, Hugh] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Hawkeswood, Jonathan] GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada		Hawkeswood, J (corresponding author), GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	jonhawkeswood@hotmail.com					Allman R M, 1999, Adv Wound Care, V12, P22; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Ferrara MS, 2000, SPORTS MED, V30, P137, DOI 10.2165/00007256-200030020-00006; Ferrara MS, 2000, INT J SPORTS MED, V21, P221, DOI 10.1055/s-2000-300; Gold JR, 2007, J R SOC PROMO HEALTH, V127, P133, DOI 10.1177/1466424007077348; International Paralympic Committee, WINTER SPORTS; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; Webborn N, 2006, MED SCI SPORT EXER, V38, P811, DOI 10.1249/01.mss.0000218120.05244.da; Wheeler G, 2002, PARALYMPIC GAMES 196, P102	9	8	8	0	1	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	SEP	2011	6	3					173	185					13	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VA0PI	WOS:000409609000003	21904696				2022-02-06	
J	Helms, A; Evans, AW; Chu, J; Sahgal, A; Ostrowski, R; Sosiak, T; Wolf, G; Gillett, J; Whelan, H				Helms, A.; Evans, A. W.; Chu, J.; Sahgal, A.; Ostrowski, R.; Sosiak, T.; Wolf, G.; Gillett, J.; Whelan, H.			Hyperbaric oxygen for neurologic indications Action plan for multicenter trials in: stroke, traumatic brain injury, radiation encephalopathy & status migrainosus	UNDERSEA AND HYPERBARIC MEDICINE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTRACRANIAL HYPERTENSION; MOLECULAR MECHANISMS; DIFFUSION MISMATCH; INDUCED NECROSIS; RECURRENT TUMOR; THERAPY; APOPTOSIS; ASSOCIATION; MANAGEMENT	The 2008 Toronto Hyperbaric Medicine Symposium was convened to discuss research into neurologic indications for hyperbaric oxygen therapy (HBO2T). Four topics were particularly addressed: acute ischemic stroke; acute traumatic brain injury; brain radiation necrosis; and status migrainosus. Four multicenter trials were designed and proposed to evaluate the efficacy of HBO2 for these indications and are presented here in addition to brief reviews of the rationale behind each.	[Helms, A.; Whelan, H.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Evans, A. W.; Chu, J.; Sahgal, A.] Univ Toronto, Toronto, ON, Canada; [Ostrowski, R.] Loma Linda Univ, Sch Med, Loma Linda, CA USA; [Sosiak, T.] Toronto Gen Hosp, Toronto, ON, Canada; [Wolf, G.] Brooks Air Force Base, Brooks City, TX USA; [Gillett, J.] McMaster Univ, Hamilton, ON, Canada		Whelan, H (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.	hwhelan@mcw.edu	Ostrowski, R./AAH-6756-2019; Ostrowski, Robert/E-9767-2013	Ostrowski, Robert P./0000-0003-1373-4452	Ontario Neurotrauma Foundation; Ontario Medical Association, Section on Hyperbaric Medicine	The authors thank the Ontario Neurotrauma Foundation for providing financial support to facilitate the 2008 Toronto Hyperbaric Medicine Symposium and this proceedings summary. Thanks also to the Ontario Medical Association, Section on Hyperbaric Medicine, which sponsored the event and the efforts of its membership through the leadership of its executive, Dr. A. W. Evans (chair) and Dr. TS. Sosiak (vice-chair). As well, we acknowledge the efforts of thank the THMS planning committee volunteers & Gavin Wort, Ray Janise, and Sandra Grgas of the University Health Network (UNH) for various support functions and UHN for providing the symposium venue plus Debra Dye for administrative support. We also appreciate artistic contributions of Al Thai - webmaster for http://www.hyperbaricmedicine.ca.	AARONSON NK, 1991, EFFECT CANC QUALITY, P185; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; ARTRU F, 1976, EUR NEUROL, V14, P310, DOI 10.1159/000114753; Badr AE, 2001, BRAIN RES, V916, P85, DOI 10.1016/S0006-8993(01)02867-0; Bennett MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005219.pub2; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; BURT JT, 1987, SURG NEUROL, V28, P265, DOI 10.1016/0090-3019(87)90304-1; Calvert JW, J APPL PHYSL, V95, P2072; *CDCP, 2008, TRAUM BRAIN INJ; Chen F, 2008, BRIT J RADIOL, V81, P192, DOI 10.1259/bjr/70940134; Chesnut R M, 1995, New Horiz, V3, P366; Chuba PJ, 1997, CANCER-AM CANCER SOC, V80, P2005, DOI 10.1002/(SICI)1097-0142(19971115)80:10<2005::AID-CNCR19>3.0.CO;2-0; CORKILL G, 1985, SURG NEUROL, V24, P206, DOI 10.1016/0090-3019(85)90186-7; Demchenko IT, 2002, CIRC RES, V91, P1031, DOI 10.1161/01.RES.0000043500.03647.81; DOOMS GC, 1986, RADIOLOGY, V158, P149, DOI 10.1148/radiology.158.1.3940373; Eftedal OS, 2004, CEPHALALGIA, V24, P639, DOI 10.1111/j.1468-2982.2004.00724.x; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Gervil M, 1999, NEUROLOGY, V53, P995, DOI 10.1212/WNL.53.5.995; Gutin P., 1991, RAD INJURY NERVOUS S, P271; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Helms AK, 2005, CEREBROVASC DIS, V20, P417, DOI 10.1159/000088979; Hjelde A, 2002, EUR J APPL PHYSIOL, V86, P401, DOI 10.1007/s00421-001-0573-1; HOLBACH KH, 1974, ACTA NEUROCHIR, V30, P247, DOI 10.1007/BF01405583; Hulshof MCCM, 2002, STRAHLENTHER ONKOL, V178, P192, DOI 10.1007/s00066-002-0916-9; Jansen O, 1999, LANCET, V353, P2036, DOI 10.1016/S0140-6736(99)01146-0; JOHNSON EM, 1995, J NEUROTRAUM, V12, P843, DOI 10.1089/neu.1995.12.843; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KAHN D, 1994, AM J ROENTGENOL, V163, P1459, DOI 10.2214/ajr.163.6.7992747; KAWAMURA S, 1990, SURG NEUROL, V34, P101, DOI 10.1016/0090-3019(90)90104-W; Kohshi K, 2003, J NEUROL SCI, V209, P115, DOI 10.1016/S0022-510X(03)00007-8; Kumar AJ, 2000, RADIOLOGY, V217, P377, DOI 10.1148/radiology.217.2.r00nv36377; LANGEMARK M, 1984, PAIN, V19, P81, DOI 10.1016/0304-3959(84)90067-8; Leber KA, 1998, STEREOT FUNCT NEUROS, V70, P229, DOI 10.1159/000056426; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Linde M, 2006, ACTA NEUROL SCAND, V114, P71, DOI 10.1111/j.1600-0404.2006.00670.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lou M, 2004, STROKE, V35, P578, DOI 10.1161/01.STR.0000111599.77426.A0; MAHONEY F I, 1965, Md State Med J, V14, P61; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McPherson CM, 2004, J NEURO-ONCOL, V68, P41, DOI 10.1023/B:NEON.0000024744.16031.e9; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; OKAMOTO M, 1993, BIOCHEM BIOPH RES CO, V196, P1356, DOI 10.1006/bbrc.1993.2402; Prosser J, 2005, STROKE, V36, P1700, DOI 10.1161/01.STR.0000173407.40773.17; Pryse-Phillips W, 2006, HEADACHE, V46, P1480, DOI 10.1111/j.1526-4610.2006.00608.x; REITAN JA, 1990, STROKE, V21, P119, DOI 10.1161/01.STR.21.1.119; Ren H, 2001, Chin J Traumatol, V4, P239; Ricci PE, 1998, AM J NEURORADIOL, V19, P407; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2010, J NEUROSURG, V112, P1078; Rockswold SB, 2010, J NEUROSURG, P1079; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Schabitz WR, 2004, STROKE, V35, P1175, DOI 10.1161/01.STR.0000125868.86298.8e; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; Takenaka N, 2003, NEUROL MED-CHIR, V43, P391, DOI 10.2176/nmc.43.391; Tandon N, 2001, J NEUROSURG, V95, P507, DOI 10.3171/jns.2001.95.3.0507; Taphoorn MJ, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2041; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; The Undersea and Hyperbaric Medical Society, GUID IND HYP OX; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thompson TP, 1999, STEREOT FUNCT NEUROS, V73, P9, DOI 10.1159/000029743; VALK PE, 1991, AM J NEURORADIOL, V12, P45; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Veltkamp R, 2000, BRAIN RES, V853, P68, DOI 10.1016/S0006-8993(99)02250-7; Warnick RE, 2002, NEUROSURGERY, V51, P560; WEINSTEIN PR, 1986, NEUROSURGERY, V18, P528, DOI 10.1227/00006123-198605000-00002; WELCH KMA, 1993, NEW ENGL J MED, V329, P1476; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wilson JR, 1998, HEADACHE, V38, P112, DOI 10.1046/j.1526-4610.1998.3802112.x; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Yin W, 2002, BRAIN RES, V926, P165, DOI 10.1016/S0006-8993(01)03304-2; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003	81	8	8	0	5	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	SEP-OCT	2011	38	5					309	319					11	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	832NT	WOS:000295812400002	22013758				2022-02-06	
J	Nguyen, MT; Billington, A; Habal, MB				Michaela T. Nguyen; Billington, Alicia; Habal, Mutaz B.			Osteoradionecrosis of the Skull After Radiation Therapy for Invasive Carcinoma	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Osteoradionecrosis; parietooccipital; debridement; infection; scalp reconstruction	TEMPORAL BONE; RECONSTRUCTION; NECK; HEAD; RADIOTHERAPY; MANAGEMENT; JAWS; COMPLICATIONS; DEFECTS; SCALP	Osteoradionecrosis (ORN) of the skull is a rare but fatal complication of radiation therapy for the treatment of head and neck malignancies. The pathogenesis of ORN follows the "3Hs Theory'' proposed by Marx (J Oral Maxillofac Surg 1983;41:283-288) in which radiation induces tissue injury by causing vessel thrombosis (hypovascularity), which leads to hypoxia, and results in cell death of the skin and the underlying structure of the bony element (hypocellularity) including the deep visceral structures. This note details a patient with severe and extensive ORN of the parietooccipital region of the skull because of a large dose of radiation therapy for the treatment of an invasive basal cell carcinoma of the scalp. The patient's condition was further complicated by an extensive infection with methicillin-resistant Staphylococcus aureus, which leads to meningitis and cerebral edema as well as cerebritis. The patient was successfully treated with interdisciplinary medical and surgical aggressive therapy and radical procedures involving 4 separate trips to the operating room for an 18-month period. Success was achieved because of early clinical diagnosis of ORN, aggressive eradication of infected and necrotic tissues including the brain, and restoration of functioning and viable tissues through the use of local flaps to change an open wound to a closed wound.	[Habal, Mutaz B.] Tampa Bay Craniofacial Ctr, Tampa, FL 33603 USA; [Michaela T. Nguyen; Billington, Alicia] Univ S Florida, Coll Med, Tampa, FL USA		Habal, MB (corresponding author), Tampa Bay Craniofacial Ctr, 205 WML King Blvd, Tampa, FL 33603 USA.	mbhabal@verizon.net					Ang E, 2003, BRIT J PLAST SURG, V56, P92, DOI 10.1016/S0007-1226(03)00085-7; BERGER RP, 1990, J ORAL MAXIL SURG, V48, P82, DOI 10.1016/0278-2391(90)90187-7; DALY TE, 1973, NATIONAL CANCER C P, V7, P147; EPSTEIN JB, 1987, J ORAL MAXIL SURG, V45, P104, DOI 10.1016/0278-2391(87)90399-5; Hanasono MM, 2008, PLAST RECONSTR SURG, V122, P1739, DOI 10.1097/PRS.0b013e31818a9afa; Hao SP, 1999, LARYNGOSCOPE, V109, P1324, DOI 10.1097/00005537-199908000-00027; Huang XM, 2006, LARYNGOSCOPE, V116, P1626, DOI 10.1097/01.mlg.0000230435.71328.b9; KVETON JF, 1988, OTOLARYNG HEAD NECK, V98, P231, DOI 10.1177/019459988809800310; Leonetti JP, 1997, AM J OTOL, V18, P223; Lyons A, 2008, BRIT J ORAL MAX SURG, V46, P653, DOI 10.1016/j.bjoms.2008.04.006; MA KH, 1988, LARYNGOSCOPE, V98, P554; MARX RE, 1983, J ORAL MAXIL SURG, V41, P283, DOI 10.1016/0278-2391(83)90294-X; MEYER I, 1970, J ORAL SURG, V28, P17; Momoh AO, 2009, ANN PLAS SURG, V62, P656, DOI 10.1097/SAP.0b013e318180c913; MORRISH RB, 1981, CANCER-AM CANCER SOC, V47, P1980, DOI 10.1002/1097-0142(19810415)47:8<1980::AID-CNCR2820470813>3.0.CO;2-Y; Nason R, 2007, OTOL NEUROTOL, V28, P1026, DOI 10.1097/MAO.0b013e318157f102; PENNINGTON DG, 1989, PLAST RECONSTR SURG, V83, P655, DOI 10.1097/00006534-198904000-00010; RAMSDEN RT, 1975, J LARYNGOL OTOL, V89, P941, DOI 10.1017/S0022215100081226; Rayatt SS, 2007, INDIAN J PLAST SURG, V40, pS65; Regaud, 1922, COMPT REND SOC BIOL, V87, P629; Reuther T, 2003, INT J ORAL MAX SURG, V32, P289, DOI 10.1054/ijom.2002.0332; RUDGE FW, 1993, MIL MED, V158, P196, DOI 10.1093/milmed/158.3.196; Sciubba JJ, 2006, LANCET ONCOL, V7, P175, DOI 10.1016/S1470-2045(06)70580-0; Serra MP, 2007, J PLAST RECONSTR AES, V60, P1158, DOI 10.1016/j.bjps.2006.06.020	24	8	8	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2011	22	5					1677	1681		10.1097/SCS.0b013e31822e5f83			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	827AY	WOS:000295398700029	21959411				2022-02-06	
J	Richardson, DR; Gause, LN				Richardson, David R.; Gause, L. Nathan			The Bridle Procedure	FOOT AND ANKLE CLINICS			English	Article						Bridle procedure; Drop-foot; Cerebral palsy; Leprosy; Traumatic brain injury; Peroneal nerve palsy	TENDON; TRANSPLANTATION; PARALYSIS; ANTERIOR; DROP; FOOT	The "bridle" procedure is a modification of the transfer of the tibialis posterior to the dorsum of the foot for the treatment of a supple equinus or equinovarus deformity of the ankle and hindfoot. Indications vary based on the underlying pathology, but is indicated primarily in the setting of a drop-foot and a steppage gait, which is awkward, energy consuming, and physically limiting. This procedure usually allows for brace-free ambulation while minimizing the risk of recurrent deformity. However, the patient and family must understand a "normal" gait is unusual.	[Richardson, David R.; Gause, L. Nathan] Univ Tennessee Campbell Clin, Campbell Clin Fdn, Memphis, TN 38104 USA		Richardson, DR (corresponding author), Univ Tennessee Campbell Clin, Campbell Clin Fdn, 1211 Union Ave, Memphis, TN 38104 USA.	drrichardson@campbellclinic.com					CLOSE JR, 1959, J BONE JOINT SURG AM, V41, P189, DOI 10.2106/00004623-195941020-00001; Elsner A, 2010, FOOT ANKLE INT, V31, P30, DOI 10.3113/FAI.2010.0030; Gellman RE, 2002, MASTER TECHNIQUES OR, P597; LIPSCOMB PR, 1961, J BONE JOINT SURG AM, V43, P60, DOI 10.2106/00004623-196143010-00003; Mayer L, 1937, J BONE JOINT SURG, V19, P389; MCCALL RE, 1991, J PEDIATR ORTHOPED, V11, P83, DOI 10.1097/01241398-199101000-00016; MYERSON MS, 2000, FOOT ANKLE DISORDERS, P885; Peabody CW, 1938, J BONE JOINT SURG, V20, P193; Prahinski JR, 1996, FOOT ANKLE INT, V17, P615, DOI 10.1177/107110079601701005; Rodriguez RP, 2009, TECH FOOT ANKLE SURG, V8, P168, DOI 10.1097/BTF.0b013e3181c24c38; RODRIGUEZ RP, 1992, FOOT ANKLE, V13, P63, DOI 10.1177/107110079201300203; SCHNEIDER M, 1977, CLIN ORTHOP RELAT R, P113; SELVAPANDIAN AJ, 1959, INDIAN J SURG, V21, P151; Soares D, 1996, J BONE JOINT SURG BR, V78B, P61, DOI 10.1302/0301-620X.78B1.0780061; STRAYER LM, 1950, J BONE JOINT SURG AM, V32-A, P671, DOI 10.2106/00004623-195032030-00022; TURNER JW, 1972, CLIN ORTHOP RELAT R, P241; WATKINS MB, 1954, J BONE JOINT SURG AM, V36-A, P1181, DOI 10.2106/00004623-195436060-00007; WILLIAMS PF, 1976, J BONE JOINT SURG BR, V58, P217, DOI 10.1302/0301-620X.58B2.777009	18	8	8	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1083-7515	1558-1934		FOOT ANKLE CLIN	Foot Ankle Clin.	SEP	2011	16	3					419	433		10.1016/j.fcl.2011.06.003			15	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	837NF	WOS:000296209800006	21925359				2022-02-06	
J	Sughrue, ME; Bloch, OG; Manley, GT; Stiver, SI				Sughrue, Michael E.; Bloch, Orin G.; Manley, Geoffrey T.; Stiver, Shirley I.			Marked reduction in wound complication rates following decompressive hemicraniectomy with an improved operative closure technique	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Complication; Hemicraniectomy; Infection; Wound	TRAUMATIC BRAIN-INJURY; INFECTION FOLLOWING CRANIOTOMY; NEUROSURGICAL SITE INFECTIONS; RISK-FACTORS; CRANIECTOMY; SECONDARY	Although decompressive hemicraniectomy with dural expansion and bone flap removal is a potentially life-saving procedure, concerns remain regarding the morbidity associated with this approach. We and others have noted the high rate of wound complications resulting from this technique, often associated with cerebrospinal fluid (CSF) absorption problems. Here, we present our experience with an improved technique for wound closure after unilateral decompressive hemicraniectomy with a wide cruciate durotomy. Data for all patients who underwent a decompressive hemicraniectomy at our institution from October 2005 to October 2009 were gathered prospectively. Starting in mid 2008, we adopted an alternate approach to operative wound closure, which involved skin closure with a running Monocryl absorbable stitch, and prolonged subgaleal drainage. We compared the rates of wound complication using this approach with those obtained with earlier conventional closure techniques. Over a 1 year period, we dramatically reduced the rate of wound complications in patients undergoing hemicraniectomy at our hospital using this new (Monocryl technique, 0% (n = 29) compared to other techniques, 35% (n = 98), chi-squared [chi(2)] p < 0.001). Patients closed using our new technique experienced markedly reduced rates of wound infection (p < 0.01), and CSF leak (p < 0.05), compared to other, more standard, techniques. Thus, attention to closure of hemicraniectomy wounds can markedly reduce the rate of wound complications, thus improving the risk-to-benefit ratio of this procedure. (C) 2011 Elsevier Ltd. All rights reserved.	[Sughrue, Michael E.; Bloch, Orin G.; Manley, Geoffrey T.; Stiver, Shirley I.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA		Stiver, SI (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101,Box 0899, San Francisco, CA 94143 USA.	sstiver@neurosurg.ucsf.edu		Bloch, Orin/0000-0001-9810-6011			Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; Chen Chun-Chung, 2007, J Chin Med Assoc, V70, P56; CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; Dashti SR, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E10; Faleiro RM, 2008, ARQ NEURO-PSIQUIAT, V66, P369, DOI 10.1590/S0004-282X2008000300017; Hughes SA, 2006, SURG NEUROL, V65, P410, DOI 10.1016/j.surneu.2005.11.052; Idali B, 2004, MED MALADIES INFECT, V34, P221, DOI 10.1016/j.medmal.2003.12.011; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Lietard C, 2008, J NEUROSURG, V109, P729, DOI 10.3171/JNS/2008/109/10/0729; Paolini S, 2008, NEUROSURGERY, V62, P490, DOI 10.1227/01.NEU.0000297077.9817-5.2E; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	19	8	9	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2011	18	9					1201	1205		10.1016/j.jocn.2011.01.016			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812VC	WOS:000294320000012	21752652				2022-02-06	
J	Wagner, PJ; Wortzel, HS; Frey, KL; Anderson, CA; Arciniegas, DB				Wagner, Peter J.; Wortzel, Hal S.; Frey, Kimberly L.; Anderson, C. Alan; Arciniegas, David B.			Clock-Drawing Performance Predicts Inpatient Rehabilitation Outcomes After Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SEVERITY; MODERATE; BATTERY	The authors used clock-drawing performance to assess cognition and predict inpatient rehabilitation outcomes among persons with traumatic brain injury. Clock-drawing performance, as assessed with the Clock Drawing Interpretation Scale, predicts rehabilitation length of stay as well as Functional Independence Measure scores at the time of neurobehavioral assessment and rehabilitation discharge. (The Journal of Neuropsychiatry and Clinical Neurosciences 2011; 23:449-453)	[Wagner, Peter J.; Wortzel, Hal S.; Frey, Kimberly L.; Anderson, C. Alan; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Aurora, CO 80045 USA; [Wortzel, Hal S.] Denver Vet Affairs Med Ctr, VISN Mental Illness Res Educ & Clin Ctr 19, Denver, CO USA; [Anderson, C. Alan; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Aurora, CO USA; [Anderson, C. Alan] Denver Vet Affairs Med Ctr, Neurol Serv, Denver, CO USA		Arciniegas, DB (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Aurora, CO 80045 USA.	David.Arciniegas@UCDenver.edu			HCA/HealthONE Spalding Rehabilitation Hospital; VA VISN-19 Mental Illness Research, Education, and Clinical Center	This work was supported in part by HCA/HealthONE Spalding Rehabilitation Hospital and the VA VISN-19 Mental Illness Research, Education, and Clinical Center.	[Anonymous], 1997, GUID UN DAT SET MED; Arciniegas DB, 2001, NEUROPSYCHIATRY INTR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McNett Molly, 2007, J Neurosci Nurs, V39, P68; MENDEZ MF, 1992, J AM GERIATR SOC, V40, P1095, DOI 10.1111/j.1532-5415.1992.tb01796.x; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; TEASDALE G, 1974, LANCET, V2, P81; Wood S, 2000, AM J GERIAT PSYCHIAT, V8, P75, DOI 10.1097/00019442-200002000-00010; Wortzel HS, 2009, J NEUROPSYCH CLIN N, V21, P463, DOI 10.1176/appi.neuropsych.21.4.463	17	8	8	1	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2011	23	4					449	453		10.1176/jnp.23.4.jnp449			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	875GT	WOS:000299019100012	22231317				2022-02-06	
J	Xiong, WH; Ping, XJ; Gao, JH; Jin, XM				Xiong, Wenhui; Ping, Xingjie; Gao, Jianhua; Jin, Xiaoming			Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 55; epilepsy; traumatic brain injury; brain; mouse; rat; surgery	V PYRAMIDAL NEURONS; SEIZURES; TRAUMA	Partially isolated cortex ("undercut") is an animal model of posttraumatic epileptogenesis. The surgical procedure involves cutting through the sensorimotor cortex and the underneath white matter (undercut) so that a specific region of the cerebral cortex is largely isolated from the neighboring cortex and subcortical regions(1-3). After a latency of two or more weeks following the surgery, epileptiform discharges can be recorded in brain slices from rodents(1); and electrical or behavior seizures can be observed in vivo from other species such as cat and monkey(4-6). This well established animal model is efficient to generate and mimics several important characteristics of traumatic brain injury. However, it is technically challenging attempting to make precise cortical lesions in the small rodent brain with a free hand. Based on the procedure initially established in Dr. David Prince's lab at the Stanford University(1), here we present an improved technique to perform a surgery for the preparation of this model in mice and rats. We demonstrate how to make a simple surgical device and use it to gain a better control of cutting depth and angle to generate more precise and consistent results. The device is easy to make, and the procedure is quick to learn. The generation of this animal model provides an efficient system for study on the mechanisms of posttraumatic epileptogenesis.	[Xiong, Wenhui; Ping, Xingjie; Gao, Jianhua; Jin, Xiaoming] Indiana Univ Sch Med, Dept Neurosurg, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA		Jin, XM (corresponding author), Indiana Univ Sch Med, Dept Neurosurg, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	xijin@iupui.edu	Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016; ping, xingjie/AAW-4597-2020	Jin, Xiaoming/0000-0002-8671-8640; 	NIH/NINDS grant [4R00 NS 057940]; Spinal Cord and Brain Injury Research fund from the Indiana State Department of Health [SCBI 200-12]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R00NS057940] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS grant 4R00 NS 057940, and grant SCBI 200-12 from the Spinal Cord and Brain Injury Research fund from the Indiana State Department of Health.	Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; ECHLIN FA, 1963, ARCH NEUROL-CHICAGO, V9, P154, DOI 10.1001/archneur.1963.00460080064009; Graber KD, 2006, MODELS OF SEIZURES AND EPILEPSY, P477, DOI 10.1016/B978-012088554-1/50040-2; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Prince D A, 1999, Adv Neurol, V79, P665; Salin P, 1995, J NEUROSCI, V15, P8234; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x	13	8	8	0	4	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	SEP	2011		55							e2840	10.3791/2840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36OY	WOS:000209222100005	21946525	Green Published			2022-02-06	
J	Asha'ari, ZA; Ahmad, R; Rahman, J; Kamarudin, N; Ishlah, LW				Asha'ari, Z. A.; Ahmad, R.; Rahman, J.; Kamarudin, N.; Ishlah, L. Wan			Contrecoup injury in patients with traumatic temporal bone fracture	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article						Temporal Bone; Skull Fractures; Brain Injuries; Contrecoup Injury; Diagnosis	BRAIN	Objective: To study the prevalence and patterns of contrecoup injury in traumatic temporal bone fracture cases. Method: A prospective, cohort study was undertaken of all patients with traumatic head injury admitted to a tertiary referral hospital in Malaysia within an 18-month period. High resolution computed tomography scans of the brain and skull base were performed in indicated cases, based on clinical findings and Glasgow coma score. Patients with a one-sided temporal bone fracture were selected and subsequent magnetic resonance imaging performed in all cases. Contrecoup injury incidence, type, severity and outcome were recorded. Results: Of 1579 head injury cases, 81 (5.1 per cent) met the inclusion criteria and were enrolled in the study. Temporal bone fractures were significantly associated with intracranial injuries (p < 0.001). The incidence of a contrecoup injury in cases with temporal bone fracture was 13.6 per cent. Contrecoup injury was significantly associated with petrous temporal bone fracture (p < 0.01). The commonest contrecoup injury was cerebral contusion, followed by extradural haematoma and subdural haematoma. Conclusion: Contrecoup injury is not uncommon in cases of temporal bone fracture, and is significantly associated with petrous temporal bone fracture.	[Asha'ari, Z. A.; Ahmad, R.; Ishlah, L. Wan] Int Islamic Univ Malaysia, Jalan Hosp, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Kuantan 25100, Pahang, Malaysia; [Rahman, J.] Int Islamic Univ Malaysia, Jalan Hosp, Fac Med, Dept Community Med, Kuantan 25100, Pahang, Malaysia; [Kamarudin, N.] Hosp Tengku Ampuan Afzan, Dept Radiol, Kuantan, Pahang, Malaysia		Asha'ari, ZA (corresponding author), Int Islamic Univ Malaysia, Jalan Hosp, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Kuantan 25100, Pahang, Malaysia.	zamzilamin@yahoo.com	R Lope Ahmad, Raja Ahmad/E-6597-2012; Asha'ari, Zamzil/E-7506-2012; Rahman, Jamalludin Ab/F-1612-2010	Rahman, Jamalludin Ab/0000-0003-4323-1194; R Lope Ahmad, Raja Ahmad/0000-0002-3559-5214			BALASUBRAMANIAM V, 1991, SURG NEUROL, V36, P462, DOI 10.1016/0090-3019(91)90161-2; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Brodie HA, 1997, AM J OTOL, V18, P188; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hardin M F, 1996, Kans Med, V97, P14; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Jones RM, 2000, ARCH OTOLARYNGOL, V126, P131, DOI 10.1001/archotol.126.2.131; Lee HJ., 1998, EMERG RADIOL, V5, P8, DOI [10.1007/BF02749121, DOI 10.1007/BF02749121]; Mitsuyama T, 2004, NEUROL MED-CHIR, V44, P584, DOI 10.2176/nmc.44.584; Morrison AL, 1998, AM J FOREN MED PATH, V19, P109, DOI 10.1097/00000433-199806000-00002; Poirier MP, 2003, CLIN PEDIATR EMERG M, V4, P179, DOI DOI 10.1016/S1522-8401(03)00061-2; RYAN GA, 1994, J TRAUMA, V36, P469; Saraiya PV, 2009, EMERG RADIOL, V16, P255, DOI 10.1007/s10140-008-0777-3; Ulug T, 2006, J OTOLARYNGOL, V35, P380, DOI 10.2310/7070.2006.0069; Yavuz MS, 2003, AM J FOREN MED PATH, V24, P339, DOI 10.1097/01.paf.0000103011.14578.c3	18	8	9	0	6	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0022-2151	1748-5460		J LARYNGOL OTOL	J. Laryngol. Otol.	AUG	2011	125	8					781	785		10.1017/S0022215111000545			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	802NA	WOS:000293517100004	21524330				2022-02-06	
J	Kutzing, MK; Luo, V; Firestein, BL				Kutzing, Melinda K.; Luo, Vincent; Firestein, Bonnie L.			Measurement of Synchronous Activity by Microelectrode Arrays Uncovers Differential Effects of Sublethal and Lethal Glutamate Concentrations on Cortical Neurons	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Microelectrode array; Glutamate-mediated neurotoxicity; Traumatic brain injury; Synchronization of action potentials	TRAUMATIC BRAIN-INJURY; IN-VITRO; NETWORKS; PATTERNS; SYNCHRONIZATION; NEUROTOXICITY; ASTROCYTES; EXPRESSION; PLASTICITY; DYNAMICS	We grew cultures of rat cortical cells on microelectrode arrays to investigate the effects of glutamate-mediated neurotoxicity as a model of traumatic brain injury. Treatment with two different concentrations of glutamate, 175 and 250 mu M, led to different outcomes. Cultures treated with 250 mu M glutamate suffered a loss in overall activity that was not seen in cultures treated with 175 mu M glutamate. An analysis of the changes in the synchronization of action potential firing between electrodes, however, revealed a loss of synchronization in subsets of electrode pairs treated with both the higher and lower concentrations of glutamate. We found that this loss of action potential synchronization was dependent on the initial amount of synchronization prior to injury. Finally, our data suggest that the synchronization of electrical activity as well as the susceptibility to loss of firing synchrony is independent of the distance between neurons in a network.	[Kutzing, Melinda K.; Luo, Vincent; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Kutzing, Melinda K.] Rutgers State Univ, Grad Program Biomed Engn, Piscataway, NJ 08854 USA; [Firestein, Bonnie L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA		Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565	New Jersey Commission on Brain Injury Research [09-3209-BIR-E-2]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32GM008339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER	This work was funded by a grant from the New Jersey Commission on Brain Injury Research, #09-3209-BIR-E-2 to BLF. MLK was supported by Biotechnology Fellowship, Grant 5T32GM008339 from National Institute of General Medical Sciences. We would like to thank Dr. Mark Plummer for his scientific guidance and support and for his critical review of this manuscript.	Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Chao TC, 2005, J COMPUT NEUROSCI, V19, P311, DOI 10.1007/s10827-005-2653-4; Chiappalone M, 2003, BIOSENS BIOELECTRON, V18, P627, DOI 10.1016/S0956-5663(03)00041-1; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Fuchs E, 2007, DEV NEUROBIOL, V67, P1802, DOI 10.1002/dneu.20557; Gopal KV, 2003, NEUROTOXICOL TERATOL, V25, P69, DOI 10.1016/S0892-0362(02)00321-5; HABETS AMMC, 1987, EXP BRAIN RES, V69, P43, DOI 10.1007/BF00247027; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; Kazanis I, 2005, BRAIN RES REV, V50, P377, DOI 10.1016/j.brainresrev.2005.09.003; Keefer EW, 2001, BIOSENS BIOELECTRON, V16, P513, DOI 10.1016/S0956-5663(01)00165-8; KWAK S, 1995, J NEUROL SCI, V129, P99, DOI 10.1016/0022-510X(95)00076-E; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Li YL, 2007, BIOSENS BIOELECTRON, V22, P2976, DOI 10.1016/j.bios.2006.12.018; Lin CH, 2008, J NEUROCHEM, V104, P1415, DOI 10.1111/j.1471-4159.2007.05098.x; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morefield SI, 2000, BIOSENS BIOELECTRON, V15, P383, DOI 10.1016/S0956-5663(00)00095-6; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parviz M, 2007, NEUROTOXICOLOGY, V28, P520, DOI 10.1016/j.neuro.2006.11.006; Selinger JV, 2004, BIOSENS BIOELECTRON, V19, P675, DOI 10.1016/S0956-5663(03)00267-7; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Streit J, 2001, EUR J NEUROSCI, V14, P191, DOI 10.1046/j.0953-816x.2001.01636.x; Tateno T, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051924; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Vargova L, 2001, J CEREBR BLOOD F MET, V21, P1077, DOI 10.1097/00004647-200109000-00005; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; WELLS K, 1994, NEUROCHEM INT, V25, P377, DOI 10.1016/0197-0186(94)90145-7; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Xia Y, 2003, ALCOHOL, V30, P167, DOI 10.1016/S0741-8329(03)00135-6; Xia Y, 2003, BRAIN RES, V973, P151, DOI 10.1016/S0006-8993(03)02367-9; Ye ZC, 1998, GLIA, V22, P237, DOI 10.1002/(SICI)1098-1136(199803)22:3<237::AID-GLIA3>3.0.CO;2-2	39	8	8	1	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	AUG	2011	39	8					2252	2262		10.1007/s10439-011-0319-0			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	785YK	WOS:000292268900013	21544673				2022-02-06	
J	Lima, FPS; Lima, MO; Leon, D; Lucareli, PRG; Falcon, C; Cogo, JC; Bargallo, N; Vidal, J; Bernabeu, M; Junque, C				Lima, F. P. S.; Lima, M. O.; Leon, D.; Lucareli, P. R. G.; Falcon, C.; Cogo, J. C.; Bargallo, N.; Vidal, J.; Bernabeu, M.; Junque, C.			fMRI of the sensorimotor cortex in patients with traumatic brain injury after intensive rehabilitation	NEUROLOGICAL SCIENCES			English	Article						fMRI; Cortical reorganisation; Plasticity; Traumatic brain injury; Motor rehabilitation; Body-weight-supported treadmill training	CORTICAL REORGANIZATION; FUNCTIONAL ACTIVATION; MOTOR RECOVERY; STROKE; PLASTICITY; MODULATION; CHILDREN; MODERATE; DAMAGE	For evaluating the patterns of brain activation in sensorimotor areas following motor rehabilitation, seven male patients diagnosed with TBI underwent an fMRI study before and after being subjected to motor rehabilitation. Six patients showed a reduction in the BOLD signal of their motor cortical areas during the second fMRI evaluation. A decrease in cerebellum activation was also observed in two patients. Newly activated areas, were observed in four patients after treatment. In addition, an increase in the activation of the supplementary motor area (SMA) following rehabilitation was observed in only one test subject. The findings show that motor rehabilitation in TBI patients produces a decrease in the BOLD signal for the sensorimotor areas that were activated prior to treatment. In addition, we observed the recruitment of different brain areas to compensate for functional loss due to TBI in line with the cortical reorganisation mechanism.	[Lima, F. P. S.; Lima, M. O.; Cogo, J. C.] Univ Vale Paraiba, Lab Engn Reabilitacao Sensorio Motora, Inst Pesquisa & Desenvolvimento IP&D, BR-12244875 Urbanova Sao Jose Dos Ca, SP, Brazil; [Leon, D.; Vidal, J.; Bernabeu, M.] Hosp Neurorreabiltac, Inst Guttmann, Barcelona 08916, Spain; [Lucareli, P. R. G.] Univ Nove Julho, Hosp Albert Einstein, Sao Paulo, Brazil; [Falcon, C.] GIB UB CIBER BBN, IDIBAPS, Barcelona 08036, Spain; [Bargallo, N.] Hosp Clin Barcelona, E-08036 Barcelona, Spain; [Junque, C.] Univ Barcelona, E-08036 Barcelona, Spain		Lima, FPS (corresponding author), Univ Vale Paraiba, Lab Engn Reabilitacao Sensorio Motora, Inst Pesquisa & Desenvolvimento IP&D, Rua Benedito Freire 326, BR-12244875 Urbanova Sao Jose Dos Ca, SP, Brazil.	fpupio@univap.br	Joan, Vidal/AAR-5232-2021; Junque, Carme/B-4400-2011; Lucareli, Paulo Roberto Garcia/D-3965-2009; Lima, Fernanda/ABG-9245-2020; Bargallo, Nuria/G-6854-2016	Junque, Carme/0000-0002-6381-3063; Lucareli, Paulo Roberto Garcia/0000-0002-7148-575X; Bargallo, Nuria/0000-0001-6284-5402; Lima, Fernanda/0000-0001-9834-7800; falcon, carles/0000-0001-5564-2025; Lima, Mario/0000-0001-9990-5296	European UnionEuropean Commission	We gratefully acknowledge support from the Al beta an Programme (European Union Programme of High Level Scholarships for Latin America).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Butefisch CM, 2006, NEUROL SCI, V27, pS18, DOI 10.1007/s10072-006-0540-z; Celnik PA, 2004, RESTOR NEUROL NEUROS, V22, P261; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Foltys H, 2003, CLIN NEUROPHYSIOL, V114, P2404, DOI 10.1016/S1388-2457(03)00263-3; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J; HEIM AM, 2007, DEV MED CHILD NEUROL, V49, P900; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/00019052-200312000-00010; Irdesel J, 2007, NEUROCIRUGIA, V18, P5; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim YH, 2004, YONSEI MED J, V45, P241, DOI 10.3349/ymj.2004.45.2.241; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Mani TM, 2007, BRAIN INJURY, V21, P1155, DOI 10.1080/02699050701687367; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Saywell Nicola, 2008, Physiotherapy Theory and Practice, V24, P321, DOI 10.1080/09593980701884832; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Stuss Donald T, 2002, PRINCIPLES FRONTAL L; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; You SH, 2005, DEV MED CHILD NEUROL, V47, P628, DOI 10.1017/S0012162205001234	34	8	8	0	6	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2011	32	4					633	639		10.1007/s10072-011-0604-6			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	791YU	WOS:000292706900014	21607756				2022-02-06	
J	Sekhon, MS; Dhingra, KV; Sekhon, IS; Henderson, WR; McLean, N; Griesdale, DEG				Sekhon, Mypinder S.; Dhingra, Vinay K.; Sekhon, Indeep S.; Henderson, William R.; McLean, Neilson; Griesdale, Donald E. G.			The safety of synthetic colloid in critically ill patients with severe traumatic brain injuries	JOURNAL OF CRITICAL CARE			English	Article						Colloid; Traumatic brain injury; Crystalloid	SEVERE HEAD-INJURY; HYDROXYETHYL STARCH; FLUID RESUSCITATION; REPERFUSION INJURY; ALBUMIN; EPIDEMIOLOGY; MANAGEMENT; PROTOCOL; OUTCOMES; IMPACT	Purpose: Although 4% albumin is associated with increased mortality in patients with traumatic brain injury (TBI), evidence concerning the safety of synthetic colloids is lacking. We aimed to determine if there is an association between synthetic colloids and mortality in patients with severe TBI. Materials and Methods: A retrospective cohort study of patients with severe TBI was conducted. Data were collected on all intravenous fluids administered during the first 14 days of admission. Multivariable Cox proportional hazards regression was used to model the association between daily cumulative pentastarch quintiles and mortality. Results: Patients receiving pentastarch had higher Acute Physiology and Chronic Health II scores (23.9 vs 21.6, P < .01), frequency of craniotomy (42.5% vs 21.6%, P = .02), longer duration of intensive care unit stay (12 vs 4 days, P < .01), and mechanical ventilation (10 vs 3 days, P < .01). On unadjusted Cox regression, patients in the highest quintile of cumulative pentastarch administration had a higher rate of mortality compared with those receiving no colloid (hazard ratio, 3.8; 95% confidence interval, 1.2-12.4; P = .03). However, this relationship did not persist in the final multivariable model (hazard ratio 1.0; 95% confidence interval, 0.25-4.1; P = .98). Conclusion: There was no association between cumulative exposure to pentastarch and mortality in patients with severe TBI. (C) 2011 Elsevier Inc. All rights reserved.	[Dhingra, Vinay K.; Henderson, William R.; McLean, Neilson; Griesdale, Donald E. G.] Vancouver Gen Hosp, Program Crit Care Med, Vancouver, BC V5Z 1M9, Canada; [Dhingra, Vinay K.; Henderson, William R.; McLean, Neilson; Griesdale, Donald E. G.] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E. G.] Vancouver Gen Hosp, Dept Anesthesia, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada		Griesdale, DEG (corresponding author), Vancouver Gen Hosp, Program Crit Care Med, Vancouver, BC V5Z 1M9, Canada.	dgriesdale@post.harvard.edu	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624	Vancouver Coastal Health Research Institute	Dr Griesdale is supported through a Clinician Scientist Award from the Vancouver Coastal Health Research Institute.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Charlton BG, 1996, J CLIN EPIDEMIOL, V49, P105, DOI 10.1016/0895-4356(95)00030-5; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Finfer S, 2004, NEW ENGL J MED, V350, P2247; GREENHALGH DG, 1995, J TRAUMA, V39, P67, DOI 10.1097/00005373-199507000-00009; Hammell CL, 2009, BMJ-BRIT MED J, V338, pb1683; Hartog C, 2009, INTENS CARE MED, V35, P1337, DOI 10.1007/s00134-009-1521-5; Huang SJ, 2006, SURG NEUROL, V66, pS26, DOI 10.1016/j.surneu.2006.07.007; Jungheinrich C, 2005, CLIN PHARMACOKINET, V44, P681, DOI 10.2165/00003088-200544070-00002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Neff TA, 2003, ANESTH ANALG, V96, P1453, DOI 10.1213/01.ANE.0000061582.09963.FD; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; SCHELL RM, 1992, ANESTHESIOLOGY, V77, P86, DOI 10.1097/00000542-199207000-00013; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; von Roten I, 2006, BRIT J ANAESTH, V96, P455, DOI 10.1093/bja/ael019; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; ZIKRIA BA, 1990, ARCH SURG-CHICAGO, V125, P930; ZIKRIA BA, 1989, CRIT CARE MED, V17, P1306, DOI 10.1097/00003246-198912000-00012	25	8	10	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	AUG	2011	26	4					357	362		10.1016/j.jcrc.2010.12.001			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816NG	WOS:000294608400006	21273030				2022-02-06	
J	Asilioglu, N; Turna, F; Paksu, MS				Asilioglu, Nazik; Turna, Fatih; Paksu, Muhammet Sukru			Admission hyperglycemia is a reliable outcome predictor in children with severe traumatic brain injury	JORNAL DE PEDIATRIA			English	Article							SEVERE HEAD-INJURY; INSULIN THERAPY	Objective: To identify the relationship between admission hyperglycemia and outcome in children with severe brain injury at hospital discharge and 6 months later. Method: A retrospective analysis of blood glucose levels was conducted in 61 children with severe brain injury admitted to the Pediatric Intensive Care Unit between November 1, 2005 and October 30, 2009. Hyperglycemia was considered for a cut off value of > 150 mg/dL, based on literature. Outcome was measured with the Glasgow Outcome Scale at hospital discharge and 6 months after discharge. Death was also analyzed as an outcome measure. Results: Mean admission blood glucose of the patients was 251 mg/dL (68-791). Hyperglycemia was noted on admission in 51 (83.6%) patients. A moderately significant positive correlation was found between admission blood glucose and severity of head trauma according to Abbreviated Injury Score (r = 0.46). Mean admission glucose level of non-survivors was significantly higher (207 mg/dL vs. 455 mg/dL, p < 0.001). Mean blood glucose level of the patients in bad outcome group was found significantly higher compared to that of the patients in good outcome group at hospital discharge and 6 months after discharge (185 mg/dL vs. 262 mg/dL, p < 0.05 and 184 mg/dL vs. 346 mg/dL, p < 0.05, respectively). Conclusions: Hyperglycemia could be considered as a marker of brain injury and, when present upon admission, could reflect extensive brain damage, frequently associated with mortality and bad outcome. Further studies are needed to investigate the effect of strict glycemic control on mortality and outcomes.	[Asilioglu, Nazik; Paksu, Muhammet Sukru] Ondokuz Mayis Univ, Div Pediat Crit Care, Sch Med, Samsun, Turkey; [Turna, Fatih] Ondokuz Mayis Univ, Dept Pediat, Sch Med, Samsun, Turkey		Asilioglu, N (corresponding author), Ondokuz Mayis Univ, Div Pediat Crit Care, Sch Med, Samsun, Turkey.	nazika@omu.edu.tr					Branco RG, 2007, J PEDIAT-BRAZIL, V83, pS128, DOI 10.2223/JPED.1710; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	14	8	8	0	3	SOC BRASIL PEDIATRIA	RIO DE JANEIRO, RJ	RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL	0021-7557			J PEDIAT-BRAZIL	J. Pediatr.	JUL-AUG	2011	87	4					325	328		10.2223/JPED.2097			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	816AW	WOS:000294572100009	21597650	Bronze			2022-02-06	
J	de Quintana-Schmidt, C; Clavel-Laria, P; Asencio-Cortes, C; Vendrell-Brucet, JM; Molet-Teixido, J				de Quintana-Schmidt, Cristian; Clavel-Laria, Pablo; Asencio-Cortes, Carlos; Vendrell-Brucet, Josep M.; Molet-Teixido, Joan			Sinking skin flap syndrome	REVISTA DE NEUROLOGIA			Spanish	Article						Complication; Craniectomy; Cranioplasty; Hemicraniectomy; Neurological deficit; Sinking skin flap	MIDDLE CEREBRAL-ARTERY; EARLY DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW; MALIGNANT INFARCTION; CONTROLLED-TRIAL; CRANIOPLASTY; HEMICRANIECTOMY; SURGERY	Introduction. The sinking skin flap syndrome is a complication of decompressive craniectomies. It is of relevance not only due to its frequency, it is often underdiagnosed, but also because of the possibility of reversing the symptoms with the proper treatment. Case report. A 53-year-old female sustained a severe head injury. The initial Glasgow Coma Scale was 6T. The CT scan showed a severe traumatic injury in the left temporal lobe that required a decompressive craniectomy. After surgery the patient developed aphasia and right hemiparesis but progressively improved. Four months after surgery, however, she presented neurological worsening. An MRI shoed skin retraction with a mass effect on the brain parenchyma at the craniectomy defect. A cranioplasty was performed and the patient progressively recovered neurologically. Conclusions. The symptoms of sinking skin flap are headache, dizziness, inappropriate behaviour, neurological functional impairment and/or seizures. The symptoms worsen with the Valsalva manoeuvres and with changes in position. Typically, symptoms 3 to 5 months to appear. Theories to explain these symptoms include a direct atmospheric pressure effect, brain blood flow changes, alteration in cerebrospinal fluid dynamics and metabolic disturbances. Diagnosis is performed through clinical observation but imaging studies are recommended to confirm the diagnosis. The treatment of choice is a cranioplasty. Prognosis is excellent and almost all patients recover completely.	[de Quintana-Schmidt, Cristian; Clavel-Laria, Pablo; Asencio-Cortes, Carlos; Molet-Teixido, Joan] Hosp Santa Creu & Sant Pau, Serv Neurocirugia, E-08025 Barcelona, Spain; [Vendrell-Brucet, Josep M.] Hosp Santa Creu & Sant Pau, Serv Neurol, E-08025 Barcelona, Spain		de Quintana-Schmidt, C (corresponding author), Hosp Santa Creu & Sant Pau, Serv Neurocirugia, St Antoni M Claret 167, E-08025 Barcelona, Spain.	cquintana@santpau.es					Antuna-Ramos A, 2009, REV NEUROLOGIA, V49, P354, DOI 10.33588/rn.4907.2008644; Delgado-Lopez P, 2004, NEUROCIRUGIA, V15, P43; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; GEORGE AE, 1974, RADIOLOGY, V111, P627; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Maekawa M, 1999, NEUROL SURG TOKYO, V27, P717; Sahuguillo J, 2008, CRANIECTOMIA DESCOMP; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Suarez JI, 1999, REV NEUROLOGIA, V29, P1337, DOI 10.33588/rn.2912.99354; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]	25	8	8	5	133	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JUN 1	2011	52	11					661	664		10.33588/rn.5211.2010732			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972ET	WOS:000306260700003	21563117				2022-02-06	
J	Dunham, CM; Carter, KJ; Castro, F; Erickson, B				Dunham, C. Michael; Carter, Kimbroe J.; Castro, Frank; Erickson, Barbara			Impact of Cervical Spine Management Brain Injury on Functional Survival Outcomes in Comatose, Blunt Trauma Patients with Extremity Movement and Negative Cervical Spine CT: Application of the Monte Carlo Simulation	JOURNAL OF NEUROTRAUMA			English	Article						computed tomography scanning; guidelines; models of injury; secondary insult; traumatic brain injury	VENTILATOR-ASSOCIATED PNEUMONIA; SEVERE HEAD-INJURY; COMPUTED-TOMOGRAPHY; POSTTRAUMATIC AMNESIA; EASTERN ASSOCIATION; OBTUNDED PATIENTS; INTENSIVE-CARE; CLEARANCE; PATHOPHYSIOLOGY; FLUOROSCOPY	Cervical spine (CS) magnetic resonance imaging (MRI) and collar use may prevent quadriplegia, yet create brain injury. We developed a computer model to assess the effect of CS management strategies on outcomes in comatose, blunt trauma patients with extremity movement and a negative CS CT scan. Strategies include early collar removal (ECR), ECR & MRI, late collar removal (LCR), and LCR & MRI. MRI risks include hypoxia, hypotension, increased intracranial pressure (up arrow ICP), and ventilator-associated pneumonia (VAP). LCR risks include up arrow ICP, VAP, and delirium. Model elements include Quadriplegia and Primary, Secondary, LCR, and MRI Brain Injury. The Monte Carlo simulation determines health outcomes (Functional Survival versus Quadriplegia, Severe Brain Disability, or Dead). Utility values are Functional Survival 0.90, Quadriplegia 0.20, Severe Brain Disability 0.10, and Dead 0.00. Years of life expectancy are Functional Survival 39.5, Quadriplegia 20.0, Severe Brain Disability 20.0, and Dead 0.0. Unstable CS rate 2.5%: Functional Survival/1,000: Unstable Patients: ECR 384, LCR 350, LCR & MRI 332, ECR & MRI 331; High-Risk Patients: ECR 161, LCR 151, LCR & MRI 140, ECR & MRI 153; Stable Patients: ECR 596, LCR 587, LCR & MRI 573, ECR & MRI 595. Quality-Adjusted Life Months for Unstable, High-Risk, and Stable Patients are greater with ECR; Stable Patient ECR and ECR & MRI are similar. Unstable CS rate 0.5%: Functional Survival/1000: Unstable Patients: ECR 394, LCR 352, LCR & MRI 332, ECR & MRI 332; High-Risk Patients: ECR 164, LCR 151, LCR & MRI 140, ECR & MRI 152; Stable Patients: ECR 611, LCR 592, LCR & MRI 576, ECR & MRI 598. Quality-Adjusted Life Months for Unstable, High-Risk, and Stable Patients are greater with ECR. LCR and MRI brain injury results in losses of functional survivorship that exceed those from quadriplegia. Model results suggest that early collar removal without cervical spine MRI is a reasonable, and likely the preferable, cervical spine management strategy for comatose, blunt trauma patients with extremity movement and a negative cervical spine CT scan.	[Dunham, C. Michael] St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA; [Carter, Kimbroe J.] St Elizabeth Hlth Ctr, Med Decis Making Soc Youngstown Ohio, Youngstown, OH USA; [Carter, Kimbroe J.; Castro, Frank; Erickson, Barbara] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Pathol, Rootstown, OH 44272 USA		Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Care Serv, 1044 Belmont Ave, Youngstown, OH 44501 USA.	dunham.michael@sbcglobal.net		Dunham, C. Michael/0000-0002-7842-9750			Adams JM, 2006, AM SURGEON, V72, P101; Bercault N, 2005, CRIT CARE MED, V33, P2471, DOI 10.1097/01.CCM.0000185644.54646.65; *BRAIN TRAUM FDN, EARL IND PROGN SEV T; Brohi K, 2005, J TRAUMA, V58, P897, DOI 10.1097/01.ta.0000171984.25699.35; Brown TB, 2007, J TRAUMA, V62, P1180, DOI 10.1097/01.ta.0000235951.21584.a0; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Como JJ, 2007, J TRAUMA, V63, P544, DOI 10.1097/TA.0b013e31812e51ae; Como JJ, 2009, J TRAUMA, V67, P651, DOI 10.1097/TA.0b013e3181ae583b; D'Alise MD, 1999, J NEUROSURG, V91, P54, DOI 10.3171/spi.1999.91.1.0054; Davis JW, 2001, J TRAUMA, V50, P1044, DOI 10.1097/00005373-200106000-00011; Dunham CM, 2008, CRIT CARE, V12, DOI 10.1186/cc6957; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Ghanta MK, 2002, AM SURGEON, V68, P563; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hogan GJ, 2005, RADIOLOGY, V237, P106, DOI 10.1148/radiol.2371040697; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kahn JM, 2008, AM J RESP CRIT CARE, V177, P285, DOI 10.1164/rccm.200708-1214OC; Kallel H, 2005, J TRAUMA, V59, P705, DOI 10.1097/01.ta.0000177749.09844.c6; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kollef MH, 1997, CHEST, V112, P765, DOI 10.1378/chest.112.3.765; Kreke Jennifer E, 2004, Curr Opin Crit Care, V10, P395, DOI 10.1097/01.ccx.0000139361.30327.20; Leone M, 2002, CRIT CARE MED, V30, P1741, DOI 10.1097/00003246-200208000-00011; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Menaker J, 2008, J TRAUMA, V64, P898, DOI 10.1097/TA.0b013e3181674675; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Padayachee L, 2006, J TRAUMA, V60, P341, DOI 10.1097/01.ta.0000195716.73126.12; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sarani B, 2007, J TRAUMA, V63, P637, DOI 10.1097/TA.0b013e31812eedb1; Schuster R, 2005, ARCH SURG-CHICAGO, V140, P762, DOI 10.1001/archsurg.140.8.762; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Stassen NA, 2006, J TRAUMA, V60, P171, DOI 10.1097/01.ta.0000197647.44202.de; Stelfox HT, 2007, J TRAUMA, V63, P630, DOI 10.1097/TA.0b013e318076b537; Stevenson MD, 2001, INJURY, V32, P267, DOI 10.1016/S0020-1383(00)00191-1; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Widder S, 2004, J TRAUMA, V56, P1179, DOI 10.1097/01.TA.0000130758.71098.78; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	43	8	8	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2011	28	6					1009	1019		10.1089/neu.2010.1301			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	788PT	WOS:000292457600014	21083417				2022-02-06	
J	Cuttica, DJ; DeCarbo, WT; Philbin, TM				Cuttica, Daniel J.; DeCarbo, William T.; Philbin, Terrence M.			Correction of Rigid Equinovarus Deformity Using a Multiplanar External Fixator	FOOT & ANKLE INTERNATIONAL			English	Article						Equinovarus; External Fixation; Foot and Ankle Deformity Correction	SURGICAL-CORRECTION; NEGLECTED CLUBFOOT; FOOT DEFORMITIES; OSTEOTOMIES	Background: The rigid equinovarus foot deformity is a challenging condition treated by the orthopaedic foot and ankle surgeon. Rapid surgical correction of the deformity may lead to skin and neurologic complications. Gradual correction of the deformity with a multiplanar external fixator may decrease these complications. The purpose of this study was to present the results of a group of patients with rigid equinovarus deformities corrected using a multiplanar external fixator. Materials and Methods: We retrospectively reviewed the results of correction of a rigid equinovarus deformity using multiplanar external fixation in a small group of patients. All patients underwent open Achilles lengthening, posterior capsule release, tibialis posterior tendon lengthening, flexor digitorum longus and flexor hallux longus lengthening, followed by application of a multiplanar external fixator with gradual correction of the deformity over a period of several weeks. Preoperative and postoperative deformity and AOFAS ankle-hindfoot scores were assessed. Results: A total of eight rigid equinovarus deformities in six patients were treated with a multiplanar external fixator. The average patient age at the time of surgery was 37.2 (range, 17 to 59 +/- 15.0) years. Causes of the deformity included trauma in three patients, traumatic brain injury in two patients, and long-standing rheumatoid arthritis in one patient. The average preoperative AOFAS ankle-hindfoot score was 28.3 (range, 12 to 38 +/- 7.7). The average postoperative AOFAS ankle-hindloot score was 68.1 (range 38 to 86 +/- 15.5) at an average followup of 71.9 (30 to 120 +/- 36.2) weeks. All deformities were gradually corrected to a plantigrade foot using a multiplanar external fixator over an average time of 5 (range, 4 to 6 +/- 0.8) weeks. After correction of the deformity, the external fixator was left in place for a time period equal to or twice the length of time it took to achieve correction. The average duration of external fixation was 10.8 (range, 8 to 16 +/- 2.8) weeks. Seven of eight deformities maintained correction at final followup. There was one case of recurrence. Conclusion: Correction of a rigid equinovarus deformity using a multiplanar external fixator was a viable treatment option. It allowed for correction of the deformity in a controlled manner, helping to reduce the risk of neurovascular complications that may result from single stage surgical correction. The risk of wound complications still exists with the correction of such a complex deformity.	[Cuttica, Daniel J.; DeCarbo, William T.; Philbin, Terrence M.] Orthoped Foot & Ankle Ctr, Westerville, OH USA; [Cuttica, Daniel J.] Ctr Orthopaed Surg & Sports Med, Indianapolis, IN USA; [DeCarbo, William T.] Orthoped Grp, Belle Vernon, PA USA		Cuttica, DJ (corresponding author), Care of Stansbury E, Orthoped Foot & Ankle Ctr, 300 Polaris Pkwy,Suite 2000, Westerville, OH 43082 USA.	ofacresearch@orthofootankle.com					Botte M J, 2000, Foot Ankle Clin, V5, P381; David A, 1996, FOOT ANKLE INT, V17, P334, DOI 10.1177/107110079601700607; DELAHUERTA F, 1994, CLIN ORTHOP RELAT R, P89; GRILL F, 1987, J BONE JOINT SURG BR, V69, P593, DOI 10.1302/0301-620X.69B4.3611163; HARITIDIS JH, 1994, FOOT ANKLE INT, V15, P548, DOI 10.1177/107110079401501005; KEENAN MAE, 1987, FOOT ANKLE, V7, P333, DOI 10.1177/107110078700700604; Kocaoglu Mehmet, 2002, J Foot Ankle Surg, V41, P30; Lamm Bradley M, 2007, J Foot Ankle Surg, V46, P201, DOI 10.1053/j.jfas.2007.01.007; Mirzayan R, 2001, FOOT ANKLE INT, V22, P209, DOI 10.1177/107110070102200307; PALEY D, 1993, CLIN ORTHOP RELAT R, P97; Paley D., 2002, PRINCIPLES DEFORMITY, P571; Philbin Terrence, 2008, Foot Ankle Spec, V1, P247, DOI 10.1177/1938640008321024.; Redfern JC, 2008, FOOT ANKLE INT, V29, P325, DOI 10.3113/FAI.2008.0325; Sammarco GJ, 2001, FOOT ANKLE INT, V22, P19, DOI 10.1177/107110070102200104; Wukich DK, 2006, OPER TECH ORTHOP, V16, P18, DOI 10.1053/j.oto.2006.02.002; YAMAMOTO H, 1992, CLIN ORTHOP RELAT R, P213; Younger ASE, 2005, J AM ACAD ORTHOP SUR, V13, P302, DOI 10.5435/00124635-200509000-00004	17	8	12	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1071-1007	1944-7876		FOOT ANKLE INT	Foot Ankle Int.	MAY	2011	32	5					533	539		10.3113/FAI.2011.0533			7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	758DC	WOS:000290139700011	21733463				2022-02-06	
J	Lane-Brown, AT; Tate, RL				Lane-Brown, Amanda T.; Tate, Robyn L.			Apathy After Traumatic Brain Injury: An Overview of the Current State of Play	BRAIN IMPAIRMENT			English	Article						apathy; traumatic brain injury; goal; motivation; activity; drive	FRONTAL-SUBCORTICAL CIRCUITS; NEUROPSYCHIATRIC INVENTORY; DIFFERENTIAL-DIAGNOSIS; ALZHEIMERS-DISEASE; BASAL GANGLIA; RATING-SCALE; BROMOCRIPTINE; DISORDERS; REHABILITATION; RELIABILITY	Apathy is a decrease in behavioural, cognitive and emotional components of goal-directed behaviour. Clinically, it is characterised by diminished initiation, reduced concern, and decreased activity. Apathy is a common occurrence following traumatic brain injury (TBI), occurring in around 60% of people. Consequences are widespread, negatively impacting independence, social integration, rehabilitation outcome, vocational outcome, coping and caregiver burden. The current knowledge base on apathy following TBI is presented, with implications for clinical practice. This includes a review of clinical presentations, neuroanatomical and neurochemical substrates associated with apathy, and differential diagnoses. Instruments to measure apathy are presented, highlighting those with demonstrated reliability and validity for the TBI population. Current evidence for pharmacological and non-pharmacological methods of treatment is described, with a model for non-pharmacological interventions provided and discussion of challenges faced by clinicians when treating the patient with apathy. In the TBI arena, greater understanding of apathy and methods of treatment is pivotal given the frequency of occurrence and widespread negative consequences.	[Lane-Brown, Amanda T.; Tate, Robyn L.] Univ Sydney, Sydney Med Sch, No Clin Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Lane-Brown, Amanda T.; Tate, Robyn L.] Royal Rehabil Ctr Sydney, Sydney, NSW, Australia		Lane-Brown, AT (corresponding author), C Royal Rehabil Ctr Sydney, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	amandal@med.usyd.edu.au					Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; *AM PSYCH ASS, 2010, DSM 5 DEV COND PROP; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Barnhart W Jason, 2004, J Psychiatr Pract, V10, P196, DOI 10.1097/00131746-200405000-00010; BARRETT K, 1991, J NEUROL NEUROSUR PS, V54, P718, DOI 10.1136/jnnp.54.8.718; Benton A. L., 1991, FRONTAL LOBE FUNCTIO; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Campbell JJ, 1997, PSYCHIAT ANN, V27, P44, DOI 10.3928/0048-5713-19970101-11; Chatterjee A, 2002, J NEUROPSYCH CLIN N, V14, P461, DOI 10.1176/appi.neuropsych.14.4.461; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Cummings J, 1985, CLIN NEUROPSYCHIATRY; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DEPOY E, 1990, Occupational Therapy in Health Care, V7, P101, DOI 10.1080/J003v07n01_09; DUFFY JD, 2006, GUIDE NEUROPSYCHIATR; Dujardin K, 2008, MOVEMENT DISORD, V23, P845, DOI 10.1002/mds.21968; *ENC BRITT, 2002, NEW ENC BRIT; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Finset A, 2000, BRAIN INJURY, V14, P887; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GLISKY EL, 1988, NEUROPSYCHOLOGIA, V26, P173, DOI 10.1016/0028-3932(88)90041-3; GOLDSTEIN FC, 1989, INTEGRATING THEORY P, P217; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; HOEHNSARIC R, 1990, J CLIN PSYCHOPHARM, V10, P343; Holmes C, 2006, INT PSYCHOGERIATR, V18, P623, DOI 10.1017/S1041610206003887; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kant R, 2002, NEUROREHABILITATION, V17, P325; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LURIA, 1973, WORKING BRAIN; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Marin RS, 1997, PSYCHIAT ANN, V27, P30, DOI 10.3928/0048-5713-19970101-08; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARIN RS, 1993, J AFFECT DISORDERS, V28, P7, DOI 10.1016/0165-0327(93)90072-R; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Migneco O, 2001, NEUROIMAGE, V13, P896, DOI 10.1006/nimg.2000.0741; MULLER U, 1994, PROG NEURO-PSYCHOPH, V18, P1103, DOI 10.1016/0278-5846(94)90114-7; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Politis AM, 2004, INT J GERIATR PSYCH, V19, P1087, DOI 10.1002/gps.1215; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Resnick B, 1998, Rehabil Nurs, V23, P141; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; ROCA RP, 1990, J AM GERIATR SOC, V38, P675, DOI 10.1111/j.1532-5415.1990.tb01428.x; Roth Robert M, 2007, Curr Treat Options Neurol, V9, P363, DOI 10.1007/s11940-007-0022-5; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Sohlberg McK. M., 1988, COGNITIVE REHABILITA, V6, P36; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; WONGPAKARAN N, 2007, DIRECTIONS PSYCHIAT, V27, P261; [No title captured]	78	8	8	0	22	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2011	12	1					43	53		10.1375/brim.12.1.43			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	795EH	WOS:000292953800005					2022-02-06	
J	Toro, K; Feher, S; Dunay, G; Pauliukevicius, A; Caplinskiene, M; Raudys, R; Lepik, D; Tuusov, J; Vali, M				Toero, Klara; Feher Szilvia; Dunay Gyoergy; Pauliukevicius, Alvydas; Caplinskiene, Marija; Raudys, Romas; Lepik, Delia; Tuusov, Jana; Vali, Marika			Fatal Traffic Injuries Among Children and Adolescents in Three Cities (Capital Budapest, Vilnius, and Tallinn)	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic sciences; road traffic accidents; children; adolescents; fatal outcome; medico-legal autopsy	TRAUMATIC BRAIN-INJURY; VEHICLE; PEDESTRIANS; RISK	Motor vehicle accidental injuries are a frequent cause of death among young children and adolescents. The goal of this study was to compare patterns of injury between three capitals (Budapest, Vilnius, and Tallinn). Information on 190 fatal traffic accidents (69 pedestrians, 14 bicyclists, and 107 motor vehicle occupants) between 2002 and 2006 was collected from databases of medico-legal autopsies. The role of victims in accidents, the location of injuries, cause of death, survival period, and blood alcohol levels were evaluated. One-hundred and forty-one (74%) victims had a passive role in traffic as pedestrians, passengers in cars, or public transport. In victims who died at the scene, the rate of head injury was higher than in cases who received medical treatment (odds ratio = 2.58, CI = 1.2-5.55, p = 0.0127). These results underline the importance of postmortem studies to examine the pathomechanism of fatal traffic accidental injuries and to provide information for the prevention of road traffic accidents against children and adolescents.	[Toero, Klara; Feher Szilvia; Dunay Gyoergy] Semmelweis Univ, Dept Forens & Insurance Med, H-1091 Budapest, Hungary; [Pauliukevicius, Alvydas; Caplinskiene, Marija; Raudys, Romas] Mykolas Romeris Univ, Inst Forens Med, LT-08303 Vilnius, Lithuania; [Lepik, Delia; Vali, Marika] Univ Tartu, Inst Pathol Anat & Forens Med, EE-50090 Tartu, Estonia; [Tuusov, Jana; Vali, Marika] Estonian Forens Sci Inst, Tallinn, Estonia		Toro, K (corresponding author), Semmelweis Univ, Dept Forens Med, Ulloi Ut 93, H-1091 Budapest, Hungary.	torok@igaz.sote.hu	Lepik, Delia/AAJ-4621-2021		Estonian Science Foundation [6592]	Supported by the Estonian Science Foundation (Grant No. 6592).	Adams J, 2005, J PUBLIC HEALTH, V27, P316, DOI 10.1093/pubmed/fdi047; BARELL V, 1990, ISRAEL J MED SCI, V26, P150; CICERA E, 2001, EUR J EPIDEMIOL, V17, P201; de Sousa RMC, 1999, REV SAUDE PUBL, V33, P85, DOI 10.1590/S0034-89101999000100011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Eastridge BJ, 1997, J TRAUMA, V42, P695, DOI 10.1097/00005373-199704000-00019; FERRANDO J, 2000, P ANN C ASSOC ADV AU, V44, P445; Fisher B, 1999, PEDIATR EMERG CARE, V15, P274; GLASS RBJ, 1994, J TRAUMA, V37, P815; Hyder AA, 2009, B WORLD HEALTH ORGAN, V87, P345, DOI 10.2471/BLT.08.055798; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; NAMDARAN F, 1998, ACCIDENT ANAL PREV, V20, P117; Pavlekic Snezana, 2006, Srp Arh Celok Lek, V134, P427; Powell M, 1997, SURGERY, V122, P654, DOI 10.1016/S0039-6060(97)90070-2; Pressley JC, 2007, PEDIATRICS, V119, pE875, DOI 10.1542/peds.2006-2412; Rao R, 1997, B NEW YORK ACAD MED, V74, P65; ROBERTS I, 1995, BMJ-BRIT MED J, V14, P91; Toro K, 2005, FORENSIC SCI INT, V151, P151, DOI 10.1016/j.forsciint.2005.01.014; Touloukian RJ, 1998, J PEDIATR SURG, V33, P1093; Vaeli M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-158; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; WHEATLEY J, 1989, MED J AUSTRALIA, V150, P72, DOI 10.5694/j.1326-5377.1989.tb136366.x; WILLIAMS AF, 1995, PUBLIC HEALTH REP, V110, P233; Winston FK, 2008, ARCH PEDIAT ADOL MED, V162, P253, DOI 10.1001/archpediatrics.2007.52	25	8	8	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	MAY	2011	56	3					617	620		10.1111/j.1556-4029.2010.01674.x			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	754YD	WOS:000289892900007	21352227				2022-02-06	
J	Weeks, DL; Greer, CL; Bray, BS; Schwartz, CR; White, JR				Weeks, Douglas L.; Greer, Christopher L.; Bray, Brenda S.; Schwartz, Catrina R.; White, John R., Jr.			Association of Antidepressant Medication Therapy With Inpatient Rehabilitation Outcomes for Stroke, Traumatic Brain Injury, or Traumatic Spinal Cord Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Depression; Length of stay; Rehabilitation; Spinal cord injuries; Stroke	EXCITATORY AMINO-ACIDS; MAJOR DEPRESSION; POSTSTROKE DEPRESSION; GLUTAMATE RELEASE; FUNCTIONAL INDEPENDENCE; NEUROLOGICAL DEFICIT; ISCHEMIC-STROKE; SYMPTOMS; CARE; ANTAGONISTS	Objective: To study whether outcomes in patients who have undergone inpatient rehabilitation for stroke, traumatic brain injury (TB!), or traumatic spinal cord injury (TSCI) differ based on antidepressant medication (ADM) use. Design: Retrospective cohort study of 867 electronic medical records of patients receiving inpatient rehabilitation for stroke, TBI, or TSCI. Four cohorts were formed within each rehabilitation condition: patients with no history of ADM use and no indication of history of depression; patients with no history of ADM use but with a secondary diagnostic code for a depressive illness; patients with a history of ADM use prior to and during inpatient rehabilitation; and patients who began ADM therapy in inpatient rehabilitation. Setting: Freestanding inpatient rehabilitation facility (IRF). Participants: Patients diagnosed with stroke (n=625), TBI (n=175), and TSCI (n=67). Interventions: Not applicable. Main Outcome Measures: FIM, rehabilitation length of stay (LOS), deviation between actual LOS and expected LOS, and functional gain per day. Results: In each impairment condition, patients initiating ADM therapy in inpatient rehabilitation had longer LOS than patients in the same impairment condition on ADM at IRF admission, and had significantly longer LOS than patients with no history of ADM use and no diagnosis of depression (P<.05). LOS for patients initiating ADM therapy as inpatients even exceeded LOS for patients without ADM history, but who had a diagnosis for a depressive disorder. Deviation in LOS was significantly larger in the stroke and TBI groups initiating ADM in IRF than their counterparts with no history of ADM use, illustrating that the group initiating ADM therapy in rehabilitation significantly exceeded expected LOS. Increased LOS did not translate into functional gains, and in fact, functional gain per day was lower in the group initiating ADM therapy in IRF. Conclusions: Explanations for unexpectedly long LOS in patients initiating ADM in inpatient rehabilitation focus on the potential for ADM to inhibit therapy-driven remodeling of the nervous system when initiated close in time to nervous system injury, or the possibility that untreated sequelae (eg, depressive symptoms or fatigue) were limiting progress in therapy, which triggered ADM treatment.	[Weeks, Douglas L.] Washington State Univ, Dept Pharmacotherapy, Coll Pharm, Spokane, WA 99210 USA; [Weeks, Douglas L.; Greer, Christopher L.] St Lukes Rehabil Inst, Spokane, WA USA		Weeks, DL (corresponding author), Washington State Univ, Dept Pharmacotherapy, Coll Pharm, Spokane, WA 99210 USA.	weeksdl@wsu.edu					Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bates B, 2005, STROKE, V36, P2049, DOI 10.1161/01.STR.0000180432.73724.AD; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonanno G, 2005, J NEUROSCI, V25, P3270, DOI 10.1523/JNEUROSCI.5033-04.2005; Bouron A, 1999, NEUROSCIENCE, V90, P729, DOI 10.1016/S0306-4522(98)00480-1; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Cardenas DD, 2002, PAIN, V96, P365, DOI 10.1016/S0304-3959(01)00483-3; CARTER GM, 2001, ANAL INITIAL IMPLEME; Carter GM, 2005, PRELIMINARY ANAL REF; CARTER GM, 1997, PB98105992 NAT TECHN; Castellanos M, 2008, NEUROLOGY, V71, P1862, DOI 10.1212/01.wnl.0000326064.42186.7e; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; CHOI DW, 1987, J NEUROSCI, V7, P357; Cohen LJ, 1997, PHARMACOTHERAPY, V17, P45; Cohen LJ, 1996, ANN PHARMACOTHER, V30, P1471, DOI 10.1177/106002809603001216; Conroy B, 2005, ARCH PHYS MED REHAB, V86, pS73, DOI 10.1016/j.apmr.2005.08.129; Consortium for Spinal Cord Medicine, 1998, DEPR FOLL SPIN CORD; CZONKOWSKA A, 2009, EXPERT OPIN PHARMACO, V10, P1249; DARER RM, 2008, TOP STROKE REHABIL, V15, P13; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dombovy ML, 1998, BRAIN INJURY, V12, P443, DOI 10.1080/026990598122412; Elliott TR, 2004, REHABIL PSYCHOL, V49, P134, DOI 10.1037/0090-5550.49.2.134; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hackett ML, 2005, STROKE, V36, P1092, DOI 10.1161/01.STR.0000162391.27991.9d; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; Ishibashi H, 2005, NEUROSCI LETT, V374, P152, DOI 10.1016/j.neulet.2004.10.045; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kemp BJ, 2004, J SPINAL CORD MED, V27, P22, DOI 10.1080/10790268.2004.11753726; Khan Fary, 2004, Aust Fam Physician, V33, P831; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Maes M, 1998, ACTA PSYCHIAT SCAND, V97, P302, DOI 10.1111/j.1600-0447.1998.tb10004.x; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Myseros JS, 1995, ANN NY ACAD SCI, V765, P262, DOI 10.1111/j.1749-6632.1995.tb16583.x; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; OLIN BR, 2004, DRUGS FACTS COMPARIS; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Papakostas GI, 2007, EUR PSYCHIAT, V22, P444, DOI 10.1016/j.eurpsy.2007.01.1220; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; Racagni G, 2010, INT CLIN PSYCHOPHARM, V25, P117, DOI 10.1097/YIC.0b013e3283311acd; Ramasubbu R, 1998, STROKE, V29, P1293, DOI 10.1161/01.STR.29.7.1293; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Robinson RG, 2005, AM J GERIAT PSYCHIAT, V13, P85, DOI 10.1176/appi.ajgp.13.2.85; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SCHUBERT DSP, 1992, PSYCHOTHER PSYCHOSOM, V57, P61, DOI 10.1159/000288575; Semla TP, 2010, GERIATRIC DOSAGE HDB; Singh A, 2000, STROKE, V31, P637, DOI 10.1161/01.STR.31.3.637; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Taylor M, 2008, J PSYCHOPHARMACOL, V22, P473, DOI 10.1177/0269881107081510; Tesio L, 1996, DISABIL REHABIL, V18, P502, DOI 10.3109/09638289609166036; Tharwani Haresh M, 2007, Curr Psychiatry Rep, V9, P225, DOI 10.1007/s11920-007-0023-9; TONI D, 1995, ARCH NEUROL-CHICAGO, V52, P670, DOI 10.1001/archneur.1995.00540310040014; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Turner-Stokes L, 2005, CLIN MED, V5, P268, DOI 10.7861/clinmedicine.5-3-268; Waldron-Perrine B, 2008, REHABIL PSYCHOL, V53, P426, DOI 10.1037/a0013530; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; West SL, 2000, J CLIN EPIDEMIOL, V53, P823, DOI 10.1016/S0895-4356(99)00237-1; Wiegand MH, 2008, DRUGS, V68, P2411, DOI 10.2165/0003495-200868170-00001; Zorowitz Richard D, 2005, Top Stroke Rehabil, V12, P28, DOI 10.1310/2403-B0CY-1UDN-4B6D; 2009, FED REG, V74, P39761	73	8	8	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2011	92	5					683	695		10.1016/j.apmr.2010.12.026			13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	759YO	WOS:000290288000001	21530715				2022-02-06	
J	Zlotnik, A; Klin, Y; Gruenbaum, BF; Gruenbaum, SE; Ohayon, S; Boyko, M; Sheiner, E; Aricha-Tamir, B; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Klin, Yael; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Ohayon, Sharon; Boyko, Mathew; Sheiner, Eyal; Aricha-Tamir, Barak; Shapira, Yoram; Teichberg, Vivian I.			The Activation of beta 2-Adrenergic Receptors in Na < ve Rats Causes a Reduction of Blood Glutamate Levels: Relevance to Stress and Neuroprotection	NEUROCHEMICAL RESEARCH			English	Article						beta 2-Adrenergic receptors; Glutamate; Recovery; Traumatic brain injury	CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; AMINO-ACIDS; EXCESS GLUTAMATE; CLINICAL-TRIALS; INFARCT SIZE; RELEASE; BLOCKADE; DISEASE; PLASMA	This study examines the effects of the activation of beta 1 and beta 2-adrenergic receptors on glutamate homeostasis in the blood of na < ve rats. Forty five male Sprague-Dawley rats were randomly assigned into one of seven treatment groups that were treated with various beta-adrenergic receptor agonist and antagonist drugs. Blood glutamate levels were determined at t = 0, 30, 60, 90, and 120 min. The activation of beta 1 and beta 2-adrenergic receptors via isoproterenol hydrochloride administration produced a marked sustained decrease in blood glutamate levels by 60 min after treatment (ANOVA, t = 60, 90 min: P < 0.05, t = 120 min: P < 0.01). Pretreatment with propranolol hydrochloride (a non-selective beta-adrenergic receptor blocker) or butaxamine hydrochloride (a selective beta 2-adrenergic receptor blocker) occluded the isoproterenol-mediated decrease in blood glutamate levels. Propranolol alone had no effect on blood glutamate levels. Selective beta 1-adrenergic receptor blockade with metoprolol resulted in decreased blood glutamate levels (ANOVA, t = 90 min: P < 0.05, t = 120 min: P < 0.01). Butaxamine hydrochloride alone resulted in a delayed-onset increase in glutamate levels (ANOVA, t = 120 min: P < 0.05). The results suggest that the activation of beta 2 receptors plays an important role in the homeostasis of glutamate in rat blood.	[Zlotnik, Alexander; Gruenbaum, Benjamin F.; Ohayon, Sharon; Boyko, Mathew; Shapira, Yoram] Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, IL-84105 Beer Sheva, Israel; [Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Sheiner, Eyal; Aricha-Tamir, Barak] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Obstet & Gynecol, IL-84105 Beer Sheva, Israel		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	SHEINER, EYAL/F-1488-2012	Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd.; Irwin Green Fund for Studying the Development of the Brain; Carl and Micaela Einhorn-Dominic Institute for Brain Research	The authors thank Dorit Reymond for her superb technical assistance. This work was supported in part by grants to VIT from the Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd., the Irwin Green Fund for Studying the Development of the Brain, the Carl and Micaela Einhorn-Dominic Institute for Brain Research. VIT is the incumbent of the Louis and Florence Katz-Cohen Chair of Neuropharmacology.	Berger C, 2008, EXP NEUROL, V210, P543, DOI 10.1016/j.expneurol.2007.12.002; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Fiordaliso F, 2007, LIFE SCI, V81, P951, DOI 10.1016/j.lfs.2007.05.027; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Han JL, 2008, NEUROSCI LETT, V432, P167, DOI 10.1016/j.neulet.2007.07.056; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KEENAN D, 1995, CIRC RES, V77, P973, DOI 10.1161/01.RES.77.5.973; Koura SS, 1998, ACT NEUR S, V71, P244; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Rutten EPA, 2005, CURR OPIN CLIN NUTR, V8, P41, DOI 10.1097/00075197-200501000-00007; Schneider AM, 2000, BEHAV NEUROSCI, V114, P1256; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; THOMASSEN A, 1991, METABOLISM, V40, P378, DOI 10.1016/0026-0495(91)90148-P; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WILSON KM, 1985, J APPL PHYSIOL, V58, P534, DOI 10.1152/jappl.1985.58.2.534; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	39	8	8	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2011	36	5					732	738		10.1007/s11064-010-0388-8			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	746BC	WOS:000289215000005	21207137				2022-02-06	
J	Tritschler, T; Sennhauser, FH; Frey, B				Tritschler, Tobias; Sennhauser, Felix H.; Frey, Bernhard			Are immigrant children admitted to intensive care at increased risk?	SWISS MEDICAL WEEKLY			English	Article						children; immigrants; severity of illness; mortality; intensive care	TRAUMATIC BRAIN-INJURY; RACIAL-DIFFERENCES; HEALTH-INSURANCE; INFANT-MORTALITY; SCREENING-TESTS; RACE; OUTCOMES; GENDER; CANCER; DISPARITIES	BACKGROUND: Racial and ethnic disparities in health care are significant predictors of the quality of health care received. Studies documenting these disparities are largely based on an adult chronic care model. There are only few reports in paediatric populations. Our objective was to evaluate the severity of illness of immigrants at admission to PICU, the proportion of immigrants in PICU compared to the general population and the quality of care they receive, in order to examine whether there are disparities in health care. METHODS: Prospectively collected data of 1009 sequential first admissions in 2007 to a multidisciplinary, 19-bed, PICU of a university children's hospital in Switzerland. The main outcome measures were expected mortality, standardised mortality ratio, proportion of immigrants in general population and in PICU. RESULTS: Children with an immigrant background are overrepresented in PICU compared with their proportion in the general population. Parents of these children are more likely to be in the lowest strata of socio-professional status than parents of Swiss children hospitalised in PICU (relative risk 9.82, 95% CI 5.16 to 18.7). However, the distribution of immigrant children and Swiss children along the strata of illness severity is equal and there is no difference in standardised mortality ratio between these two groups. CONCLUSIONS: These findings indicate that disparities may exist at a lower level of illness severity, due to many possible reasons (for example shortcomings in primary health care). However, once a child enters tertiary health care, nationality and socio-economic factors no longer influence quality of health care delivery.	[Tritschler, Tobias; Sennhauser, Felix H.; Frey, Bernhard] Univ Childrens Hosp, Dept Intens Care & Neonatol, CH-8032 Zurich, Switzerland		Tritschler, T (corresponding author), Univ Childrens Hosp, Dept Intens Care & Neonatol, CH-8032 Zurich, Switzerland.	tobias.tritschler@uzh.ch	Tritschler, Tobias/ABH-1772-2021; Frey, Bernhard/ABE-6854-2020	Tritschler, Tobias/0000-0002-8775-0511; 			Abdullah F, 2010, J PUBLIC HEALTH-UK, V32, P236, DOI 10.1093/pubmed/fdp099; Agency for Healthcare Research and Quality, 2008, AHRQ PUB; ALTHAUS F, 2010, SWISS MED FORUM, V10, P59; BRAVEMAN P, 1989, NEW ENGL J MED, V321, P508, DOI 10.1056/NEJM198908243210805; BROWN ML, 1990, PREV MED, V19, P562, DOI 10.1016/0091-7435(90)90054-N; Claydon JE, 2007, J PERINATOL, V27, P448, DOI 10.1038/sj.jp.7211766; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; CURRIE J, 1995, AM ECON REV, V85, P106; Dougherty D, 2005, MED CARE, V43, P58; *EIDG VOLKSZ, 2004, AUSL AUSL SCHWEIZ; Fiscella K, 1998, MED CARE, V36, P180, DOI 10.1097/00005650-199802000-00007; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Fontana M, 2008, SWISS MED WKLY, V138, P752, DOI 2008/49/smw-12328; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hanratty MJ, 1996, AM ECON REV, V86, P276; Heckman TG, 1998, AIDS CARE, V10, P365, DOI 10.1080/713612410; Howard I, 2005, ETHNIC DIS, V15, pS51; *I MED, 2002, UN TREATM CONFR RAC; JOYE D, 1996, SOZIALSTRUKTUR SCHWE; Lannin DR, 1998, JAMA-J AM MED ASSOC, V279, P1801, DOI 10.1001/jama.279.22.1801; LANNON C, 1995, ARCH PEDIAT ADOL MED, V149, P1070, DOI 10.1001/archpedi.1995.02170230024003; Lopez AM, 2006, PEDIATR CRIT CARE ME, V7, P2, DOI 10.1097/01.PCC.0000192319.55850.81; Mayer L, 2006, PEDIATR SURG INT, V22, P743, DOI 10.1007/s00383-006-1731-7; Moss NE, 1998, AM J PUBLIC HEALTH, V88, P1354, DOI 10.2105/AJPH.88.9.1354; Naclerio AL, 1999, ANN NY ACAD SCI, V896, P379, DOI 10.1111/j.1749-6632.1999.tb08147.x; Oddone EZ, 1998, J NATL MED ASSOC, V90, P25; *OFF NAT STAT UK, 2008, LARG DIFF INF MORT E; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Parslow RC, 2009, ARCH DIS CHILD, V94, P210, DOI 10.1136/adc.2007.134403; Petrova Anna, 2003, J Perinatol, V23, P404, DOI 10.1038/sj.jp.7210934; Pincus T, 1998, ANN INTERN MED, V129, P406, DOI 10.7326/0003-4819-129-5-199809010-00011; Potosky AL, 1998, MED CARE, V36, P257, DOI 10.1097/00005650-199803000-00004; RAPOPORT J, 1994, CRIT CARE MED, V22, P1385, DOI 10.1097/00003246-199409000-00006; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Slater A, 2003, INTENS CARE MED, V29, P271, DOI 10.1007/s00134-002-1600-3; Stallion A, 2007, J TRAUMA, V62, P1262; Thomas LR, 1996, WOMEN HEALTH, V24, P77; Valentin A, 2003, CRIT CARE MED, V31, P1901, DOI 10.1097/01.CCM.0000069347.78151.50; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Warrier I, 2006, J CLIN PHARMACOL, V46, P449, DOI 10.1177/0091270005285456; Whittle J, 1997, J GEN INTERN MED, V12, P267, DOI 10.1046/j.1525-1497.1997.012005267.x	42	8	8	0	1	E M H SWISS MEDICAL PUBLISHERS LTD	MUTTENZ	FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND	1424-7860	1424-3997		SWISS MED WKLY	Swiss Med. Wkly.	APR 29	2011	141								w13190	10.4414/smw.2011.13190			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	756WO	WOS:000290045700003	21528465	gold, Green Accepted, Green Submitted			2022-02-06	
J	Czosnowski, QA; Wood, GC; Magnotti, LJ; Croce, MA; Swanson, JM; Boucher, BA; Fabian, TC				Czosnowski, Quinn A.; Wood, G. Christopher; Magnotti, Louis J.; Croce, Martin A.; Swanson, Joseph M.; Boucher, Bradley A.; Fabian, Timothy C.			Clinical and Microbiologic Outcomes in Trauma Patients Treated for Stenotrophomonas maltophilia Ventilator-Associated Pneumonia	PHARMACOTHERAPY			English	Article						Stenotrophomonas maltophilia; Xanthomonas maltophilia; ventilator-associated pneumonia; VAP; trimethoprim-sulfamethoxazole; TMP-SMX	INADEQUATE ANTIMICROBIAL TREATMENT; INFECTIOUS-DISEASES SOCIETY; EMPIRIC ANTIBIOTIC-THERAPY; BETA-LACTAM MONOTHERAPY; CRITICALLY-ILL PATIENTS; XANTHOMONAS-MALTOPHILIA; RISK-FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE; COMBINATION THERAPY; RANDOMIZED-TRIALS	Study Objectives. To determine clinical and microbiologic plus clinical success rates in critically ill trauma patients who received treatment for Stenotrophomonas maltophilia ventilator-associated pneumonia (VAP). Design. Retrospective medical record review. Setting. Level I trauma intensive care unit of a large academic medical center. Patients. A total of 101 patients who developed S. maltophilia VAP between January 1997 and December 2007. Measurements and Main Results. Patients' baseline demographic and clinical characteristics, as. well as characteristics of their VAP, were documented. The primary study outcome was the rate of clinical success in patients with S. maltophilia VAP; a secondary outcome was microbiologic plus clinical success rate in these patients. Standard definitions were employed to determine these outcomes related to VAP treatment. The study population had higher injury severity scores and a higher rate of traumatic brain injury than is typically observed in the study's intensive care unit. The median time to diagnosis of S. maltophilia VAP was 15 days (interquartile range 11-24 days). Stenotrophomonas maltophilia was the sole organism isolated in 34% of patient; the other patients had polymicrobial VAP. Despite inadequate empiric antibiotic therapy being administered to 97% of the patients, the overall clinical success rate was 87%. The microbiologic plus clinical success rate was 82%. The most common treatments for S. maltophilia VAP were trimethoprim-sulfamethoxazole (77 patients received monotherapy, 9 received combination therapy) and ciprofloxacin (6 patients received monotherapy 8 received combination therapy); all-cause and VAP-related mortality rates were 13% and 7%, respectively. Conclusion. Critically ill trauma patients with S. maltophilia VAP responded well to therapy despite high rates of inadequate empiric antibiotic administration. Trimethoprim-sulfamethoxazole was the most common therapy, but clinical success rates did not differ significantly based on antibiotic selection. This study adds significantly to the available S. maltophilia VAP outcomes data.	[Czosnowski, Quinn A.] Univ Sci Philadelphia, Dept Pharm Practice & Adm, Philadelphia Coll Pharm, Philadelphia, PA 19104 USA; [Wood, G. Christopher; Swanson, Joseph M.; Boucher, Bradley A.] Univ Tennessee, Dept Clin Pharm, Hlth Sci Ctr, Memphis, TN USA; [Magnotti, Louis J.; Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Dept Surg, Hlth Sci Ctr, Memphis, TN USA		Czosnowski, QA (corresponding author), Univ Sci Philadelphia, Dept Pharm Practice & Adm, Philadelphia Coll Pharm, 600 S 43rd St, Philadelphia, PA 19104 USA.	q.czosnowski@usp.edu	Czosnowski, Quinn/AAY-5064-2020				Aarts MAW, 2008, CRIT CARE MED, V36, P108, DOI 10.1097/01.CCM.0000297956.27474.9D; Aisenberg G, 2007, EUR J CLIN MICROBIOL, V26, P13, DOI 10.1007/s10096-006-0243-7; Alappan R, 1996, ANN INTERN MED, V124, P316, DOI 10.7326/0003-4819-124-3-199602010-00006; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Betriu C, 2001, J ANTIMICROB CHEMOTH, V48, P152, DOI 10.1093/jac/48.1.152; Bliziotis IA, 2005, CLIN INFECT DIS, V41, P149, DOI 10.1086/430912; Croce MA, 2004, J TRAUMA, V56, P931, DOI 10.1097/01.TA.0000127769.29009.8C; Czosnowski QA, 2009, PHARMACOTHERAPY, V29, P1054, DOI 10.1592/phco.29.9.1054; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V62, P889, DOI 10.1093/jac/dkn301; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Gopalakrishnan R, 1999, HEART LUNG, V28, P134, DOI 10.1053/hl.1999.v28.a96418; GREENBERG S, 1993, ANN INTERN MED, V119, P291, DOI 10.7326/0003-4819-119-4-199308150-00007; Hanes SD, 2002, CLIN INFECT DIS, V35, P228, DOI 10.1086/341022; Hedrick Traci L, 2007, Surg Infect (Larchmt), V8, P589, DOI 10.1089/sur.2006.021; Hedrick TL, 2008, J TRAUMA, V64, P714, DOI 10.1097/TA.0b013e31811ec18e; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; KOLLEF MH, 1995, CHEST, V108, P1655, DOI 10.1378/chest.108.6.1655; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kwa ALH, 2007, DIAGN MICR INFEC DIS, V58, P99, DOI 10.1016/j.diagmicrobio.2006.11.014; Magnotti LJ, 2009, J TRAUMA, V66, P1052, DOI 10.1097/TA.0b013e31819a06e0; MANINGO E, 1995, J INFECTION, V31, P89, DOI 10.1016/S0163-4453(95)91985-6; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; MORRISON AJ, 1986, J CLIN MICROBIOL, V24, P52, DOI 10.1128/JCM.24.1.52-55.1986; Mueller EW, 2007, J TRAUMA, V63, P1329, DOI 10.1097/TA.0b013e31812f6c46; Mueller EW, 2005, J TRAUMA, V58, P94, DOI 10.1097/01.TA.0000141890.29032.9A; Nseir S, 2006, CRIT CARE, V10, DOI 10.1186/cc5063; Omi E, 2009, J TRAUMA, V66, P1058; Paul M, 2004, BMJ-BRIT MED J, V328, P668, DOI 10.1136/bmj.38028.520995.63; POULOS CD, 1995, ANTIMICROB AGENTS CH, V39, P2220, DOI 10.1128/AAC.39.10.2220; San Gabriel P, 2004, ANTIMICROB AGENTS CH, V48, P168, DOI 10.1128/AAC.48.1.168-171.2004; Schaumann R, 2001, INFECTION, V29, P205, DOI 10.1007/s15010-001-1055-4; STEVENS RC, 1993, ANTIMICROB AGENTS CH, V37, P448, DOI 10.1128/AAC.37.3.448; Tseng CC, 2009, INFECT CONT HOSP EP, V30, P1193, DOI 10.1086/648455; VanCouwenberghe CJ, 1997, INFECT CONT HOSP EP, V18, P316, DOI 10.1086/647618; Wood G Christopher, 2005, Surg Infect (Larchmt), V6, P203, DOI 10.1089/sur.2005.6.203; Wood GC, 2002, CLIN INFECT DIS, V34, P1425, DOI 10.1086/340055	37	8	8	0	0	PHARMACOTHERAPY PUBLICATIONS INC	BOSTON	NEW ENGLAND MEDICAL CENTER, 806, 750 WASHINGTON ST, BOSTON, MA 02111 USA	0277-0008			PHARMACOTHERAPY	Pharmacotherapy	APR	2011	31	4					338	345		10.1592/phco.31.4.338			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	746CR	WOS:000289220300002	21449623				2022-02-06	
J	Harbeck-Seu, A; Brunk, I; Platz, T; Vajkoczy, P; Endres, M; Spies, C				Harbeck-Seu, Anja; Brunk, Irene; Platz, Thomas; Vajkoczy, Peter; Endres, Matthias; Spies, Claudia			A speedy recovery: amphetamines and other therapeutics that might impact the recovery from brain injury	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						amphetamine; brain injury; ketamine; neuroprotection; rehabilitation; stroke	USE-DEPENDENT PLASTICITY; NF-KAPPA-B; DOUBLE-BLIND; MOTOR RECOVERY; CONTROLLED-TRIAL; BEHAVIORAL SENSITIZATION; STROKE REHABILITATION; AXONAL PLASTICITY; PHYSIOTHERAPY; KETAMINE	Purpose of review Traumatic brain injury is the leading cause of death in young patients and stroke is the leading cause of major disability in elderly patients. Both injuries are often followed by cerebral plasticity changes and increased intracerebral pressure (ICP). Aim of the review is to present current knowledge about amphetamines and other therapeutics concerning the recovery of brain injury based on contemporary findings. Recent findings On the one hand beneficial effects for cognitive and physical outcome after brain injury by coupling amphetamine with physical therapy could be demonstrated; on the other hand its efficacy was shown in only two out of 10 clinical trials. Summary Impairment after brain injury is reduced if adequate early treatment is established. On the basis of current findings amphetamine after brain injury cannot be recommended. In patients with an increased ICP the maintenance of an adequate cerebral perfusion pressure is required. In patients with increased ICP under controlled ventilation, the combination of ketamine with, for example, a short-acting benzodiazepine and opioid or methohexital is equally well tolerated. Ketamine decreases ICP without lowering blood pressure and cerebral perfusion pressure. Its neuroprotective property might reduce the exacerbation of brain injury following N-methyl-D-aspartate-receptor activation, neuronal apoptosis and systemic inflammatory responses.	[Harbeck-Seu, Anja; Spies, Claudia] Charite Univ Med Berlin, Dept Anesthesiol & Intens Care Med, Berlin, Germany; [Brunk, Irene] Charite Univ Med Berlin, Inst Integrat Neuroanat, Berlin, Germany; [Platz, Thomas] Ernst Moritz Arndt Univ Greifswald, BDH Klin Greifswald, Neurorehabil Ctr, Greifswald, Germany; [Platz, Thomas] Ernst Moritz Arndt Univ Greifswald, Spinal Cord Injury Unit, Greifswald, Germany; [Endres, Matthias] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Vajkoczy, Peter] Charite Univ Med Berlin, Dept Neurosurg, Berlin, Germany; [Endres, Matthias] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany		Spies, C (corresponding author), Charite Campus Virchow Klinikum, Dept Anesthesiol & Intens Care Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	claudia.spies@charite.de	Spies, Claudia/AAJ-5412-2020	Spies, Claudia/0000-0002-1062-0495; Platz, Thomas/0000-0003-2629-9744			Adkins DL, 2005, NEUROSCI LETT, V380, P214, DOI 10.1016/j.neulet.2005.01.036; Alaverdashvili M, 2007, EUR J NEUROSCI, V25, P3442, DOI 10.1111/j.1460-9568.2007.05594.x; *AM HEART ASS, 2003, HEART DIS STROK STAT, P13; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Auriat AM, 2008, BEHAV BRAIN RES, V186, P222, DOI 10.1016/j.bbr.2007.08.010; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Barbay S, 2006, NEUROREHAB NEURAL RE, V20, P455, DOI 10.1177/1545968306290773; Barbay S, 2009, NEUROREHABILITATION, V25, P5, DOI 10.3233/NRE-2009-0495; Bartoc C, 2006, J CARDIOTHOR VASC AN, V20, P217, DOI 10.1053/j.jvca.2005.12.005; BONGIOVANNI B, 2010, NEUROTOX RES; BOYESON MG, 1994, ARCH NEUROL-CHICAGO, V51, P405, DOI 10.1001/archneur.1994.00540160107014; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brown AW, 2004, EXP NEUROL, V190, P102, DOI 10.1016/j.expneurol.2004.07.005; Brunk I, 2008, FASEB J, V22, P3736, DOI 10.1096/fj.08-111245; Brunk I, 2010, J NEUROCHEM, V115, P234, DOI 10.1111/j.1471-4159.2010.06921.x; Butefisch CM, 2002, ANN NEUROL, V51, P59, DOI 10.1002/ana.10056; Chudasama Y, 2005, BEHAV BRAIN RES, V158, P97, DOI 10.1016/j.bbr.2004.08.011; CREESE I, 1975, BRAIN RES, V83, P419, DOI 10.1016/0006-8993(75)90834-3; Czlonkowska A, 2009, EXPERT OPIN PHARMACO, V10, P1249, DOI 10.1517/14656560902941972; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Ferdinande P, 1999, INTENS CARE MED, V25, P1441, DOI 10.1007/s001340051096; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gilmour G, 2005, BEHAV BRAIN RES, V165, P98, DOI 10.1016/j.bbr.2005.06.027; Gladstone DJ, 2006, STROKE, V37, P179, DOI 10.1161/01.STR.0000195169.42447.78; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Goldstein LB, 2009, STROKE, V40, pS133, DOI 10.1161/STROKEAHA.108.533703; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Hardman J. -G., 1996, GOODMAN GILMANS PHAR, V9th; Hesse S, 2004, RESTOR NEUROL NEUROS, V22, P359; Hudetz JA, 2009, ACTA ANAESTH SCAND, V53, P864, DOI 10.1111/j.1399-6576.2009.01978.x; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Hudetz JA, 2009, J CARDIOTHOR VASC AN, V23, P651, DOI 10.1053/j.jvca.2008.12.021; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; Krasnova IN, 2009, NEUROSCI RES, V65, P160, DOI 10.1016/j.neures.2009.06.007; LOKK J, 2010, ACTA NEUROL SCAND; Mackay J., 2004, ATLAS HEART DIS STRO; MARTIN J, 2010, GMS GER MED SCI, V8; Martinsson L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002090.pub2; Martinsson L, 2003, CEREBROVASC DIS, V16, P338, DOI 10.1159/000072555; Nudo Randolph J, 2006, NeuroRx, V3, P420; Papadopoulos CM, 2009, STROKE, V40, P294, DOI 10.1161/STROKEAHA.108.519769; Piek J, 1998, INTENS CARE MED, V24, P1221, DOI 10.1007/s001340050748; Platz T, 2005, RESTOR NEUROL NEUROS, V23, P271; Ramic M, 2006, BRAIN RES, V1111, P176, DOI 10.1016/j.brainres.2006.06.063; Rasmussen RS, 2006, ACTA NEUROL SCAND, V113, P189, DOI 10.1111/j.1600-0404.2005.00547.x; Resterneyer C, 2007, RESTOR NEUROL NEUROS, V25, P143; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Sakai T, 2000, CAN J ANAESTH, V47, P1019, DOI 10.1007/BF03024876; Sawaki L, 2002, NEUROLOGY, V59, P1262, DOI 10.1212/WNL.59.8.1262; Sonde L, 2007, ACTA NEUROL SCAND, V115, P55, DOI 10.1111/j.1600-0404.2006.00728.x; Sonde L, 2001, CEREBROVASC DIS, V12, P253, DOI 10.1159/000047712; Sprigg N, 2007, J HUM HYPERTENS, V21, P616, DOI 10.1038/sj.jhh.1002205; Sprigg N, 2009, J NEUROL SCI, V285, P3, DOI 10.1016/j.jns.2009.04.040; Tardy J, 2006, NEUROIMAGE, V33, P913, DOI 10.1016/j.neuroimage.2006.07.014; Treig T, 2003, CLIN REHABIL, V17, P590, DOI 10.1191/0269215503cr653oa; Unwin H, 2000, STROKE, V31, P1788; Walker-Batson D, 2001, STROKE, V32, P2093, DOI 10.1161/hs0901.095720; Wenzlaff, 2006, EPIDEMIOLOGIE VERSOR; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	63	8	8	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2011	24	2					144	153		10.1097/ACO.0b013e328344587f			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	732AS	WOS:000288154100005	21386667				2022-02-06	
J	Sen, O; Sonmez, E; Cekinmez, M; Ozen, O; Caner, H				Sen, Orhan; Sonmez, Erkin; Cekinmez, Melih; Ozen, Ozlem; Caner, Hakan			Antithrombin III and Enoxaparin Treatment Inhibit Contusion-Triggered Cell Death, Inflammation, Hemorrhage and Apoptosis after Severe Traumatic Brain Injury in Rats	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Antithrombin III; Enoxaparin; Cell death; Hemorrhage; Apoptosis	INTRAVASCULAR COAGULATION; CEREBRAL-ISCHEMIA; IN-VIVO; NEUROTRAUMA; EXPRESSION; EDEMA; MOTOR	AIM: In this study, we aimed to show the neuroprotective effects of AT III and Enoxaparin after severe traumatic brain injury. MATERIAL and METHODS: The animals were divided into four groups as Group 1; control group, Group 2; trauma group, Group 3; AT III group and Group 4; Enoxaparin group. Severe trauma was performed by the weight dropping technique. These animals were killed 48 hours after injury. Histopathological and immunohistochemical analysis were performed. Specimens were graded for cell death, inflammation, hemorrhage and apoptosis. RESULTS: The control group showed normal ultrastructure of brain tissue. Trauma produced obvious damage. 8 rats (80%) in the trauma group demonstrated minimal inflammation and grade 5 cell death. Trauma increased hemorrhage and apoptosis scores to statistically significant levels (p < 0.001). Enoxaparin was found to reduce neuronal cell death but not as effectively as AT III. A statistically significant difference was observed between the AT III and Enoxaparin group according to inflammation grades. Significant antiapoptotic properties of AT III were observed while hemorrhage was more common in the Enoxaparin group. CONCLUSION: Anticoagulants such as AT III and enoxaparin are promising drugs in the treatment of traumatic brain injuries.	[Sonmez, Erkin] MH Batman State Hosp, Dept Neurosurg, Batman, Turkey; [Sen, Orhan] BSK Metropk Hosp, Dept Neurosurg, Adana, Turkey; [Cekinmez, Melih] Baskent Univ, Fac Med, Adana Training & Res Hosp, Dept Neurosurg, Adana, Turkey; [Ozen, Ozlem] Baskent Univ, Fac Med, Dept Pathol, TR-06490 Ankara, Turkey; [Caner, Hakan] Baskent Univ, Fac Med, Dept Neurosurg, TR-06490 Ankara, Turkey		Sonmez, E (corresponding author), MH Batman State Hosp, Dept Neurosurg, Batman, Turkey.	erkinso@gmail.com	Ozen, Ozlem/AAK-4468-2021; Sonmez, Erkin/AAI-8820-2021	Ozen, Ozlem/0000-0002-9082-1317; Sonmez, Erkin/0000-0002-5693-3542; cekinmez, melih/0000-0001-9658-9005			Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Arai M, 2004, SPINE, V29, P405, DOI 10.1097/01.BRS.0000090887.50981.8E; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Hoots WK, 1997, SEMIN THROMB HEMOST, V23, P3; Ilias W, 2000, INTENS CARE MED, V26, P704, DOI 10.1007/s001340051236; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; Martin LJ, 2003, J NEUROCHEM, V85, P234, DOI 10.1046/j.1471-4159.2003.01659.x; Pratt J, 1998, HAEMOSTASIS, V28, P78; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Ungerstedt JS, 2003, J NEUROSURG ANESTH, V15, P13, DOI 10.1097/00008506-200301000-00003; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Waydhas C, 1998, J TRAUMA, V45, P931, DOI 10.1097/00005373-199811000-00015; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	19	8	9	0	2	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	APR	2011	21	2					203	209					7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	761CC	WOS:000290371700014	21534203	Bronze			2022-02-06	
J	Yokobori, S; Watanabe, A; Matsumoto, G; Onda, H; Masuno, T; Fuse, A; Kushimoto, S; Yokota, H				Yokobori, Shoji; Watanabe, Akihiro; Matsumoto, Gaku; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Kushimoto, Shigeki; Yokota, Hiroyuki			Lower Extracellular Glucose Level Prolonged in Elderly Patients With Severe Traumatic Brain Injury: A Microdialysis Study	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						geriatric head injury; glucose; microdialysis; traumatic brain injury; hypoperfusion	MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; HEAD-INJURY; AGE; NEURODEGENERATION; AUTOREGULATION; MORTALITY; OUTCOMES	Age may be an independent predictor of outcomes in traumatic brain injury (TBI), but the causes of the poor outcomes in elderly patients remain unclear. To clarify the differences between elderly and young patients with TBI, brain metabolism parameters were monitored with the microdialysis method in 30 patients with severe TBI (Glasgow Coma Scale scores 3-8). The microdialysis probe was inserted in the penumbra area of the brain and extracellular levels of glucose, glutamate, glycerol, lactate, and pyruvate were measured hourly for the initial 168 hours (7 days) after operation. The lactate/pyruvate ratio, which is considered to be a good indicator of neuronal ischemia, was also calculated. The patients were divided into the elderly group aged 65 years or older and the young group aged less than 65 years, and the biochemical markers were compared daily between these two groups. The value of extracellular glucose concentration was significantly lower in the elderly group than in the young group, and continued until the 7th day after injury. Moreover, the lactate/pyruvate ratio peaked on the 5th day after injury in the elderly group, later than in the young group. We concluded that neural vulnerability persisted longer in elderly patients than in young patients with TBI, and this should be considered to prevent the occurrence of additional secondary brain injury.	[Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138603, Japan		Yokobori, S (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	shoji@nms.ac.jp			Foundation of General Insurance Association of Japan	This study was supported by a grant from the Foundation of General Insurance Association of Japan (2007).	Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Chan MTV, 2005, ACT NEUR S, V95, P113; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; *JAP SOC NEUR COMM, 2006, SHINKEI GAISHO S, V29, pS15; Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; MUSHKUDIANI NA, 2004, AGING CELL, V3, P35; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stahl M., 2002, Current Pharmaceutical Biotechnology, V3, P165, DOI 10.2174/1389201023378373; Swerdlow RH, 2007, ANTIOXID REDOX SIGN, V9, P1591, DOI 10.1089/ars.2007.1676; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Toescu EC, 2003, CELL CALCIUM, V34, P311, DOI 10.1016/S0143-4160(03)00142-8; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Yokota H, 2007, NEUROL MED-CHIR, V47, P383, DOI 10.2176/nmc.47.383	33	8	9	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2011	51	4					265	271		10.2176/nmc.51.265			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	756II	WOS:000290004500001	21515947	Bronze			2022-02-06	
J	Dunmire, JJ; Bouhenni, R; Hart, ML; Wakim, BT; Chomyk, AM; Scott, SE; Nakamura, H; Edward, DP				Dunmire, Jeffrey J.; Bouhenni, Rachida; Hart, Michael L.; Wakim, Bassam T.; Chomyk, Anthony M.; Scott, Sarah E.; Nakamura, Hiroshi; Edward, Deepak P.			Novel serum proteomic signatures in a non-human primate model of retinal injury	MOLECULAR VISION			English	Article							EXPERIMENTAL AUTOIMMUNE UVEITIS; XENON ARC PHOTOCOAGULATION; PIGMENT EPITHELIAL-CELLS; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; PHOSPHOGLYCERATE KINASE; SUPERIOR COLLICULUS; LASER PHOTOCOAGULATION; SHOTGUN PROTEOMICS; PLASMA-PROTEOME	Purpose: To identify candidate protein biomarkers in sera indicative of acute retinal injury. Methods: We used laser photocoagulation as a model of acute retinal injury in Rhesus macaques. In a paired-control study design, we collected serum from each animal (n= 6) at 4 h, 1 day, and 3 days following a mock procedure and then again following retinal laser treatment that produced mild lesions. Samples were fractionated by isoelectric focusing, digested with trypsin, and analyzed by liquid chromatography/tandem mass spectrometry (LC- MS/MS). Spectral counting was used to determine relative protein abundances and identify proteins with statistically significant differences between control and treated sera. Results: Mild retinal injury was confirmed by fundus photography and histological examination. The average number of total proteins detected by LC- MS/ MS was 908 +/- 82 among samples from all three time points. Following statistical analysis and employing stringent filtering criteria, a total of 19 proteins were identified as being significantly more abundant in sera following laser- induced retinal injury, relative to control sera. Many of the proteins detected were unique to one time point. However, four proteins (phosphoglycerate kinase 1, keratin 18, Lewis alpha- 3-fucosyltransferase, and ephrin receptor A2) showed differences that were significant at both 4 h and 1 day after laser treatment, followed by a decrease to baseline levels by day 3. Conclusions: A serum biomarker response to mild retinal laser injury was demonstrated in a primate model. Among the proteins detected with highest significant differences, most are upregulated within 24 h, and their appearance in the serum is transient. It is conceivable that a panel of these proteins could provide a means for detecting the acute- phase response to retinal injury. Further investigation of these candidate biomarkers and their correlation to retinal damage is warranted.	[Dunmire, Jeffrey J.; Bouhenni, Rachida; Hart, Michael L.; Chomyk, Anthony M.; Scott, Sarah E.; Nakamura, Hiroshi; Edward, Deepak P.] Summa Hlth Syst, Dept Ophthalmol, Akron, OH USA; [Wakim, Bassam T.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA		Edward, DP (corresponding author), Summa Hlth Syst, Dept Ophthalmol, Akron, OH USA.	edwardd@summahealth.org			USAF SGR [FA701407-C-A012]	This work was supported by USAF SGR contract # FA701407-C-A012. The authors declare no commercial relationships associated with the submitted work.	Akamatsu S, 1996, GLYCOCONJUGATE J, V13, P1021, DOI 10.1007/BF01053198; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ausch C, 2009, J GASTROINTEST SURG, V13, P2020, DOI 10.1007/s11605-009-0992-6; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Bellei E, 2011, AMINO ACIDS, V40, P145, DOI 10.1007/s00726-010-0628-x; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bouhenni RA, 2011, EXP EYE RES, V92, P67, DOI 10.1016/j.exer.2010.11.004; Brandt D, 2010, EUR J CANCER, V46, P1464, DOI 10.1016/j.ejca.2010.01.037; Cailleau-Thomas A, 2000, GLYCOBIOLOGY, V10, P789, DOI 10.1093/glycob/10.8.789; CAMERON HS, 1995, J BIOL CHEM, V270, P20112, DOI 10.1074/jbc.270.34.20112; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Crane IJ, 2000, IMMUNOLOGY, V101, P426, DOI 10.1046/j.0019-2805.2000.01105.x; Crane IJ, 1998, CELL IMMUNOL, V184, P37, DOI 10.1006/cimm.1997.1235; Crane IJ, 2001, INVEST OPHTH VIS SCI, V42, P1547; Crane IJ, 2008, SEMIN IMMUNOPATHOL, V30, P165, DOI 10.1007/s00281-008-0106-7; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; Dunker S, 2001, CURR EYE RES, V23, P382, DOI 10.1076/ceyr.23.5.382.5446; FUCHS U, 1991, INVEST OPHTH VIS SCI, V32, P3178; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Guerrier L, 2005, J CHROMATOGR A, V1073, P25, DOI 10.1016/j.chroma.2004.10.002; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hollyfield JG, 2003, ADV EXP MED BIOL, V533, P83; JEZEQUELCUER M, 1992, LIVER, V12, P140; KASPER M, 1988, HISTOCHEMISTRY, V89, P369, DOI 10.1007/BF00500639; KIM K, J PROTEOME RES, V9, P689; Lam W, 2009, MOL CANCER THER, V8, P415, DOI 10.1158/1535-7163.MCT-08-0692; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Li XH, 2005, PROTEOMICS, V5, P3423, DOI 10.1002/pmic.200401226; Linder S, 2004, CANCER LETT, V214, P1, DOI 10.1016/j.canlet.2004.06.032; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; MARSHALL J, 1970, INVEST OPHTH VISUAL, V9, P97; MARSHALL J, 1975, BRIT J OPHTHALMOL, V59, P610, DOI 10.1136/bjo.59.11.610; MCKECHNIE NM, 1988, J CELL SCI, V91, P303; Meleth AD, 2005, INVEST OPHTH VIS SCI, V46, P4295, DOI 10.1167/iovs.04-1057; Mesrobian HGO, 2010, J UROLOGY, V184, P709, DOI 10.1016/j.juro.2010.03.061; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Osanai T, 2001, FEBS LETT, V488, P23, DOI 10.1016/S0014-5793(00)02407-8; PEYMAN GA, 1984, SURV OPHTHALMOL, V28, P391, DOI 10.1016/0039-6257(84)90244-3; POLLACK A, 1993, OPHTHALMIC RES, V25, P201, DOI 10.1159/000267314; Pollack JS, 1998, ARCH OPHTHALMOL-CHIC, V116, P1633, DOI 10.1001/archopht.116.12.1633; Rodger J, 2005, EUR J NEUROSCI, V22, P1840, DOI 10.1111/j.1460-9568.2005.04381.x; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; SATO Y, 1992, ARCH OPHTHALMOL-CHIC, V110, P277, DOI 10.1001/archopht.1992.01080140133040; Schutte B, 2004, EXP CELL RES, V297, P11, DOI 10.1016/j.yexcr.2004.02.019; Sharma M, 2008, PROTEOM CLIN APPL, V2, P1065, DOI 10.1002/prca.200780153; Shiga Sousuke, 1994, Nippon Ganka Gakkai Zasshi, V98, P463; Sonoda KH, 2003, J IMMUNOL, V171, P2652, DOI 10.4049/jimmunol.171.5.2652; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Stubbs J, 2000, EUR J NEUROSCI, V12, P3626, DOI 10.1046/j.1460-9568.2000.00251.x; Tackenberg MA, 2009, MOL VIS, V15, P1886; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; TONIN P, 1993, NEUROLOGY, V43, P387, DOI 10.1212/WNL.43.2.387; Toth CA, 1997, AM J OPHTHALMOL, V123, P188, DOI 10.1016/S0002-9394(14)71035-9; TSO MOM, 1977, ARCH OPHTHALMOL-CHIC, V95, P1035, DOI 10.1001/archopht.1977.04450060121012; Tummala P, 2010, MOL VIS, V16, P252; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; WALLOW IHL, 1973, AM J OPHTHALMOL, V75, P32, DOI 10.1016/0002-9394(73)90651-X; WALLOW IHL, 1973, AM J OPHTHALMOL, V75, P610, DOI 10.1016/0002-9394(73)90813-1; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wilson AS, 2003, INVEST OPHTH VIS SCI, V44, P1426, DOI 10.1167/iovs.02-0622; Xu L, 1999, BIOCHEM PHARMACOL, V58, P1183, DOI 10.1016/S0006-2952(99)00208-7; YAGO K, 1993, CANCER RES, V53, P5559; Yoshida A, 1975, Methods Enzymol, V42, P144; Yu HW, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-17; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	69	8	9	0	0	MOLECULAR VISION	ATLANTA	C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322 USA	1090-0535			MOL VIS	Mol. Vis.	MAR 23	2011	17	88					779	791					13	Biochemistry & Molecular Biology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Ophthalmology	740HA	WOS:000288781000001	21527995				2022-02-06	
J	Curtin, M; Jones, J; Tyson, GA; Mitsch, V; Alston, M; McAllister, L				Curtin, Michael; Jones, Jennifer; Tyson, Graham A.; Mitsch, Virginia; Alston, Margaret; McAllister, Lindy			Outcomes of participation objective, participation subjective (POPS) measure following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; rural; participation	COMMUNITY INTEGRATION; REHABILITATION; EPIDEMIOLOGY; ABILITIES; PEOPLE	Primary objective: To investigate the participation of adults living with traumatic brain injury in regional and rural NSW as measured by the Participation Objective Participation Subjective (POPS) measure. Research design: A quantitative survey of a single cohort as the first of a two phase mixed methods study. Methods and procedures: One hundred and thirty-one adults with a TBI were recruited through eight rural brain injury rehabilitation programmes in NSW. These adults completed a range of survey instruments, including the POPS. Main outcomes and results: The POPS measure supported findings from other research that identified varying impacts of TBI. However, in contrast to other studies, there was no correlation between participation scores and age, gender, time since injury and severity of injury. Conclusions: The findings from this study suggest that the issue of participation of adults with TBI living in non-metropolitan areas needs to be further researched.	[Curtin, Michael] Charles Sturt Univ, Sch Community Hlth, Albury, NSW 2640, Australia; [Jones, Jennifer] Univ Melbourne, Australian Ctr, Melbourne, Vic, Australia; [Tyson, Graham A.] Charles Sturt Univ, Fac Arts, Bathurst, NSW 2795, Australia; [Mitsch, Virginia] SW Brain Injury Rehabil Serv, Albury, NSW, Australia; [Alston, Margaret] Monash Univ, Gender Leadership & Social Sustainabil GLASS Res, Melbourne, Vic 3004, Australia; [McAllister, Lindy] Univ Queensland, Sch Med, Brisbane, Qld, Australia		Curtin, M (corresponding author), Charles Sturt Univ, Sch Community Hlth, POB 789, Albury, NSW 2640, Australia.	mcurtin@csu.edu.au	Jones, Jennifer/N-1940-2015; Curtin, Michael/G-2650-2014	Jones, Jennifer/0000-0003-1855-2674; Curtin, Michael/0000-0002-2152-7501; Alston, Margaret/0000-0001-9057-7767			Alston M, 2007, HEALTH SOC CARE COMM, V15, P195, DOI 10.1111/j.1365-2524.2007.00696.x; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Baum FE, 2000, J EPIDEMIOL COMMUN H, V54, P414, DOI 10.1136/jech.54.6.414; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Eriksson Gunilla, 2005, Scand J Occup Ther, V12, P40, DOI 10.1080/11038120510027630; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Fearnside MR, 1997, MED J AUSTRALIA, V167, P293, DOI 10.5694/j.1326-5377.1997.tb125070.x; Fleming J, 1999, BRAIN INJURY, V13, P417; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Gosling J, 1999, BRAIN INJURY, V13, P785; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hoofien D, 2001, BRAIN INJURY, V15, P189; Isaki E, 2000, BRAIN INJURY, V14, P441; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; NEWBERRY L, 2001, NEW DIRECTION FOLLOW; Parsons L, 2008, AUST OCCUP THER J, V55, P231, DOI 10.1111/j.1440-1630.2008.00753.x; Pink B.N., 2006, AUSTR NZ STANDARD CL; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Rochette A, 2006, DISABIL REHABIL, V28, P1231, DOI 10.1080/09638280600554827; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Ueda S, 2003, DISABIL REHABIL, V25, P596, DOI 10.1080/0963828031000137108; VELLABRODRICK D, 2004, 6 AUSTR C QUAL LIF U; WAGNER AK, 2002, J TRAUMA, V49, P411; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2007, INT CLASS FUNCT DIS	36	8	8	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2011	25	3					266	273		10.3109/02699052.2010.542793			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	734UP	WOS:000288365400002	21280979				2022-02-06	
J	Lustenberger, T; Talving, P; Lam, L; Inaba, K; Branco, BC; Plurad, D; Demetriades, D				Lustenberger, Thomas; Talving, Peep; Lam, Lydia; Inaba, Kenji; Branco, Bernardino Castelo; Plurad, David; Demetriades, Demetrios			Liver Cirrhosis and Traumatic Brain Injury: A Fatal Combination Based on National Trauma Databank Analysis	AMERICAN SURGEON			English	Article							ABDOMINAL OPERATIONS; MORTALITY; COAGULOPATHY	The purpose of this study was to evaluate the impact of liver cirrhosis on in-hospital outcomes in victims of isolated traumatic brain injury (TBI). This was a National Trauma Databank study over a 5-year period, including patients with isolated TBI. Propensity scores were calculated to match cirrhotic with noncirrhotic TBI patients in a 1:2 ratio. Primary outcomes included mortality, hospital and surgical intensive care unit length of stay, and ventilator days. Of the 35,005 patients with isolated TB!, 47 (0.13%) had documented liver cirrhosis. After matching with 94 noncirrhotic, isolated TBI patients, no differences with regards to demographic and clinical injury characteristics were observed comparing the two groups. The mean SICU length of stay for cirrhotic and noncirrhotic patients was 5.4 +/- 8.8 days and 3.7 +/- 7.0 days, respectively (P = 0.079). Cirrhotic patients experienced significantly more ventilator days compared with their noncirrhotic counterparts (2.9 +/- 6.4 days vs 2.0 +/- 6.4 days; P = 0.001). Overall mortality in the study population was 23.4 per cent with significantly higher in-hospital mortality among cirrhotic versus noncirrhotic TBI patients [34.0% vs 18.1%; odds ratio (95% confidence interval): 2.34 (1.05-5.20); P = 0.035]. Traumatic brain injury in conjunction with liver cirrhosis is associated with two-fold increased mortality and significantly prolonged ventilator requirements when compared with their noncirrhotic counterparts of isolated TBI.	[Lustenberger, Thomas; Talving, Peep; Lam, Lydia; Inaba, Kenji; Branco, Bernardino Castelo; Plurad, David; Demetriades, Demetrios] Los Angeles Cty Univ So Calif Med Ctr, Dept Surg, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, Los Angeles, CA 90033 USA		Talving, P (corresponding author), Univ So Calif, Los Angeles Cty Gen Hosp, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, 1200 N State St,IPT-C5L100, Los Angeles, CA 90033 USA.	ptalving@gmail.com	Talving, Peep/E-6015-2013; INABA, KENJI/AAC-8532-2020; Talving, Peep/G-8621-2015	Talving, Peep/0000-0002-9741-2073			ARANHA GV, 1982, AM J SURG, V143, P55, DOI 10.1016/0002-9610(82)90129-5; Chen ZB, 2007, WORLD J GASTROENTERO, V13, P5654, DOI 10.3748/wjg.v13.i42.5654; Christmas AB, 2005, AM SURGEON, V71, P996; CRYER HM, 1985, SOUTHERN MED J, V78, P138, DOI 10.1097/00007611-198502000-00005; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dangleben DA, 2006, J AM COLL SURGEONS, V203, P908, DOI 10.1016/j.jamcollsurg.2006.08.001; Demetriades D, 2004, J AM COLL SURGEONS, V199, P538, DOI 10.1016/j.jamcollsurg.2004.06.017; DOBERNECK RC, 1983, AM J SURG, V146, P306, DOI 10.1016/0002-9610(83)90402-6; Fang JF, 2003, J TRAUMA, V54, P1131, DOI 10.1097/01.TA.0000066123.32997.BB; GARRISON RN, 1984, ANN SURG, V199, P648, DOI 10.1097/00000658-198406000-00003; Georgiou C, 2009, WORLD J SURG, V33, P1087, DOI 10.1007/s00268-009-9923-7; GOMEZ GA, 1994, CRIT CARE CLIN, V10, P555, DOI 10.1016/S0749-0704(18)30118-0; Mansour A, 1997, SURGERY, V122, P730, DOI 10.1016/S0039-6060(97)90080-5; Maull KI, 2001, SOUTHERN MED J, V94, P205; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TINKOFF G, 1990, ANN SURG, V211, P172, DOI 10.1097/00000658-199002000-00009; Tripodi A, 2009, THROMB RES, V124, P132, DOI 10.1016/j.thromres.2008.11.008; Wahlstrom K, 2000, AM SURGEON, V66, P1071	20	8	8	0	5	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2011	77	3					311	314					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	730AH	WOS:000287995300011	21375843				2022-02-06	
J	Ochalski, PG; Adamo, MA; Adelson, PD; Okonkwo, DO; Pollack, IF				Ochalski, Pawel G.; Adamo, Matthew A.; Adelson, P. David; Okonkwo, David O.; Pollack, Ian F.			Fractures of the clivus and traumatic diastasis of the central skull base in the pediatric population Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						clivus; fracture; skull base; traumatic brain injury; synchondrosis; traumatic diastasis	SPHENO-OCCIPITAL SYNCHONDROSIS; HEAD-INJURY; CT; FEATURES; PATIENT; FISSURE; MR	Object. Fractures of the clivus and traumatic diastases of the clival synchondroses are rare in the pediatric population. The incidence, outcome, and biomechanics associated with these fractures have been difficult to ascertain secondary to the lack of literature pertaining to their occurrence. Methods. A Boolean search of the electronic medical record database at the Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, was performed to identify patients with fractures of the clivus that were diagnosed using CT of the head. A retrospective review of the chart and radiographic imaging was then performed to assess data regarding patient demographics, mechanism of injury, and skull and brain parenchymal injuries, as well as outcomes. Results. Between May 2002 and November 2007, 16 patients with fractures of the clivus were identified. The mean age of these patients was 9 years (range 1-16 years). Eleven (68.8%) of the 16 patients had an associated traumatic diastasis of the central skull base. Five (31.3%) of the 16 patients died. However, of the 11 patients who survived, all had a good outcome with a Glasgow Outcome Scale score of 4 or 5 at the time of discharge. The incidence of clival fractures among patients with head injuries was 0.33%. Conclusions. Clival fractures occur with a similar incidence in both the pediatric and adult trauma population. Outcome is not correlated directly with the extent of clival fracture, but rather with the presenting Glasgow Coma Scale score and concomitant brain parenchymal injuries. The identification of traumatic diastases in patients with clival fractures suggests that static loading forces are a significant factor in the biomechanics producing these types of fractures. (DOI: 10.3171/2010.12.PEDS10190)	[Adamo, Matthew A.] Albany Med Ctr, Div Neurosurg, Dept Surg, Albany, NY 12208 USA; [Ochalski, Pawel G.; Okonkwo, David O.; Pollack, Ian F.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Adelson, P. David] Phoenix Childrens Neurosci Inst, Phoenix, AZ USA; [Pollack, Ian F.] Childrens Hosp Pittsburgh, Dept Pediat Neurosurg, Pittsburgh, PA USA		Adamo, MA (corresponding author), Albany Med Ctr, Div Neurosurg, Dept Surg, 47 New Scotland Ave,MC 10, Albany, NY 12208 USA.	matthew.a.adamo@gmail.com	Adelson, David/W-2083-2019				Adem C, 1999, J RADIOL, V80, P863; Balboni AL, 2005, ANAT REC PART A, V282A, P38, DOI 10.1002/ar.a.20149; Carter DA, 1998, J TRAUMA, V44, P230, DOI 10.1097/00005373-199801000-00039; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; GROSSART K W, 1961, Clin Radiol, V12, P164, DOI 10.1016/S0009-9260(61)80003-2; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; KUROSU A, 1990, J NEUROSURG, V72, P660, DOI 10.3171/jns.1990.72.4.0660; LAINE FJ, 1990, RADIOGRAPHICS, V10, P591, DOI 10.1148/radiographics.10.4.2198631; MADELINE LA, 1995, RADIOLOGY, V196, P747, DOI 10.1148/radiology.196.3.7644639; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; Nemzek WR, 2000, AM J NEURORADIOL, V21, P1699; Ochalski PG, 2009, NEUROSURGERY, V65, P1063, DOI 10.1227/01.NEU.0000360154.18604.28; Okamoto K, 1996, AM J NEURORADIOL, V17, P117; SANDERS BB, 1973, J NEUROSURG, V39, P610, DOI 10.3171/jns.1973.39.5.0610; Takeshi M, 2006, J TRAUMA, V60, P1245, DOI 10.1097/01.ta.0000196932.11384.ac; Tortosa JG, 2004, J NEUROSURG, V100, P645, DOI 10.3171/jns.2004.100.4.0645; WACKENHEIM A, 1985, NEURORADIOLOGY, V27, P226, DOI 10.1007/BF00344493; WEST OC, 1993, RADIOLOGY, V188, P329, DOI 10.1148/radiology.188.2.8327674	19	8	8	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2011	7	3					261	267		10.3171/2010.12.PEDS10190			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	725WE	WOS:000287676800010	21361764				2022-02-06	
J	Kawahara, S; Konishi, H; Morino, M; Ohata, K; Kiyama, H				Kawahara, S.; Konishi, H.; Morino, M.; Ohata, K.; Kiyama, H.			PANCREATITIS-ASSOCIATED PROTEIN-I AND PANCREATITIS-ASSOCIATED PROTEIN-III EXPRESSION IN A RAT MODEL OF KAINIC ACID-INDUCED SEIZURE	NEUROSCIENCE			English	Article						RegIII; HIP; Reg2; dentate gyrus; epilepsy	NEUROTROPHIC FACTOR; MICROGLIAL ACTIVATION; NERVE REGENERATION; MOTOR-NEURONS; RECEPTORS; CYTOKINES; GP130; CNTF; BETA	The pancreatitis-associated protein (PAP) family (also known as the regenerating gene (Reg) family) is a group of 16 kDa secretory proteins structurally classified as the calcium dependent-type lectin superfamily. Some PAP family members are expressed in neurons following peripheral nerve injury and traumatic brain injury. To determine whether PAP family members are expressed in non-traumatic brain injury, expressions were analyzed following kainic acid (KA)-induced seizure. PAP-I (also known as Reg2 in rat and RegIII-beta in mouse) and pancreatitis associated protein-III (PAP-III; RegIII-gamma in mouse) messenger ribonucleic acid (mRNA) was transiently expressed in some restricted areas, such as the hippocampus and parahippocampal area; expression was observed immediately at a maximal level 1 day after seizure. Expression disappeared within 3 days after seizure. In situ hybridization (ISH) and immunohistochemistry revealed neuronal PAP-I and PAP-III expression in the hippocampal dentate gyrus, perirhinal and entorhinal cortices, and the posterior cortical nucleus of the amygdala. The number of PAP-III mRNA-positive neurons was significantly greater than PAP-I mRNA-positive neurons. The majority of positive neurons co-localized with c-Jun, but not with glutamic acid decarboxylase (GAD). These results may suggest that PAP-I and PAP-III induction in non-GABAergic neurons would protect neurons against damage following seizure. (c) 2011 AGA Institute. Published by Elsevier Ltd. All rights reserved.	[Kawahara, S.; Konishi, H.; Kiyama, H.] Osaka City Univ, Dept Anat & Neurobiol, Grad Sch Med, Osaka 5458585, Japan; [Kawahara, S.; Morino, M.; Ohata, K.] Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka 5458585, Japan		Kiyama, H (corresponding author), Osaka City Univ, Dept Anat & Neurobiol, Grad Sch Med, Osaka 5458585, Japan.	kiyama@med.osaka-cu.ac.jp	KONISHI, Hiroyuki/M-8871-2014; Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339	Ministry of Education, Culture, Sports, Science and Technology, the Japanese GovernmentMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	We are grateful to Ms. C. Kadono and Miss T. Okade for their technical assistance, and Miss R. Miyabe for secretarial assistance. Sequencing analysis was performed in the Central Laboratory of Osaka City University Medical School. This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government.	Ampo KI, 2009, J NEUROTRAUM, V26, P1683, DOI [10.1089/neu.2008.0847, 10.1089/neu.2008-0847]; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; Gironella M, 2007, GUT, V56, P1091, DOI 10.1136/gut.2006.116087; Hama I, 2010, BRAIN RES, V1306, P1, DOI 10.1016/j.brainres.2009.10.014; Hunt SP, 2007, HEPATOLOGY, V45, P1585, DOI 10.1002/hep.21705; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; IOVANNA JL, 1993, AM J PHYSIOL, V265, pG611, DOI 10.1152/ajpgi.1993.265.4.G611; Ito Y, 1998, BRAIN RES, V793, P321, DOI 10.1016/S0006-8993(98)00242-X; Jankowsky JL, 1999, EXP NEUROL, V159, P333, DOI 10.1006/exnr.1999.7137; Kiryu S, 1995, J NEUROSCI, V15, P7872; Kunz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-90; Lehtimaki KA, 2003, MOL BRAIN RES, V110, P253, DOI 10.1016/S0169-328X(02)00654-X; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; MAGLOCZKY Z, 1993, NEUROSCIENCE, V56, P317, DOI 10.1016/0306-4522(93)90334-C; Murakami K, 2006, NEUROSCIENCE, V141, P1961, DOI 10.1016/j.neuroscience.2006.05.026; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Namikawa K, 2006, J NEUROSCI, V26, P7460, DOI 10.1523/JNEUROSCI.0023-06.2006; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Rosell DR, 2003, NEUROSCIENCE, V122, P329, DOI 10.1016/S0306-4522(03)00593-1; Tebar LA, 2008, P NATL ACAD SCI USA, V105, P11400, DOI 10.1073/pnas.0711978105; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200	24	8	8	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 17	2011	175						273	280		10.1016/j.neuroscience.2010.11.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	718FK	WOS:000287106300026	21093549				2022-02-06	
J	Huggins, JM; Brown, JN; Capehart, B; Townsend, ML; Legge, J; Melnyk, SD				Huggins, Jenna Minton; Brown, Jamie N.; Capehart, Bruce; Townsend, Mary L.; Legge, Jenny; Melnyk, S. Dee			Medication adherence in combat veterans with traumatic brain injury	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article						Antidepressants; Brain injuries; Compliance; Department of Veterans Affairs; Patients; Rational therapy; Stress disorders	POSTTRAUMATIC-STRESS-DISORDER; IMPACT; CARE; DATABASES; PTSD; HIV	Purpose. Medication adherence in combat veterans with traumatic brain injury (TBI) was evaluated. Methods. Patients with a diagnosis of TBI were identified by a computer search of veterans enrolled in the Operation Enduring Freedom/Operation Iraqi Freedom or TBI/polytrauma clinics at Durham Veterans Affairs Medical Center (VAMC) between September 15, 2007, and September 15, 2008. Patients were included if they were at least 18 years old, received medical care and medications at the VAMC for at least 12 continuous months, and were taking at least one maintenance medication. A randomly selected age-matched comparator group without TBI was obtained through a computer-generated convenience sample. A composite adherence score for each patient was calculated using the medication possession ratio (MPR). The most commonly prescribed medications and indicators of increased adherence among the TBI group were also identified. Results. The composite MPR did not significantly differ between groups. The most commonly prescribed medications were selective serotonin-reuptake inhibitors and serotonin-norepinephrine-reuptake inhibitors and other antidepressants; however, these classes were associated with the lowest adherence rates. Factors associated with increased adherence included taking more than five maintenance medications (78%), living with a spouse or significant other (77%), owning a memory-assistance device (74%), and comorbid diagnosis of posttraumatic stress disorder (PTSD) (74%). Conclusion. Medication adherence rates were similar among combat veterans with a diagnosis of TBI and an age-matched comparator group. Factors associated with increased adherence included taking more than five maintenance medications, living with a spouse or significant other, owning a memory-assistance device, and a comorbid diagnosis of PTSD.	[Huggins, Jenna Minton] WakeMed Hlth & Hosp Raleigh Campus, Raleigh, NC 27610 USA; [Brown, Jamie N.] Durham Vet Affairs Med Ctr VAMC, Serv Pharm, Durham, NC USA; [Capehart, Bruce] Durham VAMC, OEF OIF Program, Durham, NC USA; [Capehart, Bruce] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Townsend, Mary L.] Campbell Univ, Sch Pharm, Buies Creek, NC 27506 USA; [Townsend, Mary L.; Legge, Jenny; Melnyk, S. Dee] Durham VAMC, Serv Pharm, Durham, NC USA		Huggins, JM (corresponding author), WakeMed Hlth & Hosp Raleigh Campus, 3000 New Bern Ave, Raleigh, NC 27610 USA.	jhuggins@wakemed.org	Brown, Jamie/W-4030-2019	Brown, Jamie/0000-0002-6839-5948; Townsend, Mary/0000-0002-9954-4846			Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delahanty DL, 2004, AIDS CARE, V16, P247, DOI 10.1080/09540120410001641084; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Gilmer TP, 2004, AM J PSYCHIAT, V161, P692, DOI 10.1176/appi.ajp.161.4.692; Greenwood R, 2002, J NEUROL NEUROSUR PS, V73, pI8; Haynes RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub2; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Katon W, 2005, ARCH INTERN MED, V165, P2497, DOI 10.1001/archinte.165.21.2497; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; ROSENBERG MJ, 1995, J REPROD MED, V40, P355; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shemesh E, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e29; Sledjeski EM, 2005, AIDS PATIENT CARE ST, V19, P728, DOI 10.1089/apc.2005.19.728; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Spoont M, 2005, J NERV MENT DIS, V193, P515, DOI 10.1097/01.nmd.0000172474.86877.2b; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	23	8	9	0	11	AMER SOC HEALTH-SYSTEM PHARMACISTS	BETHESDA	7272 WISCONSIN AVE, BETHESDA, MD 20814 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	FEB 1	2011	68	3					254	258		10.2146/ajhp090629			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	858CB	WOS:000297772400010	21258030				2022-02-06	
J	Takahashi, C; Okudera, H; Origasa, H; Takeuchi, E; Nakamura, K; Fukuda, O; Date, I; Tokutomi, T; Aruga, T; Sakamoto, T; Kobata, H; Ohta, T				Takahashi, Chiaki; Okudera, Hiroshi; Origasa, Hideki; Takeuchi, Eiichi; Nakamura, Kazuhito; Fukuda, Osamu; Date, Isao; Tokutomi, Takashi; Aruga, Tohru; Sakamoto, Tetsuya; Kobata, Hitoshi; Ohta, Tomio			A simple and useful coma scale for patients with neurologic emergencies: the Emergency Coma Scale	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							GLASGOW; INJURY; PREDICTION; SCORE	Objectives: The Emergency Coma Scale (ECS) was developed in Japan in 2003. We planned a multicenter study to evaluate the utility of the ECS by comparison of the ECS and the Glasgow Coma Scale (GCS). Methods: Ten medical facilities, including 4 university hospitals in Japan, participated in this study. We evaluated and recorded the level of consciousness, using the ECS and GCS, of all patients transported to these medical facilities by ambulance. We then performed a statistical analysis of the level of rater agreement of each scale using the average weighted. coefficient according to the types of diagnosis at time of discharge and the occupations of the raters. We then evaluated the relationship between outcome of patients and their scores on the ECS and GCS by logistic regression analysis. Results: The ECS showed the greater agreement among raters in patient scoring (0.802). In patients with traumatic brain injury and cerebrovascular disease, the ECS also yielded the higher agreement (0.846 and 0.779, respectively). The ECS score appears to be more strongly related than the GCS to patient outcome as measured by the Glasgow Outcome Scale (GOS). Conclusions: Our results showed that the ECS is a simple and readily understandable coma scale for a wide range of professionals in the field of neurologic emergencies. Furthermore, ECS appears to be suitable for evaluating patients in neurologic emergency settings. (C) 2011 Elsevier Inc. All rights reserved.	[Takahashi, Chiaki; Okudera, Hiroshi] Toyama Univ, Grad Sch Med, Dept Crisis Med, Toyama 9300194, Japan; [Origasa, Hideki] Toyama Univ, Grad Sch, Div Biostat & Clin Epidemiol, Toyama 9300194, Japan; [Takeuchi, Eiichi] Kyoto Fushimishimizu Hosp, Kyoto 6128321, Japan; [Nakamura, Kazuhito] Osaka City Gen Hosp, Dept Neurosurg, Osaka 5340021, Japan; [Fukuda, Osamu] Saito Mem Hosp, Dept Neurosurg, Niigata 9496602, Japan; [Date, Isao] Okayama Univ Hosp, Dept Neurosurg, Okayama 7008558, Japan; [Tokutomi, Takashi] Kurume Univ, Dept Neurosurg, Fukuoka 8300011, Japan; [Aruga, Tohru] Showa Univ, Dept Emergency & Crit Care Med, Tokyo 1428666, Japan; [Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Trauma & Crit Care Ctr, Tokyo 1730003, Japan; [Kobata, Hitoshi] Osaka Mishima Emergency & Crit Care Ctr, Div Neurosurg, Osaka 5691124, Japan; [Ohta, Tomio] Osaka Neurol Inst, Osaka 5610836, Japan		Takahashi, C (corresponding author), Toyama Univ, Grad Sch Med, Dept Crisis Med, Toyama 9300194, Japan.	d0661014@ems.u-toyama.ac.jp		Takahashi, Chiaki/0000-0002-8082-8531; Okudera, Hiroshi/0000-0003-0153-6352	Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School; Department of Neurosurgery, Saito Memorial Hospital; Kyoto Renaiss Hospital, Itoigawa General Hospital; Toyama City Hospital	We thank our colleagues, Dr Masahiro Wakasugi, Dr Takashi Asahi, Dr Daisuke Tange, and Dr Joji Hamada, as well as the nurses and young physicians in training in the ED of Toyama University Hospital. We gratefully acknowledge the support of the following individuals and institutions: Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School; Ms Kumagai, Department of Neurosurgery, Saito Memorial Hospital; Dr Koyama and Dr Ohara, ED staff members at Kyoto Renaiss Hospital, Itoigawa General Hospital, and Toyama City Hospital.	Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gotoh O, 1995, No To Shinkei, V47, P49; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; *ISLS COURS GUID E, 2007, ISLS COURS GUID BOOK; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kitamura A, 2006, STROKE, V37, P1374, DOI 10.1161/01.STR.0000221714.96986.5f; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ohta T, 2005, ACT NEUR S, V93, P191; OKUDERA H, 2004, J JPN C NEUROL EMERG, V17, P66; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; Takahashi C, 2007, PROCEEDINGS OF THE 13TH EUROPEAN CONGRESS OF NEUROSURGERY, P321; Takahashi C, 2007, PROCEEDINGS OF THE 13TH EUROPEAN CONGRESS OF NEUROSURGERY, P317; Takahashi C, 2007, NEUROSURG EMERG, V12, P129; TEASDALE G, 1983, LANCET, V2, P678; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; Wakasugii M, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P400, DOI 10.1007/4-431-28576-8_61; [No title captured]	24	8	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2011	29	2					196	202		10.1016/j.ajem.2009.09.018			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	718QG	WOS:000287139800010	20825789				2022-02-06	
J	Shen, H; Harvey, BK; Chiang, YH; Pick, CG; Wang, Y				Shen, Hui; Harvey, Brandon K.; Chiang, Yung-Hsiao; Pick, Chaim G.; Wang, Yun			Methamphetamine potentiates behavioral and electrochemical responses after mild traumatic brain injury in mice	BRAIN RESEARCH			English	Article						Head trauma; mTBI; Dopamine; Methamphetamine; Behavior	TYROSINE-HYDROXYLASE; ISCHEMIC-STROKE; RAT; IMPAIRMENT; PREVALENCE; INHALATION; SYSTEM	We previously demonstrated that high doses of methamphetamine (MA) exacerbate damage induced by severe brain trauma. The purpose of the present study was to examine if MA, at low dosage, affected abnormalities in locomotor activity and dopamine turnover in a mouse model of mild traumatic brain injury (mTBI). Adult male CD1 mice were treated with MA (5 mg/kg i.p.) or vehicle 30-min prior to mTBI, conducted by dropping a 30 g metal weight onto the temporal skull, anterior the right ear. At 15 min after mTBI, animals were put into locomotor activity chambers for up to 72 h. During the first 3 h, mTBI alone, compared with vehicle control, did not alter total distance travelled. Treatment with MA significantly increased locomotor activity in the control animals during the first 3 h; mTBI reduced MA-induced hyperactivity. In contrast, at 2 and 3 days after injury, mTBI or MA alone reduced locomotor activity. Co-treatment with MA and mTBI further reduced this activity, suggesting a differential and temporal behavioral interaction between MA and mTBI during acute and subacute phases after injury. Dopamine and DOPAC levels in striatal tissue were analyzed using HPLC-ECD. At 1 h after mTBI or injection, DA was not altered but DOPAC level and DOPAC/DA turnover ratios were significantly reduced. Co-treatment with MA further reduced the DOPAC/DA ratio. At 36 h after injury, mTBI increased tissue DA levels, but reduced DOPAC levels and DOPAC/DA ratios. Co-treatment with MA further reduced DOPAC/DA ratios in striatum. In conclusion, our data suggest that low dosage of MA worsens the suppression of locomotor responses and striatal dopamine turnover after mTBI. Published by Elsevier B.V.	[Wang, Yun] NIDA, Neural Protect & Regenerat Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei, Taiwan; [Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel		Wang, Y (corresponding author), NIDA, Neural Protect & Regenerat Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	ywang@intra.nida.nih.gov	Harvey, Brandon K/A-5559-2010; Harvey, Brandon Keith/AAY-4080-2021	Harvey, Brandon Keith/0000-0002-4036-1383	National Institute on Drug Abuse, IRP, U.S.A.United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC98-2314-B-038-011-MY3]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000461, ZIADA000576, ZIADA000443, ZIADA000429, ZIADA000526] Funding Source: NIH RePORTER	This study was supported by the National Institute on Drug Abuse, IRP, U.S.A. and National Science Council of Taiwan (NSC98-2314-B-038-011-MY3).	Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Gustavsen I, 2006, ACCIDENT ANAL PREV, V38, P490, DOI 10.1016/j.aap.2005.11.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Klette KL, 2006, J ANAL TOXICOL, V30, P319, DOI 10.1093/jat/30.5.319; KOKKINOS J, 1993, STROKE, V24, P310, DOI 10.1161/01.STR.24.2.310; Lacy BW, 2008, MIL MED, V173, P353, DOI 10.7205/MILMED.173.4.353; Logan BK, 1996, J FORENSIC SCI, V41, P457; MASSERANO JM, 1981, SCIENCE, V214, P662, DOI 10.1126/science.6117127; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Qi J, 2008, N-S ARCH PHARMACOL, V376, P441, DOI 10.1007/s00210-007-0245-8; ROTHROCK JF, 1988, NEUROLOGY, V38, P589, DOI 10.1212/WNL.38.4.589; Shen H, 2008, NEUROSCI LETT, V442, P15, DOI 10.1016/j.neulet.2008.06.052; Tominaga GT, 2004, ARCH SURG-CHICAGO, V139, P844, DOI 10.1001/archsurg.139.8.844; Verschraagen M, 2007, FORENSIC SCI INT, V170, P163, DOI 10.1016/j.forsciint.2007.03.030; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wang Y, 2001, STROKE, V32, P775, DOI 10.1161/01.STR.32.3.775; WEINER N, 1978, LIFE SCI, V22, P1197, DOI 10.1016/0024-3205(78)90088-7; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; YEN DJ, 1994, EUR NEUROL, V34, P16, DOI 10.1159/000117002; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	22	8	8	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 12	2011	1368						248	253		10.1016/j.brainres.2010.10.014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714ZJ	WOS:000286849900026	20950593	Green Accepted			2022-02-06	
J	Dahl, E				Dahl, Eilif			Wound infections on board ship - prevention, pathogens, and treatment	INTERNATIONAL MARITIME HEALTH			English	Article						injury prevention; bites; burns; abscesses; maritime medicine		Wounds are common in seafarers and they can easily become infected in the marine environment. Pre-sea tetanus immunization is essential. Without diagnostic facilities and only a limited range of antibiotics onboard, injury prevention and early treatment to reduce the likelihood of infection are important measures. Suturing clean cuts reduces healing time and risk of infection. Fresh, clean cuts, especially on the face or head, can be closed by adhesive tape or sutures, but if infection arises, then one or more sutures should be removed to enable drainage. Most wounds must be considered contaminated and should not be closed, just covered with sterile dressing after cleaning. Antibiotic treatment should be started immediately in seafarers with hand and puncture wounds. The primary treatment for a simple abscess is incision and drainage. Antibiotic treatment is recommended for abscesses if the infection spreads to the surrounding tissue (associated cellulitis), if there is lack of response to incision and drainage alone, or if the abscess is in an area difficult or dangerous to drain (e.g. face, palm, genitalia). Recommended therapy for cellulitis is 5-10 days of dicloxacillin, cephalexin, clindamycin, or erythromycin, but if there is no improvement after 2-3 days, methicillin-resistant Staphylococcus aureus (MRSA) should be suspected. Bites and burn wounds require special attention. Since wound infections can deteriorate rapidly, a telemedicine advice service (TMAS) should be consulted during the early stages, and serial digital photographs of the affected area, transmitted by e-mail to TMAS, are often useful during treatment at sea.	[Dahl, Eilif] Univ Bergen, Norwegian Ctr Maritime Med, Bergen, Norway		Dahl, E (corresponding author), Oslo Univ Hosp, Div Liver Gastrointestinal & Paediat Surg, Sect Paediat Surg, POB 4950 Nydalen, N-0514 Oslo, Norway.	eilifdahl@hotmail.com					Dahl E, 2005, INT MARIT HEALTH, V56, P115; Dahl E, 2008, INT MARIT HEALTH, V59, P19; Gilbert DN, 2010, SANDFORD GUIDE ANTIM; LaMar JE, 2003, MIL MED, V168, P135, DOI 10.1093/milmed/168.2.135; Lin M., ACAD LIFE EMERGENCY; Liu C., 2011, CLIN INFECT DIS; Lucas R, 2010, INT MARIT HEALTH, V61, P9; Lucas R, 2007, INT MARIT HEALTH, V58, P93; McPhee SJ, 2010, LANGE 2010 CURRENT M; Moran GJ, 2008, INFECT DIS CLIN N AM, V22, P117, DOI 10.1016/j.idc.2007.12.002; Murray C., MEDSCAPE REFERENCE D; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; World Health Organization, 2007, INT MED GUID SHIPS	13	8	8	0	0	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	1641-9251	2081-3252		INT MARIT HEALTH	Int. Marit. Health		2011	62	3					186	190					5	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	V1F1M	WOS:000216847300005	22258845				2022-02-06	
J	Davis, DP; Aguilar, S; Sonnleitner, C; Cohen, M; Jennings, M				Davis, Daniel P.; Aguilar, Steve; Sonnleitner, Catherine; Cohen, Maya; Jennings, Michelle			Latency and Loss of Pulse Oximetry Signal with the Use of Digital Probes during Prehospital Rapid-Sequence Intubation	PREHOSPITAL EMERGENCY CARE			English	Article; Proceedings Paper	Air Medical Transport Conference	SEP, 2008	Tampa, FL				INJURED PATIENTS; HYPOXIA; PERFUSION; HYPERVENTILATION; DESATURATION; HYPOTHERMIA; SATURATION; FOREHEAD; SPO(2); TRAUMA	Background. Prehospital personnel rely on timely and accurate pulse oximetry data when performing critical skills, such as rapid-sequence intubation (RSI). However, loss of signal may be a frequent occurrence in patients with poor peripheral perfusion. In addition, a delay or latency period in the timeliness of pulse oximetry data may exist with probes placed on the fingers. Objective. To define the incidence of pulse oximetry signal loss or a latent period during prehospital RSI. Methods. Patients with severe traumatic brain injury (TBI) (Glasgow Coma Scale score [GCS] 3-8) undergoing prehospital RSI by air medical crews were enrolled. Data from hand-held oximetry-capnometry units were analyzed for either the loss of a pulse oximetry tracing (>= 30 seconds) during the RSI procedure or the presence of a latent period, defined by the saturation of peripheral oxygen (SpO(2)) nadir occurring after intubation in patients undergoing desaturation (SpO(2) < 93%) during the procedure. Results. A total of 98 of 124 patients (79%, 95% confidence interval [CI] 71-85%) had pulse oximetry failure during critical points in the RSI procedure. In the 49 patients with a desaturation during RSI, a latent period was observed in 27 patients (55%, 95% CI 41-68%). Conclusions. A high incidence of pulse oximetry failure was observed with the use of a digital pulse oximetry probe during prehospital RSI. In addition, a latent period appears to exist in the majority of patients undergoing desaturation.	[Davis, Daniel P.; Jennings, Michelle] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Aguilar, Steve; Sonnleitner, Catherine] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Cohen, Maya] Cornell Univ, Dept Biol, Ithaca, NY USA		Davis, DP (corresponding author), Univ Calif San Diego, Dept Emergency Med, 200 W Arbor Dr, San Diego, CA 92103 USA.	davismd@cox.net					Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Bebout DE, 2001, CRIT CARE MED, V29, pA115; Davis DP, 2008, PREHOSP EMERG CARE, V12, P46, DOI 10.1080/10903120701710470; Davis DP, 2007, RESUSCITATION, V73, P354, DOI 10.1016/j.resuscitation.2006.09.015; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Kawagishi T, 2004, ANESTH ANALG, V99, P793, DOI 10.1213/01.ANE.0000130343.66453.37; MacLeod DB, 2005, ANAESTHESIA, V60, P65, DOI 10.1111/j.1365-2044.2004.04033.x; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Nishiyama T, 2006, CAN J ANAESTH, V53, P136, DOI 10.1007/BF03021817; Nuhr M, 2004, ANAESTHESIA, V59, P390, DOI 10.1111/j.1365-2044.2004.03673.x; Omert L, 2001, J TRAUMA, V51, P1065, DOI 10.1097/00005373-200112000-00007; Schallom L, 2007, HEART LUNG, V36, P188, DOI 10.1016/j.hrtlng.2006.07.007; SEVERINGHAUS JW, 1989, J CLIN MONITOR, V5, P72, DOI 10.1007/BF01617877; Tiamfook-Morgan TO, 2006, PREHOSP EMERG CARE, V10, P363, DOI 10.1080/10903120600725835; Trivedi NS, 1997, J CLIN ANESTH, V9, P184, DOI 10.1016/S0952-8180(97)00037-8; Van de Louw A, 2001, INTENS CARE MED, V27, P1606; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1197/aemj.10.7.717	19	8	8	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1090-3127			PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN	2011	15	1					18	22		10.3109/10903127.2010.514091			5	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine; Public, Environmental & Occupational Health	684GS	WOS:000284539000004	20858133				2022-02-06	
J	Lajiness-O'Neill, R; Erdodi, L; Bigler, ED				Lajiness-O'Neill, Renee; Erdodi, Laszlo; Bigler, Erin D.			Demographic and Injury-Related Moderators of Memory and Achievement Outcome in Pediatric TBI	APPLIED NEUROPSYCHOLOGY			English	Article						achievement; age; memory; outcome; structural equation modeling; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CLOSED HEAD-INJURY; 1ST YEAR; NEUROPSYCHOLOGICAL FUNCTION; ACADEMIC-ACHIEVEMENT; YOUNG-CHILDREN; ADOLESCENTS; RECOVERY; CHILDHOOD; PREDICTORS	Critical factors affecting traumatic brain injury (TBI) outcome in children and adolescents are explored with an emphasis on an examination of age at injury as a predictor of memory functioning. Age at injury and other injury-related and demographic predictors (i.e., severity, time postinjury, gender, and socioeconomic status [SES]) of memory and achievement outcome were examined in 65 children and adolescents post-TBI compared to 65 age-matched noninjured controls. Although robust findings have been found for age at injury as a general predictor of outcome, age was not found to be a significant predictor of memory functioning following pediatric TBI. Structural equation modeling suggests that the most parsimonious model of post-TBI outcome contains two causally related latent variables: one defined by gender, SES, injury severity, and age at injury, and one defined by general cognitive functioning.	[Lajiness-O'Neill, Renee; Erdodi, Laszlo] Eastern Michigan Univ, Dept Psychol, Ypsilanti, MI 48197 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA		Lajiness-O'Neill, R (corresponding author), Eastern Michigan Univ, Dept Psychol, 537 F Mark Jefferson, Ypsilanti, MI 48197 USA.	rlajines@emich.edu					Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Bigler ED, 1997, NEUROLOGY, V49, P1180, DOI 10.1212/WNL.49.4.1180-a; Bigler ED, 1996, J LEARN DISABIL, V29, P512, DOI 10.1177/002221949602900506; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Coffey C. E., 1998, TXB PEDIAT NEUROPSYC, P1093; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; DUNN LM, 1991, PEABODY PICTURE VOCA; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Graham DI, 2001, BRAIN, V124, P1261, DOI 10.1093/brain/124.7.1261; Guthrie E, 1999, CHILD ADOL PSYCH CL, V8, P807; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Jagannathan P., 2008, J NEUROSURGICAL FOCU, V25, P1; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Jastek S., 1993, WIDE RANGE ACHIEVEME; JOHNSON DA, 1992, BRIT J EDUC PSYCHOL, V62, P404, DOI 10.1111/j.2044-8279.1992.tb01033.x; Joreskog K. G., 1993, TESTING STRUCTURAL E, P294, DOI DOI 10.1093/SF/73.3.1161; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Kraus JF., 1995, TRAUMATIC HEAD INJUR, P117; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; Margulies S. S., 2000, J BIOMECHANICAL ENG, V122, P367; Marjoribanks K., 1972, J EDUC PSYCHOL, V63, P106; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Sattler J., 1990, ASSESSMENT CHILDREN; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	62	8	8	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2011	18	4					298	308		10.1080/09084282.2011.595457			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	888GS	WOS:000299992400008	22074069				2022-02-06	
J	Llompart-Pou, JA; Abadal, JM; Perez-Barcena, J; Molina, M; Brell, M; Ibanez, J; Raurich, JM; Ibanez, J; Homar, J				Llompart-Pou, J. A.; Abadal, J. M.; Perez-Barcena, J.; Molina, M.; Brell, M.; Ibanez, J.; Raurich, J-M.; Ibanez, J.; Homar, J.			Long-term follow-up of patients with post-traumatic refractory high intracranial pressure treated with lumbar drainage	ANAESTHESIA AND INTENSIVE CARE			English	Article						external lumbar drainage; intracranial pressure; second-tier therapy; traumatic brain injury; head injury	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID DRAINAGE; PRACTICAL SCALE; HYPERTENSION; MANAGEMENT; COMA	Drainage of cerebrospinal fluid by means of external lumbar drainage (ELD) is controversial in the adult population with traumatic brain injury. We report our experience with ELD in the treatment of post-traumatic high intracranial pressure (ICP) and the results of the long-term follow-up in these patients. We undertook clinical evaluation of 30 patients with traumatic brain injury and high ICP treated with second-tier measures or with first-tier measures if second-tier measures were contraindicated. The study involved a retrospective review of collected data. Outcome at intensive care unit discharge and three to five years after injury were evaluated with the Glasgow Outcome Scale. The mean age of patients was 34.9 +/- 12.5 years and 25 (83%) were male. The median (interquartile range) Glasgow Coma score was 8 (7 to 10). ICP before and one hour after ELD placement was 33.7 +/- 9.0 and 12.5 +/- 4.8 mmHg respectively, a decrease in 21.2 +/- 8.3 mmHg (P < 0.0001). ELD was placed after a mean of 8.6 +/- 3.9 days. Cerebrospinal fluid drainage was maintained for a mean of 6.6 +/- 3.5 days. Four patients (13%) required ELD replacement and one patient developed a cerebrospinal fluid infection (3%). No pupillary changes were noted within 48 hours of ELD placement. Long-term outcome was favourable (good recovery or moderate disability) in 62% of the patients studied. The use of ELD resulted in a marked decrease in ICP These patients presented a good outcome in 62% of the cases in the long-term evaluation. Few complications related with ELD use were noted.	[Brell, M.; Ibanez, J.] Son Dureta Univ Hosp, Intens Care Unit, Dept Neurosurg, Palma de Mallorca, Illes Balears, Spain		Llompart-Pou, JA (corresponding author), Hosp Univ Son Dureta, Serv Med Intens, C Andrea Doria 55, Palma De Mallorca 07014, Illes Balears, Spain.	juanantonio.llompart@ssib.es		Ibanez, Javier/0000-0003-3735-8332			Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS38; Akil H, 2007, J TRAUMA, V63, P720, DOI 10.1097/TA.0b013e318141fe4d; BALDWIN HZ, 1992, PEDIATR NEUROSURG, V17, P115, DOI 10.1159/000120579; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; Grady MS, 2009, J NEUROSURG, V110, P1198, DOI 10.3171/2008.11.JNS081336; JENNETT B, 1975, LANCET, V1, P480; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; Abadal JM, 2009, J NEUROSURG, V111, P1295, DOI 10.3171/2009.6.JNS09873; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARTINEZ E, 1994, LANCET, V344, P1015, DOI 10.1016/S0140-6736(94)91671-3; Munch EC, 2001, CRIT CARE MED, V29, P976; Murad A, 2008, ACT NEUR S, V102, P89, DOI 10.1007/978-3-211-85578-2_18; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; TEASDALE G, 1974, LANCET, V2, P81; Tomosvari Adrienn, 2005, Orvosi Hetilap, V146, P159; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; Willemse RB, 1998, ACT NEUR S, V71, P37	23	8	12	0	5	AUSTRALIAN SOC ANAESTHETISTS	EDGECLIFF	P O BOX 600, EDGECLIFF, NSW 2027, AUSTRALIA	0310-057X	1448-0271		ANAESTH INTENS CARE	Anaesth. Intensive Care	JAN	2011	39	1					79	83		10.1177/0310057X1103900113			5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	727BL	WOS:000287772200013	21375095	Bronze			2022-02-06	
J	Mayers, LB; Redick, TS; Chiffriller, SH; Simone, AN; Terraforte, KR				Mayers, Lester B.; Redick, Thomas S.; Chiffriller, Sheila H.; Simone, Ashley N.; Terraforte, Keith R.			Working memory capacity among collegiate student athletes: Effects of sport-related head contacts, concussions, and working memory demands	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Athlete; Working memory capacity; Neurocognitive tests; Brain injury; Concussion	TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; INDIVIDUAL-DIFFERENCES; EXECUTIVE ATTENTION; PERFORMANCE; IMPAIRMENT; DEFICITS; SCHOOL; TASK; MRI	Objective: To measure working memory capacity among a cohort of collegiate athletes and to compare results between athletes competing in head-contact-prone sports with those not subject to repeated head contacts. A secondary objective was to determine the effect of sport-related concussion on working memory capacity. Design: Ambidirectional cohort study. Setting: Athletics department at an American university. Participants: Student athletes competing in various sports. Interventions: None. Main outcome measurement: Automated operation span test scores. Results: Working memory capacity is not impaired in student athletes who participate in head-contact-prone sports or in student athletes with a history of diagnosed concussion, even those who are multiconcussed. Our results suggest that athletes competing in sports that impose significant working memory loading score higher on the automated operation span test than do other athletes. Conclusions: Further research is required to determine the value of measuring working memory capacity in acutely concussed, symptomatic athletes.	[Mayers, Lester B.] Pace Univ, Div Sports Med, Pleasantville, NY 10570 USA; [Redick, Thomas S.] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA; [Chiffriller, Sheila H.; Simone, Ashley N.; Terraforte, Keith R.] Pace Univ, Dept Psychol, Pleasantville, NY 10570 USA		Mayers, LB (corresponding author), Pace Univ, Div Sports Med, 861 Bedford Rd Goldstein Fitness Ctr, Pleasantville, NY 10570 USA.	lmayers@pace.edu	Redick, Thomas S/P-2027-2015				Alloway TP, 2005, BRIT J DEV PSYCHOL, V23, P417, DOI 10.1348/026151005X26804; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Furley P, 2010, PERCEPT MOTOR SKILL, V110, P801, DOI 10.2466/PMS.110.3.801-808; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Klossner D, 2008, 2008 09 NCAA SPORTS; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Rosen VM, 2002, NEUROPSYCHOLOGIA, V40, P2226, DOI 10.1016/S0028-3932(02)00132-X; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; SHUTTLEWORTHEDW.AB, 2007, S AFR J SPORTS MED, V19, P32; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Starkes J.L., 2003, EXPERT PERFORMANCE S; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007	31	8	9	3	38	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	5					532	537	PII 931968722	10.1080/13803395.2010.535506			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	773AQ	WOS:000291279800004	21218317				2022-02-06	
J	Davis, G; Marion, DW; Le Roux, P; Laws, ER; McCrory, P				Davis, G.; Marion, D. W.; Le Roux, P.; Laws, E. R.; McCrory, P.			Clinics in neurology and neurosurgery-extradural and subdural haematoma	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; HEAD-INJURY; DIFFUSION; BOXERS		[McCrory, P.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia; [Davis, G.] Cabrini Med Ctr, Malvern, Vic, Australia; [Marion, D. W.] Fus Med Educ LLC, Wakefield, MA USA; [Le Roux, P.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Laws, E. R.] Univ Virginia, Charlottesville, VA USA		McCrory, P (corresponding author), Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia.	p.mccrory@unimelb.edu.au	McCrory, Paul/Q-8688-2019; Marion, Donald/AAR-5749-2021	McCrory, Paul/0000-0003-4850-0568			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; CHAO KH, 2004, MANAGEMENT CEREBRAL, P211; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Gennarelli T, 1987, P 31 STAPP CAR CRASH; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Marion DW, 2006, NEUROSURGERY, V58, P655; MCLATCHIE G, 1994, BRIT MED J, V308, P1620, DOI 10.1136/bmj.308.6944.1620; POLIN R, 1996, NEUROLOGY TRAUMA, P166; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; Unterharnscheidt F J, 1972, Scand J Rehabil Med, V4, P77; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	27	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2010	44	16					1139	1143		10.1136/bjsm.2008.048215			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	694JZ	WOS:000285294800006	18552373				2022-02-06	
J	Pasinetti, GM; Fivecoat, H; Ho, L				Pasinetti, Giulio Maria; Fivecoat, Hayley; Ho, Lap			Personalized Medicine in Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Postconscussive traumatic brain injury; MicroRNA; Biomarker; Personalized medicine	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; COGNITIVE REHABILITATION; BREAST-CANCER; TASK-FORCE; EXPRESSION; RISK; TAU; CHEMOTHERAPY; MECHANISMS	Patients who have sustained a mild traumatic brain injury (TBI) from both civilian and military populations exhibit clinical symptoms of varying severity with minimal to profound impact on their daily functioning Although most patients make a full recovery, a subgroup of mild TBI patients develop cognitive somatic, and neurobehavioral sequelae that generally resolve over 3 to 6 months a smaller subgroup develop persisting symptoms The reason why a mild TBI results in varying clinical symptoms is currently unknown Based on evidence that microRNA species in peripheral blood mononuclear cells (PBMCs) may reflect molecular alterations in neurodegenerative disorders it can be hypothesized that at early preclinical phases of the disease PBMC may provide an ideal and clinically assessable window' into the brain Thus it is conceivable that changes in the expression profile of clinically accessible biological indices (biomarkers) such as microRNA in PBMC may reflect molecular alterations	[Pasinetti, Giulio Maria; Fivecoat, Hayley; Ho, Lap] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Pasinetti, Giulio Maria] James J Peters Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY 10468 USA		Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Neurol, 1 Gustave L Levy Pl,Box 1137, New York, NY 10029 USA.			Pasinetti, Giulio/0000-0002-1524-5196			Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Berube J, 2001, J HEAD TRAUMA REHAB, V16, P210, DOI 10.1097/00001199-200104000-00009; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Cappa SF, 2005, EUR J NEUROL, V12, P665; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Gennarelli TA, 2005, ABBREVIATED INJURY S; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; GREBERDING JL, 2003, C MILD TRAUM BRAIN I; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hornberger J, 2005, AM J MANAG CARE, V11, P313; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Takacs CM, 2010, SEMIN CELL DEV BIOL, V21, P760, DOI 10.1016/j.semcdb.2010.02.003; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; Vos PE, 2004, NEUROLOGY, V62, pA448; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	40	8	8	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X			PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					905	+		10.1016/j.psc.2010.09.003			11	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700011	21093685				2022-02-06	
J	Zadik, Y; Jeffet, U; Levin, L				Zadik, Yehuda; Jeffet, Uziel; Levin, Liran			Prevention of Dental Trauma in a High-Risk Military Population: The Discrepancy Between Knowledge and Willingness to Comply	MILITARY MEDICINE			English	Article							OROFACIAL INJURIES; FACIAL TRAUMA; ORAL TRAUMA; MOUTHGUARDS; ISRAEL; CONCUSSION; SOLDIERS	Military fighters are at high risk for oral/tooth injuries. Our aim was to evaluate the knowledge and willingness to use preventive measures among this population to reduce oral trauma. A total of 336 fighters were randomly assigned to two groups. The control group answered a structured questionnaire, which included questions regarding: knowledge of the benefits of mouthguard use, past/current use, and willingness to use a mouthguard. The intervention group received a 60-minute dental trauma lecture, and responded to the same questionnaire. Significantly more subjects in the intervention group were familiar with the benefits of mouthguards compared to the control group, but there was no difference between the groups in their willingness to use mouthguards routinely. Discomfort and potential interference to sport performance were the most common reasons for rejection. It seems that a structured lecture is not sufficient for ensuring usae of mouthguards in a military population. Emphasis on motivation or mandating use may be required.	[Zadik, Yehuda] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Oral Med, IL-91120 Jerusalem, Israel; [Jeffet, Uziel] IDF, Med Corps Headquarters, Tel Hashomer, Israel; [Jeffet, Uziel; Levin, Liran] Rambam Hlth Care Ctr, Dept Periodontol, Sch Grad Dent, IL-31096 Haifa, Israel		Zadik, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Oral Med, POB 12272, IL-91120 Jerusalem, Israel.		Zadik, Yehuda/H-7242-2019				Ashkenazi M, 2007, J DENT EDUC, V71, P287; Asimakopoulou Koula, 2009, Dent Update, V36, P626; Becker T, 2009, MIL MED, V174, P190; Blinkhorn A S, 1993, Int Dent J, V43, P294; Bourguignon Cecilia, 2009, Dent Clin North Am, V53, P729, DOI 10.1016/j.cden.2009.06.002; Bullock SH, 2010, AM J PREV MED, V38, pS156, DOI 10.1016/j.amepre.2009.10.023; Chatterjee Mahua, 2007, Prim Dent Care, V14, P111, DOI 10.1308/135576107781327151; dela Cruz GG, 2008, DENT TRAUMATOL, V24, P86, DOI 10.1111/j.1600-9657.2006.00500.x; Gardiner D M, 2000, Dent Clin North Am, V44, P53; Glendor U, 2009, DENT TRAUMATOL, V25, P12, DOI 10.1111/j.1600-9657.2008.00707.x; KATZ RV, 1979, COMMUNITY DENT ORAL, V7, P30, DOI 10.1111/j.1600-0528.1979.tb01182.x; Levin L, 2003, DENT TRAUMATOL, V19, P237, DOI 10.1034/j.1600-9657.2003.00196.x; Levin L, 2008, J ORAL MAXIL SURG, V66, P1630, DOI 10.1016/j.joms.2007.11.028; Levin L, 2007, DENT TRAUMATOL, V23, P356, DOI 10.1111/j.1600-9657.2006.00473.x; Ma WL, 2008, DENT TRAUMATOL, V24, P430, DOI 10.1111/j.1600-9657.2008.00586.x; Matalon V, 2008, DENT TRAUMATOL, V24, P462, DOI 10.1111/j.1600-9657.2008.00600.x; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; Ranalli D N, 2000, Dent Clin North Am, V44, P35; Schwartz-Arad D, 2004, DENT TRAUMATOL, V20, P344, DOI 10.1111/j.1600-9657.2004.00255.x; Schwartz-Arad Devorah, 2004, Implant Dent, V13, P120; STETSON BA, 2000, COMPEND CONTIN ED DE, V30, pS24; Walker J, 2002, ASDC J Dent Child, V69, P207; Winters JE, 2001, J ATHL TRAINING, V36, P339; Zadik Y, 2009, DENT TRAUMATOL, V25, P100, DOI 10.1111/j.1600-9657.2008.00719.x; Zadik Y, 2009, DENT TRAUMATOL, V25, P69, DOI 10.1111/j.1600-9657.2008.00708.x; Zadik Y, 2008, MIL MED, V173, P1185, DOI 10.7205/MILMED.173.12.1185	26	8	8	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	DEC	2010	175	12					1000	1003		10.7205/MILMED-D-10-00150			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691KO	WOS:000285078900015	21265309				2022-02-06	
J	Hamilton, NA; Keller, MS				Hamilton, Nicholas A.; Keller, Martin S.			Mild traumatic brain injury in children	SEMINARS IN PEDIATRIC SURGERY			English	Article						Mild traumatic brain injury; Head injury; Childhood trauma	HEAD COMPUTED-TOMOGRAPHY; GLASGOW COMA SCALE; IMMEDIATE POSTTRAUMATIC SEIZURES; SERUM BIOMARKER CONCENTRATIONS; INTRACRANIAL INJURY; DECISION RULE; RECURRENT CONCUSSION; FOOTBALL PLAYERS; HIGH-SCHOOL; MANAGEMENT	Head injury occurs frequently in childhood and results in approximately 500,000 emergency department visits and over $1 billion in costs annually. Nearly 75% of these children are ultimately diagnosed with mild traumatic brain injury (MTBI), a misnomer because many will have radiographically identified intracranial injuries and long-term consequences. Identification of the brain at risk and prevention of secondary injury is associated with the largest reduction in head trauma morbidity and mortality. This article reviews the current literature to discuss the initial evaluation, management, and long-term outcomes in children sustaining MTBI. (C) 2010 Published by Elsevier Inc.	[Hamilton, Nicholas A.; Keller, Martin S.] St Louis Childrens Hosp, St Louis, MO 63110 USA		Keller, MS (corresponding author), St Louis Childrens Hosp, 1 Childrens Pl,Suite 5S40,Campus Box 8235, St Louis, MO 63110 USA.	kellerm@wudosis.wustl.edu	Hamilton, Nicholas/AAU-5716-2020				Aitken ME, 1998, ARCH PEDIAT ADOL MED, V152, P1176; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; BIJUR PE, 1990, PEDIATRICS, V86, P337; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; *CDC, 2003, CDC REP C MILD TRAUM; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; GORDON KE, 2006, SEMIN PEDIAT NEUROL, V12, P243; Gordon KE, 2006, CLIN J SPORT MED, V16, P195, DOI 10.1097/00042752-200605000-00001; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hendrickson S G, 1998, Inj Prev, V4, P126; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Mandal K, 2001, CHILD NERV SYST, V17, P670, DOI 10.1007/s00381-001-0520-9; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Munjal SK, 2010, J TRAUMA, V68, P13, DOI 10.1097/TA.0b013e3181c9f274; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; RIVARA FP, 1984, DEV MED CHILD NEUROL, V26, P81; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	85	8	10	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1055-8586	1532-9453		SEMIN PEDIATR SURG	Semin. Pediatr. Surg.	NOV	2010	19	4					271	278		10.1053/j.sempedsurg.2010.06.005			8	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	665IL	WOS:000283028500006	20889083				2022-02-06	
J	King, DA; Hume, PA; Milburn, P; Gianotti, S				King, D. A.; Hume, P. A.; Milburn, P.; Gianotti, S.			Women's rugby league injury claims and costs in New Zealand	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORTS INJURIES; PLAYERS; FOOTBALL; PREVENTION; SEASONS; JUNIOR; SEVENS; LEVEL	Aim There is scarce information on rugby league injuries in female players. This paper provides an overview of the epidemiology of women's rugby league injuries requiring medical treatment and associated costs in New Zealand. Method New Zealand Accident Compensation Corporation injury data for the period 1999-2007 were searched for rugby league injury cases occurring in females. Data were analysed by demographics, body region, nature/severity of injury, and medical procedure and costs. Results There were 320 moderate to serious injury claims recorded for females participating in rugby league activities over the study period. There was a mean (SD) of 37.9 (9.5) injury claims per year. The mean cost per year for the study period was $ 196 514 ($ 99 133) ((sic) 76 066 ((sic) 38 374)) with half of the injury claims occurring in New Zealand Maori. Concussion/brain injuries accounted for 3.8% of total female moderate to serious injury claims but accounted for 5.4% of female injury costs ($ 84 399 ((sic) 32 688)) with the highest mean cost per claim ($ 7033 ((sic) 2724)). The lower limb accounted for 65% of the total female injury claims and 58.7% of total injury costs ($ 922 296 ((sic) 356 968)). The mean cost per claim was higher for the lower limb ($ 4434 ((sic) 1714)) than the upper ($ 3331 ((sic) 1288)) limb. Clerks recorded 16.3% of the total injury claims, 20.3% of total injury costs ($ 319 474 ((sic) 123 211)) and had the highest mean cost per claim ($ 6144 ((sic) 2370)). The 25-29 age group recorded 31.9% of injury claims and 33.8% of injury costs. The 35-39 age group recorded the highest mean cost per claim ($ 6200 ((sic) 2392)) but only 10.9% of total claims and 13.8% of total costs. Discussion When compared with other studies in rugby league injuries, it appears that females incur substantially fewer injuries (5.7%) than males (94.3%). Although no participation data by sex are available, it is likely that participation percentages are reflected in the injury percentages. The high frequency (65%) and cost proportion (58.7%) for lower limb injuries was higher in females than in male rugby league players (previously reported as 42.4% of the injury claims and 31.5% of the total injury claim costs for the lower limb). Conclusions Injury prevention programmes for women's rugby league should focus on the 25-29 age group and address ways to prevent concussion and lower limb injuries.	[King, D. A.] Hutt Valley Dist Hlth Board, Emergency Dept, Lower Hutt, New Zealand; [King, D. A.; Hume, P. A.; Gianotti, S.] Auckland Univ Technol, Inst Sports & Recreat Res New Zealand, Sch Sport & Recreat, Fac Hlth & Environm Sci, Auckland, New Zealand; [Milburn, P.] Griffith Univ, Sch Physiotherapy & Exercise Sci, Gold Coast, Qld, Australia; [Gianotti, S.] Accid Compensat Corp, Wellington, New Zealand		King, DA (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt, New Zealand.	douglas.king@huttvalleydhb.org.nz	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128			ANDERSON J, 2009, RUGBY LEAGUE CONTRIB; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bloom GA, 2008, EUR J SPORT SCI, V8, P295, DOI 10.1080/17461390802251836; Carson JD, 1999, CLIN J SPORT MED, V9, P75, DOI 10.1097/00042752-199904000-00006; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; Comstock RD, 2005, J SCI MED SPORT, V8, P101, DOI 10.1016/S1440-2440(05)80030-1; Derrick TR, 2002, MED SCI SPORT EXER, V34, P998, DOI 10.1097/00005768-200206000-00015; Doyle C, 2004, PHYS THER SPORT, V5, P44, DOI 10.1016/j.ptsp.2003.11.001; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gabbett TJ, 2007, J STRENGTH COND RES, V21, P875; Gabbett TJ, 2005, J SPORT SCI, V23, P961, DOI 10.1080/02640410400023381; Gabbett TJ, 2004, SPORTS MED, V34, P849, DOI 10.2165/00007256-200434120-00004; Gabbett TJ, 2004, J SPORT SCI, V22, P409, DOI 10.1080/02640410310001641638; Gabbett TJ, 2000, BRIT J SPORT MED, V34, P98, DOI 10.1136/bjsm.34.2.98; Gabbett TJ, 2002, BRIT J SPORT MED, V36, P23, DOI 10.1136/bjsm.36.1.23; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gabbett TJ, 2001, J SPORT SCI, V19, P341, DOI 10.1080/02640410152006117; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P43; Gianotti S, 2007, J SCI MED SPORT, V10, P436, DOI 10.1016/j.jsams.2006.10.006; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; HANCOCK A, 1999, NZ STANDARD CLASSIFI; King D, 2009, NZ J SPORTS MED, V36, P48; King D, 2007, NZ J SPORTS MED, V34, P18; King DA, 2006, J SCI MED SPORT, V9, P110, DOI 10.1016/j.jsams.2005.09.001; King DA, 2009, BRIT J SPORT MED, V43, P595, DOI 10.1136/bjsm.2009.061481; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; Little Charles., 2001, FOOTBALL STUDIES, V4, P25; Lythe M, 1992, NZ J SPORTS MED, V20, P6; Meir R, 2001, STRENGTH COND J, V23, P42, DOI 10.1519/1533-4295(2001)023<0042:IOTMRC>2.0.CO;2; Phillips LH, 1998, BRIT J SPORT MED, V32, P144, DOI 10.1136/bjsm.32.2.144; Phillips LH, 2000, BRIT J SPORT MED, V34, P133, DOI 10.1136/bjsm.34.2.133; Raftery M., 1999, INCIDENCE INJURY JUN; Schick DM, 2008, BRIT J SPORT MED, V42, P447, DOI 10.1136/bjsm.2008.046672; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Twellaar M, 1996, AM J SPORT MED, V24, P528, DOI 10.1177/036354659602400419; Twomey D, 2009, J SCI MED SPORT, V12, P452, DOI 10.1016/j.jsams.2008.04.002; WALKER RD, 1985, PRACTITIONER, V229, P205; Young K., 1995, Journal of Sport and Social Issues, V19, P45, DOI 10.1177/019372395019001004	39	8	8	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	NOV	2010	44	14					1016	1023		10.1136/bjsm.2009.064683			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	702UB	WOS:000285920300007	19846422	Green Published			2022-02-06	
J	Cassar, SC; Tovcimak, AE; Rustay, NR; Ellis, TA; Hooker, BA; Witte, DG; Li, JH; Buck, WR; Scharf, D; Muller, U; Jeromin, A; Wang, KKW; Waring, JF				Cassar, Steven C.; Tovcimak, Ann E.; Rustay, Nathan R.; Ellis, Teresa A.; Hooker, Bradley A.; Witte, David G.; Li, Jinhe; Buck, Wayne R.; Scharf, Dancia; Muller, Uwe; Jeromin, Andreas; Wang, Kevin K. W.; Waring, Jeffrey F.			Comparing levels of biochemical markers in CSF from cannulated and non-cannulated rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Biomarker; Blood-brain barrier; CSF; Spectrin; Tau	TRAUMATIC BRAIN-INJURY; SPECTRIN BREAKDOWN PRODUCTS; BETA-II-SPECTRIN; CEREBROSPINAL-FLUID; ALPHA-II; CALPAIN; DEGRADATION; COLLECTION; CASPASE; BLOOD	Cerebrospinal fluid (CSF) is commonly used for assessing biomarkers of drug efficacy or disease progression in the central nervous system. Studies of CSF from pre-clinical species can characterize biomarkers for use in clinical trials. However, obtaining CSF from pre-clinical species, particularly rodents, can be challenging due to small body sizes, and consequently, low volumes of CSF. Surgical cannulation of rats is commonly used to allow for CSF withdrawal from the cisterna magna. However, cannulae do not remain patent over multiple days, making chronic studies on the same rats difficult. Moreover, CSF biomarkers may be affected by cannulation. Thus cannulation may contribute confounding factors to the understanding of CSF biomarkers. To determine the potential impact on biomarkers, CSF was analyzed from cannulated rats, surgically implanted with catheters as well as from non-cannulated rats. Brain protein biomarkers (cell-spectrin SBDP150 and total tau) and albumin, were measured in the CSF using ELISA assays. Overall, cannulated rat CSF had elevated levels of the biomarkers examined compared to non-cannulated rat CSF. Additionally, the variation in biomarker levels observed among CSF from cannulated rats was greater than that observed for non-cannulated rat CSF. These results demonstrate that in some cases, biomarker assessment using CSF from cannulated rats may differ from that of non-cannulated animals and may contribute confounding factors to biomarker measurements and assay development for clinical use. (C) 2010 Elsevier B.V. All rights reserved.	[Cassar, Steven C.; Tovcimak, Ann E.; Rustay, Nathan R.; Ellis, Teresa A.; Hooker, Bradley A.; Witte, David G.; Li, Jinhe; Waring, Jeffrey F.] Abbott Labs, Global Pharmaceut Res & Dev, Translat Neuroimaging & Biochem Biomarkers, Abbott Pk, IL 60064 USA; [Buck, Wayne R.] Abbott Labs, Global Pharmaceut Res & Dev, Dept Cellular & Mol Toxicol, Abbott Pk, IL 60064 USA; [Scharf, Dancia; Muller, Uwe] Banyan Biomarkers Inc, Diagnost Res & Dev, Alachua, FL 32615 USA; [Jeromin, Andreas; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL 32615 USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Gainesville, FL 32610 USA; [Wang, Kevin K. W.] Univ Florida, Dept Anesthesiol, Gainesville, FL 32610 USA		Cassar, SC (corresponding author), Abbott Labs, Global Pharmaceut Res & Dev, Translat Neuroimaging & Biochem Biomarkers, 100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.	steven.cassar@abbott.com	Cassar, Steven/AAW-3201-2020	Wang, Kevin/0000-0002-9343-6473			Best JD, 2006, J PHARMACOL EXP THER, V317, P786, DOI 10.1124/jpet.105.100271; El Mouedden Mohammed, 2005, Journal of Pharmacological and Toxicological Methods, V52, P229, DOI 10.1016/j.vascn.2005.02.002; Glantz SB, 2007, BIOCHEMISTRY-US, V46, P502, DOI 10.1021/bi061504y; HABGOOD MD, 1992, J PHYSIOL-LONDON, V456, P181, DOI 10.1113/jphysiol.1992.sp019332; Hoistad M, 2005, BRAIN RES, V1041, P167, DOI 10.1016/j.brainres.2005.02.014; Huang YL, 1996, BRAIN RES BULL, V41, P273, DOI 10.1016/S0361-9230(96)00176-1; Nirogi R, 2009, J NEUROSCI METH, V178, P116, DOI 10.1016/j.jneumeth.2008.12.001; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Palmio J, 2009, SEIZURE-EUR J EPILEP, V18, P474, DOI 10.1016/j.seizure.2009.04.006; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Sharma AK, 2006, TOXICOL PATHOL, V34, P393, DOI 10.1080/01926230600798609; TAKASUGI Y, 2005, EXP ANIM, V54, P93; Veber D, 2008, NEUROSCI LETT, V440, P202, DOI 10.1016/j.neulet.2008.05.079; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang XL, 2004, SEIZURE-EUR J EPILEP, V13, P574, DOI 10.1016/j.seizure.2004.01.007; WESTERGREN I, 1991, BRAIN RES BULL, V27, P283, DOI 10.1016/0361-9230(91)90083-V; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; 2010, WEB REFERENCE CHARLE	21	8	9	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2010	192	2					249	253		10.1016/j.jneumeth.2010.07.042			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	663YK	WOS:000282925900010	20692294				2022-02-06	
J	Kavakli, HS; Erel, O; Karakayali, O; Neselioglu, S; Tanriverdi, F; Coskun, F; Kahraman, AF				Kavakli, Havva Sahin; Erel, Ozcan; Karakayali, Onur; Neselioglu, Salim; Tanriverdi, Fatih; Coskun, Figen; Kahraman, Ahmet Fatih			Oxidative stress in isolated blunt traumatic brain injury	SCIENTIFIC RESEARCH AND ESSAYS			English	Article						Traumatic brain injury; oxidative stress; symptom; outcome; glaskow coma scale	TOTAL ANTIOXIDANT CAPACITY; SYNAPTIC PROTEINS; MECHANISMS	Traumatic brain injury is a common cause of death after trauma. The aim of this study was to investigate the relationship between oxidative stress parameters and, outcomes and clinical findings in patients with isolated traumatic brain injuries. Fifty-four patients who were admitted into the emergency department of Ankara Ataturk Training and Research hospital with isolated blunt traumatic brain injuries and 33 healthy adults as control group, were included in this study. Serum oxidant status was evaluated by measuring Total Oxidant Status (TOS) levels in patients with traumatic brain injury and in healthy individuals. Serum antioxidant status was evaluated by measuring Total Antioxidant Status (TAS) levels. Then, also Oxidative Stress Index (OSI) was calculated. A total of 54 patients with isolated traumatic brain injuries (mean age 36.7 +/- 18.3 years; 60.4% male, 39.6% female) were enrolled. TOS and OSI levels increased in patient group compared to the control group. High levels of OSI, TOS and TAS were observed in patients who finally became dead. A significant correlation between symptoms including nausea, vomitus, loss of consciousness, seizing and TOS, OSI levels of all patients have been observed. Moreover, there was a meaningful correlation between Glaskow Coma Scale (GCS) score, TOS and OSI levels of patients. The oxidative stress parameters may be valuable prognostic markers in traumatic brain injury patients. It can be concluded that oxidative stress parameters may be valuable in the assessment of clinical severity and in predicting outcome of traumatic brain injury patients.	[Kavakli, Havva Sahin; Karakayali, Onur; Tanriverdi, Fatih; Coskun, Figen; Kahraman, Ahmet Fatih] Ankara Ataturk Training & Res Hosp, Dept Emergency Med, Ankara, Turkey; [Erel, Ozcan; Neselioglu, Salim] Ankara Ataturk Training & Res Hosp, Dept Biochem, Ankara, Turkey		Kavakli, HS (corresponding author), Ankara Ataturk Training & Res Hosp, Dept Emergency Med, Ankara, Turkey.	havvasahin1973@yahoo.com	EREL, Ozcan/U-1008-2019; Karakayali, Onur/AAA-6014-2019	EREL, Ozcan/0000-0002-2996-3236; Karakayali, Onur/0000-0003-1848-3461			Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Harma M, 2003, SWISS MED WKLY, V133, P563; Horoz M, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-35; Kosecik M, 2005, INT J CARDIOL, V100, P61, DOI 10.1016/j.ijcard.2004.05.069; Moriyama M, 2010, J NEUROSCI RES, V88, P2450, DOI 10.1002/jnr.22400; Nayak Chandrika D, 2007, Indian J Med Sci, V61, P381; Petronilho F., 2009, J SURG RES; Rabus M, 2008, TURK KARDIYOL DERN A, V36, P536; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Sirmatel O, 2007, GEN PHYSIOL BIOPHYS, V26, P86; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Yumru M, 2009, PROG NEURO-PSYCHOPH, V33, P1070, DOI 10.1016/j.pnpbp.2009.06.005	26	8	8	0	2	ACADEMIC JOURNALS	VICTORIA ISLAND	P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA	1992-2248			SCI RES ESSAYS	Sci. Res. Essays	OCT 4	2010	5	19					2832	2836					5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AY	WOS:000284279800001					2022-02-06	
J	Bakos, SR; Schwob, JE; Costanzo, RM				Bakos, Stephen R.; Schwob, James E.; Costanzo, Richard M.			Matrix Metalloproteinase-9 and-2 Expression in the Olfactory Bulb Following Methyl Bromide Gas Exposure	CHEMICAL SENSES			English	Article						deafferentation; inflammation; matrix metalloproteinase; methyl bromide gas; olfactory bulb; olfactory epithelium	MATRIX-METALLOPROTEINASE EXPRESSION; SPINAL-CORD-INJURY; BLOOD-BRAIN-BARRIER; GENE KNOCK-OUT; CEREBRAL-ISCHEMIA; FUNCTIONAL RECOVERY; NERVOUS-SYSTEM; INDUCED LESION; GLIAL SCAR; RAT	Matrix metalloproteinase-9 (MMP-9) and MMP-2 are important for recovery following direct traumatic injury within the central nervous system (CNS). However, most CNS injury models include both direct trauma and neuronal deafferentation. This limits the ability to determine if these MMPs are important to one or both components of injury. To establish if MMPs play a role in the deafferentation processes, we investigated MMP-9 and MMP-2 in the olfactory bulb following methyl bromide gas exposure. This injury model lesions neurons within the olfactory epithelium and thereby leads to deafferentation of the bulb without damaging it directly. We measured the response of MMP-9 and MMP-2 in the olfactory bulb from 1 to 60 days during neuronal deafferentation and recovery. MMP-9 increased rapidly on day 5 and remained elevated for 10 days. MMP-2 expression levels were low compared with MMP-9. Immunohistological staining performed on days 1, 5, and 10 revealed MMP-9 was localized to inflammatory cells within the olfactory nerve and glomerular layers. Our results demonstrate MMP-9 is present in inflammatory cells during deafferentation processes in the olfactory bulb. Although MMP-9 is elevated in other CNS injury models, this is the first report to demonstrate an increase in MMP-9 associated with neuronal deafferentation in the absence of direct trauma.	[Bakos, Stephen R.; Costanzo, Richard M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA; [Schwob, James E.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA		Costanzo, RM (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, 1101 E Marshall St, Richmond, VA 23298 USA.	rcostanz@vcu.edu		Costanzo, Richard/0000-0002-6839-3520	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DC00165, R01 DC002167]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000165, R01DC002167] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health [R01 DC00165 to R.M.C. and R01 DC002167 to J.E.S.].	Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Colin-Barenque L, 2008, J APPL TOXICOL, V28, P718, DOI 10.1002/jat.1326; Costanzo RM, 2008, NEUROREPORT, V19, P327, DOI 10.1097/WNR.0b013e3282f50c7b; Costanzo RM, 2006, NEUROREPORT, V17, P1787, DOI 10.1097/WNR.0b013e32800fef87; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Menshikov M, 2002, BIOCHEM J, V367, P833, DOI 10.1042/BJ20020663; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Noble LJ, 2002, J NEUROSCI, V22, P7526; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Schwob JE, 1999, J COMP NEUROL, V412, P439, DOI 10.1002/(SICI)1096-9861(19990927)412:3<439::AID-CNE5>3.0.CO;2-H; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; Siebert H, 2001, J NEUROPATH EXP NEUR, V60, P85, DOI 10.1093/jnen/60.1.85; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yong VW, 1998, TRENDS NEUROSCI, V21, P75; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	32	8	8	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X			CHEM SENSES	Chem. Senses	OCT	2010	35	8					655	661		10.1093/chemse/bjq056			7	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	654LX	WOS:000282170900003	20530375	Green Published, Bronze			2022-02-06	
J	Gallo, J; Cechova, I; Zapletalova, J				Gallo, J.; Cechova, I.; Zapletalova, J.			Early Complications Associated with Total Hip Arthroplasty due to Femoral Neck Fracture	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						femoral neck fracture; total hip arthroplasty; hip replacement; early complications; delirium; hip instability; hip dislocation	POSTOPERATIVE DELIRIUM; INCREASED MORTALITY; METAANALYSIS; SEDATION	PURPOSE OF THE STUDY Fractures of the femoral neck have been serious health and social issues of the recent decades. Although up-to-date implants and perioperative care are now available, the treatment is still associated with an increased risk of postoperative complications. The aim of this study was to specify early postoperative complications and to ascertain which factors, if any, can predict them. MATERIAL AND METHODS Between October 2005 and February 2007, a total of 155 patients were treated for femoral neck fractures in our department. The group of elderly patients (n=82) who underwent elective total hip arthroplasty for osteoarthritis served as controls. The selected pre-, peri- and post-operative characteristics were prospectively collected. Each patient was followed-up for at least one month after surgery. The data were first compared by univariate analysis and then, for statistically significant factors, their predictors were identified by the logistic regression. RESULTS The average age of the patients with femoral neck fracture was 77 years and that of the control patients was 75 years. The ratio of men to women was similar in both groups; the groups differed in body height, weight, preoperative morbidity, ASA score, lymphocyte counts, severity of brain atherosclerosis, independence in walking, and self-sufficient living. The number of complications in the hip-fracture group was 87 while, in the control group, it was only 15 (p=0.0002). The hip-fracture group showed significantly higher occurrence of postoperative delirium (34 versus 4; p=0.001) and prosthesis dislocation (12 versus 0; p=0.009). The subsequent multifactorial analysis showed that the risk of postoperative delirium was associated with preoperative lack of self-sufficiency (odds ratio, OR=4.814; 95 % CI, 1.551-14.942) and the length of operative time (OR=0.970; 95% CI, 0.951-0.989). Prosthesis dislocation was predicted by an increased height of the patient (OR=1.087 per each cm; 95% CI 1.001-1.159). An interval between injury and surgery longer than 48 hours was not associated with higher mortality. DISCUSSION Postoperative delirium is a complication found in up to 60% of the patients with surgery for femoral neck fracture. The frequency of this complication depends on the instruments used to identify cognitive dysfunction with a more sensitive instrument cognitive dysfunction is probably detected in more patients. The higher occurrence of dislocation in the hip-fracture group is also in agreement with the literature data. On the other hand, its association with patient height should not be overestimated, because a coincidence of several other factors may have been involved in the mechanism of dislocation. Displacement can be prevented by the use of offset acetabular components and 36-mm femoral heads for primary implantation in such patients. CONCLUSIONS A significantly higher frequency of prosthesis dislocation and postoperative delirium was found in the patients undergoing total hip arthroplasty for traumatic indication than in the patients after elective surgery. A subsequent multifactorial analysis revealed a potential association of prosthesis dislocation with the patient's height and that of postoperative delirium with the duration of operative time and the degree of preoperative self-sufficiency.	[Gallo, J.; Cechova, I.] Ortoped Klin LF UP FN Olomouc, Olomouc 77520, Czech Republic; [Zapletalova, J.] LF UP Olomouci, Ustav Biofyziky, Oddeleni Biometrie, Olomouc, Czech Republic		Gallo, J (corresponding author), Ortoped Klin LF UP FN Olomouc, IP Pavlova 6, Olomouc 77520, Czech Republic.	jiri.gallo@volny.cz		Gallo, Jiri/0000-0002-7424-8653			COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Crosby G, 2010, MAYO CLIN PROC, V85, P12, DOI 10.4065/mcp.2009.0724; Dijkman BG, 2010, ACTA ORTHOP, V81, P122, DOI 10.3109/17453671003587093; Edlund A, 2001, J AM GERIATR SOC, V49, P1335, DOI 10.1046/j.1532-5415.2001.49261.x; Fong TG, 2009, NAT REV NEUROL, V5, P210, DOI 10.1038/nrneurol.2009.24; Gillet P, 1999, LANCET, V353, P2160, DOI 10.1016/S0140-6736(05)75601-4; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Kiely DK, 2009, J AM GERIATR SOC, V57, P55, DOI 10.1111/j.1532-5415.2008.02092.x; Kopp L, 2009, ACTA CHIR ORTHOP TR, V76, P41; Koudela K, 2009, ACTA CHIR ORTHOP TR, V76, P338; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Lutonsky M, 2009, ACTA CHIR ORTHOP TR, V76, P239; Majernicek M, 2009, ACTA CHIR ORTHOP TR, V76, P319; Meek RMD, 2006, CLIN ORTHOP RELAT R, P9, DOI 10.1097/01.blo.0000218754.12311.4a; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Raaymakers Ernst L F B, 2006, Acta Chir Orthop Traumatol Cech, V73, P45; Sharma PT, 2005, ANESTH ANALG, V101, P1215, DOI 10.1213/01.ane.0000167383.44984.e5; Shiga T, 2008, CAN J ANAESTH, V55, P146, DOI 10.1007/BF03016088; Sieber Frederick E, 2009, Anesthesiol Clin, V27, P451, DOI 10.1016/j.anclin.2009.07.009; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; SKALAROSENBAUM J, 2010, INT ORTHOP      0309; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vestergaard P, 2009, ACTA ORTHOP, V80, P525, DOI 10.3109/17453670903316835; Zakriya KJ, 2002, ANESTH ANALG, V94, P1628, DOI 10.1097/00000539-200206000-00050	25	8	9	0	5	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	OCT	2010	77	5					389	394					6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	673PT	WOS:000283676100005	21040650				2022-02-06	
J	Goldshtrom, Y; Knorr, G; Goldshtrom, I				Goldshtrom, Yigal; Knorr, Gregory; Goldshtrom, Iris			Rhythmic exercises in rehabilitation of TBI patients: A case report	JOURNAL OF BODYWORK AND MOVEMENT THERAPIES			English	Article						Traumatic brain injury; Rehabilitation; Rhythm; Exercise; Cognitive; Motor; Neuroplasticity		Patients who have sustained traumatic brain injury (TBI) often present with a multiplicity of dysfunctions making rehabilitation challenging. Patients who have taken part in studies of rehabilitation exercises that incorporated monotonous timed auditory cues (using a metronome) following cerebrovascular events demonstrated improvement in gait and motor functions. The purpose of this case report is to describe the efficacy of Rhythmic Exercises with Auditory Cues (REAC) to improve functions in a patient, years after their traumatic brain injury. Methods: A single case report of a 24-year-old female patient, nine years post hemispherectomy following TBI that resulted in right hemiparesis. The patient was taught to perform REAC exercises at home. These exercises were designed to activate the body while Alternating hands and feet Bilaterally with Cross-midline movements for a short Duration while synchronizing the movements with a metronome as a Rhythm regulator. Outcome measurements included gait and functional assessment and cognitive and psychological instrument scores that were compared pre and post treatment. Clinical improvement was observed in the patient's gait pattern with reduced hip hiking motion and increased cadence. There was a decrease in spasticity in the right arm and leg with some isolated volitional movements of the hand and fingers returning. She also regained sensation in her right arm and leg. Cognitive improvement was demonstrated by increased IQ scores from 78 to 94. Published by Elsevier Ltd.	[Goldshtrom, Yigal; Knorr, Gregory; Goldshtrom, Iris] Pillar Light, Phys Therapy, 37-03 Berdan Ave, Fair Lawn, NJ 07410 USA		Goldshtrom, Y (corresponding author), Pillar Light, Phys Therapy, 37-03 Berdan Ave, Fair Lawn, NJ 07410 USA.	yigal@wellenergy		Goldshtrom, Yigal/0000-0002-4039-8098			Bowden MG, 2008, NEUROREHAB NEURAL RE, V22, P672, DOI 10.1177/1545968308318837; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Cauraugh JH, 2009, RESTOR NEUROL NEUROS, V27, P17, DOI 10.3233/RNN-2009-0455; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; de Bode S, 2007, NEUROREHAB NEURAL RE, V21, P497, DOI 10.1177/1545968307299523; de I'Etoile SK, 2008, INT J REHABIL RES, V31, P155, DOI 10.1097/MRR.0b013e3282fc0f44; DeLisa J., 1999, REHABILITATION MED P; Desrosiers J, 2005, CLIN REHABIL, V19, P581, DOI 10.1191/0269215505cr896oa; Doidge Norman, 2007, BRAIN CHANGES ITSELF; Dong Y, 2007, NEUROREHAB NEURAL RE, V21, P412, DOI 10.1177/1545968306298598; Ellis T., 2008, PHYS THERAPY; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Gray R, 2002, EXP BRAIN RES, V145, P50, DOI 10.1007/s00221-002-1085-x; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hodzic A, 2004, J NEUROSCI, V24, P442, DOI 10.1523/JNEUROSCI.3731-03.2004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Jang SH, 2007, NEUROREHABILITATION, V22, P117; Kwak EE, 2007, J MUSIC THER, V44, P198, DOI 10.1093/jmt/44.3.198; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Mudie MH, 2000, DISABIL REHABIL, V22, P23, DOI 10.1080/096382800297097; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Richards LG, 2008, NEUROPSYCHOLOGIA, V46, P3, DOI 10.1016/j.neuropsychologia.2007.08.013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sibley Kathryn M, 2008, J Neurol Phys Ther, V32, P80, DOI 10.1097/NPT.0b013e318176b466; Spence C, 2001, PSYCHOL SCI, V12, P90, DOI 10.1111/1467-9280.00316; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Stinear CM, 2008, BRAIN, V131, P1381, DOI 10.1093/brain/awn051; Stinear JW, 2004, J CLIN NEUROPHYSIOL, V21, P124, DOI 10.1097/00004691-200403000-00008; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; Thach WT, 1996, BEHAV BRAIN SCI, V19, P501, DOI 10.1017/S0140525X00082017; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; Thaut MH, 1997, J NEUROL SCI, V151, P207, DOI 10.1016/S0022-510X(97)00146-9; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; van Wegen E, 2006, J NEUROL SCI, V248, P210, DOI 10.1016/j.jns.2006.05.034; Waller SM, 2008, NEUROREHABILITATION, V23, P29; Waller SM, 2004, ARCH PHYS MED REHAB, V85, P1076, DOI 10.1016/j.apmr.2003.10.020; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whitall J., 2000, REPETITIVE BILATERAL	48	8	8	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1360-8592	1532-9283		J BODYW MOV THER	J.Bodyw. Mov. Ther.	OCT	2010	14	4					336	345		10.1016/j.jbmt.2009.06.002			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V02LJ	WOS:000213671000007	20850040				2022-02-06	
J	Xu, L; Zhang, L; Liu, L; Fang, S; Lu, Y; Wei, E; Zhang, W				Xu, L.; Zhang, L.; Liu, L.; Fang, S.; Lu, Y.; Wei, E.; Zhang, W.			Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings	PHARMAZIE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE-CELLS; CHRONIC INFLAMMATION; KINASE PATHWAY; IN-VITRO; EXPRESSION; PROLIFERATION; D-4	Cysteinyl leukotrienes (CysLTs) are potent inflammatory mediators that induce inflammation through the activation of CysLT(1) and CysLT(2) receptors. It has been reported that inflammatory mediators, such as prostaglandins, play an important role in angiogenesis. However, whether CysLTs and the receptor sub-types are involved in angiogenesis is not clarified. Here, we determined the effects of CysLT receptor agonist leukotriene D-4 (LTD4) and antagonists on angiogenesis by rat thoracic aortic ring assay. We found that the microvessel growth in 25% serum-containing cultures was significantly inhibited by the CysLT(1) receptor antagonist montelukast (0.1-1 mu M), but not by the CysLT(2) receptor antagonist BAY cyslt(2) (0.1-1 mu M). The microvessel growth in serum-free culture was affected neither by montelukast (0.01-1 mu M) nor by BAY cyslt2 (0.1-1 mu M). Furthermore, LTD4 at 100 nM significantly enhanced the microvessel growth in serum-free culture and LTD4 at 10-100 nM significantly enhanced the microvessel growth in 25% serum-containing cultures. The enhancement was abrogated by both montelukast and BAY cyslt2. Thus, CysLT(1) receptors may mediate endogenously regulated microvessel growth in normal culture; whereas the exogenous agonist LTD4 induces angiogenesis through the activation of both CysLT(1) and CysLT(2) receptors. The CysLT receptor antagonists can be developed as angiogenesis inhibitors.	[Zhang, W.] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, W.] Zhejiang Univ, Sch Med, Inst Neurosci, Hangzhou 310058, Zhejiang, Peoples R China		Zhang, W (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China.	weiping601@zju.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30873053, 30700150]	This study was supported by the National Natural Science Foundation of China (Nos. 30873053 and 30700150). We thank John Obenchain, Merck Research Laboratories, USA, for kindly providing montelukast, T. Jon Seiders, Amira Pharmaceuticals Inc., USA, for kindly providing BAY cyslt2.	Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bosse Y, 2008, CLIN EXP ALLERGY, V38, P113, DOI 10.1111/j.1365-2222.2007.02873.x; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; El-Swefy S, 2009, ANN HEPATOL, V8, P41, DOI 10.1016/S1665-2681(19)31810-1; Ge QF, 2006, J NEUROCHEM, V97, P992, DOI 10.1111/j.1471-4159.2006.03828.x; Giron-Calle J, 2002, J PHARMACOL EXP THER, V301, P87, DOI 10.1124/jpet.301.1.87; Gronert K, 2001, AM J PATHOL, V158, P3, DOI 10.1016/S0002-9440(10)63937-5; Hu H, 2005, ACTA PHARMACOL SIN, V26, P685, DOI 10.1111/j.1745-7254.2005.00092.x; Kaetsu Y, 2007, CARDIOVASC RES, V76, P160, DOI 10.1016/j.cardiores.2007.05.018; Kanazawa H, 2004, CHEST, V125, P1700, DOI 10.1378/chest.125.5.1700; Li CT, 2009, J NEUROSCI RES, V87, P991, DOI 10.1002/jnr.21913; Lotzer K, 2007, PROSTAG OTH LIPID M, V84, P108, DOI 10.1016/j.prostaglandins.2007.04.005; Majno G, 1998, AM J PATHOL, V153, P1035, DOI 10.1016/S0002-9440(10)65648-9; NICOSIA RF, 1990, LAB INVEST, V63, P115; Nicosia RF, 1997, AM J PATHOL, V151, P1379; Ost M, 1998, J VASC RES, V35, P150, DOI 10.1159/000025578; Reed MJ, 2007, MICROVASC RES, V73, P248, DOI 10.1016/j.mvr.2007.02.002; Rovati GE, 2007, THESCIENTIFICWORLDJO, V7, P1375, DOI 10.1100/tsw.2007.185; Shtivelband MI, 2003, J THROMB HAEMOST, V1, P2225, DOI 10.1046/j.1538-7836.2003.00446.x; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Thompson C, 2008, J BIOL CHEM, V283, P1974, DOI 10.1074/jbc.M608197200; TSOPANOGLOU NE, 1994, EUR J PHARMACOL, V258, P151, DOI 10.1016/0014-2999(94)90068-X; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; Yuan YM, 2009, J PHARMACOL SCI, V109, P285, DOI 10.1254/jphs.08321FP; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	27	8	8	1	4	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	OCT	2010	65	10					750	754		10.1691/ph.2010.9810			5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry	695XH	WOS:000285405400008	21105577				2022-02-06	
J	Capizzano, AA; Jorge, RE; Robinson, RG				Capizzano, Aristides A.; Jorge, Ricardo E.; Robinson, Robert G.			Limbic Metabolic Abnormalities in Remote Traumatic Brain Injury and Correlation With Psychiatric Morbidity and Social Functioning	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; HIPPOCAMPAL-NEURONS; DEPRESSION; SPECTRA; ATROPHY; VOLUME; DEATH; MRI	The aim of this study was to investigate limbic metabolic abnormalities in remote traumatic brain injury (TBI) and their psychiatric correlates. Twenty patients and 13 age-matched comparison subjects received complete psychiatric evaluation and brain MRI and MR spectroscopy at 3 Tesla. Patients had reduced NAA to creatine ratio in the left hippocampus relative to comparison subjects (mean=1.3 [SD=0.21] compared with mean=1.55 [SD=0.21]; F=10.73, df=1, 30, p=0.003), which correlated with the Social Functioning Examination scores (r(s)=-0.502, p=0.034). Furthermore, patients with mood disorders had reduced NAA to creatine ratio in the left cingulate relative to patients without mood disorders (1.47 compared with 1.68; F=3.393, df =3, 19, p=0.044). Remote TBI displays limbic metabolic abnormalities, which correlate to social outcome and psychiatric status. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22:370-377)	[Capizzano, Aristides A.] Univ Iowa, Carver Coll Med, Dept Radiol, Div Neuroradiol, Iowa City, IA 52242 USA; [Jorge, Ricardo E.; Robinson, Robert G.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA		Capizzano, AA (corresponding author), Univ Iowa, Carver Coll Med, Dept Radiol, Div Neuroradiol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	aristides-capizzano@uiowa.edu	Capizzano, Aristides A./AAC-5963-2019	Capizzano, Aristides/0000-0003-1950-8499	 [R01 MH63405-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH063405] Funding Source: NIH RePORTER	The authors acknowledge grant support from R01 MH63405-01A1 "Vascular depression and magnetic stimulation therapy." None of the authors report conflicting interests. Presented in part at the Radiological Society of North America (RSNA) 93rd Scientific Assembly and Annual Meeting, Chicago, November 2007.	Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; BUTLER JA, 2001, CENTRAL NERVOUS SYST; CAPIZZANO AA, 2006, P 14 SCI M INT SOC M; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; STARR LB, 1983, EXP AGING RES, V9, P101, DOI 10.1080/03610738308258434; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thurman DJ., 1995, GUIDELINES SURVEILLA; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362	28	8	8	0	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2010	22	4					370	377					8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	673IB	WOS:000283651600028	21037120	Green Accepted			2022-02-06	
J	Karasu, A; Aras, Y; Sabanci, PA; Saglam, G; Izgi, N; Biltekin, B; Barak, T; Hepgul, KT; Kaya, M; Bilir, A				Karasu, Aykut; Aras, Yavuz; Sabanci, Pulat Akin; Saglam, Gunseli; Izgi, Nail; Biltekin, Burcu; Barak, Tanyeri; Hepgul, Kemal Tanju; Kaya, Mehmet; Bilir, Ayhan			The effects of protein kinase C activator phorbol dibutyrate on traumatic brain edema and aquaporin-4 expression	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Aquaporin-4; brain edema; phorbol ester; phorbol dibutyrate; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; WATER TRANSPORT; CHANNELS; CELLS	BACKGROUND Aquaporin-4 (AQP4) is the major water channel in the central nervous system. Brain edema emerges from increased AQP4 expression in traumatic brain injury (TBI). Cell line studies have shown that the protein kinase activator phorbol ester exerts a suppressive effect on AQP4 and water permeability. The aim of this study was to investigate the effects of a phorbol ester, phorbol dibutyrate (PDBu), on increased TBI AQP4 expression and accompanying brain edema. METHODS Fifty-six male Wistar rats were first divided into two groups: the edema group, in which the percentage of water in brain tissue would be evaluated, and the immunohistochemical group, allowing AQP4 expression to be determined. Both groups were further sub-divided into four groups consisting of 7 subjects. These four groups were as follows: sham-operated control group, severe diffuse TBI group, 0.9% saline-treated diffuse TBI group, and the PDBu-treated diffuse TBI group (2300 mu g/kg, iv). The results were evaluated statistically. RESULTS PDBu treatment significantly reduced brain water concentration (p<0.001). Furthermore, PDBu was found to reduce trauma-induced AQP4 upregulation (p<0.05). CONCLUSION This study showed that traumatic brain edema was prevented by intravenous PDBu administration via AQP4 down-regulation, supporting the idea emphasizing the importance of AQP4 expression control in TBI.	[Karasu, Aykut; Aras, Yavuz; Sabanci, Pulat Akin; Izgi, Nail; Barak, Tanyeri; Hepgul, Kemal Tanju] Istanbul Univ, Istanbul Fac Med, Dept Neurosurg, TR-34093 Istanbul, Turkey; [Saglam, Gunseli] Istanbul Univ, Istanbul Fac Med, Dept Anesthesiol, TR-34093 Istanbul, Turkey; [Biltekin, Burcu; Bilir, Ayhan] Istanbul Univ, Istanbul Fac Med, Dept Histol & Embryol, TR-34093 Istanbul, Turkey; [Kaya, Mehmet] Istanbul Univ, Istanbul Fac Med, Dept Physiol, TR-34093 Istanbul, Turkey		Sabanci, PA (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Neurosurg, TR-34093 Istanbul, Turkey.	sabanci.akin@gmail.com	SABANCI, PULAT AKIN/AAT-1325-2020; Hepgul, Kemal Tanju/AAV-1510-2020; Izgi, Ali Nail/AAD-6197-2020; Orhun, Gunseli/AAG-4002-2019	Orhun, Gunseli/0000-0003-0173-3604; Biltekin, Burcu/0000-0002-8435-6797; Barak, Tanyeri/0000-0002-8522-1552			BROWN W, 2003, J HEAD TRAUMA REHAB, V21, P544; DUNN JA, 1983, CANCER RES, V43, P4632; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Han ZQ, 1998, J BIOL CHEM, V273, P6001, DOI 10.1074/jbc.273.11.6001; Hussaini IM, 2000, J BIOL CHEM, V275, P22348, DOI 10.1074/jbc.M003203200; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MONTASSER A, 1994, J NEUROSURG, V80, P301; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nielsen S, 1997, J NEUROSCI, V17, P171; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	17	8	10	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	SEP	2010	16	5					390	394					5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	651YI	WOS:000281963300002	21038114				2022-02-06	
J	Mueller, SV; George, S; Hildebrandt, H; Munte, TF; Reuther, P; Schoof-Tams, K; Wallesch, CW				Mueller, Sandra Verena; George, Sabine; Hildebrandt, Helmut; Muente, Thomas F.; Reuther, Paul; Schoof-Tams, Karin; Wallesch, Claus-Werner			Guideline for the diagnosis and treatment of executive dysfunction	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; MULTIPLE-SCLEROSIS; GOAL MANAGEMENT; WORKING-MEMORY; REHABILITATION; DEFICITS; SKILLS; IMPAIRMENTS; DISTURBANCE		[Mueller, Sandra Verena] Ostfalia Hsch Angew Wissensch, Fak Sozialwesen, D-38120 Braunschweig, Germany; [George, Sabine] Deutsch Verband Ergotherapeuten eV, Karlsbad, Germany; [Hildebrandt, Helmut] Klinikum Bremen Ost, Zentrum Neurol, Bremen, Germany; [Hildebrandt, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Psychol, D-2900 Oldenburg, Germany; [Muente, Thomas F.] Univ Klinikum Schleswig Holstein, Neurol Klin, D-23538 Lubeck, Germany; [Reuther, Paul] Ambulantes Neurol Rehabil Ctr Ahrweiler, Bad Neuenahr Ahrweiler, Germany; [Schoof-Tams, Karin] Neurol Klin Westend, Bad Wildungen, Germany; [Wallesch, Claus-Werner] BDH Klin Elzach, Elzach, Germany		Mueller, SV (corresponding author), Ostfalia Hsch Angew Wissensch, Fak Sozialwesen, Ludwig Winter Str 2, D-38120 Braunschweig, Germany.	s-v.mueller@ostfalia.de	Munte, Thomas/C-2077-2014				ALDERMAN N, 1995, NEUROPSYCHOL REHABIL, V5, P193, DOI 10.1080/09602019508401467; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Brokate B, 2003, NEUROPSYCHOLOGY, V17, P420, DOI 10.1037/0894-4105.17.3.420; Burgess P., 1997, METHODOLOGY FRONTAL, P81; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; DEsposito M, 1996, NEUROPSYCHOLOGY, V10, P51, DOI 10.1037/0894-4105.10.1.51; DIEHL RR, 2002, FRONTALHIRN; DOWNES JJ, 1993, BRAIN, V116, P887, DOI 10.1093/brain/116.4.887; ESLINGER PJ, 2000, BEHAV MOOD DISORDERS; Ettlin TM, 2000, CLIN REHABIL, V14, P260, DOI 10.1191/026921500669635136; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; FOXX RM, 1989, BEHAV THER, V20, P61, DOI 10.1016/S0005-7894(89)80118-2; Golz D, 2004, Z NEUROPSYCHOL, V15, P157; Harth S, 2005, NEUROPSYCHOL REHABIL, V11, P279; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hildebrandt H, 2004, NEUROPSYCHOLOGY, V18, P203, DOI 10.1037/0894-4105.18.2.203; Hildebrandt H, 2003, AKTUEL NEUROL, V30, P118, DOI 10.1055/s-2003-38272; Honey GD, 2006, NEUROPSYCHOPHARMACOL, V31, P413, DOI 10.1038/sj.npp.1300846; HUX K, 1994, APPL COGNITIVE PSYCH, V8, P259, DOI 10.1002/acp.2350080305; Jahn T, 2005, DEMENZEN, P91; Kreutzer J., 1999, NEUROREHABILITATION, P609; KUST J, 2006, RATGEBER FAHREIGNUNG; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; LIRA FT, 1983, INT J CLIN NEUROPSYC, V5, P159; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Matthes-von Cramon G., 2006, KOGNITIVE NEUROLOGIC, P168; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Montoya A, 2006, J PSYCHIATR NEUROSCI, V31, P21; Muller SV, 2003, BEHAV NEUROL, V14, P29; Muller SV, 2002, J CLIN EXP NEUROPSYC, V24, P517, DOI 10.1076/jcen.24.4.517.1043; MULLER SV, 2008, HDB BIO NEUROPSYCHOL, P494; MULLER SV, 2004, KOGNITIVE THERAPIE S; MULLER SV, 2005, FORTSCHRITTE NEUMLOG, V73, P1; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; PESCHKE V, 2006, HANDANWEISUNG BURGAU; Rebmann MJ, 1995, REHABIL PSYCHOL, V40, P279, DOI 10.1037/0090-5550.40.4.279; Sammer G, 2006, J NEUROL SCI, V248, P115, DOI 10.1016/j.jns.2006.05.028; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shad MU, 2006, SCHIZOPHR RES, V86, P54, DOI 10.1016/j.schres.2006.06.006; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sohlberg McK. M., 1988, COGNITIVE REHABILITA, V6, P36; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; TAYLOR AE, 1995, BRAIN COGNITION, V28, P281, DOI 10.1006/brcg.1995.1258; VanSpaendonck KPM, 1996, NEUROPSYCHOLOGIA, V34, P617, DOI 10.1016/0028-3932(95)00159-X; Wachowius U, 2005, J CLIN EXP NEUROPSYC, V27, P65, DOI 10.1080/138033990513645; WALLESCH CW, 2002, FRONTALHIRN, P315; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; WEBSTER JS, 1993, CLIN NEUROPSYCHOLOGY, V5, P69; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; YOUNGJOHN JR, 1989, REHABIL PSYCHOL, V34, P217, DOI 10.1037//0090-5550.34.3.217	67	8	8	0	2	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	SEP	2010	21	3					167	176		10.1024/1016-264X/a000017			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	658HR	WOS:000282481600004					2022-02-06	
J	Van Borsel, J; Drummond, D; Pereira, MMD				Van Borsel, John; Drummond, Diana; de Britto Pereira, Monica Medeiros			Delayed auditory feedback and acquired neurogenic stuttering	JOURNAL OF NEUROLINGUISTICS			English	Article						Acquired stuttering; Neurogenic stuttering; Delayed auditory feedback	SPEECH RATES; FREQUENCY	It has been suggested that neurogenic stuttering is more pervasive and more resistant to fluency enhancing techniques than developmental stuttering. Empirical studies supporting this suggestion are scarce, however. The present study reports the use of delayed auditory feedback in a 49-year-old man who started to stutter after traumatic brain injury. Delayed auditory feedback did not have an unequivocal positive effect on speech fluency. Instead a more complex picture was seen with differential effects depending on speech mode and delay time used which moreover differed for stuttered and non-stuttered disfluencies. Findings seem to support the notion that neurogenic and developmental stuttering does not have a unifying pathology. (C) 2009 Elsevier Ltd. All rights reserved.	[Van Borsel, John] Univ Ghent, B-9000 Ghent, Belgium; [Van Borsel, John; Drummond, Diana; de Britto Pereira, Monica Medeiros] Veiga Almeida Univ, Rio De Janeiro, Brazil		Van Borsel, J (corresponding author), Univ Ghent, UZ Gent 2P1,De Pintelaan 185, B-9000 Ghent, Belgium.	john.vanborsel@ugent.be					Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Andrade CRF, 2004, ABFW TESTE LINGUAGEM, P51; ANDRADE CRF, 2000, ABFW TESTE LINGUAGEM, P61; ANDREWS G, 1983, J SPEECH HEAR DISORD, V48, P226, DOI 10.1044/jshd.4803.226; Balasubramanian V, 2003, BRAIN COGNITION, V53, P185, DOI 10.1016/S0278-2626(03)00106-4; BOHR WWF, 1963, J S AFRICAN LOGOPEDI, V10, P4; CANTER GJ, 1971, BRIT J DISORD COMMUN, V6, P139; CHASE RA, 1961, J GENET PSYCHOL, V99, P101, DOI 10.1080/00221325.1961.10534396; COSTELLOINGHAM J, 1993, J FLUENCY DISORD, V18, P27; CURLEE RF, 1973, BEHAV RES THER, V11, P395, DOI 10.1016/0005-7967(73)90097-1; DOWNIE AW, 1981, J NEUROL NEUROSUR PS, V44, P852, DOI 10.1136/jnnp.44.9.852; ESTABROOKS NH, 1993, STUTTERING RELATED D, P205; ESTABROOKS NH, 1986, ATYPICAL STUTTERER P, P193; GOLDIAMOND I, 1965, RES BEHAV MODIFICATI, P106; Goodglass H., 1972, ASSESSMENT APHASIA R; INGHAM RJ, 1971, J COMMUN DISORD, V4, P279, DOI 10.1016/0021-9924(71)90007-4; Kalinowski J, 1996, EUR J DISORDER COMM, V31, P259; KALINOWSKI J, 1993, LANG SPEECH, V36, P1; Lincoln M, 2006, J FLUENCY DISORD, V31, P71, DOI 10.1016/j.jfludis.2006.04.001; LOTZMANN G, 1961, FOLIA PHONIATR, V13, P276, DOI 10.1159/000262924; MACLEOD J, 1995, J COMMUN DISORD, V28, P217, DOI 10.1016/0021-9924(94)00010-W; Marshall R.C., 1984, AUST J HUM COMMUN DI, V12, P87; Marshall R. C., 1987, J FLUENCY DISORD, V10, P241; Martins Vanessa de Oliveira, 2008, Pró-Fono R. Atual. Cient., V20, P7, DOI 10.1590/S0104-56872008000100002; NESSEL E, 1958, FOLIA PHONIATR, V10, P87; Perkins W., 1979, CONTROVERSIES STUTTE, V5, P97; Pick A., 1899, ARCH PSYCHIAT NERVEN, V32, P447; Ringo C. C., 1995, J MED SPEECH-LANG PA, V3, P111; RYAN BP, 1974, J SPEECH HEAR DISORD, V39, P3, DOI 10.1044/jshd.3901.03; SARK S, 1996, EUROPEAN J DISORDERS, V31, P259; SODERBERG GA, 1969, J SPEECH HEAR DISORD, V34, P20, DOI 10.1044/jshd.3401.20; Stuart A, 1997, J ACOUST SOC AM, V101, P3806, DOI 10.1121/1.418387; Theys C, 2008, J FLUENCY DISORD, V33, P1, DOI 10.1016/j.jfludis.2007.09.001; Van Borsel J, 2003, INT J LANG COMM DIS, V38, P119, DOI 10.1080/1368282021000042902; Van Borsel J, 2001, J COMMUN DISORD, V34, P385, DOI 10.1016/S0021-9924(01)00057-0; Van Borsel John, 2007, Pró-Fono R. Atual. Cient., V19, P323, DOI 10.1590/S0104-56872007000300011; Ward D, 2006, STUTTERING AND CLUTTERING: FRAMEWORK FOR UNDERSTANDING AND TREATMENT, P1; WINGATE M, 1976, STUTTERING THEORY TR; Zerneri L, 1966, J Fr Otorhinolaryngol Chir Maxillofac, V15, P415	39	8	9	1	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	SEP	2010	23	5			SI		479	487		10.1016/j.jneuroling.2009.01.001			9	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	635MI	WOS:000280659400005					2022-02-06	
J	Wright, DW; Goldstein, FC; Kilgo, P; Brumfield, JR; Ravichandran, T; Danielson, ML; LaPlaca, M				Wright, D. W.; Goldstein, F. C.; Kilgo, P.; Brumfield, J. R.; Ravichandran, T.; Danielson, M. L.; LaPlaca, M.			Use of a novel technology for presenting screening measures to detect mild cognitive impairment in elderly patients	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							SERIAL-ADDITION TASK; ALZHEIMERS-DISEASE; WORKING-MEMORY; DEMENTIA; MCI; PROGRESSION; INHIBITION; CONCUSSION; INSTRUMENT; PASAT	P>Background: Available screening tools for mild cognitive impairment (MCI), often a precursor to Alzheimer's disease, are insensitive or not feasible for administration in a busy primary care setting. Display Enhanced TEsting for Cognitive impairment and Traumatic brain injury (DETECT (TM)) addresses these issues by creating an immersive environment for the brief administration of neuropsychological (NP) measures. Objective: The aim of this study was to determine if the DETECT (TM) cognitive subtests can identify MCI patients as accurately as standard pen and paper NP tests. Methods: Twenty patients with MCI recruited from a memory disorders clinic and 20 age-matched controls were given both a full battery of NP tests (standard NP) and the DETECT (TM) screen. Logistic regression models were used to determine whether individual tests were predictive of group membership (MCI or control). Demographic variables including age, race, education and gender were adjusted as covariates. Selection methods were used to identify subset models that exhibited maximum discrimination between MCI patients and controls for both testing methods. Results: Both the standard NP model (C-index = 0.836) and the DETECT (TM) model (C-index = 0.865) showed very good discrimination and were not significantly different (p = 0.7323). Conclusion: The DETECT (TM) system shows good agreement with standard NP tests and is capable of identifying elderly patients with cognitive impairment.	[Wright, D. W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30303 USA; [Goldstein, F. C.; Ravichandran, T.; Danielson, M. L.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30303 USA; [Kilgo, P.] Rollins Sch Publ Hlth, Atlanta, GA USA; [Brumfield, J. R.; LaPlaca, M.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA		Wright, DW (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, 49 Jesse Hill Jr Dr,FOB Suite 126, Atlanta, GA 30303 USA.	david.wright@emory.edu	Danielson, Melissa/AAW-9816-2020; Wright, David/F-1209-2013	Wright, David/0000-0002-7145-9105; Danielson, Melissa/0000-0001-9461-0341	Wallace H. Coulter Foundation	We would like to thank the Wallace H. Coulter Foundation for funding this study and the development of the DETECT device. We would also like to thank the Wesley Woods Clinic at Emory University for the use of their facilities.	Barker J. M., 2007, Journal of Medical Engineering & Technology, V31, P161, DOI 10.1080/03091900500272781; Benton A., 1978, MULTILINGUAL APHASIA; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Crooks VC, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-10; de Jager CA, 2009, AGE AGEING, V38, P455, DOI 10.1093/ageing/afp068; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fillenbaum GG, 2008, ALZHEIMERS DEMENT, V4, P96, DOI 10.1016/j.jalz.2007.08.005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gonzalez R, 2006, CLIN NEUROPSYCHOL, V20, P396, DOI 10.1080/13854040590967559; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kelley BJ, 2007, NEUROL CLIN, V25, P577, DOI 10.1016/j.ncl.2007.03.008; Kluger A, 1999, J GERIATR PSYCH NEUR, V12, P168, DOI 10.1177/089198879901200402; Lopez OL, 2005, J AM GERIATR SOC, V53, P83, DOI 10.1111/j.1532-5415.2005.53015.x; Lu PH, 2009, NEUROLOGY, V72, P2115, DOI 10.1212/WNL.0b013e3181aa52d3; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Steenland NK, 2008, J ALZHEIMERS DIS, V15, P419; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; *US WAR DEP, 1944, ARM IND TEST BATT AI, P1; Weimer DL, 2009, ALZHEIMERS DEMENT, V5, P215, DOI 10.1016/j.jalz.2009.01.028; Winblad B, 2004, ALZ DIS ASSOC DIS, V18, pS2, DOI 10.1097/01.wad.0000127495.10774.a4; Xu GL, 2002, INT J GERIATR PSYCH, V17, P1027, DOI 10.1002/gps.744	31	8	8	0	7	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1368-5031			INT J CLIN PRACT	Int. J. Clin. Pract.	AUG	2010	64	9					1190	1197		10.1111/j.1742-1241.2009.02324.x			8	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pharmacology & Pharmacy	625ND	WOS:000279901200009	20497262				2022-02-06	
J	Uchida, K; Nakajima, H; Hirai, T; Yayama, T; Chen, KB; Kobayashi, S; Roberts, S; Johnson, WE; Baba, H				Uchida, Kenzo; Nakajima, Hideaki; Hirai, Takayuki; Yayama, Takafumi; Chen, Ke-Bing; Kobayashi, Shigeru; Roberts, Sally; Johnson, William E.; Baba, Hisatoshi			Microarray analysis of expression of cell death-associated genes in rat spinal cord cells exposed to cyclic tensile stresses in vitro	BMC NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SMOOTH-MUSCLE-CELLS; MECHANICAL STRETCH; COLLAGEN-SYNTHESIS; PATHWAYS; INTEGRINS; RESPONSES; PROFILES; SIGNALS	Background: The application of mechanical insults to the spinal cord results in profound cellular and molecular changes, including the induction of neuronal cell death and altered gene expression profiles. Previous studies have described alterations in gene expression following spinal cord injury, but the specificity of this response to mechanical stimuli is difficult to investigate in vivo. Therefore, we have investigated the effect of cyclic tensile stresses on cultured spinal cord cells from E15 Sprague-Dawley rats, using the FX3000 (R) Flexercell Strain Unit. We examined cell morphology and viability over a 72 hour time course. Microarray analysis of gene expression was performed using the Affymetrix GeneChip System (R), where categorization of identified genes was performed using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) systems. Changes in expression of 12 genes were validated with quantitative real-time reverse transcription polymerase chain reaction (RT-PCR). Results: The application of cyclic tensile stress reduced the viability of cultured spinal cord cells significantly in a dose- and time-dependent manner. Increasing either the strain or the strain rate independently was associated with significant decreases in spinal cord cell survival. There was no clear evidence of additive effects of strain level with strain rate. GO analysis identified 44 candidate genes which were significantly related to "apoptosis" and 17 genes related to "response to stimulus". KEGG analysis identified changes in the expression levels of 12 genes of the mitogen-activated protein kinase (MAPK) signaling pathway, which were confirmed to be upregulated by RT-PCR analysis. Conclusions: We have demonstrated that spinal cord cells undergo cell death in response to cyclic tensile stresses, which were dose-and time-dependent. In addition, we have identified the up regulation of various genes, in particular of the MAPK pathway, which may be involved in this cellular response. These data may prove useful, as the accurate knowledge of neuronal gene expression in response to cyclic tensile stress will help in the development of molecular- based therapies for spinal cord injury.	[Uchida, Kenzo; Nakajima, Hideaki; Hirai, Takayuki; Yayama, Takafumi; Chen, Ke-Bing; Kobayashi, Shigeru; Baba, Hisatoshi] Univ Fukui, Fac Med Sci, Dept Orthopaed & Rehabil Med, Fukui 9101193, Japan; [Roberts, Sally; Johnson, William E.] RJAH Orthopaed Hosp, Keele Univ, Inst Sci & Technol Med, Oswestry SY10 7AG, Shrops, England		Uchida, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Orthopaed & Rehabil Med, Shimoaizuki 23, Fukui 9101193, Japan.	kuchida@u-fukui.ac.jp			Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [16390435, 18390411, 19791023, 21591895, 21791389, 22390287]; Investigation Committees on Ossification of the Spinal ligaments; Research Program of Spinal Cord Intractable Pain; Japanese Ministry of Health and WelfareMinistry of Health, Labour and Welfare, Japan	We are indebted to Yoshimasa Tsujimoto (Dragon Genomics Center, TAKARA BIO INC.) for support of analysis the data. This work was supported in part by Grants-in-Aid to HB, KU and HN for General Scientific Research of the Ministry of Education, Science and Culture of Japan (grants numbers 16390435, 18390411, 19791023, 21591895, 21791389, and 22390287). This work was also supported in part by grants from the Investigation Committees on Ossification of the Spinal ligaments (2005-2009) and Research Program of Spinal Cord Intractable Pain (2009), The Public Health Bureau of the Japanese Ministry of Health and Welfare.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Banes AJ, 1995, BIOCHEM CELL BIOL, V73, P349, DOI 10.1139/o95-043; Baptiste Darryl C, 2006, Spine J, V6, p190S, DOI 10.1016/j.spinee.2006.04.024; Bilston LE, 1996, ANN BIOMED ENG, V24, P67; BURRIDGE K, 1988, ANN REV CELL BIOL, V487, P525; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Ghafoor AU, 2005, J CLIN ANESTH, V17, P640, DOI 10.1016/j.jclinane.2005.04.003; GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Haq F, 2006, BIOTECHNOL PROGR, V22, P133, DOI 10.1021/bp0501625; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; KAWAHARA N, 1991, SPINAL CORD MONITORI, P107; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Matsumoto T, 1999, SPINE, V24, P315, DOI 10.1097/00007632-199902150-00002; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; PANJABI MM, 1996, CLIN BIOMECHANICS SP, P67; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shimizu K, 2005, SPINE, V30, P2388, DOI 10.1097/01.brs.0000184378.67465.5c; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Tachibana T, 2002, NEUROSCI LETT, V327, P133, DOI 10.1016/S0304-3940(02)00375-0; Takeno K, 2007, J NEUROSURG-SPINE, V7, P637, DOI 10.3171/SPI-07/12/637; Tanoue M, 1996, J HAND SURG-BRIT EUR, V21B, P358, DOI 10.1016/S0266-7681(05)80203-7; Uchida K, 2003, ACTA NEUROPATHOL, V106, P29, DOI 10.1007/s00401-003-0691-4; UCHIDA K, J NEUROSURG SPINE, V11, P521; Uchida K, 2008, SPINE, V33, P2596, DOI 10.1097/BRS.0b013e31818917af; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767	40	8	8	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	JUL 22	2010	11								84	10.1186/1471-2202-11-84			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	637RW	WOS:000280837400001	20663127	gold, Green Published, Green Accepted			2022-02-06	
J	Schnellinger, MG; Reid, S; Louie, J				Schnellinger, Mark G.; Reid, Samuel; Louie, Jeffrey			Are Serial Brain Imaging Scans Required for Children Who Have Suffered Acute Intracranial Injury Secondary to Blunt Head Trauma?	CLINICAL PEDIATRICS			English	Article						computed tomography; traumatic brain injury; magnetic resonance imaging; International Classification of Disease-9th revision; emergency department; intracranial hemorrhage	COMPUTED-TOMOGRAPHY; MANAGEMENT; ADMISSION; TRENDS	In most instances, infants and children with moderate to severe head trauma undergo a head computed tomography (CT) scan as part of their initial evaluation. Several authors have advocated a routine second head CT after traumatic brain injury (TBI) to identify progressive lesions that may require surgical intervention. However, recent studies have challenged the need for a routine second brain imaging study after TBI. In addition, recent reports have raised concerns about the potential for malignancy following CT scanning, especially in pediatric patients. The authors performed a retrospective case series of all patients, aged 0 to 21 years,who presented to their 2 emergency departments (EDs) and received an International Classification of Disease-9th revision code related to intracranial injury. Out of 47 children, 5 (11%) underwent neurosurgical intervention following their second imaging study, and I of these interventions was unplanned after the first study. Compared with children who did not require an intervention following their second scan, children who received an intervention were more likely to have been subjected to nonaccidental trauma and to have presented to the ED more than 4 hours after the injury. Most children with intracranial injury following blunt trauma who did not require immediate neurosurgical intervention but instead underwent a follow-up brain imaging study did not require subsequent unplanned neurosurgical intervention. Serial brain imaging may not be required for all children with intracranial injury.	[Schnellinger, Mark G.; Reid, Samuel; Louie, Jeffrey] Childrens Hosp & Clin Minnesota, Minneapolis, MN 55404 USA		Schnellinger, MG (corresponding author), Childrens Hosp & Clin Minnesota, 2525 Chicago Ave S, Minneapolis, MN 55404 USA.	mark.schnellinger@childrensmn.org					af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Johnson CF., 2007, NELSON TXB PEDIAT, V18th, P171; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MAYER T, 1981, JAMA-J AM MED ASSOC, V245, P719; ROBERSON FC, 1979, SURG NEUROL, V12, P161; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954	19	8	8	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2010	49	6					569	573		10.1177/0009922809352375			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	600OT	WOS:000277997300008	20118091				2022-02-06	
J	Itoh, T; Satou, T; Takemori, K; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Takemori, Kumiko; Hashimoto, Shigeo; Ito, Hiroyuki			Neural Stem Cells and New Neurons in the Cerebral Cortex of Stroke-Prone Spontaneously Hypertensive Rats After Stroke	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Neural stem cell; SHRSP; Nestin; Doublecortin; Stroke	CHEMOKINE RECEPTOR CXCR4; TRAUMATIC BRAIN-INJURY; ADULT BRAIN; SUBVENTRICULAR ZONE; INTERMEDIATE FILAMENT; EXPRESSION; NEUROGENESIS; PROLIFERATION; ASTROCYTES; DOUBLECORTIN	Stroke-prone spontaneously hypertensive rats (SHRSP) are the only animal model that suffers from spontaneous cerebral stroke. In this study, we investigated the appearance of neural stem cells (NSCs) and new neurons in the penumbra and the subventricular zone (SVZ) after cerebral stroke in SHRSP. SHRSP before cerebral stroke were intraperitoneally injected with 5-bromo-2'-deoxyuridine (BrdU). SHRSP were divided into acute and chronic phase groups after cerebral stroke. Brain sections from both groups were studied with cell-specific markers such as BrdU, a cell division and proliferation marker, sex-determining region Y-box 2, a marker of NSCs, nestin, an NSC and immature astrocyte marker, doublecortin, an immature new neuron marker, and neuron-specific nuclear protein, a marker of mature neurons. NSCs and new neurons appeared in the penumbra in the early stages after cerebral stroke, and these cells differentiated into mature neurons in the chronic phase. Furthermore, soon after being affected by a cerebral stroke, there were many new neurons and immature cells, which appear to be NSCs, in the ipsilateral SVZ. Immature cells and new neurons from the ipsilateral SVZ might migrate into the penumbra after cerebral stroke, and this is the first report of their observation after a spontaneous cerebral stroke.	[Itoh, Tatsuki; Satou, Takao; Takemori, Kumiko; Ito, Hiroyuki] Kinki Univ, Sch Med, Dept Pathol, Osaka 5898511, Japan; [Satou, Takao] Kinki Univ Hosp, Sch Med, Div Hosp Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ, Div Sports Med, Inst Life Sci, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Div Pathol, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp					Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dempsey RJ, 2003, J NEUROCHEM, V87, P586, DOI 10.1046/j.1471-4159.2003.02022.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Ishida H, 2006, AM J HYPERTENS, V19, P33, DOI 10.1016/j.amjhyper.2005.06.023; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Nakamura T, 2004, J NEUROTRAUM, V21, P1747, DOI 10.1089/neu.2004.21.1747; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Parent JM, 1997, J NEUROSCI, V17, P3727; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Stumm RK, 2002, J NEUROSCI, V22, P5865; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	40	8	11	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2010	41	1					55	65		10.1007/s12031-009-9279-3			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	573IH	WOS:000275905400008	19669942				2022-02-06	
J	De Deyne, CS				De Deyne, Cathy S.			Therapeutic hypothermia and traumatic brain injury	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						intracranial pressure; outcome; therapeutic hypothermia; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; MILD HYPOTHERMIA; RAPID INFUSION; PREHOSPITAL INDUCTION; GENE-EXPRESSION; CLINICAL-TRIAL; CARDIAC-ARREST; RAT; MANAGEMENT; 4-DEGREES-C	Purpose of review Therapeutic hypothermia after traumatic brain injury (TBI)? For the last 10 years, no topic has been more popular and more controversial among neurointensivists. This article reviews the most current findings (experimental, clinical, adult and pediatric TBI), as well as the clinical management of therapeutic hypothermia. Recent findings Despite ample experimental evidence, the clinical utility of therapeutic hypothermia has still to be conclusively demonstrated in terms of reduced mortality or improved functional recovery after TBI (even in pediatric TBI). Current findings support that hypothermia should be initiated as soon as possible, for at least 48 h duration, and that outcome is worse when barbiturates are part of ICU management. Currently, available cooling techniques, including prehospital cooling protocols, expand and improve clinical management of therapeutic hypothermia. Summary Taking into consideration all results from clinical hypothermia TBI studies discussion has to be focused around the possibility that a better outcome could be achieved if protocols for therapeutic hypothermia are reviewed. It is possible that the negative effects of the cooling and the rewarming procedure currently overshadow the neuroprotective effects.	[De Deyne, Cathy S.] ZOL, Dept Anesthesiol & Crit Care Med, B-3600 Genk, Belgium; [De Deyne, Cathy S.] Univ Hasselt, Fac Med, Hasselt, Belgium		De Deyne, CS (corresponding author), ZOL, Dept Anesthesiol & Crit Care Med, Schiepse Bos 6, B-3600 Genk, Belgium.	cathy.dedeyne@ZOL.be					Adelson PD, 2009, J NEUROTRAUM, V26, P429, DOI 10.1089/neu.2008.0571; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Arpino PA, 2008, PHARMACOTHERAPY, V28, P102, DOI 10.1592/phco.28.1.102; Badjatia N, 2006, NEUROLOGY, V66, P1739, DOI 10.1212/01.wnl.0000218166.54150.0a; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS26; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; Gressens P, 2008, BRAIN PATHOL, V18, P10, DOI 10.1111/j.1750-3639.2007.00095.x; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hayashi N, 2009, J NEUROTRAUM, V26, P445, DOI 10.1089/neu.2008.0648; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs S. E., COCHRANE DATABASE SY; Kamarainen A, 2008, RESUSCITATION, V76, P360, DOI 10.1016/j.resuscitation.2007.08.015; Kim F, 2005, CIRCULATION, V112, P715, DOI 10.1161/CIRCULATIONAHA.105.544528; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kobayashi MS, 2008, BRAIN RES REV, V58, P171, DOI 10.1016/j.brainresrev.2008.03.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mueller-Burke D, 2008, INT J DEV NEUROSCI, V26, P67, DOI 10.1016/j.ijdevneu.2007.08.015; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49; Ohta H, 2007, NEUROSCI RES, V57, P424, DOI 10.1016/j.neures.2006.12.002; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Saxena M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub2; Schulzke Sven M, 2007, BMC Pediatr, V7, P30; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Shimohata T, 2007, J CEREBR BLOOD F MET, V27, P1463, DOI 10.1038/sj.jcbfm.9600450; Shimohata T, 2007, STROKE, V38, P375, DOI 10.1161/01.STR.0000254616.78387.ee; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Trubel H, 2004, INTENS CARE MED, V30, P1829, DOI 10.1007/s00134-004-2350-1; Zhang H, 2008, NEUROL RES, V30, P332, DOI 10.1179/174313208X300279; Zhao H, 2007, J NEUROSURG, V107, P636, DOI 10.3171/JNS-07/09/0636	47	8	9	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2010	23	2					258	262		10.1097/ACO.0b013e328336ea44			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	572GZ	WOS:000275817300021	20090519				2022-02-06	
J	Donat, CK; Walter, B; Deuther-Conrad, W; Wenzel, B; Nieber, K; Bauer, R; Brust, P				Donat, C. K.; Walter, B.; Deuther-Conrad, W.; Wenzel, B.; Nieber, K.; Bauer, R.; Brust, P.			Alterations of cholinergic receptors and the vesicular acetylcholine transporter after lateral fluid percussion injury in newborn piglets	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						muscarinic; newborn pig; nicotinic; receptor; traumatic brain injury; vesicular transporter	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; PROTEIN-KINASE-C; RAT-BRAIN; BASAL FOREBRAIN; BLOOD-FLOW; HIPPOCAMPAL; PHOSPHORYLATION; EXPRESSION; SUBTYPES	Aims: Traumatic brain injury (TBI) is one of the leading causes of death and disability in children. Adult animal models of TBI showed cholinergic alterations. However, there is no comparable data on immature animals. Therefore, this study investigates cholinergic markers in a large animal model of juvenile TBI. Methods: Twenty-seven female newborn piglets were subjected to lateral fluid percussion (FP) injury and compared with 12 untreated animals. After 6 h, animals were sacrificed and the brains removed. The hemispheres ipsilateral to FP-TBI from seven piglets and corresponding hemispheres from six control animals were used for autoradiography. Receptor density was determined with [3H]epibatidine (nicotinic acetylcholine receptors) or [3H]QNB (muscarinic acetylcholine receptors). The density of the vesicular acetylcholine transporter (vAChT) was assessed with (-)-[3H]vesamicol. Cerebral blood flow was measured by coloured microsphere method. Results: Cerebral blood flow and brain oxygen delivery were transiently reduced early after FP-TBI (P < 0.05). TBI caused reductions of muscarinic acetylcholine receptor density (fmol/mg) in the basal forebrain (sham: 10797 +/- 1339, TBI: 8791 +/- 1031), while nicotinic acetylcholine receptor remained stable. Significant increases in vAChT density (fmol/mg) were observed in the basal forebrain (sham: 2347 +/- 171, TBI: 2884 +/- 544), putamen (sham: 2276 +/- 181, TBI: 2961 +/- 386), cortex (sham: 1928 +/- 262, TBI: 2377 +/- 294), thalamic areas (sham: 2133 +/- 272, TBI: 2659 +/- 413), hippocampus (sham: 2712 +/- 145, TBI: 3391 +/- 501) and hypothalamus (sham: 2659 +/- 139, TBI: 3084 +/- 304). Conclusions: Cholinergic markers are altered after mild-to-moderate TBI in the immature brain. Whereas the ACh receptors are stable in almost any brain region after TBI, vAChT expression increases after trauma at the employed severity of this specific trauma model.	[Donat, C. K.; Deuther-Conrad, W.; Wenzel, B.; Brust, P.] Inst Interdisciplinary Isotope Res, D-04318 Leipzig, Germany; [Walter, B.; Bauer, R.] Univ Jena, Inst Mol Cell Biol, Jena, Germany; [Walter, B.] Zentralklin Bad Berka, Dept Neurosurg, Bad Berka, Germany; [Nieber, K.] Univ Leipzig, Inst Pharm, Leipzig, Germany		Donat, CK (corresponding author), Inst Interdisciplinary Isotope Res, Permoserstr 15, D-04318 Leipzig, Germany.	donat@iif-leipzig.de	Deuther-Conrad, Winnie/B-7558-2015	Wenzel, Barbara/0000-0001-7390-3575; Deuther-Conrad, Winnie/0000-0003-3168-3062			Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; ARMSTEAD WM, 2009, 24 INT S CER BLOOD F, P185; BIEGON A, 1989, NEUROBIOL AGING, V10, P305, DOI 10.1016/0197-4580(89)90040-7; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; COYLE JT, 1976, BRAIN RES, V118, P429, DOI 10.1016/0006-8993(76)90310-3; Custers FGJ, 1997, EUR J PHARMACOL, V338, P177, DOI 10.1016/S0014-2999(97)81946-2; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Erb C, 2001, J NEUROCHEM, V77, P638, DOI 10.1046/j.1471-4159.2001.00287.x; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Gallyas F, 1979, Neurol Res, V1, P203; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; Hellstrom-Lindahl E, 2000, BEHAV BRAIN RES, V113, P159, DOI 10.1016/S0166-4328(00)00210-2; HORYLEE F, 1995, J NEUROSCI, V15, P6453; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kaufer D, 1999, CHEM-BIOL INTERACT, V119, P349, DOI 10.1016/S0009-2797(99)00046-0; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; LADINSKY H, 1972, J NEUROCHEM, V19, P1947, DOI 10.1111/j.1471-4159.1972.tb01483.x; Lauder JM, 1999, ENVIRON HEALTH PERSP, V107, P65, DOI 10.2307/3434473; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCREE RC, 1995, NEUROIMAGE, V2, P55, DOI 10.1006/nimg.1995.1008; Morley BJ, 2000, HEARING RES, V147, P104, DOI 10.1016/S0378-5955(00)00124-6; Orr-Urtreger A, 2000, J NEUROCHEM, V74, P2154, DOI 10.1046/j.1471-4159.2000.0742154.x; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; PERRY EK, 1986, CAN J NEUROL SCI, V13, P521; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Prado MAM, 2002, NEUROCHEM INT, V41, P291, DOI 10.1016/S0197-0186(02)00044-X; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; VANHOOFF COM, 1989, J NEUROSCI, V9, P3753; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037; WATSON M, 1986, J PHARMACOL EXP THER, V237, P419; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287	64	8	8	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0305-1846			NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	APR	2010	36	3					225	236		10.1111/j.1365-2990.2009.01050.x			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	574WJ	WOS:000276024600005	19889177				2022-02-06	
J	Fan, JY; Kirkness, C; Vicini, P; Burr, R; Mitchell, P				Fan, Jun-Yu; Kirkness, Catherine; Vicini, Paolo; Burr, Robert; Mitchell, Pamela			An Approach to Determining Intracranial Pressure Variability Capable of Predicting Decreased Intracranial Adaptive Capacity in Patients With Traumatic Brain Injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						traumatic brain injury; intracranial adaptive capacity; intracranial pressure; intracranial hypertension; disproportionate increase in intracranial pressure (DIICP); signal variability	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; INTENSIVE-CARE; VOLUME INDEX; HYPERTENSION; MANAGEMENT; WAVE; DISPLAY; ICP	Nurses caring for traumatic brain injury (TBI) patients with intracranial hypertension (ICH) recognize that patients whose intracranial adaptive capacity is reduced are susceptible to periods of disproportionate increase in intracranial pressure (DIICP) in response to a variety of stimuli. It is possible that DIICP signals potential secondary brain damage due to sustained or intermittent ICH. However, there are few clinically accessible intracranial pressure (ICP) measurement parameters that allow nurses and other critical care clinicians to identify patients at risk of DIICP. The purpose of this study was to investigate whether there are specific minute-to-minute trends in ICP variability during the first 48 hr of monitoring that might accurately predict DIICP in patients with severe TBI. A total of 38 patients with severe TBI were sampled from the data set of a randomized controlled trial testing bedside monitoring displays and cerebral perfusion pressure management in individuals with TBI or sub-arachnoid hemorrhage. The investigators retrospectively examined the rates of change (slope) in mean, standard deviation, and variance of ICP on a 1-min basis for 30 consecutive min prior to a specified DIICP event. There was a significantly increasing linear and quadratic slope in mean ICP prior to the development of DIICP, compared with the comparison data set (p < .05). It is feasible to display moving averages in modern bedside monitoring. Such an arrangement may be useful to provide visual displays that provide immediate clinically relevant information regarding the patients with decreased adaptive capacity and therefore increased risk of DIICP.	[Fan, Jun-Yu] Chang Gung Med Fdn, Linkou Branch, Chang Gung Inst Technol, Dept Nursing, Tao Yuan 333, Taiwan; [Vicini, Paolo] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Mitchell, Pamela] SPHCM, Sch Nursing, Dept Hlth Serv, Seattle, WA USA; [Mitchell, Pamela] Univ Washington, Ctr Hlth Sci Interprofess, Seattle, WA 98195 USA		Fan, JY (corresponding author), Chang Gung Med Fdn, Linkou Branch, Chang Gung Inst Technol, Dept Nursing, 261 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	jyfan@gw.cgit.edu.tw			National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR04901]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004901] Funding Source: NIH RePORTER	The study from which the data were obtained was funded by grant R01 NR04901 from the National Institute of Nursing Research to Pamela H. Mitchell and Catherine Kirkness, principal investigators.	Ackley B. J., 2006, NURSING DIAGNOSIS HD; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Fan JY, 2008, AM J CRIT CARE, V17, P545; Germon K, 1988, J Neurosci Nurs, V20, P344; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Jones PA, 2003, PHYSIOL MEAS, V24, P201, DOI 10.1088/0967-3334/24/1/315; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Kirkness CJ, 2006, AM J CRIT CARE, V15, P600; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; Lang E W, 1995, New Horiz, V3, P400; March K, 1990, J Neurosci Nurs, V22, P375; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MCGRAW CP, 1983, INTRACRANIAL PRESSUR, V5, P558; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Miller JD, 1972, INTRACRANIAL PRESSUR, P270; Mitchell P H, 1986, J Neurosci Nurs, V18, P170; MITCHELL PH, 1981, NURS RES, V30, P212; Mitchell PH, 2002, ACT NEUR S, V81, P163; MITCHELL PH, 1978, NURS RES, V27, P4; MITCHELL PH, 1986, NURS CLIN N AM, V21, P563; Muwaswes M, 1985, J Neurosurg Nurs, V17, P238; Rauch M E, 1990, J Neurosci Nurs, V22, P173; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Rising C J, 1993, J Neurosci Nurs, V25, P302; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; TSEMENTZIS SA, 1982, ACTA NEUROCHIR, V65, P153, DOI 10.1007/BF01405841; Yau Y, 2002, ACTA NEUROCHIR SUPPL, V81, P167	35	8	8	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	APR	2010	11	4					317	324		10.1177/1099800409349164			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	574NF	WOS:000275996100001	20338894	Green Accepted			2022-02-06	
J	Figaji, AA				Figaji, Anthony A.			Practical aspects of bedside cerebral hemodynamics monitoring in pediatric TBI	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Children; Cerebral blood flow; Cerebral; Autoregulation; Transcranial Doppler; Cerebral hemodynamics	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; SEVERE HEAD-INJURY; BLOOD-FLOW VELOCITY; CEREBROVASCULAR PRESSURE REACTIVITY; CARBON-DIOXIDE REACTIVITY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; TISSUE OXYGEN; COMPUTERIZED-TOMOGRAPHY	Disturbances in cerebral hemodynamics may have a profound influence on secondary injury after traumatic brain injury (TBI), and many therapies in the neurocritical care unit may adversely affect cerebral blood flow. However, the clinician is often unaware of this when it occurs because practical methods for monitoring cerebral hemodynamics by the bedside have been lacking. Current imaging studies only provide a snapshot of the brain at one point in time, giving limited information about a dynamic condition. This review will focus on key pathophysiological concepts required to understand changes in cerebral hemodynamics after TBI and the principles, potential benefits, and limitations of currently available bedside monitoring techniques, including transcranial Doppler, autoregulation, and local/regional cerebral blood flow.	[Figaji, Anthony A.] Red Cross Childrens Hosp, ZA-7700 Cape Town, South Africa; [Figaji, Anthony A.] Univ Cape Town, Sch Child & Adolescent Hlth, Div Neurosurg, ZA-7925 Cape Town, South Africa		Figaji, AA (corresponding author), Red Cross Childrens Hosp, 617 ICH Bldg,Klipfontein Rd, ZA-7700 Cape Town, South Africa.	Anthony.Figaji@uct.ac.za		Figaji, Anthony/0000-0002-3357-6490	National Research Foundation [GUN 2072790]	This work was supported in part by a grant from the South Africa-Swedish Links Program/National Research Foundation (GUN 2072790).	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BANDRES J, 1992, J NEUROSURG ANESTH, V4, P250, DOI 10.1097/00008506-199210000-00004; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Levis S, 1998, ACT NEUR S, V71, P174; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P483, DOI 10.1152/ajplegacy.1976.231.2.483; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; Minassian AT, 1998, J NEUROSURG, V88, P996, DOI 10.3171/jns.1998.88.6.0996; Monteiro LM, 2006, INTENS CARE MED, V32, P1937, DOI 10.1007/s00134-006-0353-9; Moreno J A, 2000, Neurosurg Focus, V8, pe8; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Myburgh JA, 1998, ACT NEUR S, V71, P19; NADVI SS, 1994, BRIT J NEUROSURG, V8, P573, DOI 10.3109/02688699409002950; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Ng SCP, 2002, ACT NEUR S, V81, P125; Ng SCP, 2000, ACT NEUR S, V76, P479; Nordstrom Carl-Henrik, 2006, Neurosurgery, V58, pE590; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; POPLE IK, 1991, EUR J PEDIATR SURG, V1, P27, DOI 10.1055/s-2008-1042534; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 1998, ACT NEUR S, V71, P233; SANKER P, 1991, CHILD NERV SYST, V7, P391, DOI 10.1007/BF00304204; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SOKRAB TEO, 1989, ACTA PHYSIOL SCAND, V137, P101, DOI 10.1111/j.1748-1716.1989.tb08725.x; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Splavski B, 2006, BRIT J NEUROSURG, V20, P386, DOI 10.1080/02688690601048104; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Thome C, 2001, J NEUROSURG, V95, P402, DOI 10.3171/jns.2001.95.3.0402; Tonnesen J, 2005, EXP PHYSIOL, V90, P349, DOI 10.1113/expphysiol.2004.029512; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; TUOR UI, 1986, AM J PHYSIOL, V251, pH824, DOI 10.1152/ajpheart.1986.251.4.H824; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F	89	8	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2010	26	4					431	439		10.1007/s00381-009-1036-y			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	568QI	WOS:000275537100005	19937247				2022-02-06	
J	He, XS; Yang, GT; Zhang, X; Fei, Z				He Xiaosheng; Yang Guitao; Zhang Xiang; Fei Zhou			A morphological study of diffuse axonal injury in a rat model by lateral head rotation trauma	ACTA NEUROLOGICA BELGICA			English	Article						Diffuse axonal injury (DAI); morphological study; animal model; NF68	CYTOSKELETAL CHANGES; BRAIN-INJURY; HUMANS	Morphology in diffuse axonal injury (DAI) by lateral head rotation was investigated. SD rats were divided into injury (n = 9) and sham (n = 3) groups. A device was used to produce lateral rotational acceleration of the rats' heads. At different survival times three rats were killed for light and electron microscopic examination of the brain tissue. Sagittal sections were made from medulla oblongata and immunolabelled for NF68. At post-traumatic 30 min, NF68 immunolabelling showed a small number of swollen and irregular axons. Ultrastructurally slightly-separated myelin lamellae and disorderly arranged neurofilaments occurred. At 2 and 24 h axonal damage became more severe. Increases in immunolabelled axonal swellings, disconnected axons and axonal retraction bulbs appeared. EM provided evidence of myelin separation, peri-axonal spaces, blank areas in axoplasm, loss of microtubules, peripheral accumulation of mitochondria and clumped neurofilaments for DAI. A tendency was noted for greater labelling with NF68 as axonal damage increased. The disorderly arrangement of NFs occurred at early stage of post-traumatic axonal changes.	[He Xiaosheng; Zhang Xiang; Fei Zhou] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; [Yang Guitao] Fourth Mil Med Univ, Dept Med Teaching & Res Adm, Xijing Hosp, Xian 710032, Peoples R China		He, XS (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 15 W Changle Rd, Xian 710032, Peoples R China.	hexiaos@fmmu.edu.cn			Shaanxi Provincial NSFC [2005C209]	This work was supported by the Shaanxi Provincial NSFC Grant (No. 2005C209). The authors acknowledge the assistance of Mr. Zhexi H in tissue preparation of the experimental animals.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BENNETT M, 1995, IRISH MED J, V88, P59; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; SLANZINSKI T, 1994, J NEUROSCI NURS, V26, P151; Xiao-Sheng H, 2004, J CLIN NEUROSCI, V11, P402, DOI 10.1016/j.jocn.2004.01.001	22	8	10	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	MAR	2010	110	1					49	56					8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600VV	WOS:000278017900006	20514926				2022-02-06	
J	Jia, JX; Yan, MJ; Lu, ZF; Sun, MM; He, JH; Xia, CL				Jia, Junxia; Yan, Meijuan; Lu, Zhifang; Sun, Maomin; He, Jianghong; Xia, Chunlin			Regulated expression of pancreatic triglyceride lipase after rat traumatic brain injury	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Pancreatic triglyceride lipase; Traumatic brain injury; Lipid metabolism; Western blot; Rat	FIBROBLAST GROWTH FACTOR-2; LIPOPROTEIN-LIPASE; REACTIVE ASTROCYTES; ENDOTHELIAL LIPASE; MOUSE-BRAIN; PROTEIN; INFLAMMATION; TRAFFICKING; NEURONS; DISEASE	Pancreatic triglyceride lipase (PTL), an enzyme of digestive system, plays very important roles in the digestion and absorption of lipids. However, its distribution and function in the central nervous system (CNS) remains unclear. In the present study, we mainly investigated the expression and cellular localization of PTL during traumatic brain injury (TBI). Western blot and RT-PCR analysis revealed that PTL was present in normal rat brain cortex. It gradually increased, reached a peak at the 3rd day after TBI, and then decreased. Double immunofluorescence staining showed that PTL was co-expressed with neuron, but had a few colocalizations in astrocytes. When TBI occurred in the rat cortex, the expression of PTL gradually increased, reached the peak at the 3rd day after TBI, and then decreased. Importantly, more PTL was colocalized with astrocytes, which is positive for proliferating cell nuclear antigen (PCNA). In addition, Western blot detection showed that the 3rd day post injury was not only the proliferation peak indicated by the elevated expression of PCNA, glial fibrillary acidic protein (GFAP) and cyclin D1, but also the apoptotic peak implied by the alteration of caspase-3 and bcl-2. These data suggested that PTL may be involved in the pathophysiology of TBI and PTL may be complicated after injury, more PTL was colocalized with astrocytes. Importantly, injury-induced expression of PTL was colabelled by proliferating cell nuclear antigen (proliferating cells marker), and the western blot for GFAP, PCNA and cyclin D1, showed that 3 days post injury was the proliferation peak, in coincidence to it, the protein level change of caspase-3 and bcl-2 revealed that the stage was peak of apoptotic too. These data suggested that PTL may be involved in the pathophysiology of TBI and that PTL may be implicated in the proliferation of astrocytes and the recovery of neurological outcomes. But the inherent mechanisms remained unknown. Further studies are needed to confirm the exact role of PTL after brain injury.	[Xia, Chunlin] Soochow Univ, Cytoneurobiol Unit, Suzhou 215123, Jiangsu, Peoples R China; Soochow Univ, Coll Med, Lab Aging & Nervous Dis, Suzhou 215123, Jiangsu, Peoples R China		Xia, CL (corresponding author), Soochow Univ, Cytoneurobiol Unit, 199 Ren Ai Rd,Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China.	xclcnb@suda.edu.cn	He, Jiang/AAF-5303-2020; yan, mei/AAA-1379-2022	He, Jiang/0000-0002-8286-9652; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772242]	This work was supported by National Natural Science Foundation of China ( Grant No. 30772242). The authors thank Dr Shen Aiguo and Dr Gao Shangfeng ( Medical College of Nantong University, Nantong, China) for their generous help.	Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Adibhatla RM, 2006, AAPS J, V8, pE314; Allen RT, 1997, J PHARMACOL TOX MET, V37, P215, DOI 10.1016/S1056-8719(97)00033-6; Baum L, 1999, AM J MED GENET, V88, P136, DOI 10.1002/(SICI)1096-8628(19990416)88:2<136::AID-AJMG8>3.0.CO;2-D; Baum L, 2000, MICROSC RES TECHNIQ, V50, P291, DOI 10.1002/1097-0029(20000815)50:4<291::AID-JEMT8>3.0.CO;2-L; Blain Jean-Francois, 2004, Expert Rev Neurother, V4, P823, DOI 10.1586/14737175.4.5.823; CHEN H, 1993, J NEUROL SCI, V118, P109, DOI 10.1016/0022-510X(93)90099-K; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Clarke WE, 2001, MOL CELL NEUROSCI, V17, P17, DOI 10.1006/mcne.2000.0920; Crenon I, 1998, PROTEIN ENG, V11, P135, DOI 10.1093/protein/11.2.135; DEREWENDA ZS, 1994, ADV PROTEIN CHEM, V45, P1; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Ebara T, 2009, PANCREAS, V38, P233, DOI 10.1097/MPA.0b013e3181771659; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Erhardt L, 1996, EUR HEART J, V17, P1781; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; He JH, 2009, MOL CELL BIOCHEM, V325, P159, DOI 10.1007/s11010-009-0030-8; Helmuth L, 2001, SCIENCE, V291, P569; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Liu L, 2000, EXP BRAIN RES, V131, P64, DOI 10.1007/s002219900273; LOGAN A, 1992, J NEUROSCI, V12, P3828; LORENT K, 1995, NEUROSCIENCE, V65, P1009, DOI 10.1016/0306-4522(94)00555-J; Lowe ME, 2002, J LIPID RES, V43, P2007, DOI 10.1194/jlr.R200012-JLR200; Marsan MA, 2000, J SYST ARCHITECT, V46, P105, DOI 10.1016/S1383-7621(98)00064-2; Mattson MP, 2005, NAT CELL BIOL, V7, P1045, DOI 10.1038/ncb1105-1045; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Paradis E, 2004, NEUROBIOL DIS, V15, P312, DOI 10.1016/j.nbd.2003.09.017; Paradis E, 2003, J BIOL CHEM, V278, P9698, DOI 10.1074/jbc.M208452200; PAYNE RM, 1994, AM J PHYSIOL, V266, pG914, DOI 10.1152/ajpgi.1994.266.5.G914; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sovic A, 2005, J NEUROCHEM, V94, P109, DOI 10.1111/j.1471-4159.2005.03175.x; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Vance JE, 2006, FEBS LETT, V580, P5518, DOI 10.1016/j.febslet.2006.06.008; VILARO S, 1990, BRAIN RES, V506, P249, DOI 10.1016/0006-8993(90)91258-I; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	48	8	8	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	FEB	2010	335	1-2					127	136		10.1007/s11010-009-0249-4			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	546LK	WOS:000273812100015	19760487				2022-02-06	
J	Foley, JA; Cantagallo, A; Della Sala, S; Logie, RH				Foley, Jennifer A.; Cantagallo, Anna; Della Sala, Sergio; Logie, Robert H.			Dual task performance and post traumatic brain injury	BRAIN INJURY			English	Article						Attention; assessment; neuropsychologist; neuropsychology; traumatic brain injury; behavior	CARD SORTING TEST; ATTENTIONAL DEFICITS; EXECUTIVE FUNCTIONS; DIVIDED ATTENTION; IMPAIRMENTS; MEMORY; INFORMATION; RETRIEVAL; SPEED; TRAIL	Primary objective: To determine if people with traumatic brain injury (TBI) display deficits in dual tasking ability. Research design: Observational and correlational research design used, to identify and describe the nature of dual task impairment in people with TBI. Methods and procedures: Eighty-six people with TBI were assessed using a new standardized paper-and-pencil assessment of dual tasking ability and a number of other neuropsychological tests assessing attention, executive functioning and memory. Main outcome and results: Twenty-three out of the 86 people with TBI (26.74%) performed below the cut-off for normal performance, suggesting that only one quarter of the TBI sample assessed had deficits in attentional control. Conclusions: Deficits in task co-ordination are not a necessary consequence of TBI.	[Foley, Jennifer A.; Della Sala, Sergio; Logie, Robert H.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JK, Midlothian, Scotland; [Cantagallo, Anna] Univ Ferrara, I-44100 Ferrara, Italy; [Cantagallo, Anna] Hosp Ferrara, Dept Neurosci Rehabil, Ferrara, Italy		Foley, JA (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, 7 George Sq, Edinburgh EH8 9JK, Midlothian, Scotland.	jfoley@ed.ac.uk	Logie, Robert H/C-6965-2009	Foley, Jennifer/0000-0001-5083-2823; Logie, Robert/0000-0003-4532-9312	Alzheimer's Society [AS-90-2007]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700704B] Funding Source: researchfish	We are grateful to Dr Nicoletta Beschin and Dr Francesca Tebaldi who assisted us in testing some of the TBI patients. This work has been funded by the grant AS-90-2007 awarded by the Alzheimer's Society to Sergio Della Sala and Robert H. Logie. Jennifer A. Foley is the appointed Research Fellow on this grant.	ALBERONI M, 1992, INT J GERIATR PSYCH, V7, P639, DOI 10.1002/gps.930070905; Alderman N, 1996, NEUROPSYCHOL REHABIL, V6, P161, DOI 10.1080/713755505; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A.D., 2007, COMMUNICATION 0913; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Belleville S, 1998, MEM COGNITION, V26, P572, DOI 10.3758/BF03201163; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Caltagirone C., 1995, ARCH PSICOL NEUROL P, V56, P461; Capitani E, 1997, NEUROPSYCHOL REHABIL, V7, P295, DOI 10.1080/713755543; Capitani E., 1994, B PSICOL APPL, V209, P47; Cocchini G, 2004, REV NEUROL-FRANCE, V160, P74, DOI 10.1016/S0035-3787(04)70849-8; DALLASALA S, ARCH CLIN NEUR UNPUB; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Garcia-Villamisar Domingo, 2002, Cogn Neuropsychiatry, V7, P63, DOI 10.1080/13546800143000140; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HALL KM, 1993, FUNCTIONAL ASSESSMEN; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Logie RH, 2004, NEUROPSYCHOLOGY, V18, P504, DOI 10.1037/0894-4105.18.3.504; Logie RH, 2007, CORTEX, V43, P159, DOI 10.1016/S0010-9452(08)70453-2; MacPherson SE, 2007, CORTEX, V43, P858, DOI 10.1016/S0010-9452(08)70685-3; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MEUDELL PR, 1994, CORTEX, V30, P159, DOI 10.1016/S0010-9452(13)80331-0; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RAVEN JC, 1941, BRIT J MED PSYCHOL, V150, P1938; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SALTHOUSE TA, 1984, MEM COGNITION, V12, P613, DOI 10.3758/BF03213350; SALTHOUSE TA, 1995, MEM COGNITION, V23, P59, DOI 10.3758/BF03210557; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P8; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058	45	8	8	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	6					851	858		10.3109/02699051003789278			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700007	20433283				2022-02-06	
J	Fuentes, A; McKay, C; Hay, C				Fuentes, Amanda; McKay, Cherisse; Hay, Christina			Cognitive reserve in paediatric traumatic brain injury: Relationship with neuropsychological outcome	BRAIN INJURY			English	Article						Traumatic brain injury; Pediatric; Cognitive reserve	PREMORBID INTELLIGENCE; HEAD-INJURY; DEVELOPMENTAL PLASTICITY; CHILDREN; PREDICTORS; CHILDHOOD; COMA; TERM	Primary objective: The current study examined the relationship between neuropsychological performance and cognitive reserve (as measured by word reading and vocabulary tasks) in children with TBI. Research design: Retrospective records analysis of the neuropsychological test results of 52 participants with medically documented traumatic brain injuries, ranging from 6-16 years of age. Main outcome and results: Indicators of cognitive reserve were not correlated with the majority of well-recognized neuropsychological measures. Conclusions: Although past research has found that verbal ability is a valid indicator of CR in adult populations, the present study found evidence against the validity of this traditional reserve proxy when applied to the paediatric population. These findings suggest one of two conclusions: (1) measures used to indicate CR in adult populations (word reading, vocabulary) are not valid indicators of cognitive reserve in paediatric populations; and/or (2) the measures themselves are valid, yet there is simply not a significant relationship between cognitive reserve and short-term (i.e. less than 6 months) neuropsychological outcome in paediatric TBI.	[Fuentes, Amanda] York Univ, Toronto, ON M3J 1P3, Canada; [McKay, Cherisse; Hay, Christina] Bloorview Kids Rehab, Toronto, ON, Canada		Fuentes, A (corresponding author), York Univ, Toronto, ON M3J 1P3, Canada.	amanda19@yorku.ca					Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BICLIAUKAS LA, 2007, COGNITIVE RESERVE TH, P131; Bigler ED, 2007, COGNITIVE RESERVE TH, P85; BOLL T, 1993, CHILDRENS CATEGORY T; CAPRON D, 2004, INTELLIGENCE, V32, P445; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; DENNIS M, 2007, COGNITIVE RESERVE TH, P53; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fridlund AJ, 1994, CALIFORNIA VERBAL LE; Heaton R.K., 1981, WISCONSIN CARD SORTI; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Manly JJ, 2003, J CLIN EXP NEUROPSYC, V25, P680, DOI 10.1076/jcen.25.5.680.14579; Manly T., 1999, TEST EVERYDAY ATTENT; Meyers JE., 1995, REY COMPLEX FIGURE T; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Richards M, 2005, ANN NEUROL, V58, P617, DOI 10.1002/ana.20637; Richards M, 2003, J CLIN EXP NEUROPSYC, V25, P614, DOI 10.1076/jcen.25.5.614.14581; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Stern Y., 2007, COGNITIVE RESERVE TH, P1; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Vanderploeg RD, 1998, PSYCHOL ASSESSMENT, V10, P277, DOI 10.1037/1040-3590.10.3.277; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2001, WECHSLER INDIVIDUAL; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	33	8	9	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	7-8					995	1002		10.3109/02699052.2010.489791			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000009	20515361				2022-02-06	
J	Guerra, SD; Carvalho, LFA; Affonseca, CA; Ferreira, AR; Freire, HBM				Guerra, Sergio Diniz; Andrade Carvalho, Luis Fernando; Affonseca, Carolina Araujo; Ferreira, Alexandre Rodrigues; Machado Freire, Heliane Brant			Factors associated with intracranial hypertension in children and teenagers who suffered severe head injuries	JORNAL DE PEDIATRIA			English	Article						Pediatric head injuries; pediatric traumatic brain injury; pediatric brain injury; intracranial hypertension	TRAUMATIC BRAIN-INJURY; PRESSURE; GUIDELINES; MANAGEMENT; EDEMA; SCORE; COMA; ICP	Objective: To analyze factors associated with intracranial hypertension in pediatric patients who suffered severe head injuries. Methods: Retrospective cohort study, with data collected from September 1998 through August 2003, including patients aged 0 to 16 who suffered severe head injuries, Glasgow score < 9, and submitted to intracranial pressure (ICP) monitoring (n = 132). Intracranial hypertension (IH) was defined as an episode of ICP > 20 mmHg requiring treatment, while refractory IH was ICP over 25 mmHg requiring barbiturates or decompressive craniectomy. Univariate analysis was followed by multivariate analysis; variables were considered significant if p < 0.05. Results: Ages ranged from 2 months to 16 years, median age 9.7 (6.0-2.3) years. Glasgow scores ranged from 3 to 8, median 6 (4-7). Traffic accidents were responsible for 79.5% of events. Monitoring devices were installed, on average, 14 hours after trauma, median time 24 hours. One hundred and three patients (78%) had IH, while 57 (43.2%) had refractory IH. In multivariate analysis, younger age ranges were associated with IH [relative risk = 1.67 (1.03-2.72); p = 0.037], and abnormal postures were associated with refractory IH [relative risk = 2.25 (1.06-4.78)]. The group mortality rate was 51.5%; it was correlated with use of barbiturates in refractory IH and low cerebral perfusion pressure at the intensive care unit. Conclusions: IH and refractory IH were frequent events in pediatric patients who suffered severe head injuries. The younger the patient, the greater the chance of developing IH. The presence of abnormal postures was found to be a risk factor for refractory IH.	[Ferreira, Alexandre Rodrigues; Machado Freire, Heliane Brant] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Guerra, Sergio Diniz] Fundacao Hosp Estado Minas Gerais FHEMIG, Hosp Joao 23, UTIP, Belo Horizonte, MG, Brazil; [Andrade Carvalho, Luis Fernando] Hosp Intantil Joao Paulo II, UTIP, FHEMIG, Belo Horizonte, MG, Brazil; [Affonseca, Carolina Araujo] Hosp Joao Paulo II, FHEMIG, Belo Horizonte, MG, Brazil		Guerra, SD (corresponding author), Rua Sao Domingos Prata,683-701 Sao Pedro, BR-30330110 Belo Horizonte, MG, Brazil.	dinizguerra@gmail.com.br	Ferreira, Alexandre Rodrigues/AAK-2601-2021; Solebo, Colette N/B-6615-2008	Ferreira, Alexandre Rodrigues/0000-0001-6749-8980; Solebo, Colette N/0000-0001-9764-2541			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP P, V7; BARCENA JP, 2002, MED INTENSIVA, V26, P407; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; Brain Trauma Foundation American Association of Neurological Surgeons Joint Section on Neurotrauma and Critical Care, 1996, J NEUROTRAUMA, V13, P641; BROWDER J, 1936, AM J SURG, V31, P403; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carvalho LB, 2005, THESIS U FEDERAL MIN; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Dantas VP, 2001, ARQ NEURO-PSIQUIAT, V59, P895, DOI 10.1590/S0004-282X2001000600011; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Guerra S D, 1999, J Pediatr (Rio J), V75 Suppl 2, pS279; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Ministerio da Saude, DATASUS; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001	30	8	10	0	1	SOC BRASIL PEDIATRIA	RIO DE JANEIRO, RJ	RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL	0021-7557			J PEDIAT-BRAZIL	J. Pediatr.	JAN-FEB	2010	86	1					73	79		10.2223/JPED.1960			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	566HX	WOS:000275361800013	20151089	Bronze			2022-02-06	
J	Hall, C; Sigford, B; Sayer, N				Hall, Carmen; Sigford, Barbara; Sayer, Nina			Practice Changes Associated with the Department of Veterans Affairs' Family Care Collaborative	JOURNAL OF GENERAL INTERNAL MEDICINE			English	Article						rehabilitation; family-centered care; veterans; collaborative; attitude of health personnel; patient care team; implementation evaluation; polytrauma; practice change	TRAUMATIC BRAIN-INJURY; QUALITY IMPROVEMENT COLLABORATIVES; ORGANIZATIONAL-CHANGE; COLLECTIVE EFFICACY; CENTERED CARE; MODEL; IMPLEMENTATION; REHABILITATION; DISABILITIES; MEDICINE	The Department of Veterans Affairs (VA) provides rehabilitation for veterans with moderate to severe war injuries through four regional Polytrauma Rehabilitation Centers (PRCs). To standardize and improve care provided to these veterans' family members, health services researchers partnered with program leaders and rehabilitation specialists to implement a family care quality improvement collaborative. To describe practice changes associated with the Family Care Collaborative's intervention. Cross-site, mixed-method evaluation. Rehabilitation interdisciplinary team members (n = 226) working at the four participating sites. The collaborative developed and implemented in a 6-month pilot a web-based tool to standardize and promote family-centered care. Provider survey of family care, satisfaction with family care, and perceived competence in working with families; specific practice changes at each site; provider and facilitator perceptions of the collaborative work; and a validated measure to predict likelihood of success of the selected intervention. Family-centered practices and satisfaction improved at sites with lower baseline scores (P < 0.05) and was equivalent across sites after the pilot. Providers initiated specific family-centered practices that often began at one site and spread to the others through the collaborative. Sites standardized family education and collaboration. Providers believed that the collaborative produced a "culture change" from patient-centered to family-centered care and viewed program leadership and health services researchers' involvement as crucial for success. Scores on the measure to predict successful implementation of the intervention beyond the pilot were promising. Collaboratives that bring together clinicians, program leaders, and researchers may be useful for fostering complex change involving interdisciplinary teams.	[Hall, Carmen; Sigford, Barbara; Sayer, Nina] VA Med Ctr, Ctr Chron Dis Outcomes Res 152 2E, Minneapolis, MN 55417 USA; [Sigford, Barbara; Sayer, Nina] Univ Minnesota, St Paul, MN USA		Hall, C (corresponding author), VA Med Ctr, Ctr Chron Dis Outcomes Res 152 2E, 1 Vet Dr, Minneapolis, MN 55417 USA.	carmen.hall@va.gov	Sayer, Nina/E-3249-2016		VA Health Services Research and Development Quality Enhancement Research Initiative (QUERI) Locally Initiated Project (LIP) [PLY 05-184-3]	This project was supported through a VA Health Services Research and Development Quality Enhancement Research Initiative (QUERI) Locally Initiated Project (LIP) (PLY 05-184-3). In addition, we would like to thank the Polytrauma Rehabilitation Center clinicians who participated in the collaborative; Amy Gravely, MS, who conducted the statistical analysis; and Nancy Rettmann, MS, who helped format the manuscript, both with the Minneapolis VA Center for Chronic Disease Outcomes Research. Last, we would like to acknowledge the developers of the Organizational Change Manager, David Gustafson, PhD, and Harry Steudel, PhD, from the University of Wisconsin, who provided consultation on the Organizational Change Manager.	*AM NURS ASS, 2003, FAM CTR CAR PUTT IT; Bamm EL, 2008, ARCH PHYS MED REHAB, V89, P1618, DOI 10.1016/j.apmr.2007.12.034; Bergeson SC, 2006, JAMA-J AM MED ASSOC, V296, P2848, DOI 10.1001/jama.296.23.2848; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; DANIELSON CB, 1993, HLTH ILLNESS PERSPEC; *DEP VET AFF OFF I, 2007, 0603671120 DEP VET A; *DEP VET AFF OFF I, 2006, 0501818165 VA OFF IN; Dunn MS, 2006, PEDIATRICS, V118, pS95, DOI 10.1542/peds.2006-0913F; Dunst C J, 1996, Pediatr Nurs, V22, P334; Dunst C. J., 1999, ENABLING EMPOWERING; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Grumbach K, 2004, JAMA-J AM MED ASSOC, V291, P1246, DOI 10.1001/jama.291.10.1246; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; GUSTAFSON DH, 1998, WHAT EVERYONE HLTH C; *I FAM CTR CAR, FREQ ASK QUEST; *I HLTH CAR IMPR, 2003, BREAKTHR SER IHIS CO; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Kilo C M, 1999, Pediatrics, V103, P384; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; Law M, 2003, CHILD CARE HLTH DEV, V29, P357, DOI 10.1046/j.1365-2214.2003.00351.x; LAW M, 2003, 18 MCMAST U CANCH CT; LAW M, 2003, 1 MCMAST U CANCH CTR; Levine C., 2004, ALWAYS CALL ILLNESS; Marks Jean P, 2006, J Neurosci Nurs, V38, P84; Molfenter T, 2005, HEALTH CARE MANAGE R, V30, P270, DOI 10.1097/00004010-200507000-00011; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; Olsson Jesper, 2007, J Health Organ Manag, V21, P283, DOI 10.1108/14777260710751744; Olsson Jesper A, 2003, Qual Manag Health Care, V12, P240; Ovretveit J, 2002, QUAL SAF HEALTH CARE, V11, P345, DOI 10.1136/qhc.11.4.345; Ovretveit J., 2002, INT J HLTH CARE QUAL, V15, P192, DOI DOI 10.1108/09526860210437403; Pearson ML, 2005, HEALTH SERV RES, V40, P978, DOI 10.1111/j.1475-6773.2005.00397.x; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; SHOLEVAR GP, 1990, GEN HOSP PSYCHIAT, V12, P363, DOI 10.1016/0163-8343(90)90003-U; Shortell SM, 2004, MED CARE, V42, P1040, DOI 10.1097/00005650-200411000-00002; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Stringer E.T., 1999, ACTION RES; Tasa K, 2005, ORGAN BEHAV HUM DEC, V96, P119, DOI 10.1016/j.obhdp.2005.01.002; Tasa K, 2007, J APPL PSYCHOL, V92, P17, DOI 10.1037/0021-9010.92.1.17; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025; Wagner EH, 2004, MED CARE, V42, P1037, DOI 10.1097/01.mlr.0000145875.60036.ed; Weihs K, 2002, FAM SYST HEALTH, V20, P7, DOI [10.1037/h0089481, DOI 10.1037/H0089481]; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85	45	8	8	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0884-8734			J GEN INTERN MED	J. Gen. Intern. Med.	JAN	2010	25			1			18	26		10.1007/s11606-009-1125-3			9	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; General & Internal Medicine	544OH	WOS:000273667000004	20077147	Green Published			2022-02-06	
J	Hoffman, SW; Shesko, K; Harrison, CR				Hoffman, Stuart W.; Shesko, Kristina; Harrison, Catherine R.			Enhanced neurorehabilitation techniques in the DVBIC Assisted Living Pilot Project	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; TAI-CHI-CHUAN; ENVIRONMENTAL ENRICHMENT; VIRTUAL-REALITY; HEAD-INJURY; REHABILITATION; PROGRAM; CORTISOL	Traumatic Brain Injury has been labeled the "silent epidemic" in our current wars. Both CBO and the RAND reports predict that the costs of these injuries will be both extensive and enduring. The projected costs are based not only upon the loss contribution of these warriors to our economy, but also the long-term medical and assistive care that will be needed to support these veterans for decades to come. Thus, the primary goal of the Assisted Living Pilot Project (ALPP) at the Defense and Veterans Brain Injury Center-Johnstown (DVBIC-J) is to promote the ability of the injured warrior to move from assisted living to living independently and to be self-supporting by providing a continuum of care. To accomplish this goal the DVBIC-J ALPP is providing full set of traditional services (physical, occupational, speech, psychological/cognitive, social/familial, vocational, and spiritual), along with "cutting-edge" rehabilitative treatment technologies. These cutting-edge therapies include transdisciplinary clinical consultations, interactive patient and family counseling, and telemedicine-teleconferencing for clinical evaluations and family/significant other care participation. These services will be available to those who require assisted living through their progression to community re-entry. The ALPP also serves as a vehicle for clinical trials to investigate the effects of an enriched environment (e. g., recreational therapies, massage, multisensory stimulation, etc.) on neurorehabilitation therapy, rural telemedicine for servicemembers with traumatic brain injury, and long-term outcome measures of those who have received neurorehabilitation services at the DVBIC-J site. DVBIC-J is also developing collaborative projects with universities and private industry to create an incubator for new rehabilitation technologies. The technologies that DVBIC-J will be focusing on will include assistive technologies (to assist cognitive, physical, and communicative impairments), virtual and augmented reality simulations (for both diagnosis and treatment of TBI and PTSD), and telecommunication technologies to improve rehabilitation services to those warriors that have returned to their homes in rural areas.	[Hoffman, Stuart W.; Shesko, Kristina] Henry M Jackson Fdn Advancement Mil Med Inc, Def & Vet Brain Injury Ctr Johnstown, DCoE, Johnstown, PA 15905 USA; [Harrison, Catherine R.] USAF, Res Lab, Wright Patterson AFB, OH USA		Hoffman, SW (corresponding author), Henry M Jackson Fdn Advancement Mil Med Inc, Def & Vet Brain Injury Ctr Johnstown, DCoE, 109 Sunray Dr, Johnstown, PA 15905 USA.	ELISABETH.MARTIN@us.army.mil					Abelson JL, 2005, ARCH GEN PSYCHIAT, V62, P668, DOI 10.1001/archpsyc.62.6.668; Allen K, 2002, PSYCHOSOM MED, V64, P727, DOI 10.1097/01.PSY.0000024236.11538.41; Anderson PL, 2001, B MENNINGER CLIN, V65, P78, DOI 10.1521/bumc.65.1.78.18713; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Badger F, 2004, J CLIN NURS, V13, P526, DOI 10.1111/j.1365-2702.2004.00912.x; Barker SB, 1998, PSYCHIATR SERV, V49, P797, DOI 10.1176/ps.49.6.797; BARNASON S, 1995, HEART LUNG, V24, P124, DOI 10.1016/S0147-9563(05)80007-X; BAUN MM, 1984, NURS RES, V33, P126; Braverman SE, 1999, BRAIN INJURY, V13, P405; Brunt D, 2002, INT J SOC PSYCHIATR, V48, P243, DOI 10.1177/002076402128783280; Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Chapko MK, 2009, J AGING HEALTH, V21, P208, DOI 10.1177/0898264308328930; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; *DEF MANP DAT CTR, 2009, DAT A A P D CAS MIL; *DEF MANP DAT CTR, 2009, DAT A A P D CAS CAT; *DEP MIL VET AFF, 2009, COMM PA; Ding D, 2003, ASSIST TECHNOL, V15, P89, DOI 10.1080/10400435.2003.10131892; Dromerick Alexander W, 2006, NeuroRx, V3, P428, DOI 10.1016/j.nurx.2006.07.004; Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0; Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063; FITZGERALD FT, 1986, WESTERN J MED, V144, P103; Fleminger S, 2003, BMJ-BRIT MED J, V327, P4, DOI 10.1136/bmj.327.7405.4; FRIEDMANN E, 1983, J NERV MENT DIS, V171, P461, DOI 10.1097/00005053-198308000-00002; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Gourlay D, 2000, INT J MED INFORM, V60, P255, DOI 10.1016/S1386-5056(00)00100-3; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Guihan M, 2009, J AGING HEALTH, V21, P172, DOI 10.1177/0898264308328926; Guttman G., 1985, P INT S HUMAN PET RE, P58; Hart L. A., 1987, Anthrozoos, V1, P41, DOI 10.2752/089279388787058696; Hedrick S, 2007, GERONTOLOGIST, V47, P365, DOI 10.1093/geront/47.3.365; Hedrick SC, 2009, J AGING HEALTH, V21, P190, DOI 10.1177/0898264308328929; HOLAHAN C, 1972, J ABNORM PSYCHOL, V80, P115, DOI 10.1037/h0033404; HOLAHAN CJ, 1973, J ABNORM PSYCHOL, V82, P454, DOI 10.1037/h0035391; Hotz GA, 2006, BRAIN INJURY, V20, P879, DOI 10.1080/02699050600832635; Hudson W. H., 1970, ENV PSYCHOL MAN HIS, P419; JACKSON RD, 1989, AM J PHYS MED REHAB, V68, P18, DOI 10.1097/00002060-198902000-00006; JIN P, 1989, J PSYCHOSOM RES, V33, P197, DOI 10.1016/0022-3999(89)90047-0; JIN PT, 1992, J PSYCHOSOM RES, V36, P361, DOI 10.1016/0022-3999(92)90072-A; Jones TA, 1999, J NEUROSCI, V19, P10153; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kinosian B, 2007, GERONTOLOGIST, V47, P356, DOI 10.1093/geront/47.3.356; Klintsova AY, 2002, BRAIN RES, V937, P83, DOI 10.1016/S0006-8993(02)02492-7; Klonoff P S, 1997, Appl Neuropsychol, V4, P107, DOI 10.1207/s15324826an0402_3; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Lambert TJ, 2005, NEUROBIOL LEARN MEM, V83, P206, DOI 10.1016/j.nlm.2004.12.001; Lee JH, 2003, CYBERPSYCHOL BEHAV, V6, P383, DOI 10.1089/109493103322278763; Li JX, 2001, BRIT J SPORT MED, V35, P148, DOI 10.1136/bjsm.35.3.148; MADER B, 1989, CHILD DEV, V60, P1529, DOI 10.1111/j.1467-8624.1989.tb04023.x; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Magee WL, 2005, NEUROPSYCHOL REHABIL, V15, P522, DOI 10.1080/09602010443000461; MANOSEVITZ M, 1975, J COMP PHYSIOL PSYCH, V89, P648, DOI 10.1037/h0077426; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morganti F, 2003, CYBERPSYCHOL BEHAV, V6, P421, DOI 10.1089/109493103322278817; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; OSMOND H, 1957, MENTAL HOSP, V8, P26; Perry N, 2006, CNS DRUGS, V20, P257, DOI 10.2165/00023210-200620040-00001; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRINCIPI AJ, 2004, COMMITTEE VETERANS A; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; ROSENZWEIG MR, 1972, J COMP PHYSIOL PSYCH, V79, P56, DOI 10.1037/h0032527; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Shapira MY, 2001, ARCH PHYS MED REHAB, V82, P1283, DOI 10.1053/apmr.2001.25152; SODERBACK I, 2004, PEDIAT REHABILITATIO, V8, P235; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tchiteya BM, 2003, PSYCHONEUROENDOCRINO, V28, P674, DOI 10.1016/S0306-4530(02)00050-1; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; *US BUR CENS, 2006, STAT ABSTR US 2004 2, P28; WIDMAN DR, 1990, PHYSIOL BEHAV, V47, P57, DOI 10.1016/0031-9384(90)90042-3; Wileman SM, 2001, BRIT J PSYCHIAT, V178, P311, DOI 10.1192/bjp.178.4.311; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; WILL BE, 1977, J COMP PHYSIOL PSYCH, V91, P33, DOI 10.1037/h0077306; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; WILSON CC, 1991, J NERV MENT DIS, V179, P482, DOI 10.1097/00005053-199108000-00006; Wolf SL, 1997, ARCH PHYS MED REHAB, V78, P886, DOI 10.1016/S0003-9993(97)90206-9; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; Zimring C., 1982, ADV ENVIRON PSYCHOL, VIV, P171	86	8	8	2	42	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	3					257	269		10.3233/NRE-2010-0561			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300009	20448315				2022-02-06	
J	Kubas, B; Lebkowski, W; Lebkowska, U; Kulak, W; Tarasow, E; Walecki, J				Kubas, Bozena; Lebkowski, Wojciech; Lebkowska, Urszula; Kulak, Wojciech; Tarasow, Eugeniusz; Walecki, Jerzy			Proton MR spectroscopy in mild traumatic brain injury	POLISH JOURNAL OF RADIOLOGY			English	Article						proton spectroscopy; mild brain injury; 1H-MRS		Background: To assess the role of 1H MRS in the detection of changes in cerebral metabolite levels in pyramidal tracts after mild traumatic brain injury (MTBI) and to compare metabolite alterations to the clinical status (Glasgow Coma Scale). Material/Methods: Study group consisted of 25 patients after mild traumatic brain injury, with a score of 11 to 15 in GCS. The MR studies were performed with a 1.5 T scanner. The results of spectra approximation (presented as metabolite ratios: NAA/Cr, NAA/Cho, Cho/Cr, lac/Cr, lip/Cr, Glx/Cr) were subjected to statistical analysis. MR spectra were recorded from a normal-appearing brain region: internal capsules and cerebral peduncles. Spectra from traumatic patients were compared with a control group including 34 healthy volunteers recorded with the same techniques. Results: The statistical analysis revealed significant differences between the data obtained from various brain regions of the same patients after an MTBI and between the study and the control group. Proton MR spectroscopy detects changes in cerebral metabolite levels in apparently normal regions. In pyramidal tracts (internal capsules, cerebral peduncles), we noticed a significant reduction of NAA/Cho, lip/Cr, lac/Cr and Glx/Cr. Conclusions: In patients with mild brain injury, we can detect some metabolite abnormalities in normal-appearing brain structures. Proton MRS is a very useful tool for evaluation of major changes in metabolite levels in pyramidal tracts after mild traumatic brain injury.	[Kubas, Bozena; Lebkowska, Urszula; Tarasow, Eugeniusz] Med Univ Bialystok, Radiol Dept, Bialystok, Poland; [Lebkowski, Wojciech] Med Univ Bialystok, Neurosurg Dept, Bialystok, Poland; [Kulak, Wojciech] Med Univ Bialystok, Pediat Rehabil Dept, Bialystok, Poland; [Walecki, Jerzy] Postgrad Med Ctr, Warsaw, Poland		Kubas, B (corresponding author), Med Univ Bialystok, Radiol Dept, Bialystok, Poland.	bozenakubas@interia.pl	Lebkowska, Urszula Maria/T-6521-2018; Kulak, Wojciech/T-4796-2018; Lebkowski, Wojciech/U-6092-2018	Lebkowska, Urszula Maria/0000-0001-6916-2081; WALECKI, JERZY/0000-0001-7494-7764; Kulak, Wojciech/0000-0003-1118-9139; Lebkowski, Wojciech/0000-0002-7685-6281			Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Holshouser BA, 2000, J MAGN RESON IMAGING, V11, P9, DOI 10.1002/(SICI)1522-2586(200001)11:1<9::AID-JMRI2>3.3.CO;2-Y; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Kubas B, 2006, NEURORADIOL J, V19, P699; Kulak W, 2004, NEUROSCI LETT, V363, P62, DOI 10.1016/j.neulet.2004.03.043; Kulak W, 2009, J CHILD NEUROL, V24, P73, DOI 10.1177/0883073808321058; Lee MA, 2000, ARCH NEUROL-CHICAGO, V57, P65, DOI 10.1001/archneur.57.1.65; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Son BC, 2000, ACT NEUR S, V76, P13; Walecki J, 2003, ACAD RADIOL, V10, P145, DOI 10.1016/S1076-6332(03)80038-7; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	21	8	9	0	0	INT SCIENTIFIC INFORMATION INC	SMITHTOWN	361 FOREST LN, SMITHTOWN, NY 11787 USA	0137-7183	1899-0967		POL J RADIOL	Pol. J. Radiol.		2010	75	4					7	10					4	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	VG1ZV	WOS:000445599400001	22802797				2022-02-06	
J	Li, ZM; Wang, LX; Jiang, LC; Zhu, JX; Geng, FY; Qiang, F				Li, Zhong-Min; Wang, Le-Xin; Jiang, Li-Cheng; Zhu, Jian-Xin; Geng, Feng-Yang; Qiang, Fu			Relationship between Plasma Cortisol Levels and Stress Ulcer following Acute and Severe Head Injury	MEDICAL PRINCIPLES AND PRACTICE			English	Article						Head injury; Stress ulcer; Cortisol	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; PROPHYLAXIS; RATS	Objective: This study was designed to investigate the relationship between plasma cortisol levels and stress ulcer following acute severe head injury. Patients and Methods: The plasma cortisol levels were prospectively measured by radioimmunoassay in 68 patients following acute head injury. The diagnosis of stress ulcer was based on clinical evidence and was confirmed by endoscopic examination. Results: Patients with stress ulcer and gastrointestinal bleeding (n = 30, 44.1%) were older than those without stress ulcer (38.2 +/- 7.9 vs. 28.3 +/- 9.7 years, p < 0.01). The combined rate of poor recovery and death in the stress ulcer patients (70.0%) was significantly higher than in the nonulcer patients (42.1%, p = 0.02). On each of the first 3 days following the head injury, the average plasma cortisol levels in the stress ulcer patients were higher than in the nonulcer patients (p < 0.01). Univariate analysis showed a positive relationship between plasma cortisol on admission and stress ulcer (r = 0.329, p = 0.01). Logistic regression analysis revealed that plasma cortisol levels on admission (OR = 2.326, 95% CI = 1.982-2.466) and age (OR = 1.064, 95% CI = 0.861-1.219) were independent predictors of stress ulcer. Conclusions: The data showed that acute severe head injury was associated with a significant increase in plasma cortisol. Plasma levels of cortisol and age were independent predictors of stress ulcer following acute head injury. Copyright (C) 2009 S. Karger AG, Basel	[Wang, Le-Xin] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia; [Li, Zhong-Min; Jiang, Li-Cheng; Zhu, Jian-Xin; Geng, Feng-Yang; Qiang, Fu] Liaocheng Peoples Hosp, Dept Neurosurg, Liaocheng, Peoples R China; [Li, Zhong-Min; Jiang, Li-Cheng; Zhu, Jian-Xin; Geng, Feng-Yang; Qiang, Fu] Taishan Med Univ, Liaocheng Clin Sch, Liaocheng, Peoples R China		Wang, LX (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.	lwang@csu.edu.au					Barletta JF, 2002, CRIT CARE, V6, P526, DOI 10.1186/cc1831; Bessey Palmer Q., 1997, P325; CHAN KH, 1995, J NEUROSURG, V82, P413, DOI 10.3171/jns.1995.82.3.0413; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; GITLIN N, 1988, ALIMENT PHARM THERAP, V2, P213; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; GUDEMAN SK, 1983, NEUROSURGERY, V12, P175, DOI 10.1227/00006123-198302000-00007; HOLLARAN LG, 1980, AM J SURG, V139, P44; Hsieh JS, 2006, J TRAUMA, V61, P873, DOI 10.1097/01.ta.0000195986.50315.4f; Hwang Shiuh-Lin, 1998, Kaohsiung Journal of Medical Sciences, V14, P554; KAMADA T, 1977, AM J GASTROENTEROL, V68, P249; KAMADA T, 1997, TRAUMA, V17, P44; Katagiri F, 2006, BIOMED PHARMACOTHER, V60, P109, DOI 10.1016/j.biopha.2006.01.004; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; MCARTHUR CJ, 1995, INTENS CARE MED, V21, P573, DOI 10.1007/BF01700162; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Venkatesh B, 1999, CRIT CARE MED, V27, P1175, DOI 10.1097/00003246-199906000-00047; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yelken B, 1999, ANESTH ANALG, V89, P159, DOI 10.1097/00000539-199907000-00028; YU MK, 1996, CHIN J TRAUMA, V12, P375	23	8	12	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-7571	1423-0151		MED PRIN PRACT	Med. Princ. Pract.		2010	19	1					17	21		10.1159/000252829			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530QP	WOS:000272607700003	19996614	gold			2022-02-06	
J	Livengood, M; Anderson, JW; Schmitter-Edgecombe, M				Livengood, Michelle; Anderson, Jonathan W.; Schmitter-Edgecombe, Maureen			Assessment of memory self-awareness following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; memory awareness; metamemory; metacognition	CLOSED-HEAD-INJURY; POSTTRAUMATIC AMNESIA; ECOLOGICAL VALIDITY; PRACTICAL SCALE; TEMPORAL-LOBE; FRONTAL-LOBE; METAMEMORY; DEFICITS; ACCURACY; ADULTS	Design and methods: Participants were 23 individuals with TBI and 23 controls matched on age, education and sex. Online assessment of memory was assessed by comparing the predicted amount of information participants expected that they would remember following trial 1, trial 5 and a 20-minute delay with actual memory performance on list-learning and visuospatial memory tests. Offline assessment of memory involved contrasting self-ratings provided by TBI participants about their everyday memory functioning with ratings from knowledgeable informants and with performance on objective memory tests. Results: Individuals with TBI displayed poorer recall for newly learned information than control participants, but no significant group differences emerged in the online assessment of memory self-awareness. The offline assessment comparisons similarly demonstrated that the individuals with TBI exhibited accurate awareness for their everyday memory performances. Conclusions: These findings suggest intact memory self-awareness following moderate-to-severe TBI during the early stages of recovery (2-10 months post-injury).	[Livengood, Michelle; Anderson, Jonathan W.] Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Anderson, JW (corresponding author), Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA.	janderson@ewu.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS47690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	This study was partially supported by grant # R01NS47690 from NINDS. We would like to thank Randi McDonald, Scott Creamer, Shital Pavawalla, Jennifer McWilliams, Michelle Nuegen, Matthew Wright and Ellen Woo for their support in coordinating data collection. We give an additional thanks to the participants and the members of the Head Injury Research Team for their assistance in gathering and scoring the data.	Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton AL, 1994, MULTILINGUAL APHASIA; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Bunnell JK, 1999, NEW ZEAL J PSYCHOL, V28, P23; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 1996, BRAIN INJURY, V10, P1; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GERMAN DJ, 1990, NATL COLL ED TEST AD; HERTZOG C, 1994, AGING COGNITION, V1, P203, DOI DOI 10.1080/13825589408256577; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; ISAACS B, 1972, Age and Ageing, V1, P222; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Lee GP, 1997, CLIN NEUROPSYCHOL, V11, P59, DOI 10.1080/13854049708407030; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Long C.J., 1995, ADV MED PSYCHOTHERAP, V8, P59; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Myers JL, 2003, RES DESIGN STAT ANAL, P736; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Perrotin A, 2007, NEUROPSYCHOLOGIA, V45, P2811, DOI 10.1016/j.neuropsychologia.2007.05.003; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PONSFORD JL, 1988, AUST PSYCHOL, V23, P349, DOI 10.1080/00050068808255617; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Schmitter-Edgecombe M, 2007, NEUROPSYCHOLOGY, V21, P224, DOI 10.1037/0894-4105.21.2.224; Smith A., 1991, SYMBOL DIGIT MODALIT; Souchay C, 2006, J CLIN EXP NEUROPSYC, V28, P828, DOI 10.1080/13803390591000846; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Tabachnick B.G., 2001, COMPUTER ASSISTED RE; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zachary R., 1991, SHIPLEY I LIVING SCA	55	8	8	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	4					598	608		10.3109/02699051003652815			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	570ML	WOS:000275682300004	20235762				2022-02-06	
J	Locklin, J; Bunn, L; Roy, E; Danckert, J				Locklin, Jason; Bunn, Lindsay; Roy, Eric; Danckert, James			Measuring Deficits in Visually Guided Action Post-Concussion	SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTERIZED COGNITIVE ASSESSMENT; 2ND IMPACT SYNDROME; CLOSED-HEAD INJURY; SPORTS; STABILITY; RECOVERY	Recent concussion research has led to the development of computerized test batteries designed to measure working memory and psychomotor speed deficits in acute stage post-concussion. These tests lack a measure of motor control deficits, which may linger well after other symptoms have remitted. For athletes, this may mean returning to play while still uncoordinated or neurologically fragile. The present research involved the development of a visuomotor pointing task designed to induce a speed-accuracy trade off to measure motor planning and execution performance in concussed athletes. Data collected using this tool were contrasted with CogSport, a commercially available computerized test battery designed to assess residual cognitive effects of concussion in athletes. Results suggest that a motor task may be able to detect long-term effects of concussion not measurable with CogSport. If future research can confirm these findings, we suggest that a measure of motor control may need to be added to existing batteries to improve their sensitivity to long term effects.	[Locklin, Jason; Bunn, Lindsay; Danckert, James] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Roy, Eric] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada		Danckert, J (corresponding author), Univ Waterloo, Dept Psychol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	jdancker@uwaterloo.ca			National Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair (Tier II)Canada Research Chairs	This work was supported by National Sciences and Engineering Research Council (NSERC) of Canada, and Canada Research Chair (Tier II) awards to James Danckert. The authors have no conflicts of interest that are directly relevant to the content of this study.	CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; HAGGARD P, 1995, J NEUROL NEUROSUR PS, V58, P433, DOI 10.1136/jnnp.58.4.433; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; STEENHUIS RE, 1989, CORTEX, V25, P289, DOI 10.1016/S0010-9452(89)80044-9	21	8	8	0	10	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.		2010	40	3					183	187		10.2165/11319440-000000000-00000			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	578LF	WOS:000276294400001	20199118				2022-02-06	
B	Morris, T		Armstrong, CL; Morrow, L		Morris, Terri			Traumatic Brain Injury	HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE			English	Article; Book Chapter							POSITRON-EMISSION-TOMOGRAPHY; CARD SORTING TEST; POSTTRAUMATIC AMNESIA; WORKING-MEMORY; EMOTION RECOGNITION; NATURALISTIC ACTION; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; FRONTAL LOBES; MILD		Widener Univ, Adjunct Fac Neuropsychol, Dept Clin Psychol, Chester, PA 19013 USA		Morris, T (corresponding author), Widener Univ, Adjunct Fac Neuropsychol, Dept Clin Psychol, Chester, PA 19013 USA.	tmorrisphd@verizon.net					Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Barcelo F, 2000, REV NEUROLOGIA, V30, P855, DOI 10.33588/rn.3009.99451; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 2007, IOWA GAMBLING TASK; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Benton A., 1994, CONTRIBUTIONS NEUROP; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; BLAIR JR, 2006, PSYCHOPATH; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; *BRAIN INJ ASS AM, TYP BRIAN INJ 2007; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Burgess P, 1996, BEHAV ASSESSMENT DYS; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; CHOW TW, 1999, SCI PRACT NEUROPSYCH, P3; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Delis D.C., 2001, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; GANNARELLI TA, 2005, TXB TRAUMATIC BRAIN, P27; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; GOLDBERG E, 1994, J COGNITIVE NEUROSCI, V6, P276, DOI 10.1162/jocn.1994.6.3.276; Goldberg E, 2005, PSYCHIAT CLIN N AM, V28, P567, DOI 10.1016/j.psc.2005.05.005; GOLDBERG E, 2001, EXECUTIVE BRAIN; Golden CJ, 1978, STROOP COLOR WORD TE; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GRONWALL D, 1991, NEUROPSYCHOLOGY, V5, P254; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HANNAY HJ, 2004, NEUROPSYCHOLOGICAL A, P157; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Heaton R.K., 1981, WISCONSIN CARD SORTI; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; HILLARY FG, 2003, BEHAV NEUROLOGY NEUR, P463; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lezak MD, 2003, BEHAV NEUROLOGY NEUR, P33; LUCAS JA, 1998, CLIN NEUROPSYCHOLOGY, P243; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malloy PF., 2002, FRONTAL SYSTEMS BEHA; MAREI MG, 1993, AFINIDAD, V50, P177; Marin RA, 2005, TXB TRAUMATIC BRAIN, P337; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; McAllister T., 2005, TXB TRAUMATIC BRAIN, P279; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCullagh S, 2005, TXB TRAUMATIC BRAIN, P321; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; *NIH CONS C REH PE, REH PERS TRAUM BRAIN; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Pelham M. F., 2005, TXB TRAUMATIC BRAIN, P159; Ptito A, 2007, NEUROREHABILITATION, V22, P217; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Ramsden CM, 2008, NEUROPSYCHOLOGY, V22, P17, DOI 10.1037/0894-4105.22.1.17; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schmidt M., 1996, REY AUDITORY VERBAL; SCHNIDER A, 1999, SCI PRACT NEUROPSYCH, P487; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; Segal, 2003, NATURALISTIC ACTION; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; TEASDALE G, 1974, LANCET, V2, P81; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; Varney N R, 1995, Appl Neuropsychol, V2, P47, DOI 10.1207/s15324826an0202_1; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108; Williams AD, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P113; Wolfson, 1993, HALSTEAD REITAN NEUR; Wood Jacqueline N, 2003, Behav Cogn Neurosci Rev, V2, P97	109	8	8	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-1363-0				2010							17	32		10.1007/978-1-4419-1364-7_2	10.1007/978-1-4419-1364-7		16	Medicine, General & Internal; Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology; Psychology	BQT44	WOS:000281792900002					2022-02-06	
J	Turner-Cobb, JM; Palmer, J; Aronson, D; Russell, L; Purnell, S; Osborn, M; Jessop, DS				Turner-Cobb, Julie M.; Palmer, Jenny; Aronson, D.; Russell, Louise; Purnell, Stephanie; Osborn, Michael; Jessop, David S.			Diurnal cortisol and coping responses in close relatives of persons with acquired brain injury: A longitudinal mixed methods study	BRAIN INJURY			English	Article						Salivary cortisol; stress; coping; social support; family	SALIVARY CORTISOL; BREAST-CANCER; HEAD-INJURY; CAREGIVER BURDEN; CHRONIC STRESS; FAMILY-MEMBERS; EVENT SCALE; CARERS; IMPACT; ADULTS	Objective: To examine the impact of having a close relative experience a severe brain injury. Design: Six-month longitudinal mixed methods concurrent embedded study. Quantitative data provided the primary database and qualitative data provided the secondary source. Methods: Assessment included psychosocial factors of perceived stress, traumatic stress symptoms, coping and social support in addition to salivary cortisol as a biological marker of stress. Written accounts of the experience were provided in response to an open-ended question. Participants composed 15 close relatives of adults with severe brain injury admitted to a specialist rehabilitation facility (mean age 49.4 years; SD 11.79). Assessments were conducted on admission, at 6 weeks, 3 months and 6 months post-admission. Results: Quantitative data revealed high traumatic stress at admission, with a non-significant decline at follow-up. Diurnal cortisol output declined significantly from baseline to all follow-up assessments. Coping sub-scales of acceptance and religion were repeated associated with cortisol indices at baseline, 6 weeks, 3 months and 6 months follow-up. Qualitative data revealed two themes; 'relational impact' and 'passage of time'. Conclusions: Findings offer the potential for effective and timely intervention in family members of persons with severe brain injury.	[Turner-Cobb, Julie M.; Palmer, Jenny] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Aronson, D.; Russell, Louise; Purnell, Stephanie] RNHRD, Brain Injury Unit, Bath, Avon, England; [Osborn, Michael] Royal United Hosp, Pain Clin, Bath BA1 3NG, Avon, England; [Jessop, David S.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England		Turner-Cobb, JM (corresponding author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.	pssjmtc@bath.ac.uk	Aronson, Doron/F-3390-2010				Abelson JL, 2008, BIOL PSYCHIAT, V64, P701, DOI 10.1016/j.biopsych.2008.05.007; Abercrombie HC, 2004, PSYCHONEUROENDOCRINO, V29, P1082, DOI 10.1016/j.psyneuen.2003.11.003; Anisman H, 2001, AM J PSYCHIAT, V158, P1509, DOI 10.1176/appi.ajp.158.9.1509; Blankfeld DF, 1999, PSYCHOL HEALTH, V14, P609, DOI 10.1080/08870449908410753; Bormann JE, 2009, J PSYCHOSOM RES, V66, P161, DOI 10.1016/j.jpsychores.2008.09.017; Bower JE, 2005, PSYCHONEUROENDOCRINO, V30, P92, DOI 10.1016/j.psyneuen.2004.06.003; Breakwell G.M., 2006, RES METHODS PSYCHOL; Carrico AW, 2006, J PSYCHOSOM RES, V61, P51, DOI 10.1016/j.jpsychores.2006.04.005; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Dedert EA, 2004, INT J PSYCHIAT MED, V34, P61, DOI 10.2190/2Y72-6H80-BW93-U0T6; *DOH, 2007, NAT SERV FRAM LONG T; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; FOLKMAN S, 1994, J CONSULT CLIN PSYCH, V62, P746, DOI 10.1037/0022-006X.62.4.746; FORMISANO R, 2003, ECOLOGIA MENTE, V26, P117; Glaser R, 1997, ANN BEHAV MED, V19, P78, DOI 10.1007/BF02883323; Gray DE, 2009, DOING RES REAL WORLD; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Ivankova NV, 2009, QUALITATIVE RESEARCH IN APPLIED LINGUISTICS: A PRACTICAL INTRODUCTION, P135; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jessop DS, 2001, J CLIN ENDOCR METAB, V86, P4109, DOI 10.1210/jc.86.9.4109; KAHN JP, 1988, BIOL PSYCHIAT, V23, P335, DOI 10.1016/0006-3223(88)90284-3; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kosciulek JF, 1997, REHABIL COUNS BULL, V41, P43; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Michaud K, 2008, STRESS, V11, P177, DOI 10.1080/10253890701727874; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; *NICE, 2007, 56 NICE; O'Donnell K, 2008, PSYCHONEUROENDOCRINO, V33, P601, DOI 10.1016/j.psyneuen.2008.01.015; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Smith JA, 2003, QUALITATIVE PSYCHOL, P53; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Tyerman A, 2001, NEUROREHABILITATION, V16, P59; Vedhara K, 1999, LANCET, V353, P627, DOI 10.1016/S0140-6736(98)06098-X; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; Yehuda R, 2005, AM J PSYCHIAT, V162, P998, DOI 10.1176/appi.ajp.162.5.998; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018	55	8	8	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	6					893	903		10.3109/02699051003789211			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700012	20433287	Green Accepted			2022-02-06	
J	Walker, AJ; Batchelor, J; Shores, EA; Jones, M				Walker, Alexandra J.; Batchelor, Jennifer; Shores, E. Arthur; Jones, Mike			Effects of cultural background on WAIS-III and WMS-III performances after moderate-severe traumatic brain injury	AUSTRALIAN PSYCHOLOGIST			English	Article						Bilingualism; multilingualism; cognitive disorders; cross-cultural psychology; memory and cognition; neuropsychology	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; AFRICAN-AMERICAN ACCULTURATION; DIGIT SPAN; LANGUAGE; TESTS; IQ; VARIABLES; ADULTS; SCALE; BIAS	The assessment of cognitive function in individuals of culturally and linguistically diverse background poses considerable challenges for the psychologist, particularly when English proficiency is limited. This study explored the effects of diverse cultural background and non-Western educational background on Wechsler Adult Intelligence Scale-Third edition (WAIS-III) and Wechsler Memory Scale-Third Edition (WMS-III) performances in moderate-severe traumatic brain injury within an outpatient rehabilitation setting. Participants were aged 16-65 years and met careful selection criteria. IQ, index and age-scaled subtest scores were compared across three groups: (a) English-speaking background (n=130), (b) culturally and linguistically diverse background and education completed in English (n=33), and (c) culturally and linguistically diverse background and non-English education (n=33). Cultural backgrounds included people of Asian, European, Middle Eastern, African and Oceania origin. Results were that the English-educated culturally and linguistically diverse group performed lower than the English-speaking background group on some verbal WAIS-III measures; effect sizes were small-moderate. The non-English-educated culturally and linguistically diverse group performed lower than both groups on several WAIS-III and one WMS-III measure, with large effect sizes. Clinical implications included the need for caution in interpreting test scores to avoid diagnostic errors and the need for further development of valid assessment tools.	[Walker, Alexandra J.] Westmead Hosp, Brain Injury Unit, Sydney, NSW 2145, Australia; [Walker, Alexandra J.; Batchelor, Jennifer; Shores, E. Arthur; Jones, Mike] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Walker, AJ (corresponding author), Westmead Hosp, Brain Injury Unit, POB 533, Sydney, NSW 2145, Australia.	awalker@biru.wsahs.nsw.gov.au	Jones, Michael/A-9013-2013	Jones, Michael/0000-0003-0565-4938; Shores, Edwin A/0000-0003-1553-5131; Batchelor, Jennifer/0000-0003-4438-4993			Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; ARDILA A, 1989, BRAIN COGNITION, V11, P147, DOI 10.1016/0278-2626(89)90015-8; Ardila A, 2001, J INT NEUROPSYCH SOC, V7, P510, DOI 10.1017/S1355617701004076; Australian Bureau of Statistics, 2008, YB AUSTR 2008; Babor TF, 2001, AUDIT ALCOHOL USE DI; Baird AD, 2007, ARCH CLIN NEUROPSYCH, V22, P309, DOI 10.1016/j.acn.2007.01.005; BARONA A, 1986, INT J CLIN NEUROPSYC, V8, P169; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800; Cantlon JF, 2007, TRENDS COGN SCI, V11, P1, DOI 10.1016/j.tics.2006.10.008; Carstairs JR, 2006, AUST PSYCHOL, V41, P48, DOI 10.1080/00050060500391878; COLEMANCAREW DNM, 2002, DISS ABSTR INT B, V63, P1557; Demsky YI, 1998, ASSESSMENT, V5, P115, DOI 10.1177/107319119800500202; Echemendia RJ, 2004, APPL NEUROPSYCHOL, V11, P4, DOI 10.1207/s15324826an1101_2; Echemendia RJ, 2007, ARCH CLIN NEUROPSYCH, V22, P271, DOI 10.1016/j.acn.2007.03.001; Fortuny LA, 1998, CLIN NEUROPSYCHOL, V12, P113; Fortuny LAI, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P66; Gavett B. E., 2005, J FORENSIC NEUROPSYC, V4, P49, DOI [10.1300/j151v04n02_05, DOI 10.1300/J151V04N02_05]; Harris J. G., 2003, CLIN INTERPRETATION, P343, DOI DOI 10.1016/B978-012703570-3/50015-8; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Iverson G. L., 2000, AM J FORENSIC PSYCH, V18, P63; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; KAUFMAN AS, 1988, J CLIN PSYCHOL, V44, P231, DOI 10.1002/1097-4679(198803)44:2<231::AID-JCLP2270440224>3.0.CO;2-J; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P184, DOI 10.1080/13854040590945283; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Miletic T, 2006, GUIDELINES WORKING E; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Nell V., 2000, CROSS CULTURAL NEURO; Ogden J. A., 2003, BRAIN IMPAIR, V4, P122, DOI [10.1375/brim.4.2.122.27026, DOI 10.1375/BRIM.4.2.122.27026]; Peat J., 2005, MED STAT GUIDE DATA; Petersson KM, 2001, SCAND J PSYCHOL, V42, P251, DOI 10.1111/1467-9450.00235; *PSYCH CORP, 2001, WECHSL TEST AD READ; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; REYNOLDS CR, 1987, J SCHOOL PSYCHOL, V25, P323, DOI 10.1016/0022-4405(87)90035-5; ROGOFF B, 1995, AM PSYCHOL, V50, P859; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Shepherd I, 1999, J INT NEUROPSYCH SOC, V5, P83, DOI 10.1017/S1355617799511119; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; ShuttleworthJordan AB, 1996, S AFR J PSYCHOL, V26, P96, DOI 10.1177/008124639602600205; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Steel Z, 2001, MED J AUSTRALIA, V175, P596, DOI 10.5694/j.1326-5377.2001.tb143741.x; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TOURADJI P, 2004, DISS ABSTR INT B, V64, P4640; VARGHESE D, 2005, DISS ABSTR INT B, V65, P5455; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; [No title captured]	59	8	8	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.		2010	45	2					112	122	PII 921352362	10.1080/00050060903428210			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	593WG	WOS:000277492300005					2022-02-06	
J	Wilson, BA				Wilson, Barbara A.			Brain injury: recovery and rehabilitation	WILEY INTERDISCIPLINARY REVIEWS-COGNITIVE SCIENCE			English	Article							COGNITIVE REHABILITATION; GENDER-DIFFERENCES; NEURAL PLASTICITY; THERAPY; SYSTEM; MEMORY; DAMAGE; NEUROREHABILITATION; PREDICTORS; CHILDHOOD	This paper discusses contributing factors relating to recovery and rehabilitation among patients who have sustained nonprogressive brain injury. Following a brief description of conditions observed in people with brain damage and their incidence and prevalence, the paper then focuses on survivors of traumatic brain injury (TBI), concentrating particularly on recovery and rehabilitation within this group. As recovery means different things to different people, the term is used here to mean partial recovery of function together with substitution of function. 1 Consideration is given to factors influencing recovery from TBI, particularly age, gender, and cognitive reserve. Mechanisms of recovery are also examined, particularly regeneration, diaschisis, and plasticity. Attention is then focused on rehabilitation, a process whereby survivors of brain injury are helped to attain their optimum level of functioning and return to their own most appropriate environments. Cognitive rehabilitation is typically aimed at helping people compensate for their difficulties. The need to treat cognitive, emotional, and psychosocial consequences of brain injury is recognized, and different approaches to rehabilitation are described together with the main changes seen in the past few years. Finally, evidence for the success of neuropsychological rehabilitation is presented. (C) 2009 John Wiley & Sons, Ltd. WIREs Cogn Sci 2010 1 108-118	MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England		Wilson, BA (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England.	barbara.wilson@mrc-cbu.cam.ac.uk					Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Baxter L, 2007, EPILEPSY BEHAV, V11, P454, DOI 10.1016/j.yebeh.2007.04.022; Bigler ED, 2007, COGNITIVE RESERVE TH; Butefisch CM, 2004, NEUROSCIENTIST, V10, P163, DOI 10.1177/1073858403262152; Carlomagno S, 1997, NEUROPSYCHOL REHABIL, V7, P311, DOI 10.1080/713755542; Cecatto RB, 2007, FUNCT NEUROL, V22, P137; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clare L, 2008, NEUROPSYCHOLOG REHAB, P1; Clare L., 2001, COGNITIVE REHABILITA; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Daisley A, 2009, HEAD INJURY FACTS; Dewar B, 2007, ENCEPHALITIS ASSESSM, P240; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; Farace E, 2000, Neurosurg Focus, V8, pe6; FINGER S, 1988, BRAIN INJURY RECOVER; Fish J, 2008, J INT NEUROPSYCH SOC, V14, P154, DOI 10.1017/S1355617708080120; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Forsyth RJ, 2001, ARCH DIS CHILD, V84, P200, DOI 10.1136/adc.84.3.200; Frith Colin, 2007, MAKING MIND BRAIN CR; Grady CL, 1999, COGNITIVE NEUROREHAB; Granerod J, 2007, NEUROPSYCHOL REHABIL, V17, P406, DOI 10.1080/09602010600989620; Halligan P.W., 2005, EFFECTIVENESS REHABI; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1990, REHABILITATION ADULT, P3; Johansson BB, 2007, J CEREBR BLOOD F MET, V27, P1417, DOI 10.1038/sj.jcbfm.9600486; Johnson David A, 2003, Pediatr Rehabil, V6, P103, DOI 10.1080/1363849031000166730; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Kapur N., 2004, ESSENTIAL HDB MEMORY, P301; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kolb B., 1995, BRAIN PLASTICITY BEH; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Laatsch L, 1997, BRAIN INJURY, V11, P851; Laatsch LK, 2004, BRAIN INJURY, V18, P957, DOI 10.1080/02699050410001672369; Levin HS, 2006, ARCH PHYS MED REHAB, V87, pS1, DOI 10.1016/j.apmr.2006.09.010; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lindgren M, 1997, J CLIN EXP NEUROPSYC, V19, P772, DOI 10.1080/01688639708403759; Logan A, 2007, PROG GROWTH FACTOR R, V5, P379; [马杰 Ma J], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P2932; Markus H., 2008, MEDICINE, V36, P586, DOI [10.1016/j.mpmed.2008.08.009, DOI 10.1016/J.MPMED.2008.08.009]; MARSHALL JF, 1985, INT REV NEUROBIOL, V26, P201, DOI 10.1016/S0074-7742(08)60075-6; McLellan D.L., 1991, CLIN NEUROLOGY; McMillan TM, 1999, NEUROPSYCHOL REHABIL, V9, P241, DOI 10.1080/096020199389356; MILLER E, 1984, RECOVERY MANAGEMENT; MILLIMAN JF, 1990, RES PERS H, V2, P21; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Montour-Proulx I, 2004, J CHILD NEUROL, V19, P935, DOI 10.1177/08830738040190120501; Mosch SC, 2005, COGN BEHAV NEUROL, V18, P5, DOI 10.1097/01.wnn.0000152207.80819.3c; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1995, HDB MEMORY DISORDERS; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Robertson IH, 2002, J NEUROL NEUROSUR PS, V73, P357, DOI 10.1136/jnnp.73.4.357; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schutz LE, 2007, J HEAD TRAUMA REHAB, V22, P48, DOI 10.1097/00001199-200701000-00006; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stern Y, 2007, COGNITIVE RESERVE TH; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Taupin P, 2006, RESTOR NEUROL NEUROS, V24, P9; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; von Monakow C., 1914, LOKALISATION GROSSHI; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Whyte J, 1990, REHABILITATION ADULT, P79; Wilson B, 2009, MEMORY REHABILITATIO; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 2008, APPL NEUROPSYCHOL, V15, P229, DOI 10.1080/09084280802325017; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	84	8	8	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-5078	1939-5086		WIRES COGN SCI	Wiley Interdiscip. Rev.-Cogn. Sci.	JAN-FEB	2010	1	1					108	118		10.1002/wcs.15			11	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	863NM	WOS:000298171200014	26272844				2022-02-06	
J	Gupta, A; Kumar, NK				Gupta, Ashum; Kumar, Natasha Khullar			Indian adaptation of the Cognistat : Psychometric properties of a cognitive screening tool for patients of traumatic brain injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Cognistat; Indian Adaptation; Traumatic Brain Injury		The present study was aimed at adapting the cognitive screening tool 'Cognistat' (Neurobehavioral Cognitive Status Exam) for use with the Indian community. As a part of the Indian adaptation of the test, the 'screen and metric' approach of assessment was eliminated. However, the screening item of the construction sub-test has been retained as a separate sub-test for evaluating immediate visual memory. Culturally irrelevant test items were identified under the, repetition, naming, memory, similarities and judgment sub-tests. Changes were made to these items on the basis of recommendation of 7 psychologists of Indian origin. The psychometric properties of the scale were evaluated in a sample of 30 patients with Traumatic Brain Injury (TBI) and 55 demographically matched healthy controls. The internal consistency of the test was high (Cronbach's alpha = 0.94). The test was found to have acceptable inter-rater and test-retest reliability. The concurrent validity of the test was established by comparing the performance of patients on MMSE and sub-tests of the Indian adaptation of Cognistat The test was found to have high discriminative validity as there was a significant difference in the performance of patients and controls on all subtests (p<.001). The adaptation of Cognistat provides the Indian population with a highly valuable cognitive screening tool.	[Gupta, Ashum; Kumar, Natasha Khullar] Univ Delhi, Dept Psychol, Delhi 110007, India		Gupta, A (corresponding author), C-31 29-31 Probyn Rd,Delhi Univ Flats,Mall Rd, Delhi, India.	dr_ashumgupta@yahoo.com					Anastasi A., 1988, PSYCHOL TESTING; Bigler E. D., 1984, DIAGNOSTIC CLIN NEUR; Brodaty H, 1998, ALZ DIS ASSOC DIS, V12, P1, DOI 10.1097/00002093-199803000-00001; Cammermeyer M, 1997, J Neurosci Nurs, V29, P163; Chan CCH, 2002, BRAIN INJURY, V16, P873, DOI 10.1080/02699050210131975; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Doninger NA, 2003, REHABIL PSYCHOL, V48, P67, DOI 10.1037/0090-5550.48.2.67; Drane DL, 1997, ARCH CLIN NEUROPSYCH, V12, P139, DOI 10.1016/S0887-6177(96)00057-1; Fladby T, 1999, J GERIATR PSYCH NEUR, V12, P16, DOI 10.1177/089198879901200105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fountoulakis KN, 1998, DEMENT GERIATR COGN, V9, P329, DOI 10.1159/000017085; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; Horton AM, 2002, INT J NEUROSCI, V112, P225, DOI 10.1080/00207450212021; JACOBS DM, 1997, J INT NEUROPSYCH SOC, V4, P531; Kaplan E., 1987, MANUAL CALIFORNIA VE; Kay J., 1992, PSYCHOLINGUISTIC ASS; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kong C, 2005, BRAIN INJURY, V19, P55; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lichtenberg PA, 1998, CLIN NEUROPSYCHOL, V12, P146, DOI 10.1076/clin.12.2.146.2010; LOGUE PE, 1993, J CLIN PSYCHOL, V49, P80, DOI 10.1002/1097-4679(199301)49:1<80::AID-JCLP2270490111>3.0.CO;2-Z; Man DWK, 2006, BRAIN INJURY, V20, P205, DOI 10.1080/02699050500454621; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Margolin DI, 1991, P M AM NEUR ASS SEAT; MCCALL RB, 1994, FUNDAMENTAL STAT BEH; MITRUSHINA M, 1994, HOSP COMMUNITY PSYCH, V45, P252; Moorthi S, 1999, BRAIN INJURY, V13, P139, DOI 10.1080/026990599121809; Moroney JT, 1996, J AM GERIATR SOC, V44, P1410, DOI 10.1111/j.1532-5415.1996.tb01424.x; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; Northern California Neurobehavioral Group, 1995, COGN NEUR COGN STAT; Oehlert ME, 1997, J CLIN PSYCHOL, V53, P733, DOI 10.1002/(SICI)1097-4679(199711)53:7<733::AID-JCLP11>3.0.CO;2-M; Roper BL, 1996, NEUROPSY NEUROPSY BE, V9, P54; SABE L, 1993, BEHAV NEUROL, V6, P207, DOI 10.3233/BEN-1993-6405; Salmon DP, 2001, CLIN GERIATR MED, V17, P229, DOI 10.1016/S0749-0690(05)70067-7; Sankla SK, 1998, P 7 NAT NEUR C IND; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Schrimsher GW, 2005, J CLIN EXP NEUROPSYC, V27, P873, DOI 10.1080/13803390490919173; Spreen O., 2003, ASSESSMENT APHASIA; Strub R, 2000, MENTAL STATUS EXAMIN; Sudarsanan S, 2007, Med J Armed Forces India, V63, P259, DOI 10.1016/S0377-1237(07)80150-X; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; TEASDALE G, 1974, LANCET, V2, P81; Turner-Strokes L., 2003, ROYAL COLL PHYS BRIT; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P29, DOI 10.1076/jcen.21.1.29.939; Wallace JJ, 2000, BRAIN INJURY, V14, P63, DOI 10.1080/026990500120934; Wallesch CW, 2003, HDB CLIN NEUROPSYCHO; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; Zinn S, 2003, ADDICT BEHAV, V28, P837, DOI 10.1016/S0306-4603(02)00258-7	49	8	8	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2009	6	2					123	132		10.1016/S0973-0508(09)80006-3			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M1F	WOS:000218380600006		Bronze			2022-02-06	
J	Steencken, AC; Siebert, JR; Stelzner, DJ				Steencken, Amanda Conta; Siebert, Justin R.; Stelzner, Dennis J.			Lack of Axonal Sprouting of Spared Propriospinal Fibers Caudal to Spinal Contusion Injury Is Attributed to Chronic Axonopathy	JOURNAL OF NEUROTRAUMA			English	Article						anterograde tracing; axonal transport; fluororuby; long descending propriospinal tract; WGA-HRP	TRAUMATIC BRAIN-INJURY; SCHWANN-CELL GRAFTS; CORD-INJURY; HORSERADISH-PEROXIDASE; AXOLEMMAL PERMEABILITY; FUNCTIONAL RECOVERY; CYCLOSPORINE-A; TRACT NEURONS; RAT; REGENERATION	We have previously shown that a small percentage of long descending propriospinal tract (LDPT) axons are spared, whereas few short thoracic propriospinal (TPS) fibers survive 2 weeks following severe (50mm weight drop) low thoracic spinal cord contusion injury (SCI). Here, we extended those findings to a moderate (25mm weight drop) T9 SCI and assessed the effects of this lesion severity on propriospinal tract fibers at different time periods after injury. We anterogradely labeled fibers with fluororuby (FR) or WGA-HRP to determine their location and number 2, 4, 6, and 16 weeks post-SCI. Findings were compared with non-injured controls. At chronic time points, surviving FR-labeled LDPT fibers rostral to the injury remained as reactive endings or as putative regenerative sprouts. Caudal to the injury, spared LDPT fibers ran along a rim of lateral and ventral white matter, and ended as small abnormal-appearing putative terminal boutons or reactive endings within the intermediate gray matter of lumbosacral cord, with little axonal arborization and no evidence of injury-induced sprouting. One striking difference in the WGA-HRP experimental operates was the increased density of labeling of spared axons within the white matter caudal to the injury compared to controls. This labeling pattern was reminiscent of the labeling found after axotomy in studies by others, and raises a question as to contusion injury-induced impaired axonal transport. We hypothesize that axonal sprouting of axons after partial spinal cord injury seen in previous investigations was not found in the present investigation because of the additional pathological effects of contusion injury, similar to what is observed after traumatic brain injury.	[Siebert, Justin R.; Stelzner, Dennis J.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Coll Grad Studies, Syracuse, NY 13210 USA; [Steencken, Amanda Conta; Stelzner, Dennis J.] SUNY Upstate Med Univ, Neurosci Program, Syracuse, NY 13210 USA		Stelzner, DJ (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Coll Grad Studies, 750 E Adams St, Syracuse, NY 13210 USA.	stelzned@upstate.edu			New York State Spinal Cord Injury Research Trust Fund [C020931, C022065]	We would like to thank Mrs. Grazyna Rygiel for excellent assistance with immunohistology and axonal density fraction analysis. We thank Dr. A. Sobel for the rabbit polyclonal anti-SCG-10 antibody. The New York State Spinal Cord Injury Research Trust Fund (contract C020931 and C022065) supported this work.	Andrews MR, 2007, J NEUROTRAUM, V24, P1773, DOI 10.1089/neu.2007.0353; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BARILARI MG, 1969, BRAIN RES, V14, P321; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Beattie MS, 2000, PROG BRAIN RES, V128, P9; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; BUNGE RP, 1993, ADV NEUROL, V59, P75; CAJAL R, 1928, DEGENERATION REGENER, P452; Conta AC, 2004, J COMP NEUROL, V479, P347, DOI 10.1002/cne.20319; Conta AC, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P180, DOI 10.1016/B978-0-12-374247-6.50016-X; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DELWAIDE PJ, 1977, J NEUROL NEUROSUR PS, V40, P616, DOI 10.1136/jnnp.40.6.616; Dent LJB, 1996, J COMP NEUROL, V372, P435; EDWARDS SB, 1974, PHARMACOL BIOCHEM BE, V2, P111, DOI 10.1016/0091-3057(74)90142-7; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; Guest JD, 1997, J NEUROSCI RES, V50, P888, DOI 10.1002/(SICI)1097-4547(19971201)50:5<888::AID-JNR24>3.0.CO;2-W; Hall E D, 2001, J Spinal Cord Med, V24, P142; Hayes KC, 1997, J NEUROTRAUM, V14, P235, DOI 10.1089/neu.1997.14.235; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; HOULE JD, 1991, EXP NEUROL, V113, P1, DOI 10.1016/0014-4886(91)90139-4; Howard CV, 1998, 3 DIMENSIONAL MEASUR; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kocsis JD, 2009, NEUROSCI LETT, V456, P137, DOI 10.1016/j.neulet.2008.08.093; LAHR SP, 1990, J COMP NEUROL, V293, P377, DOI 10.1002/cne.902930305; Lepore AC, 2005, BRAIN RES, V1045, P206, DOI 10.1016/j.brainres.2005.03.050; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Liu X, 2006, J NEUROSCI, V26, P3087, DOI 10.1523/JNEUROSCI.4797-05.2006; Lopez-Vales R, 2005, J NEUROSCI RES, V81, P827, DOI 10.1002/jnr.20605; Madsen JR, 1998, EXP NEUROL, V154, P673, DOI 10.1006/exnr.1998.6974; MATSUSHITA M, 1979, J COMP NEUROL, V184, P63, DOI 10.1002/cne.901840105; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 1999, ACT NEUR S, V73, P15; PRENDERGAST J, 1976, J COMP NEUROL, V166, P145, DOI 10.1002/cne.901660203; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Ramon S, 1997, SPINAL CORD, V35, P664, DOI 10.1038/sj.sc.3100490; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Sasaki M, 2007, PROG BRAIN RES, V161, P419, DOI 10.1016/S0079-6123(06)61030-3; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Stelzner DJ, 2008, NAT MED, V14, P19, DOI 10.1038/nm0108-19; STELZNER DJ, 1991, EXP NEUROL, V114, P193, DOI 10.1016/0014-4886(91)90036-C; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VASILENKO DA, 1975, BRAIN RES, V93, P502, DOI 10.1016/0006-8993(75)90189-4; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353; YEZIERSKI RP, 1980, EXP NEUROL, V69, P493, DOI 10.1016/0014-4886(80)90047-3; Young W, 2002, PROG BRAIN RES, V137, P231; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287	81	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2279	2297		10.1089/neu.2009.0934			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200015	19645528				2022-02-06	
